Psyllid ID: psy5539
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 653 | 2.2.26 [Sep-21-2011] | |||||||
| Q9V6K3 | 724 | Tyrosine-protein kinase t | yes | N/A | 0.911 | 0.821 | 0.534 | 0.0 | |
| Q8AXY6 | 947 | Muscle, skeletal receptor | yes | N/A | 0.934 | 0.644 | 0.490 | 1e-170 | |
| Q61006 | 868 | Muscle, skeletal receptor | yes | N/A | 0.557 | 0.419 | 0.548 | 1e-113 | |
| O15146 | 869 | Muscle, skeletal receptor | no | N/A | 0.542 | 0.407 | 0.555 | 1e-112 | |
| Q62838 | 868 | Muscle, skeletal receptor | yes | N/A | 0.557 | 0.419 | 0.546 | 1e-112 | |
| Q9Z139 | 937 | Tyrosine-protein kinase t | no | N/A | 0.886 | 0.617 | 0.357 | 1e-107 | |
| Q01973 | 937 | Tyrosine-protein kinase t | no | N/A | 0.883 | 0.615 | 0.358 | 1e-106 | |
| Q01974 | 943 | Tyrosine-protein kinase t | no | N/A | 0.859 | 0.594 | 0.329 | 8e-95 | |
| Q9Z138 | 944 | Tyrosine-protein kinase t | no | N/A | 0.863 | 0.597 | 0.327 | 4e-94 | |
| Q24488 | 685 | Tyrosine-protein kinase t | no | N/A | 0.673 | 0.642 | 0.362 | 1e-80 |
| >sp|Q9V6K3|ROR2_DROME Tyrosine-protein kinase transmembrane receptor Ror2 OS=Drosophila melanogaster GN=Nrk PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 704 bits (1818), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 349/653 (53%), Positives = 440/653 (67%), Gaps = 58/653 (8%)
Query: 33 GYCSQYNGKICKNYLNRTGRVWFNSSLES-AGGDLNEQIVMALWKEMIAILANPCKQAAE 91
GYC+ Y+GK+CK YL TG+VW+ SLE GG NEQ+ ALW E+I+ L C++AAE
Sbjct: 68 GYCAPYSGKVCKEYL--TGQVWY--SLEDPTGGWKNEQVTTALWDELISDLTGLCREAAE 123
Query: 92 KLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFE 151
K+LC YAFP C G + PLC+EDC A FCYNDW IEE K R + KSRGHF
Sbjct: 124 KMLCAYAFPNCHMEGGRAVKAPLCFEDCQATHLQFCYNDWVLIEEKKERNMFIKSRGHFR 183
Query: 152 LPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRW 211
LPNC +LP Y +P CS+ LTE+K E++YDC G GRFY GT+N + G+ CQRW
Sbjct: 184 LPNCSSLPHYNASMRRPNCSYIGLTELKESEVSYDCRNGNGRFYMGTMNVSKSGIPCQRW 243
Query: 212 DAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQD 271
D + PH H +PP VF +L ENYCRNAGGEEP PWCYT+D +VRWQ C+IP C D +
Sbjct: 244 DTQYPHKHFQPPLVFHQLLEGENYCRNAGGEEPHPWCYTVDESVRWQHCDIPMCPDYVDP 303
Query: 272 DVKSWGNKIKALLEQFLSQPYFIVLAVI-FIPVASMLCLICVVCVIRLVKRNVDYAPAPS 330
+ IK +E+F + +LA I F+ + ++ +I +V + K A A +
Sbjct: 304 NAVDLNTPIK--MEKFFTPSMIFLLAGIGFVAIVTLHLMILLVYKLSKHKDYSQPAGAAT 361
Query: 331 QDVNIDL-----------------------------SKLPCNASYHQ-----------TD 350
+ ++ + + A+ H +D
Sbjct: 362 AECSVSMRGGGDCGGNLNTSRETLGGNGNTNTLAKWGTIRSTATIHSNCVALTTVTNVSD 421
Query: 351 ARL---NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA 407
A+ N +LE+LE+PR DI+YVR LGQGAFGRVFQA+APGL+ +E LVAVKMLKD+A
Sbjct: 422 AKGTKPNARLEKLEYPRGDIVYVRSLGQGAFGRVFQARAPGLVPDQEDLLVAVKMLKDDA 481
Query: 408 SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNY 467
S+ +Q DFEREACLLAEFDHPNIV+LLGVCA+G+PMCLLFEYM GDL++FLR CSP
Sbjct: 482 SDQMQMDFEREACLLAEFDHPNIVRLLGVCALGRPMCLLFEYMAPGDLSEFLRACSP--- 538
Query: 468 INGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
Y++ ++ QL+ L+ +A IA+GM+YLS+RKFVHRDLATRNCLIN+ M V
Sbjct: 539 ----YATHQAPTQDRLQLNELHLLQMAANIAAGMLYLSERKFVHRDLATRNCLINEHMAV 594
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587
KIADFGLS K+YLQDYYKGDEND IP+RWMPLESILYNK+++ESDVWA+G+CLWE+FSFA
Sbjct: 595 KIADFGLSHKIYLQDYYKGDENDFIPIRWMPLESILYNKFSLESDVWAYGICLWEVFSFA 654
Query: 588 LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
LQPY+GLTHEEV+KYIKEGN+L PDNTP ++Y LM+ CWN KP RP F I
Sbjct: 655 LQPYFGLTHEEVIKYIKEGNVLGCPDNTPLSVYALMRRCWNRKPSERPGFAEI 707
|
Tyrosine-protein kinase receptor that functions during early stages of neuronal development. Drosophila melanogaster (taxid: 7227) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q8AXY6|MUSK_CHICK Muscle, skeletal receptor tyrosine protein kinase OS=Gallus gallus GN=MUSK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 597 bits (1540), Expect = e-170, Method: Compositional matrix adjust.
Identities = 309/630 (49%), Positives = 401/630 (63%), Gaps = 20/630 (3%)
Query: 29 KQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQ 88
K GYCS Y G++C L+R V+FNSS + E +V W E+ + ++ C+
Sbjct: 311 KGDAGYCSTYRGEVCSAILSRNALVFFNSSYADPE-ETQELLVHTAWTELKTV-SSFCQP 368
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
AAE LLC Y F +C S P P+C E+C+AV+ +C+ +W +EEN RGI
Sbjct: 369 AAESLLCNYIFQECKPSGVGPAPKPICRENCLAVKDLYCFKEWLSMEENSQRGIYKPGLM 428
Query: 149 HFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLAC 208
LP C+ LP C+H + K + IT C G G+FYQG N T G+ C
Sbjct: 429 LLALPECNRLPSLH--QDPSACTHIPFFDFKKENITRTCYSGNGQFYQGWANVTASGIPC 486
Query: 209 QRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD- 267
Q+W + PH H R P VFPEL+++ENYCRN GGE PWCYT DP+V W+ C + C D
Sbjct: 487 QKWSDQAPHLHRRTPQVFPELSDAENYCRNPGGENERPWCYTKDPSVTWEYCSVSPCGDA 546
Query: 268 SMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLV-------- 319
S+ + + + L P + + +I I S LI ++ +I LV
Sbjct: 547 SLSLGTRKPNGETQNLPPPPSYSPTYSMNVIILI--ISSFALIVILGIITLVCCRRRKQW 604
Query: 320 ---KRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQG 376
KR + + + L +L N Y + LNPKL LE+PRN+I YVRD+G+G
Sbjct: 605 KNKKRESETPTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEG 664
Query: 377 AFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436
AFGRVFQA+APGLL +E FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGV
Sbjct: 665 AFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 724
Query: 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC--DLITIA 494
CAVGKPMCLLFEYM GDLN++LR SP N + +E+ + L+ C + IA
Sbjct: 725 CAVGKPMCLLFEYMAYGDLNEYLRDRSPRNLCSLVQGGLEARACLLNPLALCCTSQLCIA 784
Query: 495 LQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPV 554
Q+A+GM YLS+RKFVHRDLATRNCL+ + MVVKIADFGLSR MY DYYK +ENDAIP+
Sbjct: 785 KQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNMYSADYYKANENDAIPI 844
Query: 555 RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDN 614
RWMP ESI YN+YT ESDVWA+GV LWEIFS+ +QPYYG+ HEEV+ Y+++GNIL PDN
Sbjct: 845 RWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNILSCPDN 904
Query: 615 TPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P LY+LM+LCW+ P +RPSF +I++ L
Sbjct: 905 CPLELYNLMRLCWSKLPADRPSFASIHRIL 934
|
Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle. Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q61006|MUSK_MOUSE Muscle, skeletal receptor tyrosine-protein kinase OS=Mus musculus GN=Musk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1050), Expect = e-113, Method: Compositional matrix adjust.
Identities = 208/379 (54%), Positives = 267/379 (70%), Gaps = 15/379 (3%)
Query: 280 IKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSK 339
+ A F P + + +I I + L + + + +R ++ + + L+
Sbjct: 478 LPASTSSFAVSPAYSMTVIISIVSSFALFALLTIATLYCCRRRKEWKNKKRESTAVTLTT 537
Query: 340 LPC---------NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL 390
LP N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL
Sbjct: 538 LPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL 597
Query: 391 KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450
+E FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM
Sbjct: 598 PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 657
Query: 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLS 505
GDLN+FLR SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS
Sbjct: 658 AYGDLNEFLRSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 716
Query: 506 DRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN 565
+RKFVHRDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN
Sbjct: 717 ERKFVHRDLATRNCLVGETMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 776
Query: 566 KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKL 625
+YT ESDVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+L
Sbjct: 777 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 836
Query: 626 CWNMKPMNRPSFRTIYQTL 644
CW+ P +RPSF +I++ L
Sbjct: 837 CWSKLPADRPSFCSIHRIL 855
|
Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle. Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May regulate AChR phosphorylation and clustering through activation of ABL1 and Src family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a ternary complex with MUSK are also important for MUSK-dependent regulation of AChR clustering. May positively regulate Rho family GTPases through FNTA. Mediates the phosphorylation of FNTA which promotes prenylation, recruitment to membranes and ativation of RAC1 a regulator of the actin cytoskeleton and of gene expression. Other effectors of the MUSK signaling include DNAJA3 which functions downstream of MUSK. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|O15146|MUSK_HUMAN Muscle, skeletal receptor tyrosine-protein kinase OS=Homo sapiens GN=MUSK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1046), Expect = e-112, Method: Compositional matrix adjust.
Identities = 204/367 (55%), Positives = 264/367 (71%), Gaps = 13/367 (3%)
Query: 291 PYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPC-------- 342
P + + +I I + + ++ + + +R + + + L+ LP
Sbjct: 490 PTYSMTVIISIMSSFAIFVLLTITTLYCCRRRKQWKNKKRESAAVTLTTLPSELLLDRLH 549
Query: 343 -NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK 401
N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT+VAVK
Sbjct: 550 PNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK 609
Query: 402 MLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRI 461
MLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN+FLR
Sbjct: 610 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 669
Query: 462 CSPNNYINGTYS--SMESSIHRV--PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517
SP+ + ++S SM + + P LS + + IA Q+A+GM YLS+RKFVHRDLATR
Sbjct: 670 MSPHTVCSLSHSDLSMRAQVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 729
Query: 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFG 577
NCL+ + MVVKIADFGLSR +Y DYYK +ENDAIP+RWMP ESI YN+YT ESDVWA+G
Sbjct: 730 NCLVGENMVVKIADFGLSRNIYSADYYKANENDAIPIRWMPPESIFYNRYTTESDVWAYG 789
Query: 578 VCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
V LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P +RPSF
Sbjct: 790 VVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILSCPENCPVELYNLMRLCWSKLPADRPSF 849
Query: 638 RTIYQTL 644
+I++ L
Sbjct: 850 TSIHRIL 856
|
Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle. Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May regulate AChR phosphorylation and clustering through activation of ABL1 and Src family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a ternary complex with MUSK are also important for MUSK-dependent regulation of AChR clustering. May positively regulate Rho family GTPases through FNTA. Mediates the phosphorylation of FNTA which promotes prenylation, recruitment to membranes and ativation of RAC1 a regulator of the actin cytoskeleton and of gene expression. Other effectors of the MUSK signaling include DNAJA3 which functions downstream of MUSK. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q62838|MUSK_RAT Muscle, skeletal receptor tyrosine protein kinase OS=Rattus norvegicus GN=Musk PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1043), Expect = e-112, Method: Compositional matrix adjust.
Identities = 207/379 (54%), Positives = 266/379 (70%), Gaps = 15/379 (3%)
Query: 280 IKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSK 339
+ A F P + + +I I + + + + +R ++ + + L+
Sbjct: 478 LPASTSSFAVSPAYSMTVIISIMSCFAVFALLTITTLYCCRRRREWKNKKRESAAVTLTT 537
Query: 340 LPC---------NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL 390
LP N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL
Sbjct: 538 LPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLL 597
Query: 391 KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450
+E FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM
Sbjct: 598 PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 657
Query: 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLS 505
GDLN+FLR SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS
Sbjct: 658 AYGDLNEFLRSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 716
Query: 506 DRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN 565
+RKFVHRDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN
Sbjct: 717 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 776
Query: 566 KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKL 625
+YT ESDVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+L
Sbjct: 777 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRL 836
Query: 626 CWNMKPMNRPSFRTIYQTL 644
CW+ P +RPSF +I++ L
Sbjct: 837 CWSKLPADRPSFCSIHRIL 855
|
Receptor tyrosine kinase which plays a central role in the formation and the maintenance of the neuromuscular junction (NMJ), the synapse between the motor neuron and the skeletal muscle. Recruitment of AGRIN by LRP4 to the MUSK signaling complex induces phosphorylation and activation of MUSK, the kinase of the complex. The activation of MUSK in myotubes regulates the formation of NMJs through the regulation of different processes including the specific expression of genes in subsynaptic nuclei, the reorganization of the actin cytoskeleton and the clustering of the acetylcholine receptors (AChR) in the postsynaptic membrane. May regulate AChR phosphorylation and clustering through activation of ABL1 and Src family kinases which in turn regulate MUSK. DVL1 and PAK1 that form a ternary complex with MUSK are also important for MUSK-dependent regulation of AChR clustering. May positively regulate Rho family GTPases through FNTA. Mediates the phosphorylation of FNTA which promotes prenylation, recruitment to membranes and ativation of RAC1 a regulator of the actin cytoskeleton and of gene expression. Other effectors of the MUSK signaling include DNAJA3 which functions downstream of MUSK. May also play a role within the central nervous system by mediating cholinergic responses, synaptic plasticity and memory formation. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q9Z139|ROR1_MOUSE Tyrosine-protein kinase transmembrane receptor ROR1 OS=Mus musculus GN=Ror1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 389 bits (1000), Expect = e-107, Method: Compositional matrix adjust.
Identities = 225/630 (35%), Positives = 344/630 (54%), Gaps = 51/630 (8%)
Query: 24 AQSEMKQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI-- 81
S+ + G+C Y G C ++ R + SL G ++ QI A MI
Sbjct: 159 GSSDEYEEDGFCQPYRGIACARFIGN--RTVYMESLHMQG-EIENQITAAF--TMIGTSS 213
Query: 82 -LANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKAR 140
L++ C Q A LC YAFP C ++ +P LC ++C + C ++ + N
Sbjct: 214 HLSDKCSQFAIPSLCHYAFPYCDETSSVPKPRDLCRDECEVLENVLCQTEYIFARSNPMI 273
Query: 141 GIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVN 200
+R K LPNC+ LP+ E C + + C G Y+GTV+
Sbjct: 274 LMRLK------LPNCEDLPQPESPEAA-NCIRIGIPMADPINKNHKCYNSTGVDYRGTVS 326
Query: 201 TTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260
T G CQ W+++ PH H FPELN +YCRN G ++ +PWC+T+D N + C
Sbjct: 327 VTKSGRQCQPWNSQYPHTHSFTALRFPELNGGHSYCRNPGNQKEAPWCFTLDENFKSDLC 386
Query: 261 EIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVK 320
+IP C DS K NK++ L +I++ + IP+A + L +CV R +
Sbjct: 387 DIPAC-DSKDSKEK---NKMEIL---------YILVPSVAIPLA-IAFLFFFICVCRNNQ 432
Query: 321 RN----VDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQG 376
++ V P P + N+++S L NA PK + E P + + ++ +LG+
Sbjct: 433 KSSSPPVQRQPKPVRGQNVEMSML--NA--------YKPKSKAKELPLSAVRFMEELGEC 482
Query: 377 AFGRVFQAKA--PGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL 434
FG++++ PG+ + LVA+K LKD + T+F++EA L+AE HPNIV LL
Sbjct: 483 TFGKIYKGHLYLPGM---DHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHPNIVCLL 539
Query: 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIA 494
G +P+C+LFEYM +GDL++FL + SP++ + G S + ++ L D + IA
Sbjct: 540 GAVTQEQPVCMLFEYMNQGDLHEFLIMRSPHSDV-GCSSDEDGTVKS--SLDHGDFLHIA 596
Query: 495 LQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPV 554
+QIA+GM YLS FVH+DLA RN LI +Q+ VKI+D GLSR++Y DYY+ ++P+
Sbjct: 597 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSSLPI 656
Query: 555 RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDN 614
RWMP E+I+Y K++ +SD+W+FGV LWEIFSF LQPYYG +++EV++ +++ +L ++
Sbjct: 657 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSED 716
Query: 615 TPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P +Y LM CWN P RP F+ I+ L
Sbjct: 717 CPPRMYSLMTECWNEIPSRRPRFKDIHVRL 746
|
Tyrosine-protein kinase receptor whose role is not yet clear. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q01973|ROR1_HUMAN Tyrosine-protein kinase transmembrane receptor ROR1 OS=Homo sapiens GN=ROR1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 384 bits (987), Expect = e-106, Method: Compositional matrix adjust.
Identities = 225/628 (35%), Positives = 343/628 (54%), Gaps = 51/628 (8%)
Query: 26 SEMKQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI---L 82
S+ + G+C Y G C ++ R + SL G ++ QI A MI L
Sbjct: 161 SDEYEEDGFCQPYRGIACARFIGN--RTVYMESLHMQG-EIENQITAAF--TMIGTSSHL 215
Query: 83 ANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGI 142
++ C Q A LC YAFP C ++ +P LC ++C + C ++ + N +
Sbjct: 216 SDKCSQFAIPSLCHYAFPYCDETSSVPKPRDLCRDECEILENVLCQTEYIFARSNPMILM 275
Query: 143 RFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTT 202
R K LPNC+ LP+ E C + + C G Y+GTV+ T
Sbjct: 276 RLK------LPNCEDLPQPESPEAA-NCIRIGIPMADPINKNHKCYNSTGVDYRGTVSVT 328
Query: 203 VGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEI 262
G CQ W+++ PH H FPELN +YCRN G ++ +PWC+T+D N + C+I
Sbjct: 329 KSGRQCQPWNSQYPHTHTFTALRFPELNGGHSYCRNPGNQKEAPWCFTLDENFKSDLCDI 388
Query: 263 PTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRN 322
P C DS K NK++ L +I++ + IP+A L L +CV R +++
Sbjct: 389 PAC-DSKDSKEK---NKMEIL---------YILVPSVAIPLAIAL-LFFFICVCRNNQKS 434
Query: 323 ----VDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAF 378
V P + N+++S L NA PK + E P + + ++ +LG+ AF
Sbjct: 435 SSAPVQRQPKHVRGQNVEMSML--NA--------YKPKSKAKELPLSAVRFMEELGECAF 484
Query: 379 GRVFQAKA--PGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436
G++++ PG+ + LVA+K LKD + T+F++EA L+AE HPNIV LLG
Sbjct: 485 GKIYKGHLYLPGM---DHAQLVAIKTLKDYNNPQQWTEFQQEASLMAELHHPNIVCLLGA 541
Query: 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQ 496
+P+C+LFEY+ +GDL++FL + SP++ + G S + ++ L D + IA+Q
Sbjct: 542 VTQEQPVCMLFEYINQGDLHEFLIMRSPHSDV-GCSSDEDGTVKS--SLDHGDFLHIAIQ 598
Query: 497 IASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRW 556
IA+GM YLS FVH+DLA RN LI +Q+ VKI+D GLSR++Y DYY+ +P+RW
Sbjct: 599 IAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQSKSLLPIRW 658
Query: 557 MPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTP 616
MP E+I+Y K++ +SD+W+FGV LWEIFSF LQPYYG +++EV++ +++ +L ++ P
Sbjct: 659 MPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCP 718
Query: 617 DALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+Y LM CWN P RP F+ I+ L
Sbjct: 719 PRMYSLMTECWNEIPSRRPRFKDIHVRL 746
|
Tyrosine-protein kinase receptor whose role is not yet clear. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q01974|ROR2_HUMAN Tyrosine-protein kinase transmembrane receptor ROR2 OS=Homo sapiens GN=ROR2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 348 bits (893), Expect = 8e-95, Method: Compositional matrix adjust.
Identities = 206/626 (32%), Positives = 325/626 (51%), Gaps = 65/626 (10%)
Query: 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI---LANPCKQA 89
G+C Y G C ++ R + SL+ G ++ +I A MI L++ C Q
Sbjct: 172 GFCQPYRGIACARFIG--NRTIYVDSLQMQG-EIENRITAAF--TMIGTSTHLSDQCSQF 226
Query: 90 AEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGH 149
A C + FP C + P LC ++C + C ++ N +R
Sbjct: 227 AIPSFCHFVFPLCDARSRTPKPRELCRDECEVLESDLCRQEYTIARSNPLILMRL----- 281
Query: 150 FELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEIT--YDCIRGRGRFYQGTVNTTVGGLA 207
+LP C+ LP E P ++ + + + + C G G Y+GT +TT G
Sbjct: 282 -QLPKCEALPMPE----SPDAANCMRIGIPAERLGRYHQCYNGSGMDYRGTASTTKSGHQ 336
Query: 208 CQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267
CQ W + PH+H FPEL YCRN GG+ PWC+T + NVR + C++P+C
Sbjct: 337 CQPWALQHPHSHHLSSTDFPELGGGHAYCRNPGGQMEGPWCFTQNKNVRMELCDVPSC-- 394
Query: 268 SMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAP 327
S +D +K+ L +I++ I IP+ + CL +VC+ R ++ P
Sbjct: 395 SPRDS-----SKMGIL---------YILVPSIAIPLV-IACLFFLVCMCRNKQKASASTP 439
Query: 328 -------APSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGR 380
+PSQD+ + L + KL+++ + + ++ +LG+ FG+
Sbjct: 440 QRRQLMASPSQDMEMPL-----------INQHKQAKLKEISL--SAVRFMEELGEDRFGK 486
Query: 381 VFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440
V++ G E+ VA+K LKD+A L+ +F EA L A HPN+V LLGV
Sbjct: 487 VYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 546
Query: 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS--SMESSIHRVPQLSTCDLITIALQIA 498
+P+ ++F Y GDL++FL + SP++ + T +++S+ L D + + QIA
Sbjct: 547 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA------LEPPDFVHLVAQIA 600
Query: 499 SGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMP 558
+GM YLS VH+DLATRN L+ D++ VKI+D GL R++Y DYYK N +P+RWM
Sbjct: 601 AGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMA 660
Query: 559 LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDA 618
E+I+Y K++++SD+W++GV LWE+FS+ LQPY G ++++VV+ I+ +L PD+ P
Sbjct: 661 PEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAW 720
Query: 619 LYDLMKLCWNMKPMNRPSFRTIYQTL 644
+Y LM CWN P RP F+ I+ L
Sbjct: 721 VYALMIECWNEFPSRRPRFKDIHSRL 746
|
Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development. Phosphorylates YWHAB, leading to induction of osteogenesis and bone formation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q9Z138|ROR2_MOUSE Tyrosine-protein kinase transmembrane receptor ROR2 OS=Mus musculus GN=Ror2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 346 bits (887), Expect = 4e-94, Method: Compositional matrix adjust.
Identities = 206/629 (32%), Positives = 328/629 (52%), Gaps = 65/629 (10%)
Query: 30 QPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI---LANPC 86
Q G+C Y G C ++ R + SL+ G ++ +I A MI L++ C
Sbjct: 169 QEDGFCQPYRGIACARFIG--NRTIYVDSLQMQG-EIENRITAAF--TMIGTSTQLSDQC 223
Query: 87 KQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKS 146
Q A C + FP C + P LC ++C + C ++ N +R
Sbjct: 224 SQFAIPSFCHFVFPLCDARSRAPKPRELCRDECEVLENDLCRQEYTIARSNPLILMRL-- 281
Query: 147 RGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEIT--YDCIRGRGRFYQGTVNTTVG 204
+LP C+ LP E P ++ + + + + C G G Y+G +TT
Sbjct: 282 ----QLPKCEALPMPE----SPDAANCMRIGIPAERLGRYHQCYNGSGADYRGMASTTKS 333
Query: 205 GLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264
G CQ W + PH+H FPEL YCRN GG+ PWC+T + NVR + C++P
Sbjct: 334 GHQCQPWALQHPHSHRLSSTEFPELGGGHAYCRNPGGQVEGPWCFTQNKNVRVELCDVPP 393
Query: 265 CADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVD 324
C S +D G+K+ L +I++ I IP+ + CL +VC+ R ++
Sbjct: 394 C--SPRD-----GSKMGIL---------YILVPSIAIPLV-IACLFFLVCMCRNKQKASA 436
Query: 325 YAP-------APSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGA 377
P +PSQD+ ++P + + Q KL+++ + + ++ +LG+
Sbjct: 437 STPQRRQLMASPSQDM-----EMPLISQHKQA------KLKEISL--STVRFMEELGEDR 483
Query: 378 FGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437
FG+V++ G E VA+K LKD+A L+ +F +EA L A HPNIV LLGV
Sbjct: 484 FGKVYKGHLFGPAPGEPTQAVAIKTLKDKAEGPLREEFRQEAMLRARLQHPNIVCLLGVV 543
Query: 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS--SMESSIHRVPQLSTCDLITIAL 495
+P+ ++F Y GDL++FL + SP++ + T +++S+ L D + +
Sbjct: 544 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA------LEPPDFVHVVA 597
Query: 496 QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVR 555
QIA+GM +LS VH+DLATRN L+ D++ V+I+D GL R++Y DYYK N +P+R
Sbjct: 598 QIAAGMEFLSSHHVVHKDLATRNVLVYDKLNVRISDLGLFREVYSADYYKLMGNSLLPIR 657
Query: 556 WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNT 615
WM E+++Y K++++SD+W++GV LWE+FS+ LQPY G ++++VV+ I+ +L PD+
Sbjct: 658 WMSPEAVMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRSRQVLPCPDDC 717
Query: 616 PDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P +Y LM CWN P RP F+ I+ L
Sbjct: 718 PAWVYALMIECWNEFPSRRPRFKDIHSRL 746
|
Tyrosine-protein kinase receptor which may be involved in the early formation of the chondrocytes. It seems to be required for cartilage and growth plate development. Phosphorylates YWHAB, leading to induction of osteogenesis and bone formation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
| >sp|Q24488|ROR1_DROME Tyrosine-protein kinase transmembrane receptor Ror OS=Drosophila melanogaster GN=Ror PE=1 SV=1 | Back alignment and function description |
|---|
Score = 301 bits (770), Expect = 1e-80, Method: Compositional matrix adjust.
Identities = 189/522 (36%), Positives = 269/522 (51%), Gaps = 82/522 (15%)
Query: 148 GHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLA 207
G + +C LP+++ C +T ++ D+ T +C G Y+G N + G
Sbjct: 206 GMVGVEDCQKLPQHK------DCLSLGIT-IEVDK-TENCYWEDGSTYRGVANVSASGKP 257
Query: 208 CQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRW-QRCEIPTCA 266
C RW + FPEL +NYCRN G E SPWC+ R + C+IP CA
Sbjct: 258 CLRWSWLMKEISD-----FPELI-GQNYCRNPGSVENSPWCFVDSSRERIIELCDIPKCA 311
Query: 267 DSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVV--------CVIRL 318
D K W +A++ A +L I + ++
Sbjct: 312 D------KIW-------------------IAIVGTTAAIILIFIIIFAIILFKRRTIMHY 346
Query: 319 VKRNVDYAPAPSQDVNI---------------DLSKLPCNASYHQTDARLNPKLEQLEFP 363
RN+ PS D NI +L L + + + N L F
Sbjct: 347 GMRNIHNINTPSADKNIYGNSQLNNAQDAGRGNLGNLSDHVALNSKLIERNTLLRINHFT 406
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLL 422
D+ ++ +LG+GAFG+V++ + LL+ + T+ VA+K LK+ AS Q DF+RE L+
Sbjct: 407 LQDVEFLEELGEGAFGKVYKGQ---LLQPNKTTITVAIKALKENASVKTQQDFKREIELI 463
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
++ H NIV +LGV +P C+LFEYM GDL++FL SP
Sbjct: 464 SDLKHQNIVCILGVVLNKEPYCMLFEYMANGDLHEFLISNSPT---------------EG 508
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
LS + + IALQI+ GM YLS +VHRDLA RNCL+N+ +VVKI+DFGLSR +Y D
Sbjct: 509 KSLSQLEFLQIALQISEGMQYLSAHHYVHRDLAARNCLVNEGLVVKISDFGLSRDIYSSD 568
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
YY+ +PVRWMP ESILY K+T ESDVW+FGV LWEI+S+ +QPYYG +++EV+
Sbjct: 569 YYRVQSKSLLPVRWMPSESILYGKFTTESDVWSFGVVLWEIYSYGMQPYYGFSNQEVINL 628
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
I+ +L AP+N P A+Y LM CW+ + + RP+F I L
Sbjct: 629 IRSRQLLSAPENCPTAVYSLMIECWHEQSVKRPTFTDISNRL 670
|
Tyrosine-protein kinase receptor that functions during early stages of neuronal development. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 653 | ||||||
| 340721763 | 649 | PREDICTED: tyrosine-protein kinase trans | 0.961 | 0.967 | 0.657 | 0.0 | |
| 350426158 | 648 | PREDICTED: tyrosine-protein kinase trans | 0.964 | 0.972 | 0.654 | 0.0 | |
| 328786954 | 654 | PREDICTED: tyrosine-protein kinase trans | 0.966 | 0.964 | 0.653 | 0.0 | |
| 380016016 | 648 | PREDICTED: tyrosine-protein kinase trans | 0.957 | 0.964 | 0.650 | 0.0 | |
| 328786952 | 648 | PREDICTED: tyrosine-protein kinase trans | 0.964 | 0.972 | 0.654 | 0.0 | |
| 383860516 | 648 | PREDICTED: tyrosine-protein kinase trans | 0.961 | 0.969 | 0.651 | 0.0 | |
| 332020248 | 652 | Tyrosine-protein kinase transmembrane re | 0.937 | 0.938 | 0.658 | 0.0 | |
| 242021869 | 656 | tyrosine-protein kinase transmembrane re | 0.938 | 0.934 | 0.652 | 0.0 | |
| 307214737 | 654 | Tyrosine-protein kinase transmembrane re | 0.967 | 0.966 | 0.630 | 0.0 | |
| 270015023 | 636 | hypothetical protein TcasGA2_TC014181 [T | 0.954 | 0.979 | 0.623 | 0.0 |
| >gi|340721763|ref|XP_003399284.1| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2-like [Bombus terrestris] | Back alignment and taxonomy information |
|---|
Score = 867 bits (2239), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/651 (65%), Positives = 505/651 (77%), Gaps = 23/651 (3%)
Query: 9 MYLTWILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDL 66
M + WI+ +++ S +P QGYC+ YNGKICK YL G+VWFN S ++ GG L
Sbjct: 1 MMMFWIVSLIAIILHFSSAQTKPESQGYCAPYNGKICKKYLTGIGKVWFNDSNDNPGGWL 60
Query: 67 NEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSF 126
NE+I LW+E+I L PC+ AAEK+LC YAFPQC S G LPLCYEDC+AVR+ F
Sbjct: 61 NERITTNLWEELIQRLVEPCRSAAEKMLCMYAFPQCHNSVG----LPLCYEDCMAVRHQF 116
Query: 127 CYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYD 186
C+NDWA IE+NK R I +SRGHF LP+C++LPK VV GK TCSH LT+M + +TYD
Sbjct: 117 CFNDWAMIEDNKQRDIYIRSRGHFTLPDCESLPK--VVTGKTTCSHIHLTDMNEELVTYD 174
Query: 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSP 246
C+ G GRFY G VN T GL CQ W+A+ PH+H+RPP VFP++ ENYCRNAGGEEP P
Sbjct: 175 CVEGNGRFYMGKVNKTRLGLDCQSWNAQVPHSHDRPPDVFPQIRYGENYCRNAGGEEPMP 234
Query: 247 WCYTMDPNVRWQRCEIPTCADSMQDDVKSWGNKI--KALLEQFLSQPYFIVL--AVIFIP 302
WC+TMDP++RWQ C+IP C D+V S +I K L+ L P FI++ +++F+
Sbjct: 235 WCFTMDPHIRWQHCDIPMC-----DNVTSKVLEIDPKDLVMDTLFTPKFILILSSLVFVI 289
Query: 303 VASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEF 362
+A L+ ++ RL KR+ Y P +Q V IDL KLP N +YH+T A+LNPKLE+LEF
Sbjct: 290 IAG--SLLSIILSHRLHKRHQGYNPTDNQYVGIDLDKLPSNDAYHKTSAQLNPKLEKLEF 347
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
PRN+IIYVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLL
Sbjct: 348 PRNNIIYVRDLGQGAFGRVFQAKAPGLVPGEEFTNVAVKMLKEEASDDLLKDFEREACLL 407
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
AEFDHPNIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI S+E H
Sbjct: 408 AEFDHPNIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRSLEKDEHFT 464
Query: 483 -PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+LS DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQ
Sbjct: 465 DSRLSHMDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQ 524
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
DYYKGDE DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVK
Sbjct: 525 DYYKGDEQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVK 584
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
YIKEGN+LQ P+NTP A+YDLMKLCWN +P +RP+FRTIY TL IK +LE
Sbjct: 585 YIKEGNVLQCPENTPPAIYDLMKLCWNRRPSDRPTFRTIYNTLDTIKYNLE 635
|
Source: Bombus terrestris Species: Bombus terrestris Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|350426158|ref|XP_003494351.1| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2-like [Bombus impatiens] | Back alignment and taxonomy information |
|---|
Score = 864 bits (2233), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/645 (65%), Positives = 500/645 (77%), Gaps = 15/645 (2%)
Query: 11 LTWILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
+ WI+ +++ S +P QGYC+ YNGKICK YL G+VWFN S ++ GG LNE
Sbjct: 2 MFWIVSLIAIILHFSSAQTKPESQGYCAPYNGKICKKYLTGIGKVWFNDSNDNPGGWLNE 61
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
+I LW+E+I L PC+ AAEK+LC YAFPQC S G LPLCYEDC+AVR+ FC+
Sbjct: 62 RITTNLWEELIQRLVEPCRSAAEKMLCMYAFPQCHNSVG----LPLCYEDCMAVRHQFCF 117
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
NDWA IE+NK R I +SRGHF LP+C++LPK VV GK TCSH LT+M + +TYDC+
Sbjct: 118 NDWAMIEDNKQRDIYIRSRGHFTLPDCESLPK--VVKGKTTCSHIHLTDMNEELVTYDCV 175
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
G GRFY G VN T GL CQ W+A+ PH+H+RPP VFP++ ENYCRNAGGEEP PWC
Sbjct: 176 EGNGRFYMGKVNKTRLGLDCQSWNAQVPHSHDRPPDVFPQIRYGENYCRNAGGEEPMPWC 235
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLC 308
+TMDP++RWQ C+IP C D++ V K ++ F + I+ +++F+ +A
Sbjct: 236 FTMDPHIRWQHCDIPMC-DNVTSKVLEIDPKDLVMVTLFTPKFILILSSLVFVIIAG--S 292
Query: 309 LICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDII 368
L+ ++ RL KR+ Y P +Q V IDL KLP N +YH+T A+LNPKLE+LEFPRN+II
Sbjct: 293 LLSIILSHRLHKRHQGYNPTDNQYVGIDLDKLPSNDAYHKTTAQLNPKLEKLEFPRNNII 352
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
YVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLLAEFDHP
Sbjct: 353 YVRDLGQGAFGRVFQAKAPGLVPGEEFTNVAVKMLKEEASDDLLKDFEREACLLAEFDHP 412
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV-PQLST 487
NIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI S+E H +LS
Sbjct: 413 NIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRSLEKDEHFTDSRLSH 469
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQDYYKGD
Sbjct: 470 MDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQDYYKGD 529
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
E DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKYIKEGN
Sbjct: 530 EQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKYIKEGN 589
Query: 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+LQ P+NTP A+YDLMKLCWN +P +RP+FRTIY TL IK +LE
Sbjct: 590 VLQCPENTPPAVYDLMKLCWNRRPSDRPTFRTIYNTLDTIKYNLE 634
|
Source: Bombus impatiens Species: Bombus impatiens Genus: Bombus Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328786954|ref|XP_003250865.1| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2 isoform 1 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 862 bits (2227), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 425/650 (65%), Positives = 499/650 (76%), Gaps = 19/650 (2%)
Query: 11 LTWILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
+ WI+ +++ S +P QGYC+ YNGKICK YL G+VWFN S ++ GG LNE
Sbjct: 2 MFWIVSLVAIILHFSSAQTKPESQGYCAPYNGKICKKYLTGIGKVWFNDSNDNPGGWLNE 61
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
+I LW+E+I L PC+ AAEK+LC YAFPQC S G LPLCYEDC+AVR+ FC+
Sbjct: 62 RITTNLWEELIQRLVEPCRSAAEKMLCMYAFPQCHNSVG----LPLCYEDCMAVRHQFCF 117
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
NDWA IE+NK R I +SRGHF LP+C++LPK ++ GK TCSH LT+M D +TYDCI
Sbjct: 118 NDWAMIEDNKQRDIYIRSRGHFTLPDCESLPK--IIKGKVTCSHIHLTDMNEDLVTYDCI 175
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
+G GRFY G VN T GL CQ W+A+ PH H+RPP VFP++ ENYCRNAGG+EP PWC
Sbjct: 176 KGNGRFYMGKVNKTKLGLDCQSWNAQIPHNHDRPPDVFPQIRYGENYCRNAGGDEPMPWC 235
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKI-----KALLEQFLSQPYFIVLAVIFIPV 303
+TMDP++RWQ C+IP C + D + NKI K L+ L P FI++ V
Sbjct: 236 FTMDPHIRWQYCDIPICGRHLIPD--NITNKIPEIDPKDLVMDTLFTPMFILILSSLGFV 293
Query: 304 ASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFP 363
L+ ++ RL KR+ Y P +Q V+IDL KLP N +YH+T A+LNPKLE+LEFP
Sbjct: 294 IITGTLLSIILSHRLHKRHQGYNPTDNQYVSIDLDKLPSNDAYHKTSAQLNPKLEKLEFP 353
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
RN+IIYVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLLA
Sbjct: 354 RNNIIYVRDLGQGAFGRVFQAKAPGLVPGEEFTNVAVKMLKEEASDDLLKDFEREACLLA 413
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV- 482
EFDHPNIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI S+E H
Sbjct: 414 EFDHPNIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRSLEKDEHFTD 470
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+LS DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQD
Sbjct: 471 SRLSHMDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQD 530
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
YYKGDE DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKY
Sbjct: 531 YYKGDEQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKY 590
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
IKEGN+LQ P+NTP A+YDLMKLCWN +P +RP+FRTIY TL IK +LE
Sbjct: 591 IKEGNVLQCPENTPPAIYDLMKLCWNRRPSDRPTFRTIYNTLDTIKYNLE 640
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|380016016|ref|XP_003691989.1| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2-like [Apis florea] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 423/650 (65%), Positives = 498/650 (76%), Gaps = 25/650 (3%)
Query: 11 LTWILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
+ WI+ +++ S +P QGYC+ YNGKICK YL G+VWFN S ++ GG LNE
Sbjct: 2 MFWIVSLVAIILHFSSAQTKPESQGYCAPYNGKICKKYLTGIGKVWFNDSNDNPGGWLNE 61
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
+I LW+E+I L PC+ AAEK+LC YAFPQC S G LPLCYEDC+AVR+ FC+
Sbjct: 62 RITTNLWEELIQRLVEPCRSAAEKMLCMYAFPQCHNSVG----LPLCYEDCMAVRHQFCF 117
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
NDWA IE+NK R I +SRGHF LP+C++LPK ++ GK TCSH LT+M D +TYDC+
Sbjct: 118 NDWAMIEDNKQRDIYIRSRGHFTLPDCESLPK--IIKGKITCSHIHLTDMNEDLVTYDCV 175
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
+G GRFY G VN T GL CQ W+A+ PH H+RPP VFP++ ENYCRNAGG+EP PWC
Sbjct: 176 KGNGRFYMGKVNKTKLGLDCQSWNAQIPHNHDRPPDVFPQIRYGENYCRNAGGDEPMPWC 235
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKI-----KALLEQFLSQPYFIVLAVIFIPV 303
+TMDP++RWQ C+IP C ++ NKI K L+ L P FI++ V
Sbjct: 236 FTMDPHIRWQYCDIPICDNTT--------NKIPEIDPKDLVMDTLFTPMFILILSSLGFV 287
Query: 304 ASMLCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFP 363
L+ ++ RL KR+ Y P +Q V+IDL KLP N +YH+T A+LNPKLE+LEFP
Sbjct: 288 IITGTLLSIILSHRLHKRHQGYNPTDNQYVSIDLDKLPSNDAYHKTSAQLNPKLEKLEFP 347
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
RN+IIYVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLLA
Sbjct: 348 RNNIIYVRDLGQGAFGRVFQAKAPGLVPGEEFTNVAVKMLKEEASDDLLKDFEREACLLA 407
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV- 482
EFDHPNIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI S+E H
Sbjct: 408 EFDHPNIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRSLEKDEHFTD 464
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+LS DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQD
Sbjct: 465 SRLSHMDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQD 524
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
YYKGDE DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKY
Sbjct: 525 YYKGDEQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKY 584
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
IKEGN+LQ P+NTP A+YDLMKLCWN +P +RP+FRTIY TL IK +LE
Sbjct: 585 IKEGNVLQCPENTPPAIYDLMKLCWNRRPSDRPTFRTIYNTLDTIKYNLE 634
|
Source: Apis florea Species: Apis florea Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|328786952|ref|XP_391863.4| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2 isoform 2 [Apis mellifera] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2222), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/645 (65%), Positives = 498/645 (77%), Gaps = 15/645 (2%)
Query: 11 LTWILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
+ WI+ +++ S +P QGYC+ YNGKICK YL G+VWFN S ++ GG LNE
Sbjct: 2 MFWIVSLVAIILHFSSAQTKPESQGYCAPYNGKICKKYLTGIGKVWFNDSNDNPGGWLNE 61
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
+I LW+E+I L PC+ AAEK+LC YAFPQC S G LPLCYEDC+AVR+ FC+
Sbjct: 62 RITTNLWEELIQRLVEPCRSAAEKMLCMYAFPQCHNSVG----LPLCYEDCMAVRHQFCF 117
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
NDWA IE+NK R I +SRGHF LP+C++LPK ++ GK TCSH LT+M D +TYDCI
Sbjct: 118 NDWAMIEDNKQRDIYIRSRGHFTLPDCESLPK--IIKGKVTCSHIHLTDMNEDLVTYDCI 175
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
+G GRFY G VN T GL CQ W+A+ PH H+RPP VFP++ ENYCRNAGG+EP PWC
Sbjct: 176 KGNGRFYMGKVNKTKLGLDCQSWNAQIPHNHDRPPDVFPQIRYGENYCRNAGGDEPMPWC 235
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLC 308
+TMDP++RWQ C+IP C D++ + + K L+ L P FI++ V
Sbjct: 236 FTMDPHIRWQYCDIPIC-DNITNKIPEIDPK--DLVMDTLFTPMFILILSSLGFVIITGT 292
Query: 309 LICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDII 368
L+ ++ RL KR+ Y P +Q V+IDL KLP N +YH+T A+LNPKLE+LEFPRN+II
Sbjct: 293 LLSIILSHRLHKRHQGYNPTDNQYVSIDLDKLPSNDAYHKTSAQLNPKLEKLEFPRNNII 352
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
YVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLLAEFDHP
Sbjct: 353 YVRDLGQGAFGRVFQAKAPGLVPGEEFTNVAVKMLKEEASDDLLKDFEREACLLAEFDHP 412
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV-PQLST 487
NIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI S+E H +LS
Sbjct: 413 NIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRSLEKDEHFTDSRLSH 469
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQDYYKGD
Sbjct: 470 MDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQDYYKGD 529
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
E DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKYIKEGN
Sbjct: 530 EQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKYIKEGN 589
Query: 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+LQ P+NTP A+YDLMKLCWN +P +RP+FRTIY TL IK +LE
Sbjct: 590 VLQCPENTPPAIYDLMKLCWNRRPSDRPTFRTIYNTLDTIKYNLE 634
|
Source: Apis mellifera Species: Apis mellifera Genus: Apis Family: Apidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383860516|ref|XP_003705735.1| PREDICTED: tyrosine-protein kinase transmembrane receptor Ror2-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 855 bits (2210), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 419/643 (65%), Positives = 496/643 (77%), Gaps = 15/643 (2%)
Query: 13 WILLNCGVLVMAQSEMKQP--QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQI 70
WI+ +++ S +P QGYC+ Y GKICK YL +VWFN S ++ GG LNE+I
Sbjct: 4 WIVSLVAIILHFSSAQTKPESQGYCAPYRGKICKKYLADIEKVWFNDSNDNPGGWLNERI 63
Query: 71 VMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYND 130
LW+E+I L PC+ AAEK+LC YAFP+C S G LPLCYEDC+AVR+ FC+ND
Sbjct: 64 TTNLWEELIQRLVEPCRSAAEKMLCMYAFPRCNNSVG----LPLCYEDCMAVRHQFCFND 119
Query: 131 WAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRG 190
WA IE+NK R I +SRGHF LP C++LPK VV G+ TCSH LT+MK D ITYDCI+G
Sbjct: 120 WAIIEDNKQRDIYIRSRGHFTLPECESLPK--VVEGQTTCSHIHLTDMKEDLITYDCIKG 177
Query: 191 RGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYT 250
GRFY G VN T GL CQ W+A+ PH H+RPP VFP++ ENYCRNAGGEEP+PWC+T
Sbjct: 178 NGRFYMGKVNKTKSGLDCQPWNAQVPHDHDRPPDVFPQIRYGENYCRNAGGEEPTPWCFT 237
Query: 251 MDPNVRWQRCEIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLI 310
MDP RW+ C+IP C D++ V +K A+ F I+ ++ F+ + L +
Sbjct: 238 MDPVKRWEHCDIPIC-DNVTSKVLEVDSKDLAMDTLFTPMFILILTSLGFVIITGTL--L 294
Query: 311 CVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYV 370
++ RL KR+ Y P +Q V+IDL KLP N +YH+T A+LNPKLE+LEFPRN+IIYV
Sbjct: 295 SIILSHRLHKRHQGYNPTENQYVSIDLDKLPSNDAYHKTSAQLNPKLEKLEFPRNNIIYV 354
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
RDLGQGAFGRVFQAKAPGL+ +EEFT VAVKMLK+EASE L DFEREACLLAEFDHPNI
Sbjct: 355 RDLGQGAFGRVFQAKAPGLVPNEEFTNVAVKMLKEEASEDLLKDFEREACLLAEFDHPNI 414
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV-PQLSTCD 489
VKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP NYI ++E H +LS D
Sbjct: 415 VKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPGNYI---IRNLERDEHFTDSRLSHMD 471
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
LI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQDYYKGDE
Sbjct: 472 LINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQDYYKGDEQ 531
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVV+YIKEGN+L
Sbjct: 532 DAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVQYIKEGNVL 591
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
Q P+NTP +YDLMKLCWN +P++RP+FRTIY TL IK +LE
Sbjct: 592 QCPENTPQPIYDLMKLCWNRRPLDRPTFRTIYNTLDTIKHNLE 634
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|332020248|gb|EGI60684.1| Tyrosine-protein kinase transmembrane receptor Ror2 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 849 bits (2194), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/626 (65%), Positives = 492/626 (78%), Gaps = 14/626 (2%)
Query: 30 QPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQA 89
+ QGYC+ Y+GKICK YL+ G+VWFN S ++ GG LNE+I LW+E+I L PC+ A
Sbjct: 24 ESQGYCAPYSGKICKKYLSGIGKVWFNDSNDNPGGWLNEKITANLWEELIGTLLEPCRSA 83
Query: 90 AEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGH 149
AEK+LC YAFP C S G LPLCYEDC+AVR FC+NDWA IE+NK R I +SRGH
Sbjct: 84 AEKMLCMYAFPLCHESTG----LPLCYEDCMAVRQQFCFNDWAIIEDNKQRDIYIRSRGH 139
Query: 150 FELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQ 209
F LP C++LPK V PTCSH LT+M + +TYDCIRG GRFY G VN T GL CQ
Sbjct: 140 FVLPECESLPK--VNKETPTCSHVHLTDMDEEIVTYDCIRGNGRFYMGMVNKTKYGLDCQ 197
Query: 210 RWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSM 269
W A+ PH+H++PP VFP++ + ENYCRNAGG+EP PWC+T DP+ RWQ C+IP C D++
Sbjct: 198 SWSAQIPHSHDKPPDVFPQIRHGENYCRNAGGDEPMPWCFTTDPSTRWQHCDIPLC-DNV 256
Query: 270 QDDVKSWGNKIKALLEQFLSQPYFIVLAVI-FIPVASMLCLICVVCVIRLVKRNVDYAPA 328
V+ I +++ + ++L+ + F+ VA L+ ++ RL KR+ Y P
Sbjct: 257 TTKVEIEPKNI--MMDTLFNNTLVLILSALGFVIVAG--ALLSILLSQRLHKRHRGYNPT 312
Query: 329 PSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPG 388
+QDVNIDL KLP N +YH+T A+LNPKLE+LEFPRN+IIYVRDLGQGAFGRVFQAKAPG
Sbjct: 313 DNQDVNIDLDKLPNNEAYHKTSAQLNPKLEKLEFPRNNIIYVRDLGQGAFGRVFQAKAPG 372
Query: 389 LLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448
L+ EEFT VAVKMLK+EAS+ L DFEREACLLAEFDHPNIVKLLGVCA+G+PMCLLFE
Sbjct: 373 LVPGEEFTNVAVKMLKEEASDDLLRDFEREACLLAEFDHPNIVKLLGVCALGRPMCLLFE 432
Query: 449 YMGRGDLNDFLRICSPNNYINGTYSSME--SSIHRVPQLSTCDLITIALQIASGMVYLSD 506
YMGRGDLN+FLR CSP+NY+ S + +++ +LS DLI IALQ+ASGMVYLSD
Sbjct: 433 YMGRGDLNEFLRSCSPSNYVIRVPSVDDGGTTVGEPSRLSHMDLINIALQVASGMVYLSD 492
Query: 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK 566
RKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQDYYKGDE DAIPVRWMPLESILYNK
Sbjct: 493 RKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQDYYKGDEQDAIPVRWMPLESILYNK 552
Query: 567 YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLC 626
YTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKYIKEG +L+ PDNTP ++YDLMKLC
Sbjct: 553 YTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKYIKEGEVLRCPDNTPQSIYDLMKLC 612
Query: 627 WNMKPMNRPSFRTIYQTLWNIKRDLE 652
WN +P +RP+FRTIYQTL IK+DLE
Sbjct: 613 WNRRPSDRPTFRTIYQTLDGIKQDLE 638
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242021869|ref|XP_002431365.1| tyrosine-protein kinase transmembrane receptor Ror2 precursor, putative [Pediculus humanus corporis] gi|212516641|gb|EEB18627.1| tyrosine-protein kinase transmembrane receptor Ror2 precursor, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2161), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/627 (65%), Positives = 483/627 (77%), Gaps = 14/627 (2%)
Query: 28 MKQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCK 87
+ GYC+ Y G+ICK+YL +G VWFN S + GG LNEQI LWKE+I L PC
Sbjct: 30 LSSSAGYCALYRGEICKDYLVGSGYVWFNKSHD--GGWLNEQITTNLWKEIIVSLKEPCL 87
Query: 88 QAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSR 147
AA+KLLC YAFPQC + + LPLC EDC AV++ FC+NDWA I+ NK RGI KS+
Sbjct: 88 SAAKKLLCAYAFPQCSLQDNNAIGLPLCAEDCTAVKHLFCHNDWALIDYNKRRGIYLKSK 147
Query: 148 GHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLA 207
GHF LPNC+ LP ++ KP CSHA+LTEM +EITYDCI+GRGRFYQG +N T G+
Sbjct: 148 GHFTLPNCENLPSFKNAK-KPICSHAKLTEMPKEEITYDCIKGRGRFYQGNINHTQDGIL 206
Query: 208 CQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267
CQRWD++EPH H RPP VFPE+ N+EN+CRNAGGEEP+PWCYT++ ++RWQ C IP C +
Sbjct: 207 CQRWDSQEPHIHLRPPNVFPEIENAENFCRNAGGEEPTPWCYTVNSSIRWQHCSIPVCEN 266
Query: 268 SMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVA-SMLCLICVVCVI--RLVKRNVD 324
S V S N FL PY I+ IF V + L +I ++CV+ ++ K
Sbjct: 267 STGFKVNSENN----FFSPFLLTPYNIL---IFGAVGCAFLIVILLICVLFRKIRKYQSG 319
Query: 325 YAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQA 384
Y +D+NIDL +LP N +YH+T A+LNPKLE+LEFPRNDII++RDLGQGAFGRVFQA
Sbjct: 320 YNNPNLRDINIDLEELPSNQAYHKTGAQLNPKLEKLEFPRNDIIFIRDLGQGAFGRVFQA 379
Query: 385 KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444
KAPGL+K EEFTLVAVKMLKDEAS LQ DFEREACLLAEFDHPNIVKLLGVCA+GKPMC
Sbjct: 380 KAPGLVKGEEFTLVAVKMLKDEASPDLQVDFEREACLLAEFDHPNIVKLLGVCAIGKPMC 439
Query: 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504
LLFEYMGRGDLN+FLR CSP+NYI + V +L T DL++IA Q+ASGMVYL
Sbjct: 440 LLFEYMGRGDLNEFLRSCSPSNYIVRSVDDSGDFFKDV-RLQTLDLLSIAKQVASGMVYL 498
Query: 505 SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY 564
SDRKFVHRDLATRNCL++D M VKIADFGLS+K+YLQDYYKGDE+DAIPVRWMPLESIL+
Sbjct: 499 SDRKFVHRDLATRNCLVDDNMSVKIADFGLSQKIYLQDYYKGDEHDAIPVRWMPLESILF 558
Query: 565 NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMK 624
NKYTVE+DVWA+GVCLWEIFSFALQPYYG+ HEEVVKYIKEG +L PDNTP +Y+LMK
Sbjct: 559 NKYTVETDVWAYGVCLWEIFSFALQPYYGMNHEEVVKYIKEGKMLSCPDNTPWQVYELMK 618
Query: 625 LCWNMKPMNRPSFRTIYQTLWNIKRDL 651
CWN KP RPSFR I QTL +IK +L
Sbjct: 619 QCWNRKPQGRPSFRMICQTLDSIKDEL 645
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|307214737|gb|EFN89657.1| Tyrosine-protein kinase transmembrane receptor Ror2 [Harpegnathos saltator] | Back alignment and taxonomy information |
|---|
Score = 835 bits (2158), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/646 (63%), Positives = 488/646 (75%), Gaps = 14/646 (2%)
Query: 9 MYLTWILLNCGVLVMAQSEMKQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
+YL I L + A+SE GYC+ Y+G+ICK YL G+VWFN S ++ GG LNE
Sbjct: 7 VYLIAIFLRFSS-IQAKSE---SHGYCAPYSGEICKKYLAGIGKVWFNDSKDNPGGLLNE 62
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
QI LW E+I L PC+ AAEK+LC YAFP C S G LPLCYEDC+A+R FC+
Sbjct: 63 QITTDLWDELILRLVEPCRSAAEKMLCMYAFPLCHESVG----LPLCYEDCMAIRLQFCF 118
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
DWA IE+NK R I +SRGHF LP C++LPK V P CSH LT+M +++TYDCI
Sbjct: 119 TDWAIIEDNKQRDIYIRSRGHFVLPECESLPK--VNKTVPACSHVHLTDMDEEDVTYDCI 176
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
RG GRFY G +N T GL CQ W A+ PH+H++PP VFP++ ENYCRNAGG+EP PWC
Sbjct: 177 RGNGRFYMGKINKTKFGLNCQSWSAQIPHSHDKPPDVFPQIRYGENYCRNAGGDEPMPWC 236
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVI--FIPVASM 306
+T D ++RWQ C+IP C + ++ N + +E ++ +L+ + I V
Sbjct: 237 FTTDTSIRWQHCDIPVCDNVTSKVLEGEPNDPE--MEMLVTPAMIFMLSFVGFAIVVGIF 294
Query: 307 LCLICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRND 366
L ++ ++ +L KR Y P +QDVNIDL KLP N +YH+T A+LNPKLE+LEFPRN+
Sbjct: 295 LFVLFIMLSQKLHKRQRGYNPTDNQDVNIDLDKLPNNEAYHKTSAQLNPKLEKLEFPRNN 354
Query: 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
IIYVRDLGQGAFGRVFQAKAPGL+ EEFT VAVKMLK+EAS+ L DFEREACLLAEFD
Sbjct: 355 IIYVRDLGQGAFGRVFQAKAPGLVLGEEFTNVAVKMLKEEASDDLLVDFEREACLLAEFD 414
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNIVKLLGVCA+G+PMCLLFEYMGRGDLN+FLR CSP++Y+ + E +LS
Sbjct: 415 HPNIVKLLGVCALGRPMCLLFEYMGRGDLNEFLRSCSPSSYVIRSTQDREDGSAMDSRLS 474
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
DLI IALQ+ASGMVYLSDRKFVHRDLATRNCLINDQM+VKIADFGLS+K+YLQDYYKG
Sbjct: 475 HMDLINIALQVASGMVYLSDRKFVHRDLATRNCLINDQMIVKIADFGLSQKIYLQDYYKG 534
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
DE DAIPVRWMPLESILYNKYTVESDVWAF VCLWEIFSFALQPYYG+THEEVVKYIKEG
Sbjct: 535 DEQDAIPVRWMPLESILYNKYTVESDVWAFAVCLWEIFSFALQPYYGMTHEEVVKYIKEG 594
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
++L+ PDNTP ++Y LMKLCWN +P +RP+FRTIYQTL IK +LE
Sbjct: 595 DVLRCPDNTPQSIYYLMKLCWNRRPSDRPTFRTIYQTLDGIKHELE 640
|
Source: Harpegnathos saltator Species: Harpegnathos saltator Genus: Harpegnathos Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270015023|gb|EFA11471.1| hypothetical protein TcasGA2_TC014181 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 834 bits (2155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 404/648 (62%), Positives = 499/648 (77%), Gaps = 25/648 (3%)
Query: 9 MYLTWILLNCGVLVMAQSEMKQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE 68
MYL ILL V ++ E+ Q YC Y GKIC+NY+ + VWFN+S GG NE
Sbjct: 1 MYLLVILL--VVFSISNGEI---QSYCGIYGGKICENYVGHSKMVWFNNS----GGFENE 51
Query: 69 QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCY 128
+I ALW+E+I PC++AAEKLLC YAFP C N LPLC+EDCIAV+ FCY
Sbjct: 52 EITKALWREVIETFNEPCRRAAEKLLCFYAFPDCYLGN----PLPLCHEDCIAVKQLFCY 107
Query: 129 NDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188
+WA+IE+ K+ G FKSRGHF LP C+ LPKY++VN TCS+A L E+K DEIT+DCI
Sbjct: 108 KEWAHIEDRKSNGFVFKSRGHFRLPVCEKLPKYQIVNNTATCSYAGLVELKVDEITHDCI 167
Query: 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWC 248
+GRGRFYQG VN T GLACQRWD+++PH+H PP +FPEL NSENYCRNAGGEE PWC
Sbjct: 168 KGRGRFYQGNVNVTKDGLACQRWDSQKPHSHNSPPDIFPELKNSENYCRNAGGEEKKPWC 227
Query: 249 YTMDPNVRWQRCEIPTCADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLC 308
+T + +VRWQ C+IP C +S ++ + ++ FLS + I+ +VI + +L
Sbjct: 228 FTTNSSVRWQHCDIPRCPNSTSEESED----AAIAMDTFLSPSFLIIYSVIGLLGVIILT 283
Query: 309 LICVVCVIRLVKRNVDYAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDII 368
L+ ++C R+ K + Y P + +VNIDL KLP N +YH+ LNPKLE+LEFPRNDII
Sbjct: 284 LLILLCH-RIHKHRLGYNPTDTAEVNIDLDKLPSNMAYHRHGVTLNPKLEKLEFPRNDII 342
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
Y++DLGQGAFGRVFQAKAPGL+ EEFTLVAVKMLKD+ASE +Q DFE+EACLLAEFDHP
Sbjct: 343 YIKDLGQGAFGRVFQAKAPGLVSGEEFTLVAVKMLKDDASEDMQDDFEKEACLLAEFDHP 402
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYI-----NGTYSSMESSIHRVP 483
NIVKLLGVCA+G+PMCLLFEYMG+GDLN+FLR CSP+NY+ +G Y S + + +
Sbjct: 403 NIVKLLGVCAIGRPMCLLFEYMGKGDLNEFLRQCSPSNYVVRSVVDGEYGSRD--VFKDN 460
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
QL+ +L+ +ALQIASGMVYLSDRKFVHRDLATRNCLIN+ MVVKIADFGLS+K+YLQDY
Sbjct: 461 QLNHLELLEVALQIASGMVYLSDRKFVHRDLATRNCLINENMVVKIADFGLSQKIYLQDY 520
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
YKG E DAIPVRWMPLESILYNKYT ESDVWAFGVCLWEIFSFALQPY+G+THEEVV+++
Sbjct: 521 YKGSERDAIPVRWMPLESILYNKYTPESDVWAFGVCLWEIFSFALQPYFGMTHEEVVRFL 580
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
K GN+L +P+NTP A+Y +MK CW KP++RP+FRTI+QTL NI+ ++
Sbjct: 581 KAGNVLASPENTPAAIYQVMKDCWAQKPVDRPNFRTIHQTLTNIQSNM 628
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 653 | ||||||
| FB|FBgn0020391 | 724 | Nrk "Neurospecific receptor ki | 0.428 | 0.386 | 0.696 | 1e-191 | |
| UNIPROTKB|F1NDZ8 | 921 | MUSK "Muscle, skeletal recepto | 0.937 | 0.664 | 0.482 | 1.1e-160 | |
| UNIPROTKB|Q8AXY6 | 947 | MUSK "Muscle, skeletal recepto | 0.937 | 0.646 | 0.482 | 1.4e-160 | |
| ZFIN|ZDB-GENE-030131-6458 | 941 | musk "muscle, skeletal, recept | 0.923 | 0.640 | 0.476 | 7.2e-155 | |
| UNIPROTKB|O15146 | 869 | MUSK "Muscle, skeletal recepto | 0.471 | 0.354 | 0.637 | 4e-132 | |
| MGI|MGI:103581 | 868 | Musk "muscle, skeletal, recept | 0.470 | 0.353 | 0.638 | 2e-130 | |
| RGD|3211 | 868 | Musk "muscle, skeletal, recept | 0.470 | 0.353 | 0.638 | 2.6e-130 | |
| UNIPROTKB|Q62838 | 868 | Musk "Muscle, skeletal recepto | 0.470 | 0.353 | 0.638 | 2.6e-130 | |
| UNIPROTKB|E1BKP7 | 868 | MUSK "Uncharacterized protein" | 0.471 | 0.354 | 0.631 | 1e-128 | |
| UNIPROTKB|D4A5G5 | 878 | Musk "Muscle, skeletal recepto | 0.470 | 0.349 | 0.591 | 7.5e-120 |
| FB|FBgn0020391 Nrk "Neurospecific receptor kinase" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 1092 (389.5 bits), Expect = 1.0e-191, Sum P(2) = 1.0e-191
Identities = 200/287 (69%), Positives = 240/287 (83%)
Query: 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT 413
N +LE+LE+PR DI+YVR LGQGAFGRVFQA+APGL+ +E LVAVKMLKD+AS+ +Q
Sbjct: 428 NARLEKLEYPRGDIVYVRSLGQGAFGRVFQARAPGLVPDQEDLLVAVKMLKDDASDQMQM 487
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
DFEREACLLAEFDHPNIV+LLGVCA+G+PMCLLFEYM GDL++FLR CSP Y+
Sbjct: 488 DFEREACLLAEFDHPNIVRLLGVCALGRPMCLLFEYMAPGDLSEFLRACSP-------YA 540
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ ++ QL+ L+ +A IA+GM+YLS+RKFVHRDLATRNCLIN+ M VKIADFG
Sbjct: 541 THQAPTQDRLQLNELHLLQMAANIAAGMLYLSERKFVHRDLATRNCLINEHMAVKIADFG 600
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
LS K+YLQDYYKGDEND IP+RWMPLESILYNK+++ESDVWA+G+CLWE+FSFALQPY+G
Sbjct: 601 LSHKIYLQDYYKGDENDFIPIRWMPLESILYNKFSLESDVWAYGICLWEVFSFALQPYFG 660
Query: 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
LTHEEV+KYIKEGN+L PDNTP ++Y LM+ CWN KP RP F I
Sbjct: 661 LTHEEVIKYIKEGNVLGCPDNTPLSVYALMRRCWNRKPSERPGFAEI 707
|
|
| UNIPROTKB|F1NDZ8 MUSK "Muscle, skeletal receptor tyrosine protein kinase" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1565 (556.0 bits), Expect = 1.1e-160, P = 1.1e-160
Identities = 303/628 (48%), Positives = 394/628 (62%)
Query: 29 KQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQ 88
K GYCS Y G++C L+R V+FNSS + E +V W E+ + ++ C+
Sbjct: 285 KGDAGYCSTYRGEVCSAILSRNALVFFNSSYADPE-ETQELLVHTAWTELKTV-SSFCQP 342
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
AAE LLC Y F +C S P P+C E+C+AV+ +C+ +W +EEN RGI
Sbjct: 343 AAESLLCNYIFQECKPSGVGPAPKPICRENCLAVKDLYCFKEWLSMEENSQRGIYKPGLM 402
Query: 149 HFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLAC 208
LP C+ LP C+H + K + IT C G G+FYQG N T G+ C
Sbjct: 403 LLALPECNRLPSLH--QDPSACTHIPFFDFKKENITRTCYSGNGQFYQGWANVTASGIPC 460
Query: 209 QRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD- 267
Q+W + PH H+R P VFPEL+++ENYCRN GGE PWCYT DP+V W+ C + C D
Sbjct: 461 QKWSDQAPHLHKRTPQVFPELSDAENYCRNPGGENERPWCYTKDPSVTWEYCSVSPCGDA 520
Query: 268 SMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMXXXXXXXXXXXXXKRNVDYAP 327
S+ + + + L P + + +I I + +R +
Sbjct: 521 SLSLGTRKPNGETQNLPPPPSYSPTYSMNVIILIISSFALIVILGIITLVCCRRRKQWKN 580
Query: 328 APSQDVNIDLSKLPC---------NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAF 378
+ L+ LP N Y + LNPKL LE+PRN+I YVRD+G+GAF
Sbjct: 581 KKRESETPTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 640
Query: 379 GRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438
GRVFQA+APGLL +E FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCA
Sbjct: 641 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 700
Query: 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC--DLITIALQ 496
VGKPMCLLFEYM GDLN++LR SP N + +E+ + L+ C + IA Q
Sbjct: 701 VGKPMCLLFEYMAYGDLNEYLRDRSPRNLCSLVQGGLEARACLLNPLALCCTSQLCIAKQ 760
Query: 497 IASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRW 556
+A+GM YLS+RKFVHRDLATRNCL+ + MVVKIADFGLSR MY DYYK +ENDAIP+RW
Sbjct: 761 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNMYSADYYKANENDAIPIRW 820
Query: 557 MPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTP 616
MP ESI YN+YT ESDVWA+GV LWEIFS+ +QPYYG+ HEEV+ Y+++GNIL PDN P
Sbjct: 821 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNILSCPDNCP 880
Query: 617 DALYDLMKLCWNMKPMNRPSFRTIYQTL 644
LY+LM+LCW+ P +RPSF +I++ L
Sbjct: 881 LELYNLMRLCWSKLPADRPSFASIHRIL 908
|
|
| UNIPROTKB|Q8AXY6 MUSK "Muscle, skeletal receptor tyrosine protein kinase" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1564 (555.6 bits), Expect = 1.4e-160, P = 1.4e-160
Identities = 303/628 (48%), Positives = 393/628 (62%)
Query: 29 KQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQ 88
K GYCS Y G++C L+R V+FNSS + E +V W E+ + ++ C+
Sbjct: 311 KGDAGYCSTYRGEVCSAILSRNALVFFNSSYADPE-ETQELLVHTAWTELKTV-SSFCQP 368
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
AAE LLC Y F +C S P P+C E+C+AV+ +C+ +W +EEN RGI
Sbjct: 369 AAESLLCNYIFQECKPSGVGPAPKPICRENCLAVKDLYCFKEWLSMEENSQRGIYKPGLM 428
Query: 149 HFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLAC 208
LP C+ LP C+H + K + IT C G G+FYQG N T G+ C
Sbjct: 429 LLALPECNRLPSLH--QDPSACTHIPFFDFKKENITRTCYSGNGQFYQGWANVTASGIPC 486
Query: 209 QRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD- 267
Q+W + PH H R P VFPEL+++ENYCRN GGE PWCYT DP+V W+ C + C D
Sbjct: 487 QKWSDQAPHLHRRTPQVFPELSDAENYCRNPGGENERPWCYTKDPSVTWEYCSVSPCGDA 546
Query: 268 SMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMXXXXXXXXXXXXXKRNVDYAP 327
S+ + + + L P + + +I I + +R +
Sbjct: 547 SLSLGTRKPNGETQNLPPPPSYSPTYSMNVIILIISSFALIVILGIITLVCCRRRKQWKN 606
Query: 328 APSQDVNIDLSKLPC---------NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAF 378
+ L+ LP N Y + LNPKL LE+PRN+I YVRD+G+GAF
Sbjct: 607 KKRESETPTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAF 666
Query: 379 GRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438
GRVFQA+APGLL +E FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCA
Sbjct: 667 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 726
Query: 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC--DLITIALQ 496
VGKPMCLLFEYM GDLN++LR SP N + +E+ + L+ C + IA Q
Sbjct: 727 VGKPMCLLFEYMAYGDLNEYLRDRSPRNLCSLVQGGLEARACLLNPLALCCTSQLCIAKQ 786
Query: 497 IASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRW 556
+A+GM YLS+RKFVHRDLATRNCL+ + MVVKIADFGLSR MY DYYK +ENDAIP+RW
Sbjct: 787 VAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNMYSADYYKANENDAIPIRW 846
Query: 557 MPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTP 616
MP ESI YN+YT ESDVWA+GV LWEIFS+ +QPYYG+ HEEV+ Y+++GNIL PDN P
Sbjct: 847 MPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNILSCPDNCP 906
Query: 617 DALYDLMKLCWNMKPMNRPSFRTIYQTL 644
LY+LM+LCW+ P +RPSF +I++ L
Sbjct: 907 LELYNLMRLCWSKLPADRPSFASIHRIL 934
|
|
| ZFIN|ZDB-GENE-030131-6458 musk "muscle, skeletal, receptor tyrosine kinase" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1510 (536.6 bits), Expect = 7.2e-155, P = 7.2e-155
Identities = 299/627 (47%), Positives = 393/627 (62%)
Query: 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEK 92
GYCS Y G +C+N L R V+FN SL + D E + + W E+ + ++ C+ AA
Sbjct: 311 GYCSTYRGDVCRNVLRRDALVFFNYSLPNPE-DAQEYLAQSAWPELDGV-SSFCRPAARS 368
Query: 93 LLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFEL 152
LLC F C S P P+C E C+ V+ +CY +W EE RG + H L
Sbjct: 369 LLCHSTFQDCNPSGLGPAPKPVCREHCLTVKELYCYKEWRSAEERSQRGFQ-----HITL 423
Query: 153 PNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWD 212
P C +LP + +C+ ++K D++T C +GRFYQGT N T + CQRW+
Sbjct: 424 PECTSLPSQQA--DPSSCTAVPYVDIKKDQVTSTCYNDKGRFYQGTHNVTASSIPCQRWN 481
Query: 213 AKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQ-D 271
++PH H V PEL N+ENYCRN GGE PWCYT +PNVRW+ C +P C + +
Sbjct: 482 QQDPHQHRLSVDVIPELRNAENYCRNPGGESDRPWCYTTNPNVRWEYCLVPKCGEVISIR 541
Query: 272 DVKSWGNKIKALLEQFLSQPYF--IVLAVI--FIPVA--SMXXXXXXXXXXXXXKRNVDY 325
S +S Y +++ VI F A ++ KR
Sbjct: 542 TAPSITKPAHFYPPPSVSTAYSMSVIIFVIAGFAGAAFFTVLILMCHRRKKMWKKRKSRV 601
Query: 326 APAPSQDV---NIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVF 382
P+ + L +L N Y + LN KL LE+PRN+I YVRD+G+GAFGRVF
Sbjct: 602 LETPTLTTLPSELLLDRLHPNPMYQRLPLLLNSKLLSLEYPRNNIEYVRDIGEGAFGRVF 661
Query: 383 QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442
QA+APGLL E FT+VAVKMLK+EAS +Q DF+REA L++EFDHPNIV+LLGVCAVGKP
Sbjct: 662 QARAPGLLPTEPFTMVAVKMLKEEASTDMQNDFQREAALMSEFDHPNIVRLLGVCAVGKP 721
Query: 443 MCLLFEYMGRGDLNDFLRI-CS---PN-NYINGTYSSMESSIHRVPQLSTCDLITIALQI 497
MCL+FEYM GDLN+FLR C+ P+ + T SS+ S R P LS + ++I+ Q+
Sbjct: 722 MCLMFEYMAYGDLNEFLRRRCATQQPSLSRDTLTSSSLVSEPERYPPLSCQEQLSISKQV 781
Query: 498 ASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWM 557
A+GM YLS+RKFVHRDLATRNCL+ + +VVKIADFGLSR +Y DYYK ENDAIP+RWM
Sbjct: 782 AAGMAYLSERKFVHRDLATRNCLVAENLVVKIADFGLSRNIYAADYYKASENDAIPIRWM 841
Query: 558 PLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPD 617
P ESI YN+YT ESDVWA+GV LWEIFS+ +QPYYG+ HEEV+ Y+++GN+L P+N P
Sbjct: 842 PPESIFYNRYTSESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCPENCPQ 901
Query: 618 ALYDLMKLCWNMKPMNRPSFRTIYQTL 644
LY+LM+LCW+ P +RPSF +I++ L
Sbjct: 902 ELYNLMRLCWSGHPTDRPSFASIHRIL 928
|
|
| UNIPROTKB|O15146 MUSK "Muscle, skeletal receptor tyrosine-protein kinase" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1063 (379.3 bits), Expect = 4.0e-132, Sum P(3) = 4.0e-132
Identities = 199/312 (63%), Positives = 246/312 (78%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 545 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 604
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN
Sbjct: 605 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 664
Query: 457 DFLRICSPNNYINGTYS--SMESSIHRV--PQLSTCDLITIALQIASGMVYLSDRKFVHR 512
+FLR SP+ + ++S SM + + P LS + + IA Q+A+GM YLS+RKFVHR
Sbjct: 665 EFLRSMSPHTVCSLSHSDLSMRAQVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 724
Query: 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESD 572
DLATRNCL+ + MVVKIADFGLSR +Y DYYK +ENDAIP+RWMP ESI YN+YT ESD
Sbjct: 725 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKANENDAIPIRWMPPESIFYNRYTTESD 784
Query: 573 VWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPM 632
VWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 785 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILSCPENCPVELYNLMRLCWSKLPA 844
Query: 633 NRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 845 DRPSFTSIHRIL 856
|
|
| MGI|MGI:103581 Musk "muscle, skeletal, receptor tyrosine kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 1054 (376.1 bits), Expect = 2.0e-130, Sum P(2) = 2.0e-130
Identities = 200/313 (63%), Positives = 246/313 (78%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 544 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 603
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN
Sbjct: 604 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 663
Query: 457 DFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLSDRKFVH 511
+FLR SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS+RKFVH
Sbjct: 664 EFLRSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 722
Query: 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVES 571
RDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT ES
Sbjct: 723 RDLATRNCLVGETMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 782
Query: 572 DVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
DVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 783 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 842
Query: 632 MNRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 843 ADRPSFCSIHRIL 855
|
|
| RGD|3211 Musk "muscle, skeletal, receptor tyrosine kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 200/313 (63%), Positives = 246/313 (78%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 544 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 603
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN
Sbjct: 604 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 663
Query: 457 DFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLSDRKFVH 511
+FLR SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS+RKFVH
Sbjct: 664 EFLRSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 722
Query: 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVES 571
RDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT ES
Sbjct: 723 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 782
Query: 572 DVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
DVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 783 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 842
Query: 632 MNRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 843 ADRPSFCSIHRIL 855
|
|
| UNIPROTKB|Q62838 Musk "Muscle, skeletal receptor tyrosine protein kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 1055 (376.4 bits), Expect = 2.6e-130, Sum P(2) = 2.6e-130
Identities = 200/313 (63%), Positives = 246/313 (78%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 544 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 603
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN
Sbjct: 604 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 663
Query: 457 DFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLSDRKFVH 511
+FLR SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS+RKFVH
Sbjct: 664 EFLRSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 722
Query: 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVES 571
RDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT ES
Sbjct: 723 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 782
Query: 572 DVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
DVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 783 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 842
Query: 632 MNRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 843 ADRPSFCSIHRIL 855
|
|
| UNIPROTKB|E1BKP7 MUSK "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1046 (373.3 bits), Expect = 1.0e-128, Sum P(2) = 1.0e-128
Identities = 197/312 (63%), Positives = 244/312 (78%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 544 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 603
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN
Sbjct: 604 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 663
Query: 457 DFLRICSPNNYINGTYSSM----ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512
+FLR +P+ + S + ++S P LS + + IA Q+A+GM YLS+RKFVHR
Sbjct: 664 EFLRSMAPHPGRGLSPSDLPPGSQASSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 723
Query: 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESD 572
DLATRNCL+ + MVVKIADFGLSR +Y DYYK +ENDAIP+RWMP ESI YN+YT ESD
Sbjct: 724 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKANENDAIPIRWMPPESIFYNRYTTESD 783
Query: 573 VWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPM 632
VWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 784 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILSCPENCPLELYNLMRLCWSKVPA 843
Query: 633 NRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 844 DRPSFSSIHRIL 855
|
|
| UNIPROTKB|D4A5G5 Musk "Muscle, skeletal receptor tyrosine protein kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 952 (340.2 bits), Expect = 7.5e-120, Sum P(2) = 7.5e-120
Identities = 185/313 (59%), Positives = 233/313 (74%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT
Sbjct: 554 LDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFT 613
Query: 397 LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLG+ PM EY L+
Sbjct: 614 MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGMKTEENPMARYSEYAALWLLH 673
Query: 457 DFLRICSPNNYINGTYSSMESSIHRV-----PQLSTCDLITIALQIASGMVYLSDRKFVH 511
+FL SP+ + ++S + S+ RV P LS + + IA Q+A+GM YLS+RKFVH
Sbjct: 674 NFLGSMSPHTVCSLSHSDL-STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 732
Query: 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVES 571
RDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT ES
Sbjct: 733 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTES 792
Query: 572 DVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
DVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P
Sbjct: 793 DVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLP 852
Query: 632 MNRPSFRTIYQTL 644
+RPSF +I++ L
Sbjct: 853 ADRPSFCSIHRIL 865
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8AXY6 | MUSK_CHICK | 2, ., 7, ., 1, 0, ., 1 | 0.4904 | 0.9341 | 0.6441 | yes | N/A |
| Q62838 | MUSK_RAT | 2, ., 7, ., 1, 0, ., 1 | 0.5461 | 0.5574 | 0.4193 | yes | N/A |
| Q9V6K3 | ROR2_DROME | 2, ., 7, ., 1, 0, ., 1 | 0.5344 | 0.9111 | 0.8218 | yes | N/A |
| Q61006 | MUSK_MOUSE | 2, ., 7, ., 1, 0, ., 1 | 0.5488 | 0.5574 | 0.4193 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.10.2 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.10.1 | 0.914 |
| 3rd Layer | 2.7.10 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 653 | |||
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-166 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-121 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-120 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-119 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-118 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-110 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-106 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-100 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-94 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-91 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 7e-87 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-86 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-86 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-86 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-83 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-81 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-80 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-79 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-77 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-77 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-76 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-75 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-73 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-73 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-73 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-72 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-71 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-71 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-71 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-70 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-69 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 4e-69 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-69 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-68 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-68 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-68 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 8e-68 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-67 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-67 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-66 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-66 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-66 | |
| cd07469 | 147 | cd07469, CRD_TK_ROR_related, Cysteine-rich domain | 2e-65 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-65 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-65 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-63 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-62 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-62 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-61 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-61 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-60 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-60 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-60 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-59 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-58 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-58 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-58 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-57 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-57 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-57 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-56 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-55 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 6e-55 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-54 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-53 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-52 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-52 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-51 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-51 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-51 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-50 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-49 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-49 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-47 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-46 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-45 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-45 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-44 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-44 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-44 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-43 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-43 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 5e-41 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-40 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-40 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-38 | |
| cd00108 | 83 | cd00108, KR, Kringle domain; Kringle domains are b | 7e-38 | |
| smart00130 | 83 | smart00130, KR, Kringle domain | 4e-37 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-35 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-34 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-32 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-28 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-28 | |
| pfam00051 | 79 | pfam00051, Kringle, Kringle domain | 8e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-23 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-23 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 5e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-21 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-19 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 7e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-19 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-18 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-18 | |
| cd07459 | 135 | cd07459, CRD_TK_ROR_like, Cysteine-rich domain of | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-18 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-18 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-18 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-18 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-15 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-15 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 8e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-14 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-14 | |
| pfam01392 | 108 | pfam01392, Fz, Fz domain | 8e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-13 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-13 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-13 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-13 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 9e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-12 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-12 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-12 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-11 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 6e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-10 | |
| cd07467 | 142 | cd07467, CRD_TK_ROR1, Cysteine-rich domain of tyro | 4e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-10 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-10 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-10 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 7e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-08 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-08 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-08 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-07 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-07 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 8e-07 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-06 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-05 | |
| cd07468 | 140 | cd07468, CRD_TK_ROR2, Cysteine-rich domain of tyro | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-05 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-05 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-04 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-04 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 0.001 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.001 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 0.001 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 0.001 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 0.001 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.003 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 477 bits (1229), Expect = e-166
Identities = 187/286 (65%), Positives = 227/286 (79%), Gaps = 2/286 (0%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E+PRN+I YVRD+GQGAFGRVFQA+APGLL +E FT+VAVKMLK+EAS +Q DF+REA
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME--SS 478
L+AEFDHPNIVKLLGVCAVGKPMCLLFEYM GDLN+FLR SP + ++S+
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
LS + + IA Q+A+GM YLS+RKFVHRDLATRNCL+ + MVVKIADFGLSR +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
Y DYYK ENDAIP+RWMP ESI YN+YT ESDVWA+GV LWEIFS+ +QPYYG+ HEE
Sbjct: 181 YSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240
Query: 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
V+ Y+++GN+L PDN P LY+LM+LCW+ P +RPSF +I + L
Sbjct: 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 360 bits (926), Expect = e-121
Identities = 124/270 (45%), Positives = 172/270 (63%), Gaps = 13/270 (4%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+GAFG V++ K G T VAVK LK++ASE + DF +EA ++ + HPN+V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKT--TEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
LLGVC +P+ L+ EYM GDL D+LR P LS DL++
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVF-----------PSPEKSTLSLKDLLS 109
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
A+QIA GM YL+ +KFVHRDLA RNCL+ + +VVKI+DFGLSR +Y DYY+ +
Sbjct: 110 FAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKL 169
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
P+RWM ES+ +T +SDVW+FGV LWEIF+ PY GL++EEV++Y+++G L P
Sbjct: 170 PIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKP 229
Query: 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ PD LY+LM CW + P +RP+F + +
Sbjct: 230 EYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 359 bits (923), Expect = e-120
Identities = 123/278 (44%), Positives = 172/278 (61%), Gaps = 20/278 (7%)
Query: 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
+ + LG+GAFG V++ G T VAVK LK+ ASE + +F EA ++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGD-GEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS 59
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNIV+LLGVC G+P+ ++ EYM GDL DFLR +L+
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR-------------------KHGEKLT 100
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
DL+ +ALQIA GM YL + FVHRDLA RNCL+ + +VVKI+DFGLSR +Y DYY+
Sbjct: 101 LKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRK 160
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
+P++WM ES+ K+T +SDVW+FGV LWEIF+ QPY G+++EEV++ +++G
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L P+N PD LY+LM CW P +RP+F + + L
Sbjct: 221 YRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 354 bits (910), Expect = e-119
Identities = 126/278 (45%), Positives = 173/278 (62%), Gaps = 20/278 (7%)
Query: 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
+ + LG+GAFG V++ G +E VAVK LK++ASE +F REA ++ + D
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKE-VEVAVKTLKEDASEQQIEEFLREARIMRKLD 59
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNIVKLLGVC +P+ ++ EYM GDL D+LR +R +LS
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK------------------NRPKELS 101
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
DL++ ALQIA GM YL + F+HRDLA RNCL+ + +VVKI+DFGLSR +Y DYYK
Sbjct: 102 LSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKV 161
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
+P+RWM ES+ K+T +SDVW+FGV LWEIF+ +PY G+++ EV++Y+K+G
Sbjct: 162 K-GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG 220
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L P N P LY LM CW P +RP+F + + L
Sbjct: 221 YRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 352 bits (907), Expect = e-118
Identities = 126/274 (45%), Positives = 171/274 (62%), Gaps = 21/274 (7%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+ LG+GAFG V++ K G ++ VAVK LK++ASE +F REA ++ + DHPN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVE-VAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
VKLLGVC +P+ ++ EYM GDL +LR P LS DL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK-------------------LSLSDL 104
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
++ ALQIA GM YL + F+HRDLA RNCL+ + +VVKI+DFGLSR +Y DYY+
Sbjct: 105 LSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKR-GG 163
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
+P+RWM ES+ K+T +SDVW+FGV LWEIF+ QPY G+++EEV++Y+K G L
Sbjct: 164 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLP 223
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P N P LYDLM CW P +RP+F + + L
Sbjct: 224 QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 332 bits (852), Expect = e-110
Identities = 138/284 (48%), Positives = 186/284 (65%), Gaps = 6/284 (2%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
R+ I+ R+LG+GAFG+VF + L + LVAVK LK+ AS + DFEREA
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAE 60
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
LL F H NIVK GVC G P ++FEYM GDLN FLR P+ + ++S
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPD------AAFLKSPDS 114
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ +L+ L+ IA+QIASGMVYL+ + FVHRDLATRNCL+ +VVKI DFG+SR +Y
Sbjct: 115 PMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYT 174
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ + +P+RWMP ESI+Y K+T ESDVW+FGV LWEIF++ QP+YGL++EEV+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI 234
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ I +G +LQ P P +YD+M CW P R + + I++ L
Sbjct: 235 ECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 322 bits (827), Expect = e-106
Identities = 130/284 (45%), Positives = 184/284 (64%), Gaps = 4/284 (1%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E P + + ++ +LG+GAFG+V++ + G + T VA+K LK+ A +Q +F +EA
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAE 60
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L+++ HPNIV LLGVC +P C+LFEY+ GDL++FL SP++ +
Sbjct: 61 LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVK-- 118
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L D + IA+QIA+GM YLS FVHRDLA RNCL+ + + VKI+DFGLSR +Y
Sbjct: 119 --SSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PVRWMP E+ILY K+T ESD+W+FGV LWEIFS+ LQPYYG +++EV+
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ I+ +L P++ P +Y LM CWN P RP F+ I+ L
Sbjct: 237 EMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 306 bits (786), Expect = e-100
Identities = 117/280 (41%), Positives = 172/280 (61%), Gaps = 10/280 (3%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR I +R+LGQG+FG V++ A G++K E T VA+K + + AS + +F EA
Sbjct: 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEAS 61
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ EF+ ++V+LLGV + G+P ++ E M +GDL +LR P N
Sbjct: 62 VMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGP------ 115
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ I +A +IA GM YL+ +KFVHRDLA RNC++ + + VKI DFG++R +Y
Sbjct: 116 ----PTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PVRWM ES+ +T +SDVW+FGV LWE+ + A QPY GL++EEV+
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
K++ +G L P+N PD L +LM++CW P RP+F I
Sbjct: 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 293 bits (751), Expect = 2e-94
Identities = 124/303 (40%), Positives = 164/303 (54%), Gaps = 28/303 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLK-----------HEEFTLVAVKMLKDEASE 409
EFPR + +V LG+G FG V +A GL + LVAVK+L+ +AS+
Sbjct: 1 EFPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD 60
Query: 410 YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN 469
+ DF +E +L+ PNI +LLGVC V P+C++ EYM GDLN FL+
Sbjct: 61 NAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVA----- 115
Query: 470 GTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529
LS L+ +A QIASGM YL FVHRDLATRNCL+ +KI
Sbjct: 116 ----ETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKI 171
Query: 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA-L 588
ADFG+SR +Y DYY+ +P+RWM ES+L K+T +SDVWAFGV LWEI +
Sbjct: 172 ADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE 231
Query: 589 QPYYGLTHEEVVKYIKEGN-------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
QPY LT ++V++ L P N P +Y+LM CW +RP+FR I+
Sbjct: 232 QPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIH 291
Query: 642 QTL 644
L
Sbjct: 292 LFL 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 284 bits (729), Expect = 1e-91
Identities = 133/281 (47%), Positives = 178/281 (63%), Gaps = 6/281 (2%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
R DI+ +LG+GAFG+VF A+ LL ++ LVAVK LK EASE + DF+REA LL
Sbjct: 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALK-EASESARQDFQREAELLT 62
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
H +IV+ GVC G+P+ ++FEYM GDLN FLR P+ I
Sbjct: 63 VLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKI-----LAGGEDVAPG 117
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
QL+ ++ IA QIASGMVYL+ FVHRDLATRNCL+ +VVKI DFG+SR +Y DY
Sbjct: 118 QLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY 177
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y+ +P+RWMP ESILY K+T ESD+W+FGV LWEIF++ QP+Y L++ E ++ I
Sbjct: 178 YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+G L+ P P +Y +M+ CW +P R + I+ L
Sbjct: 238 TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 273 bits (698), Expect = 7e-87
Identities = 133/286 (46%), Positives = 189/286 (66%), Gaps = 8/286 (2%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
R++I+ R+LG+GAFG+VF A+ L ++ LVAVK LKD AS+ + DF REA LL
Sbjct: 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD-ASDNARKDFHREAELLT 62
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
H +IVK GVC G P+ ++FEYM GDLN FLR P+ + + + +R
Sbjct: 63 NLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPD-------AVLMAEGNRPA 115
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+L+ ++ IA QIA+GMVYL+ + FVHRDLATRNCL+ + ++VKI DFG+SR +Y DY
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y+ + +P+RWMP ESI+Y K+T ESDVW+ GV LWEIF++ QP+Y L++ EV++ I
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649
+G +LQ P P +YDLM CW +P R + + I+ L N+ +
Sbjct: 236 TQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 272 bits (696), Expect = 1e-86
Identities = 124/286 (43%), Positives = 189/286 (66%), Gaps = 8/286 (2%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKA--PGLLKHEEFTLVAVKMLKDEASEYLQTDFERE 418
E P + + ++ +LG+ AFG++++ PG+ + LVA+K LKD + +F++E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGM---DHAQLVAIKTLKDINNPQQWGEFQQE 57
Query: 419 ACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
A L+AE HPNIV LLGV +P+C+LFEY+ +GDL++FL + SP++ + G S + +
Sbjct: 58 ASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDV-GCSSDEDGT 116
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
+ L D + IA+QIA+GM YLS FVH+DLA RN LI +Q+ VKI+D GLSR++
Sbjct: 117 VKS--SLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
Y DYY+ +P+RWMP E+I+Y K++ +SD+W+FGV LWEIFSF LQPYYG +++E
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
Query: 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
V++ +++ +L ++ P +Y LM CW P RP F+ I+ L
Sbjct: 235 VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 272 bits (696), Expect = 1e-86
Identities = 131/281 (46%), Positives = 182/281 (64%), Gaps = 5/281 (1%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
R DI+ R+LG+GAFG+VF A+ L ++ LVAVK LKD + + DF+REA LL
Sbjct: 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLT 62
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
H +IVK GVC G P+ ++FEYM GDLN FLR P+ I ++
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAK----G 118
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+L ++ IA QIASGMVYL+ + FVHRDLATRNCL+ ++VKI DFG+SR +Y DY
Sbjct: 119 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y+ + +P+RWMP ESI+Y K+T ESDVW+FGV LWEIF++ QP++ L++ EV++ I
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI 238
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+G +L+ P P +YD+M CW +P R + + IY+ L
Sbjct: 239 TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 2e-86
Identities = 121/294 (41%), Positives = 176/294 (59%), Gaps = 17/294 (5%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
+ E PR+ + + LG+GAFG+V +A+A GL E + VAVKMLKD+A+E +D
Sbjct: 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSD--- 61
Query: 418 EACLLAEFD-------HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYING 470
L++E + H NI+ LLGVC P+ ++ EY G+L DFLR P G
Sbjct: 62 ---LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP----G 114
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530
Y+S + L+ DL++ A Q+A GM +L+ +K +HRDLA RN L+ + V+KIA
Sbjct: 115 EYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIA 174
Query: 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
DFGL+R ++ DYY+ N +PV+WM E++ YT +SDVW+FGV LWEIF+ P
Sbjct: 175 DFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
Y G+ EE+ K +KEG ++ P N LY LM+ CW+ P RP+F+ + + L
Sbjct: 235 YPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 2e-83
Identities = 112/284 (39%), Positives = 167/284 (58%), Gaps = 13/284 (4%)
Query: 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACL 421
FPR+++ + LG+G FG VF AKA G+ + TLV VK L+ E LQ++F RE +
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
+ H N+V+LLG+C +P ++ EY GDL FLR + + +
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRA-----------TKSKDEKLK 110
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
P LST + + QIA GM +LS+ +FVHRDLA RNCL++ Q VK++ LS+ +Y
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+YYK N IP+RW+ E++ + ++ +SDVW+FGV +WE+F+ P+YGL+ EEV+
Sbjct: 171 EYYK-LRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLN 229
Query: 602 YIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
++ G + L P+ P LY LM CW + P +RPSF + L
Sbjct: 230 RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 257 bits (659), Expect = 2e-81
Identities = 118/280 (42%), Positives = 167/280 (59%), Gaps = 19/280 (6%)
Query: 373 LGQGAFGRVFQAKAPGLLKH-EEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV 431
LG GAFG V++ A +L VAVK L+ A++ + +F +EA L++ F+HPNIV
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
KLLGVC + +P ++ E M GDL +LR + +E P L+ +L+
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLR-----------DARVERF--GPPLLTLKELL 109
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLINDQ-----MVVKIADFGLSRKMYLQDYYKG 546
I L +A G VYL F+HRDLA RNCL++++ VVKI DFGL+R +Y DYY+
Sbjct: 110 DICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
+ +PVRWM ES+L K+T +SDVW+FGV +WEI + QPY L ++EV++++ G
Sbjct: 170 EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646
LQ P+N PD +Y LM CW P RP+F I + L N
Sbjct: 230 GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 254 bits (650), Expect = 6e-80
Identities = 119/284 (41%), Positives = 174/284 (61%), Gaps = 10/284 (3%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R I R+LGQG+FG V++ A G++K E T VA+K + + AS + +F EA
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 61
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ EF+ ++V+LLGV + G+P ++ E M RGDL +LR P + +
Sbjct: 62 VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE--------MENNPVQ 113
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
P L +I +A +IA GM YL+ KFVHRDLA RNC++ + VKI DFG++R +Y
Sbjct: 114 APPSLKK--MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PVRWM ES+ +T SDVW+FGV LWEI + A QPY G+++E+V+
Sbjct: 172 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+++ EG +L PDN PD L++LM++CW P RPSF I ++
Sbjct: 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 253 bits (648), Expect = 2e-79
Identities = 128/303 (42%), Positives = 170/303 (56%), Gaps = 28/303 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFT---------LVAVKMLKDEASE 409
EFPR + + LG+G FG V +A G+ K ++F+ LVAVKML+++A++
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANK 60
Query: 410 YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN 469
+ DF +E +++ PNI++LL VC P+C++ EYM GDLN FL P
Sbjct: 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQE--- 117
Query: 470 GTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529
+ V +S LI +A QIASGM YLS FVHRDLATRNCL+ +KI
Sbjct: 118 ------AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKI 171
Query: 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL- 588
ADFG+SR +Y DYY+ +P+RWM ESIL K+T SDVWAFGV LWEI +
Sbjct: 172 ADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231
Query: 589 QPYYGLTHEEVVKYIKE-------GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
QPY L+ E+V++ E L P PD+LY LM CW RPSF+ I+
Sbjct: 232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291
Query: 642 QTL 644
TL
Sbjct: 292 ATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 2e-77
Identities = 111/287 (38%), Positives = 157/287 (54%), Gaps = 16/287 (5%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR+ I +R LG GAFG V++ G VAVK L + SE ++DF EA
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++++F+H NIV+L+GV P +L E M GDL FLR P
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPR-------------PE 108
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND---QMVVKIADFGLSRK 537
R L+ DL+ A +A G YL + F+HRD+A RNCL+ V KIADFG++R
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+Y YY+ +P++WMP E+ L +T ++DVW+FGV LWEIFS PY G T++
Sbjct: 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
EV++++ G L P P +Y +M CW P +RP+F TI + +
Sbjct: 229 EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 9e-77
Identities = 122/301 (40%), Positives = 174/301 (57%), Gaps = 25/301 (8%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH-----EEFT----LVAVKMLKDEASEYL 411
EFPR + LG+G FG V +A GL + EF LVAVKML+ + ++
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 412 QTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
+ DF +E +++ +PNI++LLGVC P+C++ EYM GDLN FL I T
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS----QREIEST 116
Query: 472 YSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531
++ + +P +S +L+ +A+QIASGM YL+ FVHRDLATRNCL+ + +KIAD
Sbjct: 117 FTHANN----IPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIAD 172
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL-QP 590
FG+SR +Y DYY+ +P+RWM ESIL K+T SDVWAFGV LWE+F+ QP
Sbjct: 173 FGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232
Query: 591 YYGLTHEEVVK-----YIKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
Y L+ E+V++ + +G L P ++ LM CW+ +RP+F I+
Sbjct: 233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHF 292
Query: 644 L 644
L
Sbjct: 293 L 293
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 244 bits (623), Expect = 8e-76
Identities = 121/291 (41%), Positives = 174/291 (59%), Gaps = 13/291 (4%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R I +R+LGQG+FG V++ A ++K E T VAVK + + AS + +F EA
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ F ++V+LLGV + G+P ++ E M GDL +LR P E++
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEA---------ENNPG 112
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R P + ++I +A +IA GM YL+ +KFVHRDLA RNC++ VKI DFG++R +Y
Sbjct: 113 RPPP-TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PVRWM ES+ +T SD+W+FGV LWEI S A QPY GL++E+V+
Sbjct: 172 TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
K++ +G L PDN P+ + DLM++CW P RP+F I L K DL
Sbjct: 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL---KDDL 279
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 241 bits (618), Expect = 3e-75
Identities = 102/282 (36%), Positives = 158/282 (56%), Gaps = 25/282 (8%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
+ + + +G G FG V + G LK ++ VA+K LK +S+ + DF EA ++
Sbjct: 4 SYVTIEKVIGGGEFGEVCR----GRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIM 59
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+FDHPNI++L GV +P+ ++ EYM G L+ FLR
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR-------------------END 100
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + L+ + IASGM YLS+ +VHRDLA RN L+N +V K++DFGLSR++ +
Sbjct: 101 GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE 160
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ IP+RW E+I Y K+T SDVW+FG+ +WE+ S+ +PY+ +++++V+K
Sbjct: 161 ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA 220
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+++G L P + P ALY LM CW RP+F I TL
Sbjct: 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (606), Expect = 1e-73
Identities = 99/278 (35%), Positives = 149/278 (53%), Gaps = 24/278 (8%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
++LG G FG V + L+K + VAVK LK E + +F REA ++A+ DHP I
Sbjct: 1 KELGHGNFGSVVKGVY--LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCI 58
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V+L+GVC G+P+ L+ E G L +L+ + ++ DL
Sbjct: 59 VRLIGVC-KGEPLMLVMELAPLGPLLKYLK--------------------KRREIPVSDL 97
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDEN 549
+A Q+A GM YL + FVHRDLA RN L+ ++ KI+DFG+SR + DYY+
Sbjct: 98 KELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
P++W E I Y K++ +SDVW++GV LWE FS+ +PY + EV+ ++ G L
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
P+ P +Y +M CW +P +RP+F + T
Sbjct: 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 238 bits (607), Expect = 2e-73
Identities = 112/278 (40%), Positives = 176/278 (63%), Gaps = 8/278 (2%)
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
++ +LG+ FG+V++ G E+ VA+K LKD+A L+ +F+ EA + + HP
Sbjct: 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHP 68
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS--SMESSIHRVPQLS 486
NIV LLGV +P+ ++F Y DL++FL + SP++ + T +++S+ L
Sbjct: 69 NIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST------LE 122
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
D + I QIA+GM +LS VH+DLATRN L+ D++ VKI+D GL R++Y DYYK
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL 182
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
N +P+RWM E+I+Y K++++SD+W++GV LWE+FS+ LQPY G ++++V++ I+
Sbjct: 183 MGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNR 242
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+L PD+ P +Y LM CWN P RP F+ I+ L
Sbjct: 243 QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 237 bits (605), Expect = 2e-73
Identities = 112/287 (39%), Positives = 166/287 (57%), Gaps = 29/287 (10%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTL--VAVKMLKDEASEYLQT-DFEREACLLAEFDH 427
+ LG+G FG V + + L ++ + VAVK +K + Y + +F EA + +FDH
Sbjct: 5 KILGEGEFGSVMEGQ----LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 428 PNIVKLLGVC-------AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
PN++KL+GVC + KPM +L +M GDL+ FL YS +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVIL-PFMKHGDLHSFL-----------LYSRLGGLPE 108
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
++P L+ + IA GM YLS+R F+HRDLA RNC++ + M V +ADFGLS+K+Y
Sbjct: 109 KLP---LQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYS 165
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PV+W+ +ES+ YT +SDVWAFGV +WEI + PY G+ + E+
Sbjct: 166 GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY 225
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
Y++ GN L+ P++ D LYDLM CW P +RP+F + + L NI
Sbjct: 226 DYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 234 bits (598), Expect = 9e-72
Identities = 118/290 (40%), Positives = 173/290 (59%), Gaps = 13/290 (4%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH--EEFTLVAVKMLKDEASEYLQTDFERE 418
EFPR+ ++ + LG+G FG+V +A+A G+ K ++ VAVKMLKD A++ D E
Sbjct: 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE 67
Query: 419 ACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRI---CSPNNYINGTYSS 474
L+ H NI+ LLGVC P+ ++ EY +G+L +FLR P+ + T
Sbjct: 68 MELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVP 127
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
E QLS DL++ A Q+A GM YL R+ +HRDLA RN L+ + V+KIADFGL
Sbjct: 128 EE-------QLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
+R ++ DYYK N +PV+WM E++ YT +SDVW+FG+ +WEIF+ PY G+
Sbjct: 181 ARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
EE+ K ++EG+ + P N LY LM+ CW+ P RP+F+ + + L
Sbjct: 241 PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 4e-71
Identities = 106/284 (37%), Positives = 153/284 (53%), Gaps = 27/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + R LG G FG V+ G K VAVK LK F +EA
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTK------VAVKTLKPGTMS--PEAFLQEAQ 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + H +V+L VC+ +P+ ++ EYM +G L DFL+ S E
Sbjct: 54 IMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK-------------SGEGKKL 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R+PQL + +A QIA GM YL R ++HRDLA RN L+ + +V KIADFGL+R +
Sbjct: 101 RLPQL-----VDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR-LIE 154
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
D Y E P++W E+ Y ++T++SDVW+FG+ L EI ++ PY G+T+ EV+
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ ++ G + P N P+ LYDLM CW+ P RP+F + L
Sbjct: 215 EQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 231 bits (592), Expect = 5e-71
Identities = 123/308 (39%), Positives = 169/308 (54%), Gaps = 32/308 (10%)
Query: 345 SYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK 404
Y D P + EFPRN++ + + LG GAFG+V +A A GL K + VAVKMLK
Sbjct: 15 EYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK 74
Query: 405 DEASEYLQTDFEREACLLAEF-------DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLND 457
A EREA L++E +H NIV LLG C +G P+ ++ EY GDL +
Sbjct: 75 PTAHSS-----EREA-LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 458 FLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517
FLR ES L+ DL++ + Q+A GM +L+ + +HRDLA R
Sbjct: 129 FLR------------RKRESF------LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 170
Query: 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFG 577
N L+ +VKI DFGL+R + Y N +PV+WM ESI YT ESDVW++G
Sbjct: 171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYG 230
Query: 578 VCLWEIFSFALQPYYGL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ LWEIFS PY G+ + K IKEG + P++ P +YD+MK CW+ P+ RP+
Sbjct: 231 ILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT 290
Query: 637 FRTIYQTL 644
F+ I Q +
Sbjct: 291 FKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 231 bits (591), Expect = 6e-71
Identities = 126/305 (41%), Positives = 173/305 (56%), Gaps = 24/305 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVF--QAKAPGLLKHEEFT---------LVAVKMLKDEASE 409
+FPR +++ LG+G FG V + P L +F LVAVK+L+ +A++
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 410 YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN 469
+ DF +E +L+ PNI++LLGVC P+C++ EYM GDLN FL S ++ +
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDD 117
Query: 470 GTYSSMES--SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
+ ++ H +P +S L+ +ALQIASGM YLS FVHRDLATRNCL+ + + +
Sbjct: 118 KEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTI 177
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587
KIADFG+SR +Y DYY+ +P+RWM E IL K+T SDVWAFGV LWEI
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237
Query: 588 L-QPYYGLTHEEVVKYIKE-------GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639
QPY LT E+V++ E L P P LY+LM CW+ RPSF
Sbjct: 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSD 297
Query: 640 IYQTL 644
I+ L
Sbjct: 298 IHAFL 302
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 227 bits (580), Expect = 6e-70
Identities = 103/274 (37%), Positives = 151/274 (55%), Gaps = 25/274 (9%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+G+G FG V++ LK T VAVK + L+ F +EA +L ++DHPNI
Sbjct: 1 EKIGKGNFGDVYKGV----LKGN--TEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNI 54
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
VKL+GVC +P+ ++ E + G L FLR N +L+ L
Sbjct: 55 VKLIGVCVQKQPIYIVMELVPGGSLLTFLR--KKKN-----------------RLTVKKL 95
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ ++L A+GM YL + +HRDLA RNCL+ + V+KI+DFG+SR+ Y D
Sbjct: 96 LQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
IP++W E++ Y +YT ESDVW++G+ LWE FS PY G+++++ + I+ G +
Sbjct: 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP 215
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
AP P+ +Y LM CW P NRPSF IY L
Sbjct: 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 3e-69
Identities = 123/290 (42%), Positives = 168/290 (57%), Gaps = 35/290 (12%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEE--FTLVAVKMLKDEASEYLQTDFE---REACLLAEF 425
R LG+G FG V +A LK E+ F VAVKMLK A + +D E REA + EF
Sbjct: 5 RMLGKGEFGSVREA----QLKSEDGSFQKVAVKMLK--ADIFSSSDIEEFLREAACMKEF 58
Query: 426 DHPNIVKLLGVC----AVGK---PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
DHPN++KL+GV A G+ PM +L +M GDL+ FL + S
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVIL-PFMKHGDLHTFL---------------LMSR 102
Query: 479 IHRVP-QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
I P L L+ + IASGM YLS + F+HRDLA RNC++N+ M V +ADFGLS+K
Sbjct: 103 IGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+Y DYY+ +PV+W+ LES+ N YT SDVWAFGV +WEI + PY G+ +
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
E+ Y+ +GN L+ P + + +Y+LM CW+ +P RPSF+ + L I
Sbjct: 223 EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 4e-69
Identities = 120/297 (40%), Positives = 178/297 (59%), Gaps = 15/297 (5%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH--EEFTLVAVKMLKDEASEYLQ 412
P+ + EF R+ + + LG+G FG+V A+A G+ K +E VAVKMLKD+A+E
Sbjct: 5 PEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL 64
Query: 413 TDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
+D E ++ H NI+ LLG C P+ ++ EY +G+L ++LR P
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP------- 117
Query: 472 YSSMESS--IHRVP--QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
ME S I RVP Q++ DL++ Q+A GM YL+ +K +HRDLA RN L+ + V+
Sbjct: 118 -PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVM 176
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587
KIADFGL+R + DYYK N +PV+WM E++ YT +SDVW+FGV +WEIF+
Sbjct: 177 KIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLG 236
Query: 588 LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
PY G+ EE+ K +KEG+ + P N + LY +M+ CW+ P +RP+F+ + + L
Sbjct: 237 GSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 226 bits (577), Expect = 7e-69
Identities = 118/293 (40%), Positives = 174/293 (59%), Gaps = 7/293 (2%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--EFTLVAVKMLKDEASEYLQ 412
P+ + E PR+ ++ + LG+G FG+V A+A GL K + T VAVKMLK +A+E
Sbjct: 8 PEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL 67
Query: 413 TDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
+D E ++ H NI+ LLG C P+ ++ EY +G+L ++LR P G
Sbjct: 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP----GM 123
Query: 472 YSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531
+ QLS DL++ A Q+A GM YL+ +K +HRDLA RN L+ + V+KIAD
Sbjct: 124 EYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 183
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
FGL+R ++ DYYK N +PV+WM E++ YT +SDVW+FGV LWEIF+ PY
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
G+ EE+ K +KEG+ + P N + LY +M+ CW+ P RP+F+ + + L
Sbjct: 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 2e-68
Identities = 107/282 (37%), Positives = 154/282 (54%), Gaps = 22/282 (7%)
Query: 375 QGAFGRVFQAKAPGLLKHEEFTL---VAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV 431
+G FGR+F G+L E+ V VK +KD ASE T +E+CLL H NI+
Sbjct: 16 EGTFGRIFY----GILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 432 KLLGVCA--VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+L VC P +L+ YM G+L FL+ C + LST
Sbjct: 72 PILHVCIEDGEPPF-VLYPYMNWGNLKLFLQQCR------------LGEANNPQALSTQQ 118
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
L+ +A+QIA GM YL R +H+D+A RNC+I++++ VKI D LSR ++ DY+ +N
Sbjct: 119 LVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDN 178
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
+ PV+WM LES++ +Y+ SDVW+FGV LWE+ + PY + E+ Y+K+G L
Sbjct: 179 ENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRL 238
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
P N PD L+ +M CW + P RPSF + Q L + L
Sbjct: 239 AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 223 bits (571), Expect = 2e-68
Identities = 101/288 (35%), Positives = 152/288 (52%), Gaps = 23/288 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R DI R +G+G FG V+Q + E VAVK K+ S ++ F +EA
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVY--MSPENEKIAVAVKTCKNCTSPSVREKFLQEAY 59
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +FDHP+IVKL+GV P+ ++ E G+L +L++
Sbjct: 60 IMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQV------------------- 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L LI + Q+++ + YL ++FVHRD+A RN L++ VK+ DFGLSR +
Sbjct: 100 NKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ YYK + +P++WM ESI + ++T SDVW FGVC+WEI ++P+ G+ + +V+
Sbjct: 160 ESYYKASKG-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648
I+ G L P N P LY LM CW P RP F + L +I
Sbjct: 219 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 6e-68
Identities = 109/287 (37%), Positives = 164/287 (57%), Gaps = 26/287 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R DI LG G +G V++ G+ K T VAVK LK++ E +F +EA
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYE----GVWKKYSLT-VAVKTLKEDTMEV--EEFLKEAA 54
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ E HPN+V+LLGVC P ++ E+M G+L D+LR C+
Sbjct: 55 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--------------- 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+++ L+ +A QI+S M YL + F+HRDLA RNCL+ + +VK+ADFGLSR M
Sbjct: 100 ---EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT- 155
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
D Y P++W ES+ YNK++++SDVWAFGV LWEI ++ + PY G+ +V
Sbjct: 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
+ +++G ++ P+ P +Y+LM+ CW P +RPSF I+Q +
Sbjct: 216 ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 8e-68
Identities = 99/280 (35%), Positives = 153/280 (54%), Gaps = 30/280 (10%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAE 424
++ ++++LG G FG V K G + VA+KM+++ A SE DF EA ++ +
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKID------VAIKMIREGAMSE---DDFIEEAKVMMK 55
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HPN+V+L GVC +P+ ++ EYM G L ++LR R +
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLR-------------------ERKGK 96
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
L T L+ + + M YL F+HRDLA RNCL+ + VVK++DFGL+R + L D Y
Sbjct: 97 LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQY 155
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
+ PV+W P E Y++++ +SDVW+FGV +WE+FS PY ++ EVV+ +
Sbjct: 156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
G L P P +Y +M CW+ KP +RP+F+ + L
Sbjct: 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 2e-67
Identities = 111/276 (40%), Positives = 158/276 (57%), Gaps = 4/276 (1%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G FG+V +A A L +T VAVKMLK+ AS D E LL + +HP+++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSP--NNYINGTYSSMESSIHR--VPQLSTC 488
L G C+ P+ L+ EY G L FLR +Y+ + S + L+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
DLI+ A QI+ GM YL++ K VHRDLA RN L+ + +KI+DFGLSR +Y +D Y
Sbjct: 128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS 187
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
IPV+WM +ES+ + YT +SDVW+FGV LWEI + PY G+ E + +K G
Sbjct: 188 KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYR 247
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
++ P+N + +Y+LM CW +P RP+F I + L
Sbjct: 248 MERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 220 bits (562), Expect = 8e-67
Identities = 101/296 (34%), Positives = 155/296 (52%), Gaps = 37/296 (12%)
Query: 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACL 421
F + + +++ LG+G FG+V + L VAVK L E ++DFERE +
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYD-PLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEI 59
Query: 422 LAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
L DH NIVK GVC G+ + L+ EY+ G L D+L+
Sbjct: 60 LRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR------------------ 101
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
HR Q++ L+ + QI GM YL ++++HRDLA RN L+ + +VKI+DFGL++ +
Sbjct: 102 HR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160
Query: 540 L-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF---ALQP----- 590
+DYY E P+ W E + +K++ SDVW+FGV L+E+F++ + P
Sbjct: 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL 220
Query: 591 ------YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
+ +++ +KEG L P + PD +YDLMKLCW +P +RPSF +
Sbjct: 221 RMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 221 bits (564), Expect = 1e-66
Identities = 117/295 (39%), Positives = 175/295 (59%), Gaps = 11/295 (3%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--EFTLVAVKMLKDEASEYLQ 412
P + E R + + LG+G FG+V A+A G+ K + + VAVKMLKD+A++
Sbjct: 2 PADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL 61
Query: 413 TDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
+D E ++ H NI+ LLG C P+ +L EY +G+L ++LR P G
Sbjct: 62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPP----GM 117
Query: 472 YSSMESSIHRVP--QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529
S ++ ++P QL+ DL++ A Q+A GM YL+ +K +HRDLA RN L+ + V+KI
Sbjct: 118 DYSFDTC--KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKI 175
Query: 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589
ADFGL+R ++ DYYK N +PV+WM E++ YT +SDVW+FGV LWEIF+
Sbjct: 176 ADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS 235
Query: 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
PY G+ EE+ K +KEG+ + P N LY +M+ CW+ P RP+F+ + + L
Sbjct: 236 PYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 218 bits (558), Expect = 1e-66
Identities = 101/284 (35%), Positives = 160/284 (56%), Gaps = 27/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R I +R LG G FG V++ GL + T VAVK LK + DF EA
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWE----GLWNNT--TPVAVKTLKPGTMD--PKDFLAEAQ 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + HP +++L VC + +P+ ++ E M G L ++L+ G ++
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQ--------GGAGRAL----- 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
++PQL I +A Q+ASGM YL + ++HRDLA RN L+ + + K+ADFGL+R +
Sbjct: 101 KLPQL-----IDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR-VIK 154
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+D Y+ E P++W E+ LYN+++++SDVW+FG+ L EI ++ PY G+T+ EV+
Sbjct: 155 EDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ + +G + P P LYD+M CW P +RP+F T+ L
Sbjct: 215 QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKL 258
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 4e-66
Identities = 94/288 (32%), Positives = 160/288 (55%), Gaps = 32/288 (11%)
Query: 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
++ +G+G FG V G + ++ VAVK LKD+++ F EA
Sbjct: 1 WAINSKELKLGATIGKGEFGDVML----GDYRGQK---VAVKCLKDDST--AAQAFLAEA 51
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ HPN+V+LLGV G P+ ++ EYM +G L D+LR S ++
Sbjct: 52 SVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLR-------------SRGRAV 98
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
++ + AL + GM YL ++ FVHRDLA RN L+++ +V K++DFGL++
Sbjct: 99 -----ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK--- 150
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ +G ++ +PV+W E++ K++ +SDVW+FG+ LWEI+SF PY + ++V
Sbjct: 151 --EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 208
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
V ++++G ++AP+ P +Y +MK CW + P RP+F+ + + L I
Sbjct: 209 VPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143578 cd07469, CRD_TK_ROR_related, Cysteine-rich domain of proteins similar to tyrosine kinase-like orphan receptors | Back alignment and domain information |
|---|
Score = 211 bits (540), Expect = 2e-65
Identities = 77/149 (51%), Positives = 95/149 (63%), Gaps = 3/149 (2%)
Query: 31 PQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAA 90
GYC+ Y G++C+ YL+ VWFNSS LNEQ+ LW+E+I ++ C+ AA
Sbjct: 1 SAGYCATYRGEVCRAYLSNDALVWFNSSYAD-PEGLNEQLTTGLWEELIKTVSELCRPAA 59
Query: 91 EKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHF 150
EKLLC YAFP+C S P PLC EDC+AV+ FCY DWA IEENK RGI KSRGHF
Sbjct: 60 EKLLCNYAFPECHPSGVGPTPKPLCREDCLAVKELFCYKDWALIEENKQRGIYLKSRGHF 119
Query: 151 ELPNCDTLPKYEVVNGKPTCSHAQLTEMK 179
LP C++LP P CSH LT++K
Sbjct: 120 TLPECESLPSIH--ADPPACSHIPLTDLK 146
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror) proteins, a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. Length = 147 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-65
Identities = 133/368 (36%), Positives = 178/368 (48%), Gaps = 78/368 (21%)
Query: 335 IDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEE 394
ID ++LP N E+ EFPR+++ + + LG GAFG+V +A A GL K +
Sbjct: 22 IDPTQLPYN--------------EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDN 67
Query: 395 FTLVAVKMLKDEASEYLQTDFEREACLLAEF-------DHPNIVKLLGVCAVGKPMCLLF 447
VAVKMLK A TD EREA L++E H NIV LLG C G P+ ++
Sbjct: 68 VLRVAVKMLKASA----HTD-EREA-LMSELKILSHLGQHKNIVNLLGACTHGGPVLVIT 121
Query: 448 EYMGRGDLNDFLR-------------------------ICSPNNYING----------TY 472
EY GDL +FLR I YI TY
Sbjct: 122 EYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTY 181
Query: 473 SSME--SSIHRVPQLSTC-------------DLITIALQIASGMVYLSDRKFVHRDLATR 517
M SS S DL+ + Q+A GM +L+ + +HRD+A R
Sbjct: 182 VEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241
Query: 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFG 577
N L+ D V KI DFGL+R + Y N +PV+WM ESI YTV+SDVW++G
Sbjct: 242 NVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 301
Query: 578 VCLWEIFSFALQPYYG-LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ LWEIFS PY G L + + K +K G + PD P +Y +MK+CWN++P RP+
Sbjct: 302 ILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPT 361
Query: 637 FRTIYQTL 644
F I Q +
Sbjct: 362 FSQISQLI 369
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-65
Identities = 113/287 (39%), Positives = 161/287 (56%), Gaps = 30/287 (10%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDE-ASEYLQTDFEREACLLAEFDHP 428
+ LG+G FG V + G L ++ L VAVK +K + DF EA + EFDHP
Sbjct: 5 KTLGEGEFGSVME----GQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHP 60
Query: 429 NIVKLLGVCAVG-------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
N+++L+GVC P+ +L +M GDL+ FL + S +
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVIL-PFMKHGDLHSFL---------------LYSRLGD 104
Query: 482 VPQ-LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
PQ L T L+ IASGM YLS + F+HRDLA RNC++N+ M V +ADFGLS+K+Y
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYY+ +PV+W+ +ES+ YT +SDVW+FGV +WEI + PY G+ + E+
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
Y+++GN L+ P + D LY LM CW + P +RPSF T+ L
Sbjct: 225 DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 215 bits (548), Expect = 1e-63
Identities = 126/351 (35%), Positives = 174/351 (49%), Gaps = 69/351 (19%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P + EFPRN + + + LG GAFG+V +A A GL K + VAVKMLK A
Sbjct: 25 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLT---- 80
Query: 415 FEREACLLAEF-------DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLR------I 461
EREA L++E +H NIV LLG C VG P ++ EY GDL +FLR I
Sbjct: 81 -EREA-LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFI 138
Query: 462 CSP------------------------NNYIN---------------------GTYSSME 476
C N Y++ G+Y +
Sbjct: 139 CPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQD 198
Query: 477 SSIHRVPQ----LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532
+ + + L T DL++ + Q+A GM +L+ + +HRDLA RN L+ + KI DF
Sbjct: 199 VTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDF 258
Query: 533 GLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
GL+R + Y N +PV+WM ESI YT ESDVW++G+ LWEIFS PY
Sbjct: 259 GLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYP 318
Query: 593 GL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
G+ + K IKEG + +P+ P +YD+MK CW+ P+ RP+F+ I Q
Sbjct: 319 GMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 4e-62
Identities = 96/287 (33%), Positives = 152/287 (52%), Gaps = 27/287 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + R LG G FG V++ ++ VA+K+LK + Q DF++E
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVR------VAIKILKSD-DLLKQQDFQKEVQ 54
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L H +++ L VC+VG+P+ ++ E M +G L FLR S E +
Sbjct: 55 ALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLR-------------SPEGQVL 101
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
V L I +A Q+A GM YL ++ +HRDLA RN L+ + +V K+ADFGL+R +
Sbjct: 102 PVASL-----IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLAR--LI 154
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
++ + IP +W E+ + ++ +SDVW+FG+ L+E+F++ PY G+ + EV
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
I G + P P +Y +M CW +P +RPSF+ + + L NI
Sbjct: 215 DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 5e-62
Identities = 96/277 (34%), Positives = 148/277 (53%), Gaps = 27/277 (9%)
Query: 372 DLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
LG G+FG V + G + VAVK LK + + DF +EA ++ DH N
Sbjct: 2 KLGDGSFGVVRRGEWSTSG----GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHEN 57
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+++L GV + P+ ++ E G L D LR + ++ I + CD
Sbjct: 58 LIRLYGV-VLTHPLMMVTELAPLGSLLDRLRKDALGHF----------LISTL-----CD 101
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDE 548
A+QIA+GM YL ++F+HRDLA RN L+ VKI DFGL R + +D+Y +E
Sbjct: 102 Y---AVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI-KEGN 607
+ +P W ES+ ++ SDVW FGV LWE+F++ +P+ GL+ +++K I KEG
Sbjct: 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE 218
Query: 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L+ P+ P +Y++M CW P +RP+F + + L
Sbjct: 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 204 bits (521), Expect = 3e-61
Identities = 104/280 (37%), Positives = 158/280 (56%), Gaps = 38/280 (13%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLK-----DEASEYLQTDFEREACLLAE 424
R +G+G FG V+ L+ + + AVK L +E ++L +E ++ +
Sbjct: 1 RVIGKGHFGCVYHGT---LIDSDGQKIHCAVKSLNRITDLEEVEQFL-----KEGIIMKD 52
Query: 425 FDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
F HPN++ LLG+C + G P+ +L YM GDL +F+R S + N T
Sbjct: 53 FSHPNVLSLLGICLPSEGSPLVVL-PYMKHGDLRNFIR--SETH--NPTVK--------- 98
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
DLI LQ+A GM YL+ +KFVHRDLA RNC++++ VK+ADFGL+R +Y ++
Sbjct: 99 ------DLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152
Query: 543 YYKGDENDA--IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
YY + +PV+WM LES+ K+T +SDVW+FGV LWE+ + PY + ++
Sbjct: 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT 212
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
Y+ +G L P+ PD LY++M CW+ KP RP+F +
Sbjct: 213 VYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 204 bits (520), Expect = 4e-61
Identities = 109/284 (38%), Positives = 153/284 (53%), Gaps = 40/284 (14%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+ +G G FG V K PG K E VA+K LK +E + DF EA ++ +FDHP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPG--KRE--IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHP 65
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+ L GV KP+ ++ EYM G L+ FLR Q +
Sbjct: 66 NIIHLEGVVTKSKPVMIVTEYMENGSLDAFLR-------------------KHDGQFTVI 106
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
L+ + IASGM YLSD +VHRDLA RN L+N +V K++DFGLSR + D+
Sbjct: 107 QLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE-------DD 159
Query: 549 NDA--------IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+A IP+RW E+I Y K+T SDVW++G+ +WE+ S+ +PY+ +++++V+
Sbjct: 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
K I+EG L AP + P AL+ LM CW RP F I L
Sbjct: 220 KAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSIL 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 205 bits (522), Expect = 2e-60
Identities = 121/336 (36%), Positives = 176/336 (52%), Gaps = 54/336 (16%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEY--LQTDFE 416
EFPR+ + + LG+GAFG+V QA A G+ K VAVKMLK+ A SEY L T+ +
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 417 REACLLAEFDHPNIVKLLGVCAV-GKPMCLLFEYMGRGDLNDFLR--------------- 460
L+ H N+V LLG C G P+ ++ EY G+L+++LR
Sbjct: 63 ---ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTR 119
Query: 461 ----------------ICSPNNYINGTYSSMESSIHRVP----------QLSTCDLITIA 494
+ S + + + +S L+ DLI+ +
Sbjct: 120 KREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS 179
Query: 495 LQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ-DYY-KGDENDAI 552
Q+A GM +L+ RK +HRDLA RN L+++ VVKI DFGL+R +Y DY KGD +
Sbjct: 180 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR--L 237
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIKEGNILQA 611
P++WM ESI YT +SDVW+FGV LWEIFS PY G+ EE + +KEG ++A
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297
Query: 612 PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
P+ +Y +M CW+ P +RP+F + + L ++
Sbjct: 298 PEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 3e-60
Identities = 103/272 (37%), Positives = 153/272 (56%), Gaps = 24/272 (8%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G FG VF G L+ + T VAVK ++ L+ F +EA +L ++ HPNIV+
Sbjct: 3 IGRGNFGEVFS----GRLRADN-TPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVR 57
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L+GVC +P+ ++ E + GD FLR P+L +LI
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLR-------------------TEGPRLKVKELIQ 98
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+ A+GM YL + +HRDLA RNCL+ ++ V+KI+DFG+SR+ Y I
Sbjct: 99 MVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
PV+W E++ Y +Y+ ESDVW+FG+ LWE FS PY L++++ + I++G L P
Sbjct: 159 PVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCP 218
Query: 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ PDA+Y LM+ CW P RPSF T++Q L
Sbjct: 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 7e-60
Identities = 104/274 (37%), Positives = 158/274 (57%), Gaps = 30/274 (10%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G FG VF+ G LK + T VAVK K++ + L+ F EA +L ++DHPNIVK
Sbjct: 3 LGKGNFGEVFK----GTLKDK--TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVK 56
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L+GVC +P+ ++ E + GD FLR + +L T L+
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLR-------------------KKKDELKTKQLVK 97
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD--YYKGDEND 550
AL A+GM YL + +HRDLA RNCL+ + V+KI+DFG+SR+ +D Y
Sbjct: 98 FALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ---EDDGIYSSSGLK 154
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
IP++W E++ Y +Y+ ESDVW++G+ LWE FS + PY G+T+++ + +++G +
Sbjct: 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMS 214
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P PD +Y +M+ CW+ KP NRP F + + L
Sbjct: 215 CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-59
Identities = 109/277 (39%), Positives = 154/277 (55%), Gaps = 30/277 (10%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+G G FG VF+ K PG + E VA+K LK +E + DF EA ++ +F H NI
Sbjct: 13 IGAGEFGEVFRGILKMPG--RKE--VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
++L GV KP ++ EYM G L+ +LR +G +SS + L
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLR------DHDGEFSSYQ-------------L 109
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ + IA+GM YLSD +VHRDLA RN L+N + K++DFGLSR L+D +G
Sbjct: 110 VGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR--VLEDDPEGTYTT 167
Query: 551 A---IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
+ IP+RW E+I Y K+T SDVW+FG+ +WE+ SF +PY+ +++ EV+K I +G
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF 227
Query: 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L AP + P A+Y LM CW RP F I L
Sbjct: 228 RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 1e-58
Identities = 95/281 (33%), Positives = 152/281 (54%), Gaps = 28/281 (9%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
D+ ++++LG G FG V K G +++ VA+KM+K+ + + +F EA ++
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGKWRG--QYD----VAIKMIKEGSMS--EDEFIEEAKVMM 54
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ H +V+L GVC +P+ ++ EYM G L ++LR R
Sbjct: 55 KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLR----------------EHGKR-- 96
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L+ + + GM YL ++F+HRDLA RNCL++DQ VK++DFGLSR + L D
Sbjct: 97 -FQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDE 154
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y PVRW P E +LY+K++ +SDVWAFGV +WE++S PY + E V+ +
Sbjct: 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+G L P + +Y +M CW+ K RP+F+ + ++
Sbjct: 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 3e-58
Identities = 105/279 (37%), Positives = 154/279 (55%), Gaps = 32/279 (11%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+G G FG V + K PG K E F VA+K LK +E + DF EA ++ +FDHPNI
Sbjct: 12 IGAGEFGEVCRGRLKLPG--KREIF--VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
+ L GV +P+ ++ E+M G L+ FLR N+ Q + L
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLRQ---ND----------------GQFTVIQL 108
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD-----YYK 545
+ + IA+GM YLS+ +VHRDLA RN L+N +V K++DFGLSR +L+D Y
Sbjct: 109 VGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR--FLEDDTSDPTYT 166
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
IP+RW E+I Y K+T SDVW++G+ +WE+ S+ +PY+ +++++V+ I++
Sbjct: 167 SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ 226
Query: 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L P + P AL+ LM CW RP F I TL
Sbjct: 227 DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 197 bits (501), Expect = 6e-58
Identities = 107/277 (38%), Positives = 158/277 (57%), Gaps = 13/277 (4%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLLAE 424
DI + +G+G FG+V +A ++K + + A+KMLK+ ASE DF E +L +
Sbjct: 3 DIKFEDVIGEGNFGQVIRA----MIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCK 58
Query: 425 F-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
HPNI+ LLG C + + EY G+L DFLR + + T +
Sbjct: 59 LGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLR----KSRVLETDPAFAKEHGTAS 114
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L++ L+ A +A+GM YLS+++F+HRDLA RN L+ + + KIADFGLSR ++
Sbjct: 115 TLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG---EEV 171
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y +PVRWM +ES+ Y+ YT +SDVW+FGV LWEI S PY G+T E+ + +
Sbjct: 172 YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
+G ++ P N D +Y+LM+ CW +P RP F I
Sbjct: 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 116/290 (40%), Positives = 163/290 (56%), Gaps = 16/290 (5%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLLA 423
NDI + +G+G FG+V +A+ +K + + A+K +K+ AS+ DF E +L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKAR----IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 62
Query: 424 EF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ HPNI+ LLG C + L EY G+L DFLR + + T + +
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR----KSRVLETDPAFAIANSTA 118
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
LS+ L+ A +A GM YLS ++F+HRDLA RN L+ + V KIADFGLSR Q+
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QE 175
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
Y +PVRWM +ES+ Y+ YT SDVW++GV LWEI S PY G+T E+ +
Sbjct: 176 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 235
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ +G L+ P N D +YDLM+ CW KP RPSF Q L ++ R LE
Sbjct: 236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA---QILVSLNRMLE 282
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 194 bits (493), Expect = 2e-57
Identities = 97/279 (34%), Positives = 151/279 (54%), Gaps = 29/279 (10%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
+++ V+++G G FG V+ L K + VA+K +++ A + DF EA ++ +
Sbjct: 4 SELTLVQEIGSGQFGLVW--LGYWLEKRK----VAIKTIREGAMS--EEDFIEEAQVMMK 55
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HP +V+L GVC P+CL+FE+M G L+D+LR + +
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLR-------------------AQRGK 96
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
S L+ + L + GM YL +HRDLA RNCL+ + VVK++DFG++R L D Y
Sbjct: 97 FSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQY 155
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
PV+W E ++KY+ +SDVW+FGV +WE+FS PY ++ EVV+ I
Sbjct: 156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-RTIYQ 642
G L P ++Y+LM+ CW +P +RPSF ++Q
Sbjct: 216 AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 3e-57
Identities = 113/334 (33%), Positives = 166/334 (49%), Gaps = 45/334 (13%)
Query: 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE 418
Q EFPR+ + + LG GAFG+V +A A G+ K VAVKMLK+ A+ E
Sbjct: 1 QWEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSE 60
Query: 419 ACLLAEF-DHPNIVKLLGVCAVGK-PMCLLFEYMGRGDLNDFLRI--------------- 461
+L +H N+V LLG C P+ ++ E+ G+L++FLR
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 462 ------------------CSPNNYINGTYSSMESSIHRVPQ---------LSTCDLITIA 494
+ + + S PQ L+ DLI +
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 495 LQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPV 554
Q+A GM +L+ RK +HRDLA RN L+++ VVKI DFGL+R +Y Y + +P+
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 555 RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIKEGNILQAPD 613
+WM ESI YT +SDVW+FGV LWEIFS PY G+ +EE + +K+G ++AP+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPE 300
Query: 614 NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
N +Y +M CW P RP+F + + L ++
Sbjct: 301 NATPEIYRIMLACWQGDPKERPTFSALVEILGDL 334
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (490), Expect = 2e-56
Identities = 93/282 (32%), Positives = 154/282 (54%), Gaps = 29/282 (10%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTL---VAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
LG GAFG V++ G+ E + VA+K+L++E S + EA ++A DHP+
Sbjct: 15 LGSGAFGTVYK----GVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+V+LLG+C + + L+ + M G L D++R N+ N + +
Sbjct: 71 VVRLLGIC-LSSQVQLITQLMPLGCLLDYVR----NHKDN---------------IGSQY 110
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDE 548
L+ +QIA GM YL +++ VHRDLA RN L+ VKI DFGL++ + + + Y +
Sbjct: 111 LLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+P++WM LESIL+ YT +SDVW++GV +WE+ +F +PY G+ E+ +++G
Sbjct: 171 G-KVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGER 229
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
L P +Y ++ CW + +RP+F+ + + RD
Sbjct: 230 LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 191 bits (485), Expect = 5e-55
Identities = 120/341 (35%), Positives = 171/341 (50%), Gaps = 58/341 (17%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
EFPR+ + + LG+GAFG+V +A A G+ K VAVKMLK+ A+ E
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 62
Query: 421 LLAEFDHP-NIVKLLGVCAV-GKPMCLLFEYMGRGDLNDFLR----------------IC 462
+L H N+V LLG C G P+ ++ E+ G+L+++LR
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQ 122
Query: 463 SPNNY-------------INGTYSSMESSIHRVPQLSTCD-------------------- 489
+ Y I + SS S V + S D
Sbjct: 123 GKSGYGDISEDLKRRLDSITSSQSSASSGF--VEEKSLSDVEEEEAEQEDLYKKVLTLED 180
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY--KGD 547
LI + Q+A GM +L+ RK +HRDLA RN L+++ VVKI DFGL+R +Y Y KGD
Sbjct: 181 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-THEEVVKYIKEG 606
+P++WM E+I YT++SDVW+FGV LWEIFS PY G+ EE + +KEG
Sbjct: 241 AR--LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 298
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
++APD T +Y M CW+ +P RP+F + + L N+
Sbjct: 299 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 6e-55
Identities = 109/270 (40%), Positives = 152/270 (56%), Gaps = 13/270 (4%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLLAEF-DHPNI 430
+G+G FG+V +A +K + + A+K +K+ AS+ DF E +L + HPNI
Sbjct: 3 IGEGNFGQVLKA----RIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 58
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
+ LLG C + L EY G+L DFLR + + T + + LS+ L
Sbjct: 59 INLLGACEHRGYLYLAIEYAPHGNLLDFLR----KSRVLETDPAFAIANSTASTLSSQQL 114
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ A +A GM YLS ++F+HRDLA RN L+ + V KIADFGLSR Q+ Y
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG---QEVYVKKTMG 171
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
+PVRWM +ES+ Y+ YT SDVW++GV LWEI S PY G+T E+ + + +G L+
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
P N D +YDLM+ CW KP RPSF I
Sbjct: 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 2e-54
Identities = 93/280 (33%), Positives = 150/280 (53%), Gaps = 28/280 (10%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
+++ ++++LG G FG V K +K VA+K + + A + DF EA ++ +
Sbjct: 4 SELTFMKELGSGQFGVVHLGKWRAQIK------VAIKAINEGAMS--EEDFIEEAKVMMK 55
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HP +V+L GVC KP+ ++ E+M G L ++LR R +
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLR-------------------QRQGK 96
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
LS L+++ + GM YL F+HRDLA RNCL++ VVK++DFG++R + L D Y
Sbjct: 97 LSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEY 155
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
PV+W P E ++KY+ +SDVW+FGV +WE+F+ P+ ++ EVV+ I
Sbjct: 156 TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
G L P +Y++M CW+ KP RP+F + + +
Sbjct: 216 RGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 6e-53
Identities = 100/284 (35%), Positives = 152/284 (53%), Gaps = 28/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + V+ LG G FG V+ G T VA+K LK + F EA
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWM----GYYNGH--TKVAIKSLKQGSMS--PEAFLAEAN 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L+ + HP +V+L V +P+ ++ EYM G L DFL+ + E
Sbjct: 54 LMKQLQHPRLVRLYAV-VTQEPIYIITEYMENGSLVDFLK-------------TPEGI-- 97
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+L+ LI +A QIA GM ++ + ++HRDL N L+++ + KIADFGL+R +
Sbjct: 98 ---KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR-LIE 153
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y E P++W E+I Y +T++SDVW+FG+ L EI ++ PY G+T+ EV+
Sbjct: 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ ++ G + PDN P+ LY+LM+LCW KP RP+F + L
Sbjct: 214 QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-52
Identities = 97/284 (34%), Positives = 150/284 (52%), Gaps = 27/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR I V+ LG G FG V+ + T VAVK LK + +Q F EA
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGY------YNNSTKVAVKTLK-PGTMSVQA-FLEEAN 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L+ H +V+L V +P+ ++ EYM +G L DFL+ S E
Sbjct: 54 LMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLK-------------SDEGGKV 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+P+L I + QIA GM Y+ + ++HRDL N L+++ ++ KIADFGL+R +
Sbjct: 101 LLPKL-----IDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE- 154
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y E P++W E+I + +T++SDVW+FG+ L+EI ++ PY G+++ +V+
Sbjct: 155 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
++ G + +N PD LYD+MK CW K RP+F + L
Sbjct: 215 SALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 4e-52
Identities = 99/278 (35%), Positives = 152/278 (54%), Gaps = 28/278 (10%)
Query: 372 DLGQGAFGRVFQAKAPGLLKHEEFT-LVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPN 429
+LG G FG V + G+ K ++ VAVK+LK++ + L+ + REA ++ + D+P
Sbjct: 2 ELGSGNFGTVKK----GMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPY 57
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+++G+C + L+ E G LN FL+ N ++ T ++ +H
Sbjct: 58 IVRMIGICE-AESWMLVMELAELGPLNKFLQ---KNKHV--TEKNITELVH--------- 102
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDE 548
Q++ GM YL + FVHRDLA RN L+ Q KI+DFGLS+ + ++YYK
Sbjct: 103 ------QVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+ PV+W E + Y K++ +SDVW+FGV +WE FS+ +PY G+ EV + I+ G
Sbjct: 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGER 216
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646
++ P P +YDLMKLCW RP F + L N
Sbjct: 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 5e-52
Identities = 93/276 (33%), Positives = 140/276 (50%), Gaps = 26/276 (9%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
R LG G FG + + K P K E VA+ L+ S+ + F EA L +FDH
Sbjct: 11 RILGTGRFGELCRGCLKLPS--KRE--LPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHS 66
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV+L GV G M ++ EYM G L+ FLR QL
Sbjct: 67 NIVRLEGVITRGNTMMIVTEYMSNGALDSFLR-------------------KHEGQLVAG 107
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
L+ + +ASGM YLS+ +VH+ LA L+N +V KI+ F ++ + Y
Sbjct: 108 QLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMS 167
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+ PV W E+I Y+ ++ SDVW+FG+ +WE+ S+ +PY+ ++ ++V+K +++G
Sbjct: 168 GKS-PVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFR 226
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L AP N P+ L+ LM CW + RP F I+ L
Sbjct: 227 LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 1e-51
Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 38/282 (13%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ LG+G+FG+V+ A+ + LVA+K++K + + + RE +L + HPN
Sbjct: 4 LEKLGEGSFGKVYLAR-----DKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPN 58
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+L V + L+ EY GDL D + + +LS +
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDL--------------------LKKRGRLSEDE 98
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
QI S + YL + VHRDL N L+++ VK+ADFGL+R++ +
Sbjct: 99 ARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT--- 155
Query: 550 DAIPV---RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-LTHEEVVKYIKE 605
V +M E +L Y D+W+ GV L+E+ + P+ G E+ K I +
Sbjct: 156 ---FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLT-GKPPFPGDDQLLELFKKIGK 211
Query: 606 GN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ DL++ P R + Q +
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 253
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 2e-51
Identities = 90/272 (33%), Positives = 148/272 (54%), Gaps = 34/272 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G FG V Q + G VAVK +K + + F E ++ + H N+V+
Sbjct: 14 IGEGEFGAVLQGEYTG-------QKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVR 63
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
LLGV + + ++ E M +G+L +FLR + ++ V QL +
Sbjct: 64 LLGVI-LHNGLYIVMELMSKGNLVNFLR-------------TRGRALVSVIQL-----LQ 104
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+L +A GM YL +K VHRDLA RN L+++ V K++DFGL+R G +N +
Sbjct: 105 FSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS-----MGVDNSKL 159
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
PV+W E++ + K++ +SDVW++GV LWE+FS+ PY ++ +EV + +++G ++ P
Sbjct: 160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPP 219
Query: 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ P +Y LM CW +P RPSF + + L
Sbjct: 220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKL 251
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 5e-51
Identities = 92/275 (33%), Positives = 150/275 (54%), Gaps = 26/275 (9%)
Query: 372 DLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+LG G FG V + G+ K + + VA+K+LK+E + ++ + REA ++ + D+P I
Sbjct: 2 ELGSGNFGCVKK----GVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V+++GVC M L+ E G LN FL + +++ ++
Sbjct: 58 VRMIGVCEAEALM-LVMEMASGGPLNKFL-------------------SGKKDEITVSNV 97
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD-YYKGDEN 549
+ + Q++ GM YL + FVHRDLA RN L+ +Q KI+DFGLS+ + D YYK
Sbjct: 98 VELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
P++W E I + K++ SDVW++G+ +WE FS+ +PY + EV+ +I++G L
Sbjct: 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRL 217
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P P +Y LMK CW K +RP+F + + +
Sbjct: 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERM 252
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 5e-50
Identities = 103/298 (34%), Positives = 152/298 (51%), Gaps = 45/298 (15%)
Query: 362 FPRNDIIYVRDLGQGAFGRVFQAK-APGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
F + +++ LG+G FG V + P L+ +VAVK L+ +E+L+ DFERE
Sbjct: 1 FEERHLKFIQQLGKGNFGSVELCRYDP--LQDNTGEVVAVKKLQHSTAEHLR-DFEREIE 57
Query: 421 LLAEFDHPNIVKLLGVC-AVGKP-MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
+L H NIVK GVC + G+ + L+ EY+ G L D+L +
Sbjct: 58 ILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL----------------QKH 101
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
R L L+ A QI GM YL +++VHRDLATRN L+ + VKI DFGL++ +
Sbjct: 102 RER---LDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
Query: 539 YL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA---------- 587
++YYK E P+ W ES+ +K++V SDVW+FGV L+E+F+++
Sbjct: 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF 218
Query: 588 -------LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
Q + H +++ +K L AP P +Y +MK CWN P RPSF
Sbjct: 219 MRMMGNDKQGQMIVYH--LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS 274
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-49
Identities = 96/286 (33%), Positives = 152/286 (53%), Gaps = 36/286 (12%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
++ ++ +G+G FG V G VAVK +K++A+ F EA ++
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDAT---AQAFLAEASVMT 54
Query: 424 EFDHPNIVKLLGVCAVGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ H N+V+LLGV K + ++ EYM +G L D+LR S S+
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR-------------SRGRSV--- 98
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY-LQ 541
L L+ +L + M YL FVHRDLA RN L+++ V K++DFGL+++ Q
Sbjct: 99 --LGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
D K +PV+W E++ K++ +SDVW+FG+ LWEI+SF PY + ++VV
Sbjct: 157 DTGK------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
+++G + APD P +YD+MK CW++ RPSF + + L +I
Sbjct: 211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 172 bits (437), Expect = 3e-49
Identities = 90/288 (31%), Positives = 129/288 (44%), Gaps = 44/288 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDH 427
+R LG G+FG V++AK +VAVK+LK E S+ QT RE +L H
Sbjct: 4 LRKLGSGSFGTVYKAK-----HKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSH 57
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIV+L+ + L+ EY GDL D+L R LS
Sbjct: 58 PNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLS--------------------RGGPLSE 97
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
+ IALQI G+ YL +HRDL N L+++ VVKIADFGL++K+
Sbjct: 98 DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
Query: 548 ENDAIPV---RWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYG---LTHEEVV 600
V +M E +L Y + DVW+ GV L+E+ + P+ G L +++
Sbjct: 158 -----FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKP-PFSGENILDQLQLI 211
Query: 601 KYIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ I + + + DL+K C N P RP+ I Q W
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPW 259
|
Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 9e-49
Identities = 95/284 (33%), Positives = 150/284 (52%), Gaps = 28/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + + LG G FG V+ A + + T VAVK +K + F EA
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMAT------YNKHTKVAVKTMKPGSMSV--EAFLAEAN 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ H +VKL V +P+ ++ E+M +G L DFL+ S E S
Sbjct: 54 VMKTLQHDKLVKLHAV-VTKEPIYIITEFMAKGSLLDFLK-------------SDEGSKQ 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+P+L I + QIA GM ++ R ++HRDL N L++ +V KIADFGL+R +
Sbjct: 100 PLPKL-----IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR-VIE 153
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y E P++W E+I + +T++SDVW+FG+ L EI ++ PY G+++ EV+
Sbjct: 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ ++ G + P+N P+ LY++M CW +P RP+F I L
Sbjct: 214 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 4e-47
Identities = 78/274 (28%), Positives = 113/274 (41%), Gaps = 61/274 (22%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G FG V+ A+ + VA+K++K E S L + RE +L + +HPNIVK
Sbjct: 1 LGEGGFGTVYLAR-----DKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVK 55
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L GV + L+ EY G L D L+ G S E ++
Sbjct: 56 LYGVFEDENHLYLVMEYCEGGSLKDLLK------ENEGKLSEDE-------------ILR 96
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLI-NDQMVVKIADFGLSRKMYLQDYYKGDENDA 551
I LQI G+ YL +HRDL N L+ +D VK+ADFGLS+ +
Sbjct: 97 ILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-- 154
Query: 552 IPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
+M E +L Y+ +SD+W+ GV L+E+
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------- 187
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L DL++ P RPS + I + L
Sbjct: 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 98/297 (32%), Positives = 154/297 (51%), Gaps = 32/297 (10%)
Query: 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL---VAVKMLKDEASEYLQT 413
L++ EF + ++ LG GAFG V++ GL E + VA+K L++ S
Sbjct: 4 LKETEFKK-----IKVLGSGAFGTVYK----GLWIPEGEKVKIPVAIKELREATSPKANK 54
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+ EA ++A D+P++ +LLG+C + + L+ + M G L D++R N I Y
Sbjct: 55 EILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDN--IGSQY- 110
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
L+ +QIA GM YL +R+ VHRDLA RN L+ VKI DFG
Sbjct: 111 ----------------LLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFG 154
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
L++ + + E +P++WM LESIL+ YT +SDVW++GV +WE+ +F +PY G
Sbjct: 155 LAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
Query: 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ E+ +++G L P +Y +M CW + +RP FR + + RD
Sbjct: 215 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 162 bits (410), Expect = 3e-45
Identities = 90/282 (31%), Positives = 146/282 (51%), Gaps = 23/282 (8%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
V+ LG GAFG V+ K + E + VA+K+L++ S + EA ++A P
Sbjct: 12 VKVLGSGAFGTVY--KGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+ +LLG+C + + L+ + M G L D++R ++ +
Sbjct: 70 YVCRLLGIC-LTSTVQLVTQLMPYGCLLDYVR-------------------ENKDRIGSQ 109
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
DL+ +QIA GM YL + + VHRDLA RN L+ VKI DFGL+R + + + +
Sbjct: 110 DLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHAD 169
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+P++WM LESIL+ ++T +SDVW++GV +WE+ +F +PY G+ E+ +++G
Sbjct: 170 GGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGER 229
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
L P +Y +M CW + RP FR + + RD
Sbjct: 230 LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 7e-45
Identities = 94/277 (33%), Positives = 145/277 (52%), Gaps = 28/277 (10%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + LGQG FG V+ G T VA+K LK F +EA
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGT------TRVAIKTLKPGTMS--PEAFLQEAQ 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + H +V+L V + +P+ ++ EYM +G L DFL+ G
Sbjct: 54 VMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK---------GEMGKY----L 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R+PQL + +A QIASGM Y+ +VHRDL N L+ + +V K+ADFGL+R +
Sbjct: 100 RLPQL-----VDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR-LIE 153
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y + P++W E+ LY ++T++SDVW+FG+ L E+ + PY G+ + EV+
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
++ G + P P++L+DLM CW +P RP+F
Sbjct: 214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 1e-44
Identities = 90/277 (32%), Positives = 145/277 (52%), Gaps = 28/277 (10%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + ++ LG G FG V+ G K VAVK LK F EA
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTK------VAVKTLKPGTMS--PESFLEEAQ 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + H +V+L V + +P+ ++ EYM +G L DFL+ E
Sbjct: 54 IMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLK-------------DGEGRAL 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
++P L + +A Q+A+GM Y+ ++HRDL + N L+ D +V KIADFGL+R +
Sbjct: 100 KLPNL-----VDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR-LIE 153
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y + P++W E+ LY ++T++SDVW+FG+ L E+ + PY G+ + EV+
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
+ ++ G + P + P +L++LM CW P RP+F
Sbjct: 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 159 bits (402), Expect = 2e-44
Identities = 95/284 (33%), Positives = 149/284 (52%), Gaps = 28/284 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + LGQG FG V+ G K VA+K LK + F +EA
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTK------VAIKTLK--PGTMMPEAFLQEAQ 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + H +V L V + +P+ ++ E+MG+G L DFL+ +
Sbjct: 54 IMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLK-------------EGDGKYL 99
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
++PQL + +A QIA GM Y+ ++HRDL N L+ D +V KIADFGL+R +
Sbjct: 100 KLPQL-----VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR-LIE 153
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ Y + P++W E+ LY ++T++SDVW+FG+ L E+ + PY G+ + EV+
Sbjct: 154 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ ++ G + P P++L++LMKLCW P RP+F I L
Sbjct: 214 EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 3e-44
Identities = 89/286 (31%), Positives = 147/286 (51%), Gaps = 31/286 (10%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
++G G FG+V +A + V VK L+ A+ Q F +E E +HPN+
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSK---ARVVVKELRASATPDEQLLFLQEVQPYRELNHPNV 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
++ LG C P L+ E+ GDL ++LR + ++ Q L
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDLKNYLRSN-------------RGMVAQMAQKDV--L 102
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+A ++ASG+++L F+H DLA RNC + + VKI D+GL+ + Y +DYY +
Sbjct: 103 QRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCH 162
Query: 551 AIPVRWMPLE-------SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY- 602
A+P+RW+ E +L T +S++W+ GV +WE+F+ A QPY L+ E+V+K
Sbjct: 163 AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
Query: 603 IKEGNI-LQAPD---NTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
++E +I L P D Y++M+ CW + P RP+ +++ L
Sbjct: 223 VREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-43
Identities = 93/291 (31%), Positives = 149/291 (51%), Gaps = 39/291 (13%)
Query: 370 VRDLGQGAFGRVFQAK-APGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+RDLG+G FG+V + P E VAVK LK E+ D ++E +L H
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGE--QVAVKSLKPESGGNHIADLKKEIEILRNLYHE 66
Query: 429 NIVKLLGVCA--VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
NIVK G+C G + L+ E++ G L ++L P N +++
Sbjct: 67 NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRN---------------KNKIN 107
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYK 545
+ A+QI GM YL R++VHRDLA RN L+ + VKI DFGL++ + ++YY
Sbjct: 108 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 167
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA-------------LQPYY 592
++ PV W E ++ +K+ + SDVW+FGV L+E+ ++ + P +
Sbjct: 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTH 227
Query: 593 G-LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
G +T +V+ ++EG L P N P+ +Y LM+ CW +P R +F+ + +
Sbjct: 228 GQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 98/297 (32%), Positives = 156/297 (52%), Gaps = 32/297 (10%)
Query: 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL---VAVKMLKDEASEYLQT 413
L++ E R V+ LG GAFG V++ G+ E T+ VA+K+L +
Sbjct: 4 LKETELKR-----VKVLGSGAFGTVYK----GIWVPEGETVKIPVAIKILNETTGPKANV 54
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+F EA ++A DHP++V+LLGVC + + L+ + M G L D Y++
Sbjct: 55 EFMDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLD---------YVHEHKD 104
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
++ S + L+ +QIA GM+YL +R+ VHRDLA RN L+ VKI DFG
Sbjct: 105 NIGSQL----------LLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFG 154
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
L+R + + + +P++WM LE I Y K+T +SDVW++GV +WE+ +F +PY G
Sbjct: 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
Query: 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ E+ +++G L P +Y +M CW + +RP F+ + + RD
Sbjct: 215 IPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 5e-41
Identities = 96/297 (32%), Positives = 148/297 (49%), Gaps = 49/297 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT-----LVAVKMLKDEASEYLQTDFEREACLLAE 424
+R LG+G FG+V L ++ +VAVK LK E + + +++E +L
Sbjct: 9 IRVLGEGHFGKV------SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62
Query: 425 FDHPNIVKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
H NIVK G C+ GK + L+ EY+ G L D+L P +
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL----PKH---------------- 102
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-Q 541
+L+ L+ A QI GM YL + ++HRDLA RN L+++ +VKI DFGL++ +
Sbjct: 103 -KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI-------------FSFAL 588
+YY+ E+ PV W +E + NK++ SDVW+FGV L+E+ F +
Sbjct: 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI 221
Query: 589 QPYYGL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P G T +++ ++ G L P N P +Y LMK CW + RP+FR++ L
Sbjct: 222 GPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 89/281 (31%), Positives = 139/281 (49%), Gaps = 27/281 (9%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTL---VAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
LG G FG V + G+ E ++ VA+K ++D + + + DH
Sbjct: 15 LGSGVFGTVHK----GIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAY 70
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+LLG+C G + L+ + G L D +R S+ PQ
Sbjct: 71 IVRLLGICP-GASLQLVTQLSPLGSLLDHVR-------------QHRDSLD--PQR---- 110
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
L+ +QIA GM YL + + VHR+LA RN L+ +V+IADFG++ +Y D
Sbjct: 111 LLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSE 170
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
P++WM LESIL+ +YT +SDVW++GV +WE+ S+ +PY G+ EV +++G L
Sbjct: 171 HKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERL 230
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
P +Y +M CW + RP+F+ + + RD
Sbjct: 231 AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 148 bits (374), Expect = 3e-40
Identities = 94/291 (32%), Positives = 142/291 (48%), Gaps = 41/291 (14%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+++G G FG+V + + V VK L+ AS Q F EA H N+
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQ---VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNL 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
++ LG C P L+ E+ GDL +LR C R +L T D
Sbjct: 58 LQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSC------------------RKAELMTPDP 99
Query: 491 ITI---ALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
T+ A +IA G+++L F+H DLA RNCL+ + VKI D+GLS Y +DYY
Sbjct: 100 TTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159
Query: 548 ENDAIPVRWMPLE-------SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ +P+RW+ E ++L T ES+VW+ GV +WE+F QPY L+ E+V+
Sbjct: 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL 219
Query: 601 KY-IKEGNI------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
Y ++E + L+ P D Y++M+ CW ++P RPS ++ L
Sbjct: 220 TYTVREQQLKLPKPRLKLP--LSDRWYEVMQFCW-LQPEQRPSAEEVHLLL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 145 bits (366), Expect = 6e-38
Identities = 67/161 (41%), Positives = 93/161 (57%), Gaps = 1/161 (0%)
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
L+T DL++ Q+A GM +L+ + VHRDLA RN L+ +VKI DFGL+R + Y
Sbjct: 234 LTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNY 293
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV-KYI 603
+ +PV+WM ESI N YT SDVW++G+ LWEIFS PY G+ + I
Sbjct: 294 VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKI 353
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
K G + PD+ +YD+M CWN +P RPSF + +
Sbjct: 354 KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIV 394
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|238056 cd00108, KR, Kringle domain; Kringle domains are believed to play a role in binding mediators, such as peptides, other proteins, membranes, or phospholipids | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 7e-38
Identities = 45/83 (54%), Positives = 54/83 (65%)
Query: 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEE 243
T DC G G Y+GTV+TT G CQRW+++ PH H+ P FPE ENYCRN G+
Sbjct: 1 TRDCYWGNGESYRGTVSTTKSGKPCQRWNSQLPHQHKFNPERFPEGLLEENYCRNPDGDP 60
Query: 244 PSPWCYTMDPNVRWQRCEIPTCA 266
PWCYT DPNVRW+ C+IP C
Sbjct: 61 EGPWCYTTDPNVRWEYCDIPRCE 83
|
They are autonomous structural domains, found in a varying number of copies, in blood clotting and fibrinolytic proteins, some serine proteases and plasma proteins. Plasminogen-like kringles possess affinity for free lysine and lysine-containing peptides. Length = 83 |
| >gnl|CDD|214527 smart00130, KR, Kringle domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-37
Identities = 43/83 (51%), Positives = 53/83 (63%)
Query: 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEP 244
+C G G Y+GTV+ T G CQRWD++ PH H P FP+L ENYCRN G+
Sbjct: 1 RECYAGNGESYRGTVSVTKSGKPCQRWDSQTPHLHRFTPESFPDLGLEENYCRNPDGDSE 60
Query: 245 SPWCYTMDPNVRWQRCEIPTCAD 267
PWCYT DPNVRW+ C+IP C +
Sbjct: 61 GPWCYTTDPNVRWEYCDIPQCEE 83
|
Named after a Danish pastry. Found in several serine proteases and in ROR-like receptors. Can occur in up to 38 copies (in apolipoprotein(a)). Plasminogen-like kringles possess affinity for free lysine and lysine- containing peptides. Length = 83 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-35
Identities = 70/177 (39%), Positives = 99/177 (55%), Gaps = 6/177 (3%)
Query: 467 YINGTYSSMESS-----IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521
Y S+ E + I+ P LS DL+ + Q+A+GM +L+ + VHRDLA RN LI
Sbjct: 213 YDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLI 272
Query: 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLW 581
+ +VKI DFGL+R + Y + +P++WM ESI N YT SDVW+FG+ LW
Sbjct: 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLW 332
Query: 582 EIFSFALQPYYGL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
EIF+ PY L +E+ IK G + P + D +Y++M+ CW K RP F
Sbjct: 333 EIFTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDF 389
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 82/288 (28%), Positives = 139/288 (48%), Gaps = 36/288 (12%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+++G G FG+V ++ + V VK LK AS Q +F ++ HPNI
Sbjct: 1 QEIGNGWFGKVLLSE---IYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNI 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
++ LG C P L+FEY GDL +L + + L
Sbjct: 58 LQCLGQCVEAIPYLLVFEYCELGDLKSYLS---QEQWHRRNSQLLL-------------L 101
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+A +IA+G+ ++ F+H DLA RNC + + VK+ D+G+ Y +DY + +++
Sbjct: 102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDK 161
Query: 551 AIPVRWMPLE-------SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY- 602
+P+RW+ E ++ + T S+VWA GV LWE+F A QPY L+ EV+ +
Sbjct: 162 CVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV 221
Query: 603 IKEGNI------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
IK+ + L+ P + Y++++ CW + P R + +++ L
Sbjct: 222 IKDQQVKLFKPQLELP--YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 69/277 (24%), Positives = 118/277 (42%), Gaps = 33/277 (11%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK--MLKDEASEYLQTDFEREACLLA 423
+ LG+G+FG V+ A L + L+AVK L ++ E L+ ERE +L+
Sbjct: 1 EWTRGELLGRGSFGSVYLA-----LDKDTGELMAVKSVELSGDSEEELE-ALEREIRILS 54
Query: 424 EFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
HPNIV+ G + + EY+ G L+ L+ +
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLK--------------------K 94
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+L + QI G+ YL VHRD+ N L++ VVK+ADFG ++++
Sbjct: 95 FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE--EV 599
+ +G + WM E I +Y +D+W+ G + E+ + P+ L + +
Sbjct: 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMAT-GKPPWSELGNPMAAL 213
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
K G + P++ + D ++ C P RP+
Sbjct: 214 YKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 1e-28
Identities = 64/293 (21%), Positives = 112/293 (38%), Gaps = 61/293 (20%)
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK------MLKDEASEYLQTDFEREACLL 422
++ +G+G+FG+V+ + + + L +K M + E + L E +L
Sbjct: 4 IIKQIGKGSFGKVYLVR-----RKSDGKLYVLKEIDLSNMSEKEREDALN-----EVKIL 53
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ +HPNI+K +C++ EY GDL+ ++
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQK----------------IKKQKKEG 97
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
++ +Q+ + YL RK +HRD+ +N + +VK+ DFG+S+ L
Sbjct: 98 KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSS 155
Query: 543 ------------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ- 589
YY + E Y +SD+W+ G L+E+ L+
Sbjct: 156 TVDLAKTVVGTPYY------------LSPELCQNKPYNYKSDIWSLGCVLYEL--CTLKH 201
Query: 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
P+ G E+ I +G P L +L+ P RPS I Q
Sbjct: 202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 7e-28
Identities = 66/273 (24%), Positives = 109/273 (39%), Gaps = 45/273 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G FG V++A+ +E VA+K++K E+ E + E +L + HPNIVK
Sbjct: 8 IGKGGFGEVYKARH--KRTGKE---VAIKVIKLESKEK-KEKIINEIQILKKCKHPNIVK 61
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
G + ++ E+ G L D L+ L+ +
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLLK-------------------STNQTLTESQIAY 102
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+ ++ G+ YL +HRD+ N L+ VK+ DFGLS ++ +D
Sbjct: 103 VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQL----------SDTK 152
Query: 553 PVR-------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
WM E I Y ++D+W+ G+ E+ PY L + + I
Sbjct: 153 ARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP-PYSELPPMKALFKIAT 211
Query: 606 GNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
L+ P+ D D +K C P RP+
Sbjct: 212 NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT 244
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215679 pfam00051, Kringle, Kringle domain | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 8e-27
Identities = 41/80 (51%), Positives = 49/80 (61%), Gaps = 2/80 (2%)
Query: 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPP-VFPELNNSENYCRNAGGEEPS 245
C G G Y+GT +TT G CQ WD++ PH H + P FP ENYCRN G+E
Sbjct: 1 CYHGNGESYRGTASTTESGAPCQAWDSQTPHRHSKYTPENFPAKGLGENYCRNPDGDE-R 59
Query: 246 PWCYTMDPNVRWQRCEIPTC 265
PWCYT DP VRW+ C+IP C
Sbjct: 60 PWCYTTDPRVRWEYCDIPRC 79
|
Kringle domains have been found in plasminogen, hepatocyte growth factors, prothrombin, and apolipoprotein A. Structure is disulfide-rich, nearly all-beta. Length = 79 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 7e-26
Identities = 79/292 (27%), Positives = 121/292 (41%), Gaps = 49/292 (16%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY--LQTDFEREACLLAEF 425
+R LG+G+FG V+ A+ + LVA+K+L + F RE +LA
Sbjct: 3 RILRKLGEGSFGEVYLAR--------DRKLVALKVLAKKLESKSKEVERFLREIQILASL 54
Query: 426 DHP-NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
+HP NIVKL + L+ EY+ G L D L+ I R
Sbjct: 55 NHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-----------------KIGRKGP 97
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDY 543
LS + + I QI S + YL + +HRD+ N L++ D VVK+ DFGL++ +
Sbjct: 98 LSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
Query: 544 YKGDENDAIPV----RWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+M E +L + SD+W+ G+ L+E+ + L P+ G +
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLT-GLPPFEGEKN 216
Query: 597 ----EEVVKYIKEGN--------ILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ +K I E P+ A DL+K P NR S
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 56/167 (33%), Positives = 83/167 (49%), Gaps = 30/167 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLK-DEASEYLQTDFEREACLLAEFDHPN 429
LG+G +G V++A+ ++ T +VA+K ++ D E + + RE LL E HPN
Sbjct: 7 LGEGTYGVVYKAR-------DKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPN 59
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IVKLL V + + L+FEY DL +L R LS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDM-DLKKYLD-------------------KRPGPLSPNL 99
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ +I Q+ G+ Y + +HRDL +N LIN V+K+ADFGL+R
Sbjct: 100 IKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 74/279 (26%), Positives = 119/279 (42%), Gaps = 38/279 (13%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACL 421
P + LG+G++G V++A + E +VA+K++ +E + + +E +
Sbjct: 1 PEEVFDILEKLGEGSYGSVYKA-----IHKETGQVVAIKVVPVEEDLQ----EIIKEISI 51
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
L + D P IVK G + ++ EY G G ++D ++I N T + E +
Sbjct: 52 LKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT------NKTLTEEEIA--- 102
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
I Q G+ YL K +HRD+ N L+N++ K+ADFG+S + L
Sbjct: 103 ----------AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--LT 150
Query: 542 DYYKGDENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D N I P WM E I Y ++D+W+ G+ E+ PY +
Sbjct: 151 DTM-AKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPPYSDIHPMRA 207
Query: 600 VKYI--KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ I K L P+ D +K C P RPS
Sbjct: 208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS 246
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 4e-23
Identities = 72/275 (26%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDHPNI 430
+G+GAFG V++ L E VA+K + E L+ +E LL HPNI
Sbjct: 8 IGRGAFGVVYKG-----LNLETGDFVAIKQISLEKIKEEALK-SIMQEIDLLKNLKHPNI 61
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
VK +G + ++ EY G L +I G + +++
Sbjct: 62 VKYIGSIETSDSLYIILEYAENGSL---RQIIKKF----GPFPESLVAVYVY-------- 106
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
Q+ G+ YL ++ +HRD+ N L VVK+ADFG++ K L D K D +
Sbjct: 107 -----QVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASV 159
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610
WM E I + + SD+W+ G + E+ + PYY L + I + +
Sbjct: 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLT-GNPPYYDLNPMAALFRIVQDDHPP 218
Query: 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
P+ L D + C+ P RP+ + + + W
Sbjct: 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPW 253
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 5e-23
Identities = 76/292 (26%), Positives = 129/292 (44%), Gaps = 52/292 (17%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHE---------EFTLVAVKMLKDEASEYLQTDFEREACL 421
LGQG F +++ G+L+ + + V +K+L + + L F A L
Sbjct: 1 EHLGQGTFTNIYK----GVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA--FFETASL 54
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
+++ H ++VKL GVC V ++ EY+ G L+ FL N ++ +
Sbjct: 55 MSQLSHKHLVKLYGVC-VRDENIMVEEYVKFGPLDVFLH--REKNNVSLHW--------- 102
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI-------NDQMVVKIADFGL 534
+ +A Q+AS + YL D+K VH ++ +N L+ +K++D G+
Sbjct: 103 --------KLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESI--LYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
+ ++ IP W+ E I T+ +D W+FG L EI S +P
Sbjct: 155 PITVLSREERVER----IP--WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L+ E ++ ++ + L PD L +L+ CW P RPSFR I + L
Sbjct: 209 TLSSSEKERFYQDQHRLPMPDCAE--LANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 75/278 (26%), Positives = 115/278 (41%), Gaps = 45/278 (16%)
Query: 370 VRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFD 426
V+ LGQG+ G V++ K G + A+K + D E+ + RE L +
Sbjct: 6 VKVLGQGSSGVVYKVRHKPTGKI-------YALKKIHVDGDEEFRKQ-LLRELKTLRSCE 57
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
P +VK G + ++ EYM G L D L+ +V ++
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLK--------------------KVGKIP 97
Query: 487 TCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRK----MYLQ 541
L IA QI G+ YL + R +HRD+ N LIN + VKIADFG+S+ +
Sbjct: 98 EPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC 157
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS--FALQPYYGLTHEEV 599
+ + G V +M E I Y+ +D+W+ G+ L E F P + E+
Sbjct: 158 NTFVGT------VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 600 VKYIKEGNILQAPDNTPDA-LYDLMKLCWNMKPMNRPS 636
++ I +G P D + C P RPS
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPS 249
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 73/272 (26%), Positives = 115/272 (42%), Gaps = 39/272 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK----DEASEYLQTDFEREACLLAEFDHP 428
LG G+FG V++ L ++ AVK + + + E+E LL++ HP
Sbjct: 8 LGSGSFGSVYEG-----LNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV+ LG + + E + G L L+ Y S V +L T
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----------KYGSFPEP---VIRLYT- 108
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
QI G+ YL DR VHRD+ N L++ VVK+ADFG+++++ + K +
Sbjct: 109 ------RQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFK 162
Query: 549 NDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
WM E I Y + +D+W+ G + E+ + +P + E V K G
Sbjct: 163 GSPY---WMAPEVIAQQGGYGLAADIWSLGCTVLEMATG--KPPWS-QLEGVAAVFKIGR 216
Query: 608 ILQA---PDNTPDALYDLMKLCWNMKPMNRPS 636
+ PD+ D D + C P RP+
Sbjct: 217 SKELPPIPDHLSDEAKDFILKCLQRDPSLRPT 248
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 60/307 (19%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML------KDEASEYLQTDFERE 418
+D + + +G+G+F V AK + E A+K+L K++ +Y++ E+E
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAK-----EKETNKEYAIKILDKRQLIKEKKVKYVKI--EKE 53
Query: 419 ACLLAEFDHPNIVKLLGVCAVGKPMCLLF--EYMGRGDLNDFLRICSPNNYINGTYSSME 476
HP I+KL L F EY G+L +
Sbjct: 54 VLTRLN-GHPGIIKLY--YTFQDEENLYFVLEYAPNGELLQY------------------ 92
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
I + L A +I + YL + +HRDL N L++ M +KI DFG ++
Sbjct: 93 --IRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAK 150
Query: 537 KM--------YLQDYYKGDENDAIPVR----------WMPLESILYNKYTVESDVWAFGV 578
+ D D R ++ E + SD+WA G
Sbjct: 151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGC 210
Query: 579 CLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLM-KLCWNMKPMNRPSF 637
++++ + P+ G + I + P+ PDA DL+ KL + P +R
Sbjct: 211 IIYQMLT-GKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAK-DLIEKLL-VLDPQDRLGV 267
Query: 638 RTIYQTL 644
Y L
Sbjct: 268 NEGYDEL 274
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 3e-21
Identities = 68/292 (23%), Positives = 116/292 (39%), Gaps = 46/292 (15%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF 425
+++ +G+G+FG V + + K + LV ++ +E + E +L E
Sbjct: 3 EVLET--IGKGSFGTVRKVRR----KSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL 56
Query: 426 DHPNIVKLLG--VCAVGKPMCLLFEYMGRGDLNDFLRICSPNN-YINGTYSSMESSIHRV 482
HPNIV+ + + + ++ EY GDL ++ C YI E I R+
Sbjct: 57 KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIE------EEFIWRI 110
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
L +AL +HRDL N ++ VK+ DFGL++ +
Sbjct: 111 ----LTQL-LLALYECHNRSD-PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS 164
Query: 543 ----------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-PY 591
YY M E + + Y +SD+W+ G ++E+ AL P+
Sbjct: 165 SFAKTYVGTPYY------------MSPEQLNHMSYDEKSDIWSLGCLIYEL--CALSPPF 210
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
++ IKEG + P L +++K N+ P RPS + Q
Sbjct: 211 TARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 3e-21
Identities = 61/211 (28%), Positives = 86/211 (40%), Gaps = 36/211 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHPNIV 431
+G+GA G VF+AK + E VA+K + + RE L HP +V
Sbjct: 8 IGEGAHGIVFKAKD---RETGE--TVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
KLL V G L+ EYM DL++ LR L +
Sbjct: 63 KLLDVFPHGSGFVLVMEYMPS-DLSEVLR-------------------DEERPLPEAQVK 102
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD---YYKGDE 548
+ + G+ Y+ +HRDL N LI+ V+KIADFGL+R ++ Y
Sbjct: 103 SYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH--- 159
Query: 549 NDAIPVRWMPLESILY--NKYTVESDVWAFG 577
+ RW +LY KY D+WA G
Sbjct: 160 --QVATRWYRAPELLYGARKYDPGVDLWAVG 188
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLLAE---FDHP 428
+G+GA+G V++A+ VA+K ++ SE + RE LL + F+HP
Sbjct: 7 IGEGAYGTVYKARDL-----NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 429 NIVKLLGVCAV-----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
NIV+LL VC + L+FE++ + DL +L C P
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK------------------P 102
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L + + Q+ G+ +L + VHRDL +N L+ VKIADFGL+R Y
Sbjct: 103 GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI-Y---- 157
Query: 544 YKGDENDAI-PV---RWM-PLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
A+ V W E +L + Y D+W+ G E+F +P
Sbjct: 158 ---SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR--RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 44/221 (19%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK----DEASEYLQTDFEREACLLAEFDHP 428
LG+G + V++A+ E +VA+K +K EA + + RE LL E HP
Sbjct: 8 LGEGTYAVVYKAR-----DKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHP 62
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+ LL V + L+FE+M DL ++ + I L+
Sbjct: 63 NIIGLLDVFGHKSNINLVFEFM-ETDLEKVIK----DKSI---------------VLTPA 102
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
D+ + L G+ YL +HRDL N LI V+K+ADFGL+R G
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF-------GSP 155
Query: 549 NDAIP----VRWM-PLESILY--NKYTVESDVWAFGVCLWE 582
N + RW E +L+ Y V D+W+ G E
Sbjct: 156 NRKMTHQVVTRWYRAPE-LLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 4e-20
Identities = 74/283 (26%), Positives = 136/283 (48%), Gaps = 39/283 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEF--TLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LGQG F ++F+ + + E T V +K+L Y ++ FE A ++++ H ++
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFE-AASMMSQLSHKHL 61
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V GVC G ++ EY+ G L+ +L+ N IN ++
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLK--KNKNLINISWK----------------- 102
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM--------VVKIADFGLSRKMYLQD 542
+ +A Q+A + +L D+ H ++ +N L+ + +K++D G+S + ++
Sbjct: 103 LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKE 162
Query: 543 YYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ IP W+P E I + ++ +D W+FG LWEIFS +P L ++ ++
Sbjct: 163 ILL----ERIP--WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ 216
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ ++ + L AP T L +L+ C + +P RPSFR I + L
Sbjct: 217 FYEDRHQLPAPKWT--ELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 373 LGQGAFGRVF---QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+G G+FG V+ A + L+ ++ L +V + + RE LL E H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+ LG + + EY+ G + L NNY + E ++ R
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALL-----NNY-----GAFEETLVR-------- 109
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
QI G+ YL +R +HRD+ N L++++ +KI+DFG+S+K+ + N
Sbjct: 110 --NFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA-NSLSTKTN 166
Query: 550 DAIP-----VRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
A P V WM E + YT ++D+W+ G + E+ + P+ T + + I
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT-GKHPFPDCTQLQAIFKIG 225
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
E + P N D ++ + + RP+
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEIDHNKRPT 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 80/291 (27%), Positives = 131/291 (45%), Gaps = 52/291 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---------DEASEYLQTDFEREACLLA 423
+G+G +GRV+ A L ++AVK ++ D + + E L
Sbjct: 9 IGKGTYGRVYLA-----LNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK 63
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ DH NIV+ LG + + + EY+ G + LR TY E + V
Sbjct: 64 DLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLR----------TYGRFEEQL--VR 111
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+ Q+ G+ YL + +HRDL N L++ + KI+DFG+S+K D
Sbjct: 112 FFTE--------QVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKS--DDI 161
Query: 544 YKGDENDAI--PVRWMPLESI-LYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
Y D+N ++ V WM E I Y++ Y+ + D+W+ G + E+F+ +P+ + EE
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA-GRRPW---SDEEA 217
Query: 600 VKYI-KEGNILQAPDNTPDALY-------DLMKLCWNMKPMNRPSFRTIYQ 642
+ + K GN AP PD D + C+ + P NRP+ R + Q
Sbjct: 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 1e-19
Identities = 71/279 (25%), Positives = 120/279 (43%), Gaps = 60/279 (21%)
Query: 365 NDIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
+D+ Y+ +LG G G V + + G + +AVK ++ E +E +Q RE +L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKI-------MAVKTIRLEINEAIQKQILRELDIL 53
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ + P IV G + + EYM G L+ L+ R+
Sbjct: 54 HKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ----------------GRI 97
Query: 483 PQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY-- 539
P+ L IA+ + G+ YL K +HRD+ N L+N + +K+ DFG+S ++
Sbjct: 98 PERI---LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ--PYYGLTHE 597
L + G + +M E I N Y+V+SD+W+ G+ L E+ A PY
Sbjct: 155 LAKTFVGTSS------YMAPERIQGNDYSVKSDIWSLGLSLIEL---ATGRFPYPP---- 201
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
++ PD +++L++ N P PS
Sbjct: 202 --------------ENDPPDGIFELLQYIVNEPPPRLPS 226
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (222), Expect = 2e-19
Identities = 68/222 (30%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDHPNI 430
+G+G +G+V++A+ K E LVA+K ++ +E + T RE LL + HPNI
Sbjct: 7 IGEGTYGQVYKARN---KKTGE--LVALKKIRMENEKEGFPIT-AIREIKLLQKLRHPNI 60
Query: 431 VKLLGVCAVGKP---MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
V+L + K + ++FEYM DL L SP + +
Sbjct: 61 VRLKEIV-TSKGKGSIYMVFEYMDH-DLTGLLD--SPEV-----------------KFTE 99
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR---KMYLQDYY 544
+ Q+ G+ YL +HRD+ N LIN+ V+K+ADFGL+R K DY
Sbjct: 100 SQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY- 158
Query: 545 KGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
N I + + P E +L +Y E D+W+ G L E+F
Sbjct: 159 ---TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 2e-19
Identities = 75/286 (26%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +LG GAFG+V++A+ E A K+++ E+ E L+ DF E +L+E HPN
Sbjct: 10 IGELGDGAFGKVYKAQ-----HKETGLFAAAKIIQIESEEELE-DFMVEIDILSECKHPN 63
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---PQLS 486
IV L Y L + C G S+ + R PQ+
Sbjct: 64 IVGLYEA------------YFYENKLWILIEFCD-----GGALDSIMLELERGLTEPQIR 106
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ Q+ + +L K +HRDL N L+ VK+ADFG+S K K
Sbjct: 107 Y-----VCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKN-KSTLQKR 160
Query: 547 DENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
D P WM E + N Y ++D+W+ G+ L E+ P++ L V+
Sbjct: 161 DTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME-PPHHELNPMRVLL 218
Query: 602 YIKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
I + L P + D +K C P +RP+ + + +
Sbjct: 219 KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 59/220 (26%), Positives = 93/220 (42%), Gaps = 33/220 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHP 428
+ +G+G +G V++A+ +VA+K + SE + RE LL E +HP
Sbjct: 4 LGKIGEGTYGVVYKAR-----DKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHP 58
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+KLL V + L+FE+M DL ++ R L
Sbjct: 59 NIIKLLDVFRHKGDLYLVFEFM-DTDLYKLIK-------------------DRQRGLPES 98
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGD 547
+ + Q+ G+ + +HRDL N LIN + V+K+ADFGL+R Y
Sbjct: 99 LIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY--- 155
Query: 548 ENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
+ RW +L Y+ D+W+ G E+ S
Sbjct: 156 -THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 3e-19
Identities = 64/271 (23%), Positives = 109/271 (40%), Gaps = 45/271 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDF-EREACLLAEFDHPNI 430
LG+G+FG+V + K L A+K+L K + + + + E +L+ +HP I
Sbjct: 1 LGKGSFGKVLLVRK----KDTG-KLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 431 VKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
VKL A + + L+ EY G+L F + G +S E
Sbjct: 56 VKL--HYAFQTEEKLYLVLEYAPGGEL--FSHLSK-----EGRFS--EERARF------- 97
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
A +I + YL ++RDL N L++ +K+ DFGL++++ E
Sbjct: 98 ----YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELS-------SE 146
Query: 549 NDAI--PVR---WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
++ E +L Y D W+ GV L+E+ P+Y +E+ + I
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEML-TGKPPFYAEDRKEIYEKI 205
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ L+ P+ DL+ P R
Sbjct: 206 LKDP-LRFPEFLSPEARDLISGLLQKDPTKR 235
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 7e-19
Identities = 58/220 (26%), Positives = 96/220 (43%), Gaps = 48/220 (21%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHP 428
V +G+G +G V++A+ +VA+K ++ D +E + + RE LL E +HP
Sbjct: 5 VEKIGEGTYGVVYKAR-----NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 59
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIVKLL V + L+FE++ + DL F+ + +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSG------------------IPLP 100
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ + Q+ G+ + + +HRDL +N LIN + +K+ADFGL+R
Sbjct: 101 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF---------- 150
Query: 549 NDAIPVR---------WMPLESILYNK--YTVESDVWAFG 577
+PVR W IL Y+ D+W+ G
Sbjct: 151 --GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 7e-19
Identities = 67/304 (22%), Positives = 114/304 (37%), Gaps = 67/304 (22%)
Query: 358 EQLEFPRNDIIYVRD----------LGQGAFGRVFQAKAPGLLKHEEFTLVAVKM--LKD 405
E+L+ DI+ D +G+GA G V++A +E VA+K L+
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRA--TGKE---VAIKKMRLRK 56
Query: 406 EASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPN 465
+ E + E ++ + HPNIV VG + ++ EYM G L D +
Sbjct: 57 QNKELIIN----EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFV- 111
Query: 466 NYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525
+++ + + ++ G+ YL + +HRD+ + N L++
Sbjct: 112 ------------------RMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG 153
Query: 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVR--------WMPLESILYNKYTVESDVWAFG 577
VK+ADFG + ++ R WM E I Y + D+W+ G
Sbjct: 154 SVKLADFGFAAQL----------TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLG 203
Query: 578 VCLWEIFSFALQ---PYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPM 632
+ E+ + PY + I I L+ P+ D + C P
Sbjct: 204 IMCIEM----AEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPE 259
Query: 633 NRPS 636
RPS
Sbjct: 260 KRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 76/283 (26%), Positives = 124/283 (43%), Gaps = 43/283 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD---FEREACLLAEFDHP 428
+ +GA+GRVF AK K + A+K++ K + Q D ER+ +L++ P
Sbjct: 1 ISKGAYGRVFLAK-----KKSTGDIYAIKVIKKADMIRKNQVDQVLTERD--ILSQAQSP 53
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+VKL K + L+ EY+ GDL L S++ + R
Sbjct: 54 YVVKLYYSFQGKKNLYLVMEYLPGGDLASLLEN----------VGSLDEDVAR------- 96
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
I IA +I + YL +HRDL N LI+ +K+ DFGLS K+ L
Sbjct: 97 --IYIA-EIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS-KVGLVRRQINLN 152
Query: 549 NDAIPVR-------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+D + ++ E IL ++ D W+ G L+E F + P++G T EE+ +
Sbjct: 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYE-FLVGIPPFHGETPEEIFQ 211
Query: 602 YIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I G I + + + +A+ DL+ P R ++I +
Sbjct: 212 NILNGKIEWPEDVEVSDEAI-DLISKLLVPDPEKRLGAKSIEE 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 74/274 (27%), Positives = 120/274 (43%), Gaps = 35/274 (12%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +LG GAFG+V++AK E L A K+++ ++ E L+ D+ E +LA +HP
Sbjct: 17 IGELGDGAFGKVYKAK-----NKETGALAAAKVIETKSEEELE-DYMVEIEILATCNHPY 70
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IVKLLG + G L + C P ++ ++ + PQ+
Sbjct: 71 IVKLLGA------------FYWDGKLWIMIEFC-PGGAVDAIMLELDRGLTE-PQIQV-- 114
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
I Q+ + YL K +HRDL N L+ +K+ADFG+S K ++ + D
Sbjct: 115 ---ICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRDSF 170
Query: 550 DAIPVRWMPLESILYNK-----YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
P WM E ++ Y ++D+W+ G+ L E+ P++ L V+ I
Sbjct: 171 IGTPY-WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE-PPHHELNPMRVLLKIA 228
Query: 605 EGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ L P D +K + P RPS
Sbjct: 229 KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS 262
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 86.3 bits (213), Expect = 1e-18
Identities = 68/278 (24%), Positives = 124/278 (44%), Gaps = 45/278 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G+FG V++ G+ + +VA+K++ E +E D ++E +L++ D P I +
Sbjct: 12 IGKGSFGEVYK----GIDNRTK-EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITR 66
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
G G + ++ EY+G G D L+ P L + T
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLK---PG------------------PLEETYIAT 105
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
I +I G+ YL + +HRD+ N L+++Q VK+ADFG++ ++ K +
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQL-TDTQIKRNTFVGT 164
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
P WM E I + Y ++D+W+ G+ E+ +P H V ++ P
Sbjct: 165 PF-WMAPEVIKQSAYDFKADIWSLGITAIELAKG--EPPNSDLHPMRVLFL-------IP 214
Query: 613 DNTPDALY--------DLMKLCWNMKPMNRPSFRTIYQ 642
N+P L + ++ C N P RP+ + + +
Sbjct: 215 KNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 63/223 (28%), Positives = 93/223 (41%), Gaps = 49/223 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G +G VF+AK E +VA+K ++ D+ E + + RE CLL E H NIV
Sbjct: 8 IGEGTYGTVFKAK-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
+L V K + L+FEY + DL + C NG
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSC------NGD-----------IDPEIVKSF 104
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDA 551
Q+ G+ + +HRDL +N LIN +K+ADFGL+R
Sbjct: 105 M--FQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLAR------------AFG 150
Query: 552 IPVR---------WMPLESILYNK--YTVESDVWAFGVCLWEI 583
IPVR W +L+ Y+ D+W+ G E+
Sbjct: 151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143568 cd07459, CRD_TK_ROR_like, Cysteine-rich domain of tyrosine kinase-like orphan receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 1e-18
Identities = 35/140 (25%), Positives = 57/140 (40%), Gaps = 13/140 (9%)
Query: 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMAL--WKEMIAILANPCKQAA 90
GYC Y G +C YL + + +S ++ D+ EQ+ A + C+Q A
Sbjct: 1 GYCQPYRGSVCAKYLG--NKSVYVTSKQTQE-DIEEQLSAAFTVISTSSDVSPK-CQQYA 56
Query: 91 EKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHF 150
LC YAFP C + P +C ++C + C ++A + + G +
Sbjct: 57 LPSLCYYAFPLCDEGSSTPKPRRICRDECELLENDLCKKEYAIAKRHPLIGHQ------L 110
Query: 151 ELPNCDTLPKYEVVNGKPTC 170
LP+C +LP C
Sbjct: 111 LLPDCSSLPSPGSPES-SNC 129
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror) proteins, a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. Length = 135 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/280 (24%), Positives = 124/280 (44%), Gaps = 29/280 (10%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P + +G+G+FG VF+ + + +VA+K++ E +E D ++E +L
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKG-----IDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVL 56
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
++ D P + K G + ++ EY+G G D L P
Sbjct: 57 SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE---PG----------------- 96
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
L + TI +I G+ YL K +HRD+ N L+++ VK+ADFG++ ++
Sbjct: 97 -PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQL-TDT 154
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
K + P WM E I + Y ++D+W+ G+ E+ + P+ L +V+
Sbjct: 155 QIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIEL-AKGEPPHSELHPMKVLFL 212
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I + N N L + ++ C N +P RP+ + + +
Sbjct: 213 IPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 67/219 (30%), Positives = 106/219 (48%), Gaps = 28/219 (12%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
I + LG+G + VF+ ++ K E LVA+K ++ E E RE LL + H
Sbjct: 9 IKLEKLGEGTYATVFKGRS----KLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
NIV L + K + L+FEY+ + DL ++ C G SM H V
Sbjct: 64 ANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDC-------GNIMSM----HNVK---- 107
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
QI G+ Y RK +HRDL +N LIN++ +K+ADFGL+R + K
Sbjct: 108 ----IFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT--KTY 161
Query: 548 ENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
N+ + + + P + +L ++Y+ + D+W G +E+ S
Sbjct: 162 SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 67/226 (29%), Positives = 100/226 (44%), Gaps = 43/226 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREA-CLLAEF 425
++ LG G FG V+ A+ E LVA+K +K + E + RE L
Sbjct: 4 IKQLGDGTFGSVYLAR-----NKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLN 55
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
+HPNIVKL V + +FEYM G+L Y M+ +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNL----------------YQLMKD--RKGKPF 96
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
S + +I QI G+ ++ F HRDL N L++ VVKIADFGL+R++ + Y
Sbjct: 97 SESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY- 155
Query: 546 GDENDAIPVRW-----MPLESILYNKYTVESDVWAFGVCLWEIFSF 586
D + RW + L S Y+ D+WA G + E+++
Sbjct: 156 ---TDYVSTRWYRAPEILLRSTSYSS---PVDIWALGCIMAELYTL 195
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 72/274 (26%), Positives = 118/274 (43%), Gaps = 41/274 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD------EASEYLQTDFEREACLLAEFD 426
LG+G+FG V+ K + E +K+LK+ +E +Q + +EA LL++ D
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEER-----LKVLKEIPVGELNPNETVQAN--QEAQLLSKLD 60
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP IVK C++ EY DL+ L + +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-------------LSENQ 107
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY----LQD 542
C+ +Q+ G+ Y+ R+ +HRDL +N + + + +KI DFG+SR + L
Sbjct: 108 VCEWF---IQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLAT 163
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ G +M E++ + Y +SD+W+ G L+E+ A + G VV
Sbjct: 164 TFTGTPY------YMSPEALKHQGYDSKSDIWSLGCILYEMCCLA-HAFEGQNFLSVVLR 216
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
I EG P+ L +M+ N P RPS
Sbjct: 217 IVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 70/238 (29%), Positives = 115/238 (48%), Gaps = 31/238 (13%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
I + LG+G + V++ ++ K + LVA+K ++ E E RE LL + H
Sbjct: 9 IKLDKLGEGTYATVYKGRS----KLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKH 63
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
NIV L + K + L+FEY+ + DL +L C N IN +H V
Sbjct: 64 ANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCG--NSIN---------MHNVK---- 107
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
Q+ G+ Y RK +HRDL +N LIN++ +K+ADFGL+R + K
Sbjct: 108 ----LFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT--KTY 161
Query: 548 ENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYY-GLTHEEVVKYI 603
N+ + + + P + +L Y+ + D+W G +E+ + +P + G T EE + +I
Sbjct: 162 SNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG--RPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 9e-18
Identities = 64/235 (27%), Positives = 101/235 (42%), Gaps = 52/235 (22%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVK--MLKDEASEYLQTDFEREACLLAEFDHP 428
LG+G FG V++A G +VA+K ++ +E + T RE +L + HP
Sbjct: 16 LGEGTFGEVYKARQIKTG-------RVVALKKILMHNEKDGFPITAL-REIKILKKLKHP 67
Query: 429 NIVKLLGVCAVGKP---------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
N+V L+ + AV +P + ++ YM DL+ L N +
Sbjct: 68 NVVPLIDM-AVERPDKSKRKRGSVYMVTPYMDH-DLSGLLE----NPSVK---------- 111
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
L+ + LQ+ G+ YL + +HRD+ N LI++Q ++KIADFGL+R
Sbjct: 112 -----LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166
Query: 540 LQDY---YKGDENDA-----IPVRWM-PLESILYNK-YTVESDVWAFGVCLWEIF 584
G + RW P E +L + YT D+W G E+F
Sbjct: 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 70/275 (25%), Positives = 128/275 (46%), Gaps = 32/275 (11%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKH---EEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
++ +G+G+FG+++ AKA +H +E L + + + EAS+ +E LLA+
Sbjct: 5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-------KEVILLAKMK 57
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNIV + ++ EY GDL RI + R S
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDL--MKRI----------------NRQRGVLFS 99
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYK 545
+++ +QI+ G+ ++ DRK +HRD+ ++N ++ + MV K+ DFG++R+ L D +
Sbjct: 100 EDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSME 157
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
++ E Y ++D+W+ G L+E+ + P+ G ++V I +
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK-HPFEGNNLHQLVLKICQ 216
Query: 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
G N L L+ + + P +RPS +I
Sbjct: 217 GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 66/276 (23%), Positives = 121/276 (43%), Gaps = 29/276 (10%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G+FG VF+ + + +VA+K++ E +E D ++E +L++ D P + K
Sbjct: 12 IGKGSFGEVFKG-----IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 66
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
G G + ++ EY+G G D LR G + + + T
Sbjct: 67 YYGSYLKGTKLWIIMEYLGGGSALDLLRA--------GPFDEFQ-------------IAT 105
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+ +I G+ YL K +HRD+ N L+++Q VK+ADFG++ + L D
Sbjct: 106 MLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVG 163
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
WM E I + Y ++D+W+ G+ E+ + P + V+ I + N
Sbjct: 164 TPFWMAPEVIQQSAYDSKADIWSLGITAIEL-AKGEPPNSDMHPMRVLFLIPKNNPPTLT 222
Query: 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648
+ + C N P RP+ + + + + +K
Sbjct: 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 76/300 (25%), Positives = 113/300 (37%), Gaps = 63/300 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFE------------REA 419
LG+G +G+V KA L + VA+K +K E S + D + RE
Sbjct: 17 LGEGTYGKVE--KAYDTLTGKI---VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ E H NI+ L+ V G + L+ + M DL + + I
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVV----------------DRKI 114
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK-- 537
C I LQI +G+ L F+HRDL+ N IN + + KIADFGL+R+
Sbjct: 115 RLTESQVKC----ILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYG 170
Query: 538 --MYLQDYYKGDENDAIPVRWMPLESILY----------NKYTVESDVWAFGVCLWEIFS 585
Y K DE L+ KY D+W+ G E+ +
Sbjct: 171 YPPYSDTLSK-DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229
Query: 586 -FALQPYYGLTHEEVVKYIKEGNILQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
L P E+ + + +L P DN P A + L P +TI+
Sbjct: 230 GKPLFP----GENEIDQLGRIFELLGTPNEDNWPQAKK--LPLYTEFTPRKPKDLKTIFP 283
|
Length = 335 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 34/278 (12%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEF 425
+VR +G+G++G V L++H V K+ AS + E+EA LL++
Sbjct: 3 CFVRVVGKGSYGEV------SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL 56
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMG---RGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
HPNIV LL+ MG GDL L+ E +
Sbjct: 57 KHPNIVAYRESWEGED--GLLYIVMGFCEGGDLYHKLK---------------EQKGKLL 99
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
P+ + +QIA + YL ++ +HRDL T+N + ++K+ D G++R L++
Sbjct: 100 PENQVVEWF---VQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLEN 154
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+M E Y +SDVWA G C++E+ + + +V
Sbjct: 155 QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK-HAFNAKDMNSLVYR 213
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
I EG + P + L +L+ + +P RPS ++I
Sbjct: 214 IIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 28/212 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G + VF+ ++ K E LVA+K ++ E E RE LL H NIV
Sbjct: 13 LGEGTYATVFKGRS----KLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVT 67
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L + + + L+FEY+ DL +L C G SM H V
Sbjct: 68 LHDIIHTERCLTLVFEYL-DSDLKQYLDNC-------GNLMSM----HNVK--------I 107
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
Q+ G+ Y RK +HRDL +N LIN++ +K+ADFGL+R + K N+ +
Sbjct: 108 FMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT--KTYSNEVV 165
Query: 553 PVRWMPLESIL-YNKYTVESDVWAFGVCLWEI 583
+ + P + +L +Y+ D+W G L+E+
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 68/276 (24%), Positives = 111/276 (40%), Gaps = 52/276 (18%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+G+G+FG V++A K +VA+K++ E +E D ++E L++ P I
Sbjct: 9 IGKGSFGEVYKAIDKRTN-------QVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS-PNNYINGTYSSMESSIHRVPQLSTCD 489
K G G + ++ EY G G D L+ YI
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIA-------------------- 101
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
I ++ G+ YL + +HRD+ N L++++ VK+ADFG+S ++
Sbjct: 102 --FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQL----------T 149
Query: 550 DAIPVR--------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ R WM E I + Y ++D+W+ G+ E+ P L V+
Sbjct: 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLF 208
Query: 602 YIKEGNILQAPDNT-PDALYDLMKLCWNMKPMNRPS 636
I + N N D + LC N P RPS
Sbjct: 209 LIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS 244
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 71/295 (24%), Positives = 124/295 (42%), Gaps = 51/295 (17%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFEREACLLAE 424
D+ + DLG G G V +KH T++A K++ A ++ RE ++ E
Sbjct: 6 DLETISDLGAGNGGSV------SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE 59
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
P IV G +C+ E+M G L+ + P
Sbjct: 60 CRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP-------------------- 99
Query: 485 LSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKMY--LQ 541
+ L IA+ + G+ YL + + +HRD+ N L+N + +K+ DFG+S ++ +
Sbjct: 100 IPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA 159
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI------FSFALQPYYGLT 595
D + G +M E I KYTV+SDVW+ G+ + E+ F+F+ G
Sbjct: 160 DTFVGTST------YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
Query: 596 HE-EVVKYIKEGNILQAP------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
++ +++ I+Q P + P+ L D + C P RP+ + +
Sbjct: 214 DPMGILDLLQQ--IVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 1e-16
Identities = 64/227 (28%), Positives = 91/227 (40%), Gaps = 40/227 (17%)
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-----REACLLA 423
++ +G GA+G V A VA+K + S + RE LL
Sbjct: 4 LLKPIGSGAYGVVCSAV-----DKRTGRKVAIKKI----SNVFDDLIDAKRILREIKLLR 54
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV- 482
H NI+ LL + D ND YI ME+ +H+V
Sbjct: 55 HLRHENIIGLL----------DILRPPSPEDFNDV--------YIVTEL--METDLHKVI 94
Query: 483 --PQLSTCDLI-TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
PQ T D I QI G+ YL +HRDL N L+N +KI DFGL+R +
Sbjct: 95 KSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154
Query: 540 LQDYYKGDENDAIPVRWM-PLESIL-YNKYTVESDVWAFGVCLWEIF 584
+ KG + + RW E +L ++YT D+W+ G E+
Sbjct: 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 68/292 (23%), Positives = 115/292 (39%), Gaps = 56/292 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK----DEASEYLQTDFEREACLLAEF 425
++ + +GAFG V+ AK K A+K+LK ++ ER A ++ +
Sbjct: 1 LKPISKGAFGSVYLAK-----KRSTGDYFAIKVLKKSDMIAKNQVTNVKAER-AIMMIQG 54
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
+ P + KL + L+ EY+ GD ++ +P+
Sbjct: 55 ESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG-----------------LPED 97
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
I ++ G+ L R +HRD+ N LI+ +K+ DFGLSR +
Sbjct: 98 WAKQYIA---EVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV 154
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
G + ++ E+IL SD W+ G ++E F F P++ T + V I
Sbjct: 155 GTPD------YLAPETILGVGDDKMSDWWSLGCVIFE-FLFGYPPFHAETPDAVFDNILS 207
Query: 606 GNILQAPDN-----TPDALYDLMKLCWNMKPMNR------------PSFRTI 640
I P+ +P+A+ DL+ M P R P F++I
Sbjct: 208 RRI-NWPEEVKEFCSPEAV-DLINRLLCMDPAKRLGANGYQEIKSHPFFKSI 257
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 41/285 (14%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC----- 420
D ++ LG+G++G V++ K + + A+K E + ERE
Sbjct: 1 DFKVLKKLGKGSYGSVYKVK-----RLSDNQFYALK----EVDLGSMSQKEREDAVNEIR 51
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+LA +HPNI+ G +C++ EY GDL+ I S
Sbjct: 52 ILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS---------KAI--------SKRK 94
Query: 481 RVPQLSTCDLI-TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ +L I I +Q+ G+ L ++K +HRDL + N L+ +VKI D G+S+ +
Sbjct: 95 KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL- 153
Query: 540 LQDYYKGDENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
K I P +M E Y+ +SD+W+ G L+E+ +FA P+ + +
Sbjct: 154 ----KKNMAKTQIGTPH-YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAP-PFEARSMQ 207
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
++ ++ G P L + ++ +KP RP+ I
Sbjct: 208 DLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 71/273 (26%), Positives = 108/273 (39%), Gaps = 56/273 (20%)
Query: 327 PAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKA 386
P PS + S ++ L +LE V +G GA G V++
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAA-----KSLSELE-------RVNRIGSGAGGTVYKV-- 93
Query: 387 PGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446
+ L A+K++ + ++ RE +L + +HPN+VK + + +L
Sbjct: 94 ---IHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150
Query: 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD 506
E+M G L GT+ + E L+ +A QI SG+ YL
Sbjct: 151 LEFMDGGSLE-------------GTHIADE------QFLAD-----VARQILSGIAYLHR 186
Query: 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI---- 562
R VHRD+ N LIN VKIADFG+SR L + + +M E I
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSR--ILAQTMDPCNSSVGTIAYMSPERINTDL 244
Query: 563 ---LYNKYTVESDVWAFGVCLWEI----FSFAL 588
Y+ Y D+W+ GV + E F F +
Sbjct: 245 NHGAYDGYA--GDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 68/292 (23%), Positives = 108/292 (36%), Gaps = 53/292 (18%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
I+ + LG+GA G V + + + A+K + + + LQ RE +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLK-----NTGMIFALKTITTDPNPDLQKQILRELEINKS 55
Query: 425 FDHPNIVKLLGVCAVGKP--MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
P IVK G + + EY G L+ Y ++ R+
Sbjct: 56 CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLD-------------SIYKKVKKRGGRI 102
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ- 541
L IA + G+ YL RK +HRD+ N L+ + VK+ DFG+S ++
Sbjct: 103 ---GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI----FSFALQP 590
+Y M E I Y++ SDVW+ G+ L E+ F F +
Sbjct: 160 AGTFTGTSFY------------MAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207
Query: 591 YYGLTHEEVVKYIKEGNILQAPD------NTPDALYDLMKLCWNMKPMNRPS 636
L E++ YI + D + D +K C P RP+
Sbjct: 208 EPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT 259
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 76/299 (25%), Positives = 119/299 (39%), Gaps = 59/299 (19%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAK--APGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
P+ D ++ +G G +G V++A+ A G LVA+K++K E + ++E
Sbjct: 1 PQEDYELIQRIGSGTYGDVYKARDIATG-------ELVAIKVIKLEPGDDF-EIIQQEIS 52
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L E HPNIV G + ++ EY G G L D G S E I
Sbjct: 53 MLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIY------QVTRGPLS--ELQIA 104
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS----- 535
V + L+ G+ YL + +HRD+ N L+ + VK+ADFG+S
Sbjct: 105 YV----CRE----TLK---GLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153
Query: 536 ----RKMYLQDYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFAL 588
RK ++ Y WM E + Y + D+WA G+ E+ L
Sbjct: 154 TIAKRKSFIGTPY-----------WMAPEVAAVERKGGYDGKCDIWALGITAIELAE--L 200
Query: 589 QPYYGLTHEEVVKYI--KEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
QP H ++ K L+ + +D +K C P RP+ + Q
Sbjct: 201 QPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 71/268 (26%), Positives = 114/268 (42%), Gaps = 43/268 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +LG GAFG+V++A+ E L A K++ ++ E L+ D+ E +LA DHPN
Sbjct: 10 IGELGDGAFGKVYKAQ-----NKETGVLAAAKVIDTKSEEELE-DYMVEIDILASCDHPN 63
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IVKLL + +L E+ G ++ +E + PQ+
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGA-------------VDAVMLELERPLTE-PQIRV-- 107
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS----RKMYLQDYYK 545
+ Q + YL + K +HRDL N L +K+ADFG+S R + +D +
Sbjct: 108 ---VCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI 164
Query: 546 GDENDAIPVRWMPLESILYNK-----YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
G WM E ++ Y ++DVW+ G+ L E+ P++ L V+
Sbjct: 165 GTP------YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE-PPHHELNPMRVL 217
Query: 601 KYIKEGN--ILQAPDNTPDALYDLMKLC 626
I + L P D +K C
Sbjct: 218 LKIAKSEPPTLAQPSRWSSEFKDFLKKC 245
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 31/277 (11%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDHP 428
+ +G+G F V++A LL VA+K ++ D + D +E LL + +HP
Sbjct: 8 KKIGRGQFSEVYRATC--LLDG---VPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
N++K + ++ E GDL+ ++ + +P+ +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIK-------------HFKKQKRLIPEKTVW 109
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+Q+ S + ++ R+ +HRD+ N I VVK+ D GL R +
Sbjct: 110 KYF---VQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAH 164
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-PYYG--LTHEEVVKYIKE 605
+ +M E I N Y +SD+W+ G L+E+ ALQ P+YG + + K I++
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLYSLCKKIEQ 222
Query: 606 GNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
+ P D+ + L L+ +C N P RP +Y
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVY 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 41/220 (18%)
Query: 374 GQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY--LQTDFEREACLLAEFDHPNIV 431
G+G +GRV++AK ++ A+K K + +Y + RE LL E H N+V
Sbjct: 9 GRGTYGRVYKAK---RKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 432 KLLGVCAVGKPMC--LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
L+ V LLF+Y +D +I + ++ +P
Sbjct: 66 SLVEVFLEHADKSVYLLFDYAE----HDLWQII--------KFHR-QAKRVSIPPSM--- 109
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMY--LQDY 543
+ ++ QI +G+ YL +HRDL N L+ ++ VVKI D GL+R L+
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 544 YKGDENDAIPVR---W--MPLESILYNK-YTVESDVWAFG 577
D PV W P E +L + YT D+WA G
Sbjct: 170 ADLD-----PVVVTIWYRAP-ELLLGARHYTKAIDIWAIG 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 66/284 (23%), Positives = 121/284 (42%), Gaps = 42/284 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEASEYLQT--DFEREACLLAEFDH 427
LG GAF +QA+ TL+AVK + + +SE + +E L+A +H
Sbjct: 8 LGTGAFSSCYQARDVK-----TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNH 62
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P+I+++LG L E+M G ++ L Y + + ++
Sbjct: 63 PHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----------KYGAFKEAV-------- 104
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ-MVVKIADFGLSRKMYLQ----D 542
+I Q+ G+ YL + + +HRD+ N LI+ ++IADFG + ++ +
Sbjct: 105 --IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAG 162
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
++G I +M E + +Y DVW+ G + E+ + A P+ H +
Sbjct: 163 EFQGQLLGTIA--FMAPEVLRGEQYGRSCDVWSVGCVIIEMAT-AKPPWNAEKHSNHLAL 219
Query: 603 IKEGNILQAPDNTPD----ALYDLMKLCWNMKPMNRPSFRTIYQ 642
I + + P+ L D+ C ++P +RP R + +
Sbjct: 220 IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLL---AEF 425
V ++G GA+G V++A+ P VA+K ++ + +E L RE LL F
Sbjct: 5 VAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAF 59
Query: 426 DHPNIVKLLGVCAVGK-----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
DHPNIV+L+ VCA + + L+FE++ + DL +L P
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPP---------------- 102
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
P L + + Q G+ +L VHRDL N L+ VK+ADFGL+R +
Sbjct: 103 --PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLAR---I 157
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
+ + + E +L + Y D+W+ G E+F
Sbjct: 158 YSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 47/230 (20%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAE 424
D + +G+G +G V++ + + +VA+K ++ E+ E + + RE LL E
Sbjct: 1 DYTKIEKIGEGTYGVVYKGR-----NKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKE 55
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HPNIV L V + L+FE++ DL +L Y++ ++S ++
Sbjct: 56 LQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDA--ELVKSYLY---- 108
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
QI G+++ R+ +HRDL +N LI+++ V+K+ADFGL+R
Sbjct: 109 -----------QILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------ 151
Query: 545 KGDENDAIPVR---------WMPLESILYN--KYTVESDVWAFGVCLWEI 583
IPVR W +L +Y+ D+W+ G E+
Sbjct: 152 ------GIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEM 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 61/225 (27%), Positives = 110/225 (48%), Gaps = 37/225 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLLAE---F 425
V ++G+GA+G+VF+A+ LK+ VA+K ++ + E + RE +L F
Sbjct: 6 VAEIGEGAYGKVFKARD---LKNGG-RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 61
Query: 426 DHPNIVKLLGVCAVGK-----PMCLLFEYMGRGDLNDFL-RICSPNNYINGTYSSMESSI 479
+HPN+V+L VC V + + L+FE++ + DL +L ++ P
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-------------- 106
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
VP + D++ Q+ G+ +L + VHRDL +N L+ +K+ADFGL+R
Sbjct: 107 --VPTETIKDMM---FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR--- 158
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
+ + + + + + E +L + Y D+W+ G E+F
Sbjct: 159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 2e-15
Identities = 53/231 (22%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD-FEREACLL 422
+D +++ LG G+FGRV + ++ A+K+L K + + Q + E +L
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVR---HKGSGKY--YALKILSKAKIVKLKQVEHVLNEKRIL 55
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRIC-SPNNYINGTYSSMESSIHR 481
HP +V L G + L+ EY+ G+L LR + Y++
Sbjct: 56 QSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQ------ 109
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+ +AL+ YL V+RDL N L++ +KI DFG +++
Sbjct: 110 ---------VVLALE------YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKR---- 150
Query: 542 DYYKGDENDAIPVR---------WMPLESILYNKYTVESDVWAFGVCLWEI 583
+ R ++ E IL Y D WA G+ ++E+
Sbjct: 151 ----------VKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEM 191
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 3e-15
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 50/225 (22%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G++ V++ ++ K LVA+K ++ E E REA LL + H NIV
Sbjct: 13 LGEGSYATVYKGRS----KLTG-QLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRIC----SPNNYINGTYSSMESSIHRVPQLSTC 488
L + K + L+FEY+ DL ++ C S +N
Sbjct: 68 LHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHN---------------------- 104
Query: 489 DLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR------KMYLQ 541
+ + L Q+ G+ Y R+ +HRDL +N LI+++ +K+ADFGL+R K Y
Sbjct: 105 --VRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY-- 160
Query: 542 DYYKGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
N+ + + + P + +L +Y+ D+W G +E+ +
Sbjct: 161 ------SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 30/167 (17%)
Query: 375 QGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHPNIVKL 433
+G +G V++A+ K E +VA+K LK ++ E RE +L + HPNIV +
Sbjct: 15 EGTYGVVYRARD---KKTGE--IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV 69
Query: 434 LGVCAVGKPMCLLF---EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V VG + ++ EY+ DL ME ++
Sbjct: 70 KEV-VVGSNLDKIYMVMEYV-EHDLKSL----------------ME---TMKQPFLQSEV 108
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
+ LQ+ SG+ +L D +HRDL T N L+N++ ++KI DFGL+R+
Sbjct: 109 KCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLARE 155
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 66/271 (24%), Positives = 108/271 (39%), Gaps = 29/271 (10%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFD 426
I +R LG+GAFG +A + E+ +LV K + SE + D E +L+
Sbjct: 3 IPIRVLGKGAFG-----EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ 57
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNI+ + + EY G L D + + + QL
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-------------------VRQKGQLF 98
Query: 487 TCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+++ L QI S + Y+ +HRD+ T N + ++K+ DFG+S+ + Y
Sbjct: 99 EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKIL--GSEYS 156
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
E +M E KY +SD+WA G L+E+ + + + +V I +
Sbjct: 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK-RTFDATNPLNLVVKIVQ 215
Query: 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
GN L L+ P RP+
Sbjct: 216 GNYTPVVSVYSSELISLVHSLLQQDPEKRPT 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 8e-15
Identities = 63/285 (22%), Positives = 105/285 (36%), Gaps = 55/285 (19%)
Query: 366 DIIYVRDLGQGAFGRVFQA--KAPG---LLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
D + +G+G+FG VF+ KA +K + + KM + E E + EA
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLS----KMNRREREEAI-----DEAR 51
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+LA+ D I++ + ++ EY GDL+ L++
Sbjct: 52 VLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKM------------------Q 93
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R L + +QI G+ +L +K +HRD+ + N ++ VKI D G+++ +
Sbjct: 94 RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153
Query: 541 QD----------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
YY + E Y +SDVWA GV L+E + P
Sbjct: 154 NTNFANTIVGTPYY------------LSPELCEDKPYNEKSDVWALGVVLYECCTGK-HP 200
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635
+ ++ I G L L+ C RP
Sbjct: 201 FDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 72/286 (25%), Positives = 122/286 (42%), Gaps = 47/286 (16%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDHP 428
+ +G+G F V++A + +VA+K ++ + + D +E LL + DHP
Sbjct: 8 KKIGKGQFSVVYKAI-----CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
N++K L + ++ E GDL+ ++ H Q
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIK-------------------HFKKQKRLI 103
Query: 489 DLITI---ALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
TI +Q+ S + ++ ++ +HRD+ N I VVK+ D GL R ++
Sbjct: 104 PERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR------FFS 157
Query: 546 GDENDA-----IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-PYYG--LTHE 597
A P +M E I N Y +SD+W+ G L+E+ ALQ P+YG +
Sbjct: 158 SKTTAAHSLVGTPY-YMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLY 214
Query: 598 EVVKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ K I++ + P D+ + L DL+ C N P RP + Q
Sbjct: 215 SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 71/236 (30%), Positives = 107/236 (45%), Gaps = 51/236 (21%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER---EAC 420
+ +I+ + LG+GA+G V++A + +VA+K + D TD +R E
Sbjct: 8 KYEIL--QKLGKGAYGIVWKA-----IDRRTKEVVALKKIFDAFRN--ATDAQRTFREIM 58
Query: 421 LLAEF-DHPNIVKLLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
L E DHPNIVKLL V K + L+FEYM DL+ +R +++
Sbjct: 59 FLQELGDHPNIVKLLNVIKAENDKDIYLVFEYM-ETDLHAVIR------------ANILE 105
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
+H+ I Q+ + Y+ +HRDL N L+N VK+ADFGL+R
Sbjct: 106 DVHK---------RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156
Query: 538 MYLQDYYKGDENDAIPV-------RWMPLESILY--NKYTVESDVWAFGVCLWEIF 584
+ + +EN PV RW IL +YT D+W+ G L E+
Sbjct: 157 L-----SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML 207
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 69/275 (25%), Positives = 112/275 (40%), Gaps = 38/275 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-----REACLLAEFDH 427
LG+GA+G V+ GL + L+AVK ++ + S L + E E LL H
Sbjct: 8 LGKGAYGTVYC----GLTNQGQ--LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
NIV+ LG C + + E++ G S+ S ++R L
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGG--------------------SISSILNRFGPLPE 101
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
QI G+ YL + VHRD+ N ++ ++K+ DFG +R++ +
Sbjct: 102 PVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTH 161
Query: 548 ENDAIPVR----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
N + WM E I + Y +SD+W+ G ++E+ + P + + YI
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT-GKPPLASMDRLAAMFYI 220
Query: 604 KEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPS 636
L + PD+ A D + C RPS
Sbjct: 221 GAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS 255
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 71/285 (24%), Positives = 114/285 (40%), Gaps = 44/285 (15%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDF---EREA 419
P++D ++ +G G +G V++A+ L AVK++K E + DF ++E
Sbjct: 7 PQHDYELIQRVGSGTYGDVYKAR-----NLHTGELAAVKIIKLEPGD----DFSLIQQEI 57
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ E H NIV G + + + EY G G L D + P
Sbjct: 58 FMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP--------------- 102
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
LS + + + G+ YL + +HRD+ N L+ D VK+ADFG++ K+
Sbjct: 103 -----LSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKI- 156
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
K P WM E K Y D+WA G+ E+ LQP H
Sbjct: 157 TATIAKRKSFIGTPY-WMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE--LQPPMFDLH 213
Query: 597 EEVVKYIKEGNILQAP---DNT--PDALYDLMKLCWNMKPMNRPS 636
++ + Q P D T ++ +K+ P RP+
Sbjct: 214 PMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 2e-14
Identities = 65/273 (23%), Positives = 103/273 (37%), Gaps = 38/273 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLK-----DEASEYLQTDFEREACLLAEF 425
LGQGAFGRV+ L ++ T +AVK + E + + E E LL
Sbjct: 10 LGQGAFGRVY-------LCYDVDTGRELAVKQVPFDPDSPETKKEVNA-LECEIQLLKNL 61
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
H IV+ G + + + EYM G + D L+ Y ++ ++ R
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLK----------AYGALTETVTR---- 107
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
QI G+ YL VHRD+ N L + VK+ DFG S+++
Sbjct: 108 ------KYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 546 GDENDAIPV-RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV-KYI 603
WM E I Y ++DVW+ G + E+ + P+ + K
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMAAIFKIA 220
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ Q P + + ++ + RPS
Sbjct: 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPS 253
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 31/238 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK---MLKDEASEYLQTDFEREACLLAEFDHPN 429
LG+G+FG+VF A+ G ++ F + A+K +L D+ E T E+ LA ++HP
Sbjct: 3 LGKGSFGKVFLAELKG--TNQFFAIKALKKDVVLMDDDVEC--TMVEKRVLSLA-WEHPF 57
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+ L + + + EY+ GDL ++ C + T+ + E
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE------------- 104
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
I G+ +L + V+RDL N L++ +KIADFG+ ++ L D K
Sbjct: 105 -------IICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF 156
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
P P E +L KY D W+FGV L+E+ P++G EE+ + I+ N
Sbjct: 157 CGTPDYIAP-EILLGQKYNTSVDWWSFGVLLYEML-IGQSPFHGHDEEELFQSIRMDN 212
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 72/235 (30%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-------REACLLA 423
+G+G +G V++A K G +VA+K ++ L+T+ E RE LL
Sbjct: 7 IGEGTYGVVYKARDKLTG-------EIVALKKIR------LETEDEGVPSTAIREISLLK 53
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
E +HPNIV+LL V + L+FE++ DL + M+S P
Sbjct: 54 ELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKY----------------MDS----SP 92
Query: 484 QLSTC-DLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
LI L Q+ G+ Y + +HRDL +N LI+ + +K+ADFGL+R
Sbjct: 93 LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--- 149
Query: 542 DYYKGDENDAIPVR---------WMPLESILY--NKYTVESDVWAFGVCLWEIFS 585
+PVR W IL +Y+ D+W+ G C IF+
Sbjct: 150 ---------GVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG-C---IFA 191
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 66/270 (24%), Positives = 102/270 (37%), Gaps = 66/270 (24%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFDHPN 429
+G+GA+G V + KA G +VA+K K+ E E ++ RE +L + H N
Sbjct: 9 VGEGAYGVVLKCRNKATG-------EIVAIKKFKESEDDEDVKKTALREVKVLRQLRHEN 61
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV L + L+FEY+ R L +E+S +P +
Sbjct: 62 IVNLKEAFRRKGRLYLVFEYVERTLLEL-----------------LEASPGGLPPDAVRS 104
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM------YLQDY 543
I Q+ + Y +HRD+ N L+++ V+K+ DFG +R + L DY
Sbjct: 105 YI---WQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDY 161
Query: 544 YKGDENDAIPVRWMPLESIL--YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ RW +L Y DVWA G + E+
Sbjct: 162 --------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD---------------- 197
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
G L D+ D LY + K + P
Sbjct: 198 ----GEPLFPGDSDIDQLYLIQKCLGPLPP 223
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-14
Identities = 63/255 (24%), Positives = 104/255 (40%), Gaps = 55/255 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G + V++ G + +VA+K + +A E + RE L+ E H NIV+
Sbjct: 8 LGEGTYATVYK----GRNRTTG-EIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVR 62
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L V + L+FEYM DL + M++ R D T
Sbjct: 63 LHDVIHTENKLMLVFEYM-DKDLKKY----------------MDTHGVRGA----LDPNT 101
Query: 493 I---ALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
+ Q+ G+ + + + +HRDL +N LIN + +K+ADFGL+R
Sbjct: 102 VKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAF----------- 150
Query: 550 DAIPVR---------WMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
IPV W +L Y+ D+W+ G + E+ + + G +E+
Sbjct: 151 -GIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT-GRPLFPGTNNED 208
Query: 599 VVKYIKEGNILQAPD 613
+ I I+ P
Sbjct: 209 QLLKIF--RIMGTPT 221
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 7e-14
Identities = 42/100 (42%), Positives = 56/100 (56%), Gaps = 1/100 (1%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR++++ R LG GAFGRV +A A GL + VAVKMLK A + E
Sbjct: 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELK 92
Query: 421 LLAEFD-HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFL 459
+++ H NIV LLG C G P+ ++ EY GDL D+L
Sbjct: 93 IMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 65/276 (23%), Positives = 123/276 (44%), Gaps = 27/276 (9%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+ +G+G F V++A LL + L V++ + ++ Q D +E LL + +HPN+
Sbjct: 8 KKIGRGQFSEVYRATC--LLDRKPVALKKVQIFEMMDAKARQ-DCVKEIDLLKQLNHPNV 64
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
+K L + ++ E GDL+ ++ + +P+ +
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-------------IPERTVWKY 111
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+Q+ S + ++ R+ +HRD+ N I VVK+ D GL R + +
Sbjct: 112 F---VQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR--FFSSKTTAAHSL 166
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-PYYG--LTHEEVVKYIKEGN 607
+M E I N Y +SD+W+ G L+E+ ALQ P+YG + + + I++ +
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNLFSLCQKIEQCD 224
Query: 608 ILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
P ++ + L +L+ +C P RP ++Q
Sbjct: 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|201766 pfam01392, Fz, Fz domain | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 8e-14
Identities = 29/129 (22%), Positives = 42/129 (32%), Gaps = 22/129 (17%)
Query: 35 CSQYNGKICKNYL-NRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKL 93
C G +CK N T + N + Q+ W ++ + C A +
Sbjct: 1 CEPIRGPLCKGLGYNYT--LMPNLLGHETQKEAELQL--TAWTPLVNVK---CSPALQFF 53
Query: 94 LCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP 153
LC+ P C + G+ +P C C AV+ C G EL
Sbjct: 54 LCSLYAPVC--TEGLRTPIPPCRSLCEAVK-EGCEPVM-----------ETFGFGWPELL 99
Query: 154 NCDTLPKYE 162
C LP E
Sbjct: 100 ECSKLPSPE 108
|
Also known as the CRD (cysteine rich domain), the C6 box in MuSK receptor. This domain of unknown function has been independently identified by several groups. The domain contains 10 conserved cysteines. Length = 108 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 68/300 (22%), Positives = 116/300 (38%), Gaps = 62/300 (20%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDF---EREA 419
P+ D ++ +G G +G V++A+ + L A+K++K E E DF ++E
Sbjct: 7 PQEDFELIQRIGSGTYGDVYKARNVNTGE-----LAAIKVIKLEPGE----DFAVVQQEI 57
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ + H NIV G + + E+ G G L D + P
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGP--------------- 102
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS---- 535
LS + ++ + G+ YL + +HRD+ N L+ D VK+ADFG+S
Sbjct: 103 -----LSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT 157
Query: 536 -----RKMYLQDYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFA 587
RK ++ Y WM E + Y D+WA G+ E+
Sbjct: 158 ATIAKRKSFIGTPY-----------WMAPEVAAVERKGGYNQLCDIWAVGITAIELAE-- 204
Query: 588 LQPYYGLTHEEVVKYIKEGNILQAPD-----NTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
LQP H ++ + Q P ++ + +K+ P RP+ + Q
Sbjct: 205 LQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 53/192 (27%), Positives = 83/192 (43%), Gaps = 38/192 (19%)
Query: 358 EQLEFPRNDII--YVR--DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM-LKDEASEYLQ 412
+Q EFP D + Y + +GQG FG VF+A+ + VA+K L + E
Sbjct: 1 DQYEFPFCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQI-----VALKKVLMENEKEGFP 55
Query: 413 TDFEREACLLAEFDHPNIVKLLGVCAVGKPMC--------LLFEYMGRGDLNDFLRICSP 464
RE +L H N+V L+ +C L+FE+ DL L
Sbjct: 56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLL----- 109
Query: 465 NNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524
+ N ++ S I +V + + +G+ Y+ K +HRD+ N LI
Sbjct: 110 -SNKNVKFT--LSEIKKVMK-----------MLLNGLYYIHRNKILHRDMKAANILITKD 155
Query: 525 MVVKIADFGLSR 536
++K+ADFGL+R
Sbjct: 156 GILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 68/277 (24%), Positives = 120/277 (43%), Gaps = 38/277 (13%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+R +G+G+FGR L++H A+K ++ S D +EA LLA+ HP
Sbjct: 5 LRVVGEGSFGRAL------LVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHP 58
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV + ++ EY GDL M+ + +L
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDL-------------------MQKIKLQRGKLFPE 99
Query: 489 DLI-TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG----LSRKMYLQDY 543
D I +Q+ G+ ++ +++ +HRD+ ++N + VK+ DFG L+
Sbjct: 100 DTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y G P W E++ YN +SD+W+ G L+E+ + P+ + + ++ +
Sbjct: 160 YVGTPYYVPPEIW---ENMPYNN---KSDIWSLGCILYELCTLK-HPFQANSWKNLILKV 212
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
+G+ P + L L+K + P +RPS TI
Sbjct: 213 CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 63/239 (26%), Positives = 102/239 (42%), Gaps = 45/239 (18%)
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
F A ++ + H +IV L GVC ++ E++ G L+ F+
Sbjct: 51 FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH-------------- 96
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV-------V 527
+ L+T +A Q+AS + YL D+ VH ++ T+N L+ + + +
Sbjct: 97 -----RKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151
Query: 528 KIADFG-----LSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLW 581
K++D G LSR+ + + IP W+ E + +K ++ +D W+FG LW
Sbjct: 152 KLSDPGIPITVLSRQECV---------ERIP--WIAPECVEDSKNLSIAADKWSFGTTLW 200
Query: 582 EIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
EI P T E ++ + +L P L DLM C N P RP FR I
Sbjct: 201 EICYNGEIPLKDKTLAEKERFYEGQCMLVTPSC--KELADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 66/255 (25%), Positives = 111/255 (43%), Gaps = 36/255 (14%)
Query: 398 VAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLND 457
V +K+L D + + F A L+++ H ++ + GVC G ++ E++ G L+
Sbjct: 47 VVLKVL-DPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDV 105
Query: 458 FLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517
LR RVP IT+A Q+AS + YL D+ VH ++ +
Sbjct: 106 CLR----------------KEKGRVP---VAWKITVAQQLASALSYLEDKNLVHGNVCAK 146
Query: 518 NCLI-------NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-YNKYTV 569
N L+ +K++D G+S + + + IP W+ E + N +
Sbjct: 147 NILLARLGLAEGTSPFIKLSDPGVS----FTALSREERVERIP--WIAPECVPGGNSLST 200
Query: 570 ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNM 629
+D W+FG L EI P T E ++ ++ + L P + + L L+ C
Sbjct: 201 AADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPEP-SCKE-LATLISQCLTY 258
Query: 630 KPMNRPSFRTIYQTL 644
+P RPSFRTI + L
Sbjct: 259 EPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 70/271 (25%), Positives = 108/271 (39%), Gaps = 42/271 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLLAEFDHPNIV 431
LG G FGRV K +K + T + K E Q E +L E +HP IV
Sbjct: 1 LGVGGFGRVELVK----VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIV 56
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLR-ICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
KL K + +L EY G+L LR + Y Y +
Sbjct: 57 KLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC--------------- 101
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ +A + YL +R ++RDL N L++ VK+ DFG ++K L+ K
Sbjct: 102 VVLAFE------YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKK--LKSGQKTWTFC 153
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG------LTHEEVVKYIK 604
P ++ E IL Y D W+ G+ L+E+ + P+ + +++K
Sbjct: 154 GTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLT-GRPPFGEDDEDPMEIYNDILKGNG 211
Query: 605 EGNILQAPDNTPDALYDLMK-LCWNMKPMNR 634
+ L+ P+ A DL+K L P R
Sbjct: 212 K---LEFPNYIDKAAKDLIKQLL-RRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 37/220 (16%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF 425
DI Y LG G G V++A + ++AVK++ + + LQ E +L +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRR-----ILAVKVIPLDITVELQKQIMSELEILYKC 56
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
D P I+ G V + + E+M G L+ + +I
Sbjct: 57 DSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHV-------------------- 96
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY--LQDY 543
L IA+ + G+ YL K +HRD+ N L+N + VK+ DFG+S ++ +
Sbjct: 97 ----LGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKT 152
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
Y G +M E I +Y + SDVW+ G+ E+
Sbjct: 153 YVGTN------AYMAPERISGEQYGIHSDVWSLGISFMEL 186
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 4e-13
Identities = 73/267 (27%), Positives = 131/267 (49%), Gaps = 35/267 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD---EASEYLQTDFEREACLLAEFDHPN 429
LGQG+FG+VF + + + L A+K+LK + + ++T ER+ +LAE +HP
Sbjct: 4 LGQGSFGKVFLVRK--ITGPDAGQLYAMKVLKKATLKVRDRVRTKMERD--ILAEVNHPF 59
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IVKL + L+ +++ GDL F R+ S E + T +
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDL--FTRL------------SKEV-------MFTEE 98
Query: 490 LITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ L ++A + +L ++RDL N L++++ +K+ DFGLS++ D+ K
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAY 156
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+ V +M E + +T +D W+FGV ++E+ + +L P+ G +E + I +
Sbjct: 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL-PFQGKDRKETMTMILKAK- 214
Query: 609 LQAPDN-TPDALYDLMKLCWNMKPMNR 634
L P +P+A L++ + P NR
Sbjct: 215 LGMPQFLSPEA-QSLLRALFKRNPANR 240
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 6e-13
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 41/220 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
++ L G+ GRVF A PG + V +K+ + + EA LL +HP+
Sbjct: 71 IKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKGTTLI-------EAMLLQNVNHPS 118
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
++++ G C++ + DL +L + S L
Sbjct: 119 VIRMKDTLVSGAITCMVLPHY-SSDLYTYL--------------TKRSR-----PLPIDQ 158
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
+ I QI G+ YL ++ +HRD+ T N IND V I D G ++ +
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ------FPVVAPA 212
Query: 550 D---AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586
A V E + +KY ++D+W+ G+ L+E+ ++
Sbjct: 213 FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAY 252
|
Length = 357 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 65/291 (22%), Positives = 115/291 (39%), Gaps = 53/291 (18%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE---YLQTDFEREACLLAEFDHPN 429
+G G FG+V+ A + + L+AVK ++ + ++ + E +L HPN
Sbjct: 8 IGGGTFGKVYTA-----VNLDTGELMAVKEIRIQDNDPKTIKEI--ADEMKVLELLKHPN 60
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+VK GV + + + EY G L + L +G V ++ T
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLE--------HGRILDE-----HVIRVYT-- 105
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM---------YL 540
LQ+ G+ YL VHRD+ N ++ V+K+ DFG + K+ +
Sbjct: 106 -----LQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVE---SDVWAFGVCLWEIFSFALQPYYGLTHE 597
Q P +M E I K +D+W+ G + E+ + +P+ L +E
Sbjct: 161 QSL------AGTPA-YMAPEVITGGKGKGHGRAADIWSLGCVVLEMAT-GKRPWSELDNE 212
Query: 598 EVVKY-IKEGNILQAPDNTP--DALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ + + G+ PD+ D + C P RP+ + Q +
Sbjct: 213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 1e-12
Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 43/275 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G +G V+ A+ +A+K + + S Y+Q E E L + H NIV+
Sbjct: 16 LGKGTYGIVYAAR-----DLSTQVRIAIKEIPERDSRYVQPLHE-EIALHSYLKHRNIVQ 69
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
LG + + E + G L+ LR + + G E +I I
Sbjct: 70 YLGSDSENGFFKIFMEQVPGGSLSALLR----SKW--GPLKDNEQTI-----------IF 112
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLIND-QMVVKIADFGLSRKMY----LQDYYKGD 547
QI G+ YL D + VHRD+ N L+N VVKI+DFG S+++ + + G
Sbjct: 113 YTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGT 172
Query: 548 ENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
+++M E I Y +D+W+ G + E+ + P+ L + + K
Sbjct: 173 ------LQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT-GKPPFIELGEPQAAMF-KV 224
Query: 606 GNILQAPDNTPDALY----DLMKLCWNMKPMNRPS 636
G P P++L + + C+ P R S
Sbjct: 225 GMFKIHP-EIPESLSAEAKNFILRCFEPDPDKRAS 258
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 55/234 (23%), Positives = 100/234 (42%), Gaps = 55/234 (23%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKML---KDEASEYLQTDFER 417
PR+ + +G+G+ G V A ++ T VAVK + K + E L F
Sbjct: 17 PRSYLDNFVKIGEGSTGIVCIA-------TDKSTGRQVAVKKMDLRKQQRRELL---FN- 65
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
E ++ ++ HPNIV++ VG + ++ E++ G L D + T++ M
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-----------THTRMNE 114
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
Q++T + L + + +L + +HRD+ + + L+ VK++DFG
Sbjct: 115 -----EQIAT-----VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFG---- 160
Query: 538 MYLQDYYKGDENDAIPVR--------WMPLESILYNKYTVESDVWAFGVCLWEI 583
+ + +P R WM E I Y E D+W+ G+ + E+
Sbjct: 161 ------FCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEM 208
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 69/272 (25%), Positives = 109/272 (40%), Gaps = 46/272 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
LG+G+FG+V A+ G E + AVK+LK D+ E T E+ LA
Sbjct: 3 LGKGSFGKVLLAELKG--TDELY---AVKVLKKDVILQDDDVECTMT--EKRVLALAG-K 54
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP + +L + + EY+ GDL M I R +
Sbjct: 55 HPFLTQLHSCFQTKDRLFFVMEYVNGGDL-------------------M-FHIQRSGRFD 94
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD---- 542
A +I G+ +L +R ++RDL N L++ + +KIADFG+ ++ L
Sbjct: 95 EPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS 154
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ G + P E + Y Y D WA GV L+E+ + P+ G +E+ +
Sbjct: 155 TFCGTPDYIAP------EILSYQPYGPAVDWWALGVLLYEMLA-GQSPFEGDDEDELFQS 207
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
I E + P ++K P R
Sbjct: 208 ILEDEVR-YPRWLSKEAKSILKSFLTKNPEKR 238
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G +G V++A+ E +VA+K ++ D + + RE LL HPNIV
Sbjct: 15 IGEGTYGIVYRARD---TTSGE--IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIV 69
Query: 432 KLLGVCAVGKPM---CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ-LST 487
+L V VGK + L+ EY C + + S + +P S
Sbjct: 70 ELKEV-VVGKHLDSIFLVMEY------------CEQD---------LASLLDNMPTPFSE 107
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
+ + LQ+ G+ YL + +HRDL N L+ D+ +KIADFGL+R L
Sbjct: 108 SQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA---KP 164
Query: 548 ENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIF 584
+ W +L YT D+WA G L E+
Sbjct: 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 59/225 (26%), Positives = 101/225 (44%), Gaps = 38/225 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G +G+V++A+ + LVA+K ++ D E RE +L + +H NIV
Sbjct: 15 IGEGTYGQVYKAR-----DKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 432 KLLGVCAVGKPMC----------LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
L + + L+FEYM DL +ES +
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DL----------------MGLLESGLVH 112
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+ + Q+ G+ Y + F+HRD+ N L+N++ +K+ADFGL+R +Y
Sbjct: 113 FSEDHIKSFMK---QLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR-LYNS 168
Query: 542 DYYKGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
+ + N I + + P E +L +Y DVW+ G L E+F+
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE---REACLLAEFDHPN 429
+G GA V+ A L +E+ VA+K + E QT + +E +++ +HPN
Sbjct: 9 IGVGATAVVY--AAICLPNNEK---VAIKRIDLEKC---QTSVDELRKEVQAMSQCNHPN 60
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+VK VG + L+ Y+ G L D ++ P ++ E+ I
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD------EAII---------- 104
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ-DYYKGDE 548
T+ ++ G+ YL +HRD+ N L+ + VKIADFG+S + D +
Sbjct: 105 -ATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVR 163
Query: 549 NDAI--PVRWMPLESI-LYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
+ P WM E + + Y ++D+W+FG+ E+ + A PY +V+ +
Sbjct: 164 KTFVGTPC-WMAPEVMEQVHGYDFKADIWSFGITAIELATGA-APYSKYPPMKVLMLTLQ 221
Query: 606 GNILQAPDNTPDALY-----DLMKLCWNMKPMNRPS 636
+ Y ++ LC P RP+
Sbjct: 222 NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT 257
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 2e-12
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 47/228 (20%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
V +G+G +G V++A+ + T+ K+ ++ E + + RE LL E H N
Sbjct: 7 VEKIGEGTYGVVYKARD----RVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGN 62
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+L V K + L+FEY+ DL + P+ N R+ +
Sbjct: 63 IVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSS-PDFAKN----------PRLIK----- 105
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM-VVKIADFGLSRKMYLQDYYKGDE 548
T QI G+ Y + +HRDL +N LI+ + +K+ADFGL+R
Sbjct: 106 --TYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF---------- 153
Query: 549 NDAIPVR---------WMPLESILYNK--YTVESDVWAFGVCLWEIFS 585
IPVR W IL Y+ D+W+ G E+ +
Sbjct: 154 --GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 45/222 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNI 430
+G+G +G+V++A+ H++ LVA+K++ E + + + E +L ++ +HPNI
Sbjct: 14 IGEGTYGKVYKAR------HKKTGQLVAIKIMDIIEDE--EEEIKEEYNILRKYSNHPNI 65
Query: 431 VKLLGVCAVGKPMC------LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
G P L+ E G G + D ++ + + +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK-----------------GLRKKGK 108
Query: 485 LSTCDLIT-IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+ I I + G+ YL + K +HRD+ +N L+ VK+ DFG+S ++ D
Sbjct: 109 RLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DS 165
Query: 544 YKGDENDAI--PVRWMPLESILYNK-----YTVESDVWAFGV 578
G N I P WM E I ++ Y SDVW+ G+
Sbjct: 166 TLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLGI 206
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 53/220 (24%), Positives = 95/220 (43%), Gaps = 32/220 (14%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
+ + LG+G++ V++ + LVA+K++ + E + REA LL H
Sbjct: 8 LNLEKLGEGSYATVYKG-----ISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
NIV L + + + +FEYM DL ++ I L
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYM-------------------IQHPGGLHP 102
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL--QDYYK 545
++ Q+ G+ Y+ + +HRDL +N LI+ +K+ADFGL+R + Q Y
Sbjct: 103 YNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY-- 160
Query: 546 GDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIF 584
++ + + + P + +L Y+ D+W G E+
Sbjct: 161 --SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 43/120 (35%), Positives = 59/120 (49%), Gaps = 1/120 (0%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
P Y D P + EFPR+ ++ R LG GAFG+V + A GL + + VAV
Sbjct: 13 PDGHEYIYVDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAV 72
Query: 401 KMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFL 459
KMLK A + E ++ H NIV LLG C P+ ++ EY GDL ++L
Sbjct: 73 KMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 66/269 (24%), Positives = 109/269 (40%), Gaps = 53/269 (19%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G++G V + K E +VA+K L+ E + ++ RE +L + H N+V
Sbjct: 9 VGEGSYGMVMKCK-----HKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
L+ V K + L+FE++ L+D Y NG S +
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDHTVLDDL------EKYPNGLDESR--------------VR 103
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDEND 550
QI G+ + +HRD+ N L++ VVK+ DFG +R + + Y D
Sbjct: 104 KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY----TD 159
Query: 551 AIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+ RW +L KY D+WA G + E+ + G
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT--------------------GEP 199
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
L D+ D LY ++K N+ P ++ F
Sbjct: 200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 66/226 (29%), Positives = 98/226 (43%), Gaps = 35/226 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK--MLKDEASEYLQTDFEREACLLAEFDH 427
+R LG G+ G VF A + + VAVK +L D S RE ++ DH
Sbjct: 10 LRPLGCGSNGLVFSA-----VDSDCDKRVAVKKIVLTDPQS---VKHALREIKIIRRLDH 61
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRG--DLNDFLRICSPNN--YINGTYSSMESSIHRV- 482
NIVK+ +E +G DL + + + N YI Y ME+ + V
Sbjct: 62 DNIVKV-------------YEVLGPSGSDLTEDVGSLTELNSVYIVQEY--METDLANVL 106
Query: 483 --PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMY 539
LS Q+ G+ Y+ +HRDL N IN + +V+KI DFGL+R +
Sbjct: 107 EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD 166
Query: 540 LQDYYKGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEI 583
+KG ++ + +W +L N YT D+WA G E+
Sbjct: 167 PHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEM 212
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 28/212 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G++ V++ K+ K LVA+K+++ + E REA LL H NIV
Sbjct: 13 LGEGSYATVYKGKSKVNGK-----LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L + + + L+FEY+ DL ++ + + G + ++
Sbjct: 68 LHDIIHTKETLTLVFEYV-HTDLCQYM-----DKHPGGLHPE--------------NVKL 107
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
Q+ G+ Y+ R +HRDL +N LI+D +K+ADFGL+R + + N+ +
Sbjct: 108 FLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY--SNEVV 165
Query: 553 PVRWMPLESIL-YNKYTVESDVWAFGVCLWEI 583
+ + P + +L +Y+ D+W G E+
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEM 197
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 62/280 (22%), Positives = 104/280 (37%), Gaps = 43/280 (15%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-------MLKDEASEYLQTDFEREAC 420
+R +G+GAFG+V + K + + A+K + K L ER
Sbjct: 3 ELLRVIGKGAFGKVCIVQ-----KRDTKKMFAMKYMNKQKCVEKGSVRNVLN---ERR-- 52
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L E +HP +V L + M L+ + + GDL L +S E +
Sbjct: 53 ILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQ-------KVKFS--EEQV- 102
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ C +I + YL + +HRD+ N L+++Q V I DF ++ K +
Sbjct: 103 ---KFWIC-------EIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK--V 150
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG--LTHEE 598
P +M E + Y+V D W+ GV +E +PY G T +
Sbjct: 151 TPDTLTTSTSGTPG-YMAPEVLCRQGYSVAVDWWSLGVTAYE-CLRGKRPYRGHSRTIRD 208
Query: 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
++ +E + P D + P R
Sbjct: 209 QIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-11
Identities = 69/290 (23%), Positives = 119/290 (41%), Gaps = 29/290 (10%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
++I + +LG+G +G V++ L +A+K ++ E E E +L +
Sbjct: 1 DEIEVLDELGKGNYGSVYKV-----LHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK 55
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
P IV G + + + EYM G L+ Y G + +P+
Sbjct: 56 AVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKL--------YAGG------VATEGIPE 101
Query: 485 LSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKMY--LQ 541
L I + G+ +L + +HRD+ N L+N VK+ DFG+S + L
Sbjct: 102 DV---LRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA 158
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV-- 599
G ++ P R YTV+SDVW+ G+ + E+ + PY T+ +
Sbjct: 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM-ALGRYPYPPETYANIFA 217
Query: 600 -VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648
+ I +G+ P D D + C N P RP++ + + W +K
Sbjct: 218 QLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 47/282 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV---KMLKDEASEYLQTDFEREACLLAEFD 426
+R +G+GAFG V + + + + +M KDE + + E +L
Sbjct: 5 IRVVGRGAFGIVHLCR--RKADQKLVIIKQIPVEQMTKDE-----RLAAQNECQVLKLLS 57
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNI++ K + ++ EY G L +++ + ++ +H Q
Sbjct: 58 HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYI------QKRCNSLLDEDTILHFFVQ-- 109
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND-QMVVKIADFGLSRKMYLQDYYK 545
I +AL ++ + +HRDL T+N L++ +MVVKI DFG+S+ +
Sbjct: 110 ----ILLALH------HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL------- 152
Query: 546 GDENDAIPVRWMP-------LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
++ A V P E YN+ +SD+WA G L+E+ S + +
Sbjct: 153 SSKSKAYTVVGTPCYISPELCEGKPYNQ---KSDIWALGCVLYELASLK-RAFEAANLPA 208
Query: 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
+V I G D L L+ N+ P RP I
Sbjct: 209 LVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 5e-11
Identities = 65/229 (28%), Positives = 97/229 (42%), Gaps = 34/229 (14%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACL 421
PR + +G+GA+G V A VA+K + E + Q RE +
Sbjct: 5 PRYQNLSY--IGEGAYGMVCSA-----THKPTGVKVAIKKISPFEHQTFCQRTL-REIKI 56
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
L F H NI+ +L + +P FE ND YI ME+ +++
Sbjct: 57 LRRFKHENIIGIL---DIIRPPS--FESF-----NDV--------YIVQEL--METDLYK 96
Query: 482 V--PQLSTCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
+ Q + D I L QI G+ Y+ +HRDL N L+N +KI DFGL+R
Sbjct: 97 LIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
+ + G + + RW I+ N YT D+W+ G L E+ S
Sbjct: 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 5e-11
Identities = 61/282 (21%), Positives = 104/282 (36%), Gaps = 32/282 (11%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P+ +GQGA G VF A +E + + + K E + E ++
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVAT--GQEVAIKQINLQKQPKKELIIN----EILVM 70
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
E +PNIV L VG + ++ EY+ G L D + T + M+ +
Sbjct: 71 KELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----------TETCMDEA---- 115
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + + + +L + +HRD+ + N L+ VK+ DFG ++ +
Sbjct: 116 ------QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI-TPE 168
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
K P WM E + Y + D+W+ G+ E+ PY +
Sbjct: 169 QSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYL 226
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I LQ P+ D + C M R S + + Q
Sbjct: 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 70/270 (25%), Positives = 112/270 (41%), Gaps = 44/270 (16%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE-ACLLAEFDHPNIV 431
+G+G F V +A++ K ++ A+K +K Q + RE L HPNI+
Sbjct: 7 IGEGTFSEVLKAQS---RKTGKY--YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNIL 61
Query: 432 KLLGVCAVGKPMC--LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+L+ V K L+FE M D+N Y ++ +P+
Sbjct: 62 RLIEVLFDRKTGRLALVFELM---DMN--------------LYELIKGRKRPLPEKRVKS 104
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
+ Q+ + ++ HRD+ N LI D ++K+ADFG R +Y + Y
Sbjct: 105 YMY---QLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPY----T 156
Query: 550 DAIPVRWM-PLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE-EVVKYIKEG 606
+ I RW E +L + Y + D+WA G +EI S L P + T+E + + I
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS--LFPLFPGTNELDQIAKIH-- 212
Query: 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
++L TPDA N PS
Sbjct: 213 DVL----GTPDAEVLKKFRKSRHMNYNFPS 238
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 6e-11
Identities = 50/174 (28%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLLAEFDH-P 428
+G+G +G+V++A K G LVA+K + E E + RE LL
Sbjct: 9 IGEGTYGKVYKARDKNTG-------KLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 429 NIVKLLGVCAV----GKPMC-LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
IV+LL V V GKP L+FEY+ DL F+ ++ G + + +
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFM-----DSNGRGPGRPLPAKTIK-- 113
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ-MVVKIADFGLSR 536
+ Q+ G+ + +HRDL +N L++ Q ++KIAD GL R
Sbjct: 114 --------SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 53/208 (25%), Positives = 87/208 (41%), Gaps = 31/208 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G++G VF+ + E +VA+K ++ E ++ RE +L + HPN+V
Sbjct: 9 IGEGSYGVVFKCR-----NRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
L+ V + + L+FEY LN+ +E + VP+
Sbjct: 64 NLIEVFRRKRKLHLVFEYCDHTVLNE-----------------LEKNPRGVPEHLI---K 103
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDA 551
I Q + + +HRD+ N LI Q +K+ DFG +R + D D
Sbjct: 104 KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG---DDYTDY 160
Query: 552 IPVRWMPLESILYN--KYTVESDVWAFG 577
+ RW +L +Y DVWA G
Sbjct: 161 VATRWYRAPELLVGDTQYGPPVDVWAIG 188
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 45/294 (15%)
Query: 354 NPKLEQLEF---PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEA 407
+P + +L F P +R++G G+FG V+ A+ +++ E +VA+K + ++
Sbjct: 1 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARD---VRNSE--VVAIKKMSYSGKQS 55
Query: 408 SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNY 467
+E Q D +E L + HPN ++ G L+ EY G +D L +
Sbjct: 56 NEKWQ-DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASDLLEV------ 107
Query: 468 INGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
H+ P L ++ + G+ YL +HRD+ N L+++ +V
Sbjct: 108 ------------HKKP-LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLV 154
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIF 584
K+ DFG + M + + G WM E IL +Y + DVW+ G+ E+
Sbjct: 155 KLGDFGSASIMAPANXFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208
Query: 585 SFALQPYYGLTHEEVVKYI--KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
P + + + +I E LQ+ + + + + C P +RP+
Sbjct: 209 ERK-PPLFNMNAMSALYHIAQNESPALQS-GHWSEYFRNFVDSCLQKIPQDRPT 260
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 41/228 (17%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-REACLLAEF-DH 427
+++LGQGA+G V A+ E VA+K + + S+ + RE LL F H
Sbjct: 5 IKELGQGAYGIVCSARNAE---TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME-------SSIH 480
NI L D++ I P N+ N Y E I
Sbjct: 62 KNITCLY-------------------DMD----IVFPGNF-NELYLYEELMEADLHQIIR 97
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L+ + QI G+ Y+ +HRDL N L+N +KI DFGL+R +
Sbjct: 98 SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARG-FS 156
Query: 541 QDYYKGDE--NDAIPVRWMPLESIL--YNKYTVESDVWAFGVCLWEIF 584
++ + + + RW I+ + YT DVW+ G L E+
Sbjct: 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 65/249 (26%), Positives = 110/249 (44%), Gaps = 51/249 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER----EACLLAEFDHP 428
LG+G+FG+V A+ G +E L A+K+LK + +Q D E +LA D P
Sbjct: 8 LGKGSFGKVMLAERKGT---DE--LYAIKILKKDV--VIQDDDVECTMVEKRVLALQDKP 60
Query: 429 NIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
+ L C V + + + EY+ GDL I +V +
Sbjct: 61 PFLTQLHSCFQTVDR-LYFVMEYVNGGDL--------------------MYHIQQVGKFK 99
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ A +I+ G+ +L R ++RDL N +++ + +KIADFG+ ++ +
Sbjct: 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------ 153
Query: 547 DENDAIPVR-------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D + R ++ E I Y Y D WA+GV L+E+ + P+ G +E+
Sbjct: 154 ---DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLA-GQPPFDGEDEDEL 209
Query: 600 VKYIKEGNI 608
+ I E N+
Sbjct: 210 FQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 64/254 (25%), Positives = 110/254 (43%), Gaps = 47/254 (18%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER----EACL 421
D ++ LG+G+FG+V A+ G + L A+K+LK + +Q D E +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDE-----LYAIKILKKDV--VIQDDDVECTMVEKRV 53
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
LA P + L C F+ M R + Y+NG + I +
Sbjct: 54 LALSGKPPFLTQLHSC---------FQTMDR--------LYFVMEYVNG--GDLMYQIQQ 94
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
V + + A +IA G+ +L + ++RDL N +++ + +KIADFG+ ++
Sbjct: 95 VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW- 153
Query: 542 DYYKGDENDAIPVR-------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
D + + ++ E I Y Y D WAFGV L+E+ + P+ G
Sbjct: 154 --------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGE 204
Query: 595 THEEVVKYIKEGNI 608
+E+ + I E N+
Sbjct: 205 DEDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLV-AVKMLKDEASEYLQTDFEREA 419
E +D + +LG G G VF+ + H+ L+ A K++ E ++ RE
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFK------VSHKPSGLIMARKLIHLEIKPAIRNQIIREL 54
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L E + P IV G + + E+M G L+ L+
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---------------- 98
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
R+P+ L +++ + G+ YL ++ K +HRD+ N L+N + +K+ DFG+S ++
Sbjct: 99 -RIPEQI---LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154
Query: 539 Y--LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
+ + + G + +M E + Y+V+SD+W+ G+ L E+
Sbjct: 155 IDSMANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 82/308 (26%), Positives = 119/308 (38%), Gaps = 74/308 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-------DEASEYLQTDFEREACLLAEF 425
+GQG +G+VF AK K + +VA+K +K +E L ER+ +L
Sbjct: 9 VGQGGYGQVFLAK-----KKDTGEIVALKRMKKSLLFKLNEVRHVLT---ERD--ILTTT 58
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
+VKLL + + L EY+ GD L NN G S + +
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-----NN--LGVLSEDHARFY----- 106
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+ + + + L + ++HRDL N LI+ +K+ DFGLS K
Sbjct: 107 ----MAEMFEAVDA----LHELGYIHRDLKPENFLIDASGHIKLTDFGLS---------K 149
Query: 546 GDENDAIPV----RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV-- 599
G A V +M E + Y D W+ G L+E F P+ G T E
Sbjct: 150 GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYE-FLCGFPPFSGSTPNETWE 208
Query: 600 -VKYIKEGNILQAPD------NTPDALYDLMKLCWNMKP---------MNRPSFRTIYQT 643
+KY KE LQ P N D +DL+ N N P F+ +
Sbjct: 209 NLKYWKE--TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD-- 264
Query: 644 LWNIKRDL 651
WN R+L
Sbjct: 265 -WNELREL 271
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 63/280 (22%), Positives = 110/280 (39%), Gaps = 46/280 (16%)
Query: 373 LGQGAFGRVF--QAKAPG----LLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
LG GAFG V+ + K G LK A K E + + + +
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNIV+ + ++ + + L + ++S++ R +
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH-------------FNSLKEKKQRFTEER 114
Query: 487 TCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+ I +Q+ + YL +++ VHRDL N ++ + V I DFGL+++ K
Sbjct: 115 ---IWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-------K 164
Query: 546 GDENDAIPVRWMPLESILYN--------KYTVESDVWAFGVCLWEIFSFALQP-YYGLTH 596
E+ V + +ILY+ Y ++DVWAFG L+++ LQP +Y
Sbjct: 165 QPESKLTSV----VGTILYSCPEIVKNEPYGEKADVWAFGCILYQM--CTLQPPFYSTNM 218
Query: 597 EEVVKYIKEGNILQAPDNT-PDALYDLMKLCWNMKPMNRP 635
+ I E P+ + + D++ C RP
Sbjct: 219 LSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARP 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 34/215 (15%)
Query: 372 DLGQGAFGRVFQAKAPGLLKHEEFTLV-AVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+LG G G V + + H L+ A K++ E ++ RE +L E + P I
Sbjct: 8 ELGAGNGGVVTK------VLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V G + + E+M G L+ L+ R+P+ +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLK-----------------KAGRIPE-NILGK 103
Query: 491 ITIALQIASGMVYLSD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
I+IA + G+ YL + K +HRD+ N L+N + +K+ DFG+S + L D N
Sbjct: 104 ISIA--VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ--LIDSMA---N 156
Query: 550 DAIPVR-WMPLESILYNKYTVESDVWAFGVCLWEI 583
+ R +M E + YTV+SD+W+ G+ L E+
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143576 cd07467, CRD_TK_ROR1, Cysteine-rich domain of tyrosine kinase-like orphan receptor 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-10
Identities = 39/134 (29%), Positives = 60/134 (44%), Gaps = 14/134 (10%)
Query: 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI---LANPCKQ 88
G+C Y G C ++ R + SL G ++ QI A MI L++ C Q
Sbjct: 2 DGFCQPYRGIACARFIG--NRTIYMESLHMQG-EIENQITAAF--TMIGTSSHLSDKCSQ 56
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
A LC YAFP C ++G+P LC ++C + C ++ + N +R K
Sbjct: 57 FAIPSLCHYAFPYCDETSGMPKPRDLCRDECEILENVLCQTEYIFARSNPMILMRLK--- 113
Query: 149 HFELPNCDTLPKYE 162
LPNC+ L + +
Sbjct: 114 ---LPNCEDLAQPD 124
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor 1 (Ror1), a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. Length = 142 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 63/229 (27%), Positives = 92/229 (40%), Gaps = 57/229 (24%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHP 428
++ +G GAFG V A+ L + VA+K ++K ++ L RE LL H
Sbjct: 15 LQPVGMGAFGLVCSAR--DQLTGQN---VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ---L 485
NI+ L + F+ SP I + + +HR+ L
Sbjct: 70 NIISLSDI---------------------FI---SPLEDIYFVTELLGTDLHRLLTSRPL 105
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD--- 542
+ QI G+ Y+ VHRDL N LIN+ +KI DFGL+R +QD
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQM 162
Query: 543 -------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
YY+ E I + W KY VE D+W+ G E+
Sbjct: 163 TGYVSTRYYRAPE---IMLTW--------QKYDVEVDIWSAGCIFAEML 200
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 67/282 (23%), Positives = 123/282 (43%), Gaps = 44/282 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEASEYLQTDFEREACLLAEFD 426
+R++G G+FG V+ A+ ++ E +VA+K + +++E Q D +E L +
Sbjct: 20 LREIGHGSFGAVYFARD---VRTNE--VVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQQLR 73
Query: 427 HPNIVKLLGVCAVGKPMC-LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
HPN ++ G C + + L+ EY G +D L +H+ P L
Sbjct: 74 HPNTIEYKG-CYLREHTAWLVMEYC-LGSASDIL------------------EVHKKP-L 112
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
++ I G+ YL + +HRD+ N L+ + VK+ADFG + + + +
Sbjct: 113 QEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV 172
Query: 546 GDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
G P WM E IL +Y + DVW+ G+ E+ + P + + + +
Sbjct: 173 G-----TPY-WMAPEVILAMDEGQYDGKVDVWSLGITCIEL-AERKPPLFNMNAMSALYH 225
Query: 603 IKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I + + L ++ D + + C P +RPS + +
Sbjct: 226 IAQNDSPTLS-SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-10
Identities = 65/273 (23%), Positives = 101/273 (36%), Gaps = 36/273 (13%)
Query: 373 LGQGAFGRVF--QAKAPG-LLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
LG+G FG V Q KA G + ++ +K K E E++ +L +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALN----EKK--ILEKVSSRF 54
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV L +CL+ M GDL + P
Sbjct: 55 IVSLAYAFETKDDLCLVMTLMNGGDLKYHI------------------YNVGEPGFPEAR 96
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
I A QI G+ +L R+ V+RDL N L++D V+I+D GL+ ++ KG
Sbjct: 97 AIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKG--- 153
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY--YG--LTHEEVVKYIKE 605
A +M E + Y D +A G L+E+ + P+ + EE+ + E
Sbjct: 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIA-GRSPFRQRKEKVEKEELKRRTLE 212
Query: 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
+ +P DL + P R R
Sbjct: 213 MAVEYPDKFSP-EAKDLCEALLQKDPEKRLGCR 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 5e-10
Identities = 70/294 (23%), Positives = 122/294 (41%), Gaps = 45/294 (15%)
Query: 354 NPKLEQLEF---PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEA 407
+P++ +L F P +R++G G+FG V+ A+ ++ E +VA+K + ++
Sbjct: 11 DPEIAELFFKEDPEKLFTDLREIGHGSFGAVYFARD---VRTNE--VVAIKKMSYSGKQS 65
Query: 408 SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNY 467
+E Q D +E L HPN ++ G L+ EY G +D L +
Sbjct: 66 NEKWQ-DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSASDLLEV------ 117
Query: 468 INGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
H+ P L ++ I G+ YL +HRD+ N L+ + V
Sbjct: 118 ------------HKKP-LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQV 164
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIF 584
K+ADFG + + + G WM E IL +Y + DVW+ G+ E+
Sbjct: 165 KLADFGSASIASPANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218
Query: 585 SFALQPYYGLTHEEVVKYI--KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
P + + + +I E LQ+ + + D + + C P +RP+
Sbjct: 219 ERK-PPLFNMNAMSALYHIAQNESPTLQSNEWS-DYFRNFVDSCLQKIPQDRPT 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 66/253 (26%), Positives = 109/253 (43%), Gaps = 45/253 (17%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREA 419
D ++ LG+G+FG+V A+ G +E L A+K+LK D+ E E
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKG---TDE--LYAIKILKKDVIIQDDDVECTMV----EK 51
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+LA P + L C + M L+ M Y+NG + I
Sbjct: 52 RVLALPGKPPFLTQLHSCF--QTMDRLYFVM---------------EYVNG--GDLMYHI 92
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+V + + A +IA G+ +L + ++RDL N +++ + +KIADFG+ ++
Sbjct: 93 QQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152
Query: 540 LQD----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+ G + P E I Y Y D WAFGV L+E+ + P+ G
Sbjct: 153 FGGKTTRTFCGTPDYIAP------EIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGED 205
Query: 596 HEEVVKYIKEGNI 608
+E+ + I E N+
Sbjct: 206 EDELFQSIMEHNV 218
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 8e-10
Identities = 71/289 (24%), Positives = 121/289 (41%), Gaps = 40/289 (13%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKD--EASEYLQTDFEREACL 421
+D+ + +LG+GA+G V + ++H T++AVK ++ + E + + + +
Sbjct: 1 DDLEVIEELGRGAYGVVDK------MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISM 54
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
+ D P V G LF GD+ + + + ++ Y +
Sbjct: 55 RSV-DCPYTVTFYGA---------LF---REGDVWICMEVMDTS--LDKFYKKVYDKGLT 99
Query: 482 VPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+P+ L IA+ I + YL + +HRD+ N LIN VK+ DFG+S YL
Sbjct: 100 IPEDI---LGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG--YL 154
Query: 541 QDYYKGDENDAIPVRWMPLESI----LYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-T 595
D DA +M E I Y V+SDVW+ G+ + E+ + PY T
Sbjct: 155 VDSVAKTI-DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRF-PYDSWKT 212
Query: 596 HEEVVKYIKEGNILQAPDNT--PDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ +K + E Q P P+ D + C RP++ + Q
Sbjct: 213 PFQQLKQVVEEPSPQLPAEKFSPE-FQDFVNKCLKKNYKERPNYPELLQ 260
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 53/227 (23%), Positives = 103/227 (45%), Gaps = 36/227 (15%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLV-AVKMLKDEASEYLQTDFEREA 419
E +D + +LG G G V + ++H+ L+ A K++ E ++ RE
Sbjct: 1 ELKDDDFERISELGAGNGGVVTK------VQHKPSGLIMARKLIHLEIKPAIRNQIIREL 54
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L E + P IV G + + E+M G L+ L+
Sbjct: 55 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-----------------EA 97
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
R+P+ L +++ + G+ YL ++ + +HRD+ N L+N + +K+ DFG+S ++
Sbjct: 98 KRIPEEI---LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154
Query: 539 Y--LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
+ + + G + +M E + Y+V+SD+W+ G+ L E+
Sbjct: 155 IDSMANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEL 195
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 1e-09
Identities = 60/234 (25%), Positives = 105/234 (44%), Gaps = 31/234 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK---MLKDEASEYLQTDFEREACLLAEFDHPN 429
LG+G+FG+V A+ G +E F + A+K +L+D+ E T ER LA ++HP
Sbjct: 3 LGKGSFGKVMLAELKG--TNEFFAIKALKKDVVLEDDDVE--CTMVERRVLALA-WEHPF 57
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+ L + + + EY+ GDL ++ G + + +
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-------GRFDEARARFY--------- 101
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
A +I G+ +L + ++RDL N L++ +KIADFG+ ++ + K
Sbjct: 102 ----AAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTF 156
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
P ++ E + KY D W+FGV L+E+ P++G +E+ I
Sbjct: 157 CGTP-DYIAPEILKGQKYNESVDWWSFGVLLYEML-IGQSPFHGEDEDELFDSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 67/282 (23%), Positives = 112/282 (39%), Gaps = 42/282 (14%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEASEYLQTDFEREA 419
P + + ++G G+FG V+ A +VAVK + + +E Q D +E
Sbjct: 19 PEEIFVGLHEIGHGSFGAVYFAT-----NSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEV 72
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
L + HPN ++ G L+ EY G +D L +
Sbjct: 73 KFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSASDLLEV------------------ 113
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
H+ P L ++ I G+ YL +HRD+ N L+ + VK+ADFG + K
Sbjct: 114 HKKP-LQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172
Query: 540 LQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+ + G WM E IL +Y + DVW+ G+ E+ P + +
Sbjct: 173 PANSFVGTP------YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNA 225
Query: 597 EEVVKYIKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ +I + + LQ+ + T D+ + C P RP+
Sbjct: 226 MSALYHIAQNDSPTLQSNEWT-DSFRGFVDYCLQKIPQERPA 266
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 59.0 bits (142), Expect = 2e-09
Identities = 59/282 (20%), Positives = 105/282 (37%), Gaps = 32/282 (11%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P+ +GQGA G V+ A + +E + + + + E + E ++
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAM--DVATGQEVAIRQMNLQQQPKKELIIN----EILVM 71
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
E +PNIV L VG + ++ EY+ G L D + T + M+
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----------TETCMDEG---- 116
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + + + +L + +HRD+ + N L+ VK+ DFG ++ +
Sbjct: 117 ------QIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPE 169
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
K P WM E + Y + D+W+ G+ E+ PY +
Sbjct: 170 QSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMIE-GEPPYLNENPLRALYL 227
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I LQ P+ D + C +M R S + + Q
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 3e-09
Identities = 59/216 (27%), Positives = 85/216 (39%), Gaps = 24/216 (11%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LGQGAFGRV+ + V E S+ + E E LL H IV+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKNLQHERIVQ 68
Query: 433 LLGVCA--VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
G K + + EYM G + D L+ Y ++ S+ R
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLK----------AYGALTESVTR--------- 109
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY-LQDYYKGDEN 549
QI GM YL VHRD+ N L + VK+ DFG S+++ + G +
Sbjct: 110 -KYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
WM E I Y ++DVW+ G + E+ +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 65/283 (22%), Positives = 113/283 (39%), Gaps = 49/283 (17%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV-KMLKDEASEYLQTDFEREACLLAEFDHP 428
V+ +G+G+FG+ K+ K + + KM E E +E +L+ HP
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREES-----RKEVAVLSNMKHP 59
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV+ + ++ +Y GDL + +I N G +
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDL--YKKI----NAQRGVLFPEDQ----------- 102
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG----------LSRKM 538
++ +QI + ++ DRK +HRD+ ++N + +K+ DFG L+R
Sbjct: 103 -ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTC 161
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
YY E I N+ Y +SD+WA G L+E+ + G
Sbjct: 162 IGTPYYLSPE-------------ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN 208
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
V+K I+ G+ + L +L+ + P +RPS +I
Sbjct: 209 LVLKIIR-GSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 30/233 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G+ G V A+ KH VAVKM+ + + F E ++ ++ H N+V+
Sbjct: 29 IGEGSTGIVCIARE----KHSG-RQVAVKMMDLRKQQRRELLFN-EVVIMRDYQHQNVVE 82
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
+ VG+ + +L E++ G L D + S +L+ + T
Sbjct: 83 MYKSYLVGEELWVLMEFLQGGALTDIV-----------------SQT----RLNEEQIAT 121
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+ + + YL + +HRD+ + + L+ VK++DFG ++ +D K
Sbjct: 122 VCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS-KDVPKRKSLVGT 180
Query: 553 PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
P WM E I Y E D+W+ G+ + E+ PY+ + + +K +++
Sbjct: 181 PY-WMAPEVISRTPYGTEVDIWSLGIMVIEMVD-GEPPYFSDSPVQAMKRLRD 231
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 7e-09
Identities = 58/271 (21%), Positives = 109/271 (40%), Gaps = 54/271 (19%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
PR + +G+G+ G V A KH VAVK + + + F E ++
Sbjct: 20 PREYLDSFIKIGEGSTGIVCIATE----KHTG-KQVAVKKMDLRKQQRRELLFN-EVVIM 73
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
++ H N+V + VG + ++ E++ G L D + T++ M
Sbjct: 74 RDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV-----------THTRMNEE---- 118
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ T+ L + + YL ++ +HRD+ + + L+ +K++DFG ++
Sbjct: 119 ------QIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV---- 168
Query: 543 YYKGDENDAIPVR--------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
+ +P R WM E I Y E D+W+ G+ + E+ PY+
Sbjct: 169 ------SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMID-GEPPYFNE 221
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKL 625
+ ++ I+ DN P + D K+
Sbjct: 222 PPLQAMRRIR--------DNLPPRVKDSHKV 244
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 36/279 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKH-EEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH---P 428
+G+GA+G V++ K H +VA+K++ + + +D +RE LL++ P
Sbjct: 9 IGRGAYGAVYRGK------HVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI K G G + ++ EY G + ++ P I Y
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK-AGP---IAEKY---------------I 103
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+I + +A + Y+ +HRD+ N L+ + VK+ DFG++ + Q+ K
Sbjct: 104 SVIIREVLVA--LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRST 160
Query: 549 NDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
P WM E I K Y ++D+W+ G+ ++E+ + PY + + I +
Sbjct: 161 FVGTPY-WMAPEVITEGKYYDTKADIWSLGITIYEM-ATGNPPYSDVDAFRAMMLIPKSK 218
Query: 608 ILQAPDNT-PDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ DN L + + C + +P R S + ++ W
Sbjct: 219 PPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 7e-09
Identities = 60/276 (21%), Positives = 111/276 (40%), Gaps = 54/276 (19%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
PR + +G+G+ G V A K LVAVK + + + F E ++
Sbjct: 18 PRTYLDNFIKIGEGSTGIVCIATVKSSGK-----LVAVKKMDLRKQQRRELLFN-EVVIM 71
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
++ H N+V++ VG + ++ E++ G L D + T++ M
Sbjct: 72 RDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV-----------THTRMNEE---- 116
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + L + + L + +HRD+ + + L+ VK++DFG ++
Sbjct: 117 ------QIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV---- 166
Query: 543 YYKGDENDAIPVR--------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
+ +P R WM E I Y E D+W+ G+ + E+ PY+
Sbjct: 167 ------SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNE 219
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMK 630
+ +K I+ DN P L +L K+ ++K
Sbjct: 220 PPLKAMKMIR--------DNLPPKLKNLHKVSPSLK 247
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 7e-09
Identities = 68/240 (28%), Positives = 93/240 (38%), Gaps = 50/240 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-------DEASEYLQTD---FEREACLL 422
LG+G FG+V A+ K L A+K LK DE E L + FE
Sbjct: 7 LGRGHFGKVLLAE----YKKTG-ELYAIKALKKGDIIARDEV-ESLMCEKRIFETANSER 60
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
HP +V L +C + EY GDL M IH
Sbjct: 61 ----HPFLVNLFACFQTEDHVCFVMEYAAGGDL-------------------M-MHIHT- 95
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
S + A + G+ YL + K V+RDL N L++ + VKIADFGL + +
Sbjct: 96 DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCK----EG 151
Query: 543 YYKGDENDAI---PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
GD P ++ E + YT D W GV ++E+ P+ G EEV
Sbjct: 152 MGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEML-VGESPFPGDDEEEV 209
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 9e-09
Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 31/235 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK---MLKDEASEYLQTDFEREACLLAEFDHPN 429
LG+G+FG+V A+ G K E F + A+K +L D+ E T E+ LA +++P
Sbjct: 3 LGKGSFGKVLLAELKG--KGEYFAVKALKKDVVLIDDDVEC--TMVEKRVLALA-WENPF 57
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+ L + + + E++ GDL ++ G + ++ +
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQD-------KGRFDLYRATFY--------- 101
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
A +I G+ +L + ++RDL N +++ +KIADFG+ ++ D +
Sbjct: 102 ----AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRASTF 156
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
P P E + KYT D W+FGV L+E+ P++G +E+ + I+
Sbjct: 157 CGTPDYIAP-EILQGLKYTFSVDWWSFGVLLYEML-IGQSPFHGDDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 33/238 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTD-FEREACLLAEFDHPNI 430
+G G FGRV + + A+K++ E Q E +L E HP I
Sbjct: 9 VGTGTFGRVHLVRDRISEHY-----YALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFI 63
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
++L + + +L EY+ G+L +LR +G +S+ +
Sbjct: 64 IRLFWTEHDQRFLYMLMEYVPGGELFSYLRN-------SGRFSNSTGLFY---------- 106
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
A +I + YL ++ V+RDL N L++ + +K+ DFG ++K+ + + +
Sbjct: 107 ---ASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPE 163
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
++ E I + D WA G+ ++E+ P++ + + I G +
Sbjct: 164 -----YLAPEVIQSKGHNKAVDWWALGILIYEMLV-GYPPFFDDNPFGIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 56/254 (22%), Positives = 111/254 (43%), Gaps = 34/254 (13%)
Query: 396 TLVAVKMLK--DEASEYLQTDFEREACLLAEFDHPNIVKLLG-VCAVGKPMC---LLFEY 449
V ++ K + + L E E L D NI+K+ G + + + L+ EY
Sbjct: 44 KEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103
Query: 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM--VYLSDR 507
RG L + L E + +L +A+ G+ +Y
Sbjct: 104 CTRGYLREVLD--------------KEKDLSFKTKLD------MAIDCCKGLYNLYKYTN 143
Query: 508 KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY 567
K +++L + + L+ + +KI GL + + + + N + + L I +++Y
Sbjct: 144 K-PYKNLTSVSFLVTENYKLKIICHGLEKILSSPPF--KNVNFMVYFSYKMLNDI-FSEY 199
Query: 568 TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK-YIKEGNILQAPDNTPDALYDLMKLC 626
T++ D+++ GV LWEIF+ + P+ LT +E+ I + N L+ P + P + +++ C
Sbjct: 200 TIKDDIYSLGVVLWEIFTGKI-PFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEAC 258
Query: 627 WNMKPMNRPSFRTI 640
+ + RP+ + I
Sbjct: 259 TSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 64/284 (22%), Positives = 106/284 (37%), Gaps = 36/284 (12%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM--LKDEASEYLQTDFEREAC 420
P+ +GQGA G V+ A E VA+K L+ + + L + E
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVAT-GQE----VAIKQMNLQQQPKKELIIN---EIL 68
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ E HPNIV L VG + ++ EY+ G L D + T + M+
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----------TETCMDEGQ- 116
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ + + + +L + +HRD+ + N L+ VK+ DFG ++
Sbjct: 117 ---------IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-T 166
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ K P WM E + Y + D+W+ G+ E+ PY +
Sbjct: 167 PEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRAL 224
Query: 601 KYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I LQ P+ D + C M R S + + Q
Sbjct: 225 YLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 59/233 (25%), Positives = 94/233 (40%), Gaps = 30/233 (12%)
Query: 373 LGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G FG+V + KA G + V + KDE + L E+ +L HP +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLKNTRHPFL 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
L +C + EY+ G+L F + +S + +
Sbjct: 58 TSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRER-----VFSEDRTRFY---------- 100
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+I S + YL K V+RDL N +++ +KI DFGL ++ + D
Sbjct: 101 ---GAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEG-ITDAATMKTFC 156
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
P P E + N Y D W GV ++E+ L P+Y HE++ + I
Sbjct: 157 GTPEYLAP-EVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHEKLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 1e-08
Identities = 73/292 (25%), Positives = 118/292 (40%), Gaps = 53/292 (18%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEE-FTLVAVKMLKDEA----SEYLQTDFEREA 419
D ++ + GA+G V+ L++H+E A+K + + ++ Q ER+
Sbjct: 1 EDFETIKLISNGAYGAVY------LVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDI 54
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
AE +P +V + + +C++ EY+ GD L+ + +
Sbjct: 55 LTFAE--NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA----------LPVDM 102
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
R+ T +AL+ YL + VHRDL N LI +K+ DFGLS K+
Sbjct: 103 ARMYFAET----VLALE------YLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLS-KIG 151
Query: 540 LQ----DYYKG-DENDA----------IPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
L + Y+G E D P P E IL Y D WA G+ L+E F
Sbjct: 152 LMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAP-EVILRQGYGKPVDWWAMGIILYE-F 209
Query: 585 SFALQPYYGLTHEEVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNR 634
P++G T EE+ + +I + + P DL+ P+ R
Sbjct: 210 LVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLER 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 71/279 (25%), Positives = 111/279 (39%), Gaps = 43/279 (15%)
Query: 334 NIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE 393
N+ L K + S + + K E F +R LG G+FGRV A K+E
Sbjct: 6 NLQLHKKKDSDSTKEPKRKNKMKYEDFNF-------IRTLGTGSFGRVILAT----YKNE 54
Query: 394 EFTLVAVKML-KDEASEYLQTDF---EREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449
+F VA+K K + + Q D ER+ +L +HP V L G + L+ E+
Sbjct: 55 DFPPVAIKRFEKSKIIKQKQVDHVFSERK--ILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509
+ G+ FLR R P C A QI YL
Sbjct: 113 VIGGEFFTFLR-----------------RNKRFPNDVGC---FYAAQIVLIFEYLQSLNI 152
Query: 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTV 569
V+RDL N L++ +K+ DFG ++ + + Y + ++ E +L +
Sbjct: 153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPE-----YIAPEILLNVGHGK 207
Query: 570 ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+D W G+ ++EI P+Y + + I EG I
Sbjct: 208 AADWWTLGIFIYEIL-VGCPPFYANEPLLIYQKILEGII 245
|
Length = 340 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 56/249 (22%), Positives = 101/249 (40%), Gaps = 34/249 (13%)
Query: 402 MLKDEASEYLQTDFER-EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLR 460
ML DE Q + R E LA DH IVK + L+ EY GDLN ++
Sbjct: 102 MLNDER----QAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIK 157
Query: 461 ICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520
+ +P ++ + QI + + RK +HRDL + N
Sbjct: 158 ---------------QRLKEHLP-FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 521 INDQMVVKIADFGLSRK------MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVW 574
+ ++K+ DFG S++ + + + G P W +Y+ ++D+W
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWE------RKRYSKKADMW 255
Query: 575 AFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ GV L+E+ + +P+ G + E+++ + G P + L+ + P R
Sbjct: 256 SLGVILYELLTLH-RPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALR 314
Query: 635 PSFRTIYQT 643
P+ + + T
Sbjct: 315 PTTQQLLHT 323
|
Length = 478 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 56/233 (24%), Positives = 90/233 (38%), Gaps = 60/233 (25%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE--REACLLAEFDHP 428
++G GA+G V A K VA+K + A + RE +L F H
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKK-----VAIKKIPH-AFDVPTLAKRTLRELKILRHFKHD 64
Query: 429 NIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV-- 482
NI+ + + A K + ++ DL MES +H +
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVM------DL-------------------MESDLHHIIH 99
Query: 483 -PQLSTCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR---- 536
Q T + I L Q+ G+ Y+ +HRDL N L+N+ ++I DFG++R
Sbjct: 100 SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159
Query: 537 -----KMYLQDYYKGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWE 582
K ++ +Y + RW +L +YT D+W+ G E
Sbjct: 160 SPTEHKYFMTEY--------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAE 204
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 4e-08
Identities = 59/282 (20%), Positives = 104/282 (36%), Gaps = 32/282 (11%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P+ +GQGA G V+ A + +E + + + + E + E ++
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAI--DIATGQEVAIKQMNLQQQPKKELIIN----EILVM 70
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
E +PNIV L VG + ++ EY+ G L D + T + M+
Sbjct: 71 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-----------TETCMDEG---- 115
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + + + +L + +HRD+ + N L+ VK+ DFG ++ +
Sbjct: 116 ------QIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI-TPE 168
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
K P WM E + Y + D+W+ G+ E+ PY +
Sbjct: 169 QSKRSTMVGTPY-WMAPEVVTRKAYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYL 226
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I LQ P+ D + C M R S + + Q
Sbjct: 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 28/218 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LGQGAFGRV+ + V E S+ + E E LL H IV+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNLLHERIVQ 68
Query: 433 LLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
G + + + + E+M G + D L+ +Y ++ ++ R
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLK----------SYGALTENVTR--------- 109
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY---KGD 547
QI G+ YL VHRD+ N L + VK+ DFG S++ LQ G
Sbjct: 110 -KYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR--LQTICLSGTGM 166
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
++ WM E I Y ++D+W+ G + E+ +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 4e-08
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 48/225 (21%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
+ +G GA+G+V A + VA+K L +++ + + + RE LL DH
Sbjct: 20 LSPVGSGAYGQVCSAFDTKT-GRK----VAIKKLSRPFQSAIHAKRTY-RELRLLKHMDH 73
Query: 428 PNIVKLLGVCAVGKP------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
N++ LL V + L+ MG DLN+ ++
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKC-------------------- 112
Query: 482 VPQLSTCDLIT-IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
Q + D I + QI G+ Y+ +HRDL N +N+ +KI DFGL+R
Sbjct: 113 --QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH--- 167
Query: 541 QDYYKGDE-NDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWE 582
DE + RW I+ N Y D+W+ G + E
Sbjct: 168 ----TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 5e-08
Identities = 53/227 (23%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-P 428
V +G G +G+V++ + + L A+K++ E + + ++E +L ++ H
Sbjct: 11 VELVGNGTYGQVYKGR-----HVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHR 63
Query: 429 NIVKLLGVCAVGKP------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
NI G P + L+ E+ G G + D ++ N
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT---------------- 107
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
L + I +I G+ +L K +HRD+ +N L+ + VK+ DFG+S ++ D
Sbjct: 108 --LKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL---D 162
Query: 543 YYKGDENDAIPV-RWMPLESILYNK-----YTVESDVWAFGVCLWEI 583
G N I WM E I ++ Y +SD+W+ G+ E+
Sbjct: 163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 5e-08
Identities = 61/246 (24%), Positives = 108/246 (43%), Gaps = 35/246 (14%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY--LQTDFEREACL 421
R DII R +G+G G V+ A P + VA+K ++++ SE L+ F REA +
Sbjct: 3 RYDII--RLIGKGGMGEVYLAYDPVCSRR-----VALKKIREDLSENPLLKKRFLREAKI 55
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
A+ HP IV + +C+ G P+ Y+ L L+ S+ +
Sbjct: 56 AADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKE-------SLSKELAE 108
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+ S ++I +I + + Y+ + +HRDL N L+ V I D+G + L+
Sbjct: 109 --KTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 542 DYYKGD----------ENDAIPVR------WMPLESILYNKYTVESDVWAFGVCLWEIFS 585
+ D + IP + +M E +L + +D++A GV L+++ +
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 586 FALQPY 591
+ PY
Sbjct: 227 LSF-PY 231
|
Length = 932 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 59/233 (25%), Positives = 89/233 (38%), Gaps = 56/233 (24%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD-FEREACLLAEFDHPN 429
R +G GAFG V+ P K VA+K + + + RE +L F H N
Sbjct: 6 RPIGYGAFGVVWSVTDPRDGKR-----VALKKMPNVFQNLVSCKRVFRELKMLCFFKHDN 60
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---PQLS 486
++ L + FE + Y+ M+S +H++ PQ
Sbjct: 61 VLSALDILQPPHIDP--FEEI----------------YV--VTELMQSDLHKIIVSPQPL 100
Query: 487 TCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD--- 542
+ D + + L QI G+ YL +HRD+ N L+N V+KI DFGL+R +
Sbjct: 101 SSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKH 160
Query: 543 --------YYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
YY+ E IL YT D+W+ G E+
Sbjct: 161 MTQEVVTQYYRAPE-------------ILMGSRHYTSAVDIWSVGCIFAELLG 200
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 68/266 (25%), Positives = 109/266 (40%), Gaps = 38/266 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD-FEREACLLAEFDHPNI 430
LG G+FGRV AK G ++ A+K L K E + Q +E +L E HP I
Sbjct: 26 LGTGSFGRVRIAKHKGTGEY-----YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFI 80
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS--PNNYINGTYSSMESSIHRVPQLSTC 488
V ++ + L E++ G+L LR PN+ V +
Sbjct: 81 VNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPND---------------VAKFYHA 125
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+L+ +A + YL + ++RDL N L++++ VK+ DFG ++K+ + +
Sbjct: 126 ELV-LAFE------YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC-- 176
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
P P E I + D W GV L+E F P++ T + + I G
Sbjct: 177 --GTPEYLAP-EVIQSKGHGKAVDWWTMGVLLYE-FIAGYPPFFDDTPFRIYEKILAGR- 231
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNR 634
L+ P+ DL+K R
Sbjct: 232 LKFPNWFDGRARDLVKGLLQTDHTKR 257
|
Length = 329 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 41/176 (23%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVK-MLKDEASE---YLQTDFEREACLLA 423
++ LG+G GRVF L + T L A+K + K E + + E+E +LA
Sbjct: 6 IKLLGKGDVGRVF-------LVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQE--ILA 56
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT----YSSMESSI 479
DHP + L +CL+ +Y G+L L+ P ++ Y++ E
Sbjct: 57 TLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQR-QPGKCLSEEVARFYAA-E--- 111
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
+ +AL+ YL V+RDL N L+++ + ++DF LS
Sbjct: 112 -----------VLLALE------YLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 55/239 (23%), Positives = 93/239 (38%), Gaps = 42/239 (17%)
Query: 373 LGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G FG+V + KA G + V + KDE + + E+ +L HP +
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-----ESRVLQNTRHPFL 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
L +C + EY G+L F + ++ + +
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGEL--FFHLSRER-----VFTEERARFY---------- 100
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+I S + YL R V+RD+ N +++ +KI DFGL + +G +
Sbjct: 101 ---GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK--------EGISDG 149
Query: 551 AI------PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
A ++ E + N Y D W GV ++E+ L P+Y HE + + I
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 53/226 (23%), Positives = 97/226 (42%), Gaps = 38/226 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFDH 427
+ +G+G +G+VF+ +L + + AVK+L + E ++ ++ L A DH
Sbjct: 23 IETIGKGTYGKVFK-----VLNKKNGSKAAVKILDPIHDIDEEIEAEYN---ILKALSDH 74
Query: 428 PNIVKLLGV-----CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
PN+VK G+ G + L+ E G + D ++ + R
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVK----------------GFLKRG 118
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
++ + I + G+ +L K +HRD+ N L+ + VK+ DFG+S ++
Sbjct: 119 ERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL-TST 177
Query: 543 YYKGDENDAIPVRWMPLESI-----LYNKYTVESDVWAFGVCLWEI 583
+ + + P WM E I L + Y DVW+ G+ E+
Sbjct: 178 RLRRNTSVGTPF-WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 51/214 (23%), Positives = 89/214 (41%), Gaps = 31/214 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFDHPNIV 431
+G+GA+G V + + E +VA+K KD E +E ++ RE +L NIV
Sbjct: 9 VGEGAYGVVLKCR-----HKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIV 63
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
+L + L+FEY+ + +M + +P + +
Sbjct: 64 ELKEAFRRRGKLYLVFEYVEK---------------------NMLELLEEMPNGVPPEKV 102
Query: 492 -TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ Q+ + + VHRD+ N LI+ V+K+ DFG +R L + + +
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARN--LSEGSNANYTE 160
Query: 551 AIPVRWM-PLESILYNKYTVESDVWAFGVCLWEI 583
+ RW E +L Y D+W+ G L E+
Sbjct: 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGEL 194
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 57/241 (23%), Positives = 99/241 (41%), Gaps = 43/241 (17%)
Query: 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE 416
L L P V +G G +G+V++ + + L A+K++ + +E + + +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGR-----HVKTGQLAAIKVM--DVTEDEEEEIK 60
Query: 417 REACLLAEFDH-PNIVKLLGVCAVGKP------MCLLFEYMGRGDLNDFLRICSPNNYIN 469
E +L ++ H NI G P + L+ E+ G G + D ++ N
Sbjct: 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE 120
Query: 470 GTYSSMESSIHRVPQLSTCDLIT-IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528
D I I +I G+ +L K +HRD+ +N L+ + VK
Sbjct: 121 -------------------DWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVK 161
Query: 529 IADFGLSRKMYLQDYYKGDENDAIPV-RWMPLESILYNK-----YTVESDVWAFGVCLWE 582
+ DFG+S ++ D G N I WM E I ++ Y SD+W+ G+ E
Sbjct: 162 LVDFGVSAQL---DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218
Query: 583 I 583
+
Sbjct: 219 M 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 57/241 (23%), Positives = 97/241 (40%), Gaps = 33/241 (13%)
Query: 371 RDLGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
R LG+G FG V Q +A G K + K +K E + + E +L + +
Sbjct: 6 RVLGKGGFGEVCACQVRATG--KMYACKKLEKKRIKKRKGEAMALN---EKQILEKVNSR 60
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L +CL+ M GDL + N N + + +
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDLKFHI-----YNMGNPGFDEERAVFY-------- 107
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
A +I G+ L + V+RDL N L++D ++I+D GL+ ++ + +G
Sbjct: 108 -----AAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV 162
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG----LTHEEVVKYIK 604
V +M E + +YT D W G ++E+ P+ + EEV + +K
Sbjct: 163 GT---VGYMAPEVVKNERYTFSPDWWGLGCLIYEMIE-GKSPFRQRKEKVKREEVERRVK 218
Query: 605 E 605
E
Sbjct: 219 E 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 28/234 (11%)
Query: 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE 416
LE L P + + +G+G +G+V++ + ++ +L AVK+L D S+ + + E
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYK-----VTNKKDGSLAAVKIL-DPISD-VDEEIE 66
Query: 417 REACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
E +L +HPN+VK G M + + G L L +C+ G+ + +
Sbjct: 67 AEYNILQSLPNHPNVVKFYG-------MFYKADKLVGGQLWLVLELCN-----GGSVTEL 114
Query: 476 ESSIHRVPQLSTCDLITIALQIAS-GMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
+ Q +I+ L A G+ +L + + +HRD+ N L+ + VK+ DFG+
Sbjct: 115 VKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNK-----YTVESDVWAFGVCLWEI 583
S ++ + + + P WM E I + Y DVW+ G+ E+
Sbjct: 175 SAQL-TSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 62/251 (24%), Positives = 97/251 (38%), Gaps = 27/251 (10%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
R LG+G FG V + K + K +K E + + E +L + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALN---EKQILEKVNSRFV 62
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V L +CL+ M GDL + Y G E
Sbjct: 63 VSLAYAYETKDALCLVLTLMNGGDLKFHI-------YHMGEAGFEEGRA----------- 104
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ A +I G+ L + V+RDL N L++D ++I+D GL+ + KG
Sbjct: 105 VFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF---SFALQPYYGLTHEEVVKYIKEGN 607
V +M E + +YT D WA G L+E+ S Q + EEV + +KE
Sbjct: 165 ---VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 608 ILQAPDNTPDA 618
+ +PDA
Sbjct: 222 EEYSEKFSPDA 232
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 31/234 (13%)
Query: 373 LGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G FG+V + KA G + V + KDE + L E +L HP +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT-----ENRVLQNSRHPFL 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
L +C + EY G+L F + +S + +
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-----ERVFSEDRARFY---------- 100
Query: 491 ITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
+I S + YL S++ V+RDL N +++ +KI DFGL ++ ++D
Sbjct: 101 ---GAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKTF 156
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
P P E + N Y D W GV ++E+ L P+Y HE++ + I
Sbjct: 157 CGTPEYLAP-EVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 3e-07
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 44/247 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHP 428
+G+G+FG+V AK + AVK+L+ +A E ER LL HP
Sbjct: 3 IGKGSFGKVLLAK-----HKADGKFYAVKVLQKKAILKKKEQKHIMAERNV-LLKNVKHP 56
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L + + L L +Y+NG + + R
Sbjct: 57 FLVGLH------------YSFQTADKLYFVL------DYVNG--GELFFHLQRERSFPEP 96
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
A +IAS + YL ++RDL N L++ Q V + DFGL + +
Sbjct: 97 RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKT 152
Query: 549 NDAI---PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
P P E + Y D W G L+E+ + L P+Y E+
Sbjct: 153 TSTFCGTPEYLAP-EVLRKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRDTAEMYD---- 206
Query: 606 GNILQAP 612
NIL P
Sbjct: 207 -NILNKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 56/239 (23%), Positives = 93/239 (38%), Gaps = 29/239 (12%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
R LG+G FG V + K + K +K E + + E +L + + +
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALN---EKQILEKVNSQFV 62
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V L +CL+ M GDL I + N P
Sbjct: 63 VNLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGN----------------PGFEEERA 104
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ A +I G+ L V+RDL N L++D ++I+D GL+ K+ + +G
Sbjct: 105 LFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGT 164
Query: 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG----LTHEEVVKYIKE 605
V +M E + +YT+ D W G ++E+ P+ G + EEV + + E
Sbjct: 165 ---VGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIE-GQSPFRGRKEKVKREEVDRRVLE 219
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 33/221 (14%)
Query: 371 RDL---GQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFD 426
RDL G GA+G V A L VA+K L + SE RE LL
Sbjct: 18 RDLKQVGSGAYGTVCSA-----LDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
H N++ LL V + +DF + G E +LS
Sbjct: 73 HENVIGLLDVFTPDLSL---------DRFHDFYLVMPFMGTDLGKLMKHE-------KLS 116
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ + Q+ G+ Y+ +HRDL N +N+ +KI DFGL+R+
Sbjct: 117 EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT------DS 170
Query: 547 DENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
+ + RW ++ N YT D+W+ G + E+ +
Sbjct: 171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 59/236 (25%), Positives = 96/236 (40%), Gaps = 30/236 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G +G V++AK +E+ L ++ S RE LL E HPN++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC------REIALLRELKHPNVIA 62
Query: 433 LLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP-QLSTCD 489
L V + + LLF+Y DL ++ S ++ P QL
Sbjct: 63 LQKVFLSHSDRKVWLLFDY-AEHDLWHIIKF------------HRASKANKKPMQLPRSM 109
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMYLQDYYK 545
+ ++ QI G+ YL +HRDL N L+ ++ VKIAD G +R
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 546 GDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D + + W +L YT D+WA G E+ + +P + E++
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS--EPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 59/241 (24%), Positives = 91/241 (37%), Gaps = 36/241 (14%)
Query: 373 LGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G FG+V + KA G + V + KDE + L E+ +L HP +
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT-----ESRVLQNTRHPFL 57
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
L +C + EY G+L L +S + +
Sbjct: 58 TALKYSFQTHDRLCFVMEYANGGELFFHLSRE-------RVFSEDRARFY---------- 100
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+I S + YL V+RDL N +++ +KI DFGL + + G
Sbjct: 101 ---GAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK----EGISDGATMK 153
Query: 551 AI---PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
P P E + N Y D W GV ++E+ L P+Y HE++ + I
Sbjct: 154 TFCGTPEYLAP-EVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHEKLFELILMEE 211
Query: 608 I 608
I
Sbjct: 212 I 212
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 6e-07
Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 39/222 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ--TDFEREACLLAEFDHPNI 430
+G+G++G V A VA+K + D E++ T RE LL HP+I
Sbjct: 8 IGKGSYGVVCSAI-----DTHTGEKVAIKKIND-VFEHVSDATRILREIKLLRLLRHPDI 61
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V++ + M +F I Y+ + MES +H+V + D
Sbjct: 62 VEIKHI-------------MLPPSRREFKDI-----YV--VFELMESDLHQV--IKANDD 99
Query: 491 IT------IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
+T Q+ + Y+ HRDL +N L N +KI DFGL+R +
Sbjct: 100 LTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159
Query: 545 KGDENDAIPVRWM---PLESILYNKYTVESDVWAFGVCLWEI 583
D + RW L ++KYT D+W+ G E+
Sbjct: 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV 201
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 59/227 (25%), Positives = 93/227 (40%), Gaps = 48/227 (21%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD------FEREACLLAE 424
R LG+G+FG+V A+ E L AVK+LK + LQ D E+ LA
Sbjct: 1 RVLGKGSFGKVMLARL-----KESGRLYAVKVLKKDV--ILQDDDVECTMTEKRILSLAR 53
Query: 425 FDHPNIVKLLGVCAVGKPMCLLF--EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+HP + +L C P L F E++ GDL ++ R
Sbjct: 54 -NHPFLTQLY--CCFQTPDRLFFVMEFVNGGDLMFHIQKS-----------------RRF 93
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY--- 539
+ A +I S +++L D+ ++RDL N L++ + K+ADFG+ ++
Sbjct: 94 DEARAR---FYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
Query: 540 -LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
+ G + P E + Y D WA GV L+E+
Sbjct: 151 KTTSTFCGTPDYIAP------EILQEMLYGPSVDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 48/177 (27%), Positives = 79/177 (44%), Gaps = 35/177 (19%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL------QTDFEREA 419
+ + V+ + +GAFG+V+ + K L AVK++K ++ + Q ER+A
Sbjct: 5 EFVIVKPISRGAFGKVYLGR-----KKNNSKLYAVKVVKK--ADMINKNMVHQVQAERDA 57
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
LA P IV L + L+ EY+ GD+ L I Y E ++
Sbjct: 58 --LALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG--------YFDEEMAV 107
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ + + +AL YL +HRDL N LI+++ +K+ DFGLS+
Sbjct: 108 KYISE------VALALD------YLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 59/226 (26%), Positives = 88/226 (38%), Gaps = 50/226 (22%)
Query: 373 LGQGAFGRV---FQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-REACLLAEFDHP 428
+G GA+G V F K GL VAVK L + RE LL H
Sbjct: 25 VGSGAYGSVCAAFDTKT-GLR-------VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 429 NIVKLLGVCAVGKPM------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
N++ LL V + + L+ MG DLN+ I +
Sbjct: 77 NVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNN---------------------IVKC 114
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+L+ + + QI G+ Y+ +HRDL N +N+ +KI DFGL+R
Sbjct: 115 QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR------ 168
Query: 543 YYKGDENDA-IPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
+ DE + RW I+ N Y D+W+ G + E+ +
Sbjct: 169 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 7e-07
Identities = 58/236 (24%), Positives = 95/236 (40%), Gaps = 30/236 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G +G V++AK ++ L ++ S RE LL E HPN++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSAC------REIALLRELKHPNVIS 62
Query: 433 LLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP-QLSTCD 489
L V + + LLF+Y DL ++ S ++ P QL
Sbjct: 63 LQKVFLSHADRKVWLLFDY-AEHDLWHIIKF------------HRASKANKKPVQLPRGM 109
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMYLQDYYK 545
+ ++ QI G+ YL +HRDL N L+ ++ VKIAD G +R
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 546 GDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D + + W +L YT D+WA G E+ + +P + E++
Sbjct: 170 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS--EPIFHCRQEDI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 69/306 (22%), Positives = 123/306 (40%), Gaps = 64/306 (20%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKH---EEF---TLVAVKMLKDEASEYLQTDFERE 418
N+ ++ +G G FG VF L+KH +EF ++ + LK+ L E
Sbjct: 13 NEYEVIKKIGNGRFGEVF------LVKHKRTQEFFCWKAISYRGLKEREKSQLVI----E 62
Query: 419 ACLLAEFDHPNIVKLLG--VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
++ E H NIV+ + + + + +L E+ GDL+ ++ C + +E
Sbjct: 63 VNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK------MFGKIE 116
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVY---LSD----RKFVHRDLATRNCLI-------- 521
++ I Q+ + Y L D + +HRDL +N +
Sbjct: 117 EHA----------IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166
Query: 522 ---------NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY--NKYTVE 570
N + + KI DFGLS+ + ++ P W P E +L+ Y +
Sbjct: 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSP-ELLLHETKSYDDK 223
Query: 571 SDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMK 630
SD+WA G ++E+ S + +++ +K G L + + L L+K N+
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKE-LNILIKNLLNLS 282
Query: 631 PMNRPS 636
RPS
Sbjct: 283 AKERPS 288
|
Length = 1021 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 8e-07
Identities = 63/259 (24%), Positives = 97/259 (37%), Gaps = 32/259 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+GAFG V+ + V E S+ + E E LL H IV+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNLRHDRIVQ 68
Query: 433 LLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
G K + + EYM G + D L+ Y ++ ++ R
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLK----------AYGALTENVTR--------- 109
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY---KGD 547
QI G+ YL VHRD+ N L + VK+ DFG S++ +Q G
Sbjct: 110 -RYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR--IQTICMSGTGI 166
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG--LTHEEVVKYIKE 605
++ WM E I Y ++DVW+ + E+ + +P + + K +
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT--EKPPWAEYEAMAAIFKIATQ 224
Query: 606 GNILQAPDNTPDALYDLMK 624
PD DA D +K
Sbjct: 225 PTKPMLPDGVSDACRDFLK 243
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 61/225 (27%), Positives = 92/225 (40%), Gaps = 49/225 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEASEYLQTDFEREACLLAEFDHPN 429
+G+GA+G V AK E VA+K + D + +T RE LL DH N
Sbjct: 13 IGRGAYGIVCSAK-----NSETNEKVAIKKIANAFDNRIDAKRT--LREIKLLRHLDHEN 65
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---PQLS 486
++ + + P R ND YI Y M++ +H++ Q
Sbjct: 66 VIAIKDIM---PPPH-------REAFNDV--------YI--VYELMDTDLHQIIRSSQTL 105
Query: 487 TCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR-----KMYL 540
+ D L Q+ G+ Y+ +HRDL N L+N +KI DFGL+R ++
Sbjct: 106 SDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFM 165
Query: 541 QDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEI 583
+Y RW +L N +YT DVW+ G E+
Sbjct: 166 TEYVV--------TRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 64/275 (23%), Positives = 111/275 (40%), Gaps = 47/275 (17%)
Query: 373 LGQGAFGRV--FQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G FG V Q K G K + K LK ++ E + E+E +L + + P I
Sbjct: 1 LGKGGFGEVCAVQVKNTG--KMYACKKLDKKRLKKKSGEKMAL-LEKE--ILEKVNSPFI 55
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ--LSTC 488
V L +CL+ M GDL + I+ V + L
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDL--------------------KYHIYNVGERGLEME 95
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+I + QI G+++L V+RD+ N L++DQ +++D GL+ ++ +
Sbjct: 96 RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL--------KD 147
Query: 549 NDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG----LTHEEV 599
I R +M E + Y+ D +A G ++E+ + P+ + EE+
Sbjct: 148 GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVA-GRTPFKDHKEKVAKEEL 206
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ E + N + D+ +L KP +R
Sbjct: 207 KRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDR 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 50/215 (23%), Positives = 86/215 (40%), Gaps = 47/215 (21%)
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLF-EYMGRGDLNDFLRICSPNNYINGTYSSME 476
EA LL HP ++ LL V VG CL+ +Y R DL +L
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY--RSDLYTYLG---------------- 251
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG--- 533
R+ L + +A Q+ S + Y+ +HRD+ T N L+N + + DFG
Sbjct: 252 ---ARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308
Query: 534 LSRKMYLQDYYKG-----DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWE------ 582
+R + ++ G D N E + + YT D+W+ G+ ++E
Sbjct: 309 FARGSWSTPFHYGIAGTVDTNAP--------EVLAGDPYTPSVDIWSAGLVIFEAAVHTA 360
Query: 583 -IFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTP 616
+FS + ++++ I++ + D P
Sbjct: 361 SLFSASRGDERRPYDAQILRIIRQAQV--HVDEFP 393
|
Length = 461 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 38/145 (26%), Positives = 60/145 (41%), Gaps = 28/145 (19%)
Query: 398 VAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLL--GVCAVGKPMCLLFEYMGRG 453
VA+K+L+ +A E+ + F RE L A HPNIV LL G G + +FEY+
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGR 64
Query: 454 DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513
L + L L + + LQ+ + ++ VHRD
Sbjct: 65 TLREVLAADGA--------------------LPAGETGRLMLQVLDALACAHNQGIVHRD 104
Query: 514 LATRNCLI---NDQMVVKIADFGLS 535
L +N ++ + K+ DFG+
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIG 129
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 62/259 (23%), Positives = 116/259 (44%), Gaps = 37/259 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-----EASEYLQTDFEREACLLAEFDH 427
LG+G +G+VFQ + + + + A+K+LK + T ER +L H
Sbjct: 4 LGKGGYGKVFQVRK--VTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERN--ILEAVKH 59
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P IV L+ G + L+ EY+ G+L F+ + ++ T S
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSE--------- 108
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
I++AL+ +L + ++RDL N L++ Q VK+ DFGL + + ++G
Sbjct: 109 ---ISLALE------HLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGT 155
Query: 548 ENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605
+ +M E ++ + + D W+ G ++++ + A P+ ++ + I +
Sbjct: 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA-PPFTAENRKKTIDKILK 214
Query: 606 GNILQAPDNTPDALYDLMK 624
G + P TP+A DL+K
Sbjct: 215 GKLNLPPYLTPEA-RDLLK 232
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 65/266 (24%), Positives = 108/266 (40%), Gaps = 35/266 (13%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD----EASEYLQTDFEREACLLAEFDHP 428
+G+G+FG+V Q + K + + A+K ++ SE T ER +LA+ + P
Sbjct: 1 IGKGSFGKVMQVR-----KRDTQRIYALKTIRKAHIVSRSEVTHTLAERT--VLAQVNCP 53
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
IV L F + L L +ING + + R +
Sbjct: 54 FIVPLK------------FSFQSPEKLYLVLA------FING--GELFHHLQREGRFDLS 93
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
++ + L ++RDL N L++ Q + + DFGL K+ ++D K +
Sbjct: 94 RARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLC-KLNMKDDDKTNT 152
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
P P E +L + YT D W GV L+E+ + L P+Y E+ + I +
Sbjct: 153 FCGTPEYLAP-ELLLGHGYTKAVDWWTLGVLLYEMLT-GLPPFYDENVNEMYRKILQ-EP 209
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNR 634
L+ PD DL+ + P R
Sbjct: 210 LRFPDGFDRDAKDLLIGLLSRDPTRR 235
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 65/271 (23%), Positives = 113/271 (41%), Gaps = 43/271 (15%)
Query: 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVA-VKMLKDEASEYLQTD 414
K+ L D V+ +G+GAFG V + K L++ +M+K S +
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF---- 89
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNY-INGTYS 473
F E ++A + P +V+L + + ++ EYM GDL + + +NY + ++
Sbjct: 90 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-----SNYDVPEKWA 144
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
++ + +AL M F+HRD+ N L++ +K+ADFG
Sbjct: 145 RFYTA-----------EVVLALDAIHSM------GFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-----YTVESDVWAFGVCLWEIFSFAL 588
KM + + D P P +L ++ Y E D W+ GV L+E+
Sbjct: 188 TCMKMNKEGMVRCDTAVGTPDYISP--EVLKSQGGDGYYGRECDWWSVGVFLYEML-VGD 244
Query: 589 QPYYGLTHEEVV----KYIKEGNILQAPDNT 615
P+Y + +V K + N L PD+
Sbjct: 245 TPFYA---DSLVGTYSKIMNHKNSLTFPDDN 272
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 65/256 (25%), Positives = 103/256 (40%), Gaps = 67/256 (26%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDF---EREACLLAEFDHP 428
+G+GAFG V+ + + + A+K + K + + Q ER+ +LA+ D P
Sbjct: 9 IGRGAFGEVWLVR-----DKDTGQVYAMKVLRKSDMIKRNQIAHVRAERD--ILADADSP 61
Query: 429 NIVKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
IVKL + + + L+ EYM GDL + L P+ +
Sbjct: 62 WIVKL--YYSFQDEEHLYLVMEYMPGGDLMNLL-----------------IRKDVFPEET 102
Query: 487 TCDLIT-IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM------- 538
I + L + S + F+HRD+ N LI+ +K+ADFGL +KM
Sbjct: 103 ARFYIAELVLALDS----VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 539 -YLQDYYKGDENDAIPVRWMPL-------------------ESILYNKYTVESDVWAFGV 578
YL D + D + VR E + Y +E D W+ GV
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 579 CLWE-IFSFALQPYYG 593
L+E ++ F P+Y
Sbjct: 219 ILYEMLYGFP--PFYS 232
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 63/235 (26%), Positives = 99/235 (42%), Gaps = 45/235 (19%)
Query: 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDF--EREA 419
F D+ + ++G+GAFG V + +L T++AVK ++ E Q + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTVNK-----MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV 55
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRIC------SPNNYINGTYS 473
+ + D P IVK G LF GD IC S + + Y
Sbjct: 56 VMRSS-DCPYIVKFYG---------ALFR---EGDC----WICMELMDISLDKFYKYVYE 98
Query: 474 SMESSI-HRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIAD 531
++S I + L IA+ + YL + K +HRD+ N L++ +K+ D
Sbjct: 99 VLKSVIPEEI-------LGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCD 151
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLWEI 583
FG+S L D DA +M E I + Y V SDVW+ G+ L+E+
Sbjct: 152 FGISG--QLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 69/291 (23%), Positives = 117/291 (40%), Gaps = 49/291 (16%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER---EACLLAEFDH 427
R LG GA G V AK + E F AVK++ E + D R E C L D
Sbjct: 38 RVLGSGATGTVLCAKR--VSDGEPF---AVKVVDMEG--MSEADKNRAQAEVCCLLNCDF 90
Query: 428 PNIVKLLGVCAVGKP--------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+IVK A P + L+ +Y GDL ++ + N T+ E+ +
Sbjct: 91 FSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNR---TFREHEAGL 147
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ +Q+ + ++ + +HRD+ + N L+ +VK+ DFG S KMY
Sbjct: 148 -------------LFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS-KMY 193
Query: 540 -------LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
+ + G P W Y+ ++D+++ GV L+E+ + +P+
Sbjct: 194 AATVSDDVGRTFCGTPYYVAPEIWR------RKPYSKKADMFSLGVLLYELLTLK-RPFD 246
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
G EEV+ G P + + +++ + P RPS +
Sbjct: 247 GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 56/218 (25%), Positives = 88/218 (40%), Gaps = 31/218 (14%)
Query: 373 LGQGAFGRVF--QAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER---EACLLAEFDH 427
LG+G FG V Q +A G L A K L + + + +E E +LA+
Sbjct: 1 LGKGGFGEVSACQMRATG-------KLYACKKLNKKRLKKRK-GYEGAMVEKRILAKVHS 52
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
IV L +CL+ M GDL + N P
Sbjct: 53 RFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEEN----------------PGFPE 96
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
QI SG+ +L R+ ++RDL N L+++ V+I+D GL+ + L+D
Sbjct: 97 PRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKT 154
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
+ A +M E + +Y D +A GV L+E+ +
Sbjct: 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIA 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 30/218 (13%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-REACLLAEFDHP 428
+ +G GA+G V A L + VAVK L + RE LL H
Sbjct: 20 LTPVGSGAYGSVCSAYDTRLRQK-----VAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
N++ LL V + + +F + N + ++ I + +LS
Sbjct: 75 NVIGLLDV------------FTPATSIENFNEVYLVTNLMGADLNN----IVKCQKLSDE 118
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ + Q+ G+ Y+ +HRDL N +N+ ++I DFGL+R+ D G
Sbjct: 119 HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA--DDEMTG-- 174
Query: 549 NDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIF 584
+ RW I+ N Y D+W+ G + E+
Sbjct: 175 --YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 52/186 (27%), Positives = 87/186 (46%), Gaps = 30/186 (16%)
Query: 365 NDIIYVRDLGQGAFG--RVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
D V+ +G+GAFG R+ Q K G + + TL+ +M K + +++ ER+ +L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI-YAMKTLLKSEMFKKDQLAHVKA--ERD--VL 55
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
AE D P +V L + + L+ E++ GDL L I Y + + R
Sbjct: 56 AESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IK--YDTFSEDVTRF 105
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
++ C L A++ + F+HRD+ N LI+ +K++DFGLS + Q
Sbjct: 106 -YMAECVL---AIEAVHKL------GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155
Query: 543 ---YYK 545
YY+
Sbjct: 156 DSAYYQ 161
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 65/273 (23%), Positives = 114/273 (41%), Gaps = 42/273 (15%)
Query: 327 PAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKA 386
PA ++ NID ++ ++ K+ +L+ D V+ +G+GAFG V +
Sbjct: 13 PALRKNKNID--------NFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRH 64
Query: 387 PGLLKHEEFTLVA-VKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445
K L++ +M+K S + F E ++A + P +V+L K + +
Sbjct: 65 KSSQKVYAMKLLSKFEMIKRSDSAF----FWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120
Query: 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS 505
+ EYM GDL + + +NY + + T +++ +AL M
Sbjct: 121 VMEYMPGGDLVNLM-----SNY---------DVPEKWAKFYTAEVV-LALDAIHSM---- 161
Query: 506 DRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN 565
+HRD+ N L++ +K+ADFG KM + D P P +L +
Sbjct: 162 --GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISP--EVLKS 217
Query: 566 K-----YTVESDVWAFGVCLWEIFSFALQPYYG 593
+ Y E D W+ GV L+E+ P+Y
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEML-VGDTPFYA 249
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143577 cd07468, CRD_TK_ROR2, Cysteine-rich domain of tyrosine kinase-like orphan receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 36/134 (26%), Positives = 56/134 (41%), Gaps = 16/134 (11%)
Query: 33 GYCSQYNGKICKNYL-NRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAI---LANPCKQ 88
G+C Y G C ++ NRT V SL+ G ++ +I A MI L++ C Q
Sbjct: 3 GFCQPYRGIACARFIGNRTIYV---DSLQMQG-EIENRITAAF--TMIGTSTHLSDQCSQ 56
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
A C + FP C + P LC ++C + C ++ N ++
Sbjct: 57 FAIPSFCHFVFPLCDDRSRTPKPRELCRDECEVLENDLCRQEYNIARSNPLILMQ----- 111
Query: 149 HFELPNCDTLPKYE 162
+LP C+ LP E
Sbjct: 112 -LQLPKCEELPLPE 124
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror2), a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. Length = 140 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-05
Identities = 53/230 (23%), Positives = 86/230 (37%), Gaps = 36/230 (15%)
Query: 361 EFPRNDIIYVR--DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFER 417
E P Y +G GA+G V A + VA+K L + SE R
Sbjct: 12 ELPER---YTSLKQVGSGAYGSVCSA-----IDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
E LL H N++ LL V + ++F + Y+ Y +
Sbjct: 64 ELTLLKHMQHENVIGLLDV------------FTSAVSGDEF-----QDFYLVMPYMQTDL 106
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
LS + + Q+ G+ Y+ +HRDL N +N+ +KI DFGL+R
Sbjct: 107 QKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFS 585
+ + + RW ++ N Y D+W+ G + E+ +
Sbjct: 166 -----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT 210
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 72/315 (22%), Positives = 119/315 (37%), Gaps = 80/315 (25%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-----KDEASEYL 411
++ ND+ + ++G G G+V++ + ++ ++AVK + K+E L
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMR------FKKTGHVMAVKQMRRTGNKEENKRIL 61
Query: 412 QTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
D + +L D P IVK G + + + IC
Sbjct: 62 M-DLD---VVLKSHDCPYIVKCYG--------YFITDSD--------VFIC--------- 92
Query: 472 YSSMESSIHRVPQLSTCD---------------LITIALQIASGMVYLSDRKFV-HRDLA 515
ME +STC L + + I + YL ++ V HRD+
Sbjct: 93 ---ME-------LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVK 142
Query: 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI----LYNKYTVES 571
N L++ VK+ DFG+S ++ K A +M E I KY + +
Sbjct: 143 PSNILLDASGNVKLCDFGISGRLVDS---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRA 199
Query: 572 DVWAFGVCLWEIFSFALQPYYGLTHE-EVVKYIKEGNILQAPDN---TPDALYDLMKLCW 627
DVW+ G+ L E+ + PY E EV+ I + P N +PD + LC
Sbjct: 200 DVWSLGISLVELAT-GQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD-FCSFVDLCL 257
Query: 628 NMKPMNRPSFRTIYQ 642
RP +R + Q
Sbjct: 258 TKDHRKRPKYRELLQ 272
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 51/215 (23%), Positives = 86/215 (40%), Gaps = 24/215 (11%)
Query: 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+ R LG+G FG V + K + K +K E + + +R +L + +
Sbjct: 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKR---ILEKVNSR 60
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L +CL+ M GDL I + N P
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDLK--FHIYNMGN----------------PGFDEQ 102
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
I A ++ G+ L + V+RDL N L++D+ ++I+D GL+ ++ + +G
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV 162
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
V +M E I KYT D W G ++E+
Sbjct: 163 GT---VGYMAPEVINNEKYTFSPDWWGLGCLIYEM 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 39/172 (22%), Positives = 68/172 (39%), Gaps = 34/172 (19%)
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
EA +L +HP+I++L G K CL+ + DL +L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYL-----------------A 174
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
+ + CD++ I + + YL + + +HRD+ N IN V + DFG +
Sbjct: 175 AKRNIA---ICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAA-- 229
Query: 538 MYLQDYYKGDENDAIPVRWMPL------ESILYNKYTVESDVWAFGVCLWEI 583
+ D N W E + + Y D+W+ G+ L+E+
Sbjct: 230 -----CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 64/251 (25%), Positives = 109/251 (43%), Gaps = 50/251 (19%)
Query: 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-KDEASEYLQT 413
K+ +L D ++ +G+GAFG V L++H+ + A+K+L K E + +
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEV------QLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 414 DF---EREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYING 470
F ER+ ++A + IV+L K + ++ EYM GDL + + +NY
Sbjct: 88 AFFWEERD--IMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-----SNY--- 137
Query: 471 TYSSMESSIHRVP----QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526
+P + T +++ +AL M F+HRD+ N L++
Sbjct: 138 ----------DIPEKWARFYTAEVV-LALDAIHSM------GFIHRDVKPDNMLLDKSGH 180
Query: 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-----YTVESDVWAFGVCLW 581
+K+ADFG KM + D P P +L ++ Y E D W+ GV L+
Sbjct: 181 LKLADFGTCMKMDANGMVRCDTAVGTPDYISP--EVLKSQGGDGYYGRECDWWSVGVFLY 238
Query: 582 EIFSFALQPYY 592
E+ P+Y
Sbjct: 239 EML-VGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 65/255 (25%), Positives = 105/255 (41%), Gaps = 43/255 (16%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD-FEREACLL 422
+D ++ +G+GAFG V K +KH E + A+K+L K E + +T F E +L
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVK----MKHTE-RIYAMKILNKWEMLKRAETACFREERNVL 55
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
D I L + L+ +Y GDL L S E R+
Sbjct: 56 VNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLL-------------SKFED---RL 99
Query: 483 PQ-LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM--- 538
P+ ++ + + L I S + +VHRD+ N L++ +++ADFG KM
Sbjct: 100 PEDMARFYIAEMVLAIHS----IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155
Query: 539 -YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG---- 593
+Q D I + KY E D W+ GVC++E+ + P+Y
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEML-YGETPFYAESLV 214
Query: 594 ------LTHEEVVKY 602
+ HEE ++
Sbjct: 215 ETYGKIMNHEERFQF 229
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 60/244 (24%), Positives = 92/244 (37%), Gaps = 38/244 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHP 428
+G+G+FG+V A+ E AVK+L+ +A E ER LL HP
Sbjct: 3 IGKGSFGKVLLAR-----HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHP 56
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L + + +Y+ G+L Y P+
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGEL---------------FYHLQRERCFLEPRARF- 100
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
A +IAS + YL V+RDL N L++ Q + + DFGL ++ ++
Sbjct: 101 ----YAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTST 155
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
P P E + Y D W G L+E+ + L P+Y E+ NI
Sbjct: 156 FCGTPEYLAP-EVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYD-----NI 208
Query: 609 LQAP 612
L P
Sbjct: 209 LNKP 212
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 49/192 (25%), Positives = 85/192 (44%), Gaps = 42/192 (21%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFER-EACLL 422
+D ++ +G+GAFG V + K + + A+K L K E E Q R E +L
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQ-----KKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDIL 55
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFL---RICSPNN---YINGTYSSME 476
AE D+P +VKL + L+ EY+ GD+ L + YI T +++
Sbjct: 56 AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID 115
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS- 535
SIH++ ++HRD+ N L++ + +K++DFGL
Sbjct: 116 -SIHKL-------------------------GYIHRDIKPDNLLLDAKGHIKLSDFGLCT 149
Query: 536 --RKMYLQDYYK 545
+K + ++Y+
Sbjct: 150 GLKKSHRTEFYR 161
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 20/163 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G FG V+ + K + K +K + E L + L++ D P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
+ +C + + M GDL+ L S H V S ++
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHL------------------SQHGV--FSEKEMRF 101
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
A +I G+ ++ +R V+RDL N L+++ V+I+D GL+
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 35/170 (20%), Positives = 65/170 (38%), Gaps = 21/170 (12%)
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
RE +L H I+ L+ +C++ + DL TY
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLF--------------TY- 175
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ R L ITI ++ + YL R +HRD+ T N +++ + DFG
Sbjct: 176 -----VDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
+ K+ + + E + + Y ++D+W+ G+ L+E+
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 62/263 (23%), Positives = 99/263 (37%), Gaps = 48/263 (18%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHP 428
+G+G+FG+V AK + + + AVK+L+ + E ER LL HP
Sbjct: 3 IGKGSFGKVLLAK-----RKSDGSFYAVKVLQKKTILKKKEQNHIMAERNV-LLKNLKHP 56
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L + + + +Y+ G+L F + R
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGEL--FFHL------------------QRERCFLEP 96
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
A ++AS + YL ++RDL N L++ Q V + DFGL + +G E
Sbjct: 97 RARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK--------EGVE 148
Query: 549 ND-------AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ P P E + Y D W G L+E+ + L P+Y ++
Sbjct: 149 PEETTSTFCGTPEYLAP-EVLRKEPYDRTVDWWCLGAVLYEML-YGLPPFYSRDVSQMYD 206
Query: 602 YIKEGNILQAPDNTPDALYDLMK 624
I LQ P A DL+
Sbjct: 207 NILH-KPLQLPGGKTVAACDLLV 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 45/174 (25%), Positives = 79/174 (45%), Gaps = 32/174 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-------KDEASEYLQTDFEREACLL 422
+R LG GA+G+VF + G H+ L A+K+L K + +E+ +T ER+ L
Sbjct: 5 LRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRT--ERQV-LE 59
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
A P +V L + L+ +Y+ G+L F + ++ ES +
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGEL--FTHLYQREHF-------TESEVR-- 108
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ IA +I + +L ++RD+ N L++ + V + DFGLS+
Sbjct: 109 --------VYIA-EIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 9e-04
Identities = 36/123 (29%), Positives = 51/123 (41%), Gaps = 12/123 (9%)
Query: 494 ALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI- 552
A +IAS + YL V+RDL N L++ Q V + DFGL ++ Q D
Sbjct: 102 AAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ----SDTTTTFC 157
Query: 553 -PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQA 611
++ E I Y D W G L+E+ + L P+Y E+ NIL
Sbjct: 158 GTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML-YGLPPFYCRDVAEMYD-----NILHK 211
Query: 612 PDN 614
P
Sbjct: 212 PLV 214
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 9e-04
Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTD---FEREACL 421
R +G+G++ +V + LK E + A+K++K DE +++QT+ FE+ +
Sbjct: 1 RVIGRGSYAKVLLVR----LKKTE-RIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS-- 53
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
+HP +V L + + EY+ GDL + R
Sbjct: 54 ----NHPFLVGLHSCFQTESRLFFVIEYVNGGDL--------------------MFHMQR 89
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+L + +I+ + YL +R ++RDL N L++ + +K+ D+G+ + +
Sbjct: 90 QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK----E 145
Query: 542 DYYKGDENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
GD ++ E + Y D WA GV ++E+ +
Sbjct: 146 GLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMA 191
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 60/270 (22%), Positives = 109/270 (40%), Gaps = 38/270 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE----ASEYLQTDFEREACL-LAEFDH 427
+G+G FG+V+Q + K + + A+K+L + E T ER + +
Sbjct: 1 IGKGTFGQVYQVR-----KKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDES 55
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P IV L + L+ +YM G+L L+ G +S + +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-------EGRFSEDRAKFY------I 102
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
+L+ +AL+ +L V+RDL N L++ + + DFGLS+ +
Sbjct: 103 AELV-LALE------HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA----NLTDNK 151
Query: 548 ENDAI--PVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
+ ++ E +L K YT D W+ GV ++E+ P+Y +++ + I
Sbjct: 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM-CCGWSPFYAEDTQQMYRNIA 210
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
G + + D +K N P +R
Sbjct: 211 FGKVRFPKNVLSDEGRQFVKGLLNRNPQHR 240
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 74/310 (23%), Positives = 115/310 (37%), Gaps = 77/310 (24%)
Query: 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML--KDEASEYLQTDFEREACLLAEF 425
+ ++ LG GAFG V A K + L A+K L KD + + E +LAE
Sbjct: 4 VKIKTLGIGAFGEVCLAC-----KVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA 58
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
D+ +VKL + + +Y+ GD+ L ME + +
Sbjct: 59 DNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-------------IRMEVFPEVLARF 105
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS---RKMYLQD 542
+L T+A++ M F+HRD+ N LI+ +K+ DFGL R +
Sbjct: 106 YIAEL-TLAIESVHKM------GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK 158
Query: 543 YYK------------------------GDENDAIPVR------------------WMPLE 560
YY+ GD + R ++ E
Sbjct: 159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPE 218
Query: 561 SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV-VKYIKEGNILQAPDN---TP 616
+L YT D W+ GV L+E+ P+ T E +K I N L P +P
Sbjct: 219 VLLRKGYTQLCDWWSVGVILFEML-VGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSP 277
Query: 617 DALYDLMKLC 626
+A+ + KLC
Sbjct: 278 EAVDLITKLC 287
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 56/236 (23%), Positives = 94/236 (39%), Gaps = 46/236 (19%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD------FEREACLLAEFD 426
LG+G+FG+V A+ G E + A+K+LK + LQ D E+ LA
Sbjct: 3 LGKGSFGKVMLAELKG--TDEVY---AIKVLKKDV--ILQDDDVDCTMTEKRILALAA-K 54
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP + L + + EY+ GDL I R +
Sbjct: 55 HPFLTALHCCFQTKDRLFFVMEYVNGGDL--------------------MFQIQRSRKFD 94
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY--- 543
A ++ +++L ++RDL N L++ + K+ADFG+ ++ L
Sbjct: 95 EPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTT 154
Query: 544 -YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
+ G + P E + +Y D WA GV ++E+ A QP + +E+
Sbjct: 155 TFCGTPDYIAP------EILQELEYGPSVDWWALGVLMYEM--MAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 63/264 (23%), Positives = 108/264 (40%), Gaps = 45/264 (17%)
Query: 365 NDIIYVRDLGQGAFG--RVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREAC 420
D +G+G FG +V + KA G + A+K++K ++ + FE E
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATG-------DIYAMKVMKKSVLLAQETVSFFEEERD 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L+ + P I +L + L+ EY GDL L N Y + M
Sbjct: 54 ILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDM----- 103
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
Q +L+ +A+ M Y VHRD+ N LI+ +K+ADFG + ++
Sbjct: 104 --AQFYLAELV-LAIHSVHQMGY------VHRDIKPENVLIDRTGHIKLADFGSAARLTA 154
Query: 541 QDYYKGDENDAIPV---RWMPLESIL----YNK--YTVESDVWAFGVCLWEIFSFALQPY 591
N +PV ++ E + K Y VE D W+ GV +E+ + P+
Sbjct: 155 N----KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI-YGRSPF 209
Query: 592 Y-GLTHEEVVKYIKEGNILQAPDN 614
+ G + + + L+ P++
Sbjct: 210 HEGTSAKTYNNIMNFQRFLKFPED 233
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 39/163 (23%), Positives = 68/163 (41%), Gaps = 20/163 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G FG V+ + K + K +K + E L + L++ D P IV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
+ + + + M GDL+ L S H V S ++
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHL------------------SQHGV--FSEAEMRF 101
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
A +I G+ ++ +R V+RDL N L+++ V+I+D GL+
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 51/310 (16%), Positives = 107/310 (34%), Gaps = 73/310 (23%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHPN 429
+ + + K TLVAVK + D S+ ++E + HPN
Sbjct: 8 KCFEDLMIVHLAKHKPTN-------TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPN 60
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
I+ + V + ++ M G D L+ ++ G +P+L+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLK----THFPEG-----------LPELAIAF 105
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS--------RKMYLQ 541
++ L + Y+ + F+HR + + L++ V ++ S R+ +
Sbjct: 106 ILKDVLN---ALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 542 DYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFS-----FALQPYYG 593
D+ K + + W+ E +L Y +SD+++ G+ E+ + +
Sbjct: 163 DFPKSSVKN---LPWLSPE-VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218
Query: 594 LTH------------------EEVVKYIKEG----NILQAPDNT-----PDALYDLMKLC 626
L E+ + + N + D+ + + ++LC
Sbjct: 219 LLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELC 278
Query: 627 WNMKPMNRPS 636
P +RPS
Sbjct: 279 LQRDPESRPS 288
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 29/116 (25%), Positives = 50/116 (43%), Gaps = 10/116 (8%)
Query: 509 FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---- 564
+VHRD+ N L++ +++ADFG ++ + + P P IL
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISP--EILQAMED 180
Query: 565 --NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV-KYIKEGNILQAPDNTPD 617
+Y E D W+ GVC++E+ + P+Y + E K + Q P + D
Sbjct: 181 GKGRYGPECDWWSLGVCMYEML-YGETPFYAESLVETYGKIMNHKEHFQFPPDVTD 235
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 42/170 (24%), Positives = 68/170 (40%), Gaps = 26/170 (15%)
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
RE LL +H NI+ LL V P L E+ D+ + + N +
Sbjct: 69 RELVLLKCVNHKNIISLLNVFT---PQKSLEEFQ---DVYLVMELMDAN---------LC 113
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
IH +L + + Q+ G+ +L +HRDL N ++ +KI DFGL+R
Sbjct: 114 QVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
Query: 537 KM---YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
++ Y + + E IL Y D+W+ G + E+
Sbjct: 172 TACTNFMMTPY------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 653 | |||
| KOG1026|consensus | 774 | 100.0 | ||
| KOG0197|consensus | 468 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0192|consensus | 362 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG1024|consensus | 563 | 100.0 | ||
| KOG0193|consensus | 678 | 100.0 | ||
| cd07469 | 147 | CRD_TK_ROR_related Cysteine-rich domain of protein | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0199|consensus | 1039 | 100.0 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0593|consensus | 396 | 100.0 | ||
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0616|consensus | 355 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG2052|consensus | 513 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG0578|consensus | 550 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0659|consensus | 318 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0694|consensus | 694 | 100.0 | ||
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0663|consensus | 419 | 100.0 | ||
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0658|consensus | 364 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| KOG2345|consensus | 302 | 100.0 | ||
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0596|consensus | 677 | 100.0 | ||
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07467 | 142 | CRD_TK_ROR1 Cysteine-rich domain of tyrosine kinas | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG0662|consensus | 292 | 100.0 | ||
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07468 | 140 | CRD_TK_ROR2 Cysteine-rich domain of tyrosine kinas | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG1006|consensus | 361 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4250|consensus | 732 | 99.98 | ||
| KOG0604|consensus | 400 | 99.98 | ||
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG0603|consensus | 612 | 99.97 | ||
| KOG0587|consensus | 953 | 99.97 | ||
| KOG0669|consensus | 376 | 99.97 | ||
| KOG0984|consensus | 282 | 99.97 | ||
| KOG0614|consensus | 732 | 99.97 | ||
| KOG4236|consensus | 888 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG1151|consensus | 775 | 99.97 | ||
| KOG0671|consensus | 415 | 99.97 | ||
| cd07459 | 135 | CRD_TK_ROR_like Cysteine-rich domain of tyrosine k | 99.96 | |
| KOG0695|consensus | 593 | 99.96 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG0608|consensus | 1034 | 99.96 | ||
| KOG0664|consensus | 449 | 99.96 | ||
| KOG0668|consensus | 338 | 99.95 | ||
| KOG1152|consensus | 772 | 99.95 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0576|consensus | 829 | 99.95 | ||
| smart00130 | 83 | KR Kringle domain. Named after a Danish pastry. Fo | 99.95 | |
| cd00108 | 83 | KR Kringle domain; Kringle domains are believed to | 99.95 | |
| KOG0665|consensus | 369 | 99.94 | ||
| KOG0670|consensus | 752 | 99.94 | ||
| KOG1290|consensus | 590 | 99.93 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| KOG1345|consensus | 378 | 99.93 | ||
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1167|consensus | 418 | 99.92 | ||
| PF00051 | 79 | Kringle: Kringle domain; InterPro: IPR000001 Kring | 99.92 | |
| KOG0195|consensus | 448 | 99.91 | ||
| KOG1164|consensus | 322 | 99.9 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1163|consensus | 341 | 99.88 | ||
| KOG1165|consensus | 449 | 99.85 | ||
| KOG0590|consensus | 601 | 99.85 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240|consensus | 1431 | 99.82 | ||
| KOG1023|consensus | 484 | 99.82 | ||
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG4158|consensus | 598 | 99.8 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG0603|consensus | 612 | 99.79 | ||
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1166|consensus | 974 | 99.75 | ||
| KOG1033|consensus | 516 | 99.72 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG0606|consensus | 1205 | 99.71 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.57 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| KOG0590|consensus | 601 | 99.55 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.46 | |
| KOG0601|consensus | 524 | 99.35 | ||
| KOG1266|consensus | 458 | 99.32 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.3 | |
| KOG0601|consensus | 524 | 99.27 | ||
| KOG0606|consensus | 1205 | 99.19 | ||
| KOG1243|consensus | 690 | 99.16 | ||
| PF01392 | 116 | Fz: Fz domain; InterPro: IPR020067 The frizzled (f | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.14 | |
| KOG3741|consensus | 655 | 99.06 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.03 | |
| KOG3087|consensus | 229 | 98.97 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.82 | |
| KOG2137|consensus | 700 | 98.77 | ||
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.38 | |
| cd07066 | 119 | CRD_FZ CRD_domain cysteine-rich domain, also known | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.17 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.16 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.06 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.98 | |
| KOG1235|consensus | 538 | 97.95 | ||
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.92 | |
| cd07448 | 126 | CRD_FZ4 Cysteine-rich Wnt-binding domain of the fr | 97.89 | |
| KOG0576|consensus | 829 | 97.88 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| KOG1035|consensus | 1351 | 97.78 | ||
| cd07463 | 127 | CRD_FZ9 Cysteine-rich Wnt-binding domain (CRD) of | 97.78 | |
| cd07462 | 127 | CRD_FZ10 Cysteine-rich Wnt-binding domain (CRD) of | 97.74 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.74 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.71 | |
| cd07457 | 121 | CRD_FZ9_like Cysteine-rich Wnt-binding domain (CRD | 97.7 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.61 | |
| cd07461 | 125 | CRD_FZ8 Cysteine-rich Wnt-binding domain (CRD) of | 97.47 | |
| smart00063 | 113 | FRI Frizzled. Drosophila melanogaster frizzled med | 97.46 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.45 | |
| cd07888 | 122 | CRD_corin_2 One of two cysteine-rich domains of th | 97.37 | |
| cd07464 | 127 | CRD_FZ2 Cysteine-rich Wnt-binding domain (CRD) of | 97.35 | |
| cd07466 | 125 | CRD_FZ7 Cysteine-rich Wnt-binding domain (CRD) of | 97.32 | |
| cd07465 | 127 | CRD_FZ1 Cysteine-rich Wnt-binding domain (CRD) of | 97.27 | |
| cd07458 | 119 | CRD_FZ1_like Cysteine-rich Wnt-binding domain (CRD | 97.22 | |
| cd07460 | 127 | CRD_FZ5 Cysteine-rich Wnt-binding domain (CRD) of | 97.2 | |
| cd07456 | 120 | CRD_FZ5_like Cysteine-rich Wnt-binding domain (CRD | 97.15 | |
| cd07454 | 124 | CRD_LIN_17 Cysteine-rich domain (CRD) of LIN_17. A | 97.13 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.12 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.1 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.05 | |
| cd07442 | 127 | CRD_SFRP4 Cysteine-rich domain of the secreted fri | 97.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.97 | |
| cd07441 | 126 | CRD_SFRP3 Cysteine-rich domain of the secreted fri | 96.96 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.86 |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-90 Score=757.90 Aligned_cols=585 Identities=41% Similarity=0.734 Sum_probs=479.3
Q ss_pred CCCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH-HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCC
Q psy5539 30 QPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA-LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGI 108 (653)
Q Consensus 30 ~~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~-~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~ 108 (653)
...|+|++|+|..|..+++ + .+.++.+....+ +..++++++ +|.+...+++..|+..+++++|+|+||.|.....+
T Consensus 160 ~e~~~~~~~~~~~c~~~~~-~-~~~~~~~~~~~~-~~~~~~~~~~~~v~~~~~~~~~c~~~~~~vp~~~~~~~~~~~~~~ 236 (774)
T KOG1026|consen 160 REDGFCVPYRGLACLNFLS-N-GTVANESIQLCG-EIENRIRAANLTVEEGSSITLKCSQAGIPVPCHYWFPNCLASSNT 236 (774)
T ss_pred cccCCCCCchhhHHHhhcC-C-ceehhhhhhhhc-chhhhhhhhhhhhcccchheeeeecccCCCcceeeecccccccCC
Confidence 4556999999999999998 3 455555545444 555566655 77777799999999999999999999999999999
Q ss_pred CCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccccccccccc
Q psy5539 109 PMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188 (653)
Q Consensus 109 ~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~~~~~~~C~ 188 (653)
+.+..+|+++|.......|..|+...+.+... ...+.+|.|..++... .+....|.....+ ....+.++.||
T Consensus 237 ~~~~~~c~~~~~~~~~~~c~~E~~~~~~~~~v------~~~~~~p~~~~~~~~~-~~~~~~C~~~~~~-~~~~~~~~~~~ 308 (774)
T KOG1026|consen 237 NQTSSLCRSECEVLENDLCIAENAVARSNPSI------LLVVDLPKAEVLLCSP-LSDHHNCIPIGIT-ANPGPALHWCY 308 (774)
T ss_pred CcccccccccceeeechhhHHHHhhhhcCcee------eeEEecccccccCCCC-ccccCceeeeecc-CCCCCceeeee
Confidence 99999999999988889999999888888643 3667899999988654 3446788777666 44556688999
Q ss_pred cCCccccceeeeccCCCC-cccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCe--EEEeCCCcceeecccCCC
Q psy5539 189 RGRGRFYQGTVNTTVGGL-ACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPW--CYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 189 ~~~g~~yrg~~~~t~sg~-~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pW--C~~~~~~~~~~~C~ip~C 265 (653)
++.|..|+|++++|.+|. .|++|+.+ +|.|......+|+...++||||||++-..+|| |+..+....-..|++|.|
T Consensus 309 ~~~~~~~~g~~~~t~s~~~~C~~~~~~-~h~~~~~~~~~~e~~~g~~~~r~~g~~~~~P~~~~~~~~~~~~~~~~~~ps~ 387 (774)
T KOG1026|consen 309 NGSGLNYRGTVCVTKSGKEQCLPWNDP-PHSHNGNYTLFPELPGGKNYCRNPGGFMSRPWMYCFDNDKTFEPSLCDIPSC 387 (774)
T ss_pred cCccceEecccccccccCcCCcccCcC-cccccCcceeeecccCccccccCcCccccCCCccccccccccCcccCCCCCc
Confidence 999999999999999995 99999987 88898899999999999999999999999996 444556677888999999
Q ss_pred CCCCccccccccchhHhhhhhhccCCeeeEehhHHHHHHHHHHHHHHHHHhhhcccCCCCCC---------------CCC
Q psy5539 266 ADSMQDDVKSWGNKIKALLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAP---------------APS 330 (653)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~i~~~~~~~~~~i~~~~~~~~~kr~~~~~~---------------~~~ 330 (653)
.....+. +. +..+.++++..+.++++++.+++++. ..+|++.... .+.
T Consensus 388 ~~~~~~~-~~---------------~~~~~~i~g~~~~~~~~l~~l~~~~~-~~~~~~~~~~~~~~~~~~~~g~s~~~~~ 450 (774)
T KOG1026|consen 388 DIKDKKS-ED---------------PTGISAIVGISVFAILLLLLLFFLVN-CGRRNKFGMKSSSPLHRILNGTSTPSSS 450 (774)
T ss_pred ccccccc-cC---------------CcceEEEecchHhHHHHHHHHHHhhh-hhcccccCCCcchHHHhcccCCCCcCcc
Confidence 8765432 01 22222222222222222222222221 2222211111 000
Q ss_pred CCcccC--CCCCCCCCCccccccccCccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc
Q psy5539 331 QDVNID--LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS 408 (653)
Q Consensus 331 ~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~ 408 (653)
+....+ ......+.. .......++++...++++.++.+.+.||+|+||+||+|+..++....+...||||.+++.++
T Consensus 451 ~~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~ 529 (774)
T KOG1026|consen 451 QTGEMTVLIGSTQHPVI-ENKEPQLNPDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE 529 (774)
T ss_pred cccccccccccccCCCc-cccCCCCCCccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc
Confidence 100000 000000011 11344567788889999999999999999999999999999988888999999999999999
Q ss_pred HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHH
Q psy5539 409 EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488 (653)
Q Consensus 409 ~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 488 (653)
.+.+++|+||+++++.|+|||||+|+|+|..+++++||||||.+|||++||+.++|........+. ...+|+..
T Consensus 530 ~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~------~~~~L~~~ 603 (774)
T KOG1026|consen 530 NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQD------TPPPLSTS 603 (774)
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCC------CCCCCCHH
Confidence 889999999999999999999999999999999999999999999999999998886543322111 25679999
Q ss_pred HHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC
Q psy5539 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT 568 (653)
Q Consensus 489 ~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t 568 (653)
+.+.||.|||.||+||.++.+|||||+++|+||+++..|||+||||++.+|+.||++..+....|+||||||.|.+++||
T Consensus 604 q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT 683 (774)
T KOG1026|consen 604 QFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT 683 (774)
T ss_pred HHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 569 VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 569 ~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
++||||||||+|||+||+|++||++.+++|+++.|++|+.+++|+++|.++++||..||+.+|.+||+|+||...|..+.
T Consensus 684 teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 684 TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998876
Q ss_pred HH
Q psy5539 649 RD 650 (653)
Q Consensus 649 ~~ 650 (653)
+.
T Consensus 764 ~~ 765 (774)
T KOG1026|consen 764 QA 765 (774)
T ss_pred hc
Confidence 54
|
|
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-54 Score=452.01 Aligned_cols=266 Identities=40% Similarity=0.792 Sum_probs=243.0
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
...+++.++.+.+++.||+|-||.||.|++.+. ..||||.++.... ..++|.+|+.+|++|+|+|||+++|+
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~------~~vavk~ik~~~m--~~~~f~~Ea~iMk~L~H~~lV~l~gV 269 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGS------TKVAVKTIKEGSM--SPEAFLREAQIMKKLRHEKLVKLYGV 269 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCC------CcccceEEecccc--ChhHHHHHHHHHHhCcccCeEEEEEE
Confidence 345678888889999999999999999998652 4699999987532 23578999999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
|..+++++||||||+.|+|.+||+. .....+...+.+.++.|||+||+||+++++|||||++
T Consensus 270 ~~~~~piyIVtE~m~~GsLl~yLr~------------------~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAA 331 (468)
T KOG0197|consen 270 CTKQEPIYIVTEYMPKGSLLDYLRT------------------REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAA 331 (468)
T ss_pred EecCCceEEEEEecccCcHHHHhhh------------------cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhh
Confidence 9999999999999999999999983 2346688999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+||||+++..+||+|||||+ ...++.+........|+.|.|||.+..++|+.|||||||||+||||+|.|..||.+++.
T Consensus 332 RNiLV~~~~~vKIsDFGLAr-~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn 410 (468)
T KOG0197|consen 332 RNILVDEDLVVKISDFGLAR-LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN 410 (468)
T ss_pred hheeeccCceEEEccccccc-ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH
Confidence 99999999999999999999 44566667777788899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.++++.+..|.+++.|+.||++++++|..||+.+|++||||+.+...+.++..
T Consensus 411 ~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 411 EEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred HHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 99999999999999999999999999999999999999999999888887754
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=466.30 Aligned_cols=278 Identities=46% Similarity=0.801 Sum_probs=255.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++++..+.+.+.||+|+||.||.|...+.........||||.++...++....+|.+|..+|+.++|||||+++|++...
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 57788999999999999999999998664333334669999999988888899999999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++++|||++|||..||+..+++.. ....++..+++.++.|||+|+.||+++++|||||+++|+|
T Consensus 768 ~~~~i~leyM~gGDL~sflr~~r~~~~-------------~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCL 834 (1025)
T KOG1095|consen 768 GPPLILLEYMEGGDLLSFLRESRPAPF-------------QPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCL 834 (1025)
T ss_pred CCcEEEehhcccCcHHHHHHhcccccC-------------CCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhhee
Confidence 999999999999999999997766543 2456899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
|++...|||+|||+|+.++..+++........|++|||||++..+.||.|||||||||+||||||.|.+||.+.+..+++
T Consensus 835 L~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~ 914 (1025)
T KOG1095|consen 835 LDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL 914 (1025)
T ss_pred ecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH
Confidence 99999999999999999999999887777788999999999999999999999999999999999999999999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
..+..+.+++.|..||+.++++|..||+.+|++||+|..|++.+..+.+.+
T Consensus 915 ~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 915 LDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 977777799999999999999999999999999999999999887776543
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-52 Score=448.33 Aligned_cols=269 Identities=39% Similarity=0.686 Sum_probs=248.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
|+..+.+.+.+.||.|.||.||+|+++. ..+....||||.+|....+.++.+|..|+.||.+++||||++|.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~--pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKL--PGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccC--CCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 6777889999999999999999999864 34455789999999999999999999999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
++.++|.|||++|+|..||+. +.+.+++.++..++++||.||.||.++++|||||.++|||
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~-------------------~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQ-------------------NDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL 763 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhh-------------------cCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence 999999999999999999983 3356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccc-cccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+.+..+||+||||++.+..+. .........+|++|.|||.|..+++|.+|||||||++|||.+++|..||.+++.+++
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 9999999999999999764332 223445567799999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++.|.+|..++.|.+||..|++||..||++|-.+||+|.+|+.+|..+.++
T Consensus 844 IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 999999999999999999999999999999999999999999999998764
|
|
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-48 Score=409.48 Aligned_cols=265 Identities=36% Similarity=0.593 Sum_probs=228.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceE-EEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~-VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
..++...++.+.+.||+|+||+||+|.+.| +. ||||++.... .....++|.+|+.+|.+++|||||+|+|+
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g-------~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWRG-------TDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeCC-------ceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 345555666777779999999999999865 44 9999998643 22336789999999999999999999999
Q ss_pred EecCC-ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC-ceecCC
Q psy5539 437 CAVGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK-FVHRDL 514 (653)
Q Consensus 437 ~~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-ivHrDL 514 (653)
+.... .+++|||||++|+|.++|+.. ....+++..+++++.|||+||.|||+++ ||||||
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDL 169 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKK------------------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDL 169 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhc------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeeccc
Confidence 99887 799999999999999999732 2457999999999999999999999999 999999
Q ss_pred CCCCEeEcCCC-cEEEeccCccccccccccccCCCCCCCccccccchhhc--cCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 515 ATRNCLINDQM-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL--YNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 515 kp~NILl~~~~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
||+||||+.++ ++||+|||+++...... .......||.+|||||.+. ...|+.|+||||||++||||+|+. .||
T Consensus 170 K~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~-~Pf 246 (362)
T KOG0192|consen 170 KSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGE-IPF 246 (362)
T ss_pred ChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCC-CCC
Confidence 99999999997 99999999998754322 2334478899999999999 569999999999999999999965 599
Q ss_pred CCCCHHHHHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 592 YGLTHEEVVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 592 ~~~~~~e~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
.+....++...+. .+..+..|..+++.+..+|.+||+.||.+||++.+|+..|..+....
T Consensus 247 ~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 247 EDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred CCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 9988877776664 66667778889999999999999999999999999999999887653
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=395.34 Aligned_cols=258 Identities=28% Similarity=0.403 Sum_probs=232.3
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++++.++.||+|..|+|||++++ .+++.+|+|++..+..+..++++.+|++++++.+||+||+++|.|....
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk-----~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~ 150 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHK-----PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG 150 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEc-----CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC
Confidence 44557788899999999999999975 4679999999988888888999999999999999999999999999988
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCE
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNC 519 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NI 519 (653)
...++||||++|+|.++++ ..+.+++..+-+|+.+|++||.|||+ ++||||||||+||
T Consensus 151 ~~isI~mEYMDgGSLd~~~k--------------------~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNl 210 (364)
T KOG0581|consen 151 EEISICMEYMDGGSLDDILK--------------------RVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNL 210 (364)
T ss_pred ceEEeehhhcCCCCHHHHHh--------------------hcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHe
Confidence 5999999999999999986 23568999999999999999999995 9999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-----C
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-----L 594 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~-----~ 594 (653)
||+..|+|||+|||.++.+... ......||..|||||.+.+..|+.++||||||++++|+++|.. ||.. .
T Consensus 211 LvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~Grf-P~~~~~~~~~ 285 (364)
T KOG0581|consen 211 LVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRF-PYPPPNPPYL 285 (364)
T ss_pred eeccCCCEEeccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCC-CCCCcCCCCC
Confidence 9999999999999999876433 2345688999999999999999999999999999999999665 6654 3
Q ss_pred CHHHHHHHHHcCCccCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDN-TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+..+++.+|.++..+..|+. +++++++|+..|+++||.+||+++++++|.|-.+.
T Consensus 286 ~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 286 DIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred CHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 67889999999988888887 99999999999999999999999999999986643
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=403.96 Aligned_cols=264 Identities=46% Similarity=0.841 Sum_probs=238.5
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
.|++++.+.+.++||+|-||.|.++...+ ...||||+++.++....+.+|.+||++|.+++|||||+|+|+|..
T Consensus 533 ~EfPRs~L~~~ekiGeGqFGEVhLCeveg------~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~ 606 (807)
T KOG1094|consen 533 VEFPRSRLRFKEKIGEGQFGEVHLCEVEG------PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ 606 (807)
T ss_pred hhcchhheehhhhhcCcccceeEEEEecC------ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec
Confidence 47899999999999999999999998643 578999999999999889999999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+++++||+|||++|||.+||..+.+ +.+......+|+.|||+||+||.+-++|||||.++|+
T Consensus 607 DePicmI~EYmEnGDLnqFl~ahea------------------pt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 607 DDPLCMITEYMENGDLNQFLSAHEL------------------PTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred CCchHHHHHHHhcCcHHHHHHhccC------------------cccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 9999999999999999999974422 2234455678999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC-CCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF-ALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~-~~~p~~~~~~~e 598 (653)
|+|.++++||+|||+++.+++.++++.......|++|||+|.+..+++|.+||||+||+++||+++. ..+||...+.++
T Consensus 669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 9999999999999999999999999999999999999999999999999999999999999999874 357999999888
Q ss_pred HHHHHHc-------CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKE-------GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+++.... ...+..|..++..++++|..||..+..+||+|++|+..|.+.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 8876533 123556778999999999999999999999999999998764
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=399.28 Aligned_cols=270 Identities=39% Similarity=0.777 Sum_probs=246.5
Q ss_pred CccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceE
Q psy5539 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 354 ~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
.+...++|..+.++....+||-|.||.||.|.++. ..-.||||.++++..+ .++|..|+.+|+.++|||+|+|
T Consensus 256 SPn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKk-----yslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqL 328 (1157)
T KOG4278|consen 256 SPNADKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQL 328 (1157)
T ss_pred cCCcchhhccchheeeeeccCCCcccceeeeeeec-----cceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHH
Confidence 35567889999999999999999999999999853 3467999999988765 5689999999999999999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
+|+|..+.++|||.|||.+|+|.+||+.+. ...++...++.++.||++||+||..+++||||
T Consensus 329 LGVCT~EpPFYIiTEfM~yGNLLdYLRecn------------------r~ev~avvLlyMAtQIsSaMeYLEkknFIHRD 390 (1157)
T KOG4278|consen 329 LGVCTHEPPFYIITEFMCYGNLLDYLRECN------------------RSEVPAVVLLYMATQISSAMEYLEKKNFIHRD 390 (1157)
T ss_pred hhhhccCCCeEEEEecccCccHHHHHHHhc------------------hhhcchhHHHHHHHHHHHHHHHHHHhhhhhhh
Confidence 999999999999999999999999998543 34567778899999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|.++|+|++++..|||+||||++.+..+. +........++.|.|||.+.++.++.|||||+|||+||||.|+|..||.+
T Consensus 391 LAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 391 LAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred hhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999999986544 44445556789999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 594 ~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.+..++...+..+..++.|+.||+.+++||+.||+.+|.+||+|.||++.++.|..
T Consensus 470 idlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 470 IDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 99999999999999999999999999999999999999999999999999987753
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=401.44 Aligned_cols=272 Identities=35% Similarity=0.652 Sum_probs=239.0
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc--cccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~--~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
..+++..+++.+.+.||+|+||.||+|++.-.... ....||||..+. ........+|.+|+++|+.++|||||+++|
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~-~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGF-KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCc-eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 44677888888899999999999999998531111 112299999985 356677889999999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++....++++|||+++||+|.+||+.. ...++..+.+.++.+.|.||+|||+++++||||.
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~-------------------~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIA 289 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKN-------------------KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIA 289 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhC-------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHh
Confidence 999999999999999999999999832 2358999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
++|+|++.++.+||+||||++... .+.........|++|+|||.+..+.|+.++|||||||++||+++.|..||.+..
T Consensus 290 ARNcL~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 290 ARNCLYSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred HHHheecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 999999999999999999997643 222223345789999999999999999999999999999999998888999999
Q ss_pred HHHHHHHH-HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 596 HEEVVKYI-KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 596 ~~e~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
..++...| .++...+.+...|.++..++.+||..+|++||+|.++.+.+..+....
T Consensus 368 ~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 368 NYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 99999999 778888888999999999999999999999999999999999887654
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=390.04 Aligned_cols=273 Identities=38% Similarity=0.729 Sum_probs=248.3
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
|.....++.++.+...+.||+|.||.||+|...... ....-.||||.-|.+...+..+.|..|..+|+.++|||||+|+
T Consensus 379 P~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~-kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLI 457 (974)
T KOG4257|consen 379 PTVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPE-KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLI 457 (974)
T ss_pred CCCCcceeehhhccHHHhhcCCcccceeeeEecccc-cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhhee
Confidence 344456777888888889999999999999986532 3455679999999877777788999999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
|+|.+ .+.++|||.++-|.|.+||+.+ ...|+...+..++.||..+|+|||+.++|||||
T Consensus 458 Gv~~e-~P~WivmEL~~~GELr~yLq~n-------------------k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDI 517 (974)
T KOG4257|consen 458 GVCVE-QPMWIVMELAPLGELREYLQQN-------------------KDSLPLRTLTLYCYQICTALAYLESKRFVHRDI 517 (974)
T ss_pred eeeec-cceeEEEecccchhHHHHHHhc-------------------cccchHHHHHHHHHHHHHHHHHHHhhchhhhhh
Confidence 99875 5789999999999999999833 356888899999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
..+|||+...-.|||+||||++.+..+.+++.. ....|+.|||||++..+++|.+||||-|||.+|||++.|..||.+.
T Consensus 518 AaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 518 AARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 999999999999999999999998877777665 6678999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
...+++-.|..|.+++.|++||+.++.||.+||..+|.+||.+.+|...|.++.+
T Consensus 597 kNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 597 KNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred cccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999999999999999999988765
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-45 Score=387.68 Aligned_cols=253 Identities=24% Similarity=0.389 Sum_probs=227.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.+|...+.||+|||++||.++.. .++..||+|++... .+...++.+.+||++-++|+|||||+++++|++.+.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~-----~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDL-----DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEc-----CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc
Confidence 46888999999999999999853 46789999999753 234566788999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.|||+|++.+|+|.++++ ...++++.++..+.+||+.||.|||+++|+|||||..|++|+
T Consensus 93 VYivLELC~~~sL~el~K--------------------rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~ 152 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLK--------------------RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLN 152 (592)
T ss_pred eEEEEEecCCccHHHHHH--------------------hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeec
Confidence 999999999999999997 346799999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++++|||+|||||..+...+ .......||+.|.|||++....++..+||||+||+||-|+. |.|||...+..+....
T Consensus 153 ~~~~VKIgDFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~-G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 153 ENMNVKIGDFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLV-GRPPFETKTVKETYNK 229 (592)
T ss_pred CcCcEEecccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhh-CCCCcccchHHHHHHH
Confidence 99999999999998764322 23344678999999999999999999999999999999998 6789999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|+..+. ..|..++.+..+||.++|+++|.+|||+++|+.+.+-
T Consensus 230 Ik~~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 230 IKLNEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred HHhcCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 998875 4677999999999999999999999999999998765
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.96 Aligned_cols=291 Identities=38% Similarity=0.690 Sum_probs=232.5
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
++++.++|++.+.||+|+||.||+|...+.....++..||||+++..........+.+|+.++..+ +||||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 467888999999999999999999987544444566789999998655555566789999999999 8999999999887
Q ss_pred cC-CceEEEEeecCCCChHHHHhhcCCCCCcC--------------------------CC----cccc------------
Q psy5539 439 VG-KPMCLLFEYMGRGDLNDFLRICSPNNYIN--------------------------GT----YSSM------------ 475 (653)
Q Consensus 439 ~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~--------------------------~~----~~~~------------ 475 (653)
.. ...++||||+++|+|.++++......... .. ....
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 54 46899999999999999998543210000 00 0000
Q ss_pred cccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccc
Q psy5539 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVR 555 (653)
Q Consensus 476 ~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~ 555 (653)
.........+++.+++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++...............++..
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 00001134588999999999999999999999999999999999999999999999999986543322222233455678
Q ss_pred cccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCC
Q psy5539 556 WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634 (653)
Q Consensus 556 y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 634 (653)
|||||.+.+..++.++||||||+++|||++.+..||.+... +++...+..+.....+..+++++.+|+.+||+.+|.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 99999999999999999999999999999867779877553 45566667776666778889999999999999999999
Q ss_pred CCHHHHHHHHHHHHHH
Q psy5539 635 PSFRTIYQTLWNIKRD 650 (653)
Q Consensus 635 Ps~~eil~~L~~l~~~ 650 (653)
||+.+|++.|.++.++
T Consensus 322 Ps~~el~~~l~~~~~~ 337 (338)
T cd05102 322 PTFSALVEILGDLLQE 337 (338)
T ss_pred cCHHHHHHHHHHHHhc
Confidence 9999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=370.83 Aligned_cols=252 Identities=29% Similarity=0.486 Sum_probs=218.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..+|.+.+.||+|+||+||+|+++ .++..||||.+.... ....++.+..|+++|+.++|||||.|++++..++.
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~-----~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~ 83 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHK-----KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF 83 (429)
T ss_pred cccceehhhccCcceEEEEEeEec-----cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe
Confidence 357888899999999999999974 355899999987653 56677889999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+.+|||.+||+. .+.+++..+..++.|||.||++||+++||||||||+||||+
T Consensus 84 i~lVMEyC~gGDLs~yi~~--------------------~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs 143 (429)
T KOG0595|consen 84 IYLVMEYCNGGDLSDYIRR--------------------RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLS 143 (429)
T ss_pred EEEEEEeCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEec
Confidence 9999999999999999983 34689999999999999999999999999999999999997
Q ss_pred CC------CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 523 DQ------MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 523 ~~------~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
.+ -.+||+|||+|+.+..... .....|++.|||||++...+|+.|+|+||+|++|||+++ |.+||...+.
T Consensus 144 ~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~-g~~Pf~a~t~ 219 (429)
T KOG0595|consen 144 TTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLT-GKPPFDAETP 219 (429)
T ss_pred cCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHh-CCCCccccCH
Confidence 65 5689999999998753322 234578999999999999999999999999999999999 5579999999
Q ss_pred HHHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 597 EEVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 597 ~e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.|++..++.+... ..+...+..+.+++...+..+|.+|-++.+-..+.
T Consensus 220 ~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~ 269 (429)
T KOG0595|consen 220 KELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP 269 (429)
T ss_pred HHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence 9999999887642 23344666777899999999999998887765543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=366.49 Aligned_cols=257 Identities=24% Similarity=0.397 Sum_probs=226.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
....++|++++.||+|+||+||+++.. .+++.+|+|++++..- ....+....|..+|.+++||.||+++-.|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~-----dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKK-----DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEc-----ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 345678999999999999999999853 6789999999976522 223556789999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+++.+|||+||+.||+|..+|+ ..+.+++..+..++.+|+.||.|||+++||||||||+|
T Consensus 96 t~~kLylVld~~~GGeLf~hL~--------------------~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQ--------------------REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHH--------------------hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 9999999999999999999996 34568899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||||++|.++|+||||++.....+ .......||+.|||||.+....|+..+|.||||+++|||++ |.+||.+.+..+
T Consensus 156 ILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~-G~pPF~~~~~~~ 232 (357)
T KOG0598|consen 156 ILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLT-GKPPFYAEDVKK 232 (357)
T ss_pred eeecCCCcEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhh-CCCCCcCccHHH
Confidence 999999999999999998542221 23344789999999999999999999999999999999999 667999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC----CHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP----SFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~L~ 645 (653)
+.+.|..+.....+..++.+.++++++++..+|++|. ++.+|.+|.+
T Consensus 233 ~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf 283 (357)
T KOG0598|consen 233 MYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF 283 (357)
T ss_pred HHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence 9999999987777777999999999999999999996 6777777653
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=384.98 Aligned_cols=267 Identities=28% Similarity=0.424 Sum_probs=211.2
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
..+.+++-++++|.-.+.||+|+||.||+|.+.+ +..||||++....... ..+|.+|++++.+++|||+|+|+
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~------~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~Ll 137 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD------GTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLL 137 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC------CCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEE
Confidence 4566778889999999999999999999999743 3789999988765433 45699999999999999999999
Q ss_pred eEEecCC-ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC---Cce
Q psy5539 435 GVCAVGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR---KFV 510 (653)
Q Consensus 435 g~~~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~iv 510 (653)
|+|.+.+ +.+||||||++|+|.++|+... .. .++|..+++||.++|+||+|||+. .||
T Consensus 138 GyC~e~~~~~~LVYEym~nGsL~d~L~~~~-----------------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~ii 199 (361)
T KOG1187|consen 138 GYCLEGGEHRLLVYEYMPNGSLEDHLHGKK-----------------GE-PLDWETRLKIALGAARGLAYLHEGCPPPII 199 (361)
T ss_pred EEEecCCceEEEEEEccCCCCHHHHhCCCC-----------------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEe
Confidence 9999988 5999999999999999997211 11 789999999999999999999975 599
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCC-CCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND-AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~-~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
||||||+|||||+++++||+|||+|+...... ...... .+|.+|+|||++..+..|.|+|||||||+|+||+||...
T Consensus 200 HrDiKssNILLD~~~~aKlsDFGLa~~~~~~~--~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~ 277 (361)
T KOG1187|consen 200 HRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD--TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKA 277 (361)
T ss_pred cCCCCHHHeeECCCCCEEccCccCcccCCccc--cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcc
Confidence 99999999999999999999999996543211 111111 789999999999999999999999999999999997743
Q ss_pred CCCCC--C----HHHHHHHHHcCCccCCC------CCCc-----HHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 590 PYYGL--T----HEEVVKYIKEGNILQAP------DNTP-----DALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 590 p~~~~--~----~~e~~~~i~~~~~~~~~------~~~~-----~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..... . .+.....+.++...... ...+ ..+..+..+|++.+|.+||+|.+|++.|..+.
T Consensus 278 ~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 278 VDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred cCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 22111 1 11222334443332221 1222 23556777899999999999999999886543
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=360.43 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=220.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEe-EEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLG-VCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g-~~~~~ 440 (653)
+..+|++.+.||+|.||+||+++.. .++..||.|.++-+ ......++...|+.+|+.|+|||||++++ .+...
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~-----~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~ 91 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCL-----LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIED 91 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeec-----cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhcc
Confidence 3457889999999999999999853 46789999988743 44566778999999999999999999998 34444
Q ss_pred Cc-eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh--CC--ceecCCC
Q psy5539 441 KP-MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD--RK--FVHRDLA 515 (653)
Q Consensus 441 ~~-~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~--~~--ivHrDLk 515 (653)
.. ++|||||+++|||...++... .....+++..+++++.|++.||.++|+ .. |+|||||
T Consensus 92 ~evlnivmE~c~~GDLsqmIk~~K----------------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 92 NEVLNIVMELCDAGDLSQMIKHFK----------------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred chhhHHHHHhhcccCHHHHHHHHH----------------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 44 899999999999999998443 234568999999999999999999998 44 8899999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|.||+|+.+|.|||+||||++.+.+... -.....||+.||+||.+.+..|+.+|||||+||++|||.. -.+||++.+
T Consensus 156 PaNIFl~~~gvvKLGDfGL~r~l~s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMca-L~~PF~g~n 232 (375)
T KOG0591|consen 156 PANIFLTANGVVKLGDFGLGRFLSSKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCA-LQSPFYGDN 232 (375)
T ss_pred chheEEcCCCceeeccchhHhHhcchhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHh-cCCCccccc
Confidence 9999999999999999999998744332 2345689999999999999999999999999999999997 456999999
Q ss_pred HHHHHHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
..++...|..++..+.| +..+.++..|+..|+..||+.||+.-.++.
T Consensus 233 ~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 233 LLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred HHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 99999999999988888 678999999999999999999998544433
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=370.80 Aligned_cols=256 Identities=24% Similarity=0.352 Sum_probs=215.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH------HHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY------LQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~------~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
-.+.|.+.+.||+|+||.|-+|.. ..+++.||||.++...... -....++|+++|++|+|||||++.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e-----~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYE-----KKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEE-----cccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeee
Confidence 345678889999999999999984 4688999999997542211 22346799999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+...+..||||||++||+|.+++..+ +.+.+..-..+++|++.|+.|||++||+||||||
T Consensus 245 f~~~ds~YmVlE~v~GGeLfd~vv~n--------------------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKP 304 (475)
T KOG0615|consen 245 FEVPDSSYMVLEYVEGGELFDKVVAN--------------------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKP 304 (475)
T ss_pred eecCCceEEEEEEecCccHHHHHHhc--------------------cccccchhHHHHHHHHHHHHHHHHcCcccccCCc
Confidence 99999999999999999999999632 3456666688999999999999999999999999
Q ss_pred CCEeEcCC---CcEEEeccCccccccccccccCCCCCCCccccccchhhccCC---CCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 517 RNCLINDQ---MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 517 ~NILl~~~---~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
+|||+..+ ..+||+|||+|+...... -.....||+.|.|||++.+.. +..+.|+||+||+||-+++ |.+|
T Consensus 305 eNILl~~~~e~~llKItDFGlAK~~g~~s---fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs-G~pP 380 (475)
T KOG0615|consen 305 ENILLSNDAEDCLLKITDFGLAKVSGEGS---FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS-GYPP 380 (475)
T ss_pred ceEEeccCCcceEEEecccchhhccccce---ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec-cCCC
Confidence 99999766 789999999998764222 234467899999999998764 3458899999999999999 6679
Q ss_pred CCCCCHHH-HHHHHHcCCccCCCC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 591 YYGLTHEE-VVKYIKEGNILQAPD---NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 591 ~~~~~~~e-~~~~i~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
|.+...+. +.+.|..|.....|. .++++..+||.+||..||++|||+.|+++|+|--
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 98776655 889999998766553 5789999999999999999999999999999853
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=362.82 Aligned_cols=280 Identities=46% Similarity=0.903 Sum_probs=237.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|...+.........||+|.++.........+|.+|+.++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 44578899999999999999999765444455678999999876666667789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+++|||+++|+|.+++....+...... ..........+++..++.++.|++.||.|||+.+++|+||||+|||++
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~ 158 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGA----ESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG 158 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCccccc----ccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEc
Confidence 9999999999999999986543221100 000011225689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++.....+.........++..|+|||.+....++.++||||||+++|||++.+.+||.+.+..++...
T Consensus 159 ~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 159 EGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998765444333334455678899999999999999999999999999999977889999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+..+.....+..++.++.+|+.+||+.+|.+||++++|+++|..
T Consensus 239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 98888777888899999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=360.69 Aligned_cols=258 Identities=36% Similarity=0.686 Sum_probs=222.3
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
.+.+.||.|+||.||+|.+.. ........|+||.++........++|.+|++.+++++||||++++|++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~-~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQ-KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEES-TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEc-ccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence 467889999999999999863 3455678999999987666666788999999999999999999999999888899999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.++|+.. ....+++..++.|+.||+.||.|||+++++|+||+++|||+++++.+
T Consensus 81 e~~~~g~L~~~L~~~------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~ 142 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSK------------------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQV 142 (259)
T ss_dssp E--TTEBHHHHHHHT------------------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEE
T ss_pred ccccccccccccccc------------------ccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999843 23568999999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||++.................+..|+|||.+....++.++||||||+++|||++++..||.+.+..++...+.++.
T Consensus 143 Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~ 222 (259)
T PF07714_consen 143 KLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQ 222 (259)
T ss_dssp EEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999876433333344455677899999999999999999999999999999998778999999999999999988
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
....+..++..+++++..||+.+|.+||++++|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 8888888999999999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=354.79 Aligned_cols=292 Identities=33% Similarity=0.585 Sum_probs=261.5
Q ss_pred cccccCccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC
Q psy5539 349 TDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428 (653)
Q Consensus 349 ~~~~~~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp 428 (653)
.+...+.+...+.+.+.+++....+-+|.||.||.|.+..-..-.+.+.|-||.++..+++.+...+..|..++..+.||
T Consensus 268 ~p~e~~~r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~ 347 (563)
T KOG1024|consen 268 EPEEFNRRLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHP 347 (563)
T ss_pred ChHHHhhhHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCC
Confidence 34445566677788888899889999999999999987643344455779999999999998888999999999999999
Q ss_pred ccceEEeEEec-CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5539 429 NIVKLLGVCAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR 507 (653)
Q Consensus 429 nIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 507 (653)
|+..+.+++.. .+..+.++.++.-|+|..||..++..+ ......++..+...++.|++.||+|||++
T Consensus 348 nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~------------~~~aqtvtt~qlV~masQla~am~hlh~~ 415 (563)
T KOG1024|consen 348 NLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDD------------PSYAQTVTTIQLVLMASQLAMAMEHLHNH 415 (563)
T ss_pred CccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCC------------CccccchhHHHHHHHHHHHHHHHHHHHhc
Confidence 99999999864 556788899999999999999765221 12346688889999999999999999999
Q ss_pred CceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCC
Q psy5539 508 KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 508 ~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
++||.||.++|++||+..+|||+|=.+++.+...|+.....+...|+.||+||.+....|+.+||||||||+||||+|-|
T Consensus 416 ~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 416 GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999887777778899999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 588 LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
..||...++.|+..++++|.++..|-+||++++.+|.-||...|++||+++++...|.+...++-
T Consensus 496 ~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred CCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999887763
|
|
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=379.00 Aligned_cols=266 Identities=28% Similarity=0.517 Sum_probs=230.4
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
++.++++.+++.+...||+|+||+||+|++.| .||||+++.. -.....+.|+.|+..+++-+|.||+-+.|
T Consensus 384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG 455 (678)
T KOG0193|consen 384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG 455 (678)
T ss_pred ccccccCHHHhhccceeccccccceeeccccc--------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence 47789999999999999999999999999976 5999999854 33456778999999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..... .+|.-+++|-+|+.+|+. ....++....+.||.|||+||.|||.++|||||||
T Consensus 456 ~~~~p~~-AIiTqwCeGsSLY~hlHv-------------------~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLK 515 (678)
T KOG0193|consen 456 ACMNPPL-AIITQWCEGSSLYTHLHV-------------------QETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLK 515 (678)
T ss_pred hhcCCce-eeeehhccCchhhhhccc-------------------hhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhcc
Confidence 9988776 999999999999999982 22568888999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
+.||++.+++.|||+||||+................+.+.|||||++.. +.|+..|||||||+|+|||++|.+ ||.
T Consensus 516 SnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l-Pys 594 (678)
T KOG0193|consen 516 SNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL-PYS 594 (678)
T ss_pred ccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC-CcC
Confidence 9999999999999999999876544433334455667889999999974 479999999999999999999766 888
Q ss_pred CCCHHHHHHHHHcCCccC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 593 GLTHEEVVKYIKEGNILQ----APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
....+.++-++-.|...+ ...+++.++++|+..||..++++||.|.+|+..|.++...+
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~ 657 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL 657 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence 888888888887775433 34578889999999999999999999999999888877643
|
|
| >cd07469 CRD_TK_ROR_related Cysteine-rich domain of proteins similar to tyrosine kinase-like orphan receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=324.02 Aligned_cols=146 Identities=53% Similarity=1.079 Sum_probs=138.7
Q ss_pred CCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 31 PQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 31 ~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
++|||++|||+||++||+++++||||++++++ +++||+|++++|.|++++||+.||+||+++||||+||+|++.+.+|+
T Consensus 1 ~~GyC~~Y~G~iC~~yL~~~~~V~~~~s~~~~-~~~~E~l~~~~~~e~~~~ls~~Cr~~A~~~LC~~aFP~C~~~~~~p~ 79 (147)
T cd07469 1 SAGYCATYRGEVCRAYLSNDALVWFNSSYADP-EGLNEQLTTGLWEELIKTVSELCRPAAEKLLCNYAFPECHPSGVGPT 79 (147)
T ss_pred CCCccccccchHHHHHhCCCcEEEEecCCCCH-HHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHhCCCCCCCCCCCC
Confidence 47999999999999999987899999997654 58999999999999999999999999999999999999999999999
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCcc
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMK 179 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~ 179 (653)
|+|+|||||.++++++|++||+.+++|+++|+|+++++++.||+|++||..+ .++++|+++++++.+
T Consensus 80 p~plCredC~a~~~~~C~~Ew~~~e~~~~~g~~~~~~~~~~LP~C~~LP~~~--~~~~~C~~i~~~~~~ 146 (147)
T cd07469 80 PKPLCREDCLAVKELFCYKDWALIEENKQRGIYLKSRGHFTLPECESLPSIH--ADPPACSHIPLTDLK 146 (147)
T ss_pred cCchhHHHHHHHHHHHhHHHHHHHHHhhhccccccccccccCCchhhcCCCC--CCCCceeeccccccc
Confidence 9999999999999999999999999999999999999999999999999987 567999999998765
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror) proteins, a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=355.88 Aligned_cols=264 Identities=34% Similarity=0.586 Sum_probs=227.9
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+|.+.. .......||+|.++..........|.+|+.+++.++||||+++++++..++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~--~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKL--PSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEec--CCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 455689999999999999999998642 234567899999987766666678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||+
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~-------------------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili 140 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKH-------------------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV 140 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE
Confidence 999999999999999999621 2357899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+|++|||.+........ .......++..|+|||.+.+..++.++||||||+++||+++.|..||.+.+..++.+
T Consensus 141 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~ 219 (266)
T cd05064 141 NSDLVCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIK 219 (266)
T ss_pred cCCCcEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHH
Confidence 9999999999998765322211 111223446789999999999999999999999999999886778999999999888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+.++...+.+..++..+.+++.+||+.+|.+||++++|.+.|..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 220 AVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 8888877777888999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-43 Score=376.55 Aligned_cols=292 Identities=40% Similarity=0.680 Sum_probs=232.9
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEE
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLL 434 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~ 434 (653)
....++++.++|++.+.||+|+||.||+|++.+.....++..||||+++........+.+.+|+.+++.+ +||||++++
T Consensus 26 ~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~ 105 (375)
T cd05104 26 YDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLL 105 (375)
T ss_pred CccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeee
Confidence 3445678888999999999999999999987554445567789999998655444556789999999999 899999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcC----------------------CCcc--------------c----
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN----------------------GTYS--------------S---- 474 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~----------------------~~~~--------------~---- 474 (653)
+++..++..++||||+++|+|.++++......... .+.. .
T Consensus 106 ~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 185 (375)
T cd05104 106 GACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK 185 (375)
T ss_pred eeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence 99999999999999999999999997543211000 0000 0
Q ss_pred --------------c-cccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcccccc
Q psy5539 475 --------------M-ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539 (653)
Q Consensus 475 --------------~-~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~ 539 (653)
. .........+++..+++++.||++||+|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence 0 0000123468899999999999999999999999999999999999999999999999998654
Q ss_pred ccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCccCCCCCCcHH
Q psy5539 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKYIKEGNILQAPDNTPDA 618 (653)
Q Consensus 540 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~i~~~~~~~~~~~~~~~ 618 (653)
............++..|+|||.+.+..++.++||||||+++|||++++..||.+... ....+.+..+.....+...+.+
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSE 345 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHH
Confidence 333222223344567899999999999999999999999999999977889877654 4556666666555556677899
Q ss_pred HHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 619 LYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 619 l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.+|+.+||+.+|++||++.+|++.|+..
T Consensus 346 l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 346 MYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred HHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 99999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=388.48 Aligned_cols=263 Identities=35% Similarity=0.628 Sum_probs=237.5
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
.+..+.||+|+||+||+|.+-.- ...-..+||||++.+....+...++.+|+-+|++++|||+++|+|+|.... +.||
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pe-ge~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPE-GENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhceeccccceeEEeeeEecC-CceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 34567799999999999988432 233456899999998888777889999999999999999999999998766 8899
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
++||+.|+|.+|++.+ ...+-..+++.+..|||+||.|||++++|||||.++||||.+...
T Consensus 776 tq~mP~G~LlDyvr~h-------------------r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h 836 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREH-------------------RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH 836 (1177)
T ss_pred HHhcccchHHHHHHHh-------------------hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCe
Confidence 9999999999999843 356778899999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~ 606 (653)
+||.|||+++.+..++..........++.|||-|.+....||.+||||||||++||++|.|..||.+...+|+-+.++.|
T Consensus 837 vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~g 916 (1177)
T KOG1025|consen 837 VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKG 916 (1177)
T ss_pred EEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcc
Confidence 99999999998876665555556677899999999999999999999999999999999999999999999999999999
Q ss_pred CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 607 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+.+..|+.++.+++.+|.+||..|+..||+|+++...+.++.++
T Consensus 917 eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999888877654
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=369.83 Aligned_cols=257 Identities=23% Similarity=0.340 Sum_probs=226.3
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
...++|.+.+.||+|+|++|++|+.. .+++.+|||++.+.- .+.-.+.+.+|-..|.+| .||.|++|+-.|.
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~-----~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ 144 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREK-----ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ 144 (604)
T ss_pred CChhhcchhheeccccceeEEEeeec-----CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence 34578999999999999999999863 477899999986542 222334577888999999 8999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+...+|+|+||+++|+|.++|+ +.+.+++.....++.+|+.||+|||++|||||||||+|
T Consensus 145 D~~sLYFvLe~A~nGdll~~i~--------------------K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPEN 204 (604)
T KOG0592|consen 145 DEESLYFVLEYAPNGDLLDLIK--------------------KYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPEN 204 (604)
T ss_pred cccceEEEEEecCCCcHHHHHH--------------------HhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhh
Confidence 9999999999999999999997 34678999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc---------cCC--CCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY---------KGD--ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~---------~~~--~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
||||++|.+||+|||.|+.+...... ... ....||..|.+||.+..+..+..+|+|+|||+||+|+. |
T Consensus 205 ILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla-G 283 (604)
T KOG0592|consen 205 ILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA-G 283 (604)
T ss_pred eeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc-C
Confidence 99999999999999999887533221 111 33678999999999999999999999999999999998 6
Q ss_pred CCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 588 LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+||.+.+.--+++.|.+-.. .+|+..++.+.+|+++.|-.||.+|+|.++|.+|++
T Consensus 284 ~PPFra~NeyliFqkI~~l~y-~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 284 QPPFRAANEYLIFQKIQALDY-EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred CCCCccccHHHHHHHHHHhcc-cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcc
Confidence 789999999999999988664 688899999999999999999999999999999975
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=355.46 Aligned_cols=275 Identities=43% Similarity=0.794 Sum_probs=233.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|.+.+.........||||.++.........++.+|+.+++.++|+||+++++++..+
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45667899999999999999999998664444566889999987654444566789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++|+|.++++...+.... ......+++..++.++.|++.||.|||+.+++|+||||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil 151 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMEN----------NPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccc----------cccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEE
Confidence 9999999999999999999754321100 011245688899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||+++...............++..|||||.+.+..++.++||||||+++|||++++..||.+...++..
T Consensus 152 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 152 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred EcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999986644443333333455788999999999999999999999999999999877899998888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+..+.....+..++..+.+++.+||+.+|++|||+.++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 888887776777889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=359.92 Aligned_cols=283 Identities=43% Similarity=0.779 Sum_probs=224.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCC-----------CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLL-----------KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----------~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI 430 (653)
++.++|.+.+.||+|+||.||+|.+.... ....+..||+|.++.........+|.+|+.++.+++||||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45678999999999999999999864321 1234568999999876666667789999999999999999
Q ss_pred ceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 431 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
+++++++...+..++||||+++|+|.+++............. ...........+++..+++++.||+.||.|||+.+|+
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN-DAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc-cccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999997432211100000 0001122345688999999999999999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC-CCC
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF-ALQ 589 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~-~~~ 589 (653)
||||||+|||+++++.+||+|||+++.....+.........++..|||||.+..+.++.++||||||+++|||+++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999866444433333344557889999999999999999999999999999974 456
Q ss_pred CCCCCCHHHHHHHHHc----C---CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKE----G---NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~----~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||.+.+.+++...+.. . .....+..++..+.+|+.+||+.+|.+|||+.+|.+.|.
T Consensus 241 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 8888777766554432 1 112335568899999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=357.95 Aligned_cols=277 Identities=40% Similarity=0.784 Sum_probs=234.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.+|++.+.||+|+||.||+|+..+.........||+|+++........+.+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 45677889999999999999976544445678899999987665556677999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+++||+++++|.+++....+...... ..........+++..++.++.|++.||.|||+++|+||||||+|||++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGS----TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 99999999999999974433221110 01111123468899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.+||+|||+++.....+.........+++.|+|||.+.++.++.++||||||+++|||++++.+||.+....++.+.+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998866433332223344557789999999999999999999999999999998888999999999999999
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....+..++..+.+++..||+.+|.+||++++|+..|.
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 98887788899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=372.02 Aligned_cols=294 Identities=39% Similarity=0.671 Sum_probs=232.3
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKL 433 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l 433 (653)
+....+.++.++|++.+.||+|+||.||+|+..+.....+...||||+++..........+.+|+++++.+ +|+|||++
T Consensus 28 ~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~ 107 (374)
T cd05106 28 PYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNL 107 (374)
T ss_pred cccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeE
Confidence 44556678888999999999999999999987654455566789999998765555567789999999999 89999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcC-C------------------------------------------
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN-G------------------------------------------ 470 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~-~------------------------------------------ 470 (653)
++++...+..++||||+++|+|.++++......... .
T Consensus 108 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (374)
T cd05106 108 LGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV 187 (374)
T ss_pred eeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence 999999999999999999999999997543210000 0
Q ss_pred ------Cc-ccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcccccccccc
Q psy5539 471 ------TY-SSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543 (653)
Q Consensus 471 ------~~-~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~ 543 (653)
+. ............+++..+++++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.......
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence 00 00000011234588999999999999999999999999999999999999999999999999976533222
Q ss_pred ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHcCCccCCCCCCcHHHHHH
Q psy5539 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE-EVVKYIKEGNILQAPDNTPDALYDL 622 (653)
Q Consensus 544 ~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~-e~~~~i~~~~~~~~~~~~~~~l~~l 622 (653)
........++..|||||++....++.++||||||+++|||++.|..||...... .....+..+.....+...+.++.++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 347 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSI 347 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHH
Confidence 112222345678999999999999999999999999999998667788776543 3444455544445566778999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 623 MKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 623 i~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+.+||+.+|.+||++.+|++.|.++.
T Consensus 348 i~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 348 MKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 99999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=360.50 Aligned_cols=258 Identities=26% Similarity=0.413 Sum_probs=213.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC--c
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--P 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--~ 442 (653)
.++...+.||+|+||+||++... .++...|||......... .+.+.+|+.+|.+|+|||||+.+|.....+ .
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~-----~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~ 90 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNK-----KTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDE 90 (313)
T ss_pred chhhhhccccCccceEEEEEEec-----CCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence 34667788999999999999864 236789999987654433 567899999999999999999999855444 6
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
++++|||+++|+|.+++... ...+++..+..+++||++||+|||++|||||||||+||||+
T Consensus 91 ~~i~mEy~~~GsL~~~~~~~-------------------g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~ 151 (313)
T KOG0198|consen 91 YNIFMEYAPGGSLSDLIKRY-------------------GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLD 151 (313)
T ss_pred eEeeeeccCCCcHHHHHHHc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEe
Confidence 99999999999999999722 12699999999999999999999999999999999999999
Q ss_pred C-CCcEEEeccCccccccc-cccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHH-
Q psy5539 523 D-QMVVKIADFGLSRKMYL-QDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYG-LTHE- 597 (653)
Q Consensus 523 ~-~~~vkI~DfGla~~~~~-~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~-~~~~- 597 (653)
. ++.+||+|||+++.... ...........||+.|||||++..+ ....++|||||||++.||+|| .+||.. ....
T Consensus 152 ~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg-~~PW~~~~~~~~ 230 (313)
T KOG0198|consen 152 PSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTG-KPPWSEFFEEAE 230 (313)
T ss_pred CCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCC-CCcchhhcchHH
Confidence 9 79999999999987653 1222334457889999999999964 334599999999999999997 678876 3333
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.++........+..|+.++.+.++++.+|+..+|++|||++++++|++...
T Consensus 231 ~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 231 ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 344444455556788889999999999999999999999999999998654
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=354.16 Aligned_cols=284 Identities=66% Similarity=1.135 Sum_probs=238.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
++.++|++.+.||+|+||.||+|+..+..+..+...||+|.++.........++.+|+.++++++||||+++++++..+.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 45678999999999999999999976544456678999999987666666778999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCC--cccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGT--YSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++||||+++|+|.++++...+....... .............+++..++.++.|++.||.|||+++++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 999999999999999999865432211100 000111112234688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.++|+|||+++................+..|+|||.+.+..++.++||||||+++|||++.+.+||.+...+++
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~ 241 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV 241 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999997665444333333444567899999999999999999999999999999878889999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+..+.....++..+.++.+|+.+||+.+|.+|||+.||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 242 IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 9999888877778889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-44 Score=372.04 Aligned_cols=252 Identities=35% Similarity=0.568 Sum_probs=217.4
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
+-++++.+.+.-++-||.|+.|.||+|++.+ ..||||++++- -+.+|+-|++|+|+||+.|.|+|
T Consensus 117 e~WeiPFe~IsELeWlGSGaQGAVF~Grl~n-------etVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 117 ELWEIPFEEISELEWLGSGAQGAVFLGRLHN-------ETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred hhccCCHHHhhhhhhhccCcccceeeeeccC-------ceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeee
Confidence 3456777777778889999999999999754 67999988642 24678899999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
....-+||||||++.|-|.+.|+ ....++...+..+..+||.||.|||.++|||||||+-
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLk--------------------a~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSP 241 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLK--------------------AGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSP 241 (904)
T ss_pred cCCceeEEeeeccccccHHHHHh--------------------ccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCC
Confidence 99999999999999999999997 3456888899999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||..+..|||+|||-++..... .+.-..+||+.|||||+|.....++|.||||||||||||+|+.. ||.+.+..
T Consensus 242 NiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~Ei-PYkdVdss 317 (904)
T KOG4721|consen 242 NILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEI-PYKDVDSS 317 (904)
T ss_pred ceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCC-Cccccchh
Confidence 999999999999999999875322 23446789999999999999999999999999999999999655 99877765
Q ss_pred HHHHHHHcC-CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEG-NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 e~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.++--+-.. ..++.|..+|+.++=||++||+..|..||+|++|+.||.-..
T Consensus 318 AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 318 AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 554333322 235678899999999999999999999999999999986543
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=391.46 Aligned_cols=286 Identities=43% Similarity=0.755 Sum_probs=248.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCc--cceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--EFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLG 435 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~--~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g 435 (653)
.+|++++++.+.+.||+|+||.|++|...+..... ....||||+++........+.+..|+++|..+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 67899999888889999999999999987654432 36789999999888777888999999999999 5999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
.|..++..++|+||+.+|+|.+||+.++......... ........++..+++.++.|||.||+||++.++|||||+
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~----~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLA 445 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG----VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLA 445 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccC----CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhh
Confidence 9999999999999999999999999776111110000 000011359999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCC-CCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGD-ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
++|||+.++..+||+|||+++.....+++... .....|++|||||.+....|+.+||||||||+||||+|.|..||.+.
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999987766666532 33238899999999999999999999999999999999999999997
Q ss_pred C-HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 595 T-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 595 ~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
. .+++.+.+++|..+..|..++++++++|+.||+.+|++||+|.++.+.+..+.
T Consensus 526 ~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 526 PPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 6 78889999999999999999999999999999999999999999999988753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=352.92 Aligned_cols=277 Identities=50% Similarity=0.903 Sum_probs=234.5
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|.+.+.||+|+||.||+|+........+...||||.++........+.+.+|++++++++|+||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 82 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP 82 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence 34568888999999999999998755434456688999999876665566789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++...+..... .........+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~------~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~ 156 (280)
T cd05049 83 PIMVFEYMEHGDLNKFLRSHGPDAAFL------KSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCCchhhh------cccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence 999999999999999998554321100 00112335689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++.+..||.+.+.++..+.
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 99999999999998654443333334445678899999999999999999999999999999967779988888899998
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+.....+...+..+.+++++||+.+|++||++.+|++.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 8888777777789999999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=349.30 Aligned_cols=279 Identities=43% Similarity=0.834 Sum_probs=232.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|.... .....+..|++|.++..........+.+|++++++++||||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~-~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYL-PGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEec-CCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 34678999999999999999998521 12345678999999865555556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++....+........ .........+++.+++.++.|++.||+|||+++++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~ 158 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSS---DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG 158 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCcccccc---ccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEc
Confidence 999999999999999997554322111100 00011234588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++.+.+||.+....++.+.
T Consensus 159 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05090 159 EQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM 238 (283)
T ss_pred CCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998764443333333444567899999999889999999999999999999978889998888888998
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+..+..+..++..+.+++.+||+.+|.+||++.+|.++|.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 8888877778889999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=348.94 Aligned_cols=275 Identities=43% Similarity=0.815 Sum_probs=236.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|...+.........||+|.+...........+.+|+.++..++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 56678899999999999999999998654434556889999997665555566789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++|+|.+++....+... .......+++..++.++.|++.||.|||+.+++||||||+|||
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nil 151 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAE----------NNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM 151 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchh----------hccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEE
Confidence 999999999999999999975432110 0122345789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||+++.+...+.........++..|+|||.+..+.++.++||||||+++|||++++.+||.+.+..+..
T Consensus 152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 152 VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH
Confidence 99999999999999987654443333344556788999999998899999999999999999999778899999999998
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+..+.....+..++.++.+++.+||+.+|++|||+.+|++.|.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 888887777778889999999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=367.68 Aligned_cols=294 Identities=38% Similarity=0.654 Sum_probs=235.9
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKL 433 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l 433 (653)
+....+++++++|.+.+.||+|+||.||+|++.+.........||||+++........+.+.+|++++++++ ||||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l 106 (400)
T cd05105 27 PYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNL 106 (400)
T ss_pred CCCCceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 445667888999999999999999999999976544445567899999987666666678999999999996 9999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCC---------------------Cc--------------------
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYING---------------------TY-------------------- 472 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~---------------------~~-------------------- 472 (653)
++++...+..+|||||+++|+|.++|+.......... .+
T Consensus 107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 107 LGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 9999999999999999999999999976432100000 00
Q ss_pred ---------------------------------ccccc--cccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 473 ---------------------------------SSMES--SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 473 ---------------------------------~~~~~--~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..+.. .......+++..++.++.||++||+|||+.+|+||||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 00000 0011235889999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH- 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~- 596 (653)
|||+++++.+||+|||+++...............++..|||||.+.+..++.++||||||+++|||++.+..||.+...
T Consensus 267 Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 267 NVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred hEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 9999999999999999998654333222233345677899999999999999999999999999999866668876544
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+...+..+.....+..++.++.+++.+||+.+|++||++.+|.+.|..+.
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 4455666666556667788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=351.32 Aligned_cols=286 Identities=41% Similarity=0.741 Sum_probs=240.1
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+++..++|++.+.||+|+||.||++...+.........+|+|.++.........++.+|+.++.++ +|+||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3477788999999999999999999987654333455789999998665555556789999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++..+++|||+++|+|.++++...+...... ..........+++..++.++.|++.||.|||+++|+||||||+
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 161 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYAS----PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAAR 161 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccccccee
Confidence 999999999999999999999986543322111 1111123457899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++.+..||.+....
T Consensus 162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 241 (293)
T cd05053 162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241 (293)
T ss_pred eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence 99999999999999999986544333233333445678999999999999999999999999999999777899998888
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
++.+.+..+.....+..++..+.+|+.+||..+|++|||+.++++.|..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 242 ELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 888888888776777788999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=372.71 Aligned_cols=265 Identities=35% Similarity=0.619 Sum_probs=236.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
-|+.+++...++||+|.||.|++|.+.. ...+...||||.++.........+|.+|+.+|.+|+|+|+++|||+..+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~--psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQ--PSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccC--CCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 3556677788899999999999999964 5566678999999977555567799999999999999999999999887
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..+.||||.++.|+|.+.|+.. ....|....+..++.|||.||.||.++++|||||.++|+|
T Consensus 183 qp~mMV~ELaplGSLldrLrka------------------~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNll 244 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKA------------------KKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLL 244 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhc------------------cccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhe
Confidence 7889999999999999999831 2345777888999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccc-ccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQ-DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|-....|||+||||++-+... +.+.-......++.|-|||.+....|+.+||||+|||+||||||+|..||.|....++
T Consensus 245 lasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI 324 (1039)
T KOG0199|consen 245 LASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI 324 (1039)
T ss_pred ecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH
Confidence 999999999999999877543 4444556677889999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
++.|.++++++.|+.|++++|++|+.||..+|.+||||..|.+.+..
T Consensus 325 L~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 325 LKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred HHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 99999999999999999999999999999999999999999865543
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=345.75 Aligned_cols=264 Identities=38% Similarity=0.702 Sum_probs=228.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|.+.+.||+|+||.||+|++.. .......||||.++.........+|.+|+.++++++||||+++++++..++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKL--PGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEcc--CCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 34678999999999999999998753 2234568999999876666667789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+++|+|+||||+|||++
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~ 140 (266)
T cd05033 80 VMIITEYMENGSLDKFLREN-------------------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVN 140 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEc
Confidence 99999999999999998621 23678999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.++|+|||+++................+..|+|||.+.+..++.++||||||+++|||++.+..||......++.+.
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 220 (266)
T cd05033 141 SNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA 220 (266)
T ss_pred CCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Confidence 99999999999998764222212222344567899999999999999999999999999999967779988888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+..+...+.+..++..+.+++.+||+.+|++||++++|+++|.++
T Consensus 221 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 887766666778899999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=356.01 Aligned_cols=267 Identities=33% Similarity=0.608 Sum_probs=225.5
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|+..+.||+|+||.||+|++... .......||+|.++........+++.+|+.+++.++||||++++|++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecC-CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 3456799999999999999999986431 12234569999998665556667899999999999999999999998764
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill 142 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREH-------------------KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV 142 (316)
T ss_pred CceeeeecCCCCCHHHHHHhc-------------------cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe
Confidence 578999999999999999721 2357888999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++................+..|+|||.+....++.++||||||+++|||++.+..||.+....++..
T Consensus 143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~ 222 (316)
T cd05108 143 KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 222 (316)
T ss_pred cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999866433222222333456789999999999999999999999999999997778998888888877
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.+..+.....+..++.++.+++.+||..+|.+||++.+++..+..+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 777777666777888999999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=348.53 Aligned_cols=280 Identities=47% Similarity=0.890 Sum_probs=235.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.+++|.+.+.||+|+||+||++.........+...+|+|.++... ....+.+.+|++++++++||||+++++++...+.
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDP 81 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 456789999999999999999986443334556789999987643 3445679999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++....+.... .........+++..++.++.|++.||+|||+++++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~-------~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 82 LIMVFEYMKHGDLNKFLRAHGPDAVL-------MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154 (288)
T ss_pred cEEEEEcCCCCCHHHHHHHcCCcccc-------ccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 99999999999999999754432110 00112234589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++.+||......+....
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999998654333222223344567899999999999999999999999999999977889998888888899
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+..+.....+..++.++.+++.+||+.+|.+|||+.++++.|..+.+.
T Consensus 235 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 988877677778899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=349.28 Aligned_cols=277 Identities=42% Similarity=0.783 Sum_probs=233.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|.............||+|.++..........+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 56678899999999999999999986543344556789999987655444556788999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++|+|.++++...+... .......+++..++.++.|++.||.|||+++|+||||||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nil 151 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAE----------NNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCM 151 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccc----------cCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEE
Confidence 999999999999999999975432110 0112345678889999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||+++...............++..|+|||.+.++.++.++||||||+++|||++++..||.+...+++.
T Consensus 152 i~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred EcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999986644433333333445678999999999999999999999999999999888899998888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.+..+.....+..++..+.+++.+||+.+|++|||+.++++.+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 88888777777778899999999999999999999999999887754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=345.78 Aligned_cols=272 Identities=41% Similarity=0.763 Sum_probs=229.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|.+...........||+|.++..........|.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 34567899999999999999999987542222356789999988665555567799999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++....+.. .....+++..++.++.||+.||+|||+++++|+||||+|||
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~-------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil 148 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRP-------------ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCL 148 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEE
Confidence 99999999999999999997543211 12245899999999999999999999999999999999999
Q ss_pred EcCCC---cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 INDQM---VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~~~---~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
+++++ .+||+|||+++................+..|+|||.+.+..++.++||||||+++|||++.+..||.+.+.+
T Consensus 149 ~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~ 228 (277)
T cd05036 149 LTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ 228 (277)
T ss_pred EeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 98754 699999999987643333222223344678999999999999999999999999999998788899998888
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.+.+........+..++..+.+++.+||+.+|++||++.+|+++|.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 229 EVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 888888776666667788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=350.71 Aligned_cols=288 Identities=41% Similarity=0.717 Sum_probs=236.7
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCC--ccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH--EEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLG 435 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g 435 (653)
..++..++|.+.+.||+|+||.||+|+..+.... .....+|+|.++.........++.+|+++++.+ +|+||+++++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4466678899999999999999999987542221 234679999998655445556788999999999 7999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++...+..++||||+++|+|.+++....+....... .........+++.++++++.|++.||+|||+++++|||||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 167 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCY----NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLA 167 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCccccccc----ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 999999999999999999999999865432211000 0001123458999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++.....+.........++..|||||.+.+..++.++||||||+++|||++++..||.+..
T Consensus 168 p~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~ 247 (307)
T cd05098 168 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 247 (307)
T ss_pred HHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC
Confidence 99999999999999999998765332222222233445789999999999999999999999999999997888998888
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+++.+.+..+.....+..++.++.+++.+||..+|++||++.+|++.|.++...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 8888888888776677788899999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=347.34 Aligned_cols=283 Identities=46% Similarity=0.862 Sum_probs=236.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
...+|.+.+.||+|+||.||+|+..+.....+...+++|.++.... ...+.+.+|++++++++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP 81 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence 4467889999999999999999875544445667899999876443 334678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.++++...+...... ..........+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~ 157 (291)
T cd05094 82 LIMVFEYMKHGDLNKFLRAHGPDAMILV----DGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 157 (291)
T ss_pred eEEEEecCCCCcHHHHHHhcCccccccc----ccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999999999986543211000 000011234589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.++|+|||++................++..|+|||.+.+..++.++||||||+++|||++++..||...+..++.+.
T Consensus 158 ~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 158 ANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred cCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 99999999999997664433322333445678899999999999999999999999999999977789988888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+..+.....+..++..+.+++.+||+.+|++||++++|++.|..+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 888877777778899999999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=358.83 Aligned_cols=290 Identities=39% Similarity=0.676 Sum_probs=229.9
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
++++.++|++.+.||+|+||.||+|...+.....+++.||+|+++........+.+.+|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~ 81 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACT 81 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEe
Confidence 467788999999999999999999987654455567899999998655444556788999999999 8999999999886
Q ss_pred c-CCceEEEEeecCCCChHHHHhhcCCCCCcCCCc-----------------cc------------------------cc
Q psy5539 439 V-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY-----------------SS------------------------ME 476 (653)
Q Consensus 439 ~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~-----------------~~------------------------~~ 476 (653)
. +...+++|||+++|+|.+++............- .+ ..
T Consensus 82 ~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (337)
T cd05054 82 KPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEE 161 (337)
T ss_pred cCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchh
Confidence 4 457889999999999999997543211000000 00 00
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCcccc
Q psy5539 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRW 556 (653)
Q Consensus 477 ~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y 556 (653)
........+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.+.............++..|
T Consensus 162 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 162 GDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred hhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 00001236899999999999999999999999999999999999999999999999999876433322222334556789
Q ss_pred ccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 557 MPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 557 ~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
||||.+.+..++.++||||||+++|||++.+..||.+... +.....+..+.....+...+.++.+++.+||+.+|++||
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP 321 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP 321 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence 9999999999999999999999999999866778876544 344555666655566677889999999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWNIKR 649 (653)
Q Consensus 636 s~~eil~~L~~l~~ 649 (653)
++.+|+++|..+.+
T Consensus 322 s~~ell~~l~~~~~ 335 (337)
T cd05054 322 TFSELVEILGDLLQ 335 (337)
T ss_pred CHHHHHHHHHHHHh
Confidence 99999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.20 Aligned_cols=284 Identities=39% Similarity=0.671 Sum_probs=231.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+|++.+.||+|+||.||+|+............+++|.++..........+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 35778899999999999998754333445578999999876555555679999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCC----CcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYING----TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~----~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
++||+.+|+|.+++........... ...+..........+++..++.++.|++.||+|||+.+++||||||+|||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill 160 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV 160 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE
Confidence 9999999999999975432110000 000000111223468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++..||.+...+++.+
T Consensus 161 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 240 (290)
T cd05045 161 AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFN 240 (290)
T ss_pred cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999765433322222334557789999999989999999999999999999996777999989999888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.+..+.....+...+.++.+++..||+.+|++||++.++++.|..+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 888776666677889999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.06 Aligned_cols=287 Identities=39% Similarity=0.711 Sum_probs=237.4
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCC--CCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL--KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
+++..++|.+.+.||+|+||.||+|+..+.. ...+...||+|.++.........++.+|+.+++.+ +||||++++++
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3566778999999999999999999864321 12345689999998655455567899999999999 89999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+......++||||+++|+|.+++...++...... ..-.......+++..++.++.||+.||.|||+++++||||||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS----YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccc----cccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999986543221100 000011234689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++..|+.+.+.
T Consensus 166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 99999999999999999998664333332333345567899999999999999999999999999999977789999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.++.+.+..+.....+..++..+.+++.+||+.+|.+||++.+|++.|.++..-
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 999999888777667778999999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=348.24 Aligned_cols=252 Identities=26% Similarity=0.432 Sum_probs=201.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh--CCCCccceEEeEEecCC--
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE--FDHPNIVKLLGVCAVGK-- 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~~~-- 441 (653)
.+++.+.||+|+||.||||++.+ +.||||++.... .+.|..|-+|.+. ++|+||++++++-..+.
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~-------~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN-------RLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred chhhHHHhhcCccceeehhhccC-------ceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 45677889999999999998743 789999998653 3456666666554 68999999999876655
Q ss_pred --ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC---------Cce
Q psy5539 442 --PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR---------KFV 510 (653)
Q Consensus 442 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------~iv 510 (653)
..+||+||.+.|+|.+||+. ..++|.+..+|+..+++||+|||+. .|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~---------------------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia 338 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKA---------------------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA 338 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHh---------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence 89999999999999999972 4589999999999999999999963 699
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-C-----CCchhHHHHHHHHHHHH
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-Y-----TVESDVWAFGVCLWEIF 584 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~-----t~ksDVwSlGvvl~ell 584 (653)
|||||++||||.+|++..|+|||||..+.............||.||||||++.+.. + -.+.||||+|.|||||+
T Consensus 339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~ 418 (534)
T KOG3653|consen 339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA 418 (534)
T ss_pred cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999998876444333444578999999999997652 2 25789999999999999
Q ss_pred hCCC-------CCCC---------CCCHHHHHHHH-HcCCccCCCCC-----CcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 585 SFAL-------QPYY---------GLTHEEVVKYI-KEGNILQAPDN-----TPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 585 t~~~-------~p~~---------~~~~~e~~~~i-~~~~~~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
++.. ++|+ ..+.+++.+.+ +++.++..|+. -...+++.+..||+.||+.|.|+.-+.+
T Consensus 419 SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e 498 (534)
T KOG3653|consen 419 SRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE 498 (534)
T ss_pred hhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence 8443 2222 12344554444 34444555543 3467899999999999999999999999
Q ss_pred HHHHHHH
Q psy5539 643 TLWNIKR 649 (653)
Q Consensus 643 ~L~~l~~ 649 (653)
+++++..
T Consensus 499 R~~~l~~ 505 (534)
T KOG3653|consen 499 RMAELMM 505 (534)
T ss_pred HHHHHhc
Confidence 9988754
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=343.55 Aligned_cols=267 Identities=32% Similarity=0.596 Sum_probs=223.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|.+... .......+++|.+..........++..|+.++++++||||+++++++. +..
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPE-GDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCC-CCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 446788899999999999999987321 111224688999876554445567888999999999999999999875 456
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++++||+++|+|.+++... ...+++..++.++.||+.||+|||+++++||||||+|||++
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~ 143 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQH-------------------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLK 143 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEc
Confidence 78999999999999999622 24578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++.....+.........++..|+|||.+.++.++.++||||||+++|||++.+..||.+....++.+.
T Consensus 144 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~ 223 (279)
T cd05111 144 SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDL 223 (279)
T ss_pred CCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999999999998654332222223345677899999999999999999999999999999977789998888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+..+.....+..++.++.+++.+||..+|++|||+.++++.|..+.++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 224 LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 888877777777889999999999999999999999999998887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=357.56 Aligned_cols=258 Identities=26% Similarity=0.371 Sum_probs=223.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc----ccHHHHHHHHHHHHHHhhCC-CCccceEEeE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE----ASEYLQTDFEREACLLAEFD-HPNIVKLLGV 436 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~----~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~ 436 (653)
...+.|.+.+.||+|+||+|++|+.. .++..||||.+... ......+.+.+|+.++++++ ||||++++.+
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~-----~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev 88 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHR-----LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEV 88 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeec-----cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEE
Confidence 44568899999999999999999864 35589999977553 11134556779999999999 9999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+......++||||+.+|+|.+++.. .+.+.+.++.+++.|+++|++|+|++||+||||||
T Consensus 89 ~~t~~~~~ivmEy~~gGdL~~~i~~--------------------~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ 148 (370)
T KOG0583|consen 89 FATPTKIYIVMEYCSGGDLFDYIVN--------------------KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKP 148 (370)
T ss_pred EecCCeEEEEEEecCCccHHHHHHH--------------------cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 9999999999999999999999972 45688899999999999999999999999999999
Q ss_pred CCEeEcCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CC-CchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 517 RNCLINDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YT-VESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 517 ~NILl~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t-~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
+|||++.+ +++||+|||++.... ..........|++.|+|||++.+.. |+ .++||||+||+||-|++|. .||.+
T Consensus 149 ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~-~PF~d 225 (370)
T KOG0583|consen 149 ENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGR-LPFDD 225 (370)
T ss_pred HHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCC-CCCCC
Confidence 99999999 999999999998653 1112335567899999999999977 76 8999999999999999955 49999
Q ss_pred CCHHHHHHHHHcCCccCCCCCC-cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 594 LTHEEVVKYIKEGNILQAPDNT-PDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 594 ~~~~e~~~~i~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.+...+...|..+.. .+|..+ +.++.+|+++|+..+|.+|+|+.+|+++.|-..
T Consensus 226 ~~~~~l~~ki~~~~~-~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 226 SNVPNLYRKIRKGEF-KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred ccHHHHHHHHhcCCc-cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 888888888888764 577777 999999999999999999999999999988654
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=357.04 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=211.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.+.|+.+++||+|+||.||+|+. ..++++||+|+++-+. .+.......|||.||++|+||||++|.+...+.
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~-----~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARD-----LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeee-----cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence 45678888999999999999985 4678999999998554 333445678999999999999999999998765
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..+|||||||++ ||..++. ...-.+++.++..++.||+.||+|+|++||+|||||.+|||
T Consensus 191 ~siYlVFeYMdh-DL~GLl~-------------------~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiL 250 (560)
T KOG0600|consen 191 GSIYLVFEYMDH-DLSGLLS-------------------SPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNIL 250 (560)
T ss_pred ceEEEEEecccc-hhhhhhc-------------------CCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceE
Confidence 789999999988 8888875 22346899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
||.+|.+||+|||||+...... ...-+....|..|.|||.+++. .|+.+.|+||.||||.||+. |.+.+.|.+.-+.
T Consensus 251 idn~G~LKiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~-gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 251 IDNNGVLKIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL-GKPILQGRTEVEQ 328 (560)
T ss_pred EcCCCCEEeccccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc-CCCCcCCccHHHH
Confidence 9999999999999998654333 2335667889999999999876 79999999999999999998 5678888887665
Q ss_pred HHHHHc--CC-----cc--CC-------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKE--GN-----IL--QA-------------------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~--~~-----~~--~~-------------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.|-. |. .. .. ....++...+|+..+|..||.+|.|+.+++++-+
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~sey 402 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEY 402 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcc
Confidence 555522 00 00 11 1245678889999999999999999999987643
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=355.39 Aligned_cols=291 Identities=39% Similarity=0.678 Sum_probs=229.7
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
++++.++|++.+.||+|+||.||+|.+.+.....+++.||||+++..........+.+|+.++.++ +|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 467788999999999999999999987655455677899999998655444556788999999999 6899999999886
Q ss_pred c-CCceEEEEeecCCCChHHHHhhcCCCCCcCCC--------------c----------------------------ccc
Q psy5539 439 V-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGT--------------Y----------------------------SSM 475 (653)
Q Consensus 439 ~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~--------------~----------------------------~~~ 475 (653)
. +...++||||+++|+|.++++........... . ...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 4 45689999999999999999754321100000 0 000
Q ss_pred -----cccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCC
Q psy5539 476 -----ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550 (653)
Q Consensus 476 -----~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~ 550 (653)
.........+++..+..++.||++||+|||+++|+||||||+|||+++++.+||+|||++...............
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 000001235788999999999999999999999999999999999999999999999999765332222222233
Q ss_pred CCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhcc
Q psy5539 551 AIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNM 629 (653)
Q Consensus 551 ~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~ 629 (653)
.++..|+|||.+.+..++.++||||||+++|||++.+..||.+... .+....+..+.....+...++++.+++..||+.
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 4567899999999999999999999999999999877778876543 445556666666666677888999999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHH
Q psy5539 630 KPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 630 dP~~RPs~~eil~~L~~l~~~ 650 (653)
+|.+|||+.+|+++|..+.+.
T Consensus 322 ~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 322 EPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred ChhhCcCHHHHHHHHHHHHhc
Confidence 999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=347.24 Aligned_cols=288 Identities=40% Similarity=0.731 Sum_probs=236.6
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
++++.++|.+.+.||+|+||.||+|+..+... ......+|+|.++.........++.+|+.+++++ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 7 WEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 46677889999999999999999998643221 2345679999998655555566789999999999 69999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+..++..++||||+++|+|.+++....+...... ..........+++.++++++.||+.||.|||+++++||||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 162 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYT----FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA 162 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCccccc----ccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 9999999999999999999999986443211000 000011234689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++.....+.........++..|||||.+.+..++.++||||||+++|||++++..||.+...
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~ 242 (314)
T cd05099 163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV 242 (314)
T ss_pred eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654333222222333456799999999999999999999999999999977789999998
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+++...+..+.....+..++.++.+++.+||+.+|++||++.++++.|..+...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 243 EELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 9999988887766777888999999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=341.48 Aligned_cols=268 Identities=33% Similarity=0.619 Sum_probs=226.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+|+..... ......||+|+++.........++.+|+.++..++|+||+++++++.. .
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDG-ENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCC-CccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 34568899999999999999999864311 112346899999876666667789999999999999999999999875 4
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++++||+++|+|.++++. ....+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~-------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~ 142 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRE-------------------NKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 57899999999999999862 12458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++.+||......++..
T Consensus 143 ~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~ 222 (279)
T cd05109 143 KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD 222 (279)
T ss_pred cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999999865432222122233456789999999999999999999999999999997888998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+..++.++.+++.+||+.+|++||++.++++.+..+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 223 LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 8888776666778899999999999999999999999999998877653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=338.81 Aligned_cols=261 Identities=40% Similarity=0.791 Sum_probs=224.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++...+|.+.+.||+|+||.||+|... ..+..||+|.++.... ...++.+|++++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 74 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEe-----cCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCC
Confidence 456678899999999999999999863 3467899999875432 345788999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++++|.+++... ....+++..++.++.|++.||+|||+++++||||||+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 75 PPFYIITEFMTYGNLLDYLREC------------------NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred CCcEEEEEeCCCCcHHHHHHhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 9999999999999999998622 1245789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++++..|+.+.+.++..
T Consensus 137 ~~~~~~~kl~df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~ 215 (263)
T cd05052 137 VGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 215 (263)
T ss_pred EcCCCcEEeCCCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999976533221 11222334678999999999999999999999999999999777899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+.....+..++.++.+++.+||+.+|++||++.++++.|..+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 216 ELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 88877665667778899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=359.30 Aligned_cols=291 Identities=37% Similarity=0.655 Sum_probs=232.3
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~ 436 (653)
..++++.+++.+.+.||+|+||.||+|++.+.........||||+++........+.+.+|++++.++. ||||++++++
T Consensus 30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 346788889999999999999999999987654445667899999987655555567899999999997 9999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcC------C----------------------------------------
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN------G---------------------------------------- 470 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~------~---------------------------------------- 470 (653)
+...+..++||||+++|+|.++++......... .
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999998653210000 0
Q ss_pred --------------------------------CcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 471 --------------------------------TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 471 --------------------------------~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..............+++..++.++.||+.||+|||+.+++||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 000000011223468889999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||+++++.+||+|||+++...............++..|||||.+....++.++||||||+++|||++++..||......+
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~ 349 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE 349 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH
Confidence 99999999999999999765332222222233467889999999999999999999999999999996666887655444
Q ss_pred -HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 599 -VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 599 -~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
....+..+..+..+..++.++.+++.+||+.+|.+||++++|++.|..+.
T Consensus 350 ~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 44555555555667778999999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.13 Aligned_cols=253 Identities=35% Similarity=0.704 Sum_probs=217.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||.||+|+.. +...+|+|.++.... ...++.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~------~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR------AQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPL 74 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec------cCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCE
Confidence 457888999999999999999863 235799998875432 235688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+++|+||||||+||++++
T Consensus 75 ~iv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 75 YIVTEFMENGCLLNYLRQR-------------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhC-------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 9999999999999998621 234788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++++..||...+..+....+
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 136 TGVVKVSDFGMTRYVLDDEY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred CCeEEECCCCCccccCCCce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999876532222 12223345678999999998899999999999999999999777899998888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.....+...+.++.+++.+||+.+|++||++.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 215 SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 88776666777889999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=355.87 Aligned_cols=253 Identities=29% Similarity=0.425 Sum_probs=209.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~- 441 (653)
-++|..+++||.|+||.||+|+. .+++..||||+++.......+-.-.||+..|++|+ |||||+|..++.+.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~-----~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~ 83 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKS-----KETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR 83 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeee-----cCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc
Confidence 35788889999999999999985 35677899999986643322333479999999999 999999999998877
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.+++|||||+. +|.+.++. ....+++..+..|+.||++||+|+|.+|+.||||||+|||+
T Consensus 84 ~L~fVfE~Md~-NLYqLmK~-------------------R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi 143 (538)
T KOG0661|consen 84 ILYFVFEFMDC-NLYQLMKD-------------------RNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI 143 (538)
T ss_pred eEeeeHHhhhh-hHHHHHhh-------------------cCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe
Confidence 99999999965 99999972 34679999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
..+..+||+||||||.+.+..-+ +....|-.|.|||++. .+.|+.+.|+||+|||++||++. .+.|.|.+.-+-+
T Consensus 144 ~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL-rPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 144 SGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL-RPLFPGASEIDQI 219 (538)
T ss_pred cccceeEecccccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh-cccCCCCcHHHHH
Confidence 99999999999999988655433 4556678899999876 56789999999999999999983 4567777665544
Q ss_pred HHHHc---------------------CCccCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKE---------------------GNILQA--------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~---------------------~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+|.+ -.+++. ..+.+.+..+||.+|+..||.+|||+++.+++++
T Consensus 220 ~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 220 YKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 44432 001111 1246789999999999999999999999999875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=341.55 Aligned_cols=277 Identities=47% Similarity=0.859 Sum_probs=230.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
...++.+.+.||+|+||.||++.........++..+|+|.++.. .....+.+.+|++++++++|+||+++++++..+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC-CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 45678889999999999999998654444556788999998754 34456689999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+++|||+++|+|.++++...+..... ..........+++..++.++.|++.||+|||+++++||||||+|||++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKIL-----AGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG 156 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhh-----cccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEc
Confidence 999999999999999998554321100 000011224589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++++.+||......+....
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC 236 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence 99999999999997654333222233344577899999999999999999999999999999978889988888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+.....+..++..+.+++.+||+.+|.+||++.+|.+.|.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 8777666677789999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=339.28 Aligned_cols=278 Identities=39% Similarity=0.706 Sum_probs=233.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV- 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~- 439 (653)
.+..++|++.+.||+|+||.||+|..... .......|++|+++........+.+.+|+.++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~-~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDE-KPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecC-CCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 35677899999999999999999987431 1123578999999876666667789999999999999999999998765
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+...++++||+++|+|.+++....... ......+++..++.++.|++.||+|||+.+++|+||||+||
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~------------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~ni 148 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGE------------ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNC 148 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccc------------cccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhE
Confidence 577899999999999999997432110 01235689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.+||+|||+++.+...+.........++..|+|||.+.+..++.++||||||+++||+++.+.+||...+..++
T Consensus 149 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 228 (280)
T cd05043 149 VIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM 228 (280)
T ss_pred EEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH
Confidence 99999999999999998664433322223344567899999999999999999999999999999967779988888888
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
...+..+.....+..+++++.+++.+||..+|++|||+.++++.|.++.+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~~ 280 (280)
T cd05043 229 AAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280 (280)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhcC
Confidence 8888877665566678999999999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=334.20 Aligned_cols=251 Identities=23% Similarity=0.407 Sum_probs=204.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.|+.+.++|+|+||.|||++. ..+|+.||||++.+... +...+-..|||++|+.|+|+|+|.|+.+|..+..++
T Consensus 3 kYE~LgkvGEGSYGvV~KCrn-----k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklh 77 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRN-----KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLH 77 (396)
T ss_pred HHhhhhccccCcceEEEEecc-----CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeE
Confidence 456677899999999999985 46889999999987644 556667889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|||||++..=|++ |. .....++.....+++.|++.|+.|+|++++|||||||+||||+.+
T Consensus 78 LVFE~~dhTvL~e-Le-------------------~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~ 137 (396)
T KOG0593|consen 78 LVFEYCDHTVLHE-LE-------------------RYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQN 137 (396)
T ss_pred EEeeecchHHHHH-HH-------------------hccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecC
Confidence 9999998854544 43 123457888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
|.+||+|||.|+.+.... ..-+....|-.|.|||.+.+ .+|....||||+||++.||++ |.+.|.|.+.-+....|
T Consensus 138 gvvKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~-G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 138 GVVKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT-GEPLWPGRSDIDQLYLI 214 (396)
T ss_pred CcEEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc-CCcCCCCcchHHHHHHH
Confidence 999999999999875221 11234556788999999988 689999999999999999999 45677777665544444
Q ss_pred Hc--CCc------------------cCCC----------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KE--GNI------------------LQAP----------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~--~~~------------------~~~~----------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.. |.+ ++.+ ...+.-+.+|++.|++.||.+|++-++++.|.
T Consensus 215 ~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 215 RKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred HHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 32 111 1111 13446788999999999999999999999875
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=342.90 Aligned_cols=246 Identities=22% Similarity=0.318 Sum_probs=208.7
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEec----CCceE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----GKPMC 444 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~~~~ 444 (653)
..||+|++|.||+|+.. ++.||||+++... .....+.|.+|+.+|++++|||||+++|++.. ....+
T Consensus 26 ~~i~~g~~~~v~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN-------NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEEC-------CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 56899999999999863 4789999997542 23335678899999999999999999999866 35789
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NILl~~ 523 (653)
+||||+++|+|.++++. ...+++...+.++.|++.||.|||+. +++||||||+|||+++
T Consensus 99 lv~Ey~~~g~L~~~l~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~ 158 (283)
T PHA02988 99 LILEYCTRGYLREVLDK--------------------EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTE 158 (283)
T ss_pred EEEEeCCCCcHHHHHhh--------------------CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECC
Confidence 99999999999999962 23578889999999999999999984 8999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++.+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||+++|||++| ..||.+.+..++..
T Consensus 159 ~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g-~~Pf~~~~~~~~~~ 232 (283)
T PHA02988 159 NYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG-KIPFENLTTKEIYD 232 (283)
T ss_pred CCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHC-CCCCCCCCHHHHHH
Confidence 999999999998764321 123456788999999876 6899999999999999999994 56999888888877
Q ss_pred HHHcC-CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 602 YIKEG-NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 602 ~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.+..+ .....+..++..+.+++.+||+.||++|||+++|++.|..++.
T Consensus 233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 77543 3344555789999999999999999999999999999988764
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=338.46 Aligned_cols=265 Identities=39% Similarity=0.735 Sum_probs=223.3
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc---
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP--- 442 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~--- 442 (653)
|.+.+.||+|+||.||+|+... +......||+|+++... .......+.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQ--DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEec--CCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCcccc
Confidence 3567889999999999998642 22345789999987542 33445678999999999999999999998865544
Q ss_pred ---eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 443 ---MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 443 ---~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.++++||+++|+|.+++..... ......+++..++.++.|++.||.|||+++++||||||+||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~--------------~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Ni 144 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRL--------------GGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNC 144 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhc--------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheE
Confidence 7999999999999999863221 01224588999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
++++++.+||+|||+++................+..|+|||.+....++.++||||||+++|||++++..||.+....++
T Consensus 145 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05035 145 MLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI 224 (273)
T ss_pred EECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998765444333333344567899999998889999999999999999999988889999888899
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+.+..+.....+..++.++.+++.+||+.+|++||++.++++.|.++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred HHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 998888877777888999999999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=335.22 Aligned_cols=251 Identities=40% Similarity=0.764 Sum_probs=214.7
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|+.. .+++.||+|.++..........+.+|++++++++||||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLR-----ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEe-----cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeec
Confidence 35899999999999863 3568899999876655666678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.++++. ....+++..++.++.|++.||+|||+++++|+||||+|||+++++.+||+
T Consensus 76 ~~~~L~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 136 (252)
T cd05084 76 QGGDFLTFLRT-------------------EGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKIS 136 (252)
T ss_pred cCCcHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEEC
Confidence 99999999862 12357899999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||++.................+..|+|||.+.++.++.++||||||+++|||++++..||.....++....+..+....
T Consensus 137 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 216 (252)
T cd05084 137 DFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216 (252)
T ss_pred ccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC
Confidence 99998754322111111222345679999999999999999999999999999997888998888877777777665566
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+..++..+.+++.+||+.+|++|||+.++++.|.
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 77788999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=337.36 Aligned_cols=259 Identities=36% Similarity=0.683 Sum_probs=221.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|... ++..||+|.++.... ..+.+.+|+.++++++|+||+++++.+...
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN------NSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec------CCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 456778999999999999999999863 235799999875332 245789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..+++|||+++|+|.++++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 135 (261)
T cd05072 74 EPIYIITEYMAKGSLLDFLKSD------------------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135 (261)
T ss_pred CCcEEEEecCCCCcHHHHHHHh------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 9999999999999999999632 1245788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||+++....... .......++..|+|||.+....++.++||||||+++|||++++..||.+....+..
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM 214 (261)
T ss_pred ecCCCcEEECCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH
Confidence 99999999999999976532211 12223345678999999999999999999999999999999777899888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+...+.+..++.++.+++.+||+.+|++||+++++.+.|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 215 SALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8887776555666789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=348.31 Aligned_cols=287 Identities=39% Similarity=0.709 Sum_probs=236.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCC--ccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH--EEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLG 435 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g 435 (653)
++++...+|.+.+.||+|+||.||+|+..+.... .....||+|.++........+++.+|+++++++ +||||+++++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG 85 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence 3466667899999999999999999986442221 233579999998665555567899999999999 8999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..++..++++||+++|+|.+++....+....... .........+++.+++.++.|++.||.|||+++++|||||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSF----DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCccccccc----ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 999999999999999999999999865432211000 0001123468899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++...............++..|||||.+.+..++.++||||||+++|||++++..||.+.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999999765433322223334446789999999999999999999999999999997778999999
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.++....+..+.....+...+.++.+++.+||+.+|.+||++.+|++.|..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 999988888877666777889999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.08 Aligned_cols=259 Identities=37% Similarity=0.696 Sum_probs=221.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++++++|++.+.||+|+||.||+|... .++.||+|.++.... ..+++.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~------~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN------NTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec------CCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecC
Confidence 567788999999999999999999853 236799999875432 245688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++++|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||+
T Consensus 74 ~~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 135 (261)
T cd05068 74 EPIYIVTELMKYGSLLEYLQGG------------------AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135 (261)
T ss_pred CCeeeeeecccCCcHHHHHhcc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEE
Confidence 9999999999999999998621 1245789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||+++...... .........+..|+|||.+.+..++.++||||||+++|||++++..||.+.+..++.
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 214 (261)
T cd05068 136 VGENNICKVADFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL 214 (261)
T ss_pred EcCCCCEEECCcceEEEccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 9999999999999998654221 112222333568999999999999999999999999999999777899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+........+...+..+.+++.+||+.+|.+||++.+|.+.|++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 215 QQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 8877665555667789999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=337.52 Aligned_cols=263 Identities=40% Similarity=0.738 Sum_probs=218.2
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC------
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG------ 440 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------ 440 (653)
.+.+.||+|+||.||+|+... ......||+|.++.. ......+.+.+|+++++.++|+||+++++++...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~---~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQ---DDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred ccccccCcccCceEEEeEEcc---CCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCC
Confidence 356789999999999998743 122347999988754 2344456789999999999999999999987432
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...+++|||+++|+|.+++.... .......+++..+..++.|++.||+|||+++|+||||||+|||
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil 144 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLLYSR--------------LGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCM 144 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHHHhc--------------ccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheE
Confidence 25689999999999999885211 0112345899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||+++.+..............+..|++||.+....++.++||||||+++|||++++..||.+....+..
T Consensus 145 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 224 (272)
T cd05075 145 LNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224 (272)
T ss_pred EcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987643333222233456778999999999999999999999999999999778899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.+..+.....+..++..+.+++.+||+.+|++|||+.+|++.|..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 225 DYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88888877667778899999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.99 Aligned_cols=251 Identities=23% Similarity=0.430 Sum_probs=223.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|.+.+.||+|+||+||||+- +.+.+.||+|.+.+. ..+...+.+.+|++|+++++|||||.++++|+...++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrr-----K~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRR-----KYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeeccc-----ccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceE
Confidence 4677888999999999999984 457789999998643 3445567799999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|.||+.+ +|..+|. ....+++..+..|+.++++||.|||+.+|+|||+||+|||++.
T Consensus 77 ~vVte~a~g-~L~~il~--------------------~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~ 135 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILE--------------------QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEK 135 (808)
T ss_pred EEEehhhhh-hHHHHHH--------------------hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecC
Confidence 999999977 9999996 3467999999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+|.+|++|||+|+.+..+.. .-....||+.|||||...+..|+..+|.||+||++||+++ |.+||+..+..++++.|
T Consensus 136 ~~~~KlcdFg~Ar~m~~~t~--vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~-G~PPF~a~si~~Lv~~I 212 (808)
T KOG0597|consen 136 GGTLKLCDFGLARAMSTNTS--VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYV-GQPPFYARSITQLVKSI 212 (808)
T ss_pred CCceeechhhhhhhcccCce--eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhc-CCCCchHHHHHHHHHHH
Confidence 99999999999998754332 2345678999999999999999999999999999999999 66799998888999988
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..... ..|...+..+.+++...+.+||.+|.|-.+++.|.+
T Consensus 213 ~~d~v-~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 213 LKDPV-KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred hcCCC-CCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 77553 456688899999999999999999999999998875
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=347.97 Aligned_cols=250 Identities=22% Similarity=0.341 Sum_probs=216.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .+++.||+|.++... .....+.+.+|+.++++++||||+++++++..+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDR-----ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 36888999999999999999864 356789999986432 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~ 135 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRN--------------------SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLD 135 (291)
T ss_pred EEEEEeCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEEC
Confidence 9999999999999999862 23578889999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++.... ......+++.|+|||.+.+..++.++||||||+++|||++|. .||.+.+..++.+.
T Consensus 136 ~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~-~pf~~~~~~~~~~~ 209 (291)
T cd05612 136 KEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGY-PPFFDDNPFGIYEK 209 (291)
T ss_pred CCCCEEEEecCcchhccC-----CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHH
Confidence 999999999999976522 112345788999999999999999999999999999999954 58988888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~ 646 (653)
+..+. ...+...+..+.+|+++||+.||.+||+ ++++++|.|-
T Consensus 210 i~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 210 ILAGK-LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred HHhCC-cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 87765 3566678899999999999999999995 9999999864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=341.90 Aligned_cols=276 Identities=46% Similarity=0.827 Sum_probs=222.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCC-----------CCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGL-----------LKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----------~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn 429 (653)
+++.++|++.+.||+|+||.||+++..+. ........||+|+++.........++.+|+.+++.++|+|
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (296)
T cd05095 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPN 80 (296)
T ss_pred CCChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCC
Confidence 35677899999999999999999865321 1223456799999987666666778999999999999999
Q ss_pred cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 430 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
|+++++++..++..++||||+++|+|.+++......... .......+++..++.++.|++.||+|||+.++
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i 151 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA---------EKADVVTISYSTLIFMATQIASGMKYLSSLNF 151 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc---------ccccccccCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999999999999999999999999999999854322110 01223458899999999999999999999999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC-CC
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF-AL 588 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~-~~ 588 (653)
+|+||||+|||+++++.++|+|||+++.+.............++..|++||....+.++.++||||||+++|||+++ +.
T Consensus 152 ~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~ 231 (296)
T cd05095 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKE 231 (296)
T ss_pred ecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999866443322222333456789999999889999999999999999999984 56
Q ss_pred CCCCCCCHHHHHHHHHc-------CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKE-------GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~-------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.||...+..+.+..... ....+.+..++..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 232 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 232 QPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred CCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 78877776665543321 1122345568899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=328.63 Aligned_cols=252 Identities=24% Similarity=0.399 Sum_probs=222.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
...++|++++.||.|+||+|.+++.+ .++..+|+|+++...-. .+.+-..+|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k-----~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREK-----HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEc-----cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 44568999999999999999999964 45789999999865332 233456789999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+.++|||||++||.|..+|+. .+.+++..+..+|.||+.||+|||+.+|++|||||+||
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk--------------------~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRK--------------------SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHh--------------------cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 9999999999999999999983 35688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|||.+|.+||+|||.|+..... .-...||+.|+|||.+....++.++|.|||||++|||+. |.+||+..+...+
T Consensus 176 LlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla-G~pPF~~~~~~~i 249 (355)
T KOG0616|consen 176 LLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA-GYPPFYDDNPIQI 249 (355)
T ss_pred eeccCCcEEEEeccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc-CCCCCcCCChHHH
Confidence 9999999999999999876322 234578999999999999999999999999999999998 6679999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCC-----CCHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR-----PSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~eil~~L~ 645 (653)
.+.|.++++ .+|...+.++++|++..++.|-.+| ....+|..|.|
T Consensus 250 Y~KI~~~~v-~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~w 299 (355)
T KOG0616|consen 250 YEKILEGKV-KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPW 299 (355)
T ss_pred HHHHHhCcc-cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcc
Confidence 999999985 6889999999999999999999999 35557777665
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=334.62 Aligned_cols=265 Identities=38% Similarity=0.666 Sum_probs=224.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|...+.||+|+||.||+|+... .......+|+|.++........+.+..|++++++++|+||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKM--PGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEec--CCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 445678899999999999999998743 223346899999986655555678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|.+++.. ....+++.++..++.|++.||+|||+.+++|+||||+||++
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~-------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili 140 (268)
T cd05063 80 PAMIITEYMENGALDKYLRD-------------------HDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV 140 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE
Confidence 99999999999999999862 12457899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCcccccccccccc-CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++++.+||+|||++.......... .......+..|+|||.+....++.++||||||+++|||++.+..||...+..++.
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~ 220 (268)
T cd05063 141 NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVM 220 (268)
T ss_pred cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence 999999999999987653222111 1112233567999999998999999999999999999998677799888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+...+.+..++.++.+++.+||+.+|++||++.+|++.|.++
T Consensus 221 ~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 88887766666677899999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=333.87 Aligned_cols=253 Identities=35% Similarity=0.696 Sum_probs=216.5
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 451 (653)
.||+|+||.||+|.+.. ...+..||+|+++........+.+.+|+.++++++|+||+++++++. ....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~---~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKM---RKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEec---CCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 38999999999998642 22346799999987666666678999999999999999999999875 457899999999
Q ss_pred CCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEec
Q psy5539 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531 (653)
Q Consensus 452 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~D 531 (653)
+|+|.+++.. ....+++..+++++.|++.||.|||+++++||||||+|||++.++.+||+|
T Consensus 78 ~~~L~~~l~~-------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~d 138 (257)
T cd05115 78 GGPLNKFLSG-------------------KKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISD 138 (257)
T ss_pred CCCHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEecc
Confidence 9999999862 124588999999999999999999999999999999999999999999999
Q ss_pred cCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 532 FGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 532 fGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
||+++....... ........++..|+|||.+....++.++||||||+++||+++.+..||.+....++...+..+....
T Consensus 139 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 218 (257)
T cd05115 139 FGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD 218 (257)
T ss_pred CCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC
Confidence 999975433221 1122223346789999999988999999999999999999986778999999888888888888777
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+..+++++.+++.+||..+|++||++.+|.+.|..+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 7888999999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=358.40 Aligned_cols=252 Identities=26% Similarity=0.376 Sum_probs=226.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
-+++.+.||.|+-|.|-+|+. ..+|+.+|||.+... ..+.....+++||.+|+.+.||||+++|++++.+.++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh-----~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~l 87 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKH-----AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHL 87 (786)
T ss_pred ceeccccccCCCCceehhhhc-----ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceE
Confidence 467788899999999999985 468899999998654 3344456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
|||.||+++|.|.+||. ..+++++.++.++++||+.|+.|+|..+|+||||||+|+|||.
T Consensus 88 ylvlEyv~gGELFdylv--------------------~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 88 YLVLEYVPGGELFDYLV--------------------RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred EEEEEecCCchhHHHHH--------------------hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 99999999999999997 3467899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.+++||+|||+|....... --+...|++.|++||.+.+..|. .++||||-||||+.|++|.+ ||.+.+...++.+
T Consensus 148 ~~nIKIADFGMAsLe~~gk---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~L-PFdDdNir~LLlK 223 (786)
T KOG0588|consen 148 KNNIKIADFGMASLEVPGK---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKL-PFDDDNIRVLLLK 223 (786)
T ss_pred ccCEeeeccceeecccCCc---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCC-CCCCccHHHHHHH
Confidence 9999999999997643322 23456789999999999999985 89999999999999999766 9999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
++.|.+ +.|.+++.+.++|+++|+..||++|.|+++|++|+|-.
T Consensus 224 V~~G~f-~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 224 VQRGVF-EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred HHcCcc-cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 999975 68899999999999999999999999999999999865
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=352.03 Aligned_cols=251 Identities=23% Similarity=0.317 Sum_probs=217.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|.+.+.||+|+||.||+|+.. .+++.||+|.++... .....+.+.+|+.++++++||||+++++++..+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 90 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHK-----GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE 90 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC
Confidence 3468999999999999999999864 356789999987542 223345688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 91 ~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIl 150 (329)
T PTZ00263 91 NRVYFLLEFVVGGELFTHLRK--------------------AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150 (329)
T ss_pred CEEEEEEcCCCCChHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEE
Confidence 999999999999999999862 235788889999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||+++..... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+..
T Consensus 151 l~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~pf~~~~~~~~~ 224 (329)
T PTZ00263 151 LDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIA-GYPPFFDDTPFRIY 224 (329)
T ss_pred ECCCCCEEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHc-CCCCCCCCCHHHHH
Confidence 999999999999999765221 123457889999999999999999999999999999999 45689888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
+.+..+. ...+..++..+.+|+++||+.||.+||+ ++++++|.|
T Consensus 225 ~~i~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~ 273 (329)
T PTZ00263 225 EKILAGR-LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273 (329)
T ss_pred HHHhcCC-cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence 8888775 4567778999999999999999999996 799998875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=342.25 Aligned_cols=271 Identities=42% Similarity=0.771 Sum_probs=224.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
...+..++|.+.+.||+|+||.||+|+..+.........||||+++........+.+.+|+.+++++ +|+||+++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 3466778899999999999999999986543344566789999998665555567899999999999 799999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.++++... ...+++.+++.++.|++.||+|||+++++|+||||+
T Consensus 109 ~~~~~~~lv~e~~~~~~L~~~i~~~~------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~ 170 (302)
T cd05055 109 TIGGPILVITEYCCYGDLLNFLRRKR------------------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 170 (302)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccc
Confidence 99999999999999999999996221 123799999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++++..||.+....
T Consensus 171 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~ 250 (302)
T cd05055 171 NVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250 (302)
T ss_pred eEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence 99999999999999999976532221111222345678999999999999999999999999999999677788776654
Q ss_pred H-HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 598 E-VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 598 e-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+ ....+..+.....+...+.++.+++.+||+.+|++|||+.++++.|..+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 251 SKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 4 4444455544445566789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.26 Aligned_cols=258 Identities=38% Similarity=0.740 Sum_probs=216.2
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe-cCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA-VGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-~~~~~~LV~Ey 449 (653)
+.||+|+||.||+|.... .......||+|.+.........+.+.+|+.+++.++||||+++++++. .+...++|+||
T Consensus 1 ~~lg~g~~g~v~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLID--SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEec--CCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 358999999999998642 223457899999865444445667889999999999999999999875 45568999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEE
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI 529 (653)
+.+|+|.++++.. ...+++..++.++.||++||+|||+.+++||||||+|||+++++.+||
T Consensus 79 ~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl 139 (262)
T cd05058 79 MKHGDLRNFIRSE-------------------THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKV 139 (262)
T ss_pred CCCCCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEE
Confidence 9999999999621 223567788999999999999999999999999999999999999999
Q ss_pred eccCcccccccccccc--CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 530 ADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 530 ~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
+|||+++.+....... ......++..|+|||.+....++.++||||||+++|||++++.+||...+..+....+..+.
T Consensus 140 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~ 219 (262)
T cd05058 140 ADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGR 219 (262)
T ss_pred CCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 9999997654322111 11233456789999999989999999999999999999998888998888888888888777
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
....+..++..+.+++.+||+.+|++||++.+|++.+..+..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 666677788999999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=341.93 Aligned_cols=277 Identities=43% Similarity=0.803 Sum_probs=221.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCC---------CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLL---------KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV 431 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~---------~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv 431 (653)
|++.++|++.+.||+|+||.||+++..+.. .......||+|.++..........|.+|++++++++|+||+
T Consensus 1 ~~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CCchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456778999999999999999999864321 11233569999998765666677899999999999999999
Q ss_pred eEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 432 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
++++++...+..++||||+++++|.+++....... ..........+++..++.++.|++.||+|||+.+++|
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H 152 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIES--------TFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVH 152 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccc--------cccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeec
Confidence 99999999999999999999999999996432100 0011112345789999999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC-CCCC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF-ALQP 590 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~-~~~p 590 (653)
+||||+|||+++++.+||+|||+++...............++..|+|||.+..+.++.++||||||+++|||+++ +..|
T Consensus 153 ~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 153 RDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred cccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999765433332223334457789999999999999999999999999999984 5568
Q ss_pred CCCCCHHHHHHHHHc-----C--CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKE-----G--NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~-----~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|...+.++++..+.. + .....+...+..+.+|+.+||+.+|++||++++|++.|.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 233 YSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred CcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 887777666554422 1 112334567899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=339.11 Aligned_cols=276 Identities=38% Similarity=0.664 Sum_probs=224.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|.... ......+++|.++........+.+.+|++++.++ +||||+++++++......
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~ 78 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL 78 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC---CCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence 578899999999999999998643 1122457889888655555566789999999999 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+++|+|.++++........... .........+++..++.++.|++.||+|||+++++||||||+|||+++
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 79 YIAIEYAPYGNLLDFLRKSRVLETDPAF----AKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccc----ccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 9999999999999999753321110000 001112346899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++.... ..........+..|+|||.+....++.++||||||+++|||++.+..||.+....++...+
T Consensus 155 ~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 155 NLASKIADFGLSRGEE---VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred CCeEEECCcCCCcccc---ceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999986421 1111222334567999999999999999999999999999998667799999888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+.....+..++..+.+|+.+||+.+|.+||++++|++.|..+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~ 278 (297)
T cd05089 232 PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278 (297)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 77766666777899999999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=334.20 Aligned_cols=263 Identities=36% Similarity=0.657 Sum_probs=222.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.+++++.+.||+|+||.||+|+... .......||||.++....+....+|..|+.+++.++||||+++++++..+...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKL--PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEec--CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3568899999999999999998753 22234679999998765566677899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.++++.. ...+++.+++.++.|++.||.|||+.+++|+||||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~ 141 (269)
T cd05065 81 MIITEFMENGALDSFLRQN-------------------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS 141 (269)
T ss_pred EEEEecCCCCcHHHHHhhC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcC
Confidence 9999999999999998621 235789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCcccccccccccc---CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYK---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.+||+|||++.......... .......+..|+|||.+.+..++.++||||||+++||+++.+..||.+.+..++.
T Consensus 142 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~ 221 (269)
T cd05065 142 NLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221 (269)
T ss_pred CCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH
Confidence 9999999999987543222111 1111223567999999999999999999999999999998677799888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+......+.+..++..+.+++.+||+.+|.+||++.+|+..|..+
T Consensus 222 ~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 222 NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 88876655556677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.03 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=205.9
Q ss_pred CccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh--CCCCccc
Q psy5539 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE--FDHPNIV 431 (653)
Q Consensus 354 ~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~--l~HpnIv 431 (653)
.|.|.+..++ .++.+.+.||+|.||.||+|+++| ..||||++...... .+.+|.++... |+|+||+
T Consensus 201 lplLVQRTia-rqI~L~e~IGkGRyGEVwrG~wrG-------e~VAVKiF~srdE~----SWfrEtEIYqTvmLRHENIL 268 (513)
T KOG2052|consen 201 LPLLVQRTIA-RQIVLQEIIGKGRFGEVWRGRWRG-------EDVAVKIFSSRDER----SWFRETEIYQTVMLRHENIL 268 (513)
T ss_pred chhHhHHhhh-heeEEEEEecCccccceeeccccC-------CceEEEEecccchh----hhhhHHHHHHHHHhccchhh
Confidence 3445554444 478999999999999999999876 67999999764433 34566666554 6999999
Q ss_pred eEEeEEecC----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-
Q psy5539 432 KLLGVCAVG----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD- 506 (653)
Q Consensus 432 ~l~g~~~~~----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~- 506 (653)
.+++....+ ..++||.+|.++|+|+|||.. ..++....++++..+|.||+|||-
T Consensus 269 gFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r---------------------~tv~~~~ml~LalS~AsGLaHLH~e 327 (513)
T KOG2052|consen 269 GFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR---------------------NTVTTEGMLKLALSIASGLAHLHME 327 (513)
T ss_pred hhhhccccCCCceEEEEEeeecccCCcHHHHHhh---------------------ccCCHHHHHHHHHHHhhhHHHHHHH
Confidence 999886543 378999999999999999972 458999999999999999999994
Q ss_pred -------CCceecCCCCCCEeEcCCCcEEEeccCcccccccc--ccccCCCCCCCccccccchhhccCC------CCCch
Q psy5539 507 -------RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ--DYYKGDENDAIPVRWMPLESILYNK------YTVES 571 (653)
Q Consensus 507 -------~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~--~~~~~~~~~~~t~~y~aPE~~~~~~------~t~ks 571 (653)
..|.|||||+.||||..++.+.|+|+|||-..... ..........||.+|||||++...- .-..+
T Consensus 328 I~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~A 407 (513)
T KOG2052|consen 328 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRA 407 (513)
T ss_pred HhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHH
Confidence 36999999999999999999999999999765433 1223455678999999999986541 23679
Q ss_pred hHHHHHHHHHHHHh----CC-----CCCCCCC-----CHHHHHHHHHcCCccC-CCCC-----CcHHHHHHHHHhhccCC
Q psy5539 572 DVWAFGVCLWEIFS----FA-----LQPYYGL-----THEEVVKYIKEGNILQ-APDN-----TPDALYDLMKLCWNMKP 631 (653)
Q Consensus 572 DVwSlGvvl~ellt----~~-----~~p~~~~-----~~~e~~~~i~~~~~~~-~~~~-----~~~~l~~li~~cl~~dP 631 (653)
||||||+|+||+.. || .+||++. +.+++.+.+...+..+ .|.. ....+.++|+.||..+|
T Consensus 408 DIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np 487 (513)
T KOG2052|consen 408 DIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANP 487 (513)
T ss_pred HHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCc
Confidence 99999999999984 33 2577754 4456666555444332 2322 23567889999999999
Q ss_pred CCCCCHHHHHHHHHHHHHH
Q psy5539 632 MNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 632 ~~RPs~~eil~~L~~l~~~ 650 (653)
..|.|+-.|.+.|.++.+.
T Consensus 488 ~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 488 AARLTALRIKKTLAKLSNS 506 (513)
T ss_pred hhhhHHHHHHHHHHHHhcC
Confidence 9999999999999988753
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.20 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=222.6
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+....+..++|+.+..||+|+||.||+|+- ..+|..+|+|++++... ....+-++.|-.+|...+.|.||+|+
T Consensus 133 ~~R~r~~~~DFe~Lk~IgkGAfGeVrLarK-----k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLy 207 (550)
T KOG0605|consen 133 LRRTRLSLDDFELLKVIGKGAFGEVRLARK-----KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLY 207 (550)
T ss_pred hccccCCcccchhheeeccccceeEEEEEE-----ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEE
Confidence 344467788999999999999999999984 46789999999986532 23345678899999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
-.|.+.+.+||||||++|||+..+|. ..+.|++..+..++.+.+.|++.||+.|+|||||
T Consensus 208 YsFQD~~~LYLiMEylPGGD~mTLL~--------------------~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDI 267 (550)
T KOG0605|consen 208 YSFQDKEYLYLIMEYLPGGDMMTLLM--------------------RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDI 267 (550)
T ss_pred EEecCCCeeEEEEEecCCccHHHHHH--------------------hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccC
Confidence 99999999999999999999999996 3467899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCcccccccc----------------------cccc----C-------------------CCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQ----------------------DYYK----G-------------------DEN 549 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~----------------------~~~~----~-------------------~~~ 549 (653)
||+|+|||..|++||+||||+.-+... +... . ...
T Consensus 268 KPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~S 347 (550)
T KOG0605|consen 268 KPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYS 347 (550)
T ss_pred ChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhc
Confidence 999999999999999999998533110 0000 0 011
Q ss_pred CCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHh
Q psy5539 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLC 626 (653)
Q Consensus 550 ~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~c 626 (653)
..||+-|||||++.+..|+...|.||||||+|||+. |.+||.+.++.+....|.... .+..|+ .++++..+||.+|
T Consensus 348 tVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLv-GyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rl 426 (550)
T KOG0605|consen 348 TVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLV-GYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRL 426 (550)
T ss_pred ccCCccccchHHHhcCCCCccccHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHH
Confidence 357899999999999999999999999999999998 778999999999998887654 244443 4779999999999
Q ss_pred hccCCCCCC---CHHHHHHHHHH
Q psy5539 627 WNMKPMNRP---SFRTIYQTLWN 646 (653)
Q Consensus 627 l~~dP~~RP---s~~eil~~L~~ 646 (653)
+. ||++|. +++||.+|+|-
T Consensus 427 l~-d~~~RLG~~G~~EIK~HPfF 448 (550)
T KOG0605|consen 427 LC-DPENRLGSKGAEEIKKHPFF 448 (550)
T ss_pred hc-CHHHhcCcccHHHHhcCCcc
Confidence 99 999998 58899888753
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=331.95 Aligned_cols=251 Identities=37% Similarity=0.715 Sum_probs=214.3
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
.||+|+||.||+|.+.. ..++..+|+|+++... .....+++.+|+.+++.++|+||+++++++. .+..++||||+
T Consensus 2 ~lg~G~~g~v~~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM---KKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEec---CCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecC
Confidence 58999999999997642 2356789999987543 3345678999999999999999999999875 45779999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+|||+++++.+||+
T Consensus 78 ~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~ 137 (257)
T cd05116 78 ELGPLNKFLQK--------------------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKIS 137 (257)
T ss_pred CCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEEC
Confidence 99999999862 2347889999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcc
Q psy5539 531 DFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609 (653)
Q Consensus 531 DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~ 609 (653)
|||+++........ .......++..|+|||.+....++.++||||||+++|||++.+..||.+....++.+.+..+...
T Consensus 138 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 217 (257)
T cd05116 138 DFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217 (257)
T ss_pred CCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC
Confidence 99999765433221 11222334678999999988889999999999999999998677899888888899999888777
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 610 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..++.++.++|.+||+.+|++||++++|.+.|.+
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 7888899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=333.52 Aligned_cols=263 Identities=39% Similarity=0.679 Sum_probs=222.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||.||+|+... .......+|+|.++........+.+.+|+.++++++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~--~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKL--PGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEec--CCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4578899999999999999998632 22344689999998665555667899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ....+++.+++.++.|++.||.|||+.+++||||||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~ 141 (267)
T cd05066 81 MIVTEYMENGSLDAFLRK-------------------HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS 141 (267)
T ss_pred EEEEEcCCCCCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECC
Confidence 999999999999999962 1235789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCcccccccccccc-CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.++|+|||++.......... .......+..|+|||.+.+..++.++||||||+++||+++.+..||.+....+....
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~ 221 (267)
T cd05066 142 NLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA 221 (267)
T ss_pred CCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH
Confidence 9999999999997653222111 112223356899999999999999999999999999999867779988888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.++...+.+..++..+.+++.+||+.+|.+||++.++++.|..+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 222 IEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 887765556667889999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=340.03 Aligned_cols=275 Identities=45% Similarity=0.803 Sum_probs=224.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCC-----------CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLL-----------KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~-----------~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI 430 (653)
++.++|++.+.||+|+||.||+|+..... .......||+|.++........+.+.+|++++++++||||
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCE
Confidence 45678899999999999999999875422 1224467999999876666667789999999999999999
Q ss_pred ceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 431 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
+++++++..++..++++||+++++|.+++......... .......+++..++.++.|++.||+|||+.+++
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~ 152 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSG---------LACNSKSLSFSTLLYMATQIASGMRYLESLNFV 152 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccc---------ccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 99999999999999999999999999999744321100 012234689999999999999999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC-CCC
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF-ALQ 589 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~-~~~ 589 (653)
|+||||+||++++++.++|+|||+++.....+.........++..|||||.+....++.++||||||+++|||+++ +..
T Consensus 153 H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 153 HRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred ccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 9999999999999999999999999876544433333444567889999999988999999999999999999984 567
Q ss_pred CCCCCCHHHHHHHHHcC-------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEG-------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~-------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||...+..+++..+... .....+..++.++.+++.+||+.+|.+|||+.+|++.|.
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 233 PYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred CCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 88877777766655432 112334557789999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=340.12 Aligned_cols=278 Identities=40% Similarity=0.667 Sum_probs=225.3
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 441 (653)
..++|++.+.||+|+||.||+|++.. ......+++|.++..........+.+|++++.++ +|+||+++++++..++
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 45688999999999999999998642 1222457888887655555667889999999999 8999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.++++.......... ..........+++.+++.++.|++.||+|||+++++||||||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPA----FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhccccccccc----ccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 99999999999999999975432111000 00001123468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++... ..........+..|+|||.+.+..++.++||||||+++|||++.+..||.+.+..+..+
T Consensus 158 ~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 158 GENYVAKIADFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred cCCCcEEeCccccCcccc---hhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 999999999999986321 11112223446789999999888899999999999999999996667998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+...+.++.+|+.+||+.+|++||+++++++.+..+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 8777655556667889999999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=351.23 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=218.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|.+.+.||+|+||.||+|+..+ .....||+|.+.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~ 101 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKN----EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK 101 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEEC----CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE
Confidence 3455689999999999999999998632 234689999986432 2233456889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.++..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus 102 ~~~~~~lv~Ey~~~g~L~~~i~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 102 DESYLYLVLEFVIGGEFFTFLRR--------------------NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred eCCEEEEEEeCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 99999999999999999999862 2357889999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||+++.... ......+|+.|||||.+.+..++.++||||||+++|||++| ..||.+.+...
T Consensus 162 ILl~~~~~ikL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~~~ 235 (340)
T PTZ00426 162 LLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG-CPPFYANEPLL 235 (340)
T ss_pred EEECCCCCEEEecCCCCeecCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcC-CCCCCCCCHHH
Confidence 9999999999999999976421 12334678899999999999999999999999999999995 45998888888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+.+.+..+.. ..|...+..+.+++++|++.+|.+|+ +++++++|+|
T Consensus 236 ~~~~i~~~~~-~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 236 IYQKILEGII-YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred HHHHHhcCCC-CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 8888877653 46778899999999999999999995 8999999875
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=333.91 Aligned_cols=268 Identities=33% Similarity=0.631 Sum_probs=228.1
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+...+|++.+.||+|+||.||+|...... ......+|+|.++.........++.+|+.++++++|+||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEG-EKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCC-CCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45567899999999999999999864321 222457999998876655566789999999999999999999999887 7
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+++|+|.+++... ...+++..++.++.||+.||+|||+++++|+||||+|||+
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~ 142 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNH-------------------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV 142 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE
Confidence 889999999999999998621 2348899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++................+..|+|||.+....++.++||||||+++||+++.+..||.+...+++.+
T Consensus 143 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 222 (279)
T cd05057 143 KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPD 222 (279)
T ss_pred cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 99999999999999865432221122223346789999999888999999999999999999996777999999899998
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+..++..+.+++.+||..+|.+||++.++++.+.++.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 8888877777778889999999999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=353.39 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=218.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++..|....+||+|+-|.||.|+.. ..+..||||++..... ..++-+.+|+.+|+..+|+|||.++..+..++.
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~-----~~~~~VaiK~m~l~~Q-~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de 344 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKI-----STKQEVAIKRMDLRKQ-PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE 344 (550)
T ss_pred hhhhhcchhhhccccccceeeeeec-----cCCceEEEEEEEeccC-CchhhhHHHHHHHHhccchHHHHHHHHhcccce
Confidence 3446777788999999999999854 3557799999864322 234457899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
+|.|||||++|+|.+.+. ...+++.++..|+++++.||+|||.++|+|||||.+|||++
T Consensus 345 LWVVMEym~ggsLTDvVt---------------------~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVT---------------------KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT 403 (550)
T ss_pred eEEEEeecCCCchhhhhh---------------------cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence 999999999999999875 23489999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.+|.+||+|||++..+..... ......||+.|||||++....|..|.||||||++++||+. |.+||...++-..+..
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMve-GEPPYlnE~PlrAlyL 480 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVE-GEPPYLNENPLRALYL 480 (550)
T ss_pred cCCcEEEeeeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhc-CCCCccCCChHHHHHH
Confidence 999999999999987643332 3345678999999999999999999999999999999998 5678887777666666
Q ss_pred HHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|..... +..++.++..+++|+.+||..|+.+|+++.|+++|.+-
T Consensus 481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl 526 (550)
T KOG0578|consen 481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL 526 (550)
T ss_pred HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence 655443 45677899999999999999999999999999999864
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.27 Aligned_cols=257 Identities=21% Similarity=0.343 Sum_probs=213.1
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+++.. .++..+|+|.++........+.+.+|++++++++||||+++++++..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHK-----PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEEC-----CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45678999999999999999999864 3567899999987655556678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCEe
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCL 520 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NIL 520 (653)
..++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 77 EISICMEHMDGGSLDQVLKE--------------------AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred EEEEEeecCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 99999999999999999862 23478889999999999999999986 6999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|. .||...+..++.
T Consensus 137 ~~~~~~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~-~p~~~~~~~~~~ 211 (331)
T cd06649 137 VNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR-YPIPPPDAKELE 211 (331)
T ss_pred EcCCCcEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC-CCCCCCCHHHHH
Confidence 999999999999998754221 123346788999999999999999999999999999999965 487665554443
Q ss_pred HHHH----------------------------------------------cCCccCCC-CCCcHHHHHHHHHhhccCCCC
Q psy5539 601 KYIK----------------------------------------------EGNILQAP-DNTPDALYDLMKLCWNMKPMN 633 (653)
Q Consensus 601 ~~i~----------------------------------------------~~~~~~~~-~~~~~~l~~li~~cl~~dP~~ 633 (653)
..+. .......+ ...+.++.+|+.+||..||++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~ 291 (331)
T cd06649 212 AIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAE 291 (331)
T ss_pred HHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCccc
Confidence 3221 11111111 236788999999999999999
Q ss_pred CCCHHHHHHHHHHHH
Q psy5539 634 RPSFRTIYQTLWNIK 648 (653)
Q Consensus 634 RPs~~eil~~L~~l~ 648 (653)
|||+++|++++|--.
T Consensus 292 Rpt~~ell~h~~~~~ 306 (331)
T cd06649 292 RADLKMLMNHTFIKR 306 (331)
T ss_pred CCCHHHHhcChHHhh
Confidence 999999999987543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.84 Aligned_cols=253 Identities=36% Similarity=0.745 Sum_probs=216.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||.||+|+..+ ...+|+|.++.... ..+++.+|+.++++++||||+++++++......
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~------~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG------QYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPI 74 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC------CCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCc
Confidence 4578899999999999999998642 24599999875432 235689999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+.+|+|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+|||+++
T Consensus 75 ~lv~e~~~~~~l~~~i~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 75 YIVTEYMSNGCLLNYLREH-------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 9999999999999998621 225789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++.+..||......++...+
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 136 QGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred CCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 99999999999876533221 12223345678999999998899999999999999999999677799888888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.....+...+..+++++.+||+.+|.+||++.+|++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~ 255 (256)
T cd05113 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI 255 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence 88776666677889999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=335.86 Aligned_cols=262 Identities=22% Similarity=0.382 Sum_probs=219.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
....++|++...||.|.-++||+|+... .+..||||++.-+......+.+++|+..|+.++||||++++..|..+
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p-----~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~ 96 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIP-----TNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD 96 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecc-----cCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec
Confidence 4456689999999999999999999743 33789999998665544567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..+|+||.||.+|++.+.++..-+ ..+++..+..|++++++||.|||.+|.||||||+.|||
T Consensus 97 ~~LWvVmpfMa~GS~ldIik~~~~------------------~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 97 SELWVVMPFMAGGSLLDIIKTYYP------------------DGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred ceeEEeehhhcCCcHHHHHHHHcc------------------ccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 999999999999999999984332 34899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccccccc-CC-CCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYK-GD-ENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~-~~-~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|+++|.|||+|||.+..+....... .. ....+++.|||||++.. ..|+.|+||||||++..||.+ |..||..+.+
T Consensus 159 i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~-G~aPf~k~pP 237 (516)
T KOG0582|consen 159 IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH-GHAPFSKYPP 237 (516)
T ss_pred EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc-CCCCcccCCh
Confidence 9999999999999987765433111 11 34578999999999654 369999999999999999998 5669999988
Q ss_pred HHHHHHHHcCCccCC-----C----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQA-----P----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~-----~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
-+++-.-..+..+.. + ...+..++.++..|+.+||++|||+++++++.|-
T Consensus 238 mkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FF 296 (516)
T KOG0582|consen 238 MKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFF 296 (516)
T ss_pred HHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHH
Confidence 877666555544211 1 1245678999999999999999999999998763
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=349.45 Aligned_cols=246 Identities=23% Similarity=0.334 Sum_probs=210.1
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
+.||+|+||.||+|+.. .+++.||||+++... .......+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREK-----ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 35899999999999863 456889999997542 22334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEE
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vk 528 (653)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|
T Consensus 76 ~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~k 135 (323)
T cd05571 76 YANGGELFFHLSR--------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIK 135 (323)
T ss_pred CCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEE
Confidence 9999999999862 24578999999999999999999999999999999999999999999
Q ss_pred EeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Q psy5539 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608 (653)
Q Consensus 529 I~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~ 608 (653)
|+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++|. .||.+.+...+...+..+.
T Consensus 136 l~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05571 136 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR-LPFYNQDHEKLFELILMEE- 211 (323)
T ss_pred EeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCC-CCCCCCCHHHHHHHHHcCC-
Confidence 99999987532111 1122345789999999999999999999999999999999954 5888888888877776654
Q ss_pred cCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 609 LQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 609 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...+...+.++.+++++||+.||++|| ++.++++|.|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~ 253 (323)
T cd05571 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRF 253 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCC
Confidence 456778899999999999999999999 8999998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.51 Aligned_cols=252 Identities=25% Similarity=0.373 Sum_probs=206.6
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|...+.||+|.||.||+|++ .++++.||||+++... .+.......|||+.|+.++|+||+.|++++-..+.+-
T Consensus 3 rY~~~~~lGEG~~gvVyka~d-----~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~ 77 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARD-----TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLS 77 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEe-----cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceE
Confidence 566678899999999999996 3578899999998553 2333456789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
||+|||+. ||...++ .+.-.++..++..++.++++||+|||++.|+||||||.|+|++++
T Consensus 78 lVfEfm~t-dLe~vIk-------------------d~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~ 137 (318)
T KOG0659|consen 78 LVFEFMPT-DLEVVIK-------------------DKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD 137 (318)
T ss_pred EEEEeccc-cHHHHhc-------------------ccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC
Confidence 99999976 9999887 234568999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
|.+||+|||+|+...+.+. .......|-.|.|||.+.+. .|+...|+||.|||+.||+- +.+-+.|.+.-+.+..|
T Consensus 138 g~lKiADFGLAr~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELll-r~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 138 GQLKIADFGLARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLL-RVPFFPGDSDIDQLSKI 214 (318)
T ss_pred CcEEeecccchhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHc-cCCCCCCCchHHHHHHH
Confidence 9999999999998754442 23334678899999999876 69999999999999999997 56666776654444333
Q ss_pred Hc----------------------CCccCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KE----------------------GNILQA-----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~----------------------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
-. ...+.. -...+++..+|+..+|..||.+|+|++|.+++..
T Consensus 215 f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 215 FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 21 000000 0124567899999999999999999999998764
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=331.70 Aligned_cols=267 Identities=37% Similarity=0.731 Sum_probs=227.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|..... ......|+||...........+.+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~--~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~- 78 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSP--ENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE- 78 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecC--CCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-
Confidence 45567789999999999999999986431 123457999998876555566789999999999999999999998875
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+++|+||||+|||
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nil 139 (270)
T cd05056 79 NPVWIVMELAPLGELRSYLQVN-------------------KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVL 139 (270)
T ss_pred CCcEEEEEcCCCCcHHHHHHhC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEE
Confidence 5678999999999999999621 234789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++........ ......++..|+|||.+....++.++||||||+++||+++.+..||.+.+..+..
T Consensus 140 i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 218 (270)
T cd05056 140 VSSPDCVKLGDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218 (270)
T ss_pred EecCCCeEEccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999998765433222 1223345668999999988899999999999999999998677899888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+..+.....+..++..+.+++.+||..+|.+|||+.++++.|..+..+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 219 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 88888877777888999999999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=318.19 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=226.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
..+.++|++.+.||+|-||.||+|+.+ .+.-.||+|++....- .....++.+|+++.+.|+||||+++++++.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarek-----ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREK-----KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeec-----cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 456689999999999999999999853 4668999999865422 233457899999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+....||++||.++|+|...|+. .....+++.....++.|+|.||.|+|.++|+||||||+|
T Consensus 93 d~~riyLilEya~~gel~k~L~~------------------~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpen 154 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQE------------------GRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPEN 154 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHh------------------cccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHH
Confidence 99999999999999999999972 233557888889999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
+|++..+.+||+|||.+..-. ........||..|.|||...+..++...|+|++|++.||++. |.+||...+..+
T Consensus 155 lLlg~~~~lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv-g~ppFes~~~~e 229 (281)
T KOG0580|consen 155 LLLGSAGELKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV-GLPPFESQSHSE 229 (281)
T ss_pred hccCCCCCeeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh-cCCchhhhhhHH
Confidence 999999999999999985421 122234568999999999999999999999999999999998 678999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+.|..-. ...|..++.+..++|.+|+..+|.+|.+..+++.|+|-..
T Consensus 230 tYkrI~k~~-~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 230 TYKRIRKVD-LKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHHHcc-ccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 999998866 4677999999999999999999999999999999998543
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.32 Aligned_cols=259 Identities=36% Similarity=0.685 Sum_probs=223.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
|.+..+|.+.+.||+|+||.||+|...+ +..+++|.++.... .....+.+|+.+++.++|+||+++++++...
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~------~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKN------RVRVAIKILKSDDL-LKQQDFQKEVQALKRLRHKHLISLFAVCSVG 74 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecC------CCcEEEEeccccch-hhHHHHHHHHHHHhcCCCcchhheeeeEecC
Confidence 3455678899999999999999998632 57899999876543 2345789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++.. ....+++..++.++.||+.||.|||+++++|+||||+|||
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nil 136 (261)
T cd05148 75 EPVYIITELMEKGSLLAFLRSP------------------EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136 (261)
T ss_pred CCeEEEEeecccCCHHHHHhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEE
Confidence 9999999999999999999621 2245789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++....... .......++..|+|||.+....++.++||||||+++|+|++++..||.+.+..++.
T Consensus 137 v~~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~ 214 (261)
T cd05148 137 VGEDLVCKVADFGLARLIKEDV--YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214 (261)
T ss_pred EcCCceEEEccccchhhcCCcc--ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 9999999999999997653221 11224456778999999998999999999999999999999778899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+.....+..+++.+.+++.+||+.+|.+|||+.+|.+.|..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 215 DQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred HHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 8888776666778899999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=329.01 Aligned_cols=255 Identities=38% Similarity=0.715 Sum_probs=217.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|.... .......+|+|.++........+++.+|+.+++.++|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~--~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLM--KSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeec--cCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 368999999999998643 222447899999987665555678999999999999999999999876 45689999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++.. ...+++..++.++.|++.||+|||+.+++|+||||+|||+++++.+||+
T Consensus 78 ~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~ 137 (257)
T cd05060 78 PLGPLLKYLKK--------------------RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKIS 137 (257)
T ss_pred CCCcHHHHHHh--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEec
Confidence 99999999962 2257899999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcc
Q psy5539 531 DFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609 (653)
Q Consensus 531 DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~ 609 (653)
|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++++..||...+..++...+..+...
T Consensus 138 df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd05060 138 DFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL 217 (257)
T ss_pred cccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC
Confidence 99999865433221 11222234568999999999999999999999999999998777799888888888888888777
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 610 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+..++..+++++.+||..+|++||++.+|++.|..+.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 778889999999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=337.98 Aligned_cols=251 Identities=22% Similarity=0.306 Sum_probs=207.2
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
|+..+.||+|+||.||+|... .+++.||+|.+..... ......+.+|+.++++++|+||+++++++...+..+
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~ 76 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEe-----cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEE
Confidence 677899999999999999864 3568999999865322 223346789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+||||||+|||++++
T Consensus 77 lv~e~~~~g~L~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 77 LVLTIMNGGDLKFHIYNM------------------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred EEEEecCCCcHHHHHHhh------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 999999999999888521 12357899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE----EVV 600 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~----e~~ 600 (653)
+.+||+|||++....... ......++..|||||.+.+..++.++||||||+++|||++| ..||.+.... ++.
T Consensus 139 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g-~~pf~~~~~~~~~~~~~ 214 (285)
T cd05631 139 GHIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQG-QSPFRKRKERVKREEVD 214 (285)
T ss_pred CCEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhC-CCCCCCCCcchhHHHHH
Confidence 999999999997642221 12334678999999999999999999999999999999995 4588765432 233
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
..+... ....+...+.++.+|+++||+.+|.+||+ +++++++.|
T Consensus 215 ~~~~~~-~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~ 263 (285)
T cd05631 215 RRVKED-QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPI 263 (285)
T ss_pred HHhhcc-cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence 333332 23456678899999999999999999997 899999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=330.76 Aligned_cols=253 Identities=37% Similarity=0.735 Sum_probs=216.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
..+|.+.+.||+|+||.||+|+.. ....+|+|.++.... ...++.+|+++++.++|+||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~------~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR------GKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPI 74 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec------CCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCce
Confidence 346788899999999999999863 235699999865332 234688899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.++++.. ...+++..++.++.|++.||+|||+.+++||||||+||++++
T Consensus 75 ~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 75 FIVTEYMANGCLLNYLRER-------------------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred EEEEecCCCCCHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 9999999999999999621 235789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++...... .........+..|+|||.+.+..++.++||||||+++|||++++..||...+..+....+
T Consensus 136 ~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05059 136 DNVVKVSDFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214 (256)
T ss_pred CCcEEECCcccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH
Confidence 9999999999997653221 111222334568999999999999999999999999999999778899888888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 215 SAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 87766666777899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.26 Aligned_cols=257 Identities=21% Similarity=0.294 Sum_probs=218.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.|.+.+.||+|+||.||+|.... ..+..||+|.+.... ......+.+|+.+++.++|||||++++++..++..+|
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~----~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGS----DPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcC----CCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 48899999999999999998532 224678888775433 3344568889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.++|+... .....+++.++..++.||+.||+|||+++|+||||||+|||+++++
T Consensus 143 v~E~~~gg~L~~~l~~~~----------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~ 206 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRL----------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG 206 (478)
T ss_pred EEECCCCCCHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC
Confidence 999999999999986321 1234588999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+++..+..
T Consensus 207 ~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg-~~Pf~~~~~~~~~~~~~~ 285 (478)
T PTZ00267 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL-HRPFKGPSQREIMQQVLY 285 (478)
T ss_pred cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHh
Confidence 9999999999865332222223344588999999999999999999999999999999995 569988888888888888
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
+.....+..++.++.+++.+||+.+|++||++++++++.
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~ 324 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTE 324 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCH
Confidence 877667778899999999999999999999999998764
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=359.92 Aligned_cols=263 Identities=22% Similarity=0.297 Sum_probs=222.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+...++|.+.+.||+|+||+||+|+.. .+++.||||.++.. ..+.....+.+|+.++..++|+||+++...+..
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~ 102 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRV-----SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK 102 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEc-----CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence 445578999999999999999999853 35689999998643 334455678899999999999999999877654
Q ss_pred CC--------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 440 GK--------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 440 ~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
.+ ..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+++|+|
T Consensus 103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~----------------~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiH 166 (496)
T PTZ00283 103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRA----------------KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIH 166 (496)
T ss_pred ccccCcccceEEEEEEeCCCCCcHHHHHHHhh----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 32 3689999999999999997321 12346889999999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
|||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++|. .||
T Consensus 167 rDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~-~Pf 245 (496)
T PTZ00283 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK-RPF 245 (496)
T ss_pred CCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCC-CCC
Confidence 9999999999999999999999997653322222223456789999999999999999999999999999999954 599
Q ss_pred CCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 592 ~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.+..+++..+..+.....+..+++++.+++.+||+.+|.+||++.+++++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~ 299 (496)
T PTZ00283 246 DGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI 299 (496)
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence 998988998888888777778889999999999999999999999999998754
|
|
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.47 Aligned_cols=250 Identities=25% Similarity=0.424 Sum_probs=218.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.+|++.+.||+|.||+|-+|.. ...++.||||.++...-+ +....+++||+||+.|+||||+.++.+|+..+.
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e-----~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK 127 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYE-----HKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK 127 (668)
T ss_pred hHHHHHHHhcCCcccceeehhh-----ccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce
Confidence 4688889999999999999974 356789999999866433 333458899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
..|||||..+|+|.+|+. ..+.|++.++.++++||.+++.|+|.++++|||||.+|||+|
T Consensus 128 IvivMEYaS~GeLYDYiS--------------------er~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD 187 (668)
T KOG0611|consen 128 IVIVMEYASGGELYDYIS--------------------ERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLD 187 (668)
T ss_pred EEEEEEecCCccHHHHHH--------------------HhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeec
Confidence 999999999999999996 346799999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+|+++||+||||+......... ....|++.|.+||.+.+..|. +..|-|||||+||-|..| ..||.|.+...++.
T Consensus 188 ~N~NiKIADFGLSNly~~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG-tMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 188 QNNNIKIADFGLSNLYADKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG-TMPFDGRDHKRLVR 263 (668)
T ss_pred CCCCeeeeccchhhhhccccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc-ccccCCchHHHHHH
Confidence 9999999999999654322221 345678899999999999885 899999999999999975 45999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.|..|...+ +..|.+..-||+.||-.+|++|.|+.+|..|.|
T Consensus 264 QIs~GaYrE--P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 264 QISRGAYRE--PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred HhhcccccC--CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 999998643 345667888999999999999999999999976
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=327.07 Aligned_cols=261 Identities=48% Similarity=0.898 Sum_probs=225.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|..... ...+..|++|.++........+.+.+|++++..++|+||+++++++..+...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~--~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGK--DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecC--CCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 3589999999999997531 13367899999987665555678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.++++...+.. .......+++.++..++.|++.||+|||+++++|+||||+||++++++.+||+
T Consensus 79 ~~~~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~ 147 (262)
T cd00192 79 EGGDLLDYLRKSRPVF-----------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKIS 147 (262)
T ss_pred cCCcHHHHHhhccccc-----------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEc
Confidence 9999999997432110 00113568999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||.+................++..|+|||.+....++.++||||||++++||+++|..||...+..++.+.+..+....
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd00192 148 DFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP 227 (262)
T ss_pred ccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999876544433334455678899999999988999999999999999999998888999999999999998887777
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.+..++.++.+++.+||+.+|.+|||+.+++++|
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 261 (262)
T cd00192 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVERL 261 (262)
T ss_pred CCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 8888999999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=328.52 Aligned_cols=259 Identities=36% Similarity=0.649 Sum_probs=218.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+++.++|.+.+.||+|+||.||+|+..+ ...||+|.++.... ..+.+.+|++++++++|+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~------~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (262)
T cd05071 2 EIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVS-E 72 (262)
T ss_pred CCChHHeeEeeecCCCCCCcEEEEEecC------CceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEEC-C
Confidence 4566789999999999999999998632 24599999975332 2346899999999999999999999874 4
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++|+|.+++... ....+++..++.++.|++.||+|||+.+++|+||||+||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nil 134 (262)
T cd05071 73 EPIYIVTEYMSKGSLLDFLKGE------------------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 134 (262)
T ss_pred CCcEEEEEcCCCCcHHHHHhhc------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEE
Confidence 5689999999999999999621 1234788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++++..||.+....++.
T Consensus 135 l~~~~~~~L~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~ 213 (262)
T cd05071 135 VGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 213 (262)
T ss_pred EcCCCcEEeccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH
Confidence 99999999999999976532221 12223445678999999999999999999999999999999888899888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.+..+.....+..++..+.+++.+||+.+|++||++.++++.|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 214 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 88777655556677899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=346.62 Aligned_cols=252 Identities=24% Similarity=0.418 Sum_probs=222.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.|...+.||+|+||.||+|.+ ..+.+.||+|++.-+..+...+++++|+.+++.++++||.+++|.+..+..+++
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d-----~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi 88 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAID-----NKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI 88 (467)
T ss_pred ccccchhccccccceeeeeee-----ccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence 455668899999999999985 457789999999988777788899999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
+|||+.+|++.+.|+. ...+.+..+.-|+++++.||.|||.++.+|||||+.|||+..+|
T Consensus 89 iMey~~gGsv~~lL~~--------------------~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g 148 (467)
T KOG0201|consen 89 IMEYCGGGSVLDLLKS--------------------GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG 148 (467)
T ss_pred HHHHhcCcchhhhhcc--------------------CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC
Confidence 9999999999999862 22346667778899999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.|||+|||.+..+..... ......||+.|||||++....|+.|+||||||++.+||.+ |.+|+.+..+..++..|..
T Consensus 149 ~vkl~DfgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~-GePP~s~~hPmrvlflIpk 225 (467)
T KOG0201|consen 149 DVKLADFGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAK-GEPPHSKLHPMRVLFLIPK 225 (467)
T ss_pred cEEEEecceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhc-CCCCCcccCcceEEEeccC
Confidence 999999999977644433 2356789999999999998899999999999999999998 6689999888777777766
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+.....+++.+++||..|++++|+.||++.++++|-+
T Consensus 226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F 265 (467)
T KOG0201|consen 226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF 265 (467)
T ss_pred CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence 6655556688999999999999999999999999998754
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=336.17 Aligned_cols=268 Identities=34% Similarity=0.631 Sum_probs=223.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|+..+.||+|+||.||+|+..... ......||+|.+..........++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEG-ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCC-CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 34567888999999999999999864211 1123468999998765555566789999999999999999999998754
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++++||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+|+||||+|||+
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~-------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill 142 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEH-------------------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV 142 (303)
T ss_pred CceeeehhcCCCCHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee
Confidence 467999999999999998621 2357888999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++.+..||.+....++.+
T Consensus 143 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~ 222 (303)
T cd05110 143 KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD 222 (303)
T ss_pred cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999865432222222234456789999999999999999999999999999986667998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+..++..+.+++..||..+|++||+++++++.+..+.++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 8877776666677889999999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=345.41 Aligned_cols=250 Identities=26% Similarity=0.331 Sum_probs=212.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .++..||||+++.... ......+.+|++++..++||||+++++++..++.
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKK-----DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 36889999999999999999864 3457899999975432 2234568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 135 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNN--------------------LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLID 135 (333)
T ss_pred EEEEEeCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 9999999999999999862 23578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++.... ......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....
T Consensus 136 ~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~ 209 (333)
T cd05600 136 ASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG-FPPFSGSTPNETWEN 209 (333)
T ss_pred CCCCEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhC-CCCCCCCCHHHHHHH
Confidence 999999999999975422 22345678899999999999999999999999999999995 569988888887776
Q ss_pred HHcCCc-cCCCC------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNI-LQAPD------NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~-~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..... ...+. .++.++.+++.+||..+|.+||++++++++.|
T Consensus 210 i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 210 LKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred HHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 654321 12221 45889999999999999999999999999875
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.56 Aligned_cols=244 Identities=23% Similarity=0.339 Sum_probs=208.0
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||.||+|+.. .++..||+|.++... .......+.+|+.++.+++||||+++++++...+..++||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKR-----DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 699999999999864 356789999987532 2334456889999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+
T Consensus 76 ~~g~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~ 135 (312)
T cd05585 76 NGGELFHHLQR--------------------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALC 135 (312)
T ss_pred CCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEE
Confidence 99999999862 2357889999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++...+..+. ..
T Consensus 136 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg-~~pf~~~~~~~~~~~~~~~~-~~ 211 (312)
T cd05585 136 DFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG-LPPFYDENVNEMYRKILQEP-LR 211 (312)
T ss_pred ECcccccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhC-CCCcCCCCHHHHHHHHHcCC-CC
Confidence 999987532221 122334578899999999999999999999999999999995 56998888888887776654 45
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCC---CHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRP---SFRTIYQTLW 645 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~L~ 645 (653)
.+..++.++.+++.+||+.||.+|| ++.++++|+|
T Consensus 212 ~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~ 249 (312)
T cd05585 212 FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPF 249 (312)
T ss_pred CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCC
Confidence 6778899999999999999999997 5788888765
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=324.16 Aligned_cols=248 Identities=40% Similarity=0.793 Sum_probs=214.1
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 451 (653)
.||+|+||.||+|... ++..+|+|.++..........+.+|+++++.++||||+++++++...+..++||||++
T Consensus 2 ~ig~g~~g~vy~~~~~------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 75 (250)
T cd05085 2 LLGKGNFGEVFKGTLK------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVP 75 (250)
T ss_pred ccCCCCCceEEEEEec------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCC
Confidence 5899999999999752 3578999999876655566679999999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEec
Q psy5539 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531 (653)
Q Consensus 452 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~D 531 (653)
+++|.+++.. ....+++..++.++.|++.+|.|||+++++|+||||+||++++++.+||+|
T Consensus 76 ~~~L~~~~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d 136 (250)
T cd05085 76 GGDFLSFLRK-------------------KKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISD 136 (250)
T ss_pred CCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECC
Confidence 9999999862 123478999999999999999999999999999999999999999999999
Q ss_pred cCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCC
Q psy5539 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQA 611 (653)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~ 611 (653)
||++....... ........++..|+|||.+....++.++||||||+++||+++.+..||.+....+....+..+.....
T Consensus 137 ~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 215 (250)
T cd05085 137 FGMSRQEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC 215 (250)
T ss_pred Cccceeccccc-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99987542211 11222334467899999999999999999999999999999977789998888888888887766677
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 612 PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 612 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..++..+.+++.+||+.+|++||++.++.+.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 7789999999999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=328.40 Aligned_cols=258 Identities=38% Similarity=0.733 Sum_probs=219.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|... ++..||+|.+...... ..++.+|+.++++++|+||+++++++. .
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~------~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYN------GHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVT-Q 72 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecC------CCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEc-c
Confidence 567788999999999999999999753 3467999998754332 357889999999999999999999864 5
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..+++|||+++|+|.+++... ....+++.+++.++.|++.||+|||+.+++|+||||+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~ 134 (260)
T cd05067 73 EPIYIITEYMENGSLVDFLKTP------------------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANIL 134 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEE
Confidence 5789999999999999998621 2245788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||++....... ........++..|+|||.+....++.++||||||+++|||++++..||.+.+..++.
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 213 (260)
T cd05067 135 VSETLCCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI 213 (260)
T ss_pred EcCCCCEEEccCcceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH
Confidence 9999999999999987653222 112223345678999999999999999999999999999999677799988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..+...+.+...+.++.+++.+||+.+|++||+++++.+.|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 214 QNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 8887776666777889999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=329.19 Aligned_cols=254 Identities=33% Similarity=0.614 Sum_probs=206.0
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 451 (653)
.||+|+||.||+|+... ......+++|.++..........+.+|+.+++.++|+||+++++.+......++||||++
T Consensus 2 ~lg~G~fg~v~~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHR---GMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEec---CCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 58999999999997533 234567999998766555566788999999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEec
Q psy5539 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531 (653)
Q Consensus 452 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~D 531 (653)
+|+|.++++..... .....++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|
T Consensus 79 ~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~d 143 (269)
T cd05042 79 LGDLKNYLRSNRGM---------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGD 143 (269)
T ss_pred CCcHHHHHHhcccc---------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEec
Confidence 99999999743211 112356778899999999999999999999999999999999999999999
Q ss_pred cCccccccccccccCCCCCCCccccccchhhcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-------NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
||+++.....+.........++..|+|||.+.. ..++.++||||||+++|||++++..||......+....+.
T Consensus 144 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 223 (269)
T cd05042 144 YGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVV 223 (269)
T ss_pred cccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 999876544333333344456778999998753 3568899999999999999998888998887766655544
Q ss_pred cCCccC-----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 605 EGNILQ-----APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 605 ~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
...... .+...+..+.+++..|| .+|++|||+++|++.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 224 REQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred hccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 333222 23357788999999999 5999999999998876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.58 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=204.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.++..........+.+|+.++++++||||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 46899999999999999999864 3567899999875443333456789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++ +|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++++
T Consensus 80 lv~e~~~~-~l~~~l~~~-------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~ 139 (288)
T cd07871 80 LVFEYLDS-DLKQYLDNC-------------------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEK 139 (288)
T ss_pred EEEeCCCc-CHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC
Confidence 99999975 999988621 2346888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|||++|. +||.+.+..+.+..+
T Consensus 140 ~~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~-~pf~~~~~~~~~~~~ 216 (288)
T cd07871 140 GELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLI 216 (288)
T ss_pred CCEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHH
Confidence 999999999997543221 12233456889999998875 56899999999999999999954 688877766554443
Q ss_pred HcCCc---------------------c--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNI---------------------L--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~---------------------~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..... . ......+.+..+|+++|++.||.+|||++++++|.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~ 287 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence 21100 0 001235678999999999999999999999998865
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.42 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=209.2
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
+.||+|+||.||+++.. .++..||+|.++... .......+.+|+++++.++||||+++++++...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 35899999999999863 356889999997542 22334567789999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEE
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vk 528 (653)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 76 ~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~k 135 (323)
T cd05595 76 YANGGELFFHLSR--------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 135 (323)
T ss_pred CCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEE
Confidence 9999999988862 23578999999999999999999999999999999999999999999
Q ss_pred EeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Q psy5539 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608 (653)
Q Consensus 529 I~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~ 608 (653)
|+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++|. .||.+.+..+....+....
T Consensus 136 L~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~-~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05595 136 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR-LPFYNQDHERLFELILMEE- 211 (323)
T ss_pred ecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCC-CCCCCCCHHHHHHHHhcCC-
Confidence 99999987532211 1122345788999999999999999999999999999999955 5888888888777776654
Q ss_pred cCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 609 LQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 609 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...+..+++++.+++.+||+.+|.+|| ++.+++++.|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~ 253 (323)
T cd05595 212 IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 253 (323)
T ss_pred CCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCC
Confidence 346678899999999999999999998 8999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=327.89 Aligned_cols=258 Identities=34% Similarity=0.661 Sum_probs=217.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|... .+..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. .
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~------~~~~~~~k~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~ 72 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN------GNTKVAVKTLKPGTM--SPESFLEEAQIMKKLRHDKLVQLYAVVS-E 72 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec------CCceeEEEEecCCCC--CHHHHHHHHHHHHhcCCCceEEEEeEEC-C
Confidence 456678899999999999999999763 235699999875432 2346899999999999999999999875 4
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...+++|||+++++|.++++.. ....+++..++.++.|++.||+|||+++++||||||+||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nil 134 (260)
T cd05070 73 EPIYIVTEYMSKGSLLDFLKDG------------------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANIL 134 (260)
T ss_pred CCcEEEEEecCCCcHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEE
Confidence 5689999999999999998621 1235789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++++..||.+.+..+..
T Consensus 135 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~ 213 (260)
T cd05070 135 VGDGLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL 213 (260)
T ss_pred EeCCceEEeCCceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999976532221 11122345678999999998999999999999999999999778899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..+...+.+...+..+.+++.+||..+|.+|||+.++.+.|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8887766666677889999999999999999999999999888764
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=344.66 Aligned_cols=246 Identities=23% Similarity=0.342 Sum_probs=209.5
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
+.||+|+||.||+++.. .++..||+|.++... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREK-----ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 35899999999999863 356889999997542 22344578899999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEE
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vk 528 (653)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 76 y~~~g~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~k 135 (328)
T cd05593 76 YVNGGELFFHLSR--------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIK 135 (328)
T ss_pred CCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEE
Confidence 9999999988852 23578999999999999999999999999999999999999999999
Q ss_pred EeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Q psy5539 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608 (653)
Q Consensus 529 I~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~ 608 (653)
|+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++|. .||.+.+..++.+.+..+.
T Consensus 136 L~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~-~Pf~~~~~~~~~~~~~~~~- 211 (328)
T cd05593 136 ITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR-LPFYNQDHEKLFELILMED- 211 (328)
T ss_pred EecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCC-CCCCCCCHHHHHHHhccCC-
Confidence 99999987532211 1122345788999999999999999999999999999999955 5888888888777776554
Q ss_pred cCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 609 LQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 609 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...+..++.++.+++++||..+|++|| ++.+++++.|
T Consensus 212 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 253 (328)
T cd05593 212 IKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSF 253 (328)
T ss_pred ccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCC
Confidence 356778899999999999999999997 8999998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=327.51 Aligned_cols=267 Identities=40% Similarity=0.677 Sum_probs=217.3
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEEeec
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
.||+|+||.||+|++.. ......+++|.++........+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~v~~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 2 VIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred cCCCCCCceEEEEEEcC---CCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 58999999999998743 1122467999988655555566889999999999 8999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.++++.......... ..........+++.+++.++.|++.||+|||+.+++||||||+|||+++++.+||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~ 154 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPA----FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 154 (270)
T ss_pred CCCcHHHHHHhccccccccc----cccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEEC
Confidence 99999999975432111000 00011223458899999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||++.... ..........+..|+|||++....++.++||||||+++|||++.+..||.+.+..+..+.+..+....
T Consensus 155 dfgl~~~~~---~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 231 (270)
T cd05047 155 DFGLSRGQE---VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 231 (270)
T ss_pred CCCCccccc---hhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC
Confidence 999985321 11112223346679999999989999999999999999999986777998888888888887776666
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.+...+.++.+++.+||..+|.+|||+.++++.|..+.
T Consensus 232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 67778899999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=345.10 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=207.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|+..+.||+|+||.||+|+.. .+++.||||.+...........+.+|+++++.++|+||+++++++..++.
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHR-----PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEEC-----CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 3456788899999999999999864 35678999999766555667789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+.. ..++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 147 ~~lv~e~~~~~~L~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 147 IQVLLEFMDGGSLEGTH------------------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202 (353)
T ss_pred EEEEEecCCCCcccccc------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 99999999999886432 245677889999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQPYYGLT-- 595 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-- 595 (653)
+++.+||+|||+++.+.... .......++..|+|||.+.. ...+.++||||||+++|||++|.. ||....
T Consensus 203 ~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~-pf~~~~~~ 279 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF-PFGVGRQG 279 (353)
T ss_pred CCCCEEEcccccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC-CCCCCCCc
Confidence 99999999999997653211 12234567899999998743 234568999999999999999654 775332
Q ss_pred -HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 596 -HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 596 -~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
...+...+........+..++.++.+||.+||+.+|++||++.+|++|.|-..
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~ 333 (353)
T PLN00034 280 DWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333 (353)
T ss_pred cHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence 23334444444445556678899999999999999999999999999987544
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=351.55 Aligned_cols=255 Identities=24% Similarity=0.361 Sum_probs=220.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|.+++.||+|.||+|+++..++ ++..+|||++++.. ..+..+....|.+++... +||.++.|+..+
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~-----~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKG-----TNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcC-----CCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 5667899999999999999999999864 55799999998763 223345567787777776 599999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+++++||||+.|||+..+. ....+++..+..++..|+.||+|||+++||+||||.+
T Consensus 439 QT~~~l~fvmey~~Ggdm~~~~---------------------~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd 497 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLMHHI---------------------HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD 497 (694)
T ss_pred ccCCeEEEEEEecCCCcEEEEE---------------------ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence 9999999999999999954322 3467899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||||.+|.+||+|||+++...... .......||+.|||||++.+..||...|.|||||+||||+. |..||.+.+.+
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~-Gq~PF~gddEe 574 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLV-GESPFPGDDEE 574 (694)
T ss_pred heEEcccCcEEecccccccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHc-CCCCCCCCCHH
Confidence 9999999999999999998653222 24456789999999999999999999999999999999998 55699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
|+++.|...+. ..|..++.+..++|++++.++|++|..+ .+|.+|++
T Consensus 575 e~FdsI~~d~~-~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpF 626 (694)
T KOG0694|consen 575 EVFDSIVNDEV-RYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPF 626 (694)
T ss_pred HHHHHHhcCCC-CCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCc
Confidence 99999988764 4778899999999999999999999854 67777763
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=342.98 Aligned_cols=249 Identities=22% Similarity=0.344 Sum_probs=211.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+++... ....++.||||+++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~lg~G~~g~V~~~~~~~--~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVT--GADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred ceeeecCCeEEEEEEEcc--cCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEE
Confidence 579999999999998642 23467899999987532 1223346788999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 80 e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 139 (323)
T cd05584 80 EYLSGGELFMHLER--------------------EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHV 139 (323)
T ss_pred eCCCCchHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCE
Confidence 99999999999862 2346788889999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....+..+.
T Consensus 140 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G-~~pf~~~~~~~~~~~~~~~~ 216 (323)
T cd05584 140 KLTDFGLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG-APPFTAENRKKTIDKILKGK 216 (323)
T ss_pred EEeeCcCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcC-CCCCCCCCHHHHHHHHHcCC
Confidence 999999987532221 112234578999999999999999999999999999999995 56998888888888887765
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...+..++.++.+++++||+.+|++|| ++++++++.|
T Consensus 217 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~ 258 (323)
T cd05584 217 -LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258 (323)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCC
Confidence 356777899999999999999999999 8999998875
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=330.02 Aligned_cols=261 Identities=44% Similarity=0.836 Sum_probs=219.1
Q ss_pred eecccCCeeEEEEEeCCCC-CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 372 DLGQGAFGRVFQAKAPGLL-KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~-~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
.||+|+||.||+|+..... .......+|||.+...........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 5899999999999875422 123346899999876554445667899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC-----
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM----- 525 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~----- 525 (653)
++|+|.++++...... .....+++.+++.++.|++.||.|||+.+++|+||||+||++++++
T Consensus 82 ~~~~L~~~l~~~~~~~-------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~ 148 (269)
T cd05044 82 EGGDLLSYLRDARVER-------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADR 148 (269)
T ss_pred CCCcHHHHHHHhhhcc-------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCc
Confidence 9999999997432110 0234578899999999999999999999999999999999999887
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||+++.....+..........+..|+|||.+.++.++.++||||||+++|||++.+..||...+..+....+..
T Consensus 149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 228 (269)
T cd05044 149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228 (269)
T ss_pred ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc
Confidence 89999999998664443333333445577899999999999999999999999999999967779988888888888877
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.....+...+..+.+++.+||..+|.+||++.+|++.|.
T Consensus 229 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 7666677788999999999999999999999999998875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=329.46 Aligned_cols=271 Identities=40% Similarity=0.774 Sum_probs=225.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|+............|++|.+.....+...+++.+|++++++++|+||+++++++.....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 44678899999999999999999765444456678999998765555466789999999999999999999999999899
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++...... .......+++..+..++.|++.||+|||+.+|+||||||+|||++
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~-----------~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~ 151 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKD-----------EKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVS 151 (275)
T ss_pred ceEEEEecCCCcHHHHHHhccccc-----------ccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEe
Confidence 999999999999999997332110 001123589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++++..||.+....++...
T Consensus 152 ~~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 152 SQREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred CCCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 9999999999998754322221 223345577899999998888999999999999999999988889988888888888
Q ss_pred HHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+... ..+..++..+.+++.+||+.+|.+||++.++++.|.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 7766542 345678899999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=324.87 Aligned_cols=253 Identities=36% Similarity=0.728 Sum_probs=219.9
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+|... ++.||+|.++.... ..+.+.+|+.++++++|+||+++++++....
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~-------~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 73 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR-------GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGN 73 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec-------CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCC
Confidence 34567889999999999999999863 47799999986543 4567899999999999999999999999899
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|.++++.. ....+++..+..++.|++.||.|||+++++|+||||+||++
T Consensus 74 ~~~~v~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili 135 (256)
T cd05039 74 PLYIVTEYMAKGSLVDYLRSR------------------GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV 135 (256)
T ss_pred CeEEEEEecCCCcHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE
Confidence 999999999999999999722 11358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...... .....+..|+|||.+..+.++.++||||||+++||+++.+..||......++..
T Consensus 136 ~~~~~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05039 136 SEDLVAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred eCCCCEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999997652111 123446789999999989999999999999999999986777998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+.....+..+++++.+++.+||..+|++||+++++++.|..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 211 HVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred HHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 887766566677789999999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=336.64 Aligned_cols=257 Identities=24% Similarity=0.362 Sum_probs=210.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH---------H----HHHHHHHHHHHHhhCCCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE---------Y----LQTDFEREACLLAEFDHPN 429 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~---------~----~~~~f~~Ei~il~~l~Hpn 429 (653)
..++|.+.+.||+|.||.|-+|+.. .+++.||||++...... . -.+...+||.+|++++|||
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~-----~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDE-----VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeec-----CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 3478999999999999999999853 57789999998643211 1 1246889999999999999
Q ss_pred cceEEeEEec--CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCC-CCHHHHHHHHHHHHHHHHHhhh
Q psy5539 430 IVKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ-LSTCDLITIALQIASGMVYLSD 506 (653)
Q Consensus 430 Iv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~ 506 (653)
||+|+.+..+ .+.+|||+||+..|.+.+- ....+ ++..++++++++++.||+|||.
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~---------------------p~d~~els~~~Ar~ylrDvv~GLEYLH~ 228 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWC---------------------PPDKPELSEQQARKYLRDVVLGLEYLHY 228 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccC---------------------CCCcccccHHHHHHHHHHHHHHHHHHHh
Confidence 9999999865 5689999999998876431 11223 8999999999999999999999
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCcccccccccc---ccCCCCCCCccccccchhhccCC----CCCchhHHHHHHH
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY---YKGDENDAIPVRWMPLESILYNK----YTVESDVWAFGVC 579 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~----~t~ksDVwSlGvv 579 (653)
+|||||||||+|+||+++|+|||+|||.+......+. ...-....||+.|||||...++. .+.+.||||+||+
T Consensus 229 QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVT 308 (576)
T KOG0585|consen 229 QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVT 308 (576)
T ss_pred cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhh
Confidence 9999999999999999999999999999875422111 01112367899999999988743 3578999999999
Q ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 580 LWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDN--TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 580 l~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
||-|+-|. .||.+....+++++|....+ .+|+. +.+++++||.++|++||++|.++.+|..|+|..
T Consensus 309 LYCllfG~-~PF~~~~~~~l~~KIvn~pL-~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 309 LYCLLFGQ-LPFFDDFELELFDKIVNDPL-EFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred HHHhhhcc-CCcccchHHHHHHHHhcCcc-cCCCcccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence 99999754 59999999999999987653 45543 688999999999999999999999999999854
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=339.71 Aligned_cols=256 Identities=22% Similarity=0.356 Sum_probs=209.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||++++. .++..+|+|.++..........+.+|+++++.++|+||+++++++..++
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 76 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHK-----PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG 76 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEEC-----CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECC
Confidence 45678999999999999999999864 3567899999876655556677999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCEe
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCL 520 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NIL 520 (653)
..++||||+++|+|.++++. ...+++..+..++.|++.||.|||+. +++||||||+|||
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nil 136 (333)
T cd06650 77 EISICMEHMDGGSLDQVLKK--------------------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136 (333)
T ss_pred EEEEEEecCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEE
Confidence 99999999999999999862 23478888999999999999999975 7999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|.. ||......++.
T Consensus 137 i~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~-p~~~~~~~~~~ 211 (333)
T cd06650 137 VNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRY-PIPPPDAKELE 211 (333)
T ss_pred EcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCC-CCCCcchhHHH
Confidence 999999999999998754221 1223457889999999999899999999999999999999655 77654433322
Q ss_pred HH--------------------------------------------HHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCC
Q psy5539 601 KY--------------------------------------------IKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 601 ~~--------------------------------------------i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RP 635 (653)
.. +........+ ...+.++.+|+.+||+.||++||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp 291 (333)
T cd06650 212 LMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA 291 (333)
T ss_pred HHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc
Confidence 11 1111111111 12567899999999999999999
Q ss_pred CHHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWNI 647 (653)
Q Consensus 636 s~~eil~~L~~l 647 (653)
|+.+++++.|--
T Consensus 292 t~~ell~h~~~~ 303 (333)
T cd06650 292 DLKQLMVHAFIK 303 (333)
T ss_pred CHHHHhhCHHHh
Confidence 999999988743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.45 Aligned_cols=258 Identities=36% Similarity=0.687 Sum_probs=216.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|...+ ...+|+|.++.... ..+.+.+|+.++++++|+|++++++++. .
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~------~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 72 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNG------TTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVS-E 72 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcC------CceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEc-C
Confidence 3455678999999999999999998643 23589998875432 2456889999999999999999999875 4
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++.. ....+++..+..++.|++.||.|||+.+++|+||||+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nil 134 (260)
T cd05069 73 EPIYIVTEFMGKGSLLDFLKEG------------------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANIL 134 (260)
T ss_pred CCcEEEEEcCCCCCHHHHHhhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 5689999999999999999621 1234788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++++..||.+....+..
T Consensus 135 l~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 213 (260)
T cd05069 135 VGDNLVCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL 213 (260)
T ss_pred EcCCCeEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999976532221 11222345678999999999999999999999999999999777899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..+.....+...+..+.+++++||..+|.+||++++|.+.|.+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 214 EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred HHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 8777765555667789999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=324.60 Aligned_cols=251 Identities=35% Similarity=0.680 Sum_probs=214.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe-cCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA-VGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-~~~ 441 (653)
...+|++.+.||+|+||.||++... +..||+|.++... ..+.+.+|+.++++++|+|++++++++. .+.
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~-------~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 73 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc-------CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCC
Confidence 3457889999999999999999754 3679999987543 2457889999999999999999999764 456
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++++||+++|+|.++++.. ....+++..++.++.|++.||+|||+++++||||||+||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~ 135 (256)
T cd05082 74 GLYIVTEYMAKGSLVDYLRSR------------------GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV 135 (256)
T ss_pred ceEEEEECCCCCcHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE
Confidence 789999999999999998622 12347899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++..... ......+..|+|||.+....++.++||||||+++|||++.+..||...+..++..
T Consensus 136 ~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 136 SEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred cCCCcEEecCCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999998754221 1233446689999999998999999999999999999986777998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+.....++.++..+.+++.+||+.+|++|||+.++++.|..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 887776666677889999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.52 Aligned_cols=259 Identities=39% Similarity=0.731 Sum_probs=221.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+++.++|.+.+.||+|+||.||+|...+ ...||||.++.... ..+++.+|+.++++++|+||+++++++...
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~------~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 73 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNG------TTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcC------CceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecC
Confidence 5678899999999999999999998632 36699999875433 235689999999999999999999999988
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++++|.+++... ....+++..+..++.|++.||.|||+++++|+||||+||+
T Consensus 74 ~~~~~v~e~~~~~~L~~~i~~~------------------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil 135 (261)
T cd05034 74 EPIYIVTEYMSKGSLLDFLKSG------------------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135 (261)
T ss_pred CceEEEEeccCCCCHHHHHhcc------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence 9999999999999999999621 1245789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++....... .........+..|+|||.+.+..++.++||||||+++||+++++..||.+.+..+..
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 214 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL 214 (261)
T ss_pred EcCCCCEEECccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9999999999999987653221 112223334568999999999999999999999999999999777899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..+.....+...+.++.+++.+||..+|.+||+++++.+.|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 215 EQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 8887766556677789999999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=333.98 Aligned_cols=254 Identities=22% Similarity=0.298 Sum_probs=204.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|+.. .++..||+|+++... .....+.+.+|+.+++.++||||+++++++..++..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHK-----ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEEC-----CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEE
Confidence 46889999999999999999864 356789999987542 233455788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||++++.|..+.+ ....+++..+..++.||+.||.|||+.+|+||||||+|||++.
T Consensus 76 ~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~ 135 (287)
T cd07848 76 YLVFEYVEKNMLELLEE--------------------MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH 135 (287)
T ss_pred EEEEecCCCCHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 99999999876665432 1235788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++|. +||.+.+..+....+
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~-~pf~~~~~~~~~~~~ 213 (287)
T cd07848 136 NDVLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ-PLFPGESEIDQLFTI 213 (287)
T ss_pred CCcEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC-CCCCCCCHHHHHHHH
Confidence 99999999999976532211 1122345788999999999999999999999999999999954 688876654433222
Q ss_pred HcC--C--------------c--cC-------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEG--N--------------I--LQ-------------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~--~--------------~--~~-------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
... . . .. ....++.++.+|+++||+.||++|||++++++|.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~ 286 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA 286 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 110 0 0 00 01135778999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=332.57 Aligned_cols=254 Identities=26% Similarity=0.438 Sum_probs=200.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhC---CCCccceEEeEEe--
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEF---DHPNIVKLLGVCA-- 438 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~-- 438 (653)
++|++.+.||+|+||.||+|+... ..+..||+|.++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~ 76 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 76 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcC----CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecc
Confidence 367889999999999999998632 2457899998864322 22233456777777665 6999999999985
Q ss_pred ---cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 439 ---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 439 ---~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
.....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++|+|||||
T Consensus 77 ~~~~~~~~~lv~e~~~-~~l~~~~~~~------------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 77 RTDRETKLTLVFEHVD-QDLTTYLDKV------------------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred cCCCCCcEEEEEccCC-CCHHHHHHhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 2456899999996 6999998622 12347899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++..... .......++..|+|||.+....++.++||||||+++|||++ +.+||.+.+
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~-g~~~f~~~~ 213 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSS 213 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHc-CCCCcCCCC
Confidence 99999999999999999999754322 12234457889999999999999999999999999999998 566888877
Q ss_pred HHHHHHHHHcCCccC--------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQ--------------------------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~--------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.+..+.+..... .....+..+.+++.+||+.+|++|||+.++++|.|
T Consensus 214 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~ 289 (290)
T cd07862 214 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289 (290)
T ss_pred HHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence 766655554321100 01245678899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.97 Aligned_cols=256 Identities=34% Similarity=0.626 Sum_probs=203.9
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|...+ ......+|+|.++..........+.+|+.++++++||||+++++++......++||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS---GYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcC---CCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 358999999999998642 23456799999987655555567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.++++..... .....++..++.++.|++.||+|||+.+++|+||||+||++++++.+||+
T Consensus 78 ~~g~L~~~l~~~~~~---------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~ 142 (269)
T cd05087 78 PLGDLKGYLRSCRKA---------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIG 142 (269)
T ss_pred CCCcHHHHHHHhhhc---------------ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEC
Confidence 999999999743211 12345677888999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccC-------CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-------KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
|||+++.....+.........++..|+|||.+... .++.++||||||+++|||++.|..||......+.....
T Consensus 143 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~ 222 (269)
T cd05087 143 DYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT 222 (269)
T ss_pred CccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 99999765433333333344567889999988642 35889999999999999997566799877766654443
Q ss_pred HcCCccCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNILQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.....+ ...+..+.++|..|| .+|++|||+++|++.|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 223 VREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 332222221 235678999999999 58999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=338.81 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=208.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHH---hhCCCCccceEEeEEecCC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLL---AEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il---~~l~HpnIv~l~g~~~~~~ 441 (653)
|++.+.||+|+||.||+|+.. .+++.||||.++... .....+.+.+|++++ +.++||||+++++++..++
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYK-----KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 567889999999999999864 356889999997542 122334566666554 5678999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|..+++ ...+++..++.++.||+.||+|||+.+|+||||||+|||+
T Consensus 76 ~~~lv~E~~~~~~L~~~~~---------------------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill 134 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIH---------------------TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134 (324)
T ss_pred EEEEEEcCCCCCcHHHHhh---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE
Confidence 9999999999999988875 1358899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...... .......++..|||||.+.+..++.++||||||+++|||++| ..||.+.+..++..
T Consensus 135 ~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G-~~pf~~~~~~~~~~ 211 (324)
T cd05589 135 DTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG-ESPFPGDDEEEVFD 211 (324)
T ss_pred CCCCcEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhC-CCCCCCCCHHHHHH
Confidence 999999999999986532211 112334578899999999999999999999999999999995 45998888888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
.+..+.. ..+..++..+.+++.+||+.||.+|| ++.+++++.|
T Consensus 212 ~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~ 259 (324)
T cd05589 212 SIVNDEV-RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPF 259 (324)
T ss_pred HHHhCCC-CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCC
Confidence 8877654 46677899999999999999999999 6888888764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=324.90 Aligned_cols=265 Identities=42% Similarity=0.752 Sum_probs=218.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC----
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK---- 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~---- 441 (653)
|.+.+.||+|+||.||+|.+.. ....+..||||.++... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKS--EDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeec--cCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCc
Confidence 3566789999999999998643 23456899999987543 3334567889999999999999999999886432
Q ss_pred --ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 442 --PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 442 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++++||+.+|+|.+++..... ......+++..++.++.|++.||+|||+.+|+||||||+||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~--------------~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ni 144 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRI--------------GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNC 144 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcc--------------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhE
Confidence 24788999999999998852210 01123578899999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
++++++.+||+|||+++...............++..|++||.+....++.++||||||+++|||++++.+||.+.+..+.
T Consensus 145 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~ 224 (273)
T cd05074 145 MLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224 (273)
T ss_pred EEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH
Confidence 99999999999999998764433333333445567899999999999999999999999999999988889998888888
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+..+.....+...+..+.+++.+||+.+|++||++.++++.|..+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 225 YNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 888877766666667889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=327.59 Aligned_cols=259 Identities=34% Similarity=0.599 Sum_probs=208.3
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--CceE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--KPMC 444 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~~ 444 (653)
+++.+.||+|+||+||++.... ....++..||+|.++..........+.+|++++++++||||+++++++... ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDP-ANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEcc-ccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 4788999999999999876532 233466789999998665545567789999999999999999999987653 4579
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.+++.. ..+++.+++.++.|++.||.|||+++|+||||||+|||++++
T Consensus 85 lv~e~~~~~~l~~~~~~---------------------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~ 143 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK---------------------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143 (283)
T ss_pred EEecCCCCCCHHHHHHH---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCC
Confidence 99999999999999861 248999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--------
Q psy5539 525 MVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-------- 595 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-------- 595 (653)
+.+||+|||+++........ .......++..|+|||.+....++.++||||||+++|||++|.. |+....
T Consensus 144 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~-p~~~~~~~~~~~~~ 222 (283)
T cd05080 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCD-SKQSPPKKFEEMIG 222 (283)
T ss_pred CcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCC-CCCCCcchhhhhhc
Confidence 99999999999765332211 11223345667999999998999999999999999999999654 554321
Q ss_pred -------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 596 -------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 596 -------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
...+.+.+..+...+.+..++.++.+++.+||+.+|++|||+++|++.|..++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 223 PKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred ccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11122223333334456678899999999999999999999999999998775
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=322.23 Aligned_cols=258 Identities=35% Similarity=0.687 Sum_probs=219.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|... .+..+|+|.++... ...+.+.+|++++++++|+||+++++++..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~------~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~- 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK- 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec------CCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-
Confidence 567789999999999999999999753 23569999887542 234578899999999999999999999877
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...+++|||+++|+|.+++... ....+++..++.++.|++.||.|||+.+++|+||||+||+
T Consensus 73 ~~~~~v~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~ 134 (260)
T cd05073 73 EPIYIITEFMAKGSLLDFLKSD------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134 (260)
T ss_pred CCeEEEEEeCCCCcHHHHHHhC------------------CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 7789999999999999999621 1235788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||++........ .......++..|+|||.+....++.++||||||+++|++++++..||.+.+..++.
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~ 213 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999875432221 12223345678999999999899999999999999999999788899988888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+...+.+...+.++.+++.+||+.+|++||++.++++.|..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 214 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred HHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 8888776666677888999999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=341.61 Aligned_cols=246 Identities=24% Similarity=0.341 Sum_probs=208.8
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
+.||+|+||.||+++.. .++..||+|.++... .......+.+|++++..++||||+++++++...+..++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 35899999999999863 356889999997542 22334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcCCCcE
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~v 527 (653)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+ .+|+||||||+|||+++++.+
T Consensus 76 ~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~ 135 (325)
T cd05594 76 YANGGELFFHLSR--------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 135 (325)
T ss_pred CCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCE
Confidence 9999999998852 2357899999999999999999997 799999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|||||.+.+..++.++||||||+++|||++|. .||.+.+.++....+....
T Consensus 136 kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~-~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 136 KITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR-LPFYNQDHEKLFELILMEE 212 (325)
T ss_pred EEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCC-CCCCCCCHHHHHHHHhcCC
Confidence 999999987532211 1112345789999999999999999999999999999999954 5898888888887776654
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...+...+.++.+++.+||+.||++|+ ++.++++|.|
T Consensus 213 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~ 254 (325)
T cd05594 213 -IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254 (325)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCC
Confidence 356777899999999999999999997 8999998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=319.77 Aligned_cols=250 Identities=40% Similarity=0.761 Sum_probs=214.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|... . ++.|++|.++..........+.+|++++++++|+||+++++++......++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~-----~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 74 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK-----G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELV 74 (251)
T ss_pred CccccCCCceEEEEEEe-----C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcC
Confidence 36899999999999863 2 57899999886655455678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.++++. ....+++..++.++.+++.||+|||+++++||||||+|||+++++.+||+
T Consensus 75 ~~~~l~~~l~~-------------------~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~ 135 (251)
T cd05041 75 PGGSLLTFLRK-------------------KKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKIS 135 (251)
T ss_pred CCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEe
Confidence 99999999862 12357888999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||++.................+..|+|||.+.++.++.++||||||+++|||++++..||.+....+....+..+....
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~ 215 (251)
T cd05041 136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP 215 (251)
T ss_pred eccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC
Confidence 99999765322221122223446779999999989999999999999999999998888998888888888777765556
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.++..+.++.+++.+||..+|.+||++.+|++.|.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 67788999999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=333.03 Aligned_cols=255 Identities=25% Similarity=0.398 Sum_probs=201.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||.++..........+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSK-----VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEEC-----CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeE
Confidence 367899999999999999999864 356789999987543333344678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+. ++|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||+++
T Consensus 79 ~lv~e~~~-~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 138 (303)
T cd07869 79 TLVFEYVH-TDLCQYMDK-------------------HPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138 (303)
T ss_pred EEEEECCC-cCHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 99999995 688888862 1245788899999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVK 601 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~ 601 (653)
++.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|||++|. .||.+... .+..+
T Consensus 139 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~ 215 (303)
T cd07869 139 TGELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGV-AAFPGMKDIQDQLE 215 (303)
T ss_pred CCCEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCC-CCCCCCccHHHHHH
Confidence 9999999999987542211 12233456889999999875 45889999999999999999954 58876432 23222
Q ss_pred HHHc--CCc--------------------cCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKE--GNI--------------------LQAP---------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~--~~~--------------------~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.. +.. ...+ ...+..+.+|+.+|++.||++|||++++++|.|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f 291 (303)
T cd07869 216 RIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYF 291 (303)
T ss_pred HHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCccc
Confidence 2211 000 0000 1234678899999999999999999999998763
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=337.78 Aligned_cols=251 Identities=25% Similarity=0.399 Sum_probs=210.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCC-ccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHP-NIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~Hp-nIv~l~g~~~~~~~ 442 (653)
+|++.+.||+|+||.||+|+.. .+++.||||.++... .....+.+..|++++..++|+ +|+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 4788999999999999999864 345789999987542 223345678899999999765 58889999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~ 135 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQ--------------------VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135 (324)
T ss_pred EEEEEcCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEc
Confidence 9999999999999999862 23578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~pf~~~~~~~~~~~ 212 (324)
T cd05587 136 AEGHIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDEDELFQS 212 (324)
T ss_pred CCCCEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 99999999999986432111 11223457889999999999999999999999999999999 4569999888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
+.... ...+...+.++.+++++||+.+|.+|++. ++++++++
T Consensus 213 i~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~ 259 (324)
T cd05587 213 IMEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAF 259 (324)
T ss_pred HHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCC
Confidence 87755 35667789999999999999999999976 78887754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=338.81 Aligned_cols=246 Identities=23% Similarity=0.352 Sum_probs=208.1
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .+++.||||.++... .......+.+|+.++..+ +||||+++++++...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLK-----ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 35899999999999864 356889999987542 222345667888888876 6999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+
T Consensus 76 Ey~~~g~L~~~i~~--------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~ 135 (320)
T cd05590 76 EFVNGGDLMFHIQK--------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHC 135 (320)
T ss_pred cCCCCchHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 99999999998862 2357889999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++...+..+.
T Consensus 136 kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 136 KLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCG-HAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred EEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhC-CCCCCCCCHHHHHHHHhcCC
Confidence 999999987532211 122334678999999999999999999999999999999995 56999999888888887765
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSF------RTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~L~ 645 (653)
. ..+..++.++.+++++||+.||.+||++ +++++|.|
T Consensus 213 ~-~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~ 255 (320)
T cd05590 213 V-VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPF 255 (320)
T ss_pred C-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCC
Confidence 3 4566789999999999999999999998 88888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=341.88 Aligned_cols=255 Identities=20% Similarity=0.282 Sum_probs=208.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++... .......+.+|+.++.+++|+||+++++.+..+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKK-----DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 47889999999999999999863 356789999997532 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~ 135 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMK--------------------KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLD 135 (363)
T ss_pred EEEEEcCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEEC
Confidence 9999999999999999862 24588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccc---------------------------------cCCCCCCCccccccchhhccCCCCC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYY---------------------------------KGDENDAIPVRWMPLESILYNKYTV 569 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~t~ 569 (653)
+++.+||+|||+++.+...... .......||+.|+|||.+.+..++.
T Consensus 136 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~ 215 (363)
T cd05628 136 SKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNK 215 (363)
T ss_pred CCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCC
Confidence 9999999999998754221100 0011235789999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhc--cCCCCCCCHHHHHHHH
Q psy5539 570 ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWN--MKPMNRPSFRTIYQTL 644 (653)
Q Consensus 570 ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~--~dP~~RPs~~eil~~L 644 (653)
++|||||||++|||++| ..||.+.+..+....+.... ....|. .+++++.+++.+++. .++..||++++|++|.
T Consensus 216 ~~DvwSlGvil~ell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp 294 (363)
T cd05628 216 LCDWWSLGVIMYEMLIG-YPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNP 294 (363)
T ss_pred chhhhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCC
Confidence 99999999999999995 56999888888888776532 222332 467899999998654 2333578999999986
Q ss_pred H
Q psy5539 645 W 645 (653)
Q Consensus 645 ~ 645 (653)
|
T Consensus 295 ~ 295 (363)
T cd05628 295 F 295 (363)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=338.24 Aligned_cols=246 Identities=21% Similarity=0.302 Sum_probs=208.6
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||||+++... .....+.+..|.+++..+ +||||+++++++..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELK-----GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 35899999999999864 356789999987542 223344577888888866 7999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+++++.+
T Consensus 76 E~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~ 135 (321)
T cd05591 76 EYVNGGDLMFQIQR--------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHC 135 (321)
T ss_pred eCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCE
Confidence 99999999998862 2357888999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..++.+.+..+.
T Consensus 136 kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~t-g~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 136 KLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMA-GQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred EEeecccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhc-CCCCCCCCCHHHHHHHHHcCC
Confidence 999999987532221 11233457889999999999999999999999999999999 456999999888888887765
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCC-------CHHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRP-------SFRTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-------s~~eil~~L~ 645 (653)
. ..+..++.++.+++.+||+.+|++|| ++++++++.|
T Consensus 213 ~-~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~ 256 (321)
T cd05591 213 V-LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256 (321)
T ss_pred C-CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCc
Confidence 3 45566889999999999999999999 8999998875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.72 Aligned_cols=246 Identities=23% Similarity=0.360 Sum_probs=203.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhh-CCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAE-FDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|.++... .....+.+..|..++.. .+||||+++++++..++..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELK-----GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 35899999999999864 356789999997542 12223345566666664 48999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.++++. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+
T Consensus 76 e~~~gg~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~ 135 (316)
T cd05592 76 EYLNGGDLMFHIQS--------------------SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHI 135 (316)
T ss_pred cCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCE
Confidence 99999999998862 2357888999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++...+....
T Consensus 136 kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G-~~Pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05592 136 KIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIG-QSPFHGEDEDELFDSILNDR 212 (316)
T ss_pred EEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCC
Confidence 999999997542222 122334678999999999999999999999999999999995 56999888888888776543
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFR-TIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~ 645 (653)
...+..++.++.+++.+||+.+|.+||++. +++++.+
T Consensus 213 -~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05592 213 -PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPF 250 (316)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcc
Confidence 456677889999999999999999999875 6766643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=319.98 Aligned_cols=253 Identities=37% Similarity=0.760 Sum_probs=216.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
..+|++.+.||+|+||.||+|.+. .+..+|+|.++..... ..+|.+|++++++++||||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~------~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL------EKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPI 74 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe------CCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCce
Confidence 457889999999999999999863 2357999998754322 34688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.+++|+||||+||+++.
T Consensus 75 ~~v~e~~~~~~L~~~~~~-------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 75 CLVFEFMEHGCLSDYLRA-------------------QRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred EEEEEcCCCCcHHHHHHh-------------------CccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 999999999999999862 1235788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++...... .........+.+|+|||.+.++.++.++||||||+++|||++.+..||......++.+.+
T Consensus 136 ~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05112 136 NQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214 (256)
T ss_pred CCeEEECCCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 9999999999987543221 112223345678999999999999999999999999999999777899888888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.....+...+..+.+|+.+||+.+|++|||+.++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 87755555667889999999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=320.81 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=217.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|+||.||+|+.. .++..|++|.+... .......++.+|++++++++||||+++++++..++..+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRK-----ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEc-----CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEE
Confidence 4678899999999999999864 35678999988643 23445667999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|.++++.. ....+++..++.++.|++.||.|||+.+++|+||||+||+++++
T Consensus 76 lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQ------------------RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred EEEEeCCCCcHHHHHHHh------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 999999999999999732 12457899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++| ..||...+..+....+.
T Consensus 138 ~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~~~~~~~ 214 (256)
T cd08529 138 DNVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG-KHPFDANNQGALILKII 214 (256)
T ss_pred CCEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Confidence 9999999999876533221 12233567889999999999999999999999999999995 55888888888888888
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....+...+.++.+++.+||+.+|++||++.+++++.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 255 (256)
T cd08529 215 RGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPS 255 (256)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCC
Confidence 77776667788899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=344.44 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=215.1
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
...++..++|++.+.||+|+||.||+|+.. .++..||+|.++... .....+.+.+|+.+++.++||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~ 110 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHK-----SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEE
Confidence 344566778999999999999999999864 356789999986432 2223345788999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..+...++||||+++|+|.++++. ..++...+..++.||+.||+|||+++|+|||||
T Consensus 111 ~~~~~~~~~lv~Ey~~gg~L~~~l~~---------------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLk 169 (370)
T cd05596 111 AFQDDKYLYMVMEYMPGGDLVNLMSN---------------------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVK 169 (370)
T ss_pred EEecCCEEEEEEcCCCCCcHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 99999999999999999999999861 236788889999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC----CCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN----KYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
|+|||+++++.+||+|||++........ .......+++.|||||.+... .++.++||||||+++|||++| .+||
T Consensus 170 p~NILl~~~~~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG-~~Pf 247 (370)
T cd05596 170 PDNMLLDKSGHLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG-DTPF 247 (370)
T ss_pred HHHEEEcCCCCEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhC-CCCc
Confidence 9999999999999999999976532221 122345688999999998653 478999999999999999995 5699
Q ss_pred CCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q psy5539 592 YGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLW 645 (653)
Q Consensus 592 ~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~ 645 (653)
.+.+..+....+..+. ....+. ..+.++.+++.+|+..+|.+ |++++++++|.|
T Consensus 248 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 248 YADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 8888877777776543 233343 47899999999999999988 999999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=321.36 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=216.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+|++.+.||+|+||.||+++.. .++..+|+|.++........+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHV-----NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEc-----CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 4678899999999999999864 35678999998654444456678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.+++... ....++...++.++.|++.||.|||+++++|+||||+||++++++
T Consensus 76 v~e~~~~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~ 137 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQ------------------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG 137 (255)
T ss_pred EEeeCCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC
Confidence 99999999999988621 123478889999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++| ..||...+.......+..
T Consensus 138 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g-~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 138 KVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTL-KHPFQANSWKNLILKVCQ 214 (255)
T ss_pred cEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhc-cCCCCCCCHHHHHHHHhc
Confidence 999999999876532221 12234577889999999998999999999999999999995 558988888888888877
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
+.....+..++..+.+++.+||+.+|.+||++.+|+..
T Consensus 215 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 77766777889999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.87 Aligned_cols=260 Identities=23% Similarity=0.402 Sum_probs=214.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc--cccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~--~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .++..||||.++. .........+.+|+++++.++||||+++++++...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCL-----LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEe-----CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 57889999999999999999864 3567899998753 2234455678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++|+||+++|+|.+++.... .....++...++.++.|++.||.|||+++++|+||||+|||++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~ 140 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFK----------------KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhh----------------hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEc
Confidence 999999999999999986322 1224578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL--THEEVV 600 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~--~~~e~~ 600 (653)
.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|+. ||... +..++.
T Consensus 141 ~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~-p~~~~~~~~~~~~ 217 (267)
T cd08228 141 ATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLFSLC 217 (267)
T ss_pred CCCCEEECccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCC-CCccccccHHHHH
Confidence 999999999999876532221 1123456788999999998899999999999999999999666 55433 335566
Q ss_pred HHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 601 ~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+.+......+.+ +..+..+.+++.+||+.+|++||++.++++.+..++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 666665443332 457789999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=319.81 Aligned_cols=254 Identities=35% Similarity=0.659 Sum_probs=213.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+.||+|+||.||+|.+.. .......||||.++........+.+.+|+.++++++||||+++++++.. ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWST--SGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEec--CCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 358999999999998743 1233457999999876554566789999999999999999999999888 8899999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++.... ...+++..++.++.|++.||+|||+++++|+||||+||+++.++.+||+
T Consensus 78 ~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~ 139 (257)
T cd05040 78 PLGSLLDRLRKDA------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIG 139 (257)
T ss_pred CCCcHHHHHHhcc------------------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEec
Confidence 9999999997221 1357899999999999999999999999999999999999999999999
Q ss_pred ccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCc
Q psy5539 531 DFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE-GNI 608 (653)
Q Consensus 531 DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~-~~~ 608 (653)
|||+++....... +.......++..|+|||.+....++.++||||||+++|||++.|..||...+..++.+.+.. +..
T Consensus 140 dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 219 (257)
T cd05040 140 DFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGER 219 (257)
T ss_pred cccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCc
Confidence 9999987643221 11222345677899999999999999999999999999999977779988888877766653 333
Q ss_pred cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 609 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 4455678899999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=343.72 Aligned_cols=254 Identities=22% Similarity=0.311 Sum_probs=210.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .......+.+|+.++..++||||+++++++..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKK-----DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 47889999999999999999864 356789999997532 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~ 135 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMK--------------------KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLD 135 (364)
T ss_pred EEEEECCCCCcHHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEEC
Confidence 9999999999999999862 23588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCcccccccccccc------------------------------------CCCCCCCccccccchhhccCC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYK------------------------------------GDENDAIPVRWMPLESILYNK 566 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~ 566 (653)
.++.+||+|||+++.+....... ......||+.|||||.+....
T Consensus 136 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 215 (364)
T cd05599 136 AKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215 (364)
T ss_pred CCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC
Confidence 99999999999987542211000 001134789999999999999
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhccCCCCCCC---HHHH
Q psy5539 567 YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWNMKPMNRPS---FRTI 640 (653)
Q Consensus 567 ~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~RPs---~~ei 640 (653)
++.++|||||||++|||++| ..||.+.+..+....+.... ....+. .+++++.+++++|+. +|.+|++ ++++
T Consensus 216 ~~~~~DiwSlG~il~el~~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~l 293 (364)
T cd05599 216 YNKECDWWSLGVIMYEMLVG-YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEI 293 (364)
T ss_pred CCCeeeeecchhHHHHhhcC-CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHH
Confidence 99999999999999999995 56998888877777665533 223333 468899999999996 8999997 9999
Q ss_pred HHHHH
Q psy5539 641 YQTLW 645 (653)
Q Consensus 641 l~~L~ 645 (653)
+++.|
T Consensus 294 l~h~~ 298 (364)
T cd05599 294 KSHPF 298 (364)
T ss_pred hcCCC
Confidence 99875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=323.14 Aligned_cols=254 Identities=31% Similarity=0.582 Sum_probs=204.1
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 451 (653)
.||+|+||.||+|+... ......+++|.++........+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~---~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYT---DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEc---CCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 58999999999997532 223456788888766555567789999999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEec
Q psy5539 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531 (653)
Q Consensus 452 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~D 531 (653)
+|+|.++++.... ....++...+..++.||+.||+|||+.+++||||||+|||+++++.+||+|
T Consensus 79 ~~~L~~~l~~~~~----------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~D 142 (268)
T cd05086 79 LGDLKSYLSQEQW----------------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGD 142 (268)
T ss_pred CCcHHHHHHhhhc----------------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecc
Confidence 9999999973211 123456777889999999999999999999999999999999999999999
Q ss_pred cCccccccccccccCCCCCCCccccccchhhcc-------CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-------NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
||++......+.........++..|+|||.+.. ..++.++||||||+++|||++++.+||...+..+.+..+.
T Consensus 143 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 222 (268)
T cd05086 143 YGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVI 222 (268)
T ss_pred cccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999864433322223334557789999998753 2457899999999999999998888998888777666554
Q ss_pred cCCcc-----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNIL-----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+... ..+...++.+.+++..|| .+|++||++++|++.|.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 223 KDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33221 223346788999999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=343.08 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=212.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||+||+|+.. .+++.||||+++... .......+.+|++++..++|+||+++++++..++.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDK-----DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEEC-----CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 46889999999999999999864 356889999997542 12344578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~ 135 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIR--------------------KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135 (350)
T ss_pred EEEEEcCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 9999999999999999862 24578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccc---------------------------cccCCCCCCCccccccchhhccCCCCCchhHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQD---------------------------YYKGDENDAIPVRWMPLESILYNKYTVESDVWA 575 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~---------------------------~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwS 575 (653)
.++.+||+|||++....... .........+|+.|+|||.+.+..++.++||||
T Consensus 136 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 215 (350)
T cd05573 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWS 215 (350)
T ss_pred CCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEe
Confidence 99999999999997654322 001123346788999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CccCCC--CCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q psy5539 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEG-NILQAP--DNTPDALYDLMKLCWNMKPMNRPS-FRTIYQTLW 645 (653)
Q Consensus 576 lGvvl~ellt~~~~p~~~~~~~e~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~ 645 (653)
||+++|||++|. .||.+.+..+....+... .....+ ..+++++.+++.+|+. +|.+||+ ++++++++|
T Consensus 216 lG~il~ell~g~-~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 216 LGVILYEMLYGF-PPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred cchhhhhhccCC-CCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 999999999955 588888877776666551 112223 3368999999999997 9999999 999999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=325.53 Aligned_cols=263 Identities=33% Similarity=0.603 Sum_probs=212.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--Cc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--KP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~ 442 (653)
..|++++.||+|+||.||+++... ....++..||+|.++..........+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~-~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDP-EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEcc-CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 356788999999999999998642 123456889999998665555667899999999999999999999998764 56
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+++++||||||+|||++
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~-------------------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~ 143 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN-------------------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVE 143 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEc
Confidence 89999999999999998621 23478999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--------
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-------- 593 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~-------- 593 (653)
+++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||+++..+.+..
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~ 223 (284)
T cd05079 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMI 223 (284)
T ss_pred CCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhc
Confidence 9999999999999865332211 1112344567899999999889999999999999999999865422111
Q ss_pred ------CCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 594 ------LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 594 ------~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.........+..+...+.+..++..+.+|+.+||+.+|.+||++.++++.+..+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 224 GPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 112233444555555556677899999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=319.06 Aligned_cols=257 Identities=49% Similarity=0.901 Sum_probs=222.1
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
.+.+.||+|+||.||+++..... ......||+|.++........+.+..|+.++..++|+||+++++++...+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLS-GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCC-CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 45678999999999999975321 12347899999987665546678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++++|.+++.... ...+++..+..++.|++.||+|||+.+++|+||||+||++++++.+
T Consensus 81 e~~~~~~l~~~~~~~~------------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~ 142 (258)
T smart00219 81 EYMEGGDLLDYLRKNR------------------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVV 142 (258)
T ss_pred eccCCCCHHHHHHhhh------------------hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeE
Confidence 9999999999997221 1128999999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
+|+|||+++........... ...++..|+|||.+.+..++.++||||||++++||++++.+||...+..++.+.+..+.
T Consensus 143 ~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 221 (258)
T smart00219 143 KISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY 221 (258)
T ss_pred EEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999999876544333222 33467899999999888999999999999999999998888999989899999888888
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
....+...+.++.+++.+||..+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 7777788999999999999999999999999998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=335.83 Aligned_cols=250 Identities=25% Similarity=0.383 Sum_probs=210.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
+|.+.+.||+|+||.||+|+.. .++..||||.++.... ......+..|..++..+ +|++|+++++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 4788999999999999999864 3557899999875421 22334566788888777 58999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 135 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQ--------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLD 135 (323)
T ss_pred EEEEEcCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEEC
Confidence 9999999999999998862 23578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..++.+.
T Consensus 136 ~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt-g~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 136 SEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDEDELFQS 212 (323)
T ss_pred CCCcEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 99999999999987532211 11233457889999999999999999999999999999999 5569999888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTL 644 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L 644 (653)
+..... ..|...+.++.+++.+|++.+|++|++. .++.++.
T Consensus 213 i~~~~~-~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05616 213 IMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 258 (323)
T ss_pred HHhCCC-CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCC
Confidence 887653 4667889999999999999999999974 7777664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=336.58 Aligned_cols=254 Identities=22% Similarity=0.278 Sum_probs=199.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC----
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG---- 440 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~---- 440 (653)
+|++.+.||+|+||.||+|+.. .++..||||+++... .......+.+|++++++++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDT-----HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEEC-----CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCC
Confidence 4788899999999999999863 456889999987432 222334688999999999999999999987543
Q ss_pred -CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 441 -KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 441 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
...++||||+. ++|.+++.. ...+++..+..++.||++||.|||+++|+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI 134 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKA--------------------NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNI 134 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHh--------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 24799999995 689998862 23578999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|+++++.+||+|||+++........ .......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+.
T Consensus 135 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg-~~pf~~~~~ 213 (338)
T cd07859 135 LANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNV 213 (338)
T ss_pred EECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcC-CCCCCCCCh
Confidence 9999999999999999754322211 11133467889999999875 6789999999999999999995 568876554
Q ss_pred HHHHHHHH---------------------------cCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIK---------------------------EGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~---------------------------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+....+. ...... .....+..+.+++.+||+.+|++|||+++++++.|-
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f 293 (338)
T cd07859 214 VHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYF 293 (338)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchh
Confidence 32221111 000000 012456789999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=323.53 Aligned_cols=262 Identities=36% Similarity=0.632 Sum_probs=209.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~ 441 (653)
.++|++.+.||+|+||.||+++..+. ....+..||+|.++... ....+.+.+|++++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~-~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPL-QDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCC-cCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 35788999999999999999986431 23456789999987543 3345678999999999999999999998754 34
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+++|+|.+++.. ....+++..++.++.|++.||+|||+++++||||||+|||+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~-------------------~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili 141 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQK-------------------HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV 141 (284)
T ss_pred ceEEEEEecCCCCHHHHHHh-------------------cCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE
Confidence 68999999999999999862 12357899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-----
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT----- 595 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~----- 595 (653)
++++.+||+|||+++........ ........+..|+|||.+.+..++.++||||||+++|||+++.. ++....
T Consensus 142 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~-~~~~~~~~~~~ 220 (284)
T cd05081 142 ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD-KSCSPPAEFMR 220 (284)
T ss_pred CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCC-cCCCcchhhhh
Confidence 99999999999999865332211 11122334556999999999999999999999999999999654 322111
Q ss_pred -----------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 -----------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 -----------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+.+.+..+.....+..++.++.+|+.+||+.+|++|||+.+|++.|..+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 221 MMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 1122333444444455667889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=337.31 Aligned_cols=255 Identities=22% Similarity=0.297 Sum_probs=207.6
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGK 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 441 (653)
+|++.+.||+|+||.||+++... ...++..||+|+++... .....+.+.+|+.++..+ +|+||+++++++...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVT--GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcc--cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCC
Confidence 47889999999999999998643 23467899999986532 222345678899999999 5999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili 138 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQ--------------------RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL 138 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE
Confidence 99999999999999999862 2357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC----CH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGL----TH 596 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~----~~ 596 (653)
++++.+||+|||+++....... .......+|..|||||.+.+. .++.++||||||+++|||++|. .||... ..
T Consensus 139 ~~~~~~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~ 216 (332)
T cd05614 139 DSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA-SPFTLEGERNTQ 216 (332)
T ss_pred CCCCCEEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC-CCCCCCCCCCCH
Confidence 9999999999999976432221 112234578999999999865 4789999999999999999965 477532 33
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
.++...+.... ...+..++..+.+++.+||+.||++|| ++++++++.|
T Consensus 217 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~ 269 (332)
T cd05614 217 SEVSRRILKCD-PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF 269 (332)
T ss_pred HHHHHHHhcCC-CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence 44444444433 345667899999999999999999999 8889998875
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=342.75 Aligned_cols=254 Identities=23% Similarity=0.315 Sum_probs=206.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.|..++.||+|+||+||+|+.. .++..||||+++... .......+.+|+.++++++|+||+++++++...+..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKV-----DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 5788999999999999999864 356889999997532 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+||||+.
T Consensus 77 ~lv~E~~~gg~L~~~l~~--------------------~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~ 136 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIR--------------------MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDL 136 (381)
T ss_pred EEEEecCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECC
Confidence 999999999999999862 234788889999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccc---ccc------------------------------------------CCCCCCCcccccc
Q psy5539 524 QMVVKIADFGLSRKMYLQD---YYK------------------------------------------GDENDAIPVRWMP 558 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~---~~~------------------------------------------~~~~~~~t~~y~a 558 (653)
++.+||+|||+++...... ... ......||+.|||
T Consensus 137 ~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (381)
T cd05626 137 DGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIA 216 (381)
T ss_pred CCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccC
Confidence 9999999999975321000 000 0012357899999
Q ss_pred chhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CccCCC--CCCcHHHHHHHHHh--hccCCCC
Q psy5539 559 LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG-NILQAP--DNTPDALYDLMKLC--WNMKPMN 633 (653)
Q Consensus 559 PE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~-~~~~~~--~~~~~~l~~li~~c--l~~dP~~ 633 (653)
||.+.+..++.++|||||||++|||++|. .||...+..+....+... .....+ ..+++++.+|+.++ +..++..
T Consensus 217 PE~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 217 PEVLLRKGYTQLCDWWSVGVILFEMLVGQ-PPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLG 295 (381)
T ss_pred HHHHcCCCCCCccceeehhhHHHHHHhCC-CCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccC
Confidence 99999999999999999999999999955 588877776655555432 222333 35789999999984 4556666
Q ss_pred CCCHHHHHHHHH
Q psy5539 634 RPSFRTIYQTLW 645 (653)
Q Consensus 634 RPs~~eil~~L~ 645 (653)
||+++++++|.|
T Consensus 296 R~~~~~~l~hp~ 307 (381)
T cd05626 296 RNGADDIKAHPF 307 (381)
T ss_pred CCCHHHHhcCcc
Confidence 999999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.04 Aligned_cols=246 Identities=23% Similarity=0.351 Sum_probs=204.5
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhh-CCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAE-FDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|.++.... ......+..|..++.. ++||||+++++++..++..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELK-----GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 36899999999999864 3567899999975421 1223456677777765 48999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 76 E~~~~g~L~~~i~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~ 135 (316)
T cd05620 76 EFLNGGDLMFHIQD--------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHI 135 (316)
T ss_pred CCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 99999999998862 2357888999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++.+.+..+.
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g-~~Pf~~~~~~~~~~~~~~~~ 212 (316)
T cd05620 136 KIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIG-QSPFHGDDEDELFESIRVDT 212 (316)
T ss_pred EeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHHHHhCC
Confidence 999999986432111 122334578999999999999999999999999999999995 56998888888888877654
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCH-HHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSF-RTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-~eil~~L~ 645 (653)
...+..++.++.+++.+||+.||++||++ +++++|.|
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~ 250 (316)
T cd05620 213 -PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPF 250 (316)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCC
Confidence 34566788999999999999999999998 47776654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=339.71 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=211.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||+||+|+.. .++..||+|+++.... ....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREK-----ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 46889999999999999999864 3567899999975432 3345678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~-------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~ 136 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRY-------------------EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136 (330)
T ss_pred EEEEECCCCCCCHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEEC
Confidence 99999999999999999722 24588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc------cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL------YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
.++.+||+|||++......... ......+++.|+|||.+. ...++.++||||||+++|||++|. .||.+.+.
T Consensus 137 ~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~-~Pf~~~~~ 214 (330)
T cd05601 137 RTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR-SPFHEGTS 214 (330)
T ss_pred CCCCEEeccCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC-CCCCCCCH
Confidence 9999999999999765322211 222346788999999987 456789999999999999999954 58888777
Q ss_pred HHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....+.... ....+. .++.++.+|+..|+. +|.+||+++++++|.|
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred HHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 77777665543 223332 478899999999998 9999999999998875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.87 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=207.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+++.||+|+||.||+++.. .++..||||.+.... .....+.+.+|++++++++||||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKK-----DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 46889999999999999999864 356789999986432 23344578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--------------------~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~ 135 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIK--------------------YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILID 135 (377)
T ss_pred eEEEEeCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEC
Confidence 9999999999999999862 23578888999999999999999999999999999999999
Q ss_pred CCCcEEEeccCcccccccccc------------cc---------------------------------CCCCCCCccccc
Q psy5539 523 DQMVVKIADFGLSRKMYLQDY------------YK---------------------------------GDENDAIPVRWM 557 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~------------~~---------------------------------~~~~~~~t~~y~ 557 (653)
.++.+||+|||+++....... .. ......+|+.|+
T Consensus 136 ~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 215 (377)
T cd05629 136 RGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYI 215 (377)
T ss_pred CCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcccc
Confidence 999999999999863311000 00 001135788999
Q ss_pred cchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CccCCCC--CCcHHHHHHHHHhhccCCCCC
Q psy5539 558 PLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG-NILQAPD--NTPDALYDLMKLCWNMKPMNR 634 (653)
Q Consensus 558 aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~-~~~~~~~--~~~~~l~~li~~cl~~dP~~R 634 (653)
|||.+.+..++.++|||||||++|||++| .+||.+.+..+....+... .....++ .++.++.+|+.+|+. +|.+|
T Consensus 216 aPE~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r 293 (377)
T cd05629 216 APEIFLQQGYGQECDWWSLGAIMFECLIG-WPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENR 293 (377)
T ss_pred CHHHHccCCCCCceeeEecchhhhhhhcC-CCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhc
Confidence 99999999999999999999999999994 5689888877777666542 2233333 478899999999997 66665
Q ss_pred ---CCHHHHHHHHH
Q psy5539 635 ---PSFRTIYQTLW 645 (653)
Q Consensus 635 ---Ps~~eil~~L~ 645 (653)
+++.+++++.|
T Consensus 294 ~~r~~~~~~l~hp~ 307 (377)
T cd05629 294 LGRGGAHEIKSHPF 307 (377)
T ss_pred CCCCCHHHHhcCCC
Confidence 69999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=338.72 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=209.1
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.||+|+||.||+++... ...++..||+|+++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 2 KVLGQGSFGKVFLVRKIT--GPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred ceeeeCCCEEEEEEEEec--cCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 569999999999997531 234678999999975432 22334577899999999999999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEE
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI 529 (653)
+++|+|.+++.. ...+++..+..++.||+.||+|||+.+|+||||||+|||+++++.+||
T Consensus 80 ~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL 139 (318)
T cd05582 80 LRGGDLFTRLSK--------------------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 139 (318)
T ss_pred CCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEE
Confidence 999999999862 235789999999999999999999999999999999999999999999
Q ss_pred eccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcc
Q psy5539 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609 (653)
Q Consensus 530 ~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~ 609 (653)
+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....+.... .
T Consensus 140 ~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg-~~p~~~~~~~~~~~~i~~~~-~ 215 (318)
T cd05582 140 TDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-SLPFQGKDRKETMTMILKAK-L 215 (318)
T ss_pred eeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccC-CCCCCCCCHHHHHHHHHcCC-C
Confidence 9999987543221 112234578899999999998999999999999999999995 55998888888888776654 3
Q ss_pred CCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 610 QAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 610 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
..+..++.++.+++++||+.||++||+ +.+++++.|
T Consensus 216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~ 256 (318)
T cd05582 216 GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPF 256 (318)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCC
Confidence 566778999999999999999999999 666776653
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.54 Aligned_cols=246 Identities=25% Similarity=0.366 Sum_probs=208.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||+||+|+.. .++..||||.++... .......+.+|++++..+ +||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELK-----GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 35899999999999864 345789999997542 223345677888998888 7999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||+++++.+
T Consensus 76 e~~~~~~L~~~~~~--------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~ 135 (318)
T cd05570 76 EYVNGGDLMFHIQR--------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHI 135 (318)
T ss_pred cCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcE
Confidence 99999999998862 2358899999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++| ..||.+.+..++...+....
T Consensus 136 kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G-~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 136 KIADFGMCKEGILGGV--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG-QSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred EecccCCCeecCcCCC--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC-CCCCCCCCHHHHHHHHHcCC
Confidence 9999999864321111 11233578899999999999999999999999999999995 55998888888888877665
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
. ..+..++.++.+|+++||+.||.+||++ .+++++.|
T Consensus 213 ~-~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~ 254 (318)
T cd05570 213 V-RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254 (318)
T ss_pred C-CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCC
Confidence 4 4566789999999999999999999999 99988764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=334.35 Aligned_cols=246 Identities=26% Similarity=0.385 Sum_probs=204.8
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhh-CCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAE-FDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||||.++.... ......+..|..++.. ++||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELK-----GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 35899999999999864 3567899999975421 2223456677777776 59999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.++++. ...+++.++..++.|++.||+|||+++|+||||||+|||+++++.+
T Consensus 76 ey~~~g~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~ 135 (316)
T cd05619 76 EYLNGGDLMFHIQS--------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHI 135 (316)
T ss_pred eCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCE
Confidence 99999999999862 2347888999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.+..++.+.+....
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~-~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 136 KIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ-SPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred EEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhCC
Confidence 999999987432111 1122345788999999999999999999999999999999955 5998888888888877654
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFR-TIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~ 645 (653)
. ..+...+.++.+++.+||+.+|++||++. ++.++.+
T Consensus 213 ~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~ 250 (316)
T cd05619 213 P-CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPF 250 (316)
T ss_pred C-CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcc
Confidence 3 45566889999999999999999999997 7777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=327.90 Aligned_cols=253 Identities=20% Similarity=0.277 Sum_probs=207.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
+|+..+.||+|+||+||++... .++..||+|.+..... ......+.+|+.++++++||||+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEc-----CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 3678899999999999999863 3568999999865322 22234577899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||++++
T Consensus 76 ~lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 137 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNM------------------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDD 137 (285)
T ss_pred EEEEeccCCCcHHHHHHhc------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECC
Confidence 9999999999999988621 1235889999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH----
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV---- 599 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~---- 599 (653)
++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++| ..||.+......
T Consensus 138 ~~~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g-~~pf~~~~~~~~~~~~ 213 (285)
T cd05605 138 YGHIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEG-KSPFRQRKEKVKREEV 213 (285)
T ss_pred CCCEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHC-CCCCCCCchhhHHHHH
Confidence 9999999999987642221 11234578899999999999999999999999999999995 558877655433
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
...+... ....+...+..+.+|+.+||+.||.+|| ++++++++.|-
T Consensus 214 ~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~ 264 (285)
T cd05605 214 ERRVKED-QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF 264 (285)
T ss_pred HHHhhhc-ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence 2333322 2344566889999999999999999999 89999988654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=335.91 Aligned_cols=246 Identities=24% Similarity=0.331 Sum_probs=203.5
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHH-HHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREAC-LLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||+||+|+.. .+++.||+|.+..... ......+.+|.. +++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHK-----ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 35899999999999864 3568899999865321 122234445544 567899999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||+++++.+
T Consensus 76 e~~~~g~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~ 135 (323)
T cd05575 76 DYVNGGELFFHLQR--------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHV 135 (323)
T ss_pred cCCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcE
Confidence 99999999999862 2357888999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++.+.+..+.
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 136 VLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred EEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcC-CCCCCCCCHHHHHHHHHcCC
Confidence 999999987532211 122334578899999999999999999999999999999995 46998888888888877665
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSF----RTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~ 645 (653)
. ..+...+..+.+++++||+.+|.+||++ .+++++.|
T Consensus 213 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~ 253 (323)
T cd05575 213 L-RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVF 253 (323)
T ss_pred C-CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCC
Confidence 3 4556679999999999999999999987 57777654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=319.36 Aligned_cols=255 Identities=24% Similarity=0.337 Sum_probs=209.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc----HHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++|.+.+.||+|+||.||+|... .++..||+|.++.... ....+.+.+|++++++++||||+++++++..+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDV-----DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEc-----CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC
Confidence 46788899999999999999853 3567899998864321 12335688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~--------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil 136 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKA--------------------YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL 136 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHH--------------------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 999999999999999999862 234788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccC-CCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKG-DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++++.++|+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+.
T Consensus 137 v~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~~~~~~~ 215 (263)
T cd06625 137 RDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEK-PPWAEFEAMAA 215 (263)
T ss_pred EcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCC-CCccccchHHH
Confidence 99999999999999875432211111 12344677899999999999999999999999999999965 57876655544
Q ss_pred HHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+. .......+...+..+.+++++||..+|.+|||+.+++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 262 (263)
T cd06625 216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262 (263)
T ss_pred HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence 43333 33334566778999999999999999999999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=317.98 Aligned_cols=247 Identities=36% Similarity=0.695 Sum_probs=212.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||++.. .+..||+|.++.... ...+.+|+.++++++||||+++++++... ..+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-------~~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-------TGQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-------CCCceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence 5688999999999999999864 346799999875432 35688999999999999999999998654 479
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+++||||||+|||++.+
T Consensus 75 ~v~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~ 136 (254)
T cd05083 75 IVMELMSKGNLVNFLRTR------------------GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSED 136 (254)
T ss_pred EEEECCCCCCHHHHHHhc------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCC
Confidence 999999999999999732 12357889999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.+||+|||++..... .......+..|+|||.+.++.++.++||||||+++|||++++.+||...+..+....+.
T Consensus 137 ~~~kl~Dfg~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 211 (254)
T cd05083 137 GVAKVSDFGLARVGSM-----GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211 (254)
T ss_pred CcEEECCCccceeccc-----cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh
Confidence 9999999999875321 11223345689999999989999999999999999999997888999988888888887
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....++.++..+.+++.+||+.+|.+||++++|++.|.
T Consensus 212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 212 KGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 77666666778999999999999999999999999988775
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=325.05 Aligned_cols=249 Identities=23% Similarity=0.284 Sum_probs=202.6
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||+||+++.. .+++.||+|.+..... ....+.+..|+++++.++|+||+++.+++..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMR-----ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEc-----cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 699999999999864 3567899999865422 223356788999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++.... .....+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+
T Consensus 76 ~~g~L~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~ 139 (280)
T cd05608 76 NGGDLRYHIYNVD----------------EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRIS 139 (280)
T ss_pred CCCCHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 9999998885221 123468999999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH----EEVVKYIKEG 606 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~----~e~~~~i~~~ 606 (653)
|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|. .||..... .++...+...
T Consensus 140 dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~ 216 (280)
T cd05608 140 DLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKVENKELKQRILND 216 (280)
T ss_pred eCccceecCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCC-CCCCCCCcchhHHHHHHhhccc
Confidence 999997653222 1122346788999999999999999999999999999999955 57765432 2333333332
Q ss_pred CccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 607 NILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 607 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
....+..++..+.+++.+||+.+|++|| +++++++|.|-
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~ 260 (280)
T cd05608 217 -SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260 (280)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence 2345567899999999999999999999 78999998763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.59 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=214.5
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+..++...++|++.+.||+|+||.||+|+.. .++..+|+|.++... .......+.+|+.+++.++||||++++
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHK-----SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4455667788999999999999999999864 356789999986421 222345688999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++..++..++||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++|+||||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~l~~---------------------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDL 168 (370)
T cd05621 110 CAFQDDKYLYMVMEYMPGGDLVNLMSN---------------------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDV 168 (370)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCC
Confidence 999999999999999999999999861 23678889999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC----CCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN----KYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||+|||+++++.+||+|||++........ .......+|+.|||||.+... .++.++||||||+++|||++| ..|
T Consensus 169 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G-~~P 246 (370)
T cd05621 169 KPDNMLLDKHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG-DTP 246 (370)
T ss_pred CHHHEEECCCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhC-CCC
Confidence 99999999999999999999976532221 112345688999999998764 378999999999999999995 568
Q ss_pred CCCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLWN 646 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~ 646 (653)
|.+.+..+....+.... ....+. .++..+.+++..|+..++.+ |+++.++++|.|-
T Consensus 247 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~ 307 (370)
T cd05621 247 FYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF 307 (370)
T ss_pred CCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence 88888777777776543 233343 46889999999999865544 8999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.79 Aligned_cols=246 Identities=20% Similarity=0.331 Sum_probs=202.1
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|.++... .....+.+.+|+.++..+ +||||+++++++......++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELK-----KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 35899999999999864 356789999997542 223345688899999998 7999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 76 e~~~~g~L~~~~~~--------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~ 135 (329)
T cd05588 76 EFVSGGDLMFHMQR--------------------QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHI 135 (329)
T ss_pred eCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 99999999998852 2458999999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---------CHHH
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL---------THEE 598 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~---------~~~e 598 (653)
||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++|. .||... ..+.
T Consensus 136 kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~-~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 136 KLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR-SPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred EECcCccccccccCC--CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC-CCcccccccccccccchHH
Confidence 999999986432111 1122345788999999999999999999999999999999955 577521 1122
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS------FRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~L~ 645 (653)
+.+.+..+. ...|..++.++.+++++||+.+|.+||+ ++++++|.|
T Consensus 213 ~~~~~~~~~-~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05588 213 LFQVILEKQ-IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264 (329)
T ss_pred HHHHHHcCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCC
Confidence 444444443 4567788999999999999999999987 789988865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.64 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=209.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 442 (653)
+|++.+.||+|+||+||+|+.. .++..||+|.++... .....+.+..|+.++..+. |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERK-----GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 4678899999999999999864 356789999987542 1223445778888888886 5778889999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~--------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~ 135 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQ--------------------VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135 (323)
T ss_pred EEEEEcCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 9999999999999999862 24588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++.+.
T Consensus 136 ~~~~ikL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG-~~pf~~~~~~~~~~~ 212 (323)
T cd05615 136 SEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAG-QPPFDGEDEDELFQS 212 (323)
T ss_pred CCCCEEEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 99999999999987532211 112334578999999999999999999999999999999994 569999888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTL 644 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L 644 (653)
+..... ..+...+.++.+++.+||+.+|.+|++ .+++.++.
T Consensus 213 i~~~~~-~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~ 258 (323)
T cd05615 213 IMEHNV-SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHA 258 (323)
T ss_pred HHhCCC-CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCc
Confidence 877653 566778999999999999999999997 46676664
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=340.96 Aligned_cols=253 Identities=23% Similarity=0.313 Sum_probs=206.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.|..++.||+|+||.||+|+.. .+++.||+|.+.... .......+.+|+.+++.++|+||+++++.+..++..
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKV-----DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 5788999999999999999864 356789999987532 233455788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 ~lv~E~~~gg~L~~~l~~--------------------~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~ 136 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIR--------------------MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDR 136 (382)
T ss_pred EEEEeCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999862 234788889999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccc---cc------------------------------------------cCCCCCCCcccccc
Q psy5539 524 QMVVKIADFGLSRKMYLQD---YY------------------------------------------KGDENDAIPVRWMP 558 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~---~~------------------------------------------~~~~~~~~t~~y~a 558 (653)
++.+||+|||+++...... .. .......+|+.|||
T Consensus 137 ~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~a 216 (382)
T cd05625 137 DGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIA 216 (382)
T ss_pred CCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCC
Confidence 9999999999975321000 00 00012357889999
Q ss_pred chhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-ccCCC--CCCcHHHHHHHHHhhccCCCCCC
Q psy5539 559 LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN-ILQAP--DNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 559 PE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~RP 635 (653)
||.+.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ...++++.+++.+++ .+|.+|+
T Consensus 217 PE~~~~~~~~~~~DiwSlGvil~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~ 294 (382)
T cd05625 217 PEVLLRTGYTQLCDWWSVGVILYEMLV-GQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRL 294 (382)
T ss_pred HHHhcCCCCCCeeeEEechHHHHHHHh-CCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcC
Confidence 999999999999999999999999999 556998887776665554422 22222 357889999999876 5999999
Q ss_pred C---HHHHHHHHH
Q psy5539 636 S---FRTIYQTLW 645 (653)
Q Consensus 636 s---~~eil~~L~ 645 (653)
+ +.++++|.|
T Consensus 295 ~~~~~~ei~~hp~ 307 (382)
T cd05625 295 GKNGADEIKAHPF 307 (382)
T ss_pred CCCCHHHHhcCCC
Confidence 7 999998865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=315.49 Aligned_cols=254 Identities=24% Similarity=0.335 Sum_probs=218.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|+..+.||+|+||.||.++.. .++..+++|.+... .......++.+|++++++++|+||+++++++...+..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRT-----EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEc-----CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEE
Confidence 4788999999999999999853 45678999987643 23445667899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
++|||+++|+|.+++... ....+++.++..++.|++.||.|||+.+++|+||+|+||+++++
T Consensus 76 ~~~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQ------------------KGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred EEEEecCCCcHHHHHHhc------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 999999999999999622 12457899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+....+.
T Consensus 138 ~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~-~~~~~~~~~~~~~~~~ 214 (256)
T cd08221 138 GLIKLGDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK-RTFDATNPLNLVVKIV 214 (256)
T ss_pred CCEEECcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC-CCCCCCCHHHHHHHHH
Confidence 9999999999876533221 223345688999999999888999999999999999999965 5888888888888888
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....+...+.++.+++.+||+.+|.+||++++++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~ 255 (256)
T cd08221 215 QGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255 (256)
T ss_pred cCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence 87776666778999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=336.70 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=227.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP- 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~- 442 (653)
++|..++.+|+|+||.+++++.+ .+.+.+++|.+.-. ..+..+.....|+.++++++|||||.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk-----~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~ 78 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHK-----SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQL 78 (426)
T ss_pred chhhhhhhcCccccchhhhhhhc-----cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCce
Confidence 56888999999999999998854 45678999988643 334455578999999999999999999999998888
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||+|++||+|.+.+... +...++++.+..++.|++.|+.|||+++|+|||||+.||+++
T Consensus 79 l~Ivm~Y~eGg~l~~~i~~~------------------k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Niflt 140 (426)
T KOG0589|consen 79 LCIVMEYCEGGDLAQLIKEQ------------------KGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLT 140 (426)
T ss_pred EEEEEeecCCCCHHHHHHHH------------------hhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhcc
Confidence 99999999999999999732 234589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.+..|||+|||+|+.+...+ .......||+.||.||.+.+..|..|+|||||||++|||++- .++|.+.+...++..
T Consensus 141 k~~~VkLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~l-k~aF~a~~m~~Li~k 217 (426)
T KOG0589|consen 141 KDKKVKLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTL-KPAFKASNMSELILK 217 (426)
T ss_pred ccCceeecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhc-ccccCccchHHHHHH
Confidence 99999999999999886554 233456889999999999999999999999999999999984 469999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|..+...+.|...+.+++.+|+.|+..+|..||++.+++.++..
T Consensus 218 i~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l 261 (426)
T KOG0589|consen 218 INRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHL 261 (426)
T ss_pred HhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhh
Confidence 99998888999999999999999999999999999999987543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=341.88 Aligned_cols=254 Identities=21% Similarity=0.275 Sum_probs=207.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++++.||+|+||.||+|+.. .+++.||||.+.... .......+.+|++++++++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKV-----DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEEC-----CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 36889999999999999999864 356889999986432 12234568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~~g~L~~~i~~--------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~ 135 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIR--------------------LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135 (376)
T ss_pred EEEEEeCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEEC
Confidence 9999999999999999862 23578888899999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccc---c--------------------------------------ccCCCCCCCccccccchh
Q psy5539 523 DQMVVKIADFGLSRKMYLQD---Y--------------------------------------YKGDENDAIPVRWMPLES 561 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~---~--------------------------------------~~~~~~~~~t~~y~aPE~ 561 (653)
.++.+||+|||++..+.... . ........||..|||||.
T Consensus 136 ~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~ 215 (376)
T cd05598 136 RDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEV 215 (376)
T ss_pred CCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHH
Confidence 99999999999975321000 0 000112357889999999
Q ss_pred hccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-cCC--CCCCcHHHHHHHHHhhccCCCCCC---
Q psy5539 562 ILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI-LQA--PDNTPDALYDLMKLCWNMKPMNRP--- 635 (653)
Q Consensus 562 ~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~-~~~--~~~~~~~l~~li~~cl~~dP~~RP--- 635 (653)
+.+..++.++|||||||++|||++| ..||.+.+..+....+..... ... ...++.++.+++.+|+ .+|.+|+
T Consensus 216 ~~~~~~~~~~DiwSlGvilyell~G-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~ 293 (376)
T cd05598 216 LLRTGYTQLCDWWSVGVILYEMLVG-QPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKN 293 (376)
T ss_pred HcCCCCCcceeeeeccceeeehhhC-CCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCC
Confidence 9999999999999999999999995 559988887776666554321 222 2357889999999976 5999999
Q ss_pred CHHHHHHHHH
Q psy5539 636 SFRTIYQTLW 645 (653)
Q Consensus 636 s~~eil~~L~ 645 (653)
++.++++|.|
T Consensus 294 t~~ell~h~~ 303 (376)
T cd05598 294 GADEIKAHPF 303 (376)
T ss_pred CHHHHhCCCC
Confidence 9999999876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=337.87 Aligned_cols=262 Identities=21% Similarity=0.293 Sum_probs=214.4
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+...++..++|++.+.||+|+||.||+|+.. .++..+|+|.++... .......+.+|+.+++.++||||++++
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-----~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~ 109 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEEC-----CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3445677789999999999999999999864 356789999986422 223345678999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+.+..+...++||||+++|+|.++++. ..++...+..++.||+.||+|||+++|+||||
T Consensus 110 ~~~~~~~~~~lv~Ey~~gg~L~~~~~~---------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (371)
T cd05622 110 YAFQDDRYLYMVMEYMPGGDLVNLMSN---------------------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (371)
T ss_pred EEEEcCCEEEEEEcCCCCCcHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 999999999999999999999999861 23678888999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC----CCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN----KYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||+|||+++++.+||+|||+++....... .......+|+.|||||.+... .++.++||||||+++|||++| ..|
T Consensus 169 kp~NIll~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G-~~P 246 (371)
T cd05622 169 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG-DTP 246 (371)
T ss_pred CHHHEEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhC-CCC
Confidence 99999999999999999999976532221 122345688999999998754 378999999999999999994 569
Q ss_pred CCCCCHHHHHHHHHcCC-ccCCC--CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGN-ILQAP--DNTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLWN 646 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~ 646 (653)
|.+.+.......+.... ....+ ..++..+.+++..|+...+.+ |+++++|++|+|-
T Consensus 247 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~ 307 (371)
T cd05622 247 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 307 (371)
T ss_pred CCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence 98888877777776543 22333 358899999999999854443 7899999998753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=315.34 Aligned_cols=260 Identities=24% Similarity=0.411 Sum_probs=217.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc--cccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~--~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|... .+++.||+|.++. .......+.+.+|++++++++|+||+++++++...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICL-----LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEc-----CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 57899999999999999999864 3567899998863 2233446678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+++|+||+|+||+++
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~ 140 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFIT 140 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhc----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEEC
Confidence 999999999999999986322 1234578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL--THEEVV 600 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~--~~~e~~ 600 (653)
+++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++|.. ||... +..++.
T Consensus 141 ~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~-p~~~~~~~~~~~~ 217 (267)
T cd08224 141 ATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLYSLC 217 (267)
T ss_pred CCCcEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCC-CcccCCccHHHHH
Confidence 99999999999987543221 11223456778999999999999999999999999999999665 66443 345666
Q ss_pred HHHHcCCccCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPD-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 601 ~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+.+..+...+.+. ..+..+.+++.+||+.+|++||++.+|++.+..++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 218 KKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 7777666655555 67889999999999999999999999999998775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=328.13 Aligned_cols=254 Identities=27% Similarity=0.433 Sum_probs=204.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.++..........+.+|+.++++++||||+++++++..++..+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSK-----LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEec-----CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEE
Confidence 57899999999999999999864 3457899999875443333446788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++ +|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++++
T Consensus 81 lv~e~~~~-~l~~~~~~~-------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~ 140 (309)
T cd07872 81 LVFEYLDK-DLKQYMDDC-------------------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINER 140 (309)
T ss_pred EEEeCCCC-CHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 99999975 888887521 2347888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+..+....+
T Consensus 141 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg-~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 141 GELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RPLFPGSTVEDELHLI 217 (309)
T ss_pred CCEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHHH
Confidence 999999999987542221 11223456789999998865 4689999999999999999995 4688777665544333
Q ss_pred HcC---------------------Ccc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEG---------------------NIL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~---------------------~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
... ... .....++.++.+++++|++.||.+|||+++++++.|-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 210 000 0112467889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=338.79 Aligned_cols=251 Identities=21% Similarity=0.285 Sum_probs=198.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|.+.+.||+|+||.||+|.+. .++..||+|.... ..+.+|++++++++|||||++++++..+.
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~-----~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 156 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDN-----KTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNK 156 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEEC-----CCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECC
Confidence 45578999999999999999999864 4567899997532 34678999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+|++. ++|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||+
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAA--------------------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred eeEEEEecCC-CCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 9999999985 689888852 2357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC------
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT------ 595 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~------ 595 (653)
+.++.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++|..++|....
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~ 294 (391)
T PHA03212 216 NHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCD 294 (391)
T ss_pred cCCCCEEEEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCc
Confidence 999999999999996432111 1112234689999999999999999999999999999999997765443211
Q ss_pred HHHHHHHHH--------------------------cCCcc---CCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 596 HEEVVKYIK--------------------------EGNIL---QAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 596 ~~e~~~~i~--------------------------~~~~~---~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
....+..+. ..... ..+ ...+.++.+|+.+||+.||.+|||+++++
T Consensus 295 ~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 295 SDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred hhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 111111110 00000 000 12456899999999999999999999999
Q ss_pred HHHHH
Q psy5539 642 QTLWN 646 (653)
Q Consensus 642 ~~L~~ 646 (653)
++.|-
T Consensus 375 ~hp~f 379 (391)
T PHA03212 375 DFAAF 379 (391)
T ss_pred cChhh
Confidence 98874
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.66 Aligned_cols=245 Identities=26% Similarity=0.421 Sum_probs=197.4
Q ss_pred eecccCCeeEEEEEeCCC-------------------CCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccce
Q psy5539 372 DLGQGAFGRVFQAKAPGL-------------------LKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~-------------------~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~ 432 (653)
.||+|+||.||+|..... ........|++|.+..... .....|.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 589999999999975210 0112235699999875433 34457889999999999999999
Q ss_pred EEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 433 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
+++++..+...++||||+++|+|..+++. ....+++..++.++.||++||+|||+++|+||
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~ 141 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRK-------------------EKGRVPVAWKITVAQQLASALSYLEDKNLVHG 141 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCccCC
Confidence 99999999999999999999999999862 22457889999999999999999999999999
Q ss_pred CCCCCCEeEcCCC-------cEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHH
Q psy5539 513 DLATRNCLINDQM-------VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 513 DLkp~NILl~~~~-------~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ell 584 (653)
||||+|||+++.+ .+|++|||++..... .....++..|+|||.+.. ..++.++||||||+++|||+
T Consensus 142 dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 142 NVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred CCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999997654 489999999864321 122346678999998875 56899999999999999997
Q ss_pred hCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 585 SFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 585 t~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+..||.+....+....+.... ..+.....++.+++.+||+.+|++||++.+|++.|
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 216 FDGEVPLKERTPSEKERFYEKKH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hCCCCCccccChHHHHHHHHhcc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 66777998777666555444322 33445567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=317.72 Aligned_cols=246 Identities=26% Similarity=0.428 Sum_probs=197.2
Q ss_pred eeecccCCeeEEEEEeCCCC-------CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 371 RDLGQGAFGRVFQAKAPGLL-------KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~-------~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
+.||+|+||.||+|+..... .......|++|.+.... ......|.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 35899999999999853211 01223468999887543 33456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|..++.. ....+++..+++++.||++||+|||+++|+||||||+|||++.
T Consensus 80 ~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~ 140 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHR-------------------KSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAR 140 (262)
T ss_pred EEEEecccCCCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEec
Confidence 999999999999998862 1245789999999999999999999999999999999999987
Q ss_pred CCc-------EEEeccCccccccccccccCCCCCCCccccccchhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 524 QMV-------VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 524 ~~~-------vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
++. ++++|||++..... .....++..|+|||.+. +..++.++||||||+++|||++++..|+....
T Consensus 141 ~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~ 214 (262)
T cd05077 141 EGIDGECGPFIKLSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKT 214 (262)
T ss_pred CCccCCCCceeEeCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcc
Confidence 664 89999999865421 22345677899999887 46789999999999999999976777887766
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+..... .+.. ......+.++.+||.+||+.+|.+||++.+|++++
T Consensus 215 ~~~~~~~~-~~~~-~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 215 LAEKERFY-EGQC-MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred hhHHHHHH-hcCc-cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 55543322 2222 22334567899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=314.91 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=213.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEec-CCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV-GKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~ 443 (653)
+|++.+.||+|++|.||+++.. .+++.||+|.+.... .....+.+.+|++++++++|+|++++++.+.. ....
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHR-----TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLL 75 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEc-----CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEE
Confidence 4788999999999999999864 345789999986432 33445678899999999999999999988764 4467
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+++|||+++++|.++++.. ....+++.+++.++.|++.||++||+.+++|+||||+||++++
T Consensus 76 ~lv~e~~~~~~l~~~l~~~------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~ 137 (257)
T cd08223 76 YIVMGFCEGGDLYHKLKEQ------------------KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137 (257)
T ss_pred EEEecccCCCcHHHHHHHh------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec
Confidence 8999999999999999721 1245789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.++|+|||++....... .......+++.|+|||.+.+..++.++||||||++++||++|. .||...+..+....+
T Consensus 138 ~~~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~-~~~~~~~~~~~~~~~ 214 (257)
T cd08223 138 TNIIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLK-HAFNAKDMNSLVYRI 214 (257)
T ss_pred CCcEEEecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCC-CCCCCCCHHHHHHHH
Confidence 9999999999997653222 1222345678899999999999999999999999999999965 588887777777777
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.....+...+.++.+++.+||+.+|++||++.+++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 256 (257)
T cd08223 215 IEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY 256 (257)
T ss_pred HhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 777665667778999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=333.30 Aligned_cols=246 Identities=20% Similarity=0.326 Sum_probs=201.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|.++... .......+.+|+.++.++ +||||+++++++..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLK-----KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 36899999999999864 356789999987542 223345678888888876 8999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+
T Consensus 76 E~~~~~~L~~~~~~--------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~ 135 (329)
T cd05618 76 EYVNGGDLMFHMQR--------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHI 135 (329)
T ss_pred eCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCE
Confidence 99999999988852 2458899999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---------CCHHH
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG---------LTHEE 598 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~---------~~~~e 598 (653)
||+|||+++...... .......+|..|+|||.+.+..++.++||||||+++|||++|. .||.. .....
T Consensus 136 kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 136 KLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR-SPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred EEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC-CCCccCCCcCCcccccHHH
Confidence 999999987532111 1123346789999999999999999999999999999999965 57742 11223
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS------FRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~L~ 645 (653)
+.+.+... ....|...+..+.+++++||+.||.+||+ +.++++|.|
T Consensus 213 ~~~~i~~~-~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~ 264 (329)
T cd05618 213 LFQVILEK-QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 264 (329)
T ss_pred HHHHHhcC-CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCC
Confidence 44444443 34567788999999999999999999998 578888764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.74 Aligned_cols=262 Identities=37% Similarity=0.691 Sum_probs=213.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 442 (653)
.+|.+.+.||+|+||.||+|+.... ....+..+|||.++........+.|.+|+++++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPL-GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCC-CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 4677889999999999999986431 1345789999999866544456789999999999999999999999877 567
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++... ...+++..++.++.|++.||+|||+.+++|+||||+||+++
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~-------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~ 143 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRH-------------------RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVE 143 (284)
T ss_pred eEEEEecCCCCCHHHHHHhC-------------------ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence 89999999999999999621 12588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccc-cccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC------
Q psy5539 523 DQMVVKIADFGLSRKMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT------ 595 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~------ 595 (653)
.++.++|+|||++....... ..........+..|+|||.+....++.++||||||+++|||++|.. |+....
T Consensus 144 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~-p~~~~~~~~~~~ 222 (284)
T cd05038 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD-PSQSPPAEFLRM 222 (284)
T ss_pred CCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC-Ccccccchhccc
Confidence 99999999999998664221 1122223345667999999998999999999999999999999765 443321
Q ss_pred ---------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 ---------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 ---------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+.+.+..+.....+..++.++.+++.+||+.+|.+|||+.+|++.|..+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 223 IGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred cccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2233444455554555667889999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=332.67 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=200.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHH-HHHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREA-CLLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|++..... ......+..|. .+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHK-----AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 35899999999999864 3557899999875321 12223344444 4578899999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 76 e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~ 135 (325)
T cd05602 76 DYINGGELFYHLQR--------------------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHI 135 (325)
T ss_pred eCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCE
Confidence 99999999999862 2346788888999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|||||.+.+..++.++||||||+++|||++| ..||.+.+..+..+.+....
T Consensus 136 kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05602 136 VLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRNTAEMYDNILNKP 212 (325)
T ss_pred EEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcC-CCCCCCCCHHHHHHHHHhCC
Confidence 999999987532211 122334578999999999999999999999999999999995 46898888888887776654
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHH----HHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFR----TIYQTL 644 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~----eil~~L 644 (653)
. ..+..++..+.+++.+|++.+|.+||++. ++.+++
T Consensus 213 ~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~ 252 (325)
T cd05602 213 L-QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHI 252 (325)
T ss_pred c-CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCc
Confidence 3 45567899999999999999999999876 555554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=315.28 Aligned_cols=244 Identities=29% Similarity=0.493 Sum_probs=198.8
Q ss_pred eeecccCCeeEEEEEeCCCCC-----CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLK-----HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~-----~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+.||+|+||.||+|.+..... ......+++|.++..... ...|.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 358999999999999854220 122246888887654332 5678999999999999999999999888 77899
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 78 v~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~ 138 (259)
T cd05037 78 VEEYVKFGPLDVFLHRE-------------------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYG 138 (259)
T ss_pred EEEcCCCCcHHHHHHhh-------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCc
Confidence 99999999999999721 12578899999999999999999999999999999999999887
Q ss_pred -------cEEEeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 526 -------VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 526 -------~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
.+||+|||++..... .....++..|+|||++... .++.++||||||+++|||++++..|+...+.
T Consensus 139 ~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~ 212 (259)
T cd05037 139 LNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212 (259)
T ss_pred cccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc
Confidence 899999999976532 2233455679999999877 7899999999999999999987888877765
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.+........... +......+.+++.+||..+|.+|||+.+|++.|
T Consensus 213 ~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 213 SEKERFYQDQHRL--PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred hhHHHHHhcCCCC--CCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 5555444443322 223347899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.35 Aligned_cols=245 Identities=23% Similarity=0.318 Sum_probs=202.6
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHH-HHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREAC-LLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~-il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..+|+|++.... .......+.+|.. +++.++||||+++++++..++..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRK-----LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 35899999999999863 456889999986542 1223344555554 577799999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++. ....+++..+..++.||+.||+|||+.+|+||||||+|||+++++.+
T Consensus 76 e~~~~~~L~~~l~--------------------~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~ 135 (325)
T cd05604 76 DFVNGGELFFHLQ--------------------RERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHV 135 (325)
T ss_pred cCCCCCCHHHHHH--------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCE
Confidence 9999999998886 22457899999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......++..|||||.+.+..++.++||||||+++|||++| ..||...+..++.+.+..+.
T Consensus 136 kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G-~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 136 VLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG-LPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred EEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcC-CCCCCCCCHHHHHHHHHcCC
Confidence 999999987532211 122334578899999999999999999999999999999995 46898888888888877765
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCHH----HHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFR----TIYQTL 644 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~----eil~~L 644 (653)
. ..+...+..+.+++++|++.+|.+||++. +++++.
T Consensus 213 ~-~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~ 252 (325)
T cd05604 213 L-VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHP 252 (325)
T ss_pred c-cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCC
Confidence 3 34456889999999999999999999764 666654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=323.87 Aligned_cols=254 Identities=23% Similarity=0.357 Sum_probs=208.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+++.. .++..+|+|.++..........+.+|++++.+++||||+++++.+..++..+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHR-----PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEc-----CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEE
Confidence 46889999999999999999864 3557899999876655556677899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~ 523 (653)
+||||+++++|.++++. ...+++..+..++.||++||.|||+ .+++|+||||+|||+++
T Consensus 76 lv~ey~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~ 135 (308)
T cd06615 76 ICMEHMDGGSLDQVLKK--------------------AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNS 135 (308)
T ss_pred EEeeccCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEec
Confidence 99999999999999962 2457888999999999999999997 59999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|.. ||...+..+....+
T Consensus 136 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~-p~~~~~~~~~~~~~ 210 (308)
T cd06615 136 RGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRY-PIPPPDAKELEAMF 210 (308)
T ss_pred CCcEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCC-CCCCcchhhHHHhh
Confidence 999999999998754221 1233456789999999988889999999999999999999664 66544433332222
Q ss_pred H------------------------------------cCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 K------------------------------------EGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~------------------------------------~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
. .......+ ...+.++.+++.+||..+|++||++++|++++|-
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 290 (308)
T cd06615 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290 (308)
T ss_pred cCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 1 11111111 1357789999999999999999999999999885
Q ss_pred HH
Q psy5539 647 IK 648 (653)
Q Consensus 647 l~ 648 (653)
..
T Consensus 291 ~~ 292 (308)
T cd06615 291 KR 292 (308)
T ss_pred hh
Confidence 44
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=320.57 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=203.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||.||+|+.. .++..||+|+++..... ....+.+|+.++++++||||+++++++..++..
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~~~-~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~ 81 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNL-----HTGELAAVKIIKLEPGD-DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKL 81 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEEC-----CCCeEEEEEEEecCccc-hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEE
Confidence 457889999999999999999863 35678999998754332 234678999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.++++. ...+++..+..++.|++.||.|||+++|+||||||+||++++
T Consensus 82 ~iv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~ 141 (267)
T cd06646 82 WICMEYCGGGSLQDIYHV--------------------TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred EEEEeCCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 999999999999999862 235788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.+||+|||+++...... .......++..|+|||.+. ...++.++||||||+++|||++|.. |+......+..
T Consensus 142 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~-p~~~~~~~~~~ 218 (267)
T cd06646 142 NGDVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP-PMFDLHPMRAL 218 (267)
T ss_pred CCCEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCC-Cccccchhhhh
Confidence 9999999999997653221 1122345678899999884 3457889999999999999999665 66554443332
Q ss_pred HHHHcCCcc----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEGNIL----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+...... .....++..+.+++++||+.+|++||++++|+++|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 219 FLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred eeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 222222211 112346789999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=331.34 Aligned_cols=246 Identities=24% Similarity=0.340 Sum_probs=202.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHH-HHHhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREA-CLLAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei-~il~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|+.. .++..||+|++.... .......+.+|. .+++.++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRK-----SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 35899999999999864 356889999986532 122233455555 4678899999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 76 e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~ 135 (321)
T cd05603 76 DYVNGGELFFHLQR--------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHV 135 (321)
T ss_pred cCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 99999999988852 2357888899999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++...... .......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++.+.+..+.
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 136 VLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG-LPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred EEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcC-CCCCCCCCHHHHHHHHhcCC
Confidence 999999987532211 122334578899999999999999999999999999999995 56998888888888777654
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSF----RTIYQTLW 645 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~ 645 (653)
...+...+.++.+++.+||+.+|.+||+. .++++++|
T Consensus 213 -~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05603 213 -LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVF 253 (321)
T ss_pred -CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCC
Confidence 45667788999999999999999999865 46666543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=319.21 Aligned_cols=254 Identities=26% Similarity=0.417 Sum_probs=216.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||.|+||.||+|+.. .++..||+|.+...........+.+|+.+++.++|+||+++++++..+...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDK-----RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEEC-----CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEE
Confidence 35777888999999999999864 3568899999876544445567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.++++. ..+++..+..++.|++.||.|||+++++|+||+|+||+++++
T Consensus 76 ~v~e~~~~~~L~~~~~~---------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~ 134 (274)
T cd06609 76 IIMEYCGGGSCLDLLKP---------------------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEE 134 (274)
T ss_pred EEEEeeCCCcHHHHHhh---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCC
Confidence 99999999999999861 257899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||+++.+.... .......++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+.
T Consensus 135 ~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~t-g~~p~~~~~~~~~~~~~~ 211 (274)
T cd06609 135 GDVKLADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAK-GEPPLSDLHPMRVLFLIP 211 (274)
T ss_pred CCEEEcccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccCchHHHHHHhh
Confidence 999999999997764321 12233456778999999999899999999999999999999 556887777767666666
Q ss_pred cCCccCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 605 EGNILQAPDN-TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 605 ~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+.....+.. ++.++.+++.+||..+|++|||+++++++.|-.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~ 255 (274)
T cd06609 212 KNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255 (274)
T ss_pred hcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhc
Confidence 6655444545 788999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.03 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=210.2
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--------HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--------EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--------~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
|.+.+.||+|+||.||+|... .++..+|+|.+..... ....+.+.+|+.++++++||||+++++++.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNA-----SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL 76 (267)
T ss_pred ccccceeecCCCeEEEEEEec-----CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE
Confidence 456778999999999999853 3457899998864321 223457889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++|+||+++++|.++++. ...+++..+..++.|++.||+|||+.+++||||+|+|
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~n 136 (267)
T cd06628 77 DADHLNIFLEYVPGGSVAALLNN--------------------YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGAN 136 (267)
T ss_pred eCCccEEEEEecCCCCHHHHHHh--------------------ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHH
Confidence 99999999999999999999962 2347888899999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccccc----CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYK----GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
|++++++.++|+|||+++......... ......++..|+|||.+.+..++.++||||||+++|+|++| ..||.+.
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~ 215 (267)
T cd06628 137 ILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTG-KHPFPDC 215 (267)
T ss_pred EEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhC-CCCCCCc
Confidence 999999999999999998664221111 11123467889999999999999999999999999999995 5588877
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+....+..+........+...+..+.+++++||+.+|.+||++.+|+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 266 (267)
T cd06628 216 TQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF 266 (267)
T ss_pred cHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence 666555555555555667788999999999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.55 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=197.6
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||.||+++.. .++..+|+|.+..... ......+..|++++++++||||+++++++..+...++||||+
T Consensus 1 lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVK-----NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEc-----cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 699999999999864 3568899999864322 122345567999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++|+|.+++... ....+++..+..++.||+.||+|||+.+|+||||||+|||+++++.++|+
T Consensus 76 ~g~~L~~~~~~~------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~ 137 (277)
T cd05607 76 NGGDLKYHIYNV------------------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLS 137 (277)
T ss_pred CCCCHHHHHHhc------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEe
Confidence 999999888521 12347889999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHcC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT----HEEVVKYIKEG 606 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~----~~e~~~~i~~~ 606 (653)
|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|. .||.+.. ..++.......
T Consensus 138 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~-~p~~~~~~~~~~~~~~~~~~~~ 213 (277)
T cd05607 138 DLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGR-TPFKDHKEKVAKEELKRRTLED 213 (277)
T ss_pred eceeeeecCCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCC-CCCCCCcchhhHHHHHHHhhcc
Confidence 999987653221 112345788999999999999999999999999999999955 5776543 23444444443
Q ss_pred CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHH----HHHHHH
Q psy5539 607 NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT----IYQTLW 645 (653)
Q Consensus 607 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e----il~~L~ 645 (653)
.........+.++.+|+++||+.+|.+||++++ +++|.|
T Consensus 214 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~ 256 (277)
T cd05607 214 EVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEF 256 (277)
T ss_pred ccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChh
Confidence 333333467899999999999999999999954 545544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=329.56 Aligned_cols=255 Identities=20% Similarity=0.294 Sum_probs=206.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+++.. .+++.||+|.++.. ......+.+.+|+.++..++|+||+++++++..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMK-----NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 46889999999999999999864 35678999998642 122334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++... ...+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~ 136 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKF-------------------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD 136 (331)
T ss_pred EEEEEecCCCCcHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEEC
Confidence 99999999999999999621 23578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
.++.+||+|||++........ .......+|+.|||||.+.. ..++.++||||||+++|||++| ..||.+.+..
T Consensus 137 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g-~~Pf~~~~~~ 214 (331)
T cd05597 137 KNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG-ETPFYAESLV 214 (331)
T ss_pred CCCCEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhC-CCCCCCCCHH
Confidence 999999999999876432221 11222457899999999873 4578899999999999999995 5689888777
Q ss_pred HHHHHHHcCC-ccCCC---CCCcHHHHHHHHHhhccCCC--CCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGN-ILQAP---DNTPDALYDLMKLCWNMKPM--NRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~-~~~~~---~~~~~~l~~li~~cl~~dP~--~RPs~~eil~~L~ 645 (653)
+....+.... ....+ ..++..+.+++++|+..+++ .||+++++++|.|
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 7766665432 12222 34789999999998865444 3889999999976
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.30 Aligned_cols=248 Identities=25% Similarity=0.393 Sum_probs=204.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|... .++..||+|.+...........+.+|++++++++||||+++++++...+..+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHL-----LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence 36788899999999999999864 3567899999876544555667999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|..+. .+++..+..++.|++.||.|||+.+|+|+||||+|||++.+
T Consensus 76 lv~e~~~~~~l~~~~------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~ 131 (279)
T cd06619 76 ICTEFMDGGSLDVYR------------------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTR 131 (279)
T ss_pred EEEecCCCCChHHhh------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCC
Confidence 999999999986543 25778889999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------HH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-------HE 597 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-------~~ 597 (653)
+.++|+|||++...... ......++..|+|||.+.+..++.++||||||+++|+|++|.. ||.... ..
T Consensus 132 ~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~-pf~~~~~~~~~~~~~ 206 (279)
T cd06619 132 GQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF-PYPQIQKNQGSLMPL 206 (279)
T ss_pred CCEEEeeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC-CchhhcccccccchH
Confidence 99999999999754221 1233467889999999999999999999999999999999554 665422 12
Q ss_pred HHHHHHHcCCccCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQA-PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+........ ....+.++.+++.+||+.+|.+||++++++++.|.
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 207 QLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred HHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 33333333322222 23467889999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=321.55 Aligned_cols=252 Identities=24% Similarity=0.421 Sum_probs=212.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.|+..+.||+|+||.||+|.+. .++..||+|.++........+.+.+|++++++++||||+++++++..+...++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDN-----RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEc-----CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEE
Confidence 3556678999999999999863 35678999998765545556789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
|+||+++++|.+++. ...+++..+..++.|++.||.|||+++++|+||+|+||++++++
T Consensus 80 v~e~~~~~~L~~~~~---------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~ 138 (277)
T cd06642 80 IMEYLGGGSALDLLK---------------------PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG 138 (277)
T ss_pred EEEccCCCcHHHHhh---------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC
Confidence 999999999999885 13478889999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++....... .......++..|+|||++.+..++.++||||||+++|||++|. .|+......+....+..
T Consensus 139 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~~~~~~~ 215 (277)
T cd06642 139 DVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE-PPNSDLHPMRVLFLIPK 215 (277)
T ss_pred CEEEccccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCC-CCCcccchhhHHhhhhc
Confidence 99999999987653221 1122234677899999999999999999999999999999954 58776666666666655
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.....+...+.++.+++.+||+.+|++||++.+++++.|-
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 256 (277)
T cd06642 216 NSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHH
Confidence 55445556678899999999999999999999999998764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=334.70 Aligned_cols=253 Identities=23% Similarity=0.309 Sum_probs=202.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
+|++.+.||+|+||.||+|+.. .+++.||||.+.... .....+.+.+|+++++.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDP-----RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEEC-----CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccc
Confidence 4677889999999999999863 356889999986532 2233457889999999999999999999998766
Q ss_pred --ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 442 --PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 442 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++|+||+. ++|.+++. ....+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni 134 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIV--------------------SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNL 134 (372)
T ss_pred cceEEEEeeccc-cCHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHE
Confidence 7899999996 58888775 224588999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|+++++.+||+|||+++....... .......++..|+|||.+.+. .++.++||||||+++|||++| ..||.+.+..+
T Consensus 135 li~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~ 212 (372)
T cd07853 135 LVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGR-RILFQAQSPIQ 212 (372)
T ss_pred EECCCCCEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcC-CCCCCCCCHHH
Confidence 999999999999999975432221 122234567889999998875 479999999999999999995 56888776655
Q ss_pred HHHHHHcC-----------------------Cc--------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKEG-----------------------NI--------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~~-----------------------~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+.+.+. .. .......++++.+|+.+||+.||.+|||+.+++++.|-
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 291 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhh
Confidence 44443220 00 01223457889999999999999999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=336.00 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=209.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++++.||+|+||+||+|+.. .++..||+|.++... .......+.+|+.++..++|+||+++++.+..++.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKK-----DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 46889999999999999999864 356789999987432 23344568889999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~E~~~gg~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~ 135 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMK--------------------KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLD 135 (360)
T ss_pred EEEEEeCCCCccHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEEC
Confidence 9999999999999999862 24578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccc---------------------------------cCCCCCCCccccccchhhccCCCCC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYY---------------------------------KGDENDAIPVRWMPLESILYNKYTV 569 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~---------------------------------~~~~~~~~t~~y~aPE~~~~~~~t~ 569 (653)
.++.+||+|||+++........ .......||+.|+|||.+.+..++.
T Consensus 136 ~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~ 215 (360)
T cd05627 136 AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215 (360)
T ss_pred CCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCC
Confidence 9999999999998754211000 0011235789999999999999999
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-ccCCCC--CCcHHHHHHHHHhhccCCCCCC---CHHHHHHH
Q psy5539 570 ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN-ILQAPD--NTPDALYDLMKLCWNMKPMNRP---SFRTIYQT 643 (653)
Q Consensus 570 ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~-~~~~~~--~~~~~l~~li~~cl~~dP~~RP---s~~eil~~ 643 (653)
++|||||||++|||++| .+||.+.+..+....+.... ....+. .++.++.+++.+++. +|.+|+ +++++++|
T Consensus 216 ~~DiwSlGvilyel~tG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 216 LCDWWSLGVIMYEMLIG-YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred cceeccccceeeecccC-CCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99999999999999995 56998888888777776532 222333 368899999999764 999998 57899988
Q ss_pred HH
Q psy5539 644 LW 645 (653)
Q Consensus 644 L~ 645 (653)
.|
T Consensus 294 p~ 295 (360)
T cd05627 294 PF 295 (360)
T ss_pred CC
Confidence 75
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.61 Aligned_cols=254 Identities=21% Similarity=0.368 Sum_probs=216.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|++.+.||+|+||.||+++.. .+++.||+|.+... ......+++.+|+.++++++||||+++++++...+..+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSK-----EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEc-----CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEE
Confidence 4788999999999999999863 35678999998643 23344567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.+++... ....+++..++.++.|++.||.|||+.+++|+||+|+|||++.+
T Consensus 76 lv~e~~~~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQ------------------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred EEEecCCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 999999999999998621 12347888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++++|++|. .||...+..+....+.
T Consensus 138 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~-~~~~~~~~~~~~~~~~ 214 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK-HAFEAGNMKNLVLKII 214 (256)
T ss_pred CCEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC-CCccCCCHHHHHHHHh
Confidence 9999999999976532221 112234677899999999999999999999999999999955 5887778888888887
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....+...+.++.+++.+||+.+|.+||++.+|+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~ 255 (256)
T cd08218 215 RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255 (256)
T ss_pred cCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence 77777777788999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.66 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=215.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
+.|++.+.||+|+|+.||++.. ..+++.+|+|.+.-. .+....+++++|++|-+.|+|||||+|.....+.+..
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~-----~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ 85 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVH-----KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 85 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHh-----ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccccee
Confidence 4677788899999999998754 345566676665422 1122456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN- 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~- 522 (653)
+||||+|.||+|..-+... ...++..+-+.++||+++|.|+|.++|||||+||.|+|+-
T Consensus 86 ylvFe~m~G~dl~~eIV~R--------------------~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLAS 145 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAR--------------------EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLAS 145 (355)
T ss_pred EEEEecccchHHHHHHHHH--------------------HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeee
Confidence 9999999999998876521 2367888999999999999999999999999999999994
Q ss_pred --CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
..--+||+|||+|..+. ....-....||+.|||||++...+|+..+|||+-||+||-|+. |.+||++.+..++.
T Consensus 146 K~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~-G~~PF~~~~~~rly 221 (355)
T KOG0033|consen 146 KAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV-GYPPFWDEDQHRLY 221 (355)
T ss_pred ccCCCceeecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHh-CCCCCCCccHHHHH
Confidence 44578999999998774 1223456789999999999999999999999999999999998 55699999999999
Q ss_pred HHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.|..|...-.+ ++++++.++|+++|+..||.+|.|+.|.++|+|--
T Consensus 222 e~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 222 EQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred HHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 999998764333 46889999999999999999999999999998843
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=318.13 Aligned_cols=253 Identities=25% Similarity=0.432 Sum_probs=214.6
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.|+..+.||+|+||.||+|... ..+..||+|.++..........+.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDN-----RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWI 79 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEc-----cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence 4667788999999999999863 34678999998765544556789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.++++. ..+++.++..++.|++.||+|||+.+++|+||+|+||++++++
T Consensus 80 v~e~~~~~~L~~~i~~---------------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~ 138 (277)
T cd06640 80 IMEYLGGGSALDLLRA---------------------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138 (277)
T ss_pred EEecCCCCcHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC
Confidence 9999999999998851 2467888999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++| .+|+......+....+..
T Consensus 139 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg-~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06640 139 DVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKG-EPPNSDMHPMRVLFLIPK 215 (277)
T ss_pred CEEEcccccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHC-CCCCCCcChHhHhhhhhc
Confidence 999999999976533221 12233567789999999988999999999999999999995 468888777776666655
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.....+...+..+.+++.+||+.+|++||++.+++++.+-.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 216 NNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred CCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 555555566788999999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=317.25 Aligned_cols=246 Identities=26% Similarity=0.472 Sum_probs=200.5
Q ss_pred eeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
+.||+|+||.||+|....... ......|++|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 358999999999998643211 1234568889886533 3345678899999999999999999999999899999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc--
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV-- 526 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~-- 526 (653)
|+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.
T Consensus 80 ~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~ 140 (258)
T cd05078 80 YVKFGSLDTYLKKN-------------------KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRK 140 (258)
T ss_pred cCCCCcHHHHHhcC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccc
Confidence 99999999999722 235788899999999999999999999999999999999987765
Q ss_pred ------EEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 527 ------VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 527 ------vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
++++|||++..... .....+++.|+|||.+.+. .++.++||||||+++|||++|+.+|+...+....
T Consensus 141 ~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 141 TGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred cCCCceEEecccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 69999999865422 2233466789999999874 5799999999999999999987778877776655
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
...... ....+...+.++.+++.+||+.+|++|||+++|++.|
T Consensus 215 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 215 LQFYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred HHHHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 444333 2345566778899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=339.81 Aligned_cols=255 Identities=18% Similarity=0.304 Sum_probs=200.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..+..+|.+.+.||+|+||.||+|... .++..||||++..... ...+|+.+++.++|||||++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~l~~~~~~~ 131 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICI-----DTSEKVAIKKVLQDPQ-----YKNRELLIMKNLNHINIIFLKDYYYTE 131 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEEC-----CCCCEEEEEEEecCcc-----hHHHHHHHHHhcCCCCCcceeeeEeec
Confidence 345568999999999999999999864 3557899998864321 245799999999999999999886432
Q ss_pred --------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 441 --------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 441 --------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
..+++||||+++ +|.+++.... .....+++..+..++.||+.||+|||+++|+||
T Consensus 132 ~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr 194 (440)
T PTZ00036 132 CFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYA----------------RNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194 (440)
T ss_pred ccccCCCceEEEEEEecCCc-cHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 246799999975 7888876321 123568899999999999999999999999999
Q ss_pred CCCCCCEeEcCCC-cEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 513 DLATRNCLINDQM-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 513 DLkp~NILl~~~~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||||+||||+.++ .+||+|||+++.+.... ......++..|||||.+.+. .++.++|||||||++|||++| .+|
T Consensus 195 DLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG-~~p 270 (440)
T PTZ00036 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YPI 270 (440)
T ss_pred CcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhC-CCC
Confidence 9999999999664 79999999998653222 12234568889999998764 689999999999999999995 568
Q ss_pred CCCCCHHHHHHHHHcC--C-----------------c---------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEG--N-----------------I---------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~--~-----------------~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
|.+.+..+.+..+... . . ...|...+.++.+|+.+||..+|.+|||+.++++
T Consensus 271 f~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 271 FSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 8887665544333210 0 0 0123346789999999999999999999999999
Q ss_pred HHHH
Q psy5539 643 TLWN 646 (653)
Q Consensus 643 ~L~~ 646 (653)
|+|-
T Consensus 351 hp~f 354 (440)
T PTZ00036 351 DPFF 354 (440)
T ss_pred ChhH
Confidence 9873
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.85 Aligned_cols=251 Identities=29% Similarity=0.494 Sum_probs=204.8
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHH-HHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ-TDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~-~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
|++.+.||+|+||+||+++.. .++..+|+|.+......... ....+|+.++++++||||+++++++......++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNK-----KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEET-----TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEEC-----CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccc
Confidence 678899999999999999975 35678999999866443332 244669999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++++|.+++.. ...++...++.++.|++.||++||+.+++|+||||+||++++++
T Consensus 76 v~~~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~ 135 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQK--------------------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG 135 (260)
T ss_dssp EEEEETTEBHHHHHHH--------------------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS
T ss_pred cccccccccccccccc--------------------cccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999961 24578999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE---EVVK 601 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~---e~~~ 601 (653)
.++|+|||++... ...........++..|+|||.+. +..++.++||||||+++|+|++|. .||...... +...
T Consensus 136 ~~~l~Dfg~~~~~--~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~-~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 136 EVKLIDFGSSVKL--SENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGK-LPFEESNSDDQLEIIE 212 (260)
T ss_dssp EEEESSGTTTEES--TSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSS-SSSTTSSHHHHHHHHH
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccc-cccccccchhhhhhhh
Confidence 9999999999753 11122334556788999999998 889999999999999999999965 577776332 3333
Q ss_pred HHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.......... ....+.++.+++.+||+.+|++||++.++++++|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~ 259 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW 259 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence 3322221111 1223489999999999999999999999998875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=340.02 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=201.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
...|.+.+.||+|+||.||+|+... .+..||||.... ..+.+|++++++++|+|||++++++..++..
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~-----~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~ 235 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD-----YPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT 235 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC-----CCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 4578999999999999999998743 457899996432 2356899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|||++. ++|.+++.. ....+++.+++.|+.||+.||.|||+++|+||||||+||||+.
T Consensus 236 ~lv~e~~~-~~L~~~l~~-------------------~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 236 CLVLPKYR-SDLYTYLGA-------------------RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred EEEEEccC-CCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 99999995 799998852 1235899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-------CH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-------TH 596 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-------~~ 596 (653)
++.+||+|||+++...............+|..|||||++.+..++.++|||||||+||||++++.+.|... ..
T Consensus 296 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~ 375 (461)
T PHA03211 296 PEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375 (461)
T ss_pred CCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcH
Confidence 99999999999976532221112223468999999999999999999999999999999998765444322 23
Q ss_pred HHHHHHHHcCCcc--CCC-------------------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 597 EEVVKYIKEGNIL--QAP-------------------------------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 597 ~e~~~~i~~~~~~--~~~-------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
.++.+.+...... ..+ ...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 376 ~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 376 AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred HHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 3444444432211 000 0234578999999999999999999999998
Q ss_pred HHH
Q psy5539 644 LWN 646 (653)
Q Consensus 644 L~~ 646 (653)
.|-
T Consensus 456 p~f 458 (461)
T PHA03211 456 PLF 458 (461)
T ss_pred ccc
Confidence 763
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=319.50 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=213.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.++|++.+.||+|+||.||+|+.. .++..+|+|.++... ....+.+.+|++++++++|+||+++++++..+..
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHK-----ETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENK 76 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEc-----CCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe
Confidence 3457888999999999999999864 256789999987543 3345678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++... ...+++..+..++.|++.||.|||+.+|+|+||||+||+++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~-------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~ 137 (280)
T cd06611 77 LWILIEFCDGGALDSIMLEL-------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137 (280)
T ss_pred EEEEeeccCCCcHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC
Confidence 99999999999999998621 23588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
.++.++|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|. +||...+..
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~-~p~~~~~~~ 214 (280)
T cd06611 138 LDGDVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQME-PPHHELNPM 214 (280)
T ss_pred CCCCEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCC-CCcccCCHH
Confidence 99999999999986542221 1223345678899999875 345778999999999999999954 688888777
Q ss_pred HHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+..+... ..+..++.++.+++.+||+.+|.+||++.+++++.|-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 265 (280)
T cd06611 215 RVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265 (280)
T ss_pred HHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhh
Confidence 776666665432 3355688999999999999999999999999999773
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=317.84 Aligned_cols=256 Identities=21% Similarity=0.362 Sum_probs=204.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 440 (653)
-+.+.|.+.+.||+|+||.||+|... .++..||+|.+..... ....+.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKK 75 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEc-----CCCcEEEEEEEEcCCc--cHHHHHHHHHHHHHhcCCCCeeeEeeEEeec
Confidence 34567888889999999999999864 3567899999865432 235678999999998 799999999998643
Q ss_pred ------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 441 ------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 441 ------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
...++||||+++|+|.+++... ....+++..+..++.|++.||+|||+++|+|+||
T Consensus 76 ~~~~~~~~~~iv~e~~~~~~L~~~l~~~------------------~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl 137 (272)
T cd06637 76 NPPGMDDQLWLVMEFCGAGSVTDLIKNT------------------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDI 137 (272)
T ss_pred CCCCCCcEEEEEEEcCCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 4579999999999999998721 1245789999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
||+||++++++.++|+|||++...... ........++..|+|||.+. ...++.++||||||+++|||++|..
T Consensus 138 ~~~nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~- 214 (272)
T cd06637 138 KGQNVLLTENAEVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214 (272)
T ss_pred CHHHEEECCCCCEEEccCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCC-
Confidence 999999999999999999998754221 12223455778899999986 3468889999999999999999665
Q ss_pred CCCCCCHHHHHHHHHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||...........+.... ....+..++.++.+|+.+||..+|.+|||+.+++++.|
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 271 (272)
T cd06637 215 PLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271 (272)
T ss_pred CccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence 776555444333333322 22233457889999999999999999999999998865
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=328.52 Aligned_cols=255 Identities=20% Similarity=0.269 Sum_probs=208.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||.||+++..+ .++.+|+|.+.... .......+.+|+.++..++|+||+++++.+...+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN-----ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC-----CCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 468899999999999999998743 45789999986421 22334458899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~-------------------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~ 136 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKF-------------------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 136 (332)
T ss_pred EEEEEeccCCCcHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence 99999999999999999721 23578889999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
.++.+||+|||++........ .......+|+.|||||.+. ...++.++||||||+++|||++| ..||.+.+..
T Consensus 137 ~~~~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g-~~Pf~~~~~~ 214 (332)
T cd05623 137 MNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG-ETPFYAESLV 214 (332)
T ss_pred CCCCEEEeecchheecccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcC-CCCCCCCCHH
Confidence 999999999999875432221 1122346789999999986 34688999999999999999995 4589888887
Q ss_pred HHHHHHHcCCc----cCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNI----LQAPDNTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~ 645 (653)
+....+..... ......++.++.+|+++|+..++.+ |++++++++|.|
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~ 268 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPF 268 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCC
Confidence 77777765432 2222457899999999998665544 789999999865
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=332.56 Aligned_cols=245 Identities=22% Similarity=0.312 Sum_probs=201.7
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhC---CCCccceEEeEEecCCceEEEE
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEF---DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
||+|+||+||+|+.. .++..||||++..... ......+..|..++..+ +||||+++++++......++||
T Consensus 1 lG~G~~g~Vy~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKK-----DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEEC-----CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 799999999999863 4567899999864321 11223345566666655 6999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||++||+|||+++|+||||||+|||+++++.+
T Consensus 76 e~~~~g~L~~~l~~--------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~ 135 (330)
T cd05586 76 DYMSGGELFWHLQK--------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHI 135 (330)
T ss_pred cCCCCChHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCE
Confidence 99999999998862 2457899999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~ 606 (653)
||+|||+++...... .......++..|||||.+.+. .++.++||||||+++|||++|. .||.+.+..++...+..+
T Consensus 136 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~-~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 136 ALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW-SPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred EEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC-CCCCCCCHHHHHHHHHcC
Confidence 999999987532222 122334578899999998765 4899999999999999999954 588888888888888777
Q ss_pred CccCCCCCCcHHHHHHHHHhhccCCCCCC----CHHHHHHHHH
Q psy5539 607 NILQAPDNTPDALYDLMKLCWNMKPMNRP----SFRTIYQTLW 645 (653)
Q Consensus 607 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~eil~~L~ 645 (653)
.........++++.+++++||+.+|.+|| ++.++++|.|
T Consensus 213 ~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~ 255 (330)
T cd05586 213 KVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPF 255 (330)
T ss_pred CCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcc
Confidence 65433345789999999999999999998 6889988865
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.67 Aligned_cols=246 Identities=20% Similarity=0.311 Sum_probs=201.2
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||+||+|+.. ..++.||+|+++.... ....+.+.+|+.++.++ +||||+++++++...+..++||
T Consensus 1 ~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLK-----KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 36899999999999864 3567899999976432 23345688999999888 6999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 76 e~~~~~~L~~~~~~--------------------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~ 135 (327)
T cd05617 76 EYVNGGDLMFHMQR--------------------QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHI 135 (327)
T ss_pred eCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCE
Confidence 99999999998852 2358899999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC------C-HHHHH
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL------T-HEEVV 600 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~------~-~~e~~ 600 (653)
||+|||+++...... .......+|..|+|||.+.+..++.++||||||+++|||++|. .||... . .+.+.
T Consensus 136 kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~-~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 136 KLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR-SPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred EEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC-CCCCccCCCcccccHHHHH
Confidence 999999987432111 1122345788999999999999999999999999999999965 577431 2 22344
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS------FRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~L~ 645 (653)
..+... ....|...+..+.+++++||+.||.+|++ ++++++|.+
T Consensus 213 ~~~~~~-~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~ 262 (327)
T cd05617 213 QVILEK-PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTF 262 (327)
T ss_pred HHHHhC-CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCC
Confidence 444443 34567788999999999999999999997 568887753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=319.78 Aligned_cols=254 Identities=21% Similarity=0.280 Sum_probs=206.2
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
|+..+.||+|+||.||++... .+++.||+|.+..... ......+.+|+.++++++|+||+++++.+..++..+
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALC 76 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEc-----CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEE
Confidence 567788999999999999864 3568999999864322 223345778999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+|+||||||+||+++++
T Consensus 77 lv~e~~~g~~L~~~l~~~------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 77 LVLTLMNGGDLKFHIYHM------------------GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred EEEEecCCCcHHHHHHHh------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 999999999999998622 12347889999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH---EEVVK 601 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~---~e~~~ 601 (653)
+.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++| ..||..... .+...
T Consensus 139 ~~~~l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g-~~Pf~~~~~~~~~~~~~ 214 (285)
T cd05630 139 GHIRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKIKREEVE 214 (285)
T ss_pred CCEEEeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhC-CCCCCCCCccchHHHHH
Confidence 999999999987542221 11234678899999999999999999999999999999995 458875432 12222
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLWNI 647 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l 647 (653)
.+........+..++.++.+|+++||+.+|++||| ++++++|.|-.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~ 265 (285)
T cd05630 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFK 265 (285)
T ss_pred hhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhh
Confidence 22222222345678899999999999999999999 89999988743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.76 Aligned_cols=260 Identities=23% Similarity=0.415 Sum_probs=212.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||.||+|+.. .++..+|||.+... .......++.+|+.+++.++|+||+++++++..++.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeec-----CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 46778889999999999999853 35678999987642 223345678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+++|||+++++|.++++... .....+++..++.++.||+.||.|||+++++|+||||+||+++
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 140 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFK----------------KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFIT 140 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhh----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 999999999999999987321 1234588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT--HEEVV 600 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~--~~e~~ 600 (653)
.++.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|.. ||.+.. ..+..
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~~~~~ 217 (267)
T cd08229 141 ATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLYSLC 217 (267)
T ss_pred CCCCEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCC-CcccccchHHHHh
Confidence 99999999999987543221 11223456788999999999999999999999999999999665 775443 34555
Q ss_pred HHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 601 ~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+.+........+ ...+..+.+++.+||+.+|++|||+.+|++.+.++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 555554433332 457889999999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=328.87 Aligned_cols=251 Identities=23% Similarity=0.271 Sum_probs=198.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
.++|++.+.||+|+||.||+++.. .++..||||.++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDT-----VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEc-----CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCC
Confidence 367999999999999999999863 35688999998643 22334557889999999999999999999986443
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
..++||||+++ +|.+.++ ..++...+..++.||+.||.|||+++|+||||||
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~----------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp 151 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIH----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 151 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHh----------------------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 47999999975 6766654 2367888999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||++.++.+||+|||+++..... .......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.+.
T Consensus 152 ~NIl~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~-~pf~~~~~ 227 (359)
T cd07876 152 SNIVVKSDCTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGS-VIFQGTDH 227 (359)
T ss_pred HHEEECCCCCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCH
Confidence 9999999999999999999754221 1123346788999999999999999999999999999999954 58876654
Q ss_pred HHHHHHHHc-----------------------CCcc------------------CCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 597 EEVVKYIKE-----------------------GNIL------------------QAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 597 ~e~~~~i~~-----------------------~~~~------------------~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
.+....+.. .... ......+.++.+|+.+||..||++||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 307 (359)
T cd07876 228 IDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI 307 (359)
T ss_pred HHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC
Confidence 332211110 0000 00112356789999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
|+.|+++|+|-
T Consensus 308 t~~e~l~hp~~ 318 (359)
T cd07876 308 SVDEALRHPYI 318 (359)
T ss_pred CHHHHhcCchh
Confidence 99999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=311.06 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=204.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-HHHHHHHHHHHHHhhCCCCccceEEeEEec--C
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDFEREACLLAEFDHPNIVKLLGVCAV--G 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~ 440 (653)
.++|+.++.|++|+||.||+|+++ .+...||+|+++.+... ..--.-.|||.+|.+.+|||||.+-.+... -
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk-----~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~ 149 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDK-----KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM 149 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccC-----CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc
Confidence 356888999999999999999853 57789999999865322 112235799999999999999999887653 4
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..||||||+++ ||...|... ..++...+...+..|+++|++|||.+.|+||||||+|+|
T Consensus 150 d~iy~VMe~~Eh-DLksl~d~m-------------------~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLL 209 (419)
T KOG0663|consen 150 DKIYIVMEYVEH-DLKSLMETM-------------------KQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLL 209 (419)
T ss_pred ceeeeeHHHHHh-hHHHHHHhc-------------------cCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhee
Confidence 579999999988 999988722 246888999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++.|.+||+|||||+...+. .+.-+....|..|.|||.+.+. .|++..|+||+|||+.||++ +.+-|.|.+.-+.
T Consensus 210 m~~~G~lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~-~kPlf~G~sE~dQ 286 (419)
T KOG0663|consen 210 LSHKGILKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT-QKPLFPGKSEIDQ 286 (419)
T ss_pred eccCCcEEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh-cCCCCCCCchHHH
Confidence 999999999999999976433 3445667789999999999876 58999999999999999998 5567777766554
Q ss_pred HHHHHc--C-------------------CccCCC---------C-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKE--G-------------------NILQAP---------D-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~--~-------------------~~~~~~---------~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.|-. | .+.+.| . ..++.-.+|+..++..||.+|.|+++.++|-|
T Consensus 287 l~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 287 LDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred HHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 444422 0 000001 0 14477889999999999999999999998755
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=318.61 Aligned_cols=253 Identities=22% Similarity=0.384 Sum_probs=208.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
..+|.+.+.||+|+||.||+|... .++..|++|.+...... ..+.+.+|+.+++.++|+||+++++.+..+...
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~ 92 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEEC-----CCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence 357889999999999999999853 35678999988754433 245688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+|+|+||||+|||+++
T Consensus 93 ~lv~e~~~~~~L~~~~~~---------------------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~ 151 (296)
T cd06654 93 WVVMEYLAGGSLTDVVTE---------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (296)
T ss_pred EEeecccCCCCHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 999999999999999851 23688899999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++........ ......++..|+|||.+.+..++.++||||||+++|||++|. +||......+....+
T Consensus 152 ~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~-~pf~~~~~~~~~~~~ 228 (296)
T cd06654 152 DGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-PPYLNENPLRALYLI 228 (296)
T ss_pred CCCEEECccccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCHHHhHHHH
Confidence 99999999999876432221 122345778899999999888999999999999999999955 588766654433322
Q ss_pred H-cCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 K-EGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~-~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
. .+. ....+...+..+.+++.+||..+|++||++.+|+++.|-
T Consensus 229 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~ 273 (296)
T cd06654 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (296)
T ss_pred hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhh
Confidence 2 221 123355678899999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=320.87 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=204.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.++..........+.+|+.++++++||||+++++++......+
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSK-----LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEc-----CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEE
Confidence 57899999999999999999864 3557899999875443333456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||++ ++|.+++.. ....+++..+..++.||+.||+|||+.+|+|+||||+|||++++
T Consensus 81 lv~e~~~-~~l~~~l~~-------------------~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~ 140 (301)
T cd07873 81 LVFEYLD-KDLKQYLDD-------------------CGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINER 140 (301)
T ss_pred EEEeccc-cCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCC
Confidence 9999997 589988862 12357888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||++....... .......++..|+|||.+.+. .++.++||||||+++|||++| .+||.+.+..+....+
T Consensus 141 ~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg-~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 141 GELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RPLFPGSTVEEQLHFI 217 (301)
T ss_pred CcEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Confidence 999999999987542221 112234557889999988754 578999999999999999995 5688877765544333
Q ss_pred HcC---------------------CccC--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEG---------------------NILQ--------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~---------------------~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
... .... ....++.++.+|+.+|++.||.+|||+++++++.|-
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 210 0000 012467889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.51 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=203.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+...+|.+++.||+|+||.||++...+ ...+..||+|.+... ..+.+|++++++++||||+++++++....
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~---~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHG---DEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcC---CccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345679999999999999999997643 245678999988653 23568999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|||++. ++|.+++. ....+++.+++.++.||+.||.|||+++|+||||||+|||+
T Consensus 160 ~~~lv~e~~~-~~l~~~l~--------------------~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill 218 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVD--------------------RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL 218 (392)
T ss_pred EEEEEehhcC-CCHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 9999999985 68988884 22458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH----H
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH----E 597 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~----~ 597 (653)
+.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++|.. ||.+... .
T Consensus 219 ~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~-pf~~~~~~~~~~ 297 (392)
T PHA03207 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV-TLFGKQVKSSSS 297 (392)
T ss_pred cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCC-CCCCCCCCCcHH
Confidence 9999999999999976543332223334568999999999999999999999999999999999766 5544321 1
Q ss_pred HHHHHHHc---CC----------------------cc--CCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKE---GN----------------------IL--QAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~---~~----------------------~~--~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+...+.. .. .. ..+ ...+.++.+++++||..+|++|||+.+++.+.|
T Consensus 298 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 298 QLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred HHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 11111110 00 00 000 124567889999999999999999999999987
Q ss_pred HHH
Q psy5539 646 NIK 648 (653)
Q Consensus 646 ~l~ 648 (653)
-.+
T Consensus 378 f~~ 380 (392)
T PHA03207 378 FTK 380 (392)
T ss_pred hhc
Confidence 654
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=313.69 Aligned_cols=258 Identities=25% Similarity=0.362 Sum_probs=206.4
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++++++++.....||+|+||.||+|++. .++..|++|.++..... ..+.+.+|+.++++++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 76 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDL-----STQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSE 76 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEec-----CCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeecc
Confidence 4566677777788999999999999863 35678999988765433 34578999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCC--CHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL--STCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
++..++|+||+++++|.++++.. ...+ ++..+..++.||+.||+|||+++|+||||||+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~ 137 (268)
T cd06624 77 NGFFKIFMEQVPGGSLSALLRSK-------------------WGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGD 137 (268)
T ss_pred CCEEEEEEecCCCCCHHHHHHHh-------------------cccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 99999999999999999999722 1223 77888999999999999999999999999999
Q ss_pred CEeEcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 518 NCLIND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 518 NILl~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+++. ++.++|+|||++......+ .......++..|+|||.+.... ++.++||||||+++|+|++|. +||...
T Consensus 138 nil~~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~-~p~~~~ 214 (268)
T cd06624 138 NVLVNTYSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK-PPFIEL 214 (268)
T ss_pred HEEEcCCCCeEEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCC-CCCccc
Confidence 999976 6799999999987543221 1222345678999999987654 789999999999999999954 577654
Q ss_pred CHH-H-HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THE-E-VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~-e-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
... . .............+...++++.+++.+||+.+|.+|||+.+++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 267 (268)
T cd06624 215 GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267 (268)
T ss_pred cChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence 322 2 22211122233456678899999999999999999999999998865
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=312.15 Aligned_cols=254 Identities=26% Similarity=0.462 Sum_probs=209.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.++|++.+.||+|+||.||+|... .++..+++|.++..... ..+.+.+|++++++++||||+++++++..++.
T Consensus 1 ~~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (262)
T cd06613 1 PQEDYELIQRIGSGTYGDVYKARDI-----ATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK 74 (262)
T ss_pred CccceEEEEEecCCCceEEEEeEec-----CCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE
Confidence 3568999999999999999999863 24568999998755433 45678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+++|||+++++|.++++.. ...++..++..++.|++.||.|||+.+++|+||+|+||+++
T Consensus 75 ~~l~~e~~~~~~l~~~~~~~-------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 75 LWIVMEYCGGGSLQDIYQVT-------------------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred EEEEEeCCCCCcHHHHHHhh-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 99999999999999998621 14578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++.+||+|||++....... .......++..|+|||.+... .++.++||||||+++|||++|. .|+.+.+..+.
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~-~p~~~~~~~~~ 212 (262)
T cd06613 136 EDGDVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ-PPMFDLHPMRA 212 (262)
T ss_pred CCCCEEECccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCC-CCCCCCCHHHH
Confidence 99999999999987643211 112234567789999998877 8899999999999999999955 58877666555
Q ss_pred HHHHHcCCc----cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 600 VKYIKEGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 600 ~~~i~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
...+..... ...+...+.++.+++++||..+|.+|||+++|+.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~ 261 (262)
T cd06613 213 LFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261 (262)
T ss_pred HHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence 444443321 112234567899999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=327.95 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=207.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+++.. .+++.||+|.++... .......+.+|+.++..++|+||+++++++..++.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMK-----HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 47899999999999999999864 356789999986431 22234458889999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++.. ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~-------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~ 136 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKF-------------------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLD 136 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEc
Confidence 99999999999999999721 23578889999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
.++.+||+|||+++....... .......+++.|||||.+.+ +.++.++||||||+++|||++| ..||.+.+..
T Consensus 137 ~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g-~~Pf~~~~~~ 214 (331)
T cd05624 137 MNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG-ETPFYAESLV 214 (331)
T ss_pred CCCCEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhC-CCCccCCCHH
Confidence 999999999999976533221 11223458899999999875 5688999999999999999995 4588888877
Q ss_pred HHHHHHHcCC-ccCCC---CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGN-ILQAP---DNTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~-~~~~~---~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~ 645 (653)
+....+.... ..+.+ ..++.++.+++.+|+...+.+ |++++++++|.|
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~ 268 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAF 268 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence 7777665532 12222 346889999999999866554 568999998864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=316.97 Aligned_cols=251 Identities=27% Similarity=0.408 Sum_probs=207.7
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
|++.+.||+|+||.||+|+.. .++..+++|.+.... ....+.+.+|+++++.++||||+++++++..+...++|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v 80 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNK-----ETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL 80 (282)
T ss_pred HHHHhhcccCCCeEEEEEEEC-----CCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence 567788999999999999864 356789999986543 33456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
+||+++++|.+++.. ....+++..+..++.|++.||.|||+.+++||||||+|||++.++.
T Consensus 81 ~e~~~~~~l~~~~~~-------------------~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~ 141 (282)
T cd06643 81 IEFCAGGAVDAVMLE-------------------LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD 141 (282)
T ss_pred EEecCCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC
Confidence 999999999988752 1245889999999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+||+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|. +||...+..+...
T Consensus 142 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~-~p~~~~~~~~~~~ 218 (282)
T cd06643 142 IKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIE-PPHHELNPMRVLL 218 (282)
T ss_pred EEEccccccccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCC-CCccccCHHHHHH
Confidence 9999999987542211 1223345788999999874 345788999999999999999865 6888777766655
Q ss_pred HHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+..... ...+..++.++.+++.+||+.+|.+||++.+++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 219 KIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred HHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 5544332 2345568899999999999999999999999998875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=316.03 Aligned_cols=251 Identities=21% Similarity=0.290 Sum_probs=206.0
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
|+..+.||+|+||+||+|+.. .+++.+|+|.+..... ......+.+|+++++.++|+||+++.+.+..++..+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVR-----ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEE
Confidence 567788999999999999864 3567999999865322 223445788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++++
T Consensus 77 lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNM------------------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred EEEEeccCccHHHHHHHh------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 999999999999988621 12358999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI- 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i- 603 (653)
+.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++|. .||.+.......+.+
T Consensus 139 ~~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~P~~~~~~~~~~~~~~ 214 (285)
T cd05632 139 GHIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ-SPFRGRKEKVKREEVD 214 (285)
T ss_pred CCEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHH
Confidence 999999999986542211 112346789999999999999999999999999999999954 588776654333322
Q ss_pred ---HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 604 ---KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 604 ---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
..+. ...+...+.++.+|+..||+.+|.+||+ +.+++++.+
T Consensus 215 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05632 215 RRVLETE-EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263 (285)
T ss_pred Hhhhccc-cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChh
Confidence 2222 2345668889999999999999999999 888888754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.58 Aligned_cols=253 Identities=25% Similarity=0.429 Sum_probs=215.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
-|+..+.||+|+||.||+|... .++..||+|.+...........+.+|+.++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEEC-----CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEE
Confidence 3567788999999999999753 35678999998755444456689999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++++|.+++. ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++
T Consensus 80 v~e~~~~~~l~~~i~---------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~ 138 (277)
T cd06641 80 IMEYLGGGSALDLLE---------------------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG 138 (277)
T ss_pred EEEeCCCCcHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC
Confidence 999999999999985 12478999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++..+..... ......++..|+|||.+....++.++||||||+++|+|++| ..|+...........+..
T Consensus 139 ~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06641 139 EVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKG-EPPHSELHPMKVLFLIPK 215 (277)
T ss_pred CEEEeecccceecccchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcC-CCCCCccchHHHHHHHhc
Confidence 999999999876533221 12233567789999999988999999999999999999995 558877777777776666
Q ss_pred CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 606 GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 606 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.....+...+.++.+++.+||+.+|.+||++.+++++.+-.
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~ 257 (277)
T cd06641 216 NNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV 257 (277)
T ss_pred CCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence 655556667889999999999999999999999999987654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=309.77 Aligned_cols=252 Identities=25% Similarity=0.385 Sum_probs=214.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|+..+.||+|+||.||++... .++..+|+|.+... ........+.+|++++++++||||+++++.+..++..+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRK-----ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEc-----CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEE
Confidence 4788899999999999999864 35678999988643 23344567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|.+++.... ...+++..+..++.|++.||+|||+++++|+||+|+||+++++
T Consensus 76 lv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRC------------------NSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred EEEecCCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999999999999997321 2347899999999999999999999999999999999999854
Q ss_pred -CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 -MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 -~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||++....... ......++..|+|||.+....++.++||||||+++|+|++|. .||.+.+.......+
T Consensus 138 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~-~~~~~~~~~~~~~~~ 213 (256)
T cd08220 138 KMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLK-RAFEAANLPALVLKI 213 (256)
T ss_pred CCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCC-CCcccCchHHHHHHH
Confidence 568999999997653221 122345677899999999888999999999999999999964 588888877777777
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.....++..+.++.+++.+||+.+|.+|||+++++++.
T Consensus 214 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p 254 (256)
T cd08220 214 MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254 (256)
T ss_pred HhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence 77766667778899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=320.02 Aligned_cols=255 Identities=25% Similarity=0.400 Sum_probs=210.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||+||++... .+++.||+|.+.........+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHI-----PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEc-----CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence 457888899999999999999863 356789999887665555677899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEc
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLIN 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~ 522 (653)
++||||+++++|.+++.. .+.+++..+..++.+++.||.|||+ ++++|+||||+||+++
T Consensus 79 ~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 138 (284)
T cd06620 79 CMCMEFMDCGSLDRIYKK--------------------GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN 138 (284)
T ss_pred EEEEecCCCCCHHHHHHh--------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC
Confidence 999999999999998862 2357899999999999999999997 6899999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE----- 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~----- 597 (653)
+++.++|+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|. .||......
T Consensus 139 ~~~~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~-~p~~~~~~~~~~~~ 213 (284)
T cd06620 139 SRGQIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK-FPFAFSNIDDDGQD 213 (284)
T ss_pred CCCcEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC-CCCcccchhhhhhh
Confidence 9999999999998654211 112345788999999999889999999999999999999955 577654431
Q ss_pred ------HHHHHHHcCCccCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 ------EVVKYIKEGNILQAPD-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 ------e~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+....+........+. .++.++.+|+.+||+.+|.+|||+.+++++++-++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred hhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 2333333332222222 37789999999999999999999999999876654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=312.46 Aligned_cols=253 Identities=24% Similarity=0.396 Sum_probs=206.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-----cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-----SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+|.+.+.||+|+||.||+|.. .++..+|||.++... .......+.+|++++++++|+||+++++++...
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 74 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT------NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD 74 (265)
T ss_pred CccccceEeccCCeEEEEEEE------cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC
Confidence 356778899999999999974 245789999886432 123345688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+|+|+||+|+||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 134 (265)
T cd06631 75 NTISIFMEFVPGGSISSILNR--------------------FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVM 134 (265)
T ss_pred CeEEEEEecCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEE
Confidence 999999999999999999962 134788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccc----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYY----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+++++.++|+|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|. .||...+.
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~-~p~~~~~~ 213 (265)
T cd06631 135 LMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGK-PPLASMDR 213 (265)
T ss_pred ECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCC-CccccCCh
Confidence 999999999999998754221111 1112345678899999999999999999999999999999955 58876665
Q ss_pred HHHHHHHHcC--CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEG--NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....+... .....+...+.++.+++++||+.+|.+||++.+++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~ 264 (265)
T cd06631 214 LAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264 (265)
T ss_pred HHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 5444333332 334456678899999999999999999999999998754
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=310.26 Aligned_cols=256 Identities=22% Similarity=0.389 Sum_probs=217.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 442 (653)
+|++.+.||.|+||.||+|... .++..+|+|.++.. ......+.+.+|+.++++++|+||+++++++.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRK-----SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQT 75 (265)
T ss_pred CceeeeeeccCCCeEEEEeeec-----CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCE
Confidence 4678899999999999999853 35678999998643 234445678899999999999999999998753 456
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh-----hCCceecCCCCC
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS-----DRKFVHRDLATR 517 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-----~~~ivHrDLkp~ 517 (653)
.+++|||+++++|.+++.... .....+++..++.++.||+.||.||| +.+++|+||+|+
T Consensus 76 ~~~~~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~ 139 (265)
T cd08217 76 LYIVMEYCEGGDLAQLIQKCK----------------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPA 139 (265)
T ss_pred EEEEehhccCCCHHHHHHHHh----------------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHH
Confidence 799999999999999997332 12356899999999999999999999 899999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||++++++.+||+|||++......... .....++..|+|||.+....++.++||||||+++|+|++| ..||...+..
T Consensus 140 nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~ 216 (265)
T cd08217 140 NIFLDANNNVKLGDFGLAKILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCAL-SPPFTARNQL 216 (265)
T ss_pred HEEEecCCCEEEecccccccccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHC-CCcccCcCHH
Confidence 999999999999999999865433211 2234567889999999999999999999999999999995 4588888888
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.+.+..+.....+...+.++.+++.+|++.+|++||++.+|+++.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~ 264 (265)
T cd08217 217 QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264 (265)
T ss_pred HHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCC
Confidence 888888888777778889999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=311.38 Aligned_cols=252 Identities=26% Similarity=0.434 Sum_probs=209.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||.||+|... .++..+++|.++.... .+++.+|++++++++|+||+++++++..+...
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 73 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHK-----ETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDL 73 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEc-----CCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcE
Confidence 467888999999999999999864 2457899999875432 56899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++++||+++++|.+++.. ....+++..+..++.|++.||.|||+.+++|+||+|+||++++
T Consensus 74 ~l~~e~~~~~~L~~~l~~-------------------~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~ 134 (256)
T cd06612 74 WIVMEYCGAGSVSDIMKI-------------------TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNE 134 (256)
T ss_pred EEEEecCCCCcHHHHHHh-------------------CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECC
Confidence 999999999999999862 1245789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++| ..|+......+....+
T Consensus 135 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g-~~p~~~~~~~~~~~~~ 211 (256)
T cd06612 135 EGQAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG-KPPYSDIHPMRAIFMI 211 (256)
T ss_pred CCcEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC-CCCCCCcchhhhhhhh
Confidence 9999999999987653222 112234467789999999999999999999999999999995 4588776665544443
Q ss_pred HcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..... ...+..++.++.+++.+||+.+|++|||+++|+++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~ 255 (256)
T cd06612 212 PNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255 (256)
T ss_pred ccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence 33221 2234457789999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=317.56 Aligned_cols=257 Identities=25% Similarity=0.412 Sum_probs=211.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|+.. ..+..||+|.++..........+.+|+.++.+++|+||+++++.+...+..+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHR-----PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEc-----CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence 36788899999999999999864 3567899999876545555568899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~ 523 (653)
+||||+++++|.++++... ....+++..+..++.|++.||.|||+ .+|+|+||||+||+++.
T Consensus 76 lv~e~~~~~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~ 138 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGV-----------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNG 138 (286)
T ss_pred EEEeecCCCCHHHHHHhcc-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECC
Confidence 9999999999999986221 12358999999999999999999996 59999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC------CCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK------YTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~------~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++.+||+|||++...... ......++..|+|||.+.+.. ++.++||||||+++|||++|.. ||......
T Consensus 139 ~~~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~-pf~~~~~~ 213 (286)
T cd06622 139 NGQVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRY-PYPPETYA 213 (286)
T ss_pred CCCEEEeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCC-CCCCcchh
Confidence 999999999998754211 122345677899999986543 5889999999999999999655 77655544
Q ss_pred HHH---HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 EVV---KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 e~~---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
... ..+..+.....+..++.++.+++.+||+.+|++||++.+++++.|-..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~ 267 (286)
T cd06622 214 NIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVK 267 (286)
T ss_pred hHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhh
Confidence 433 334455555666778999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=310.64 Aligned_cols=258 Identities=23% Similarity=0.389 Sum_probs=212.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||.|+||+||+|... .++..+++|++.........+.+.+|+++++.++|+||+++++.+..++..+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICL-----PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEc-----CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEE
Confidence 46889999999999999999863 2557899999975544345678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.++++...+ ...+++..+..++.|++.||+|||+.+++|+||+|+||+++++
T Consensus 76 iv~e~~~~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~ 138 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYP-----------------RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGED 138 (267)
T ss_pred EEEeccCCCcHHHHHHHhcc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCC
Confidence 99999999999999973221 2357899999999999999999999999999999999999999
Q ss_pred CcEEEeccCcccccccccccc--CCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++|+|||++.......... ......++..|+|||.+... .++.++||||||+++|||++|. .||...+..+...
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~-~p~~~~~~~~~~~ 217 (267)
T cd06610 139 GSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA-APYSKYPPMKVLM 217 (267)
T ss_pred CCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC-CCccccChhhhHH
Confidence 999999999987664433221 12233567889999998877 7899999999999999999955 5887776665555
Q ss_pred HHHcCCccCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNILQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+........+ ...+..+.+++.+||..+|++||++.+|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~ 266 (267)
T cd06610 218 LTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266 (267)
T ss_pred HHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence 54443322222 246788999999999999999999999998764
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.92 Aligned_cols=255 Identities=22% Similarity=0.384 Sum_probs=212.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
...+|++.+.||.|+||.||+|... .++..|++|.+...... ..+.+.+|+.+++.++|+||+++++++..++.
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 90 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDV-----ATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDE 90 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEc-----CCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence 3457899999999999999999853 35678999988654332 34578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++|+||+++++|.+++.. ..+++.+++.++.|++.||+|||+.+++|+||||+||+++
T Consensus 91 ~~lv~e~~~~~~L~~~~~~---------------------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~ 149 (296)
T cd06655 91 LFVVMEYLAGGSLTDVVTE---------------------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149 (296)
T ss_pred EEEEEEecCCCcHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 9999999999999998851 2478999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||++........ ......++..|+|||.+....++.++||||||+++|+|++| ..||.+.+..+....
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg-~~pf~~~~~~~~~~~ 226 (296)
T cd06655 150 MDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPPYLNENPLRALYL 226 (296)
T ss_pred CCCCEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 999999999999876533321 12234567789999999988999999999999999999995 458877766554444
Q ss_pred HHcCC--ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 603 IKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 603 i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+.... ....+..++..+.+++++||..+|.+||++.+|+++.|--
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 43322 2334567889999999999999999999999999988753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=327.03 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=220.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCC-CCccceEEeEEecC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFD-HPNIVKLLGVCAVG 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~ 440 (653)
...|.+.+.||+|.||.||+++.+ .++..+|+|.++..... .....+.+|+.+|+++. |||||.+.++++..
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-----~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREK-----STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEec-----CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 456888899999999999999865 35789999999765332 23468999999999998 99999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++|||++.||.|.+.+.. . .+++.++..++.||+.++.|||+.||+||||||+|+|
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~-------------------~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L 167 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVK-------------------K--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLL 167 (382)
T ss_pred CeEEEEEEecCCchHHHHHHH-------------------c--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHee
Confidence 999999999999999999861 1 2899999999999999999999999999999999999
Q ss_pred EcCC----CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 521 INDQ----MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 521 l~~~----~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+... +.+|++|||++..... ........||+.|+|||++....|+.++||||+|+++|.|++ |.+||.+.+.
T Consensus 168 ~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~-G~~PF~~~~~ 243 (382)
T KOG0032|consen 168 LASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLS-GVPPFWGETE 243 (382)
T ss_pred eccccCCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhh-CCCCCcCCCh
Confidence 9533 5799999999987643 223355688999999999999999999999999999999987 6779999999
Q ss_pred HHHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....|..+...... +.++..+.++++.++..||..|+|+.++++|+|
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 9999999998763222 357899999999999999999999999999987
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=319.05 Aligned_cols=253 Identities=25% Similarity=0.392 Sum_probs=202.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|++.+.||+|+||.||+|+.. .++..||+|.++.... ......+.+|++++++++|+||+++++++......+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~-----~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEEC-----CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceE
Confidence 3678899999999999999864 3567899999864322 223356788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||++ ++|.+++.. ....+++..++.++.||++||.|||+++++||||||+||+++.+
T Consensus 76 lv~e~~~-~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~ 135 (284)
T cd07839 76 LVFEYCD-QDLKKYFDS-------------------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKN 135 (284)
T ss_pred EEEecCC-CCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCC
Confidence 9999997 588888752 12458999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|||++|+.+++.+.+..+..+.+
T Consensus 136 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~ 213 (284)
T cd07839 136 GELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 213 (284)
T ss_pred CcEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHH
Confidence 999999999987542211 112234567889999998765 47899999999999999999888777776665544433
Q ss_pred HcCC-------------------cc---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGN-------------------IL---------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~-------------------~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.... .. +.....+.++.+++++||+.||.+|||+++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~ 283 (284)
T cd07839 214 FRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283 (284)
T ss_pred HHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence 2100 00 011246788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=317.58 Aligned_cols=255 Identities=23% Similarity=0.340 Sum_probs=210.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+++.. ..+..|++|.+..... ....+.+.+|+++++.++||||+++++.+..++.
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHK-----ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEEC-----CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE
Confidence 46889999999999999999864 3567899999876532 2334578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.++++. ...+++..+..++.|++.||.|||+++++||||||+||+++
T Consensus 76 ~~lv~e~~~g~~L~~~l~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~ 135 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKN--------------------IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT 135 (305)
T ss_pred EEEEEecCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEEC
Confidence 9999999999999999962 23578899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCcccccccccc-------------ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDY-------------YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
+++.+||+|||+++....... ........++..|+|||.+....++.++||||||+++|||++|. .
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~-~ 214 (305)
T cd05609 136 SMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC-V 214 (305)
T ss_pred CCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC-C
Confidence 999999999999864211100 00111234577899999999889999999999999999999955 5
Q ss_pred CCCCCCHHHHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCC---HHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS---FRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~L~ 645 (653)
||.+.+.+++...+..+.. +......+.++.+++.+||+.+|++||+ +.+++++.|
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~ 275 (305)
T cd05609 215 PFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF 275 (305)
T ss_pred CCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence 8888888888887766543 2222357899999999999999999998 577777765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=328.83 Aligned_cols=251 Identities=22% Similarity=0.241 Sum_probs=200.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|.+.+.||+|+||.||+|... ..+..||||.++... .......+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEEC-----CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccc
Confidence 468999999999999999999863 345789999987532 233445688999999999999999999987543
Q ss_pred ----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 441 ----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 441 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...++||||+++ +|.+++. ..+++..+..++.|++.||+|||+++|+||||||
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 154 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQ----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 154 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHH----------------------hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCH
Confidence 357999999965 7877764 2367888999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++|. .||.+.+.
T Consensus 155 ~NIll~~~~~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~ 230 (364)
T cd07875 155 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFPGTDH 230 (364)
T ss_pred HHEEECCCCcEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCC-CCCCCCCH
Confidence 99999999999999999997542211 123346788999999999999999999999999999999965 58877766
Q ss_pred HHHHHHHHcCCccC-----------------------------------------CCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 597 EEVVKYIKEGNILQ-----------------------------------------APDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 597 ~e~~~~i~~~~~~~-----------------------------------------~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
.+....+......+ .....+.++.+|+.+|++.||.+||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~ 310 (364)
T cd07875 231 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 310 (364)
T ss_pred HHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC
Confidence 55444332210000 0011345789999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
|+.++++|.|-
T Consensus 311 t~~e~L~hp~~ 321 (364)
T cd07875 311 SVDEALQHPYI 321 (364)
T ss_pred CHHHHhcCccc
Confidence 99999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=313.51 Aligned_cols=253 Identities=27% Similarity=0.447 Sum_probs=212.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|... .++..||+|.+...........+.+|++++++++||||+++++++..+...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHR-----PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEc-----CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence 35778889999999999999864 3568899999877655556678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~ 523 (653)
+++||+++++|.+++... ...++...+..++.|++.||+|||+ .+++|+||||+||++++
T Consensus 76 lv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~ 136 (265)
T cd06605 76 ICMEYMDGGSLDKILKEV-------------------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136 (265)
T ss_pred EEEEecCCCcHHHHHHHc-------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC
Confidence 999999999999998722 1457888999999999999999999 99999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----CHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-----THEE 598 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-----~~~e 598 (653)
++.++|+|||++........ ....++..|+|||.+.+..++.++||||||+++|+|++|.. ||... ...+
T Consensus 137 ~~~~~l~d~g~~~~~~~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~~~~~~~ 211 (265)
T cd06605 137 RGQIKLCDFGVSGQLVNSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRF-PYPPENDPPDGIFE 211 (265)
T ss_pred CCCEEEeecccchhhHHHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC-CCCccccccccHHH
Confidence 99999999999875532211 12556778999999999999999999999999999999654 66543 3344
Q ss_pred HHHHHHcCCccCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDN-TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+.+..+.....+.. .+.++.++|.+||..+|++|||+.+++++.|-
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 260 (265)
T cd06605 212 LLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260 (265)
T ss_pred HHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence 5555555544444444 78899999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-37 Score=327.10 Aligned_cols=251 Identities=22% Similarity=0.253 Sum_probs=198.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|++.+.||+|+||.||+|... ..+..||||.++... .......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 90 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKS 90 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEec-----CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccc
Confidence 468999999999999999999853 356789999987542 333455778999999999999999999988643
Q ss_pred ----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 441 ----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 441 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...++||||+++ +|.+++. ..+++..+..++.|++.||+|||+++|+||||||
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp 147 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQ----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 147 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHh----------------------hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence 357999999965 6777664 2367888999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...... ......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.+.
T Consensus 148 ~Nill~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~ 223 (355)
T cd07874 148 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK-ILFPGRDY 223 (355)
T ss_pred HHEEECCCCCEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCH
Confidence 99999999999999999997542211 123346788999999999999999999999999999999955 58876654
Q ss_pred HHHHHHHHcC-----------------------Cc------------------cCCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 597 EEVVKYIKEG-----------------------NI------------------LQAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 597 ~e~~~~i~~~-----------------------~~------------------~~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
.+....+... .. ...+...+.++.+|+.+|+..||++||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp 303 (355)
T cd07874 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC
Confidence 3322211100 00 000112346789999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
|+.++++++|-
T Consensus 304 s~~ell~hp~~ 314 (355)
T cd07874 304 SVDEALQHPYI 314 (355)
T ss_pred CHHHHhcCcch
Confidence 99999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=315.62 Aligned_cols=254 Identities=23% Similarity=0.421 Sum_probs=204.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.++|.+.+.||+|+||.||+|+.. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++.
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~-~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~ 80 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNV-----NTGELAAIKVIKLEPGE-DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK 80 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEc-----CCCcEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence 4457888899999999999999863 35678999998765433 33467899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++|+||+++++|.++++. ...+++.+++.++.|++.||.|||+.+++|+||||+||+++
T Consensus 81 ~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~ 140 (267)
T cd06645 81 LWICMEFCGGGSLQDIYHV--------------------TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred EEEEEeccCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 9999999999999999862 23578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
.++.+||+|||++...... ........++..|+|||.+. ...++.++||||||+++|||+++.. |+........
T Consensus 141 ~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~-p~~~~~~~~~ 217 (267)
T cd06645 141 DNGHVKLADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP-PMFDLHPMRA 217 (267)
T ss_pred CCCCEEECcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCC-Ccccccchhh
Confidence 9999999999998755321 12223446788999999874 4568899999999999999999665 6655443333
Q ss_pred HHHHHcCCccC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKEGNILQ----APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
........... ....++..+.+++.+||..+|++||++++|+++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 218 LFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 32222222211 11246788999999999999999999999988753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=315.88 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=209.6
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.+.+.|++++.||+|+||.||+|+.. .++..+++|.+.... ....+.+.+|+.+++.++|+||+++++.+..++
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 82 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNK-----ETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDG 82 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEEC-----CCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC
Confidence 34456889999999999999999864 356789999987543 334567889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|..++.. ....+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 83 ~~~lv~e~~~~~~l~~~~~~-------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili 143 (292)
T cd06644 83 KLWIMIEFCPGGAVDAIMLE-------------------LDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL 143 (292)
T ss_pred eEEEEEecCCCCcHHHHHHh-------------------hcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE
Confidence 99999999999999988752 12357899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+.++.+||+|||++...... ........++..|+|||.+. ...++.++||||||+++|||++|. +|+...+.
T Consensus 144 ~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~-~p~~~~~~ 220 (292)
T cd06644 144 TLDGDIKLADFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE-PPHHELNP 220 (292)
T ss_pred cCCCCEEEccCccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCC-CCCccccH
Confidence 99999999999998653221 11122345677899999885 345788999999999999999965 58877666
Q ss_pred HHHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....+...... ..+..++.++.+++.+||+.+|++||++++++++.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 221 MRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred HHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 6655555443322 234567889999999999999999999999998865
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.50 Aligned_cols=254 Identities=17% Similarity=0.255 Sum_probs=198.9
Q ss_pred EEeeeccc--CCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 369 YVRDLGQG--AFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 369 ~~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+++.||+| +||+||+++.. .++..||+|+++... .......+.+|+.+++.++||||+++++++..++..++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYK-----PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeec-----ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEE
Confidence 45679999 78999999864 467889999997543 23445568889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.+++..+ ....+++..++.++.|++.||+|||+++|+||||||+|||++.++
T Consensus 77 v~e~~~~~~l~~~~~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~ 138 (327)
T cd08227 77 VTSFMAYGSAKDLICTH------------------FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138 (327)
T ss_pred EEeccCCCcHHHHHHhh------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC
Confidence 99999999999998632 123478999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccc-----cCCCCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
.++++|||.+......... .......++..|+|||.+.+ ..++.++||||||+++|||++|. .||......+
T Consensus 139 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~~~ 217 (327)
T cd08227 139 KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH-VPFKDMPATQ 217 (327)
T ss_pred cEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCC-CCCCCcchhH
Confidence 9999999875433211110 01122345677999999976 35899999999999999999954 5887665544
Q ss_pred HHHHHHcCCccC---------------------------------------------CCCCCcHHHHHHHHHhhccCCCC
Q psy5539 599 VVKYIKEGNILQ---------------------------------------------APDNTPDALYDLMKLCWNMKPMN 633 (653)
Q Consensus 599 ~~~~i~~~~~~~---------------------------------------------~~~~~~~~l~~li~~cl~~dP~~ 633 (653)
.......+.... .....++++.+|+.+||+.||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 218 MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 333322221110 01124568999999999999999
Q ss_pred CCCHHHHHHHHHH
Q psy5539 634 RPSFRTIYQTLWN 646 (653)
Q Consensus 634 RPs~~eil~~L~~ 646 (653)
|||++++++++|-
T Consensus 298 Rpt~~ell~~p~f 310 (327)
T cd08227 298 RPSASTLLNHSFF 310 (327)
T ss_pred cCCHHHHhcChhh
Confidence 9999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.72 Aligned_cols=263 Identities=23% Similarity=0.397 Sum_probs=208.0
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEe
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLG 435 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g 435 (653)
+..+..+.++|++.+.||+|+||.||+|+.. ..++.+|+|.++.... ....+.+|+.+++++ +||||+++++
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~ 82 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNK-----KNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYG 82 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEEC-----CCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeee
Confidence 3445567789999999999999999999864 3467899998865322 235678899999999 6999999999
Q ss_pred EEe-----cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 436 VCA-----VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 436 ~~~-----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
++. .+...++||||+++++|.++++... .....+++..+..++.|++.||.|||+.+++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 146 (286)
T cd06638 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFL----------------KRGERMEEPIIAYILHEALMGLQHLHVNKTI 146 (286)
T ss_pred eeeecccCCCCeEEEEEeecCCCCHHHHHHHhh----------------ccCccccHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 874 3456899999999999999886221 1234578889999999999999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHh
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt 585 (653)
||||||+||++++++.+||+|||+++....... ......++..|+|||.+.. ..++.++||||||+++|||++
T Consensus 147 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 147 HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred ccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 999999999999999999999999876532221 1223457889999998753 457899999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 586 FALQPYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 586 ~~~~p~~~~~~~e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.. |+......+....+..... ...+..++.++.+++.+||+.+|++|||+.+|+++++
T Consensus 225 g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 225 GDP-PLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred CCC-CCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 654 7766554443333322221 2234456789999999999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=313.44 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=203.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCc-cceEEeEEecCC-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPN-IVKLLGVCAVGK- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~- 441 (653)
..|..+++||+|+||+||+|+.. .+++.||+|+++-+.. +..-....+|+.++++|+|+| ||+|++++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~-----~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~ 85 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSK-----RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN 85 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEe-----cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence 34666778999999999999964 4568999999976543 223345689999999999999 999999998776
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
.++|||||+.. ||..|+....+.. ..++...+..++.||+.||+|||+++|+||||||
T Consensus 86 ~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~----------------~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKP 148 (323)
T KOG0594|consen 86 HRGIGKLYLVFEFLDR-DLKKYMDSLPKKP----------------QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKP 148 (323)
T ss_pred ccccceEEEEEEeecc-cHHHHHHhccccc----------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCc
Confidence 78999999966 9999998543211 3456688999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+||||+++|.+||+|||+|+...... ..-....+|..|.|||++.+. .|+...||||+|||+.||++ +.+-|.+.+
T Consensus 149 QNlLi~~~G~lKlaDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~-~~~LFpG~s 225 (323)
T KOG0594|consen 149 QNLLISSSGVLKLADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFT-RRPLFPGDS 225 (323)
T ss_pred ceEEECCCCcEeeeccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHh-CCCCCCCCc
Confidence 99999999999999999998553222 123445678899999999987 79999999999999999999 666888877
Q ss_pred HHHHHHHHHcC--Cc--------c-------CCC------------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 596 HEEVVKYIKEG--NI--------L-------QAP------------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 596 ~~e~~~~i~~~--~~--------~-------~~~------------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+....|-.- .. . ..+ +....+..+++.+|++.+|.+|.|++.+++|.
T Consensus 226 e~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~ 303 (323)
T KOG0594|consen 226 EIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHP 303 (323)
T ss_pred HHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcCh
Confidence 76555444220 00 0 000 11224788999999999999999999999884
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=315.16 Aligned_cols=249 Identities=24% Similarity=0.382 Sum_probs=214.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||.||++... .++..||+|.++... .....+.+.+|++++++++||||+++++++..+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHK-----GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 46889999999999999999864 356789999986532 22344678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++.. ...++...+..++.|++.||.|||+.+++|+||+|+|||++
T Consensus 76 ~~~v~e~~~~~~L~~~~~~--------------------~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~ 135 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRK--------------------SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLD 135 (290)
T ss_pred EEEEEecCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 9999999999999999862 24578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||++...... .....+++.|+|||.+.+...+.++||||||+++|+|++| ..||...+..+..+.
T Consensus 136 ~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~~~~~ 209 (290)
T cd05580 136 SDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG-YPPFFDDNPIQIYEK 209 (290)
T ss_pred CCCCEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 9999999999998765322 2334577899999999888899999999999999999995 568887777777776
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+..+. ...+...+..+.+++.+||..+|.+|+ ++++++++.|
T Consensus 210 ~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 210 ILEGK-VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred HhcCC-ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 66554 456677889999999999999999999 8999998875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=316.92 Aligned_cols=252 Identities=27% Similarity=0.412 Sum_probs=196.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-HHHHHHHHHHHHHhhC---CCCccceEEeEEec--
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDFEREACLLAEF---DHPNIVKLLGVCAV-- 439 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~-- 439 (653)
+|++.+.||+|+||.||+|+.. .+++.||+|.++..... .....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~ 75 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSR 75 (288)
T ss_pred CceEeeEEeecCCeEEEEEEEC-----CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeecccc
Confidence 4778899999999999999864 35688999998753221 1123455677776665 79999999998754
Q ss_pred ---CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 440 ---GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 440 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
....++||||+++ +|.+++... ....+++..+..++.||+.||.|||+++|+||||||
T Consensus 76 ~~~~~~~~lv~e~~~~-~l~~~~~~~------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp 136 (288)
T cd07863 76 TDRETKVTLVFEHVDQ-DLRTYLDKV------------------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKP 136 (288)
T ss_pred CCCCceEEEEEccccc-CHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 3457999999974 899988621 123478999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++ +.+||.+...
T Consensus 137 ~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~-g~~~f~~~~~ 212 (288)
T cd07863 137 ENILVTSGGQVKLADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSE 212 (288)
T ss_pred HHEEECCCCCEEECccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHh-CCcCcCCCCH
Confidence 99999999999999999997653211 1223456888999999999999999999999999999997 5668877665
Q ss_pred HHHHHHHHcCC------------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGN------------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....+.... .. .....++..+.+++.+|++.||++|||+.+++++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~ 287 (288)
T cd07863 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287 (288)
T ss_pred HHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence 55443332200 00 011346778899999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=347.37 Aligned_cols=269 Identities=22% Similarity=0.302 Sum_probs=210.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .+++.||||+++... .+...+++.+|++++++++||||+++++++..++.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~-----~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDP-----VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEEC-----CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 57899999999999999999864 356789999997542 24456679999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++......... .......+++..+++++.||++||+|||+++|+||||||+|||++
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l---------~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd 147 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESL---------SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLG 147 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhcccc---------chhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEc
Confidence 99999999999999999743211100 001124567888999999999999999999999999999999999
Q ss_pred CCCcEEEeccCcccccccccc----------------ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDY----------------YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~----------------~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~ 586 (653)
.++.+||+|||+++....... ........||+.|||||.+.+..++.++||||||+++|||++|
T Consensus 148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence 999999999999976521110 0011223578999999999999999999999999999999996
Q ss_pred CCCCCCCCCHHHHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRP-SFRTIYQTLWNIK 648 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 648 (653)
. .||......++......... ......+++.+.+++.+|++.+|++|| +++++.+.|....
T Consensus 228 ~-~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 228 S-FPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred C-CCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 5 58876555444332111111 111235788999999999999999996 5666777766553
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.07 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=200.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|+||.||+|+.. .++..||+|.++.... +.....+.+|+.++++++||||+++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNK-----KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEEC-----CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEE
Confidence 4778899999999999999864 3467899999864322 223456789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||++ ++|.+++.... ....+++..+..++.||+.||+|||+.+++|+||||+|||++++
T Consensus 76 ~v~e~~~-~~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~ 137 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLP-----------------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK 137 (285)
T ss_pred EEEecCC-CCHHHHHhcCC-----------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCC
Confidence 9999997 68999886221 22458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY- 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~- 602 (653)
+.+||+|||++....... .......++..|+|||.+.+. .++.++||||||+++|||++| .+||.+....+....
T Consensus 138 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg-~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 138 GVIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK-KPLFHGDSEIDQLFRI 214 (285)
T ss_pred CcEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHH
Confidence 999999999987543221 112233557889999988754 578999999999999999996 457776554322211
Q ss_pred HHc---------------------------CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKE---------------------------GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~---------------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.. +........++.++.+++++||+.||.+|||+.+|+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 110 0001112346788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=310.53 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=203.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc----ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE----ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~----~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~- 439 (653)
.+|...+.||+|+||.||+|... .++..|++|.++.. ........+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 76 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDV-----DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR 76 (266)
T ss_pred CCccccceecCCCCEEEEEEEEc-----CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC
Confidence 46788899999999999999864 35678999987632 122334578899999999999999999998865
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+...++++||+++++|.+++.. ...+++...+.++.|++.||+|||+.+|+|+||||+|
T Consensus 77 ~~~~~~l~~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~n 136 (266)
T cd06651 77 AEKTLTIFMEYMPGGSVKDQLKA--------------------YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGAN 136 (266)
T ss_pred CCCEEEEEEeCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 3567899999999999999862 2347888899999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++++++.+||+|||+++.+...... .......++..|+|||.+.+..++.++||||||+++|||++|. .||......
T Consensus 137 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~-~pf~~~~~~ 215 (266)
T cd06651 137 ILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK-PPWAEYEAM 215 (266)
T ss_pred EEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCC-CCccccchH
Confidence 99999999999999998765321111 1112344678899999999989999999999999999999955 588766554
Q ss_pred HHHHHH-HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYI-KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+..+ ........+...++.+.+++ .||..+|++||++++|++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~ 263 (266)
T cd06651 216 AAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF 263 (266)
T ss_pred HHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence 433333 33333444556778888988 688889999999999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=312.99 Aligned_cols=262 Identities=21% Similarity=0.366 Sum_probs=210.5
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
..+.-+.++|.+.+.||+|+||.||+|... .+++.+|+|.+.... .....+.+|+.++.++ +||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-----~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~ 87 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNK-----KDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGM 87 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence 344556788999999999999999999863 356789999986532 2345678899999999 89999999999
Q ss_pred EecC-----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 437 CAVG-----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 437 ~~~~-----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
+... ...++|+||+++|+|.++++... .....+++..++.++.|++.||+|||+.+++|
T Consensus 88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~----------------~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (291)
T cd06639 88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLL----------------ICGQRLDEAMISYILYGALLGLQHLHNNRIIH 151 (291)
T ss_pred EEeccccCCCeeEEEEEECCCCcHHHHHHHhh----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 8643 35899999999999999986321 12345789999999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-----CCCCchhHHHHHHHHHHHHhC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-----KYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~t~ksDVwSlGvvl~ellt~ 586 (653)
+||||+||++++++.+||+|||++........ ......++..|+|||.+... .++.++||||||+++|||++|
T Consensus 152 ~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g 229 (291)
T cd06639 152 RDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229 (291)
T ss_pred cCCCHHHEEEcCCCCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhC
Confidence 99999999999999999999999876532221 11234567889999987654 368999999999999999995
Q ss_pred CCCCCCCCCHHHHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+||......+....+..+... ..++..+..+.+++.+||+.+|++||++.+|+++.|
T Consensus 230 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~ 289 (291)
T cd06639 230 -DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289 (291)
T ss_pred -CCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence 5688777665555555444322 234557788999999999999999999999998865
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=324.37 Aligned_cols=250 Identities=25% Similarity=0.350 Sum_probs=198.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
....+|.+.+.||+|+||.||+|+..+ .+..||+|..... ....|+.++++++|+||+++++++..+.
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 130 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPG-----QPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGA 130 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECC-----CCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCC
Confidence 344579999999999999999998643 4578999986433 2346899999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+. ++|.+++.. ....+++..++.|+.||+.||.|||+++|+||||||+|||+
T Consensus 131 ~~~lv~e~~~-~~l~~~l~~-------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill 190 (357)
T PHA03209 131 ITCMVLPHYS-SDLYTYLTK-------------------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI 190 (357)
T ss_pred eeEEEEEccC-CcHHHHHHh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 9999999995 689998862 23458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-----
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH----- 596 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~----- 596 (653)
++++.+||+|||+++..... .......+|..|+|||.+.+..++.++||||||+++|||++++.++|.....
T Consensus 191 ~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~ 267 (357)
T PHA03209 191 NDVDQVCIGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY 267 (357)
T ss_pred CCCCCEEEecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence 99999999999999743211 1122345788999999999999999999999999999999987766654221
Q ss_pred -----HHHHHHHHcCCc--cCCC------------------------------CCCcHHHHHHHHHhhccCCCCCCCHHH
Q psy5539 597 -----EEVVKYIKEGNI--LQAP------------------------------DNTPDALYDLMKLCWNMKPMNRPSFRT 639 (653)
Q Consensus 597 -----~e~~~~i~~~~~--~~~~------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~e 639 (653)
..+...+..... ...+ ..++.++.+||.+||+.||.+|||+.|
T Consensus 268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e 347 (357)
T PHA03209 268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEE 347 (357)
T ss_pred HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHH
Confidence 111111111000 0000 134566778999999999999999999
Q ss_pred HHHHHHH
Q psy5539 640 IYQTLWN 646 (653)
Q Consensus 640 il~~L~~ 646 (653)
+++|.|-
T Consensus 348 ~l~hp~f 354 (357)
T PHA03209 348 ILNYPMF 354 (357)
T ss_pred HhcCchh
Confidence 9999874
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=306.83 Aligned_cols=254 Identities=28% Similarity=0.414 Sum_probs=217.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|++|.||+|+.. .++..|+||.+...........+.+|+..+.+++|+||+++++++......+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHK-----PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEc-----CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEE
Confidence 46788999999999999999864 3568899999887654455678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~ 523 (653)
+|+||+++++|.+++.. ...+++..++.++.|++.||.|||+ .+++|+||+|+||++++
T Consensus 76 lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~ 135 (264)
T cd06623 76 IVLEYMDGGSLADLLKK--------------------VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINS 135 (264)
T ss_pred EEEEecCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECC
Confidence 99999999999999962 1457899999999999999999999 99999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL---THEEVV 600 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~---~~~e~~ 600 (653)
++.++|+|||++........ ......++..|+|||.+....++.++||||||+++|||++|. .||... ...+..
T Consensus 136 ~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~-~p~~~~~~~~~~~~~ 212 (264)
T cd06623 136 KGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK-FPFLPPGQPSFFELM 212 (264)
T ss_pred CCCEEEccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC-CCCccccccCHHHHH
Confidence 99999999999876532221 112345678899999999999999999999999999999954 577665 556667
Q ss_pred HHHHcCCccCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDN-TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+........+.. ++..+.+++.+||+.+|++||++.+++++.|-
T Consensus 213 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~ 259 (264)
T cd06623 213 QAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFI 259 (264)
T ss_pred HHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHH
Confidence 77776665556666 88999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=307.47 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=207.6
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc----cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
|+..+.||+|+||.||+|... .++..|++|.+.... .+...+.+.+|+.++++++|+||+++++++..+..
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNL-----DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN 76 (258)
T ss_pred ccccceeeecCCceEEEEEEc-----CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe
Confidence 456678999999999999863 356789999886432 23455678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++++||+++++|.++++. ...+++..+..++.||+.||+|||+.+++|+||+|+||+++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~ 136 (258)
T cd06632 77 LYIFLELVPGGSLAKLLKK--------------------YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVD 136 (258)
T ss_pred EEEEEEecCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 9999999999999999862 23478889999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+++.+||+|||++....... ......++..|++||.+.... ++.++|+||||+++|+|++|. .||......+...
T Consensus 137 ~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~-~pf~~~~~~~~~~ 212 (258)
T cd06632 137 TNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK-PPWSQLEGVAAVF 212 (258)
T ss_pred CCCCEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC-CCcccCcHHHHHH
Confidence 99999999999987653222 123445678899999988776 899999999999999999955 5876665544444
Q ss_pred HHHc-CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKE-GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.. ......+..++..+.+++++||+.+|.+||++.+++++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~ 257 (258)
T cd06632 213 KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF 257 (258)
T ss_pred HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence 4433 4445566678899999999999999999999999998753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=310.22 Aligned_cols=253 Identities=24% Similarity=0.322 Sum_probs=200.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-----
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----- 439 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----- 439 (653)
.|..++.||+|+||.|.+|... .++..||||++... ......++-.||+++|+.++|+||+.+++++..
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~-----~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDK-----RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eecccccccCcceeeEEEEEEc-----CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 4445788999999999999864 46689999999733 233445567899999999999999999999854
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
-...|+|+|+| ..||+..++ ....|+......++.|+++||.|+|+.+|+||||||+|+
T Consensus 98 f~DvYiV~elM-etDL~~iik--------------------~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNl 156 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIK--------------------SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNL 156 (359)
T ss_pred cceeEEehhHH-hhHHHHHHH--------------------cCccccHHHHHHHHHHHHHhcchhhcccccccccchhhe
Confidence 45789999999 459999886 234488999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|++.+..+||+|||+|+...........+....|-.|.|||.+.. ..||.+.||||.|||+.||++ +.+-|.|.+.-+
T Consensus 157 l~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~-gkplFpG~d~v~ 235 (359)
T KOG0660|consen 157 LLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLT-GKPLFPGKDYVH 235 (359)
T ss_pred eeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHc-CCCCCCCCchHH
Confidence 999999999999999997643211111244566888999998864 579999999999999999998 455777655333
Q ss_pred HHHH---------------HH---------c-CCccCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKY---------------IK---------E-GNILQA-----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~---------------i~---------~-~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.. |. . +..... -.+.++...+|+.+||..||.+|+|++|.++|+.
T Consensus 236 Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY 312 (359)
T KOG0660|consen 236 QLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY 312 (359)
T ss_pred HHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence 2222 22 1 111111 1356788999999999999999999999999874
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=311.03 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=201.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---------HHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---------EYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---------~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
+|...+.||+|+||.||+|... .++..||+|.++.... ....+.+.+|+.+++.++|+||++++++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNV-----TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeec-----CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 3567788999999999999853 3567899998753211 1123568889999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+...+..++||||+++|+|.++++. ...+++..+..++.||+.||.|||+++++|+||+|
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~ 136 (272)
T cd06629 77 ETTEEYLSIFLEYVPGGSIGSCLRT--------------------YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKA 136 (272)
T ss_pred eccCCceEEEEecCCCCcHHHHHhh--------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCCh
Confidence 9999999999999999999999862 24578889999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
+||++++++.++|+|||+++...............++..|+|||.+.... ++.++||||||+++||+++| ..||...
T Consensus 137 ~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~ 215 (272)
T cd06629 137 DNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG-RRPWSDE 215 (272)
T ss_pred hhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC-CCCCcCc
Confidence 99999999999999999987542211111122345678999999987654 88999999999999999995 4577655
Q ss_pred CHHHHHHHHH-cCCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIK-EGNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~-~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+....+. .......+ ..++..+.+++.+||..+|++||++++|+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (272)
T cd06629 216 EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271 (272)
T ss_pred chHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence 5443332222 22222222 245789999999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=312.23 Aligned_cols=252 Identities=21% Similarity=0.407 Sum_probs=209.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC---CCccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD---HPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~ 442 (653)
.|+..+.||+|+||.||+|... .++..||+|.++.........++.+|+.++++++ |||++++++++..+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHV-----PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEc-----CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE
Confidence 3567788999999999999863 3567899999876544445567889999999997 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.++++. ..+++..++.++.|++.||.|||+.+++|+||+|+||+++
T Consensus 77 ~~lv~e~~~~~~L~~~~~~---------------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~ 135 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKA---------------------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVT 135 (277)
T ss_pred EEEEEecCCCCcHHHHHHc---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEc
Confidence 9999999999999999861 2578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+++.++|+|||++....... .......++..|+|||.+..+ .++.++||||||+++|+|++| ..||.+........
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g-~~p~~~~~~~~~~~ 212 (277)
T cd06917 136 NTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG-NPPYSDVDAFRAMM 212 (277)
T ss_pred CCCCEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhC-CCCCCCCChhhhhh
Confidence 99999999999987654332 122334577889999988754 468999999999999999995 56888777665555
Q ss_pred HHHcCCccCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPD-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+........+. ..+.++.+++.+||+.+|++||++.+++++.|-
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 213 LIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred ccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 444433333333 378899999999999999999999999998765
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.82 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=203.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|+.. .++..||+|++.... .....+.+.+|+.++++++|+||+++++++..+...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNR-----ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEEC-----CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEE
Confidence 46888999999999999999864 356889999886432 222345678999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|..++. ....+++..++.++.|++.||+|||+.+++|+||||+||++++
T Consensus 76 ~~v~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~ 135 (286)
T cd07847 76 HLVFEYCDHTVLNELEK--------------------NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITK 135 (286)
T ss_pred EEEEeccCccHHHHHHh--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcC
Confidence 99999999988887764 2235889999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+..+....
T Consensus 136 ~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~-~p~~~~~~~~~~~~ 212 (286)
T cd07847 136 QGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ-PLWPGKSDVDQLYL 212 (286)
T ss_pred CCcEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Confidence 99999999999976533221 1123346778999999876 45789999999999999999964 68877665544333
Q ss_pred HHcC--C------------------ccCC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--N------------------ILQA----------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--~------------------~~~~----------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... . ..+. .+..+..+.+|+.+||+.+|++||++.+++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~ 285 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence 2210 0 0000 1235678999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=347.44 Aligned_cols=263 Identities=22% Similarity=0.375 Sum_probs=209.1
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
+...+...++|.+++.||+|+||+||+|+.. ..+..||+|.+... ........|.+|+.+++.|+|||||++++
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk-----~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d 79 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHK-----RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYID 79 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEEC-----CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEE
Confidence 3444566679999999999999999999864 35678999988643 23344567899999999999999999999
Q ss_pred EEec--CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC------
Q psy5539 436 VCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR------ 507 (653)
Q Consensus 436 ~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------ 507 (653)
++.. ...++|||||+++|+|.++|.... .....+++..++.|+.||+.||.|||+.
T Consensus 80 ~f~de~~~~lyIVMEY~~gGSL~~lL~k~~----------------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~ 143 (1021)
T PTZ00266 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCY----------------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNG 143 (1021)
T ss_pred EEEecCCCEEEEEEeCCCCCcHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHhccccccc
Confidence 8854 456899999999999999997321 1224689999999999999999999984
Q ss_pred -CceecCCCCCCEeEcC-----------------CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc--CCC
Q psy5539 508 -KFVHRDLATRNCLIND-----------------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY--NKY 567 (653)
Q Consensus 508 -~ivHrDLkp~NILl~~-----------------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~ 567 (653)
+||||||||+||||+. .+.+||+|||++..+.... ......+|+.|+|||.+.+ ..+
T Consensus 144 k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~ 220 (1021)
T PTZ00266 144 ERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSY 220 (1021)
T ss_pred CCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCC
Confidence 5999999999999964 3458999999997653221 1233467899999999864 458
Q ss_pred CCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 568 TVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 568 t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.++|||||||+||||++|. .||...+ ..+++..+..+... .....+.++.+||..||+.+|.+||++.+++.+.+
T Consensus 221 s~KSDVWSLG~ILYELLTGk-~PF~~~~~~~qli~~lk~~p~l-pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ 297 (1021)
T PTZ00266 221 DDKSDMWALGCIIYELCSGK-TPFHKANNFSQLISELKRGPDL-PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297 (1021)
T ss_pred CchhHHHHHHHHHHHHHHCC-CCCCcCCcHHHHHHHHhcCCCC-CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence 89999999999999999955 5776544 44555555554322 22356889999999999999999999999997755
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.92 Aligned_cols=253 Identities=22% Similarity=0.366 Sum_probs=208.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
..+|.+.+.||+|+||.||+|... .++..||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 91 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDI-----ATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 91 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEEC-----CCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence 357889999999999999999853 35678999998754333 345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.+++.. ..+++.++..++.|++.||.|||+.+++||||||+|||++.
T Consensus 92 ~lv~e~~~~~~L~~~~~~---------------------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~ 150 (297)
T cd06656 92 WVVMEYLAGGSLTDVVTE---------------------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGM 150 (297)
T ss_pred EEeecccCCCCHHHHHHh---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 999999999999999851 24688899999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.++|+|||++........ ......+++.|+|||.+.+..++.++||||||+++|+|++|. +||.+.+..+....+
T Consensus 151 ~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~-~pf~~~~~~~~~~~~ 227 (297)
T cd06656 151 DGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE-PPYLNENPLRALYLI 227 (297)
T ss_pred CCCEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC-CCCCCCCcchheeee
Confidence 99999999999876432221 122345678899999999989999999999999999999954 588665543332222
Q ss_pred HcCC--ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.... ....+...+..+.+++.+||..+|++||++++|+++.|-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (297)
T cd06656 228 ATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272 (297)
T ss_pred ccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchh
Confidence 2211 123455678899999999999999999999999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=307.98 Aligned_cols=254 Identities=24% Similarity=0.330 Sum_probs=203.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc----ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE----ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~----~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++|.+.+.||+|+||.||+|... .++..||||.+... ......+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 76 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDA-----DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP 76 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEc-----CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC
Confidence 47888999999999999999863 35678999987532 1123346788999999999999999999988653
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...+++|||+++++|.+++.. ...+++...++++.|++.||+|||+.+++|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (265)
T cd06652 77 MERTLSIFMEHMPGGSIKDQLKS--------------------YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGAN 136 (265)
T ss_pred CCceEEEEEEecCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 467899999999999999862 1346788899999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||+++++.++|+|||+++........ .......++..|+|||.+.+..++.++||||||+++|||++|. +||......
T Consensus 137 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~-~p~~~~~~~ 215 (265)
T cd06652 137 ILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK-PPWAEFEAM 215 (265)
T ss_pred EEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCC-CCCCccchH
Confidence 99999999999999998765321111 1122334678899999999889999999999999999999955 587766544
Q ss_pred HHHHHHHc-CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKE-GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+..+.. ......+...+..+.+++++|+. +|.+||++++|+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~ 263 (265)
T cd06652 216 AAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF 263 (265)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence 44433332 22333455677889999999995 8999999999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=311.38 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=217.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++++.||.|.-|+||++++.+ +...+|+|++..+.. .....+.+.|-+||+.++||.++.||+.++
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~-----t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe 147 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRG-----TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE 147 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecC-----CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee
Confidence 4455678889999999999999999865 348899999976533 333446778999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..||+|||++||||+..+++ +....+++..+..++.+|+.||+|||-.|||.|||||+|
T Consensus 148 t~~~~cl~meyCpGGdL~~Lrqk------------------Qp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPEN 209 (459)
T KOG0610|consen 148 TDKYSCLVMEYCPGGDLHSLRQK------------------QPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPEN 209 (459)
T ss_pred ccceeEEEEecCCCccHHHHHhh------------------CCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcce
Confidence 99999999999999999998762 234568999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccc---------------------------------cccc---------------------
Q psy5539 519 CLINDQMVVKIADFGLSRKMYL---------------------------------QDYY--------------------- 544 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~---------------------------------~~~~--------------------- 544 (653)
|||-++|++-|+||.|+..... .+..
T Consensus 210 ILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~ 289 (459)
T KOG0610|consen 210 ILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTG 289 (459)
T ss_pred eEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCC
Confidence 9999999999999999743310 0000
Q ss_pred cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCC--CCcHHHHHH
Q psy5539 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPD--NTPDALYDL 622 (653)
Q Consensus 545 ~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~--~~~~~l~~l 622 (653)
.......||-.|.|||++.+...+.++|.|+|||+||||+. |..||.|.+..+.+..|..... .+|+ .++..+++|
T Consensus 290 ~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLy-G~TPFKG~~~~~Tl~NIv~~~l-~Fp~~~~vs~~akDL 367 (459)
T KOG0610|consen 290 ARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLY-GTTPFKGSNNKETLRNIVGQPL-KFPEEPEVSSAAKDL 367 (459)
T ss_pred ccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHh-CCCCcCCCCchhhHHHHhcCCC-cCCCCCcchhHHHHH
Confidence 00112346778999999999999999999999999999997 5569999999988888776543 3333 577899999
Q ss_pred HHHhhccCCCCCCC----HHHHHHHHH
Q psy5539 623 MKLCWNMKPMNRPS----FRTIYQTLW 645 (653)
Q Consensus 623 i~~cl~~dP~~RPs----~~eil~~L~ 645 (653)
|++.|.+||++|.. +.||.+|.+
T Consensus 368 Ir~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 368 IRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred HHHHhccChhhhhccccchHHhhcCcc
Confidence 99999999999997 899998874
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=311.72 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=195.5
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC----
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK---- 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~---- 441 (653)
.|...+.+|.|+||.||+|.+.. +...||||+.-.+.. .-.+|+++|+.++|||||+|+-++....
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e-----~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~ 94 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRE-----TEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE 94 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcC-----CCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence 46678889999999999999753 367899998865432 1257999999999999999998875422
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...||||||+. +|.++++... .....++...+.-+..||.+||.|||+.+|+||||||+|+|
T Consensus 95 ~~lnlVleymP~-tL~~~~r~~~----------------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlL 157 (364)
T KOG0658|consen 95 VYLNLVLEYMPE-TLYRVIRHYT----------------RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLL 157 (364)
T ss_pred hHHHHHHHhchH-HHHHHHHHHh----------------hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEE
Confidence 45789999987 9999998432 22356777888899999999999999999999999999999
Q ss_pred EcCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 521 INDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 521 l~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
+|.+ |.+||+|||.|+.+.... .+....-|-.|.|||.+.+. .||.+.||||.|||+.||+- |.+-|.|.+..+
T Consensus 158 vD~~tg~LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~-g~plFpG~s~~d 233 (364)
T KOG0658|consen 158 VDPDTGVLKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK-GQPLFPGDSSVD 233 (364)
T ss_pred EcCCCCeEEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc-CCcccCCCCHHH
Confidence 9966 999999999998763222 22233446679999999875 79999999999999999998 445777766544
Q ss_pred HHHHHHc------------C----------CccC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKYIKE------------G----------NILQ------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~------------~----------~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+..|.. . ++.. .....+++..+|+.+++..+|.+|.++.+++.|.+
T Consensus 234 QL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 234 QLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 3332211 0 0000 12346789999999999999999999999998764
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=310.33 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=208.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~ 442 (653)
++|...+.||.|++|.||+|... ..+..+|+|.+...........+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 75 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLK-----NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSS 75 (287)
T ss_pred CceEEEEEeccCCceEEEEEEEC-----CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCe
Confidence 46889999999999999999974 35688999999765554556779999999999999999999998864 346
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++.... .....++...+..++.||+.||.|||+.+++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~ 139 (287)
T cd06621 76 IGIAMEYCEGGSLDSIYKKVK----------------KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT 139 (287)
T ss_pred EEEEEEecCCCCHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 899999999999999886322 1234578889999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-----CHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-----THE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-----~~~ 597 (653)
+++.++|+|||++....... .....++..|+|||.+.+..++.++||||||+++|||++|.. ||... ...
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~~~~~ 214 (287)
T cd06621 140 RKGQVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRF-PFPPEGEPPLGPI 214 (287)
T ss_pred cCCeEEEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCC-CCCcccCCCCChH
Confidence 99999999999986543211 123345778999999999999999999999999999999665 66544 334
Q ss_pred HHHHHHHcCCccCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAP------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+........+ ...++.+.+++.+||+.+|++|||+.+|+++.|-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 215 ELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred HHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 555555543322222 1245789999999999999999999999998874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=315.76 Aligned_cols=258 Identities=22% Similarity=0.285 Sum_probs=211.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|+..+.||+|+||.||+|...+ ++..+|+|.+...... ...+.+.+|+++++.++|+||+++++.+..+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~-----~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG-----TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC-----CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 368889999999999999998642 5678999998754322 245578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+.+++|.+++... ....+++..+..++.|++.||+|||+.+++|+||||+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~ 137 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQ------------------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLH 137 (316)
T ss_pred EEEEEEecCCCCHHHHHHhC------------------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEc
Confidence 99999999999999998621 124578999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCcccccccccccc---------------------------CCCCCCCccccccchhhccCCCCCchhHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYK---------------------------GDENDAIPVRWMPLESILYNKYTVESDVWA 575 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~---------------------------~~~~~~~t~~y~aPE~~~~~~~t~ksDVwS 575 (653)
+++.++|+|||++.......... ......++..|+|||.+.+..++.++||||
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~s 217 (316)
T cd05574 138 ESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWT 217 (316)
T ss_pred CCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHH
Confidence 99999999999986542211100 011234677899999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCC----HHHHHHHHHH
Q psy5539 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPS----FRTIYQTLWN 646 (653)
Q Consensus 576 lGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs----~~eil~~L~~ 646 (653)
||+++|+|++| ..||.+.+..+....+...... ......+..+.+++.+||+.+|++||+ +.+++++.|-
T Consensus 218 lG~ll~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~ 292 (316)
T cd05574 218 LGILLYEMLYG-TTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292 (316)
T ss_pred HHHHHHHHhhC-CCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence 99999999994 5588888777666655544322 122236899999999999999999999 9999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=311.14 Aligned_cols=258 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHH-HhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACL-LAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|+.. .++..||+|+++.........++..|+.+ ++.++||||+++++++..++..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHV-----PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEc-----CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcE
Confidence 46889999999999999999864 45789999998765433334455666665 6667999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCEeEc
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLIN 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NILl~ 522 (653)
+++|||++ |+|.++++... .....+++..++.++.||+.||+|||++ +++||||||+|||++
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~ 138 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVY----------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLIN 138 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhc----------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEEC
Confidence 99999996 68998886321 1224689999999999999999999997 999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc----CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY----NKYTVESDVWAFGVCLWEIFSFALQPYYGL-THE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~----~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-~~~ 597 (653)
+++.+||+|||+++..... .......++..|+|||.+.+ ..++.++|+||||+++|||++|. .||... ...
T Consensus 139 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~ 214 (283)
T cd06617 139 RNGQVKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR-FPYDSWKTPF 214 (283)
T ss_pred CCCCEEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCC-CCCCccccCH
Confidence 9999999999998764221 11223456778999998865 45689999999999999999955 477542 222
Q ss_pred HHHHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 598 e~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+....+..+.....+ +.++.++.+++.+||..+|.+||++.+|+++.|-..
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~ 266 (283)
T cd06617 215 QQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL 266 (283)
T ss_pred HHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence 333333343333333 357899999999999999999999999999877544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=305.28 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=208.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|++.+.||+|+||.||+|... .++..|++|.++.... ....+.+.+|+.++++++|+||+++++++...+..+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNL-----DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEEC-----CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEE
Confidence 4678899999999999999863 3467899999875433 245678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++++
T Consensus 76 lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~ 135 (264)
T cd06626 76 IFMEYCSGGTLEELLEH--------------------GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHN 135 (264)
T ss_pred EEEecCCCCcHHHHHhh--------------------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 99999999999999862 2346788899999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCC--CCCCCccccccchhhccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCC-CHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGD--ENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFALQPYYGL-THEE 598 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~--~~~~~t~~y~aPE~~~~~~---~t~ksDVwSlGvvl~ellt~~~~p~~~~-~~~e 598 (653)
+.+||+|||++............ ....++..|+|||.+.... .+.++||||||+++||+++|. .||... ....
T Consensus 136 ~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~-~pf~~~~~~~~ 214 (264)
T cd06626 136 GVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGK-RPWSELDNEFQ 214 (264)
T ss_pred CCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCC-CCccCCcchHH
Confidence 99999999999776433321111 1345678999999998776 899999999999999999955 578655 3344
Q ss_pred HHHHHHcCCccCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDN--TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
....+..+.....+.. ++..+.+++.+||+.+|.+||++.+++.+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~ 263 (264)
T cd06626 215 IMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263 (264)
T ss_pred HHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence 4444444444444444 4889999999999999999999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.77 Aligned_cols=253 Identities=26% Similarity=0.325 Sum_probs=204.7
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|++.+.||+|+||.||+|+.. .++..||+|.++.... ......+.+|+.++++++||||+++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDR-----ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEEC-----CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeE
Confidence 4678899999999999999864 3467899999875432 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+++|+||||+||+++++
T Consensus 76 ~v~e~~-~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~ 135 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDE-------------------ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISAD 135 (286)
T ss_pred EEeccc-CCCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCC
Confidence 999999 99999998621 2458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.++|+|||++........ .......++..|+|||.+.+. .++.++||||||+++|||++| .++|.+....+....+
T Consensus 136 ~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~~~~~~~~~~~~~~~ 213 (286)
T cd07832 136 GVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIV 213 (286)
T ss_pred CcEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcC-CcCcCCCCHHHHHHHH
Confidence 9999999999976533221 112334578889999988755 468999999999999999997 6677666554443332
Q ss_pred HcCC---------------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGN---------------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~---------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.... .. ......+..+.+++++|++.+|++||+++++++|.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 214 FRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred HHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 2210 00 011245688999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=306.67 Aligned_cols=245 Identities=27% Similarity=0.353 Sum_probs=207.3
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||.|+||.||+|+.. ..+..+|+|.+.... .....+.+.+|+.+++.++||||+++++++..+...++|+||+
T Consensus 1 lg~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVK-----SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEEC-----CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999974 356789999986543 2234567999999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++++++.++|+
T Consensus 76 ~~~~L~~~l~~--------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~ 135 (262)
T cd05572 76 LGGELWTILRD--------------------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLV 135 (262)
T ss_pred CCCcHHHHHhh--------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEe
Confidence 99999999962 2347888999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc-CC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT--HEEVVKYIKE-GN 607 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~--~~e~~~~i~~-~~ 607 (653)
|||++....... ......++..|++||.+....++.++|+||||+++|||++| .+||.... ..++...+.. ..
T Consensus 136 df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~ 211 (262)
T cd05572 136 DFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTG-RPPFGEDDEDPMEIYNDILKGNG 211 (262)
T ss_pred eCCcccccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhC-CCCcCCCCCCHHHHHHHHhccCC
Confidence 999997653321 12233567789999999888999999999999999999995 55887766 6666666654 33
Q ss_pred ccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHH
Q psy5539 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLWN 646 (653)
Q Consensus 608 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~ 646 (653)
....+...+.++.++|.+||+.+|++||+ +++++++.|-
T Consensus 212 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~ 255 (262)
T cd05572 212 KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255 (262)
T ss_pred CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence 45566677899999999999999999999 9999998874
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=305.76 Aligned_cols=254 Identities=24% Similarity=0.421 Sum_probs=212.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|+||.||+|... .++..+|+|.+.... .....+.+.+|+.+++.++|+||+++++.+......+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAK-----SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEc-----CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEE
Confidence 4678899999999999999864 356779999986532 1223456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.+++... ....+++..+..++.|++.||.|||+.+++|+||||+||+++++
T Consensus 76 lv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQ------------------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred EEEecCCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 999999999999998621 12347899999999999999999999999999999999999988
Q ss_pred C-cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 M-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+ .+||+|||.+....... .......++..|+|||.+....++.++||||||+++|||++|. .||...+..+....+
T Consensus 138 ~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~~ 214 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK-HPFEGNNLHQLVLKI 214 (257)
T ss_pred CCeEEecccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCccHHHHHHHH
Confidence 5 56999999987653221 1112345778899999998889999999999999999999955 588777777777666
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.....+...+.++.+++.+||..+|++|||+.+|+++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~ 256 (257)
T cd08225 215 CQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF 256 (257)
T ss_pred hcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence 666665566678899999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=306.40 Aligned_cols=256 Identities=21% Similarity=0.392 Sum_probs=210.7
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc---------ccHHHHHHHHHHHHHHhh-CCCCccceEEe
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---------ASEYLQTDFEREACLLAE-FDHPNIVKLLG 435 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~---------~~~~~~~~f~~Ei~il~~-l~HpnIv~l~g 435 (653)
+|.+.+.||+|+||.||+|.+.+ ..+..+|+|.+... .......++.+|+.++.+ ++||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~----~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKN----NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcC----CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 35677889999999999999743 24578999987532 122334567788888875 79999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDL 514 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDL 514 (653)
++..++..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+ .+++|+||
T Consensus 77 ~~~~~~~~~lv~e~~~~~~l~~~l~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl 140 (269)
T cd08528 77 TFLENDRLYIVMDLIEGAPLGEHFNSLK----------------EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL 140 (269)
T ss_pred eEccCCeEEEEEecCCCCcHHHHHHHHH----------------hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCC
Confidence 9999999999999999999999986321 123458889999999999999999996 68999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
+|+|||+++++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++| .+||...
T Consensus 141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g-~~p~~~~ 216 (269)
T cd08528 141 TPNNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTL-QPPFYST 216 (269)
T ss_pred CHHHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhC-CCccccc
Confidence 9999999999999999999997653322 22344567889999999998999999999999999999996 5688877
Q ss_pred CHHHHHHHHHcCCccCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPD-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
........+..+...+.+. ..+..+.+++.+||+.||++||++.++..++.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 217 NMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred CHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 7777777777665544443 57889999999999999999999999988764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.61 Aligned_cols=259 Identities=22% Similarity=0.362 Sum_probs=205.1
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..+.+.|++.+.||+|+||.||+|+.. ..+..+|+|.+.... ....++..|+.++.++ +|+||+++++++
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~ 82 (282)
T cd06636 10 ALRDPAGIFELVEVVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAF 82 (282)
T ss_pred hhcChhhhhhhheeeccCCCeEEEEEEEc-----CCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence 33445678889999999999999999864 355789999885432 2345688999999998 799999999998
Q ss_pred ec------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 438 AV------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 438 ~~------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
.. ....+++|||+++|+|.+++... ....+++..++.++.||+.||.|||+.+|+|
T Consensus 83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH 144 (282)
T cd06636 83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNT------------------KGNALKEDWIAYICREILRGLAHLHAHKVIH 144 (282)
T ss_pred hcccccCCCCEEEEEEEeCCCCcHHHHHHHc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 53 45789999999999999998632 1234778889999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~ 586 (653)
+||+|+||++++++.++|+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|
T Consensus 145 ~dl~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g 222 (282)
T cd06636 145 RDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222 (282)
T ss_pred CCCCHHHEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhC
Confidence 9999999999999999999999987542211 1223345678899999876 34688899999999999999996
Q ss_pred CCCCCCCCCHHHHHHHHHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
. +||......+....+..... ......++.++.++|++||+.+|.+||++.+|+++.|
T Consensus 223 ~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~ 281 (282)
T cd06636 223 A-PPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF 281 (282)
T ss_pred C-CCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence 5 57766655443333333222 2223457899999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=322.12 Aligned_cols=250 Identities=23% Similarity=0.287 Sum_probs=198.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
++|.+.+.||+|+||.||+|... .++..||||.++.... ......+.+|+.++++++||||+++++++...
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDT-----RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhheecccCCCeEEEEEEEC-----CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 57888999999999999999863 3567899999875422 22345677899999999999999999887532
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...++++|++ +++|.++++ ...+++..+..++.||+.||+|||+++|+||||||+
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~ 147 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVK---------------------CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPS 147 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChh
Confidence 4578999987 779988774 134889999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||+++++.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+.
T Consensus 148 Nil~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~ 221 (343)
T cd07878 148 NVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK-ALFPGNDY 221 (343)
T ss_pred hEEECCCCCEEEcCCccceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCC-CCCCCCCH
Confidence 99999999999999999976422 1233457889999999876 56899999999999999999954 58876655
Q ss_pred HHHHHHHHcCC----------------------ccCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGN----------------------ILQA--------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~~~----------------------~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.+..+.... .... ....++.+.+|+.+|++.||.+|||+.++++|.|-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~ 301 (343)
T cd07878 222 IDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301 (343)
T ss_pred HHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 44333332110 0000 11345668899999999999999999999999875
Q ss_pred H
Q psy5539 647 I 647 (653)
Q Consensus 647 l 647 (653)
.
T Consensus 302 ~ 302 (343)
T cd07878 302 S 302 (343)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=314.77 Aligned_cols=252 Identities=19% Similarity=0.360 Sum_probs=207.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.+.....||+|+||.||++... .++..||||.+.... ....+.+.+|+.+++.++|+||+++++.+..++..++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~l 96 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEK-----HTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWV 96 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEEC-----CCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEE
Confidence 3444567999999999999853 346789999986543 3345568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++++|.+++. ...+++..+..++.||+.||+|||+++|+||||||+||++++++
T Consensus 97 v~e~~~~~~L~~~~~---------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 97 VMEFLEGGALTDIVT---------------------HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155 (292)
T ss_pred EEeCCCCCcHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 999999999999875 12478889999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++....... .......++..|+|||.+....++.++||||||+++|||++|. .||.+.+..+.+..+..
T Consensus 156 ~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~-~p~~~~~~~~~~~~~~~ 232 (292)
T cd06658 156 RIKLSDFGFCAQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE-PPYFNEPPLQAMRRIRD 232 (292)
T ss_pred CEEEccCcchhhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHh
Confidence 99999999987542211 1122345678899999998889999999999999999999955 58877777666665554
Q ss_pred CCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 606 GNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 606 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.... ......+..+.+++.+||..+|.+|||+++++++.|-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~ 276 (292)
T cd06658 233 NLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276 (292)
T ss_pred cCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence 3221 22235678899999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.93 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=202.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|... ..++.||+|++..... ....+.+.+|+++++.++||||+++++++..+...
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHK-----ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEEC-----CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeE
Confidence 46888999999999999999864 2457899998865322 23456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+++++|.++.. ....+++..++.++.||+.||+|||+.+++|+||+|+||++++
T Consensus 76 ~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~ 135 (286)
T cd07846 76 YLVFEFVDHTVLDDLEK--------------------YPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQ 135 (286)
T ss_pred EEEEecCCccHHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 99999999998888764 1234789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|||++| .+||...+..+....
T Consensus 136 ~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g-~~~~~~~~~~~~~~~ 212 (286)
T cd07846 136 SGVVKLCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG-EPLFPGDSDIDQLYH 212 (286)
T ss_pred CCcEEEEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcC-CCCCCCCchHHHHHH
Confidence 9999999999987653322 112233467889999998754 578899999999999999996 467765554333222
Q ss_pred HHc--------------------CC-cc---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKE--------------------GN-IL---------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~--------------------~~-~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.. +. .. .....++..+.+++.+||+.+|++||++.+|+++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~ 285 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence 211 00 00 012356788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=296.89 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=213.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-------ccHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-------ASEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-------~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
|.-.+.||.|..++|-++.. ..++...|+|++... ......+.-.+|+.||+++ .||+|+++.++++
T Consensus 19 y~pkeilgrgvss~vrRci~-----k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIH-----KETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred cChHHHhcccchhhhhhhhh-----cccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 44456789999999988764 346677888877422 2234455667899999998 6999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
....+++|+|.|+.|.|.|||. ..-.++++...+|++|+..|+.|||.++||||||||+|
T Consensus 94 s~sF~FlVFdl~prGELFDyLt--------------------s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpEN 153 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLT--------------------SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPEN 153 (411)
T ss_pred CcchhhhhhhhcccchHHHHhh--------------------hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhh
Confidence 9999999999999999999996 23568999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC------CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN------KYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
||+|+++++||+|||.|..+..... -....||++|.|||.+.-. .|+.+.|+||.||+||-|+. |.+||+
T Consensus 154 ILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLa-GcpPFw 229 (411)
T KOG0599|consen 154 ILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLA-GCPPFW 229 (411)
T ss_pred eeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHc-CCCchh
Confidence 9999999999999999987643332 2345789999999988643 58899999999999999998 557998
Q ss_pred CCCHHHHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 593 GLTHEEVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
....--++..|.+|+..... .++++..++|+.+|++.||++|.|++|.+.|+|.++
T Consensus 230 HRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 230 HRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred HHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 87777788899999875443 357789999999999999999999999999998754
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=307.63 Aligned_cols=249 Identities=21% Similarity=0.324 Sum_probs=209.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
+|++.+.||+|+||.||+|+.. .++..||+|.+.... .....+.+.+|++++++++||||+++++.+..+...
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKR-----DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEc-----cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 4788999999999999999863 356789999987532 223456899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+.+++|.+++.. ...+++..+..++.|+++||.|||+.+++|+||+|+||++++
T Consensus 76 ~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~ 135 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQ--------------------KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDE 135 (258)
T ss_pred EEEEeCCCCCCHHHHHHh--------------------cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcC
Confidence 999999999999999862 135788999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT---HEEVV 600 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~---~~e~~ 600 (653)
++.++|+|||++....... ......++..|+|||.+....++.++||||||+++|+|++|. .||...+ ..++.
T Consensus 136 ~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~-~p~~~~~~~~~~~~~ 211 (258)
T cd05578 136 QGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGK-RPYRGHSRTIRDQIR 211 (258)
T ss_pred CCCEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCC-CCCCCCCccHHHHHH
Confidence 9999999999987653322 123345677899999999889999999999999999999965 5777666 44554
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH--HHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF--RTIYQTL 644 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~eil~~L 644 (653)
..... .....+...+..+.+++.+||+.+|.+||++ ++++++.
T Consensus 212 ~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~ 256 (258)
T cd05578 212 AKQET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHP 256 (258)
T ss_pred HHhcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCC
Confidence 44443 3445667789999999999999999999999 8887654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=311.48 Aligned_cols=253 Identities=24% Similarity=0.417 Sum_probs=206.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+...|...+.||+|+||.||+|+.. .++..||+|.++.. ......+++.+|+++++.++||||+++++++..+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~ 87 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE 87 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEc-----CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC
Confidence 3456888899999999999999864 34678999988643 2233445788999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++|+||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+++|+||+|+||+
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~-------------------~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl 147 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEV-------------------HKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNIL 147 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHH-------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEE
Confidence 99999999997 578777752 1235789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
+++++.++|+|||++..... .....++..|+|||.+. .+.++.++||||||+++|||++| .+||.+.+..
T Consensus 148 ~~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg-~~p~~~~~~~ 220 (307)
T cd06607 148 LTEPGTVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER-KPPLFNMNAM 220 (307)
T ss_pred ECCCCCEEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcC-CCCCCCccHH
Confidence 99999999999999875421 12345677899999874 45688999999999999999995 4588777766
Q ss_pred HHHHHHHcCCccCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQA-PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 598 e~~~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.....+........ +..++..+.+++.+||+.+|++||++.+|++++|..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 221 SALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred HHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 65555544333222 334778999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.01 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=189.7
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~E 448 (653)
+.||+|+||.||+|+... ..++..||+|.++.... ...+.+|+.++++++||||+++++++.. +...++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~---~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKD---GKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred cccccCCCeEEEEEEEcc---CCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 569999999999998642 24567899999875432 2356789999999999999999998854 456899999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE----cCC
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQ 524 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl----~~~ 524 (653)
|+. ++|.+++....... .......+++..+..++.||+.||.|||+++|+||||||+|||+ +.+
T Consensus 81 ~~~-~~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~ 148 (317)
T cd07868 81 YAE-HDLWHIIKFHRASK-----------ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred ccC-CCHHHHHHhccccc-----------ccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCc
Confidence 986 58999886432111 01123458899999999999999999999999999999999999 466
Q ss_pred CcEEEeccCccccccccccc-cCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH------
Q psy5539 525 MVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH------ 596 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~------ 596 (653)
+.+||+|||+++........ .......+|..|+|||.+.+. .++.++||||+|+++|||++|. +||.....
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~~f~~~~~~~~~~~ 227 (317)
T cd07868 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSN 227 (317)
T ss_pred CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCC-CCccCCcccccccc
Confidence 89999999999765322211 112334678899999999874 5899999999999999999955 57753221
Q ss_pred ---HHHHHHHHc----------------------------CCccC---------CCCCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 597 ---EEVVKYIKE----------------------------GNILQ---------APDNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 597 ---~e~~~~i~~----------------------------~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
.+....+.. ..... .....+.++.+|+++|++.||.+|||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 307 (317)
T cd07868 228 PYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT 307 (317)
T ss_pred cccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC
Confidence 011111100 00000 00112456889999999999999999
Q ss_pred HHHHHHHHH
Q psy5539 637 FRTIYQTLW 645 (653)
Q Consensus 637 ~~eil~~L~ 645 (653)
++|+++|.|
T Consensus 308 ~~e~l~hp~ 316 (317)
T cd07868 308 SEQAMQDPY 316 (317)
T ss_pred HHHHhcCCC
Confidence 999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=331.32 Aligned_cols=254 Identities=18% Similarity=0.271 Sum_probs=197.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC------CccceE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH------PNIVKL 433 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H------pnIv~l 433 (653)
+....++|++.+.||+|+||+||+|.+. ..+..||||+++... ....++..|+.++..++| .+++++
T Consensus 124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i 196 (467)
T PTZ00284 124 IDVSTQRFKILSLLGEGTFGKVVEAWDR-----KRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKI 196 (467)
T ss_pred cccCCCcEEEEEEEEeccCEEEEEEEEc-----CCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeee
Confidence 4556788999999999999999999864 346789999996432 233456677777777755 458888
Q ss_pred EeEEecC-CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCcee
Q psy5539 434 LGVCAVG-KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVH 511 (653)
Q Consensus 434 ~g~~~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivH 511 (653)
++++... ...++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ .+|||
T Consensus 197 ~~~~~~~~~~~~iv~~~~-g~~l~~~l~~--------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiH 255 (467)
T PTZ00284 197 QRYFQNETGHMCIVMPKY-GPCLLDWIMK--------------------HGPFSHRHLAQIIFQTGVALDYFHTELHLMH 255 (467)
T ss_pred EEEEEcCCceEEEEEecc-CCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCeec
Confidence 8888654 5789999987 6789988862 2458899999999999999999998 59999
Q ss_pred cCCCCCCEeEcCCC----------------cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHH
Q psy5539 512 RDLATRNCLINDQM----------------VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWA 575 (653)
Q Consensus 512 rDLkp~NILl~~~~----------------~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwS 575 (653)
|||||+|||++.++ .+||+|||++.... .......+|..|||||.+.+..++.++||||
T Consensus 256 rDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 256 TDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 99999999998765 49999999875321 1223456789999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--Cc-----------------------cCC--C-------------C-C
Q psy5539 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEG--NI-----------------------LQA--P-------------D-N 614 (653)
Q Consensus 576 lGvvl~ellt~~~~p~~~~~~~e~~~~i~~~--~~-----------------------~~~--~-------------~-~ 614 (653)
|||++|||++| .+||.+.+..+.+..+... .+ ... + + .
T Consensus 331 lGvil~elltG-~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (467)
T PTZ00284 331 MGCIIYELYTG-KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVI 409 (467)
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhh
Confidence 99999999995 5688877665544333221 00 000 0 0 0
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 615 TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 615 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+.+.+||.+||..||.+|||++|+++|+|-.
T Consensus 410 ~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~ 442 (467)
T PTZ00284 410 RDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVL 442 (467)
T ss_pred chHHHHHHHHHhCCcChhhCCCHHHHhcCcccc
Confidence 134577999999999999999999999998854
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=305.68 Aligned_cols=258 Identities=23% Similarity=0.391 Sum_probs=207.3
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 440 (653)
-+.++|++.+.||+|+||.||+|... .++..+++|.++.... ..+.+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 75 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHK-----KTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKK 75 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEEC-----CCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEec
Confidence 35678999999999999999999864 3457899999875433 346789999999999 799999999998654
Q ss_pred C------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 441 K------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 441 ~------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
. ..++||||+++++|.++++... .....+++..+..++.|++.||.|||+.+++|+||
T Consensus 76 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l 139 (275)
T cd06608 76 NPPGNDDQLWLVMELCGGGSVTDLVKGLR----------------KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDI 139 (275)
T ss_pred CCCCcceEEEEEEEcCCCCcHHHHHHHHh----------------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 4 4899999999999999986321 11346889999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
+|+||++++++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|+|++| ..
T Consensus 140 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g-~~ 216 (275)
T cd06608 140 KGQNILLTKNAEVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG-KP 216 (275)
T ss_pred CHHHEEEccCCeEEECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhC-CC
Confidence 9999999999999999999987543211 12233457788999998754 3467899999999999999995 55
Q ss_pred CCCCCCHHHHHHHHHcCCccC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNILQ--APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||......+....+..+.... .+...+.++.+++.+||..||++|||+.+++++.|
T Consensus 217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~ 274 (275)
T cd06608 217 PLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274 (275)
T ss_pred CccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence 887666555554444433222 23346789999999999999999999999998765
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.59 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=211.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc---ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~---~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
-|.-++.||.|+||.||-|++. .+...||||+..-. ..+.+ +++..|+..|.+++|||++.+-|.|.....
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~-----~n~evVAIKKMsySGKQs~EKW-qDIlKEVrFL~~l~HPntieYkgCyLre~T 100 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKW-QDILKEVRFLRQLRHPNTIEYKGCYLREHT 100 (948)
T ss_pred HHHHHHHhcCCccceeEEeecc-----CccceeeeeeccccccccHHHH-HHHHHHHHHHHhccCCCcccccceeeccch
Confidence 3566788999999999999863 45689999998643 23333 478999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.|||||||- |+-.|.|..+ ..++.+.++..|..+.+.||+|||+.+.||||||+.|||++
T Consensus 101 aWLVMEYCl-GSAsDlleVh-------------------kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLs 160 (948)
T KOG0577|consen 101 AWLVMEYCL-GSASDLLEVH-------------------KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLS 160 (948)
T ss_pred HHHHHHHHh-ccHHHHHHHH-------------------hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEec
Confidence 999999995 4788887633 35688899999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+.|.|||+|||.|..+ .+.....||+.|||||+|. .+.|+-++||||||++..||.. ..+|+..++.-..
T Consensus 161 e~g~VKLaDFGSAsi~------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE-RkPPlFnMNAMSA 233 (948)
T KOG0577|consen 161 EPGLVKLADFGSASIM------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKPPLFNMNAMSA 233 (948)
T ss_pred CCCeeeeccccchhhc------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhh-cCCCccCchHHHH
Confidence 9999999999999765 3345578999999999986 4689999999999999999998 5678888887777
Q ss_pred HHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+..|-....+..+ ..+++.+++|+..||++-|.+|||.+++++|.+-+
T Consensus 234 LYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~ 282 (948)
T KOG0577|consen 234 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVL 282 (948)
T ss_pred HHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhc
Confidence 7777665544433 45889999999999999999999999999886543
|
|
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=294.21 Aligned_cols=266 Identities=20% Similarity=0.277 Sum_probs=208.4
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+.+..++|.+.+.||+|||+.||+++. ..++..+|+|++.-.. .+..+...+|++..++++||||++++++...
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~-----~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKG-----LSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecc-----cCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 356677899999999999999999983 3456889999998665 3456678999999999999999999988643
Q ss_pred -----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceec
Q psy5539 440 -----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHR 512 (653)
Q Consensus 440 -----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHr 512 (653)
....||+++|...|+|.+.++... .+...+++.+.+.|+.+|.+||++||+.. ++||
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k----------------~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~ 153 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLK----------------IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHR 153 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHh----------------hcCCccCHHHHHHHHHHHHHHHHHHhccCCccccc
Confidence 345899999999999999997432 23457899999999999999999999987 9999
Q ss_pred CCCCCCEeEcCCCcEEEeccCccccccccccccC-------CCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHH
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG-------DENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWE 582 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~e 582 (653)
||||.|||+.+.+.++|.|||.+......-.... .....-|+.|.|||.+.- ...++++|||||||+||+
T Consensus 154 DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 154 DIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred CCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence 9999999999999999999999875421110000 011234778999998863 467899999999999999
Q ss_pred HHhCCCCCCCCCCH--HHHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 583 IFSFALQPYYGLTH--EEVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 583 llt~~~~p~~~~~~--~e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
|+-|. .||...-. ..+.-.+..+++. +.....++.+.++++.|++.||.+||++.+++.++..+.
T Consensus 234 ~mf~~-sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 234 MMFGE-SPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred HHHcC-CcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 99744 47743211 1122223333331 222348899999999999999999999999999988764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=298.31 Aligned_cols=251 Identities=24% Similarity=0.415 Sum_probs=209.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+|...+.||+|++|.||++... .++..+++|+++.... ...+.+.+|+++++.++|+||+++++++......++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 74 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHK-----RTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI 74 (253)
T ss_pred CceeeeeeccCCceEEEEEEEC-----CCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence 4677889999999999999864 2567899999976544 345678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
++||+++++|.+++... ...+++..+..++.|++.||.+||+.+++|+||+|+||++++++
T Consensus 75 ~~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 75 VMEFCSGGSLKDLLKST-------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135 (253)
T ss_pred EEecCCCCcHHHHHhhc-------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC
Confidence 99999999999998621 14689999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||.+........ .....++..|+|||.+....++.++||||||+++++|++|. .|+...+..+....+..
T Consensus 136 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~~~~ 211 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK-PPYSELPPMKALFKIAT 211 (253)
T ss_pred eEEEeecccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCC-CCCCCCchHHHHHHHHh
Confidence 999999999876533221 23445678899999999888999999999999999999955 58877655555444444
Q ss_pred CCccCCCCC--CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 606 GNILQAPDN--TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 606 ~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
......+.. ++..+.+++.+||+.+|++|||+.+++++.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 212 NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 333333333 3889999999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=333.67 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=212.3
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~ 436 (653)
..+++...++.+.+.|.+|||+.||+|++.+ .+..+|+|++-.. .+...+.+.+||++|+.|+ |+|||.+++.
T Consensus 30 ~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~-----~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yids 103 (738)
T KOG1989|consen 30 QTFTVGSHRVTVEKVLAEGGFAQVYLAQDVK-----GGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDS 103 (738)
T ss_pred eEEEECCEEEEEEEEEccCCcEEEEEEEecC-----CCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEecc
Confidence 4457778889999999999999999999743 2378999998765 5667778999999999997 9999999993
Q ss_pred -Eec------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC-
Q psy5539 437 -CAV------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK- 508 (653)
Q Consensus 437 -~~~------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~- 508 (653)
... .-+.+|+||||.+|.|-++|+..- ...|++.++++|+.|+++|+++||..+
T Consensus 104 s~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rl------------------q~~lte~eVLkIf~dv~~AVa~mH~~~p 165 (738)
T KOG1989|consen 104 SAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRL------------------QTRLTEDEVLKIFYDVCEAVAAMHYLKP 165 (738)
T ss_pred ccccccCCCceeEEEeehhhccCCcHHHHHHHHH------------------hccCChHHHHHHHHHHHHHHHHHhcCCC
Confidence 321 236799999999999999998432 234899999999999999999999775
Q ss_pred -ceecCCCCCCEeEcCCCcEEEeccCcccccccccc-------ccCCCCCCCccccccchhhc---cCCCCCchhHHHHH
Q psy5539 509 -FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY-------YKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFG 577 (653)
Q Consensus 509 -ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~-------~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlG 577 (653)
|||||||-+||||+.++..||||||.+......-. ....-....|+.|.|||.+. +..+++|+||||||
T Consensus 166 PiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALG 245 (738)
T KOG1989|consen 166 PIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALG 245 (738)
T ss_pred ccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHH
Confidence 99999999999999999999999999864321110 01111234688999999875 55789999999999
Q ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 578 VCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 578 vvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
|+||-|+.+. .||.+... ..|..+.+...+ +..+..+.+||+.||+.+|.+||++.+++..+.+|..
T Consensus 246 clLYkLCy~t-~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 246 CLLYKLCYFT-TPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred HHHHHHHHhC-CCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 9999998754 58876532 234555543322 5789999999999999999999999999999988864
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=299.56 Aligned_cols=256 Identities=23% Similarity=0.420 Sum_probs=219.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|+||.||++... .++..+++|++..... ......+.+|+++++.++|+|++++++.+..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRK-----SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEc-----CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEE
Confidence 4678899999999999999864 3567899999875432 345567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.++++... .....+++..+..++.+++.||.|||+.+++|+||+|+||+++++
T Consensus 76 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~ 139 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQK----------------KEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSN 139 (258)
T ss_pred EEEEecCCCcHHHHHHHhh----------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCC
Confidence 9999999999999997321 123568999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||++....... .......++..|+|||......++.++||||||+++++|++| ..||...+..++...+.
T Consensus 140 ~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~p~~~~~~~~~~~~~~ 216 (258)
T cd08215 140 GLVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTL-KHPFEGENLLELALKIL 216 (258)
T ss_pred CcEEECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcC-CCCCCCCcHHHHHHHHh
Confidence 999999999987653322 112234567789999999999999999999999999999985 56888888888888887
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.......+...+.++.+++++||..+|++||++.+++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~ 257 (258)
T cd08215 217 KGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF 257 (258)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence 77777777788999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-36 Score=309.62 Aligned_cols=253 Identities=25% Similarity=0.400 Sum_probs=197.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|+.. .+++.||||.++..........+.+|++++++++|+||+++++++..++..+
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSK-----LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLT 79 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEc-----CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEE
Confidence 57889999999999999999863 3567899999875433323345678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++ +|.+++... ...+++..+..++.|+++||.|||+++|+||||||+|||++++
T Consensus 80 lv~e~~~~-~L~~~~~~~-------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~ 139 (291)
T cd07844 80 LVFEYLDT-DLKQYMDDC-------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISER 139 (291)
T ss_pred EEEecCCC-CHHHHHHhC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCC
Confidence 99999985 999988621 2357889999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKY 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e~~~~ 602 (653)
+.+||+|||+++....... ......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.. ..+.+..
T Consensus 140 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g-~~~~~~~~~~~~~~~~ 216 (291)
T cd07844 140 GELKLADFGLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RPLFPGSTDVEDQLHK 216 (291)
T ss_pred CCEEECccccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhC-CCCCCCCccHHHHHHH
Confidence 9999999999875422111 1122345778999998875 4589999999999999999995 45776554 2222222
Q ss_pred HHcCC-----------------------c------cCCCCCCc--HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGN-----------------------I------LQAPDNTP--DALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~-----------------------~------~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+.. . ........ .++.+++.+|++.+|++|||+.+++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~ 290 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence 11100 0 00001233 77889999999999999999999988754
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.74 Aligned_cols=251 Identities=20% Similarity=0.350 Sum_probs=208.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.+...+.||+|++|.||++... .++..+++|.++... ....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~ 93 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDK-----STGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV 93 (285)
T ss_pred hhhcceEeccCCCeEEEEEEEC-----CCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence 3455678999999999999853 345789999886433 2334568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
|+||+++++|.+++.. ..+++..+..++.|++.||+|||+++++||||+|+||++++++
T Consensus 94 v~e~~~~~~L~~~~~~---------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~ 152 (285)
T cd06648 94 VMEFLEGGALTDIVTH---------------------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG 152 (285)
T ss_pred EEeccCCCCHHHHHHh---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC
Confidence 9999999999999861 3478889999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.++|+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+....+..
T Consensus 153 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~-~p~~~~~~~~~~~~~~~ 229 (285)
T cd06648 153 RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE-PPYFNEPPLQAMKRIRD 229 (285)
T ss_pred cEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCC-CCCcCCCHHHHHHHHHh
Confidence 99999999886542211 1122345778899999999889999999999999999999955 58877777777776666
Q ss_pred CCccCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 606 GNILQA--PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 606 ~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
...... +..++..+.+++.+||+.+|++||++.+++++.+-
T Consensus 230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (285)
T cd06648 230 NLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFL 272 (285)
T ss_pred cCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCccc
Confidence 533222 23378899999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=312.67 Aligned_cols=253 Identities=21% Similarity=0.384 Sum_probs=208.5
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
|.....||+|+||.||+|... .++..||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv 96 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREK-----HSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL 96 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEc-----CCCCEEEEEEEEeccc-chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence 334456999999999999863 3567899999865432 2345688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
+||+++++|.+++. ...+++..++.++.|++.||.|||+.+++|+||||+||++++++.
T Consensus 97 ~e~~~~~~L~~~~~---------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~ 155 (297)
T cd06659 97 MEFLQGGALTDIVS---------------------QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155 (297)
T ss_pred EecCCCCCHHHHHh---------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc
Confidence 99999999998774 134788999999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~ 606 (653)
+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+....+...
T Consensus 156 ~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~-~p~~~~~~~~~~~~~~~~ 232 (297)
T cd06659 156 VKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE-PPYFSDSPVQAMKRLRDS 232 (297)
T ss_pred EEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHhcc
Confidence 9999999987543221 1123345778999999999889999999999999999999955 588777766666665543
Q ss_pred Cc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 607 NI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 607 ~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.. ...+...+..+.+++++||+.+|.+||++++++++.+..+.
T Consensus 233 ~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 233 PPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred CCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 22 12234577899999999999999999999999998776543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=308.82 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=202.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc----HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+|++.+.||+|+||.||+|... .+++.||||.++.... ......+..|++++++++|+||+++++++...+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDK-----ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEEC-----CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCC
Confidence 3677889999999999999864 3467899999975432 223456778999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+ +|+|.++++.. ...+++..++.++.||++||.|||+++++|+||+|+|||+
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~-------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill 135 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDK-------------------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI 135 (298)
T ss_pred EEEEEEccc-CCCHHHHHhcc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE
Confidence 999999999 89999998621 1258899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+.++.++|+|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+..+..
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g-~~~~~~~~~~~~~ 212 (298)
T cd07841 136 ASDGVLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR-VPFLPGDSDIDQL 212 (298)
T ss_pred cCCCCEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcC-CccccCCccHHHH
Confidence 999999999999997653221 11223345678999998865 4678999999999999999996 6677766654444
Q ss_pred HHHHcCCc----------------------c-----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNI----------------------L-----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~----------------------~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..... . ......+..+.+++.+||+.+|++|||+.+++++.|-
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~ 285 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccc
Confidence 33321100 0 0113356789999999999999999999999998663
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=301.22 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=218.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|++.+.||+|+||.||+++.. .++..+++|.++... ......++.+|+++++.++|+||+++++++..+...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRL-----SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEEC-----CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEE
Confidence 4678899999999999999853 356789999987532 3344567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.+++.... .....+++..++.++.|++.||+|||+.+++|+||+|+||+++++
T Consensus 76 ~v~e~~~~~~L~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~ 139 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRK----------------KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAN 139 (256)
T ss_pred EEehhcCCCCHHHHHHHHH----------------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecC
Confidence 9999999999999987321 123467899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.+||+|||++...... ......++..|+|||.+.+..++.++|+||||+++|||++ +..||...+..++...+.
T Consensus 140 ~~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~-g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08530 140 DLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT-FAPPFEARSMQDLRYKVQ 214 (256)
T ss_pred CcEEEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHh
Confidence 99999999999765332 2223456788999999999999999999999999999998 456999888888888888
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.+.....+...+.++.+++.+||+.+|++||++.++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p 254 (256)
T cd08530 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254 (256)
T ss_pred cCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence 8777777778899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=307.54 Aligned_cols=254 Identities=25% Similarity=0.411 Sum_probs=197.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||.||+|... .++..||+|+++..........+.+|+.+++.++|+||+++++++..++..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 78 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISR-----INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETL 78 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEc-----CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeE
Confidence 467899999999999999999864 345789999987654443344678899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+. ++|.+++.. ....+++..+..++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 79 ~lv~e~~~-~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~ 138 (291)
T cd07870 79 TFVFEYMH-TDLAQYMIQ-------------------HPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISY 138 (291)
T ss_pred EEEEeccc-CCHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcC
Confidence 99999995 688877641 1234678888999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVK 601 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~ 601 (653)
++.+||+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|||++|. .||.+.+. .+.+.
T Consensus 139 ~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~-~~f~~~~~~~~~~~ 215 (291)
T cd07870 139 LGELKLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ-PAFPGVSDVFEQLE 215 (291)
T ss_pred CCcEEEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCC-CCCCCchhHHHHHH
Confidence 9999999999987543221 112233457889999998764 5789999999999999999965 57765442 22222
Q ss_pred HHHc--C-----------Cc--------cCC-C---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKE--G-----------NI--------LQA-P---------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~--~-----------~~--------~~~-~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.. + .. ... + ...+.++.+++.+|+..||++|||+.+++.+.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~ 290 (291)
T cd07870 216 KIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290 (291)
T ss_pred HHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence 1110 0 00 000 0 012568899999999999999999999998754
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.22 Aligned_cols=249 Identities=23% Similarity=0.344 Sum_probs=197.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecC--Cce
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVG--KPM 443 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~--~~~ 443 (653)
|++.+.||+|+||.||+|+.. .++..||+|.++............+|+.++.++. |+||+++++++..+ +..
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSR-----KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRL 75 (282)
T ss_pred CceEeeccccccceEEEEEEc-----CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcE
Confidence 467889999999999999863 3567899999876433323334567899999985 99999999999877 889
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||++ |+|.+++.. ....+++.+++.++.|++.||+|||+.+++||||+|+||++++
T Consensus 76 ~lv~e~~~-~~l~~~l~~-------------------~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~ 135 (282)
T cd07831 76 ALVFELMD-MNLYELIKG-------------------RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD 135 (282)
T ss_pred EEEEecCC-ccHHHHHHh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC
Confidence 99999997 588888762 1245899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+.+||+|||+++....... .....++..|+|||.+.. ..++.++||||||+++|||++ +.+||.+.+..+.+..
T Consensus 136 -~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~-~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 136 -DILKLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS-LFPLFPGTNELDQIAK 210 (282)
T ss_pred -CCeEEEecccccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc-CCcCCCCCCHHHHHHH
Confidence 9999999999976532221 122346778999997754 457899999999999999998 5669987776555444
Q ss_pred HHcCC---------------c--cCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGN---------------I--LQA-----------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~---------------~--~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+.. . ... ....+.++.+++.+||+.+|++||++++++++.|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~ 281 (282)
T cd07831 211 IHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281 (282)
T ss_pred HHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence 43210 0 000 1246789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=310.29 Aligned_cols=252 Identities=23% Similarity=0.416 Sum_probs=206.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.|...+.||+|+||.||+|+.. .++..||+|.+... ........+.+|++++++++|+|++++++++..+..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDV-----RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEc-----CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe
Confidence 34677888999999999999863 34678999998643 223345578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||++ |+|.+++.. ....+++.++..++.|++.||.|||+.+|+|+||+|+||+++
T Consensus 100 ~~lv~e~~~-g~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~ 159 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEV-------------------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLT 159 (317)
T ss_pred EEEEEeCCC-CCHHHHHHH-------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEEC
Confidence 999999997 588887752 124588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++.+||+|||++.... ......++..|+|||.+. .+.++.++||||||+++|||++|. .||...+..+.
T Consensus 160 ~~~~~kl~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~-~p~~~~~~~~~ 232 (317)
T cd06635 160 EPGQVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNAMSA 232 (317)
T ss_pred CCCCEEEecCCCccccC------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCC-CCCCCccHHHH
Confidence 99999999999986432 122345677899999974 457899999999999999999965 47777666655
Q ss_pred HHHHHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 600 ~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
...+..+.. .......+..+.+++.+||+.+|.+||++.+|+++++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 555554433 2334467889999999999999999999999999887544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.82 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=212.4
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..+.|...+.||+|+||.||+|... .++..|++|.++.... ....+.+|+++++.++|+||+++++.+.....
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 89 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDR-----ATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDE 89 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEc-----cCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE
Confidence 3456778889999999999999864 2457899999975433 45678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~-------------------~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~ 150 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNF-------------------VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLS 150 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhc-------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEc
Confidence 999999999999999997321 3588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++| ..||...+.......
T Consensus 151 ~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g-~~p~~~~~~~~~~~~ 227 (286)
T cd06614 151 KDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG-EPPYLREPPLRALFL 227 (286)
T ss_pred CCCCEEECccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 999999999999865432211 11223456789999999988899999999999999999995 458887776665555
Q ss_pred HHcCCccCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 603 IKEGNILQA--PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 603 i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+........ +..++..+.+++.+||+.+|.+||++.+|+++.+-.
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 554433332 233789999999999999999999999999887654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.94 Aligned_cols=253 Identities=24% Similarity=0.406 Sum_probs=200.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|+.++.||+|+||.||+|+.. .++..||||.++.... ......+.+|++++++++||||+++++++..++..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEEC-----CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEE
Confidence 4778899999999999999864 3567899999875432 223356889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+. ++|.+++... ....+++..++.++.|++.||+|||+.+++|+||+|+||+++++
T Consensus 76 ~v~e~~~-~~l~~~~~~~------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 76 LVFEFLH-QDLKKFMDAS------------------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred EEeeccc-cCHHHHHHhC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 9999996 6899988621 23458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY- 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~- 602 (653)
+.+||+|||++....... .......++..|+|||.+.+.. ++.++||||||+++|||++|. .||.+.+..+....
T Consensus 137 ~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~-~p~~~~~~~~~~~~~ 213 (284)
T cd07860 137 GAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRI 213 (284)
T ss_pred CCEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC-CCCCCCCHHHHHHHH
Confidence 999999999987543221 1122334577899999887654 588999999999999999965 47766554332222
Q ss_pred HHcCCc---------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNI---------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~---------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..... ......++.++++++.+||+.||.+|||+++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~ 283 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence 211000 0112346788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=322.22 Aligned_cols=250 Identities=24% Similarity=0.363 Sum_probs=203.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-C-----CccceEEeEEec
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-H-----PNIVKLLGVCAV 439 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-H-----pnIv~l~g~~~~ 439 (653)
+|.+.+.||+|+||.|-+|.+. .++..||||+++... ....+...|+.+|..|+ | -|+|++++++..
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~-----~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f 259 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDH-----KTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF 259 (586)
T ss_pred EEEEEEEecccccceeEEEEec-----CCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc
Confidence 7889999999999999999864 567899999998653 34455678999999997 4 499999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+++|||+|.+.. ||.++|+.+ +...++...+..|+.||+.||.+||+.+|||+||||+||
T Consensus 260 r~HlciVfELL~~-NLYellK~n------------------~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENI 320 (586)
T KOG0667|consen 260 RNHLCIVFELLST-NLYELLKNN------------------KFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENI 320 (586)
T ss_pred ccceeeeehhhhh-hHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhhe
Confidence 9999999999865 999999843 345689999999999999999999999999999999999
Q ss_pred eEcCC--CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 520 LINDQ--MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 520 Ll~~~--~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||.+- ..+||+|||.|......-+ ...-+..|.|||++.+.+|+.+.||||||||++||++| .+.|.|.+..
T Consensus 321 LL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG-~PLfpG~ne~ 394 (586)
T KOG0667|consen 321 LLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTG-EPLFPGDNEY 394 (586)
T ss_pred eeccCCcCceeEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcC-ccccCCCCHH
Confidence 99744 4899999999976422111 22335569999999999999999999999999999995 7788888776
Q ss_pred HHHHHHHc---------------------C--Ccc----------------------------CCC-C----------CC
Q psy5539 598 EVVKYIKE---------------------G--NIL----------------------------QAP-D----------NT 615 (653)
Q Consensus 598 e~~~~i~~---------------------~--~~~----------------------------~~~-~----------~~ 615 (653)
+.+..|.+ . ..+ ..| . ..
T Consensus 395 DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~ 474 (586)
T KOG0667|consen 395 DQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKAD 474 (586)
T ss_pred HHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhccccc
Confidence 65555432 0 000 001 0 11
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 616 PDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 616 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+.+++++|++.||.+|+|..+.++|.|--
T Consensus 475 ~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 475 DKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred HHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 24678999999999999999999999998743
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=303.33 Aligned_cols=253 Identities=25% Similarity=0.430 Sum_probs=203.4
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
|+..+.||+|+||.||+|+.. .++..||+|.++.... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~lg~g~~~~v~~~~~~-----~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 76 (268)
T cd06630 2 WLKGQQLGTGAFSSCYQARDV-----KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS 76 (268)
T ss_pred ccccceecCcCceEEEEEEEc-----CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCC
Confidence 566788999999999999853 4567899998864321 224567899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+++++|.+++.. ...+++..++.++.||+.||.|||+++++|+||+|+||++
T Consensus 77 ~~~~v~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~ 136 (268)
T cd06630 77 HFNLFVEWMAGGSVSHLLSK--------------------YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI 136 (268)
T ss_pred eEEEEEeccCCCcHHHHHHH--------------------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99999999999999999862 2357888999999999999999999999999999999999
Q ss_pred cCCC-cEEEeccCccccccccccccC--CCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-
Q psy5539 522 NDQM-VVKIADFGLSRKMYLQDYYKG--DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE- 597 (653)
Q Consensus 522 ~~~~-~vkI~DfGla~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~- 597 (653)
+.++ .+||+|||++........... .....++..|+|||.+.+..++.++||||||+++|+|++|. .||......
T Consensus 137 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~ 215 (268)
T cd06630 137 DSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK-PPWNAEKHSN 215 (268)
T ss_pred cCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCC-CCCCCCCCcc
Confidence 8775 699999999876643211111 12235678899999998889999999999999999999955 577544322
Q ss_pred --HHHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 --EVVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 --e~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.....+. .......++..+.++.+++.+||..+|.+||++.+++++.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~ 266 (268)
T cd06630 216 HLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV 266 (268)
T ss_pred hHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence 2222221 22234455667889999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=323.79 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=206.2
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 451 (653)
.||+|.||+||-|++. .+...+|||-+.+..++. .+-+.+||.+-++|+|.|||+++|.+..++.+-+.||-++
T Consensus 582 VLGKGTYG~VYA~RD~-----~tqvrIaIKEIpekdsr~-~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP 655 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDM-----DTQVRIAIKEIPEKDSRE-VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP 655 (1226)
T ss_pred EeecCceeEEEeeccc-----cceeEEEeeecccccchh-hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence 4999999999999864 355789999998776654 3468899999999999999999999999999999999999
Q ss_pred CCChHHHHhhcCCCCCcCCCcccccccccCCCCC--CHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-CCCcEE
Q psy5539 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL--STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVK 528 (653)
Q Consensus 452 ~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~-~~~~vk 528 (653)
||+|.+.|+.+ =+++ ++.++-.+.+||++||.|||+..|||||||-+||||+ -.|.+|
T Consensus 656 GGSLSsLLrsk-------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlK 716 (1226)
T KOG4279|consen 656 GGSLSSLLRSK-------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLK 716 (1226)
T ss_pred CCcHHHHHHhc-------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEE
Confidence 99999999832 1334 7778889999999999999999999999999999996 679999
Q ss_pred EeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHH-
Q psy5539 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIK- 604 (653)
Q Consensus 529 I~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e~~~~i~- 604 (653)
|+|||-++++.. ...-.+...||..|||||++..+ .|..++|||||||++.||.| |.+||.... ++..+-++-
T Consensus 717 ISDFGTsKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMAT-GrPPF~ElgspqAAMFkVGm 793 (1226)
T KOG4279|consen 717 ISDFGTSKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMAT-GRPPFVELGSPQAAMFKVGM 793 (1226)
T ss_pred ecccccchhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeecc-CCCCeeecCChhHhhhhhcc
Confidence 999999987632 22345667899999999999876 58899999999999999999 556887553 333333322
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
-+..++.|+..+.+.+++|.+|+.++|.+||+++++++.++
T Consensus 794 yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpF 834 (1226)
T KOG4279|consen 794 YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPF 834 (1226)
T ss_pred eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcc
Confidence 22335677888899999999999999999999999998765
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=310.27 Aligned_cols=256 Identities=23% Similarity=0.351 Sum_probs=189.7
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~~~~LV~E 448 (653)
..||+|+||.||+|+... ..++..||+|.++.... ...+.+|++++++++||||+++++++.. +...++|||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~---~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKD---GKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred eEeccCCCeeEEEEEecC---CCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 569999999999998642 23557899999875432 2357889999999999999999998853 567899999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE----cCC
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQ 524 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl----~~~ 524 (653)
|+++ +|.+++....... .......+++..+..++.||+.||.|||+.+|+||||||+|||+ +++
T Consensus 81 ~~~~-~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~ 148 (317)
T cd07867 81 YAEH-DLWHIIKFHRASK-----------ANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148 (317)
T ss_pred eeCC-cHHHHHHhhhccc-----------cCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCC
Confidence 9864 8888886332110 01123458899999999999999999999999999999999999 567
Q ss_pred CcEEEeccCccccccccccc-cCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH-----
Q psy5539 525 MVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE----- 597 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~----- 597 (653)
+.+||+|||+++........ .......+|..|+|||.+.+. .++.++||||||+++|||++|. +||.....+
T Consensus 149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~-~~f~~~~~~~~~~~ 227 (317)
T cd07867 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSN 227 (317)
T ss_pred CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCC-CCcccccccccccc
Confidence 89999999999865332211 112234568899999998764 5899999999999999999955 577532211
Q ss_pred -----HHHHHHH--------------c-------------CCc---------cCCCCCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 598 -----EVVKYIK--------------E-------------GNI---------LQAPDNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 598 -----e~~~~i~--------------~-------------~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
.+...+. . ... .......+..+.+|+.+|+..||.+|||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t 307 (317)
T cd07867 228 PFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT 307 (317)
T ss_pred cccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC
Confidence 1100000 0 000 0001123456889999999999999999
Q ss_pred HHHHHHHHH
Q psy5539 637 FRTIYQTLW 645 (653)
Q Consensus 637 ~~eil~~L~ 645 (653)
++|+++|+|
T Consensus 308 ~~e~l~hp~ 316 (317)
T cd07867 308 SEQALQDPY 316 (317)
T ss_pred HHHHhcCCC
Confidence 999998865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=305.52 Aligned_cols=254 Identities=23% Similarity=0.371 Sum_probs=203.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|... .++..||+|.++... .....+.+.+|++++++++|+||+++++++..++..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~-----~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNK-----ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeC-----CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEE
Confidence 36889999999999999999864 346789999987532 333456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||++++.|..+++ ....+++..+..++.||+.||.|||+.+++|+||+|+||++++
T Consensus 76 ~iv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~ 135 (288)
T cd07833 76 YLVFEYVERTLLELLEA--------------------SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSE 135 (288)
T ss_pred EEEEecCCCCHHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECC
Confidence 99999999877766553 2234789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||++........ .......++..|+|||.+.+. .++.++||||||+++|+|++|. +||.+....+....
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~-~~~~~~~~~~~~~~ 213 (288)
T cd07833 136 SGVLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYL 213 (288)
T ss_pred CCCEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHH
Confidence 99999999999876543321 112234457789999999888 8899999999999999999954 57776554433222
Q ss_pred HHc--------------------C-Ccc----------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKE--------------------G-NIL----------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~--------------------~-~~~----------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.. + ... ..+..++.++.+++++||+.+|++||++++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 287 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence 211 0 000 012234788999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=295.56 Aligned_cols=254 Identities=26% Similarity=0.430 Sum_probs=211.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC--Cc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--KP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~ 442 (653)
+|...+.||+|++|.||+|... .+++.|++|.++.... ....+.+.+|+.++++++|+||+++++.+... ..
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDK-----DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT 75 (260)
T ss_pred CceeeeEeeecCceEEEEEEEC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCe
Confidence 3677889999999999999864 3567899999875432 34566789999999999999999999999888 88
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+++|+||+|+||+++
T Consensus 76 ~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~ 135 (260)
T cd06606 76 LNIFLEYVSGGSLSSLLKK--------------------FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVD 135 (260)
T ss_pred EEEEEEecCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 9999999999999999862 12689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e~~~ 601 (653)
+++.++|+|||.+................++..|+|||.+.....+.++||||||+++++|++|. .||.... ......
T Consensus 136 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~-~p~~~~~~~~~~~~ 214 (260)
T cd06606 136 SDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK-PPWSELGNPMAALY 214 (260)
T ss_pred CCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCchHHHHH
Confidence 99999999999987664333211123456778899999999888999999999999999999954 5776654 333333
Q ss_pred HHHc-CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKE-GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.. +.....+...+..+.+++.+|++.+|++||++.+++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~ 259 (260)
T cd06606 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF 259 (260)
T ss_pred hccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence 3332 3445566778999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=301.42 Aligned_cols=246 Identities=28% Similarity=0.394 Sum_probs=206.1
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||.||+++.. .++..+++|.++.... ....+.+.+|++++++++|+||+++++.+..+...++++||+
T Consensus 1 lg~g~~~~vy~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKK-----STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEEC-----CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 689999999999864 3467899999875432 244567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||+|+||++++++.++|+
T Consensus 76 ~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~ 135 (265)
T cd05579 76 PGGDLASLLEN--------------------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLT 135 (265)
T ss_pred CCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEE
Confidence 99999999862 1357899999999999999999999999999999999999999999999
Q ss_pred ccCcccccccccc------ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 531 DFGLSRKMYLQDY------YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 531 DfGla~~~~~~~~------~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
|||++........ ........++..|+|||.......+.++||||||+++|||++| ..||......+....+.
T Consensus 136 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g-~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 136 DFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG-IPPFHGETPEEIFQNIL 214 (265)
T ss_pred ecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHh
Confidence 9999875432211 0112233456789999999988899999999999999999995 56888888888888877
Q ss_pred cCCccCCCCCC--cHHHHHHHHHhhccCCCCCCCH---HHHHHHHH
Q psy5539 605 EGNILQAPDNT--PDALYDLMKLCWNMKPMNRPSF---RTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~--~~~l~~li~~cl~~dP~~RPs~---~eil~~L~ 645 (653)
.+.. ..+... +..+.+++.+||+.+|.+|||+ .+++++.|
T Consensus 215 ~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~ 259 (265)
T cd05579 215 NGKI-EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF 259 (265)
T ss_pred cCCc-CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence 6543 344444 8999999999999999999999 77777665
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=298.62 Aligned_cols=254 Identities=25% Similarity=0.332 Sum_probs=205.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc----ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE----ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~----~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+|++.+.||+|+||.||+|+.. .++..||+|.+... ........+.+|++++++++|+||+++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 76 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDA-----DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP 76 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEc-----CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC
Confidence 57889999999999999999863 35678999987432 1223445789999999999999999999998654
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++++||+++++|.+++.. ...+++..+..++.||+.||.|||+.+++|+||||+|
T Consensus 77 ~~~~~~~v~e~~~~~~L~~~~~~--------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~n 136 (264)
T cd06653 77 EEKKLSIFVEYMPGGSIKDQLKA--------------------YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGAN 136 (264)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 458899999999999999862 2347888899999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++++++.++|+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++| .+||......
T Consensus 137 i~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~ 215 (264)
T cd06653 137 ILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTE-KPPWAEYEAM 215 (264)
T ss_pred EEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhC-CCCCCccCHH
Confidence 9999999999999999976422110 0111223467889999999988899999999999999999995 4688776655
Q ss_pred HHHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+..+. .+.....++..++.+.+++.+||. +|.+||+..++++|++
T Consensus 216 ~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 216 AAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred HHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 5444443 333345677788999999999999 5799999999988753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=306.63 Aligned_cols=254 Identities=22% Similarity=0.368 Sum_probs=207.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||.||++... .++..|++|.+..... ...+.+.+|+.++++++||||+++++++...+..
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDV-----ATGQEVAIKQMNLQQQ-PKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEc-----CCCCEEEEEEeccccc-hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 357889999999999999999753 3457899999864332 2345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+++++|.+++.. ..+++.++..++.|++.||.|||+++++|+||||+||++++
T Consensus 92 ~lv~e~~~~~~L~~~~~~---------------------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~ 150 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTE---------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 150 (293)
T ss_pred EEEEecCCCCcHHHHHhh---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcC
Confidence 999999999999999861 24678899999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.++|+|||++........ ......++..|+|||.+....++.++||||||+++|++++| .+||...+..+.+..+
T Consensus 151 ~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g-~~pf~~~~~~~~~~~~ 227 (293)
T cd06647 151 DGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG-EPPYLNENPLRALYLI 227 (293)
T ss_pred CCCEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCChhhheeeh
Confidence 99999999999875533221 12233567889999999888899999999999999999995 5688766554433333
Q ss_pred HcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 604 KEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 604 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+.. ...++..+..+.+++++||..+|++||++.+++.+.|--
T Consensus 228 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~ 273 (293)
T cd06647 228 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (293)
T ss_pred hcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 22221 122345678899999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=303.79 Aligned_cols=254 Identities=24% Similarity=0.394 Sum_probs=203.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
+|++.+.||+|++|.||+|+.. .++..||||.++..........+.+|+.++++++|+||+++++++...+..++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNR-----TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEEC-----CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEE
Confidence 4788999999999999999863 35688999998765443344567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++ +|.+++.... ....+++..+..++.|++.||.|||+.+++|+||||+||++++++
T Consensus 76 v~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~ 137 (284)
T cd07836 76 VFEYMDK-DLKKYMDTHG-----------------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG 137 (284)
T ss_pred EEecCCc-cHHHHHHhcC-----------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC
Confidence 9999985 8999886321 124589999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
.++|+|||++....... .......++..|++||.+.+. .++.++||||||+++|||++| .+||.+.+..+....+.
T Consensus 138 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g-~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 138 ELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RPLFPGTNNEDQLLKIF 214 (284)
T ss_pred cEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHH
Confidence 99999999997543211 112234457789999988664 578999999999999999995 56887766555444332
Q ss_pred cCC--------------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGN--------------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~--------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
... .. ...+..+..+.+++.+|++.+|.+||++.+++++.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 215 RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred HHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 110 00 001235678899999999999999999999998754
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=312.67 Aligned_cols=254 Identities=23% Similarity=0.289 Sum_probs=199.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
.++|.+.+.||+|+||.||+|+.. .++..||||.++..........+.+|+.++++++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHK-----PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEc-----CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccccc
Confidence 357999999999999999999863 356789999987544344456688999999999999999999987543
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++|+||+.+ +|.++++ ...+++..+..++.|++.||.|||+.+|+||||||+|
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~---------------------~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~N 136 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIK---------------------TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSN 136 (336)
T ss_pred ccceEEEEehhccc-CHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHH
Confidence 357999999974 8887764 2358899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccccc-CCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
||+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+.
T Consensus 137 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G-~~~f~~~~~ 215 (336)
T cd07849 137 LLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGKDY 215 (336)
T ss_pred EEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCH
Confidence 999999999999999997653322111 1122456788999998765 4689999999999999999995 568866554
Q ss_pred HHHHHHHHc---------------C---------Ccc------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKE---------------G---------NIL------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~---------------~---------~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
......+.+ . ... ......+.++.+++.+||+.+|++|||+.+++++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~ 294 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPY 294 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 332221111 0 000 011235678999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=302.81 Aligned_cols=246 Identities=25% Similarity=0.308 Sum_probs=199.9
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||+||+|... .+++.+|+|.+.... .......+.+|++++++++||||+++++++...+..++||||+
T Consensus 1 lg~g~~g~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVK-----ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEc-----CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999853 356789999986432 1223445678999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.+++.... ...+++.+++.++.|++.||.|||+.+++|+||+|+||++++++.++|+
T Consensus 76 ~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~ 137 (277)
T cd05577 76 NGGDLKYHIYNVG------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRIS 137 (277)
T ss_pred CCCcHHHHHHHcC------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEc
Confidence 9999999986221 1357899999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH----EEVVKYIKEG 606 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~----~e~~~~i~~~ 606 (653)
|||++..... ........++..|+|||.+.++.++.++||||||+++|+|++|. .||..... .++...+..
T Consensus 138 dfg~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~~~~~~~~~~~~~- 212 (277)
T cd05577 138 DLGLAVELKG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR-SPFRQRKEKVEKEELKRRTLE- 212 (277)
T ss_pred cCcchhhhcc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCC-CCCCCCcccccHHHHHhcccc-
Confidence 9999875422 11222345677899999999888999999999999999999954 57765543 233332222
Q ss_pred CccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 607 NILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 607 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
.....+...++.+.+++.+||+.+|.+|| ++.+++++.|-
T Consensus 213 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 22345566889999999999999999999 88889988764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=327.58 Aligned_cols=264 Identities=19% Similarity=0.205 Sum_probs=194.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCC----------ccceE----EEEEEccccccHHHHHHHHHHHHHHhhCCCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKH----------EEFTL----VAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~----------~~~~~----VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn 429 (653)
.++|++++.||+|+||+||++........ ..+.. ++.|.++ ........+++|+.++++++|||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~--~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK--AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh--cchHHHHHHHHHHHHHHhCCCCC
Confidence 46899999999999999999875321100 00011 1112222 12234456889999999999999
Q ss_pred cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 430 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
||++++++...+..++|+|++. ++|.+++..... ..........+..|+.||+.||+|||+++|
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~---------------~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI 288 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAF---------------DWKDRPLLKQTRAIMKQLLCAVEYIHDKKL 288 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccc---------------cccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999999999999999999985 588888752210 111223456778899999999999999999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
+||||||+|||++.++.+||+|||+++.+..... .......++..|+|||.+.+..++.++|||||||++|||++++..
T Consensus 289 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~ 367 (501)
T PHA03210 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFC 367 (501)
T ss_pred ecCCCCHHHEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999999999999999999976532211 122335688999999999999999999999999999999998877
Q ss_pred CCCCCC---HHHHHHHHH---------------------cCCccCCC---------CCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 590 PYYGLT---HEEVVKYIK---------------------EGNILQAP---------DNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 590 p~~~~~---~~e~~~~i~---------------------~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
|+.+.. ..++.+.+. .......+ ...+.++.+++.+|++.||.+|||
T Consensus 368 p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps 447 (501)
T PHA03210 368 PIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG 447 (501)
T ss_pred CccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC
Confidence 775432 122222221 11110011 124567788899999999999999
Q ss_pred HHHHHHHHHH
Q psy5539 637 FRTIYQTLWN 646 (653)
Q Consensus 637 ~~eil~~L~~ 646 (653)
+.|++++.|.
T Consensus 448 a~elL~hp~f 457 (501)
T PHA03210 448 AAELLALPLF 457 (501)
T ss_pred HHHHhhChhh
Confidence 9999998874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.57 Aligned_cols=257 Identities=25% Similarity=0.367 Sum_probs=204.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC-
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG- 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~- 440 (653)
+.++|++.+.||+|+||.||+|... .++..||+|.++.... ......+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDT-----TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH 79 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEEC-----CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence 3467899999999999999999864 3567899999864322 22233467899999999999999999998654
Q ss_pred -CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 441 -KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 441 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+..++||||+.+ +|.+++... ...+++.+++.++.||+.||+|||+.+++||||||+||
T Consensus 80 ~~~~~lv~e~~~~-~l~~~l~~~-------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni 139 (309)
T cd07845 80 LDSIFLVMEYCEQ-DLASLLDNM-------------------PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL 139 (309)
T ss_pred CCeEEEEEecCCC-CHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 568999999964 899888621 14588999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
++++++.+||+|||++....... ........+..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+..+
T Consensus 140 l~~~~~~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g-~~~f~~~~~~~ 216 (309)
T cd07845 140 LLTDKGCLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIE 216 (309)
T ss_pred EECCCCCEEECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhC-CCCCCCCCHHH
Confidence 99999999999999997653322 11222334678999999876 4579999999999999999995 56888877776
Q ss_pred HHHHHHcCCc---------------------cCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNI---------------------LQA--------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~---------------------~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+..+.+... ... ....+..+.++|.+|++.||++|||++++++|.|--
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred HHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 6655543100 000 012467889999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=306.41 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=201.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 443 (653)
+++...+.||+|+||.||+++.. .++..+|+|.+...........+.+|+.++.++. |+||+++++++..++..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHK-----PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEEC-----CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence 45666788999999999999864 3568899999876544455667899999999996 99999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCEeEc
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNCLIN 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NILl~ 522 (653)
+++|||+.. +|.++..... ......+++..+..++.|++.||+|||+. +++||||||+|||++
T Consensus 79 ~~~~e~~~~-~l~~l~~~~~---------------~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~ 142 (288)
T cd06616 79 WICMELMDI-SLDKFYKYVY---------------EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLD 142 (288)
T ss_pred EEEEecccC-CHHHHHHHHH---------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEc
Confidence 999999864 6666543110 01235689999999999999999999975 999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EE 598 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e 598 (653)
+++.+||+|||+++...... ......++..|+|||.+... .++.++||||||+++|||++|. .||..... .+
T Consensus 143 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~~~~~~~ 218 (288)
T cd06616 143 RNGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK-FPYPKWNSVFD 218 (288)
T ss_pred cCCcEEEeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC-CCchhcchHHH
Confidence 99999999999997543221 11233567889999998876 6899999999999999999955 57765432 22
Q ss_pred HHHHHHcCCccCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQA----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+..+..... +..++.++.+|+.+||+.+|++|||+++|+++.|-
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~ 270 (288)
T cd06616 219 QLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI 270 (288)
T ss_pred HHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence 2233222222221 12478899999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=294.20 Aligned_cols=251 Identities=26% Similarity=0.445 Sum_probs=211.5
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|++|.||+|+.. ..+..|++|.+..... +...+.+.+|++++++++|+|++++++++..+...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNL-----ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEc-----CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEE
Confidence 4677899999999999999863 3457899999876532 234567999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++++
T Consensus 76 ~v~e~~~~~~L~~~~~~--------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~ 135 (254)
T cd06627 76 IILEYAENGSLRQIIKK--------------------FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKD 135 (254)
T ss_pred EEEecCCCCcHHHHHHh--------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCC
Confidence 99999999999999862 2458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||++........ ......++..|+|||...+..++.++||||||+++|+|++|. .|+...+.......+.
T Consensus 136 ~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~-~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 136 GVVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN-PPYYDLNPMAALFRIV 212 (254)
T ss_pred CCEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCC-CCCCCccHHHHHHHHh
Confidence 9999999999986543221 123345678899999998888999999999999999999965 5777666555555555
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.......+...+..+.+++.+||..+|++||++.+++.+.
T Consensus 213 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~ 252 (254)
T cd06627 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP 252 (254)
T ss_pred ccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence 5555566778899999999999999999999999998764
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=305.28 Aligned_cols=250 Identities=23% Similarity=0.402 Sum_probs=216.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
-|.++.+||+|+||.||+|.+ .+.|..+|||.+.-+. ..+++..|+.+|.+.+.|++|++||.+.....+++
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH-----~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWI 105 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIH-----RESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWI 105 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHH-----hccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEe
Confidence 377889999999999999974 4788999999997643 24578899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+..|++.+.++. ...+|++.++..+++..++||+|||...=+|||||+.|||++.+|
T Consensus 106 VMEYCGAGSiSDI~R~-------------------R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G 166 (502)
T KOG0574|consen 106 VMEYCGAGSISDIMRA-------------------RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG 166 (502)
T ss_pred ehhhcCCCcHHHHHHH-------------------hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc
Confidence 9999999999999983 346799999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.+||+|||.+..+. +.........||+.|||||++..-.|+.++||||||++..||.. |.+||.+..+-..+-.|..
T Consensus 167 ~AKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAE-G~PPYsDIHPMRAIFMIPT 243 (502)
T KOG0574|consen 167 IAKLADFGVAGQLT--DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAE-GRPPYSDIHPMRAIFMIPT 243 (502)
T ss_pred hhhhhhccccchhh--hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhc-CCCCcccccccceeEeccC
Confidence 99999999996543 22233345678999999999999999999999999999999998 6679988776555555544
Q ss_pred CCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 606 GNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 606 ~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+ ..|+.+++++-++++.|+-++|++|-|+.++++|.+
T Consensus 244 ~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 244 KPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred CCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence 4332 235678899999999999999999999999999864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=303.63 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=204.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~ 439 (653)
.+..++|.+.+.||+|+||.||+|+.. .++..||||.++.........++.+|+.++.+.. |+||+++++++..
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~ 85 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFK-----KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT 85 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEEC-----CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec
Confidence 455678899999999999999999864 2468899999976544444556777887776765 9999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCC
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRN 518 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~N 518 (653)
+...+++|||++ ++|.+++.. ....+++..+..++.||+.||+|||+ .+|+||||+|+|
T Consensus 86 ~~~~~~v~e~~~-~~l~~l~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~n 145 (296)
T cd06618 86 DSDVFICMELMS-TCLDKLLKR-------------------IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSN 145 (296)
T ss_pred CCeEEEEeeccC-cCHHHHHHH-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHH
Confidence 999999999985 477777652 12368899999999999999999997 599999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK----YTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
|++++++.+||+|||++..+.... ......++..|+|||.+.+.. ++.++||||||+++|||++|. .||...
T Consensus 146 ill~~~~~~kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~~ 221 (296)
T cd06618 146 ILLDASGNVKLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ-FPYKNC 221 (296)
T ss_pred EEEcCCCCEEECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCC-CCCCcc
Confidence 999999999999999987543211 112334677899999987654 789999999999999999955 577553
Q ss_pred C-HHHHHHHHHcCCccCCC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 595 T-HEEVVKYIKEGNILQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 595 ~-~~e~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
. ..+....+........+ ..++.++.+++.+||+.+|.+||++.+++++.|-.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 277 (296)
T cd06618 222 KTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence 2 33445444444332222 24688999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=302.85 Aligned_cols=245 Identities=20% Similarity=0.283 Sum_probs=192.2
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHH---HhhCCCCccceEEeEEecCCceEEE
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACL---LAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~i---l~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
.||+|+||.||++... .+++.+|+|.+..... ......+.+|..+ +...+||||+.+++++..++..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEEC-----CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 3899999999999863 3567899998864321 1122234444433 3344799999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||+++++.
T Consensus 76 ~e~~~~~~L~~~i~~--------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~ 135 (279)
T cd05633 76 LDLMNGGDLHYHLSQ--------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH 135 (279)
T ss_pred EecCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC
Confidence 999999999998862 235899999999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH--EEVVKYI 603 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~--~e~~~~i 603 (653)
++|+|||++...... ......++..|+|||.+.. ..++.++||||||+++|||++|. .||..... .+.....
T Consensus 136 ~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~~~~~~~ 210 (279)
T cd05633 136 VRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGH-SPFRQHKTKDKHEIDRM 210 (279)
T ss_pred EEEccCCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC-CCcCCCCCcCHHHHHHH
Confidence 999999998654211 1223457889999999864 56899999999999999999955 47754322 1222222
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
........++.++.++.+++.+||..||.+|| +++++++|+|.
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 211 TLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred hhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 22223345667889999999999999999999 69999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=322.07 Aligned_cols=253 Identities=27% Similarity=0.438 Sum_probs=213.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+-+.++..||.|+||+||+|..+ .++...|-|++... ++...++|.-||+||+..+||+||+|++.|...+.++
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nk-----et~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNK-----ETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcc-----cchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 34677888999999999999743 45556677777543 3445678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|+.|||+||-....+- .-...|++.++.-+++|++.+|.|||+++|||||||+.|||++-+
T Consensus 106 iliEFC~GGAVDaiml-------------------EL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIML-------------------ELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred EEEeecCCchHhHHHH-------------------HhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 9999999998887664 234578999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|.++|+|||.+..... .........||+.|||||+.. ...|+.++||||||++|.||.. ..+|-...++-.+
T Consensus 167 GdirLADFGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAq-iEPPHhelnpMRV 243 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQ-IEPPHHELNPMRV 243 (1187)
T ss_pred CcEeeecccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhc-cCCCccccchHHH
Confidence 9999999999864321 122334567899999999875 4589999999999999999997 5578888888888
Q ss_pred HHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+-.|..... +-.|..++..+.+++.+||.+||..||++.+|++|+|
T Consensus 244 llKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 244 LLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred HHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcc
Confidence 777765543 3456789999999999999999999999999999876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=297.36 Aligned_cols=245 Identities=23% Similarity=0.342 Sum_probs=199.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHH-HhhCCCCccceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACL-LAEFDHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~i-l~~l~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
+.||+|+||.||+|... .+++.||+|.++.... ......+..|..+ ....+|+||+++++++..++..++|+
T Consensus 2 ~~l~~g~~~~v~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKR-----STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEec-----CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 46899999999999863 3557899999865321 1222334455444 45568999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcE
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~v 527 (653)
||+++++|.++++. ...++...+..++.||+.||.|||+.+++|+||+|+||++++++.+
T Consensus 77 e~~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~ 136 (260)
T cd05611 77 EYLNGGDCASLIKT--------------------LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHL 136 (260)
T ss_pred eccCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcE
Confidence 99999999999862 2357889999999999999999999999999999999999999999
Q ss_pred EEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Q psy5539 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607 (653)
Q Consensus 528 kI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~ 607 (653)
||+|||+++.... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...+..++...+..+.
T Consensus 137 ~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~-g~~p~~~~~~~~~~~~~~~~~ 209 (260)
T cd05611 137 KLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF-GYPPFHAETPDAVFDNILSRR 209 (260)
T ss_pred EEeecccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHHhcc
Confidence 9999999875422 223456778999999998889999999999999999999 456898888888777776654
Q ss_pred cc---CCCCCCcHHHHHHHHHhhccCCCCCC---CHHHHHHHHHHH
Q psy5539 608 IL---QAPDNTPDALYDLMKLCWNMKPMNRP---SFRTIYQTLWNI 647 (653)
Q Consensus 608 ~~---~~~~~~~~~l~~li~~cl~~dP~~RP---s~~eil~~L~~l 647 (653)
.. .....++.++.+++.+||+.+|++|| ++++++.+.|-.
T Consensus 210 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~ 255 (260)
T cd05611 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFK 255 (260)
T ss_pred cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhh
Confidence 32 12235789999999999999999999 457888887653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=302.10 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=213.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGK 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~ 441 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|++.... .......+.+|++++++++ |+||+++++++..++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEK-----ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEc-----CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 46889999999999999999864 356889999987532 2334567889999999998 999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|.++++. ...+++..++.++.|++.||.|||+.+++|+||+|+||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i 135 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRK--------------------YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL 135 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence 99999999999999999962 2368999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccc------------------cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYY------------------KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~------------------~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~el 583 (653)
+.++.++|+|||++......... .......++..|+|||......++.++||||||++++++
T Consensus 136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l 215 (280)
T cd05581 136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQM 215 (280)
T ss_pred CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHH
Confidence 99999999999998765432211 111223457889999999988899999999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHHHH
Q psy5539 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF----RTIYQTLW 645 (653)
Q Consensus 584 lt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~ 645 (653)
++ +..||...+.......+.... ...+...+..+.+++.+||+.+|.+||++ ++++++.|
T Consensus 216 ~~-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~ 279 (280)
T cd05581 216 LT-GKPPFRGSNEYLTFQKILKLE-YSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279 (280)
T ss_pred Hh-CCCCCCCccHHHHHHHHHhcC-CCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence 99 556888777666666665433 34667789999999999999999999999 99988764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=305.13 Aligned_cols=253 Identities=25% Similarity=0.374 Sum_probs=200.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC--C
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--K 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~ 441 (653)
++|++.+.||+|+||.||+|+.. .+++.+++|.++.... +.....+.+|+.++++++||||+++++++... .
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDK-----KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD 79 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEEC-----CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCC
Confidence 46788899999999999999864 3467899999875432 22334567899999999999999999998776 8
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||++ ++|.+++... ...+++..++.++.||+.||+|||+.+++|+||||+|||+
T Consensus 80 ~~~lv~e~~~-~~L~~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 80 KIYMVMEYVE-HDLKSLMETM-------------------KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred cEEEEehhcC-cCHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 8999999997 4999988621 1358999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++++.+||+|||++....... .......++..|+|||.+.+.. ++.++|+||||+++|||++| .+||...+..+..
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~~f~~~~~~~~~ 216 (293)
T cd07843 140 NNRGILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTK-KPLFPGKSEIDQL 216 (293)
T ss_pred CCCCcEEEeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhC-CCCCCCCChHHHH
Confidence 999999999999987653321 1122344577899999987654 68999999999999999995 5588776655544
Q ss_pred HHHHcCC---------------------c---------cCCCCC-CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEGN---------------------I---------LQAPDN-TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~---------------------~---------~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.... . ...+.. .+..+.+++++||+.+|++|||+.|++++.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~ 292 (293)
T cd07843 217 NKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292 (293)
T ss_pred HHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence 4332110 0 001112 4788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=300.82 Aligned_cols=252 Identities=28% Similarity=0.414 Sum_probs=201.1
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--Cce
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--KPM 443 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~~~ 443 (653)
|++.+.||+|+||.||+|+.. .++..+|+|.++... .......+.+|+++++.++|+|++++++++... +..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNK-----KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSI 75 (287)
T ss_pred CeeeEEeccCCCeEEEEEEEC-----CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcE
Confidence 467889999999999999864 346789999998653 233445688999999999999999999999887 899
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+++ +|.+++.. ....+++..++.++.||+.||+|||+.+++|+||+|+||++++
T Consensus 76 ~lv~e~~~~-~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~ 135 (287)
T cd07840 76 YMVFEYMDH-DLTGLLDS-------------------PEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINN 135 (287)
T ss_pred EEEeccccc-cHHHHHhc-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcC
Confidence 999999975 89888751 1145889999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++| ..||...+..+....
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~-~~p~~~~~~~~~~~~ 213 (287)
T cd07840 136 DGVLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG-KPIFQGSTELEQLEK 213 (287)
T ss_pred CCCEEEccccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Confidence 99999999999976543321 11233455778999998765 4678999999999999999996 568877766554444
Q ss_pred HHcCCcc-----------------------------C-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNIL-----------------------------Q-APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~-----------------------------~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+.... . ....++..+.+++++||+.+|.+||++++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~ 286 (287)
T cd07840 214 IFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286 (287)
T ss_pred HHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence 3321000 0 00113788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=298.52 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=205.8
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+|.+.+.||+|+||.||+++.... .......++|.+... ........+.+|+.++++++||||+++++++......+
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKA--VAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFC 78 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCC--CCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceE
Confidence 467889999999999999986431 112223333333221 12222345778999999999999999999999888999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+|+||+++++|.+++.... .....+++..++.++.|++.||.|||+++++|+||+|+||++++
T Consensus 79 lv~e~~~~~~l~~~~~~~~----------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~- 141 (260)
T cd08222 79 IITEYCEGRDLDCKLEELK----------------HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN- 141 (260)
T ss_pred EEEEeCCCCCHHHHHHHHh----------------hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-
Confidence 9999999999999986321 12346899999999999999999999999999999999999976
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.++|+|||++........ ......++..|+|||.+.+..++.++||||||+++|+|+++. .|+......+....+.
T Consensus 142 ~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~-~~~~~~~~~~~~~~~~ 218 (260)
T cd08222 142 NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA-HAFEGQNFLSVVLRIV 218 (260)
T ss_pred CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC-CCCCCccHHHHHHHHH
Confidence 5699999999876532221 122334677899999998888999999999999999999955 4777777777777776
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.....+...+.++.++|.+||..+|++||++.+++++.|
T Consensus 219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 259 (260)
T cd08222 219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF 259 (260)
T ss_pred cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence 77666667778899999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.24 Aligned_cols=257 Identities=23% Similarity=0.351 Sum_probs=198.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|... .+++.||||.++.... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~-----~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 75 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDK-----NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEK 75 (295)
T ss_pred CCceEeeEecccCCeEEEEEEEC-----CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCC
Confidence 36888999999999999999864 3567899998865422 223356788999999995 6999999999876655
Q ss_pred -----eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 443 -----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 443 -----~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.++||||+++ +|.+++..... .....+++..++.++.||+.||.|||+++|+||||||+
T Consensus 76 ~~~~~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~ 139 (295)
T cd07837 76 NGKPSLYLVFEYLDS-DLKKFMDSNGR---------------GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQ 139 (295)
T ss_pred CCCceEEEEeeccCc-CHHHHHHHhcc---------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChH
Confidence 8999999985 89998863211 11245799999999999999999999999999999999
Q ss_pred CEeEcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 518 NCLIND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 518 NILl~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||+++. ++.+||+|||+++...... .......+++.|+|||.+.+ ..++.++||||||+++|||++|. +||.+.+
T Consensus 140 nil~~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~~~~~~~ 216 (295)
T cd07837 140 NLLVDKQKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ-PLFPGDS 216 (295)
T ss_pred HEEEecCCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCC-CCCCCCC
Confidence 999998 8999999999987542211 11123345778999998865 45799999999999999999964 5877665
Q ss_pred HHHHHHHHHcC----C---------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEG----N---------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~----~---------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+... . .. ...+..+.++.+++.+||..+|.+||++++++.+.|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~ 293 (295)
T cd07837 217 ELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293 (295)
T ss_pred HHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence 43322222110 0 00 001346788999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=352.33 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=189.5
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.+...+.||+|+||.||+|+.. .++..||||+++.... ....|++.+++++|||||+++|++...+..++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~l 760 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSI-----KNGMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYL 760 (968)
T ss_pred hCCcccEEccCCCeeEEEEEEC-----CCCcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEE
Confidence 3455677999999999999863 3567899999875332 12356889999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh---hCCceecCCCCCCEeEc
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS---DRKFVHRDLATRNCLIN 522 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH---~~~ivHrDLkp~NILl~ 522 (653)
||||+++|+|.++++ .++|..+.+|+.|||+||+||| +.+|+||||||+||+++
T Consensus 761 v~Ey~~~g~L~~~l~-----------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~ 817 (968)
T PLN00113 761 IHEYIEGKNLSEVLR-----------------------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817 (968)
T ss_pred EEeCCCCCcHHHHHh-----------------------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEEC
Confidence 999999999999985 2688999999999999999999 66999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--HHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT--HEEVV 600 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~--~~e~~ 600 (653)
.++.+++. ||...... ......++..|||||++.+..++.++|||||||++|||++|.. ||.... ...+.
T Consensus 818 ~~~~~~~~-~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~-p~~~~~~~~~~~~ 889 (968)
T PLN00113 818 GKDEPHLR-LSLPGLLC------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKS-PADAEFGVHGSIV 889 (968)
T ss_pred CCCceEEE-eccccccc------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCC-CCCcccCCCCcHH
Confidence 99988875 66654321 1223367889999999999999999999999999999999665 653211 11111
Q ss_pred HHHH------------cCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 601 KYIK------------EGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 601 ~~i~------------~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+..+ +..... .+.....++.+++.+||+.+|++|||++++++.|+.+.+
T Consensus 890 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 890 EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1111 000000 011122467789999999999999999999999988755
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=303.78 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=196.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC--
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK-- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-- 441 (653)
++|.+.+.||+|+||.||+|+.. .++..||||.+.... .+.....+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHK-----KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEEC-----CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 47899999999999999999864 356899999886432 2222345678999999999999999999986544
Q ss_pred ------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 442 ------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 442 ------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
..++||||+.+ +|.+++.. ....+++.+++.++.||+.||+|||+++++|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~-------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~ 146 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSN-------------------KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMK 146 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHh-------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 45999999964 88888751 12358899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccc--cCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|+||++++++.+||+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|||++| .+||.
T Consensus 147 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~-~~~~~ 225 (310)
T cd07865 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQ 225 (310)
T ss_pred HHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhC-CCCCC
Confidence 99999999999999999999765332211 1112334677899999887654 78999999999999999994 56887
Q ss_pred CCCHHHHHHHHHc--CCc----------------cCCC-------------CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 593 GLTHEEVVKYIKE--GNI----------------LQAP-------------DNTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 593 ~~~~~e~~~~i~~--~~~----------------~~~~-------------~~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
+.+.......+.. +.. ...+ ...+..+.+++.+||..+|.+|||+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l 305 (310)
T cd07865 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTAL 305 (310)
T ss_pred CCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHh
Confidence 7665443332222 000 0000 11246678999999999999999999999
Q ss_pred HHHH
Q psy5539 642 QTLW 645 (653)
Q Consensus 642 ~~L~ 645 (653)
++.|
T Consensus 306 ~h~~ 309 (310)
T cd07865 306 NHDF 309 (310)
T ss_pred cCCC
Confidence 8765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.59 Aligned_cols=251 Identities=23% Similarity=0.262 Sum_probs=198.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|+..+.||+|+||.||+|+.. .++..||||.++.. ........+.+|+.++++++|+||+++++++...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDT-----VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEEC-----CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCC
Confidence 467899999999999999999863 35678999998643 2333445677899999999999999999988643
Q ss_pred ----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 441 ----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 441 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...++||||+. ++|.+++. ..++...+..++.|++.||+|||+.+|+||||||
T Consensus 90 ~~~~~~~~lv~e~~~-~~l~~~~~----------------------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (353)
T cd07850 90 LEEFQDVYLVMELMD-ANLCQVIQ----------------------MDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 146 (353)
T ss_pred ccccCcEEEEEeccC-CCHHHHHh----------------------hcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 35799999996 58888775 1278888999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|+|++|. .||...+.
T Consensus 147 ~Nil~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~-~pf~~~~~ 222 (353)
T cd07850 147 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT-VLFPGTDH 222 (353)
T ss_pred HHEEECCCCCEEEccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCC-CCCCCCCH
Confidence 99999999999999999997653221 122335678899999999999999999999999999999955 47766554
Q ss_pred HHHHHHHHc-----------------------CCcc-------------------CCCCCCcHHHHHHHHHhhccCCCCC
Q psy5539 597 EEVVKYIKE-----------------------GNIL-------------------QAPDNTPDALYDLMKLCWNMKPMNR 634 (653)
Q Consensus 597 ~e~~~~i~~-----------------------~~~~-------------------~~~~~~~~~l~~li~~cl~~dP~~R 634 (653)
.+....+.. .... ..+...+..+.+++.+||+.||++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 302 (353)
T cd07850 223 IDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKR 302 (353)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhC
Confidence 332222211 0000 0011245678999999999999999
Q ss_pred CCHHHHHHHHHH
Q psy5539 635 PSFRTIYQTLWN 646 (653)
Q Consensus 635 Ps~~eil~~L~~ 646 (653)
||+.+++++.|-
T Consensus 303 ~t~~eiL~~~~~ 314 (353)
T cd07850 303 ISVDDALQHPYI 314 (353)
T ss_pred cCHHHHhcChhH
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=304.88 Aligned_cols=253 Identities=22% Similarity=0.411 Sum_probs=205.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.+.|...+.||+|+||.||+|+.. .++..+|+|.+... .......++.+|+++++.++|+|++++++++....
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 88 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEc-----CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence 345677788999999999999864 34578999988632 23334456889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+++||||+|+|||+
T Consensus 89 ~~~lv~e~~~-~~l~~~~~~-------------------~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~ 148 (308)
T cd06634 89 TAWLVMEYCL-GSASDLLEV-------------------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148 (308)
T ss_pred eeEEEEEccC-CCHHHHHHH-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE
Confidence 9999999996 688887751 12347889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
++++.++|+|||++..... .....++..|+|||.+. .+.++.++||||||+++|||++|. .|+...+..+
T Consensus 149 ~~~~~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~~~~~~ 221 (308)
T cd06634 149 SEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNAMS 221 (308)
T ss_pred CCCCcEEECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCC-CCCccccHHH
Confidence 9999999999999875422 22345677899999975 356889999999999999999955 5777766655
Q ss_pred HHHHHHcCCccC-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQ-APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 599 ~~~~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
....+..+.... .....+..+.+++.+||+.+|.+||++.+++++.|.+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred HHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 555555444332 23467888999999999999999999999999887543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=304.42 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=201.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
...++|++.+.||+|+||.||+|... .+++.||+|.++... .......+.+|++++++++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~ 78 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDK-----DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDK 78 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEEC-----CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCc
Confidence 34567889999999999999999974 345789999987542 222335678899999999999999999998765
Q ss_pred C----------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 441 K----------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 441 ~----------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
. ..++|+||+++ +|.+++.. ....+++..+..++.||+.||+|||+.+|+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~ 138 (302)
T cd07864 79 QDALDFKKDKGAFYLVFEYMDH-DLMGLLES-------------------GLVHFSEDHIKSFMKQLLEGLNYCHKKNFL 138 (302)
T ss_pred chhhhccccCCcEEEEEcccCc-cHHHHHhc-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4 78999999976 77777651 124589999999999999999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
|+||||+||++++++.+||+|||++........ ........+..|+|||.+.+. .++.++||||||+++|||++| .+
T Consensus 139 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g-~~ 216 (302)
T cd07864 139 HRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTK-KP 216 (302)
T ss_pred cCCCCHHHEEECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhC-CC
Confidence 999999999999999999999999976533221 112223456789999988654 578999999999999999995 56
Q ss_pred CCCCCCHHHHHHHHHcC---Ccc--------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEG---NIL--------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~---~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
||...+..+....+... ... .....++..+.+++..||+.+|.+||++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 88766655444333221 000 0112467899999999999999999999999
Q ss_pred HHHHH
Q psy5539 641 YQTLW 645 (653)
Q Consensus 641 l~~L~ 645 (653)
+++.|
T Consensus 297 l~~~~ 301 (302)
T cd07864 297 LNSPW 301 (302)
T ss_pred hcCCC
Confidence 88754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=299.07 Aligned_cols=258 Identities=15% Similarity=0.256 Sum_probs=188.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHH----------HHHHHHHHHHHhhCCCCcc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL----------QTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~----------~~~f~~Ei~il~~l~HpnI 430 (653)
++..++|++.+.||+|+||+||+|+..+. ......+|+|.......... ......+...+..++|+|+
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~--~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASD--HCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCC--cccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 45557899999999999999999987431 11235567775432211100 0112233445667799999
Q ss_pred ceEEeEEecCC----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5539 431 VKLLGVCAVGK----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD 506 (653)
Q Consensus 431 v~l~g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 506 (653)
+++++.+.... ..++++|+... ++.+.+.. ....++..+..|+.|++.||+|||+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~ 144 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR--------------------IKCKNKKLIKNIMKDMLTTLEYIHE 144 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh--------------------hccCCHHHHHHHHHHHHHHHHHHHh
Confidence 99998765433 34677777643 66666541 1234677889999999999999999
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHH
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLW 581 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ 581 (653)
.+|+||||||+|||+++++.++|+|||+|+........ .......+|+.|+|||.+.+..++.++||||||+++|
T Consensus 145 ~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~ 224 (294)
T PHA02882 145 HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCML 224 (294)
T ss_pred CCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999999999999999765322111 1112245889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCC-HHH--------HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 582 EIFSFALQPYYGLT-HEE--------VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 582 ellt~~~~p~~~~~-~~e--------~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
||++| ..||.+.. ..+ ....+..+.. .....+..+.+++..||..+|++||++.+|.+.+
T Consensus 225 el~~g-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 225 KWAGI-KLPWKGFGHNGNLIHAAKCDFIKRLHEGKI--KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhC-CCCCCccccchHHHHHhHHHHHHHhhhhhh--ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 99995 56887763 222 2333333332 2345788999999999999999999999998765
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=299.09 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=199.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|++|.||+|+.. .+++.||+|.++.... ....+.+.+|++++++++|+||+++++++..+...
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDR-----VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEec-----CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeE
Confidence 47889999999999999999863 3567899999864322 23345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||++ ++|.+++... ....+++..+..++.||+.||+|||+++++|+||+|+||++++
T Consensus 77 ~lv~e~~~-~~l~~~~~~~------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~ 137 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSS------------------PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDR 137 (294)
T ss_pred EEEEeccc-ccHHHHHHhC------------------CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEEC
Confidence 99999996 5888887521 1123577888899999999999999999999999999999985
Q ss_pred -CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 -QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 -~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++.+||+|||++...... ........++..|+|||.+.+. .++.++||||||+++|+|++| .+||...+..+...
T Consensus 138 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg-~~pf~~~~~~~~~~ 214 (294)
T PLN00009 138 RTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ-KPLFPGDSEIDELF 214 (294)
T ss_pred CCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Confidence 567999999999754221 1111233557889999988764 578999999999999999995 56887665544333
Q ss_pred HHHc--CC------------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKE--GN------------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~--~~------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.. +. .. ......+.++.+++.+|++.+|++||++.+++++.|-
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~ 287 (294)
T PLN00009 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF 287 (294)
T ss_pred HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence 2211 00 00 0123467889999999999999999999999998764
|
|
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=305.88 Aligned_cols=251 Identities=24% Similarity=0.338 Sum_probs=217.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
-|.+.+.||+|-|+.|-+|++ -.+|..||||++.+.. .......+.+|++-|+.++|||||+||.+......+|
T Consensus 19 LYDLekTlG~GHFAVVKLArH-----VFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKly 93 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARH-----VFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLY 93 (864)
T ss_pred eehhhhhhcCCceehhhhhhh-----hcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEE
Confidence 366778899999999999874 4678899999996542 2334456789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC-
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND- 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~- 523 (653)
||+|.-.+|||++|+-.+ ...+.+..+.+++.||+.++.|+|+..+|||||||+||.+.+
T Consensus 94 LiLELGD~GDl~DyImKH-------------------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK 154 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKH-------------------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK 154 (864)
T ss_pred EEEEecCCchHHHHHHhh-------------------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee
Confidence 999999999999999632 356889999999999999999999999999999999998864
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
-|-|||.|||++-.+..... -+...|+..|-|||.+.+..|+ ++.||||||||||.|.+ |.+||+..+..|.+-+
T Consensus 155 lGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC-Gq~PFqeANDSETLTm 230 (864)
T KOG4717|consen 155 LGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC-GQPPFQEANDSETLTM 230 (864)
T ss_pred cCceEeeeccccccCCCcch---hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh-CCCccccccchhhhhh
Confidence 58999999999865533322 2345678899999999999987 78999999999999998 5679999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.+-.. ..|..++.+.++||..||..||.+|.+.++|..+.|
T Consensus 231 ImDCKY-tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~W 272 (864)
T KOG4717|consen 231 IMDCKY-TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSW 272 (864)
T ss_pred hhcccc-cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcccc
Confidence 988764 578899999999999999999999999999998876
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.17 Aligned_cols=248 Identities=20% Similarity=0.355 Sum_probs=206.4
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEee
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
...||+|+||.||++... .++..||||.+.... ......+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 25 ~~~lg~g~~g~v~~~~~~-----~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 25 FIKIGEGSTGIVCIATVK-----SSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred HHHcCCCCCeEEEEEEEc-----CCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 356999999999999863 356899999886433 33456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEE
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI 529 (653)
+++++|.+++. ...+++..+..++.|++.||+|||+.+++|+||+|+||++++++.++|
T Consensus 99 ~~~~~L~~~~~---------------------~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l 157 (292)
T cd06657 99 LEGGALTDIVT---------------------HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKL 157 (292)
T ss_pred CCCCcHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEE
Confidence 99999999874 124688899999999999999999999999999999999999999999
Q ss_pred eccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc-
Q psy5539 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI- 608 (653)
Q Consensus 530 ~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~- 608 (653)
+|||++....... .......++..|+|||.+....++.++||||||+++|||++|. .||.+....+....+.....
T Consensus 158 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~-~p~~~~~~~~~~~~~~~~~~~ 234 (292)
T cd06657 158 SDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE-PPYFNEPPLKAMKMIRDNLPP 234 (292)
T ss_pred cccccceeccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHhhCCc
Confidence 9999987543221 1122345678899999998888999999999999999999955 58877777666666554322
Q ss_pred -cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 609 -LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 609 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.......+..+.+++.+||+.+|.+||++.+++++.|-.
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~ 274 (292)
T cd06657 235 KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 274 (292)
T ss_pred ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHh
Confidence 223345788999999999999999999999999987644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=300.73 Aligned_cols=252 Identities=25% Similarity=0.415 Sum_probs=198.3
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
|++.+.||+|++|.||+|... .++..||+|+++.... ......+.+|++++++++||||+++++++..++..++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDK-----LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEc-----CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEE
Confidence 456788999999999999864 3568899999874422 2233567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
+|||++ ++|.+++.... ...+++..++.++.|++.||+|||+++++|+||+|+||++++++
T Consensus 76 v~e~~~-~~l~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~ 136 (283)
T cd07835 76 VFEFLD-LDLKKYMDSSP------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG 136 (283)
T ss_pred EEeccC-cCHHHHHhhCC------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 999995 68999986211 13589999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
.++|+|||++....... .......++..|+|||.+.+. .++.++||||||+++|||++|. +||.+.+..+....+.
T Consensus 137 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 137 ALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIF 213 (283)
T ss_pred cEEEeecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHH
Confidence 99999999987542221 111223457789999988765 5789999999999999999965 5776655432221111
Q ss_pred cC----------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EG----------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+. .........+..+.+++.+||+.+|.+|||+++++++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~ 282 (283)
T cd07835 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282 (283)
T ss_pred HHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence 10 001112456788999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.53 Aligned_cols=251 Identities=20% Similarity=0.344 Sum_probs=195.1
Q ss_pred eeccc--CCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEe
Q psy5539 372 DLGQG--AFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 372 ~LG~G--~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~E 448 (653)
.||+| +||+||+|++. .+++.||+|.++... .....+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e 79 (328)
T cd08226 5 EIGRGFCNLTSVYLARHT-----PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79 (328)
T ss_pred HhCCcccCceeEEEEEEc-----CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEe
Confidence 46666 99999999853 456899999987532 33445688999999999999999999999999999999999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEE
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vk 528 (653)
|+.+|+|.++++... ...+++..+..++.|++.||+|||+.+++||||||+|||++.++.++
T Consensus 80 ~~~~~~l~~~l~~~~------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~ 141 (328)
T cd08226 80 FMAYGSANSLLKTYF------------------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVS 141 (328)
T ss_pred cccCCCHHHHHHhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEE
Confidence 999999999987322 13478899999999999999999999999999999999999999999
Q ss_pred EeccCccccccccccc-----cCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 529 IADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 529 I~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++||+.+......... .......++..|||||.+.+. .++.++||||||+++|||++|. .||.+....+...
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~-~p~~~~~~~~~~~ 220 (328)
T cd08226 142 LSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR-VPFQDMLRTQMLL 220 (328)
T ss_pred EechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCcChHHHHH
Confidence 9999865433211110 011112345679999998764 4789999999999999999955 5887665444332
Q ss_pred HHHcCCc----------------------------------------------cCCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 602 YIKEGNI----------------------------------------------LQAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 602 ~i~~~~~----------------------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
....+.. ...+...+..+.+|+++||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 2221110 001123557799999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
|+.+++++.|-
T Consensus 301 ta~e~l~~~~~ 311 (328)
T cd08226 301 SASSLLSHAFF 311 (328)
T ss_pred CHHHHhhCHHH
Confidence 99999998874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=291.10 Aligned_cols=256 Identities=25% Similarity=0.371 Sum_probs=219.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+.-++|.+++.||+|.||+|-+++- +.+++.+|+|+++++.- .+...--..|-++|..-+||.+..|--.+.
T Consensus 164 kvTm~dFdfLKvLGkGTFGKVIL~rE-----Kat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFDFLKVLGKGTFGKVILCRE-----KATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhhHHHHhcCCccceEEEEee-----cccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 45567899999999999999999984 45789999999987632 222223456889999999999999988889
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+.+|+||||+.||.|.-+|.+ ...+++.....+...|+.||.|||+++||.||||.+|
T Consensus 239 t~drlCFVMeyanGGeLf~HLsr--------------------er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLEN 298 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSR--------------------ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLEN 298 (516)
T ss_pred cCceEEEEEEEccCceEeeehhh--------------------hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhh
Confidence 99999999999999999888752 2457778888899999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
.|+|.+|.+||+||||.+.-.. +........||+.|.|||++..+.|..+.|.|.+||++|||++|.+ ||+..+++.
T Consensus 299 LlLDkDGHIKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRL-PFyn~dh~k 375 (516)
T KOG0690|consen 299 LLLDKDGHIKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRL-PFYNKDHEK 375 (516)
T ss_pred heeccCCceEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccC-cccccchhH
Confidence 9999999999999999975422 1233455789999999999999999999999999999999999665 999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+++.|.... +.+|..++++.+.|+...+.+||.+|. .+.||.++-+
T Consensus 376 LFeLIl~ed-~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~F 426 (516)
T KOG0690|consen 376 LFELILMED-LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRF 426 (516)
T ss_pred HHHHHHhhh-ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhh
Confidence 999998876 478899999999999999999999997 5677777654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=296.55 Aligned_cols=244 Identities=20% Similarity=0.279 Sum_probs=193.4
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHH---HHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREA---CLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei---~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
.||+|+||.||+|+.. .+++.||+|.+...... .....+..|. .+++...||||+++++++...+..++|
T Consensus 1 ~ig~g~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEe-----cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEE
Confidence 3799999999999863 35678999988643211 1112233333 445556899999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
|||+++|+|.+++. ....+++..+..++.|++.||.|||+.+++||||||+||++++++.
T Consensus 76 ~e~~~g~~L~~~l~--------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~ 135 (278)
T cd05606 76 LDLMNGGDLHYHLS--------------------QHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 135 (278)
T ss_pred EecCCCCcHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC
Confidence 99999999999885 1245899999999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGL---THEEVVKY 602 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~---~~~e~~~~ 602 (653)
+||+|||++...... ......++..|+|||.+..+ .++.++||||+|+++|||++|. .||.+. ...+....
T Consensus 136 ~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~-~p~~~~~~~~~~~~~~~ 210 (278)
T cd05606 136 VRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH-SPFRQHKTKDKHEIDRM 210 (278)
T ss_pred EEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCC-CCCCCCCccchHHHHHH
Confidence 999999998754322 12234578899999998755 6899999999999999999955 477655 33333332
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
+ .......+...+.++.+++.+|+..+|.+|| ++.+++++.|-
T Consensus 211 ~-~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~ 258 (278)
T cd05606 211 T-LTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258 (278)
T ss_pred h-hccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccc
Confidence 2 2223455667789999999999999999999 99999988753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=302.90 Aligned_cols=260 Identities=24% Similarity=0.367 Sum_probs=198.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--C
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--K 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--~ 441 (653)
.|.+.+.||+|+||.||+|+... ...+..||+|.++... .......+.+|+.++++++||||+++++++... .
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKN---GKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecC---CCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCc
Confidence 36788899999999999999642 1256899999997632 122334678899999999999999999999887 7
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++ +|.+++..... .....+++..++.++.||+.||+|||+.+|+||||||+|||+
T Consensus 78 ~~~lv~e~~~~-~l~~~~~~~~~---------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~ 141 (316)
T cd07842 78 SVYLLFDYAEH-DLWQIIKFHRQ---------------AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141 (316)
T ss_pred eEEEEEeCCCc-CHHHHHHhhcc---------------CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE
Confidence 89999999975 78777753221 112468899999999999999999999999999999999999
Q ss_pred cC----CCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 522 ND----QMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 522 ~~----~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+. ++.+||+|||++........ ........++..|+|||.+.+. .++.++||||||++++||++| .+||.+..
T Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~-~~~~~~~~ 220 (316)
T cd07842 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTL-EPIFKGRE 220 (316)
T ss_pred cCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhc-CCCCcCCc
Confidence 99 99999999999976532221 1122234567889999988764 589999999999999999995 45776543
Q ss_pred HHH-------------HHHHH---------------------HcCCccCCC-----------CCCcHHHHHHHHHhhccC
Q psy5539 596 HEE-------------VVKYI---------------------KEGNILQAP-----------DNTPDALYDLMKLCWNMK 630 (653)
Q Consensus 596 ~~e-------------~~~~i---------------------~~~~~~~~~-----------~~~~~~l~~li~~cl~~d 630 (653)
... ++..+ ........+ ...+.++.+++.+||+.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 300 (316)
T cd07842 221 AKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYD 300 (316)
T ss_pred ccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCC
Confidence 221 11100 000001111 145678999999999999
Q ss_pred CCCCCCHHHHHHHHH
Q psy5539 631 PMNRPSFRTIYQTLW 645 (653)
Q Consensus 631 P~~RPs~~eil~~L~ 645 (653)
|++|||+.+++++.|
T Consensus 301 P~~Rps~~eil~~~~ 315 (316)
T cd07842 301 PTKRITAEEALEHPY 315 (316)
T ss_pred cccCcCHHHHhcCCC
Confidence 999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.08 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=198.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
++|.+.+.||+|+||+||+|+.. .++..||||.++... .......+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~ 79 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNS-----ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHRE 79 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEec-----CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheeccccc
Confidence 46889999999999999999853 456899999987532 222334677899999999999999999987543
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++|+||+. ++|.+++. ....+++..+..++.|++.||.|||+++++||||||+|
T Consensus 80 ~~~~~~lv~e~~~-~~L~~~~~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~N 138 (337)
T cd07858 80 AFNDVYIVYELMD-TDLHQIIR--------------------SSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSN 138 (337)
T ss_pred ccCcEEEEEeCCC-CCHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 35799999996 68988885 22458899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|+++.++.+||+|||++....... .......++..|+|||.+.. ..++.++||||||+++|+|++| .+||.+.+..
T Consensus 139 il~~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~ 215 (337)
T cd07858 139 LLLNANCDLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR-KPLFPGKDYV 215 (337)
T ss_pred EEEcCCCCEEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC-CCCCCCCChH
Confidence 999999999999999997653221 11123346778999998875 4689999999999999999985 5688765543
Q ss_pred HHHHHHHc------------------------C------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKE------------------------G------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~------------------------~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+.. . ......+.++.++.+++++||+.+|++|||+++++++.|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~ 294 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence 32221110 0 0001123577889999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=297.11 Aligned_cols=254 Identities=21% Similarity=0.312 Sum_probs=201.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGK 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 441 (653)
+|++.+.||+|+||.||+++..+ ...++..||||.++... .....+.+.+|+.++.++ +||||+++++.+..+.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~--~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVG--GHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEec--cccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCC
Confidence 36788999999999999998643 23456789999987432 123345688999999999 5999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.. ...+++..+..++.|+++||.|||+.+++|+||+|+||++
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~ 138 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQ--------------------REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138 (288)
T ss_pred EEEEEEecCCCCcHHHHHhh--------------------cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 99999999999999999851 2347888999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCC----C
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGL----T 595 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~t~ksDVwSlGvvl~ellt~~~~p~~~~----~ 595 (653)
++++.++|+|||+++....... .......++..|+|||.+.+.. .+.++||||||+++|||++|. .||... .
T Consensus 139 ~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~-~p~~~~~~~~~ 216 (288)
T cd05583 139 DSEGHVVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGA-SPFTVDGEQNS 216 (288)
T ss_pred CCCCCEEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCC-CCcccCcccch
Confidence 9999999999999876533221 1112234678899999987765 789999999999999999955 466432 2
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH---HHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI---YQTL 644 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei---l~~L 644 (653)
..++.+.+.... ...+..++..+.+++.+||+.+|++|||+.++ ++++
T Consensus 217 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 217 QSEISRRILKSK-PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHHHHHHccC-CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 334444443332 34566688999999999999999999996554 5554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.67 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=219.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
....|.+...||+|.|++|.+|+.. .++..||||.+.+... ....+.+.+|+++|..|+|||||+++.+.....
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~-----~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHI-----LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEec-----CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 3457889999999999999999964 3568899999976543 233445889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.+++||||+.+|.+.+||..+ +.+.+..+..++.|+.++++|||++.|+|||||++||||
T Consensus 129 ~lylV~eya~~ge~~~yl~~~--------------------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL 188 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKH--------------------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL 188 (596)
T ss_pred eeEEEEEeccCchhHHHHHhc--------------------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc
Confidence 999999999999999999733 345567888999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+.++++||+|||++..+.... ......|++.|.|||.+.+..| .++.|+||+|++||-|++|.+ ||.+.+..++.
T Consensus 189 ~~~mnikIaDfgfS~~~~~~~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL-PFDG~~lk~Lr 264 (596)
T KOG0586|consen 189 DENMNIKIADFGFSTFFDYGL---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL-PFDGQNLKELR 264 (596)
T ss_pred ccccceeeeccccceeecccc---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc-ccCCccccccc
Confidence 999999999999998764222 2345678889999999998877 489999999999999999655 99999988888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+..+.+ ..|...+.+..+++++++-.+|.+|+++++|.++-|.
T Consensus 265 ~rvl~gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~ 309 (596)
T KOG0586|consen 265 PRVLRGKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWR 309 (596)
T ss_pred chheeeee-cccceeechhHHHHHHhhccCccccCCHHHhhhhccc
Confidence 87777764 4566677889999999999999999999999988763
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=299.61 Aligned_cols=247 Identities=23% Similarity=0.427 Sum_probs=200.0
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
|...+.||+|+||+||+|+.. .++..|++|.+.... .......+.+|+++++.++|||++++++++..+...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~-----~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNS-----HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEEC-----CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence 455677999999999999863 356789999986432 2334456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+. |+|.+++.. ....+++.+++.++.||+.||.|||+.+++|+||+|+||+++++
T Consensus 98 lv~e~~~-~~l~~~l~~-------------------~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~ 157 (313)
T cd06633 98 LVMEYCL-GSASDLLEV-------------------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 157 (313)
T ss_pred EEEecCC-CCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCC
Confidence 9999996 588887752 12457899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.+||+|||++.... ......++..|+|||.+. ...++.++||||||+++|||++|. .|+.+.+......
T Consensus 158 ~~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~-~p~~~~~~~~~~~ 230 (313)
T cd06633 158 GQVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNAMSALY 230 (313)
T ss_pred CCEEEeecCCCcccC------CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCChHHHHH
Confidence 999999999986431 122345678899999974 456889999999999999999965 4777666555444
Q ss_pred HHHcCCccC-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNILQ-APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....... ....++..+.+++.+||+.+|.+||++.+++++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 231 HIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred HHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 444433222 23456788999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=297.02 Aligned_cols=255 Identities=20% Similarity=0.304 Sum_probs=203.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---HHHHHHHHHHHHHHhhC-CCCccceEEeEEecCC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---EYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGK 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 441 (653)
+|++.+.||+|+||.||+|+... ...++..||+|+++.... ....+.+.+|+.++.++ +|+||+++++.+..+.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~--~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVS--GHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEecc--CCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCC
Confidence 36788999999999999998643 224568899999875321 22345678999999999 5999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+|||+
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~ 138 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQ--------------------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL 138 (290)
T ss_pred eEEEEEecCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE
Confidence 99999999999999999862 2347788999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC----C
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGL----T 595 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~----~ 595 (653)
++++.+||+|||+++....... .......++..|+|||.+... .++.++||||||+++|+|++|. .||... .
T Consensus 139 ~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~-~p~~~~~~~~~ 216 (290)
T cd05613 139 DSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGA-SPFTVDGEKNS 216 (290)
T ss_pred CCCCCEEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCC-CCCCcCCcccc
Confidence 9999999999999976432221 112234467889999998753 4688999999999999999955 477532 2
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
..++.+.+.... ...+...+..+.+++++||+.+|.+|| ++++++.+.+
T Consensus 217 ~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~ 270 (290)
T cd05613 217 QAEISRRILKSE-PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270 (290)
T ss_pred HHHHHHHhhccC-CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcc
Confidence 344444443332 345667889999999999999999997 8889888754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=295.52 Aligned_cols=240 Identities=23% Similarity=0.332 Sum_probs=190.7
Q ss_pred CeeEEee--ecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 366 DIIYVRD--LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~--LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
++.+.+. ||+|+||.||+++.. .++..+|+|.++...... . |+.....+ +|+||+++++.+...+.
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~-----~~~~~~~~k~~~~~~~~~----~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHK-----PTQKLFVQKIIKAKNFNA----I--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred hhccccceeecCCCceEEEEEEEc-----CCCcEEEEEEEehhhcch----h--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 4445554 599999999999864 356789999986532111 1 22222212 79999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.++++. ...+++.++..++.|+++||.|||+.+++||||||+||+++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~ 143 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK--------------------EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe
Confidence 9999999999999999962 13689999999999999999999999999999999999999
Q ss_pred CCC-cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Q psy5539 523 DQM-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE--- 598 (653)
Q Consensus 523 ~~~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e--- 598 (653)
.++ .++|+|||+++.... .....++..|+|||.+.+..++.++||||||+++|||++|. .||.....++
T Consensus 144 ~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~-~p~~~~~~~~~~~ 216 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGT------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK-HPFKEDEDEELDL 216 (267)
T ss_pred CCCCeEEEecCccceecCC------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCC-CCCCCCCcchhhH
Confidence 998 999999999875421 12335678999999999999999999999999999999965 5776554332
Q ss_pred --HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q psy5539 599 --VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-FRTIYQTLW 645 (653)
Q Consensus 599 --~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~ 645 (653)
+.... ......+...+..+.+++.+||+.+|.+||+ ++++++|.|
T Consensus 217 ~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~ 264 (267)
T PHA03390 217 ESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPF 264 (267)
T ss_pred HHHHHhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCc
Confidence 22222 2223445578899999999999999999995 699998876
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=290.54 Aligned_cols=244 Identities=25% Similarity=0.365 Sum_probs=206.7
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
||+|+||.||++... .++..+|+|.++.... ......+.+|+.++++++|+||+++++.+..+...++||||+
T Consensus 1 lg~G~~~~v~~~~~~-----~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKK-----DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEEC-----CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 699999999999864 2467899999875432 234567899999999999999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||++++++.++|+
T Consensus 76 ~~~~L~~~l~~--------------------~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~ 135 (250)
T cd05123 76 PGGELFSHLSK--------------------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLT 135 (250)
T ss_pred CCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEe
Confidence 99999999862 2357899999999999999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||++....... .......++..|++||.+.+...+.++|+||||+++||+++| ..||...+..+....+.... ..
T Consensus 136 d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g-~~p~~~~~~~~~~~~~~~~~-~~ 211 (250)
T cd05123 136 DFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTG-KPPFYAEDRKEIYEKILKDP-LR 211 (250)
T ss_pred ecCcceecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCHHHHHHHHhcCC-CC
Confidence 999987653322 122344567789999999988899999999999999999994 56887777777777776643 56
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCH---HHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSF---RTIYQTLW 645 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~---~eil~~L~ 645 (653)
.+...+..+.+++++||..+|++||++ ++++++.|
T Consensus 212 ~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~ 249 (250)
T cd05123 212 FPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249 (250)
T ss_pred CCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence 677789999999999999999999999 77776653
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=297.08 Aligned_cols=251 Identities=25% Similarity=0.360 Sum_probs=202.0
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-HHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
|.+.+.||+|++|.||+|... .++..+++|.++..... .....+.+|+.++++++|+||+++++++..+...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDK-----LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcC-----CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEE
Confidence 356678999999999999853 35688999998754322 345678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
|+||+++ +|.+++.. ....+++..+..++.||+.||.|||+.+|+|+||+|+||++++++
T Consensus 76 v~e~~~~-~l~~~l~~-------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~ 135 (283)
T cd05118 76 VFEFMDT-DLYKLIKD-------------------RQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG 135 (283)
T ss_pred EEeccCC-CHHHHHHh-------------------hcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC
Confidence 9999975 89888862 124688999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
.++|+|||.+....... .......++..|+|||.+.+. .++.++||||||+++|+|++| ..||.+.+..+....+.
T Consensus 136 ~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg-~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 136 VLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKSEIDQLFKIF 212 (283)
T ss_pred cEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Confidence 99999999987654332 112234566789999998876 789999999999999999996 46887766554433332
Q ss_pred cCCc-----------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EGNI-----------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.... ....+..+.++.+++.+||+.+|.+||++++++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~ 282 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence 1100 0011236788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=302.64 Aligned_cols=257 Identities=23% Similarity=0.298 Sum_probs=214.1
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..+..+.|..-+.||+|+||.||-++.+ .+|+++|.|.+....- .....-...|-.+|.+++.+.||.+--.+
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvr-----aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf 254 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVR-----ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF 254 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEe-----cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee
Confidence 3455677888999999999999998854 5778999988754321 22334567899999999999999998889
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
+..+.++||+..|+||||.-+|-. ...+.+++..++.++.+|+.||++||+++||.|||||+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn------------------~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPe 316 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYN------------------HGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPE 316 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeec------------------cCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChh
Confidence 999999999999999999877642 23467999999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC---
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL--- 594 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~--- 594 (653)
|||+|+.|+++|+|+|||..+.... ......||++|||||++..+.|+...|.|||||+||||+. |..||...
T Consensus 317 NILLDd~GhvRISDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~-G~sPFr~~KeK 392 (591)
T KOG0986|consen 317 NILLDDHGHVRISDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA-GHSPFRQRKEK 392 (591)
T ss_pred heeeccCCCeEeeccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc-ccCchhhhhhh
Confidence 9999999999999999998764332 3345689999999999999999999999999999999998 55588653
Q ss_pred -CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q psy5539 595 -THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTL 644 (653)
Q Consensus 595 -~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L 644 (653)
..+|+-+++.+.. ...++..+++.++|.+..|++||++|. +++++.+|+
T Consensus 393 vk~eEvdrr~~~~~-~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 393 VKREEVDRRTLEDP-EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred hhHHHHHHHHhcch-hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 3446666655543 456788999999999999999999998 455777665
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=306.65 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=208.4
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc-cccHHHHHHHHHHHHHHhhCC-CCccceEEeE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFD-HPNIVKLLGV 436 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~-~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~ 436 (653)
.+.+....|++++.||+||.++||++.- .+...+|+|++.. .+......-|..|+.+|.+|+ |.+||.|++|
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~------s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DY 428 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLN------SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDY 428 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeec------CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeee
Confidence 3455566788899999999999999974 3446777777653 455666778999999999995 8999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
-..++.+||||||= ..||..+|++.. ..++...+..+..|++.++.++|++||||-||||
T Consensus 429 Ev~d~~lYmvmE~G-d~DL~kiL~k~~-------------------~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKP 488 (677)
T KOG0596|consen 429 EVTDGYLYMVMECG-DIDLNKILKKKK-------------------SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKP 488 (677)
T ss_pred eccCceEEEEeecc-cccHHHHHHhcc-------------------CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCc
Confidence 99999999999985 569999998432 2223237788999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-----------CCCchhHHHHHHHHHHHHh
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-----------YTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-----------~t~ksDVwSlGvvl~ellt 585 (653)
.|+|+-. |.+||+|||+|..+.............||+.||+||.+.... .+.+|||||||||||+|+.
T Consensus 489 ANFLlVk-G~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 489 ANFLLVK-GRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred ccEEEEe-eeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 9999976 489999999999887666666667789999999999987543 5588999999999999996
Q ss_pred CCCCCCCCCC-HHHHHHHHHcCCc-cCCCCCCc-HHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 586 FALQPYYGLT-HEEVVKYIKEGNI-LQAPDNTP-DALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 586 ~~~~p~~~~~-~~e~~~~i~~~~~-~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+||.... ...-+..|.+... .++|+.-+ .++.++|+.||.+||.+|||+.+++++.+-
T Consensus 568 -gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl 630 (677)
T KOG0596|consen 568 -GKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFL 630 (677)
T ss_pred -cCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccc
Confidence 667887654 3334455555422 23444333 349999999999999999999999998753
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=304.89 Aligned_cols=256 Identities=21% Similarity=0.301 Sum_probs=200.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
++|++.+.||+|+||.||+|... .++..||+|+++.... ......+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 79 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDT-----RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGAD 79 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEc-----CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCC
Confidence 57888999999999999999864 3567899999875422 2334567889999999999999999988753
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+. |+|.+++. ....+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 80 ~~~~~lv~e~~~-~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Ni 138 (334)
T cd07855 80 FKDVYVVMDLME-SDLHHIIH--------------------SDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNL 138 (334)
T ss_pred CceEEEEEehhh-hhHHHHhc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 346899999996 68988875 123488999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
++++++.+||+|||++.......... ......++..|+|||.+.. ..++.++||||||+++|||++ +.+||.+.+.
T Consensus 139 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~-g~~pf~~~~~ 217 (334)
T cd07855 139 LVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLG-RRQLFPGKNY 217 (334)
T ss_pred EEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHc-CCCccCCCCh
Confidence 99999999999999987653222111 1123456788999998865 468999999999999999998 4568876654
Q ss_pred HHHHHHHHc-------------------------CCccCC-----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKE-------------------------GNILQA-----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~-------------------------~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.+..+.. ...... ....+.++.+++++||+.+|.+||++++++.++|.
T Consensus 218 ~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 218 VHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred HHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 332222111 000001 13467899999999999999999999999999875
Q ss_pred H
Q psy5539 647 I 647 (653)
Q Consensus 647 l 647 (653)
-
T Consensus 298 ~ 298 (334)
T cd07855 298 A 298 (334)
T ss_pred h
Confidence 4
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=296.47 Aligned_cols=251 Identities=28% Similarity=0.423 Sum_probs=197.7
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~L 445 (653)
|++.+.||+|+||.||+|+... .+..|+||++.............+|+..+++++ |+||+++++++..++..++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~-----~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE-----TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECC-----CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEE
Confidence 4677889999999999998642 457899999876543223334567999999999 9999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+ +|+|.+++... ....+++..++.++.|++.+|.|||+.+++|+||+|+||++++++
T Consensus 76 v~e~~-~~~l~~~~~~~------------------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~ 136 (283)
T cd07830 76 VFEYM-EGNLYQLMKDR------------------KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE 136 (283)
T ss_pred EEecC-CCCHHHHHHhc------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC
Confidence 99999 88999988622 124579999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
.++|+|||++........ .....++..|+|||.+.. ..++.++||||||+++|||++|. +||......+....+.
T Consensus 137 ~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~-~~~~~~~~~~~~~~~~ 212 (283)
T cd07830 137 VVKIADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PLFPGSSEIDQLYKIC 212 (283)
T ss_pred CEEEeecccceeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC-CccCCCChHHHHHHHH
Confidence 999999999976532211 123446778999998754 45799999999999999999964 6776655443332221
Q ss_pred cC-C----------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EG-N----------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~-~----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.. . ........+.++.+++++||+.+|++||++++++.+.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~ 282 (283)
T cd07830 213 SVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282 (283)
T ss_pred HhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence 10 0 00001123678999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07467 CRD_TK_ROR1 Cysteine-rich domain of tyrosine kinase-like orphan receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=263.55 Aligned_cols=138 Identities=25% Similarity=0.592 Sum_probs=118.6
Q ss_pred CCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHH-HHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCC
Q psy5539 31 PQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMAL-WKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIP 109 (653)
Q Consensus 31 ~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~-~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~ 109 (653)
.+|||++|||+||++||.+ ..|||++. .++ +++++++++++ |-+.+++||+.||+||+++||||+||.|++++..|
T Consensus 1 ~~GyC~~YrG~vC~~~L~~-~~Vf~~~~-~~~-~~~E~~l~aa~~~i~~s~~vs~~Cr~~A~~~LC~~~FP~C~~~~~~P 77 (142)
T cd07467 1 EDGFCQPYRGIACARFIGN-RTIYMESL-HMQ-GEIENQITAAFTMIGTSSHLSDKCSQFAIPSLCHYAFPYCDETSGMP 77 (142)
T ss_pred CCCccccccchHHHHHhCC-CeEEEeCC-CCH-HHHHHHHHHHHHHhhcccchhHHHHHHHHHHHHHHhCCCCcccCCCC
Confidence 4799999999999999984 57999844 444 46777777553 44446899999999999999999999999999999
Q ss_pred CCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCc
Q psy5539 110 MSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEM 178 (653)
Q Consensus 110 ~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~ 178 (653)
+|+|+||++|+++++++|++||+++++++..+ .++.||+|+.||..+ +...+.|++++++..
T Consensus 78 ~pr~iCreeC~~le~~~C~~Ey~~a~~~~~i~------~~~~LP~C~~LP~~~-~~~~~~C~~igi~~~ 139 (142)
T cd07467 78 KPRDLCRDECEILENVLCQTEYIFARSNPMIL------MRLKLPNCEDLAQPD-SPEAANCIRIGIPMA 139 (142)
T ss_pred CcchHHHHHHHHHHHHHhHHHHHHHHhCcccc------cccCCCChhhcCCCC-CCCCCCceeeCCCCC
Confidence 99999999999999999999999999997543 467899999999887 377899999998754
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor 1 (Ror1), a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=330.40 Aligned_cols=249 Identities=24% Similarity=0.409 Sum_probs=190.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|+.++.||+||||.|||++. .-+|+.+|||++.-..+......+.+|+..+++|+|||||+++..|.+.....
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRN-----KlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRN-----KLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEee-----cccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcc
Confidence 4677788899999999999985 35789999999987766666677899999999999999999998764322111
Q ss_pred --------------------------------------------------------------------------------
Q psy5539 445 -------------------------------------------------------------------------------- 444 (653)
Q Consensus 445 -------------------------------------------------------------------------------- 444 (653)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred ---------------------------------------EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCC
Q psy5539 445 ---------------------------------------LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485 (653)
Q Consensus 445 ---------------------------------------LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l 485 (653)
|-||||+...|.++++ ...+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~---------------------~N~~ 692 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIR---------------------RNHF 692 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHH---------------------hccc
Confidence 1122222211111111 1112
Q ss_pred --CHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcccccc----cc------------ccccCC
Q psy5539 486 --STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY----LQ------------DYYKGD 547 (653)
Q Consensus 486 --~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~----~~------------~~~~~~ 547 (653)
.....++++++|+.||+|+|++|||||||||.||+++++..|||+|||+|.... .. ......
T Consensus 693 ~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~ 772 (1351)
T KOG1035|consen 693 NSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL 772 (1351)
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence 356779999999999999999999999999999999999999999999998731 00 001123
Q ss_pred CCCCCccccccchhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCccCC---CCCCcHHHH
Q psy5539 548 ENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLWEIFSFALQPYY-GLTHEEVVKYIKEGNILQA---PDNTPDALY 620 (653)
Q Consensus 548 ~~~~~t~~y~aPE~~~~~---~~t~ksDVwSlGvvl~ellt~~~~p~~-~~~~~e~~~~i~~~~~~~~---~~~~~~~l~ 620 (653)
+...||.-|+|||.+.+. .|+.|+|+|||||||+||+. ||. .+....++..++++.++.. ...--+.-.
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y----PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~ 848 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY----PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEA 848 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc----cCCchHHHHHHHHhcccCCCCCCcccccccchHHH
Confidence 456789999999998765 49999999999999999995 653 4556677888888887655 333445678
Q ss_pred HHHHHhhccCCCCCCCHHHHHHH
Q psy5539 621 DLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 621 ~li~~cl~~dP~~RPs~~eil~~ 643 (653)
++|+.++++||++|||+.|+++.
T Consensus 849 slI~~Ll~hdP~kRPtA~eLL~s 871 (1351)
T KOG1035|consen 849 SLIRWLLSHDPSKRPTATELLNS 871 (1351)
T ss_pred HHHHHHhcCCCccCCCHHHHhhc
Confidence 99999999999999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=293.01 Aligned_cols=251 Identities=28% Similarity=0.439 Sum_probs=198.7
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhC---CCCccceEEeEEecCCc
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEF---DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~~~~ 442 (653)
|++.+.||+|+||.||+|+.. .+++.+|+|+++.... ......+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 75 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDL-----NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRT 75 (287)
T ss_pred CeEEEEecccCceEEEEEEEC-----CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccC
Confidence 467889999999999999964 2467899999974322 22234566787777665 69999999999987776
Q ss_pred -----eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 443 -----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 443 -----~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.+++|||+++ +|.+++.... ...+++..++.++.|++.||.|||+.+++|+||+|+
T Consensus 76 ~~~~~~~l~~e~~~~-~l~~~l~~~~------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~ 136 (287)
T cd07838 76 DRELKLTLVFEHVDQ-DLATYLSKCP------------------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136 (287)
T ss_pred CCCceeEEEehhccc-CHHHHHHHcc------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChh
Confidence 9999999974 8999886221 135789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||++++++.+||+|||++....... ......++..|+|||.+.+..++.++||||||+++|||++| .+||.+.+..
T Consensus 137 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~-~~~~~~~~~~ 212 (287)
T cd07838 137 NILVTSDGQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRR-RPLFRGTSEA 212 (287)
T ss_pred hEEEccCCCEEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhC-CCcccCCChH
Confidence 9999999999999999987653221 11223467889999999999999999999999999999995 6788887766
Q ss_pred HHHHHHHcCCcc------------------C--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL------------------Q--------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~------------------~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+....+.+.... . .....+..+.+++.+||+.+|.+||++.+++++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~ 286 (287)
T cd07838 213 DQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286 (287)
T ss_pred HHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence 655544321000 0 00124567889999999999999999999998754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.44 Aligned_cols=255 Identities=28% Similarity=0.364 Sum_probs=198.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhC-CCCccceEEeEEec--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV-- 439 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~-- 439 (653)
.++|.+.+.||+|+||.||+|.+. .++..+|+|++... ........+.+|+.+++++ +|+||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~ 80 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDR-----RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEN 80 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEc-----CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCC
Confidence 356788899999999999999863 34678999988542 2223345677899999999 99999999999864
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+...++||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.+|+||||||+||
T Consensus 81 ~~~~~lv~e~~~-~~L~~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~ni 138 (337)
T cd07852 81 DKDIYLVFEYME-TDLHAVIRA---------------------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNI 138 (337)
T ss_pred CceEEEEecccc-cCHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 346899999997 599988851 1567888999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccc---cCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYY---KGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
++++++.+||+|||++......... .......++..|+|||.+.. ..++.++||||||+++|||++|. .||.+..
T Consensus 139 ll~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~-~pf~~~~ 217 (337)
T cd07852 139 LLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTS 217 (337)
T ss_pred EEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCC-CCCCCCC
Confidence 9999999999999999866433221 11122346788999998765 46789999999999999999964 5787655
Q ss_pred HHHHHHHHHcCC---------------------------c---cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGN---------------------------I---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~---------------------------~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+.... . .......+.++.+++.+||+.+|++|||+.+++++.+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~ 297 (337)
T cd07852 218 TLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY 297 (337)
T ss_pred hHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence 443333221110 0 0111236789999999999999999999999999865
Q ss_pred H
Q psy5539 646 N 646 (653)
Q Consensus 646 ~ 646 (653)
-
T Consensus 298 ~ 298 (337)
T cd07852 298 V 298 (337)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=311.38 Aligned_cols=248 Identities=24% Similarity=0.355 Sum_probs=203.1
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc---cccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC--
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD---EASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK-- 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~---~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-- 441 (653)
.++...||+|+|-+||+|.+ ..++..||--.++. ..++...+.|..|+.+|+.|+|||||+++.+|.+..
T Consensus 42 ~k~~evLGrGafKtVYka~D-----e~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~ 116 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFD-----EEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK 116 (632)
T ss_pred eehhhhcccccceeeeeccc-----cccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence 35567899999999999975 35566666443322 233445578999999999999999999999997655
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC--CceecCCCCCCE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR--KFVHRDLATRNC 519 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--~ivHrDLkp~NI 519 (653)
..-+|+|.+..|+|..|++++ ...+...+.++++||++||.|||++ +|||||||-+||
T Consensus 117 ~in~iTEL~TSGtLr~Y~kk~--------------------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNI 176 (632)
T KOG0584|consen 117 TINFITELFTSGTLREYRKKH--------------------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNI 176 (632)
T ss_pred eeeeeeecccCCcHHHHHHHh--------------------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceE
Confidence 488999999999999999843 4567789999999999999999976 799999999999
Q ss_pred eEcCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHH
Q psy5539 520 LINDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-LTHE 597 (653)
Q Consensus 520 Ll~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~-~~~~ 597 (653)
+|+.+ |.|||+|+|||..+... ......||+.|||||... ..|++..||||||+.++||.|+.. ||.. .++.
T Consensus 177 FinG~~G~VKIGDLGLAtl~r~s----~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eY-PYsEC~n~A 250 (632)
T KOG0584|consen 177 FVNGNLGEVKIGDLGLATLLRKS----HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEY-PYSECTNPA 250 (632)
T ss_pred EEcCCcCceeecchhHHHHhhcc----ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccC-ChhhhCCHH
Confidence 99754 89999999999876321 122357999999999766 899999999999999999999665 7754 5678
Q ss_pred HHHHHHHcCCccCCCC-CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPD-NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
++.+++..|.-+.... --.+++++||.+|+.. .++|||+.|++++.+.
T Consensus 251 QIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff 299 (632)
T KOG0584|consen 251 QIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFF 299 (632)
T ss_pred HHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhh
Confidence 8999998886543322 2457899999999999 9999999999988653
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=303.28 Aligned_cols=251 Identities=26% Similarity=0.368 Sum_probs=197.8
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH-------------HHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-------------LQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~-------------~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
+.+.||+|+||.||+|... ..++.||||.++...... ....+.+|++++++++|+||+++++
T Consensus 13 ~~~~ig~G~~g~vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDT-----LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred hhhcccCCCceeEEEEEEC-----CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4467999999999999863 356789999886542211 1124778999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..++..++||||+. |+|.+++.. ...++......++.|++.||+|||+.+++|+||+
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~--------------------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~ 146 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR--------------------KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLS 146 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9999999999999997 699998861 2347889999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCcccccccccc------------ccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHH
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDY------------YKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWE 582 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~e 582 (653)
|+||+++.++.++|+|||+++....... ........++..|+|||.+.+. .++.++||||||+++||
T Consensus 147 ~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~e 226 (335)
T PTZ00024 147 PANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226 (335)
T ss_pred HHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999999976531110 0011123356789999998764 47899999999999999
Q ss_pred HHhCCCCCCCCCCHHHHHHHHHcC----Cc-----------------------cCCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 583 IFSFALQPYYGLTHEEVVKYIKEG----NI-----------------------LQAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 583 llt~~~~p~~~~~~~e~~~~i~~~----~~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
|++ +.+||.+.+..+....+... .. .......+.++.+++++||+.+|++||
T Consensus 227 l~t-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 305 (335)
T PTZ00024 227 LLT-GKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305 (335)
T ss_pred HHh-CCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence 999 55688877766544443220 00 001124578899999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
++++++.+.|-
T Consensus 306 s~~~~l~~~~~ 316 (335)
T PTZ00024 306 SAKEALKHEYF 316 (335)
T ss_pred CHHHHhcCccc
Confidence 99999998774
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.92 Aligned_cols=250 Identities=23% Similarity=0.319 Sum_probs=199.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
.++|++.+.||+|+||.||+|... .++..||||.++.. ........+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDR-----RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEEC-----CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 567999999999999999999853 35688999998643 23334557889999999999999999999986543
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
..++||||+ +++|.+++. ...+++..++.++.||+.||+|||+.+|+||||||
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~---------------------~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp 146 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMK---------------------HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKP 146 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 458999998 679988875 13478899999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+||++++++.++|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|+|++| .+||.+.+
T Consensus 147 ~Nill~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g-~~pf~~~~ 220 (343)
T cd07880 147 GNLAVNEDCELKILDFGLARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG-KPLFKGHD 220 (343)
T ss_pred HHEEEcCCCCEEEeeccccccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCC
Confidence 999999999999999999975421 1223456778999999876 4688999999999999999995 45887665
Q ss_pred HHHHHHHHHcCC------------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGN------------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.......+.... ........+..+.+++.+|++.+|++|||+.+++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~ 300 (343)
T cd07880 221 HLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300 (343)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 433322221100 00112356778999999999999999999999998876
Q ss_pred H
Q psy5539 646 N 646 (653)
Q Consensus 646 ~ 646 (653)
-
T Consensus 301 ~ 301 (343)
T cd07880 301 F 301 (343)
T ss_pred H
Confidence 3
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=301.72 Aligned_cols=254 Identities=22% Similarity=0.288 Sum_probs=205.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
+|++.+.||+|+||.||+|+.. ..+..||||.+..... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDK-----RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeC-----CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCccc
Confidence 4678899999999999999864 3467899999876432 334567899999999999999999999987765
Q ss_pred --ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 442 --PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 442 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++||||++ ++|.++++ ....+++..++.++.||+.||+|||+++|+|+||||+||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~l~--------------------~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~ni 134 (330)
T cd07834 76 FNDVYIVTELME-TDLHKVIK--------------------SPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNI 134 (330)
T ss_pred ccceEEEecchh-hhHHHHHh--------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 7899999998 48888885 223688999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|+++++.++|+|||++......... .......++..|+|||.+.+. .++.++||||||+++|+|++ +.+||.+.+..
T Consensus 135 li~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~-g~~pf~~~~~~ 213 (330)
T cd07834 135 LVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPLFPGRDYI 213 (330)
T ss_pred EEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc-CCCCcCCCCHH
Confidence 9999999999999999765332210 112234567789999999888 89999999999999999999 45688877766
Q ss_pred HHHHHHHcCCc------------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNI------------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+....- .......+.++.+++++||+.+|.+||++++++++.|-
T Consensus 214 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~ 292 (330)
T cd07834 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL 292 (330)
T ss_pred HHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence 55544433110 00112367889999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=298.51 Aligned_cols=250 Identities=17% Similarity=0.283 Sum_probs=190.8
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.+|.|+++.||+++ .+++.||||+++.. ......+.+.+|+++++.++|+||+++++++...+..+++|||
T Consensus 8 ~~~~~~~~v~~~~~~-------~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~ 80 (314)
T cd08216 8 KCFEDLMIVHLAKHK-------PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL 80 (314)
T ss_pred HhhcCCceEEEEEec-------CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence 334455555555443 25688999998754 3344556799999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEE
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI 529 (653)
+++|+|.++++... ...+++..+..++.|++.||+|||+++|+||||||+|||+++++.+||
T Consensus 81 ~~~~~l~~~l~~~~------------------~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl 142 (314)
T cd08216 81 MAYGSCEDLLKTHF------------------PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVL 142 (314)
T ss_pred cCCCCHHHHHHHhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEE
Confidence 99999999997321 234788889999999999999999999999999999999999999999
Q ss_pred eccCccccccccccc-----cCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH-HHH
Q psy5539 530 ADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE-VVK 601 (653)
Q Consensus 530 ~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e-~~~ 601 (653)
+|||.+......... .......++..|+|||.+... .++.++||||||+++|||++ +..||....... ..+
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~-g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN-GHVPFKDMPATQMLLE 221 (314)
T ss_pred ecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 999998755322211 111223456789999998764 58899999999999999999 556887654432 223
Q ss_pred HHHcCC---------------cc-----------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGN---------------IL-----------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~---------------~~-----------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.... .. ......+.++.+++.+||..+|++|||+++++++++-
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 322110 00 0001123578899999999999999999999998873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=301.89 Aligned_cols=247 Identities=23% Similarity=0.338 Sum_probs=194.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
++|...+.||+|+||.||+|+.. .++..||||.++... .+.....+.+|+.+++.++|+||+++++++...
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~ 89 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDK-----RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG 89 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeC-----CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence 47889999999999999999863 356789999986432 233345678999999999999999999998654
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+++++||||||+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~----------------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~ 146 (342)
T cd07879 90 DEFQDFYLVMPYMQT-DLQKIMG----------------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPG 146 (342)
T ss_pred CCCceEEEEeccccc-CHHHHHc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 346999999864 6766542 24788899999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||++.++.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+.
T Consensus 147 NIll~~~~~~kL~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~-~pf~~~~~ 220 (342)
T cd07879 147 NLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDY 220 (342)
T ss_pred HEEECCCCCEEEeeCCCCcCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC-CCCCCCCH
Confidence 99999999999999999875321 1223355778999999876 46899999999999999999954 58877665
Q ss_pred HHHHHHHHcCC----------------------ccCC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGN----------------------ILQA--------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~----------------------~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.+..+.... .... ....+..+.+++.+||+.+|.+||++++++.+.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~ 299 (342)
T cd07879 221 LDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299 (342)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 44333322210 0000 1245678999999999999999999999998854
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=292.83 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=200.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
|+..+.||+|+||.||+|+.. .++..+|+|.++... .+...+.+.+|+.++++++|+||+++++++...+..++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~-----~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDK-----KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeec-----CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEE
Confidence 356678999999999999863 356889999987643 23344567889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
|+||++ ++|.+++... ...+++..+..++.|++.||+|||+.+|+|+||+|+||++++++
T Consensus 76 v~e~~~-~~l~~~i~~~-------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~ 135 (282)
T cd07829 76 VFEYCD-MDLKKYLDKR-------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG 135 (282)
T ss_pred EecCcC-cCHHHHHHhh-------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC
Confidence 999998 5999999722 13588999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
.++|+|||+++....... .......+..|+|||.+... .++.++||||||+++|||++| .+||.+.+..+....+.
T Consensus 136 ~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~-~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 136 VLKLADFGLARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG-KPLFPGDSEIDQLFKIF 212 (282)
T ss_pred CEEEecCCcccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhC-CCCCCCccHHHHHHHHH
Confidence 999999999876532221 12223446779999998777 889999999999999999996 56887766544333322
Q ss_pred cC--------------------Ccc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 605 EG--------------------NIL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 605 ~~--------------------~~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.. ... ......+..+.+++++||..+|++||++++++++.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~ 281 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence 10 000 001234678999999999999999999999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=296.93 Aligned_cols=256 Identities=26% Similarity=0.327 Sum_probs=196.7
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhC-CCCccceEEeEEecC---
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~--- 440 (653)
+|.+.+.||+|+||.||+++..+ ...+..||+|.++... .....+.+.+|+++++++ +||||+++++.....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~---~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 77 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAE---TSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGN 77 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCC---CCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecccc
Confidence 46788999999999999999743 1125789999987532 222345678899999999 599999999875432
Q ss_pred -CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 441 -KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 441 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
...++++||+. ++|.+++. ....+++..+..++.||+.||.|||+.+++||||||+||
T Consensus 78 ~~~~~~~~e~~~-~~L~~~l~--------------------~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Ni 136 (332)
T cd07857 78 FNELYLYEELME-ADLHQIIR--------------------SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNL 136 (332)
T ss_pred CCcEEEEEeccc-CCHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHe
Confidence 45788899886 68998885 224578999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|+++++.+||+|||+++......... ......++..|+|||.+.+ ..++.++||||||+++|+|++| .+||.+.+.
T Consensus 137 li~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g-~~pf~~~~~ 215 (332)
T cd07857 137 LVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR-KPVFKGKDY 215 (332)
T ss_pred EEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC-CcCCCCCCH
Confidence 99999999999999997653222111 1122356888999998766 4689999999999999999974 568876554
Q ss_pred HHHHHHHHcC---------------------------C---ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKEG---------------------------N---ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~~---------------------------~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.+..+... . +.......+..+.+++.+|++.+|.+|||+.+++++.|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~ 295 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL 295 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence 3333222110 0 001112357889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=299.78 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=198.6
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..+++|.+.+.||+|+||.||+|... .++..||+|+++... .....+.+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEc-----CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34578999999999999999999853 356889999987532 223345678899999999999999999987543
Q ss_pred ------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 441 ------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 441 ------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
...++++|++ +++|.++++ ...+++..+..++.|++.||+|||+.+|+||||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dl 146 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK---------------------CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 146 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCC
Confidence 3467888876 779988775 124788999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
||+||++++++.+||+|||+++.... ......++..|+|||.+.+ ..++.++||||||+++|||++|. .||..
T Consensus 147 kp~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~-~pf~~ 220 (345)
T cd07877 147 KPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-TLFPG 220 (345)
T ss_pred ChHHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCC-CCCCC
Confidence 99999999999999999999875421 1223456778999998866 46889999999999999999965 57766
Q ss_pred CCHHHHHHHHHcCCc----------------------cC--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 594 LTHEEVVKYIKEGNI----------------------LQ--------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 594 ~~~~e~~~~i~~~~~----------------------~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
.+..+....+..... .. .....+.++.+++.+|++.+|.+||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 221 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 554443332211100 00 011356789999999999999999999999999
Q ss_pred HHH
Q psy5539 644 LWN 646 (653)
Q Consensus 644 L~~ 646 (653)
.|-
T Consensus 301 ~~f 303 (345)
T cd07877 301 AYF 303 (345)
T ss_pred hhh
Confidence 874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=279.11 Aligned_cols=257 Identities=22% Similarity=0.355 Sum_probs=210.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 439 (653)
....++++++..||.|+-|.|++++.. .++..+|||......+....+++...+.++..- +.|.||+.+|+|..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~r-----s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~ 162 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFR-----STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT 162 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEc-----ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence 344567788899999999999999874 467899999998776666666677777666554 48999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCC
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRN 518 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~N 518 (653)
+...++.||.|.- .+..+|++. .+++++..+-++...+++||.||-+ ++|+|||+||+|
T Consensus 163 n~dV~IcMelMs~-C~ekLlkri-------------------k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 163 NTDVFICMELMST-CAEKLLKRI-------------------KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred CchHHHHHHHHHH-HHHHHHHHh-------------------cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 9999999999854 566666522 2458888889999999999999986 589999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC---CCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLWEIFSFALQPYYGL- 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~t~ksDVwSlGvvl~ellt~~~~p~~~~- 594 (653)
||+|+.|++|++|||++.++... +..+..+|-+.|||||.+... +|+.++||||||++|+||.|| ..||.+-
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg-~yPy~~c~ 298 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATG-QYPYKGCK 298 (391)
T ss_pred eEEccCCCEEeecccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcc-cCCCCCCC
Confidence 99999999999999999876432 345667788899999998754 789999999999999999995 4588774
Q ss_pred CHHHHHHHHHcCCccCCC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
...+++-.|.+.+.+..+ ...++.+.+++..||.+|+.+||...++++|.+-
T Consensus 299 tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi 352 (391)
T KOG0983|consen 299 TDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFI 352 (391)
T ss_pred ccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcce
Confidence 456777777665443333 2378999999999999999999999999998753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=301.15 Aligned_cols=253 Identities=26% Similarity=0.330 Sum_probs=196.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG---- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~---- 440 (653)
.+|.+.+.||+|+||.||+|... .++..||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~-----~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDS-----DCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEEC-----CCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccc
Confidence 57899999999999999999863 4568899999865433 2345688999999999999999999876543
Q ss_pred ----------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 441 ----------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 441 ----------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
...++||||++ ++|.+++. ...+++..+..++.||++||.|||+.+|+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~giv 136 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLE---------------------QGPLSEEHARLFMYQLLRGLKYIHSANVL 136 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHH---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 35789999997 58988875 13478899999999999999999999999
Q ss_pred ecCCCCCCEeEc-CCCcEEEeccCcccccccccccc-CCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCC
Q psy5539 511 HRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 511 HrDLkp~NILl~-~~~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
||||||+||+++ +++.+||+|||+++......... ......++..|+|||.+.. ..++.++||||||+++|||++|.
T Consensus 137 H~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~ 216 (342)
T cd07854 137 HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216 (342)
T ss_pred cCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCC
Confidence 999999999997 56688999999997653221111 1122345778999998754 56889999999999999999965
Q ss_pred CCCCCCCCHHHHHHHHHcCC------------------------cc-----CCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q psy5539 588 LQPYYGLTHEEVVKYIKEGN------------------------IL-----QAPDNTPDALYDLMKLCWNMKPMNRPSFR 638 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i~~~~------------------------~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 638 (653)
.||.+.+..+....+.+.. .. ......+.++.+++.+||..+|.+|||++
T Consensus 217 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 295 (342)
T cd07854 217 -PLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAE 295 (342)
T ss_pred -CCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHH
Confidence 5777665443333222110 00 01134678899999999999999999999
Q ss_pred HHHHHHHH
Q psy5539 639 TIYQTLWN 646 (653)
Q Consensus 639 eil~~L~~ 646 (653)
+++++.|-
T Consensus 296 ell~h~~~ 303 (342)
T cd07854 296 EALMHPYM 303 (342)
T ss_pred HHhCCCcc
Confidence 99988764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=336.50 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=213.6
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+++....||.|.||.||-|.. ..+|...|+|-++-... ........+|+.++..|+|||+|+++|+-...+..+
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN-----~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVN-----LDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred eeccccccCCcceeeeEEeec-----CCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 455566799999999999974 35778899998764432 233456789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|.|||+.+|+|.+.++ .....++.....+..|++.|++|||++|||||||||.||+|+.+
T Consensus 1311 IFMEyC~~GsLa~ll~--------------------~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~ 1370 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLE--------------------HGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFN 1370 (1509)
T ss_pred HHHHHhccCcHHHHHH--------------------hcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecC
Confidence 9999999999999987 22335666677888999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccc--cCCCCCCCccccccchhhccCC---CCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIFSFALQPYYGLT-HEE 598 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~---~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e 598 (653)
|.+|++|||.|..+...-.. ..-....||+.|||||++.+.. ...+.||||||||++||+||.. ||...+ ...
T Consensus 1371 g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkr-PW~~~dne~a 1449 (1509)
T KOG4645|consen 1371 GLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKR-PWAELDNEWA 1449 (1509)
T ss_pred CcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCC-chhhccchhH
Confidence 99999999999876433111 1112457899999999998754 5578999999999999999776 776655 457
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++..+-.|..++.|+.++.+-++++..|+..||++|.++.||+++-+
T Consensus 1450 IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f 1496 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAF 1496 (1509)
T ss_pred HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhc
Confidence 88889999999999999999999999999999999999999987753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=296.99 Aligned_cols=252 Identities=26% Similarity=0.309 Sum_probs=198.5
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEec-
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV- 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~- 439 (653)
...++|.+.+.||+|+||.||+|+.. .++..||||.+.... .....+.+.+|+++++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 81 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQ-----LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP 81 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEEC-----CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC
Confidence 35678999999999999999999854 356789999876432 22334567899999999999999999998865
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+...++|+||+ +++|.++++ ...++...+..++.|+++||.|||+.+|+||||+|+||
T Consensus 82 ~~~~~lv~e~~-~~~L~~~~~---------------------~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Ni 139 (328)
T cd07856 82 LEDIYFVTELL-GTDLHRLLT---------------------SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNI 139 (328)
T ss_pred CCcEEEEeehh-ccCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 56789999998 568988875 12467888889999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|+++++.++|+|||++..... ......++..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.....
T Consensus 140 li~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg-~~~f~~~~~~~ 213 (328)
T cd07856 140 LINENCDLKICDFGLARIQDP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGKDHVN 213 (328)
T ss_pred eECCCCCEEeCccccccccCC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHH
Confidence 999999999999999875321 1122345778999998766 5689999999999999999995 56887655432
Q ss_pred HHHHHHc---------------CC------------ccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKE---------------GN------------ILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~---------------~~------------~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
....+.+ .. ..+ ....++..+.++|++||+.+|++||++++++.+.|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~ 291 (328)
T cd07856 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL 291 (328)
T ss_pred HHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence 2211110 00 000 112467899999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=295.84 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=195.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|.+.+.||+|+||.||+|+.. .++..+|||.+..... ......+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~-----~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQI-----KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccc
Confidence 468999999999999999999864 3557899998864322 22234567899999999999999999887443
Q ss_pred ------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 441 ------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 441 ------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
...++|+||+.+ +|.+.+.. ....+++..+..++.|+++||.|||+++|+|+||
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~-------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl 141 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLEN-------------------PSVKLTESQIKCYMLQLLEGINYLHENHILHRDI 141 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 346999999875 77777651 1235899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccC---------CCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHH
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKG---------DENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ell 584 (653)
||+|||+++++.++|+|||+++.......... .....++..|+|||.+.+. .++.++||||||+++|||+
T Consensus 142 ~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 221 (311)
T cd07866 142 KAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221 (311)
T ss_pred CHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHH
Confidence 99999999999999999999976532221111 0112346779999988654 5899999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHHHHcCCc----------------------cCCC-------CCCcHHHHHHHHHhhccCCCCCC
Q psy5539 585 SFALQPYYGLTHEEVVKYIKEGNI----------------------LQAP-------DNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 585 t~~~~p~~~~~~~e~~~~i~~~~~----------------------~~~~-------~~~~~~l~~li~~cl~~dP~~RP 635 (653)
+| .+||.+.+..+..+.+..... ...+ ......+.+++.+||+.+|.+||
T Consensus 222 ~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~ 300 (311)
T cd07866 222 TR-RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300 (311)
T ss_pred hC-CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc
Confidence 95 568877665544333321000 0000 12346788999999999999999
Q ss_pred CHHHHHHHHH
Q psy5539 636 SFRTIYQTLW 645 (653)
Q Consensus 636 s~~eil~~L~ 645 (653)
|+.+++.+.|
T Consensus 301 t~~ell~~~~ 310 (311)
T cd07866 301 TASDALEHPY 310 (311)
T ss_pred CHHHHhcCCC
Confidence 9999998754
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.74 Aligned_cols=249 Identities=24% Similarity=0.327 Sum_probs=200.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.++|.+.+.||+|+||.||+|+.. .++..||||++.... .....+.+.+|+.+++.++|+||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDT-----KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEEC-----CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 457999999999999999999864 356789999987532 22334567889999999999999999988766554
Q ss_pred ------eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 443 ------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 443 ------~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
.++|+||+ +++|.+++. ...+++..+..++.|++.||+|||+.+|+||||||
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~---------------------~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp 146 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVK---------------------CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKP 146 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 89999998 569999885 13588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+||++++++.++|+|||++...... .....++..|+|||.+.. ..++.++||||||+++|||++|. .||.+.+
T Consensus 147 ~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~-~pf~~~~ 220 (343)
T cd07851 147 SNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSD 220 (343)
T ss_pred HHeEECCCCCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCC-CCCCCCC
Confidence 9999999999999999999754221 223456778999998865 36789999999999999999954 5887666
Q ss_pred HHHHHHHHHcCCcc------------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNIL------------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+.+.... ......+.++.+++++||+.+|.+|||+.+|+++.|
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~ 300 (343)
T cd07851 221 HIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300 (343)
T ss_pred hHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCC
Confidence 55444443221100 011235788999999999999999999999998875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=286.88 Aligned_cols=264 Identities=24% Similarity=0.352 Sum_probs=198.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-HHHHHHHHHHHHHhhCCCCccceEEeEEec-CCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDFEREACLLAEFDHPNIVKLLGVCAV-GKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~ 442 (653)
..|+.+..||+|.||.||+|.-....+.. .+.+|||+++.+... ......-||+.+++.++||||+.|..++.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr-~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKR-TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCccc-chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 46788889999999999999654322221 357999999865221 123456899999999999999999999876 788
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|++||+++ ||...++.++. .....++.....+|++||+.|++|||++=|+||||||.||||.
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~---------------~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvm 166 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRA---------------SKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVM 166 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhcc---------------chhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEe
Confidence 9999999988 99999985542 1235789999999999999999999999999999999999998
Q ss_pred CC----CcEEEeccCcccccccccccc-CCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCC-------
Q psy5539 523 DQ----MVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQ------- 589 (653)
Q Consensus 523 ~~----~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~------- 589 (653)
.+ |.|||+|||+++.+...-... .......|+.|.|||.+.+. .||.+.||||.|||+.||++- .+
T Consensus 167 gdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl-~PlF~g~E~ 245 (438)
T KOG0666|consen 167 GDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTL-EPLFKGREE 245 (438)
T ss_pred ccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHcc-Cccccchhh
Confidence 77 999999999999764332222 22334568999999999986 589999999999999999972 22
Q ss_pred ------CCCCCCHHHHHHHH------------------------HcCCccCC--------CCCCcHHHHHHHHHhhccCC
Q psy5539 590 ------PYYGLTHEEVVKYI------------------------KEGNILQA--------PDNTPDALYDLMKLCWNMKP 631 (653)
Q Consensus 590 ------p~~~~~~~e~~~~i------------------------~~~~~~~~--------~~~~~~~l~~li~~cl~~dP 631 (653)
||.....+.+++.+ +....... -..-++..++|+.++|..||
T Consensus 246 k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP 325 (438)
T KOG0666|consen 246 KIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDP 325 (438)
T ss_pred hcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCc
Confidence 33221111122111 10000000 01123457899999999999
Q ss_pred CCCCCHHHHHHHHHH
Q psy5539 632 MNRPSFRTIYQTLWN 646 (653)
Q Consensus 632 ~~RPs~~eil~~L~~ 646 (653)
.+|.|+++.+++...
T Consensus 326 ~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 326 IKRITAEQALEHPYF 340 (438)
T ss_pred hhhccHHHHhccccc
Confidence 999999999988643
|
|
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=263.53 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=204.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.|.-+++||+|.||+||+|+. .++...||+|+++-+. .+..-....+||.+++.++|.|||+++++..+++.+-
T Consensus 3 ~ydkmekigegtygtvfkarn-----~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARN-----RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEeccc-----CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeE
Confidence 345567899999999999984 3577899999987442 2333446789999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
||+||+.. +|..|.... .+.++.+...+++.|+++||.|.|++++.||||||+|.||+.+
T Consensus 78 lvfe~cdq-dlkkyfdsl-------------------ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~n 137 (292)
T KOG0662|consen 78 LVFEFCDQ-DLKKYFDSL-------------------NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRN 137 (292)
T ss_pred EeHHHhhH-HHHHHHHhc-------------------CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccC
Confidence 99999965 888887622 3567888999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
|++|++|||+++.+...- +--+....|..|.+|.++.+.+ |+...|+||-||++.|+...|.+.|.+.+..+....|
T Consensus 138 gelkladfglarafgipv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkri 215 (292)
T KOG0662|consen 138 GELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRI 215 (292)
T ss_pred CcEEecccchhhhcCCce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHH
Confidence 999999999998653221 1224456788999999999875 7899999999999999999999999998887766555
Q ss_pred Hc--C-----C---ccCCCC------------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 604 KE--G-----N---ILQAPD------------------NTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 604 ~~--~-----~---~~~~~~------------------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
-. | + +.+.|+ .....-++++++.+.-+|.+|.++++.++++
T Consensus 216 f~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp 284 (292)
T KOG0662|consen 216 FRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP 284 (292)
T ss_pred HHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence 32 1 0 011111 1223457899999999999999999998875
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.52 Aligned_cols=147 Identities=28% Similarity=0.455 Sum_probs=130.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||.||+|.+. .++..||||+++.. ........+.+|+.+++.++|+||+++++++.....
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 78 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKK-----NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN 78 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE
Confidence 57899999999999999999864 35678999998743 233445678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+.+++|.++++. ...+++..++.|+.||+.||.|||+++|+||||||+||||+
T Consensus 79 ~~lVmEy~~g~~L~~li~~--------------------~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~ 138 (669)
T cd05610 79 VYLVMEYLIGGDVKSLLHI--------------------YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS 138 (669)
T ss_pred EEEEEeCCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEc
Confidence 9999999999999999862 23478888999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccc
Q psy5539 523 DQMVVKIADFGLSR 536 (653)
Q Consensus 523 ~~~~vkI~DfGla~ 536 (653)
.++.+||+|||+++
T Consensus 139 ~~g~vkL~DFGls~ 152 (669)
T cd05610 139 NEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCEEEEeCCCCc
Confidence 99999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07468 CRD_TK_ROR2 Cysteine-rich domain of tyrosine kinase-like orphan receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=255.91 Aligned_cols=136 Identities=22% Similarity=0.543 Sum_probs=119.4
Q ss_pred CCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH-HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCC
Q psy5539 31 PQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA-LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIP 109 (653)
Q Consensus 31 ~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~-~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~ 109 (653)
.+|||++|+|+||++||.+ ..||++... ++++++++|+++ +|.+.+++||+.|++||+++||||+||.|++++..|
T Consensus 1 ~~G~C~~Y~G~vC~~yL~~-~~V~v~~~~--~~~~ie~~l~aa~~~i~~s~~ls~~Cr~~A~~~LC~~~Fp~C~~~~~~p 77 (140)
T cd07468 1 KDGFCQPYRGIACARFIGN-RTIYVDSLQ--MQGEIENRITAAFTMIGTSTHLSDQCSQFAIPSFCHFVFPLCDDRSRTP 77 (140)
T ss_pred CCCcceeccChHHHHHhCC-CeEEEecCC--chHHHHHHHHHHHhhhhccccccHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 3799999999999999985 569997764 345667766665 577778999999999999999999999999999999
Q ss_pred CCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCC
Q psy5539 110 MSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLT 176 (653)
Q Consensus 110 ~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~ 176 (653)
+|+|+||++|+++++++|++||++++++...+ +++.||+|+.||... +..+++|++++++
T Consensus 78 ~pr~iCreeC~~l~~~~C~~Ey~~a~~~~~i~------~~~~LP~C~~LP~~~-~~~~~~C~riGi~ 137 (140)
T cd07468 78 KPRELCRDECEVLENDLCRQEYNIARSNPLIL------MQLQLPKCEELPLPE-SPEAANCMRIGIP 137 (140)
T ss_pred CCcchHHHHHHHHHHHHhHHHHHHHhhccccc------ccccCCchhhCCCCC-CCCCCCcceeCCc
Confidence 99999999999999999999999999997443 568899999999876 3788999999876
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror2), a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=277.52 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=204.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.||+|+|+.|--+.. ..++..+|||++.+. ....+.++.+|++++... .|+||+.|+.+++++..+|||||-
T Consensus 84 e~LGeGAyasVqtcv~-----i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEK 157 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVS-----IQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEK 157 (463)
T ss_pred HHhcCccceeeeeeee-----eccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEec
Confidence 4589999999988763 356788999999765 445677888999999988 599999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC---c
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM---V 526 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~---~ 526 (653)
|.||.|..++. +...+++.++.+++++|+.||.|||.+||.||||||+|||-.+.. -
T Consensus 158 m~GGplLshI~--------------------~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsP 217 (463)
T KOG0607|consen 158 MRGGPLLSHIQ--------------------KRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSP 217 (463)
T ss_pred ccCchHHHHHH--------------------HhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCc
Confidence 99999999886 335689999999999999999999999999999999999986544 5
Q ss_pred EEEeccCccccccccccccC-C----CCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-
Q psy5539 527 VKIADFGLSRKMYLQDYYKG-D----ENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLT- 595 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~-~----~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~- 595 (653)
+||+||.|..-+........ . ....|+..|||||+.. ...|+.+.|.||||||||-|++ |.+||.|.-
T Consensus 218 vKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs-GYpPFvG~Cg 296 (463)
T KOG0607|consen 218 VKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS-GYPPFVGHCG 296 (463)
T ss_pred eeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh-CCCCccCccC
Confidence 79999988754322211111 1 1234566899999864 2368999999999999999998 667998642
Q ss_pred --------------HHHHHHHHHcCCccCCCC----CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 596 --------------HEEVVKYIKEGNILQAPD----NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 596 --------------~~e~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
...+++.|.+|.. ++|+ .++.+..++++..+-.++.+|.++.++++++|-
T Consensus 297 ~dCGWdrGe~Cr~CQ~~LFesIQEGkY-eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~ 364 (463)
T KOG0607|consen 297 ADCGWDRGEVCRVCQNKLFESIQEGKY-EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWV 364 (463)
T ss_pred CcCCccCCCccHHHHHHHHHHHhccCC-cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccc
Confidence 3468899999986 4554 478899999999999999999999999998874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=280.18 Aligned_cols=228 Identities=17% Similarity=0.211 Sum_probs=183.3
Q ss_pred cCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecCCCCh
Q psy5539 376 GAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDL 455 (653)
Q Consensus 376 G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 455 (653)
|.||+||++++. .+++.+|+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|
T Consensus 4 g~~~~v~~~~~~-----~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 72 (237)
T cd05576 4 GVIDKVLLVMDT-----RTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL 72 (237)
T ss_pred cccceEEEEEEc-----cCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence 899999999864 456789999997642 234455556667899999999999999999999999999999
Q ss_pred HHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcc
Q psy5539 456 NDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535 (653)
Q Consensus 456 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla 535 (653)
.+++.. ...+++..+..++.|+++||+|||+++|+||||||+||++++++.++++|||++
T Consensus 73 ~~~l~~--------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~ 132 (237)
T cd05576 73 WSHISK--------------------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRW 132 (237)
T ss_pred HHHHHH--------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccch
Confidence 999862 134789999999999999999999999999999999999999999999999988
Q ss_pred ccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCC
Q psy5539 536 RKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNT 615 (653)
Q Consensus 536 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~ 615 (653)
...... .....++..|+|||.+....++.++||||+|+++|||++|. .|+..... . +........+..+
T Consensus 133 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~-~~~~~~~~-~----~~~~~~~~~~~~~ 201 (237)
T cd05576 133 SEVEDS-----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGK-TLVECHPS-G----INTHTTLNIPEWV 201 (237)
T ss_pred hccccc-----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCc-chhhcCch-h----cccccccCCcccC
Confidence 654221 12234466799999998888999999999999999999965 34432211 1 1111223456678
Q ss_pred cHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 616 PDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 616 ~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
+..+++++.+|++.||++||++ +++++|.|
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~ 236 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence 8999999999999999999986 77776653
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=317.45 Aligned_cols=263 Identities=22% Similarity=0.290 Sum_probs=222.3
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceE
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
+...+...+++|.+++.||+|+||.|..++.+ .+++++|.|++..- .......-|..|-.+|..-+.+=|+.+
T Consensus 66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-----~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~L 140 (1317)
T KOG0612|consen 66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHK-----STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQL 140 (1317)
T ss_pred HHHHHhCCHHhhHHHHHhcccccceeEEEEee-----ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHH
Confidence 44566788899999999999999999999975 46789999999752 112234568899999999999999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
.-.|.+...+|||||||+||||-.+|. +...+++..+..++..|+.||.-||+.|+||||
T Consensus 141 hyAFQD~~~LYlVMdY~pGGDlltLlS--------------------k~~~~pE~~ArFY~aEiVlAldslH~mgyVHRD 200 (1317)
T KOG0612|consen 141 HYAFQDERYLYLVMDYMPGGDLLTLLS--------------------KFDRLPEDWARFYTAEIVLALDSLHSMGYVHRD 200 (1317)
T ss_pred HHHhcCccceEEEEecccCchHHHHHh--------------------hcCCChHHHHHHHHHHHHHHHHHHHhccceecc
Confidence 999999999999999999999999985 233689999999999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc----c-CCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL----Y-NKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~----~-~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
|||+|||||..|++||+|||.+-.+..+ ..-......|||-|.+||++. + +.|....|.||+||++|||+. |.
T Consensus 201 iKPDNvLld~~GHikLADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly-G~ 278 (1317)
T KOG0612|consen 201 IKPDNVLLDKSGHIKLADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY-GE 278 (1317)
T ss_pred CCcceeEecccCcEeeccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc-CC
Confidence 9999999999999999999998776433 334456678999999999985 3 679999999999999999997 55
Q ss_pred CCCCCCCHHHHHHHHHcC-CccCCC--CCCcHHHHHHHHHhhccCCCCCCC---HHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEG-NILQAP--DNTPDALYDLMKLCWNMKPMNRPS---FRTIYQTLWN 646 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~eil~~L~~ 646 (653)
.||+..+.-+....|.+. +.+.+| ..++.+.++||...+. +|+.|.. +++|..|++.
T Consensus 279 TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF 341 (1317)
T KOG0612|consen 279 TPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFF 341 (1317)
T ss_pred CcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccc
Confidence 699888877777777654 345666 3589999999999887 5778877 9999999864
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=277.68 Aligned_cols=261 Identities=22% Similarity=0.323 Sum_probs=209.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh-CCCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE-FDHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~ 438 (653)
.++..++++-+..||.|+||+|+|-.+ ...++.+|||+++....+..++++..|.+...+ -+.||||+++|.+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~h-----k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F 133 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLH-----KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF 133 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhc-----CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh
Confidence 466677778888899999999999775 457899999999988777778888888876554 47899999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATR 517 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~ 517 (653)
.++..|+-||.|. .+|..+-+... ......+++..+-+|..-.+.||.||-+ .+|||||+||+
T Consensus 134 ~EGdcWiCMELMd-~SlDklYk~vy---------------~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPS 197 (361)
T KOG1006|consen 134 SEGDCWICMELMD-ISLDKLYKRVY---------------SVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPS 197 (361)
T ss_pred cCCceeeeHHHHh-hhHHHHHHHHH---------------HHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChh
Confidence 9999999999995 47776654211 1233568888888999999999999985 48999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||||+..|.+||+|||++..+... ...+..+|-..|||||.+... .|+.+|||||||++|+|+.||.. ||.+.+
T Consensus 198 NILldr~G~vKLCDFGIcGqLv~S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f-Pyr~w~ 273 (361)
T KOG1006|consen 198 NILLDRHGDVKLCDFGICGQLVDS---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF-PYRKWD 273 (361)
T ss_pred heEEecCCCEeeecccchHhHHHH---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC-CcchHH
Confidence 999999999999999998654211 233556777789999999754 48999999999999999999665 887654
Q ss_pred H-HHHHHHHHcCCcc--CCCC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 H-EEVVKYIKEGNIL--QAPD---NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~-~e~~~~i~~~~~~--~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
. .|.+..+..|..+ ..+. +.+..+..++..|+.+|-+.||++.+++++.+
T Consensus 274 svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f 329 (361)
T KOG1006|consen 274 SVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF 329 (361)
T ss_pred HHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence 3 3444455555432 2222 36788999999999999999999999988765
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=280.88 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=208.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH--HHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY--LQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~--~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+...+|.++..||+|+||+|-+|.-+| +...+|||+++.+.--+ ..+--..|-++|+.. +-|.++.+...+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkg-----tdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScF 419 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKG-----TDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCF 419 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccC-----cchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHh
Confidence 4556789999999999999999998544 55789999998753211 011123455666655 578999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..-+.+++||||+.+|||--.+++ .+.+.+..+..+|..||-||-|||++||+.||||.+
T Consensus 420 QTmDRLyFVMEyvnGGDLMyhiQQ--------------------~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLD 479 (683)
T KOG0696|consen 420 QTMDRLYFVMEYVNGGDLMYHIQQ--------------------VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLD 479 (683)
T ss_pred hhhhheeeEEEEecCchhhhHHHH--------------------hcccCCchhhhhhHHHHHHhhhhhcCCeeeeecccc
Confidence 999999999999999999888863 345777888999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+|.+|.+||+|||+++.-...+ .+.....||+.|+|||.+.+..|....|.|||||+||||+. |.+||.+.+.+
T Consensus 480 NvmLd~eGHiKi~DFGmcKEni~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla-GQpPFdGeDE~ 556 (683)
T KOG0696|consen 480 NVMLDSEGHIKIADFGMCKENIFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQPPFDGEDED 556 (683)
T ss_pred ceEeccCCceEeeecccccccccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc-CCCCCCCCCHH
Confidence 9999999999999999997643322 23345678999999999999999999999999999999998 66799999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
++++.|.+.+. ..|...+.+..++.+..+.+.|.+|..
T Consensus 557 elF~aI~ehnv-syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 557 ELFQAIMEHNV-SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHHHHHHHccC-cCcccccHHHHHHHHHHhhcCCccccC
Confidence 99999999874 578889999999999999999999973
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-31 Score=269.14 Aligned_cols=240 Identities=30% Similarity=0.417 Sum_probs=201.8
Q ss_pred CCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecCCCChH
Q psy5539 377 AFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456 (653)
Q Consensus 377 ~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 456 (653)
+||.||+|...+ ++..+++|++.........+.+.+|++.+++++|+||+++++.+......++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~-----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKK-----TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECC-----CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHH
Confidence 589999998742 467899999976544332578999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 457 DFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 457 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
+++... ..+++..++.++.+++.+|.+||+.+++|+||+|+||++++++.++|+|||.+.
T Consensus 76 ~~~~~~--------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~ 135 (244)
T smart00220 76 DLLKKR--------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLAR 135 (244)
T ss_pred HHHHhc--------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEcccccee
Confidence 998621 227889999999999999999999999999999999999999999999999997
Q ss_pred cccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHHHHHcCCccCCCCC-
Q psy5539 537 KMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-LTHEEVVKYIKEGNILQAPDN- 614 (653)
Q Consensus 537 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~-~~~~e~~~~i~~~~~~~~~~~- 614 (653)
...... ......++..|++||.+....++.++||||||+++++|+++. .||.. .....+.+.+..+........
T Consensus 136 ~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 211 (244)
T smart00220 136 QLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGK-PPFPGDDQLLELFKKIGKPKPPFPPPEW 211 (244)
T ss_pred eecccc---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHhccCCCCccccc
Confidence 654332 223345677899999999889999999999999999999955 58876 666667777666554333322
Q ss_pred -CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 615 -TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 615 -~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.++.+++.+||..+|++||++.+++++.+
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~ 243 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQHPF 243 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhhCCC
Confidence 8899999999999999999999999998643
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-32 Score=294.89 Aligned_cols=256 Identities=27% Similarity=0.426 Sum_probs=197.4
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC------
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG------ 440 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~------ 440 (653)
+...+.||+||||.||+|+. .++|..||||.++........+..-+|+++|++|+|+|||+++++-...
T Consensus 15 W~~~e~LG~Ga~g~V~rgrn-----ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRN-----KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred eeehhhhcCCccceeeeecc-----cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 44556799999999999984 4688999999999876666677788999999999999999999985443
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
....+||||+++|||...|++ | .+...|++.+++.++.++..||.|||++||+||||||.||+
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~--P---------------EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIv 152 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNS--P---------------ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIV 152 (732)
T ss_pred ccceEEEeecCCCcHHHHhcC--c---------------ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Confidence 457899999999999999972 2 23456999999999999999999999999999999999999
Q ss_pred Ec--CCC--cEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCC---
Q psy5539 521 IN--DQM--VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYY--- 592 (653)
Q Consensus 521 l~--~~~--~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~--- 592 (653)
+- ++| .-||+|||.|+.+..+. .-....||..|.+||.... ..|+...|.|||||++||..||.+ ||-
T Consensus 153 l~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l-PF~p~~ 228 (732)
T KOG4250|consen 153 LQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL-PFIPFG 228 (732)
T ss_pred EeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC-CCCcCC
Confidence 84 333 56999999999874433 3355689999999999984 889999999999999999999776 553
Q ss_pred CC-CHHHHHHHHHcCCc--------------------cCCCCCCc----HHHHHHHHHhhccCCCCCC--CHHHHHHHHH
Q psy5539 593 GL-THEEVVKYIKEGNI--------------------LQAPDNTP----DALYDLMKLCWNMKPMNRP--SFRTIYQTLW 645 (653)
Q Consensus 593 ~~-~~~e~~~~i~~~~~--------------------~~~~~~~~----~~l~~li~~cl~~dP~~RP--s~~eil~~L~ 645 (653)
+. +..+++..+..++. ++.|...+ ..+-..+..++..+|.+|- .+.+....+.
T Consensus 229 ~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 229 GPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred CccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 22 22334433332111 12222222 3445566678888888888 6665555555
Q ss_pred HHH
Q psy5539 646 NIK 648 (653)
Q Consensus 646 ~l~ 648 (653)
.+.
T Consensus 309 dIL 311 (732)
T KOG4250|consen 309 DIL 311 (732)
T ss_pred HHH
Confidence 443
|
|
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=270.25 Aligned_cols=252 Identities=22% Similarity=0.340 Sum_probs=205.2
Q ss_pred CCCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEec--
Q psy5539 364 RNDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV-- 439 (653)
Q Consensus 364 ~~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~-- 439 (653)
+++|.+. +.||-|-.|+|-.+.. +.++..+|+|++.+.. ..++|+++--.. .|||||.++++++.
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~-----k~T~ekfALKvL~Ds~------KARrEVeLHw~~s~h~~iV~IidVyeNs~ 128 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVH-----KRTQEKFALKVLLDSP------KARREVELHWMASGHPHIVSIIDVYENSY 128 (400)
T ss_pred hhhheehhhhhccccCCceEEEEe-----ccchhhhHHHHHhcCH------HHHhHhhhhhhhcCCCceEEeehhhhhhc
Confidence 3455553 4699999999999875 3567889999997532 346788764444 69999999999854
Q ss_pred --CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 --GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..-+.+|||.|+||+|...++.. ....+++.++..|.+||..|+.|||+.+|.||||||+
T Consensus 129 ~~rkcLLiVmE~meGGeLfsriq~~------------------g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpE 190 (400)
T KOG0604|consen 129 QGRKCLLIVMECMEGGELFSRIQDR------------------GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPE 190 (400)
T ss_pred cCceeeEeeeecccchHHHHHHHHc------------------ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChh
Confidence 45688999999999999988732 3467999999999999999999999999999999999
Q ss_pred CEeEc---CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 518 NCLIN---DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 518 NILl~---~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
|+|.. .|-.+||+|||.|+.-.... .-....-|+.|.|||++...+|+...|+||+||++|-|++ |.+||+..
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLC-GyPPFYS~ 266 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC-GYPPFYSN 266 (400)
T ss_pred heeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhc-CCCccccc
Confidence 99996 45689999999998643211 1233455789999999999999999999999999999998 67888865
Q ss_pred C----HHHHHHHHHcCCccCCCC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 595 T----HEEVVKYIKEGNILQAPD---NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 595 ~----~~e~~~~i~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
. ...+..+|+.|+.....+ .++++.+++|+.+|..+|++|.|+++++.+.|-.+
T Consensus 267 hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 267 HGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQ 327 (400)
T ss_pred CCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcc
Confidence 4 345778889988643332 36788999999999999999999999999988654
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=300.80 Aligned_cols=278 Identities=16% Similarity=0.174 Sum_probs=176.4
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeE---
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV--- 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~--- 436 (653)
..+..++|.+.+.||+|+||.||+|++.... ...+..||||+++...... .+..| .+....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~-~~~~~~vAvK~~~~~~~~e---~~~~e--~l~~~~~~~~~~~~~~~~~ 200 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQ-SKKEGKYVLKKATEYGAVE---IWMNE--RVRRACPNSCADFVYGFLE 200 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCc-cccCcEEEEEEecccchhH---HHHHH--HHHhhchhhHHHHHHhhhc
Confidence 3556789999999999999999999975321 1236789999886432211 11111 1222223333322221
Q ss_pred ---EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 437 ---CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 437 ---~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
...+...+||+||+++++|.++++.............................+..++.||+.||+|||+++|+|||
T Consensus 201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD 280 (566)
T PLN03225 201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD 280 (566)
T ss_pred ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence 24567899999999999999999743210000000000000001112233455678999999999999999999999
Q ss_pred CCCCCEeEcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC----------------------CCCCc
Q psy5539 514 LATRNCLIND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN----------------------KYTVE 570 (653)
Q Consensus 514 Lkp~NILl~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----------------------~~t~k 570 (653)
|||+|||+++ ++.+||+|||+|+.+.....+ ......+++.|||||.+... .++.+
T Consensus 281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k 359 (566)
T PLN03225 281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359 (566)
T ss_pred CCHHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence 9999999985 689999999999765322221 22344668899999966432 24456
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc--------------------cCCCCCCcHHHHHHHHHhhccC
Q psy5539 571 SDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI--------------------LQAPDNTPDALYDLMKLCWNMK 630 (653)
Q Consensus 571 sDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~--------------------~~~~~~~~~~l~~li~~cl~~d 630 (653)
+|||||||+||||+++.. +.. .........+..... .+..+.......+|+.+|++.|
T Consensus 360 ~DVwSlGviL~el~~~~~-~~~-~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 360 FDIYSAGLIFLQMAFPNL-RSD-SNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cccHHHHHHHHHHHhCcC-CCc-hHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 799999999999998443 221 111111111111100 0011122344568999999999
Q ss_pred CCCCCCHHHHHHHHHH
Q psy5539 631 PMNRPSFRTIYQTLWN 646 (653)
Q Consensus 631 P~~RPs~~eil~~L~~ 646 (653)
|++|||++++++|+|-
T Consensus 438 P~kR~ta~e~L~Hpff 453 (566)
T PLN03225 438 GRQRISAKAALAHPYF 453 (566)
T ss_pred cccCCCHHHHhCCcCc
Confidence 9999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=292.33 Aligned_cols=282 Identities=19% Similarity=0.182 Sum_probs=196.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCC-----------CCCccceEEEEEEccccccHHHHH--------------HH
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGL-----------LKHEEFTLVAVKMLKDEASEYLQT--------------DF 415 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~-----------~~~~~~~~VAVK~l~~~~~~~~~~--------------~f 415 (653)
.+..++|++.++||+|+||.||+|..... .....++.||||+++..... ..+ .+
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~-~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQG-VRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchh-hHHHHHhhhhhhhcccchh
Confidence 45678999999999999999999975221 12234568999998754321 122 23
Q ss_pred HHHHHHHhhCCCCcc-----ceEEeEEec--------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcc------ccc
Q psy5539 416 EREACLLAEFDHPNI-----VKLLGVCAV--------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS------SME 476 (653)
Q Consensus 416 ~~Ei~il~~l~HpnI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~------~~~ 476 (653)
..|+.++.+++|.++ +++++++.. .+..+|||||+++|+|.++|+...... ..... ...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~--~~~L~e~l~~g~~l 297 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPF--PGCLEEFMMAGKKI 297 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCC--cchHHHHHhcCCch
Confidence 457777888877654 677777643 356899999999999999997432110 00000 000
Q ss_pred ccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCcccc
Q psy5539 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRW 556 (653)
Q Consensus 477 ~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y 556 (653)
........+++..+..++.|++.||.|||+.+|+||||||+|||++.++.+||+|||+++.+..... .......+++.|
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y 376 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRY 376 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcce
Confidence 0011223568889999999999999999999999999999999999999999999999976532211 112223447899
Q ss_pred ccchhhccCCC----------------------CCchhHHHHHHHHHHHHhCCCCCCCCCCHH--H---------HHHHH
Q psy5539 557 MPLESILYNKY----------------------TVESDVWAFGVCLWEIFSFALQPYYGLTHE--E---------VVKYI 603 (653)
Q Consensus 557 ~aPE~~~~~~~----------------------t~ksDVwSlGvvl~ellt~~~~p~~~~~~~--e---------~~~~i 603 (653)
+|||.+..... ..+.||||+||+++||+++...|+.+.... + ....+
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~ 456 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY 456 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh
Confidence 99998764321 134799999999999999888787643211 1 01111
Q ss_pred HcCCc-cCCCCCCcHHHHHHHHHhhccCC---CCCCCHHHHHHHHHH
Q psy5539 604 KEGNI-LQAPDNTPDALYDLMKLCWNMKP---MNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~~-~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~eil~~L~~ 646 (653)
..... ....+..++...+|+.+++..+| .+|+|++|+++|.|-
T Consensus 457 ~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f 503 (507)
T PLN03224 457 KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFF 503 (507)
T ss_pred cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCc
Confidence 11111 22235578899999999999866 689999999999875
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-32 Score=291.72 Aligned_cols=243 Identities=24% Similarity=0.361 Sum_probs=201.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
.+.|.+...+|.|+|+.|-.+... .+.+..+||++..... +-.+|+.++... +||||+++.+++..+.+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~-----~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESS-----PTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeecc-----ccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCce
Confidence 566788888999999999988753 3557789999976522 235667555554 79999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE-
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI- 521 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl- 521 (653)
.++|||.+.+|-|.+.+... . ....++..|+.+|+.++.|||++|+|||||||+|||+
T Consensus 391 ~~~v~e~l~g~ell~ri~~~--------------------~-~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~ 449 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSK--------------------P-EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD 449 (612)
T ss_pred eeeeehhccccHHHHHHHhc--------------------c-hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec
Confidence 99999999999888877511 1 2226778899999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~ 600 (653)
++.++++|+|||.++..... -.....|..|.|||++....||+++|+||||++||+|++|. .||..... .++.
T Consensus 450 ~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~-tp~~~~P~~~ei~ 523 (612)
T KOG0603|consen 450 GSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGR-TLFAAHPAGIEIH 523 (612)
T ss_pred CCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCC-CccccCCchHHHH
Confidence 69999999999999865322 12346678899999999999999999999999999999955 57765544 4777
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+.. .+.++++.++|++.||+.||.+||++.++..+.|.
T Consensus 524 ~~i~~~~~---s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 524 TRIQMPKF---SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HhhcCCcc---ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 77766643 37899999999999999999999999999999886
|
|
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=295.17 Aligned_cols=260 Identities=22% Similarity=0.421 Sum_probs=213.8
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
..+..+.+.+++.+.||.|.+|.||+++. ..+++.+|+|++..... .+++.+.|.++++.+ +|||++.++|+
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~-----~~~~~~aa~kI~~~~~d--~deEiE~eynil~~~~~hpnv~~fyg~ 84 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRH-----VKTGQLAAIKIMDPTED--EEEEIELEYNMLKKYSHHPNVATFYGA 84 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEee-----eecCceeeeEeecCCcc--ccHHHHHHHHHHHhccCCCCcceEEEE
Confidence 34455677899999999999999999984 34667888888765433 456778889999888 69999999999
Q ss_pred Eec-----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 437 CAV-----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 437 ~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
+.. ++.+|||||||.+|+..|+++.. ....+.|..+..|++.++.||.+||...++|
T Consensus 85 ~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~------------------~g~rl~E~~IaYI~re~lrgl~HLH~nkviH 146 (953)
T KOG0587|consen 85 FIKKDPGNGDQLWLVMEFCGGGSVTDLVKNT------------------KGNRLKEEWIAYILREILRGLAHLHNNKVIH 146 (953)
T ss_pred EEEecCCCCCeEEEEeeccCCccHHHHHhhh------------------cccchhhHHHHHHHHHHHHHHHHHhhcceee
Confidence 853 57899999999999999999721 1467899999999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-----CCCCchhHHHHHHHHHHHHhC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-----KYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~t~ksDVwSlGvvl~ellt~ 586 (653)
||||-.|||+++++.||+.|||.+..+.+. ........||+.|||||++... .|+.++|+||||++..||.-
T Consensus 147 RDikG~NiLLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIElad- 223 (953)
T KOG0587|consen 147 RDIKGQNVLLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAE- 223 (953)
T ss_pred ecccCceEEEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcC-
Confidence 999999999999999999999999765332 2334456789999999999754 57889999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.+|+.++-+-..+-.|..... +..|..++.++.++|..|+.+|..+||++.++++|.+
T Consensus 224 G~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 224 GAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred CCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 5568887776554444433222 2235678899999999999999999999999998864
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-33 Score=266.13 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=199.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccc-cccHHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~-~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
+.|.-..+||+|.||.||+|+.. .+++.||+|.+-- +..+..-....+|+++|..|+|+|++.++..|..
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~-----n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSK-----NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhc-----CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 34555677999999999999853 4667788886532 2233333456799999999999999999988743
Q ss_pred ----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 440 ----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 440 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
...++|||.++++ ||...|. .....++..++.++..++..||.|+|...|+|||+|
T Consensus 92 ~~r~r~t~ylVf~~ceh-DLaGlLs-------------------n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFCEH-DLAGLLS-------------------NRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred cccccceeeeeHHHhhh-hHHHHhc-------------------CccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 3458999999987 8888774 223568889999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccC--CCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKG--DENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|.|+||+.+|.+||+|||+++.+...+.... -++...|..|.+||.+.+. .|+++.|||+-||++.||++ +.+-++
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwt-rspimq 230 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWT-RSPIMQ 230 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHc-cCcccc
Confidence 9999999999999999999976644332222 2355678999999998875 68999999999999999999 445677
Q ss_pred CCCHHHHHHHHHc--CCc-------------------cCCCC-------------CCcHHHHHHHHHhhccCCCCCCCHH
Q psy5539 593 GLTHEEVVKYIKE--GNI-------------------LQAPD-------------NTPDALYDLMKLCWNMKPMNRPSFR 638 (653)
Q Consensus 593 ~~~~~e~~~~i~~--~~~-------------------~~~~~-------------~~~~~l~~li~~cl~~dP~~RPs~~ 638 (653)
+.+.+..+..|.. |.+ .+.+. .-.++..+|+.+++..||.+|+.++
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad 310 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDAD 310 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchH
Confidence 7766655555432 111 00110 1134678999999999999999999
Q ss_pred HHHHHHHHHH
Q psy5539 639 TIYQTLWNIK 648 (653)
Q Consensus 639 eil~~L~~l~ 648 (653)
++++|.+..+
T Consensus 311 ~alnh~~F~k 320 (376)
T KOG0669|consen 311 QALNHDFFWK 320 (376)
T ss_pred hhhchhhhhc
Confidence 9998876543
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=247.87 Aligned_cols=222 Identities=27% Similarity=0.392 Sum_probs=182.3
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh-CCCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE-FDHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~-l~HpnIv~l~g~~~ 438 (653)
++++.+++.-+..||+|++|.|-+-++. .+++..|+|+++.....+.++...+|+.+..+ ...|.+|.++|...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~-----~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHI-----QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeec-----cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 5788888888899999999999888753 57899999999887666777788888877555 57999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATR 517 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~ 517 (653)
.....++.||.|+- +|..|-+.. ......+++..+-+|+..|+.||.|||++ .++|||+||+
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v----------------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPs 178 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKV----------------LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPS 178 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHH----------------HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcc
Confidence 99999999999954 888877632 34567789999999999999999999987 8999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC----CCCCchhHHHHHHHHHHHHhCCCCCCC-
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN----KYTVESDVWAFGVCLWEIFSFALQPYY- 592 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~----~~t~ksDVwSlGvvl~ellt~~~~p~~- 592 (653)
||||+..|+|||+|||++..+... ...+..+|--.|||||.+..+ .|+.+|||||||+++.||.++.. ||.
T Consensus 179 NiLIn~~GqVKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~-PY~~ 254 (282)
T KOG0984|consen 179 NILINYDGQVKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRF-PYES 254 (282)
T ss_pred eEEEccCCcEEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccc-cccc
Confidence 999999999999999999755221 122335566679999988643 68999999999999999999665 664
Q ss_pred CCCHHHHHHHHHcCC
Q psy5539 593 GLTHEEVVKYIKEGN 607 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~ 607 (653)
..++.+.+..+.+..
T Consensus 255 w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 255 WGTPFQQLKQVVEEP 269 (282)
T ss_pred cCCHHHHHHHHhcCC
Confidence 456666666665543
|
|
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=279.76 Aligned_cols=257 Identities=23% Similarity=0.318 Sum_probs=220.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+...+++.+..||-|+||.|=+++..+ ....+|+|.+++. .....++-+..|-.+|...+.|.||++|-.+.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~-----~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNS-----QKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecc-----cchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 344567778889999999999998743 2225788887654 223345567789999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..||+||-+-||.|+..|+ +.+.++......++..+++|++|||+++||.|||||+|+
T Consensus 492 ~kyvYmLmEaClGGElWTiLr--------------------dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILR--------------------DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred chhhhhhHHhhcCchhhhhhh--------------------hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 999999999999999999997 345678888899999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+|.+|-+||.|||.|+.+..... .-...||+.|.|||.+.....+.+.|.||||++++||++ |.+||.+.++-..
T Consensus 552 lLd~~Gy~KLVDFGFAKki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~-G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 552 LLDNRGYLKLVDFGFAKKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLT-GSPPFSGVDPMKT 627 (732)
T ss_pred eeccCCceEEeehhhHHHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHc-CCCCCCCCchHHH
Confidence 999999999999999998744332 234678999999999999999999999999999999999 6689999999888
Q ss_pred HHHHHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHHHH
Q psy5539 600 VKYIKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~~l 647 (653)
...|..|- ....|..++....+||++.+..+|.+|.. +.+|.+|-|-.
T Consensus 628 Yn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 628 YNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred HHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 88887764 35778889999999999999999999985 78899888754
|
|
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=277.25 Aligned_cols=246 Identities=22% Similarity=0.365 Sum_probs=206.6
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.||+|.||+||-|+. ..+|+.||||++.+.. .......+++|+.||..++||.||.|-..++..+..+.|||.
T Consensus 570 evLGSGQFG~VYgg~h-----RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEK 644 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKH-----RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEK 644 (888)
T ss_pred hhccCCcceeeeccee-----cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehh
Confidence 4699999999999875 4678999999986542 233446789999999999999999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC---Cc
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ---MV 526 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~---~~ 526 (653)
+ +||..+.+- ....+.|++.....++.||+.||.|||.++|+|+||||+|||+.+. -.
T Consensus 645 l-~GDMLEMIL------------------SsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQ 705 (888)
T KOG4236|consen 645 L-HGDMLEMIL------------------SSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQ 705 (888)
T ss_pred h-cchHHHHHH------------------HhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCc
Confidence 8 567777663 2345678999999999999999999999999999999999999643 58
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~ 606 (653)
+||+|||.|+.+...... ....||+.|.|||++....|+..-|+||.||++|--++|.. ||. ..+++-+.|...
T Consensus 706 vKlCDFGfARiIgEksFR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTF-PFN--EdEdIndQIQNA 779 (888)
T KOG4236|consen 706 VKLCDFGFARIIGEKSFR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTF-PFN--EDEDINDQIQNA 779 (888)
T ss_pred eeeccccceeecchhhhh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccc-cCC--CccchhHHhhcc
Confidence 999999999987554432 34578999999999999999999999999999999999655 664 345677777777
Q ss_pred CccCCCC---CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 607 NILQAPD---NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 607 ~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.++-.+. .++++..+||...++..-.+|.|.+.-+.|+|.
T Consensus 780 aFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wl 822 (888)
T KOG4236|consen 780 AFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWL 822 (888)
T ss_pred ccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhh
Confidence 6654443 477899999999999999999999998888763
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=289.22 Aligned_cols=245 Identities=27% Similarity=0.338 Sum_probs=192.1
Q ss_pred EeeecccCCee-EEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCceEEEE
Q psy5539 370 VRDLGQGAFGR-VFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 370 ~~~LG~G~fG~-Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~~LV~ 447 (653)
.+.+|.|+.|+ ||+|.. +++.||||++-.+. .+...+||..|..- +|||||++++.-.+....|+..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-------e~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-------EGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred HHHcccCCCCcEEEEEee-------CCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 34589999976 799986 44799999986543 33567899998887 6999999999999999999999
Q ss_pred eecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC----
Q psy5539 448 EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND---- 523 (653)
Q Consensus 448 Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~---- 523 (653)
|.+.- +|.+++..... ..........+.+..|+++||++||+-+||||||||.||||+.
T Consensus 583 ELC~~-sL~dlie~~~~----------------d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~ 645 (903)
T KOG1027|consen 583 ELCAC-SLQDLIESSGL----------------DVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSAD 645 (903)
T ss_pred hHhhh-hHHHHHhcccc----------------chhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCC
Confidence 99965 99999984210 0111122456788899999999999999999999999999975
Q ss_pred -CCcEEEeccCccccccccc-cccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 -QMVVKIADFGLSRKMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 -~~~vkI~DfGla~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
...++|+|||+++.+.... .+.......||-+|+|||.+....-+.+.||||||||+|+.++||..||.+.-..+ .
T Consensus 646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~ 723 (903)
T KOG1027|consen 646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--A 723 (903)
T ss_pred cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--h
Confidence 2588999999999886443 23345567889999999999999999999999999999999999999997544332 1
Q ss_pred HHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 602 YIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 602 ~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.|..+.. .........+..+||.+|++++|..||++.+|+.|+
T Consensus 724 NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 724 NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 2233322 111111122789999999999999999999999886
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=270.84 Aligned_cols=256 Identities=25% Similarity=0.382 Sum_probs=201.5
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--c----cHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--A----SEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~----~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
.-.++|.++..||+|||+.||+|.+ ..+.+.||||+-.-+ . .+...+-..+|.+|-+.|+||.||++|+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFD-----l~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFD-----LTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcc-----cchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 3445677788899999999999985 346688999975422 1 1222334568999999999999999999
Q ss_pred EEe-cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC--Cceec
Q psy5539 436 VCA-VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR--KFVHR 512 (653)
Q Consensus 436 ~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--~ivHr 512 (653)
++. +.+.+|-|+||++|.||.-||+++ ..+++.++..|+.||+.+|.||.+. +|||-
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQh--------------------klmSEKEARSIiMQiVnAL~YLNEikpPIIHY 594 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQH--------------------KLMSEKEARSIIMQIVNALKYLNEIKPPIIHY 594 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhh--------------------hhhhHHHHHHHHHHHHHHHHHHhccCCCeeee
Confidence 986 456889999999999999999843 3578999999999999999999965 79999
Q ss_pred CCCCCCEeEcC---CCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccC----CCCCchhHHHHHHHH
Q psy5539 513 DLATRNCLIND---QMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYN----KYTVESDVWAFGVCL 580 (653)
Q Consensus 513 DLkp~NILl~~---~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~----~~t~ksDVwSlGvvl 580 (653)
||||.|||+-+ -|.+||.||||++.+....+. ......+||..|.+||.+.-+ +.+.|.||||.|||+
T Consensus 595 DLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIF 674 (775)
T KOG1151|consen 595 DLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIF 674 (775)
T ss_pred ccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhh
Confidence 99999999954 478999999999988654443 234567899999999987644 678999999999999
Q ss_pred HHHHhCCCCCCCCC-CHHHHHHH---HHcCCccCCC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 581 WEIFSFALQPYYGL-THEEVVKY---IKEGNILQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 581 ~ellt~~~~p~~~~-~~~e~~~~---i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
|+.+.|.. ||... +.+++++. +...+ ..+| +.++.+..++|++||+..-++|....++..+.
T Consensus 675 yQClYGrK-PFGhnqsQQdILqeNTIlkAtE-VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dp 742 (775)
T KOG1151|consen 675 YQCLYGRK-PFGHNQSQQDILQENTILKATE-VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDP 742 (775)
T ss_pred hhhhccCC-CCCCchhHHHHHhhhchhccee-ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCc
Confidence 99997555 77544 44555443 12222 2222 45789999999999999999999888876653
|
|
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=266.94 Aligned_cols=254 Identities=22% Similarity=0.305 Sum_probs=198.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC--C----ccceEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH--P----NIVKLL 434 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H--p----nIv~l~ 434 (653)
..-.++|.++..+|+|.||+|-++.+. +.+..||||+++.- ....+...-|++++.++.+ | -+|.+.
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~-----~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDR-----ETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeec-----CCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 344678999999999999999999864 33689999999853 3456677889999999942 2 467788
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++.-.++.|+|+|.+ |-++.+||+.+ +..+++...+..|+.|++++++|||+.+++|-||
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N------------------~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDL 218 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN------------------NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDL 218 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC------------------CccccchHHHHHHHHHHHHHHHHHHhcceeecCC
Confidence 8899999999999988 45999999722 3456888999999999999999999999999999
Q ss_pred CCCCEeEc--------------------CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHH
Q psy5539 515 ATRNCLIN--------------------DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVW 574 (653)
Q Consensus 515 kp~NILl~--------------------~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVw 574 (653)
||+|||+. .+..++|+|||.|+..... ......|-.|.|||++.+-.++..+|||
T Consensus 219 KPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvW 293 (415)
T KOG0671|consen 219 KPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVW 293 (415)
T ss_pred ChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCce
Confidence 99999982 1346899999999764221 1334557789999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC-----------------ccC------------------------
Q psy5539 575 AFGVCLWEIFSFALQPYYGLTHEE---VVKYIKEGN-----------------ILQ------------------------ 610 (653)
Q Consensus 575 SlGvvl~ellt~~~~p~~~~~~~e---~~~~i~~~~-----------------~~~------------------------ 610 (653)
|+||||.|+++|.. .|+..+..| +++.|...- .+.
T Consensus 294 SiGCIL~ElytG~~-LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~ 372 (415)
T KOG0671|consen 294 SIGCILVELYTGET-LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM 372 (415)
T ss_pred eeeeEEEEeeccce-ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence 99999999999665 555444333 333332100 000
Q ss_pred -CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 611 -APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 611 -~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+....++.+|+++||..||.+|+|+.|++.|++-
T Consensus 373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF 409 (415)
T KOG0671|consen 373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFF 409 (415)
T ss_pred ccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHh
Confidence 001123478999999999999999999999999874
|
|
| >cd07459 CRD_TK_ROR_like Cysteine-rich domain of tyrosine kinase-like orphan receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.1e-30 Score=231.94 Aligned_cols=132 Identities=27% Similarity=0.621 Sum_probs=115.6
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH--HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA--LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~--~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
|||++|+|.+|++||. +..|||++.. +++.++++|.++ +|++. ++||+.|++||+++||+|+||+|++....|.
T Consensus 1 G~C~~Y~G~vC~~~L~-~~~Vyv~~~~--~q~~~e~~l~~~~~~i~~~-~~ls~~C~~~a~~~lC~~~FP~C~~~~~~~~ 76 (135)
T cd07459 1 GYCQPYRGSVCAKYLG-NKSVYVTSKQ--TQEDIEEQLSAAFTVISTS-SDVSPKCQQYALPSLCYYAFPLCDEGSSTPK 76 (135)
T ss_pred CcCccccchhhHHhcC-CCeEEEeCCC--CHHHHHHHHHHHHHHHHhc-ccccHHHHHHHHHHHHHhhCCCCCCCCCCCC
Confidence 8999999999999998 5679996653 355777788776 45555 7899999999999999999999999888899
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQL 175 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~ 175 (653)
|+++||++|+.++.++|.+||+++++++.+| +++.+|+|+.||..+. .+++.|+.+++
T Consensus 77 p~~iCre~C~~l~~~~C~~E~~~~~~~~~~g------~~~~lp~C~~LP~~~~-~~~~~C~~ig~ 134 (135)
T cd07459 77 PRRICRDECELLENDLCKKEYAIAKRHPLIG------HQLLLPDCSSLPSPGS-PESSNCIRLGI 134 (135)
T ss_pred CCcccHHHHHHHHHhHhHHHHHHHHhCcccC------CccCCCCccCCCCCCC-CCCCCCeecCC
Confidence 9999999999999999999999999999877 6789999999998873 57889988765
|
The cysteine-rich domain (CRD) is an essential part of the tyrosine kinase-like orphan receptor (Ror) proteins, a conserved family of tyrosine kinases that function in various processes, including neuronal and skeletal development, cell polarity, and cell movement. Ror proteins are receptors of Wnt proteins, which are key players in a number of fundamental cellular processes in embryogenesis and postnatal development. In different cellular contexts, Ror proteins can either activate or repress transcription of Wnt target genes, and can modulate Wnt signaling by sequestering Wnt ligands. In addition, a number of Wnt-independent functions have been proposed for both Ror1 and Ror2. |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=248.53 Aligned_cols=256 Identities=20% Similarity=0.336 Sum_probs=206.7
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
..+..++|.+++.||+|+|++|.++++. .+.+.+|+|+++++. .....+-.+.|-.+.... +||.+|.|...
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~-----~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhsc 319 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSC 319 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehc-----ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhh
Confidence 4556789999999999999999999864 456899999998652 112233455666665554 79999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+..+..+++|.||+++|+|--+++ ....++++.+..+...|..+|.|||++||+.||||.
T Consensus 320 fqtesrlffvieyv~ggdlmfhmq--------------------rqrklpeeharfys~ei~lal~flh~rgiiyrdlkl 379 (593)
T KOG0695|consen 320 FQTESRLFFVIEYVNGGDLMFHMQ--------------------RQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKL 379 (593)
T ss_pred hcccceEEEEEEEecCcceeeehh--------------------hhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccc
Confidence 999999999999999999976664 345789999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC--C-
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY--G- 593 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~--~- 593 (653)
+|||+|..|.+||.|+|+.+...... .......||+.|.|||.+.+..|....|.|+|||+++||+.|. .||. +
T Consensus 380 dnvlldaeghikltdygmcke~l~~g--d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagr-spfdivgm 456 (593)
T KOG0695|consen 380 DNVLLDAEGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR-SPFDIVGM 456 (593)
T ss_pred cceEEccCCceeecccchhhcCCCCC--cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCC-CCcceecC
Confidence 99999999999999999997643222 2335567899999999999999999999999999999999855 4774 2
Q ss_pred ----CCHHH-HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC------CHHHHHHHH
Q psy5539 594 ----LTHEE-VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP------SFRTIYQTL 644 (653)
Q Consensus 594 ----~~~~e-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~eil~~L 644 (653)
++.++ +++.|.+.++ ..|...+-....+++.-+++||.+|. .++++..|.
T Consensus 457 ~n~d~ntedylfqvilekqi-riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ 517 (593)
T KOG0695|consen 457 DNPDMNTEDYLFQVILEKQI-RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHA 517 (593)
T ss_pred CCcccchhHHHHHHHhhhcc-cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcch
Confidence 23333 5566666553 56777777788899999999999986 456666554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-28 Score=236.06 Aligned_cols=213 Identities=36% Similarity=0.562 Sum_probs=183.7
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecCC
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGR 452 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 452 (653)
||+|++|.||+++..+ .+..+++|.+.........+.+.+|+..++.++|++|+++++++......++++||+++
T Consensus 1 l~~g~~~~v~~~~~~~-----~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKK-----TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecC-----CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCC
Confidence 6899999999998642 46789999998665433456799999999999999999999999998999999999999
Q ss_pred CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC-CCcEEEec
Q psy5539 453 GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND-QMVVKIAD 531 (653)
Q Consensus 453 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~-~~~vkI~D 531 (653)
++|.+++... ...++...+..++.+++++|.+||+.+++|+||+|.||++++ ++.++|+|
T Consensus 76 ~~l~~~~~~~-------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d 136 (215)
T cd00180 76 GSLKDLLKEN-------------------EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136 (215)
T ss_pred CcHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEec
Confidence 9999998621 135789999999999999999999999999999999999999 89999999
Q ss_pred cCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 532 fGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
||.+........ ..........|++||.+... ..+.++|+|++|+++++|
T Consensus 137 ~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------- 187 (215)
T cd00180 137 FGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------- 187 (215)
T ss_pred CCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------
Confidence 999976532211 12334566789999999887 889999999999999998
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
..+.+++..|++.+|++||++.++++++
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6789999999999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=265.84 Aligned_cols=258 Identities=21% Similarity=0.302 Sum_probs=200.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.....-|..++.||-|+||.|.+++- ..+...+|.|.+++.. ......-++.|-.||+.-+.+=||+||-.|.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~K-----vDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQ 699 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRK-----VDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQ 699 (1034)
T ss_pred hccccceEEEeeecccccceeEEEee-----cchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEec
Confidence 34566788899999999999999973 3346789999997542 1223344678999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+++.+|+||||++|||+-.+|- ..+-+.+..+..++.+++.++++.|..|+|||||||+|
T Consensus 700 DkdnLYFVMdYIPGGDmMSLLI--------------------rmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDN 759 (1034)
T KOG0608|consen 700 DKDNLYFVMDYIPGGDMMSLLI--------------------RMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN 759 (1034)
T ss_pred cCCceEEEEeccCCccHHHHHH--------------------HhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccc
Confidence 9999999999999999999886 23557888889999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccc--------c-ccccc-------------------------------CCCCCCCcccccc
Q psy5539 519 CLINDQMVVKIADFGLSRKMY--------L-QDYYK-------------------------------GDENDAIPVRWMP 558 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~--------~-~~~~~-------------------------------~~~~~~~t~~y~a 558 (653)
||||.+|.+||.||||..-+. . .+... ......||..|+|
T Consensus 760 ILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyia 839 (1034)
T KOG0608|consen 760 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIA 839 (1034)
T ss_pred eEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccC
Confidence 999999999999999975331 0 00000 0112347889999
Q ss_pred chhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCccCCC--CCCcHHHHHHHHHhhccCCCCCC
Q psy5539 559 LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK-EGNILQAP--DNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 559 PE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~-~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RP 635 (653)
||++....++.-.|.||.||||+||+- |.+||...++.+...+|. -...+.++ .+++.+..+||.+++. +++.|.
T Consensus 840 pevl~r~g~~q~cdwws~gvil~em~~-g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL 917 (1034)
T KOG0608|consen 840 PEVLARTGYTQLCDWWSVGVILYEMLV-GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL 917 (1034)
T ss_pred hHHhcccCccccchhhHhhHHHHHHhh-CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence 999999999999999999999999997 567888776655433332 22334443 4678888888887544 456665
Q ss_pred ---CHHHHHHHHH
Q psy5539 636 ---SFRTIYQTLW 645 (653)
Q Consensus 636 ---s~~eil~~L~ 645 (653)
..++|..|.|
T Consensus 918 Gkng~d~vKaHpf 930 (1034)
T KOG0608|consen 918 GKNGADQVKAHPF 930 (1034)
T ss_pred cccchhhhhcCcc
Confidence 4455665543
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=247.81 Aligned_cols=248 Identities=25% Similarity=0.389 Sum_probs=187.9
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC-----Cce
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-----KPM 443 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-----~~~ 443 (653)
-+.||-|+||.||.++++ ++++.||.|++..-. +-..-+.+.+|+++|..++|.|++..++...-. .+.
T Consensus 58 DRPIGYGAFGVVWsVTDP-----RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDP-----RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred CCcccccceeEEEeccCC-----CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 356899999999999865 578899999886432 223345788999999999999999999886543 356
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
|.|.|.|.. ||++.+. ....++...+.-++.||++||.|||+.+|.||||||.|.|++.
T Consensus 133 YV~TELmQS-DLHKIIV--------------------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNS 191 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIV--------------------SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNS 191 (449)
T ss_pred HHHHHHHHh-hhhheec--------------------cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEecc
Confidence 778888854 7776654 3456777778888999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
|..+||+|||+++.-.. +.....+....|-.|.|||.+.+. .|+.+.||||.||++.||+. ..-.|+..++-+.++.
T Consensus 192 NCvLKICDFGLARvee~-d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg-RrILFQAq~PiqQL~l 269 (449)
T KOG0664|consen 192 NCILKICDFGLARTWDQ-RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ-RKILFQAAGPIEQLQM 269 (449)
T ss_pred CceEEecccccccccch-hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh-hhhhhhccChHHHHHH
Confidence 99999999999986432 222333445567789999999876 68999999999999999995 4446665554433333
Q ss_pred HHc---------------CCc-------cCC-----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKE---------------GNI-------LQA-----------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~---------------~~~-------~~~-----------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.+ |.. ... ++.-..+...+..+++..+|+.|.+..+.+.++.
T Consensus 270 ItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 270 IIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred HHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 322 110 011 1223356778888999999999999998887764
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=233.14 Aligned_cols=247 Identities=20% Similarity=0.349 Sum_probs=191.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEec--C
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAV--G 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~--~ 440 (653)
.++|++++++|+|.|+.||.|... .+...++||++++-. .+.+.+|+.+|..|+ ||||++|+++..+ .
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~-----~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S 107 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINI-----TNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPES 107 (338)
T ss_pred cchHHHHHHHcCccHhhHhccccc-----CCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence 357899999999999999999742 345679999998642 346889999999997 9999999999865 4
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
....||+||+.+.|..... +.++..++..++.++++||.|+|++||.|||+||.|++
T Consensus 108 ktpaLiFE~v~n~Dfk~ly-----------------------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvm 164 (338)
T KOG0668|consen 108 KTPSLIFEYVNNTDFKQLY-----------------------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVM 164 (338)
T ss_pred cCchhHhhhhccccHHHHh-----------------------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceee
Confidence 5678999999998776654 45788899999999999999999999999999999999
Q ss_pred EcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 521 IND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 521 l~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||. ...++|+|+|||........+ .....+-.|.-||.+.. ..|+..-|+|||||+|..|+-.+.+.|.|.+..+
T Consensus 165 Idh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D 241 (338)
T KOG0668|consen 165 IDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 241 (338)
T ss_pred echhhceeeeeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH
Confidence 995 468999999999765332221 12233445788998764 5688999999999999999986666666655433
Q ss_pred HH-------------HHHHcCCc-------------cCC-------C---CCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 599 VV-------------KYIKEGNI-------------LQA-------P---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 599 ~~-------------~~i~~~~~-------------~~~-------~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
.+ ..+..=++ ... + ...+++..+|+.+.+..|-.+|||++|.+.
T Consensus 242 QLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 242 QLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 21 22211000 000 0 124588999999999999999999999998
Q ss_pred HHH
Q psy5539 643 TLW 645 (653)
Q Consensus 643 ~L~ 645 (653)
|+.
T Consensus 322 Hpy 324 (338)
T KOG0668|consen 322 HPY 324 (338)
T ss_pred Cch
Confidence 875
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=258.85 Aligned_cols=199 Identities=29% Similarity=0.387 Sum_probs=166.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHH-----HHHHHHHHHhhCC---CCccceEE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQT-----DFEREACLLAEFD---HPNIVKLL 434 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~-----~f~~Ei~il~~l~---HpnIv~l~ 434 (653)
.+|..++.||+|+||.|++|.++ +....|+||++.++.- ..+.+ .+--||.||+.++ |+||++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K-----~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL 635 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHK-----ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL 635 (772)
T ss_pred ccceeeeeccccccceEEEeeec-----ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence 35788899999999999999874 3468899999976521 11111 2457999999998 99999999
Q ss_pred eEEecCCceEEEEeec-CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 435 GVCAVGKPMCLLFEYM-GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~-~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
++|++++.++|+||-. ++.||.+|+. ..+.+++.++..|++||+.|+++||+.+|||||
T Consensus 636 dfFEddd~yyl~te~hg~gIDLFd~IE--------------------~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrd 695 (772)
T KOG1152|consen 636 DFFEDDDYYYLETEVHGEGIDLFDFIE--------------------FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRD 695 (772)
T ss_pred heeecCCeeEEEecCCCCCcchhhhhh--------------------ccCccchHHHHHHHHHHHhccccccccCceecc
Confidence 9999999999999975 4679999986 235689999999999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
||-+||.++.+|.+||+|||.|....+ .+-....||+.|.|||++.+.+| ...-|||++|++||-++. +..||+
T Consensus 696 ikdenvivd~~g~~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivy-kenpyy 770 (772)
T KOG1152|consen 696 IKDENVIVDSNGFVKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVY-KENPYY 770 (772)
T ss_pred cccccEEEecCCeEEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEe-ccCCCc
Confidence 999999999999999999999865321 12234678999999999999987 577899999999999885 666876
Q ss_pred C
Q psy5539 593 G 593 (653)
Q Consensus 593 ~ 593 (653)
.
T Consensus 771 n 771 (772)
T KOG1152|consen 771 N 771 (772)
T ss_pred C
Confidence 4
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=229.00 Aligned_cols=216 Identities=34% Similarity=0.466 Sum_probs=178.3
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
|.+.+.||+|++|.||++...+ ++..+++|.+.........+.+.+|++.+++++|+|++++++++......+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~-----~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG-----TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC-----CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEE
Confidence 3567889999999999998642 45789999998654433466889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCC-CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ-LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
+||+++++|.+++... .. +++.....++.+++.++.+||+.+++|+||+|+||+++.++
T Consensus 76 ~e~~~~~~L~~~~~~~--------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~ 135 (225)
T smart00221 76 MEYCEGGDLFDYLRKK--------------------GGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG 135 (225)
T ss_pred EeccCCCCHHHHHHhc--------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 9999999999998621 12 78889999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhh-ccCCCCCchhHHHHHHHHHHHHhCCCCCCCC--CCHHHHHHH
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI-LYNKYTVESDVWAFGVCLWEIFSFALQPYYG--LTHEEVVKY 602 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~-~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~--~~~~e~~~~ 602 (653)
.++|+|||++........ .......++..|++||.. ....++.++|||+||++++||++ +..||.. ....++.+.
T Consensus 136 ~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~-g~~pf~~~~~~~~~~~~~ 213 (225)
T smart00221 136 LVKLADFGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW-GPEPFSGEGEFTSLLSDV 213 (225)
T ss_pred CEEEeeCceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH-CCCCccccchhHHHHHHH
Confidence 999999999876533210 011234456789999998 66778889999999999999999 5668877 344577788
Q ss_pred HHcCCcc
Q psy5539 603 IKEGNIL 609 (653)
Q Consensus 603 i~~~~~~ 609 (653)
+..+...
T Consensus 214 ~~~~~~~ 220 (225)
T smart00221 214 WSFGVPL 220 (225)
T ss_pred HhcCCcc
Confidence 8776543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=263.48 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=205.6
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
-++++|..+..+|.|.||.|||+++. ..+...|||+++-+.... ..-.++|+-+++.-+|||||.++|.+...+
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~-----~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~d 85 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDK-----RSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRD 85 (829)
T ss_pred CCccchhheeeecCCcccchhhhccc-----ccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhc
Confidence 35568999999999999999999863 567899999998765543 345778999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.+++.|||+.+|+|.+.-+ ..+++++.++..+.+..++||+|||+.+=+|||||-.|||+
T Consensus 86 klwicMEycgggslQdiy~--------------------~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 86 KLWICMEYCGGGSLQDIYH--------------------VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred CcEEEEEecCCCcccceee--------------------ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 9999999999999987543 45789999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
++.|.+|++|||.+..+.. .........||+.|||||+.. .+.|...+|||++|+...|+-. -.+|..+.-+..
T Consensus 146 td~gDvklaDfgvsaqita--ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e-Lqpplfdlhpmr 222 (829)
T KOG0576|consen 146 TDEGDVKLADFGVSAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE-LQPPLFDLHPMR 222 (829)
T ss_pred cccCceeecccCchhhhhh--hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh-cCCcccccchHH
Confidence 9999999999999865421 122335578999999999864 4578999999999999999864 223333333333
Q ss_pred HHHHHH-cCCc---cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 599 VVKYIK-EGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 599 ~~~~i~-~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
...... .+.. ++.+..+.+.+.+|++.++.++|.+||+++.+++|.
T Consensus 223 ~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~ 272 (829)
T KOG0576|consen 223 ALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHP 272 (829)
T ss_pred HHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheece
Confidence 333332 2221 223345788999999999999999999999988765
|
|
| >smart00130 KR Kringle domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=202.35 Aligned_cols=82 Identities=54% Similarity=1.209 Sum_probs=77.3
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
+||.|+|..|||++++|.+|++||.|+++.++.+.+.+..+|...+.||||||||++..+|||||.++...||||+||+|
T Consensus 2 ~Cy~g~G~~YrG~~s~T~sG~~Cl~W~s~~~~~~~~~~~~~~~~~~~hNyCRNPd~~~~~PWCyv~~~~~~~e~C~ip~C 81 (83)
T smart00130 2 DCYAGNGESYRGTVSVTKSGKPCQRWDSQTPHLHRFTPESFPEAGLEENYCRNPDGDSEGPWCYTTDPNVRWEYCDIPQC 81 (83)
T ss_pred cCcCCCCCcccccceECCCCCcccCccCCCCcccccChhhCccccccccccCCCCCCCCCCEEEeCCCCcceEeCCCCcC
Confidence 79999999999999999999999999999999998888899988899999999999766999999888899999999999
Q ss_pred CC
Q psy5539 266 AD 267 (653)
Q Consensus 266 ~~ 267 (653)
.+
T Consensus 82 ~~ 83 (83)
T smart00130 82 EE 83 (83)
T ss_pred CC
Confidence 74
|
Named after a Danish pastry. Found in several serine proteases and in ROR-like receptors. Can occur in up to 38 copies (in apolipoprotein(a)). Plasminogen-like kringles possess affinity for free lysine and lysine- containing peptides. |
| >cd00108 KR Kringle domain; Kringle domains are believed to play a role in binding mediators, such as peptides, other proteins, membranes, or phospholipids | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=202.22 Aligned_cols=82 Identities=54% Similarity=1.144 Sum_probs=77.7
Q ss_pred cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 185 ~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
.+||.|+|..|||++++|.+|++||.|+++.++.|.+.+..+|...+.||||||||++..+|||||.++...||||+||+
T Consensus 2 ~~Cy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~~~hNyCRNPd~~~~~PWCyv~~~~~~~eyC~ip~ 81 (83)
T cd00108 2 RDCYWGNGESYRGTVSTTKSGKPCQRWNSQLPHQHKFNPERFPEGLLEENYCRNPDGDPEGPWCYTTDPNVRWEYCDIPR 81 (83)
T ss_pred CcCCCCCCCcccCceeECCCCCcccCCcccCcccccccccccccccccccccCCCCCCCCCCEEEeCCCCccEeecCCCc
Confidence 47999999999999999999999999999999999999999998889999999999995699999998889999999999
Q ss_pred CC
Q psy5539 265 CA 266 (653)
Q Consensus 265 C~ 266 (653)
|+
T Consensus 82 C~ 83 (83)
T cd00108 82 CE 83 (83)
T ss_pred Cc
Confidence 95
|
They are autonomous structural domains, found in a varying number of copies, in blood clotting and fibrinolytic proteins, some serine proteases and plasma proteins. Plasminogen-like kringles possess affinity for free lysine and lysine-containing peptides. |
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-27 Score=236.48 Aligned_cols=247 Identities=23% Similarity=0.272 Sum_probs=187.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
.+|.-++.+|.|+- .|-.|.+ ...++.||+|.+... ......++..+|..++..++|+||++++.++.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D-----~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l 90 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFD-----QVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTL 90 (369)
T ss_pred eeeeeecccCCCCc-eEEecch-----hhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccH
Confidence 35677778899988 5655543 345688999987543 2223345678999999999999999999998543
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.+.++|||||.. +|.+.+. ..++...+..|+.|++.|+.|||+.+|+||||||+
T Consensus 91 ~~~~e~y~v~e~m~~-nl~~vi~----------------------~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPs 147 (369)
T KOG0665|consen 91 EEFQEVYLVMELMDA-NLCQVIL----------------------MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPS 147 (369)
T ss_pred HHHHhHHHHHHhhhh-HHHHHHH----------------------HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcc
Confidence 367999999954 8888775 34688899999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||++..+..+||.|||+|+.-.. .-..+....+-.|.|||++.+..+.+.+||||+||++.||++|.. .|.|.+.-
T Consensus 148 nivv~~~~~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~V-lf~g~d~i 223 (369)
T KOG0665|consen 148 NIVVNSDCTLKILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTV-LFPGKDHI 223 (369)
T ss_pred cceecchhheeeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceE-EecCchHH
Confidence 99999999999999999975321 123344556678999999999999999999999999999998654 44444322
Q ss_pred HHHHHHHc--------------------------------------CCc---cCCCCCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 598 EVVKYIKE--------------------------------------GNI---LQAPDNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 598 e~~~~i~~--------------------------------------~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
+-..++.+ ..+ ++.+......+++++.+||-.+|++|.+
T Consensus 224 dQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris 303 (369)
T KOG0665|consen 224 DQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS 303 (369)
T ss_pred HHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc
Confidence 11111100 000 0001112356889999999999999999
Q ss_pred HHHHHHHH
Q psy5539 637 FRTIYQTL 644 (653)
Q Consensus 637 ~~eil~~L 644 (653)
++++++|+
T Consensus 304 v~daL~HP 311 (369)
T KOG0665|consen 304 VDDALRHP 311 (369)
T ss_pred HHHHhcCC
Confidence 99999886
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-27 Score=246.42 Aligned_cols=257 Identities=20% Similarity=0.313 Sum_probs=202.8
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC------CCccceE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD------HPNIVKL 433 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~------HpnIv~l 433 (653)
.|+-.++|.+....|+|-|++|.+|.+. ..+..||||+++.+ +.+.+.=.+|+++|++|+ --|+++|
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~-----~r~~~vAiKIIRnN--E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl 499 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQ-----ARGQEVAIKIIRNN--EVMHKTGLKELEILKKLNDADPEDKFHCLRL 499 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeecccc-----CCCCeeEEEEeecc--hHHhhhhhHHHHHHHHhhccCchhhhHHHHH
Confidence 3556678888889999999999999863 34558999999854 556667789999999995 3589999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
+..|...+++|||||-+. -+|.+.|+.... .-.|.......++.|+..||..|-.-+|+|.|
T Consensus 500 ~r~F~hknHLClVFE~Ls-lNLRevLKKyG~-----------------nvGL~ikaVRsYaqQLflALklLK~c~vlHaD 561 (752)
T KOG0670|consen 500 FRHFKHKNHLCLVFEPLS-LNLREVLKKYGR-----------------NVGLHIKAVRSYAQQLFLALKLLKKCGVLHAD 561 (752)
T ss_pred HHHhhhcceeEEEehhhh-chHHHHHHHhCc-----------------ccceeehHHHHHHHHHHHHHHHHHhcCeeecc
Confidence 999999999999999874 599999985542 33577788999999999999999999999999
Q ss_pred CCCCCEeEcCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 514 LATRNCLINDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 514 Lkp~NILl~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|||+|||++++ ..+||||||.|.....++. +....+-.|.|||.+.+-.|+...|+||.||+||||+||.. .|.
T Consensus 562 IKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkI-lFp 636 (752)
T KOG0670|consen 562 IKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKI-LFP 636 (752)
T ss_pred cCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccce-ecC
Confidence 99999999976 5789999999976532221 11223346999999999999999999999999999999765 677
Q ss_pred CCCHHHHHHHHHc------------CCccC--------------------------------------------CCCC--
Q psy5539 593 GLTHEEVVKYIKE------------GNILQ--------------------------------------------APDN-- 614 (653)
Q Consensus 593 ~~~~~e~~~~i~~------------~~~~~--------------------------------------------~~~~-- 614 (653)
|.+.-+++....+ |++.. .|+.
T Consensus 637 G~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~ 716 (752)
T KOG0670|consen 637 GRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQP 716 (752)
T ss_pred CCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhH
Confidence 7665554433221 11110 0000
Q ss_pred -CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 615 -TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 615 -~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.-.++.+|+..|+..||++|.|..+.++|++-
T Consensus 717 ~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi 749 (752)
T KOG0670|consen 717 KIVQQLRDLLDKMLILDPEKRITVNQALKHPFI 749 (752)
T ss_pred HHHHHHHHHHHHHhccChhhcCCHHHHhcCCcc
Confidence 11478899999999999999999999998864
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=231.62 Aligned_cols=135 Identities=25% Similarity=0.385 Sum_probs=114.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-----C---Cccce
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-----H---PNIVK 432 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-----H---pnIv~ 432 (653)
.|...+|.+.++||-|-|++||++.+. ...+.||+|+.+.. +...+....||++|++++ | .+||+
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDt-----q~~r~VAlKVvKSA--qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~ 146 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDT-----QNKRYVALKVVKSA--QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQ 146 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeec-----cCCeEEEEEEEehh--hHHHHHHHHHHHHHHHHHhcCCCCCCCceeee
Confidence 466689999999999999999999864 45688999999853 445667889999999984 2 47999
Q ss_pred EEeEEec----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-
Q psy5539 433 LLGVCAV----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR- 507 (653)
Q Consensus 433 l~g~~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~- 507 (653)
|++.|.. +.+.|||+|++ |-+|..++... ....++...+.+|++||+.||.|||.+
T Consensus 147 LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s------------------~YrGlpl~~VK~I~~qvL~GLdYLH~ec 207 (590)
T KOG1290|consen 147 LLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS------------------NYRGLPLSCVKEICRQVLTGLDYLHREC 207 (590)
T ss_pred eeccceecCCCCcEEEEEehhh-hhHHHHHHHHh------------------CCCCCcHHHHHHHHHHHHHHHHHHHHhc
Confidence 9999864 56899999999 45899988732 235688999999999999999999976
Q ss_pred CceecCCCCCCEeE
Q psy5539 508 KFVHRDLATRNCLI 521 (653)
Q Consensus 508 ~ivHrDLkp~NILl 521 (653)
||||-||||+|||+
T Consensus 208 gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 208 GIIHTDLKPENVLL 221 (590)
T ss_pred CccccCCCcceeee
Confidence 99999999999998
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-26 Score=271.46 Aligned_cols=200 Identities=15% Similarity=0.128 Sum_probs=143.2
Q ss_pred hCCC-CccceEEeEE-------ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHH
Q psy5539 424 EFDH-PNIVKLLGVC-------AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIAL 495 (653)
Q Consensus 424 ~l~H-pnIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 495 (653)
.++| +||+++++++ ...+.+.+++||+ +++|.++|+. ....+++.+++.++.
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~-------------------~~~~~~~~~~~~i~~ 87 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN-------------------PDRSVDAFECFHVFR 87 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc-------------------ccccccHHHHHHHHH
Confidence 3445 5788888877 2334678889987 5699999961 124589999999999
Q ss_pred HHHHHHHHhhhCCceecCCCCCCEeEcC-------------------CCcEEEeccCcccccccccc--------cc---
Q psy5539 496 QIASGMVYLSDRKFVHRDLATRNCLIND-------------------QMVVKIADFGLSRKMYLQDY--------YK--- 545 (653)
Q Consensus 496 qia~gL~yLH~~~ivHrDLkp~NILl~~-------------------~~~vkI~DfGla~~~~~~~~--------~~--- 545 (653)
||++||.|||+++|+||||||+||||+. ++.+||+|||+++....... ..
T Consensus 88 qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~ 167 (793)
T PLN00181 88 QIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQP 167 (793)
T ss_pred HHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCC
Confidence 9999999999999999999999999954 44566666666653211000 00
Q ss_pred ---CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHH
Q psy5539 546 ---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDL 622 (653)
Q Consensus 546 ---~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~l 622 (653)
......+|+.|||||.+.+..++.++|||||||+||||++ +.+|+.. ..+.+..+.................++
T Consensus 168 ~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~-~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (793)
T PLN00181 168 FPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFC-PVSSREE--KSRTMSSLRHRVLPPQILLNWPKEASF 244 (793)
T ss_pred CcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhh-CCCchhh--HHHHHHHHHHhhcChhhhhcCHHHHHH
Confidence 0011346778999999999999999999999999999998 3445432 122333333222211111234567789
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 623 MKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 623 i~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+..||+.+|.+||++.+|++++|-
T Consensus 245 ~~~~L~~~P~~Rps~~eil~h~~~ 268 (793)
T PLN00181 245 CLWLLHPEPSCRPSMSELLQSEFI 268 (793)
T ss_pred HHHhCCCChhhCcChHHHhhchhh
Confidence 999999999999999999998764
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=220.85 Aligned_cols=241 Identities=22% Similarity=0.301 Sum_probs=182.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE-EecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV-CAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~-~~~~~~ 442 (653)
+.|.+.+.||+|.||.+-++++++ +.+.+++|.+.... .-+++|.+|..---.| .|.||+.-+++ ++..+.
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~-----s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~ 96 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQ-----SKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDA 96 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccC-----CceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCce
Confidence 457888899999999999999754 55889999987543 3467899998765555 58999988765 466778
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++++||++.|||.+-+. ...+.+....+++.|+++|+.|||++++||||||.+||||-
T Consensus 97 YvF~qE~aP~gdL~snv~---------------------~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif 155 (378)
T KOG1345|consen 97 YVFVQEFAPRGDLRSNVE---------------------AAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIF 155 (378)
T ss_pred EEEeeccCccchhhhhcC---------------------cccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEe
Confidence 899999999999987653 24567888899999999999999999999999999999994
Q ss_pred --CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-----CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-----KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+...+||+|||+++..... -....-+..|-+||....- ...+.+|||.||++++.+++|.. ||+...
T Consensus 156 ~~df~rvKlcDFG~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~-PWQka~ 229 (378)
T KOG1345|consen 156 DADFYRVKLCDFGLTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKF-PWQKAS 229 (378)
T ss_pred cCCccEEEeeecccccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCC-cchhhh
Confidence 3458999999998754211 1222334568899876532 35688999999999999999665 777432
Q ss_pred H-----HHHHHHHHcCCccCCCC---CCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 596 H-----EEVVKYIKEGNILQAPD---NTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 596 ~-----~e~~~~i~~~~~~~~~~---~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
. .+..++ ..+..+..|. ..++.+..+.++-+.+++++|-...++
T Consensus 230 ~~d~~Y~~~~~w-~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 230 IMDKPYWEWEQW-LKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred ccCchHHHHHHH-hcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 2 223333 2333334443 477889999999999999999444433
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.3e-25 Score=211.53 Aligned_cols=163 Identities=19% Similarity=0.308 Sum_probs=128.3
Q ss_pred CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEecc
Q psy5539 453 GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532 (653)
Q Consensus 453 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~Df 532 (653)
|+|.++++. ....+++.+++.|+.||+.||+|||+++ ||+|||+++++.+|+ |
T Consensus 1 GsL~~~l~~-------------------~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--f 53 (176)
T smart00750 1 VSLADILEV-------------------RGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--D 53 (176)
T ss_pred CcHHHHHHH-------------------hCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--c
Confidence 688888862 1345899999999999999999999998 999999999999999 9
Q ss_pred CccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHHHHcCCccC-
Q psy5539 533 GLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKYIKEGNILQ- 610 (653)
Q Consensus 533 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~i~~~~~~~- 610 (653)
|+++.... ....+++.|||||.+.+..++.++||||||+++|||++|.. ||..... ......+..+....
T Consensus 54 G~~~~~~~-------~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~ 125 (176)
T smart00750 54 GSVAFKTP-------EQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYEL-PYNEERELSAILEILLNGMPADD 125 (176)
T ss_pred cceEeecc-------ccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCC-CccccchhcHHHHHHHHHhccCC
Confidence 99876422 12257889999999999999999999999999999999665 7654432 23333333222111
Q ss_pred -----CCCCCcH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 611 -----APDNTPD--ALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 611 -----~~~~~~~--~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+...+. ++.+++.+||+.+|.+||++.+++++++.+..+
T Consensus 126 ~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 126 PRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 1112233 699999999999999999999999999987654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=230.17 Aligned_cols=256 Identities=23% Similarity=0.388 Sum_probs=195.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~ 439 (653)
....+.|..+++||+|.|++||++.+.. .......||+|.+...... ..+..|+++|..+. +.||+++.+.+..
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~--~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rn 106 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIE--QDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRN 106 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhh--hccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhcc
Confidence 3345678889999999999999998743 1235678999999765544 35789999999995 8999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
++...+|+||+++.+..++++ .++..++..+++.++.||.++|..|||||||||+|+
T Consensus 107 nd~v~ivlp~~~H~~f~~l~~-----------------------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNF 163 (418)
T KOG1167|consen 107 NDQVAIVLPYFEHDRFRDLYR-----------------------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNF 163 (418)
T ss_pred CCeeEEEecccCccCHHHHHh-----------------------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccc
Confidence 999999999999999988885 367888999999999999999999999999999999
Q ss_pred eEc-CCCcEEEeccCcccccc--c-----c---------------------------cccc--------CCCCCCCcccc
Q psy5539 520 LIN-DQMVVKIADFGLSRKMY--L-----Q---------------------------DYYK--------GDENDAIPVRW 556 (653)
Q Consensus 520 Ll~-~~~~vkI~DfGla~~~~--~-----~---------------------------~~~~--------~~~~~~~t~~y 556 (653)
|.+ ..+.-.|.|||||.... . . .+.. ..-..+||++|
T Consensus 164 L~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~Gf 243 (418)
T KOG1167|consen 164 LYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGF 243 (418)
T ss_pred ccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCC
Confidence 997 45678999999986210 0 0 0000 01135689999
Q ss_pred ccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCC-CCHHH-------------HHHHH-HcCC--c----------
Q psy5539 557 MPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYG-LTHEE-------------VVKYI-KEGN--I---------- 608 (653)
Q Consensus 557 ~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~-~~~~e-------------~~~~i-~~~~--~---------- 608 (653)
.|||++.. ..-|.++||||.|||++-++++.. ||.. .+.-+ +.+.. ..|. +
T Consensus 244 RaPEvL~k~~~QttaiDiws~GVI~Lslls~~~-PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~ 322 (418)
T KOG1167|consen 244 RAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRY-PFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIP 322 (418)
T ss_pred CchHHHhhccCcCCccceeeccceeehhhcccc-ccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccH
Confidence 99999875 467899999999999999998555 5542 21111 11000 0011 0
Q ss_pred ------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 609 ------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 609 ------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
....+..+..+++|+.+|++.||.+|.|+++.++|.+
T Consensus 323 e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpF 383 (418)
T KOG1167|consen 323 ELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPF 383 (418)
T ss_pred HHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcC
Confidence 0011224568999999999999999999999998864
|
|
| >PF00051 Kringle: Kringle domain; InterPro: IPR000001 Kringles are autonomous structural domains, found throughout the blood clotting and fibrinolytic proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-26 Score=189.17 Aligned_cols=78 Identities=47% Similarity=1.164 Sum_probs=71.3
Q ss_pred cccCCccccceeeeccCCCCcccccCCCCCCCCC-CCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE-RPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 187 C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~-~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
||.|+|..|||++++|.+|++|++|+++.++.+. +.+..++...++||||||||++.. |||||.++.+.||||+||.|
T Consensus 1 Cy~~~G~~YrG~~~~T~sG~~C~~W~~~~~~~~~~~~~~~~~~~~l~~NyCRNPd~~~~-PWCy~~~~~~~~~~C~Ip~C 79 (79)
T PF00051_consen 1 CYTGNGQDYRGTVNVTESGKPCLPWNSQSPHKHSFYTPSSYPEAGLGHNYCRNPDGDPR-PWCYTKDPGIRWEYCDIPKC 79 (79)
T ss_dssp SBSTTSTTBSSSCTBBTTSCBBE-TTSCSSSHHSSSSTTTSTTSTHTTTSSBETTSCSS-SEEEBSSTTESEEEBSSEBS
T ss_pred CCCCCCCcceeceeECCCCCccccCccCCCcccccceeccccccCcCcceeeCCCCCCC-cceEecCCCceEEecCCCcC
Confidence 8999999999999999999999999999988754 367788888899999999999994 99999889999999999998
|
Kringle domains are believed to play a role in binding mediators (e.g., membranes, other proteins or phospholipids), and in the regulation of proteolytic activity [, , ]. Kringle domains [, , ] are characterised by a triple loop, 3-disulphide bridge structure, whose conformation is defined by a number of hydrogen bonds and small pieces of anti-parallel beta-sheet. They are found in a varying number of copies in some plasma proteins including prothrombin and urokinase-type plasminogen activator, which are serine proteases belonging to MEROPS peptidase family S1A. Steroid or nuclear hormone receptors (4A nuclear receptor, NRs) constitute an important superfamily of transcription regulators that are involved in widely diverse physiological functions, including control of embryonic development, cell differentiation and homeostasis. Members of the superfamily include the steroid hormone receptors and receptors for thyroid hormone, retinoids, 1,25-dihydroxy-vitamin D3 and a variety of other ligands []. The proteins function as dimeric molecules in nuclei to regulate the transcription of target genes in a ligand-responsive manner [, ]. In addition to C-terminal ligand-binding domains, these nuclear receptors contain a highly-conserved, N-terminal zinc-finger that mediates specific binding to target DNA sequences, termed ligand-responsive elements. In the absence of ligand, steroid hormone receptors are thought to be weakly associated with nuclear components; hormone binding greatly increases receptor affinity. NRs are extremely important in medical research, a large number of them being implicated in diseases such as cancer, diabetes, hormone resistance syndromes, etc. While several NRs act as ligand-inducible transcription factors, many do not yet have a defined ligand and are accordingly termed 'orphan' receptors. During the last decade, more than 300 NRs have been described, many of which are orphans, which cannot easily be named due to current nomenclature confusions in the literature. However, a new system has recently been introduced in an attempt to rationalise the increasingly complex set of names used to describe superfamily members.; PDB: 1JFN_A 3HN4_A 2FEB_A 4A5T_S 5HPG_B 4DUR_B 4DUU_A 2KNF_A 2QJ4_B 2QJ2_A .... |
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.3e-25 Score=213.00 Aligned_cols=253 Identities=23% Similarity=0.435 Sum_probs=201.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
...++.+..+|.+...|..|+|++.+ ..+++|+++-. .......+|..|.-.|+-+.||||++++|.|....
T Consensus 188 d~~~lnl~tkl~e~hsgelwrgrwqg-------ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnspp 260 (448)
T KOG0195|consen 188 DVSSLNLITKLAESHSGELWRGRWQG-------NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPP 260 (448)
T ss_pred chhhhhhhhhhccCCCcccccccccC-------cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence 33455667789999999999999865 34677777532 23344568999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-Cce-ecCCCCCCE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFV-HRDLATRNC 519 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~iv-HrDLkp~NI 519 (653)
.+.++..||+.|+|...|+.. ..-..+..++.+++.++|+||+|||+. .++ ---|.+..|
T Consensus 261 nlv~isq~mp~gslynvlhe~------------------t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hv 322 (448)
T KOG0195|consen 261 NLVIISQYMPFGSLYNVLHEQ------------------TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHV 322 (448)
T ss_pred CceEeeeeccchHHHHHHhcC------------------ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceE
Confidence 999999999999999999722 122356778999999999999999985 343 456899999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC---CchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT---VESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t---~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+||++.+++|+ ++-++. .-......-.+.||+||.+...+-+ .+.|+|||++++|||-|.. .||.+.++
T Consensus 323 midedltaris-mad~kf------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre-vpfadlsp 394 (448)
T KOG0195|consen 323 MIDEDLTARIS-MADTKF------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE-VPFADLSP 394 (448)
T ss_pred Eecchhhhhee-ccccee------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc-cccccCCc
Confidence 99999988875 222221 1122334556789999999876543 6799999999999999955 58988777
Q ss_pred HHH-HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 597 EEV-VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 597 ~e~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
-|. ++...+|.....|+.++..+.+||..|.+.||.+||.|..|+-.|++++
T Consensus 395 mecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 395 MECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 665 4445678888899999999999999999999999999999999988774
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-22 Score=211.77 Aligned_cols=259 Identities=17% Similarity=0.219 Sum_probs=197.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC----CccceEEeEE-ecC
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH----PNIVKLLGVC-AVG 440 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H----pnIv~l~g~~-~~~ 440 (653)
+|.+.+.||+|+||.||+|..... ....+|+|........... .+..|+.++..+.. +++..+++.. ..+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~----~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~ 93 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSE----KNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE 93 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCC----CCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence 789999999999999999986431 1467888887654332222 57788888888873 5888888888 477
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||+.+ |.+|.++.+.. ....++..+.+.|+.|++.+|++||+.|++||||||.|++
T Consensus 94 ~~~~iVM~l~-G~sL~dl~~~~------------------~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~ 154 (322)
T KOG1164|consen 94 DFNFIVMSLL-GPSLEDLRKRN------------------PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFV 154 (322)
T ss_pred ceeEEEEecc-CccHHHHHHhC------------------CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHee
Confidence 7889999987 66999977522 1356899999999999999999999999999999999999
Q ss_pred EcCC-----CcEEEeccCccc--cccccccc---c--C-CCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCC
Q psy5539 521 INDQ-----MVVKIADFGLSR--KMYLQDYY---K--G-DENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 521 l~~~-----~~vkI~DfGla~--~~~~~~~~---~--~-~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
++.. ..+.|.|||+++ ........ . . .....||.+|+++....+...+.+.|+||++.++.|++.|.
T Consensus 155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~ 234 (322)
T KOG1164|consen 155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGS 234 (322)
T ss_pred ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCC
Confidence 9865 469999999998 33222211 1 1 12345899999999999999999999999999999999866
Q ss_pred CCCCCCCCHHHHHHHH---HcCCccC-CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 588 LQPYYGLTHEEVVKYI---KEGNILQ-APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i---~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
.||.+.........+ ....... .....+.++.+++..+-..+..++|....+...+.....
T Consensus 235 -LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 235 -LPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred -CCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 588665532222222 2221111 234456788888888888999999999999888776544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.6e-23 Score=216.93 Aligned_cols=169 Identities=17% Similarity=0.069 Sum_probs=127.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc----cHHHHHHHHHHHHHHhhCCCCccce-EEeE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHPNIVK-LLGV 436 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~----~~~~~~~f~~Ei~il~~l~HpnIv~-l~g~ 436 (653)
...++|.+.+.||+|+||+||+|+... .++..||||++.... .......|.+|+++|++++|+|+++ +++.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~----~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAG----DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcC----CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 344679999999999999999998632 245668999875331 2334667999999999999999995 4432
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC-C
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL-A 515 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL-k 515 (653)
+..+|||||+++++|.. +. + .. ...++.|++++|.|||++||+|||| |
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~---~--------------------~~---~~~~~~~i~~aL~~lH~~gIiHrDL~K 139 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-AR---P--------------------HG---DPAWFRSAHRALRDLHRAGITHNDLAK 139 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hC---c--------------------cc---hHHHHHHHHHHHHHHHHCCCeeCCCCC
Confidence 45799999999999962 11 0 00 1367889999999999999999999 9
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccC------CCCCCCccccccchhhccC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKG------DENDAIPVRWMPLESILYN 565 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~------~~~~~~t~~y~aPE~~~~~ 565 (653)
|+|||++.++.+||+|||+|+.......... -....++..|+|||.+...
T Consensus 140 P~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 140 PQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 9999999999999999999986643221100 0223456678999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-21 Score=200.91 Aligned_cols=251 Identities=30% Similarity=0.437 Sum_probs=199.7
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH--HHHHHHHHHHHHhhCCCC-ccceEEeEEecCCce
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY--LQTDFEREACLLAEFDHP-NIVKLLGVCAVGKPM 443 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~--~~~~f~~Ei~il~~l~Hp-nIv~l~g~~~~~~~~ 443 (653)
|.+.+.||.|+||.||++... ..+++|.+....... ....+.+|+.+++.+.|+ +|+++++++......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 567888999999999999863 678999987664433 467899999999999988 799999999777778
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++++||+.+++|.+++..... . ..++......++.|++.++.|+|+.+++|||+||+||+++.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~----------------~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~ 136 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGR----------------K-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR 136 (384)
T ss_pred EEEEecCCCCcHHHHHHhccc----------------c-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC
Confidence 999999999999977752110 0 35788899999999999999999999999999999999999
Q ss_pred CC-cEEEeccCcccccccccccc----CCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 524 QM-VVKIADFGLSRKMYLQDYYK----GDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 524 ~~-~vkI~DfGla~~~~~~~~~~----~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
.+ .++++|||+++......... ......++..|++||.+.+ ...+...|+||+|+++++++++.. |+....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~-p~~~~~ 215 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP-PFEGEK 215 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCC-CCCCCC
Confidence 88 79999999997553332221 2355678899999999988 688999999999999999998554 666555
Q ss_pred ----HHHHHHHHHcCCcc-CCCC---CC----cHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 596 ----HEEVVKYIKEGNIL-QAPD---NT----PDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 596 ----~~e~~~~i~~~~~~-~~~~---~~----~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
..+....+...... .... .. ...+.+++..++..+|..|.+..+....
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 216 NSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 35555555544322 1111 11 1578999999999999999998877654
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-21 Score=186.57 Aligned_cols=259 Identities=20% Similarity=0.292 Sum_probs=203.6
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC-CccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-PNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~ 440 (653)
+..+.|.++++||.|+||.+|+|... .++..||||+-+..+.. -.+..|..+.+.|++ ..|..+..+..++
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i-----~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISI-----TSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeec-----cCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 44568999999999999999999753 46788999998765443 246788899999976 5677777777888
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..-.||||.+ |-+|.+.+..++ ..++.++.+-++-|++.-++|+|.+++|||||||+|+|
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~-------------------R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFL 143 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCS-------------------RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFL 143 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHh-------------------hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcccee
Confidence 8899999988 669999987543 35788899999999999999999999999999999999
Q ss_pred EcCC---CcEEEeccCcccccccccc-----ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 521 INDQ---MVVKIADFGLSRKMYLQDY-----YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 521 l~~~---~~vkI~DfGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
.+-+ ..+.++|||||+....... +..+....||.+|++-....+-..+.+.|+-|+|.+|..+.- |..||+
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr-G~LPWQ 222 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR-GSLPWQ 222 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec-CCCccc
Confidence 9744 5789999999987643322 234456678999999998888888999999999999988775 556999
Q ss_pred CCCHH---HHHHHHHcCCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 593 GLTHE---EVVKYIKEGNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 593 ~~~~~---e~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+.... +-.+.|.+......+ ...|.++.-.+.-|-..--++-|...-|-+....+..
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr 286 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR 286 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence 87543 445556555443222 4578899999999999888888987766555444433
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-20 Score=185.20 Aligned_cols=257 Identities=18% Similarity=0.307 Sum_probs=202.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~ 443 (653)
-.|.+.++||+|+||.++.|+. ...+..||||.-...... -+++.|.+..+.|. .++|...+-+...+..-
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~N-----l~nne~VAIKfEPrkS~A---PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKN-----LYNNEPVAIKFEPRKSEA---PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred ccceeccccccCcceeeecccc-----cccCceEEEEeccccCCc---chHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 3689999999999999999973 345689999986543221 24567777777774 58888888888888888
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
.||+|.+ |-+|.|+..-+ ...++.++.+-||.|++.-++|+|++.+|.|||||+|+||+.
T Consensus 100 iLVidLL-GPSLEDLFD~C-------------------gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGr 159 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLC-------------------GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGR 159 (449)
T ss_pred hhhhhhh-CcCHHHHHHHh-------------------cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecC
Confidence 9999988 56899888633 256899999999999999999999999999999999999974
Q ss_pred C-----CcEEEeccCcccccccccc-----ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 524 Q-----MVVKIADFGLSRKMYLQDY-----YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 524 ~-----~~vkI~DfGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
. ..+.|+|||+|+....... +.......||.+||+--...+..-+.+.|+-|||-++.+.+- |..||+|
T Consensus 160 p~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLR-GsLPWQG 238 (449)
T KOG1165|consen 160 PGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLR-GSLPWQG 238 (449)
T ss_pred CCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhcc-CCCcccc
Confidence 3 4689999999987543332 222345678999999999999999999999999999999997 4559987
Q ss_pred CC---HHHHHHHHHcCCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 594 LT---HEEVVKYIKEGNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 594 ~~---~~e~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.. ..+-.++|-+....... +..|.++..-|+..-..+-.+-|..+-+...+.++...
T Consensus 239 LKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr 302 (449)
T KOG1165|consen 239 LKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDR 302 (449)
T ss_pred ccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHh
Confidence 54 45566666665543322 45788999999988888999999988777666666554
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.85 E-value=6e-22 Score=223.32 Aligned_cols=256 Identities=21% Similarity=0.261 Sum_probs=188.0
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEc-cccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l-~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
...+.+|.|++|.|+.+...........+.+.+| . +..........+..|..+-..|+|+|++..+..........-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence 3456789999998888765432222222333333 2 2223333333477888889999999998887777666655556
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
|||+++ ||..++. ....++..++..++.|++.|+.|||+.||.|||||++|+++..+|.
T Consensus 400 mE~~~~-Dlf~~~~--------------------~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~ 458 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVM--------------------SNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI 458 (601)
T ss_pred hhcccH-HHHHHHh--------------------cccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc
Confidence 999999 9999986 1235788899999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccc--cCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--H
Q psy5539 527 VKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVV--K 601 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~--~ 601 (653)
+||+|||.+......... .......|+-.|+|||.+.+..|+ ...||||.|+++..|.++ ..||.....++.. +
T Consensus 459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~-~~~Wk~a~~~~~~~~~ 537 (601)
T KOG0590|consen 459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILG-RFPWKVAKKSDNSFKT 537 (601)
T ss_pred eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecC-CCccccccccccchhh
Confidence 999999998755322211 223345677789999999999987 568999999999999996 5677654433221 1
Q ss_pred HHH--cCCcc----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIK--EGNIL----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~--~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
... ..... .....++.+.+.+|.++++.+|.+|.|+++|++..|-
T Consensus 538 ~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~ 588 (601)
T KOG0590|consen 538 NNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWI 588 (601)
T ss_pred hccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHh
Confidence 111 11111 1113467889999999999999999999999998874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.8e-21 Score=187.41 Aligned_cols=174 Identities=15% Similarity=0.197 Sum_probs=133.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHH------HHHHHHHHhhCCCCccce
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTD------FEREACLLAEFDHPNIVK 432 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~------f~~Ei~il~~l~HpnIv~ 432 (653)
.+-.++|+.++.||+|+||.||++.. ++..+|||.+++.... ..... +++|+..+.+++|++|..
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 34578899999999999999999753 1346999999865332 22222 689999999999999999
Q ss_pred EEeEEecC--------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5539 433 LLGVCAVG--------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504 (653)
Q Consensus 433 l~g~~~~~--------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 504 (653)
+..++... ...+|||||++|.+|.++.. ++. ....+++.+|..|
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------------------------~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------------------------ISE----DVKAKIKASIESL 151 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh------------------------ccH----HHHHHHHHHHHHH
Confidence 98885532 35899999999999987642 122 2456999999999
Q ss_pred hhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHH
Q psy5539 505 SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 505 H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ell 584 (653)
|+.|++|||++|+||++++++ ++|+|||.+....... +. ........+..++|+||||+++..+.
T Consensus 152 H~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~--------a~------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 152 HQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK--------AK------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh--------hH------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999999998 9999999886431111 00 11344556778999999999887665
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=181.35 Aligned_cols=138 Identities=23% Similarity=0.200 Sum_probs=105.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--H-----------------------HHHHHHHHHHHHhhC
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--Y-----------------------LQTDFEREACLLAEF 425 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~-----------------------~~~~f~~Ei~il~~l 425 (653)
..||+|+||.||+|... +++.||||+++..... . ......+|++++.++
T Consensus 3 ~~ig~G~~~~Vy~a~~~------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 3 GCISTGKEANVYHATTA------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CccccccceEEEEEECC------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 46899999999999852 5689999999754210 0 011234599999999
Q ss_pred CCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh-
Q psy5539 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL- 504 (653)
Q Consensus 426 ~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL- 504 (653)
.++++.....+.. ...+|||||+++++|...+. ....++..++..++.|++.+|.+|
T Consensus 77 ~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~--------------------~~~~~~~~~~~~i~~qi~~~L~~l~ 134 (190)
T cd05147 77 VTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRL--------------------KDAPLSESKARELYLQVIQIMRILY 134 (190)
T ss_pred HHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhh--------------------hcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 8887644333322 22389999999887764421 123578889999999999999999
Q ss_pred hhCCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 505 SDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 505 H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
|+.+|+||||||+|||+++ +.++|+|||+|..
T Consensus 135 H~~giiHrDlkP~NIli~~-~~v~LiDFG~a~~ 166 (190)
T cd05147 135 QDCRLVHADLSEYNLLYHD-GKLYIIDVSQSVE 166 (190)
T ss_pred HhCCcccCCCCHHHEEEEC-CcEEEEEcccccc
Confidence 7999999999999999984 7899999999964
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.1e-21 Score=213.37 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=180.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHH---HHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE---REACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~---~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++.+.+.||++.|=+|.+|+++ +| .|+||++-..........|. +|++ .+.++|||.+++.-+-.....
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~------eG-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA 95 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDR------EG-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA 95 (1431)
T ss_pred ceeeecccCchhhhhhhhccCC------Cc-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH
Confidence 6788999999999999999864 23 38888875443222222333 3444 566799999999888777788
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
-|||-+|..+ +|+|.|. ..+.+...+..-|+.|++.||.-+|..||+|+|||.+||||+
T Consensus 96 AylvRqyvkh-nLyDRlS--------------------TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiT 154 (1431)
T KOG1240|consen 96 AYLVRQYVKH-NLYDRLS--------------------TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILIT 154 (1431)
T ss_pred HHHHHHHHhh-hhhhhhc--------------------cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEe
Confidence 8999999876 8888774 345678888899999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCC-----CCCccccccchhhccC-----------CCCCchhHHHHHHHHHHHHhC
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDEN-----DAIPVRWMPLESILYN-----------KYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~-----~~~t~~y~aPE~~~~~-----------~~t~ksDVwSlGvvl~ellt~ 586 (653)
.-.-+.|+||..-+..|.......+-. ...-..|.|||.+... ..+++.||||+||++.||++-
T Consensus 155 SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~E 234 (1431)
T KOG1240|consen 155 SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLE 234 (1431)
T ss_pred eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhc
Confidence 999999999988766554332111100 1112469999987541 267899999999999999998
Q ss_pred CCCCCCCCCHHHHHHHHHcCCccCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNILQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
|.++|. ..+++.+ +.+. ...+ .-.+..+++|+..|++.||++|.++++.++.
T Consensus 235 g~PlF~---LSQL~aY-r~~~-~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 235 GRPLFT---LSQLLAY-RSGN-ADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CCCccc---HHHHHhH-hccC-ccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 888874 2222222 1111 0000 0112368999999999999999999999876
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.8e-20 Score=197.08 Aligned_cols=208 Identities=27% Similarity=0.487 Sum_probs=164.9
Q ss_pred HhhCCCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHH
Q psy5539 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM 501 (653)
Q Consensus 422 l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 501 (653)
|+.+.|.|+.+++|.+..+...+.|.+|+..|+|.|.+.. ....+++.-...++++|++||
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-------------------~~~~~d~~F~~s~~rdi~~Gl 61 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-------------------EDIKLDYFFILSFIRDISKGL 61 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-------------------cccCccHHHHHHHHHHHHHHH
Confidence 4578999999999999999999999999999999999962 235688889999999999999
Q ss_pred HHhhhCCc-eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC---C----CCCchhH
Q psy5539 502 VYLSDRKF-VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---K----YTVESDV 573 (653)
Q Consensus 502 ~yLH~~~i-vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~----~t~ksDV 573 (653)
+|||+..| .|+.|+++|+++|..+.+||+|||+.................-..-|.|||.+... . .+.+.||
T Consensus 62 ~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 62 AYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred HHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 99998876 89999999999999999999999998765321111111222234569999998764 1 4778999
Q ss_pred HHHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHc-CCccCCCC-----CCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 574 WAFGVCLWEIFSFALQPYYG----LTHEEVVKYIKE-GNILQAPD-----NTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 574 wSlGvvl~ellt~~~~p~~~----~~~~e~~~~i~~-~~~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
||||++++|+++... ||.. .++.+++..++. +.....|. ..++++..+++.||..+|.+||++++|-..
T Consensus 142 Ys~~ii~~ei~~r~~-~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSG-PFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ehHHHHHHHHHhccC-ccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 999999999998554 6654 344678888877 33222222 345679999999999999999999999887
Q ss_pred HHHHHH
Q psy5539 644 LWNIKR 649 (653)
Q Consensus 644 L~~l~~ 649 (653)
+..+..
T Consensus 221 ~~~~~~ 226 (484)
T KOG1023|consen 221 LLTINK 226 (484)
T ss_pred hhhhcc
Confidence 765543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=175.08 Aligned_cols=139 Identities=19% Similarity=0.155 Sum_probs=108.6
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-------------------------HHHHHHHHHHHHHHhh
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-------------------------EYLQTDFEREACLLAE 424 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-------------------------~~~~~~f~~Ei~il~~ 424 (653)
...||+|+||.||+|+.. +++.||||+++.... ......+.+|.+.+.+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 2 NGCISTGKEANVYHARTG------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CceeecCCCcEEEEEEcC------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 357999999999999852 568999999875421 0112235689999999
Q ss_pred CCCCccceEEeEEecCCceEEEEeecCCCChHHH-HhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDF-LRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 425 l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
+.|+++.....+... ..+|||||++++++... +. ...++..+...++.|++.+|.+
T Consensus 76 l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~---------------------~~~~~~~~~~~i~~~l~~~l~~ 132 (190)
T cd05145 76 LYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLK---------------------DVPLEEEEAEELYEQVVEQMRR 132 (190)
T ss_pred HHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhh---------------------hccCCHHHHHHHHHHHHHHHHH
Confidence 999987554444333 24899999998755432 22 1346778899999999999999
Q ss_pred hhh-CCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 504 LSD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 504 LH~-~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
||+ .||+||||||+|||++ ++.++|+|||++..+
T Consensus 133 lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 133 LYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred HHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 999 9999999999999999 789999999999764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=2e-19 Score=183.30 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=175.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCC------------------------------ccceEEEEEEccc----c
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH------------------------------EEFTLVAVKMLKD----E 406 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~------------------------------~~~~~VAVK~l~~----~ 406 (653)
.+..++|++.+.||+|....||.|+++..... ...-+.|||++-. .
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 34567899999999999999999987531100 0112356665421 1
Q ss_pred ccHHHHHHHHHHH------HH--------Hhh--------CCCCccceEEeEEec-------------------------
Q psy5539 407 ASEYLQTDFEREA------CL--------LAE--------FDHPNIVKLLGVCAV------------------------- 439 (653)
Q Consensus 407 ~~~~~~~~f~~Ei------~i--------l~~--------l~HpnIv~l~g~~~~------------------------- 439 (653)
......+.+-+|. .. .+. -+|||||+++++|.+
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 1222222222221 11 111 259999999987632
Q ss_pred --CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 --GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
+..+|+||.-.+. +|.+||.. ...+.....-|+.|+++|+.|||.+||.|||||++
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~---------------------~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSD 370 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWT---------------------RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSD 370 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhc---------------------CCCchHHHHHHHHHHHHHHHHHHHccchhhccccc
Confidence 2367899987765 89999862 23455667788999999999999999999999999
Q ss_pred CEeE--cCCC--cEEEeccCccccccc---c-ccccCCCCCCCccccccchhhccCC------CCCchhHHHHHHHHHHH
Q psy5539 518 NCLI--NDQM--VVKIADFGLSRKMYL---Q-DYYKGDENDAIPVRWMPLESILYNK------YTVESDVWAFGVCLWEI 583 (653)
Q Consensus 518 NILl--~~~~--~vkI~DfGla~~~~~---~-~~~~~~~~~~~t~~y~aPE~~~~~~------~t~ksDVwSlGvvl~el 583 (653)
|||| |+++ .+.|+|||.+---.. . .+....-...|....||||...... -..|+|.|+.|.+.||+
T Consensus 371 NiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEI 450 (598)
T KOG4158|consen 371 NILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEI 450 (598)
T ss_pred ceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHH
Confidence 9998 4444 678999998621100 0 1111112234566789999876432 23689999999999999
Q ss_pred HhCCCCCCCCCCHHHH-HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 584 FSFALQPYYGLTHEEV-VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 584 lt~~~~p~~~~~~~e~-~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
+. ...||++...-.+ .....+.+++..|+.+++.+++++...+++||++|++..-..+
T Consensus 451 fg-~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAAN 509 (598)
T KOG4158|consen 451 FG-RSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAAN 509 (598)
T ss_pred hc-cCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHh
Confidence 96 6678887321110 1113556677888999999999999999999999998765443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=183.64 Aligned_cols=239 Identities=21% Similarity=0.314 Sum_probs=152.4
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCC----------CccceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDH----------PNIVKL 433 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~H----------pnIv~l 433 (653)
.+...+.||.|+|+.||.+++. +++..+|+|.+.-. ......+++++|.-....+.+ -.++.-
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~-----~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P 87 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDV-----ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVP 87 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---
T ss_pred EEEEccccccCCceEEEEEEEc-----cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEee
Confidence 4567788999999999999964 56789999987432 233345567777655555432 122222
Q ss_pred EeEEe---------cCC--------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHH
Q psy5539 434 LGVCA---------VGK--------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQ 496 (653)
Q Consensus 434 ~g~~~---------~~~--------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 496 (653)
++... .+. +.+++|+-+ .+||.+++..... .......+....++.+..|
T Consensus 88 ~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~-------------~~~~~~~l~~~arl~lT~Q 153 (288)
T PF14531_consen 88 LDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFS-------------RAQTHSPLAFAARLSLTVQ 153 (288)
T ss_dssp SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHH-------------HTTTSHHHHHHHHHHHHHH
T ss_pred eEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhh-------------cccccchhHHHHHHHHHHH
Confidence 22221 111 346778776 5699888752211 0011223455667888899
Q ss_pred HHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC--------CCC
Q psy5539 497 IASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--------KYT 568 (653)
Q Consensus 497 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--------~~t 568 (653)
+++.+++||+.|++|+||+|+|++++++|.++|+||+....... ... . ...+..|.|||..... .+|
T Consensus 154 ~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~~~--~-~~~~~~~~PPe~~~~~~~~~~~~~~~t 228 (288)
T PF14531_consen 154 MIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--RYR--C-SEFPVAFTPPELESCAGQFGQNNAPYT 228 (288)
T ss_dssp HHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTE--EEE--G-GGS-TTTS-HHHHHHHTSCHHSEEEE-
T ss_pred HHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCc--eee--c-cCCCcccCChhhhhhhcccCcccceee
Confidence 99999999999999999999999999999999999987754321 111 1 3345679999976442 578
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCC
Q psy5539 569 VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634 (653)
Q Consensus 569 ~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 634 (653)
.+.|.|+||+++|.|.++.. ||........... .+..+. +.|+.++.||+.+|+++|.+|
T Consensus 229 ~~~DaW~LG~~ly~lWC~~l-Pf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 229 FATDAWQLGITLYSLWCGRL-PFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHHHHSS--STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred eccCHHHHHHHHHHHHHccC-CCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999999999765 7765543211111 344566 899999999999999999988
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.4e-20 Score=201.22 Aligned_cols=229 Identities=25% Similarity=0.372 Sum_probs=185.6
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH-HHHHHHHHHHHHhhCC-CCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-LQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~-~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+|+|+||.|++++-.+ ....+..+|.|+++...... .+.....|..++...+ ||.+|++.-.+..+...+++++|.
T Consensus 2 lg~g~~gkvfLvrk~~--g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAG--GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhc--cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 7999999999976433 33456788888887543211 1113445778888887 999999999999999999999999
Q ss_pred CCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEe
Q psy5539 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530 (653)
Q Consensus 451 ~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~ 530 (653)
.+|+|...+. ....++..........++-+++++|+.+++|||+|++||+++.+|.+++.
T Consensus 80 rgg~lft~l~--------------------~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~t 139 (612)
T KOG0603|consen 80 RGGDLFTRLS--------------------KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLT 139 (612)
T ss_pred ccchhhhccc--------------------cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccC
Confidence 9999987664 33456777778888899999999999999999999999999999999999
Q ss_pred ccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC
Q psy5539 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ 610 (653)
Q Consensus 531 DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~ 610 (653)
|||+++....... ..|+..|||||.+. .....+|.||||++++||++|.. ||.+ ++...|...+ +.
T Consensus 140 dfglske~v~~~~------~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~-pf~~----~~~~~Il~~~-~~ 205 (612)
T KOG0603|consen 140 DFGLSKEAVKEKI------ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTL-PFGG----DTMKRILKAE-LE 205 (612)
T ss_pred CchhhhHhHhhhh------cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCC-CCch----HHHHHHhhhc-cC
Confidence 9999987533221 27899999999988 67789999999999999999655 7766 6666666544 35
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSF 637 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~ 637 (653)
.|........+++..++.++|..|...
T Consensus 206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 206 MPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 677888899999999999999999754
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=168.47 Aligned_cols=186 Identities=14% Similarity=0.084 Sum_probs=134.5
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---HHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceE
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---EYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 444 (653)
....|++|+||+||.+.. .+..++.+.++.... ......|.+|+++|++|+ |+++++++++ +..+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-------~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-------GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred cceeecCCCcceEEEeec-------CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 456799999999997753 346788777765432 112235889999999995 5889999886 4469
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC-CCCCEeEcC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL-ATRNCLIND 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL-kp~NILl~~ 523 (653)
++|||+.|.+|.+.+. . ....++.|++.+|.++|+.||+|||| ||+|||+++
T Consensus 75 lvmeyI~G~~L~~~~~--------------------------~-~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~ 127 (218)
T PRK12274 75 LDRSYLAGAAMYQRPP--------------------------R-GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQE 127 (218)
T ss_pred EEEeeecCccHHhhhh--------------------------h-hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcC
Confidence 9999999988865331 0 11357789999999999999999999 799999999
Q ss_pred CCcEEEeccCccccccccccc----c-C------CCCCCCccccccchhhccC-CCC-CchhHHHHHHHHHHHHhCCCCC
Q psy5539 524 QMVVKIADFGLSRKMYLQDYY----K-G------DENDAIPVRWMPLESILYN-KYT-VESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~----~-~------~~~~~~t~~y~aPE~~~~~-~~t-~ksDVwSlGvvl~ellt~~~~p 590 (653)
++.++|+|||++......... . . ......++.+++|+....- ..+ ...+.++-|.-+|.++|++..-
T Consensus 128 ~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~ 207 (218)
T PRK12274 128 DGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH 207 (218)
T ss_pred CCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence 999999999999743211100 0 0 0011235567777654322 333 5678899999999999998865
Q ss_pred CC
Q psy5539 591 YY 592 (653)
Q Consensus 591 ~~ 592 (653)
|.
T Consensus 208 ~~ 209 (218)
T PRK12274 208 WE 209 (218)
T ss_pred cc
Confidence 54
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.2e-17 Score=161.62 Aligned_cols=135 Identities=16% Similarity=0.196 Sum_probs=111.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-------HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-------EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-------~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
+.||+|++|.||+|... +..|++|....... ......+.+|++++..++|++|.....++...+..
T Consensus 2 ~~l~~G~~~~vy~~~~~-------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 74 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFL-------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENF 74 (211)
T ss_pred cccccCceEEEEEEeeC-------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCC
Confidence 56899999999999853 35688887653211 11234678999999999999988777777777788
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.+++.. ... .+..++.+++.+|.+||+.+++|+|++|.|||++
T Consensus 75 ~lv~e~~~G~~L~~~~~~-----------------------~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~- 129 (211)
T PRK14879 75 IIVMEYIEGEPLKDLINS-----------------------NGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS- 129 (211)
T ss_pred EEEEEEeCCcCHHHHHHh-----------------------ccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-
Confidence 999999999999998851 111 7789999999999999999999999999999999
Q ss_pred CCcEEEeccCcccc
Q psy5539 524 QMVVKIADFGLSRK 537 (653)
Q Consensus 524 ~~~vkI~DfGla~~ 537 (653)
++.++|+|||++..
T Consensus 130 ~~~~~liDf~~a~~ 143 (211)
T PRK14879 130 GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCEEEEECCcccC
Confidence 78999999999863
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=165.07 Aligned_cols=135 Identities=17% Similarity=0.251 Sum_probs=102.3
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-----CCCccceEEeEEecCC---
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-----DHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-----~HpnIv~l~g~~~~~~--- 441 (653)
.+.||+|+||.||. .+ .+.. .+||++...... ..+++.+|+.+++.+ +||||++++|++..+.
T Consensus 7 ~~~LG~G~~~~Vy~--hp-----~~~~-k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g 77 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HP-----EDAQ-RCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTG 77 (210)
T ss_pred cceecCCCceEEEE--CC-----CCcC-eEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCe
Confidence 35699999999995 32 1223 368887654322 346789999999999 6799999999998763
Q ss_pred c-eEEEEee--cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHH-HHhhhCCceecCCCCC
Q psy5539 442 P-MCLLFEY--MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM-VYLSDRKFVHRDLATR 517 (653)
Q Consensus 442 ~-~~LV~Ey--~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL-~yLH~~~ivHrDLkp~ 517 (653)
. ..+|+|| ..+|+|.++++. ..+++. ..++.|++.++ +|||+++|+||||||+
T Consensus 78 ~v~~~I~e~~G~~~~tL~~~l~~---------------------~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~ 134 (210)
T PRK10345 78 YVYDVIADFDGKPSITLTEFAEQ---------------------CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQ 134 (210)
T ss_pred EEEEEEecCCCCcchhHHHHHHc---------------------ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHH
Confidence 3 3478999 557999999962 123433 35677888777 9999999999999999
Q ss_pred CEeEcC----CCcEEEeccCccc
Q psy5539 518 NCLIND----QMVVKIADFGLSR 536 (653)
Q Consensus 518 NILl~~----~~~vkI~DfGla~ 536 (653)
|||++. +..++|+||+.+.
T Consensus 135 NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 135 NILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred HEEEeccCCCCCcEEEEECCCCc
Confidence 999974 3489999955443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=192.06 Aligned_cols=246 Identities=17% Similarity=0.191 Sum_probs=174.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC---CCccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD---HPNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~ 436 (653)
.++....|.+.+.||+|+||+||+|... +++.||+|+-+...... |---.+++.||+ -+-|+.+...
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~------~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a 762 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHS------NGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSA 762 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecC------CCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHH
Confidence 3555667888999999999999999852 37999999988764431 222233444554 2344444444
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+.-.+..+||+||.+.|+|.++++ ....+++.....++.|++..+++||..+|||+||||
T Consensus 763 ~~~~~~S~lv~ey~~~Gtlld~~N--------------------~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKP 822 (974)
T KOG1166|consen 763 HVFQNASVLVSEYSPYGTLLDLIN--------------------TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKP 822 (974)
T ss_pred HccCCcceeeeeccccccHHHhhc--------------------cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCc
Confidence 556677899999999999999986 234578889999999999999999999999999999
Q ss_pred CCEeEc-------CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 517 RNCLIN-------DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 517 ~NILl~-------~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
+|+||. ++..++|+|||.+..+..-.....-.....|-.+--+|...+..++.+.|.|.|+.+++-|+-|..
T Consensus 823 DNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y- 901 (974)
T KOG1166|consen 823 DNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY- 901 (974)
T ss_pred ceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH-
Confidence 999993 345789999999977643221112233445667888999999999999999999999999997543
Q ss_pred CCCCCCHHHHHHHHHcCCccCCCC----CCcHHH-HHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNILQAPD----NTPDAL-YDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~~~~~----~~~~~l-~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
++ ...|....... .+..++ .+++..+|+.+-..=|...+|...+.+.
T Consensus 902 ----------~q-~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 902 ----------ME-VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred ----------HH-hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 22 33333322222 222333 4577778884444445555555555443
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-18 Score=181.64 Aligned_cols=176 Identities=23% Similarity=0.305 Sum_probs=137.1
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.+++.|+++...+|.+||+... .....++...+.++.|++.|++| ++.+|||+||.||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-----------------~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~ 389 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-----------------TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF 389 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-----------------cccccchhHHHHHHHhhccchhh---ccchhhhcccccccc
Confidence 5889999999999999997332 23346778889999999999999 999999999999999
Q ss_pred cCCCcEEEeccCccccccccc----cccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQD----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~----~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
..+..+||.|||+...+.... .....+...+|..||+||.+.+..|+.++||||||++|+|++..-.. .+...
T Consensus 390 ~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T---~~er~ 466 (516)
T KOG1033|consen 390 SDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFST---QFERI 466 (516)
T ss_pred ccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhcc---HHHHH
Confidence 999999999999987653332 12234567889999999999999999999999999999999972111 12223
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
..+..++++.+++....--+.-+.|+.+++.+.|.+||++.+.
T Consensus 467 ~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 467 ATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHH
Confidence 3455566776653222223446789999999999999955443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.2e-17 Score=165.29 Aligned_cols=142 Identities=19% Similarity=0.141 Sum_probs=108.2
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----------------------HHHHHHHHHHHHHHh
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----------------------EYLQTDFEREACLLA 423 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----------------------~~~~~~f~~Ei~il~ 423 (653)
|.+.+.||+|+||.||+|.+. ..++..||+|.++.... ......+.+|+.++.
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~----~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~ 105 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDF----DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQ 105 (237)
T ss_pred HHhCCeeccCcceeEEEEEec----CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 667788999999999999721 13568899999874321 012234678999999
Q ss_pred hCCCCc--cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHH
Q psy5539 424 EFDHPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM 501 (653)
Q Consensus 424 ~l~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 501 (653)
++.+.. +.++++. ...+|||||+++++|..++. ....+...+...++.||+.+|
T Consensus 106 ~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l 161 (237)
T smart00090 106 RLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL--------------------KDVEPEEEEEFELYDDILEEM 161 (237)
T ss_pred HHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc--------------------ccCCcchHHHHHHHHHHHHHH
Confidence 997633 3344443 23589999999988866432 112345566789999999999
Q ss_pred HHhhhCC-ceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 502 VYLSDRK-FVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 502 ~yLH~~~-ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
++||+.+ |+||||||+||+++ ++.++|+|||.+..
T Consensus 162 ~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 162 RKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 99999999999999 88999999999864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.8e-17 Score=157.84 Aligned_cols=131 Identities=18% Similarity=0.171 Sum_probs=104.8
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--c-----HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--S-----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.||+|+||.||+|... +..|++|...... . ......+.+|++++..++|+++.....++......+
T Consensus 1 ~ig~G~~~~vy~~~~~-------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 73 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKT 73 (199)
T ss_pred CCCCCceEEEEEeecC-------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCE
Confidence 3799999999999853 3678888854321 1 112356789999999999887665555555666779
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|.+++... . ..++.+++.+|.+||+.+++|+|++|.||+++ +
T Consensus 74 lv~e~~~g~~l~~~~~~~--------------------~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~ 125 (199)
T TIGR03724 74 IVMEYIEGKPLKDVIEEG--------------------N-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-D 125 (199)
T ss_pred EEEEEECCccHHHHHhhc--------------------H-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-C
Confidence 999999999999987510 0 07899999999999999999999999999999 7
Q ss_pred CcEEEeccCcccc
Q psy5539 525 MVVKIADFGLSRK 537 (653)
Q Consensus 525 ~~vkI~DfGla~~ 537 (653)
+.++++|||+++.
T Consensus 126 ~~~~liDfg~a~~ 138 (199)
T TIGR03724 126 DKLYLIDFGLGKY 138 (199)
T ss_pred CcEEEEECCCCcC
Confidence 8999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.3e-17 Score=186.23 Aligned_cols=208 Identities=26% Similarity=0.406 Sum_probs=153.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|..++.|..|+||.||.++++ ...+.+|.|+=++. .+.|. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~-----~trqrfa~kiNkq~-------lilRn--ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHK-----ETRQRFAMKINKQN-------LILRN--ILTFAGNPFVV------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeecc-----ccccchhhcccccc-------hhhhc--cccccCCccee------------
Confidence 357889999999999999999864 34467777433221 11111 22222333333
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
||-...++ ..++++.. ++.+++|||+-+|+|||+||+|.||+.
T Consensus 136 ---------gDc~tllk--------------------~~g~lPvd--------mvla~Eylh~ygivhrdlkpdnllIT~ 178 (1205)
T KOG0606|consen 136 ---------GDCATLLK--------------------NIGPLPVD--------MVLAVEYLHSYGIVHRDLKPDNLLITS 178 (1205)
T ss_pred ---------chhhhhcc--------------------cCCCCcch--------hhHHhHhhccCCeecCCCCCCcceeee
Confidence 45544443 22233322 278899999999999999999999999
Q ss_pred CCcEEEeccCcccccccccc-------------ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 524 QMVVKIADFGLSRKMYLQDY-------------YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~-------------~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
-|.+|+.|||+++....... .-.+....+|+.|.|||++....|...+|.|++|+|+||.+-|.. |
T Consensus 179 mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcv-p 257 (1205)
T KOG0606|consen 179 MGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV-P 257 (1205)
T ss_pred cccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeee-e
Confidence 99999999999875421100 012334578999999999999999999999999999999998654 9
Q ss_pred CCCCCHHHHHHHHHcCC--ccCCCCCCcHHHHHHHHHhhccCCCCCC
Q psy5539 591 YYGLTHEEVVKYIKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RP 635 (653)
|.+.++++++..+..-. .++-.+..+.+.++++.++++.+|..|.
T Consensus 258 ffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 258 FFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred ccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 99999999988875533 3344456789999999999999999996
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.2e-16 Score=180.44 Aligned_cols=135 Identities=22% Similarity=0.268 Sum_probs=108.3
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEE-c-c---cc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM-L-K---DE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~-l-~---~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+...+.||+|+||+||+|.+.+ ..+++|+ . + .. ......+.+.+|++++..++|++++....++..
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~-------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG-------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cCccceeccCCcEEEEEEeecC-------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3456789999999999998643 1223332 1 1 11 111223568899999999999999988877777
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++++|.+++. ....++.+++.+|.+||+.+++||||||+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~----------------------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI 459 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE----------------------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF 459 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH----------------------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence 778899999999999999874 2467899999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccc
Q psy5539 520 LINDQMVVKIADFGLSRK 537 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~ 537 (653)
|+ +++.++|+|||+++.
T Consensus 460 Ll-~~~~~~liDFGla~~ 476 (535)
T PRK09605 460 IV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EE-ECCcEEEEeCccccc
Confidence 99 677999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.1e-16 Score=155.22 Aligned_cols=136 Identities=18% Similarity=0.180 Sum_probs=105.5
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---------------------HHHHHHHHHHHHHHhhC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---------------------EYLQTDFEREACLLAEF 425 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---------------------~~~~~~f~~Ei~il~~l 425 (653)
+.+.+.||+|+||.||++... ++..||||+++.... ......+.+|..++..+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 90 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL 90 (198)
T ss_pred hhcCCccccCcceEEEEEEcC------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH
Confidence 556788999999999999752 468899998654320 01122467889999999
Q ss_pred CCCc--cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 426 DHPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 426 ~Hpn--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
.|++ +...++ ....++||||+++++|.+... ......++.+++.++.+
T Consensus 91 ~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~--------------------------~~~~~~~~~~i~~~l~~ 140 (198)
T cd05144 91 YEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV--------------------------LEDPEEVLDEILEEIVK 140 (198)
T ss_pred HHcCCCCCceee----cCCceEEEEEeCCcchhhccc--------------------------cccHHHHHHHHHHHHHH
Confidence 8874 444443 245589999999998865431 02346788999999999
Q ss_pred hhhCCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 504 LSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 504 LH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
+|+.+|+|+||||+||++++++.++|+|||++...
T Consensus 141 lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 141 AYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred HHHCCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 99999999999999999999999999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.7e-14 Score=145.78 Aligned_cols=135 Identities=19% Similarity=0.179 Sum_probs=102.0
Q ss_pred eeec-ccCCeeEEEEEeCCCCCCccceEEEEEEccccc------------cHHHHHHHHHHHHHHhhCCCCcc--ceEEe
Q psy5539 371 RDLG-QGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA------------SEYLQTDFEREACLLAEFDHPNI--VKLLG 435 (653)
Q Consensus 371 ~~LG-~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~------------~~~~~~~f~~Ei~il~~l~HpnI--v~l~g 435 (653)
..|| .|+.|+||.++.. +..++||++.... .......+.+|++++.+|+|++| ++.++
T Consensus 37 ~~lg~~~g~gtv~~v~~~-------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~ 109 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIA 109 (239)
T ss_pred ceeecCCCCccEEEEEeC-------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEe
Confidence 3477 8888999998763 3568888774311 11233567899999999998875 66777
Q ss_pred EEecC-Cc---eEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 436 VCAVG-KP---MCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 436 ~~~~~-~~---~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
+.... .. .++|+||+++ .+|.+++.. ..++.. .+.+|+.+|.+||+.||+
T Consensus 110 ~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~---------------------~~l~~~----~~~~i~~~l~~lH~~GI~ 164 (239)
T PRK01723 110 ARVVRHGLFYRADILIERIEGARDLVALLQE---------------------APLSEE----QWQAIGQLIARFHDAGVY 164 (239)
T ss_pred eeeeecCcceeeeEEEEecCCCCCHHHHHhc---------------------CCCCHH----HHHHHHHHHHHHHHCCCC
Confidence 64432 22 3599999997 699988751 123332 357899999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
||||||.|||++.++.++|+|||.+..
T Consensus 165 HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 165 HADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.5e-15 Score=143.50 Aligned_cols=136 Identities=24% Similarity=0.233 Sum_probs=95.9
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHH---------------------HHHHHHHHhhCC
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTD---------------------FEREACLLAEFD 426 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~---------------------f~~Ei~il~~l~ 426 (653)
.+.||+|+||+||+|... ++..||||+++..... ..... ...|...+.++.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 2 GGPIGTGKEADVYLALDG------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CcccccccceeEEEEECC------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 356999999999999853 4578999988753211 11111 135566666664
Q ss_pred CCc--cceEEeEEecCCceEEEEeecCCCChHHH-HhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 427 HPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDF-LRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 427 Hpn--Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~-L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
+.. +.+.++. ...++||||++++++... +. .. ... .+...++.+++.++.+
T Consensus 76 ~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~--------------------~~-~~~-~~~~~~~~~~~~~l~~ 129 (187)
T cd05119 76 EAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLK--------------------DV-RLL-EDPEELYDQILELMRK 129 (187)
T ss_pred HcCCCCCceEec----CCCEEEEEEeCCCCccChhhh--------------------hh-hhc-ccHHHHHHHHHHHHHH
Confidence 432 4444443 246899999999654321 11 00 001 5678899999999999
Q ss_pred hhh-CCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 504 LSD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 504 LH~-~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
+|+ .+|+|+||||+||+++ ++.++|+|||.+...
T Consensus 130 lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 130 LYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred HhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 999 9999999999999999 889999999999653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.8e-14 Score=132.01 Aligned_cols=132 Identities=23% Similarity=0.262 Sum_probs=110.5
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC--CccceEEeEEecCCceEEE
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH--PNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~LV 446 (653)
+++.||+|.++.||+++..+ ..+++|..+.... ...+.+|+.++..++| .++.+++++....+..+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-------~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v 71 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-------EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL 71 (155)
T ss_pred cceecccccccceEEEEecC-------CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence 35679999999999998632 5799999876543 4578899999999977 5899999988888889999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC---CceecCCCCCCEeEcC
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR---KFVHRDLATRNCLIND 523 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~ivHrDLkp~NILl~~ 523 (653)
+||++++.+..+ +......++.+++.+|++||.. +++|+|++|+|||+++
T Consensus 72 ~e~~~g~~~~~~---------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~ 124 (155)
T cd05120 72 MEWIEGETLDEV---------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124 (155)
T ss_pred EEecCCeecccC---------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC
Confidence 999988655321 4456678899999999999985 6999999999999999
Q ss_pred CCcEEEeccCcccc
Q psy5539 524 QMVVKIADFGLSRK 537 (653)
Q Consensus 524 ~~~vkI~DfGla~~ 537 (653)
++.++++|||+++.
T Consensus 125 ~~~~~l~Df~~~~~ 138 (155)
T cd05120 125 GKILGIIDWEYAGY 138 (155)
T ss_pred CcEEEEEecccccC
Confidence 99999999999863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.55 E-value=3e-16 Score=177.33 Aligned_cols=261 Identities=20% Similarity=0.260 Sum_probs=192.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~ 441 (653)
...|.+.+.||+|+|+.|-..... ......+|+|.+.... ..........|..+-..+. |+|++++++.....+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~----~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~ 94 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNS----RDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPR 94 (601)
T ss_pred cccccccccccccccchhhhhhhc----CCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCc
Confidence 345667777999999999877642 2334567777765442 3334445556888877887 999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceecCCCCCCEe
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS-DRKFVHRDLATRNCL 520 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NIL 520 (653)
..++++||..+|++.+.+. .......+......++.|+..++.|+| ..++.|+|+||+|.+
T Consensus 95 ~~~~~~~~s~g~~~f~~i~------------------~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 95 SYLLSLSYSDGGSLFSKIS------------------HPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred ccccccCcccccccccccc------------------cCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 9999999999999887652 011113455566788999999999999 999999999999999
Q ss_pred EcCCC-cEEEeccCccccccc-cccccCCCCCCC-ccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 521 INDQM-VVKIADFGLSRKMYL-QDYYKGDENDAI-PVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 521 l~~~~-~vkI~DfGla~~~~~-~~~~~~~~~~~~-t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
++.++ ..+++|||+|..... ...........+ ++.|+|||...+. ......|+||.|+++.-+++|.. |+.....
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~-p~~~~~~ 235 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGEL-PWDFPSR 235 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCC-Ccccccc
Confidence 99999 999999999986644 222223334455 8899999998874 45688999999999999999776 4433222
Q ss_pred H--HHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 597 E--EVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 597 ~--e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
. .....+..... ............+++.+++..+|..|.+.+++....|..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~ 290 (601)
T KOG0590|consen 236 KDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLS 290 (601)
T ss_pred ccccceeecccccccccCccccCChhhhhcccccccCCchhcccccccccccccc
Confidence 1 11222222211 223345778889999999999999999999988766644
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.1e-12 Score=141.74 Aligned_cols=140 Identities=22% Similarity=0.264 Sum_probs=99.5
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHH--------------------------------------
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ-------------------------------------- 412 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~-------------------------------------- 412 (653)
+.||.|++|.||+|+++ +|+.||||+.++...+...
T Consensus 123 ~plasaSigQVh~A~l~------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred cceeeeehhheEEEEec------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 46999999999999974 4578999998765322111
Q ss_pred -HHHHHHHHHHhhCC----CCccceEEeEE-ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCC
Q psy5539 413 -TDFEREACLLAEFD----HPNIVKLLGVC-AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486 (653)
Q Consensus 413 -~~f~~Ei~il~~l~----HpnIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~ 486 (653)
-+|.+|++.+.+++ |.+-+.+-.++ ......+|||||++|++|.+++.... ...
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-------------------~~~- 256 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-------------------AGL- 256 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-------------------cCC-
Confidence 13556666666652 33333332333 23456799999999999998765210 011
Q ss_pred HHHHHHHHHHHHH-HHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 487 TCDLITIALQIAS-GMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 487 ~~~~~~i~~qia~-gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
....++.+++. .+..+|..|++|+|++|.||++++++.++++|||++..+
T Consensus 257 --~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 257 --DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred --CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 23456666666 478899999999999999999999999999999998754
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.35 E-value=7.9e-13 Score=143.47 Aligned_cols=255 Identities=19% Similarity=0.165 Sum_probs=186.3
Q ss_pred CCCCeeEEeeecc--cCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 363 PRNDIIYVRDLGQ--GAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 363 ~~~~~~~~~~LG~--G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
..+.+.+...+|. |.+|.||.++.. ..++...+|+|+-+...+ ......=.+|+..-+.+ .|+|.++....+.
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~---~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCT---NSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCC---cccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3445566777899 999999998752 246778899998443222 11122234566666666 4999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHH----HHHHhhhCCceecCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIAS----GMVYLSDRKFVHRDL 514 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~----gL~yLH~~~ivHrDL 514 (653)
.++..++-+|++. .+|.++.+. ....++...++.+..+..+ ||.++|+.+++|-|+
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~-------------------~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~ 248 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHT-------------------PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDL 248 (524)
T ss_pred cCCcceeeecccc-chhHHhhhc-------------------ccccCCchhhhhHHhhhhhcccccccccCCCccccccc
Confidence 9999999999886 688877651 2234677788888888888 999999999999999
Q ss_pred CCCCEeEcCC-CcEEEeccCccccccccccccCC---CCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 515 ATRNCLINDQ-MVVKIADFGLSRKMYLQDYYKGD---ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 515 kp~NILl~~~-~~vkI~DfGla~~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||.||+..++ ...+++|||+...+...+..... ....+...|++||.+. +-++..+|+||+|.++.+...+-.+|
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999 89999999999877554432211 2225567899999754 57889999999999999998877766
Q ss_pred CCCCCHHHHHHHHHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
-.+.... ...++.+.+ .+.-+..+.++...+..+++.+|..|++.+.+..+
T Consensus 328 ~~g~~~~--W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 328 SVGKNSS--WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred cCCCCCC--ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 6653221 111222221 12223455677779999999999999998877653
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-12 Score=130.91 Aligned_cols=206 Identities=20% Similarity=0.239 Sum_probs=147.2
Q ss_pred HHHhhCCCCccceEEeEEecC-----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHH
Q psy5539 420 CLLAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIA 494 (653)
Q Consensus 420 ~il~~l~HpnIv~l~g~~~~~-----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 494 (653)
.-|-.+.|-|||++..++.+. ....++.|||..|+|..||+.... ....+......+++
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~----------------~~~a~~~~~wkkw~ 182 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK----------------NQKALFQKAWKKWC 182 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH----------------hhhhhhHHHHHHHH
Confidence 345556799999999998653 357899999999999999985432 33557788888999
Q ss_pred HHHHHHHHHhhh--CCceecCCCCCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccCCCCCc
Q psy5539 495 LQIASGMVYLSD--RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNKYTVE 570 (653)
Q Consensus 495 ~qia~gL~yLH~--~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~t~k 570 (653)
.||+.||.|||+ ..|+|+++.-+-|++..+|-+||.--.-......-.... ......+-++|-+||+-.....+.+
T Consensus 183 tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a 262 (458)
T KOG1266|consen 183 TQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA 262 (458)
T ss_pred HHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc
Confidence 999999999996 489999999999999999998875322211111111000 1112334568999998888888999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 571 SDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 571 sDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+|||+||...+||.-+..+|-.+.+.-++-..+..--+ ...+ ..-+.++.+|++..|..||++++++.|+.
T Consensus 263 ~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~-~len---~lqr~~i~kcl~~eP~~rp~ar~llfHpl 333 (458)
T KOG1266|consen 263 SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVII-GLEN---GLQRGSITKCLEGEPNGRPDARLLLFHPL 333 (458)
T ss_pred hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhee-eccC---ccccCcCcccccCCCCCCcchhhhhcCce
Confidence 99999999999999888777655443322222221111 0111 11246788999999999999999988763
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.6e-11 Score=136.45 Aligned_cols=146 Identities=17% Similarity=0.208 Sum_probs=93.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH---------------------------------HH
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY---------------------------------LQ 412 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~---------------------------------~~ 412 (653)
+|+. +.||+|++|.||+|+++. +|+.||||++++...+. ..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~-----~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKD-----NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECC-----CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 3444 679999999999999742 36889999997652111 11
Q ss_pred H------HHHHHHHHHhhCC----CCccceEEeEEe-cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccC
Q psy5539 413 T------DFEREACLLAEFD----HPNIVKLLGVCA-VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481 (653)
Q Consensus 413 ~------~f~~Ei~il~~l~----HpnIv~l~g~~~-~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~ 481 (653)
+ +|.+|+..+.+++ +.+.+.+=.++. -....+|||||++|++|.++-..... . ..
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~-g-------------~d 260 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAA-G-------------TD 260 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhc-C-------------CC
Confidence 1 2445555555542 333343333332 24567899999999999875321000 0 00
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC----cEEEeccCccccc
Q psy5539 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM----VVKIADFGLSRKM 538 (653)
Q Consensus 482 ~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~----~vkI~DfGla~~~ 538 (653)
...+....+..++.| +...|++|+|+||.||+++.++ .++++|||++..+
T Consensus 261 ~~~la~~~v~~~~~Q-------if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 261 MKLLAERGVEVFFTQ-------VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred HHHHHHHHHHHHHHH-------HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 011222223333333 3468999999999999999888 9999999998754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.1e-11 Score=118.07 Aligned_cols=127 Identities=17% Similarity=0.130 Sum_probs=95.3
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccc-eEEeEEecCCceEEEEe
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV-KLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~LV~E 448 (653)
++.|+.|.++.||+++.. +..+++|....... ....+.+|+.++..+.+.+++ +++.+. ....++|||
T Consensus 3 ~~~l~~G~~~~vy~~~~~-------~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e 71 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-------NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITE 71 (170)
T ss_pred eeecCCcccCceEEEEEC-------CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEE
Confidence 466899999999999853 36799999865532 123467899999998766555 444443 334589999
Q ss_pred ecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc-----eecCCCCCCEeEcC
Q psy5539 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF-----VHRDLATRNCLIND 523 (653)
Q Consensus 449 y~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i-----vHrDLkp~NILl~~ 523 (653)
|+++.++.+.. . ....++.+++++|+.||+.++ +|+|++|.||+++
T Consensus 72 ~i~G~~l~~~~-------------------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 72 FIEGSELLTED-------------------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred ecCCCcccccc-------------------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 99998764320 0 012456789999999999875 9999999999999
Q ss_pred CCcEEEeccCccc
Q psy5539 524 QMVVKIADFGLSR 536 (653)
Q Consensus 524 ~~~vkI~DfGla~ 536 (653)
++.++++|||.+.
T Consensus 123 ~~~~~liDf~~a~ 135 (170)
T cd05151 123 DGRLWLIDWEYAG 135 (170)
T ss_pred CCeEEEEeccccc
Confidence 6689999999985
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.27 E-value=4e-12 Score=138.01 Aligned_cols=252 Identities=18% Similarity=0.153 Sum_probs=184.9
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHH-HHHHHHHHHHhhC-CCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ-TDFEREACLLAEF-DHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~-~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 439 (653)
....+|..+..||.|.|+.|++... ...++..+++|.+......... ..-..|+.+...+ .|.++++....+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~----r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSK----RPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred eecCCcceeEEccCCccccceeeee----cCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 3456788999999999999999763 2256688999988765432222 2234566666665 58899998888888
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++-.||++++++...+. ....++....+++..|++.++.++|++.++|+|+||+||
T Consensus 338 ~r~~~ip~e~~~~~s~~l~~~--------------------~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni 397 (524)
T KOG0601|consen 338 LRQGYIPLEFCEGGSSSLRSV--------------------TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNI 397 (524)
T ss_pred cccccCchhhhcCcchhhhhH--------------------HHHhcCcchhhhhHHHHHhccccccchhhhcccccccce
Confidence 888889999999998877653 123466777889999999999999999999999999999
Q ss_pred eEcCC-CcEEEeccCccccccccccccCCCCCCCccccc--cchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 520 LINDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWM--PLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 520 Ll~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~--aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
++..+ +..++.|||.+..+.... ......-+++ ++.......+-.+.|++|||..+.|.+++...+..+..
T Consensus 398 ~i~~~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~- 471 (524)
T KOG0601|consen 398 LISNDGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ- 471 (524)
T ss_pred eeccchhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-
Confidence 99886 788999999986532211 1122223444 44455556788999999999999999986655544333
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...|..+.....+. ...++..+.+.+..+++..||.+.++..+....
T Consensus 472 ---~~~i~~~~~p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 472 ---SLTIRSGDTPNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---ceeeecccccCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 23344454433333 337788888999999999999999887766544
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.8e-12 Score=141.76 Aligned_cols=253 Identities=19% Similarity=0.237 Sum_probs=184.6
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
.....+++.+.+.+-+|+++.++.++-.+ .+...++|..+.... ....+...++-.++-..++|-++...-.+
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~-----sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~ 873 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAG-----SGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF 873 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccc-----cccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC
Confidence 45667788888999999999999886433 334444444432111 00011223333333334556666655555
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
....+..|+++|+.+++|...|+.. +..+..-.......+...+++||+..+.|+|++|.
T Consensus 874 ~~rsP~~L~~~~~~~~~~~Skl~~~--------------------~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~ 933 (1205)
T KOG0606|consen 874 PCRSPLPLVGHYLNGGDLPSKLHNS--------------------GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPD 933 (1205)
T ss_pred CCCCCcchhhHHhccCCchhhhhcC--------------------CCcccccccchhHHHHhhhhccccchhhccccccc
Confidence 6678999999999999999888622 23344444556667888999999999999999999
Q ss_pred CEeEcCCCcEEEeccCcccccccc--------------------cc---------ccCCCCCCCccccccchhhccCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQ--------------------DY---------YKGDENDAIPVRWMPLESILYNKYT 568 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~--------------------~~---------~~~~~~~~~t~~y~aPE~~~~~~~t 568 (653)
|.|+..++..+++|||........ .. ........+|+.|.+||...+....
T Consensus 934 ~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hg 1013 (1205)
T KOG0606|consen 934 SLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHG 1013 (1205)
T ss_pred chhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCC
Confidence 999999999999999843322100 00 0112234568889999999999999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q psy5539 569 VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638 (653)
Q Consensus 569 ~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 638 (653)
..+|.|++|++++|.++ |.+|+....++.+++.+..+.. ...+...+.+..+++...+..+|.+|..+.
T Consensus 1014 s~ad~~~~g~~l~e~l~-g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1014 SAADWWSSGVCLFEVLT-GIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhhhhhhhhhhc-CCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99999999999999999 6679999999999988877654 334566788999999999999999998765
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.16 E-value=4.4e-10 Score=123.41 Aligned_cols=164 Identities=20% Similarity=0.233 Sum_probs=122.3
Q ss_pred ccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCc
Q psy5539 393 EEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472 (653)
Q Consensus 393 ~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~ 472 (653)
.++.+|.|...+.... .......+-++.|+.+|||||++++..+...+..|||+|-+. -|..+++
T Consensus 35 ~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk------------ 99 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK------------ 99 (690)
T ss_pred ccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH------------
Confidence 4556777777765544 344556778899999999999999999999999999999874 4777775
Q ss_pred ccccccccCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCC
Q psy5539 473 SSMESSIHRVPQLSTCDLITIALQIASGMVYLS-DRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDA 551 (653)
Q Consensus 473 ~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~ 551 (653)
.+........+.||+.||.||| +.+++|++|.-+.|+|++.|..||++|.++......+. ......
T Consensus 100 -----------~l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~ 166 (690)
T KOG1243|consen 100 -----------ELGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLY 166 (690)
T ss_pred -----------HhHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccch
Confidence 1335566778899999999998 56899999999999999999999999988754311110 011111
Q ss_pred CccccccchhhccCCCCCchhHHHHHHHHHHHHhC
Q psy5539 552 IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 552 ~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~ 586 (653)
.-..|..|+.+.... -..|.|-||+++||++.|
T Consensus 167 ~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 167 LIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 112356666544333 346999999999999986
|
|
| >PF01392 Fz: Fz domain; InterPro: IPR020067 The frizzled (fz) domain is an extracellular domain of about 120 amino acids | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.9e-11 Score=109.27 Aligned_cols=109 Identities=19% Similarity=0.422 Sum_probs=70.4
Q ss_pred cccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCCCc
Q psy5539 35 CSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPL 114 (653)
Q Consensus 35 c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~p~ 114 (653)
|++|++..|+.++- +..+|.|......+ .+......+|..+ ++..|++++..+||+++||+|...+..+ +.+.
T Consensus 1 C~pi~~~~C~~~~y-~~t~~pn~~~~~~~--~~~~~~~~~~~~l---~~~~C~~~~~~flC~~~~P~C~~~~~~~-~~~p 73 (116)
T PF01392_consen 1 CEPITLSFCRGLPY-NQTSFPNSLGHQTQ--DEASQQLNAFSTL---VNSGCHPYLRPFLCSLYFPPCDEGGPTP-PLPP 73 (116)
T ss_dssp EEE---GGGTTSS--TEEESSETTTSSSH--HHHHHHHHCCHHH---HCCTSHTTHHHHHHHHHS-BBBSSSSSS-B-EB
T ss_pred CccCChHHhcCCCC-CceEeecccCCcCH--HHHHHHHHHHHHH---hcchhhHHHhhhhhcccCCcCCCCCccc-ccCC
Confidence 89999999999864 44555555532222 1212223346666 4459999999999999999997655433 3889
Q ss_pred ccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCc
Q psy5539 115 CYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYE 162 (653)
Q Consensus 115 C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~ 162 (653)
||+.|+.++. .|..+|..+ +.+....++|+.+|...
T Consensus 74 Cr~~C~~v~~-~C~~~~~~~-----------~~~~~~~~~C~~lP~~~ 109 (116)
T PF01392_consen 74 CRSLCEEVKS-SCSPELENL-----------GLGWPSFLDCSNLPESN 109 (116)
T ss_dssp -HHHHHHHHH-HHHHHHHHT-----------TTTTSGGG-GGGSS-TT
T ss_pred CHHHcccccc-ccHHHHHHh-----------cCCCCCCCCcccCCCCC
Confidence 9999999997 999999762 12334578999999765
|
It was first identified in the alpha-1 chain of type XVIII collagen and in members of the Frizzled family of seven transmembrane (7TM) proteins which act as receptors for secreted Wingless (Wg)/Wnt glycoproteins []. In addition to these proteins, one or two copies of the fz domain are also found [, , , , ] in: The frizbee (Frzb) family; secreted frizzled-like proteins. Smoothened; another 7TM receptor involved in hedgehog signaling. Carboxpeptidase Z (CPZ). Transmembrane serine protease corin. Two receptor tyrosine kinases (RTKs) subfamilies, the Ror family and the muscle-specific kinase (MuSK) family. As the fz domain contains 10 cysteines which are largely conserved, it has also been called cysteine-rich domain (CRD) []. The fz domain also contains several other highly conserved residues, for example, a basic amino acid follows C6, and a conserved proline residues lies four residues C-terminal to C9 []. The crystal structure of a fz domain shows that it is predominantly alpha-helical with all cysteines forming disulphide bonds. In addition to helical regions, two short beta-strands at the N terminus form a minimal beta-sheet with the second beta sheet passing through a knot created by disulphide bonds []. Several fz domains have been shown to be both necessary and sufficient for Wg/Wnt ligand binding, strongly suggesting that the fz domain is a Wg/Wnt interacting domain [, ].; GO: 0005515 protein binding; PDB: 1IJX_E 3HKL_B 1IJY_B 4F0A_A. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.14 E-value=7.6e-10 Score=107.56 Aligned_cols=141 Identities=21% Similarity=0.209 Sum_probs=98.1
Q ss_pred eeecccCCeeEEEEEeCCC-CCCccceEEEEEEcccccc-------------------------HHHHHHHHHHHHHHhh
Q psy5539 371 RDLGQGAFGRVFQAKAPGL-LKHEEFTLVAVKMLKDEAS-------------------------EYLQTDFEREACLLAE 424 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~-~~~~~~~~VAVK~l~~~~~-------------------------~~~~~~f~~Ei~il~~ 424 (653)
..||.|--+.||.|...+. .....+..+|||..+.... .......++|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 3589999999999974310 0011346899997642110 0111223489999999
Q ss_pred CCC--CccceEEeEEecCCceEEEEeecCCCChHH-HHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHH
Q psy5539 425 FDH--PNIVKLLGVCAVGKPMCLLFEYMGRGDLND-FLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM 501 (653)
Q Consensus 425 l~H--pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 501 (653)
+.. -++.+.+++ ..-+|||||+.++.+.. .|+ ...++..+...+..+++.+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk---------------------d~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK---------------------DAKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh---------------------ccccCHHHHHHHHHHHHHHH
Confidence 853 466666765 56789999997754421 121 11244556678889999999
Q ss_pred HHh-hhCCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 502 VYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 502 ~yL-H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
..| |+.++||+||++.|||+++ +.+.|+|||.+..
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~~-~~v~iIDF~qav~ 173 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWHD-GKVWFIDVSQSVE 173 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEEC-CcEEEEECCCcee
Confidence 999 8999999999999999974 6799999998854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.06 E-value=4.9e-09 Score=111.83 Aligned_cols=228 Identities=11% Similarity=0.125 Sum_probs=162.5
Q ss_pred CeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe----cCCceEEEEeecCC-
Q psy5539 378 FGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA----VGKPMCLLFEYMGR- 452 (653)
Q Consensus 378 fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~----~~~~~~LV~Ey~~~- 452 (653)
-.+.||+.. ..+|..+++|+++..... .......-++.++++.|.|||++..++. .+..+++||+|.++
T Consensus 289 ~~Ttyk~~s-----~~DG~~YvLkRlhg~r~~-~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s 362 (655)
T KOG3741|consen 289 SITTYKATS-----NVDGNAYVLKRLHGDRDQ-STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS 362 (655)
T ss_pred cceeEeeee-----ccCCceeeeeeecccccc-CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence 367888874 467889999999533221 1112234578899999999999998875 34578999999986
Q ss_pred CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEecc
Q psy5539 453 GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532 (653)
Q Consensus 453 gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~Df 532 (653)
++|.++--...+.... .+ ..........++..+|.++.|++.||.++|+.|+.-+-|.+++||++.+.+++|+.-
T Consensus 363 ~TL~d~~F~~~~~t~~-~n----~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C 437 (655)
T KOG3741|consen 363 PTLYDLYFANPPFTKR-TN----SFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGC 437 (655)
T ss_pred chHHHHHccCCccccc-cc----cccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecc
Confidence 7888765433332200 00 011123456789999999999999999999999999999999999999999999988
Q ss_pred CccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHcCCccCC
Q psy5539 533 GLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV-VKYIKEGNILQA 611 (653)
Q Consensus 533 Gla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~-~~~i~~~~~~~~ 611 (653)
|....+..+. + |-+. --.+-|.=.||.+++.|.+|...-+.....++. .+.|.
T Consensus 438 ~i~Dvl~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------- 491 (655)
T KOG3741|consen 438 GIMDVLQEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT------- 491 (655)
T ss_pred cceeeecCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-------
Confidence 8876543222 0 1111 124678889999999999987765554444433 33332
Q ss_pred CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 612 PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 612 ~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
...+.++++++......++++ -++.+++.++
T Consensus 492 -~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~ 522 (655)
T KOG3741|consen 492 -TTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI 522 (655)
T ss_pred -hhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence 356788999999999988887 6788877654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.8e-09 Score=101.81 Aligned_cols=131 Identities=21% Similarity=0.207 Sum_probs=94.6
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEE-cccc-cc-----HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM-LKDE-AS-----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~-l~~~-~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.+++|+-+.+|.+.+.+ ..+++|. +++. .. .--...-.+|+.++++++--.|-.-+=+..+.....
T Consensus 3 ~i~~GAEa~i~~~~~~g-------~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~ 75 (204)
T COG3642 3 LIKQGAEAIIYLTDFLG-------LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGL 75 (204)
T ss_pred hhhCCcceeEEeeeccC-------cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCE
Confidence 47899999999986643 2355553 2221 11 112334568999999986544443333445667778
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|+|||.++..|.+++... ...++..|-.-+.-||..||+|+||.++||++..+
T Consensus 76 I~me~I~G~~lkd~l~~~---------------------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~ 128 (204)
T COG3642 76 IVMEYIEGELLKDALEEA---------------------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG 128 (204)
T ss_pred EEEEEeCChhHHHHHHhc---------------------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC
Confidence 999999999999888611 24566777778888999999999999999999877
Q ss_pred CcEEEeccCcccc
Q psy5539 525 MVVKIADFGLSRK 537 (653)
Q Consensus 525 ~~vkI~DfGla~~ 537 (653)
. +.++||||+..
T Consensus 129 ~-i~~IDfGLg~~ 140 (204)
T COG3642 129 R-IYFIDFGLGEF 140 (204)
T ss_pred c-EEEEECCcccc
Confidence 5 99999999863
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=108.12 Aligned_cols=139 Identities=22% Similarity=0.225 Sum_probs=94.9
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC--CccceEEeEEecC---CceEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH--PNIVKLLGVCAVG---KPMCL 445 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~---~~~~L 445 (653)
+.||.|..+.||+++.. ++..+++|.............+.+|++++..+++ .++.+++.+.... +..++
T Consensus 4 ~~l~~G~~n~~~~v~~~------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~ 77 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFY 77 (223)
T ss_pred eecCCCccceEEEEEec------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceE
Confidence 56899999999999753 2467999987654322234468899999999976 4457778776654 25689
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh--------------------
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS-------------------- 505 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-------------------- 505 (653)
||||+++.+|.+.+.. ..++..+...++.++++.|..||
T Consensus 78 v~e~i~G~~l~~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~ 136 (223)
T cd05154 78 VMERVDGRVLRDRLLR---------------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLE 136 (223)
T ss_pred EEEEeCCEecCCCCCC---------------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHH
Confidence 9999999887664310 11222223333333333333333
Q ss_pred ------------------------------------hCCceecCCCCCCEeEcC--CCcEEEeccCccc
Q psy5539 506 ------------------------------------DRKFVHRDLATRNCLIND--QMVVKIADFGLSR 536 (653)
Q Consensus 506 ------------------------------------~~~ivHrDLkp~NILl~~--~~~vkI~DfGla~ 536 (653)
...++|+|+.+.|||+++ ++.+.|+||+.+.
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 137 RQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 235799999999999998 6778999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-08 Score=105.91 Aligned_cols=253 Identities=18% Similarity=0.190 Sum_probs=164.0
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE-------ecC
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC-------AVG 440 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~-------~~~ 440 (653)
..+.||+|+-+.+|-.- +..--+-|+.+...... +. +.++.|... .||-+-.-+.+= ..+
T Consensus 15 ~gr~LgqGgea~ly~l~--------e~~d~VAKIYh~Pppa~-~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~ 82 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--------EVRDQVAKIYHAPPPAA-QA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRG 82 (637)
T ss_pred CCccccCCccceeeecc--------hhhchhheeecCCCchH-HH---HHHHHhccCCCCcchhhhhcccHHHhhCCCcc
Confidence 34568999999999642 11223345554332221 11 122233333 455433211111 122
Q ss_pred CceEEEEeecCCC-ChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 441 KPMCLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 441 ~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++|..+++. -+..+++ ........+...|.-+++.++.+|.+.+.||+.|.+-+|+.++|+
T Consensus 83 ~~iGflmP~v~g~~pI~~~y~--------------p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~ 148 (637)
T COG4248 83 KVIGFLMPKVSGKEPIHMIYS--------------PATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSF 148 (637)
T ss_pred ceeEEecccCCCccchhhhcC--------------chhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccce
Confidence 2366777777653 1222221 111223456789999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
|+++++.|.|.|-..-..- .+ ........+...|.+||... +-.-+..+|.|.||+++++++-||..||.|.
T Consensus 149 lVsd~~~V~LVdsDsfqi~-~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 149 LVSDDSKVVLVDSDSFQIN-AN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred eeecCceEEEEcccceeec-cC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 9999999999986543221 11 11223456677899999765 3355788999999999999999999999874
Q ss_pred C-------HHHHHHHHHcCCc----------cCCC-----CCCcHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHHHHH
Q psy5539 595 T-------HEEVVKYIKEGNI----------LQAP-----DNTPDALYDLMKLCWNM--KPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 595 ~-------~~e~~~~i~~~~~----------~~~~-----~~~~~~l~~li~~cl~~--dP~~RPs~~eil~~L~~l~~~ 650 (653)
. +-| ..|-.|.+ .+.| ...++++..|..+|+.. ++.-|||++..+..|..+.++
T Consensus 226 ~~~~~ap~p~E--~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 226 PLISDAPNPLE--TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred cccCCCCCcch--hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 2 111 01111111 1112 23568899999999985 356899999999999999888
Q ss_pred hh
Q psy5539 651 LE 652 (653)
Q Consensus 651 l~ 652 (653)
|.
T Consensus 304 L~ 305 (637)
T COG4248 304 LK 305 (637)
T ss_pred hh
Confidence 75
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=98.97 E-value=6.9e-09 Score=97.36 Aligned_cols=144 Identities=23% Similarity=0.239 Sum_probs=98.8
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEE-----Ecccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-----MLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK-----~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.+..|-+|+-+.|+++.+.| ....|| ..+...- .-...+-.+|++++.+++--.|.--.-++.+..
T Consensus 11 ~l~likQGAEArv~~~~~~G-------e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~ 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSG-------EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY 83 (229)
T ss_pred cceeeeccceeeEeeeccCC-------ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC
Confidence 45668899999999998754 444454 2222221 223456778999999986444432222334445
Q ss_pred ceEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 442 PMCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 442 ~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
.-.|+|||+++ -++.+|+...-. ..........++..|-+.+.-||..+|+|+||.++||+
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~------------------~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNil 145 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTME------------------DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNIL 145 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHcc------------------CcccchhHHHHHHHHHHHHHHhhhCCeecccccccceE
Confidence 55789999976 488888863211 11222333678888999999999999999999999999
Q ss_pred EcCCC---cEEEeccCcccc
Q psy5539 521 INDQM---VVKIADFGLSRK 537 (653)
Q Consensus 521 l~~~~---~vkI~DfGla~~ 537 (653)
|..++ .+.++|||++..
T Consensus 146 l~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 146 LRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EecCCCcCceEEEeecchhc
Confidence 96554 458999999853
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.9e-08 Score=101.67 Aligned_cols=132 Identities=10% Similarity=0.062 Sum_probs=94.0
Q ss_pred eEEEEEeCCCCCCccceEEEEEEccccccHHHHH----------HHHHHHHHHhhCCCC--ccceEEeEEec-----CCc
Q psy5539 380 RVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT----------DFEREACLLAEFDHP--NIVKLLGVCAV-----GKP 442 (653)
Q Consensus 380 ~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~----------~f~~Ei~il~~l~Hp--nIv~l~g~~~~-----~~~ 442 (653)
.|+++... ++.+.||+..........+ .+.+|...+.++... .+...+++... ...
T Consensus 37 rvvr~~~~-------g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 37 RTLRFELA-------GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred eEEEEEEC-------CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 35566542 3578888765433221111 377898888888433 33455555543 234
Q ss_pred eEEEEeecCCC-ChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 443 MCLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 443 ~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
-+||+|++++- +|.+++.... ....+......++.+++..+.-||+.||+|+||+++|||+
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~------------------~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl 171 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWA------------------TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLL 171 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhc------------------ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEE
Confidence 78999999986 8999885211 1234556777899999999999999999999999999999
Q ss_pred cC-------CCcEEEeccCccc
Q psy5539 522 ND-------QMVVKIADFGLSR 536 (653)
Q Consensus 522 ~~-------~~~vkI~DfGla~ 536 (653)
+. ++.+.++||+.++
T Consensus 172 ~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 172 HLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eccccCCCCCceEEEEECCccc
Confidence 75 4789999999885
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.5e-08 Score=95.51 Aligned_cols=125 Identities=24% Similarity=0.285 Sum_probs=81.6
Q ss_pred eEEEEEeCCCCCCccceEEEEEEcccc-------------------------ccHHHHHHHHHHHHHHhhCCCC--ccce
Q psy5539 380 RVFQAKAPGLLKHEEFTLVAVKMLKDE-------------------------ASEYLQTDFEREACLLAEFDHP--NIVK 432 (653)
Q Consensus 380 ~Vy~a~~~~~~~~~~~~~VAVK~l~~~-------------------------~~~~~~~~f~~Ei~il~~l~Hp--nIv~ 432 (653)
.||.|..+ ++..+|||..+.. .........++|.+.|.++..- ++.+
T Consensus 1 ~Vy~~~~~------~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~ 74 (188)
T PF01163_consen 1 DVYHAIDP------DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPK 74 (188)
T ss_dssp EEEEEEEC------TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--
T ss_pred CEEEEECC------CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCc
Confidence 37888753 4568999976322 1122344577899999999765 4566
Q ss_pred EEeEEecCCceEEEEeecC--CCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH-hhhCCc
Q psy5539 433 LLGVCAVGKPMCLLFEYMG--RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY-LSDRKF 509 (653)
Q Consensus 433 l~g~~~~~~~~~LV~Ey~~--~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y-LH~~~i 509 (653)
++++ ..-.|||||++ +..+..+.. ..++..+...++.+++..+.. +|..||
T Consensus 75 p~~~----~~~~ivME~I~~~G~~~~~l~~----------------------~~~~~~~~~~~~~~il~~~~~~~~~~gi 128 (188)
T PF01163_consen 75 PYDY----NRNVIVMEYIGEDGVPLPRLKD----------------------VDLSPEEPKELLEEILEEIIKMLHKAGI 128 (188)
T ss_dssp EEEE----ETTEEEEE--EETTEEGGCHHH----------------------CGGGGSTHHHHHHHHHHHHHHHHHCTTE
T ss_pred EEEE----eCCEEEEEecCCCccchhhHHh----------------------ccccchhHHHHHHHHHHHHHHHHHhcCc
Confidence 6655 24579999998 555544332 011134456777888886665 579999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
+|+||.+.|||++++ .+.|+|||.+..
T Consensus 129 vHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 129 VHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp EESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred eecCCChhhEEeecc-eEEEEecCccee
Confidence 999999999999988 999999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.9e-09 Score=115.76 Aligned_cols=150 Identities=19% Similarity=0.224 Sum_probs=108.8
Q ss_pred HHHHHHHHHHhhhC-CceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCC-------CCCCccccccchhhccC
Q psy5539 494 ALQIASGMVYLSDR-KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE-------NDAIPVRWMPLESILYN 565 (653)
Q Consensus 494 ~~qia~gL~yLH~~-~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~-------~~~~t~~y~aPE~~~~~ 565 (653)
+.+++.||.|+|.. ++||++|.|++|.++.++.+||+.|+.+........+.-.. ...-...|.|||++...
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 34566999999954 89999999999999999999999999876543311111111 11223469999999998
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 566 KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV---KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 566 ~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~---~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
..+.++|+||+|+++|-++.+|..-+......... ....+........++|.++++=+.+++..++.-||++.++..
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 99999999999999999997776544433221111 111111223345679999999999999999999998877764
Q ss_pred H
Q psy5539 643 T 643 (653)
Q Consensus 643 ~ 643 (653)
.
T Consensus 265 ~ 265 (700)
T KOG2137|consen 265 I 265 (700)
T ss_pred c
Confidence 3
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.5e-07 Score=89.65 Aligned_cols=105 Identities=21% Similarity=0.174 Sum_probs=82.3
Q ss_pred HHHHHHHHHHhhCCC--CccceEEeEEecCC----ceEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCC
Q psy5539 413 TDFEREACLLAEFDH--PNIVKLLGVCAVGK----PMCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485 (653)
Q Consensus 413 ~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~----~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l 485 (653)
....+|...+.+|.. -.+.+.+++..... ..+||+|++++ -+|.+++... ..+
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~--------------------~~~ 115 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW--------------------EQL 115 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh--------------------ccc
Confidence 356788887777743 34556666665432 45899999988 4899988621 114
Q ss_pred CHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC---cEEEeccCcccc
Q psy5539 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM---VVKIADFGLSRK 537 (653)
Q Consensus 486 ~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~---~vkI~DfGla~~ 537 (653)
+......++.+++..+.-||+.||+|+|+++.|||++.+. .+.++||+.++.
T Consensus 116 ~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 116 DPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred chhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 5667788999999999999999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-06 Score=84.96 Aligned_cols=139 Identities=16% Similarity=0.112 Sum_probs=100.3
Q ss_pred cccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----HHHHHHHHHHHHHHhhCCCC--ccceEEeEEecC----Cc
Q psy5539 374 GQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----EYLQTDFEREACLLAEFDHP--NIVKLLGVCAVG----KP 442 (653)
Q Consensus 374 G~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~~~~~----~~ 442 (653)
|+||-+-|++....| ..+-+|+-..... ...+..|.+|...+.+|..- .+.+.+...... -.
T Consensus 27 ~rgG~SgV~r~~~~g-------~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~r 99 (216)
T PRK09902 27 RRNGMSGVQCVERNG-------KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWR 99 (216)
T ss_pred CCCCcceEEEEEeCC-------cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceE
Confidence 779999999987543 3588887642211 12346789999999998532 244444221121 23
Q ss_pred eEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 443 MCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 443 ~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
-+||+|-+++ -||.+++... ...+.+......+..+++..+.-||+.|+.|+|+.+.|||+
T Consensus 100 A~LVTe~L~g~~~L~~~l~~~------------------~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll 161 (216)
T PRK09902 100 ALLVTEDMAGFISIADWYAQH------------------AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYV 161 (216)
T ss_pred EEEEEEeCCCCccHHHHHhcC------------------CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheee
Confidence 6899997764 6898888521 12345677788999999999999999999999999999999
Q ss_pred cCCCc--EEEeccCcccc
Q psy5539 522 NDQMV--VKIADFGLSRK 537 (653)
Q Consensus 522 ~~~~~--vkI~DfGla~~ 537 (653)
+.++. ++++||.-++.
T Consensus 162 ~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 162 KTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred cCCCCeeEEEEEhhccch
Confidence 86666 99999987754
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.52 E-value=6.6e-06 Score=91.42 Aligned_cols=140 Identities=19% Similarity=0.262 Sum_probs=93.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHH-------------------------------------
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT------------------------------------- 413 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~------------------------------------- 413 (653)
+.|+.++-|.||+|+++ +|+.||||+.+++..+....
T Consensus 131 ~PiAsASIaQVH~A~L~------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 131 EPIASASIAQVHRAVLK------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred CchhhhhHhhheeEEec------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 45899999999999985 36899999986653322111
Q ss_pred --HHHHHHHHHhhCC-----CCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCC
Q psy5539 414 --DFEREACLLAEFD-----HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486 (653)
Q Consensus 414 --~f~~Ei~il~~l~-----HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~ 486 (653)
++.+|+..+.+++ .+++.---=++.-.....|+|||++|..+.+..... ...++
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-------------------~~g~d 265 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-------------------SAGID 265 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-------------------hcCCC
Confidence 2345666666652 233321122233456788999999998888874311 12233
Q ss_pred HHHHHHHHHHHHHH-HHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 487 TCDLITIALQIASG-MVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 487 ~~~~~~i~~qia~g-L~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
.. .++..++.+ +..+-..|++|.|..|.||+++.+|.+.+.|||+...+
T Consensus 266 ~k---~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l 315 (517)
T COG0661 266 RK---ELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL 315 (517)
T ss_pred HH---HHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence 22 333333332 33344579999999999999999999999999998654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.5e-06 Score=86.88 Aligned_cols=134 Identities=22% Similarity=0.198 Sum_probs=96.7
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-------------------c--HHHHHHHHHHHHHHhhCC
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-------------------S--EYLQTDFEREACLLAEFD 426 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-------------------~--~~~~~~f~~Ei~il~~l~ 426 (653)
.+...||-|--+.||.|..+ .+..+|||.-+... + ...+...++|.+.|.+|.
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~------~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP------KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred hhccccccCccceEEEEECC------CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 34577999999999999864 46789999643221 1 122345678999999986
Q ss_pred CC--ccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5539 427 HP--NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504 (653)
Q Consensus 427 Hp--nIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 504 (653)
-. .|.+-+++ +.-.+||||+++-.|... +++....-.|+..|+.-+.-+
T Consensus 168 ~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-------------------------r~~~en~~~il~~il~~~~~~ 218 (304)
T COG0478 168 PEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-------------------------RLDVENPDEILDKILEEVRKA 218 (304)
T ss_pred hcCCCCCCcccc----ccceeeeehcccceeecc-------------------------cCcccCHHHHHHHHHHHHHHH
Confidence 54 66666654 556899999988655421 112334445556666666666
Q ss_pred hhCCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 505 SDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 505 H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
-..|+||+|+.+=|||++++|.+.++||--+.
T Consensus 219 ~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v 250 (304)
T COG0478 219 YRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV 250 (304)
T ss_pred HHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence 68999999999999999999999999997654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.38 E-value=6.7e-06 Score=80.73 Aligned_cols=139 Identities=17% Similarity=0.180 Sum_probs=95.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHH---------HHHHHHHhhCC---CC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDF---------EREACLLAEFD---HP 428 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f---------~~Ei~il~~l~---Hp 428 (653)
.+..++|...+.+-......|.+-.. ++..+++|..++..... ++.| .+++..+.+++ --
T Consensus 27 ~i~~~~~~~~kv~k~~~r~~ValIei-------~~~kyIlK~pr~~~~r~-er~~~sf~kg~~~~~l~~~~~~i~~~g~~ 98 (229)
T PF06176_consen 27 KILDNNYKIIKVFKNTKRNYVALIEI-------DGKKYILKEPREENRRP-ERRFKSFFKGSEYSRLINNTDKIRNEGFT 98 (229)
T ss_pred HHHhCCceEEEeecCCCccEEEEEEE-------CCcEEEEeccchhhhhH-HHHHHHHhccHHHHHHHHHHHHHHHcCcc
Confidence 34567788888888888888888765 34789999988764332 2222 24444444443 23
Q ss_pred ccceEEeEEec-----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 429 NIVKLLGVCAV-----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 429 nIv~l~g~~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
....++.+... ....+|||||++|..|.++.. ++. .++..++++|.-
T Consensus 99 ~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------------------------i~e----~~~~ki~~~ikq 150 (229)
T PF06176_consen 99 EPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------------------------IDE----DLAEKIVEAIKQ 150 (229)
T ss_pred ccccceeeeeeeeccceeEEEEEEEEecCeecccchh------------------------cCH----HHHHHHHHHHHH
Confidence 33333333322 245679999999988876542 222 245667888999
Q ss_pred hhhCCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 504 LSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 504 LH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
||+.|++|+|..|.|+++++++ ++++||+..+
T Consensus 151 lH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 151 LHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred HHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 9999999999999999999665 9999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd07066 CRD_FZ CRD_domain cysteine-rich domain, also known as Fz (frizzled) domain | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.2e-06 Score=78.62 Aligned_cols=109 Identities=19% Similarity=0.386 Sum_probs=72.4
Q ss_pred ccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCCC
Q psy5539 34 YCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLP 113 (653)
Q Consensus 34 ~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~p 113 (653)
.|+++++..|+.+ ..+ .+++....... .++| .... ...+...++..|++.+..++|+.+||.|...+. .+++
T Consensus 1 ~C~pi~~~~C~~~-~Yn-~t~~pn~~~~~--~~~~-a~~~-~~~~~~l~~~~C~~~~~~f~Cs~~~P~C~~~~~--~~~~ 72 (119)
T cd07066 1 KCEPIPLPLCRGL-PYN-TTRFPNLLGHE--SQEE-AEQE-LESFTPLVNSGCHPDLRFFLCSLYFPECTPDGD--RPIP 72 (119)
T ss_pred CCccCCHHHhCCC-CCC-ceeCCCccCCC--CHHH-HHHH-HHHHHHHHhcCCChhHHHHHHhccCccccCCCC--CcCC
Confidence 4999999999998 443 45554442211 1222 1111 123323588999999999999999999977644 4588
Q ss_pred cccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCc
Q psy5539 114 LCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYE 162 (653)
Q Consensus 114 ~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~ 162 (653)
.||..|+.++ ..|...+..+.. .--..++|+.+|...
T Consensus 73 PCRs~Ceev~-~~C~~~~~~~~~-----------~wp~~~~C~~~p~~~ 109 (119)
T cd07066 73 PCRSLCEEVR-DSCEPLMLAFGF-----------PWPEPLDCDRFPDSN 109 (119)
T ss_pred ChHHHHHHHH-HHHHHHHHHhCC-----------CCCCcCCccccCCCC
Confidence 9999999998 889655433200 011467899998753
|
CRD_FZ is an essential component of a number of cell surface receptors, which are involved in multiple signal transduction pathways, particularly in modulating the activity of the Wnt proteins, which play a fundamental role in the early development of metazoans. CRD is also found in secreted frizzled related proteins (SFRPs), which lack the transmembrane segment found in the frizzled protein. The CRD domain is also present in the alpha-1 chain of mouse type XVIII collagen, in carboxypeptidase Z, several receptor tyrosine kinases, and the mosaic transmembrane serine protease corin. The CRD domain is well conserved in metazoans - 10 frizzled proteins have been identified in mammals, 4 in Drosophila and 3 in Caenorhabditis elegans. CRD domains have also been identified in multiple tandem copies in a Dictyostelium discoideum protein. Very little is known about the mechanism by which CRD domains interact wit |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.2e-05 Score=80.63 Aligned_cols=72 Identities=14% Similarity=0.158 Sum_probs=52.9
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc--cceEEeEEecCCceEEEEe
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN--IVKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~~LV~E 448 (653)
..||+|..+.||+.. +..+++|..+.... .....+|.++++.+..-. +.+.+++....+...+|||
T Consensus 7 ~~i~~G~t~~~y~~~---------~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e 74 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---------TGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE 74 (226)
T ss_pred eeecCCCCcceeEec---------CCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence 568999999999831 12467888775432 234688999998886443 4577788777778899999
Q ss_pred ecCCCC
Q psy5539 449 YMGRGD 454 (653)
Q Consensus 449 y~~~gs 454 (653)
+++|.+
T Consensus 75 ~i~G~~ 80 (226)
T TIGR02172 75 LIVGKR 80 (226)
T ss_pred ecCCcc
Confidence 999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.17 E-value=6.2e-06 Score=80.11 Aligned_cols=102 Identities=26% Similarity=0.300 Sum_probs=80.2
Q ss_pred HHHHHHHhhCCC-CccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHH
Q psy5539 416 EREACLLAEFDH-PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIA 494 (653)
Q Consensus 416 ~~Ei~il~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 494 (653)
..|.-++..+++ +++.+++|+|- .++|.||.+.+++.+.-. ........+|..+.+||
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~-----------------~l~~~~~~~w~~R~~iA 65 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYR-----------------PLSQFLQSPWEQRAKIA 65 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccccc-----------------ccccccccCHHHHHHHH
Confidence 458888888977 69999999984 367899998876642100 00011236899999999
Q ss_pred HHHHHHHHHhhh---CCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 495 LQIASGMVYLSD---RKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 495 ~qia~gL~yLH~---~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
.++++.+++|++ ..+.-.|++++|+-+++++.+|++|...+...
T Consensus 66 ~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 66 LQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 999999999997 45778999999999999999999999887543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.3e-05 Score=74.23 Aligned_cols=138 Identities=25% Similarity=0.346 Sum_probs=97.1
Q ss_pred cCccccccccCCCCeeEEeeecccCC-eeEEEEEeCCCCCCccceEEEEEEccc-----------ccc--H-------HH
Q psy5539 353 LNPKLEQLEFPRNDIIYVRDLGQGAF-GRVFQAKAPGLLKHEEFTLVAVKMLKD-----------EAS--E-------YL 411 (653)
Q Consensus 353 ~~~~l~~~e~~~~~~~~~~~LG~G~f-G~Vy~a~~~~~~~~~~~~~VAVK~l~~-----------~~~--~-------~~ 411 (653)
..|+|+....-..++++++.||.|.- |.||+++..| ..+|+|.++. ... + ..
T Consensus 25 ~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~g-------~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y 97 (207)
T PF13095_consen 25 PGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEIDG-------RIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHY 97 (207)
T ss_pred CCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEECC-------eEEEEEEeeccccCCCccccccccccccccchhhhh
Confidence 34566665555578999999999999 9999999754 7899999321 000 0 22
Q ss_pred HHHHHHHHHHHhhCC---CCcc--ceEEeEEecC------------------CceEEEEeecCCCChHHHHhhcCCCCCc
Q psy5539 412 QTDFEREACLLAEFD---HPNI--VKLLGVCAVG------------------KPMCLLFEYMGRGDLNDFLRICSPNNYI 468 (653)
Q Consensus 412 ~~~f~~Ei~il~~l~---HpnI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~ 468 (653)
...|..|.+...+|+ +.++ |+.+||..-. ....||.||++...
T Consensus 98 ~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------- 163 (207)
T PF13095_consen 98 ADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------- 163 (207)
T ss_pred cChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------
Confidence 346889999988885 4456 8888887322 02345666554421
Q ss_pred CCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcc
Q psy5539 469 NGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535 (653)
Q Consensus 469 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla 535 (653)
.+ ..+-+.+|.+-|..+|..||+-+|+++.|.. .-||+|||.+
T Consensus 164 ---------------~~----~~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 164 ---------------PL----QIRDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred ---------------cc----chhHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 11 2234567888889999999999999999986 4488999864
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.06 E-value=6e-05 Score=75.04 Aligned_cols=78 Identities=22% Similarity=0.329 Sum_probs=55.8
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC--ccceEEeEEec---CCceE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP--NIVKLLGVCAV---GKPMC 444 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~~~~---~~~~~ 444 (653)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++..... ....+
T Consensus 2 i~~l~~G~~n~~~~v~~~~-------~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~ 71 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-------GRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPY 71 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-------SEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEE
T ss_pred CccCCCCCeeeEEEEEECC-------cEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccce
Confidence 4678999999999998532 47999997654 3455678888888888533 34566664432 33468
Q ss_pred EEEeecCCCChHH
Q psy5539 445 LLFEYMGRGDLND 457 (653)
Q Consensus 445 LV~Ey~~~gsL~~ 457 (653)
++|+++++..+..
T Consensus 72 ~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 72 LLMEYIPGRPLDD 84 (239)
T ss_dssp EEEEEESSEEHHH
T ss_pred EEEEEeccccccc
Confidence 9999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.98 E-value=8.1e-05 Score=75.40 Aligned_cols=75 Identities=13% Similarity=0.096 Sum_probs=51.7
Q ss_pred ecccCC-eeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAF-GRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~f-G~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
|-.|.. ..||+.... +..+.||...... ..++.+|++++..+. +--+.+++++...++..++|||++
T Consensus 6 ~~~g~~~~~v~~~~~~-------~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i 74 (244)
T cd05150 6 VTEGQSGATVYRLDGK-------NPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV 74 (244)
T ss_pred cCCCCCcCeEEEEcCC-------CCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence 444555 789998632 2468888876542 234678888888874 334557777777666789999999
Q ss_pred CCCChHHH
Q psy5539 451 GRGDLNDF 458 (653)
Q Consensus 451 ~~gsL~~~ 458 (653)
+|.+|.+.
T Consensus 75 ~G~~l~~~ 82 (244)
T cd05150 75 PGVPAAAL 82 (244)
T ss_pred CCccHhHh
Confidence 99877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.95 E-value=6e-05 Score=83.66 Aligned_cols=139 Identities=20% Similarity=0.267 Sum_probs=89.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHH------------------------------------HHH
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL------------------------------------QTD 414 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~------------------------------------~~~ 414 (653)
+.||..+.|.||+|++++ |..||||+-++.-.+.. .-+
T Consensus 167 ~piaaASlaQVhrA~L~~------G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELD 240 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN------GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELD 240 (538)
T ss_pred chhhhcchhheEEEEecC------CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcc
Confidence 468999999999999853 68899999765432211 112
Q ss_pred HHHHHHHHhhC----CCCc------cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCC
Q psy5539 415 FEREACLLAEF----DHPN------IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484 (653)
Q Consensus 415 f~~Ei~il~~l----~Hpn------Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~ 484 (653)
|.+|++-..++ .|-+ |.+++ +.......|+||||+|..+.|.-.- ....
T Consensus 241 F~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i-------------------~~~g 299 (538)
T KOG1235|consen 241 FTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAI-------------------DKRG 299 (538)
T ss_pred hHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHH-------------------HHcC
Confidence 44555544443 3545 22222 2334578999999999887765321 1123
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC----CCcEEEeccCccccc
Q psy5539 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND----QMVVKIADFGLSRKM 538 (653)
Q Consensus 485 l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~----~~~vkI~DfGla~~~ 538 (653)
++...+..-+.+...-+ +=..|++|.|-.|-||+++. ++.+.+-|||+...+
T Consensus 300 i~~~~i~~~l~~~~~~q--If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 300 ISPHDILNKLVEAYLEQ--IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCHHHHHHHHHHHHHHH--HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 44444333333322222 22468999999999999983 678999999998765
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00022 Score=71.02 Aligned_cols=138 Identities=20% Similarity=0.230 Sum_probs=91.0
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH-----------------------HHHHHHHHHHHHhhCC
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY-----------------------LQTDFEREACLLAEFD 426 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~-----------------------~~~~f~~Ei~il~~l~ 426 (653)
.-.|+.|.-+.||+|.. .++..+|||+.+.....- ...-..+|..-|.++.
T Consensus 53 ~g~istGKEA~Vy~a~~------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~ 126 (268)
T COG1718 53 VGCISTGKEANVYLAET------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAY 126 (268)
T ss_pred EeeecCCcceEEEeecc------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34688899999999864 346789999986443210 1112235666666653
Q ss_pred --CCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5539 427 --HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504 (653)
Q Consensus 427 --HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 504 (653)
+-.+.+-+++ ..-.|||||+...-+ ..| .. +...+...+...+..+++++|.-|
T Consensus 127 eAGVrvP~Pi~~----~~nVLvMEfIg~~g~------pAP-------------~L-kDv~~e~~e~~~~~~~~v~~~~~l 182 (268)
T COG1718 127 EAGVRVPEPIAF----RNNVLVMEFIGDDGL------PAP-------------RL-KDVPLELEEAEGLYEDVVEYMRRL 182 (268)
T ss_pred HcCCCCCCceee----cCCeEEEEeccCCCC------CCC-------------Cc-ccCCcCchhHHHHHHHHHHHHHHH
Confidence 2333333433 234699999965310 000 01 112233336778888999999998
Q ss_pred hh-CCceecCCCCCCEeEcCCCcEEEeccCccccc
Q psy5539 505 SD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538 (653)
Q Consensus 505 H~-~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~ 538 (653)
-. .++||+||..=|||+. ++.+.|+|||-|...
T Consensus 183 ~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 183 YKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred HHhcCcccccchhhheEEE-CCeEEEEECcccccc
Confidence 77 8999999999999999 779999999988643
|
|
| >cd07448 CRD_FZ4 Cysteine-rich Wnt-binding domain of the frizzled 4 (Fz4) receptor | Back alignment and domain information |
|---|
Probab=97.89 E-value=3.2e-05 Score=69.51 Aligned_cols=120 Identities=20% Similarity=0.414 Sum_probs=75.6
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMS 111 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~ 111 (653)
.+.|++-+-..|.. |..+...|=|.-.-..+.+.+.++ ..|..| +...|++.+..+||.-+||.|.... +.+
T Consensus 1 ~~~Cepi~~~~C~~-l~Yn~T~~PN~lgh~sq~ea~~~l--~~~~pL---v~~~Csp~l~~flCsl~~P~C~~~~--~~~ 72 (126)
T cd07448 1 DRRCEPIRIEMCQG-LGYNVTRMPNLVGHELQTDAELQL--QTFTPL---IQYGCSSQLKFFLCSVYVPMCTEKV--PVP 72 (126)
T ss_pred CCeeeeCCHHHhCC-CCcccccCCCcCCCcCHHHHHHHH--HHHHHH---hhcCCChhHHhHhhhccccccCCCC--CCc
Confidence 36789988899988 555544443332111122222222 346666 5569999999999999999996533 345
Q ss_pred CCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCCCCC
Q psy5539 112 LPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHAQLT 176 (653)
Q Consensus 112 ~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~~~~ 176 (653)
.+-||.-|+.+| .-|. ..++. ..+..| +|+.+|... .....|..++.+
T Consensus 73 i~PCRslCe~vr-~~C~---~~m~~-----------~g~~WP~~l~C~~fP~~~--~~~~~C~~~~~~ 123 (126)
T cd07448 73 IGPCRPLCLSVK-KRCL---PVLKE-----------FGFPWPEALNCSKFPPQN--NHNHMCMEGPGD 123 (126)
T ss_pred CCcCHHHHHHHH-HHHH---HHHHH-----------hCCCCCCcCCcccCCCCC--CCCCccCCCCCc
Confidence 777999999999 6673 22221 122333 799999754 334467655443
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 4 (Fz4) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and the Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Frizzled 4 (Fz4) activates the Ca(2+)/calmodulin-dependent protein kinase II and protein kinase C of the Wnt/Ca(2+) signaling pathway during retinal angiogenesis. Mutations in Fz4 lead to familial exudative vitreoretinopathy (FEVR |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=2.4e-06 Score=93.79 Aligned_cols=182 Identities=15% Similarity=0.112 Sum_probs=130.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc-cceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN-IVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~ 443 (653)
.-+.....+++|++++++|.+.. .+ +....+.+... ....-++++|.+.+||| .+..++-+..+...
T Consensus 242 kws~~fh~fvK~altknpKkRpt-----ae-klL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPT-----AE-KLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCC-----hh-hheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 34455667899999999998742 11 23335555433 24456889999999999 77777777778888
Q ss_pred EEEEeecCCC-ChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 444 CLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 444 ~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
+++++++..+ +-..-. ....-.+...+...+.+.-++++++||+..=+|+| |||..
T Consensus 310 ~i~~~i~s~~rs~~~~~-------------------~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s 366 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEM-------------------TVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGS 366 (829)
T ss_pred chhhhhhcCCccccccC-------------------ChhhHhhhhhhhhhhhhhhcccccccccccccCcc----ccccc
Confidence 9999998776 111100 01112344556667778888999999988778999 77776
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHh
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt 585 (653)
+ +..+..||+....+.... ......++..|+|||+...+.+....|+|++|+--.++--
T Consensus 367 ~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 367 E-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred c-cccccccccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC
Confidence 6 688999999987653222 2345567889999999999999999999999975555543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00015 Score=86.44 Aligned_cols=84 Identities=15% Similarity=0.202 Sum_probs=57.4
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCcc--ceEEeEEecC---Cc
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNI--VKLLGVCAVG---KP 442 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnI--v~l~g~~~~~---~~ 442 (653)
-++.|+.|.+..+|+.+..+. .....+++|+............+.+|.++++.+. |.+| .+++.++.+. +.
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~---~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~ 118 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNG---GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT 118 (822)
T ss_pred eEEEeCCCCcCceEEEEECCC---CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence 356789999999999876321 1113567777654322122346889999999995 6665 7778887654 45
Q ss_pred eEEEEeecCCCCh
Q psy5539 443 MCLLFEYMGRGDL 455 (653)
Q Consensus 443 ~~LV~Ey~~~gsL 455 (653)
.++||||+++..+
T Consensus 119 ~flVME~v~G~~~ 131 (822)
T PLN02876 119 AFYIMEYLEGRIF 131 (822)
T ss_pred ceEEEEecCCccc
Confidence 7899999987643
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00011 Score=86.32 Aligned_cols=200 Identities=17% Similarity=0.169 Sum_probs=138.9
Q ss_pred HHHHHHHHHHHhhCCCCccceEEeEEecCCceE----EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCH
Q psy5539 412 QTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC----LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487 (653)
Q Consensus 412 ~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~----LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 487 (653)
....+.|...+..+.|+|++.++.|-....... +.-|++..-++...+. ....++.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q--------------------~v~~i~~ 285 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ--------------------SVGSIPL 285 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh--------------------hccccCH
Confidence 344566788888999999999998876543332 3345666666666654 3355778
Q ss_pred HHHHHHHHHHHHHHHHhhhCCceecCCCCC---CEeEcCCCcEEEe--ccCccccccccccccCCCCCCCccccccchhh
Q psy5539 488 CDLITIALQIASGMVYLSDRKFVHRDLATR---NCLINDQMVVKIA--DFGLSRKMYLQDYYKGDENDAIPVRWMPLESI 562 (653)
Q Consensus 488 ~~~~~i~~qia~gL~yLH~~~ivHrDLkp~---NILl~~~~~vkI~--DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~ 562 (653)
...+.+..++.+||.|+|+....|.-|..+ +...+..+.+.++ ||+.++....... ......+..+.++|..
T Consensus 286 ~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~ 362 (1351)
T KOG1035|consen 286 ETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDL 362 (1351)
T ss_pred HHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCcccccccccc
Confidence 888889999999999999997766666555 4555666777777 8988876533222 1222334457788877
Q ss_pred ccCCCCC--chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 563 LYNKYTV--ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 563 ~~~~~t~--ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
..+.++. ..|+|.+|.++..+..+...+-.......+.. ......+.+...+|+..++++|++..++
T Consensus 363 ~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~~~~l~-----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 363 KENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVPVSLLD-----------VLSTSELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred ccccchhhhhhHHHHHHHHHhhhhhcCcccccccchhhhhc-----------cccchhhhhhhhhhcchhhhhccchhhh
Confidence 7666554 47999999999999886654433222222111 1122267888889999999999999999
Q ss_pred HHHHH
Q psy5539 641 YQTLW 645 (653)
Q Consensus 641 l~~L~ 645 (653)
+.+.+
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 98865
|
|
| >cd07463 CRD_FZ9 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 9 (Fz9) receptor | Back alignment and domain information |
|---|
Probab=97.78 E-value=7.1e-05 Score=67.19 Aligned_cols=118 Identities=19% Similarity=0.392 Sum_probs=76.1
Q ss_pred CCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHH-HHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCC
Q psy5539 31 PQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQI-VMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIP 109 (653)
Q Consensus 31 ~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~-~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~ 109 (653)
.++.|++-.=..|..+ ..+.. .|..... -..++|.. ....|.-| +...|++...-+||..+||.|.... +
T Consensus 1 ~~~~CepI~~~~C~~l-~Yn~T-~~PN~lg--h~sq~ea~~~~~~f~pL---v~~~Csp~l~~FlCS~~~P~C~~~~--~ 71 (127)
T cd07463 1 RAAKCQPVVIPMCRGI-GYNLT-RMPNFLG--HDSQREAAIKLNEFAPL---VEYGCHVHLRFFLCSLYAPMCTDQV--S 71 (127)
T ss_pred CCCccccCChhhhCCC-CcCcc-cCCcccC--CcCHHHHHHHHHHHHHH---HhcCCChhhHHHhhhccccccCCCC--C
Confidence 3678999999999984 54444 4444322 11222221 22235555 7789999999999999999996543 3
Q ss_pred CCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCCC
Q psy5539 110 MSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHAQ 174 (653)
Q Consensus 110 ~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~~ 174 (653)
.+.|-||.-|+.+| .-|... ++. ..+..| +|+.+|... .....|..++
T Consensus 72 ~~i~PCRslCe~vr-~~C~~~---m~~-----------fg~~WP~~l~C~~fP~~~--~~~~~C~~~~ 122 (127)
T cd07463 72 TSIPACRPMCEQAR-QKCSPI---MEQ-----------FNFGWPESLDCSRLPTRN--DPNALCMEAP 122 (127)
T ss_pred CcCCccHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCChhhCCCCC--CCCcccCCCC
Confidence 44777999999999 667322 221 123444 799999765 3344676544
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 9 (Fz9) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Fz9 may play a signaling role in lymphoid development and maturation, particularly at points where B cells undergo self-renewal prior to further differentiation. |
| >cd07462 CRD_FZ10 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 10 (Fz10) receptor | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00011 Score=66.02 Aligned_cols=117 Identities=21% Similarity=0.428 Sum_probs=75.0
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHH-HHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQ-IVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~-~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.|.|++-+=..|+.+ ..+. ..|..... -..+.|- +....|.-| +...|++.+.-+||.-+||.|.... +.
T Consensus 2 ~~~C~pI~~~~C~~l-~Yn~-T~~PN~lg--H~~q~ea~~~~~~f~pL---v~~~C~p~l~~FlCsl~~P~C~~~~--~~ 72 (127)
T cd07462 2 EGRCQPIEIPMCKDI-GYNM-TRMPNLMG--HENQREAAIQLHEFAPL---VEYGCHSHLKFFLCSLYAPMCTEQV--ST 72 (127)
T ss_pred CCeeeecChhhhCCC-CcCc-eeCCcccC--CcCHHHHHHHHHHHHHH---hccCCChhhHHHHHhccccccCCCC--CC
Confidence 588999999999984 4444 44444322 1122221 222234444 7799999999999999999996532 34
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHAQ 174 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~~ 174 (653)
+.|-||.-|+.+| .-|.... + + ..+..| +|+.+|... +....|...+
T Consensus 73 ~i~PCRslCe~vr-~~C~~~m---~---~--------~g~~WP~~l~C~~fP~~~--~~~~lc~~~~ 122 (127)
T cd07462 73 PIPACRVMCEQAR-LKCSPIM---E---Q--------FNFKWPDSLDCSKLPNKN--DPNYLCMEAP 122 (127)
T ss_pred cCCccHHHHHHHH-HHHHHHH---H---H--------hCCCCCCcCCcccCCCCC--CCCcccCCCC
Confidence 4667999999999 6774332 1 1 123444 899999765 2234566443
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 10 (Fz10) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. The cellular functon of Fz10 is unknown. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00015 Score=68.37 Aligned_cols=129 Identities=20% Similarity=0.269 Sum_probs=89.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccc-eEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV-KLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~ 444 (653)
.....+.||+|.+|.||++.+.+ ..+|+|+-+.++. +..++.|+++|..+.-.++. +++.+. .-+
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~-------~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg----~~~ 88 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRG-------GEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYG----EDF 88 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccC-------ceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEec----hhh
Confidence 44566779999999999999854 4799998876544 45788999999998876665 344442 223
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC-C-CCEeEc
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA-T-RNCLIN 522 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk-p-~NILl~ 522 (653)
+.|||+.|-.|.+.-. ..+.. -...+++.---|-..||-|..|. | .||+++
T Consensus 89 i~me~i~G~~L~~~~~-----------------------~~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~ 141 (201)
T COG2112 89 IRMEYIDGRPLGKLEI-----------------------GGDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVN 141 (201)
T ss_pred hhhhhhcCcchhhhhh-----------------------cccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEec
Confidence 4599999888876543 01222 23345555444556688888876 3 455555
Q ss_pred CCCcEEEeccCccc
Q psy5539 523 DQMVVKIADFGLSR 536 (653)
Q Consensus 523 ~~~~vkI~DfGla~ 536 (653)
+ +.+.|+||..|+
T Consensus 142 ~-~~~~iIDFd~At 154 (201)
T COG2112 142 D-RDVYIIDFDSAT 154 (201)
T ss_pred C-CcEEEEEccchh
Confidence 4 499999999886
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00052 Score=67.13 Aligned_cols=128 Identities=19% Similarity=0.298 Sum_probs=88.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---------------cHHHHHHHHHHHHHHhhCC------CCc
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---------------SEYLQTDFEREACLLAEFD------HPN 429 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---------------~~~~~~~f~~Ei~il~~l~------Hpn 429 (653)
..||+|+.-.||.- + ......||+.+... .....++..+|+.-...+. +.+
T Consensus 7 ~~i~~G~~R~cy~H--P------~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P------DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred cccccCCCceEEEC--C------CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 45899999999952 2 22457788877654 1112345667776666655 889
Q ss_pred cceEEeEEecCCceEEEEeecCC------CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 430 IVKLLGVCAVGKPMCLLFEYMGR------GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 430 Iv~l~g~~~~~~~~~LV~Ey~~~------gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
|.+++|+...+.-..+|+|.+.+ -+|.++++ ...++. .+...+-+-..|
T Consensus 79 i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~---------------------~~~~~~----~~~~~L~~f~~~ 133 (199)
T PF10707_consen 79 IPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLK---------------------EGGLTE----ELRQALDEFKRY 133 (199)
T ss_pred cccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHH---------------------cCCccH----HHHHHHHHHHHH
Confidence 99999999999999999998643 24556654 123444 233444455677
Q ss_pred hhhCCceecCCCCCCEeEcCCC----cEEEec
Q psy5539 504 LSDRKFVHRDLATRNCLINDQM----VVKIAD 531 (653)
Q Consensus 504 LH~~~ivHrDLkp~NILl~~~~----~vkI~D 531 (653)
|-+.+|+.+||+|.||++..+. .+.|+|
T Consensus 134 l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 134 LLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred HHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 8889999999999999996332 567776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd07457 CRD_FZ9_like Cysteine-rich Wnt-binding domain (CRD) of receptors similar to frizzled 9 | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.0001 Score=65.77 Aligned_cols=106 Identities=21% Similarity=0.456 Sum_probs=68.2
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHH-HHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE-QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMS 111 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e-~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~ 111 (653)
|.|++-+-..|..+ ..+. ..|..... -..++| ......|.-| +...|++.+..+||.-+||.|.... +.+
T Consensus 1 ~~CepI~~~~C~~l-~Yn~-T~~PN~lg--h~~q~ea~~~~~~~~pL---v~~~Csp~l~~FlCsl~~P~C~~~~--~~~ 71 (121)
T cd07457 1 GKCERITIPMCQGI-GYNM-TRMPNLLG--HESQSEAAISIHEFAPL---VQYGCAEHLRFFLCSLYAPMCTEQV--SIP 71 (121)
T ss_pred CcCccCChHhhCCC-CCCc-eeCCCcCC--CcCHHHHHHHHHHHHHH---HhcCCChhHHHHhhhccCcccCCCC--CCc
Confidence 67999998999884 5443 45544321 112222 1122235555 6679999999999999999996532 345
Q ss_pred CCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCC---CCCCCCCCCc
Q psy5539 112 LPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFEL---PNCDTLPKYE 162 (653)
Q Consensus 112 ~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~l---p~C~~lp~~~ 162 (653)
.+-||.-|+.+| .-|... ++.- .+.. -+|+.+|...
T Consensus 72 i~PCRslCe~vr-~~C~~~---m~~~-----------g~~WP~~l~C~~fP~~~ 110 (121)
T cd07457 72 IPACRSMCEQAR-DKCSPI---MEQF-----------SFSWPDSLDCDRLPRKN 110 (121)
T ss_pred CCccHHHHHHHH-HHHHHH---HHHh-----------CCCCCCcCCcccCCCCC
Confidence 777999999999 677432 2211 1222 3799999754
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 9 (Fz9) and frizzled 10 (Fz10) receptors, and similar proteins. This domain is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. The CRD domain is well conserved in metazoans - 10 frizzled proteins have been identified in mammals, 4 in Drosophila and 3 in Caenorhabditis elegans. Very little is known about the mechanism by which CRD domains interact with their ligands. The domain contains 10 conserved cysteines. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00046 Score=69.58 Aligned_cols=73 Identities=11% Similarity=0.168 Sum_probs=45.2
Q ss_pred eeecccCCe-eEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC---ccceEEeEEecC---Cce
Q psy5539 371 RDLGQGAFG-RVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP---NIVKLLGVCAVG---KPM 443 (653)
Q Consensus 371 ~~LG~G~fG-~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp---nIv~l~g~~~~~---~~~ 443 (653)
+.|+.|+.. .||+.. ..+++|..+... ....+.+|.+++..+... -+.+.++..... ...
T Consensus 3 ~~~~~gG~~n~vy~~~----------~~~VlR~~~~~~---~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~ 69 (235)
T cd05155 3 EPVDSGGTDNATFRLG----------DDMSVRLPSAAG---YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP 69 (235)
T ss_pred eeccCCCcccceEEcC----------CceEEEcCCccc---hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence 457777766 599752 236677765432 234688999999887532 233444443322 234
Q ss_pred EEEEeecCCCChH
Q psy5539 444 CLLFEYMGRGDLN 456 (653)
Q Consensus 444 ~LV~Ey~~~gsL~ 456 (653)
++|||+++|.++.
T Consensus 70 ~~l~~~i~G~~l~ 82 (235)
T cd05155 70 WSVYRWLEGETAT 82 (235)
T ss_pred eEEEEeecCCCCC
Confidence 8899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd07461 CRD_FZ8 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 8 (Fz8) receptor | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.00032 Score=62.90 Aligned_cols=115 Identities=19% Similarity=0.342 Sum_probs=73.3
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHH-HHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQI-VMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~-~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.+.|++-+=..|+.+ ..+...|-|.-.- ..++|.. ....|.-| +...|++.+.-+||.-+||.|.+... .
T Consensus 2 ~~~C~pI~~~~C~~l-~Yn~T~~PN~l~H---~sq~ea~~~~~~f~pL---v~~~Csp~l~~FlCSl~~P~C~~~~~--~ 72 (125)
T cd07461 2 ELQCQEITVPLCKGI-GYNYTYMPNQFNH---DTQDEAGLEVHQFWPL---VEIQCSPDLKFFLCSMYTPICLEDYK--K 72 (125)
T ss_pred CCcccccCHHHhCCC-CCCcccCCCccCC---CCHHHHHHHHHHHHHH---HhCCCChhHHHHhhhccCcccCCCCC--C
Confidence 467999998899875 5554544444321 1223221 22235555 66799999999999999999965433 4
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCC---CCCCCCCCCcccCCCCcCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFEL---PNCDTLPKYEVVNGKPTCSH 172 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~l---p~C~~lp~~~~~~~~~~C~~ 172 (653)
+.+-||.-|+.+| .-|.. .++. .++.. -+|+.+|... +....|..
T Consensus 73 ~i~PCRslCe~vr-~~C~~---~m~~-----------~g~~WP~~l~C~~fP~~~--~~~~~C~~ 120 (125)
T cd07461 73 PLPPCRSVCERAK-AGCAP---LMRQ-----------YGFPWPDRMRCDLLPEQG--NPDTLCMD 120 (125)
T ss_pred cCCccHHHHHHHH-HHHHH---HHHH-----------hCCCCCCcCChhhCCCCC--CCCCccCC
Confidence 4777999999999 66732 2221 12233 4799999765 22345653
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 8 (Fz8) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Xenopus Fz8 is important in Wnt/beta-catenin signaling pathways controlling the transcriptional activation of target genes Siamois and Xnr3 in the animal caps of late blastula. |
| >smart00063 FRI Frizzled | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00022 Score=62.96 Aligned_cols=104 Identities=20% Similarity=0.337 Sum_probs=64.6
Q ss_pred cccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCCCc
Q psy5539 35 CSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPL 114 (653)
Q Consensus 35 c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~p~ 114 (653)
|++-+-..|+.. ..+...|=|.-.-..+.+.+ .....|..| +...|++.+..+||.-+||.|.+.+. +.+-
T Consensus 1 C~pi~~~~C~~l-~Yn~T~~PN~l~h~~q~ea~--~~l~~~~~L---~~~~C~p~l~~flCsl~~P~C~~~~~---~~~P 71 (113)
T smart00063 1 CEPITIPLCKDL-GYNLTSMPNLLGHTTQEEAG--LELEQFHPL---LNVQCSPDLRFFLCSVYAPICTEDLR---PILP 71 (113)
T ss_pred CcCCCcHhHCCC-CcccccCCCccCCCCHHHHH--HHHHHHHhh---ccCCCChhHHHHhHhccCcccCCCCC---cCCc
Confidence 556666778764 34444443432221121222 223456777 44569999999999999999976443 5777
Q ss_pred ccchhhhhhhccchhHHHHHHhhhccccccccCCCcCC---CCCCCCCCCc
Q psy5539 115 CYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFEL---PNCDTLPKYE 162 (653)
Q Consensus 115 C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~l---p~C~~lp~~~ 162 (653)
||.-|+.+| .-|.... +.. .+.. -+|+.+|...
T Consensus 72 CRs~Ce~vr-~~C~~~~---~~~-----------g~~WP~~l~C~~fP~~~ 107 (113)
T smart00063 72 CRSLCEAAR-EGCEPLM---EKF-----------GFPWPEFLRCDRFPVQE 107 (113)
T ss_pred CHHHHHHHH-HHHHHHH---HHh-----------CCCCCCcCCcccCCCCC
Confidence 999999999 7774332 111 1233 3899998753
|
Drosophila melanogaster frizzled mediates signalling that polarises a precursor cell along the anteroposterior axis. Homologues of the N-terminal region of frizzled exist either as transmembrane or secreted molecules. Frizzled homologues are reported to be receptors for the Wnt growth factors. (Not yet in MEDLINE: the FRI domain occurs in several receptor tyrosine kinases [Xu, Y.K. and Nusse, Curr. Biol. 8 R405-R406 (1998); Masiakowski, P. and Yanopoulos, G.D., Curr. Biol. 8, R407 (1998)]. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0022 Score=67.17 Aligned_cols=79 Identities=14% Similarity=0.148 Sum_probs=56.2
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC---CccceEEeEEec---C
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH---PNIVKLLGVCAV---G 440 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H---pnIv~l~g~~~~---~ 440 (653)
+.-.+.||.|..+.||+.... + ..+.+|..+.... ...|..|.+.|+.|.- ..+.++++++.. .
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~------~-~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~ 85 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDS------Q-GNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSP 85 (297)
T ss_pred hheeeecCCccceeEEEEEcC------C-CCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcC
Confidence 345677999999999997642 1 2366677543211 2367899999988853 367788888754 3
Q ss_pred CceEEEEeecCCCCh
Q psy5539 441 KPMCLLFEYMGRGDL 455 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL 455 (653)
+..+||||+++++++
T Consensus 86 g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 86 GPDVLLLERLRGVSV 100 (297)
T ss_pred CCeEEEEeccCCEec
Confidence 668999999998765
|
|
| >cd07888 CRD_corin_2 One of two cysteine-rich domains of the corin protein, a type II transmembrane serine protease | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.00044 Score=61.73 Aligned_cols=114 Identities=18% Similarity=0.356 Sum_probs=68.5
Q ss_pred cccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCCCc
Q psy5539 35 CSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLPL 114 (653)
Q Consensus 35 c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~p~ 114 (653)
|++-+=..|.. +..+.. .|..-.. -..++|-..+..+..+..-+...|++.+.-+||.-+||.|...+..+ .|=
T Consensus 2 CepI~~~~C~~-l~Yn~T-~~PN~lg--H~sq~ea~~~~~~~~f~pLv~~~Csp~l~~FlCsl~~P~C~~~~~~~--i~P 75 (122)
T cd07888 2 CEPITLELCMN-LPYNTT-RYPNYLG--HRTQKEASISWESSLFPALVQTNCYKYLMFFACTILVPKCDPVTQQR--IPP 75 (122)
T ss_pred CccCCHhhhCC-CCcCcc-cCCcccC--CCCHHHHHHhhhHHHHHhHHhcCCChhHHHHHHhccCccccCCCCCC--CCC
Confidence 77777778886 344443 3433221 11233321111012322336789999999999999999996544433 667
Q ss_pred ccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCC
Q psy5539 115 CYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCS 171 (653)
Q Consensus 115 C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~ 171 (653)
||.-|+.+| .-|... ++. -.+..| +|+.+|... .....|.
T Consensus 76 CRslCe~vr-~~C~~~---m~~-----------fg~~WP~~l~C~~fP~~~--~~~~~C~ 118 (122)
T cd07888 76 CRSLCRNSK-ERCESV---LGI-----------VGLQWPEDTDCAQFPEEN--SDNQTCL 118 (122)
T ss_pred cHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCccccCCCCC--CCCCcCC
Confidence 999999999 777322 221 123455 799999754 3344564
|
The cysteine-rich domain (CRD) is an essential component of corin, a type II transmembrane serine protease which functions as the convertase of the pro-atrial natriuretic peptide (pro-ANP) in the heart. Corin contains two CRDs in its extracellular region, which play an important role in recognition of the physiological substrate, pro-ANP. This model characterizes the second (C-terminal) CRD. |
| >cd07464 CRD_FZ2 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 2 (Fz2) receptor | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.00057 Score=61.32 Aligned_cols=114 Identities=17% Similarity=0.403 Sum_probs=73.2
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHH-HHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQ-IVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~-~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.|.|++-+=..|+.+ ..+...|=|.-.- ..++|- .....|.-| +...|++.+.-+||..+||.|.. .. .
T Consensus 2 ~~~CepI~~~~C~~l-~Yn~T~~PN~lgH---~sq~ea~~~~~~f~pL---v~~~Csp~l~~FlCSl~~P~C~~-~~--~ 71 (127)
T cd07464 2 HGFCQPISIPLCTDI-AYNQTIMPNLLGH---TNQEDAGLEVHQFYPL---VKVQCSLELRFFLCSMYAPVCTV-LE--Q 71 (127)
T ss_pred CCccccCChhhhCCC-CCCcccCCcccCC---CCHHHHHHHHHHHHHH---HhcCCChhHHHHHhhccCCccCC-CC--C
Confidence 588999999999975 5454444333221 122221 122345555 67899999999999999999965 22 3
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHA 173 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~ 173 (653)
+.|=||.-|+.+| .-|.... +. -.+..| +|+++|... +...|...
T Consensus 72 ~i~PCRslCe~vr-~~C~~~m---~~-----------fg~~WP~~l~C~~fP~~~---~~~~C~~~ 119 (127)
T cd07464 72 AIPPCRSICERAR-QGCEALM---NK-----------FGFQWPERLRCENFPRHG---AEQICVGQ 119 (127)
T ss_pred cCCCcHHHHHHHH-HHHHHHH---HH-----------hCCCCCCcCCcccCCCCC---CCCcCCCC
Confidence 3556999999999 7774332 21 123455 799999753 23456533
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 2 (Fz2) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Fz2 is involved in the Wnt/beta-catenin signaling pathway and in the activation of protein kinase C and calcium/calmodulin-dependent protein kinase (CaM kinase). |
| >cd07466 CRD_FZ7 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 7 (Fz7) receptor | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.00068 Score=60.71 Aligned_cols=115 Identities=17% Similarity=0.394 Sum_probs=73.9
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHH-HHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE-QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e-~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.|.|++-+=..|+.+ ..+...|=|.-.- ..++| ......|.-| |...|++.+.-+||..+||.|.. .. .
T Consensus 2 ~~~CepI~~~~C~~l-~Yn~T~~PN~lgH---~~q~ea~~~~~~f~pL---v~~~Csp~l~~FlCsl~~P~C~~-~~--~ 71 (125)
T cd07466 2 HGFCQPISIPLCTDI-AYNQTIMPNLLGH---TNQEDAGLEVHQFYPL---VKVQCSPELKFFLCSMYAPVCTV-LE--Q 71 (125)
T ss_pred CCccccCCHHHhCCC-CCCcccCCcccCC---CCHHHHHHHHHHHHHH---HhCCCChhHHHHhhhccCCccCC-CC--C
Confidence 589999999999975 5444433333211 12222 1122335555 77899999999999999999964 22 3
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHAQ 174 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~~ 174 (653)
+.|=||.-|+.+| .-|... ++. -.+..| +|+++|... +...|....
T Consensus 72 ~i~PCRslCe~vr-~~C~~~---m~~-----------fg~~WP~~l~C~~fP~~~---~~~~Ci~~~ 120 (125)
T cd07466 72 AIPPCRSLCERAR-QGCEAL---MNK-----------FGFQWPERLRCENFPVHG---AGEICVGQN 120 (125)
T ss_pred cCCCcHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCCcccCCCCC---CCCcCcCCC
Confidence 4667999999999 677322 221 123455 799999753 244565443
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 7 (Fz7) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Xenopus Fz7 is important in Wnt/beta-catenin signaling pathways controlling the transcriptional activation of target genes Siamois and Xnr3 in the animal caps of late blastula. |
| >cd07465 CRD_FZ1 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 1 (Fz1) receptor | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.00074 Score=60.65 Aligned_cols=114 Identities=18% Similarity=0.410 Sum_probs=73.7
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHH-HHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE-QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e-~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.|.|++-+=..|..+ ..+...|=|.- . -..++| .+....|.-| |...|++...-+||..+||.|.. . +.
T Consensus 2 ~~~Cepi~~~~C~~l-~Yn~T~~PN~l-g--h~~q~ea~~~~~~f~pL---v~~~Csp~l~~FLCSl~~P~C~~-~--~~ 71 (127)
T cd07465 2 HGYCQPISIPLCTDI-AYNQTIMPNLL-G--HTNQEDAGLEVHQFYPL---VKVQCSAELKFFLCSMYAPVCTV-L--EQ 71 (127)
T ss_pred CCeeeeCCHHHhCCC-CCCcccCCccc-C--CCCHHHHHHHHHHHHHH---HhCCCChhhHhHhhhccCCcccC-C--CC
Confidence 589999999999985 44444433332 1 112222 2222335555 77899999999999999999965 2 23
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHA 173 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~ 173 (653)
+.|=||.-|+.+| .-|... ++. -.+..| +|+.+|... +...|...
T Consensus 72 ~i~PCRslCe~vr-~~C~~~---m~~-----------fg~~WP~~l~C~~fP~~~---~~~~C~~~ 119 (127)
T cd07465 72 ALPPCRSLCERAR-QGCEAL---MNK-----------FGFQWPDTLRCEKFPVHG---AGELCVGQ 119 (127)
T ss_pred cCCccHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCCcccCCCCC---CCCcccCC
Confidence 4667999999999 667322 211 123455 899999753 24456543
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 1 (Fz1) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. |
| >cd07458 CRD_FZ1_like Cysteine-rich Wnt-binding domain (CRD) of receptors similar to frizzled 1 | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0008 Score=59.83 Aligned_cols=105 Identities=18% Similarity=0.442 Sum_probs=67.3
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHH-HHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQ-IVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMS 111 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~-~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~ 111 (653)
|.|++-+=..|+. +..+... |..... -..++|- +....|..| +...|++..+.+||.-+||.|.. .. .+
T Consensus 1 ~~C~pi~~~~C~~-l~Yn~T~-~PN~lg--h~~q~ea~~~l~~~~pL---v~~~C~p~l~~FlCsl~~P~C~~-~~--~~ 70 (119)
T cd07458 1 GKCEPITIPLCTD-IPYNMTI-FPNLLG--HTKQEDAGLEVHQFYPL---VKVQCSPDLKFFLCSVYAPVCTV-LE--RP 70 (119)
T ss_pred CccccCChHHhCC-CCCCccC-CCCccC--CCCHHHHHHHHHHHHHH---HhCCCChhHHHHhhhccccccCC-CC--Cc
Confidence 5788888889987 4444443 333321 1122332 122234455 67899999999999999999964 22 34
Q ss_pred CCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCc
Q psy5539 112 LPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYE 162 (653)
Q Consensus 112 ~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~ 162 (653)
.+=||.-|+.+| .-|.. .++. -.+..| +|+.+|...
T Consensus 71 i~PCRslCe~vr-~~C~~---~m~~-----------~g~~WP~~l~C~~fP~~~ 109 (119)
T cd07458 71 IPPCRSLCESAR-QGCEA---LMNK-----------FGFQWPESLDCEKFPVHG 109 (119)
T ss_pred CCccHHHHHHHH-HHHHH---HHHH-----------hCCCCCCCCCcccCCCCC
Confidence 667999999999 67733 2221 123444 899999753
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 1 (Fz1), frizzled 2 (Fz2), and frizzled 7 (Fz7) receptors, and similar proteins. This domain is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. The CRD domain is well conserved in metazoans - 10 frizzled proteins have been identified in mammals, 4 in Drosophila and 3 in Caenorhabditis elegans. Very little is known about the mechanism by which CRD domains interact with their ligands. The domain contains 10 conserved cysteines. |
| >cd07460 CRD_FZ5 Cysteine-rich Wnt-binding domain (CRD) of the frizzled 5 (Fz5) receptor | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0008 Score=60.39 Aligned_cols=115 Identities=20% Similarity=0.383 Sum_probs=71.3
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH--HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA--LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~--~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
-.|++-+=..|..+ ..+...|=|.-.- ..++| .... .|.-| +...|++.+.-+||.-+||.|.+... .
T Consensus 3 ~~CepI~~~~C~~l-~Yn~T~~PN~lgh---~~q~e-a~~~~~~f~pL---v~~~Csp~l~~FlCS~~~P~C~~~~~--~ 72 (127)
T cd07460 3 LVCQEITVPMCKGI-GYNLTYMPNQFNH---DTQDE-AGLEVHQFWPL---VEIQCSPDLRFFLCSMYTPICLPDYR--K 72 (127)
T ss_pred CEecccChhhhCCC-CCCcccCCCccCC---CCHHH-HHHHHHHHHHH---HhCCCChhHHHHhhhccCccccCCCC--C
Confidence 35888888889875 4444333333211 12222 2222 35555 56799999999999999999965433 3
Q ss_pred CCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCcccCCCCcCCCCC
Q psy5539 111 SLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYEVVNGKPTCSHAQ 174 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~~~~~~~~C~~~~ 174 (653)
+.+=||.-|+.+| .-|.. .++. ..+..| +|+.+|... .....|...+
T Consensus 73 ~i~PCRslCe~vr-~~C~~---~m~~-----------fg~~WP~~l~C~~fP~~~--~~~~~C~~~~ 122 (127)
T cd07460 73 PLPPCRSVCERAK-AGCSP---LMRQ-----------YGFAWPERMNCDRLPVLG--DPETLCMDYN 122 (127)
T ss_pred cCCccHHHHHHHH-HHHHH---HHHH-----------hCCCCCCcCChhhCCCCC--CCCCccCCCC
Confidence 4666999999999 66732 2221 123334 799999765 2344566443
|
proteins. The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 5 (Fz5) receptor, and is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. CRD containing Fzs have been found in diverse species from amoebas to mammals. 10 different frizzled proteins are found in vertebrata. Fz5 plays critical regulating roles in the yolk sac and placental angiogenesis, in the maturation of the Paneth cell phenotype, in governing the neural potential of progenitors in the developing retina, and in neuronal s |
| >cd07456 CRD_FZ5_like Cysteine-rich Wnt-binding domain (CRD) of receptors similar to frizzled 5 | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0014 Score=58.47 Aligned_cols=105 Identities=19% Similarity=0.418 Sum_probs=66.8
Q ss_pred ccccCccchhhhhhcCCCeEEEcCCCcCCcccHHH-HHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCC
Q psy5539 34 YCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNE-QIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSL 112 (653)
Q Consensus 34 ~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e-~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~ 112 (653)
.|++-+=..|+.+ ..+. ..|..... -..++| ......|..| +...|++.+.-+||.-++|.|.... +.+.
T Consensus 1 ~Cepi~~~~C~~l-~Yn~-T~~PN~lg--h~~q~ea~~~~~~~~pL---v~~~Csp~l~~FlCsl~~P~C~~~~--~~~i 71 (120)
T cd07456 1 KCEEITIPMCKGI-GYNM-TYMPNQFN--HDTQEEAGLEVHQFWPL---VEIQCSPDLKFFLCSMYTPICLEDY--DKPL 71 (120)
T ss_pred CccccChhhhCCC-CCCc-ccCCCcCC--CcCHHHHHHHHHHHHHH---HhCCCChhHHHHhHhccCcccCCCC--CCcC
Confidence 3777777888874 5443 44444322 122333 2222235555 6679999999999999999996543 3347
Q ss_pred CcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCC---CCCCCCCCCc
Q psy5539 113 PLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFEL---PNCDTLPKYE 162 (653)
Q Consensus 113 p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~l---p~C~~lp~~~ 162 (653)
+-||.-|+.++ .-|.. .++.. .+.. .+|+.+|...
T Consensus 72 ~PCRslCe~vr-~~C~~---~m~~~-----------g~~WP~~l~C~~fP~~~ 109 (120)
T cd07456 72 PPCRSVCERAR-DGCAP---IMRQY-----------GFAWPERMSCDALPEGG 109 (120)
T ss_pred CccHHHHHHHH-HHHHH---HHHHh-----------CCCCCCcCChhhCCCCC
Confidence 77999999999 67732 22211 1233 5899999754
|
The cysteine-rich domain (CRD) is an essential extracellular portion of the frizzled 5 (Fz5) and frizzled 8 (Fz8) receptors, and similar proteins. This domain is required for binding Wnt proteins, which play fundamental roles in many aspects of early development, such as cell and tissue polarity, neural synapse formation, and the regulation of proliferation. Fz proteins serve as Wnt receptors for multiple signal transduction pathways, including both beta-catenin dependent and -independent cellular signaling, as well as the planar cell polarity pathway and Ca(2+) modulating signaling pathway. The CRD domain is well conserved in metazoans - 10 frizzled proteins have been identified in mammals, 4 in Drosophila and 3 in Caenorhabditis elegans. Very little is known about the mechanism by which CRD domains interact with their ligands. The domain contains 10 conserved cysteines. |
| >cd07454 CRD_LIN_17 Cysteine-rich domain (CRD) of LIN_17 | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00085 Score=60.07 Aligned_cols=88 Identities=19% Similarity=0.490 Sum_probs=59.8
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCc-CCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLE-SAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~-~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.|.|++-+=..|+. |..+.. .|..... ..+.+.+ .....|.-| +...|++...-+||.-+||.|.... +.
T Consensus 2 ~~~C~Pi~~~~C~~-l~Yn~T-~~PN~lgh~~q~ea~--~~~~~f~pL---v~~~C~p~l~~FlCsl~~P~C~~~~--~~ 72 (124)
T cd07454 2 KGKCIPIDIELCKD-LPYNYT-YFPNTILHNDQHTLQ--THTEHFKPL---MKTKCHPHIHFFICSVFAPMCPIGM--PQ 72 (124)
T ss_pred CCccccCChhhhCC-CCcCcc-cCCcccCCCCHHHHH--HHHHHHHHH---HhcCCChhHHHHhhcccccccCCCC--CC
Confidence 57899999999997 455444 4443321 1111222 112235555 7799999999999999999996543 34
Q ss_pred CCCcccchhhhhhhccchh
Q psy5539 111 SLPLCYEDCIAVRYSFCYN 129 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~ 129 (653)
+.+-||.-|+.+| .-|..
T Consensus 73 ~i~PCRslCe~vr-~~C~~ 90 (124)
T cd07454 73 AVTSCKSVCEQVK-ADCFS 90 (124)
T ss_pred cCCCChhHHHHHH-HHHHH
Confidence 4777999999999 67743
|
A cysteine-rich domain (CRD) is an essential component of a number of cell surface receptors, which are involved in multiple signal transduction pathways, particularly in modulating the activity of the Wnt proteins, which play a fundamental role in the early development of metazoans. CRD is also found in secreted frizzled related proteins (SFRPs), which lack the transmembrane segment found in the frizzled protein. The CRD domain is also present in the alpha-1 chain of mouse type XVIII collagen, in carboxypeptidase Z, several receptor tyrosine kinases, and the mosaic transmembrane serine protease corin. The CRD domain is well conserved in metazoans - 10 frizzled proteins have been identified in mammals, 4 in Drosophila and 3 in Caenorhabditis elegans. CRD domains have also been identified in multiple tandem copies in a Dictyostelium discoideum protein. Very little is known about the mechanism by which CRD domains interact with the |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0017 Score=66.32 Aligned_cols=72 Identities=18% Similarity=0.167 Sum_probs=45.2
Q ss_pred ecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccc-eEEeEEecCCceEEEEeecC
Q psy5539 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV-KLLGVCAVGKPMCLLFEYMG 451 (653)
Q Consensus 373 LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~~ 451 (653)
+..|-.+.+|+... ++..+++|........ ...+..+|.++++.+....++ ++++... -++|+||++
T Consensus 4 ~~~G~tn~~y~~~~-------~~~~~vlR~~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~ 71 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-------PGISFVWRPQSPVCKA-LGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLE 71 (256)
T ss_pred CCCcCcCCeEEEEe-------CCccEEEeeCCccccc-ccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEecc
Confidence 45677889998763 2356888876543222 112357788888888644343 4444432 369999999
Q ss_pred CCChH
Q psy5539 452 RGDLN 456 (653)
Q Consensus 452 ~gsL~ 456 (653)
|..+.
T Consensus 72 G~~~~ 76 (256)
T TIGR02721 72 GEVIT 76 (256)
T ss_pred Ccccc
Confidence 86654
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0046 Score=62.04 Aligned_cols=77 Identities=16% Similarity=0.246 Sum_probs=48.2
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc-ceEEeEEecCCceEEEEe
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI-VKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E 448 (653)
++.|..|-...+|+....+ .....+++|........ ..+.++|+.++..+...++ .++++... -.+|||
T Consensus 3 i~~l~gG~tN~~~~v~~~~----~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e 72 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKE----DNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYE 72 (235)
T ss_pred EEEcCCcccceEEEEEcCC----CCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEE
Confidence 4567788888999986421 02356888877643221 1234578888888854333 34444332 248999
Q ss_pred ecCCCChH
Q psy5539 449 YMGRGDLN 456 (653)
Q Consensus 449 y~~~gsL~ 456 (653)
|+++.++.
T Consensus 73 ~i~G~~l~ 80 (235)
T cd05157 73 FIPGRTLE 80 (235)
T ss_pred eeCCCcCC
Confidence 99987763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0064 Score=63.88 Aligned_cols=157 Identities=13% Similarity=0.216 Sum_probs=82.7
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC--ccceEEeEE------
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP--NIVKLLGVC------ 437 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~~------ 437 (653)
....++.++.|.-..+|+.+.. + ..+++|..+..... +....|.+++..|... .+.+++...
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~------~-~~~vLK~~~~~~~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTD------V-GRYILTLYEKRVKA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CceeccccCCccccceEEEEeC------C-CcEEEEEecCCCCH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 3455677888888899988642 2 24777876543222 2344566666666322 234444321
Q ss_pred ecCCceEEEEeecCCCChH-----------HHHhhcCC--CCCcCCC-----ccccccccc----CCCCCCHHHHHHHHH
Q psy5539 438 AVGKPMCLLFEYMGRGDLN-----------DFLRICSP--NNYINGT-----YSSMESSIH----RVPQLSTCDLITIAL 495 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~-----------~~L~~~~~--~~~~~~~-----~~~~~~~~~----~~~~l~~~~~~~i~~ 495 (653)
...+..++++||++|..+. +.|...+. ..+.... ......... ....+.. ....
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~----~~~~ 168 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEA----HMGA 168 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCH----HHHH
Confidence 2245678999999885542 11111110 0000000 000000000 0001111 1112
Q ss_pred HHHHHHHHhh-------hCCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 496 QIASGMVYLS-------DRKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 496 qia~gL~yLH-------~~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
.+...++++. ..+++|+|+.+.||++++++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 169 ELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 2334455553 2589999999999999998878999999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd07442 CRD_SFRP4 Cysteine-rich domain of the secreted frizzled-related protein 4 (SFRP4), a Wnt antagonist | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0017 Score=58.20 Aligned_cols=105 Identities=21% Similarity=0.446 Sum_probs=68.4
Q ss_pred ccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH--HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCC
Q psy5539 34 YCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA--LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMS 111 (653)
Q Consensus 34 ~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~--~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~ 111 (653)
.|++-+=..|.. +..+ ...|..... ...|+....+ .|.-| |...|++...-+||..+||.|... ..+.+
T Consensus 4 ~CepI~i~~C~~-l~Yn-~T~~PN~lg---H~~q~ea~~~~~~f~pL---v~~~Csp~l~~FLCS~~~P~C~~~-~~~~~ 74 (127)
T cd07442 4 PCEAVRIPMCRH-MPWN-ITRMPNHLH---HSTQENAVLAIEQYEEL---VDTGCSPVLPFFLCAMYAPICTLE-FLYDP 74 (127)
T ss_pred cccccChhhhCC-CCcC-cccCcCccC---CCCHHHHHHHHHHHHHH---HcCCCCcchHHHHHhhcCCccCCC-CCCCc
Confidence 588888888987 4444 344444322 1223222222 34455 779999999999999999999543 23455
Q ss_pred CCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCc
Q psy5539 112 LPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYE 162 (653)
Q Consensus 112 ~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~ 162 (653)
.+=||.-|+.+| .-|. ..++. -.+..| +|+++|...
T Consensus 75 i~PCRslCe~vr-~~C~---~~m~~-----------fg~~WP~~L~C~~fP~~~ 113 (127)
T cd07442 75 IKPCRSVCQRAR-DGCE---PIMRR-----------YNHSWPESLACDDLPVYD 113 (127)
T ss_pred CCccHHHHHHHH-HHHH---HHHHH-----------hCCCCCCcCCcccCCCCC
Confidence 777999999999 6673 22321 124555 799999743
|
The cysteine-rich domain (CRD) is an essential part of the secreted frizzled-related Protein 4 (SFRP4), which regulates the activity of Wnt proteins, key players in a number of fundamental cellular processes such as embryogenesis and postnatal development. SFRPs antagonize the activation of Wnt signaling by binding to the CRDs domains of frizzled (Fz) proteins, thereby preventing Wnt proteins from binding to these receptors. SFRPs are also known to have functions unrelated to Wnt, as enhancers of procollagen cleavage by the TLD proteinases. SFRPs and Fz proteins both contain CRD domains, but SFRPs lack the seven-pass transmembrane domain which is an integral part of Fzs. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.011 Score=64.13 Aligned_cols=78 Identities=17% Similarity=0.083 Sum_probs=51.7
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc------HHHHHHHHHHHHHHhhCC---CCccceEEeEEecC
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS------EYLQTDFEREACLLAEFD---HPNIVKLLGVCAVG 440 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~------~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~ 440 (653)
.+.||.|.+..||+++..+ ..+.|+||.-.+... ....+.+..|.+.|..+. ..++.+++.+ +.
T Consensus 31 ~~elggGn~N~VyrV~~~~-----g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~ 103 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTE-----GGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE 103 (401)
T ss_pred eeEcCCCceEEEEEEEeCC-----CCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence 4678999999999998631 114799997542110 112345667777777763 3456777776 33
Q ss_pred CceEEEEeecCCCC
Q psy5539 441 KPMCLLFEYMGRGD 454 (653)
Q Consensus 441 ~~~~LV~Ey~~~gs 454 (653)
+..++||||+++..
T Consensus 104 ~~~~lVME~L~~~~ 117 (401)
T PRK09550 104 ELAVTVMEDLSDHK 117 (401)
T ss_pred CCCEEEEecCCCcc
Confidence 55789999998643
|
|
| >cd07441 CRD_SFRP3 Cysteine-rich domain of the secreted frizzled-related protein 3 (SFRP3, alias FRZB), a Wnt antagonist | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.0017 Score=58.06 Aligned_cols=107 Identities=20% Similarity=0.384 Sum_probs=68.5
Q ss_pred ccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCCC
Q psy5539 34 YCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSLP 113 (653)
Q Consensus 34 ~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~p 113 (653)
.|++-+-..|..+ ..+ ..+|..... ...|+....++ .++...|...|++...-+||..+||.|... ..+.+.+
T Consensus 3 ~CepI~~~~C~~l-~Yn-~T~~PN~lg---H~~q~ea~~~~-~~f~pLv~~~Csp~l~~FLCS~~~P~C~~~-~~~~~i~ 75 (126)
T cd07441 3 SCEPVRIPMCKSM-PWN-MTKMPNHLH---HSTQANAVLAI-EQFEGLLGTQCSPDLLFFLCAMYAPICTID-FQHEPIK 75 (126)
T ss_pred cccccChhhhCCC-CcC-cccCCcccC---CCCHHHHHHHH-HHHHHHhcCCCCccchhHHhhccCcccCCC-CCCCcCC
Confidence 5888888889873 444 445554422 22233222222 333344789999999999999999999543 2234577
Q ss_pred cccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCCc
Q psy5539 114 LCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKYE 162 (653)
Q Consensus 114 ~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~~ 162 (653)
=||.-|+.+| .-|... ++. -.+..| +|+++|...
T Consensus 76 PCRslCe~vr-~~C~~~---m~~-----------fg~~WP~~L~C~~fP~~~ 112 (126)
T cd07441 76 PCKSVCERAR-AGCEPV---LIR-----------YRHTWPESLACEELPVYD 112 (126)
T ss_pred ccHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCCcccCCCCC
Confidence 7999999999 667322 211 124555 799999753
|
The cysteine-rich domain (CRD) is an essential part of the secreted frizzled-related protein 3 (SFRP3, alias FRZB), which plays important roles in embryogenesis and postnatal development as an antagonist of Wnt proteins, key players in a number of fundamental cellular processes. SFRPs antagonize the activation of Wnt signaling by binding to the CRD domains of frizzled proteins (Fz), thereby preventing Wnt proteins from binding to these receptors. SFRPs are also known to have functions unrelated to Wnt, as enhancers of procollagen cleavage by the TLD proteinases. SFRPs and Fz proteins both contain CRD domains, but SFRPs lack the seven-pass transmembrane domain which is an integral part of Fzs. SFRP3 regulates Wnt signaling activity in bone development and homeostasis. It is also involved in the control of planar cell polarity. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.012 Score=62.09 Aligned_cols=30 Identities=27% Similarity=0.397 Sum_probs=26.5
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
.+++|+|+.+.|||++++...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 379999999999999977667899999875
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 653 | ||||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-112 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-72 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-71 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-70 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-70 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-70 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-66 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-66 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-65 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-65 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-65 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-65 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-65 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-65 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-65 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 9e-65 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 4e-63 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-62 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-62 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-62 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-62 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-62 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-61 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-61 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-61 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-59 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-59 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-59 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-59 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-59 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-59 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-59 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-59 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-59 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-59 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-59 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 9e-59 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-58 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-58 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-58 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-58 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-58 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-58 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-58 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-58 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-58 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-57 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-57 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-57 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-57 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-56 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-55 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-55 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-55 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-55 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-55 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-55 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-55 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-55 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-55 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-55 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-55 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-55 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 8e-55 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-55 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-55 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-55 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-54 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-54 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-54 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-54 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-54 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-54 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-54 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-54 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-54 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-54 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-54 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-54 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-54 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-54 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-54 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-54 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-54 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-54 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-54 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-54 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-54 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-54 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-54 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-54 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-54 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-54 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-54 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-53 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-53 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-53 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-52 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-52 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-52 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-52 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-52 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-52 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-52 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-52 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-50 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-50 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-50 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-50 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-50 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-50 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 8e-50 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-50 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-49 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-49 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-49 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-49 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-49 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-49 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-49 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-49 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-49 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-49 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-49 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-49 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-49 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-49 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-48 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-48 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-48 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-48 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-48 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-48 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-48 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-48 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-48 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-47 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-47 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-47 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-47 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-47 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-47 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-47 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-47 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-47 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-46 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-46 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-46 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-46 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-46 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-46 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-46 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-46 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-46 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-46 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-46 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-45 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-45 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-45 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-45 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-45 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-45 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-45 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-45 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-45 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-45 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-45 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-45 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-45 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-45 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-45 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-45 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-45 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-45 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-45 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-45 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-45 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-45 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-45 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-45 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-45 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-45 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-45 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-45 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-44 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-44 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-44 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-43 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-43 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-43 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-43 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-43 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-43 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-43 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 6e-43 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-43 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-43 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-43 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-43 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-42 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-42 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-42 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-42 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-42 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-42 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-42 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-42 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-42 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-42 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-42 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-42 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-41 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-41 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-41 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 6e-41 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-41 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-41 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-40 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-39 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-39 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-39 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-39 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-39 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-39 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-39 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-39 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-39 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-39 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-39 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-39 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-39 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-39 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-39 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 5e-39 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-39 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-39 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-39 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-39 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-39 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-39 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-39 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 6e-39 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 7e-39 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-39 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-39 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-39 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 8e-39 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-39 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-39 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-38 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-38 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-38 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-38 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-38 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-38 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-38 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-38 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-38 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-38 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-38 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-38 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-38 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-38 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-38 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-38 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-38 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-38 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-38 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-38 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-38 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-38 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-38 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-38 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-38 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-38 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-38 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-38 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-38 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-38 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 4e-38 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-38 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-38 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-38 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-37 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-37 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-36 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-36 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-36 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-36 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-36 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-36 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-36 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-35 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-35 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-35 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-35 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-35 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-35 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-34 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-34 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-34 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-34 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-34 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-34 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-34 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-34 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-34 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-34 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-34 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-34 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-34 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-34 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-33 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-33 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-32 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-32 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-32 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-31 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-29 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-29 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-28 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-27 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-27 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-25 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-21 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-20 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-20 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-20 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-19 | ||
| 2l0s_A | 83 | Solution Structure Of Human Plasminogen Kringle 3 L | 2e-19 | ||
| 4dur_A | 791 | The X-Ray Crystal Structure Of Full-Length Type Ii | 3e-19 | ||
| 1ki0_A | 253 | The X-Ray Structure Of Human Angiostatin Length = 2 | 6e-19 | ||
| 2qj4_A | 184 | A Mechanistic Basis For Converting A Receptor Tyros | 1e-18 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-18 | ||
| 2kj4_A | 87 | Solution Structure Of The Complex Of Vek-30 And Pla | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-18 | ||
| 1gp9_A | 177 | A New Crystal Form Of The Nk1 Splice Variant Of Hgf | 4e-18 | ||
| 1gmn_A | 183 | Crystal Structures Of Nk1-Heparin Complexes Reveal | 5e-18 | ||
| 1bht_A | 176 | Nk1 Fragment Of Human Hepatocyte Growth Factor Leng | 5e-18 | ||
| 1nk1_A | 183 | Nk1 Fragment Of Human Hepatocyte Growth FactorSCATT | 5e-18 | ||
| 2qj2_A | 184 | A Mechanistic Basis For Converting A Receptor Tyros | 5e-18 | ||
| 1i5k_A | 84 | Structure And Binding Determinants Of The Recombina | 5e-18 | ||
| 1b2i_A | 83 | Kringle 2 Domain Of Human Plasminogen: Nmr Solution | 9e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-17 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-17 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-17 | ||
| 2feb_A | 102 | Nmr Solution Structure, Dynamics And Binding Proper | 2e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-17 | ||
| 3hn4_A | 264 | Crystal Structure Of The Nk2 Fragment (28-289) Of H | 3e-17 | ||
| 1jfn_A | 119 | Solution Structure Of Human Apolipoprotein(A) Kring | 3e-17 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 4e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 5e-17 | ||
| 3mkp_A | 183 | Crystal Structure Of 1k1 Mutant Of Hepatocyte Growt | 5e-17 | ||
| 3sp8_A | 264 | Crystal Structure Of Nk2 In Complex With Fractionat | 5e-17 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-17 | ||
| 3hkl_A | 197 | Crystal Structure Of The Frizzled-Like Cysteine-Ric | 7e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 8e-17 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-16 | ||
| 4iua_A | 262 | Crystal Structure Of The Nk2 Fragment (31-290) Of T | 2e-16 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-16 | ||
| 2doh_X | 234 | The X-Ray Crystallographic Structure Of The Angioge | 4e-16 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 4e-16 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-16 | ||
| 1i71_A | 83 | High Resolution Crystal Structure Of Apolipoprotein | 7e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-15 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-15 | ||
| 1kiv_A | 78 | Recombinant Kringle Iv-10M66 VARIANT OF HUMAN Apoli | 1e-15 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-15 | ||
| 3kiv_A | 79 | Recombinant Kringle Iv-10/m66 Variant Of Human Apol | 7e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-14 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-14 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-14 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-14 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-14 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-14 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-14 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-14 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-14 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-14 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-14 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-14 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-14 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-14 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-14 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-14 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-14 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-14 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-14 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-14 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-14 | ||
| 4kiv_A | 79 | Recombinant Kringle Iv-10W72R MUTANT OF HUMAN Apoli | 4e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 8e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-13 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-13 | ||
| 2knf_A | 86 | Solution Structure And Functional Characterization | 2e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-13 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 5hpg_A | 84 | Structure And Ligand Determinants Of The Recombinan | 3e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-13 | ||
| 1cea_A | 88 | The Structure Of The Non-Covalent Complex Of Recomb | 4e-13 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-13 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-13 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-13 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 5e-13 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-13 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-13 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-13 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-13 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-13 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-13 | ||
| 1pkr_A | 82 | The Structure Of Recombinant Plasminogen Kringle 1 | 6e-13 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-13 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-13 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-13 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 9e-13 | ||
| 2pf1_A | 156 | Structure Of Bovine Prothrombin Fragment 1 Refined | 1e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-12 | ||
| 1hpj_A | 79 | Solution Nmr Structure Of The Human Plasminogen Kri | 1e-12 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-12 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-12 | ||
| 1nl1_A | 147 | Bovine Prothrombin Fragment 1 In Complex With Calci | 2e-12 | ||
| 2spt_A | 145 | Differences In The Metal Ion Structure Between Sr-A | 2e-12 | ||
| 1nl2_A | 146 | Bovine Prothrombin Fragment 1 In Complex With Calci | 2e-12 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-12 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-12 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-12 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 5e-12 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-12 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 8e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 1pmk_A | 88 | Kringle-Kringle Interactions In Multimer Kringle St | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-11 | ||
| 2pk4_A | 80 | The Refined Structure Of The Epsilon-Aminocaproic A | 2e-11 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-11 | ||
| 1pk4_A | 79 | Crystal And Molecular Structure Of Human Plasminoge | 3e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 7e-10 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 8e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 8e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-09 | ||
| 1a0h_A | 159 | The X-Ray Crystal Structure Of Ppack-Meizothrombin | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-09 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 6e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 6e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-08 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-08 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-08 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-08 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-08 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-08 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-08 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-08 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-08 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-08 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-08 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-08 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 4e-08 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-08 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-08 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-08 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 5e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 5e-08 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 8e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 8e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 8e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-07 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3e6p_L | 158 | Crystal Structure Of Human Meizothrombin Desf1 Leng | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 3k65_A | 116 | Crystal Structure Of Prethombin-2FRAGMENT-2 Complex | 2e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 3e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 3e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 4e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 4e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 4e-07 | ||
| 2hpp_P | 79 | Structures Of The Noncovalent Complexes Of Human An | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 6e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 8e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-06 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-06 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3nxp_A | 424 | Crystal Structure Of Human Prethrombin-1 Length = 4 | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-06 | ||
| 2hpq_P | 79 | Structures Of The Noncovalent Complexes Of Human An | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-06 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-05 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 6e-05 | ||
| 1pk2_A | 90 | Solution Structure Of The Tissue-Type Plasminogen A | 6e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-05 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1pml_A | 86 | Kringle-Kringle Interactions In Multimer Kringle St | 8e-05 | ||
| 1tpk_A | 88 | Crystal Structure Of The Kringle-2 Domain Of Tissue | 8e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-04 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-04 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-04 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-04 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-04 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-04 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-04 |
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2L0S|A Chain A, Solution Structure Of Human Plasminogen Kringle 3 Length = 83 | Back alignment and structure |
|
| >pdb|4DUR|A Chain A, The X-Ray Crystal Structure Of Full-Length Type Ii Human Plasminogen Length = 791 | Back alignment and structure |
|
| >pdb|1KI0|A Chain A, The X-Ray Structure Of Human Angiostatin Length = 253 | Back alignment and structure |
|
| >pdb|2QJ4|A Chain A, A Mechanistic Basis For Converting A Receptor Tyrosine Kinase Agonist To An Antagonist Length = 184 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2KJ4|A Chain A, Solution Structure Of The Complex Of Vek-30 And Plasminogen Kringle 2 Length = 87 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1GP9|A Chain A, A New Crystal Form Of The Nk1 Splice Variant Of HgfSF Demonstrates Extensive Hinge Movement And Suggests That The Nk1 Dimer Originates By Domain Swapping Length = 177 | Back alignment and structure |
|
| >pdb|1GMN|A Chain A, Crystal Structures Of Nk1-Heparin Complexes Reveal The Basis For Nk1 Activity And Enable Engineering Of Potent Agonists Of The Met Receptor Length = 183 | Back alignment and structure |
|
| >pdb|1BHT|A Chain A, Nk1 Fragment Of Human Hepatocyte Growth Factor Length = 176 | Back alignment and structure |
|
| >pdb|1NK1|A Chain A, Nk1 Fragment Of Human Hepatocyte Growth FactorSCATTER Factor (HgfSF) AT 2.5 ANGSTROM RESOLUTION Length = 183 | Back alignment and structure |
|
| >pdb|2QJ2|A Chain A, A Mechanistic Basis For Converting A Receptor Tyrosine Kinase Agonist To An Antagonist Length = 184 | Back alignment and structure |
|
| >pdb|1I5K|A Chain A, Structure And Binding Determinants Of The Recombinant Kringle-2 Domain Of Human Plasminogen To An Internal Peptide From A Group A Streptococcal Surface Protein Length = 84 | Back alignment and structure |
|
| >pdb|1B2I|A Chain A, Kringle 2 Domain Of Human Plasminogen: Nmr Solution Structure Of Trans-4-Aminomethylcyclohexane-1-Carboxylic Acid (Amcha) Complex Length = 83 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2FEB|A Chain A, Nmr Solution Structure, Dynamics And Binding Properties Of The Kringle Iv Type 8 Module Of Apolipoprotein(A) Length = 102 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3HN4|A Chain A, Crystal Structure Of The Nk2 Fragment (28-289) Of Human Hepatocyte Growth FactorSCATTER FACTOR Length = 264 | Back alignment and structure |
|
| >pdb|1JFN|A Chain A, Solution Structure Of Human Apolipoprotein(A) Kringle Iv Type 6 Length = 119 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MKP|A Chain A, Crystal Structure Of 1k1 Mutant Of Hepatocyte Growth FactorSCATTER Factor Fragment Nk1 In Complex With Heparin Length = 183 | Back alignment and structure |
|
| >pdb|3SP8|A Chain A, Crystal Structure Of Nk2 In Complex With Fractionated Heparin Dp10 Length = 264 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HKL|A Chain A, Crystal Structure Of The Frizzled-Like Cysteine-Rich Domain Of Musk Length = 197 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4IUA|A Chain A, Crystal Structure Of The Nk2 Fragment (31-290) Of The Mouse Hepatocyte Growth Factor/scatter Factor Length = 262 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2DOH|X Chain X, The X-Ray Crystallographic Structure Of The Angiogenesis Inhibitor, Angiostatin, Bound A To A Peptide From The Group A Streptococcal Surface Protein Pam Length = 234 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1I71|A Chain A, High Resolution Crystal Structure Of Apolipoprotein(A) Kringle Iv Type 7: Insights Into Ligand Binding Length = 83 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1KIV|A Chain A, Recombinant Kringle Iv-10M66 VARIANT OF HUMAN Apolipoprotein(A) Length = 78 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3KIV|A Chain A, Recombinant Kringle Iv-10/m66 Variant Of Human Apolipoprotein(a) Length = 79 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4KIV|A Chain A, Recombinant Kringle Iv-10W72R MUTANT OF HUMAN Apolipoprotein(A) Length = 79 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2KNF|A Chain A, Solution Structure And Functional Characterization Of Human Plasminogen Kringle 5 Length = 86 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|5HPG|A Chain A, Structure And Ligand Determinants Of The Recombinant Kringle 5 Domain Of Human Plasminogen Length = 84 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1CEA|A Chain A, The Structure Of The Non-Covalent Complex Of Recombinant Kringle 1 Domain Of Human Plasminogen With Eaca (Epsilon- Aminocaproic Acid) Length = 88 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1PKR|A Chain A, The Structure Of Recombinant Plasminogen Kringle 1 And The Fibrin Binding Site Length = 82 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PF1|A Chain A, Structure Of Bovine Prothrombin Fragment 1 Refined At 2.25 Angstroms Resolution Length = 156 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1HPJ|A Chain A, Solution Nmr Structure Of The Human Plasminogen Kringle 1 Domain Complexed With 6-Aminohexanoic Acid At Ph 5.3, 310k, Derived From Randomly Generated Structures Using Simulated Annealing, 12 Structures Length = 79 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1NL1|A Chain A, Bovine Prothrombin Fragment 1 In Complex With Calcium Ion Length = 147 | Back alignment and structure |
|
| >pdb|2SPT|A Chain A, Differences In The Metal Ion Structure Between Sr-And Ca-Prothrombin Fragment 1 Length = 145 | Back alignment and structure |
|
| >pdb|1NL2|A Chain A, Bovine Prothrombin Fragment 1 In Complex With Calcium And Lysophosphotidylserine Length = 146 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1PMK|A Chain A, Kringle-Kringle Interactions In Multimer Kringle Structures Length = 88 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2PK4|A Chain A, The Refined Structure Of The Epsilon-Aminocaproic Acid Complex Of Human Plasminogen Kringle Length = 80 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1PK4|A Chain A, Crystal And Molecular Structure Of Human Plasminogen Kringle 4 Refined At 1.9-angstroms Resolution Length = 79 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1A0H|A Chain A, The X-Ray Crystal Structure Of Ppack-Meizothrombin Desf1: KringleTHROMBIN AND CARBOHYDRATEKRINGLETHROMBIN INTERACTIONS AND Location Of The Linker Chain Length = 159 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E6P|L Chain L, Crystal Structure Of Human Meizothrombin Desf1 Length = 158 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K65|A Chain A, Crystal Structure Of Prethombin-2FRAGMENT-2 Complex Length = 116 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2HPP|P Chain P, Structures Of The Noncovalent Complexes Of Human And Bovine Prothrombin Fragment 2 With Human Ppack-Thrombin Length = 79 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NXP|A Chain A, Crystal Structure Of Human Prethrombin-1 Length = 424 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2HPQ|P Chain P, Structures Of The Noncovalent Complexes Of Human And Bovine Prothrombin Fragment 2 With Human Ppack-thrombin Length = 79 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1PK2|A Chain A, Solution Structure Of The Tissue-Type Plasminogen Activator Kringle 2 Domain Complexed To 6-Aminohexanoic Acid An Antifibrinolytic Drug Length = 90 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1PML|A Chain A, Kringle-Kringle Interactions In Multimer Kringle Structures Length = 86 | Back alignment and structure |
|
| >pdb|1TPK|A Chain A, Crystal Structure Of The Kringle-2 Domain Of Tissue Plasminogen Activator At 2.4-Angstroms Resolution Length = 88 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-165
Identities = 199/324 (61%), Positives = 245/324 (75%), Gaps = 4/324 (1%)
Query: 334 NIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE 393
+ L +L N Y + LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E
Sbjct: 16 ELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYE 75
Query: 394 EFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRG 453
FT+VAVKMLK+EAS +Q DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM G
Sbjct: 76 PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 135
Query: 454 DLNDFLRICSPNNYINGTYS----SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509
DLN+FLR SP+ + ++S S P LS + + IA Q+A+GM YLS+RKF
Sbjct: 136 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 195
Query: 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTV 569
VHRDLATRNCL+ + MVVKIADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 255
Query: 570 ESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNM 629
ESDVWA+GV LWEIFS+ LQPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+
Sbjct: 256 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSK 315
Query: 630 KPMNRPSFRTIYQTLWNIKRDLEN 653
P +RPSF +I++ L + E
Sbjct: 316 LPADRPSFCSIHRILQRMCERAEG 339
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 445 bits (1147), Expect = e-154
Identities = 130/292 (44%), Positives = 185/292 (63%), Gaps = 5/292 (1%)
Query: 353 LNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ 412
++ + R DI+ R+LG+GAFG+VF A+ L ++ LVAVK LK + + +
Sbjct: 3 MHSGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALK-DPTLAAR 61
Query: 413 TDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472
DF+REA LL H +IVK GVC G P+ ++FEYM GDLN FLR P+ I
Sbjct: 62 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 473 SSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532
++ +L ++ IA QIASGMVYL+ + FVHRDLATRNCL+ ++VKI DF
Sbjct: 122 QPRQAK----GELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 533 GLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
G+SR +Y DYY+ + +P+RWMP ESI+Y K+T ESDVW+FGV LWEIF++ QP++
Sbjct: 178 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 237
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
L++ EV++ I +G +L+ P P +YD+M CW +P R + + IY+ L
Sbjct: 238 QLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYKIL 289
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-153
Identities = 115/284 (40%), Positives = 174/284 (61%), Gaps = 4/284 (1%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E + + ++ +LG+ FG+V++ G E+ VA+K LKD+A L+ +F EA
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAM 64
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L A HPN+V LLGV +P+ ++F Y GDL++FL + SP++ + T
Sbjct: 65 LRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVK-- 122
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L D + + QIA+GM YLS VH+DLATRN L+ D++ VKI+D GL R++Y
Sbjct: 123 --SALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
DYYK N +P+RWM E+I+Y K++++SD+W++GV LWE+FS+ LQPY G ++++VV
Sbjct: 181 ADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 240
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ I+ +L PD+ P +Y LM CWN P RP F+ I+ L
Sbjct: 241 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 444 bits (1143), Expect = e-153
Identities = 136/320 (42%), Positives = 186/320 (58%), Gaps = 10/320 (3%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQL----EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH 392
LS S Q NP+ R DI+ +LG+GAFG+VF A+ LL
Sbjct: 9 LSPTEGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPE 68
Query: 393 EEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGR 452
++ LVAVK LK EASE + DF+REA LL H +IV+ GVC G+P+ ++FEYM
Sbjct: 69 QDKMLVAVKALK-EASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRH 127
Query: 453 GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512
GDLN FLR P+ + + L L+ +A Q+A+GMVYL+ FVHR
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPG-----PLGLGQLLAVASQVAAGMVYLAGLHFVHR 182
Query: 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESD 572
DLATRNCL+ +VVKI DFG+SR +Y DYY+ +P+RWMP ESILY K+T ESD
Sbjct: 183 DLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESD 242
Query: 573 VWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPM 632
VW+FGV LWEIF++ QP+Y L++ E + I +G L+ P P +Y +M+ CW +P
Sbjct: 243 VWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQ 302
Query: 633 NRPSFRTIYQTLWNIKRDLE 652
R S + ++ L + +
Sbjct: 303 QRHSIKDVHARLQALAQAPP 322
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 440 bits (1135), Expect = e-152
Identities = 115/294 (39%), Positives = 165/294 (56%), Gaps = 4/294 (1%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
+ + EFPR +++ + LG+G FG+V +A A L +T VAVKMLK+ AS D
Sbjct: 13 LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRD 72
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNY----ING 470
E +L + +HP+++KL G C+ P+ L+ EY G L FLR G
Sbjct: 73 LLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGG 132
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530
+ +S L+ DLI+ A QI+ GM YL++ K VHRDLA RN L+ + +KI+
Sbjct: 133 SRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
DFGLSR +Y +D Y IPV+WM +ES+ + YT +SDVW+FGV LWEI + P
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
Y G+ E + +K G+ ++ PDN + +Y LM CW +P RP F I + L
Sbjct: 253 YPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-150
Identities = 119/290 (41%), Positives = 176/290 (60%), Gaps = 10/290 (3%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
++ E R I R+LGQG+FG V++ A G++K E T VA+K + + AS + +
Sbjct: 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
F EA ++ EF+ ++V+LLGV + G+P ++ E M RGDL +LR P
Sbjct: 75 FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA--------- 125
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
++ + S +I +A +IA GM YL+ KFVHRDLA RNC++ + VKI DFG+
Sbjct: 126 -MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
+R +Y DYY+ +PVRWM ES+ +T SDVW+FGV LWEI + A QPY GL
Sbjct: 185 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 244
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
++E+V++++ EG +L PDN PD L++LM++CW P RPSF I ++
Sbjct: 245 SNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 294
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 437 bits (1125), Expect = e-150
Identities = 118/311 (37%), Positives = 177/311 (56%), Gaps = 7/311 (2%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--E 394
LS P+ + EFPR+ + + LG+G FG+V A+A G+ K + E
Sbjct: 53 LSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKE 112
Query: 395 FTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRG 453
VAVKMLKD+A+E +D E ++ H NI+ LLG C P+ ++ EY +G
Sbjct: 113 AVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 172
Query: 454 DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513
+L ++LR P G S + + Q++ DL++ Q+A GM YL+ +K +HRD
Sbjct: 173 NLREYLRARRPP----GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRD 228
Query: 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDV 573
LA RN L+ + V+KIADFGL+R + DYYK N +PV+WM E++ YT +SDV
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 288
Query: 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMN 633
W+FGV +WEIF+ PY G+ EE+ K +KEG+ + P N + LY +M+ CW+ P
Sbjct: 289 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQ 348
Query: 634 RPSFRTIYQTL 644
RP+F+ + + L
Sbjct: 349 RPTFKQLVEDL 359
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 431 bits (1110), Expect = e-148
Identities = 117/306 (38%), Positives = 177/306 (57%), Gaps = 7/306 (2%)
Query: 342 CNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--EFTLVA 399
+ P+ + EFPR+ + + LG+GAFG+V A+A G+ K + E VA
Sbjct: 12 QDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVA 71
Query: 400 VKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDF 458
VKMLKD+A+E +D E ++ H NI+ LLG C P+ ++ EY +G+L ++
Sbjct: 72 VKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 131
Query: 459 LRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518
LR P G S + + Q++ DL++ Q+A GM YL+ +K +HRDLA RN
Sbjct: 132 LRARRPP----GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 187
Query: 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGV 578
L+ + V+KIADFGL+R + DYYK N +PV+WM E++ YT +SDVW+FGV
Sbjct: 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
Query: 579 CLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
+WEIF+ PY G+ EE+ K +KEG+ + P N + LY +M+ CW+ P RP+F+
Sbjct: 248 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFK 307
Query: 639 TIYQTL 644
+ + L
Sbjct: 308 QLVEDL 313
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 429 bits (1105), Expect = e-147
Identities = 113/313 (36%), Positives = 168/313 (53%), Gaps = 11/313 (3%)
Query: 335 IDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEE 394
+D +LP + + L + EFPR+ + + LG+GAFG+V +A A G+ K
Sbjct: 1 MDPDELPLDEHCER----LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTAT 56
Query: 395 FTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVC-AVGKPMCLLFEYMGR 452
VAVKMLK+ A+ E +L H N+V LLG C G P+ ++ E+
Sbjct: 57 CRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKF 116
Query: 453 GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512
G+L+ +LR + L+ LI + Q+A GM +L+ RK +HR
Sbjct: 117 GNLSTYLRSKRNEF----VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172
Query: 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESD 572
DLA RN L++++ VVKI DFGL+R +Y Y + +P++WM E+I YT++SD
Sbjct: 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232
Query: 573 VWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKP 631
VW+FGV LWEIFS PY G+ EE + +KEG ++APD T +Y M CW+ +P
Sbjct: 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEP 292
Query: 632 MNRPSFRTIYQTL 644
RP+F + + L
Sbjct: 293 SQRPTFSELVEHL 305
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 425 bits (1096), Expect = e-146
Identities = 116/301 (38%), Positives = 167/301 (55%), Gaps = 4/301 (1%)
Query: 346 YHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD 405
Y D P + EFPRN + + + LG GAFG+V +A A GL+K + VAVKMLK
Sbjct: 4 YVYIDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 406 EASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSP 464
A + E +L+ +H NIV LLG C +G P ++ EY GDL +FLR
Sbjct: 64 SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123
Query: 465 NNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524
+ + T ++ L DL++ + Q+A GM +L+ + +HRDLA RN L+
Sbjct: 124 SFICSKTSPAIMED--DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181
Query: 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
+ KI DFGL+R + Y N +PV+WM ESI YT ESDVW++G+ LWE+F
Sbjct: 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
Query: 585 SFALQPYYGL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
S PY G+ + K IKEG + +P++ P +YD+MK CW+ P+ RP+F+ I Q
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 644 L 644
+
Sbjct: 302 I 302
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 426 bits (1098), Expect = e-146
Identities = 110/309 (35%), Positives = 156/309 (50%), Gaps = 5/309 (1%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
+ Y D R + EFPR ++ + + LG GAFG+V A A G+ K VAV
Sbjct: 21 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 80
Query: 401 KMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFL 459
KMLK++A + E ++ + H NIV LLG C + P+ L+FEY GDL ++L
Sbjct: 81 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 140
Query: 460 RICSP---NNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516
R + I + L+ DL+ A Q+A GM +L + VHRDLA
Sbjct: 141 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 200
Query: 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAF 576
RN L+ VVKI DFGL+R + Y N +PV+WM ES+ YT++SDVW++
Sbjct: 201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 577 GVCLWEIFSFALQPYYGL-THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635
G+ LWEIFS + PY G+ K I+ G + P + +Y +M+ CW RP
Sbjct: 261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 320
Query: 636 SFRTIYQTL 644
SF + L
Sbjct: 321 SFPNLTSFL 329
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 424 bits (1093), Expect = e-145
Identities = 106/309 (34%), Positives = 161/309 (52%), Gaps = 16/309 (5%)
Query: 345 SYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK 404
+ + + + E PR +I +R LG GAFG V++ + G+ VAVK L
Sbjct: 51 PNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP 110
Query: 405 DEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSP 464
+ SE + DF EA ++++F+H NIV+ +GV P +L E M GDL FLR P
Sbjct: 111 EVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRP 170
Query: 465 NNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-- 522
L+ DL+ +A IA G YL + F+HRD+A RNCL+
Sbjct: 171 RPSQP-------------SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP 217
Query: 523 -DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLW 581
V KI DFG++R +Y YY+ +PV+WMP E+ + +T ++D W+FGV LW
Sbjct: 218 GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLW 277
Query: 582 EIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
EIFS PY +++EV++++ G + P N P +Y +M CW +P +RP+F I
Sbjct: 278 EIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337
Query: 642 QTLWNIKRD 650
+ + +D
Sbjct: 338 ERIEYCTQD 346
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-144
Identities = 108/311 (34%), Positives = 163/311 (52%), Gaps = 17/311 (5%)
Query: 343 NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM 402
N +Y + + + E PR +I +R LG GAFG V++ + G+ VAVK
Sbjct: 9 NPNY-CFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 67
Query: 403 LKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRIC 462
L + SE + DF EA ++++F+H NIV+ +GV P +L E M GDL FLR
Sbjct: 68 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 463 SPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522
P L+ DL+ +A IA G YL + F+HRD+A RNCL+
Sbjct: 128 RPRPSQP-------------SSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLT 174
Query: 523 ---DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579
V KI DFG++R +Y YY+ +PV+WMP E+ + +T ++D W+FGV
Sbjct: 175 CPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVL 234
Query: 580 LWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639
LWEIFS PY +++EV++++ G + P N P +Y +M CW +P +RP+F
Sbjct: 235 LWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAI 294
Query: 640 IYQTLWNIKRD 650
I + + +D
Sbjct: 295 ILERIEYCTQD 305
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-144
Identities = 121/322 (37%), Positives = 174/322 (54%), Gaps = 8/322 (2%)
Query: 325 YAPAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQA 384
Y P V + + SY D P E+ EFPRN++ + + LG GAFG+V +A
Sbjct: 6 YKQKPKYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEA 65
Query: 385 KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPM 443
A GL K + VAVKMLK A + E +++ H NIV LLG C G P+
Sbjct: 66 TAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPV 125
Query: 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503
++ EY GDL +FLR S + ++ S+ ST DL+ + Q+A GM +
Sbjct: 126 LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST------ASTRDLLHFSSQVAQGMAF 179
Query: 504 LSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL 563
L+ + +HRD+A RN L+ + V KI DFGL+R + Y N +PV+WM ESI
Sbjct: 180 LASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIF 239
Query: 564 YNKYTVESDVWAFGVCLWEIFSFALQPYYG-LTHEEVVKYIKEGNILQAPDNTPDALYDL 622
YTV+SDVW++G+ LWEIFS L PY G L + + K +K+G + P P +Y +
Sbjct: 240 DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSI 299
Query: 623 MKLCWNMKPMNRPSFRTIYQTL 644
M+ CW ++P +RP+F+ I L
Sbjct: 300 MQACWALEPTHRPTFQQICSFL 321
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 421 bits (1084), Expect = e-143
Identities = 121/307 (39%), Positives = 181/307 (58%), Gaps = 8/307 (2%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE--EFTLV 398
++ L P+ + E PR+ ++ + LG+GAFG+V A+A GL K + T V
Sbjct: 46 FQGMLAGVSEYEL-PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV 104
Query: 399 AVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLND 457
AVKMLK +A+E +D E ++ H NI+ LLG C P+ ++ EY +G+L +
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164
Query: 458 FLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517
+L+ P G S S + QLS+ DL++ A Q+A GM YL+ +K +HRDLA R
Sbjct: 165 YLQARRPP----GLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220
Query: 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFG 577
N L+ + V+KIADFGL+R ++ DYYK N +PV+WM E++ YT +SDVW+FG
Sbjct: 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 280
Query: 578 VCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
V LWEIF+ PY G+ EE+ K +KEG+ + P N + LY +M+ CW+ P RP+F
Sbjct: 281 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTF 340
Query: 638 RTIYQTL 644
+ + + L
Sbjct: 341 KQLVEDL 347
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 413 bits (1063), Expect = e-141
Identities = 115/310 (37%), Positives = 163/310 (52%), Gaps = 12/310 (3%)
Query: 346 YHQTDARLNPKLEQL-EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK 404
+H + NP NDI + +G+G FG+V +A+ + K A+K +K
Sbjct: 5 HHHHHGKNNPDPTIYPVLDWNDIKFQDVIGEGNFGQVLKAR---IKKDGLRMDAAIKRMK 61
Query: 405 DEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS 463
+ AS+ DF E +L + HPNI+ LLG C + L EY G+L DFLR
Sbjct: 62 EYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121
Query: 464 PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523
+ ++ LS+ L+ A +A GM YLS ++F+HRDLA RN L+ +
Sbjct: 122 VLETDPAFAIANSTA----STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE 177
Query: 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
V KIADFGLSR Q+ Y +PVRWM +ES+ Y+ YT SDVW++GV LWEI
Sbjct: 178 NYVAKIADFGLSRG---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234
Query: 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
S PY G+T E+ + + +G L+ P N D +YDLM+ CW KP RPSF I +
Sbjct: 235 VSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
Query: 644 LWNIKRDLEN 653
L + + +
Sbjct: 295 LNRMLEERKT 304
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-139
Identities = 106/312 (33%), Positives = 164/312 (52%), Gaps = 22/312 (7%)
Query: 348 QTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE- 406
+ L KLE + RN +I + LG+G FG V + + VAVK +K +
Sbjct: 17 RGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ--EDGTSLKVAVKTMKLDN 74
Query: 407 ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC-----LLFEYMGRGDLNDFLRI 461
+S+ +F EA + +F HPN+++LLGVC ++ +M GDL+ +L
Sbjct: 75 SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY 134
Query: 462 CSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521
+ L+ + IA GM YLS+R F+HRDLA RNC++
Sbjct: 135 SRLET--------------GPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLW 581
D M V +ADFGLS+K+Y DYY+ +PV+W+ +ES+ YT +SDVWAFGV +W
Sbjct: 181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMW 240
Query: 582 EIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
EI + + PY G+ + E+ Y+ G+ L+ P++ D LY++M CW P++RP+F +
Sbjct: 241 EIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLR 300
Query: 642 QTLWNIKRDLEN 653
L + L +
Sbjct: 301 LQLEKLLESLPD 312
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-138
Identities = 118/310 (38%), Positives = 159/310 (51%), Gaps = 23/310 (7%)
Query: 350 DARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-S 408
L KLE + P R LG+G FG V +A+ + F VAVKMLK + +
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ--EDGSFVKVAVKMLKADIIA 65
Query: 409 EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP------MCLLFEYMGRGDLNDFLRIC 462
+F REA + EFDHP++ KL+GV + ++ +M GDL+ FL
Sbjct: 66 SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS 125
Query: 463 SPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522
L L+ + IA GM YLS R F+HRDLA RNC++
Sbjct: 126 RIGE--------------NPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171
Query: 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWE 582
+ M V +ADFGLSRK+Y DYY+ +PV+W+ LES+ N YTV SDVWAFGV +WE
Sbjct: 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWE 231
Query: 583 IFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I + PY G+ + E+ Y+ GN L+ P + +YDLM CW+ P RPSF +
Sbjct: 232 IMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291
Query: 643 TLWNIKRDLE 652
L NI L
Sbjct: 292 ELENILGHLS 301
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-128
Identities = 103/316 (32%), Positives = 157/316 (49%), Gaps = 30/316 (9%)
Query: 347 HQTDARLNPKLEQ------LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
H + LNP+L Q + + + +G+G FG V+ + AV
Sbjct: 1 HIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKK--IHCAV 58
Query: 401 KMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK-PMCLLFEYMGRGDLNDFL 459
K L + F E ++ +F HPN++ LLG+C + ++ YM GDL +F+
Sbjct: 59 KSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118
Query: 460 RICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519
R + + DLI LQ+A GM YL+ +KFVHRDLA RNC
Sbjct: 119 R-------------------NETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNC 159
Query: 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDA--IPVRWMPLESILYNKYTVESDVWAFG 577
+++++ VK+ADFGL+R MY ++YY +PV+WM LES+ K+T +SDVW+FG
Sbjct: 160 MLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFG 219
Query: 578 VCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
V LWE+ + PY + ++ Y+ +G L P+ PD LY++M CW+ K RPSF
Sbjct: 220 VLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF 279
Query: 638 RTIYQTLWNIKRDLEN 653
+ + I
Sbjct: 280 SELVSRISAIFSTFIG 295
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-125
Identities = 100/337 (29%), Positives = 161/337 (47%), Gaps = 30/337 (8%)
Query: 326 APAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQ------LEFPRNDIIYVRDLGQGAFG 379
+ + + + + H + LNP+L Q + + + +G+G FG
Sbjct: 44 STSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFG 103
Query: 380 RVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439
V+ + AVK L + F E ++ +F HPN++ LLG+C
Sbjct: 104 CVYHGTLLDNDGKK--IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 161
Query: 440 GK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIA 498
+ ++ YM GDL +F+R + + DLI LQ+A
Sbjct: 162 SEGSPLVVLPYMKHGDLRNFIR-------------------NETHNPTVKDLIGFGLQVA 202
Query: 499 SGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY--YKGDENDAIPVRW 556
GM +L+ +KFVHRDLA RNC+++++ VK+ADFGL+R MY +++ +PV+W
Sbjct: 203 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262
Query: 557 MPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTP 616
M LES+ K+T +SDVW+FGV LWE+ + PY + ++ Y+ +G L P+ P
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCP 322
Query: 617 DALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
D LY++M CW+ K RPSF + + I
Sbjct: 323 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-124
Identities = 92/312 (29%), Positives = 150/312 (48%), Gaps = 37/312 (11%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
+++ F + + +RDLG+G FG+V + + VAVK LK E+ D
Sbjct: 11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTG-EQVAVKSLKPESGGNHIAD 69
Query: 415 FEREACLLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472
++E +L H NIVK G+C G + L+ E++ G L ++L
Sbjct: 70 LKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-------- 121
Query: 473 SSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532
+++ + A+QI GM YL R++VHRDLA RN L+ + VKI DF
Sbjct: 122 -----------KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDF 170
Query: 533 GLSRKMYL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF----- 586
GL++ + ++YY ++ PV W E ++ +K+ + SDVW+FGV L E+ ++
Sbjct: 171 GLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230
Query: 587 ---------ALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
+ +T +V +KEG L P N PD +Y LM+ CW +P NR SF
Sbjct: 231 SPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSF 290
Query: 638 RTIYQTLWNIKR 649
+ + + + +
Sbjct: 291 QNLIEGFEALLK 302
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 367 bits (944), Expect = e-123
Identities = 96/309 (31%), Positives = 157/309 (50%), Gaps = 26/309 (8%)
Query: 350 DARLNPKLEQLEFP--RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA 407
D+ L +++ + P R R +G+G FG V+ + ++ A+K L
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNR--IQCAIKSLSRIT 61
Query: 408 SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL-FEYMGRGDLNDFLRICSPNN 466
F RE L+ +HPN++ L+G+ + + + YM GDL F+R
Sbjct: 62 EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR------ 115
Query: 467 YINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526
+ DLI+ LQ+A GM YL+++KFVHRDLA RNC++++
Sbjct: 116 -------------SPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT 162
Query: 527 VKIADFGLSRKMYLQDYYKGDENDA--IPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
VK+ADFGL+R + ++YY ++ +PV+W LES+ ++T +SDVW+FGV LWE+
Sbjct: 163 VKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
Query: 585 SFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ PY + ++ ++ +G L P+ PD+LY +M+ CW P RP+FR + +
Sbjct: 223 TRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEV 282
Query: 645 WNIKRDLEN 653
I L
Sbjct: 283 EQIVSALLG 291
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 364 bits (935), Expect = e-122
Identities = 98/328 (29%), Positives = 155/328 (47%), Gaps = 39/328 (11%)
Query: 343 NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM 402
N + + +F + +++ LG+G FG V + L + +VAVK
Sbjct: 19 NLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKK 77
Query: 403 LKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLR 460
L+ E+L+ DFERE +L H NIVK GVC A + + L+ EY+ G L D+L+
Sbjct: 78 LQHSTEEHLR-DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ 136
Query: 461 ICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520
++ L+ QI GM YL ++++HRDLATRN L
Sbjct: 137 -------------------KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNIL 177
Query: 521 INDQMVVKIADFGLSRKMYL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579
+ ++ VKI DFGL++ + ++YYK E P+ W ES+ +K++V SDVW+FGV
Sbjct: 178 VENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVV 237
Query: 580 LWEIFSFA---------------LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMK 624
L+E+F++ + +++ +K L PD PD +Y +M
Sbjct: 238 LYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMT 297
Query: 625 LCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
CWN RPSFR + + I+ +
Sbjct: 298 ECWNNNVNQRPSFRDLALRVDQIRDQMA 325
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 359 bits (924), Expect = e-121
Identities = 102/302 (33%), Positives = 149/302 (49%), Gaps = 23/302 (7%)
Query: 351 ARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY 410
+ E R I R +G+G FG V Q + VA+K K+ S+
Sbjct: 1 GAMGSSTRDYEIQRERIELGRCIGEGQFGDVHQGIY--MSPENPALAVAIKTCKNCTSDS 58
Query: 411 LQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYING 470
++ F +EA + +FDHP+IVKL+GV P+ ++ E G+L FL+
Sbjct: 59 VREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---------- 107
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530
R L LI A Q+++ + YL ++FVHRD+A RN L++ VK+
Sbjct: 108 ---------VRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 158
Query: 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
DFGLSR M YYK +P++WM ESI + ++T SDVW FGVC+WEI ++P
Sbjct: 159 DFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ G+ + +V+ I+ G L P N P LY LM CW P RP F + L I +
Sbjct: 218 FQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277
Query: 651 LE 652
+
Sbjct: 278 EK 279
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 360 bits (927), Expect = e-120
Identities = 103/319 (32%), Positives = 155/319 (48%), Gaps = 26/319 (8%)
Query: 339 KLPCNASYHQTDARLNPKLEQL----EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEE 394
KLP Y + P E + I + +G G G V + + +
Sbjct: 19 KLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRL--RVPGQR 76
Query: 395 FTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGD 454
VA+K LK +E + DF EA ++ +FDHPNI++L GV G+ ++ EYM G
Sbjct: 77 DVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGS 136
Query: 455 LNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514
L+ FLR Q + L+ + + +GM YLSD +VHRDL
Sbjct: 137 LDTFLR-------------------THDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDL 177
Query: 515 ATRNCLINDQMVVKIADFGLSRKMYL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDV 573
A RN L++ +V K++DFGLSR + D IP+RW E+I + ++ SDV
Sbjct: 178 AARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDV 237
Query: 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMN 633
W+FGV +WE+ ++ +PY+ +T+ +V+ ++EG L AP P AL+ LM CW+
Sbjct: 238 WSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQ 297
Query: 634 RPSFRTIYQTLWNIKRDLE 652
RP F I L + R E
Sbjct: 298 RPRFSQIVSVLDALIRSPE 316
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 356 bits (917), Expect = e-119
Identities = 95/310 (30%), Positives = 153/310 (49%), Gaps = 39/310 (12%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
+F + +++ LG+G FG V + L + +VAVK L+ E+L+ DFERE
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTG-EVVAVKKLQHSTEEHLR-DFEREIE 63
Query: 421 LLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
+L H NIVK GVC A + + L+ EY+ G L D+L+
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ------------------ 105
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
++ L+ QI GM YL ++++HRDLATRN L+ ++ VKI DFGL++ +
Sbjct: 106 -KHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164
Query: 539 YL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA---------- 587
++++K E P+ W ES+ +K++V SDVW+FGV L+E+F++
Sbjct: 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF 224
Query: 588 -----LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ +++ +K L PD PD +Y +M CWN RPSFR +
Sbjct: 225 MRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284
Query: 643 TLWNIKRDLE 652
+ I+ ++
Sbjct: 285 RVDQIRDNMA 294
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-119
Identities = 105/299 (35%), Positives = 163/299 (54%), Gaps = 26/299 (8%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P ++ E R DI LG G +G V++ VAVK LK++ E +
Sbjct: 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAVKTLKEDTME--VEE 55
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
F +EA ++ E HPN+V+LLGVC P ++ E+M G+L D+LR
Sbjct: 56 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE------------- 102
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
++S L+ +A QI+S M YL + F+HRDLA RNCL+ + +VK+ADFGL
Sbjct: 103 -----CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
SR + D Y P++W ES+ YNK++++SDVWAFGV LWEI ++ + PY G+
Sbjct: 158 SR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+V + +++ ++ P+ P+ +Y+LM+ CW P +RPSF I+Q + ++
Sbjct: 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI 275
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 355 bits (914), Expect = e-119
Identities = 70/295 (23%), Positives = 132/295 (44%), Gaps = 39/295 (13%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE 418
+ D+I+ LGQG F ++F+ + G T V +K+L Y + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSE-SFFEA 62
Query: 419 ACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
A ++++ H ++V GVC G L+ E++ G L+ +L+
Sbjct: 63 ASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK------------------ 104
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN--------DQMVVKIA 530
++ + +A Q+A+ M +L + +H ++ +N L+ + +K++
Sbjct: 105 -KNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLS 163
Query: 531 DFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQ 589
D G+S + +D + + W+P E I K + +D W+FG LWEI S +
Sbjct: 164 DPGISITVLPKDILQ------ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
Query: 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P L + +++ ++ + L AP L +L+ C + +P +RPSFR I + L
Sbjct: 218 PLSALDSQRKLQFYEDRHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDL 270
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 356 bits (915), Expect = e-119
Identities = 103/325 (31%), Positives = 152/325 (46%), Gaps = 38/325 (11%)
Query: 346 YHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD 405
+H A+L + F + Y+ LG+G FG V + L + LVAVK L+
Sbjct: 4 HHHHHAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTG-ALVAVKQLQH 62
Query: 406 EASEYLQTDFEREACLLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICS 463
+ Q DF+RE +L IVK GV + + L+ EY+ G L DFL+
Sbjct: 63 SGPD-QQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR-- 119
Query: 464 PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523
HR +L L+ + QI GM YL R+ VHRDLA RN L+
Sbjct: 120 ----------------HR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVES 162
Query: 524 QMVVKIADFGLSRKMYL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWE 582
+ VKIADFGL++ + L +DYY E P+ W ES+ N ++ +SDVW+FGV L+E
Sbjct: 163 EAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYE 222
Query: 583 IFSFALQPYY--------------GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWN 628
+F++ + +++ ++EG L AP P +++LMKLCW
Sbjct: 223 LFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWA 282
Query: 629 MKPMNRPSFRTIYQTLWNIKRDLEN 653
P +RPSF + L +
Sbjct: 283 PSPQDRPSFSALGPQLDMLWSGSRG 307
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 357 bits (917), Expect = e-118
Identities = 108/291 (37%), Positives = 153/291 (52%), Gaps = 22/291 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E +I + +G G FG V + K E VA+K LK +E + DF EA
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKE--ISVAIKTLKVGYTEKQRRDFLGEAS 98
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +FDHPNI++L GV KP+ ++ EYM G L+ FLR
Sbjct: 99 IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-------------------K 139
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY- 539
Q + L+ + IASGM YLSD +VHRDLA RN LIN +V K++DFGL R +
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED 199
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ IP+RW E+I Y K+T SDVW++G+ LWE+ S+ +PY+ +++++V
Sbjct: 200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+K + EG L P + P ALY LM CW NRP F I L + R+
Sbjct: 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-118
Identities = 104/317 (32%), Positives = 166/317 (52%), Gaps = 35/317 (11%)
Query: 345 SYHQTDA-----RLNPKLEQL------EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHE 393
+ + + L + D++ +G+G FG VF G L+ +
Sbjct: 83 DHLLSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFS----GRLRAD 138
Query: 394 EFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRG 453
TLVAVK ++ L+ F +EA +L ++ HPNIV+L+GVC +P+ ++ E + G
Sbjct: 139 N-TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 454 DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513
D FLR +L L+ + A+GM YL + +HRD
Sbjct: 198 DFLTFLR-------------------TEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRD 238
Query: 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDV 573
LA RNCL+ ++ V+KI+DFG+SR+ Y +PV+W E++ Y +Y+ ESDV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMN 633
W+FG+ LWE FS PY L++++ +++++G L P+ PDA++ LM+ CW +P
Sbjct: 299 WSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQ 358
Query: 634 RPSFRTIYQTLWNIKRD 650
RPSF TIYQ L +I++
Sbjct: 359 RPSFSTIYQELQSIRKR 375
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 354 bits (910), Expect = e-118
Identities = 87/310 (28%), Positives = 138/310 (44%), Gaps = 39/310 (12%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
F + + +RDLG+G FG+V +VAVK LK +A ++ +++E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTG-EMVAVKALKADAGPQHRSGWKQEID 85
Query: 421 LLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
+L H +I+K G C A + L+ EY+ G L D+L
Sbjct: 86 ILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP------------------ 127
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
+ L+ A QI GM YL + ++HRDLA RN L+++ +VKI DFGL++ +
Sbjct: 128 ---RHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
Query: 539 YL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-------- 589
+YY+ E+ PV W E + K+ SDVW+FGV L+E+ +
Sbjct: 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF 244
Query: 590 ------PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643
+T + + ++ G L PD P +Y LMK CW + RP+F +
Sbjct: 245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPI 304
Query: 644 LWNIKRDLEN 653
L + +
Sbjct: 305 LKTVHEKYQG 314
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-118
Identities = 98/293 (33%), Positives = 149/293 (50%), Gaps = 23/293 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
R D++ R LG+G FG V++ E VAVK K + + + F EA
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTN--HKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ DHP+IVKL+G+ +P ++ E G+L +L
Sbjct: 66 IMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLE-------------------R 105
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L L+ +LQI M YL VHRD+A RN L+ VK+ DFGLSR +
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+DYYK +P++WM ESI + ++T SDVW F VC+WEI SF QP++ L +++V+
Sbjct: 166 EDYYKA-SVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+++G+ L PD P LY LM CW+ P +RP F + +L ++ + ++
Sbjct: 225 GVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEKD 277
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 351 bits (903), Expect = e-118
Identities = 90/289 (31%), Positives = 148/289 (51%), Gaps = 28/289 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
+++ +V+++G G FG V G ++ VA+K +++ A + DF EA
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHL----GYWLNK--DKVAIKTIREGAMS--EEDFIEEAE 55
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + HP +V+L GVC P+CL+ E+M G L+D+LR
Sbjct: 56 VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-------------------T 96
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ + L+ + L + GM YL + +HRDLA RNCL+ + V+K++DFG++R +
Sbjct: 97 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL- 155
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
D Y PV+W E +++Y+ +SDVW+FGV +WE+FS PY ++ EVV
Sbjct: 156 DDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649
+ I G L P +Y +M CW +P +RP+F + + L I
Sbjct: 216 EDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 351 bits (903), Expect = e-117
Identities = 98/310 (31%), Positives = 158/310 (50%), Gaps = 30/310 (9%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
P + + A L E D+ ++++LG G FG V G + + VA+
Sbjct: 2 PLGSKNAPSTAGLGY--GSWEIDPKDLTFLKELGTGQFGVVKY----GKWRGQ--YDVAI 53
Query: 401 KMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLR 460
KM+K+ + + +F EA ++ H +V+L GVC +P+ ++ EYM G L ++LR
Sbjct: 54 KMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR 111
Query: 461 ICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520
+ T L+ + + M YL ++F+HRDLA RNCL
Sbjct: 112 -------------------EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 152
Query: 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCL 580
+NDQ VVK++DFGLSR + D Y PVRW P E ++Y+K++ +SD+WAFGV +
Sbjct: 153 VNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLM 211
Query: 581 WEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
WEI+S PY T+ E ++I +G L P + +Y +M CW+ K RP+F+ +
Sbjct: 212 WEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKIL 271
Query: 641 YQTLWNIKRD 650
+ ++ +
Sbjct: 272 LSNILDVMDE 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 352 bits (906), Expect = e-117
Identities = 92/299 (30%), Positives = 151/299 (50%), Gaps = 22/299 (7%)
Query: 355 PKLEQLEF-PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT 413
P L + ++ LG GAFG V++ + + VA+K L++ S
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANK 62
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+ EA ++A D+P++ +LLG+C + + L+ + M G L D++R
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR------------- 108
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ + L+ +QIA GM YL DR+ VHRDLA RN L+ VKI DFG
Sbjct: 109 ------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
L++ + ++ E +P++WM LESIL+ YT +SDVW++GV +WE+ +F +PY G
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
Query: 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ E+ +++G L P +Y +M+ CW + +RP FR + + RD +
Sbjct: 223 IPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 362 bits (930), Expect = e-116
Identities = 103/296 (34%), Positives = 148/296 (50%), Gaps = 23/296 (7%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P E R I R +G+G FG V Q + VA+K K+ S+ ++
Sbjct: 380 PSTRDYEIQRERIELGRCIGEGQFGDVHQGIY--MSPENPAMAVAIKTCKNCTSDSVREK 437
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
F +EA + +FDHP+IVKL+GV P+ ++ E G+L FL+
Sbjct: 438 FLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ-------------- 482
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
R L LI A Q+++ + YL ++FVHRD+A RN L++ VK+ DFGL
Sbjct: 483 -----VRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 537
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
SR M YYK +P++WM ESI + ++T SDVW FGVC+WEI ++P+ G+
Sbjct: 538 SRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ +V+ I+ G L P N P LY LM CW P RP F + L I +
Sbjct: 597 KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 345 bits (887), Expect = e-115
Identities = 92/293 (31%), Positives = 149/293 (50%), Gaps = 28/293 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R +I +++LG G FG V G K + VAVKM+K+ + + +F +EA
Sbjct: 4 ELKREEITLLKELGSGQFGVVKL----GKWKGQ--YDVAVKMIKEGSMS--EDEFFQEAQ 55
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+ + HP +VK GVC+ P+ ++ EY+ G L ++LR
Sbjct: 56 TMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-------------------S 96
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L L+ + + GM +L +F+HRDLA RNCL++ + VK++DFG++R +
Sbjct: 97 HGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
Y PV+W E Y KY+ +SDVWAFG+ +WE+FS PY T+ EVV
Sbjct: 157 DQYVS-SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ +G+ L P D +Y +M CW+ P RP+F+ + ++ ++ ++
Sbjct: 216 LKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDKH 268
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 347 bits (891), Expect = e-115
Identities = 101/291 (34%), Positives = 153/291 (52%), Gaps = 21/291 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E + + + +G G FG V++ +E VA+K LK +E + DF EA
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKE-VPVAIKTLKAGYTEKQRVDFLGEAG 98
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +F H NI++L GV + KPM ++ EYM G L+ FLR
Sbjct: 99 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-------------------E 139
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY- 539
+ + S L+ + IA+GM YL++ +VHRDLA RN L+N +V K++DFGLSR +
Sbjct: 140 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ IP+RW E+I Y K+T SDVW+FG+ +WE+ ++ +PY+ L++ EV
Sbjct: 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+K I +G L P + P A+Y LM CW + RP F I L + R
Sbjct: 260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 343 bits (881), Expect = e-114
Identities = 98/299 (32%), Positives = 155/299 (51%), Gaps = 27/299 (9%)
Query: 358 EQLEFPRNDI-IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDF 415
+++ R + + ++LG G FG V + + VAVK+LK+EA++ L+ +
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALKDEL 65
Query: 416 EREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
EA ++ + D+P IV+++G+C + L+ E G LN +L+
Sbjct: 66 LAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR------------ 112
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
+ ++I + Q++ GM YL + FVHRDLA RN L+ Q KI+DFGLS
Sbjct: 113 --------HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164
Query: 536 RKMYL-QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
+ + ++YYK + PV+W E I Y K++ +SDVW+FGV +WE FS+ +PY G+
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
EV +++G + P P +YDLM LCW NRP F + L N D+ N
Sbjct: 225 KGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 283
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-113
Identities = 92/298 (30%), Positives = 152/298 (51%), Gaps = 25/298 (8%)
Query: 358 EQLEFPRNDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE 416
++L R++++ +LG G FG V Q ++ VA+K+LK + +
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGV---YRMRKKQIDVAIKVLKQGTEKADTEEMM 58
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
REA ++ + D+P IV+L+GVC + + L+ E G G L+ FL
Sbjct: 59 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV---------------- 101
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ ++ ++ + Q++ GM YL ++ FVHRDLA RN L+ ++ KI+DFGLS+
Sbjct: 102 ---GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 158
Query: 537 KMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+ D YY P++W E I + K++ SDVW++GV +WE S+ +PY +
Sbjct: 159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
Query: 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
EV+ +I++G ++ P P LY LM CW K +RP F T+ Q + L +
Sbjct: 219 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 340 bits (875), Expect = e-113
Identities = 85/292 (29%), Positives = 137/292 (46%), Gaps = 21/292 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
F ++ ++ LG G FG V + + + V +K+++D++
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIK-IPVCIKVIEDKSGRQSFQAVTDHML 67
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+ DH +IV+LLG+C G + L+ +Y+ G L D +R
Sbjct: 68 AIGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVR-------------------Q 107
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L L+ +QIA GM YL + VHR+LA RN L+ V++ADFG++ +
Sbjct: 108 HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
D P++WM LESI + KYT +SDVW++GV +WE+ +F +PY GL EV
Sbjct: 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+++G L P +Y +M CW + RP+F+ + + RD
Sbjct: 228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPP 279
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 339 bits (872), Expect = e-112
Identities = 92/299 (30%), Positives = 150/299 (50%), Gaps = 22/299 (7%)
Query: 355 PKLEQLEF-PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT 413
P L + ++ LG GAFG V++ + + VA+K L++ S
Sbjct: 4 PNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVK-IPVAIKELREATSPKANK 62
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+ EA ++A D+P++ +LLG+C + + L+ + M G L D++R
Sbjct: 63 EILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVR------------- 108
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ + L+ +QIA GM YL DR+ VHRDLA RN L+ VKI DFG
Sbjct: 109 ------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
L++ + ++ E +P++WM LESIL+ YT +SDVW++GV +WE+ +F +PY G
Sbjct: 163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 222
Query: 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ E+ +++G L P +Y +M CW + +RP FR + + RD +
Sbjct: 223 IPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 281
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 337 bits (866), Expect = e-112
Identities = 92/291 (31%), Positives = 150/291 (51%), Gaps = 34/291 (11%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
++ ++ +G+G FG V G VAVK +K++A+ F EA
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDATA---QAFLAEAS 66
Query: 421 LLAEFDHPNIVKLLGVCAVGKP-MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ + H N+V+LLGV K + ++ EYM +G L D+LR +
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-------------- 112
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
L L+ +L + M YL FVHRDLA RN L+++ V K++DFGL++
Sbjct: 113 ----VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--- 165
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ + +PV+W E++ K++ +SDVW+FG+ LWEI+SF PY + ++V
Sbjct: 166 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 223
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
V +++G + APD P A+Y++MK CW++ RPSF + + L +IK
Sbjct: 224 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-109
Identities = 100/293 (34%), Positives = 150/293 (51%), Gaps = 28/293 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + V LG G FG V+ G K VAVK LK + F EA
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTK------VAVKSLKQGSMS--PDAFLAEAN 60
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L+ + H +V+L V +P+ ++ EYM G L DFL+
Sbjct: 61 LMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKT------------------P 101
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+L+ L+ +A QIA GM ++ +R ++HRDL N L++D + KIADFGL+R +
Sbjct: 102 SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+Y E P++W E+I Y +T++SDVW+FG+ L EI + PY G+T+ EV+
Sbjct: 162 NEYTA-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ ++ G + PDN P+ LY LM+LCW +P +RP+F + L + E
Sbjct: 221 QNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-109
Identities = 106/313 (33%), Positives = 167/313 (53%), Gaps = 26/313 (8%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
P T ++P ++ E R DI LG G +G V++ VAV
Sbjct: 196 PAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKK-----YSLTVAV 250
Query: 401 KMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLR 460
K LK++ E +F +EA ++ E HPN+V+LLGVC P ++ E+M G+L D+LR
Sbjct: 251 KTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR 308
Query: 461 ICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520
++S L+ +A QI+S M YL + F+HR+LA RNCL
Sbjct: 309 E------------------CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350
Query: 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCL 580
+ + +VK+ADFGLSR + D Y P++W ES+ YNK++++SDVWAFGV L
Sbjct: 351 VGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409
Query: 581 WEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
WEI ++ + PY G+ +V + +++ ++ P+ P+ +Y+LM+ CW P +RPSF I
Sbjct: 410 WEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 469
Query: 641 YQTLWNIKRDLEN 653
+Q + ++
Sbjct: 470 HQAFETMFQESSI 482
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 333 bits (855), Expect = e-109
Identities = 113/354 (31%), Positives = 171/354 (48%), Gaps = 53/354 (14%)
Query: 340 LPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVA 399
LP + + L + EFPR+ + + LG+GAFG+V +A A G+ K VA
Sbjct: 1 LPLDEHCER----LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVA 56
Query: 400 VKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVC-AVGKPMCLLFEYMGRGDLND 457
VKMLK+ A+ E +L H N+V LLG C G P+ ++ E+ G+L+
Sbjct: 57 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 116
Query: 458 FLR---------------ICSPNNYINGTYSSMESSIHRVPQ------------------ 484
+LR +Y+ ++ + +
Sbjct: 117 YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176
Query: 485 -------------LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531
L+ LI + Q+A GM +L+ RK +HRDLA RN L++++ VVKI D
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICD 236
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
FGL+R +Y Y + +P++WM E+I YT++SDVW+FGV LWEIFS PY
Sbjct: 237 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 296
Query: 592 YGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
G+ EE + +KEG ++APD T +Y M CW+ +P RP+F + + L
Sbjct: 297 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 325 bits (836), Expect = e-107
Identities = 94/290 (32%), Positives = 138/290 (47%), Gaps = 30/290 (10%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEA--SEYLQTDFE 416
D+ + LG G+FG V + G + VAVK LK + DF
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRR----GEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
RE + DH N+++L GV + PM ++ E G L D LR
Sbjct: 70 REVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLR---------------- 112
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
L A+Q+A GM YL ++F+HRDLA RN L+ + +VKI DFGL R
Sbjct: 113 ---KHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169
Query: 537 KMYLQ-DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+ D+Y E+ +P W ES+ ++ SD W FGV LWE+F++ +P+ GL
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
Query: 596 HEEVVKYI-KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+++ I KEG L P++ P +Y++M CW KP +RP+F + L
Sbjct: 230 GSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-107
Identities = 92/311 (29%), Positives = 152/311 (48%), Gaps = 35/311 (11%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
P + ++ ++ +G+G FG V G VAV
Sbjct: 170 PKVMEGTVAAQDEFYR-SGWALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAV 221
Query: 401 KMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP-MCLLFEYMGRGDLNDFL 459
K +K++A+ F EA ++ + H N+V+LLGV K + ++ EYM +G L D+L
Sbjct: 222 KCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL 278
Query: 460 RICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519
R + L L+ +L + M YL FVHRDLA RN
Sbjct: 279 RSRGRS------------------VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNV 320
Query: 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579
L+++ V K++DFGL++ + + +PV+W E++ K++ +SDVW+FG+
Sbjct: 321 LVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 375
Query: 580 LWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639
LWEI+SF PY + ++VV +++G + APD P A+YD+MK CW++ RP+F
Sbjct: 376 LWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQ 435
Query: 640 IYQTLWNIKRD 650
+ + L +I+
Sbjct: 436 LREQLEHIRTH 446
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 333 bits (854), Expect = e-106
Identities = 93/302 (30%), Positives = 155/302 (51%), Gaps = 27/302 (8%)
Query: 355 PKLEQLEFPRNDIIYVRD-LGQGAFGRVFQAKAPGLLKHEEFTL-VAVKMLKDEASEYLQ 412
K ++L R++++ LG G FG V Q G+ + + + VA+K+LK +
Sbjct: 325 LKDKKLFLKRDNLLIADIELGCGNFGSVRQ----GVYRMRKKQIDVAIKVLKQGTEKADT 380
Query: 413 TDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472
+ REA ++ + D+P IV+L+GVC + + L+ E G G L+ FL
Sbjct: 381 EEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLV------------ 427
Query: 473 SSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADF 532
+ ++ ++ + Q++ GM YL ++ FVHR+LA RN L+ ++ KI+DF
Sbjct: 428 -------GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDF 480
Query: 533 GLSRKMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
GLS+ + D YY P++W E I + K++ SDVW++GV +WE S+ +PY
Sbjct: 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
+ EV+ +I++G ++ P P LY LM CW K +RP F T+ Q + L
Sbjct: 541 KKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600
Query: 652 EN 653
+
Sbjct: 601 AS 602
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 321 bits (824), Expect = e-103
Identities = 92/293 (31%), Positives = 146/293 (49%), Gaps = 28/293 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + + LG G FG V+ A T VAVK +K + F EA
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNK------HTKVAVKTMKPGSMS--VEAFLAEAN 235
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ H +VKL V +P+ ++ E+M +G L DFL+
Sbjct: 236 VMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKS------------------D 276
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ LI + QIA GM ++ R ++HRDL N L++ +V KIADFGL+R +
Sbjct: 277 EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+Y E P++W E+I + +T++SDVW+FG+ L EI ++ PY G+++ EV+
Sbjct: 337 NEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ ++ G + P+N P+ LY++M CW +P RP+F I L + E+
Sbjct: 396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES 448
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 318 bits (817), Expect = e-102
Identities = 97/313 (30%), Positives = 149/313 (47%), Gaps = 31/313 (9%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
C S QT + E PR + LGQG FG V+ G T VA+
Sbjct: 163 VCPTSKPQTQG---LAKDAWEIPRESLRLEVKLGQGCFGEVWM----GTWNGT--TRVAI 213
Query: 401 KMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLR 460
K LK F +EA ++ + H +V+L V +P+ ++ EYM +G L DFL+
Sbjct: 214 KTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLK 270
Query: 461 ICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520
L L+ +A QIASGM Y+ +VHRDL N L
Sbjct: 271 G------------------ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANIL 312
Query: 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCL 580
+ + +V K+ADFGL+R + +Y + P++W E+ LY ++T++SDVW+FG+ L
Sbjct: 313 VGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371
Query: 581 WEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
E+ + PY G+ + EV+ ++ G + P P++L+DLM CW +P RP+F +
Sbjct: 372 TELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYL 431
Query: 641 YQTLWNIKRDLEN 653
L + E
Sbjct: 432 QAFLEDYFTSTEP 444
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-102
Identities = 92/293 (31%), Positives = 144/293 (49%), Gaps = 28/293 (9%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E PR + LGQG FG V+ G + VA+K LK F +EA
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTR------VAIKTLKPGTMS--PEAFLQEAQ 314
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ + H +V+L V +P+ ++ EYM +G L DFL+
Sbjct: 315 VMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG------------------E 355
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L L+ +A QIASGM Y+ +VHRDL N L+ + +V K+ADFGL+R +
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+Y + P++W E+ LY ++T++SDVW+FG+ L E+ + PY G+ + EV+
Sbjct: 416 NEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
++ G + P P++L+DLM CW +P RP+F + L + E
Sbjct: 475 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 1e-84
Identities = 72/306 (23%), Positives = 119/306 (38%), Gaps = 40/306 (13%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
F +D+I+ LG+G FG+ + + ++ +K L E Q F +E
Sbjct: 6 IFRPSDLIHGEVLGKGCFGQAIK----VTHRETG-EVMVMKELIRFDEE-TQRTFLKEVK 59
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +HPN++K +GV K + + EY+ G L ++
Sbjct: 60 VMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIK-------------------S 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
Q ++ A IASGM YL +HRDL + NCL+ + V +ADFGL+R M
Sbjct: 101 MDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160
Query: 541 QDYYKGDENDAIPV------------RWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588
+ WM E I Y + DV++FG+ L EI +
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR-V 219
Query: 589 QPYYGLT--HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646
+ ++ P N P + + + C ++ P RPSF + L
Sbjct: 220 NADPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLET 279
Query: 647 IKRDLE 652
++ L
Sbjct: 280 LRMHLA 285
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 9e-79
Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 38/302 (12%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFE 416
+ E P I + +G G+FG V++ G + VAVKML + F+
Sbjct: 17 DDWEIPDGQITVGQRIGSGSFGTVYK----GKWHGD----VAVKMLNVTAPTPQQLQAFK 68
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
E +L + H NI+ +G + ++ ++ L L
Sbjct: 69 NEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLH---------------- 111
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ LI IA Q A GM YL + +HRDL + N +++ VKI DFGL+
Sbjct: 112 ---ASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLAT 168
Query: 537 KMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYG 593
+ E + + WM E I N Y+ +SDV+AFG+ L+E+ + PY
Sbjct: 169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT-GQLPYSN 227
Query: 594 LTH-EEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648
+ + +++++ + G+ + + N P + LM C K RPSF I + +
Sbjct: 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
Query: 649 RD 650
R+
Sbjct: 288 RE 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 1e-75
Identities = 90/303 (29%), Positives = 131/303 (43%), Gaps = 48/303 (15%)
Query: 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ---TDFE 416
LE ++ +G G FG+V++A G VAVK + + E + +
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIG-------DEVAVKAARHDPDEDISQTIENVR 54
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
+EA L A HPNI+ L GVC +CL+ E+ G LN L
Sbjct: 55 QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----------------- 97
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRK---FVHRDLATRNCLIN--------DQM 525
++ L+ A+QIA GM YL D +HRDL + N LI
Sbjct: 98 ----SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNK 153
Query: 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
++KI DFGL+R+ + + A WM E I + ++ SDVW++GV LWE+ +
Sbjct: 154 ILKITDFGLAREWH-RTTKMS---AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLT 209
Query: 586 FALQPYYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P+ G+ V + + L P P+ LM+ CWN P +RPSF I L
Sbjct: 210 -GEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268
Query: 645 WNI 647
I
Sbjct: 269 TTI 271
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 239 bits (613), Expect = 3e-74
Identities = 82/298 (27%), Positives = 133/298 (44%), Gaps = 31/298 (10%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFE 416
+ ++ P D+ +G G+FG V +A+ G + VAVK+L ++ +F
Sbjct: 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-------SDVAVKILMEQDFHAERVNEFL 82
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
RE ++ HPNIV +G + ++ EY+ RG L L
Sbjct: 83 REVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGARE---------- 132
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYL--SDRKFVHRDLATRNCLINDQMVVKIADFGL 534
QL +++A +A GM YL + VHR+L + N L++ + VK+ DFGL
Sbjct: 133 -------QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL 185
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
SR + ++ A WM E + +SDV++FGV LWE+ + QP+ L
Sbjct: 186 SRLK--ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNL 242
Query: 595 THEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
+VV + L+ P N + +++ CW +P RPSF TI L + +
Sbjct: 243 NPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 7e-71
Identities = 59/309 (19%), Positives = 111/309 (35%), Gaps = 43/309 (13%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQT 413
L++ + P + +G+G FG+V+ G E VA++++ + +E
Sbjct: 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYH----GRWHGE----VAIRLIDIERDNEDQLK 74
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
F+RE + H N+V +G C + ++ L +R
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR------------- 121
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
L IA +I GM YL + +H+DL ++N D V I DFG
Sbjct: 122 ------DAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFG 174
Query: 534 LSRKMYLQDYYKGDENDAIPV---RWM---------PLESILYNKYTVESDVWAFGVCLW 581
L + + ++ I + P ++ SDV+A G +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 582 EIFSFALQPYYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
E+ + P+ E ++ + G + + D++ CW + RP+F +
Sbjct: 235 ELHA-REWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKL 293
Query: 641 YQTLWNIKR 649
L + +
Sbjct: 294 MDMLEKLPK 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-68
Identities = 76/299 (25%), Positives = 123/299 (41%), Gaps = 41/299 (13%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
+I +G+GAFG V +AK VA+K ++ E+ F E
Sbjct: 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRA-------KDVAIKQIESESER---KAFIVELR 53
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L+ +HPNIVKL G C P+CL+ EY G L + L
Sbjct: 54 QLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLH-----------------GAE 94
Query: 481 RVPQLSTCDLITIALQIASGMVYL---SDRKFVHRDLATRNCLINDQM-VVKIADFGLSR 536
+P + ++ LQ + G+ YL + +HRDL N L+ V+KI DFG +
Sbjct: 95 PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC 154
Query: 537 KMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+ N+ WM E + Y+ + DV+++G+ LWE+ + +P+ +
Sbjct: 155 DIQ-----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVIT-RRKPFDEIGG 208
Query: 597 EE--VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
++ + G N P + LM CW+ P RPS I + + ++ R
Sbjct: 209 PAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 1e-67
Identities = 59/301 (19%), Positives = 108/301 (35%), Gaps = 42/301 (13%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFE 416
+ + ++ L + G +++ + G + VK+LK + S DF
Sbjct: 3 KHSGIDFKQLNFLTKLNENHSGELWKGRWQG-------NDIVVKVLKVRDWSTRKSRDFN 55
Query: 417 REACLLAEFDHPNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
E L F HPN++ +LG C L+ +M G L + L
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE------------- 102
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYL--SDRKFVHRDLATRNCLINDQMVVKIADF 532
+ + AL +A GM +L + L +R+ +I++ M +I+
Sbjct: 103 -----GTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157
Query: 533 GLSRKMYLQDYYKGDENDAIPVRWMP---LESILYNKYTVESDVWAFGVCLWEIFSFALQ 589
+ W+ L+ + +D+W+F V LWE+ +
Sbjct: 158 DVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REV 209
Query: 590 PYYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648
P+ L++ E+ + + P + LMK+C N P RP F I L ++
Sbjct: 210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
Query: 649 R 649
Sbjct: 270 D 270
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-67
Identities = 76/311 (24%), Positives = 136/311 (43%), Gaps = 50/311 (16%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEAS 408
PK N+I Y + +G+G FG V + + L ++ ++VA+K L +
Sbjct: 9 PKSRLPTLADNEIEYEKQIGKGGFGLVHKGR----LVKDK-SVVAIKSLILGDSEGETEM 63
Query: 409 EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYI 468
+F+RE +++ +HPNIVKL G+ P ++ E++ GDL L
Sbjct: 64 IEKFQEFQREVFIMSNLNHPNIVKLYGLMH--NPPRMVMEFVPCGDLYHRLL-------- 113
Query: 469 NGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL--SDRKFVHRDLATRNCLI----- 521
+ + + + L IA G+ Y+ + VHRDL + N +
Sbjct: 114 -----------DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162
Query: 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVC 579
N + K+ADFGLS++ +WM E+I YT ++D ++F +
Sbjct: 163 NAPVCAKVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMI 217
Query: 580 LWEIFSFALQPYYGLTHEEV---VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
L+ I + P+ ++ ++ +EG P++ P L ++++LCW+ P RP
Sbjct: 218 LYTILT-GEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPH 276
Query: 637 FRTIYQTLWNI 647
F I + L +
Sbjct: 277 FSYIVKELSEL 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 2e-50
Identities = 72/339 (21%), Positives = 125/339 (36%), Gaps = 73/339 (21%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P L Q + I V+ +G+G +G V+ K + E+ VAVK+ E
Sbjct: 28 PLLVQRTIAK-QIQMVKQIGKGRYGEVWMGK----WRGEK---VAVKVFFTT--EEASWF 77
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKP----MCLLFEYMGRGDLNDFLRICSPNNYING 470
E E H NI+ + G + L+ +Y G L D+L+
Sbjct: 78 RETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK---------- 127
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYL--------SDRKFVHRDLATRNCLIN 522
L ++ +A SG+ +L HRDL ++N L+
Sbjct: 128 -----------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176
Query: 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPV---RWMP---LESILYNK---YTVESDV 573
IAD GL+ K ++ D + D V R+MP L+ L + +D+
Sbjct: 177 KNGTCCIADLGLAVK-FISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 574 WAFGVCLWEIFS---------FALQPYYGL-----THEEVVKYIKEGNI------LQAPD 613
++FG+ LWE+ PY+ L ++E++ + + + + D
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 614 NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ LM CW P +R + + +TL + +
Sbjct: 296 ECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 74/337 (21%), Positives = 119/337 (35%), Gaps = 73/337 (21%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P L Q R I+ +G+G FG V++ K + EE VAVK+ E
Sbjct: 33 PLLVQRTIAR-TIVLQESIGKGRFGEVWRGK----WRGEE---VAVKIFSSR--EERSWF 82
Query: 415 FEREACLLAEFDHPNIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYING 470
E E H NI+ + + L+ +Y G L D+L
Sbjct: 83 REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL----------- 131
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYL--------SDRKFVHRDLATRNCLIN 522
+R ++ +I +AL ASG+ +L HRDL ++N L+
Sbjct: 132 ---------NR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181
Query: 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPV---RWMPLE------SILYNKYTVESDV 573
IAD GL+ + D V R+M E ++ + + +D+
Sbjct: 182 KNGTCCIADLGLAV-RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 574 WAFGVCLWEIFSFAL---------QPYYGL-----THEEVVKYIKEGNI------LQAPD 613
+A G+ WEI PYY L + EE+ K + E +
Sbjct: 241 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 300
Query: 614 NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ +M+ CW R + I +TL + +
Sbjct: 301 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 3e-49
Identities = 75/323 (23%), Positives = 117/323 (36%), Gaps = 72/323 (22%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF 425
DI + +G+G +G V++ + E VAVK+ + E E
Sbjct: 9 DITLLECVGKGRYGEVWRGS----WQGEN---VAVKIFSSR--DEKSWFRETELYNTVML 59
Query: 426 DHPNIVKLLGVCAVGK----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
H NI+ + + + L+ Y G L D+L+
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--------------------- 98
Query: 482 VPQLSTCDLITIALQIASGMVYL--------SDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ L T + I L IASG+ +L HRDL ++N L+ IAD G
Sbjct: 99 LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 158
Query: 534 LSRKMYLQDYYKGDENDAIPV---RWMPLE------SILYNKYTVESDVWAFGVCLWEIF 584
L+ M+ Q + D + V R+M E + D+WAFG+ LWE+
Sbjct: 159 LAV-MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 585 SFAL---------QPYYGL-----THEEVVKYIKEGNI------LQAPDNTPDALYDLMK 624
+ P+Y + + E++ K + D T +L LMK
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277
Query: 625 LCWNMKPMNRPSFRTIYQTLWNI 647
CW P R + I +TL I
Sbjct: 278 ECWYQNPSARLTALRIKKTLTKI 300
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-47
Identities = 71/351 (20%), Positives = 122/351 (34%), Gaps = 78/351 (22%)
Query: 343 NASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKM 402
+H + ++ E L F + + +G FG V++A+ VAVK+
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN-------EYVAVKI 54
Query: 403 LKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG----KPMCLLFEYMGRGDLNDF 458
+ + Q E E L H NI++ +G G + L+ + +G L+DF
Sbjct: 55 FPIQDKQSWQ--NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF 112
Query: 459 LRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL----------SDRK 508
L+ +S +L IA +A G+ YL
Sbjct: 113 LK---------------------ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151
Query: 509 FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPV----RWMP---LES 561
HRD+ ++N L+ + + IADFGL+ K D R+M LE
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK----SAGDTHGQVGTRRYMAPEVLEG 207
Query: 562 ILY--NKYTVESDVWAFGVCLWEIFS-----FALQPYYGLTHEEVVKYIKEGNILQA--- 611
+ + D++A G+ LWE+ S Y L EE + +Q
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVV 267
Query: 612 -------------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649
L + ++ CW+ R S + + + ++R
Sbjct: 268 HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 56/347 (16%), Positives = 108/347 (31%), Gaps = 81/347 (23%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
+ +++ + +G+G +G V++ L VAVK+ + E+
Sbjct: 6 SEPSLDLDNLKLLELIGRGRYGAVYKGS----LDERP---VAVKVFSFANRQNFIN--EK 56
Query: 418 EACLLAEFDHPNIVKLLGVCAVG-----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472
+ +H NI + + L+ EY G L +L
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------------ 104
Query: 473 SSMESSIHRVPQLSTCDLITIALQIASGMVYL---------SDRKFVHRDLATRNCLIND 523
+ +A + G+ YL HRDL +RN L+ +
Sbjct: 105 ---------LHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN 155
Query: 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIP------VRWMP---LESIL----YNKYTVE 570
I+DFGLS ++ + E D +R+M LE + +
Sbjct: 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ 215
Query: 571 SDVWAFGVCLWEIFSFA------------LQPYYGL-----THEEVVKYIKEGNI----- 608
D++A G+ WEIF + T E++ +
Sbjct: 216 VDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP 275
Query: 609 --LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ +L + ++ CW+ R + + + + + E
Sbjct: 276 EAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWER 322
|
| >3hkl_A Muscle, skeletal receptor tyrosine protein kinase; MUSK, receptor tyrosine kinase, frizzled CRD, ATP-binding, D bond, glycoprotein; HET: NAG; 2.10A {Rattus norvegicus} Length = 197 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-45
Identities = 47/174 (27%), Positives = 76/174 (43%), Gaps = 5/174 (2%)
Query: 29 KQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQ 88
+ +GYC+QY G++C L + V+FN+S + E ++ W E+ A+ + C+
Sbjct: 14 RGSKGYCAQYRGEVCDAVLVKDSLVFFNTSYPD-PEEAQELLIHTAWNELKAV-SPLCRP 71
Query: 89 AAEKLLCTYAFPQCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRG 148
AAE LLC + F +C P +P+C E C+AV+ FC +W +E RG+
Sbjct: 72 AAEALLCNHLFQECSPGVL-PTPMPICREYCLAVKELFCAKEWLAMEGKTHRGLYRSGMH 130
Query: 149 HFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTT 202
+P C LP C+ + K + IT + N
Sbjct: 131 FLPVPECSKLPSMH--QDPTACTRLPYLDYKKENITTFPSITSSKPSVDIPNLP 182
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 38/302 (12%)
Query: 346 YHQTDARLNPKLEQLEFPR-NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK 404
+H + ++ E L F + ++ +G+G+FG+ K E+ +K +
Sbjct: 4 HHHHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVK-----STEDGRQYVIKEIN 58
Query: 405 -DEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS 463
S + + RE +LA HPNIV+ + ++ +Y GDL +
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ- 117
Query: 464 PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523
G E I + +QI + ++ DRK +HRD+ ++N +
Sbjct: 118 -----KGVLFQ-EDQI-----------LDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160
Query: 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVR----WMPLESILYNKYTVESDVWAFGVC 579
V++ DFG++R + A ++ E Y +SD+WA G
Sbjct: 161 DGTVQLGDFGIARVL------NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCV 214
Query: 580 LWEIFSFALQ-PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
L+E+ L+ + + + +V I G+ + L L+ + P +RPS
Sbjct: 215 LYEL--CTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVN 272
Query: 639 TI 640
+I
Sbjct: 273 SI 274
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 6e-36
Identities = 69/302 (22%), Positives = 111/302 (36%), Gaps = 59/302 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +G G FG+VF+AK + +K +K ERE LA+ DH N
Sbjct: 16 IELIGSGGFGQVFKAK-----HRIDGKTYVIKRVKYN-----NEKAEREVKALAKLDHVN 65
Query: 430 IVKLLG----------------VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
IV G + K + + E+ +G L ++ G
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR------RGEKL 119
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ + + QI G+ Y+ +K ++RDL N + D VKI DFG
Sbjct: 120 D-KVLA-----------LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFG 167
Query: 534 LSRKMYLQDYYKGDENDAIPV---RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
L + K D R+M E I Y E D++A G+ L E+
Sbjct: 168 LVTSL------KNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA 221
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+ + +++G I D L++ + KP +RP+ I +TL K+
Sbjct: 222 FET---SKFFTDLRDGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
Query: 651 LE 652
E
Sbjct: 276 PE 277
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 9e-36
Identities = 59/294 (20%), Positives = 104/294 (35%), Gaps = 49/294 (16%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
++ LG+G FG VF+AK + A+K ++ E + RE LA+ +HP
Sbjct: 10 IQCLGRGGFGVVFEAK-----NKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 430 IVKLLGVC------------AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
IV+ + + + + + +L D++ S
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE------RS 118
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
I LQIA + +L + +HRDL N VVK+ DFGL
Sbjct: 119 VCLH-----------IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 538 MYLQDYYKGDENDAIPVR----------WMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587
M + + +M E I N Y+ + D+++ G+ L+E+
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL---- 223
Query: 588 LQPYY-GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640
L P+ + + ++ Y +++ + PM RP I
Sbjct: 224 LYPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 62/292 (21%), Positives = 114/292 (39%), Gaps = 54/292 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
+ +G G++GR + + + + ++ K L +E + E LL E HP
Sbjct: 11 LYTIGTGSYGRCQKIR-----RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 429 NIVKLLG--VCAVGKPMCLLFEYMGRGDLNDFLRICSPNN-YINGTYSSMESSIHRVPQL 485
NIV+ + + ++ EY GDL + + Y++ E +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD------EEFV------ 113
Query: 486 STCDLITIALQIASGMVYLSDRKF-----VHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ + Q+ + R +HRDL N ++ + VK+ DFGL+R +
Sbjct: 114 -----LRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 541 QD----------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
YY M E + Y +SD+W+ G L+E+ + P
Sbjct: 169 DTSFAKTFVGTPYY------------MSPEQMNRMSYNEKSDIWSLGCLLYELCALMP-P 215
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ + +E+ I+EG + P D L +++ N+K +RPS I +
Sbjct: 216 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 66/297 (22%), Positives = 116/297 (39%), Gaps = 47/297 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK--MLKDEASEYLQTDFEREACLLAEFDH 427
+ +G+G F V++A + VA+K + D + D +E LL + +H
Sbjct: 37 EKKIGRGQFSEVYRAA-----CLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNN-YINGTYSSMESSIHRVPQLS 486
PN++K + ++ E GDL+ ++ I E ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP------ERTV------- 138
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+Q+ S + ++ R+ +HRD+ N I VVK+ D GL R
Sbjct: 139 ----WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF-------- 186
Query: 547 DENDAIPVR-------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-PYYG--LTH 596
+ +M E I N Y +SD+W+ G L+E+ ALQ P+YG +
Sbjct: 187 -SSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM--AALQSPFYGDKMNL 243
Query: 597 EEVVKYIKEGNILQAPDNT-PDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ K I++ + P + + L L+ +C N P RP +Y +
Sbjct: 244 YSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA 300
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 54/292 (18%), Positives = 102/292 (34%), Gaps = 53/292 (18%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAE-FDHPNI 430
+G G FG VF+ K + + A+K K A + + RE A H ++
Sbjct: 19 IGSGEFGSVFKCV-----KRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V+ A M + EY G L D + +L
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIM----------------SYFKEAEL 117
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLIN-------------------DQMVVKIAD 531
+ LQ+ G+ Y+ VH D+ N I+ ++++ KI D
Sbjct: 118 KDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQP 590
G ++ +GD R++ E + N + ++D++A + + +P
Sbjct: 178 LGHVTRISSPQVEEGD------SRFLANEVLQENYTHLPKADIFALALTVVCA--AGAEP 229
Query: 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
+ I++G + + P +L+K+ + P RPS + +
Sbjct: 230 LPRNGDQ--WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-33
Identities = 56/304 (18%), Positives = 109/304 (35%), Gaps = 63/304 (20%)
Query: 365 NDIIYVRD--LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACL 421
IY +G G +VFQ +E+ + A+K + +EA + E
Sbjct: 26 KGRIYSILKQIGSGGSSKVFQVL------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 422 LAEFDHPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
L + + I++L + + ++ E DLN +L+
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK------------------- 119
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ + + + + + + VH DL N LI ++K+ DFG++ +M
Sbjct: 120 -KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM- 176
Query: 540 LQDYYKGDENDAIPVR--------WMPLESIL-----------YNKYTVESDVWAFGVCL 580
+ V+ +MP E+I +K + +SDVW+ G L
Sbjct: 177 -------QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 581 WEIFSFALQPYYGLTH--EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
+ + P+ + + ++ I + ++ PD L D++K C P R S
Sbjct: 230 YYMTYGKT-PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 639 TIYQ 642
+
Sbjct: 289 ELLA 292
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 49/278 (17%), Positives = 88/278 (31%), Gaps = 40/278 (14%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAE-FDH 427
+ LG G++G VF+ + E+ L AVK + E + H
Sbjct: 62 LSRLGHGSYGEVFKVR-----SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P V+L G + L E G L L
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE-------------------AWGASLPE 156
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY---Y 544
+ + +L + VH D+ N + + K+ DFGL ++
Sbjct: 157 AQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
+GD P R+M E +L Y +DV++ G+ + E+ P+ G +++ +
Sbjct: 217 EGD-----P-RYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL 269
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
L ++ + P R + +
Sbjct: 270 PPEF---TAGLSSELRSVLVMMLEPDPKLRATAEALLA 304
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 8e-33
Identities = 57/310 (18%), Positives = 112/310 (36%), Gaps = 69/310 (22%)
Query: 365 NDIIYVRD--------LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDF 415
N+ I V+ +G G +VFQ +E+ + A+K + +EA +
Sbjct: 1 NECISVKGRIYSILKQIGSGGSSKVFQVL------NEKKQIYAIKYVNLEEADNQTLDSY 54
Query: 416 EREACLLAEFDHPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
E L + + I++L + + ++ E DLN +L+
Sbjct: 55 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK------------- 100
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
+ + + + + + + VH DL N LI ++K+ DFG
Sbjct: 101 -------KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFG 152
Query: 534 LSRKMYLQDYYKGDENDAIPVR--------WMPLESIL-----------YNKYTVESDVW 574
++ +M + V+ +MP E+I +K + +SDVW
Sbjct: 153 IANQM--------QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204
Query: 575 AFGVCLWEIFSFALQPYYGLTH--EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPM 632
+ G L+ + P+ + + ++ I + ++ PD L D++K C P
Sbjct: 205 SLGCILYYMTYGKT-PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPK 263
Query: 633 NRPSFRTIYQ 642
R S +
Sbjct: 264 QRISIPELLA 273
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 63/321 (19%), Positives = 114/321 (35%), Gaps = 63/321 (19%)
Query: 364 RNDIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACL 421
+D + LGQGAFG+V +A A+K ++ + + E L
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDS-------RYYAIKKIRHTEEK--LSTILSEVML 55
Query: 422 LAEFDHPNIVKLLGV-------------CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYI 468
LA +H +V+ + + EY G L D I S N
Sbjct: 56 LASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD--LIHSENLNQ 113
Query: 469 NGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528
R + QI + Y+ + +HRDL N I++ VK
Sbjct: 114 Q------RDEYWR-----------LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156
Query: 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLES-----------ILYNK--YTVESDVWA 575
I DFGL++ ++ ++ +P L S +L Y + D+++
Sbjct: 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS 216
Query: 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL---QAPDNTPDALYDLMKLCWNMKPM 632
G+ +E+ G+ ++K ++ +I DN +++L + P
Sbjct: 217 LGIIFFEM---IYPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPN 273
Query: 633 NRPSFRTIYQTLWNIKRDLEN 653
RP RT+ + W + ++
Sbjct: 274 KRPGARTLLNSGW-LPVKHQD 293
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 58/304 (19%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
++ LG+G F V + H+ ++L E + + + +REA + F+HPN
Sbjct: 34 IQKLGEGGFSYVDLVEG----LHDGHFYALKRILCHEQQD--REEAQREADMHRLFNHPN 87
Query: 430 IVKLLGVCAVGKP----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
I++L+ C + LL + RG L + + L
Sbjct: 88 ILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKG----------------NFL 131
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK-------- 537
+ ++ + L I G+ + + + HRDL N L+ D+ + D G +
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 538 ---MYLQD--------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586
+ LQD Y+ E + + +DVW+ G L+ +
Sbjct: 192 RQALTLQDWAAQRCTISYRAPE--------L-FSVQSHCVIDERTDVWSLGCVLYAMMFG 242
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQAPDNTP--DALYDLMKLCWNMKPMNRPSFRTIYQTL 644
PY + + + N L P + AL+ L+ + P RP + L
Sbjct: 243 EG-PYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
Query: 645 WNIK 648
++
Sbjct: 302 EALQ 305
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 56/304 (18%), Positives = 109/304 (35%), Gaps = 63/304 (20%)
Query: 365 NDIIYVRD--LGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACL 421
IY +G G +VFQ +E+ + A+K + +EA + E
Sbjct: 54 KGRIYSILKQIGSGGSSKVFQVL------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 107
Query: 422 LAEFDHPN--IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
L + + I++L + + ++ E DLN +L+
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLK------------------- 147
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ + + + + + + VH DL N LI ++K+ DFG++ +M
Sbjct: 148 -KKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQM- 204
Query: 540 LQDYYKGDENDAIPVR--------WMPLESIL-----------YNKYTVESDVWAFGVCL 580
+ V+ +MP E+I +K + +SDVW+ G L
Sbjct: 205 -------QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 581 WEIFSFALQPYYGLTH--EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
+ + P+ + + ++ I + ++ PD L D++K C P R S
Sbjct: 258 YYMTYGKT-PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 316
Query: 639 TIYQ 642
+
Sbjct: 317 ELLA 320
|
| >3k65_A Prothrombin; coagulation, zymogen, hydrolase; 1.85A {Homo sapiens} PDB: 2hpq_P* 2hpp_P* Length = 116 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-30
Identities = 24/87 (27%), Positives = 42/87 (48%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
C+ RG+ YQG + T GL C W + + A + + EN+CRN G+E
Sbjct: 14 QCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEG 73
Query: 246 PWCYTMDPNVRWQRCEIPTCADSMQDD 272
WCY + C++ C ++++++
Sbjct: 74 VWCYVAGKPGDFGYCDLNYCEEAVEEE 100
|
| >5hpg_A Plasminogen; serine protease, kringle 5, fibrinolysis; 1.66A {Homo sapiens} SCOP: g.14.1.1 PDB: 2knf_A Length = 84 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-30
Identities = 36/83 (43%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE-RPPPVFPELNNSENYCRNAGGEEP 244
DC+ G G+ Y+G TTV G CQ W A+EPH H P P +NYCRN G+
Sbjct: 1 DCMFGNGKGYRGKRVTTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVG 60
Query: 245 SPWCYTMDPNVRWQRCEIPTCAD 267
PWCYT +P + C++P CA
Sbjct: 61 GPWCYTTNPRKLYDYCDVPQCAA 83
|
| >2qj2_A Hepatocyte growth factor; HGF/SF, hormone/growth factor; 1.81A {Homo sapiens} SCOP: g.10.1.1 g.14.1.1 PDB: 1nk1_A 3mkp_A* 1gmn_A* 1gmo_A* 1bht_A* 1gp9_A* 2qj4_A Length = 184 | Back alignment and structure |
|---|
Score = 115 bits (288), Expect = 8e-30
Identities = 41/115 (35%), Positives = 61/115 (53%)
Query: 153 PNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWD 212
C P + +G + + + +CI G+GR Y+GTV+ T G+ CQ W
Sbjct: 69 KQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSGIKCQPWS 128
Query: 213 AKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267
+ PH H P + + ENYCRN GEE PWC+T +P VR++ C+IP C++
Sbjct: 129 SMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSE 183
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 64/269 (23%), Positives = 104/269 (38%), Gaps = 31/269 (11%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G +G V+ +A+K + + S Y Q E L H NIV+
Sbjct: 30 LGKGTYGIVYAG-----RDLSNQVRIAIKEIPERDSRYSQ-PLHEEIALHKHLKHKNIVQ 83
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
LG + + + E + G L+ LR G E +I
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLR------SKWGPLKDNEQTI-----------GF 126
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQM-VVKIADFGLSRKMYLQDYYKGDENDA 551
QI G+ YL D + VHRD+ N LIN V+KI+DFG S++ L E
Sbjct: 127 YTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFT 184
Query: 552 IPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY-IKEGNI 608
+++M E I Y +D+W+ G + E+ + P+Y L + + + +
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT-GKPPFYELGEPQAAMFKVGMFKV 243
Query: 609 L-QAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ P++ + C+ P R
Sbjct: 244 HPEIPESMSAEAKAFILKCFEPDPDKRAC 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 1e-29
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 42/276 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIV 431
LG GA G + G+ + + VAVK + E + +RE LL E D HPN++
Sbjct: 32 LGHGAEGTIVYR---GMFDNRD---VAVKRILPECFSFA----DREVQLLRESDEHPNVI 81
Query: 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLI 491
+ + + E L + + + + I
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQE--YVEQKDF-----------------AHLGLEPI 121
Query: 492 TIALQIASGMVYLSDRKFVHRDLATRNCLI-----NDQMVVKIADFGLSRKMYLQDYYKG 546
T+ Q SG+ +L VHRDL N LI + ++ I+DFGL +K+ + +
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181
Query: 547 DENDAI-PVRWMP---LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ W+ L T D+++ G + + S P+ +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL 241
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ ++ L + +L++ M P RPS
Sbjct: 242 LGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 60/328 (18%), Positives = 108/328 (32%), Gaps = 60/328 (18%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
D ++ +G+G FG VF+AK + A+K ++ E + RE LA
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAK-----NKVDDCNYAIKRIRLPNRELAREKVMREVKALA 59
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ +HP IV+ + P E M L D ++ S++
Sbjct: 60 KLEHPGIVRYFN-AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPF 118
Query: 484 --------------------QLSTC------DLIT---------------IALQIASGMV 502
Q+ C D + I +QIA +
Sbjct: 119 STKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVE 178
Query: 503 YLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWM----- 557
+L + +HRDL N VVK+ DFGL M + +
Sbjct: 179 FLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238
Query: 558 -PL----ESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP 612
L E I N Y+ + D+++ G+ L+E+ ++ + ++ ++
Sbjct: 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELL-YSFST--QMERVRIITDVRNLKFPLLF 295
Query: 613 DNTPDALYDLMKLCWNMKPMNRPSFRTI 640
+ +++ + P RP I
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDI 323
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 65/280 (23%), Positives = 107/280 (38%), Gaps = 49/280 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFDHPNIV 431
+G+G+F V++ L E VA L+D + ++ + F+ EA +L HPNIV
Sbjct: 34 IGRGSFKTVYKG-----LDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIV 88
Query: 432 KLLG--VCAVGKPMCLLF--EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
+ V C++ E M G L +L+ R +
Sbjct: 89 RFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK--------------------RFKVMKI 128
Query: 488 CDLITIALQIASGMVYLSDRK--FVHRDLATRNCLINDQM-VVKIADFGLSRKMYLQDYY 544
L + QI G+ +L R +HRDL N I VKI D GL+
Sbjct: 129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------ 182
Query: 545 KGDENDAIPVR----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ A V +M E + KY DV+AFG+C+ E+ + PY + +
Sbjct: 183 --RASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEY-PYSECQNAAQI 238
Query: 601 -KYIKEGNILQAPDNTPDA-LYDLMKLCWNMKPMNRPSFR 638
+ + G + D + ++++ C R S +
Sbjct: 239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIK 278
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 60/319 (18%), Positives = 103/319 (32%), Gaps = 70/319 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LGQGA VF+ + + T L A+K+ + + RE +L + +H NI
Sbjct: 17 LGQGATANVFRGR-------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 431 VKLLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
VKL + + L+ E+ G L L L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-----------------EPSNAYGLPES 112
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMYLQDYY 544
+ + + + GM +L + VHR++ N + + Q V K+ DFG +R++ + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 545 K---GDENDAIP--VRWMPLESILYNKYTVESDVWAFGVCLWEIFS----FALQPYYGLT 595
G E P L KY D+W+ GV + + F
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF-RPFEGPRR 231
Query: 596 HEEVVKYIKEGNI--------------------LQAPDNTPDALYDLMK------LCWNM 629
++EV+ I G + + L L+ L +
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD- 290
Query: 630 KPMNRPSFRTIYQTLWNIK 648
F + +I
Sbjct: 291 -QEKCWGFDQFFAETSDIL 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 66/225 (29%), Positives = 107/225 (47%), Gaps = 46/225 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK---DEASEYLQTDFEREACLLAEFDHPN 429
+G+G FG V++ G + + T VAVK L D +E L+ F++E ++A+ H N
Sbjct: 39 MGEGGFGVVYK----GYVNN---TTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+V+LLG + G +CL++ YM G L D L S + P LS
Sbjct: 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRL-----------------SCLDGTPPLSWHM 134
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
IA A+G+ +L + +HRD+ + N L+++ KI+DFGL+R +
Sbjct: 135 RCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLAR------ASEKFAQ 188
Query: 550 DAIPVRWM-------PLESILY--NKYTVESDVWAFGVCLWEIFS 585
+ R + P E + T +SD+++FGV L EI +
Sbjct: 189 TVMTSRIVGTTAYMAP-E---ALRGEITPKSDIYSFGVVLLEIIT 229
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 81/305 (26%), Positives = 129/305 (42%), Gaps = 61/305 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G G FG+V++ G+L + VA+K E S +FE E L+ HP++V
Sbjct: 47 IGHGVFGKVYK----GVL--RDGAKVALKRRTPE-SSQGIEEFETEIETLSFCRHPHLVS 99
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L+G C M L+++YM G+L L Y S ++ +S +
Sbjct: 100 LIGFCDERNEMILIYKYMENGNLKRHL------------YGSDLPTMS----MSWEQRLE 143
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
I + A G+ YL R +HRD+ + N L+++ V KI DFG+S+ KG E D
Sbjct: 144 ICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--------KGTELDQT 195
Query: 553 PV--RWM-------PLESILYNKYTVESDVWAFGVCLWEIFSFALQPY-YGLTHEEV--- 599
+ P E + + T +SDV++FGV L+E+ A L E V
Sbjct: 196 HLSTVVKGTLGYIDP-EYFIKGRLTEKSDVYSFGVVLFEVLC-ARSAIVQSLPREMVNLA 253
Query: 600 ---VKYIKEGNILQAPDN------TPDALYDLMKL---CWNMKPMNRPSFRTIYQTLWNI 647
V+ G + Q D P++L C + +RP ++ LW +
Sbjct: 254 EWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP---SMGDVLWKL 310
Query: 648 KRDLE 652
+ L
Sbjct: 311 EYALR 315
|
| >3e6p_L Prothrombin; meizothrombin, allostery, linkage, Na+ binding, AC phase, blood coagulation, cleavage on PAIR of basic residue disease mutation; HET: DFK NAG; 2.10A {Homo sapiens} PDB: 1a0h_A* Length = 158 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-27
Identities = 24/88 (27%), Positives = 42/88 (47%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
C+ RG+ YQG + T GL C W + + A + + EN+CRN G+E
Sbjct: 7 QCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEG 66
Query: 246 PWCYTMDPNVRWQRCEIPTCADSMQDDV 273
WCY + C++ C ++++++
Sbjct: 67 VWCYVAGKPGDFGYCDLNYCEEAVEEET 94
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 62/320 (19%), Positives = 110/320 (34%), Gaps = 70/320 (21%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LGQGA VF+ + + T L A+K+ + + RE +L + +H NI
Sbjct: 17 LGQGATANVFRGR-------HKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 431 VKLLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
VKL + + L+ E+ G L + + P+N L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSL--YTVLEEPSN---------------AYGLPES 112
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMYLQDYY 544
+ + + + GM +L + VHR++ N + + Q V K+ DFG +R++ + +
Sbjct: 113 EFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQF 172
Query: 545 K---GDENDAIP--VRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY----GLT 595
G E P L KY D+W+ GV + + +L P+
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL-PFRPFEGPRR 231
Query: 596 HEEVVKYIKEGN--------------------ILQAPDNTPDALYDLMK------LCWNM 629
++EV+ I G + + L L+ L +
Sbjct: 232 NKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD- 290
Query: 630 KPMNRPSFRTIYQTLWNIKR 649
F + +I
Sbjct: 291 -QEKCWGFDQFFAETSDILH 309
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 48/272 (17%), Positives = 87/272 (31%), Gaps = 42/272 (15%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
+G+G+FG V + K G AVK ++ L+ E A P I
Sbjct: 66 VGRGSFGEVHRMKDKQTG-------FQCAVKKVR------LEVFRVEELVACAGLSSPRI 112
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
V L G G + + E + G L ++ G E
Sbjct: 113 VPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-------GCLP--EDRA----------- 152
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ-MVVKIADFGLSRKMYLQDYYKGDEN 549
+ Q G+ YL R+ +H D+ N L++ + DFG + + K
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT 212
Query: 550 DAIPV---RWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG 606
M E ++ + D+W+ + + + P+ + I
Sbjct: 213 GDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN-GCHPWTQYFRGPLCLKIASE 271
Query: 607 N--ILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
I + P + ++ +P++R S
Sbjct: 272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS 303
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 43/283 (15%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKML-KDE-ASEYLQTDFEREACLLAEFD 426
R LG+G F + F+ + T + A K++ K + + E +
Sbjct: 47 RFLGKGGFAKCFEIS-------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
H ++V G + ++ E R L + + + E+
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEAR-------- 144
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK- 545
QI G YL + +HRDL N +N+ + VKI DFGL+ K+ K
Sbjct: 145 -----YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 199
Query: 546 ---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
G N P E + ++ E DVW+ G ++ + P+ +E
Sbjct: 200 VLCGTPNYIAP------EVLSKKGHSFEVDVWSIGCIMYTLLVGKP-PFETSCLKETYLR 252
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
IK+ P + L++ P RP+ + +
Sbjct: 253 IKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 294
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-27
Identities = 63/294 (21%), Positives = 118/294 (40%), Gaps = 38/294 (12%)
Query: 348 QTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDE 406
+ +A L K + E +D + +LG G G VF+ H+ ++A K++ E
Sbjct: 16 RLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVS------HKPSGLVMARKLIHLE 69
Query: 407 ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNN 466
++ RE +L E + P IV G + + E+M G L+ L+
Sbjct: 70 IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-- 127
Query: 467 YINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQM 525
+ L +++ + G+ YL K +HRD+ N L+N +
Sbjct: 128 ------------------IPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG 169
Query: 526 VVKIADFGLSRKM--YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583
+K+ DFG+S ++ + + + G + +M E + Y+V+SD+W+ G+ L E+
Sbjct: 170 EIKLCDFGVSGQLIDSMANSFVGTRS------YMSPERLQGTHYSVQSDIWSMGLSLVEM 223
Query: 584 FS--FALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635
+ + P E + EG+ + P L K + +P
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAI 277
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 56/283 (19%), Positives = 98/283 (34%), Gaps = 43/283 (15%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKML-KDE-ASEYLQTDFEREACLLAEFD 426
R LG+G F + F+ + T + A K++ K + + E +
Sbjct: 21 RFLGKGGFAKCFEIS-------DADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
H ++V G + ++ E R L + + + E+
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKR-------RKALTEPEAR-------- 118
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK- 545
QI G YL + +HRDL N +N+ + VKI DFGL+ K+ K
Sbjct: 119 -----YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK 173
Query: 546 ---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
G N P E + ++ E DVW+ G ++ + P+ +E
Sbjct: 174 VLCGTPNYIAP------EVLSKKGHSFEVDVWSIGCIMYTLLVGKP-PFETSCLKETYLR 226
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
IK+ P + L++ P RP+ + +
Sbjct: 227 IKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEF 268
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-26
Identities = 70/276 (25%), Positives = 114/276 (41%), Gaps = 43/276 (15%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
+ LG GA+G V K + A+K++ K S + E +L DH
Sbjct: 43 KKLGSGAYGEVLLCRDKVTHVE-------RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNI+KL + L+ E G+L F I ++ ++++
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGEL--FDEIIH-----RMKFNEVDAA--------- 139
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM---VVKIADFGLSRKMYLQDYY 544
I Q+ SG+ YL VHRDL N L+ + ++KI DFGLS Q
Sbjct: 140 ----VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 545 KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
K A ++ E +L KY + DVW+ GV L+ + + P+ G T +E+++ ++
Sbjct: 196 KERLGTAY---YIAPE-VLRKKYDEKCDVWSIGVILFILLA-GYPPFGGQTDQEILRKVE 250
Query: 605 EGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+G + + + A DL+K R S
Sbjct: 251 KGKYTFDSPEWKNVSEGAK-DLIKQMLQFDSQRRIS 285
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-26
Identities = 58/296 (19%), Positives = 96/296 (32%), Gaps = 46/296 (15%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
LG G FG V + + G VA+K + E S + + E ++ + +HP
Sbjct: 20 ERLGTGGFGYVLRWIHQDTG-------EQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 429 NIVKLLGV------CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
N+V V A L EY GDL + N E I +
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDL--RKYLNQFENCCGLK----EGPIRTL 126
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMY 539
I+S + YL + + +HRDL N ++ +++ KI D G ++++
Sbjct: 127 LS-----------DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 540 LQDYYK---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+ G P E + KYTV D W+FG +E + P+
Sbjct: 176 QGELCTEFVGTLQYLAP------ELLEQKKYTVTVDYWSFGTLAFECITGFR-PFLPNWQ 228
Query: 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
+ D + P + W ++ L
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW-LQCMLM 283
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 63/283 (22%), Positives = 111/283 (39%), Gaps = 42/283 (14%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKML-KDE-ASEYLQTDFEREACLLAEFD 426
LG+G+F V++A+ T VA+KM+ K + + E + +
Sbjct: 17 NLLGKGSFAGVYRAE-------SIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK 69
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP+I++L + L+ E G++N +L+ +RV S
Sbjct: 70 HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK-------------------NRVKPFS 110
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK- 545
+ QI +GM+YL +HRDL N L+ M +KIADFGL+ ++ +
Sbjct: 111 ENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY 170
Query: 546 ---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
G N P E + + +ESDVW+ G + + P+ T + +
Sbjct: 171 TLCGTPNYISP------EIATRSAHGLESDVWSLGCMFYTLLIGRP-PFDTDTVKNTLNK 223
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ + + P DL+ P +R S ++ +
Sbjct: 224 VVLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPF 265
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-25
Identities = 73/277 (26%), Positives = 114/277 (41%), Gaps = 44/277 (15%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML--KDEASEYLQTDFEREACLLAEFD 426
R LG+G+FG V K G AVK++ + + + RE LL + D
Sbjct: 32 RVLGKGSFGEVILCKDKITGQE-------CAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNI+KL L+ E G+L F I S +S ++++
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL--FDEIIS-----RKRFSEVDAA-------- 129
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDY 543
I Q+ SG+ Y+ K VHRDL N L+ + ++I DFGLS
Sbjct: 130 -----RIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
K A ++ E +L+ Y + DVW+ GV L+ + S P+ G +++K +
Sbjct: 185 MKDKIGTAY---YIAPE-VLHGTYDEKCDVWSTGVILYILLS-GCPPFNGANEYDILKKV 239
Query: 604 KEGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
++G Q + A DL++ P R S
Sbjct: 240 EKGKYTFELPQWKKVSESAK-DLIRKMLTYVPSMRIS 275
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 44/316 (13%), Positives = 93/316 (29%), Gaps = 47/316 (14%)
Query: 340 LPCNASYHQTDARLNPKLEQLEFPRNDIIYV--RDLGQGAFGRVFQAKAPGLLKHEEFTL 397
+ + + +L + EF + LG+GAF +V++A L +
Sbjct: 38 VSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK 97
Query: 398 VAVKML-KDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLN 456
+K+ E+ E L +K L+ E G L
Sbjct: 98 FVLKVQKPANPWEFYIGTQLME--RLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLL 155
Query: 457 DFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516
+ IN ++ E +PQ ++ + + D + +H D+
Sbjct: 156 N---------AINLYKNTPE---KVMPQGLVISFAM---RMLYMIEQVHDCEIIHGDIKP 200
Query: 517 RNCLINDQMV-----------VKIADFGLSRKMYLQDYYKGDENDAIPVRW-----MPLE 560
N ++ + + + + D G S M L + + +E
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLF-----PKGTIFTAKCETSGFQCVE 255
Query: 561 SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALY 620
+ + + D + ++ + L Y E + EG + P D
Sbjct: 256 MLSNKPWNYQIDYFGVAATVYCM----LFGTYMKVKNEGGECKPEGLFRRLPH--LDMWN 309
Query: 621 DLMKLCWNMKPMNRPS 636
+ + N+ +
Sbjct: 310 EFFHVMLNIPDCHHLP 325
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 51/286 (17%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD-FEREACLLAEFDHP 428
R LG+G FG V+ A+ K +F ++A+K+L K + + RE + + HP
Sbjct: 15 RPLGKGKFGNVYLAR----EKQSKF-ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI++L G + L+ EY G + L+ + ++
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-------SKFDEQRTA---------- 112
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ------- 541
T ++A+ + Y ++ +HRD+ N L+ +KIADFG S
Sbjct: 113 ---TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCG 169
Query: 542 --DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
DY +P E I + + D+W+ GV +E P+ T++E
Sbjct: 170 TLDY-------------LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-PFEANTYQET 215
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
K I PD + DL+ P RP R + + W
Sbjct: 216 YKRISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 71/281 (25%), Positives = 118/281 (41%), Gaps = 40/281 (14%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
+ +G+G F +V A+ H VA+K++ K + + RE ++ +HP
Sbjct: 21 KTIGKGNFAKVKLAR------HILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHP 74
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIVKL V K + L+ EY G++ D+ + ++
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDY--------------------LVAHGRMKEK 114
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK--- 545
+ + QI S + Y ++ VHRDL N L++ M +KIADFG S + +
Sbjct: 115 EARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC 174
Query: 546 GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
G A P E KY E DVW+ GV L+ + S +L P+ G +E+ + +
Sbjct: 175 GAPPYAAP------ELFQGKKYDGPEVDVWSLGVILYTLVSGSL-PFDGQNLKELRERVL 227
Query: 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
G + P +L+K + P+ R + I + W
Sbjct: 228 RG-KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRW 267
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 64/286 (22%), Positives = 98/286 (34%), Gaps = 61/286 (21%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
R LG GAFG V ++ GL +K + + S+ E E +L DHP
Sbjct: 28 RKLGSGAFGDVHLVEERSSGLE-------RVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+K+ V M ++ E G+L RI S S +
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGEL--LERIVS-AQARGKALSEGYVA---------- 127
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM----YLQ 541
+ Q+ + + Y + VH+DL N L + +KI DFGL+ +
Sbjct: 128 ---ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 542 D-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL----QPYY 592
+ Y E + T + D+W+ GV + + L P+
Sbjct: 185 NAAGTALYMAPE-------------VFKRDVTFKCDIWSAGVVM-----YFLLTGCLPFT 226
Query: 593 GLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
G + EEV + DL+K P RPS
Sbjct: 227 GTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPS 272
|
| >1i71_A APO(A), apolipoprotein(A); alipoprotein(A), kringle, protein-ligand interaction, lysine binding, hydrolase; 1.45A {Homo sapiens} SCOP: g.14.1.1 PDB: 1kiv_A 3kiv_A 4kiv_A 1krn_A 1pmk_A 2pk4_A 1pk4_A Length = 83 | Back alignment and structure |
|---|
Score = 97.5 bits (242), Expect = 7e-25
Identities = 37/80 (46%), Positives = 48/80 (60%), Gaps = 1/80 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
DC G G+ Y+G+ +TTV G CQ W + PH H+R +P + NYCRN E
Sbjct: 1 DCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDA-EIR 59
Query: 246 PWCYTMDPNVRWQRCEIPTC 265
PWCYTMDP+VRW+ C + C
Sbjct: 60 PWCYTMDPSVRWEYCNLTQC 79
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 40/297 (13%)
Query: 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFERE 418
+E +D+ + +LG+GA+G V + + H ++AVK ++ + Q +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMR------HVPSGQIMAVKRIRATVNSQEQKRLLMD 55
Query: 419 -ACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
+ D P V G + + E M L+ F +
Sbjct: 56 LDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKG----------- 103
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+P+ L IA+ I + +L S +HRD+ N LIN VK+ DFG+S
Sbjct: 104 --QTIPEDI---LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG 158
Query: 537 KMYLQDYYKGDENDAIPVRWMPLESIL----YNKYTVESDVWAFGVCLWEIFSFALQ--P 590
L D D + +M E I Y+V+SD+W+ G+ + E+ A+ P
Sbjct: 159 Y--LVDDVAKDIDAGCK-PYMAPERINPELNQKGYSVKSDIWSLGITMIEL---AILRFP 212
Query: 591 YYGLTHE-EVVKYIKEGNILQAPDNT-PDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
Y + +K + E Q P + D C RP++ + Q +
Sbjct: 213 YDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF 269
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/226 (26%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G FG+V++ G L TLVAVK LK+E ++ + F+ E +++ H N+++
Sbjct: 38 LGRGGFGKVYK----GRLADG--TLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLR 91
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH-RVPQLSTCDLI 491
L G C L++ YM N S+ S + R D
Sbjct: 92 LRGFCMTPTERLLVYPYM-------------ANG-------SVASCLRERPESQPPLDWP 131
Query: 492 T---IALQIASGMVYL---SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
IAL A G+ YL D K +HRD+ N L++++ + DFGL++ L D
Sbjct: 132 KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK---LMD--- 185
Query: 546 GDENDAIPVR------WMPLESILYNKYTVESDVWAFGVCLWEIFS 585
++ + + E + K + ++DV+ +GV L E+ +
Sbjct: 186 -YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELIT 230
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 43/310 (13%), Positives = 79/310 (25%), Gaps = 41/310 (13%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML--KDEASEYLQTDFEREAC 420
+ V L G VF + L+ A+K+ E S
Sbjct: 60 GERKLKLVEPLRVGDRSVVFLVRDVERLED-----FALKVFTMGAENSRSELERLHEATF 114
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLL--------FEYMGRGDLNDFLRICSPNNYINGTY 472
A + + + P + + D +
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDL 174
Query: 473 SSMESSIHRVPQ----LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528
+ S++ V L + Q+ L + VH N I +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLM 234
Query: 529 IADFGLSRKMYLQDYYKGDENDAI--PVRWMPLESIL---YNKYTVESDVWAFGVCLWEI 583
+ D K+ G A PV + P L +T + W G+ ++ +
Sbjct: 235 LGDVSALWKV-------GTRGPASSVPVTYAP-REFLNASTATFTHALNAWQLGLSIYRV 286
Query: 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPD--------NTPDALYDLMKLCWNMKPMNRP 635
+ L P+ +T + + + D PD + L+ N R
Sbjct: 287 WCLFL-PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
Query: 636 SFRTIYQTLW 645
+T
Sbjct: 346 LPLEAMETPE 355
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-24
Identities = 72/285 (25%), Positives = 111/285 (38%), Gaps = 61/285 (21%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
LG+G+FG V + + AVK++ K A + RE LL + DH
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNI+KL + ++ E G+L F I +S +++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIK-----RKRFSEHDAA--------- 124
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM----YL 540
I Q+ SG+ Y+ VHRDL N L+ +KI DFGLS +
Sbjct: 125 ----RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 541 QD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+D YY E +L Y + DVW+ GV L+ + S P+YG
Sbjct: 181 KDRIGTAYYIAPE-------------VLRGTYDEKCDVWSAGVILYILLS-GTPPFYGKN 226
Query: 596 HEEVVKYIKEGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+++K ++ G Q + DA DL++ P R +
Sbjct: 227 EYDILKRVETGKYAFDLPQWRTISDDAK-DLIRKMLTFHPSLRIT 270
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 68/286 (23%), Positives = 114/286 (39%), Gaps = 51/286 (17%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD-FEREACLLAEFDHP 428
R LG+G FG V+ A+ K +F ++A+K+L K + + RE + + HP
Sbjct: 20 RPLGKGKFGNVYLAR----EKQNKF-IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+++ K + L+ E+ RG+L L+ +G + S+
Sbjct: 75 NILRMYNYFHDRKRIYLMLEFAPRGELYKELQ-------KHGRFDEQRSA---------- 117
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ------- 541
T ++A + Y +RK +HRD+ N L+ + +KIADFG S
Sbjct: 118 ---TFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCG 174
Query: 542 --DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
DY +P E I + + D+W GV +E P+ +H E
Sbjct: 175 TLDY-------------LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMP-PFDSPSHTET 220
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ I + L+ P D DL+ P R + + + W
Sbjct: 221 HRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPW 265
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 3e-24
Identities = 70/321 (21%), Positives = 111/321 (34%), Gaps = 77/321 (23%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVK-MLKDEASEYLQTDFEREACLLAEFD-HP 428
LG G+ G V + F VAVK ML D E LL E D HP
Sbjct: 23 LGYGSSGTVV-------FQGS-FQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHP 69
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
N+++ + + + E +L D + S N +
Sbjct: 70 NVIRYYCSETTDRFLYIALELCN-LNLQD--LVESKNVSD-----------ENLKLQKEY 115
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI-------------NDQMVVKIADFGLS 535
+ I++ QIASG+ +L K +HRDL +N L+ + + + I+DFGL
Sbjct: 116 NPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
Query: 536 RKMYLQDYYKGDENDAIPV---RWMPLESIL-------YNKYTVESDVWAFGVCLWEIFS 585
K N P W E + + T D+++ G + I S
Sbjct: 176 -KKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS 234
Query: 586 FALQPYYGLTHEEVVKYIKEGNILQA------------PDNTPDALYDLMKLCWNMKPMN 633
P+ KY +E NI++ +A DL+ + P+
Sbjct: 235 KGKHPFGD-------KYSRESNIIRGIFSLDEMKCLHDRSLIAEAT-DLISQMIDHDPLK 286
Query: 634 RPSFRTIYQ--TLWNIKRDLE 652
RP+ + + W + LE
Sbjct: 287 RPTAMKVLRHPLFWPKSKKLE 307
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 64/231 (27%), Positives = 99/231 (42%), Gaps = 68/231 (29%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-------REACLLAEF 425
+G+G +G V++A+ + A+K ++ L+ + E RE +L E
Sbjct: 10 IGEGTYGVVYKAQ------NNYGETFALKKIR------LEKEDEGIPSTTIREISILKEL 57
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
H NIVKL V K + L+FE++ + DL L +C L
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEG-------------------GL 97
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+ + LQ+ +G+ Y DR+ +HRDL +N LIN + +KIADFGL+R
Sbjct: 98 ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAF------- 150
Query: 546 GDENDAIPVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIF 584
IPVR + +L KY+ D+W+ G C IF
Sbjct: 151 -----GIPVRKYTHEIVTLWYRAPD-VLMGSKKYSTTIDIWSVG-C---IF 191
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 61/231 (26%), Positives = 93/231 (40%), Gaps = 68/231 (29%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-------REACLLAEF 425
+G+G +G V++AK + +VA+K ++ L + E RE LL E
Sbjct: 29 VGEGTYGVVYKAK------DSQGRIVALKRIR------LDAEDEGIPSTAIREISLLKEL 76
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
HPNIV L+ V + + L+FE+M + DL L L
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-------------------L 116
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+ Q+ G+ + + +HRDL +N LIN +K+ADFGL+R
Sbjct: 117 QDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAF------- 169
Query: 546 GDENDAIPVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIF 584
IPVR + +L KY+ D+W+ G C IF
Sbjct: 170 -----GIPVRSYTHEVVTLWYRAPD-VLMGSKKYSTSVDIWSIG-C---IF 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 58/230 (25%), Positives = 89/230 (38%), Gaps = 62/230 (26%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE----REACLLAEFD 426
LG+G F V++A+ ++ T +VA+K +K + RE LL E
Sbjct: 18 LGEGQFATVYKAR-------DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS 70
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HPNI+ LL + L+F++M DL ++ S L+
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSL-------------------VLT 110
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ L G+ YL +HRDL N L+++ V+K+ADFGL++
Sbjct: 111 PSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-------- 162
Query: 547 DENDAIPVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIF 584
P R E +L+ Y V D+WA G C I
Sbjct: 163 ----GSPNRAYTHQVVTRWYRAPE-LLFGARMYGVGVDMWAVG-C---IL 203
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 62/304 (20%), Positives = 105/304 (34%), Gaps = 54/304 (17%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE-FDHP 428
R L +G F V++A+ A+K L E + +E C + + HP
Sbjct: 33 RRVLAEGGFAFVYEAQ-----DVGSGREYALKRLLSNEEEKNR-AIIQEVCFMKKLSGHP 86
Query: 429 NIVKLLGVCAVGKPM-------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
NIV+ ++GK LL + +G L +FL+
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP-------------- 132
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRK--FVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
LS ++ I Q + ++ +K +HRDL N L+++Q +K+ DFG + +
Sbjct: 133 ---LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTIS 189
Query: 540 LQDYYKGDENDAIPVR----------WMPLESI-LYNK--YTVESDVWAFGVCLWEIFSF 586
Y V + E I LY+ + D+WA G L+ +
Sbjct: 190 HYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQAPDNTP--DALYDLMKLCWNMKPMNRPSFRTIYQTL 644
P+ I G P + + L++ + P R S + L
Sbjct: 250 QH-PFED----GAKLRIVNGKY-SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
Query: 645 WNIK 648
I
Sbjct: 304 QEIA 307
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A Length = 791 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 8e-24
Identities = 38/83 (45%), Positives = 49/83 (59%), Gaps = 1/83 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
+C+ G Y G ++ T+ GL CQ WD++ PHAH P FP N +NYCRN E
Sbjct: 165 ECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDR-ELR 223
Query: 246 PWCYTMDPNVRWQRCEIPTCADS 268
PWC+T DPN RW+ C+IP C
Sbjct: 224 PWCFTTDPNKRWELCDIPRCTTP 246
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A Length = 791 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 9e-23
Identities = 36/113 (31%), Positives = 51/113 (45%), Gaps = 2/113 (1%)
Query: 155 CDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAK 214
C + + + L E K +C G G+ Y+GT++ T G+ CQ+W +
Sbjct: 54 CVIMAENRKSSIIIRMRDVVLFEKK--VYLSECKTGNGKNYRGTMSKTKNGITCQKWSST 111
Query: 215 EPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267
PH P P ENYCRN + PWCYT DP R+ C+I C +
Sbjct: 112 SPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILECEE 164
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A Length = 791 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 40/120 (33%), Positives = 54/120 (45%), Gaps = 3/120 (2%)
Query: 155 CDTLPKYEVVNGKPTCSHAQLTEMKTDEITY-DCIRGRGRFYQGTVNTTVGGLACQRWDA 213
C+ L K + + + DC+ G G+ Y+G TTV G CQ W A
Sbjct: 430 CN-LKKCSGTEASVVAPPPVVLLPDVETPSEEDCMFGNGKGYRGKRATTVTGTPCQDWAA 488
Query: 214 KEPHAH-ERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQDD 272
+EPH H P P +NYCRN G+ PWCYT +P + C++P CA D
Sbjct: 489 QEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQCAAPSFDC 548
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A Length = 791 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 7e-22
Identities = 42/85 (49%), Positives = 53/85 (62%), Gaps = 1/85 (1%)
Query: 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEE 243
TY C++G G Y+G V TV G CQ W A+ PH H R P FP N ENYCRN G +
Sbjct: 253 TYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDG-K 311
Query: 244 PSPWCYTMDPNVRWQRCEIPTCADS 268
+PWC+T + VRW+ C+IP+C S
Sbjct: 312 RAPWCHTTNSQVRWEYCKIPSCDSS 336
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A Length = 791 | Back alignment and structure |
|---|
Score = 95.5 bits (237), Expect = 1e-20
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 21/162 (12%)
Query: 113 PLCYEDCIAVRYSFCYND------WAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNG 166
P + C + ++C N W + ++ R + ++P+CD+ P
Sbjct: 292 PENFP-CKNLDENYCRNPDGKRAPWCHTTNSQVR------WEYCKIPSCDSSPVST---- 340
Query: 167 KPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVF 226
+ A + DC G G+ Y+GT +TT G CQ W + PH H++ P +
Sbjct: 341 EQLAPTAPPELTPVVQ---DCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENY 397
Query: 227 PELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADS 268
P + NYCRN ++ PWC+T DP+VRW+ C + C+ +
Sbjct: 398 PNAGLTMNYCRNPDADK-GPWCFTTDPSVRWEYCNLKKCSGT 438
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 63/307 (20%), Positives = 105/307 (34%), Gaps = 74/307 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+G+G++G V A K A K + E + F++E ++ DHP
Sbjct: 15 NTIGRGSWGEVKIAVQKGTR-------IRRAAKKIPKYFVEDVD-RFKQEIEIMKSLDHP 66
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI++L + L+ E G+L F R+ + +++
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGEL--FERVVH-----KRVFRESDAA---------- 109
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM----YLQ 541
I + S + Y HRDL N L + +K+ DFGL+ + ++
Sbjct: 110 ---RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166
Query: 542 D-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL----QPYY 592
YY + +L Y E D W+ GV + + L P+
Sbjct: 167 TKVGTPYYVSPQ-------------VLEGLYGPECDEWSAGVMM-----YVLLCGYPPFS 208
Query: 593 GLTHEEVVKYIKEGNI-LQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL---WN 646
T EV+ I+EG N L++ P R T Q L W
Sbjct: 209 APTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI---TSLQALEHEW- 264
Query: 647 IKRDLEN 653
++ L +
Sbjct: 265 FEKQLSS 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 62/303 (20%), Positives = 104/303 (34%), Gaps = 55/303 (18%)
Query: 349 TDARLNPKLEQLEFPRN-DIIY--VRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML 403
+D + KL + + Y +GQGA G V+ A A G VA++ +
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATG-------QEVAIRQM 53
Query: 404 KDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS 463
+ + E ++ E +PNIV L VG + ++ EY+ G L D +
Sbjct: 54 NLQQQPKKE-LIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT--- 109
Query: 464 PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523
++ E I + + + +L + +HRD+ + N L+
Sbjct: 110 -ETCMD------EGQIA-----------AVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151
Query: 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVR--------WMPLESILYNKYTVESDVWA 575
VK+ DFG ++ R WM E + Y + D+W+
Sbjct: 152 DGSVKLTDFGFCAQI----------TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMN 633
G+ E+ PY + I LQ P+ D + C M
Sbjct: 202 LGIMAIEMIEGE-PPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEK 260
Query: 634 RPS 636
R S
Sbjct: 261 RGS 263
|
| >1jfn_A APO(A) KIV-T6, apolipoprotein A, KIV-T6, apolipoprotein; kringle domain, protein-protein recognition, LP(A), lipid transport; NMR {Homo sapiens} SCOP: g.14.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 95.7 bits (237), Expect = 9e-24
Identities = 39/85 (45%), Positives = 50/85 (58%), Gaps = 1/85 (1%)
Query: 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEE 243
DC G G+ Y+G+ +TTV G CQ W + PH H+R +P + NYCRN E
Sbjct: 22 VQDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDA-E 80
Query: 244 PSPWCYTMDPNVRWQRCEIPTCADS 268
SPWCYTMDPNVRW+ C + C +
Sbjct: 81 ISPWCYTMDPNVRWEYCNLTQCPVT 105
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 62/234 (26%), Positives = 96/234 (41%), Gaps = 67/234 (28%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
+G+G +G VF+AK T +VA+K ++ L D E RE CLL
Sbjct: 10 IGEGTYGTVFKAK-------NRETHEIVALKRVR------LDDDDEGVPSSALREICLLK 56
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
E H NIV+L V K + L+FE+ + DL + C+
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNG------------------- 96
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L + + Q+ G+ + R +HRDL +N LIN +K+A+FGL+R
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAF----- 151
Query: 544 YKGDENDAIPVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIFS 585
IPVR P + +L+ Y+ D+W+ G E+ +
Sbjct: 152 -------GIPVRCYSAEVVTLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELAN 197
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 65/288 (22%), Positives = 104/288 (36%), Gaps = 53/288 (18%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-KDEASEYLQTDF------EREACLL 422
LG GAFG V+ A +E V VK + K++ E + E +L
Sbjct: 30 SPLGSGAFGFVWTAV------DKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESSIHR 481
+ +H NI+K+L + L+ E G G DL F I R
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAF--------------------IDR 123
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
P+L I Q+ S + YL + +HRD+ N +I + +K+ DFG + +
Sbjct: 124 HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183
Query: 542 DYYK---GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ G P E ++ N Y E ++W+ GV L+ + P+ L
Sbjct: 184 KLFYTFCGTIEYCAP------EVLMGNPYRGPELEMWSLGVTLYTLVFEEN-PFCEL--- 233
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ E + P L L+ P R + + W
Sbjct: 234 ---EETVEAA-IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 62/304 (20%), Positives = 116/304 (38%), Gaps = 46/304 (15%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFE 416
+ +F D+ + ++G+GA+G V + H+ ++AVK ++ E Q
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMV------HKPSGQIMAVKRIRSTVDEKEQKQLL 68
Query: 417 RE-ACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
+ ++ D P IV+ G + E M + F +
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYV------------Y 115
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGL 534
+P+ L I L + +L + K +HRD+ N L++ +K+ DFG+
Sbjct: 116 SVLDDVIPEEI---LGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESI----LYNKYTVESDVWAFGVCLWEI----FSF 586
S L D DA +M E I Y V SDVW+ G+ L+E+ F
Sbjct: 173 SG--QLVD-SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF-- 227
Query: 587 ALQPYYGL-THEEVVKYIKEGNILQAPDNTP----DALYDLMKLCWNMKPMNRPSFRTIY 641
PY + + + + +G+ Q ++ + + + LC RP ++ +
Sbjct: 228 ---PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284
Query: 642 QTLW 645
+ +
Sbjct: 285 KHPF 288
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 2e-23
Identities = 65/257 (25%), Positives = 99/257 (38%), Gaps = 64/257 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
LG+G+FG V + + AVK++ K A + RE LL + DH
Sbjct: 28 CMLGKGSFGEVLKCKDRITQQE-------YAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNI+KL + ++ E G+L F I +S +++
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL--FDEIIK-----RKRFSEHDAA--------- 124
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM----YL 540
I Q+ SG+ Y+ VHRDL N L+ +KI DFGLS +
Sbjct: 125 ----RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM 180
Query: 541 QD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL----QPY 591
+D YY E +L Y + DVW+ GV L + L P+
Sbjct: 181 KDRIGTAYYIAPE-------------VLRGTYDEKCDVWSAGVIL-----YILLSGTPPF 222
Query: 592 YGLTHEEVVKYIKEGNI 608
YG +++K ++ G
Sbjct: 223 YGKNEYDILKRVETGKY 239
|
| >1pml_A Tissue plasminogen activator kringle 2; hydrolase(serine protease); 2.38A {Homo sapiens} SCOP: g.14.1.1 PDB: 1pk2_A* 1tpk_A Length = 86 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 2e-23
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 5/85 (5%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPP---PVFPELNNSENYCRNAGGE 242
DC G G Y+GT + T G +C W++ NYCRN G
Sbjct: 2 DCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDG- 60
Query: 243 EPSPWCYTM-DPNVRWQRCEIPTCA 266
+ PWC+ + + + W+ C++P+C+
Sbjct: 61 DAKPWCHVLKNRRLTWEYCDVPSCS 85
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 52/254 (20%), Positives = 94/254 (37%), Gaps = 52/254 (20%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM-----LKDEASEYLQTDFEREACLLA 423
+LG G F V + K+ GL A K + + + ERE +L
Sbjct: 18 EELGSGQFAIVKKCREKSTGLE-------YAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ H N++ L V + L+ E + G+L F + +
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESL---------------- 112
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMY 539
S + + QI G+ YL +K H DL N ++ +K+ DFGL+ ++
Sbjct: 113 --SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI- 169
Query: 540 LQDYYKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
++ ++ E + Y +E+D+W+ GV + + S P+ G
Sbjct: 170 -------EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGD 221
Query: 595 THEEVVKYIKEGNI 608
T +E + I +
Sbjct: 222 TKQETLANITSVSY 235
|
| >3sp8_A Hepatocyte growth factor alpha chain; kringle domain, Met tyrosine kinase, hormone; HET: MES; 1.86A {Homo sapiens} PDB: 3hn4_A* Length = 264 | Back alignment and structure |
|---|
Score = 99.3 bits (246), Expect = 2e-23
Identities = 40/122 (32%), Positives = 60/122 (49%)
Query: 155 CDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAK 214
C P + +G + + + +CI G+GR Y+GTV+ T + CQ W +
Sbjct: 71 CLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCIIGKGRSYKGTVSITKSDIKCQPWSSM 130
Query: 215 EPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQDDVK 274
PH H P + + ENYCRN GEE PWC+T +P VR++ C+IP C++
Sbjct: 131 IPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSEVECMTSN 190
Query: 275 SW 276
Sbjct: 191 GE 192
|
| >3sp8_A Hepatocyte growth factor alpha chain; kringle domain, Met tyrosine kinase, hormone; HET: MES; 1.86A {Homo sapiens} PDB: 3hn4_A* Length = 264 | Back alignment and structure |
|---|
Score = 82.8 bits (203), Expect = 9e-18
Identities = 39/105 (37%), Positives = 54/105 (51%), Gaps = 6/105 (5%)
Query: 166 GKPTC-----SHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE 220
G P C +C+ G Y+G ++ T G CQRWD + PH H+
Sbjct: 160 GGPWCFTSNPEVRYEVCDIPQCSEVECMTSNGESYRGLMDHTESGKICQRWDHQTPHRHK 219
Query: 221 RPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265
P +P+ +NYCRN G +P PWCYT+DP+ RW+ C+I TC
Sbjct: 220 FLPERYPDKGFDDNYCRNPDG-QPRPWCYTLDPHTRWEYCKIKTC 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/254 (21%), Positives = 95/254 (37%), Gaps = 52/254 (20%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM-----LKDEASEYLQTDFEREACLLA 423
+LG G F V + K+ GL A K + + + ERE +L
Sbjct: 18 EELGSGQFAIVKKCREKSTGLE-------YAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ HPNI+ L V + L+ E + G+L F + +
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGEL--FDFLAQKESL---------------- 112
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMY 539
S + + QI G+ YL +K H DL N ++ +K+ DFGL+ ++
Sbjct: 113 --SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI- 169
Query: 540 LQDYYKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
++ ++ E + Y +E+D+W+ GV + + S P+ G
Sbjct: 170 -------EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGD 221
Query: 595 THEEVVKYIKEGNI 608
T +E + I +
Sbjct: 222 TKQETLANITAVSY 235
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 55/274 (20%), Positives = 109/274 (39%), Gaps = 48/274 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G+G+ G V A+ + VAVKM+ + + E ++ ++ H N+V+
Sbjct: 53 IGEGSTGIVCLAR-----EKHSGRQVAVKMMDLRKQQRRE-LLFNEVVIMRDYQHFNVVE 106
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
+ VG+ + +L E++ G L D + + E I T
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS--------QVRLN--EEQIA-----------T 145
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
+ + + YL + +HRD+ + + L+ VK++DFG ++ + +
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI----------SKDV 195
Query: 553 PVR--------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604
P R WM E I + Y E D+W+ G+ + E+ PY+ + + +K ++
Sbjct: 196 PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE-PPYFSDSPVQAMKRLR 254
Query: 605 EGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ L+ L D ++ P R +
Sbjct: 255 DSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-23
Identities = 73/296 (24%), Positives = 116/296 (39%), Gaps = 72/296 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLK------------DEASEYLQTDFE 416
R LG GA+G V K A+K++K ++ E +
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSE-------KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
E LL DHPNI+KL V K L+ E+ G+L F +I + + +
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL--FEQIIN-----RHKFDECD 147
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFG 533
++ I QI SG+ YL VHRD+ N L+ N + +KI DFG
Sbjct: 148 AA-------------NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 534 LSRKM----YLQD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
LS L+D YY E +L KY + DVW+ GV ++ +
Sbjct: 195 LSSFFSKDYKLRDRLGTAYYIAPE-------------VLKKKYNEKCDVWSCGVIMYILL 241
Query: 585 SFALQPYYGLTHEEVVKYIKEGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
P+ G ++++K +++G + + +A +L+KL R +
Sbjct: 242 C-GYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK-ELIKLMLTYDYNKRCT 295
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 57/308 (18%), Positives = 112/308 (36%), Gaps = 45/308 (14%)
Query: 351 ARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASE 409
L ++ + ND+ + ++G G G+V++ + + ++AVK ++ ++
Sbjct: 11 GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMR------FRKTGHVIAVKQMRRSGNK 64
Query: 410 YLQTDFERE-ACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYI 468
+ +L D P IV+ G + + E MG R+ P
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGP---- 120
Query: 469 NGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVV 527
L + + I + YL +HRD+ N L++++ +
Sbjct: 121 -----------IPERILGK-----MTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQI 164
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWE 582
K+ DFG+S ++ K + A +M E I Y + +DVW+ G+ L E
Sbjct: 165 KLCDFGISGRL---VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221
Query: 583 IFSFALQ--PYYGLTHE-EVVKYIKEGNILQAPDNT--PDALYDLMKLCWNMKPMNRPSF 637
+ A PY + EV+ + + P + +K C RP +
Sbjct: 222 L---ATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKY 278
Query: 638 RTIYQTLW 645
+ + +
Sbjct: 279 NKLLEHSF 286
|
| >2k4r_A Neurotrypsin; kringle domain, disulfide-rich protein fold, serine endopeptidase, hydrolase, extracellular proteolysis; NMR {Rattus norvegicus} PDB: 2k51_A Length = 77 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-23
Identities = 23/77 (29%), Positives = 31/77 (40%), Gaps = 7/77 (9%)
Query: 190 GRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPEL-NNSENYCRNAGGEEPSPWC 248
G G + N T G+ C WD P PP + EL N+CR+ G PWC
Sbjct: 3 GAGEPW---GNATNLGVPCLHWDEVPPFLERSPPASWAELRGQPHNFCRSPDGAG-RPWC 58
Query: 249 YTMDPN--VRWQRCEIP 263
+ + V W C+
Sbjct: 59 FYRNAQGKVDWGYCDCG 75
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 4e-23
Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 54/224 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG+G + V++ K+ + LVA+K ++ E E RE LL + H NIV
Sbjct: 10 LGEGTYATVYKGKSK---LTDN--LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVT 64
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L + K + L+FEY+ + DL +L C ++ ++
Sbjct: 65 LHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGN-------------------IINMHNVKL 104
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
Q+ G+ Y +K +HRDL +N LIN++ +K+ADFGL+R K I
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR-------AKS-----I 152
Query: 553 PVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIF 584
P + P + IL Y+ + D+W G C IF
Sbjct: 153 PTKTYDNEVVTLWYRPPD-ILLGSTDYSTQIDMWGVG-C---IF 191
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 7e-23
Identities = 61/257 (23%), Positives = 93/257 (36%), Gaps = 63/257 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
+LG+GAF V + K GL A K++ + S EREA + + H
Sbjct: 35 EELGKGAFSVVRRCVHKTTGLE-------FAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIV+L L+F+ + G+L F I + YS ++S
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVA-----REFYSEADAS--------- 131
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM----YL 540
QI + Y VHR+L N L+ VK+ADFGL+ ++
Sbjct: 132 ----HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 187
Query: 541 QD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ----PY 591
Y + E + + Y+ D+WA GV L + L P+
Sbjct: 188 HGFAGTPGY------------LSPEVLKKDPYSKPVDIWACGVIL-----YILLVGYPPF 230
Query: 592 YGLTHEEVVKYIKEGNI 608
+ + IK G
Sbjct: 231 WDEDQHRLYAQIKAGAY 247
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 8e-23
Identities = 59/235 (25%), Positives = 93/235 (39%), Gaps = 65/235 (27%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE----REACLLAE-- 424
+G GA+G V++A+ + + VA+K ++ RE LL
Sbjct: 17 IGVGAYGTVYKAR-------DPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69
Query: 425 -FDHPNIVKLLGVCAVGKPMC-----LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
F+HPN+V+L+ VCA + L+FE++ + DL +L P
Sbjct: 70 AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP-------------- 114
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
P L + + Q G+ +L VHRDL N L+ VK+ADFGL+R
Sbjct: 115 ----PGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 539 YLQDYYKGDENDAIPVRWMPL---------ESILYNKYTVESDVWAFGVCLWEIF 584
+ + P+ E +L + Y D+W+ G C IF
Sbjct: 171 ------------SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVG-C---IF 209
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 1e-22
Identities = 61/257 (23%), Positives = 94/257 (36%), Gaps = 63/257 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
+LG+GAF V + K GL A K++ + S EREA + + H
Sbjct: 12 EELGKGAFSVVRRCVHKTTGLE-------FAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIV+L L+F+ + G+L F I + YS ++S
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL--FEDIVA-----REFYSEADAS--------- 108
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQD-- 542
QI + Y VHR+L N L+ VK+ADFGL+ ++ +
Sbjct: 109 ----HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW 164
Query: 543 -------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ----PY 591
Y + E + + Y+ D+WA GV L + L P+
Sbjct: 165 HGFAGTPGY------------LSPEVLKKDPYSKPVDIWACGVIL-----YILLVGYPPF 207
Query: 592 YGLTHEEVVKYIKEGNI 608
+ + IK G
Sbjct: 208 WDEDQHRLYAQIKAGAY 224
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 59/290 (20%), Positives = 104/290 (35%), Gaps = 57/290 (19%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-KDEASEYLQTDF----EREACLLAE 424
LG G FG V+ VA+K + KD S++ + E LL +
Sbjct: 49 PLLGSGGFGSVYSGI------RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 425 FDH--PNIVKLLGVCAVGKPMCLLFEY-MGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
+++LL L+ E DL DF+ G +
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE-------RGALQEELAR--- 152
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYL 540
+ Q+ + + + +HRD+ N LI+ ++ +K+ DFG L
Sbjct: 153 ----------SFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LL 200
Query: 541 QD-YYK---GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLT 595
+D Y G + P E I Y++Y + VW+ G+ L+++ + P+
Sbjct: 201 KDTVYTDFDGTRVYSPP------EWIRYHRYHGRSAAVWSLGILLYDMVCGDI-PFEH-- 251
Query: 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ I G + L++ C ++P +RP+F I W
Sbjct: 252 ----DEEIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 1e-22
Identities = 40/303 (13%), Positives = 90/303 (29%), Gaps = 47/303 (15%)
Query: 371 RDLGQGAFGRVFQAK----------------------APGLLKHEEFTLVAVKMLKDEAS 408
LGQ +A A +K E L ++ +K++
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 409 EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG-RGDLNDFLRICSPNNY 467
+ F L+ + ++++ + F Y + +L F + ++
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 468 INGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVV 527
+ + + + LQ+ + L VH L + +++ + V
Sbjct: 199 THKSLVHHAR-------------LQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGV 245
Query: 528 KIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-----YTVESDVWAFGVCLWE 582
+ F + + P +I Y++ T D WA G+ ++
Sbjct: 246 FLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 583 IFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642
I+ L P ++ I ++ N P + L++ +R +
Sbjct: 306 IWCADL-PITKDAALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359
Query: 643 TLW 645
T
Sbjct: 360 TPE 362
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 69/306 (22%), Positives = 126/306 (41%), Gaps = 61/306 (19%)
Query: 349 TDARLNPKLEQLEFPRND--IIYVRD--LGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML 403
+ + L ++ + D ++ + +G+G+FG VF+ +VA+K++
Sbjct: 2 AHSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGI------DNRTQKVVAIKII 55
Query: 404 KDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS 463
E +E D ++E +L++ D P + K G + ++ EY+G G D L
Sbjct: 56 DLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--- 112
Query: 464 PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523
G E+ I TI +I G+ YL K +HRD+ N L+++
Sbjct: 113 -----PGPLD--ETQIA-----------TILREILKGLDYLHSEKKIHRDIKAANVLLSE 154
Query: 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVR--------WMPLESILYNKYTVESDVWA 575
VK+ADFG++ ++ D R WM E I + Y ++D+W+
Sbjct: 155 HGEVKLADFGVAGQL----------TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWS 204
Query: 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP-----DNTPDALYDLMKLCWNMK 630
G+ E+ +P + H V ++ I + N L + ++ C N +
Sbjct: 205 LGITAIELAR--GEPPHSELHPMKVLFL----IPKNNPPTLEGNYSKPLKEFVEACLNKE 258
Query: 631 PMNRPS 636
P RP+
Sbjct: 259 PSFRPT 264
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 1e-22
Identities = 45/164 (27%), Positives = 72/164 (43%), Gaps = 20/164 (12%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
LG G + V++ VA+K +K ++ E + RE L+ E H NIV+
Sbjct: 13 LGNGTYATVYKGLN---KTTGV--YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVR 67
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
L V + L+FE+M DL ++ + N G L +
Sbjct: 68 LYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRG--------------LELNLVKY 112
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
Q+ G+ + + K +HRDL +N LIN + +K+ DFGL+R
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 60/329 (18%), Positives = 107/329 (32%), Gaps = 66/329 (20%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLK----DEASEYLQTDFEREACLLAE 424
+GQG++G V A + A+K++ + + + E L+ +
Sbjct: 32 GAIGQGSYGVVRVAIENQTRAI-------RAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HPNI +L V + +CL+ E G L ++ + G + P
Sbjct: 85 LHHPNIARLYEVYEDEQYICLVMELCHGGHL--LDKLNVFIDDSTGKCAMDVVKTQICPC 142
Query: 485 LSTCDLIT----------------------IALQIASGMVYLSDRKFVHRDLATRNCLI- 521
+ I QI S + YL ++ HRD+ N L
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFS 202
Query: 522 -NDQMVVKIADFGLSRKMYLQDYYKGDENDAI--------PVRWMPLESILYN--KYTVE 570
N +K+ DFGLS++ Y + + P E + Y +
Sbjct: 203 TNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP------EVLNTTNESYGPK 256
Query: 571 SDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI-LQAP--DNTPDALYDLMKLCW 627
D W+ GV L + P+ G+ + + + + + P + DL+
Sbjct: 257 CDAWSAGVLLH-LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315
Query: 628 NMKPMNRPSFRTIYQTL---WNIKRDLEN 653
N R + L W I + +
Sbjct: 316 NRNVDERF---DAMRALQHPW-ISQFSDK 340
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 2e-22
Identities = 67/330 (20%), Positives = 112/330 (33%), Gaps = 66/330 (20%)
Query: 340 LPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTL 397
L N + D ++ + + R++ I + LG GA G V A +
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC-------KK 162
Query: 398 VAVKML-------KDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYM 450
VA++++ + E E +L + +HP I+K+ + ++ E M
Sbjct: 163 VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELM 221
Query: 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510
G+L F ++ N Q+ + YL + +
Sbjct: 222 EGGEL--FDKVVG-----NKRLKEATCK-------------LYFYQMLLAVQYLHENGII 261
Query: 511 HRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDYYK---GDENDAIP-VRWMPLESIL 563
HRDL N L+ + ++KI DFG S+ + + G P V L S+
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEV----LVSVG 317
Query: 564 YNKYTVESDVWAFGVCLWEIFSFAL----QPYYG-LTHEEVVKYIKEGNI----LQAPDN 614
Y D W+ GV L F P+ T + I G +
Sbjct: 318 TAGYNRAVDCWSLGVIL-----FICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 615 TPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ AL DL+K + P R T + L
Sbjct: 373 SEKAL-DLVKKLLVVDPKARF---TTEEAL 398
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 43/267 (16%), Positives = 92/267 (34%), Gaps = 62/267 (23%)
Query: 345 SYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK 404
S + LN +++ + ND +R L QG F ++ + A+K +
Sbjct: 11 SNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDN-------KFYALKKYE 63
Query: 405 ----------------DEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFE 448
+ + DF+ E ++ + + + G+ + +++E
Sbjct: 64 KSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYE 123
Query: 449 YMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL-SDR 507
YM + F + + + I + + Y+ +++
Sbjct: 124 YMENDSILKFDEYFFVLDKN------------YTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 508 KFVHRDLATRNCLINDQMVVKIADFGLSRKM---YLQ------DYYKGDENDAIPVRWMP 558
HRD+ N L++ VK++DFG S M ++ ++ MP
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEF-------------MP 218
Query: 559 LESILYNK---YTVESDVWAFGVCLWE 582
E N+ + D+W+ G+CL+
Sbjct: 219 PE-FFSNESSYNGAKVDIWSLGICLYV 244
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 2e-22
Identities = 59/233 (25%), Positives = 89/233 (38%), Gaps = 56/233 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT-LVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV 431
+G+G +G V++AK K + A+K ++ + RE LL E HPN++
Sbjct: 29 VGRGTYGHVYKAKR----KDGKDDKDYALKQIEGTG--ISMSAC-REIALLRELKHPNVI 81
Query: 432 KLLGVCAVGKPMC---LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
L V + LLF+Y DL ++ + + + QL
Sbjct: 82 SLQKVF-LSHADRKVWLLFDYAEH-DLWHIIKFHRASK-----------ANKKPVQLPRG 128
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMY--LQD 542
+ ++ QI G+ YL +HRDL N L+ ++ VKIAD G +R L+
Sbjct: 129 MVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKP 188
Query: 543 YYKGDENDAIPV--RWMPLESILY---------NKYTVESDVWAFGVCLWEIF 584
D V W Y YT D+WA G C IF
Sbjct: 189 LADLDPV----VVTFW-------YRAPELLLGARHYTKAIDIWAIG-C---IF 226
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-22
Identities = 57/258 (22%), Positives = 91/258 (35%), Gaps = 64/258 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
+LG+GAF V + G A ++ + S EREA + H
Sbjct: 17 EELGKGAFSVVRRCVKVLAG-------QEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIV+L + L+F+ + G+L F I + YS ++S
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGEL--FEDIVA-----REYYSEADAS--------- 113
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM-----Y 539
QI +++ VHR+L N L+ VK+ADFGL+ ++
Sbjct: 114 ----HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169
Query: 540 LQD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ----P 590
Y + E + + Y D+WA GV L + L P
Sbjct: 170 WFGFAGTPGY------------LSPEVLRKDPYGKPVDLWACGVIL-----YILLVGYPP 212
Query: 591 YYGLTHEEVVKYIKEGNI 608
++ + + IK G
Sbjct: 213 FWDEDQHRLYQQIKAGAY 230
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 59/238 (24%), Positives = 100/238 (42%), Gaps = 73/238 (30%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
+G+GA+G+VF+A+ + VA+K ++ +QT E RE +L
Sbjct: 19 IGEGAYGKVFKAR------DLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAVLR 66
Query: 424 E---FDHPNIVKLLGVCAVGKP-----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
F+HPN+V+L VC V + + L+FE++ + DL +L
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKV------------- 112
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
P + T + + Q+ G+ +L + VHRDL +N L+ +K+ADFGL+
Sbjct: 113 -----PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167
Query: 536 RKMYLQDYYKGDENDAIPVRWMPL---------ESILYNKYTVESDVWAFGVCLWEIF 584
R + + + E +L + Y D+W+ G C IF
Sbjct: 168 RIY------------SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG-C---IF 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 68/281 (24%), Positives = 118/281 (41%), Gaps = 55/281 (19%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG GAFG+V++A K G L A K+++ ++ E L+ D+ E +LA DHP I
Sbjct: 27 LGDGAFGKVYKAKNKETG-------ALAAAKVIETKSEEELE-DYIVEIEILATCDHPYI 78
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
VKLLG + ++ E+ G ++ + + + E I
Sbjct: 79 VKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL------DRGLT--EPQIQ---------- 120
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
+ Q+ + +L ++ +HRDL N L+ + +++ADFG+S K
Sbjct: 121 -VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN----------LK 169
Query: 551 AIPVR--------WMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ R WM E ++ Y ++D+W+ G+ L E+ P++ L
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE-PPHHELNPM 228
Query: 598 EVVKYIKEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
V+ I + + L P D +K+ + P RPS
Sbjct: 229 RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPS 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 52/254 (20%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM-----LKDEASEYLQTDFEREACLLA 423
+LG G F V + K+ GL A K K + D ERE +L
Sbjct: 17 EELGSGQFAVVKKCREKSTGLQ-------YAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
E HPN++ L V + L+ E + G+L F + +
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGEL--FDFLAEKESL---------------- 111
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMY 539
+ + QI +G+ YL + H DL N ++ + +KI DFGL+ K+
Sbjct: 112 --TEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI- 168
Query: 540 LQDYYKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
D + ++ E + Y +E+D+W+ GV + + S P+ G
Sbjct: 169 -------DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGD 220
Query: 595 THEEVVKYIKEGNI 608
T +E + + N
Sbjct: 221 TKQETLANVSAVNY 234
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-22
Identities = 58/252 (23%), Positives = 101/252 (40%), Gaps = 45/252 (17%)
Query: 366 DIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
+ LG G FG+V + A GL +A K++K + + + + E ++
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLK-------LAAKIIKTRGMK-DKEEVKNEISVMN 141
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ DH N+++L + L+ EY+ G+L F RI I
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGEL--FDRI-----------------IDESY 182
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN--CLINDQMVVKIADFGLSRKMYLQ 541
L+ D I QI G+ ++ +H DL N C+ D +KI DFGL+R+
Sbjct: 183 NLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY--- 239
Query: 542 DYYKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+ + V ++ E + Y+ + +D+W+ GV + + S L P+ G
Sbjct: 240 -----KPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLS-GLSPFLGDND 293
Query: 597 EEVVKYIKEGNI 608
E + I
Sbjct: 294 AETLNNILACRW 305
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 49/226 (21%), Positives = 79/226 (34%), Gaps = 48/226 (21%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-------KDEASEYLQTDFEREACL 421
+ LG GA G V A + VA+K++ + E E +
Sbjct: 16 KTLGSGACGEVKLAFERKTC-------KKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
L + +HP I+K+ + ++ E M G+L F ++ N
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGEL--FDKVVG-----NKRLKEATCK--- 117
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM 538
Q+ + YL + +HRDL N L+ + ++KI DFG S+ +
Sbjct: 118 ----------LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 539 YLQDYYK---GDENDAIP-VRWMPLESILYNKYTVESDVWAFGVCL 580
+ G P V L S+ Y D W+ GV L
Sbjct: 168 GETSLMRTLCGTPTYLAPEV----LVSVGTAGYNRAVDCWSLGVIL 209
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-22
Identities = 52/247 (21%), Positives = 94/247 (38%), Gaps = 45/247 (18%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+LG GAFG V + KA G + K + + E ++ + HP
Sbjct: 57 EELGSGAFGVVHRCVEKATGRV-------FVAKFINTPYPLDKY-TVKNEISIMNQLHHP 108
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
++ L M L+ E++ G+L F RI ++S
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGEL--FDRI-----------------AAEDYKMSEA 149
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ--MVVKIADFGLSRKMYLQDYYKG 546
++I Q G+ ++ + VH D+ N + + VKI DFGL+ K+
Sbjct: 150 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL-------- 201
Query: 547 DENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ ++ + V + E + +D+WA GV + + S L P+ G E ++
Sbjct: 202 NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS-GLSPFAGEDDLETLQ 260
Query: 602 YIKEGNI 608
+K +
Sbjct: 261 NVKRCDW 267
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 6e-22
Identities = 60/267 (22%), Positives = 99/267 (37%), Gaps = 73/267 (27%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM-------LKDEASEYLQTDFEREACL 421
+G+G V + +A G AVK+ L E E ++ RE +
Sbjct: 100 DVIGRGVSSVVRRCVHRATG-------HEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 422 LAE-FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
L + HP+I+ L+ M L+F+ M +G+L F + S E+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL--FDYLTE-----KVALSEKETR-- 203
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM-- 538
+I + + +L VHRDL N L++D M ++++DFG S +
Sbjct: 204 -----------SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
Query: 539 --YLQD-----YY------KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
L++ Y K ++ P Y E D+WA GV L
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHP------------GYGKEVDLWACGVIL----- 295
Query: 586 FAL----QPYYGLTHEEVVKYIKEGNI 608
F L P++ +++ I EG
Sbjct: 296 FTLLAGSPPFWHRRQILMLRMIMEGQY 322
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 97.8 bits (243), Expect = 6e-22
Identities = 38/296 (12%), Positives = 74/296 (25%), Gaps = 34/296 (11%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML--KDEASEYLQTDFEREAC---LLAEF 425
LGQ +A E V + + + E LL
Sbjct: 84 TVLGQEDPYAYLEATDQET--GES---FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 426 DHPNIV----KLLGVCAVGKPMCLLFEYMGRGDLNDF--LRICSPNNYINGTYSSMESSI 479
+ + + + K R D D L + + +
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 480 HRVPQ----LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
L + + LQ+ + L VH L + +++ + V + F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 536 RKMYLQDYYKGDENDA------IPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589
+ R +P T D W G+ ++ I+ L
Sbjct: 259 VRD--GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL- 315
Query: 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
P ++ I ++ N P + L++ +R +T
Sbjct: 316 PNTDDAALGGSEW-----IFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 42/247 (17%), Positives = 96/247 (38%), Gaps = 46/247 (18%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
DLG+G FG V + + K +K + ++ Q ++E +L H
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKT-------YMAKFVKVKGTD--QVLVKKEISILNIARHR 61
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+ L + + ++FE++ D+ F RI +L+
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDI--FERI-----------------NTSAFELNER 102
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ--MVVKIADFGLSRKMYLQDYYKG 546
++++ Q+ + +L H D+ N + + +KI +FG +R++
Sbjct: 103 EIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL-------- 154
Query: 547 DENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
D + + E ++ + +D+W+ G ++ + S + P+ T++++++
Sbjct: 155 KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIE 213
Query: 602 YIKEGNI 608
I
Sbjct: 214 NIMNAEY 220
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 9e-22
Identities = 53/258 (20%), Positives = 92/258 (35%), Gaps = 60/258 (23%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM-----LKDEASEYLQTDFEREACLLA 423
+LG G F V + K G A K L + + ERE +L
Sbjct: 11 EELGSGQFAIVRKCRQKGTGKE-------YAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
E HPNI+ L + + L+ E + G+L F + +
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGEL--FDFLAEKESL---------------- 105
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKM- 538
+ + QI G+ YL ++ H DL N ++ +K+ DFG++ K+
Sbjct: 106 --TEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163
Query: 539 ---YLQD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590
++ + + E + Y +E+D+W+ GV + + S P
Sbjct: 164 AGNEFKNIFGTPEF------------VAPEIVNYEPLGLEADMWSIGVITYILLS-GASP 210
Query: 591 YYGLTHEEVVKYIKEGNI 608
+ G T +E + I N
Sbjct: 211 FLGETKQETLTNISAVNY 228
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/238 (24%), Positives = 96/238 (40%), Gaps = 77/238 (32%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
LG+G +G V++A + T VA+K ++ L+ + E RE LL
Sbjct: 42 LGEGTYGEVYKAI-------DTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLLK 88
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
E H NI++L V + L+FEY DL + + + P
Sbjct: 89 ELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKY--------------------MDKNP 127
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-----DQMVVKIADFGLSRKM 538
+S + + Q+ +G+ + R+ +HRDL +N L++ + V+KI DFGL+R
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
Query: 539 YLQDYYKGDENDAIPVRWM----------PLESILY--NKYTVESDVWAFGVCLWEIF 584
IP+R P E IL Y+ D+W+ C I+
Sbjct: 188 ------------GIPIRQFTHEIITLWYRPPE-ILLGSRHYSTSVDIWSIA-C---IW 228
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 2e-21
Identities = 49/247 (19%), Positives = 93/247 (37%), Gaps = 45/247 (18%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
+LG GAFG V + +A G A K + + +E ++ HP
Sbjct: 163 EELGTGAFGVVHRVTERATGNN-------FAAKFVMTPHES-DKETVRKEIQTMSVLRHP 214
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+V L M +++E+M G+L F ++ +N +S
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGEL--FEKVADEHNK-----------------MSED 255
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRN--CLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ + Q+ G+ ++ + +VH DL N +K+ DFGL+ +
Sbjct: 256 EAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL-------- 307
Query: 547 DENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
D ++ V + E +D+W+ GV + + S L P+ G +E ++
Sbjct: 308 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLR 366
Query: 602 YIKEGNI 608
+K +
Sbjct: 367 NVKSCDW 373
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 41/282 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+G GA V A + VA+K + E + + +E +++ HPNIV
Sbjct: 23 IGSGATAVVQAAYCAPKKE-----KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492
V + L+ + + G + D ++ ES+I T
Sbjct: 78 YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTI-----------AT 125
Query: 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI 552
I ++ G+ YL +HRD+ N L+ + V+IADFG+S + G +
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL-----ATGGDITRN 180
Query: 553 PVR--------WMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
VR WM E + + Y ++D+W+FG+ E+ + A PY+ +V+
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA-APYHKYPPMKVLMLT 239
Query: 604 KEGN--ILQAPDNTPD-------ALYDLMKLCWNMKPMNRPS 636
+ + L+ + + ++ LC P RP+
Sbjct: 240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 66/293 (22%), Positives = 105/293 (35%), Gaps = 61/293 (20%)
Query: 371 RDLGQGAFGRVFQAK--APGLLKHEEFTLVAVKML-KDEASEYLQTD----FEREACLL- 422
LG+G FG VF L VA+K++ ++ + E LL
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQ-------VAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 423 ---AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESS 478
A HP +++LL + L+ E DL D++ G S
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE-------KGPLGEGPS- 141
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM-VVKIADFGLSRK 537
R Q+ + + + R VHRD+ N LI+ + K+ DFG
Sbjct: 142 --RC----------FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA- 188
Query: 538 MYLQD-YYK---GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYY 592
L D Y G + P E I ++Y + + VW+ G+ L+++ + P+
Sbjct: 189 -LLHDEPYTDFDGTRVYSPP------EWISRHQYHALPATVWSLGILLYDMVCGDI-PFE 240
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ I E L P + L++ C KP +RPS I W
Sbjct: 241 R------DQEILEAE-LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 61/255 (23%), Positives = 95/255 (37%), Gaps = 62/255 (24%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
LG GAF VF + G L A+K +K ++ + + E E +L + H
Sbjct: 15 EVLGSGAFSEVFLVKQRLTG-------KLFALKCIK-KSPAFRDSSLENEIAVLKKIKHE 66
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV L + L+ + + G+L F RI G Y+ ++S
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGEL--FDRILE-----RGVYTEKDAS---------- 109
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKM---YLQD 542
+ Q+ S + YL + VHRDL N L + + I DFGLS+ +
Sbjct: 110 ---LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166
Query: 543 -----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL----QPYYG 593
Y + E + Y+ D W+ GV + L P+Y
Sbjct: 167 ACGTPGY------------VAPEVLAQKPYSKAVDCWSIGVIT-----YILLCGYPPFYE 209
Query: 594 LTHEEVVKYIKEGNI 608
T ++ + IKEG
Sbjct: 210 ETESKLFEKIKEGYY 224
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 66/307 (21%), Positives = 109/307 (35%), Gaps = 80/307 (26%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVK--------MLKDEASEYLQTDFEREAC 420
LG+G V + K AVK E + L+ +E
Sbjct: 23 EILGRGVSSVVRRCIHKPTC-------KEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 421 LLAEFD-HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L + HPNI++L L+F+ M +G+L F + T S E+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--FDYLTE-----KVTLSEKETR- 127
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM- 538
I + + L VHRDL N L++D M +K+ DFG S ++
Sbjct: 128 ------------KIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175
Query: 539 ---YLQD-----YY------KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
L++ Y + ND + Y E D+W+ GV +
Sbjct: 176 PGEKLREVCGTPSYLAPEIIECSMNDN------------HPGYGKEVDMWSTGVIM---- 219
Query: 585 SFAL----QPYYGLTHEEVVKYIKEGNI-LQAP--DNTPDALYDLMKLCWNMKPMNRPSF 637
+ L P++ +++ I GN +P D+ D + DL+ ++P R
Sbjct: 220 -YTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY-- 276
Query: 638 RTIYQTL 644
T + L
Sbjct: 277 -TAEEAL 282
|
| >1ki0_A Angiostatin; kringle domains, hydrolase; HET: BCN; 1.75A {Homo sapiens} SCOP: g.14.1.1 g.14.1.1 g.14.1.1 PDB: 2doh_X* 2doi_X 1cea_A 1ceb_A* 1b2i_A* 1pkr_A 2l0s_A 2kj4_A 1i5k_A 1hpj_A 1hpk_A* Length = 253 | Back alignment and structure |
|---|
Score = 92.1 bits (227), Expect = 5e-21
Identities = 32/91 (35%), Positives = 44/91 (48%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
+C G G+ Y+GT++ T G+ CQ+W + PH P P ENYCRN +
Sbjct: 3 ECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQG 62
Query: 246 PWCYTMDPNVRWQRCEIPTCADSMQDDVKSW 276
PWCYT DP R+ C+I C +
Sbjct: 63 PWCYTTDPEKRYDYCDILECEEECMHCSGEN 93
|
| >1ki0_A Angiostatin; kringle domains, hydrolase; HET: BCN; 1.75A {Homo sapiens} SCOP: g.14.1.1 g.14.1.1 g.14.1.1 PDB: 2doh_X* 2doi_X 1cea_A 1ceb_A* 1b2i_A* 1pkr_A 2l0s_A 2kj4_A 1i5k_A 1hpj_A 1hpk_A* Length = 253 | Back alignment and structure |
|---|
Score = 88.3 bits (217), Expect = 1e-19
Identities = 50/143 (34%), Positives = 67/143 (46%), Gaps = 8/143 (5%)
Query: 123 RYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDE 182
Y +++N R + R P C T + T +
Sbjct: 119 GYIPSKFPNKNLKKNYCRNPDRELR-----PWCFTTDPN--KRWELCDIPRCTTPPPSSG 171
Query: 183 ITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGE 242
TY C++G G Y+G V TV G CQ W A+ PH HER P FP N ENYCRN G+
Sbjct: 172 PTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHERTPENFPCKNLDENYCRNPDGK 231
Query: 243 EPSPWCYTMDPNVRWQRCEIPTC 265
+PWC+T + VRW+ C+IP+C
Sbjct: 232 R-APWCHTTNSQVRWEYCKIPSC 253
|
| >1ki0_A Angiostatin; kringle domains, hydrolase; HET: BCN; 1.75A {Homo sapiens} SCOP: g.14.1.1 g.14.1.1 g.14.1.1 PDB: 2doh_X* 2doi_X 1cea_A 1ceb_A* 1b2i_A* 1pkr_A 2l0s_A 2kj4_A 1i5k_A 1hpj_A 1hpk_A* Length = 253 | Back alignment and structure |
|---|
Score = 71.3 bits (173), Expect = 6e-14
Identities = 49/174 (28%), Positives = 69/174 (39%), Gaps = 17/174 (9%)
Query: 103 VTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYE 162
T NGI C + + ++ + E + P C T
Sbjct: 18 KTKNGIT-----CQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYT----- 67
Query: 163 VVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERP 222
T + E +C+ G Y G ++ T+ GL CQ WD++ PHAH
Sbjct: 68 ------TDPEKRYDYCDILECEEECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYI 121
Query: 223 PPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQDDVKSW 276
P FP N +NYCRN E PWC+T DPN RW+ C+IP C ++
Sbjct: 122 PSKFPNKNLKKNYCRNPDR-ELRPWCFTTDPNKRWELCDIPRCTTPPPSSGPTY 174
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 5e-21
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 47/228 (20%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
V+ LG+GA+G V A + T VAVK++ + + + ++E C+ +H
Sbjct: 12 VQTLGEGAYGEVQLAV------NRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
N+VK G G L EY G+L F RI + ++ R
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEP-----DIGMPEPDA--QRFFH--- 112
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK-- 545
Q+ +G+VYL HRD+ N L++++ +KI+DFGL+ + +
Sbjct: 113 --------QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 546 ----GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFAL 588
G P E + ++ DVW+ G+ L A+
Sbjct: 165 NKMCGTLPYVAP------ELLKRREFHAEPVDVWSCGIVL-----TAM 201
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-21
Identities = 76/282 (26%), Positives = 117/282 (41%), Gaps = 41/282 (14%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEA--SEYLQTDFEREACLLAEFDH 427
LG G FG+V + H+ VAVK+L + S + +RE L F H
Sbjct: 17 DTLGVGTFGKVKIGE------HQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P+I+KL V + ++ EY+ G+L D++ RV ++
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-----------------CKHGRVEEMEA 113
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK-- 545
L QI S + Y VHRDL N L++ M KIADFGLS M ++ +
Sbjct: 114 RRLFQ---QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170
Query: 546 -GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
G N A P E I Y E D+W+ GV L+ + L P+ + K I
Sbjct: 171 CGSPNYAAP------EVISGRLYAGPEVDIWSCGVILYALLCGTL-PFDDEHVPTLFKKI 223
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ G + P+ ++ L+ + P+ R + + I + W
Sbjct: 224 RGG-VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEW 264
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 60/257 (23%), Positives = 97/257 (37%), Gaps = 56/257 (21%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML---KDEASEYLQT-DFEREACLLAE 424
+G+G F V + + G AVK++ K +S L T D +REA +
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQ-------FAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HP+IV+LL + + ++FE+M DL I + YS +S
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADL--CFEIVKRAD-AGFVYSEAVAS------ 133
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMY-- 539
QI + Y D +HRD+ L+ + VK+ FG++ ++
Sbjct: 134 -------HYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES 186
Query: 540 ---LQD-----YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
++ M E + Y DVW GV L+ + S P+
Sbjct: 187 GLVAGGRVGTPHF------------MAPEVVKREPYGKPVDVWGCGVILFILLS-GCLPF 233
Query: 592 YGLTHEEVVKYIKEGNI 608
YG T E + + I +G
Sbjct: 234 YG-TKERLFEGIIKGKY 249
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 9e-21
Identities = 55/228 (24%), Positives = 92/228 (40%), Gaps = 47/228 (20%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
V+ LG+GA+G V A + T VAVK++ + + + ++E C+ +H
Sbjct: 12 VQTLGEGAYGEVQLAV------NRV-TEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 64
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
N+VK G G L EY G+L F RI + ++ R
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGEL--FDRIEP-----DIGMPEPDA--QRFFH--- 112
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK-- 545
Q+ +G+VYL HRD+ N L++++ +KI+DFGL+ + +
Sbjct: 113 --------QLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164
Query: 546 ----GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFAL 588
G P E + ++ DVW+ G+ L A+
Sbjct: 165 NKMCGTLPYVAP------ELLKRREFHAEPVDVWSCGIVL-----TAM 201
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 41/174 (23%), Positives = 70/174 (40%), Gaps = 44/174 (25%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
+G+G++G V + + + T +VA+K + + + RE LL
Sbjct: 33 VGEGSYGMVMKCR-------NKDTGRIVAIKKFLESDDD------KMVKKIAMREIKLLK 79
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ H N+V LL VC K L+FE++ + D L P
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLE--------------------LFP 118
Query: 484 QLSTCDLI-TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
++ QI +G+ + +HRD+ N L++ VVK+ DFG +R
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 41/174 (23%), Positives = 66/174 (37%), Gaps = 44/174 (25%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
+G+G++G VF+ + T +VA+K D RE +L
Sbjct: 11 IGEGSYGVVFKCR-------NRDTGQIVAIKKFL------ESEDDPVIKKIALREIRMLK 57
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ HPN+V LL V + + L+FEY + L R
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELD--------------------RYQ 96
Query: 484 QLSTCDLI-TIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ L+ +I Q + + +HRD+ N LI V+K+ DFG +R
Sbjct: 97 RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 76/283 (26%), Positives = 113/283 (39%), Gaps = 44/283 (15%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDE--ASEYLQTDFEREACLLAEFD 426
LG+G+FG+V A H + T VA+K + + + ERE L
Sbjct: 15 ETLGEGSFGKVKLAT------HYK-TQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP+I+KL V + ++ EY G G+L D++ R+ +
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYAG-GELFDYI-----------------VEKKRMTEDE 109
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK- 545
QI + Y K VHRDL N L++D + VKIADFGLS M ++ K
Sbjct: 110 GRRFFQ---QIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166
Query: 546 --GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
G N A P E I Y E DVW+ G+ L+ + L P+ + K
Sbjct: 167 SCGSPNYAAP------EVINGKLYAGPEVDVWSCGIVLYVMLVGRL-PFDDEFIPNLFKK 219
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ + PD L++ PM R + + I + W
Sbjct: 220 VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 52/182 (28%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFE-------REACLLA 423
+GQG FG VF+A+ T VA+K + ++ + E RE +L
Sbjct: 25 IGQGTFGEVFKAR-------HRKTGQKVALKKVL------MENEKEGFPITALREIKILQ 71
Query: 424 EFDHPNIVKLLGVCAVGKPMC---------LLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
H N+V L+ +C K L+F++ DL L
Sbjct: 72 LLKHENVVNLIEIC-RTKASPYNRCKGSIYLVFDFCEH-DLAGLLS-------------- 115
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
+ + + + ++ + + +G+ Y+ K +HRD+ N LI V+K+ADFGL
Sbjct: 116 -----NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
Query: 535 SR 536
+R
Sbjct: 171 AR 172
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-20
Identities = 56/250 (22%), Positives = 95/250 (38%), Gaps = 46/250 (18%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDH 427
++LG+G F V Q K+ G A K L K + + + E +L
Sbjct: 35 KELGRGKFAVVRQCISKSTGQE-------YAAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 428 -PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
P ++ L V + L+ EY G++ F S E+
Sbjct: 88 CPRVINLHEVYENTSEIILILEYAAGGEI--FSLCLPEL---AEMVS--EN--------- 131
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDY 543
D+I + QI G+ YL VH DL +N L+ +KI DFG+SRK+
Sbjct: 132 --DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----- 184
Query: 544 YKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
+ ++ E + Y+ T +D+W G+ + + + P+ G ++E
Sbjct: 185 ---GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT-HTSPFVGEDNQE 240
Query: 599 VVKYIKEGNI 608
I + N+
Sbjct: 241 TYLNISQVNV 250
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 52/276 (18%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI 430
LG+G++G V++A K G +VA+K + E+ + +E ++ + D P++
Sbjct: 37 LGEGSYGSVYKAIHKETG-------QIVAIKQVPVESDL---QEIIKEISIMQQCDSPHV 86
Query: 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL 490
VK G + ++ EY G G ++D +R+ N + E I
Sbjct: 87 VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLR--NKTLT------EDEIA---------- 128
Query: 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEND 550
TI G+ YL + +HRD+ N L+N + K+ADFG++ ++ D
Sbjct: 129 -TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL----------TD 177
Query: 551 AIPVR--------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ R WM E I Y +D+W+ G+ E+ PY + +
Sbjct: 178 TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK-PPYADIHPMRAIFM 236
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
I + P+ D D +K C P R +
Sbjct: 237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT 272
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 61/258 (23%), Positives = 90/258 (34%), Gaps = 60/258 (23%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDI--IYV--RDLGQGAFGRVFQA--KAPGLLKHEE 394
AS A L P R+ + + +LG+GA V++ K
Sbjct: 25 SVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQ------ 78
Query: 395 FTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGD 454
A+K+LK + E +L HPNI+KL + + L+ E + G+
Sbjct: 79 -KPYALKVLKKTVDK---KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE 134
Query: 455 LNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514
L F RI G YS +++ QI + YL + VHRDL
Sbjct: 135 L--FDRIVE-----KGYYSERDAA-------------DAVKQILEAVAYLHENGIVHRDL 174
Query: 515 ATRNCLI---NDQMVVKIADFGLSRKMYLQD---------YYKGDENDAIPVRWMPLESI 562
N L +KIADFGLS+ + Q Y E +
Sbjct: 175 KPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGY------------CAPEIL 222
Query: 563 LYNKYTVESDVWAFGVCL 580
Y E D+W+ G+
Sbjct: 223 RGCAYGPEVDMWSVGIIT 240
|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A Length = 122 | Back alignment and structure |
|---|
Score = 84.9 bits (209), Expect = 7e-20
Identities = 24/102 (23%), Positives = 32/102 (31%), Gaps = 5/102 (4%)
Query: 169 TCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHER---PPPV 225
C + + + C G G FY+G +T G C W++
Sbjct: 22 NCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDA 81
Query: 226 FPELNNSENYCRNAGGEEPSPWCYTMDPN-VRWQRCEIPTCA 266
NYCRN PWCY Q C + CA
Sbjct: 82 LQLGLGKHNYCRNPDNRR-RPWCYVQVGLKPLVQECMVHDCA 122
|
| >3nxp_A Prethrombin-1; allostery, blood coagulation, hydro kringle, serine protease, zymogen; HET: NAG; 2.20A {Homo sapiens} Length = 424 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 2e-19
Identities = 24/87 (27%), Positives = 42/87 (48%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
C+ RG+ YQG + T GL C W + + A + + EN+CRN G+E
Sbjct: 14 QCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEG 73
Query: 246 PWCYTMDPNVRWQRCEIPTCADSMQDD 272
WCY + C++ C ++++++
Sbjct: 74 VWCYVAGKPGDFGYCDLNYCEEAVEEE 100
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 49/225 (21%), Positives = 84/225 (37%), Gaps = 50/225 (22%)
Query: 373 LGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE-FDHPN 429
LG+GA RV +E+ AVK+++ + +++ RE +L + H N
Sbjct: 21 LGEGAHARVQTCINLITS----QEY---AVKIIEKQPGH-IRSRVFREVEMLYQCQGHRN 72
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+++L+ L+FE M G + I ++ +E+S
Sbjct: 73 VLELIEFFEEEDRFYLVFEKMRGGSI--LSHIHK-----RRHFNELEAS----------- 114
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDYYKG 546
+ +AS + +L ++ HRDL N L N VKI DF L + L
Sbjct: 115 --VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSP 172
Query: 547 DENDAIP-------------VRWMPLESILYNKYTVESDVWAFGV 578
+ V E+ +Y+K D+W+ GV
Sbjct: 173 ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGV 214
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-19
Identities = 87/282 (30%), Positives = 120/282 (42%), Gaps = 41/282 (14%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDE--ASEYLQTDFEREACLLAEFDH 427
LG G FG+V K HE VAVK+L + S + RE L F H
Sbjct: 22 DTLGVGTFGKVKVGK------HELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
P+I+KL V + + ++ EY+ G+L F IC NG ES R+ Q
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGEL--FDYICK-----NGRLDEKES--RRLFQ--- 123
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK-- 545
QI SG+ Y VHRDL N L++ M KIADFGLS M ++ +
Sbjct: 124 --------QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175
Query: 546 -GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
G N A P E I Y E D+W+ GV L+ + L P+ + K I
Sbjct: 176 CGSPNYAAP------EVISGRLYAGPEVDIWSSGVILYALLCGTL-PFDDDHVPTLFKKI 228
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+G I P ++ L+K + PM R + + I + W
Sbjct: 229 CDG-IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
|
| >1nl1_A Prothrombin; hydrolase; HET: CGU NAG; 1.90A {Bos taurus} SCOP: g.14.1.1 g.32.1.1 PDB: 2pf2_A* 2pf1_A* 1nl2_A* 2spt_A* Length = 147 | Back alignment and structure |
|---|
Score = 83.5 bits (205), Expect = 5e-19
Identities = 35/118 (29%), Positives = 49/118 (41%)
Query: 150 FELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQ 209
FE + S E + + +C G G Y+G V+ T G+ CQ
Sbjct: 29 FEALESLSATDAFWAKYTACESARNPREKLNECLEGNCAEGVGMNYRGNVSVTRSGIECQ 88
Query: 210 RWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267
W ++ PH E P + EN+CRN G PWCYT P +R + C +P C
Sbjct: 89 LWRSRYPHKPEINSTTHPGADLRENFCRNPDGSITGPWCYTTSPTLRREECSVPVCGQ 146
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 50/225 (22%), Positives = 82/225 (36%), Gaps = 61/225 (27%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE-ACLLAEFDH 427
D+G G++ + KA EF AVK++ + D E LL H
Sbjct: 28 EDIGVGSYSVCKRCIHKATN----MEF---AVKIIDKS-----KRDPTEEIEILLRYGQH 75
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNI+ L V GK + ++ E M G+L +I +S E+S
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGEL--LDKILR-----QKFFSEREAS--------- 119
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI----NDQMVVKIADFGLSRKMYLQD- 542
+ I + YL + VHRDL N L + ++I DFG ++++ ++
Sbjct: 120 ----AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175
Query: 543 ---------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGV 578
+ + E + Y D+W+ GV
Sbjct: 176 LLMTPCYTANF------------VAPEVLERQGYDAACDIWSLGV 208
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 56/240 (23%), Positives = 94/240 (39%), Gaps = 43/240 (17%)
Query: 354 NPKLEQLEFPRN-DIIY--VRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKM--LKDE 406
+P + +L F + + ++ +R++G G+FG V+ A +VA+K +
Sbjct: 40 DPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNS-------EVVAIKKMSYSGK 92
Query: 407 ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNN 466
S D +E L + HPN ++ G L+ EY G +D L +
Sbjct: 93 QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVH---- 147
Query: 467 YINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526
E I + G+ YL +HRD+ N L+++ +
Sbjct: 148 --KKPLQ--EVEIA-----------AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 192
Query: 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEI 583
VK+ DFG + M + + G P WM E IL Y + DVW+ G+ E+
Sbjct: 193 VKLGDFGSASIMAPANSFVGT-----P-YWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 86.9 bits (215), Expect = 2e-18
Identities = 39/248 (15%), Positives = 82/248 (33%), Gaps = 35/248 (14%)
Query: 347 HQTDARLNPKLEQLEFPRNDIIYVRDLGQGA--FGRVFQAKAPGLLKHEEF-TLVAVKML 403
H + + + +G+G V A+ ++ V V+ +
Sbjct: 7 HHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLAR------YKPTGEYVTVRRI 60
Query: 404 K-DEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRIC 462
+ S + T + E + F+HPNIV + ++ +M G D +
Sbjct: 61 NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC-- 118
Query: 463 SPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522
+ + E +I I + + Y+ +VHR + + LI+
Sbjct: 119 ---THFMDGMN--ELAI-----------AYILQGVLKALDYIHHMGYVHRSVKASHILIS 162
Query: 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVR-----WMPLESILYNK--YTVESDVWA 575
V ++ + M + +D W+ E + N Y +SD+++
Sbjct: 163 VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222
Query: 576 FGVCLWEI 583
G+ E+
Sbjct: 223 VGITACEL 230
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 55/224 (24%), Positives = 84/224 (37%), Gaps = 59/224 (26%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-H 427
+ LG+G+F + K + F AVK++ + ++E L + H
Sbjct: 17 KPLGEGSFSICRKCVHKKSN----QAF---AVKIISKRMEA----NTQKEITALKLCEGH 65
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIVKL V L+ E + G+L F RI +S E+S
Sbjct: 66 PNIVKLHEVFHDQLHTFLVMELLNGGEL--FERIKK-----KKHFSETEAS--------- 109
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQD-- 542
I ++ S + ++ D VHRDL N L ND + +KI DFG +R +
Sbjct: 110 ----YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165
Query: 543 --------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGV 578
+Y E + N Y D+W+ GV
Sbjct: 166 LKTPCFTLHY------------AAPELLNQNGYDESCDLWSLGV 197
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 63/293 (21%), Positives = 109/293 (37%), Gaps = 55/293 (18%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTL--VAVKML---KDEASEYLQTDFEREACLLAEF 425
LG+G++G+V + E TL AVK+L K + + ++E LL
Sbjct: 11 DLLGEGSYGKVKEVL------DSE-TLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 426 DHPNIVKLLGV--CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
H N+++L+ V + M ++ EY G + R P
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE----------------KRFP 107
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
Q+ G+ YL + VH+D+ N L+ +KI+ G++ +
Sbjct: 108 VCQAHGYFC---QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL---HP 161
Query: 544 YKGDE---------NDAIPVRWMPLESILYNK-YT-VESDVWAFGVCLWEIFSFALQPYY 592
+ D+ P E ++ + D+W+ GV L+ I + P+
Sbjct: 162 FAADDTCRTSQGSPAFQPP------EIANGLDTFSGFKVDIWSAGVTLYNITTGLY-PFE 214
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
G ++ + I +G P + L DL+K +P R S R I Q W
Sbjct: 215 GDNIYKLFENIGKG-SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 61/219 (27%), Positives = 89/219 (40%), Gaps = 43/219 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEFDH 427
V+D+G G FG + + T LVAVK + E + + +RE H
Sbjct: 25 VKDIGSGNFGVARLMR------DKL-TKELVAVKYI--ERGAAIDENVQREIINHRSLRH 75
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
PNIV+ V + ++ EY G+L + RIC+ G +S E+ Q
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASGGEL--YERICN-----AGRFSEDEA--RFFFQ--- 123
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQMVVKIADFGLSRKMYLQDYYK 545
Q+ SG+ Y + HRDL N L+ + +KI DFG S+ L K
Sbjct: 124 --------QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175
Query: 546 ---GDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCL 580
G P E +L +Y +DVW+ GV L
Sbjct: 176 STVGTPAYIAP------EVLLRQEYDGKIADVWSCGVTL 208
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 5e-18
Identities = 59/246 (23%), Positives = 99/246 (40%), Gaps = 47/246 (19%)
Query: 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYL 411
L L P V +G G +G+V++ G L A+K++ E
Sbjct: 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTG-------QLAAIKVMDVTGDE-- 63
Query: 412 QTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMC------LLFEYMGRGDLNDFLRICSP 464
+ + ++E +L ++ H NI G P L+ E+ G G + D ++
Sbjct: 64 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG 123
Query: 465 NNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524
N + E I I +I G+ +L K +HRD+ +N L+ +
Sbjct: 124 N-------TLKEEWIA-----------YICREILRGLSHLHQHKVIHRDIKGQNVLLTEN 165
Query: 525 MVVKIADFGLSRKMYLQDYYKGDENDAI--PVRWMPLESILYNK-----YTVESDVWAFG 577
VK+ DFG+S ++ D G N I P WM E I ++ Y +SD+W+ G
Sbjct: 166 AEVKLVDFGVSAQL---DRTVGRRNTFIGTP-YWMAPEVIACDENPDATYDFKSDLWSLG 221
Query: 578 VCLWEI 583
+ E+
Sbjct: 222 ITAIEM 227
|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Length = 145 | Back alignment and structure |
|---|
Score = 80.4 bits (197), Expect = 5e-18
Identities = 25/104 (24%), Positives = 33/104 (31%), Gaps = 5/104 (4%)
Query: 169 TCSHAQLTEMKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE---RPPPV 225
C + + + C G G FY+G +T G C W++
Sbjct: 34 NCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDA 93
Query: 226 FPELNNSENYCRNAGGEEPSPWCYTMDPN-VRWQRCEIPTCADS 268
NYCRN PWCY Q C + CAD
Sbjct: 94 LQLGLGKHNYCRNPDNRR-RPWCYVQVGLKPLVQECMVHDCADG 136
|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* Length = 145 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 2e-06
Identities = 4/33 (12%), Positives = 5/33 (15%), Gaps = 1/33 (3%)
Query: 233 ENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265
N C + C P
Sbjct: 7 HQVPSNCDCLN-GGTCVSNKYFSNIHWCNCPKK 38
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 48/221 (21%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +G G+FG V+QAK L E LVA+K + + RE ++ + DH N
Sbjct: 59 TKVIGNGSFGVVYQAK---LCDSGE--LVAIKKVLQDKRFKN-----RELQIMRKLDHCN 108
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV------- 482
IV+L + G+ D + Y+N + +++RV
Sbjct: 109 IVRLRYF------------FYSSGEKKDEV-------YLNLVLDYVPETVYRVARHYSRA 149
Query: 483 PQLSTCDLI-TIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYL 540
Q + Q+ + Y+ HRD+ +N L++ D V+K+ DFG +++
Sbjct: 150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 206
Query: 541 QDYYKGDEN-DAIPVRW--MPLESIL-YNKYTVESDVWAFG 577
+G+ N I R+ P E I YT DVW+ G
Sbjct: 207 --LVRGEPNVSYICSRYYRAP-ELIFGATDYTSSIDVWSAG 244
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 9e-18
Identities = 58/272 (21%), Positives = 93/272 (34%), Gaps = 64/272 (23%)
Query: 328 APSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYV--RDLGQGAFGRVFQA- 384
P+ + ++ P + L+ + D V + LG G G+V Q
Sbjct: 23 PPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIF 82
Query: 385 -KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE-ACLLAEFDHPNIVKLLGVC--AVG 440
K E+F A+KML+D RE P+IV+++ V
Sbjct: 83 NKRTQ----EKF---ALKMLQDCP------KARREVELHWRASQCPHIVRIVDVYENLYA 129
Query: 441 KPMCLL--FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIA 498
CLL E + G+L F RI + ++ E+S I I
Sbjct: 130 GRKCLLIVMECLDGGEL--FSRIQDRGD---QAFTEREAS-------------EIMKSIG 171
Query: 499 SGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQD---------YYKG 546
+ YL HRD+ N L ++K+ DFG +++ + YY
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYY-- 229
Query: 547 DENDAIPVRWMPLESILYNKYTVESDVWAFGV 578
+ E + KY D+W+ GV
Sbjct: 230 ----------VAPEVLGPEKYDKSCDMWSLGV 251
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 54/245 (22%), Positives = 86/245 (35%), Gaps = 68/245 (27%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKML-------------------------K 404
++G+G++G V A +E T A+K+L
Sbjct: 19 DEIGKGSYGVVKLAY------NENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 405 DEASEYLQTDFEREACLLAEFDHPNIVKLLGV--CAVGKPMCLLFEYMGRGDLNDFLRIC 462
+E +L + DHPN+VKL+ V + ++FE + +G + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-- 130
Query: 463 SPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522
S E Q + G+ YL +K +HRD+ N L+
Sbjct: 131 ------LKPLS--EDQARFYFQ-----------DLIKGIEYLHYQKIIHRDIKPSNLLVG 171
Query: 523 DQMVVKIADFGLSRKMYLQDYYK----GDENDAIPVRWMPLESILYNKYTV---ESDVWA 575
+ +KIADFG+S + D G P ES+ + DVWA
Sbjct: 172 EDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAP------ESLSETRKIFSGKALDVWA 225
Query: 576 FGVCL 580
GV L
Sbjct: 226 MGVTL 230
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 51/255 (20%), Positives = 90/255 (35%), Gaps = 66/255 (25%)
Query: 347 HQTDARLNPKLEQLEFPRNDI-----IYVRDLGQGAFGRVFQA--KAPGLLKHEEFTLVA 399
H + L + E + + + + LG G G+V + + G ++ A
Sbjct: 6 HHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTG----QKC---A 58
Query: 400 VKMLKDEASEYLQTDFERE-ACLLAEFDHPNIVKLLGVC----AVGKPMCLLFEYMGRGD 454
+K+L D +E P+IV +L V + + ++ E M G+
Sbjct: 59 LKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112
Query: 455 LNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514
L F RI + ++ E++ I I + + +L HRD+
Sbjct: 113 L--FSRIQERGD---QAFTEREAA-------------EIMRDIGTAIQFLHSHNIAHRDV 154
Query: 515 ATRNCLI---NDQMVVKIADFGLSRKM---YLQD-----YYKGDENDAIPVRWMPLESIL 563
N L V+K+ DFG +++ LQ YY + E +
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY------------VAPEVLG 202
Query: 564 YNKYTVESDVWAFGV 578
KY D+W+ GV
Sbjct: 203 PEKYDKSCDMWSLGV 217
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 39/216 (18%), Positives = 68/216 (31%), Gaps = 41/216 (18%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK 432
+ G G ++ A + V +K L Q E LAE HP+IV+
Sbjct: 88 IAHGGLGWIYLALDRNVNGRP----VVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 433 LL--GVCAVGKPMCLLF---EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLST 487
+ + + EY+G L +L
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG----------------------QKLPV 181
Query: 488 CDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGD 547
+ I L+I + YL V+ DL N ++ ++ +K+ D G ++
Sbjct: 182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI-------NS 233
Query: 548 ENDAI-PVRWMPLESILYNKYTVESDVWAFGVCLWE 582
+ E I+ TV +D++ G L
Sbjct: 234 FGYLYGTPGFQAPE-IVRTGPTVATDIYTVGRTLAA 268
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 5e-17
Identities = 65/277 (23%), Positives = 102/277 (36%), Gaps = 40/277 (14%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
N+ Y++ LG+G FG+V K + A+K+LK E E T E
Sbjct: 148 NEFEYLKLLGKGTFGKVILVK-----EKATGRYYAMKILKKEVIVAKDEVAHTLTEN--R 200
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L HP + L +C + EY G+L F +
Sbjct: 201 VLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHL------------------S 240
Query: 481 RVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
R S +I S + YL S++ V+RDL N +++ +KI DFGL +
Sbjct: 241 RERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--- 297
Query: 540 LQDYYKGDENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ G ++ E + N Y D W GV ++E+ P+Y HE
Sbjct: 298 -EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHE 355
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
++ + I I P+A L+ P R
Sbjct: 356 KLFELILMEEIRFPRTLGPEAK-SLLSGLLKKDPKQR 391
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 8e-17
Identities = 50/238 (21%), Positives = 84/238 (35%), Gaps = 57/238 (23%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD-FE---------REA 419
R + G++G V E VA+K + + S+ + RE
Sbjct: 27 QRFISSGSYGAVCAGV------DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
LL F HPNI+ L + F + ++ Y+ M + +
Sbjct: 81 RLLNHFHHPNILGLRDI----------FVHFEEPAMHKL--------YL--VTELMRTDL 120
Query: 480 HRVPQLSTCDLIT-----IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
+V + I G+ L + VHRDL N L+ D + I DF L
Sbjct: 121 AQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180
Query: 535 SRKM----YLQDYYKGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
+R+ Y + RW P E ++ + +T D+W+ G + E+F+
Sbjct: 181 AREDTADANKTHY--------VTHRWYRAP-ELVMQFKGFTKLVDMWSAGCVMAEMFN 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 49/221 (22%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTDFEREACLLAEFDHP 428
+ +G G+FG VFQAK L++ +E VA+K +L+D+ + RE ++ HP
Sbjct: 45 CKVIGNGSFGVVFQAK---LVESDE---VAIKKVLQDKRFKN------RELQIMRIVKHP 92
Query: 429 NIVKLLGVCAVGKPMC------LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
N+V L L+ EY+ + R ++
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASR-----------------HYAKL 134
Query: 483 PQLSTCDLITIAL-QIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYL 540
Q LI + + Q+ + Y+ HRD+ +N L++ V+K+ DFG ++ +
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-- 192
Query: 541 QDYYKGDEN-DAIPVRW--MPLESIL-YNKYTVESDVWAFG 577
G+ N I R+ P E I YT D+W+ G
Sbjct: 193 ---IAGEPNVSYICSRYYRAP-ELIFGATNYTTNIDIWSTG 229
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 47/220 (21%), Positives = 76/220 (34%), Gaps = 65/220 (29%)
Query: 371 RDLGQGAFGRVFQA--KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE-ACLLAEFDH 427
+ LG G G+V Q K A+KML+D RE
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEK-------FALKMLQDCP------KARREVELHWRASQC 70
Query: 428 PNIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
P+IV+++ V A K + ++ E + G+L F RI + ++ E+S
Sbjct: 71 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL--FSRIQDRGD---QAFTEREAS----- 120
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ---MVVKIADFGLSRKMYL 540
I I + YL HRD+ N L + ++K+ DFG +++
Sbjct: 121 --------EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--- 169
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCL 580
KY D+W+ GV +
Sbjct: 170 ---------------------TTGEKYDKSCDMWSLGVIM 188
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 53/273 (19%), Positives = 104/273 (38%), Gaps = 51/273 (18%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
D + + LG+G+F V A+ + A+K+L+ ++ ER+
Sbjct: 30 EDFKFGKILGEGSFSTVVLAR-----ELATSREYAIKILEKRHIIKENKVPYVTRERD-- 82
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+++ DHP VKL + + Y G+L ++R G++ + +
Sbjct: 83 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-------GSFDETCTRFY 135
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+I S + YL + +HRDL N L+N+ M ++I DFG +
Sbjct: 136 -------------TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTA----- 177
Query: 541 QDYYKGDENDAIPVR---------WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
K ++ R ++ E + SD+WA G ++++ + L P+
Sbjct: 178 ----KVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA-GLPPF 232
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMK 624
+ + I + P+ DL++
Sbjct: 233 RAGNEYLIFQKIIKLE-YDFPEKFFPKARDLVE 264
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 3e-16
Identities = 54/249 (21%), Positives = 87/249 (34%), Gaps = 66/249 (26%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
+G G++G V +A E +VA+K + E + RE +L +H
Sbjct: 58 RHLIGTGSYGHVCEAY-----DKLEKRVVAIKKILRVFEDLIDCKRIL-REIAILNRLNH 111
Query: 428 PNIVKLLGVCAVGKPMC-----LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
++VK+L + ++ E D R + ++
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFR----------------TPVY-- 152
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
L+ + T+ + G+ Y+ +HRDL NCL+N VK+ DFGL+R + +
Sbjct: 153 --LTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210
Query: 543 YYKGDENDAIPV------------------------RW--MPLESIL-YNKYTVESDVWA 575
+ RW P E IL YT DVW+
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP-ELILLQENYTEAIDVWS 269
Query: 576 FGVCLWEIF 584
G C IF
Sbjct: 270 IG-C---IF 274
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 59/224 (26%), Positives = 92/224 (41%), Gaps = 27/224 (12%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEF-TLVAVKMLKDEASEYLQTDFEREACLLAEFDHP 428
++ LG G G VF A + VA+K + + ++ RE ++ DH
Sbjct: 16 LKPLGCGGNGLVFSAV------DNDCDKRVAIKKIVLTDPQSVKHAL-REIKIIRRLDHD 68
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---PQL 485
NIVK+ + L + +LN YI ME+ + V L
Sbjct: 69 NIVKVFEILGPSGSQ-LTDDVGSLTELNSV--------YI--VQEYMETDLANVLEQGPL 117
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYY 544
Q+ G+ Y+ +HRDL N IN + +V+KI DFGL+R M +
Sbjct: 118 LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH 177
Query: 545 KGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
KG ++ + +W P +L N YT D+WA G E+ +
Sbjct: 178 KGHLSEGLVTKWYRSP-RLLLSPNNYTKAIDMWAAGCIFAEMLT 220
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 5e-16
Identities = 48/244 (19%), Positives = 91/244 (37%), Gaps = 44/244 (18%)
Query: 362 FPRNDIIY--VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
+ Y + LG G+FG V + ++ + A+K + + RE
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVF---DIESGK--RFALKKVLQDPRYKN-----REL 51
Query: 420 CLLAEFDHPNIVKLL-------------GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNN 466
++ DH NI+KL+ + S N
Sbjct: 52 DIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNK 111
Query: 467 YINGTYSSMESSIHRV-------PQLSTCDLITIAL-QIASGMVYLSDRKFVHRDLATRN 518
Y+N + ++H+V + +LI+I + Q+ + ++ HRD+ +N
Sbjct: 112 YLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQN 171
Query: 519 CLINDQM-VVKIADFGLSRKMYLQDYYKGDEN-DAIPVRW--MPLESIL-YNKYTVESDV 573
L+N + +K+ DFG ++K + + I R+ P E +L +YT D+
Sbjct: 172 LLVNSKDNTLKLCDFGSAKK-----LIPSEPSVAYICSRFYRAP-ELMLGATEYTPSIDL 225
Query: 574 WAFG 577
W+ G
Sbjct: 226 WSIG 229
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 64/290 (22%), Positives = 101/290 (34%), Gaps = 67/290 (23%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFERE 418
ND Y++ LG+G FG+V + + A+K+L+ + + T E
Sbjct: 5 NDFDYLKLLGKGTFGKVILVR-----EKATGRYYAMKILRKEVIIAKDEVAHTVT----E 55
Query: 419 ACLLAEFDHPNIVKLLGVCAVGKPMCLLF--EYMGRGDLNDFLRICSPNNYINGTYSSME 476
+ +L HP + L A L F EY G+L F
Sbjct: 56 SRVLQNTRHPFLTALK--YAFQTHDRLCFVMEYANGGEL--FFH---------------- 95
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ R + +I S + YL R V+RD+ N +++ +KI DFGL
Sbjct: 96 --LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC- 152
Query: 537 KMYLQD------------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
K + D Y + E + N Y D W GV ++E+
Sbjct: 153 KEGISDGATMKTFCGTPEY-------------LAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 585 SFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
P+Y HE + + I I +P+A L+ P R
Sbjct: 200 C-GRLPFYNQDHERLFELILMEEIRFPRTLSPEAK-SLLAGLLKKDPKQR 247
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 9e-16
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
++ +G GA G V A L ++ VA+K L + + + + RE L+ +H
Sbjct: 67 LKPIGSGAQGIVCAAYDAVLDRN-----VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 120
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ--L 485
NI+ LL V K + D Y+ M++++ +V Q L
Sbjct: 121 KNIISLLNVFTPQKT---------LEEFQDV--------YL--VMELMDANLCQVIQMEL 161
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM----YLQ 541
+ + Q+ G+ +L +HRDL N ++ +KI DFGL+R +
Sbjct: 162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 221
Query: 542 DYYKGDENDAIPVRW--MPLESILYNKYTVESDVWAFGVCLWEIFS 585
Y + R+ P E IL Y D+W+ G + E+
Sbjct: 222 PY--------VVTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMVR 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 57/232 (24%), Positives = 86/232 (37%), Gaps = 45/232 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD-EASEYLQTDFEREACLLAEFDHP 428
LG+GA+G V A +VA+K ++ + + RE +L F H
Sbjct: 16 KSLLGEGAYGVVCSAT-----HKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHE 69
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+ + + + N+ YI M++ +HRV +ST
Sbjct: 70 NIITIFNI----------QRPDSFENFNEV--------YI--IQELMQTDLHRV--ISTQ 107
Query: 489 DLIT-----IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L Q + L +HRDL N LIN +K+ DFGL+R +
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167
Query: 544 YKGDENDAIPV-------RW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
+ RW P E +L KY+ DVW+ G L E+F
Sbjct: 168 DNSEPTGQQSGMVEFVATRWYRAP-EVMLTSAKYSRAMDVWSCGCILAELFL 218
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 42/170 (24%), Positives = 66/170 (38%), Gaps = 35/170 (20%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD------FEREACLLAEFD 426
LG G V+ A+ L VA+K + + FERE ++
Sbjct: 19 LGGGGMSTVYLAEDTILNIK-----VAIKAIFIP----PREKEETLKRFEREVHNSSQLS 69
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
H NIV ++ V L+ EY+ L+++ I LS
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEY--------------------IESHGPLS 109
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
I QI G+ + D + VHRD+ +N LI+ +KI DFG+++
Sbjct: 110 VDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAK 159
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.8 bits (188), Expect = 2e-15
Identities = 35/208 (16%), Positives = 60/208 (28%), Gaps = 33/208 (15%)
Query: 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT-------D 414
P + +G+G FG VFQ A T VA+K++ E + + +
Sbjct: 17 LPTEKLQRCEKIGEGVFGEVFQTIADH-------TPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 415 FEREACLLAEF---------DHPNIVKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICS 463
E + E + L V V P LL +
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 464 PNNYINGTYSSMESSIH-------RVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLA 515
+ + +E R S +I Q+ + + +F HRDL
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 516 TRNCLINDQMVVKIADFGLSRKMYLQDY 543
N L+ + K+ + +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSC 217
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 57/231 (24%), Positives = 89/231 (38%), Gaps = 50/231 (21%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE---------REAC 420
+ +G+GA+G V A + VA+K + + FE RE
Sbjct: 32 LSYIGEGAYGMVCSAY-----DNLNKVRVAIKKI---------SPFEHQTYCQRTLREIK 77
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L F H NI+ + + + D YI ME+ ++
Sbjct: 78 ILLRFRHENIIGINDI----------IRAPTIEQMKDV--------YI--VQDLMETDLY 117
Query: 481 RV---PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
++ LS + QI G+ Y+ +HRDL N L+N +KI DFGL+R
Sbjct: 118 KLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 538 MYLQDYYKGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
+ G + + RW P E +L YT D+W+ G L E+ S
Sbjct: 178 ADPDHDHTGFLTEYVATRWYRAP-EIMLNSKGYTKSIDIWSVGCILAEMLS 227
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
++ +G GA G V A L ++ VA+K L + + + + RE L+ +H
Sbjct: 30 LKPIGSGAQGIVCAAYDAILERN-----VAIKKLSRPFQNQTHAKRAY-RELVLMKCVNH 83
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV--PQL 485
NI+ LL V K + D YI M++++ +V +L
Sbjct: 84 KNIIGLLNVFTPQKS---------LEEFQDV--------YI--VMELMDANLCQVIQMEL 124
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM----YLQ 541
+ + Q+ G+ +L +HRDL N ++ +KI DFGL+R +
Sbjct: 125 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT 184
Query: 542 DYYKGDENDAIPVRW--MPLESILYNKYTVESDVWAFGVCLWEIFS 585
Y + R+ P E IL Y D+W+ G + E+
Sbjct: 185 PY--------VVTRYYRAP-EVILGMGYKENVDIWSVGCIMGEMIK 221
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 61/283 (21%), Positives = 98/283 (34%), Gaps = 48/283 (16%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
N R LG+G FG V + + A K L+ + E++
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQ-----VRATGKMYACKKLEKKRIKKRKGEAMALNEKQ-- 236
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L + + +V L +CL+ M GDL I
Sbjct: 237 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL--KFHI----------------YHM 278
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ A +I G+ L + V+RDL N L++D ++I+D GL+ +
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHV-- 336
Query: 541 QDYYKGDENDAIPVR-----WMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG-- 593
E I R +M E + +YT D WA G L+E+ + P+
Sbjct: 337 ------PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA-GQSPFQQRK 389
Query: 594 --LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ EEV + +KE + +P A L P R
Sbjct: 390 KKIKREEVERLVKEVPEEYSERFSPQAR-SLCSQLLCKDPAER 431
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 5e-15
Identities = 36/172 (20%), Positives = 63/172 (36%), Gaps = 33/172 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDH 427
R +G+G G V++A+ + VA+K++ + S +T +REA
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERI-----VALKLMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 428 PNIVKLLGVCAVGKPMCLLF---EYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
P++V + G+ L+ + DL LR P
Sbjct: 94 PHVV---PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-------------------- 130
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
L+ + I QI S + HRD+ N L++ + DFG++
Sbjct: 131 LAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIAS 182
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 2e-14
Identities = 42/199 (21%), Positives = 76/199 (38%), Gaps = 41/199 (20%)
Query: 398 VAVKMLKDEASEYLQTD------FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451
VAVK+L+ + L D F REA A +HP IV V G E
Sbjct: 40 VAVKVLRAD----LARDPSFYLRFRREAQNAAALNHPAIV---AVYDTG-------EAET 85
Query: 452 RGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511
++ + Y++G ++ +H ++ I + + + +H
Sbjct: 86 PAGPLPYIVM----EYVDGV--TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIH 139
Query: 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY------- 564
RD+ N +I+ VK+ DFG++R + D +++ + + Y
Sbjct: 140 RDVKPANIMISATNAVKVMDFGIARAI-------ADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 565 -NKYTVESDVWAFGVCLWE 582
+ SDV++ G L+E
Sbjct: 193 GDSVDARSDVYSLGCVLYE 211
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 4e-14
Identities = 51/243 (20%), Positives = 84/243 (34%), Gaps = 59/243 (24%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
+G+G++G V+ A VA+K + E + RE +L
Sbjct: 31 KHLIGRGSYGYVYLAY-----DKNTEKNVAIKKVNRMFEDLIDCKRIL-REITILNRLKS 84
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---PQ 484
I++L + ++ YI +S + ++ P
Sbjct: 85 DYIIRLYDL----------IIPDDLLKFDEL--------YI--VLEIADSDLKKLFKTPI 124
Query: 485 -LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L+ + TI + G ++ + +HRDL NCL+N VK+ DFGL+R + +
Sbjct: 125 FLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 544 YKGDENDAIPV-------------------RW--MPLESIL-YNKYTVESDVWAFGVCLW 581
+ RW P E IL YT D+W+ G C
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAP-ELILLQENYTKSIDIWSTG-C-- 240
Query: 582 EIF 584
IF
Sbjct: 241 -IF 242
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 59/274 (21%), Positives = 102/274 (37%), Gaps = 53/274 (19%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQ---TDFEREAC 420
+ ++ LG G+FGRV K E A+K+L K + + Q T E+
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVK-----HKESGNHYAMKILDKQKVVKLKQIEHTLNEKR-- 93
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+L + P +VKL + ++ EY+ G++ LR
Sbjct: 94 ILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-------------------- 133
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R+ + S A QI YL ++RDL N LI+ Q +++ DFG ++++
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 541 Q--------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
+ + + E IL Y D WA GV ++E + P++
Sbjct: 194 RTWTLCGTPEA-------------LAPEIILSKGYNKAVDWWALGVLIYE-MAAGYPPFF 239
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLC 626
++ + I G + + D L L
Sbjct: 240 ADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 64/280 (22%), Positives = 109/280 (38%), Gaps = 41/280 (14%)
Query: 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTD 414
K+ L D V+ +G+GAFG V + + A+K+L K E + +
Sbjct: 60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVR-----HKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 415 F---EREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
F ER+ ++A + P +V+L + + ++ EYM GDL + +
Sbjct: 115 FFWEERD--IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMS----------- 161
Query: 472 YSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531
+ VP+ A ++ + + F+HRD+ N L++ +K+AD
Sbjct: 162 -------NYDVPEKWAR--FYTA-EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESIL----YNKYTVESDVWAFGVCLWEIFSFA 587
FG KM + + D P P E + Y E D W+ GV L+E+
Sbjct: 212 FGTCMKMNKEGMVRCDTAVGTPDYISP-EVLKSQGGDGYYGRECDWWSVGVFLYEML-VG 269
Query: 588 LQPYYGLTHEEVVKYIKEG-NILQAPDNT--PDALYDLMK 624
P+Y + I N L PD+ +L+
Sbjct: 270 DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 43/225 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
+G GA+G V A + VA+K L ++ + + + RE LL H
Sbjct: 29 PTHVGSGAYGSVCSAIDKRSGEK-----VAIKKLSRPFQSEIFAKRAY-RELLLLKHMQH 82
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV--PQL 485
N++ LL V + + DF Y+ M++ + ++ +
Sbjct: 83 ENVIGLLDVFTPASSL---------RNFYDF--------YL--VMPFMQTDLQKIMGLKF 123
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM--YLQDY 543
S + + Q+ G+ Y+ VHRDL N +N+ +KI DFGL+R + Y
Sbjct: 124 SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 544 YKGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
+ RW P E IL + Y D+W+ G + E+ +
Sbjct: 184 --------VVTRWYRAP-EVILSWMHYNQTVDIWSVGCIMAEMLT 219
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 8e-14
Identities = 69/296 (23%), Positives = 108/296 (36%), Gaps = 72/296 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
LG+G+FG+VF A+ + A+K LK D+ E E+ L ++
Sbjct: 25 LGKGSFGKVFLAE-----FKKTNQFFAIKALKKDVVLMDDDVECTMV--EKRV-LSLAWE 76
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP + + + + + EY+ GDL I +
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHI------------------QSCHKFD 116
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ----- 541
A +I G+ +L + V+RDL N L++ +KIADFG+ K +
Sbjct: 117 LSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC-KENMLGDAKT 175
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
DY + E +L KY D W+FGV L+E P++G
Sbjct: 176 NTFCGTPDY-------------IAPEILLGQKYNHSVDWWSFGVLLYE-MLIGQSPFHGQ 221
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR----------PSFRTI 640
EE+ I+ N +A DL+ + +P R P FR I
Sbjct: 222 DEEELFHSIRMDNPFYPRWLEKEAK-DLLVKLFVREPEKRLGVRGDIRQHPLFREI 276
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 9e-14
Identities = 53/239 (22%), Positives = 94/239 (39%), Gaps = 54/239 (22%)
Query: 365 NDIIYVR-----DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
+D + R +G+G+FG+V +A H+ VA+KM+++E + Q E
Sbjct: 92 HDHVAYRYEVLKVIGKGSFGQVVKAY-----DHKVHQHVALKMVRNEKRFHRQAAEEIRI 146
Query: 420 -CLLAEFDHP---NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
L + D N++ +L +C+ FE + +L + ++ N +
Sbjct: 147 LEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSM-NLYELIKK---NKFQG------ 196
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM--VVKIADFG 533
S + A I + L + +H DL N L+ Q +K+ DFG
Sbjct: 197 ---------FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 534 LSRKM------YLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
S Y+Q +Y+ P E IL +Y + D+W+ G L E+ +
Sbjct: 248 SSCYEHQRVYTYIQSRFYRA-----------P-EVILGARYGMPIDMWSLGCILAELLT 294
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 62/284 (21%), Positives = 104/284 (36%), Gaps = 47/284 (16%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
+ + R LG+G FG VF + L A K L + Y E++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQ-----MKATGKLYACKKLNKKRLKKRKGYQGAMVEKK-- 237
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+LA+ IV L +CL+ M GD+ I + +
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVD--------------E 281
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
P I QI SG+ +L R ++RDL N L++D V+I+D GL+
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---- 337
Query: 541 QDYYKGDENDAIP------VRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG- 593
+ +M E +L +Y D +A GV L+E+ + A P+
Sbjct: 338 ----ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA-ARGPFRAR 392
Query: 594 ---LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ ++E+ + + E + +P + D + P R
Sbjct: 393 GEKVENKELKQRVLEQAVTYPDKFSPASK-DFCEALLQKDPEKR 435
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 55/227 (24%), Positives = 79/227 (34%), Gaps = 54/227 (23%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS----EYLQTDFEREACLLAEF 425
R GQG FG V K VA+K + + E + LA
Sbjct: 28 ERMAGQGTFGTVQLGK---EKSTGM--SVAIKKVIQDPRFRNREL------QIMQDLAVL 76
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV--- 482
HPNIV+L F +G D D Y+N + ++HR
Sbjct: 77 HHPNIVQLQSY----------FYTLGERDRRDI--------YLNVVMEYVPDTLHRCCRN 118
Query: 483 ----PQLSTCDLITIAL-QIASGMVYLSDRKF--VHRDLATRNCLINDQM-VVKIADFGL 534
LI + L Q+ + L HRD+ N L+N+ +K+ DFG
Sbjct: 119 YYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178
Query: 535 SRKMYLQDYYKGDEN-DAIPVRW--MPLESIL-YNKYTVESDVWAFG 577
++K + N I R+ P E I YT D+W+ G
Sbjct: 179 AKK-----LSPSEPNVAYICSRYYRAP-ELIFGNQHYTTAVDIWSVG 219
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-13
Identities = 61/280 (21%), Positives = 103/280 (36%), Gaps = 62/280 (22%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
LG+G+FG+V A+ E L AVK+LK D+ E T E+ L +
Sbjct: 31 LGKGSFGKVMLAR-----VKETGDLYAVKVLKKDVILQDDDVECTMT--EKRI-LSLARN 82
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP + +L + + E++ GDL I + +
Sbjct: 83 HPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFH------------------IQKSRRFD 122
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ----- 541
A +I S +++L D+ ++RDL N L++ + K+ADFG+ K +
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC-KEGICNGVTT 181
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
DY + E + Y D WA GV L+E+ P+
Sbjct: 182 ATFCGTPDY-------------IAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAE 227
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+++ + I ++ DA ++K P R
Sbjct: 228 NEDDLFEAILNDEVVYPTWLHEDAT-GILKSFMTKNPTMR 266
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 49/231 (21%), Positives = 82/231 (35%), Gaps = 64/231 (27%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEF-DH 427
VR LG+G + VF+A + V VK+LK + + RE +L
Sbjct: 41 VRKLGRGKYSEVFEA-----INITNNEKVVVKILKPVKKKKIK-----REIKILENLRGG 90
Query: 428 PNIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
PNI+ L + V + L+FE++ D L
Sbjct: 91 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----------------------QTL 127
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQD-- 542
+ D+ +I + Y +HRD+ N +I+ + +++ D+GL+ Y
Sbjct: 128 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQE 186
Query: 543 --------YYKGDENDAIPVRWMPLESIL--YNKYTVESDVWAFGVCLWEI 583
Y+KG E +L Y Y D+W+ G L +
Sbjct: 187 YNVRVASRYFKGPE-------------LLVDYQMYDYSLDMWSLGCMLASM 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 59/281 (20%), Positives = 103/281 (36%), Gaps = 54/281 (19%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQT 413
K++Q+ R D ++ +G+GAFG V K + A+K+L K E + +T
Sbjct: 64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVK-----LKNADKVFAMKILNKWEMLKRAET 118
Query: 414 DF---EREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYING 470
ER+ +L D I L + L+ +Y GDL
Sbjct: 119 ACFREERD--VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL--------------- 161
Query: 471 TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIA 530
+ + R+P+ +A ++ + + +VHRD+ N L++ +++A
Sbjct: 162 -LTLLSKFEDRLPEEMAR--FYLA-EMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLA 217
Query: 531 DFGLSRKMYLQDYYKGDENDAIPVRWMP-----------LESILYNK--YTVESDVWAFG 577
DFG D + L+++ K Y E D W+ G
Sbjct: 218 DFGSC---------LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLG 268
Query: 578 VCLWEIFSFALQPYYGLTHEEVVKYIKEGNI-LQAPDNTPD 617
VC++E+ + P+Y + E I Q P D
Sbjct: 269 VCMYEML-YGETPFYAESLVETYGKIMNHKERFQFPTQVTD 308
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 44/226 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
++ +G GA+G V A + VA+K L ++ + + + RE LL H
Sbjct: 30 LQPVGSGAYGAVCSA-----VDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRH 83
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ--- 484
N++ LL V + D DF Y+ M + + ++ +
Sbjct: 84 ENVIGLLDVFTPDET---------LDDFTDF--------YL--VMPFMGTDLGKLMKHEK 124
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM--YLQD 542
L + + Q+ G+ Y+ +HRDL N +N+ +KI DFGL+R+ +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG 184
Query: 543 YYKGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
Y + RW P E IL + +YT D+W+ G + E+ +
Sbjct: 185 Y--------VVTRWYRAP-EVILNWMRYTQTVDIWSVGCIMAEMIT 221
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 4e-13
Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 49/282 (17%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---ASEYLQTDFEREACL 421
+ ++ LGQG+FG+VF K + L A+K+LK + ++T ER+ +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQ--LYAMKVLKKATLKVRDRVRTKMERD--I 79
Query: 422 LAEFDHPNIVKLLGVCA---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
L E +HP IVKL A GK + L+ +++ GDL F R
Sbjct: 80 LVEVNHPFIVKL--HYAFQTEGK-LYLILDFLRGGDL--FTR------------------ 116
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
+ + + D+ ++A + +L ++RDL N L++++ +K+ DFGLS K
Sbjct: 117 LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS-KE 175
Query: 539 YLQDYYKGD------ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592
+ K E +M E + +T +D W+FGV ++E+ + L P+
Sbjct: 176 SIDHEKKAYSFCGTVE-------YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL-PFQ 227
Query: 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
G +E + I + + +P+A L+++ + P NR
Sbjct: 228 GKDRKETMTMILKAKLGMPQFLSPEAQ-SLLRMLFKRNPANR 268
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 48/244 (19%), Positives = 89/244 (36%), Gaps = 65/244 (26%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFERE------ACLLA 423
VR LG G F V+ AK T VA+K+++ + + E +
Sbjct: 24 VRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNT 78
Query: 424 EFDHP---NIVKLLGV----CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
+ D +I+KLL G + ++FE +G +L ++ +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGE-NLLALIKK---YEH--------- 125
Query: 477 SSIHRVPQLSTCDLI-TIALQIASGMVYLSDR-KFVHRDLATRNCLIND------QMVVK 528
+P + I+ Q+ G+ Y+ R +H D+ N L+ + +K
Sbjct: 126 ---RGIP----LIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK 178
Query: 529 IADFGLSRKM------YLQ-DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLW 581
IAD G + +Q Y R P E +L + +D+W+ ++
Sbjct: 179 IADLGNACWYDEHYTNSIQTREY----------RS-P-EVLLGAPWGCGADIWSTACLIF 226
Query: 582 EIFS 585
E+ +
Sbjct: 227 ELIT 230
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 63/301 (20%), Positives = 113/301 (37%), Gaps = 54/301 (17%)
Query: 337 LSKLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT 396
L++ A + Q + +L+++ R+D ++ +G+GAF V K +
Sbjct: 33 LAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVK-----MKQTGQ 87
Query: 397 LVAVKMLKDEA----SEYLQTDFEREACLLAEFDHPNIVKLLGVCA--VGKPMCLLFEYM 450
+ A+K++ E ER+ +L D I +L A + L+ EY
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERD--VLVNGDRRWITQLH--FAFQDENYLYLVMEYY 143
Query: 451 GRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510
GDL + + R+P +A +I + + +V
Sbjct: 144 VGGDL----------------LTLLSKFGERIPAEMAR--FYLA-EIVMAIDSVHRLGYV 184
Query: 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPV---RWMPLESIL---- 563
HRD+ N L++ +++ADFG K+ G + V ++ E +
Sbjct: 185 HRDIKPDNILLDRCGHIRLADFGSCLKLRA----DGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 564 ---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALY 620
Y E D WA GV +E+F + P+Y + E Y G I+ ++ L
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMF-YGQTPFYADSTAET--Y---GKIVHYKEHLSLPLV 294
Query: 621 D 621
D
Sbjct: 295 D 295
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 62/280 (22%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
LG+G+FG+V ++ + L AVK+LK D+ E E+ L
Sbjct: 28 LGKGSFGKVMLSE-----RKGTDELYAVKILKKDVVIQDDDVECTMV--EKRV-LALPGK 79
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
P + +L + + EY+ GDL I +V +
Sbjct: 80 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHI------------------QQVGRFK 119
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ----- 541
+ A +IA G+ +L + ++RDL N +++ + +KIADFG+ K +
Sbjct: 120 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTT 178
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
DY + E I Y Y D WAFGV L+E+ + P+ G
Sbjct: 179 KTFCGTPDY-------------IAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGE 224
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+E+ + I E N+ + +A+ + K P R
Sbjct: 225 DEDELFQSIMEHNVAYPKSMSKEAV-AICKGLMTKHPGKR 263
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 5e-13
Identities = 66/290 (22%), Positives = 115/290 (39%), Gaps = 63/290 (21%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-----DEASEYLQTDFEREA 419
+R LG+G +G+VFQ + + + A+K+LK A + T ER
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGK--IFAMKVLKKAMIVRNAKDTAHTKAERN- 73
Query: 420 CLLAEFDHPNIVKLLGVCA---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
+L E HP IV L+ A GK + L+ EY+ G+L F++
Sbjct: 74 -ILEEVKHPFIVDLI--YAFQTGGK-LYLILEYLSGGEL--FMQ---------------- 111
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ R +I+ + +L + ++RDL N ++N Q VK+ DFGL
Sbjct: 112 --LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC- 168
Query: 537 KMYLQD------------YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
K + D Y M E ++ + + D W+ G ++++
Sbjct: 169 KESIHDGTVTHTFCGTIEY-------------MAPEILMRSGHNRAVDWWSLGALMYDML 215
Query: 585 SFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ A P+ G ++ + I + + P T +A DL+K +R
Sbjct: 216 TGAP-PFTGENRKKTIDKILKCKLNLPPYLTQEAR-DLLKKLLKRNAASR 263
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 62/280 (22%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
LG+G+FG+V ++ + L AVK+LK D+ E E+ L
Sbjct: 349 LGKGSFGKVMLSE-----RKGTDELYAVKILKKDVVIQDDDVECTMV--EKRV-LALPGK 400
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
P + +L + + EY+ GDL I +V +
Sbjct: 401 PPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHI------------------QQVGRFK 440
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ----- 541
+ A +IA G+ +L + ++RDL N +++ + +KIADFG+ K +
Sbjct: 441 EPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC-KENIWDGVTT 499
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
DY + E I Y Y D WAFGV L+E+ + P+ G
Sbjct: 500 KTFCGTPDY-------------IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA-PFEGE 545
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+E+ + I E N+ + +A+ + K P R
Sbjct: 546 DEDELFQSIMEHNVAYPKSMSKEAV-AICKGLMTKHPGKR 584
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 53/226 (23%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEFDH 427
+ +G GA+G V A VAVK L ++ + + + RE LL H
Sbjct: 34 LSPVGSGAYGSVCAAFDTKTGLR-----VAVKKLSRPFQSIIHAKRTY-RELRLLKHMKH 87
Query: 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ--- 484
N++ LL V + + ND Y+ M + ++ + +
Sbjct: 88 ENVIGLLDVFTPARS---------LEEFNDV--------YL--VTHLMGADLNNIVKCQK 128
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM--YLQD 542
L+ + + QI G+ Y+ +HRDL N +N+ +KI DFGL+R +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG 188
Query: 543 YYKGDENDAIPVRW--MPLESIL-YNKYTVESDVWAFGVCLWEIFS 585
Y + RW P E +L + Y D+W+ G + E+ +
Sbjct: 189 Y--------VATRWYRAP-EIMLNWMHYNQTVDIWSVGCIMAELLT 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 7e-13
Identities = 59/280 (21%), Positives = 101/280 (36%), Gaps = 65/280 (23%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
D +R LG G+FGRV + A+K+LK E + T+ ER
Sbjct: 6 QDFQILRTLGTGSFGRVHLIR-----SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL-- 58
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICS--PNN----YINGTYSS 474
+L+ HP I+++ G + + ++ +Y+ G+L LR PN Y
Sbjct: 59 MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY------- 111
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
A ++ + YL + ++RDL N L++ +KI DFG
Sbjct: 112 -------------------AAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF 152
Query: 535 SRKMYLQ--------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586
++ + DY + E + Y D W+FG+ ++E
Sbjct: 153 AKYVPDVTYTLCGTPDY-------------IAPEVVSTKPYNKSIDWWSFGILIYE-MLA 198
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLC 626
P+Y + + I + P D L +L
Sbjct: 199 GYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 238
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 61/283 (21%), Positives = 101/283 (35%), Gaps = 68/283 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
+G+G+FG+V A+ E AVK+L+ + +++ + ER LL
Sbjct: 46 IGKGSFGKVLLAR-----HKAEEVFYAVKVLQKKAILKKKEEKHIMS--ERNV-LLKNVK 97
Query: 427 HPNIVKLLGVCA---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
HP +V L + K + + +Y+ G+L F + R
Sbjct: 98 HPFLVGL--HFSFQTADK-LYFVLDYINGGEL--FYHL------------------QRER 134
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ-- 541
A +IAS + YL V+RDL N L++ Q + + DFGL K ++
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC-KENIEHN 193
Query: 542 ----------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
+Y + E + Y D W G L+E+ L P+
Sbjct: 194 STTSTFCGTPEY-------------LAPEVLHKQPYDRTVDWWCLGAVLYEMLY-GLPPF 239
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
Y E+ I + P+ T A L++ R
Sbjct: 240 YSRNTAEMYDNILNKPLQLKPNITNSAR-HLLEGLLQKDRTKR 281
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 51/287 (17%), Positives = 95/287 (33%), Gaps = 56/287 (19%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
ND R +G+G FG V+ + K + + A+K L + E L E
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCR-----KADTGKMYAMKCLDKKR--IKMKQ--GETLALNE 239
Query: 425 ---------FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
D P IV + + + + M GDL +
Sbjct: 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL--HYHL-------------- 283
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535
+ S D+ A +I G+ ++ +R V+RDL N L+++ V+I+D GL+
Sbjct: 284 ----SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
Query: 536 RKMYLQDYYKGDENDAIP----VRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQP 590
+ +M E + Y +D ++ G L+++ P
Sbjct: 340 C--------DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSP 390
Query: 591 YYGLT---HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ E+ + + +P+ L++ R
Sbjct: 391 FRQHKTKDKHEIDRMTLTMAVELPDSFSPELR-SLLEGLLQRDVNRR 436
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 5e-12
Identities = 54/278 (19%), Positives = 104/278 (37%), Gaps = 49/278 (17%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
+G+G++ +V + + + A++++K DE +++QT E+ +
Sbjct: 60 IGRGSYAKVLLVR-----LKKTDRIYAMRVVKKELVNDDEDIDWVQT--EKHV-FEQASN 111
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP +V L + + EY+ GDL + R +L
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHM------------------QRQRKLP 151
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKG 546
+ +I+ + YL +R ++RDL N L++ + +K+ D+G+ K L+ G
Sbjct: 152 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRP---G 207
Query: 547 DENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWE--------IFSFALQPYYGLTH 596
D ++ E + Y D WA GV ++E + T
Sbjct: 208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267
Query: 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ + + I E I + A ++K N P R
Sbjct: 268 DYLFQVILEKQIRIPRSLSVKAA-SVLKSFLNKDPKER 304
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 47/283 (16%), Positives = 100/283 (35%), Gaps = 48/283 (16%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREAC 420
+ +R +G+G+FG+V + K++ + A+K + + +E E +
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQ-----KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ-- 67
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +HP +V L + M ++ + + GDL +
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL--RYHL---------------QQNV 110
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ + + I ++ + YL +++ +HRD+ N L+++ V I DF ++
Sbjct: 111 HFKEETVK--LFIC-ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA---- 163
Query: 541 QDYYKGDENDAI---PVRWMP--LESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+ + + P S Y+ D W+ GV +E +PY+ +
Sbjct: 164 -MLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYE-LLRGRRPYHIRS 221
Query: 596 HEEVVKYIKEGNILQAPDNTPDAL----YDLMKLCWNMKPMNR 634
+ + P A L+K P R
Sbjct: 222 STSSKEIVH--TFETTVVTYPSAWSQEMVSLLKKLLEPNPDQR 262
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 63/235 (26%), Positives = 92/235 (39%), Gaps = 57/235 (24%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKD--EASEYLQTDFEREACLLAEF-D 426
V+ LG+GA+G V+++ +VAVK + D + S Q F RE +L E
Sbjct: 14 VKKLGKGAYGIVWKSI-----DRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSG 67
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV---P 483
H NIV LL V + + D Y+ + ME+ +H V
Sbjct: 68 HENIVNLLNVL---RAD----------NDRDV--------YL--VFDYMETDLHAVIRAN 104
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
L + Q+ + YL +HRD+ N L+N + VK+ADFGLSR
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 544 YKGDENDAIPV------------------RW--MPLESIL-YNKYTVESDVWAFG 577
+ +I RW P E +L KYT D+W+ G
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAP-EILLGSTKYTKGIDMWSLG 218
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 24/238 (10%), Positives = 53/238 (22%), Gaps = 69/238 (28%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDE--ASEYLQTDFEREACLLAEF 425
+ G + +QA + VA+ + + + + + L+
Sbjct: 36 LIFHGGVPPLQFWQA-------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
D P + ++L V ++ E++ G L +
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD----------------------TSP 126
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
S I +A+ ++ V +A + D
Sbjct: 127 SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-----TMPD--- 178
Query: 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL---QPYYGLTHEEVV 600
+ D+ G L+ L P +
Sbjct: 179 ---------------------ANPQDDIRGIGASLYA----LLVNRWPLPEAGVRSGL 211
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 2e-11
Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 69/288 (23%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK------DEASEYLQTDFEREACLLAEFD 426
+G+G++ +V + + + A+K++K DE +++QT E+ +
Sbjct: 17 IGRGSYAKVLLVR-----LKKTDRIYAMKVVKKELVNDDEDIDWVQT--EKHV-FEQASN 68
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
HP +V L + + EY+ GDL + R +L
Sbjct: 69 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHM------------------QRQRKLP 108
Query: 487 TCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ----- 541
+ +I+ + YL +R ++RDL N L++ + +K+ D+G+ K L+
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC-KEGLRPGDTT 167
Query: 542 -------DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWE--------IFSF 586
+Y + E + Y D WA GV ++E
Sbjct: 168 STFCGTPNY-------------IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR 634
+ T + + + I E I + A ++K N P R
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA-SVLKSFLNKDPKER 261
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 56/241 (23%), Positives = 98/241 (40%), Gaps = 56/241 (23%)
Query: 365 NDIIYVR-----DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
+ R +G+G+FG+V +A E VA+K++K++ + Q E
Sbjct: 49 GEKWMDRYEIDSLIGKGSFGQVVKAY-----DRVEQEWVAIKIIKNKKAFLNQAQIEVRL 103
Query: 420 -CLLAEFDHPN---IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
L+ + D IV L +CL+FE + +L D LR N+ G
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRN---TNF-RG----- 153
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF--VHRDLATRNCLINDQ--MVVKIAD 531
+S A Q+ + +++L+ + +H DL N L+ + +KI D
Sbjct: 154 ---------VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVD 204
Query: 532 FGLSRKM------YLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIF 584
FG S ++ Y+Q +Y+ P E +L Y + D+W+ G L E+
Sbjct: 205 FGSSCQLGQRIYQYIQSRFYRS-----------P-EVLLGMPYDLAIDMWSLGCILVEMH 252
Query: 585 S 585
+
Sbjct: 253 T 253
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 69/280 (24%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-------DEASEYLQTDFER 417
+ ++ LG GA+G+VF + + L A+K+LK + +E+ +T ER
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGK--LYAMKVLKKATIVQKAKTTEHTRT--ER 109
Query: 418 EACLLAEFDH-PNIVKLLGVCA---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+ +L P +V L A K + L+ +Y+ G+L F +
Sbjct: 110 Q--VLEHIRQSPFLVTL--HYAFQTETK-LHLILDYINGGEL--FTHL------------ 150
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
S R + I + +I + +L ++RD+ N L++ V + DFG
Sbjct: 151 ---SQRERFTEHEVQ--IYVG-EIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 534 LSRKMYLQDY------------YKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVC 579
LS K ++ D Y M + + + D W+ GV
Sbjct: 205 LS-KEFVADETERAYDFCGTIEY------------MAPDIVRGGDSGHDKAVDWWSLGVL 251
Query: 580 LWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDAL 619
++E+ + A P+ + I IL++ P +
Sbjct: 252 MYELLTGAS-PFTVDGEKNSQAEISR-RILKSEPPYPQEM 289
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 58/258 (22%), Positives = 92/258 (35%), Gaps = 60/258 (23%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL-----AE 424
+R +G G FGRV + + AVK++++ + EA +L +
Sbjct: 40 IRKMGDGTFGRVLLCQ-----HIDNKKYYAVKVVRNIKKYTRSA--KIEADILKKIQNDD 92
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
++ NIVK G MCL+FE +G L + + NNY NG
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPLGP-SLYEIITR---NNY-NG-------------- 133
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY 544
D+ ++I + YL H DL N L++D K +
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 545 KGDENDAIPV----------------------RWMPLESILYNKYTVESDVWAFGVCLWE 582
++ I + R E IL + V SD+W+FG L E
Sbjct: 194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYR--APEVILNLGWDVSSDMWSFGCVLAE 251
Query: 583 IFS-FALQPYYGLTHEEV 599
+++ L THE +
Sbjct: 252 LYTGSLLFR----THEHM 265
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 25/182 (13%), Positives = 61/182 (33%), Gaps = 38/182 (20%)
Query: 373 LGQGAFGRVFQAK---APGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ G +++A + ++K+ + + + +F + A + +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN--K 107
Query: 430 IVKLLGVCAVGKPMC------------LLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
KL + P C L+ +GR L L + S
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSP-----KHVLS---- 157
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQMVVKIADFGLS 535
+ + +A ++ + +L + ++VH ++ N + DQ V +A +G +
Sbjct: 158 -------ERSV--LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 536 RK 537
+
Sbjct: 209 FR 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.5 bits (125), Expect = 4e-07
Identities = 92/626 (14%), Positives = 163/626 (26%), Gaps = 225/626 (35%)
Query: 10 YLTWILL-----------------NCGVLVMA-QSEMKQPQG----YCSQ----YNG--K 41
L W LL N L+ ++E +QP Y Q YN
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQV 125
Query: 42 ICKNYLNRTGRVWFNSSLESAGGDLN-EQIV----MA-LWKEMIAILANPCKQAAEKLLC 95
K ++R L A +L + V + K +A+ C + K+ C
Sbjct: 126 FAKYNVSRLQPYL---KLRQALLELRPAKNVLIDGVLGSGKTWVALDV--CL--SYKVQC 178
Query: 96 TYAFP-------QCVTSNGIPMSL-PLCYE-DC-IAVRYSFCYNDWAYIEENKARGIR-F 144
F C + + L L Y+ D R N I +A R
Sbjct: 179 KMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLL 238
Query: 145 KSRGHFELPNC----DTLPKYEVVNG-KPTCSHAQLTEMKTDEITYDCIRGRGRFYQGTV 199
KS+ + NC + + N +C K T V
Sbjct: 239 KSKPY---ENCLLVLLNVQNAKAWNAFNLSC--------KILLTTRF----------KQV 277
Query: 200 NTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQR 259
+ + P+ ++ P P +
Sbjct: 278 TDFLSAAT-----TTHISLDHHSMTLTPD--EVKSLLLKYLDCRPQ-----DLPR---EV 322
Query: 260 CEI-P----TCADSMQDDVKSWGN-------KIKALLEQFLS-------QPYFIVLAVIF 300
P A+S++D + +W N K+ ++E L+ + F L+ +F
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLS-VF 381
Query: 301 -----IPVASMLCL------------ICVVCVIR-LVKRN-------------------- 322
IP +L L + LV++
Sbjct: 382 PPSAHIP-TILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE 440
Query: 323 ---------VD-YAPAPSQDVNIDLSKLPCNA------SYHQTDARLNPKLEQLEFPRND 366
VD Y + D + DL + +H + ++ F
Sbjct: 441 NEYALHRSIVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHPERMT--LFRM-- 495
Query: 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD 426
+++ D R + K ++H+ A + + + + + +
Sbjct: 496 -VFL-DF------RFLEQK----IRHDSTAWNASGSILN-----TLQQLKFYKPYICD-N 537
Query: 427 HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
P +L+ + DFL N +
Sbjct: 538 DPKYERLVN------------------AILDFLPKIEEN-------------LICSKY-- 564
Query: 487 TCDLITIALQIASGMVYLSDRKFVHR 512
DL+ IAL ++ K V R
Sbjct: 565 -TDLLRIALMAEDEAIFEEAHKQVQR 589
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 4e-06
Identities = 80/565 (14%), Positives = 153/565 (27%), Gaps = 176/565 (31%)
Query: 117 EDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPN-CDTLPKYEVVNGKPTCSHAQL 175
E+ + + Y F + + + R L N KY V +P + +L
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP---YLKL 140
Query: 176 TE--MKTDEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVF------- 226
+ ++ I G G+ T V C + + + +F
Sbjct: 141 RQALLELRPAKNVLIDGVL----GSGKTWVALDVCLSYKVQC----KMDFKIFWLNLKNC 192
Query: 227 --PE--LNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCADSMQDDVKSWGNKIKA 282
PE L + Y +DPN R + + +++
Sbjct: 193 NSPETVLEMLQKLL------------YQIDPNWT-SRSDHSSNIKLRIHSIQAE------ 233
Query: 283 LLEQFLSQPYFIVLAVIFIPVASMLCLICVVCVIRLVKRNVDYAPAPSQDVNI----DLS 338
L S+PY L LV NV Q+ +LS
Sbjct: 234 LRRLLKSKPYENCL---------------------LVLLNV-------QNAKAWNAFNLS 265
Query: 339 KLPCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLV 398
C + ++ R V + H
Sbjct: 266 ---C-----KI-----------------LLTTRFKQ------VTDFLSAATTTHISLDHH 294
Query: 399 AVKMLKDEA----SEYLQTDFE---REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMG 451
++ + DE +YL + RE +P + ++ + ++
Sbjct: 295 SMTLTPDEVKSLLLKYLDCRPQDLPREVLTT----NPRRLSIIA--ESIRDGLATWDNWK 348
Query: 452 RGDLNDFLRICSPNNYINGTYSSMESSIHR--------------VPQ--LST--CDLITI 493
+ + I I + + +E + +R +P LS D+I
Sbjct: 349 HVNCDKLTTI------IESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS 402
Query: 494 ALQIASGMVYLSDRKFVHRDLATRNCLIND-QMVVKI---ADFGLSRKMYLQDYYKG--- 546
+ + + L V + I + +K+ ++ L R + D+Y
Sbjct: 403 DVMVV--VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRS--IVDHYNIPKT 458
Query: 547 -DENDAIPVRWMPLESILYN------KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D +D IP L+ Y+ K + ++ F F L+
Sbjct: 459 FDSDDLIPP---YLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF-LE---------- 504
Query: 600 VKYIKEGNILQAPDNTPDALYDLMK 624
K + A + + L L
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKF 529
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 47/256 (18%), Positives = 84/256 (32%), Gaps = 70/256 (27%)
Query: 365 NDIIYVR-----DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
D + R +LG+G FG+V + + VA+K++++ E
Sbjct: 14 GDWLQERYEIVGNLGEGTFGKVVECLD----HARGKSQVALKIIRNVGKYREAARLEINV 69
Query: 420 C-LLAEFDHPN---IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
+ E D N V + MC+ FE +G+ + +FL+ N
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGK-NTFEFLK----ENNFQP----- 119
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV--------- 526
+ +A Q+ + +L + + H DL N L +
Sbjct: 120 ---------YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS 170
Query: 527 ----------VKIADFG----LSRKM--YLQD-YYKGDENDAIPVRWMPLESILYNKYTV 569
+++ADFG + +Y+ P E IL +
Sbjct: 171 CEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRP------P------EVILELGWAQ 218
Query: 570 ESDVWAFGVCLWEIFS 585
DVW+ G L+E +
Sbjct: 219 PCDVWSIGCILFEYYR 234
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 35/202 (17%), Positives = 68/202 (33%), Gaps = 50/202 (24%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE-------REACLLAEF 425
+G G FG ++ A K E+ A ++K E E E + + ++
Sbjct: 45 IGSGGFGLIYLAF--PTNKPEK---DARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKW 99
Query: 426 DHPNIVKLLGVCAV----------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
+ LG+ ++ E +G DL GT+
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI-DLQKISGQN-------GTFK-- 149
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQMVVKIADFG 533
ST + + +++ + Y+ + ++VH D+ N L+ + V +AD+G
Sbjct: 150 ---------KSTV--LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYG 198
Query: 534 LSRKMYLQDYYKGDENDAIPVR 555
LS + Y +
Sbjct: 199 LSYR-----YCPNGNHKQYQEN 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 48/273 (17%), Positives = 92/273 (33%), Gaps = 83/273 (30%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACL-LAEFD-- 426
+R LG G F V+ + ++ ++F VA+K++K E + D
Sbjct: 42 IRKLGWGHFSTVWLSWD---IQGKKF--VAMKVVKSAEHYTETALDEIRLLKSVRNSDPN 96
Query: 427 HPN---IVKLL------GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
PN +V+LL GV G +C++FE +G L ++ +S
Sbjct: 97 DPNREMVVQLLDDFKISGVN--GTHICMVFEVLGH-HLLKWII---------------KS 138
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCL--INDQMVVKIADFGL 534
+ +P + I Q+ G+ YL + + +H D+ N L +N+Q + ++A
Sbjct: 139 NYQGLPLPC---VKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEAT 195
Query: 535 SRKMYLQDYYKGDENDAIPVRWM------------------------------------- 557
+ G P
Sbjct: 196 EWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ 255
Query: 558 -----PLESILYNKYTVESDVWAFGVCLWEIFS 585
LE ++ + Y +D+W+ +E+ +
Sbjct: 256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 56/270 (20%), Positives = 91/270 (33%), Gaps = 75/270 (27%)
Query: 365 NDIIYVR-----DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
D++ R LG+GAFG+V + VAVK++K+ E +
Sbjct: 9 GDVLSARYEIVDTLGEGAFGKVVECID----HKAGGRHVAVKIVKNVDRYCEAARSEIQV 64
Query: 420 C-LLAEFDHPN---IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
L D + V++L +C++FE +G DF++ N +
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKE---NGF-------- 112
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV--------- 526
+P + +A QI + +L K H DL N L
Sbjct: 113 ------LP-FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK 165
Query: 527 ----------VKIADFG----LSRKM--YLQD-YYKGDENDAIPVRWMPLESILYNKYTV 569
+K+ DFG + +Y+ P E IL ++
Sbjct: 166 RDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRA------P------EVILALGWSQ 213
Query: 570 ESDVWAFGVCLWEIFS-FALQPYYGLTHEE 598
DVW+ G L E + F + P TH+
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFP----THDS 239
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 40/173 (23%), Positives = 69/173 (39%), Gaps = 34/173 (19%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-PN 429
+ +G G FG + K L +E VA+K+ ++ E +
Sbjct: 15 KKIGCGNFGELRLGK--NLYTNEY---VAIKLEPMKSR---APQLHLEYRFYKQLGSGDG 66
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
I ++ GK ++ E +G L D +C + T+S L T
Sbjct: 67 IPQVYYFGPCGKYNAMVLELLGP-SLEDLFDLC------DRTFS-----------LKTV- 107
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI-----NDQMVVKIADFGLSRK 537
+ IA+Q+ S M Y+ + ++RD+ N LI Q V+ I DF L+++
Sbjct: 108 -LMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159
|
| >1z8g_A Serine protease hepsin; serine protease hepsin, protease, hydrolase-hydrolase inhibi complex; HET: AR7; 1.55A {Homo sapiens} SCOP: b.47.1.2 d.170.1.2 PDB: 3t2n_A 1o5e_H* 1o5f_H* 1p57_B* 1o5e_L* 1o5f_L* 1p57_A* Length = 372 | Back alignment and structure |
|---|
Score = 49.0 bits (117), Expect = 3e-06
Identities = 12/69 (17%), Positives = 18/69 (26%), Gaps = 6/69 (8%)
Query: 200 NTTVGGLACQRWDAKEPHAHER-PPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQ 258
N V GL+C+ H S +C + G +T
Sbjct: 37 NARVAGLSCEEMGFLRALTHSELDVRTAGAAGTSGFFCVDEG-----RLPHTQRLLEVIS 91
Query: 259 RCEIPTCAD 267
C+ P
Sbjct: 92 VCDCPRGRF 100
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 6e-06
Identities = 35/202 (17%), Positives = 66/202 (32%), Gaps = 47/202 (23%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKM-------LKDEASEYLQTDFEREACLLAEF 425
+GQG FG ++ A VK+ L E Y + + + ++
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA---AKPEQIQKW 99
Query: 426 DHPNIVKLLGVCAV----------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475
+K LGV ++ + G DL +S
Sbjct: 100 IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYEAN------AKRFS-- 150
Query: 476 ESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN--DQMVVKIADFG 533
T + ++L+I + Y+ + ++VH D+ N L+N + V + D+G
Sbjct: 151 ---------RKTV--LQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYG 199
Query: 534 LSRKMYLQDYYKGDENDAIPVR 555
L+ + Y + A
Sbjct: 200 LAYR-----YCPEGVHKAYAAD 216
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 32/174 (18%), Positives = 62/174 (35%), Gaps = 34/174 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-P 428
R +G+G+FG +F+ LL +++ +K E E
Sbjct: 15 GRRIGEGSFGVIFEGT--NLLNNQQV------AIKFEPRRSDAPQLRDEYRTYKLLAGCT 66
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
I + G L+ + +G L D L +C +S + T
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLC------GRKFS-----------VKTV 108
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI-----NDQMVVKIADFGLSRK 537
A Q+ + + + ++ V+RD+ N LI + ++ + DFG+ +
Sbjct: 109 --AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 37/190 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHP 428
R +G G+FG ++ + +EE VA+K+ + +++ Q E+ +
Sbjct: 12 GRKIGSGSFGEIYLGT--NIQTNEE---VAIKLENVK-TKHPQ--LLYESKIYRILQGGT 63
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
I + G L+ + +G L D C + S L T
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFC------SRKLS-----------LKTV 105
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDYYK 545
+ +A Q+ + + ++ + F+HRD+ N L+ V I DFGL++K Y
Sbjct: 106 --LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK-----YRD 158
Query: 546 GDENDAIPVR 555
+ IP R
Sbjct: 159 TSTHQHIPYR 168
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 44/190 (23%), Positives = 76/190 (40%), Gaps = 37/190 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-P 428
R +G G+FG ++ + EE VA+K+ + +++ Q E+ +
Sbjct: 14 GRKIGSGSFGDIYLGT--DIAAGEE---VAIKLECVK-TKHPQ--LHIESKIYKMMQGGV 65
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
I + A G ++ E +G L D C + +S L T
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFC------SRKFS-----------LKTV 107
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGLSRKMYLQDYYK 545
+ +A Q+ S + Y+ + F+HRD+ N L+ +V I DFGL++K Y
Sbjct: 108 --LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK-----YRD 160
Query: 546 GDENDAIPVR 555
+ IP R
Sbjct: 161 ARTHQHIPYR 170
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 653 | |||
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3hkl_A | 197 | Muscle, skeletal receptor tyrosine protein kinase; | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 1i71_A | 83 | APO(A), apolipoprotein(A); alipoprotein(A), kringl | 99.97 | |
| 2qj2_A | 184 | Hepatocyte growth factor; HGF/SF, hormone/growth f | 99.97 | |
| 5hpg_A | 84 | Plasminogen; serine protease, kringle 5, fibrinoly | 99.96 | |
| 1jfn_A | 119 | APO(A) KIV-T6, apolipoprotein A, KIV-T6, apolipopr | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1pml_A | 86 | Tissue plasminogen activator kringle 2; hydrolase( | 99.95 | |
| 3sp8_A | 264 | Hepatocyte growth factor alpha chain; kringle doma | 99.95 | |
| 3k65_A | 116 | Prothrombin; coagulation, zymogen, hydrolase; 1.85 | 99.95 | |
| 1nl1_A | 147 | Prothrombin; hydrolase; HET: CGU NAG; 1.90A {Bos t | 99.94 | |
| 3sp8_A | 264 | Hepatocyte growth factor alpha chain; kringle doma | 99.94 | |
| 3e6p_L | 158 | Prothrombin; meizothrombin, allostery, linkage, Na | 99.94 | |
| 1ki0_A | 253 | Angiostatin; kringle domains, hydrolase; HET: BCN; | 99.93 | |
| 1ki0_A | 253 | Angiostatin; kringle domains, hydrolase; HET: BCN; | 99.92 | |
| 4dur_A | 791 | Plasminogen, serine protease; fibrinolysis, hydrol | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 2i9a_A | 145 | Urokinase-type plasminogen activator; growth facto | 99.91 | |
| 2fd6_A | 122 | Urokinase-type plasminogen activator; UPAR, ATF, A | 99.91 | |
| 2k4r_A | 77 | Neurotrypsin; kringle domain, disulfide-rich prote | 99.9 | |
| 4dur_A | 791 | Plasminogen, serine protease; fibrinolysis, hydrol | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 3nxp_A | 424 | Prethrombin-1; allostery, blood coagulation, hydro | 99.86 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.11 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.8 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.61 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.36 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.05 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.73 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.41 | |
| 1ijy_A | 130 | Frizzled homolog 8; WNT receptor, frizzled protein | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.33 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.15 | |
| 1ijx_A | 127 | Secreted frizzled-related sequence protein 3; WNT | 97.04 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.95 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.81 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.78 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.63 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.4 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.27 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.16 | |
| 3e6p_L | 158 | Prothrombin; meizothrombin, allostery, linkage, Na | 95.82 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 94.33 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 93.19 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.31 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.49 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.69 |
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=490.73 Aligned_cols=283 Identities=41% Similarity=0.776 Sum_probs=244.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+++.+++++.+.||+|+||+||+|++.+..+..+++.||||+++........++|.+|+.++++++|||||+++|++..+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~ 101 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD 101 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC
Confidence 56677899999999999999999998765556677899999998776666677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..+|||||+++|||.++|+...+..... ...........+++.++++|+.|||.||+|||+++||||||||+|||
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVG----STDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC---------CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCcccccc----ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 99999999999999999998655432211 01111122357999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
|++++.+||+|||+|+.....+.........+|++|||||.+.++.|+.++|||||||+||||+|+|.+||.+.+..+++
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~ 257 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV 257 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999998776665555666789999999999999999999999999999999999888899999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+..++.|+.+++++++||.+||+.||++||||++|+++|+.+
T Consensus 258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 99999999899999999999999999999999999999999998753
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-59 Score=485.64 Aligned_cols=282 Identities=46% Similarity=0.878 Sum_probs=243.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+.+++|.+.+.||+|+||+||+|++.+.....++..||||+++.. .....++|.+|+++|++++|||||+++|++.++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA-SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC-ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4667889999999999999999999876556667899999999864 445677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..+|||||+++|||.++|+...+... ..........+++.+++.|+.|||+||+|||+++||||||||+|||
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~-------~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NIL 160 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAV-------LMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCL 160 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHH-------HC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccc-------cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEE
Confidence 999999999999999999985432110 0001123457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
|++++.+||+|||+|+.....+.........+|++|||||.+.+..|+.++|||||||+||||+|+|..||.+.+..+++
T Consensus 161 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 240 (299)
T 4asz_A 161 VGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 240 (299)
T ss_dssp ECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred ECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999987765555444455678999999999999999999999999999999999778899999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+..+..++.|..+++++++||.+||+.||++|||+++|++.|+.+.+.
T Consensus 241 ~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 241 ECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999998889999999999999999999999999999999999988764
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-58 Score=483.82 Aligned_cols=284 Identities=45% Similarity=0.842 Sum_probs=236.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++.++++.+.++||+|+||+||+|++.+.....++..||||+++.. .....++|.+|+++|++++|||||+++|++.++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 115 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-SESARQDFQREAELLTMLQHQHIVRFFGVCTEG 115 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 5667789999999999999999999877666677899999999864 455677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..+|||||+++|+|.++|+...+...... ........++++.+++.|+.|||+||+|||+++||||||||+|||
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NIL 190 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLA-----GGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC----------------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCccccccc-----ccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEE
Confidence 999999999999999999986543221100 001123457999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
|++++.+||+|||+|+.+...+.........+|++|||||++.+..++.++|||||||+||||+|+|..||.+.+..+++
T Consensus 191 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~ 270 (329)
T 4aoj_A 191 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI 270 (329)
T ss_dssp EETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHH
T ss_pred ECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999997765555445556678999999999999999999999999999999999777899999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+..+..++.|..+++++++||.+||+.||++|||+++|+++|+.+.+.
T Consensus 271 ~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~ 320 (329)
T 4aoj_A 271 DCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA 320 (329)
T ss_dssp HHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence 99999988889999999999999999999999999999999999988764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-57 Score=477.99 Aligned_cols=293 Identities=38% Similarity=0.656 Sum_probs=249.0
Q ss_pred CccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC-Cccce
Q psy5539 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-PNIVK 432 (653)
Q Consensus 354 ~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H-pnIv~ 432 (653)
.....++|+++++|++.+.||+|+||+||+|++.+.......+.||||+++........++|.+|+++|++++| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 33445679999999999999999999999999877666677889999999887776677889999999999966 89999
Q ss_pred EEeEEec-CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 433 LLGVCAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 433 l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
++|+|.. ++.++|||||+++|+|.++|+.......... ..........+++.+++.|+.|||+||+|||+++|||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiH 208 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK----VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIH 208 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-----------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc----ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeec
Confidence 9999965 5678999999999999999985432111000 0000112356899999999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
|||||+||||++++.+||+|||+|+.+.............+|++|||||++.+..|+.++|||||||+||||+|.|..||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999987755444333445568999999999999999999999999999999999777899
Q ss_pred CCCC-HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 592 YGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 592 ~~~~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+.+ .+++...+.++..+..|+.++++++++|.+||+.||++|||+++|+++|..+.+.
T Consensus 289 ~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 289 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp TTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 8865 5667788889988889999999999999999999999999999999999988653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=457.00 Aligned_cols=266 Identities=26% Similarity=0.452 Sum_probs=220.1
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
..+|++.+++.+.+.||+|+||+||+|++.+ .||||+++.. ......+.|.+|++++++++|||||+++|+
T Consensus 29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~--------~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHG--------DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCCBCCTTSCCEEEECCCCSSSEEEEEESSS--------EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cCcEEcHHHeEEeeEEeeCCCcEEEEEEECC--------cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3468889999999999999999999998642 4899999743 345566789999999999999999999998
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+.. +.++|||||+++|+|.++|+. ....+++.+++.|+.|||.||+|||+++||||||||
T Consensus 101 ~~~-~~~~iVmEy~~gGsL~~~l~~-------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp 160 (307)
T 3omv_A 101 MTK-DNLAIVTQWCEGSSLYKHLHV-------------------QETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKS 160 (307)
T ss_dssp ECS-SSCEEEEECCSSCBHHHHHHT-------------------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCS
T ss_pred EEC-CeEEEEEEcCCCCCHHHHHhh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCH
Confidence 764 568999999999999999972 234689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
+||||++++.+||+|||+|+.....+.........||+.|||||++.+ +.|+.++|||||||+||||+| |..||.+
T Consensus 161 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt-g~~Pf~~ 239 (307)
T 3omv_A 161 NNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT-GELPYSH 239 (307)
T ss_dssp SSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH-SSCTTTT
T ss_pred HHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH-CCCCCCC
Confidence 999999999999999999987644333333445679999999999964 468999999999999999999 5569988
Q ss_pred CCHH-HHHHHHHcCCcc----CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 594 LTHE-EVVKYIKEGNIL----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 594 ~~~~-e~~~~i~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
.+.. .+...+..+... ..+..+++++.+||.+||+.||++|||+++|+++|+.++..+.
T Consensus 240 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 240 INNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp CCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 6654 445555554332 3456789999999999999999999999999999999987664
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=451.79 Aligned_cols=257 Identities=21% Similarity=0.348 Sum_probs=222.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++.. ......+.+.+|+++|++|+|||||++++++.+++..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 98 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKST-----EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSL 98 (350)
T ss_dssp CCEEEEEEC------CEEEEEET-----TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cceEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence 68999999999999999999864 45689999999643 3445567899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+|||||+++|+|.++|+.. ....+++.+++.|+.||+.||+|||+++||||||||+||||++
T Consensus 99 yiVmEy~~gg~L~~~i~~~------------------~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 160 (350)
T 4b9d_A 99 YIVMDYCEGGDLFKRINAQ------------------KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160 (350)
T ss_dssp EEEEECCTTCBHHHHHHHT------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECT
T ss_pred EEEEeCCCCCcHHHHHHHc------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECC
Confidence 9999999999999999732 2345789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+|+.+..... ......||+.|||||++.+..|+.++|||||||+||||++| .+||.+.+..+++..+
T Consensus 161 ~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG-~~PF~~~~~~~~~~~i 237 (350)
T 4b9d_A 161 DGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL-KHAFEAGSMKNLVLKI 237 (350)
T ss_dssp TCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHHH
T ss_pred CCCEEEcccccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-CCCCCCcCHHHHHHHH
Confidence 99999999999987533211 11234589999999999999999999999999999999994 5699999999999999
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+...+.+..+++++.+||.+||+.||++|||++|+++|.|-.
T Consensus 238 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 281 (350)
T 4b9d_A 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIA 281 (350)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred HcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhh
Confidence 99988778888999999999999999999999999999998743
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-53 Score=437.63 Aligned_cols=254 Identities=20% Similarity=0.305 Sum_probs=223.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|++++|||||++++++.+++
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 105 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE 105 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence 357999999999999999999864 467899999997532 1223457899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..+|||||+++|+|.++|+. .+.+++.++..++.||+.||+|||+++|+||||||+||||
T Consensus 106 ~~yivmEy~~gG~L~~~i~~--------------------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl 165 (311)
T 4aw0_A 106 KLYFGLSYAKNGELLKYIRK--------------------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 165 (311)
T ss_dssp EEEEEECCCTTEEHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred EEEEEEecCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE
Confidence 99999999999999999973 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..+++.
T Consensus 166 ~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~ 244 (311)
T 4aw0_A 166 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-LPPFRAGNEGLIFA 244 (311)
T ss_dssp CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Confidence 99999999999999876443333333456799999999999999999999999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
.|..+.. ..|+.+++++.+|+.+||..||++|||++|++.+.
T Consensus 245 ~i~~~~~-~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~ 286 (311)
T 4aw0_A 245 KIIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG 286 (311)
T ss_dssp HHHHTCC-CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH
T ss_pred HHHcCCC-CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH
Confidence 9988874 57788999999999999999999999998864433
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=440.85 Aligned_cols=253 Identities=19% Similarity=0.347 Sum_probs=221.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.+.|++.+.||+|+||+||+|+.. .+++.||||+++..... ..+.+.+|+.+|++++|||||++++++..++.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~ 146 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDEL 146 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEEC-----CCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356999999999999999999864 46789999999643222 234688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+|||||+++|+|.++++. ..+++.++..++.||+.||+|||+++||||||||+||||++
T Consensus 147 ~ivmEy~~gg~L~~~l~~---------------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 205 (346)
T 4fih_A 147 WVVMEFLEGGALTDIVTH---------------------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTH 205 (346)
T ss_dssp EEEECCCTTEEHHHHHHH---------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEeCCCCCcHHHHHHc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECC
Confidence 999999999999999861 34899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+|+.+.... .......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+++..+
T Consensus 206 ~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~-G~~PF~~~~~~~~~~~i 282 (346)
T 4fih_A 206 DGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVD-GEPPYFNEPPLKAMKMI 282 (346)
T ss_dssp TCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH-SSCTTTTSCHHHHHHHH
T ss_pred CCCEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHHH
Confidence 9999999999998753322 22345679999999999999999999999999999999999 45699999999999988
Q ss_pred HcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+... ..+..+++++.+||.+||+.||++|||++|+++|.|-
T Consensus 283 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~ 327 (346)
T 4fih_A 283 RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 327 (346)
T ss_dssp HHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence 876433 2334689999999999999999999999999999874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=436.92 Aligned_cols=257 Identities=18% Similarity=0.223 Sum_probs=220.1
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..+.|.+.+.||+|+||+||+|++. .+++.||||+++.+.. +.+|+.++++++|||||++++++.+++.
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~-----~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~ 124 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDK-----QTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPW 124 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTE
T ss_pred chhheEeCcEeccCCCeEEEEEEEC-----CCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 4467899999999999999999864 4568999999975422 2579999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+++|+|.++|+.. +.+++.++..++.||+.||+|||+++||||||||+||||+
T Consensus 125 ~~ivmEy~~gg~L~~~l~~~--------------------~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~ 184 (336)
T 4g3f_A 125 VNIFMELLEGGSLGQLIKQM--------------------GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEC
T ss_pred EEEEEeccCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEe
Confidence 99999999999999999732 4589999999999999999999999999999999999999
Q ss_pred CCC-cEEEeccCcccccccccccc---CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 523 DQM-VVKIADFGLSRKMYLQDYYK---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 523 ~~~-~vkI~DfGla~~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
.++ .+||+|||+|+.+....... ......||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..+
T Consensus 185 ~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG-~~Pf~~~~~~~ 263 (336)
T 4g3f_A 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG-CHPWTQYFRGP 263 (336)
T ss_dssp TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSSTTTCCSC
T ss_pred CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-cCCCCCCCHHH
Confidence 987 69999999998764332211 12334689999999999999999999999999999999995 56998887777
Q ss_pred HHHHHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 599 VVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 599 ~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+...+..+.. ...++.+++++.+|+.+||+.||.+|||+.||+++|....+++
T Consensus 264 ~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~ 318 (336)
T 4g3f_A 264 LCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEV 318 (336)
T ss_dssp CHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhh
Confidence 7777776653 3467789999999999999999999999999999998877654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=423.21 Aligned_cols=251 Identities=29% Similarity=0.402 Sum_probs=208.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|++++++++|||||++++++...+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHT-----TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECT-----TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 57999999999999999999853 467899999986542 23345679999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+ +|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++
T Consensus 88 ~~ivmEy~-~g~L~~~l~~--------------------~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~ 146 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQ--------------------RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLD 146 (275)
T ss_dssp EEEEEECC-CEEHHHHHHH--------------------SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEEC
T ss_pred EEEEEeCC-CCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEEC
Confidence 99999999 6899999862 24689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+++.+||+|||+|+...... ......||+.|||||.+.+..+ +.++|||||||++|||++| ..||.+.+..++.+
T Consensus 147 ~~~~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg-~~PF~~~~~~~~~~ 222 (275)
T 3hyh_A 147 EHLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR-RLPFDDESIPVLFK 222 (275)
T ss_dssp TTCCEEECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred CCCCEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC-CCCCCCCCHHHHHH
Confidence 99999999999998653222 2234578999999999998876 5899999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+.. ..|..+++++.+|+.+||+.||++|||++|+++|.|-
T Consensus 223 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~ 266 (275)
T 3hyh_A 223 NISNGVY-TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF 266 (275)
T ss_dssp HHHHTCC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred HHHcCCC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence 9988764 5678899999999999999999999999999999984
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=435.27 Aligned_cols=257 Identities=25% Similarity=0.365 Sum_probs=217.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
..++|++++.||+|+||+||+|+... ...+++.||||+++... .......+.+|+++|++++|||||++++++.+++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKIS--GSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECS--STTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred CccccEEEEEEecCCCeEEEEEEEcc--CCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 34689999999999999999998632 33467899999986432 1112335789999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..+|||||+++|||.++|+. ...+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~--------------------~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 159 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK--------------------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH--------------------HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred EEEEEEEcCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE
Confidence 99999999999999999973 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+|+...... .......||+.|||||.+.+..|+.++|||||||++|||++| .+||.+.+..+++.
T Consensus 160 ~~~g~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG-~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 160 DEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG-TLPFQGKDRKETMT 236 (304)
T ss_dssp CTTSCEEEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred cCCCCEEecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhC-CCCCCCcCHHHHHH
Confidence 999999999999998653322 223346799999999999999999999999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
.+..+.. ..|..+++++.+|+++||+.||++||| ++|+++|.|
T Consensus 237 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~ 284 (304)
T 3ubd_A 237 MILKAKL-GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284 (304)
T ss_dssp HHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred HHHcCCC-CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence 9988764 577889999999999999999999998 589999876
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=422.38 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=209.1
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec----CC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----GK 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~ 441 (653)
+++.+.||+|+||+||+|++. .++..||||.+... ......+.|.+|++++++++|||||++++++.. ++
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred EEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence 467788999999999999864 35688999998654 344556789999999999999999999999864 35
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCCCCCE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHRDLATRNC 519 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHrDLkp~NI 519 (653)
.++|||||+++|+|.++|+.. ..+++..+..++.||+.||+|||+++ ||||||||+||
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~--------------------~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NI 162 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRF--------------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 162 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGE
T ss_pred EEEEEEeCCCCCCHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhhe
Confidence 689999999999999999732 45899999999999999999999998 99999999999
Q ss_pred eEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHH
Q psy5539 520 LIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-THE 597 (653)
Q Consensus 520 Ll~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-~~~ 597 (653)
||+ +++.+||+|||+|+..... ......||+.|||||.+. +.|+.++|||||||+||||++|. +||.+. +..
T Consensus 163 Ll~~~~g~vKl~DFGla~~~~~~----~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~-~Pf~~~~~~~ 236 (290)
T 3fpq_A 163 FITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSE-YPYSECQNAA 236 (290)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSS-CTTTTCSSHH
T ss_pred eEECCCCCEEEEeCcCCEeCCCC----ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCC-CCCCCCCcHH
Confidence 997 4899999999999753221 123457899999999876 47999999999999999999955 588664 456
Q ss_pred HHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
++...+..+... ..+...++++.+|+.+||+.||++|||++++++|+|-
T Consensus 237 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~ 286 (290)
T 3fpq_A 237 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286 (290)
T ss_dssp HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 677777666432 3445678899999999999999999999999999873
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=442.46 Aligned_cols=254 Identities=20% Similarity=0.356 Sum_probs=222.2
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.+.|++.+.||+|+||+||+|+.. .+++.||||+++..... ..+.+.+|+.+|++++|||||++++++..++.
T Consensus 149 p~~~y~~~~~iG~G~fG~V~~a~~~-----~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~ 222 (423)
T 4fie_A 149 PRSYLDNFIKIGEGSTGIVCIATVR-----SSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDE 222 (423)
T ss_dssp GGGTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhHhcEeeeEeccCcCcEEEEEEEC-----CCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCE
Confidence 3457999999999999999999964 46789999998643222 23468899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
+||||||+++|+|.++++. ..+++.++..|+.||+.||+|||+++||||||||+||||+
T Consensus 223 ~~iVmEy~~gG~L~~~i~~---------------------~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~ 281 (423)
T 4fie_A 223 LWVVMEFLEGGALTDIVTH---------------------TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLT 281 (423)
T ss_dssp EEEEEECCTTEEHHHHHHH---------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEEC
T ss_pred EEEEEeCCCCCcHHHHHhc---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEc
Confidence 9999999999999999861 3489999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.+|.+||+|||+|+.+.... .......||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..+++..
T Consensus 282 ~~g~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G-~~PF~~~~~~~~~~~ 358 (423)
T 4fie_A 282 HDGRVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG-EPPYFNEPPLKAMKM 358 (423)
T ss_dssp TTCCEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHHH
T ss_pred CCCCEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC-CCCCCCcCHHHHHHH
Confidence 99999999999998753322 223445789999999999999999999999999999999995 569999999999998
Q ss_pred HHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|..+.. ...+..+++++.+||.+||..||++|||++|+++|.|-
T Consensus 359 i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~ 404 (423)
T 4fie_A 359 IRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 404 (423)
T ss_dssp HHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred HHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence 887643 23445789999999999999999999999999999874
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=420.96 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=201.5
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC----
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK---- 441 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~---- 441 (653)
++.+.+.||+|+||+||+|++. ++.||||+++..... ...++.|+..+.+++|||||+++|++...+
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~~-------g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEET-------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred EEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 5788999999999999999874 478999999764332 233456777778899999999999997643
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC--------CceecC
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR--------KFVHRD 513 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~ivHrD 513 (653)
.++|||||+++|+|.++|+. ..+++..+++++.|++.||+|||++ +|||||
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~---------------------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRD 133 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR---------------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRD 133 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSC
T ss_pred EEEEEecCCCCCcHHHHHHh---------------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeecc
Confidence 57999999999999999972 2478999999999999999999987 999999
Q ss_pred CCCCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccC------CCCCchhHHHHHHHHHHHHh
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYN------KYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~------~~t~ksDVwSlGvvl~ellt 585 (653)
|||+||||++++.+||+|||+|+......... ......||+.|||||++.+. .++.++|||||||+||||+|
T Consensus 134 lKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~t 213 (303)
T 3hmm_A 134 LKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR 213 (303)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHH
Confidence 99999999999999999999998764333211 22345789999999999764 46789999999999999999
Q ss_pred CCC---------CCCCCC-----CHHHHHHHHHcCCc-cCCCCC-----CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 586 FAL---------QPYYGL-----THEEVVKYIKEGNI-LQAPDN-----TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 586 ~~~---------~p~~~~-----~~~e~~~~i~~~~~-~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.. .||.+. ..+++...+..... +..|.. .+..+.+||.+||+.||++||||.+|++.|.
T Consensus 214 g~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 293 (303)
T 3hmm_A 214 RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293 (303)
T ss_dssp TBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHH
Confidence 643 244332 33455555544332 233322 3357899999999999999999999999999
Q ss_pred HHHHH
Q psy5539 646 NIKRD 650 (653)
Q Consensus 646 ~l~~~ 650 (653)
.+.++
T Consensus 294 ~l~~~ 298 (303)
T 3hmm_A 294 QLSQQ 298 (303)
T ss_dssp HHHHC
T ss_pred HHHHH
Confidence 88754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=421.55 Aligned_cols=255 Identities=23% Similarity=0.342 Sum_probs=199.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++....+...+.+.+|+++|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~ 79 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTE 79 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEET-----TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---
T ss_pred hhCEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccc
Confidence 36899999999999999999864 4568999999976666666778999999999999999999999986533
Q ss_pred ---------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 442 ---------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 442 ---------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
.++|||||+++|+|.++++... .....++..++.|+.||+.||+|||+++|+||
T Consensus 80 ~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHR 142 (299)
T 4g31_A 80 KLQPSSPKVYLYIQMQLCRKENLKDWMNGRC-----------------TIEERERSVCLHIFLQIAEAVEFLHSKGLMHR 142 (299)
T ss_dssp -------CEEEEEEEECCCSCCHHHHHHTCC-----------------SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccCCCcEEEEEEecCCCCcHHHHHHhcC-----------------CCChhHHHHHHHHHHHHHHHHHHHHHCcCccc
Confidence 3799999999999999997322 11234567789999999999999999999999
Q ss_pred CCCCCCEeEcCCCcEEEeccCcccccccccccc----------CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHH
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYK----------GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWE 582 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~----------~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~e 582 (653)
||||+||||+.++.+||+|||+|+.+....... ......||+.|||||.+.+..|+.++|||||||++||
T Consensus 143 DlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilye 222 (299)
T 4g31_A 143 DLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222 (299)
T ss_dssp CCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred cCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHH
Confidence 999999999999999999999998764332111 1123468999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCC-HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 583 IFSFALQPYYGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 583 llt~~~~p~~~~~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|++ ||.+.. ....+..+......+.....++.+.+|+++||+.||++|||+.++++|.|
T Consensus 223 ll~----Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~ 282 (299)
T 4g31_A 223 LLY----PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV 282 (299)
T ss_dssp HHS----CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred Hcc----CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 996 775432 22344455555443333345567889999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=404.55 Aligned_cols=309 Identities=63% Similarity=1.093 Sum_probs=251.2
Q ss_pred CCccccccccCccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHh
Q psy5539 344 ASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423 (653)
Q Consensus 344 ~~~~~~~~~~~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~ 423 (653)
......+...++++..+++..++|++.+.||+|+||.||+|+..+.....++..||||.++........+.+.+|+.+++
T Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~ 105 (343)
T 1luf_A 26 PMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105 (343)
T ss_dssp ---------CCHHHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHH
T ss_pred cchhccccccCcccceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHH
Confidence 33344444455677778899999999999999999999999986544446778999999987766777788999999999
Q ss_pred hCCCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccc----cccccCCCCCCHHHHHHHHHHHHH
Q psy5539 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM----ESSIHRVPQLSTCDLITIALQIAS 499 (653)
Q Consensus 424 ~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~~~~i~~qia~ 499 (653)
+++||||+++++++..++..++||||+++|+|.++++...+........... .........+++.+++.++.||+.
T Consensus 106 ~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~ 185 (343)
T 1luf_A 106 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAA 185 (343)
T ss_dssp TCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred hCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999998654322110000000 000112367999999999999999
Q ss_pred HHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHH
Q psy5539 500 GMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579 (653)
Q Consensus 500 gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvv 579 (653)
||.|||+++|+||||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||++
T Consensus 186 ~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 265 (343)
T 1luf_A 186 GMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVV 265 (343)
T ss_dssp HHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHH
Confidence 99999999999999999999999999999999999987655444444455677899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 580 LWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 580 l~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
+|||++++..||.+.+..++...+.++.....+..++.++.+++++||+.+|.+|||+.+|+++|..+.++++
T Consensus 266 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 266 LWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred HHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 9999997778999999999999999998888888999999999999999999999999999999998876543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=409.78 Aligned_cols=255 Identities=20% Similarity=0.265 Sum_probs=211.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|++++|||||++++++..
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~-----~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 128 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRR-----LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPY 128 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCT
T ss_pred CCeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccc
Confidence 57999999999999999999864 467899999997542 33445678899999999999999999999753
Q ss_pred --CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 --GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.+.+||||||++ |+|.+++. ....+++..+..++.||+.||+|||+++||||||||+
T Consensus 129 ~~~~~~~ivmE~~~-g~L~~~i~--------------------~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~ 187 (398)
T 4b99_A 129 GEFKSVYVVLDLME-SDLHQIIH--------------------SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPS 187 (398)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHT--------------------SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCCEEEEEEeCCC-CCHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcc
Confidence 367899999996 68999986 2356899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccc--cCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
|||++.++.+||+|||+|+.+...... .......||+.|||||++.+. .++.++||||+||++|||++| .+||.+.
T Consensus 188 NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G-~~pF~g~ 266 (398)
T 4b99_A 188 NLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLAR-RQLFPGK 266 (398)
T ss_dssp GEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT-SCSSCCS
T ss_pred ccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHC-CCCCCCC
Confidence 999999999999999999866432211 123345789999999998875 569999999999999999994 5699999
Q ss_pred CHHHHHHHHHcCCccC------------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQ------------------------------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 644 (653)
+..+.+..|....... .....++++.+|+.+||..||++|||++|+++|+
T Consensus 267 ~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp 346 (398)
T 4b99_A 267 NYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHP 346 (398)
T ss_dssp SHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSG
T ss_pred CHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCH
Confidence 8888777765321100 0124678999999999999999999999999998
Q ss_pred HH
Q psy5539 645 WN 646 (653)
Q Consensus 645 ~~ 646 (653)
|-
T Consensus 347 ~f 348 (398)
T 4b99_A 347 FL 348 (398)
T ss_dssp GG
T ss_pred hh
Confidence 73
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=401.33 Aligned_cols=288 Identities=40% Similarity=0.718 Sum_probs=245.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCC--CCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL--KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
.++..++|.+.+.||+|+||.||+|++.+.. ....+..||||+++........+.+.+|+++++++ +||||++++++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 4567789999999999999999999875322 22456789999998776666677899999999999 89999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+...+..++||||+++|+|.++++...+...... ..........+++.+++.++.||+.||+|||+++|+||||||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 231 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS----YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 231 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCcccccc----ccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence 9999999999999999999999986543211000 000011234689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+...
T Consensus 232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 99999999999999999998765444444445566788999999999999999999999999999999977789999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
.++...+..+.....+..++.++.++|.+||+.+|.+||++.+|+++|..+.+..
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 312 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp GGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 9999999998888888899999999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=406.96 Aligned_cols=268 Identities=38% Similarity=0.745 Sum_probs=238.1
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+++..++|.+.+.||+|+||.||+|++. .+++.||||.++........+.|.+|++++++++||||+++++++.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 182 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLR-----ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEe-----cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45677789999999999999999999974 2467899999987666666678999999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.++..++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 183 ~~~~~~lv~e~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 243 (377)
T 3cbl_A 183 QKQPIYIVMELVQGGDFLTFLRTE-------------------GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN 243 (377)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHH-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred cCCCcEEEEEcCCCCCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence 999999999999999999999732 2347899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||+++++.+||+|||+++...............+|+.|+|||.+.++.++.++||||||+++|||++++..||.+.+..+
T Consensus 244 il~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~ 323 (377)
T 3cbl_A 244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323 (377)
T ss_dssp EEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH
T ss_pred EEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999865333222222334467889999999999999999999999999999997888999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+.+.+..+...+.+..+++++.+||.+||+.||++|||+++|++.|..+.++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 324 TREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 9999998888888889999999999999999999999999999999998765
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=402.09 Aligned_cols=277 Identities=38% Similarity=0.757 Sum_probs=241.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||+||+|++.+.....++..||||+++..........+.+|+.++++++||||+++++++...
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 146 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 146 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 56678899999999999999999998665455677899999998766666677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++|+|.++++...+.. .....+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 147 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 213 (367)
T 3l9p_A 147 LPRFILLELMAGGDLKSFLRETRPRP-------------SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 213 (367)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHSCCS-------------SSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCCEEEEEeCCCCCHHHHHHhhcccc-------------CccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEE
Confidence 99999999999999999998554321 12356899999999999999999999999999999999999
Q ss_pred EcCCC---cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 INDQM---VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~~~---~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++.++ .+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+..
T Consensus 214 l~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 214 LTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99554 599999999986654444344444567889999999999999999999999999999999788899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++...+..+.....+..++..+.+|+.+||+.+|.+|||+.+|+++|+.+.++
T Consensus 294 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 294 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 99999999888888889999999999999999999999999999999988764
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=388.63 Aligned_cols=270 Identities=36% Similarity=0.633 Sum_probs=236.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|++.. ....+..||||.++........+.|.+|+.++++++||||+++++++..+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRV--PGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECC--TTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEec--CCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 5667789999999999999999999753 23455789999998776666778899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++. ....+++.+++.++.||+.||.|||+.+|+||||||+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 183 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRT-------------------HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVL 183 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHT-------------------TTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CccEEEeeCCCCCcHHHHHHh-------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence 999999999999999999962 2245899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
++.++.+||+|||+++....... ........+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....++
T Consensus 184 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~ 263 (325)
T 3kul_A 184 VDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV 263 (325)
T ss_dssp ECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred ECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999986543221 11223345577899999999999999999999999999999977789999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
...+..+.....+..++.++.+|+..||+.||.+|||+++|++.|..+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~ 315 (325)
T 3kul_A 264 ISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315 (325)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence 9999998877888899999999999999999999999999999999987654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=393.31 Aligned_cols=290 Identities=41% Similarity=0.722 Sum_probs=249.5
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCC--CCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL--KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLL 434 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~ 434 (653)
..+++..++|.+.+.||+|+||.||+|++.+.. ....+..||||+++..........+.+|+++++++ +||||++++
T Consensus 62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 445778889999999999999999999975432 22456789999998777776778899999999999 999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++..++..++||||+++|+|.+++....+...... ..........+++.+++.++.||+.||+|||+++|+||||
T Consensus 142 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 217 (382)
T 3tt0_A 142 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS----YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217 (382)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSC----CCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHHhcccccccc----cccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCC
Confidence 999999999999999999999999986654321110 0111123456999999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.
T Consensus 218 kp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~ 297 (382)
T 3tt0_A 218 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297 (382)
T ss_dssp CGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654444444455667889999999999999999999999999999999777799999
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+..++.+.+..+.....+..++.++.+|+.+||+.+|++|||+++|+++|..+....
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 298 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred CHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 999999999998888888899999999999999999999999999999999887653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=393.95 Aligned_cols=299 Identities=37% Similarity=0.639 Sum_probs=243.7
Q ss_pred CccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccce
Q psy5539 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVK 432 (653)
Q Consensus 354 ~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~ 432 (653)
......++++.++|++.+.||+|+||.||+|++.+.....+++.||||+++........+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 344566788999999999999999999999997665566778999999998776666677899999999999 7899999
Q ss_pred EEeEEecCC-ceEEEEeecCCCChHHHHhhcCCCCCcCCC----c-----------------------------------
Q psy5539 433 LLGVCAVGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGT----Y----------------------------------- 472 (653)
Q Consensus 433 l~g~~~~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~----~----------------------------------- 472 (653)
+++++...+ ..++||||+++|+|.++++........... +
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999987754 589999999999999999854321000000 0
Q ss_pred ---cc----ccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcccccccccccc
Q psy5539 473 ---SS----MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545 (653)
Q Consensus 473 ---~~----~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~ 545 (653)
.. ..........+++..++.++.||+.||+|||+++|+||||||+|||+++++.+||+|||+++.........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch
Confidence 00 00000012338999999999999999999999999999999999999999999999999998664433333
Q ss_pred CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHHHcCCccCCCCCCcHHHHHHHH
Q psy5539 546 GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEEVVKYIKEGNILQAPDNTPDALYDLMK 624 (653)
Q Consensus 546 ~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~ 624 (653)
......+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.. .+.+...+..+.....+..+++++.+++.
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 330 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML 330 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 34455678899999999999999999999999999999996667887765 45666777777777788889999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 625 LCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 625 ~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
+||+.+|.+|||+++|+++|..+.+...
T Consensus 331 ~~l~~dP~~Rps~~ell~~L~~~~~~~~ 358 (359)
T 3vhe_A 331 DCWHGEPSQRPTFSELVEHLGNLLQANA 358 (359)
T ss_dssp HHTCSSGGGSCCHHHHHHHHHHHHHHHT
T ss_pred HHccCChhhCCCHHHHHHHHHHHHHHhc
Confidence 9999999999999999999999887654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=394.70 Aligned_cols=253 Identities=19% Similarity=0.234 Sum_probs=203.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||+||+|+.+. ...+++.||||.+...... ..+.+|+++|+.+ +|||||++++++...+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~--~~~~~~~vAiK~i~~~~~~---~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQL--QVGPEEKIALKHLIPTSHP---IRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEB--TTSCEEEEEEEEECTTSCH---HHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcc--cCCCCCEEEEEEEccccCH---HHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 3679999999999999999998631 2345689999998765432 3578999999998 69999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+++|+|.++++ .+++.++..++.||+.||+|||++||+||||||+|||++
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----------------------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----------------------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----------------------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEEeCCCcccHHHHHc-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence 999999999999999884 378899999999999999999999999999999999998
Q ss_pred CC-CcEEEeccCccccccccccc--------------------------cCCCCCCCccccccchhhccC-CCCCchhHH
Q psy5539 523 DQ-MVVKIADFGLSRKMYLQDYY--------------------------KGDENDAIPVRWMPLESILYN-KYTVESDVW 574 (653)
Q Consensus 523 ~~-~~vkI~DfGla~~~~~~~~~--------------------------~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVw 574 (653)
.+ +.+||+|||+|+........ .......||+.|||||.+.+. .++.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 77 89999999999754321100 011234689999999999876 589999999
Q ss_pred HHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHc--------------------------------------C---------
Q psy5539 575 AFGVCLWEIFSFALQPY-YGLTHEEVVKYIKE--------------------------------------G--------- 606 (653)
Q Consensus 575 SlGvvl~ellt~~~~p~-~~~~~~e~~~~i~~--------------------------------------~--------- 606 (653)
|+||++|||++|.. || .+.+..+.+..|.. .
T Consensus 232 SlG~il~ell~G~~-Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~ 310 (361)
T 4f9c_A 232 SAGVIFLSLLSGRY-PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTS 310 (361)
T ss_dssp HHHHHHHHHHHTCS-SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-----------
T ss_pred hhHHHHHHHHHCCC-CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccc
Confidence 99999999999665 55 44444444333311 0
Q ss_pred ------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 607 ------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 607 ------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
........+++++.+|+++||..||++|||++|+++|+|
T Consensus 311 ~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~ 355 (361)
T 4f9c_A 311 DIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPF 355 (361)
T ss_dssp -----------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred ccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcc
Confidence 000112357889999999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=383.89 Aligned_cols=292 Identities=39% Similarity=0.689 Sum_probs=244.8
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+++..++|.+.+.||+|+||.||+|+........++..||||.++........+.+.+|++++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 44777889999999999999999999875443445678999999987766666778999999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcC----CCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYIN----GTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
..+..++||||+++|+|.+++.......... ...............+++.+++.++.||+.||+|||+++|+||||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~di 176 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDL 176 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccccc
Confidence 9999999999999999999998654211000 000000000112345899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654444444455667889999999999999999999999999999999677799999
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...++...+..+.....+..+++++.+++.+||+.||.+|||+.+|+++|..+..+
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 257 PPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 98899999988887778888999999999999999999999999999999988764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=417.98 Aligned_cols=252 Identities=19% Similarity=0.328 Sum_probs=220.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|+.. .+++.||||.++... ....+.+.+|+.+|+.++|||||++++++...+.++
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~-----~tg~~~AiK~i~~~~-~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cccEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEeccc-hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 57999999999999999999864 467899999987543 334567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|||||+++|+|.++|. .....+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 231 iv~E~~~gg~L~~~i~-------------------~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~ 291 (573)
T 3uto_A 231 MIYEFMSGGELFEKVA-------------------DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 291 (573)
T ss_dssp EEEECCCCCBHHHHHT-------------------CTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS
T ss_pred EEEeecCCCcHHHHHH-------------------HhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCC
Confidence 9999999999999985 123468999999999999999999999999999999999999854
Q ss_pred --CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 525 --MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 525 --~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+.+||+|||+|+.+...... ....||+.|||||.+.+..|+.++|||||||++|||++ |.+||.+.+..+++..
T Consensus 292 ~~~~vKl~DFG~a~~~~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~-G~~Pf~~~~~~~~~~~ 367 (573)
T 3uto_A 292 RSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRN 367 (573)
T ss_dssp SCCCEEECCCSSCEECCTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH-SCCSSCCSSHHHHHHH
T ss_pred CCCCEEEeeccceeEccCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHH-CCCCCCCcCHHHHHHH
Confidence 89999999999876433221 23468999999999999999999999999999999999 5569999999999999
Q ss_pred HHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|..+.... ....+++++.+||++||..||.+|||++|+++|.|
T Consensus 368 i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw 413 (573)
T 3uto_A 368 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 413 (573)
T ss_dssp HHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcC
Confidence 98876432 22468999999999999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=375.44 Aligned_cols=269 Identities=37% Similarity=0.694 Sum_probs=224.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
..++..++|++.+.||+|+||.||+|+... ....+..||+|.++........+.+.+|+.++++++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMS--PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECC--C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEec--CCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 346677899999999999999999998743 234567899999987666667788999999999999999999999974
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.+..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+++|+||||||+|
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 146 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVR-------------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 146 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHT-------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred -cCccEEEEecCCCCCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence 56789999999999999999722 2358899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....+
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~ 225 (281)
T 1mp8_A 147 VLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225 (281)
T ss_dssp EEEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEECCCCCEEECccccccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence 9999999999999999986543222 122334567889999999999999999999999999999987788999998888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+...+..+.....+..+++++.+++.+||+.+|++|||+.+++++|..+.++
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 226 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 8999988887778889999999999999999999999999999999988765
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=413.87 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=213.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-----cHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-----SEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
+..++|++++.||+|+||+||+|+.. .+++.||||+++... ........++++.+++.++|||||+++++
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~-----~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~ 260 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYA 260 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEE
T ss_pred CchHHeEEEEEEecccCeEEEEEEEC-----CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEE
Confidence 34568999999999999999999964 467899999996432 12222233455777888899999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+.+.+.+||||||++||+|.++|.. .+.+++..+..++.||+.||+|||+++||||||||
T Consensus 261 f~~~~~lylVmEy~~GGdL~~~l~~--------------------~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP 320 (689)
T 3v5w_A 261 FHTPDKLSFILDLMNGGDLHYHLSQ--------------------HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 320 (689)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHH--------------------HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred EEECCEEEEEEecCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence 9999999999999999999999973 24589999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGL- 594 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~- 594 (653)
+||||+++|.+||+|||+|+.+... ......||+.|||||++.. ..|+.++|||||||+||||++| .+||.+.
T Consensus 321 eNILld~~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG-~~PF~~~~ 395 (689)
T 3v5w_A 321 ANILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-HSPFRQHK 395 (689)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS-SCTTCGGG
T ss_pred HHeEEeCCCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCC
Confidence 9999999999999999999865322 2234579999999999975 5799999999999999999995 5688753
Q ss_pred --CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 595 --THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 595 --~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
+..++...+.... ...|..+++++.+|+.+||..||.+|++ +++|++|.|
T Consensus 396 ~~~~~~i~~~i~~~~-~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf 452 (689)
T 3v5w_A 396 TKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452 (689)
T ss_dssp CCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred hHHHHHHHHhhcCCC-CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence 4456666666655 4577889999999999999999999998 799999886
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=381.40 Aligned_cols=292 Identities=40% Similarity=0.710 Sum_probs=244.2
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCC--CCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccce
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLL--KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVK 432 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~--~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~ 432 (653)
....+++..++|.+.+.||+|+||.||+|++.+.. ...++..||||+++........+.+.+|+++++++ +||||++
T Consensus 26 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 105 (334)
T 2pvf_A 26 EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIN 105 (334)
T ss_dssp CCTTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEee
Confidence 34455788899999999999999999999975422 12456789999998776666677899999999999 8999999
Q ss_pred EEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 433 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
+++++...+..++||||+++|+|.+++....+..... ...........+++.+++.++.||+.||.|||+++|+||
T Consensus 106 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 181 (334)
T 2pvf_A 106 LLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEY----SYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHR 181 (334)
T ss_dssp EEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCS----CC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEEEEccCCceEEEEECCCCCcHHHHHHHhccccccc----cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 9999999999999999999999999998544321100 000001123458999999999999999999999999999
Q ss_pred CCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
||||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.
T Consensus 182 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999999999999999999999876544443444556678899999999999999999999999999999997778999
Q ss_pred CCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 593 GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+....++...+..+.....+..++.++.+++.+||+.+|.+|||+.+|+++|..+....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~ 320 (334)
T 2pvf_A 262 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320 (334)
T ss_dssp TCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 99999999999888877788889999999999999999999999999999999887643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=369.62 Aligned_cols=263 Identities=34% Similarity=0.706 Sum_probs=232.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+.+..++|++.+.||+|+||.||+|+.. ++..||+|+++..... .+++.+|++++++++||||+++++++..
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 76 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE 76 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET------TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec------CCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4566788999999999999999999863 3467999999865432 3568999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++|+|.++++. ....+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 137 (269)
T 4hcu_A 77 QAPICLVFEFMEHGCLSDYLRT-------------------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 137 (269)
T ss_dssp SSSEEEEEECCTTCBHHHHHHT-------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CCceEEEEEeCCCCcHHHHHHh-------------------cCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheE
Confidence 9999999999999999999962 234589999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+..++
T Consensus 138 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~ 216 (269)
T 4hcu_A 138 LVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 216 (269)
T ss_dssp EECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EEcCCCCEEeccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999999999998653322 22334456678899999999999999999999999999999977889999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...+..+.....+...+.++.+++.+||+.+|.+|||+++++++|.++.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 217 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 999998877777888999999999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.81 Aligned_cols=293 Identities=39% Similarity=0.672 Sum_probs=240.1
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
..+++..++|.+.+.||+|+||.||+|++.+..+..++..||||.++........+.+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 44577888999999999999999999997655556778999999998766656677899999999999 99999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+..++..++||||+++|+|.+++............. ..........+++..++.++.||+.||+|||+++|+||||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS--PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhccccccccccc--ccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 999999999999999999999998554221110000 000112234689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999998664433322333445678899999999999999999999999999999977778877654
Q ss_pred -HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 597 -EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 597 -~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
..+...+..+.....+...+.++.+++.+||+.||.+|||+.+++++|..+..+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence 44555566665555677899999999999999999999999999999998887654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=377.21 Aligned_cols=287 Identities=37% Similarity=0.699 Sum_probs=231.9
Q ss_pred ccccCccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCC
Q psy5539 350 DARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHP 428 (653)
Q Consensus 350 ~~~~~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~Hp 428 (653)
...+..++....+..++|.+.+.||+|+||.||+|+... ....+..||||.++.. ......+.+.+|+.++++++||
T Consensus 19 ~eel~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~ 96 (313)
T 3brb_A 19 SEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ--EDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHP 96 (313)
T ss_dssp -----CCTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEEC--TTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCT
T ss_pred hHhhhhhHHhcccCHHHeeeccceeecCCeEEEEEEEec--cCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCC
Confidence 334556777888889999999999999999999998743 3345678999999754 3344556799999999999999
Q ss_pred ccceEEeEEecCC-----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 429 NIVKLLGVCAVGK-----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 429 nIv~l~g~~~~~~-----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
||+++++++.... ..++||||+++|+|.+++..... ......+++..++.++.||+.||.|
T Consensus 97 ~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~qi~~aL~~ 162 (313)
T 3brb_A 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRL--------------ETGPKHIPLQTLLKFMVDIALGMEY 162 (313)
T ss_dssp TBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTB--------------TTSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred CeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhh--------------hcCCccCCHHHHHHHHHHHHHHHHH
Confidence 9999999997654 35999999999999999963221 1234568999999999999999999
Q ss_pred hhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHH
Q psy5539 504 LSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583 (653)
Q Consensus 504 LH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~el 583 (653)
||+++|+||||||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||
T Consensus 163 LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 242 (313)
T 3brb_A 163 LSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242 (313)
T ss_dssp HHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHH
T ss_pred HHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHH
Confidence 99999999999999999999999999999999876544433444455678899999999999999999999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 584 lt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
++++..||.+....++...+..+.....+..+++++.+++.+||+.+|.+|||+++|+++|..+.+++.
T Consensus 243 ~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 243 ATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HTTSCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred HhcCCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 998888999999888888888887777888899999999999999999999999999999999988765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=383.97 Aligned_cols=293 Identities=37% Similarity=0.629 Sum_probs=231.5
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.++++.++|.+.+.||+|+||.||+|+..+......+..||||.++........+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4678889999999999999999999997554445677899999998665555567899999999999 899999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCC---CcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYING---TYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~---~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
...+..++||||+++|+|.+++........... ..............+++..++.++.||+.||+|||+++|+||||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 198 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 999999999999999999999985432100000 00000000112345899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||++.++.+||+|||++................+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999986644333222334456788999999999999999999999999999999677799876
Q ss_pred CH-HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 595 TH-EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 595 ~~-~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
.. ..+...+..+.....+..+++++.+|+.+||+.||.+|||+.+|+++|+.+..+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 279 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred CcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 64 4455556666566677789999999999999999999999999999999887654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=391.06 Aligned_cols=269 Identities=39% Similarity=0.694 Sum_probs=223.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|+... ....+..||||.++........++|.+|+.++++++||||+++++++...
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKL--PSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBC--TTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEec--CCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 4556688999999999999999998642 23456789999998766666777899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++. ....+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~-------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 179 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRK-------------------HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNIL 179 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHT-------------------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CceEEEEeCCCCCcHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEE
Confidence 999999999999999999972 2245899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
++.++.+||+|||+++........ .......+++.|+|||.+.+..++.++||||||+++|||++.+..||.+.+..++
T Consensus 180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~ 259 (373)
T 2qol_A 180 INSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV 259 (373)
T ss_dssp ECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH
T ss_pred EcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999865432211 1122334577899999999999999999999999999999977789999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...+..+...+.+..++.++.+++.+||+.+|.+||++++|++.|..+.++
T Consensus 260 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 260 IKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 999988877777788999999999999999999999999999999988654
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=380.52 Aligned_cols=280 Identities=43% Similarity=0.799 Sum_probs=242.2
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..+++..++|.+.+.||+|+||.||+|++.+......+..||||.++..........+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 45577788999999999999999999987543344567899999998766666667899999999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++..++||||+++|+|.++++...+.. ........+++..++.++.||+.||+|||+++|+||||||+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~----------~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~ 167 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAM----------ANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAAR 167 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHH----------HHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGG
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhh----------ccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccc
Confidence 99999999999999999999997432100 00012245789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+..
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 99999999999999999987654443333444566889999999999999999999999999999999888899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
++...+..+.....+..++..+.+++.+||+.+|.+|||+.+++++|..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 248 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 99999998888788889999999999999999999999999999998765
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=382.40 Aligned_cols=268 Identities=34% Similarity=0.615 Sum_probs=223.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||+||+|++... .......||+|.++........+.+.+|+.++++++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC-----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCC-CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 3456799999999999999999987431 112234589999976655556678999999999999999999999998754
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.++|+||+.+|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 91 -~~~v~e~~~~g~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll 150 (327)
T 3poz_A 91 -VQLITQLMPFGCLLDYVREH-------------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150 (327)
T ss_dssp -EEEEEECCTTCBHHHHHHHS-------------------TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -eEEEEEecCCCcHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE
Confidence 78999999999999999732 3458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....++..
T Consensus 151 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 230 (327)
T 3poz_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH
Confidence 99999999999999876544433334445668899999999999999999999999999999997778999999888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+..++.++.+++.+||+.+|.+||++++++++|..+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 231 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 8888887778888999999999999999999999999999999887653
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=380.25 Aligned_cols=280 Identities=41% Similarity=0.731 Sum_probs=219.3
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
..++...+..++|.+.+.||+|+||.||+|++.. .......||||.++... .....+.+.+|++++++++||||+++
T Consensus 13 ~~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 90 (323)
T 3qup_A 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQ--EDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90 (323)
T ss_dssp ---CTTBCC---CEEEEEEEEETTEEEEEEEC---------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred HHhhhcccChhHeEEeceecccCCeEEEEEEEcc--cCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehh
Confidence 4566678888999999999999999999998643 12223479999997542 23345679999999999999999999
Q ss_pred EeEEecCCce------EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5539 434 LGVCAVGKPM------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR 507 (653)
Q Consensus 434 ~g~~~~~~~~------~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 507 (653)
++++...... ++||||+++|+|.+++..... ......+++..++.++.||+.||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 156 (323)
T 3qup_A 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRI--------------GENPFNLPLQTLVRFMVDIACGMEYLSSR 156 (323)
T ss_dssp CEEEECC-------CEEEEEECCTTCBHHHHHHHHHC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hceeeccccccCCCccEEEEEeccCCcHHHHHHhhhc--------------cccccccCHHHHHHHHHHHHHHHHHHHcC
Confidence 9999876655 999999999999999974321 11223589999999999999999999999
Q ss_pred CceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCC
Q psy5539 508 KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 508 ~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
+|+||||||+|||+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++++
T Consensus 157 ~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 157 NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence 99999999999999999999999999998765544444444556788999999999999999999999999999999978
Q ss_pred CCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 588 LQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..||.+.+..++...+..+.....+..+++++.+|+.+||+.||.+|||+.++++.|.++...
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 889999999999999988887888889999999999999999999999999999999887654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=396.36 Aligned_cols=259 Identities=35% Similarity=0.677 Sum_probs=228.2
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+++..++|++.+.||+|+||.||+|+.. ++.||||+++... ..+.|.+|+.++++++||||+++++++.
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~ 256 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIV 256 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEec-------CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence 45778889999999999999999999874 3689999998654 2457899999999999999999999987
Q ss_pred cCC-ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 439 VGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 439 ~~~-~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..+ ..++||||+++|+|.++++... ...+++..++.++.||+.||+|||+++|+||||||+
T Consensus 257 ~~~~~~~iv~e~~~~g~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 318 (450)
T 1k9a_A 257 EEKGGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR 318 (450)
T ss_dssp CTTSCEEEEEECCTTCBHHHHHHHHC------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred cCCCceEEEEEecCCCcHHHHHHhcC------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 655 7999999999999999997321 234789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.+||+|||+++..... .....+|+.|+|||.+.+..++.++||||||+++|||+++|..||.+.+..
T Consensus 319 Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 393 (450)
T 1k9a_A 319 NVLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393 (450)
T ss_dssp GEEECTTSCEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT
T ss_pred hEEECCCCCEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999999754211 122356889999999999999999999999999999999777899999888
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++...+..+.....+..+++++++||.+||+.||.+|||+.+|++.|..+...
T Consensus 394 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 394 DVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp THHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 99999999888888899999999999999999999999999999999988754
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=367.92 Aligned_cols=266 Identities=35% Similarity=0.705 Sum_probs=231.5
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
...+++..++|++.+.||+|+||.||+|+.. .+..||||+++..... .+++.+|++++++++||||++++++
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET------TTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc------CCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 3455778889999999999999999999864 3467999999865432 3568999999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+...+..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++|+||||||
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp 148 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLRE-------------------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAA 148 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHC-------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHH-------------------hccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCcc
Confidence 9999999999999999999999972 123589999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+.
T Consensus 149 ~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 149 RNCLVNDQGVVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp GGEEECTTSCEEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEEEcCCCCEEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 99999999999999999998654332 22334455678899999999999999999999999999999977789999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+....+..+.....+...++.+.+++.+||+.+|.+|||+++++++|..+..+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 228 SETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 999999998877777888999999999999999999999999999999988764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=399.80 Aligned_cols=264 Identities=34% Similarity=0.671 Sum_probs=232.1
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..++++.++|.+.+.||+|+||.||+|++. .+..||||+++.... ..+.|.+|+.++++++|||||++++++
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~------~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~ 252 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYN------KHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVV 252 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEET------TTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEEC------CccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEE
Confidence 456888899999999999999999999874 246799999986543 246799999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
. .+..++||||+++|+|.++|+.. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus 253 ~-~~~~~lv~e~~~~g~L~~~l~~~------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 313 (454)
T 1qcf_A 253 T-KEPIYIITEFMAKGSLLDFLKSD------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA 313 (454)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHHSH------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred e-CCccEEEEeecCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 6 66789999999999999999721 1124788899999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.+||+|||+++...... ........+|+.|+|||.+....++.++||||||+++|||++++..||.+.+..
T Consensus 314 Nill~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~ 392 (454)
T 1qcf_A 314 NILVSASLVCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 392 (454)
T ss_dssp GEEECTTCCEEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred HEEECCCCcEEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998754322 223344556889999999999999999999999999999999777899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
++...+..+...+.+..+++++.+||.+||+.||++|||+++|++.|..+..
T Consensus 393 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 393 EVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 9999999888888888999999999999999999999999999999987754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=378.74 Aligned_cols=277 Identities=38% Similarity=0.758 Sum_probs=232.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|++.+.....++..||||.++..........+.+|+.++++++||||+++++++...
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 56678899999999999999999997543344567899999998666666677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++....+.. .....+++.+++.++.||+.||.|||+++|+||||||+|||
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIl 172 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRP-------------SQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCS-------------SSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccc-------------cccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEE
Confidence 99999999999999999998543211 12345899999999999999999999999999999999999
Q ss_pred EcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 IND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++. +..+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++++..||.+....
T Consensus 173 i~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 252 (327)
T 2yfx_A 173 LTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252 (327)
T ss_dssp ESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred EecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH
Confidence 984 45699999999986544433333344566889999999999999999999999999999999788899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++.+.+..+.....+..++..+.+++.+||+.+|.+||++.+|+++|+.+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 253 EVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 99999998887778888999999999999999999999999999999988654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=377.21 Aligned_cols=288 Identities=39% Similarity=0.678 Sum_probs=238.2
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
..+++..++|.+.+.||+|+||.||+|+..+.........||+|.++........+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 45688899999999999999999999998765445556789999998776666677899999999999 89999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+..++..++||||+++|+|.+++......... ..........+++..++.++.||+.||+|||+++|+||||||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLET------DPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSC------C-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccc------cccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 99999999999999999999999743210000 000001134689999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 99999999999999999998654333322334455678899999999999999999999999999999977889987654
Q ss_pred -HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 597 -EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 597 -~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
..+...+..+.....+...+..+.+++..||+.+|.+|||+.+|+++|..+..+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED 328 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence 4445555666556667778999999999999999999999999999999886653
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=367.69 Aligned_cols=270 Identities=34% Similarity=0.641 Sum_probs=233.9
Q ss_pred cccCCCCeeEEe-eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
+.+..++|.+.+ .||+|+||.||+|.+.. ...+..||||.++........+.+.+|++++++++||||+++++++
T Consensus 4 ~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~---~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~- 79 (287)
T 1u59_A 4 LFLKRDNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC- 79 (287)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred ccccHHHhhhhhccccccCceeEEEeEecc---CCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-
Confidence 456667888887 89999999999998642 2356789999998766666777899999999999999999999998
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 140 (287)
T 1u59_A 80 QAEALMLVMEMAGGGPLHKFLVG-------------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140 (287)
T ss_dssp ESSSEEEEEECCTTEEHHHHHTT-------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred cCCCcEEEEEeCCCCCHHHHHHh-------------------CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence 45678999999999999999861 23458999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||+++++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....
T Consensus 141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 220 (287)
T 1u59_A 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220 (287)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999999876433221 22233456889999999999999999999999999999999677799999989
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
++...+..+.....+..+++++.+++..||+.+|.+||++.+++++|+.+..+..
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 275 (287)
T 1u59_A 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 9999999888788888999999999999999999999999999999999877643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=374.96 Aligned_cols=292 Identities=37% Similarity=0.651 Sum_probs=239.2
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEE
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLL 434 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~ 434 (653)
....+++..++|.+.+.||+|+||.||+|++.+.....+++.||||.++........+.+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445677888999999999999999999997654455678999999998776666677899999999999 799999999
Q ss_pred eEEecC-CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 435 GVCAVG-KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 435 g~~~~~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
+++... ...++||||+++|+|.+++........... ..........+++..++.++.||+.||.|||+++|+|||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~d 173 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK----VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRD 173 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-----------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhccccccccc----ccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 998765 458999999999999999984432110000 000001123488999999999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|||+|||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999999998654333222233445678899999999999999999999999999999977778877
Q ss_pred CC-HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 594 LT-HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 594 ~~-~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
.. ..++...+..+.....+...++++.+++.+||+.+|.+|||+.+|+++|..+.+..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 254 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 65 45666777777777778889999999999999999999999999999999887653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=366.75 Aligned_cols=264 Identities=34% Similarity=0.692 Sum_probs=230.9
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+++..++|++.+.||+|+||.||+|+.. .+..||||+++..... .+++.+|++++++++||||+++++++..
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 74 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWK------GQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSK 74 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred eEechhheeeeeeeccCCCceEEEEEec------CceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3566788999999999999999999864 3467999999865432 3568999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++|+|.++++.. ...+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Ni 135 (268)
T 3sxs_A 75 EYPIYIVTEYISNGCLLNYLRSH-------------------GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNC 135 (268)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHH-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGE
T ss_pred CCceEEEEEccCCCcHHHHHHHc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceE
Confidence 99999999999999999999732 23488999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++++..||......+.
T Consensus 136 l~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (268)
T 3sxs_A 136 LVDRDLCVKVSDFGMTRYVLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV 214 (268)
T ss_dssp EECTTCCEEECCTTCEEECCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH
T ss_pred EECCCCCEEEccCccceecchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH
Confidence 999999999999999976543322 2233455678899999999999999999999999999999977789999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
...+..+.....+...++.+.+++..||+.+|.+|||+.+++++|..++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 215 VLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred HHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 9999888877778889999999999999999999999999999999887653
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=401.64 Aligned_cols=266 Identities=39% Similarity=0.784 Sum_probs=235.5
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
....+++..++|.+.+.||+|+||.||+|++. ..+..||||.++..... .++|.+|+.+|++++|||||++++
T Consensus 211 ~~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~-----~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~ 283 (495)
T 1opk_A 211 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283 (495)
T ss_dssp SSSCCBCCGGGEEEEEESGGGTTSSEEEEEEG-----GGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccccCHHHceeeeEecCCCCeEEEEEEEc-----CCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEE
Confidence 34567888899999999999999999999874 34688999999865432 457999999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++...+..+|||||+++|+|.++|+.. ....+++..++.|+.||+.||+|||+++|+|||||
T Consensus 284 ~~~~~~~~~lv~E~~~~g~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlk 345 (495)
T 1opk_A 284 VCTREPPFYIITEFMTYGNLLDYLREC------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLA 345 (495)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHS------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEecCCcEEEEEEccCCCCHHHHHHhc------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 999999999999999999999999732 12458899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+
T Consensus 346 p~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~ 424 (495)
T 1opk_A 346 ARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424 (495)
T ss_dssp GGGEEECGGGCEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCcEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998754322 2333445567899999999999999999999999999999998888999999
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..++.+.+..+.....+..+++++.+||.+||+.+|.+|||+.+|++.|..+
T Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 425 LSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 9999998888877788889999999999999999999999999999998765
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=371.37 Aligned_cols=267 Identities=31% Similarity=0.536 Sum_probs=219.2
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
....++..++|++.+.||+|+||+||+|+.. +..||||++.... .....+.+.+|++++++++||||+++++
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 101 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEET-------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEEC-------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 3455778889999999999999999999863 4789999987543 3445567999999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHRD 513 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHrD 513 (653)
++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+++ |+|||
T Consensus 102 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~D 164 (309)
T 3p86_A 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSG-----------------AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164 (309)
T ss_dssp EECSTTCCEEEEECCTTCBHHHHHHSTT-----------------HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTT
T ss_pred EEEECCceEEEEecCCCCcHHHHHhhcC-----------------CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCC
Confidence 9999999999999999999999997211 1123889999999999999999999999 99999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|||+|||+++++.+||+|||+++..... ........+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+
T Consensus 165 ikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~Pf~~ 241 (309)
T 3p86_A 165 LKSPNLLVDKKYTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATL-QQPWGN 241 (309)
T ss_dssp CCGGGEEECTTCCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHC-CCTTTT
T ss_pred CChhhEEEeCCCcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCC
Confidence 9999999999999999999999754322 1223445688999999999999999999999999999999996 559999
Q ss_pred CCHHHHHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 594 LTHEEVVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 594 ~~~~e~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..++...+. .......+..+++++.+|+.+||+.+|.+|||+++|++.|..+.++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 242 LNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp SCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 88888777765 3444567788999999999999999999999999999999988654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=373.72 Aligned_cols=270 Identities=37% Similarity=0.663 Sum_probs=228.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|.+.+.||+|+||.||+|+.... ....+..||||.++..........+.+|+.++++++||||+++++++...
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecC-CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 56778899999999999999999987431 12335679999998766666677899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++. ....+++..++.++.||+.||.|||+++|+||||||+|||
T Consensus 119 ~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 179 (333)
T 1mqb_A 119 KPMMIITEYMENGALDKFLRE-------------------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 179 (333)
T ss_dssp SSEEEEEECCTTEEHHHHHHH-------------------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CCcEEEEeCCCCCcHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEE
Confidence 999999999999999999972 2245889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++++..||.+.+..++
T Consensus 180 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~ 259 (333)
T 1mqb_A 180 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259 (333)
T ss_dssp ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 999999999999999865432211 1122344578899999999999999999999999999999967779999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...+..+.....+..++..+.+++.+||+.+|.+||++.+|+++|..+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 260 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 999988877777788999999999999999999999999999999988654
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=366.58 Aligned_cols=273 Identities=34% Similarity=0.684 Sum_probs=235.4
Q ss_pred ccccCCCC--eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 359 QLEFPRND--IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 359 ~~e~~~~~--~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
...++.++ |...+.||+|+||.||+|+... .......||+|.++........+.+.+|+.++++++||||++++++
T Consensus 13 ~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 90 (298)
T 3pls_A 13 DVLIPHERVVTHSDRVIGKGHFGVVYHGEYID--QAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGI 90 (298)
T ss_dssp GGBCCGGGEEEEEEEEEEEETTEEEEEEEEEC--SSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred heEccccceEEccCceeccCCCceEEEEEEec--CCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 33444444 4556899999999999998643 2345568999999876666667789999999999999999999999
Q ss_pred EecCCce-EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 437 CAVGKPM-CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 437 ~~~~~~~-~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
+...+.. ++||||+.+|+|.++++. ....+++..++.++.|++.||+|||+++|+|||||
T Consensus 91 ~~~~~~~~~~v~e~~~~~~L~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dik 151 (298)
T 3pls_A 91 MLPPEGLPHVLLPYMCHGDLLQFIRS-------------------PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLA 151 (298)
T ss_dssp ECCSSSCCEEEECCCTTCBHHHHHHC-------------------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EecCCCCcEEEEecccCCCHHHHHhc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 9876655 999999999999999972 23457899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccc--cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|+|||+++++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|+.+|+.+
T Consensus 152 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 152 ARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp GGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred cceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 99999999999999999999865433322 2233456788999999999999999999999999999999999999999
Q ss_pred CCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 594 LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 594 ~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
.+..++...+..+.....+..+++.+.+++.+||+.+|.+|||++++++.|..+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 232 IDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp SCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred CCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 99989999998888777888899999999999999999999999999999999987753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=364.71 Aligned_cols=268 Identities=36% Similarity=0.674 Sum_probs=229.3
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
..+..++|.+.+.||+|+||.||+|+... ....+..||||.++........+.+.+|+.++++++||||+++++++..
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTN--HKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEEC--TTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcC--CCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 35667789999999999999999998743 2345678999999876666667789999999999999999999999765
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+..++||||+++++|.++++.. ...+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 85 -~~~~~v~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Ni 144 (281)
T 3cc6_A 85 -EPTWIIMELYPYGELGHYLERN-------------------KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNI 144 (281)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH-------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred -CCCEEEEecCCCCCHHHHHHhc-------------------cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceE
Confidence 4578999999999999999732 24578999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++++..||......++
T Consensus 145 l~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~ 223 (281)
T 3cc6_A 145 LVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV 223 (281)
T ss_dssp EEEETTEEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH
T ss_pred EECCCCcEEeCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH
Confidence 999999999999999986543222 2223455678999999999999999999999999999999966779988888888
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...+..+.....+..+++.+.+++.+||+.+|++|||+.+++++|..+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 224 IGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 888888877777888999999999999999999999999999999887653
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=368.13 Aligned_cols=267 Identities=36% Similarity=0.702 Sum_probs=229.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe-cCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA-VGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-~~~~~ 443 (653)
.+|++.+.||+|+||.||+|+... .......+|+|.++........+.+.+|+.++++++||||+++++++. .++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLD--NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEec--CCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 357889999999999999998743 223456799999987666666778999999999999999999999864 55688
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.++++. ....+++..++.++.|++.||+|||+++|+||||||+|||+++
T Consensus 103 ~~v~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~ 163 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRN-------------------ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDE 163 (298)
T ss_dssp EEEEECCTTCBHHHHHHC-------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEeCCCCCCHHHHHHh-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECC
Confidence 999999999999999962 2345789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccc--cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++|+.+||.+.+..+...
T Consensus 164 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~ 243 (298)
T 3f66_A 164 KFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 243 (298)
T ss_dssp TCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH
T ss_pred CCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence 999999999999866433322 123345667899999999999999999999999999999999999999988888888
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
.+..+.....+..+++.+.+++.+||+.+|.+|||++++++.|..+..++.
T Consensus 244 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 244 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 888888777788899999999999999999999999999999999887653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=385.54 Aligned_cols=265 Identities=35% Similarity=0.693 Sum_probs=219.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-CCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV-GKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~ 444 (653)
.|.+.+.||+|+||.||+|++.. .......||||.++........+.|.+|+.++++++||||+++++++.. ++..+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLD--NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEE--TTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred eeecCcEeeeCCCeEEEEEEEEC--CCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 46778999999999999998642 2234567999999866555667789999999999999999999998754 56789
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.++++. ....+++.+++.++.||+.||+|||+++|+||||||+|||++++
T Consensus 168 lv~e~~~~g~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 228 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRN-------------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK 228 (373)
T ss_dssp EEEECCTTCBHHHHHHC-------------------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred EEEECCCCCCHHHHHhh-------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCC
Confidence 99999999999999972 22457889999999999999999999999999999999999999
Q ss_pred CcEEEeccCcccccccccccc--CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++++.+||.+.+..++...
T Consensus 229 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~ 308 (373)
T 3c1x_A 229 FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 308 (373)
T ss_dssp CCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH
T ss_pred CCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH
Confidence 999999999998664332211 223445678999999999999999999999999999999999999998888888888
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+..+.....+..++..+.++|.+||+.+|++|||+++++++|..+...+
T Consensus 309 ~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 309 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 8888877788889999999999999999999999999999999987664
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=374.99 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=222.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||.||+|++. .+++.||||++... ......+.+.+|+++++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 88 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHI-----LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT 88 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 458999999999999999999863 45688999998654 234456678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~--------------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~ 148 (328)
T 3fe3_A 89 LYLIMEYASGGEVFDYLVAH--------------------GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLD 148 (328)
T ss_dssp EEEEECCCTTCBHHHHHHHH--------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred EEEEEECCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEc
Confidence 99999999999999999632 3588999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
.++.+||+|||+++...... ......+|+.|+|||.+.+..++ .++||||||+++|||++| ..||.+.+..++..
T Consensus 149 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~ 224 (328)
T 3fe3_A 149 ADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-SLPFDGQNLKELRE 224 (328)
T ss_dssp TTSCEEECSTTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred CCCCEEEeeccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC-CCCCCCCCHHHHHH
Confidence 99999999999997653322 12345689999999999988875 799999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+.. ..|...++++.+|+++||..||.+|||++++++|.|-
T Consensus 225 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 268 (328)
T 3fe3_A 225 RVLRGKY-RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268 (328)
T ss_dssp HHHHCCC-CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTT
T ss_pred HHHhCCC-CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhh
Confidence 9888764 5677789999999999999999999999999998763
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=368.92 Aligned_cols=270 Identities=34% Similarity=0.624 Sum_probs=220.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV- 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~- 439 (653)
++..++|++.+.||+|+||+||+|++.. ....++..||||+++... ....+.+.+|++++++++||||+++++++..
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDP-LQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECT-TCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEec-ccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 4566789999999999999999998643 234567899999997643 4455679999999999999999999999865
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
....++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N 144 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKH-------------------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 144 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHC-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CCCceEEEEEeCCCCCHHHHHHhc-------------------ccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence 35689999999999999999732 2348899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-- 595 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-- 595 (653)
||++.++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++|.. |+....
T Consensus 145 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~-~~~~~~~~ 223 (295)
T 3ugc_A 145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-KSKSPPAE 223 (295)
T ss_dssp EEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTC-TTCSHHHH
T ss_pred EEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhccc-ccCCChHH
Confidence 9999999999999999986543322 122334556788999999999999999999999999999999654 543221
Q ss_pred --------------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 596 --------------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 596 --------------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
..++.+.+..+...+.+..+++++.+++.+||+.+|++|||+++|++.|..+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l~ 294 (295)
T 3ugc_A 224 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294 (295)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred HHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhcc
Confidence 124455666666677788899999999999999999999999999999999987753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=360.15 Aligned_cols=262 Identities=34% Similarity=0.691 Sum_probs=230.8
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+.+..++|++.+.||+|+||.||+|+.. ++..||+|.++..... .+.+.+|++++++++||||+++++++..
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 74 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLE 74 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec------CCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 3566778999999999999999999863 3467999999865432 3578999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++++|.++++.. ...+++..++.++.|++.||+|||+++++||||||+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 135 (267)
T 3t9t_A 75 QAPICLVTEFMEHGCLSDYLRTQ-------------------RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNC 135 (267)
T ss_dssp SSSCEEEECCCTTCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred CCCeEEEEeCCCCCcHHHHHhhC-------------------cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheE
Confidence 99999999999999999999722 24578999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++++..||.+.+..++
T Consensus 136 li~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 214 (267)
T 3t9t_A 136 LVGENQVIKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV 214 (267)
T ss_dssp EECGGGCEEECCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred EECCCCCEEEccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH
Confidence 99999999999999998653322 22334456678999999999999999999999999999999977889999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
...+..+.....+...+..+.+++.+||+.+|.+|||+++++++|..+.+
T Consensus 215 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 215 VEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99998887777778889999999999999999999999999999998875
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=394.84 Aligned_cols=265 Identities=35% Similarity=0.637 Sum_probs=226.3
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..++++.++|++.+.||+|+||.||+|++.+ ...||||+++..... .++|.+|+.++++++||||+++++++
T Consensus 177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~ 248 (452)
T 1fmk_A 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 248 (452)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccChhHceeeeeecCCCCeEEEEEEECC------CceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4467888899999999999999999998743 356999999865432 35789999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.. +..++||||+++|+|.++++.. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus 249 ~~-~~~~iv~e~~~~gsL~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~ 309 (452)
T 1fmk_A 249 SE-EPIYIVTEYMSKGSLLDFLKGE------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 309 (452)
T ss_dssp CS-SSCEEEECCCTTCBHHHHHSHH------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cC-CceEEEehhhcCCCHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence 76 7789999999999999999621 1235789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||+++++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....
T Consensus 310 Nill~~~~~~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~ 388 (452)
T 1fmk_A 310 NILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 388 (452)
T ss_dssp GEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred hEEECCCCCEEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654322 222334456789999999999999999999999999999999778899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++...+..+...+.+..+++.+.+||.+||+.+|++|||+++|++.|..+...
T Consensus 389 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 389 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999888888889999999999999999999999999999999876543
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=404.16 Aligned_cols=271 Identities=33% Similarity=0.638 Sum_probs=230.5
Q ss_pred ccccCCCCeeEEe-eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
...+..+++.+.+ .||+|+||.||+|.+.. ...+..||||+++........++|.+|+++|++++|||||++++++
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEEC---SSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEec---CCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 3456677777777 89999999999998642 2345789999998765544567899999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.. +..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~-------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~ 465 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVG-------------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAAR 465 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTT-------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHH
Confidence 76 569999999999999999962 2345899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
||||++++.+||+|||+++.+..... ........+|+.|+|||.+.+..++.++||||||+++|||+++|..||.+.+.
T Consensus 466 NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 466 NVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp GEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred HEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 99999999999999999987543221 12222344578999999999999999999999999999999977789999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
.++...+..+..+..+..+++++++||..||+.+|++||++.+|++.|..+..++.
T Consensus 546 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~ 601 (613)
T 2ozo_A 546 PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601 (613)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence 99999999998888899999999999999999999999999999999998876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=378.37 Aligned_cols=268 Identities=31% Similarity=0.573 Sum_probs=226.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+..++|++.+.||+|+||+||+|++... .......||+|.+...........+.+|+.++++++||||+++++++. +
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPE-GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCT-TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCC-CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 45567899999999999999999997532 122234589998865443333446788999999999999999999886 5
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 147 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQ-------------------HRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVL 147 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHS-------------------SGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEE
T ss_pred CccEEEEEeCCCCCHHHHHHH-------------------ccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEE
Confidence 678999999999999999972 1235788899999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++...............+|..|+|||.+.+..++.++||||||+++|||++++..||.+....++.
T Consensus 148 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~ 227 (325)
T 3kex_A 148 LKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP 227 (325)
T ss_dssp ESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH
T ss_pred ECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH
Confidence 99999999999999987654443333345567889999999999999999999999999999999677799999888999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
..+..+.....+..++.++.+++.+||+.+|.+|||+++++++|..+.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 228 DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp HHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred HHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 9999888888888899999999999999999999999999999988754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=365.52 Aligned_cols=270 Identities=39% Similarity=0.778 Sum_probs=236.5
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+.+..+++..++|.+.+.||+|+||.||+|++. .++..||||.++.... ..+.+.+|+.++++++||||++++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~ 75 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLL 75 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEG-----GGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEec-----CCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEE
Confidence 455677888899999999999999999999864 3568999999976543 346789999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++...+..++||||+++|+|.++++.. ....+++..++.++.||+.||+|||+++|+||||
T Consensus 76 ~~~~~~~~~~~v~e~~~~~~L~~~~~~~------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 137 (288)
T 3kfa_A 76 GVCTREPPFYIITEFMTYGNLLDYLREC------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 137 (288)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHC------------------CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCC
T ss_pred EEEccCCCEEEEEEcCCCCcHHHHHHhc------------------ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 9999999999999999999999999732 2345899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||+++++.+||+|||++....... ........+++.|+|||.+.+..++.++||||||+++|+|++++..||.+.
T Consensus 138 kp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~ 216 (288)
T 3kfa_A 138 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216 (288)
T ss_dssp SGGGEEECGGGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CcceEEEcCCCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999999999999999997653222 122233445778999999999999999999999999999999778899999
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+..++.+.+........+..+++++.+++.+||+.||.+|||++++++.|..+..+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 217 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 98888888888877778888999999999999999999999999999999887654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=373.41 Aligned_cols=268 Identities=34% Similarity=0.620 Sum_probs=223.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+|++... .......||+|.++........+.+.+|+.++++++||||+++++++..+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCT-TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCC-CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 4567899999999999999999997532 122234679998876555445678999999999999999999999998754
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
.++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+++|+||||||+|||+
T Consensus 91 -~~~v~~~~~~g~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~ 150 (327)
T 3lzb_A 91 -VQLITQLMPFGCLLDYVREH-------------------KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV 150 (327)
T ss_dssp -EEEEECCCSSCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred -ceEEEEecCCCcHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE
Confidence 78999999999999999732 2458899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++++..||.+....++..
T Consensus 151 ~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~ 230 (327)
T 3lzb_A 151 KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS 230 (327)
T ss_dssp EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 99999999999999876444333334445668899999999999999999999999999999997778999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....+..++.++.+++++||+.+|.+|||+.++++.|..+..+
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 9988887788888999999999999999999999999999999988643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=362.62 Aligned_cols=269 Identities=36% Similarity=0.678 Sum_probs=228.5
Q ss_pred ccccCCCCeeEEe-eecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 359 QLEFPRNDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 359 ~~e~~~~~~~~~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
...+..++|.+.+ .||+|+||.||+|.+. ....+..||||+++... .....+.+.+|+.+++.++||||++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~---~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 86 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGI 86 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEE---CSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred eeeecchhhhhccCccccccCeeeEeeeec---CCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456667889988 9999999999999653 23457899999997543 23346789999999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+ ..+..++||||+++++|.++++. ...+++..++.++.||+.||+|||+++|+||||||
T Consensus 87 ~-~~~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp 145 (291)
T 1xbb_A 87 C-EAESWMLVMEMAELGPLNKYLQQ--------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 145 (291)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHHH--------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred E-CCCCcEEEEEeCCCCCHHHHHHh--------------------CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCc
Confidence 8 56778999999999999999972 23588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||++.++.+||+|||++........ ........+++.|+|||.+.+..++.++||||||+++|||++++..||.+.+
T Consensus 146 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 225 (291)
T 1xbb_A 146 RNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225 (291)
T ss_dssp GGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred ceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999976533222 1222334567889999999999999999999999999999996777999999
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
..++...+..+.....+..++.++.+++.+||+.||.+||++.+|++.|..+..+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 226 GSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 99999999988877888889999999999999999999999999999999887654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=373.13 Aligned_cols=254 Identities=22% Similarity=0.346 Sum_probs=220.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|++.+.||+|+||+||+|+.. .+++.||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 4468999999999999999999864 356889999997542 122345688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 137 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRE--------------------RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEE
Confidence 9999999999999999998622 35789999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++.
T Consensus 138 l~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~ 214 (337)
T 1o6l_A 138 LDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLPFYNQDHERLF 214 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred ECCCCCEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcC-CCCCCCCCHHHHH
Confidence 9999999999999997542221 122345689999999999999999999999999999999995 5699998988888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+.+..+. ...|..+++++.+|+.+||+.||.+|| ++++|++|.|
T Consensus 215 ~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~ 263 (337)
T 1o6l_A 215 ELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence 8887765 356778999999999999999999999 9999999876
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=359.43 Aligned_cols=265 Identities=37% Similarity=0.692 Sum_probs=229.7
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+++..++|++.+.||+|+||.||+|+.. .+..||||.++..... .+.+.+|++++++++||||+++++++.
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~ 78 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVT 78 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc------CCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence 45677789999999999999999999863 3467999999764332 457899999999999999999999976
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.+..++||||+++++|.+++... ....+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 79 -~~~~~~v~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N 139 (279)
T 1qpc_A 79 -QEPIYIITEYMENGSLVDFLKTP------------------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAAN 139 (279)
T ss_dssp -SSSCEEEEECCTTCBHHHHTTSH------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred -CCCcEEEEecCCCCCHHHHHhcC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhh
Confidence 45689999999999999998621 11258899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||+++++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++++..||.+.+..+
T Consensus 140 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 218 (279)
T 1qpc_A 140 ILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (279)
T ss_dssp EEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred EEEcCCCCEEECCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH
Confidence 999999999999999998654322 2223345567889999999999999999999999999999997778999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+...+..+.....+..++.++.+++.+||+.+|++|||+++|++.|..+....
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 219 VIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred HHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 99998888777777889999999999999999999999999999999887654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=366.52 Aligned_cols=252 Identities=21% Similarity=0.377 Sum_probs=215.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||+||+|+.. .+++.||||.+...... ..+.+.+|+.++++++||||+++++++..++..
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBT-----TTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhceeeeeeeccCCCeEEEEEEEC-----CCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 457889999999999999999853 45688999998654332 245688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~~~~---------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~ 151 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTE---------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (297)
T ss_dssp EEEEECCTTCBHHHHHHH---------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEECCCCCCHHHHHhh---------------------cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECC
Confidence 999999999999999862 24789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....+
T Consensus 152 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~ 228 (297)
T 3fxz_A 152 DGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPPYLNENPLRALYLI 228 (297)
T ss_dssp TCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHHHH
T ss_pred CCCEEEeeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHH
Confidence 9999999999997653322 223445789999999999999999999999999999999995 4588888776665555
Q ss_pred HcCC--ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGN--ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.... ....+..++..+.+|+.+||+.||.+|||+++++++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~ 272 (297)
T 3fxz_A 229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF 272 (297)
T ss_dssp HHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGG
T ss_pred HhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChh
Confidence 4332 23445678999999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=398.67 Aligned_cols=264 Identities=35% Similarity=0.638 Sum_probs=231.5
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..+++..++|++.+.||+|+||.||+|++.+ ...||||+++..... .++|.+|+++|++++||||+++++++
T Consensus 260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~ 331 (535)
T 2h8h_A 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 331 (535)
T ss_dssp TCSBCCGGGEEEEEEEEECSSEEEEEEEETT------TEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceecchhhhhhheecccCCCeEEEEEEECC------CceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 4467888899999999999999999998743 356999999865432 35789999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.. +..+|||||+++|+|.++|+.. ....+++.+++.|+.||+.||+|||+++|+||||||+
T Consensus 332 ~~-~~~~lv~e~~~~gsL~~~l~~~------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~ 392 (535)
T 2h8h_A 332 SE-EPIYIVTEYMSKGSLLDFLKGE------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 392 (535)
T ss_dssp CS-SSCEEEECCCTTEEHHHHHSHH------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ee-ccceEeeehhcCCcHHHHHhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence 76 7789999999999999999621 1234789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||++++.+||+|||+++...... ........+++.|+|||.+.+..++.++||||||++||||++++..||.+....
T Consensus 393 NIll~~~~~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~ 471 (535)
T 2h8h_A 393 NILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 471 (535)
T ss_dssp GEEECGGGCEEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred hEEEcCCCcEEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654322 223344557889999999999999999999999999999999778899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
++.+.+..+.....+..++.++.+||.+||+.+|++|||+++|++.|..+..
T Consensus 472 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 472 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 9999999988888888999999999999999999999999999999987654
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=367.31 Aligned_cols=261 Identities=28% Similarity=0.450 Sum_probs=215.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+..++|.+.+.||+|+||+||+|++. .++..||+|.+... .....+.+.+|++++++++||||+++++++..+
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-----~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 79 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHR-----ETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD 79 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET
T ss_pred eeChhHeeccceecCCCCEEEEEEEEC-----CCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC
Confidence 355678999999999999999999864 35688999988653 445567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil 140 (310)
T 3s95_A 80 KRLNFITEYIKGGTLRGIIKSM-------------------DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCL 140 (310)
T ss_dssp TEEEEEEECCTTCBHHHHHHHC-------------------CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred CeeEEEEEecCCCcHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEE
Confidence 9999999999999999999732 245899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccccccc------------CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYK------------GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~------------~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
+++++.+||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++|..
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 220 (310)
T 3s95_A 141 VRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220 (310)
T ss_dssp ECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred ECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCC
Confidence 9999999999999998654322211 0113468899999999999999999999999999999999654
Q ss_pred CCCCCCCHH------HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 589 QPYYGLTHE------EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 589 ~p~~~~~~~------e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
|+...... ....... ...+..+++.+.+++.+||+.||++|||+.++++.|..++..+
T Consensus 221 -~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 221 -ADPDYLPRTMDFGLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -SSTTTSCBCTTSSBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -CCcchhhhHHHHhhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 55432211 1111111 1245678889999999999999999999999999999988764
|
| >3hkl_A Muscle, skeletal receptor tyrosine protein kinase; MUSK, receptor tyrosine kinase, frizzled CRD, ATP-binding, D bond, glycoprotein; HET: NAG; 2.10A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=336.11 Aligned_cols=151 Identities=30% Similarity=0.723 Sum_probs=136.1
Q ss_pred CCCCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCC
Q psy5539 29 KQPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGI 108 (653)
Q Consensus 29 ~~~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~ 108 (653)
.+++|||++|||+||++||+|+++||||+|+.+++ ++||+|++++|+++ ++||+.||+||+++||+|+||+|++ +.+
T Consensus 14 ~~~~GyC~~YrG~vC~~yL~g~~~Vf~nsS~~dp~-~~~E~l~~aaw~el-~~lS~~Cr~aAe~lLC~yaFP~Cd~-~~g 90 (197)
T 3hkl_A 14 RGSKGYCAQYRGEVCDAVLVKDSLVFFNTSYPDPE-EAQELLIHTAWNEL-KAVSPLCRPAAEALLCNHLFQECSP-GVL 90 (197)
T ss_dssp ---CEEEECCCCSSSTTTSCTTCCEEEETTSSSHH-HHHHHHHHHHHHHH-TTSCTTTHHHHHHHHHHHHTCBBCS-SSS
T ss_pred CCCCcccccccchHHHHHhCCCceEEEecCcCCHH-HHHHHHHHHHHHHH-HhhcHHHHHHHHHHHHHhhCCCCCC-CCC
Confidence 47899999999999999999889999999988765 79999999999999 9999999999999999999999988 889
Q ss_pred CCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccccccc
Q psy5539 109 PMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEIT 184 (653)
Q Consensus 109 ~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~~~~~ 184 (653)
|+|+|+|||||+++++++|++||+++++++++|+|+++++++.||+|+.||+.+ .++.+|++++++++++++++
T Consensus 91 P~P~pLCREdC~alk~~~C~~Ew~~~e~~~~~G~~~~~~~~l~LP~Ce~LP~~~--~~~~~Ct~ig~~d~~~e~it 164 (197)
T 3hkl_A 91 PTPMPICREYCLAVKELFCAKEWLAMEGKTHRGLYRSGMHFLPVPECSKLPSMH--QDPTACTRLPYLDYKKENIT 164 (197)
T ss_dssp CCBCCBCHHHHHHHHHTTTTTTHHHHHHHHHHHHHHHTCCCCCCCCGGGSCCTT--TCTTSSBCCTTTC-------
T ss_pred CCCcchhHHHHHHHHHHHhHHHHHHHHhccccccccccccceeCCchhhCCCCC--CCCCcceecccccccccccc
Confidence 999999999999999999999999999999999999999999999999999987 58999999999999988876
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=399.10 Aligned_cols=269 Identities=36% Similarity=0.682 Sum_probs=227.3
Q ss_pred ccCCCCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+....+.+. +.||+|+||.||+|.+. ....++.||||+++.... ....+++.+|++++++++|||||++++++.
T Consensus 364 ~~~~~~~~l~~~~LG~G~fG~Vy~~~~~---~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 364 YLDRKLLTLEDKELGSGNFGTVKKGYYQ---MKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEE---CSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cccchhccccCCEeccCCCEEEEEEEEc---CCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3444455543 47999999999999753 234568999999986432 334568999999999999999999999986
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
. +..++||||+++|+|.++++. ...+++..++.|+.||+.||+|||+++|+||||||+|
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~N 499 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ--------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 499 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH--------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred c-CCEEEEEEccCCCCHHHHHhh--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHh
Confidence 4 568999999999999999962 2458899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++++.+||+|||+++.+..... ........+|+.|+|||.+.+..++.++||||||+++|||+++|..||.+.+..
T Consensus 500 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~ 579 (635)
T 4fl3_A 500 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 579 (635)
T ss_dssp EEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999986643322 222334456789999999999999999999999999999999777899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhhC
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~~ 653 (653)
++...+..+.....+..++.++.+||..||+.||++||++++|++.|..+..++.|
T Consensus 580 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~n 635 (635)
T 4fl3_A 580 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 635 (635)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhcC
Confidence 99999999988888999999999999999999999999999999999999887754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=361.80 Aligned_cols=268 Identities=34% Similarity=0.616 Sum_probs=222.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+..+.|++.+.||+|+||.||+|++.. .+..+++.||||+++........+.+.+|++++++++||||+++++++...
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDP-EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECT-TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEcc-ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 4556679999999999999999998532 234567999999998655444556789999999999999999999999876
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++||||+++|+|.+++... ...+++..++.++.|++.||+|||+++|+||||||+|
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 156 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKN-------------------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 156 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHH-------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEEeCCCCcHHHHHHhc-------------------cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence 6689999999999999999622 2458999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC--------
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ-------- 589 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~-------- 589 (653)
||++.++.+||+|||++........ ........+|..|+|||.+.+..++.++||||||+++|||++|..+
T Consensus 157 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 236 (302)
T 4e5w_A 157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALF 236 (302)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred EEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHH
Confidence 9999999999999999986643322 1233455678889999999999999999999999999999997652
Q ss_pred -----CCC-CCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 590 -----PYY-GLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 590 -----p~~-~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
|+. ......+...+..+.....+..+++++.+|+.+||+.||.+|||++++++.|..+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 237 LKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111 22334566677777777788899999999999999999999999999999998775
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=374.43 Aligned_cols=256 Identities=21% Similarity=0.343 Sum_probs=217.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|++.+.||+|+||+||+|+.. .+++.||||+++... .......+.+|+.+++.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~ 93 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVK-----ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF 93 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEc-----CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE
Confidence 345678999999999999999999864 356899999997542 222345678899999988 799999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.++++.. ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 94 ~~~~~~~lv~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 153 (353)
T 3txo_A 94 QTPDRLFFVMEFVNGGDLMFHIQKS--------------------RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLD 153 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHH
Confidence 9999999999999999999999732 35899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||+.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..
T Consensus 154 NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-G~~Pf~~~~~~ 230 (353)
T 3txo_A 154 NVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC-GHAPFEAENED 230 (353)
T ss_dssp GEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH-SSCSSCCSSHH
T ss_pred HEEECCCCCEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh-CCCCCCCCCHH
Confidence 9999999999999999997532221 22334568999999999999999999999999999999999 55699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF------RTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~L~ 645 (653)
++...+..+.. ..|...+.++.+|+++||+.||.+||++ ++|++|.|
T Consensus 231 ~~~~~i~~~~~-~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~ 283 (353)
T 3txo_A 231 DLFEAILNDEV-VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283 (353)
T ss_dssp HHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred HHHHHHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence 99999988764 4677789999999999999999999998 89998875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=371.17 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=219.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.++|.+.+.||+|+||.||+|+.. .++..||+|.++..... ...+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~-----~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 85 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE 85 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEEC-----CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE
Confidence 357999999999999999999864 35689999998754321 12457899999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.....++||||+++|+|.+++. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N 145 (361)
T 2yab_A 86 NRTDVVLILELVSGGELFDFLA--------------------QKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPEN 145 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHT--------------------TCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHH
Confidence 9999999999999999999985 22458999999999999999999999999999999999
Q ss_pred EeEcCCC----cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 519 CLINDQM----VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 519 ILl~~~~----~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+++++ .+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.+.
T Consensus 146 Ill~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g-~~Pf~~~ 221 (361)
T 2yab_A 146 IMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-ASPFLGD 221 (361)
T ss_dssp EEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-CCSSCCS
T ss_pred EEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhC-CCCCCCC
Confidence 9998877 79999999998653321 22345689999999999999999999999999999999995 5699999
Q ss_pred CHHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..++...+..+..... ...+++++.+|+.+||..||.+|||+.++++|+|
T Consensus 222 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 275 (361)
T 2yab_A 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (361)
T ss_dssp SHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred CHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence 99999998887764322 2568899999999999999999999999999876
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=365.63 Aligned_cols=254 Identities=17% Similarity=0.273 Sum_probs=219.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||.||+|+.. .++..||+|.++... .....+.+|+.+++.++||||+++++++...+..
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 76 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred hhceEeeeEEecCCCeEEEEEEEC-----CCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEE
Confidence 468999999999999999999864 456899999987543 2345689999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 ~lv~e~~~g~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 77 VMIFEFISGLDIFERINT-------------------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTS-------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEEeCCCCCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 999999999999999861 2245899999999999999999999999999999999999987
Q ss_pred --CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 --QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 --~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..++..
T Consensus 138 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~ 213 (321)
T 1tki_A 138 RRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG-INPFLAETNQQIIE 213 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHS-SCTTCCSSHHHHHH
T ss_pred CCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhC-CCCCcCCCHHHHHH
Confidence 78999999999986532221 1234578899999999998899999999999999999995 56999999999988
Q ss_pred HHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 602 ~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+..+...... ..++.++.+|+.+||..||.+|||+.++++|+|-.
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~ 262 (321)
T 1tki_A 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK 262 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence 88877653222 46889999999999999999999999999999853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=369.97 Aligned_cols=256 Identities=23% Similarity=0.344 Sum_probs=210.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|+.. .+++.||||++.........+.+.+|+.+++.++||||+++++++..++..+
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 81 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhceeeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 58999999999999999999864 3567899999875544445567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++|+|.++++ ....+++.+++.++.||+.||+|||+++|+||||||+|||++.+
T Consensus 82 lv~e~~~~~~L~~~l~--------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~ 141 (323)
T 3tki_A 82 LFLEYCSGGELFDRIE--------------------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (323)
T ss_dssp EEEECCTTEEGGGGSB--------------------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred EEEEcCCCCcHHHHHh--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC
Confidence 9999999999998875 23458999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTH--EEVVK 601 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~--~e~~~ 601 (653)
+.+||+|||+++...............+|+.|+|||.+.+..+ +.++||||||+++|||++|. .||.+... .....
T Consensus 142 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~~ 220 (323)
T 3tki_A 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSD 220 (323)
T ss_dssp CCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSS-CSCSSSCTTSHHHHH
T ss_pred CCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCchHHHHHHH
Confidence 9999999999986543333333345678999999999988775 78999999999999999955 58866544 23333
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.............++.++.+|+.+||+.||.+|||+++++++.|-
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~ 265 (323)
T 3tki_A 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 265 (323)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred HhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhh
Confidence 333333333335688999999999999999999999999998763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=363.09 Aligned_cols=251 Identities=22% Similarity=0.362 Sum_probs=220.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|++.+.||+|+||+||+|+.. .+++.||+|+++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 3468999999999999999999864 35689999999754221 2245678999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl 138 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRK--------------------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL 138 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--------------------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred CEEEEEEeCCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEE
Confidence 999999999999999999972 235889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++.... ......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+..
T Consensus 139 l~~~g~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~ 212 (318)
T 1fot_A 139 LDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG-YTPFYDSNTMKTY 212 (318)
T ss_dssp ECTTSCEEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS-SCTTCCSSHHHHH
T ss_pred EcCCCCEEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhC-CCCCCCCCHHHHH
Confidence 99999999999999986422 22345689999999999999999999999999999999995 5699888888888
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
..+..+. ...+...+.++.+++.+||..||++|| ++++|++|.|
T Consensus 213 ~~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~ 261 (318)
T 1fot_A 213 EKILNAE-LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261 (318)
T ss_dssp HHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHHhCC-CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence 8888765 456778999999999999999999999 8999999876
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=395.12 Aligned_cols=271 Identities=37% Similarity=0.688 Sum_probs=234.5
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
....++..++|++.+.||+|+||.||+|++.. ....+..||||.++........+.+.+|+.++++++||||++++++
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~--~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~ 459 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMS--PENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGV 459 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECC--SSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEec--CCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34566778899999999999999999998753 2345678999999876666677889999999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+. .+..++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+||||||
T Consensus 460 ~~-~~~~~lv~E~~~~g~L~~~l~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp 519 (656)
T 2j0j_A 460 IT-ENPVWIIMELCTLGELRSFLQVR-------------------KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAA 519 (656)
T ss_dssp EC-SSSCEEEEECCTTCBHHHHHHHT-------------------TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred Ee-cCceEEEEEcCCCCcHHHHHHhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccch
Confidence 85 46789999999999999999721 23588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||++.++.+||+|||+++....... .......+|+.|||||.+.+..++.++||||||+++|||++++..||.+...
T Consensus 520 ~NILl~~~~~vkL~DFG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 520 RNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp GGEEEEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred HhEEEeCCCCEEEEecCCCeecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999986533322 2223345678999999999999999999999999999999878889999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.++...+..+.....+..+++.+.++|.+||+.||.+|||+.+|++.|..+.++
T Consensus 599 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 599 NDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 999999999888888889999999999999999999999999999999988654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=357.12 Aligned_cols=254 Identities=25% Similarity=0.408 Sum_probs=212.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .......+.+|+.++++++||||+++++++..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CCceeeeEecCCCCeEEEEEEEC-----CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEE
Confidence 57999999999999999999864 356889999986442 333456788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 ~lv~e~~~~-~l~~~~~~-------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~ 136 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDS-------------------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EEEEECCSE-EHHHHHHH-------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEecCCC-CHHHHHHh-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 999999975 66666642 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||+++..... ........+|..|+|||.+.+.. ++.++||||||+++|||++++.++|.+.+..+....
T Consensus 137 ~~~~kl~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~ 214 (292)
T 3o0g_A 137 NGELKLANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp TSCEEECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred CCCEEEeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHH
Confidence 999999999999765322 12234456789999999998766 899999999999999999999888888888777666
Q ss_pred HHcCC----------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGN----------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.... ........+.++.+|+++||+.||++|||++++++|.|
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 54310 01112347789999999999999999999999999876
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=365.34 Aligned_cols=279 Identities=39% Similarity=0.672 Sum_probs=226.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccce--EEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFT--LVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~--~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|++.+.||+|+||.||+|+... ++. .||||.++........+.+.+|+++++++ +||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 95 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKK-----DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC 95 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEE-----TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred cccHHHccceeeeecCCCceEEEEEEcc-----CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceee
Confidence 3455789999999999999999998642 333 46999987655555566799999999999 999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.+++......... ............+++..++.++.||+.||+|||+++|+||||||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~ 171 (327)
T 1fvr_A 96 EHRGYLYLAIEYAPHGNLLDFLRKSRVLETD----PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAAR 171 (327)
T ss_dssp EETTEEEEEECCCTTCBHHHHHHTTCHHHHC----HHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred eeCCceEEEEecCCCCCHHHHHHhccccccc----ccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccc
Confidence 9999999999999999999999732100000 000000012346899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+||+|||+++.... ........+++.|+|||.+.+..++.++||||||+++|||++++..||.+.+..
T Consensus 172 NIl~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~ 248 (327)
T 1fvr_A 172 NILVGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA 248 (327)
T ss_dssp GEEECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred eEEEcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH
Confidence 99999999999999999874321 122234456788999999999999999999999999999999667799999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
++...+..+.....+..+++++.+|+.+||+.+|.+|||+++++++|..+.++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 249 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 999888888767777889999999999999999999999999999999887653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.32 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=211.6
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+.+..++|++.+.||+|+||+||+|+.. ++.||||+++.... ....+++|+.++++++||||+++++++.
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~ 88 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL-------NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEK 88 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET-------TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred ccccchhhchhhheecccCceEEEEEEEC-------CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceec
Confidence 34567789999999999999999999864 37899999976433 3345677999999999999999999997
Q ss_pred cCC----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-------
Q psy5539 439 VGK----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR------- 507 (653)
Q Consensus 439 ~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~------- 507 (653)
... ..++||||+++|+|.++++. ..+++..++.++.||+.||+|||+.
T Consensus 89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~---------------------~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~ 147 (322)
T 3soc_A 89 RGTSVDVDLWLITAFHEKGSLSDFLKA---------------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147 (322)
T ss_dssp EECSSSEEEEEEEECCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTE
T ss_pred cCCCCCceEEEEEecCCCCCHHHHHHh---------------------cCCCHHHHHHHHHHHHHHHHHHHhhccccccc
Confidence 644 47999999999999999962 2478999999999999999999999
Q ss_pred ---CceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-----CCCCchhHHHHHHH
Q psy5539 508 ---KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-----KYTVESDVWAFGVC 579 (653)
Q Consensus 508 ---~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-----~~t~ksDVwSlGvv 579 (653)
+|+||||||+|||+++++.+||+|||+++...............+|+.|+|||.+.+. .++.++||||||++
T Consensus 148 ~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~i 227 (322)
T 3soc_A 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLV 227 (322)
T ss_dssp EECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHH
T ss_pred cCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHH
Confidence 9999999999999999999999999999876544433334446789999999999873 45678899999999
Q ss_pred HHHHHhCCCCCCCCC----------------CHHHHHHHHHcCCccCCCC------CCcHHHHHHHHHhhccCCCCCCCH
Q psy5539 580 LWEIFSFALQPYYGL----------------THEEVVKYIKEGNILQAPD------NTPDALYDLMKLCWNMKPMNRPSF 637 (653)
Q Consensus 580 l~ellt~~~~p~~~~----------------~~~e~~~~i~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~ 637 (653)
+|||++|.. ||.+. ...++...+......+... ..++++.+|+.+||+.||++|||+
T Consensus 228 l~el~tg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 306 (322)
T 3soc_A 228 LWELASRCT-AADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306 (322)
T ss_dssp HHHHHTTBT-TSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHHhCCC-CCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCH
Confidence 999999654 66542 2334444443333222111 134569999999999999999999
Q ss_pred HHHHHHHHHHHHH
Q psy5539 638 RTIYQTLWNIKRD 650 (653)
Q Consensus 638 ~eil~~L~~l~~~ 650 (653)
.+|++.|..+.+.
T Consensus 307 ~ell~~L~~l~~~ 319 (322)
T 3soc_A 307 GCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
Confidence 9999999999865
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=363.76 Aligned_cols=259 Identities=21% Similarity=0.318 Sum_probs=213.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
.+..++|++.+.||+|+||.||+|+... ...+++.||+|+++... .......+.+|+.+++.++||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~--~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 90 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVT--GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAF 90 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECS--STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEec--cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEE
Confidence 3455789999999999999999998632 23567899999997642 122345678999999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++..++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+
T Consensus 91 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 150 (327)
T 3a62_A 91 QTGGKLYLILEYLSGGELFMQLERE--------------------GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPE 150 (327)
T ss_dssp ECSSCEEEEEECCTTEEHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHH
Confidence 9999999999999999999999732 34788999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus 151 Nill~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~ 227 (327)
T 3a62_A 151 NIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG-APPFTGENRK 227 (327)
T ss_dssp TEEECTTSCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHH
T ss_pred HeEECCCCcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHC-CCCCCCCCHH
Confidence 9999999999999999997542221 122345688999999999999999999999999999999995 5699999988
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+....+..+. ...+..++.++.+|+.+||+.||.+|| ++.++++|.|
T Consensus 228 ~~~~~i~~~~-~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 228 KTIDKILKCK-LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp HHHHHHHHTC-CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred HHHHHHHhCC-CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 8888887765 356778899999999999999999999 8899999876
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=377.58 Aligned_cols=254 Identities=23% Similarity=0.300 Sum_probs=218.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|... .++..+|+|.++... .....+.+.+|+.+++.++||||+++++++..++..
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~-----~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKV-----LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEET-----TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred CCeEEEEEeccCCCeEEEEEEEC-----CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 47899999999999999999863 467899999987543 334456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN- 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~- 522 (653)
++||||+++|+|.+++.. ...+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus 86 ~lv~E~~~gg~L~~~i~~--------------------~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~ 145 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVA--------------------REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLAS 145 (444)
T ss_dssp EEEECCCBCCBHHHHHHH--------------------CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESB
T ss_pred EEEEEeCCCCCHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEec
Confidence 999999999999999862 24589999999999999999999999999999999999998
Q ss_pred --CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|+|++| .+||.+.+..++.
T Consensus 146 ~~~~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G-~~Pf~~~~~~~~~ 222 (444)
T 3soa_A 146 KLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG-YPPFWDEDQHRLY 222 (444)
T ss_dssp SSTTCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHH
T ss_pred cCCCCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhC-CCCCCCccHHHHH
Confidence 56889999999997653322 122345789999999999999999999999999999999995 5699999999999
Q ss_pred HHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+...... ..+++++.+|+.+||+.||.+|||+.++++|+|-
T Consensus 223 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~ 271 (444)
T 3soa_A 223 QQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271 (444)
T ss_dssp HHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred HHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence 999887653222 3678999999999999999999999999998763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=356.48 Aligned_cols=258 Identities=35% Similarity=0.671 Sum_probs=218.4
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+.+..++|++.+.||+|+||.||+|+.. +..||||.++... ..+.+.+|+.++++++||||+++++++..
T Consensus 16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (278)
T 1byg_A 16 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE 85 (278)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred ccCChhhceEEeEEecCCCceEEEEEEc-------CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 3556678999999999999999999863 4789999998653 34578999999999999999999999754
Q ss_pred C-CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 G-KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 ~-~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
. +..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||+++++||||||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 86 EKGGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHH------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CCCceEEEEecCCCCCHHHHHHhcc------------------cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 4 57899999999999999997321 1237888999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||+++++.+||+|||++...... .....++..|+|||.+.+..++.++||||||+++|||++++..||...+..+
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 222 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 222 (278)
T ss_dssp EEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred EEEeCCCcEEEeecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998754221 2233567889999999999999999999999999999997778999888888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+...+..+.....+..+++.+.+++.+||+.||.+|||+.++++.|..++..
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 223 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 8888888777777888999999999999999999999999999999998764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=361.11 Aligned_cols=268 Identities=31% Similarity=0.565 Sum_probs=224.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec--
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV-- 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-- 439 (653)
+..+.|++++.||+|+||+||++.... ....+++.||||+++........+.+.+|++++++++||||+++++++..
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDP-TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECS-CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEcc-CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 334456999999999999999997643 23456789999999877666677889999999999999999999999986
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++|+|.+++.. ..+++..++.++.||+.||.|||+.+|+||||||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~---------------------~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni 165 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR---------------------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV 165 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG---------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CceEEEEEecccCCcHHHHHhh---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence 4578999999999999999861 2378999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT--- 595 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~--- 595 (653)
|++.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++|.. ||....
T Consensus 166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~-p~~~~~~~~ 244 (318)
T 3lxp_A 166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCD-SSQSPPTKF 244 (318)
T ss_dssp EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC-GGGSHHHHH
T ss_pred EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCC-cccccchhh
Confidence 999999999999999987643322 122344567888999999999999999999999999999999654 664322
Q ss_pred ------------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 596 ------------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 596 ------------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
..++.+.+..+.....+..++.++.+|+++||+.||.+|||++++++.|..+.+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 245 LELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred hhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 123455566676777788899999999999999999999999999999999988764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=353.33 Aligned_cols=256 Identities=25% Similarity=0.394 Sum_probs=219.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|+.. .++..||||++...... .....+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEc-----cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 455678999999999999999999864 35678999998654322 22456889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~N 139 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKL--------------------SKFDEQRTATYITELANALSYCHSKRVIHRDIKPEN 139 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGG
T ss_pred cCCEEEEEEecCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHh
Confidence 999999999999999999999632 347899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+
T Consensus 140 ili~~~~~~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~ 214 (279)
T 3fdn_A 140 LLLGSAGELKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVG-KPPFEANTYQE 214 (279)
T ss_dssp EEECTTSCEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS-SCTTCCSSHHH
T ss_pred EEEcCCCCEEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHC-CCCCCCCcHHH
Confidence 99999999999999998654221 12345678899999999999999999999999999999995 56999989888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
....+..... ..+...+.++.+|+.+||+.+|.+|||++++++|.|--
T Consensus 215 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~ 262 (279)
T 3fdn_A 215 TYKRISRVEF-TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWIT 262 (279)
T ss_dssp HHHHHHHTCC-CCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHH
T ss_pred HHHHHHhCCC-CCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcccc
Confidence 8888877653 46777899999999999999999999999999999854
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.10 Aligned_cols=256 Identities=26% Similarity=0.394 Sum_probs=219.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|.+.+.||+|+||+||+|+.. .+++.||||+++.... ......+.+|..++..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 456679999999999999999999964 3578999999975421 12234577889998876 999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.++++.. ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 147 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSC--------------------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLD 147 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChh
Confidence 9999999999999999999999732 35789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus 148 NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~ 224 (345)
T 1xjd_A 148 NILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG-QSPFHGQDEE 224 (345)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSCCSSHH
T ss_pred hEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcC-CCCCCCCCHH
Confidence 9999999999999999997542222 123445789999999999999999999999999999999995 5699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR-TIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~ 645 (653)
++...+..+.. ..+..++.++.+|+.+||..||++||++. +|++|.|
T Consensus 225 ~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~ 272 (345)
T 1xjd_A 225 ELFHSIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 272 (345)
T ss_dssp HHHHHHHHCCC-CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred HHHHHHHhCCC-CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCcc
Confidence 99998887753 56777999999999999999999999998 8887765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=367.83 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=218.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|.+.+.||+|+||.||+|... .++..||+|.++.. ......+.+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 57899999999999999999864 35688999999654 2344456789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++. ....+++.++..++.||+.||.|||+++|+||||||+|||++.
T Consensus 104 ~lv~e~~~gg~L~~~l~--------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~ 163 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIV--------------------AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLAS 163 (362)
T ss_dssp EEEECCCCSCBHHHHHT--------------------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESC
T ss_pred EEEEecCCCCCHHHHHH--------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 99999999999999985 2245899999999999999999999999999999999999986
Q ss_pred C---CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 Q---MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ~---~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+ +.+||+|||++....... ......+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..++.
T Consensus 164 ~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~Pf~~~~~~~~~ 239 (362)
T 2bdw_A 164 KAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG-YPPFWDEDQHRLY 239 (362)
T ss_dssp SSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred CCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCHHHHH
Confidence 5 469999999997653221 22345689999999999999999999999999999999995 5699999999999
Q ss_pred HHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+...... ..+++++.+|+.+||+.||.+|||+.+++++.|-
T Consensus 240 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 288 (362)
T 2bdw_A 240 AQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288 (362)
T ss_dssp HHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred HHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence 888887653222 3578999999999999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=367.55 Aligned_cols=256 Identities=24% Similarity=0.363 Sum_probs=219.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|++.+.||+|+||+||+|+.. .+++.||||+++.... ....+.+.+|..++..+ +||||+++++++
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~ 90 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 90 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEET-----TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE
Confidence 455678999999999999999999864 4678999999975421 12245678899999988 899999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++|+||||||+
T Consensus 91 ~~~~~~~lv~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 150 (353)
T 2i0e_A 91 QTMDRLYFVMEYVNGGDLMYHIQQV--------------------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150 (353)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred EcCCEEEEEEeCCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHH
Confidence 9999999999999999999999732 35889999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..
T Consensus 151 NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G-~~Pf~~~~~~ 227 (353)
T 2i0e_A 151 NVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QAPFEGEDED 227 (353)
T ss_dssp GEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS-SCSSCCSSHH
T ss_pred HEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcC-CCCCCCCCHH
Confidence 9999999999999999997532221 123445689999999999999999999999999999999994 5699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
++.+.+..+.. ..|..++.++.+|+++||+.||.+||+ +++|++|.|
T Consensus 228 ~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~ 279 (353)
T 2i0e_A 228 ELFQSIMEHNV-AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279 (353)
T ss_dssp HHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred HHHHHHHhCCC-CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence 99999888764 567789999999999999999999994 689998875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=349.69 Aligned_cols=254 Identities=35% Similarity=0.577 Sum_probs=207.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH---HHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE---YLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~---~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
++..++|++.+.||+|+||.||+|++. +..||||+++..... ...+.+.+|+++++.++||||+++++++
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 75 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI-------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC 75 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET-------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc-------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 566789999999999999999999863 478999998754322 2245789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC---ceecCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK---FVHRDL 514 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---ivHrDL 514 (653)
..++..++||||+++++|.++++ ...+++..++.++.|++.||+|||+++ |+||||
T Consensus 76 ~~~~~~~lv~e~~~~~~L~~~~~---------------------~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~di 134 (271)
T 3dtc_A 76 LKEPNLCLVMEFARGGPLNRVLS---------------------GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDL 134 (271)
T ss_dssp CCC--CEEEEECCTTEEHHHHHT---------------------SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCC
T ss_pred ecCCceEEEEEcCCCCCHHHHhh---------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCC
Confidence 99999999999999999999985 235889999999999999999999998 899999
Q ss_pred CCCCEeEcC--------CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhC
Q psy5539 515 ATRNCLIND--------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 515 kp~NILl~~--------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~ 586 (653)
||+|||+++ ++.+||+|||+++...... .....+++.|+|||.+.+..++.++||||||+++|||++|
T Consensus 135 kp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 135 KSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp SGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred chHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999986 7789999999997653221 2244678999999999999999999999999999999995
Q ss_pred CCCCCCCCCHHHHHHHHHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..||.+.+..+....+..... ...+..+++++.+++.+||+.+|.+|||+.+++++|..+
T Consensus 211 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 211 -EVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp -CCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred -CCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 459988888777766665443 456678899999999999999999999999999998753
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=360.41 Aligned_cols=261 Identities=25% Similarity=0.468 Sum_probs=218.6
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
++..++|.+.+.||+|+||+||+|+...... ......||+|.++.... ...+.+.+|+.++++++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 4556789999999999999999998643111 11236799999975433 34567999999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.++..++||||+++|+|.++++.. ...+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 83 ~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 143 (289)
T 4fvq_A 83 CGDENILVQEFVKFGSLDTYLKKN-------------------KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN 143 (289)
T ss_dssp CTTCCEEEEECCTTCBHHHHHHHT-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred eCCCCEEEEECCCCCCHHHHHHhC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcce
Confidence 999999999999999999999732 1337899999999999999999999999999999999
Q ss_pred EeEcCCCc--------EEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 519 CLINDQMV--------VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 519 ILl~~~~~--------vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
||++.++. +||+|||++....... ...+++.|+|||.+.+ ..++.++||||||+++|||++|+.+
T Consensus 144 Ill~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 217 (289)
T 4fvq_A 144 ILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217 (289)
T ss_dssp EEEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCC
Confidence 99998887 9999999997543221 2235678999999987 6799999999999999999999988
Q ss_pred CCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
|+............... ...+...+.++.+++.+||+.||.+|||+++++++|..+..
T Consensus 218 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 218 PLSALDSQRKLQFYEDR--HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp TTTTSCHHHHHHHHHTT--CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CccccchHHHHHHhhcc--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 99888887776666553 34556678889999999999999999999999999987643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=354.63 Aligned_cols=263 Identities=29% Similarity=0.485 Sum_probs=207.6
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
...++..++|.+.+.||+|+||.||+|+.. ..||||+++... .....+.+.+|+.++++++||||++++++
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS--------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc--------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence 445888899999999999999999999853 249999987543 34456789999999999999999999996
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
. .....++||||+++++|.+++.. ....+++..++.++.||+.||.|||+++|+||||||
T Consensus 89 ~-~~~~~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp 148 (289)
T 3og7_A 89 S-TAPQLAIVTQWCEGSSLYHHLHA-------------------SETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKS 148 (289)
T ss_dssp E-CSSSCEEEEECCCEEEHHHHHTT-------------------C---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred c-cCCccEEEEEecCCCcHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCcc
Confidence 5 55678999999999999999851 234589999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
+|||++.++.+||+|||+++...............+|+.|+|||.+. +..++.++||||||+++|||++|. .||.+
T Consensus 149 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~ 227 (289)
T 3og7_A 149 NNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ-LPYSN 227 (289)
T ss_dssp GGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSS-CTTSS
T ss_pred ceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCC-CCccc
Confidence 99999999999999999997654322222333456789999999987 667889999999999999999955 57766
Q ss_pred C-CHHHHHHHHHcCCccC----CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 594 L-THEEVVKYIKEGNILQ----APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 594 ~-~~~e~~~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
. ..+.+...+..+.... ....+++++.+|+.+||+.+|.+|||++++++.|.++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 228 INNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred cchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 4 4455666666654432 234688999999999999999999999999999988754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=357.21 Aligned_cols=254 Identities=25% Similarity=0.329 Sum_probs=209.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-------------------------HHHHHHHHH
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-------------------------YLQTDFERE 418 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-------------------------~~~~~f~~E 418 (653)
.++|.+.+.||+|+||.||+|+.. .+++.||||+++..... ...+.+.+|
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNE-----NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEET-----TTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 468999999999999999999863 45689999998654211 123568899
Q ss_pred HHHHhhCCCCccceEEeEEec--CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHH
Q psy5539 419 ACLLAEFDHPNIVKLLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQ 496 (653)
Q Consensus 419 i~il~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 496 (653)
++++++++||||+++++++.. .+..++||||+++|+|.+++. ...+++.+++.++.|
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~~~~~~q 145 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT---------------------LKPLSEDQARFYFQD 145 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC---------------------SSCCCHHHHHHHHHH
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh---------------------cCCCCHHHHHHHHHH
Confidence 999999999999999999986 568899999999999876542 246899999999999
Q ss_pred HHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC---CCCchhH
Q psy5539 497 IASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK---YTVESDV 573 (653)
Q Consensus 497 ia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~t~ksDV 573 (653)
|+.||+|||+++|+||||||+|||++.++.+||+|||+++....... ......+|+.|+|||.+.+.. ++.++||
T Consensus 146 i~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 223 (298)
T 2zv2_A 146 LIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDV 223 (298)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred HHHHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhh
Confidence 99999999999999999999999999999999999999986543221 123456899999999998765 3788999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 574 wSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
||||+++|||++|. .||.+....++...+...... +....+++++.+|+.+||+.||++|||+.++++|.|-
T Consensus 224 ~slG~~l~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~ 296 (298)
T 2zv2_A 224 WAMGVTLYCFVFGQ-CPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296 (298)
T ss_dssp HHHHHHHHHHHHSS-CSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHH
T ss_pred HhHHHHHHHHHHCC-CCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccc
Confidence 99999999999954 589888888877777765432 2234688999999999999999999999999999874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.11 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=214.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
-.++|++.+.||+|+||.||+|+.. ..+..||+|.+... ......+.+.+|+.++++++||||+++++++..+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~ 83 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDT-----ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED 83 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEET-----TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS
T ss_pred hhccEEEEEEEccCCCEEEEEEEEC-----CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC
Confidence 3468999999999999999999864 35678999988532 3445567899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+|||
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil 143 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESH--------------------GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNIL 143 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHH--------------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred CeEEEEEeCCCCCCHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 9999999999999999999732 35899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++...... ........+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+..
T Consensus 144 ~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~~~~~~ 221 (294)
T 4eqm_A 144 IDSNKTLKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVG-EPPFNGETAVSIA 221 (294)
T ss_dssp ECTTSCEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHS-SCSSCSSCHHHHH
T ss_pred ECCCCCEEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhC-CCCCCCCChHHHH
Confidence 9999999999999997653222 1222344678999999999999999999999999999999994 5699888877665
Q ss_pred HHHHcCCccC----CCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQ----APDNTPDALYDLMKLCWNMKPMNRP-SFRTIYQTLWNIK 648 (653)
Q Consensus 601 ~~i~~~~~~~----~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 648 (653)
.......... .+..+++.+.+++.+||+.||.+|| +++++.+.|..+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~ 274 (294)
T 4eqm_A 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL 274 (294)
T ss_dssp HHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred HHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence 5554443322 3466899999999999999999999 8888888887653
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-42 Score=349.27 Aligned_cols=256 Identities=23% Similarity=0.414 Sum_probs=218.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++..++|++.+.||+|+||.||+|++. +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ-------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQS 78 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECT
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC-------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEcc
Confidence 455678999999999999999999873 4789999997543 34456679999999999999999999999987
Q ss_pred C--CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCC
Q psy5539 440 G--KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHRDLA 515 (653)
Q Consensus 440 ~--~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHrDLk 515 (653)
. ...++||||+++|+|.++++.. ....+++..++.++.||+.||+|||+++ ++|||||
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 79 PPAPHPTLITHWMPYGSLYNVLHEG------------------TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp TTSSSCEEEEECCTTCBHHHHHHSC------------------SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred CCCCCeEeeecccCCCcHHHHHhhc------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 6 7889999999999999999721 1235899999999999999999999999 9999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCC---chhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTV---ESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~---ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|+|||+++++.++|+|||++... ......+|+.|+|||.+.+..++. ++||||||+++|||++ +..||.
T Consensus 141 p~Nil~~~~~~~~l~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~-g~~p~~ 212 (271)
T 3kmu_A 141 SRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT-REVPFA 212 (271)
T ss_dssp GGGEEECTTSCEEEEGGGSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH-CSCTTT
T ss_pred cceEEEcCCcceeEEeccceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh-CCCCcc
Confidence 99999999999999999887532 223456789999999998765554 8999999999999999 556998
Q ss_pred CCCHHHHHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 593 GLTHEEVVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 593 ~~~~~e~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+.+..+....+. .+.....+..+++++.+++.+||+.||++|||++++++.|..+.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 213 DLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp TSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 888877655554 444556778899999999999999999999999999999998864
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=367.24 Aligned_cols=250 Identities=24% Similarity=0.340 Sum_probs=220.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||.||+|+.. .++..||||+++.... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred HHHCEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 468999999999999999999864 3568999999865421 123456889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.++++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 174 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRI--------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEEcCCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE
Confidence 999999999999999999732 358899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||+++..... .....+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.+..++..
T Consensus 175 ~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~~~ 248 (350)
T 1rdq_E 175 DQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYE 248 (350)
T ss_dssp CTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred CCCCCEEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhC-CCCCCCCCHHHHHH
Confidence 99999999999999865321 2345689999999999999999999999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
.+..+. ...|..++.++.+++.+||+.||.+||+ +++|++|.|
T Consensus 249 ~i~~~~-~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~ 296 (350)
T 1rdq_E 249 KIVSGK-VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHHCC-CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHcCC-CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcC
Confidence 998876 4567789999999999999999999998 999999876
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=362.20 Aligned_cols=252 Identities=26% Similarity=0.391 Sum_probs=216.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cceEeceEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 46899999999999999999864 35688999998654321 124578999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++|+|.+++. ....+++..++.++.||+.||.|||+.+|+||||||+||
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~--------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI 145 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLA--------------------EKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 145 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHT--------------------TSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCEEEEEEEcCCCCCHHHHHH--------------------hcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence 999999999999999999985 224589999999999999999999999999999999999
Q ss_pred eEcCCC----cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 520 LINDQM----VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 520 Ll~~~~----~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+++++ .+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+.+
T Consensus 146 ll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~ 221 (326)
T 2y0a_A 146 MLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDT 221 (326)
T ss_dssp EESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC-CSSCCSS
T ss_pred EEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCc-CCCCCCC
Confidence 999887 89999999998653222 223456899999999999999999999999999999999955 5998888
Q ss_pred HHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+........ ...++..+.+|+++||+.||.+|||++++++|+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 274 (326)
T 2y0a_A 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274 (326)
T ss_dssp HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 8888888776553221 2467899999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=365.47 Aligned_cols=271 Identities=27% Similarity=0.375 Sum_probs=217.3
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
.+..++...++|++.+.||+|+||.||+|++. ++..||||++...... ..+.+.+|+.+++.++||||+++++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~ 102 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR------DGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIG 102 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT------TCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEE
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEEC------CCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEE
Confidence 34455667789999999999999999999852 3578999998765433 4567899999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..++..++||||+++|+|.+++.... .....+++..++.++.||+.||+|||+++|+|||||
T Consensus 103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk 166 (321)
T 2qkw_B 103 FCDERNEMILIYKYMENGNLKRHLYGSD----------------LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK 166 (321)
T ss_dssp ECCCTTCCEEEEECCTTCBTGGGSSSSC----------------CCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred EEcCCCeEEEEEEcCCCCcHHHHHhccC----------------CCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC
Confidence 9999999999999999999999885211 122458999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++...............+|+.|+|||.+.+..++.++||||||+++|||++|.. ||.+..
T Consensus 167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~-p~~~~~ 245 (321)
T 2qkw_B 167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS-AIVQSL 245 (321)
T ss_dssp STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCT-TCSCSS
T ss_pred HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCC-cccccC
Confidence 9999999999999999999976543332223334457899999999999999999999999999999999654 665433
Q ss_pred HHHH-------HHHHHcCCccC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 596 HEEV-------VKYIKEGNILQ---------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 596 ~~e~-------~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+. ......+.... .+...+..+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 246 PREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 2211 11111221111 1122456789999999999999999999999999988754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.67 Aligned_cols=252 Identities=20% Similarity=0.359 Sum_probs=216.3
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCL 445 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~L 445 (653)
.|...+.||+|+||.||+|+.. .+++.||||+++..... ..+.+.+|+.++++++||||+++++++..++..++
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~-----~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 119 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREK-----HSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWV 119 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTCC-SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhccEEeccCCCeEEEEEEEC-----CCCcEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEE
Confidence 3677889999999999999864 35689999998754322 34568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC
Q psy5539 446 LFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM 525 (653)
Q Consensus 446 V~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~ 525 (653)
||||+++|+|.+++. ...+++..+..++.||+.||+|||+++|+||||||+|||++.++
T Consensus 120 v~e~~~~~~L~~~l~---------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~ 178 (321)
T 2c30_A 120 LMEFLQGGALTDIVS---------------------QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG 178 (321)
T ss_dssp EECCCCSCBHHHHHT---------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEecCCCCCHHHHHH---------------------hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC
Confidence 999999999999985 13489999999999999999999999999999999999999999
Q ss_pred cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Q psy5539 526 VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKE 605 (653)
Q Consensus 526 ~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~ 605 (653)
.+||+|||++....... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....+..
T Consensus 179 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g-~~pf~~~~~~~~~~~~~~ 255 (321)
T 2c30_A 179 RVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG-EPPYFSDSPVQAMKRLRD 255 (321)
T ss_dssp CEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHHHHHH
T ss_pred cEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHhc
Confidence 99999999997653221 122345789999999999999999999999999999999995 568888888888887777
Q ss_pred CCccC--CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 606 GNILQ--APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 606 ~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..... .+..+++++.+++.+||+.||++|||++++++++|-.
T Consensus 256 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~ 299 (321)
T 2c30_A 256 SPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299 (321)
T ss_dssp SSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred CCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence 64332 2345789999999999999999999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=362.49 Aligned_cols=254 Identities=20% Similarity=0.308 Sum_probs=215.6
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEec
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV 439 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 439 (653)
..++|++.+.||+|+||.||+|+.. .+++.||+|+++... .....+.+.+|+.++.++ +||||+++++++..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~ 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred chhheEEEEEEEecCCeEEEEEEEC-----CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe
Confidence 3468999999999999999999864 356899999997542 344556788999999988 89999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 82 ~~~~~lv~e~~~gg~L~~~l~~~--------------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI 141 (345)
T 3a8x_A 82 ESRLFFVIEYVNGGDLMFHMQRQ--------------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNV 141 (345)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred CCEEEEEEeCCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence 99999999999999999999722 3588999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC------
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG------ 593 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~------ 593 (653)
|++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++|. .||..
T Consensus 142 ll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~ 218 (345)
T 3a8x_A 142 LLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR-SPFDIVGSSDN 218 (345)
T ss_dssp EECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS-CTTTTTTC---
T ss_pred EECCCCCEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCC-CCcCCcccccc
Confidence 99999999999999997532221 1234457899999999999999999999999999999999954 58864
Q ss_pred ---CCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH------HHHHHHHH
Q psy5539 594 ---LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF------RTIYQTLW 645 (653)
Q Consensus 594 ---~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~eil~~L~ 645 (653)
.....+.+.+..+. ...|...+.++.+|+.+||+.||.+||++ ++|++|.|
T Consensus 219 ~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~ 278 (345)
T 3a8x_A 219 PDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278 (345)
T ss_dssp ----CHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred cccccHHHHHHHHHcCC-CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence 23445566666654 45677899999999999999999999984 78988875
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=364.57 Aligned_cols=258 Identities=22% Similarity=0.315 Sum_probs=214.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc----HHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS----EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++|++.+.||+|+||.||+|+.. .+++.||||+++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINR-----ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cceEEeeEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 46899999999999999999864 3568999999864321 11245789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.... .....+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl 162 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRA----------------DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CEEEEEEeCCCCCCHHHHHHHhc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeE
Confidence 99999999999999999886321 12245899999999999999999999999999999999999
Q ss_pred EcCCCc---EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 INDQMV---VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~~~~---vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++.++. +||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+. ..
T Consensus 163 ~~~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~-~~ 238 (351)
T 3c0i_A 163 LASKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGC-LPFYGT-KE 238 (351)
T ss_dssp ECSSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS-CSSCSS-HH
T ss_pred EecCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCC-CCCCCc-HH
Confidence 986654 9999999998653322 1223456899999999999999999999999999999999954 588764 45
Q ss_pred HHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 598 e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
++...+..+.....+ ..++.++.+|+++||+.||++|||+.++++|.|--
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~ 291 (351)
T 3c0i_A 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLK 291 (351)
T ss_dssp HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhc
Confidence 666777666543222 46889999999999999999999999999988743
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=377.44 Aligned_cols=265 Identities=20% Similarity=0.271 Sum_probs=222.5
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceE
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
++..+++..++|++.+.||+|+||+||+|+.. .+++.||||+++..... .....+.+|+.++..++||||+++
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l 139 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLK-----NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEc-----CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEE
Confidence 44566778899999999999999999999974 35689999999753211 112238899999999999999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
++++..++..+|||||+++|+|.++++. ....+++..+..++.||+.||+|||+.+|+|||
T Consensus 140 ~~~~~~~~~~~lV~Ey~~gg~L~~~l~~-------------------~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrD 200 (437)
T 4aw2_A 140 HYAFQDDNNLYLVMDYYVGGDLLTLLSK-------------------FEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRD 200 (437)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHT-------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred EEEEeeCCEEEEEEecCCCCcHHHHHHH-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecc
Confidence 9999999999999999999999999972 124689999999999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
|||+||||+.++.+||+|||+++....... .......||+.|||||.+. ...++.++||||||+++|||++| .
T Consensus 201 LKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG-~ 278 (437)
T 4aw2_A 201 IKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG-E 278 (437)
T ss_dssp CSGGGEEECTTSCEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHS-S
T ss_pred cCHHHeeEcCCCCEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhC-C
Confidence 999999999999999999999976533222 2223457899999999987 56789999999999999999995 5
Q ss_pred CCCCCCCHHHHHHHHHcC----CccCCCCCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEG----NILQAPDNTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLWN 646 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~ 646 (653)
+||.+.+..+....+... ........+++++.+|+++||..+|++ ||++++|++|+|-
T Consensus 279 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff 342 (437)
T 4aw2_A 279 TPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF 342 (437)
T ss_dssp CTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred CCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence 699999988888777543 222233458999999999999888888 9999999999874
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=379.83 Aligned_cols=256 Identities=24% Similarity=0.342 Sum_probs=213.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|+.. .++..||||+++... .......+.+|+.+++.++||||+++++++.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~ 218 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEK-----ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ 218 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEc-----CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe
Confidence 455678999999999999999999864 456899999997542 2333456789999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATR 517 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~ 517 (653)
..+..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+
T Consensus 219 ~~~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~ 278 (446)
T 4ejn_A 219 THDRLCFVMEYANGGELFFHLSR--------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLE 278 (446)
T ss_dssp ETTEEEEEECCCSSCBHHHHHHH--------------------HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGG
T ss_pred eCCEEEEEEeeCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHH
Confidence 99999999999999999999862 2358899999999999999999998 99999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||+.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus 279 NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~ 355 (446)
T 4ejn_A 279 NLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLPFYNQDHE 355 (446)
T ss_dssp GEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHH
T ss_pred HEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhC-CCCCCCCCHH
Confidence 9999999999999999997542222 223345789999999999999999999999999999999995 5699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
++...+..... ..+..+++++.+|+.+||+.||.+|| +++++++|.|
T Consensus 356 ~~~~~i~~~~~-~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~ 407 (446)
T 4ejn_A 356 KLFELILMEEI-RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407 (446)
T ss_dssp HHHHHHHHCCC-CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHHHHHhCCC-CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcc
Confidence 88888877653 56778999999999999999999999 9999999876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=368.98 Aligned_cols=255 Identities=20% Similarity=0.323 Sum_probs=214.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEEe
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVCA 438 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~ 438 (653)
+..++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|..++.++ +|||||++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLK-----KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 44568999999999999999999864 356899999997543 222334578899999887 8999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~--------------------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~N 183 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQ--------------------RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDN 183 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHH
Confidence 999999999999999999998732 358999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL---- 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~---- 594 (653)
|||+.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||...
T Consensus 184 ILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G-~~Pf~~~~~~~ 260 (396)
T 4dc2_A 184 VLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG-RSPFDIVGSSD 260 (396)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSTTTTC--
T ss_pred EEECCCCCEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhC-CCCCccccccc
Confidence 999999999999999997532221 223445789999999999999999999999999999999995 5588532
Q ss_pred -----CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC------HHHHHHHHH
Q psy5539 595 -----THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS------FRTIYQTLW 645 (653)
Q Consensus 595 -----~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs------~~eil~~L~ 645 (653)
....+.+.+..+. ...|..++.++.+|+++||+.||.+||+ +++|++|.|
T Consensus 261 ~~~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf 321 (396)
T 4dc2_A 261 NPDQNTEDYLFQVILEKQ-IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321 (396)
T ss_dssp ----CCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred ccchhhHHHHHHHHhccc-cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence 2344566666654 4577889999999999999999999998 478988875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.25 Aligned_cols=255 Identities=23% Similarity=0.307 Sum_probs=219.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||.||+|... .++..||+|+++... .....+.+.+|+.++++++||||+++++++..++.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHK-----TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEc-----CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE
Confidence 468999999999999999999864 356789999986543 34455678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+|+||||||+|||++
T Consensus 80 ~~~v~e~~~~~~l~~~~~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~ 139 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVA--------------------REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLA 139 (284)
T ss_dssp EEEEECCCCSCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred EEEEEecCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEe
Confidence 9999999999999998862 23588999999999999999999999999999999999997
Q ss_pred CCCc---EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMV---VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~---vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
.++. +||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|+|++|. .||.+.+..+.
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~-~pf~~~~~~~~ 215 (284)
T 3kk8_A 140 SKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY-PPFWDEDQHRL 215 (284)
T ss_dssp SSSTTCCEEECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS-CSSCCSSHHHH
T ss_pred cCCCCCcEEEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC-CCCCCCchhHH
Confidence 6655 9999999997653222 223456889999999999999999999999999999999954 58988888888
Q ss_pred HHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+..+..... ...+++++.+++.+||+.||++|||+++++++.|--
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~ 266 (284)
T 3kk8_A 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC 266 (284)
T ss_dssp HHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence 888887654322 246789999999999999999999999999998753
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=353.31 Aligned_cols=256 Identities=25% Similarity=0.426 Sum_probs=224.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.+.|.+.+.||+|+||.||+|+.. .++..||||.++........+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDN-----RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEEC-----CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 356899999999999999999863 356889999997654444566899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.+++. ...+++..++.++.||+.||.|||+.+|+|+||||+|||++.
T Consensus 96 ~lv~e~~~~~~L~~~~~---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 154 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLE---------------------PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 154 (303)
T ss_dssp EEEEECCTTEEHHHHHT---------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEEeCCCCcHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECC
Confidence 99999999999999985 135889999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++| ..||......+....+
T Consensus 155 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~~~~~~ 231 (303)
T 3a7i_A 155 HGEVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARG-EPPHSELHPMKVLFLI 231 (303)
T ss_dssp TSCEEECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHHHH
T ss_pred CCCEEEeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccC-CCCCCCcCHHHHHHHh
Confidence 9999999999997653322 122345678999999999999999999999999999999995 4689888888888888
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+.....+..++..+.+|+.+||+.+|.+|||+.++++++|-..
T Consensus 232 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 232 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred hcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 877776777889999999999999999999999999999987543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=363.72 Aligned_cols=256 Identities=21% Similarity=0.314 Sum_probs=205.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
++|++.+.||+|+||.||+|+.. .+++.||||+++....+...+.+.+|++++++++||||+++++++....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNK-----VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEET-----TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEc-----CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccch
Confidence 46899999999999999999864 3568899999976555556678999999999999999999999986543
Q ss_pred ------------------------------------------------------ceEEEEeecCCCChHHHHhhcCCCCC
Q psy5539 442 ------------------------------------------------------PMCLLFEYMGRGDLNDFLRICSPNNY 467 (653)
Q Consensus 442 ------------------------------------------------------~~~LV~Ey~~~gsL~~~L~~~~~~~~ 467 (653)
..++||||+++|+|.++++...
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---- 156 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC---- 156 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC----
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc----
Confidence 2799999999999999997322
Q ss_pred cCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCcccccccccc----
Q psy5539 468 INGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY---- 543 (653)
Q Consensus 468 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~---- 543 (653)
.....++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 157 -------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~ 223 (332)
T 3qd2_B 157 -------------SLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223 (332)
T ss_dssp -------------SGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------
T ss_pred -------------CccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccc
Confidence 122356778899999999999999999999999999999999999999999999987643321
Q ss_pred ------ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcH
Q psy5539 544 ------YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPD 617 (653)
Q Consensus 544 ------~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~ 617 (653)
........+|+.|+|||.+.+..++.++||||||+++|||+++.. |+ ....+....+............++
T Consensus 224 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~ 300 (332)
T 3qd2_B 224 LTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-TQ--MERVRIITDVRNLKFPLLFTQKYP 300 (332)
T ss_dssp --------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCC-CH--HHHHHHHHHHHTTCCCHHHHHHCH
T ss_pred cccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCC-Ch--hHHHHHHHHhhccCCCcccccCCh
Confidence 112234568999999999999999999999999999999998432 22 122334444555443333344567
Q ss_pred HHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 618 ALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 618 ~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.+|+.+||+.||.+|||+++++++.|
T Consensus 301 ~~~~li~~~l~~~p~~Rps~~~~l~~~~ 328 (332)
T 3qd2_B 301 QEHMMVQDMLSPSPTERPEATDIIENAI 328 (332)
T ss_dssp HHHHHHHHHHCSSGGGSCCHHHHHHSTT
T ss_pred hHHHHHHHHccCCCCcCCCHHHHhhchh
Confidence 8899999999999999999999998865
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=356.55 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=205.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
-.++|++++.||+|+||+||+|+.. +++.||+|+++.... ......+.+|++++++++||||+++++++..++
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 92 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDS------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSER 92 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEET------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSS
T ss_pred hHhhhHhhhhccCCCCeEEEEEEEC------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCC
Confidence 3468999999999999999999862 357899999975432 223467889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 93 ~~~lv~e~~~~-~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~ 152 (311)
T 3niz_A 93 CLTLVFEFMEK-DLKKVLDE-------------------NKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI 152 (311)
T ss_dssp CEEEEEECCSE-EHHHHHHT-------------------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred EEEEEEcCCCC-CHHHHHHh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE
Confidence 99999999985 88888862 23458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+.++.+||+|||+++...... .......+|..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+..+..
T Consensus 153 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~ 229 (311)
T 3niz_A 153 NSDGALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQL 229 (311)
T ss_dssp CTTCCEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS-CSCCCSSTTTHH
T ss_pred CCCCCEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC-CCCCCCChHHHH
Confidence 999999999999997653221 22334567899999999876 56899999999999999999955 688877665554
Q ss_pred HHHHcC--Ccc---------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEG--NIL---------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~--~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+... ... ...+..+.++.+|+.+||+.||++|||++++++|.|
T Consensus 230 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 303 (311)
T 3niz_A 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303 (311)
T ss_dssp HHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence 444320 000 011346788999999999999999999999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=375.78 Aligned_cols=262 Identities=21% Similarity=0.296 Sum_probs=221.0
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+..+++..++|++.+.||+|+||+||+|+.. .+++.||+|+++..... ...+.+.+|+.+++.++|||||+++
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 135 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEE
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEEC-----CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 3455677889999999999999999999964 35688999998653211 1123478999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++..++..+|||||+++|+|.++++. ..+++..+..++.||+.||+|||+++|+||||
T Consensus 136 ~~~~~~~~~~lV~E~~~gg~L~~~l~~---------------------~~~~e~~~~~~~~qi~~aL~~LH~~givHrDL 194 (410)
T 3v8s_A 136 YAFQDDRYLYMVMEYMPGGDLVNLMSN---------------------YDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 194 (410)
T ss_dssp EEEECSSEEEEEECCCTTEEHHHHHHH---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEEECCEEEEEEeCCCCCcHHHHHHc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccC
Confidence 999999999999999999999999862 24789999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC----CCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK----YTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+.. ++.++||||||+++|||++ |.+|
T Consensus 195 Kp~NILl~~~g~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~-G~~P 272 (410)
T 3v8s_A 195 KPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV-GDTP 272 (410)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH-SSCT
T ss_pred CHHHeeECCCCCEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh-CCCC
Confidence 99999999999999999999986543221 1223457899999999998765 8899999999999999999 4569
Q ss_pred CCCCCHHHHHHHHHcCC-ccCCC--CCCcHHHHHHHHHhhccCCCC--CCCHHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGN-ILQAP--DNTPDALYDLMKLCWNMKPMN--RPSFRTIYQTLWN 646 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~-~~~~~--~~~~~~l~~li~~cl~~dP~~--RPs~~eil~~L~~ 646 (653)
|.+.+..+....+..+. ....| ..++.++.+|+.+||..+|.+ ||++++|++|.|-
T Consensus 273 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 273 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp TCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred CCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 99999888888886642 12233 468999999999999999988 9999999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=359.09 Aligned_cols=259 Identities=23% Similarity=0.379 Sum_probs=200.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||.||+|+.. .++..||||.++........+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNK-----TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKL 78 (317)
T ss_dssp ---------------CEEEEEECS-----SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEEC-----CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeE
Confidence 357899999999999999999853 456899999987544333345688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||++ |+|.+++...... .....+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~--------------~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~ 143 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVG--------------NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINK 143 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSS--------------SCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred EEEEEecC-CCHHHHHHhcccc--------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcC
Confidence 99999998 5999999743211 12345899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||+++...... .......+|+.|+|||.+.+. .++.++||||||+++|||++| ..||.+.+..+....
T Consensus 144 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g-~~pf~~~~~~~~~~~ 220 (317)
T 2pmi_A 144 RGQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEEQLKL 220 (317)
T ss_dssp TCCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHH
T ss_pred CCCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCChHHHHHH
Confidence 9999999999997653221 222345678999999999764 689999999999999999995 469988888777666
Q ss_pred HHcC--Cc-------------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--NI-------------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--~~-------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+. .. ...+...+.++.+|+.+||+.||++|||+++++++.|
T Consensus 221 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 296 (317)
T 2pmi_A 221 IFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296 (317)
T ss_dssp HHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChh
Confidence 5431 00 0112356789999999999999999999999999876
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=367.34 Aligned_cols=261 Identities=17% Similarity=0.236 Sum_probs=210.7
Q ss_pred ccCCCCeeEEeeeccc--CCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQG--AFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G--~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
....++|++.+.||+| +||.||+|+.. .++..||||+++... .....+.+.+|+.+++.++|||||++++++
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYK-----PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEET-----TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEc-----CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 3345689999999999 99999999974 356899999997543 344567789999999999999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++..++||||+++|+|.+++... ....+++..+..++.||+.||+|||+++|+||||||+
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~ 157 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTH------------------FMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS 157 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHT------------------CTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EECCEEEEEEEccCCCCHHHHHhhh------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9999999999999999999999732 1245899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
|||++.++.+||+|||++......... .......+|..|+|||.+.+ ..++.++||||||+++|||++| ..|
T Consensus 158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g-~~p 236 (389)
T 3gni_B 158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG-HVP 236 (389)
T ss_dssp GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHS-SCT
T ss_pred HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHC-CCC
Confidence 999999999999999998655322211 11233467889999999987 5799999999999999999995 558
Q ss_pred CCCCCHHHHHHHHHcCCc---------------------------------------------cCCCCCCcHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGNI---------------------------------------------LQAPDNTPDALYDLMKL 625 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~~---------------------------------------------~~~~~~~~~~l~~li~~ 625 (653)
|.+.+..+....+..+.. ...+..+++++.+|+++
T Consensus 237 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 316 (389)
T 3gni_B 237 FKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQ 316 (389)
T ss_dssp TTTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHH
T ss_pred CCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHH
Confidence 877654443332221111 01234577899999999
Q ss_pred hhccCCCCCCCHHHHHHHHH
Q psy5539 626 CWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 626 cl~~dP~~RPs~~eil~~L~ 645 (653)
||+.||++|||++++++|.|
T Consensus 317 ~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 317 CLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp HTCSCTTTSCCHHHHTTSGG
T ss_pred HhhcCcccCCCHHHHhcCHH
Confidence 99999999999999998865
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=358.87 Aligned_cols=267 Identities=36% Similarity=0.588 Sum_probs=222.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe--c
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA--V 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~ 439 (653)
+..++|++.+.||+|+||.||+|++.. .+...+..||||+++... ....+.+.+|++++++++||||+++++++. .
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDP-LGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECT-TSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEecc-CCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 456789999999999999999998643 234567899999997653 345567999999999999999999999986 4
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NI 158 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRH-------------------RARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNI 158 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHH-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CceEEEEEeecCCCCHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhE
Confidence 56689999999999999999732 13489999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC---
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT--- 595 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~--- 595 (653)
|+++++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||++|.. ||....
T Consensus 159 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~-p~~~~~~~~ 237 (327)
T 3lxl_A 159 LVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD-KSCSPSAEF 237 (327)
T ss_dssp EEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTC-GGGSHHHHH
T ss_pred EECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCC-CCccccchh
Confidence 999999999999999986543221 123344567888999999999999999999999999999999665 553322
Q ss_pred ------------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 596 ------------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 596 ------------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..++.+.+..+.....+..+++++.+|+.+||+.||.+|||+++++++|..+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 238 LRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred hhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 2345666677777777888999999999999999999999999999999877543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=363.00 Aligned_cols=270 Identities=15% Similarity=0.219 Sum_probs=210.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHH----------HHHHHHHHHHHhhCCCCcc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL----------QTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~----------~~~f~~Ei~il~~l~HpnI 430 (653)
++..++|++.+.||+|+||.||+|++........++.||||++........ ...+.+|+..++.++||||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 355678999999999999999999986543334568899999875432111 1123456677888899999
Q ss_pred ceEEeEEecC----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5539 431 VKLLGVCAVG----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD 506 (653)
Q Consensus 431 v~l~g~~~~~----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 506 (653)
+++++++... ...+|||||+ +++|.++++. ....+++..++.|+.||+.||+|||+
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~-------------------~~~~l~~~~~~~i~~qi~~~l~~lH~ 170 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA-------------------NAKRFSRKTVLQLSLRILDILEYIHE 170 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH-------------------TTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 9999998764 4589999999 9999999972 22468999999999999999999999
Q ss_pred CCceecCCCCCCEeEc--CCCcEEEeccCcccccccccccc-----CCCCCCCccccccchhhccCCCCCchhHHHHHHH
Q psy5539 507 RKFVHRDLATRNCLIN--DQMVVKIADFGLSRKMYLQDYYK-----GDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~--~~~~vkI~DfGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvv 579 (653)
++|+||||||+|||++ .++.+||+|||+++.+....... ......+|+.|||||.+.+..++.++||||||++
T Consensus 171 ~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 250 (364)
T 3op5_A 171 HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYC 250 (364)
T ss_dssp TTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHH
Confidence 9999999999999999 88999999999998764332211 1123448999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC-CHHHHHHHHHcC---Ccc------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 580 LWEIFSFALQPYYGL-THEEVVKYIKEG---NIL------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 580 l~ellt~~~~p~~~~-~~~e~~~~i~~~---~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+|||++|. .||.+. ............ ... .....++.++.+++..||+.+|.+||++++|++.|..+.+
T Consensus 251 l~el~~g~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 251 MIQWLTGH-LPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp HHHHHHSC-CTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHHHHhCC-CCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 99999954 588753 222222211111 000 0125678999999999999999999999999999998877
Q ss_pred Hh
Q psy5539 650 DL 651 (653)
Q Consensus 650 ~l 651 (653)
++
T Consensus 330 ~~ 331 (364)
T 3op5_A 330 AI 331 (364)
T ss_dssp HT
T ss_pred Hc
Confidence 64
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=359.99 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=207.6
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCC--CccceEEeE
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDH--PNIVKLLGV 436 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~ 436 (653)
+++..++|++.+.||+|+||.||+|... ++..||||+++.. ......+.+.+|+.++.+++| +||++++++
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~ 77 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY 77 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECT------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeC------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeee
Confidence 4566778999999999999999999852 3578999998643 344456789999999999987 999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+..++..++||| +.+|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||
T Consensus 78 ~~~~~~~~lv~e-~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp 136 (343)
T 3dbq_A 78 EITDQYIYMVME-CGNIDLNSWLKK--------------------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136 (343)
T ss_dssp EECSSEEEEEEC-CCSEEHHHHHHH--------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred EeeCCEEEEEEe-CCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence 999999999999 467899999972 24588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----------CCCCCchhHHHHHHHHHHHHh
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----------NKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~t~ksDVwSlGvvl~ellt 585 (653)
+|||++ ++.+||+|||+++...............+|+.|+|||.+.+ ..++.++||||||+++|||++
T Consensus 137 ~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~ 215 (343)
T 3dbq_A 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215 (343)
T ss_dssp GGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHH
T ss_pred ceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHh
Confidence 999997 57899999999987643333223345578999999999875 678999999999999999999
Q ss_pred CCCCCCCCCC-HHHHHHHHHc-CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 586 FALQPYYGLT-HEEVVKYIKE-GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 586 ~~~~p~~~~~-~~e~~~~i~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|. .||.+.. .......+.. ......+...+.++.+|+.+||+.||.+|||+.++++|+|-
T Consensus 216 g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 216 GK-TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp SS-CTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CC-CcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 55 5776643 3333333333 33345667788899999999999999999999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=352.16 Aligned_cols=255 Identities=29% Similarity=0.527 Sum_probs=210.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||.||+|+.. ++.||||.+.... ..+.|.+|++++++++||||+++++++. +
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR-------AKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACL--N 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET-------TEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCT--T
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC-------CeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEc--C
Confidence 34568999999999999999999864 3779999997532 3467899999999999999999999876 4
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh---CCceecCCCCCC
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD---RKFVHRDLATRN 518 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~---~~ivHrDLkp~N 518 (653)
..++||||+++|+|.++++... ....+++..++.++.|+++||+|||+ ++|+||||||+|
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~N 135 (307)
T 2eva_A 73 PVCLVMEYAEGGSLYNVLHGAE-----------------PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPN 135 (307)
T ss_dssp TTEEEEECCTTCBHHHHHHCSS-----------------SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGG
T ss_pred CcEEEEEcCCCCCHHHHHhccC-----------------CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhH
Confidence 5899999999999999997321 12347889999999999999999999 899999999999
Q ss_pred EeEcCCCc-EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--C
Q psy5539 519 CLINDQMV-VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL--T 595 (653)
Q Consensus 519 ILl~~~~~-vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~--~ 595 (653)
||+++++. +||+|||++..... ......++..|+|||.+.+..++.++||||||+++|||++|. .||... .
T Consensus 136 Ill~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~-~p~~~~~~~ 209 (307)
T 2eva_A 136 LLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR-KPFDEIGGP 209 (307)
T ss_dssp EEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTC-CTTTTTCSS
T ss_pred EEEeCCCCEEEEccccccccccc-----ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCC-CCchhhCcc
Confidence 99998886 79999999975422 123345789999999999999999999999999999999955 577643 3
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
..++...+..+.....+..++..+.+++.+||+.+|.+|||+++++++|..+.+.+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 44555666677666777889999999999999999999999999999999887654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=350.58 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=205.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||+||+|+. .++..||||+++.... ....+.+.+|+.++++++||||+++++++..++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN------NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE------TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCE
T ss_pred ccchhhhhcccCCCEEEEEEEc------CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeE
Confidence 5789999999999999999986 2457899999864422 22335688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++ +|.+++.. ....+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 76 ~lv~e~~~~-~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 76 VLVFEHLDQ-DLKKLLDV-------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp EEEEECCSE-EHHHHHHT-------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEEEEecCC-CHHHHHHh-------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 999999985 99999862 2245889999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||+++...... .......+|+.|+|||.+.+. .++.++||||||+++|||++| .+||.+.+..+....
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~ 212 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMR 212 (288)
T ss_dssp TSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHH
T ss_pred CCCEEEeECccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 9999999999997653211 122334678899999999764 589999999999999999995 468888877666555
Q ss_pred HHcC--Cc--------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--NI--------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... .. ......+++++.+|+.+||+.||++|||++++++|.|
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 283 (288)
T 1ob3_A 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (288)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 4321 00 0112357889999999999999999999999999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=359.34 Aligned_cols=251 Identities=22% Similarity=0.408 Sum_probs=213.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
+.|...+.||+|+||+||+|+.. .++..||||+++.. ......+.+.+|++++++++||||+++++++..++.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeeEEccCCCEEEEEEEEc-----cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe
Confidence 45899999999999999999863 46689999998643 233445678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+. |+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 188 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVH-------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS 188 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHH-------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE
T ss_pred EEEEEecCC-CCHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEC
Confidence 999999997 6898888622 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+++.+||+|||+++.... .....+|+.|+|||.+. .+.++.++||||||+++|||++|. +||.+.+..+.
T Consensus 189 ~~~~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~ 261 (348)
T 1u5q_A 189 EPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNAMSA 261 (348)
T ss_dssp TTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSS-CTTTTSCHHHH
T ss_pred CCCCEEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCC-CCCCCCChHHH
Confidence 999999999999976422 23456889999999985 567899999999999999999955 58888777666
Q ss_pred HHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 600 VKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 600 ~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
...+..+... ..+..+++.+.+|+.+||+.+|++|||++++++++|-.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~ 310 (348)
T 1u5q_A 262 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310 (348)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhh
Confidence 6666554433 33456899999999999999999999999999988754
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=351.14 Aligned_cols=267 Identities=33% Similarity=0.580 Sum_probs=214.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|++.. .......||||.++... .....+.+.+|++++++++||||+++++++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 91 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEEC--TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhHeeeeeeecCCCceeEEEEEecc--CCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc
Confidence 3455689999999999999999998632 22334579999987542 2345668999999999999999999999987
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
... .++|+||+++|+|.+++... ...+++..++.++.||+.||.|||+++|+|+||||+|
T Consensus 92 ~~~-~~~v~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 151 (291)
T 1u46_A 92 TPP-MKMVTELAPLGSLLDRLRKH-------------------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151 (291)
T ss_dssp SSS-CEEEEECCTTCBHHHHHHHH-------------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred cCC-ceeeEecccCCCHHHHHHhc-------------------cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence 654 89999999999999999732 1347899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||++.++.+||+|||++......... .......+|..|+|||.+.+..++.++||||||+++|||++++..||.+.+..
T Consensus 152 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 99999999999999999765432221 12234556788999999999999999999999999999999677799999988
Q ss_pred HHHHHHHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 598 e~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
++...+.... ....+..++.++.+++.+||+.+|.+|||+.++++.|.++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 8888776543 345567789999999999999999999999999999987754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=354.98 Aligned_cols=270 Identities=34% Similarity=0.618 Sum_probs=223.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
.+..++|++.+.||+|+||.||+|+... ....++..||||.++.... ...+.+.+|++++++++||||+++++++...
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDP-LQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECT-TSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEecc-ccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 4556689999999999999999998642 1345678999999976543 4456799999999999999999999998654
Q ss_pred C--ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 K--PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 ~--~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+ ..++||||+++|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N 175 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKH-------------------KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN 175 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHS-------------------TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred CCCceEEEEECCCCCCHHHHHHhc-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence 3 789999999999999999732 2358899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-- 595 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-- 595 (653)
||+++++.+||+|||+++....... ........++..|+|||.+.+..++.++||||||+++|||++|.. |+....
T Consensus 176 Ili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~-~~~~~~~~ 254 (326)
T 2w1i_A 176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE-KSKSPPAE 254 (326)
T ss_dssp EEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTC-GGGSHHHH
T ss_pred EEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCC-CCCCCHHH
Confidence 9999999999999999986643322 122334566788999999999999999999999999999999654 443211
Q ss_pred --------------HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 596 --------------HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 596 --------------~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
..++.+.+..+...+.+..++.++.+++++||+.+|++|||+.+|++.|..+.+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 255 FMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp HHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 113445555665666778899999999999999999999999999999999998874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=366.65 Aligned_cols=251 Identities=27% Similarity=0.378 Sum_probs=211.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|.+.+.||+|+||.||+|+.. .+++.||||+++..... .....+.+|+.+++.++||||+++++++...+.
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHY-----KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 57999999999999999999864 35688999998653221 123468899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+ +|+|.+++.. ...+++.++..++.||+.||.|||+++|+||||||+|||++
T Consensus 84 ~~lv~E~~-~g~l~~~l~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~ 142 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVE--------------------KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLD 142 (336)
T ss_dssp EEEEECCC-CEEHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEEC
T ss_pred EEEEEECC-CCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEc
Confidence 99999999 7899999862 23589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+++.+||+|||++....... ......+|+.|+|||.+.+..+ +.++||||||+++|+|++|. .||.+....++..
T Consensus 143 ~~~~~kl~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~Pf~~~~~~~~~~ 218 (336)
T 3h4j_B 143 DNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR-LPFDDEFIPNLFK 218 (336)
T ss_dssp TTCCEEECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSS-CSSBCSSSTTCBC
T ss_pred CCCCEEEEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCC-CCCCCccHHHHHH
Confidence 99999999999997653322 2234568899999999988776 78999999999999999955 5887765554444
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+. ...|+.+++++.+|+++||+.||.+|||++++++++|-
T Consensus 219 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~ 262 (336)
T 3h4j_B 219 KVNSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262 (336)
T ss_dssp CCCSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred HHHcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence 433332 34567789999999999999999999999999999885
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=364.45 Aligned_cols=255 Identities=19% Similarity=0.323 Sum_probs=215.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|+.. .+++.||+|.++... .....+.+.+|+.+++.++|||||++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKN-----DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 445578999999999999999999864 356889999986532 1122456889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+.+|+|.+++. ....+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~N 145 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQ--------------------QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHH--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred eCCEEEEEEecCCCCcHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHH
Confidence 9999999999999999999996 23458999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCC--
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYG-- 593 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~~-- 593 (653)
|||+.++.+||+|||+++..... .......+|+.|+|||.+.. ..++.++||||||+++|||++|. .||..
T Consensus 146 Ill~~~g~vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~-~Pf~~~~ 221 (384)
T 4fr4_A 146 ILLDEHGHVHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGR-RPYHIRS 221 (384)
T ss_dssp EEECTTSCEEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSS-CSSCCCT
T ss_pred eEECCCCCEEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCC-CCCCCCC
Confidence 99999999999999999865322 22344578999999999874 45899999999999999999955 58864
Q ss_pred -CCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHHH
Q psy5539 594 -LTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-FRTIYQTLW 645 (653)
Q Consensus 594 -~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~ 645 (653)
....++...+.... ...+..++.++.+|+.+||+.+|.+||+ +++|+++.|
T Consensus 222 ~~~~~~~~~~~~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~ 274 (384)
T 4fr4_A 222 STSSKEIVHTFETTV-VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPY 274 (384)
T ss_dssp TSCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred CccHHHHHHHHhhcc-cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence 34456666665543 4567889999999999999999999998 888888765
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=346.82 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=221.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|+.. .++..||||.+..... ......+.+|++++++++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREK-----QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEc-----CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 445578999999999999999999864 3568899999865322 122457899999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N 144 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKH--------------------GRFDEQRSATFMEELADALHYCHERKVIHRDIKPEN 144 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGG
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHH
Confidence 999999999999999999999732 347899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||++...... ......++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+
T Consensus 145 il~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~ 219 (284)
T 2vgo_A 145 LLMGYKGELKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM-PPFDSPSHTE 219 (284)
T ss_dssp EEECTTCCEEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSS-CTTCCSSHHH
T ss_pred EEEcCCCCEEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCC-CCCCCCCHhH
Confidence 99999999999999998654321 123456789999999999999999999999999999999954 6998888888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
....+.... ...+..++.++.+++.+||+.+|.+|||+++++++.|--
T Consensus 220 ~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~ 267 (284)
T 2vgo_A 220 THRRIVNVD-LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267 (284)
T ss_dssp HHHHHHTTC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred HHHHHhccc-cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence 887777655 356677899999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=360.50 Aligned_cols=251 Identities=24% Similarity=0.293 Sum_probs=198.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|+.. .+++.||||+++... ..+.+.+|++++++++||||+++++++...+.
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 122 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQK-----GTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE 122 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe
Confidence 3467999999999999999999974 345789999997543 23568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++. ....+++.+++.++.||+.||.|||+.+|+||||||+|||++
T Consensus 123 ~~lv~e~~~~~~L~~~l~--------------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~ 182 (349)
T 2w4o_A 123 ISLVLELVTGGELFDRIV--------------------EKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYA 182 (349)
T ss_dssp EEEEECCCCSCBHHHHHT--------------------TCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred EEEEEEeCCCCCHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEe
Confidence 999999999999999986 224588999999999999999999999999999999999997
Q ss_pred C---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-HHH
Q psy5539 523 D---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HEE 598 (653)
Q Consensus 523 ~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-~~e 598 (653)
. ++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|.. ||.+.. .+.
T Consensus 183 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~-pf~~~~~~~~ 258 (349)
T 2w4o_A 183 TPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE-PFYDERGDQF 258 (349)
T ss_dssp SSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSC-TTCCTTCHHH
T ss_pred cCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCC-CCCCCcccHH
Confidence 5 8899999999997653221 1234567899999999999999999999999999999999665 665544 444
Q ss_pred HHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+...+..+..... ...++.++.+|+++||+.||++|||+.+++++.|
T Consensus 259 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 308 (349)
T 2w4o_A 259 MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW 308 (349)
T ss_dssp HHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 6677766554322 2468899999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=347.55 Aligned_cols=263 Identities=18% Similarity=0.263 Sum_probs=217.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEec
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV 439 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~ 439 (653)
.+..++|++.+.||+|+||.||+|+.. .+++.||||+++.... .+.+.+|+.+++.+ +|+|++++++++..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 77 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQE 77 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCC
Confidence 344678999999999999999999853 4568999999865432 23578899999999 79999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+...++||||+ +++|.++++.. ...+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 78 ~~~~~lv~e~~-~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NI 137 (298)
T 1csn_A 78 GLHNVLVIDLL-GPSLEDLLDLC-------------------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNF 137 (298)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred CceeEEEEEec-CCCHHHHHHHh-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence 99999999999 99999999732 23589999999999999999999999999999999999
Q ss_pred eEcCCCc-----EEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 520 LINDQMV-----VKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 520 Ll~~~~~-----vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
|++.++. +||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++|. .
T Consensus 138 l~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~-~ 216 (298)
T 1csn_A 138 LIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-L 216 (298)
T ss_dssp EECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-C
T ss_pred EeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCC-C
Confidence 9987776 999999999866433221 1234456889999999999999999999999999999999955 5
Q ss_pred CCCCC---CHHHHHHHHHcCC----ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 590 PYYGL---THEEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 590 p~~~~---~~~e~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
||.+. ...+....+..+. .......+++++.+++.+||+.+|++||++++|++.|..+.+++.
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~ 286 (298)
T 1csn_A 217 PWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 286 (298)
T ss_dssp TTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence 88763 3444444443322 222335789999999999999999999999999999999887653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=365.15 Aligned_cols=252 Identities=21% Similarity=0.333 Sum_probs=216.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|... .++..||+|.+..... .....+.+|+.+++.++||||+++++++......+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 124 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 124 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCEEEEEEEEC-----CCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEE
Confidence 57999999999999999999864 3567899999875433 23457899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC-
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND- 523 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~- 523 (653)
+||||+++|+|.+++.. ....+++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 125 lv~E~~~gg~L~~~l~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~ 185 (387)
T 1kob_A 125 LILEFLSGGELFDRIAA-------------------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185 (387)
T ss_dssp EEEECCCCCBHHHHTTC-------------------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEEEcCCCCcHHHHHHh-------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecC
Confidence 99999999999999851 2235899999999999999999999999999999999999974
Q ss_pred -CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 -QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 -~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+....
T Consensus 186 ~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~ 261 (387)
T 1kob_A 186 KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG-LSPFAGEDDLETLQN 261 (387)
T ss_dssp TCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS-CCSSCCSSHHHHHHH
T ss_pred CCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 57899999999986533221 1223578999999999999999999999999999999995 569999888888888
Q ss_pred HHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+....... ....+++++.+|+.+||+.||.+|||+.+++++.|
T Consensus 262 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (387)
T 1kob_A 262 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 307 (387)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCcc
Confidence 87765422 23468899999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=373.05 Aligned_cols=256 Identities=28% Similarity=0.390 Sum_probs=221.7
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+..++|.+.+.||+|+||.||+|+.. .++..||||+++..... .....+.+|+.+++.++||||+++++++..
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~ 87 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHE-----LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST 87 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEET-----TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34468999999999999999999864 35688999999754221 234578999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 88 ~~~~~lv~E~~~gg~L~~~l~--------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI 147 (476)
T 2y94_A 88 PSDIFMVMEYVSGGELFDYIC--------------------KNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV 147 (476)
T ss_dssp SSEEEEEEECCSSEEHHHHTT--------------------SSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred CCEEEEEEeCCCCCcHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence 999999999999999999985 234589999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|++.++.+||+|||+++...... ......+|+.|+|||.+.+..+ +.++||||||+++|||++| ..||.+.+..+
T Consensus 148 ll~~~~~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG-~~Pf~~~~~~~ 223 (476)
T 2y94_A 148 LLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCG-TLPFDDDHVPT 223 (476)
T ss_dssp EECTTCCEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHS-SCSSCCSSSHH
T ss_pred EEecCCCeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhC-CCCCCCCCHHH
Confidence 99999999999999998653322 1234568899999999988765 6899999999999999995 46998888888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+...+..+.. ..+..+++++.+|+++||+.||.+|||+++|++|.|--
T Consensus 224 ~~~~i~~~~~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~ 271 (476)
T 2y94_A 224 LFKKICDGIF-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271 (476)
T ss_dssp HHHHHHTTCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred HHHHHhcCCc-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhh
Confidence 8888888754 56677899999999999999999999999999998753
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=362.37 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=209.5
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
+...+.||+|+||.||+|+.. .++..||+|+++.... ...+.+.+|++++++++||||+++++++...+..+||
T Consensus 91 ~~~~~~lG~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 91 VSKTEILGGGRFGQVHKCEET-----ATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp EEEEEECC-----CEEEEEET-----TTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eecceEEecCcCEEEEEEEEc-----CCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 344678999999999999864 3568899999976433 3456799999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE--cCC
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQ 524 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl--~~~ 524 (653)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+|+||||||+|||+ +++
T Consensus 165 ~E~~~~~~L~~~l~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~ 225 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-------------------SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDA 225 (373)
T ss_dssp EECCTTCEEHHHHHHT-------------------GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTT
T ss_pred EeCCCCCcHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCC
Confidence 9999999999998621 2347899999999999999999999999999999999999 567
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..+.+..+.
T Consensus 226 ~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~pf~~~~~~~~~~~i~ 301 (373)
T 2x4f_A 226 KQIKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-LSPFLGDNDAETLNNIL 301 (373)
T ss_dssp TEEEECCCSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHS-SCTTCCSSHHHHHHHHH
T ss_pred CcEEEEeCCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHH
Confidence 899999999998653322 12334688999999999999999999999999999999995 56999988888888877
Q ss_pred cCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 605 EGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 605 ~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
....... ...+++++.+|+.+||+.||.+|||+.+++++.|-
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~ 346 (373)
T 2x4f_A 302 ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346 (373)
T ss_dssp HTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred hccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence 7654222 24678999999999999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=349.42 Aligned_cols=255 Identities=25% Similarity=0.374 Sum_probs=211.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.+.........+.+.+|++++++++||||+++++++...+..+
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 96 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEER-----SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMY 96 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeccCCCeEEEEEEEc-----cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEE
Confidence 47899999999999999999864 3567899999876554444567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE---
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--- 521 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl--- 521 (653)
+||||+++|+|.+++.... .....+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 97 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~ 160 (285)
T 3is5_A 97 IVMETCEGGELLERIVSAQ----------------ARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT 160 (285)
T ss_dssp EEECCCSCCBHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS
T ss_pred EEEEeCCCCcHHHHHHhhh----------------hcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC
Confidence 9999999999999986321 123568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||+++...... ......++..|+|||.+. +.++.++||||||+++|||++| ..||.+.+..++..
T Consensus 161 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g-~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 161 SPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG-CLPFTGTSLEEVQQ 235 (285)
T ss_dssp STTCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred CCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC-CCCCCCCCHHHHHh
Confidence 456889999999997653221 223456789999999875 5789999999999999999995 46999988888877
Q ss_pred HHHcCCccCC--CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 602 YIKEGNILQA--PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+........ ....++++.+|+.+||+.||++|||+.+++++.|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 281 (285)
T 3is5_A 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEW 281 (285)
T ss_dssp HHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred hhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 7766543222 2347899999999999999999999999998876
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=371.83 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=218.4
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
+...++..++|++.+.||+|+||+||+|+.. .+++.||||+++.... ....+.+.+|+.++..++||||++++
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-----~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 4455677889999999999999999999864 3568999999965321 11223478999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++...+..+|||||+++|+|.++++.. ...+++..+..++.||+.||+|||+++|+||||
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~-------------------~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDL 188 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKF-------------------GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDI 188 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHH-------------------SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccc
Confidence 9999999999999999999999999732 235889999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-------cCCCCCchhHHHHHHHHHHHHhCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-------YNKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-------~~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
||+|||++.++.+||+|||+++....... .......+|+.|+|||.+. ...++.++||||||+++|||++|
T Consensus 189 Kp~NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG- 266 (412)
T 2vd5_A 189 KPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG- 266 (412)
T ss_dssp SGGGEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHS-
T ss_pred CHHHeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhC-
Confidence 99999999999999999999986533221 1223457899999999987 35789999999999999999995
Q ss_pred CCCCCCCCHHHHHHHHHcCC----ccCCCCCCcHHHHHHHHHhhccCCCCC---CCHHHHHHHHHH
Q psy5539 588 LQPYYGLTHEEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNR---PSFRTIYQTLWN 646 (653)
Q Consensus 588 ~~p~~~~~~~e~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~eil~~L~~ 646 (653)
.+||.+.+..++...+.... ....+..++.++.+|+++||. +|.+| |++++|++|.|-
T Consensus 267 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff 331 (412)
T 2vd5_A 267 QTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF 331 (412)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred CCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence 56999998888877776432 222235789999999999999 99988 699999998763
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=351.53 Aligned_cols=259 Identities=23% Similarity=0.405 Sum_probs=220.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEe--cC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCA--VG 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~~ 440 (653)
.++|++.+.||+|+||.||+|+.. .+++.||+|.++... .....+.+.+|+.++++++||||+++++++. .+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGG
T ss_pred hhheeeehhccCCCCcEEEEEEEC-----CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCC
Confidence 357999999999999999999864 356889999987542 3455678999999999999999999999874 45
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----ceecCCC
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK-----FVHRDLA 515 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----ivHrDLk 515 (653)
...++||||+++|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+|||||
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~ 143 (279)
T 2w5a_A 80 TTLYIVMEYCEGGDLASVITKGT----------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143 (279)
T ss_dssp TEEEEEEECCTTEEHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCS
T ss_pred ceEEEEEeCCCCCCHHHHHHhhc----------------ccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccc
Confidence 68899999999999999997432 12345899999999999999999999998 9999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++........ .....++..|+|||.+.+..++.++||||||+++|||++| ..||...+
T Consensus 144 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~ 220 (279)
T 2w5a_A 144 PANVFLDGKQNVKLGDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFS 220 (279)
T ss_dssp GGGEEECSSSCEEECCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred hhhEEEcCCCCEEEecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHC-CCCCcccC
Confidence 99999999999999999999765322110 1123467889999999999999999999999999999995 56999999
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..++...+..+.....+..++.++.+++.+||+.+|.+|||+++|+++++.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 221 QKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp HHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 999999999988877888899999999999999999999999999998764
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.37 Aligned_cols=252 Identities=21% Similarity=0.282 Sum_probs=216.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||+|.+...... ..+.+.+|++++++++||||+++++++..++..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQK-----GTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIY 82 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeC-----CCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEE
Confidence 46899999999999999999864 35578999998754332 2457899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE---
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--- 521 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl--- 521 (653)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+++|+||||||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~ 142 (277)
T 3f3z_A 83 LVMELCTGGELFERVVH--------------------KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD 142 (277)
T ss_dssp EEEECCCSCBHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS
T ss_pred EEEeccCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC
Confidence 99999999999999862 2348899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||++....... ......+|+.|+|||.+.+ .++.++||||||+++|||++| ..||.+.+..++..
T Consensus 143 ~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~~ 217 (277)
T 3f3z_A 143 SPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCG-YPPFSAPTDSEVML 217 (277)
T ss_dssp STTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred CCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHC-CCCCCCCCHHHHHH
Confidence 788999999999997653222 2234568899999998765 499999999999999999994 56999999988888
Q ss_pred HHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 602 ~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.+..+...... ..+++++.+++.+||+.||.+|||+.+++++.|--
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~ 266 (277)
T 3f3z_A 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFE 266 (277)
T ss_dssp HHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence 88887643222 26889999999999999999999999999988743
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.60 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=217.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++|++.+.||+|+||.||+|+.. .++..||||.++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREK-----STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccEEEeeEeeecCCEEEEEEEEC-----CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 46899999999999999999864 35688999998654321 124678999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NI 146 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQ--------------------KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI 146 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHT--------------------CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCEEEEEEEcCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHE
Confidence 9999999999999999999962 24578999999999999999999999999999999999
Q ss_pred eEcCCC----cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 520 LINDQM----VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 520 Ll~~~~----~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+++++ .+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+.+
T Consensus 147 l~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~ 222 (321)
T 2a2a_A 147 MLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGDT 222 (321)
T ss_dssp EESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC-CSSCCSS
T ss_pred EEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC-CCCCCCC
Confidence 999888 79999999997653221 223456889999999999999999999999999999999955 5998888
Q ss_pred HHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+........ +...+..+.+|+.+||+.||++|||+++++++.|
T Consensus 223 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~ 275 (321)
T 2a2a_A 223 KQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPW 275 (321)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred HHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence 8888888877654222 2467899999999999999999999999999876
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=354.45 Aligned_cols=259 Identities=21% Similarity=0.270 Sum_probs=210.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
..++|.+.+.||+|+||+||+|+.. .+++.||||+++........+.+.+|++++++++||||+++++++....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 7 SNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp SSEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCEEEEEEecCCCCeEEEEEEEC-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 4567999999999999999999874 3567999999986544444567889999999999999999999987655
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..++||||+++|+|.++++... ....+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 144 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPS-----------------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGG-----------------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ceEEEEEeCCCCCCHHHHHHHhc-----------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 7799999999999999997321 2234899999999999999999999999999999999999
Q ss_pred E----cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc--------cCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 521 I----NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL--------YNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 521 l----~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--------~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
+ +.++.+||+|||+++...... ......+|..|+|||.+. +..++.++||||||+++|||++|.
T Consensus 145 l~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~- 220 (319)
T 4euu_A 145 RVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS- 220 (319)
T ss_dssp EEECTTSCEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSS-
T ss_pred EeccCCCCceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCC-
Confidence 9 888899999999998653322 223456889999999986 578899999999999999999955
Q ss_pred CCCCCCC----HHHHHHHHHcCCccC------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 589 QPYYGLT----HEEVVKYIKEGNILQ------------------------APDNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 589 ~p~~~~~----~~e~~~~i~~~~~~~------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
.||.... ..+++..+..+.... .+...+..+.+++++||+.||++|||++|+
T Consensus 221 ~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~el 300 (319)
T 4euu_A 221 LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300 (319)
T ss_dssp CSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHH
T ss_pred CCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHh
Confidence 5775432 344555554433211 112244678899999999999999999999
Q ss_pred HHHHHHH
Q psy5539 641 YQTLWNI 647 (653)
Q Consensus 641 l~~L~~l 647 (653)
++++.+-
T Consensus 301 l~h~~d~ 307 (319)
T 4euu_A 301 FAETSDI 307 (319)
T ss_dssp HHHHHHH
T ss_pred hhccHHH
Confidence 9998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=364.02 Aligned_cols=256 Identities=23% Similarity=0.331 Sum_probs=210.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHH-HhhCCCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACL-LAEFDHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~i-l~~l~HpnIv~l~g~~ 437 (653)
.+..++|++.+.||+|+||+||+|+.. .++..||||+++.... ......+.+|..+ ++.++||||+++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHK-----AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEET-----TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEc-----CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 345578999999999999999999864 3568899999975432 2233456677766 5778999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.++++.. ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~ 168 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRE--------------------RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPE 168 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHH
Confidence 9999999999999999999999732 35788999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..
T Consensus 169 NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G-~~Pf~~~~~~ 245 (373)
T 2r5t_A 169 NILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG-LPPFYSRNTA 245 (373)
T ss_dssp GEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCTTCCSBHH
T ss_pred HEEECCCCCEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcC-CCCCCCCCHH
Confidence 9999999999999999997542221 223345689999999999999999999999999999999995 5699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH----HHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF----RTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~eil~~L~ 645 (653)
++.+.+..+. ...+..++.++.+|+.+||+.||.+||++ .+|++|.|
T Consensus 246 ~~~~~i~~~~-~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~ 296 (373)
T 2r5t_A 246 EMYDNILNKP-LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296 (373)
T ss_dssp HHHHHHHHSC-CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGG
T ss_pred HHHHHHHhcc-cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCcc
Confidence 9998888765 35667899999999999999999999986 57776654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=355.02 Aligned_cols=258 Identities=19% Similarity=0.261 Sum_probs=208.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
-.++|++.+.||+|+||.||+|++. .+++.||||+++... .......+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 84 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDL-----RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAE 84 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEEC-----CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeecc
Confidence 3568999999999999999999863 457899999997542 344566799999999999999999999998765
Q ss_pred Cc----eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 441 KP----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 441 ~~----~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
.. .++||||+++|+|.++++. ...+++.+++.++.||+.||+|||+++|+||||||
T Consensus 85 ~~~~~~~~lv~e~~~g~~L~~~l~~--------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp 144 (311)
T 3ork_A 85 TPAGPLPYIVMEYVDGVTLRDIVHT--------------------EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKP 144 (311)
T ss_dssp ETTEEEEEEEEECCCEEEHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred CCCCcccEEEEecCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 54 3999999999999999972 23588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||++.++.+||+|||+++........ .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+
T Consensus 145 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g-~~pf~~~~ 223 (311)
T 3ork_A 145 ANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG-EPPFTGDS 223 (311)
T ss_dssp GGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS-SCSCCCSS
T ss_pred HHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhC-CCCCCCCC
Confidence 9999999999999999999765332211 122334578999999999999999999999999999999994 56998888
Q ss_pred HHHHHHHHHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+....+....... ....++.++.+++.+||+.||.+||+..+++++.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 277 (311)
T 3ork_A 224 PVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 277 (311)
T ss_dssp HHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred hHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence 877766655543322 134688999999999999999999988777766553
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.02 Aligned_cols=254 Identities=29% Similarity=0.517 Sum_probs=209.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---HHHH---HHHHHHHHHHhhCCCCccceEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---EYLQ---TDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---~~~~---~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
.+..++|++.+.||+|+||.||+|++. .+++.||||++..... .... +.+.+|+.++++++||||++++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 89 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLV-----KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEET-----TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEE
T ss_pred hhhhccceehhccccCCceeEEEEEEc-----CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhh
Confidence 456788999999999999999999864 3568899999864322 1111 5789999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceec
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHR 512 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHr 512 (653)
+++.... ++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+++ |+||
T Consensus 90 ~~~~~~~--~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~ 148 (287)
T 4f0f_A 90 GLMHNPP--RMVMEFVPCGDLYHRLLD-------------------KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHR 148 (287)
T ss_dssp EEETTTT--EEEEECCTTCBHHHHHHC-------------------TTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCS
T ss_pred eeecCCC--eEEEEecCCCCHHHHHhc-------------------ccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecC
Confidence 9986554 799999999999998861 2346899999999999999999999999 9999
Q ss_pred CCCCCCEeEcCCCc-----EEEeccCccccccccccccCCCCCCCccccccchhhc--cCCCCCchhHHHHHHHHHHHHh
Q psy5539 513 DLATRNCLINDQMV-----VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL--YNKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 513 DLkp~NILl~~~~~-----vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~t~ksDVwSlGvvl~ellt 585 (653)
||||+|||++.++. +||+|||+++.... ......+++.|+|||.+. ...++.++||||||+++|||++
T Consensus 149 dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~ 223 (287)
T 4f0f_A 149 DLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223 (287)
T ss_dssp CCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHH
T ss_pred CCCcceEEEeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHc
Confidence 99999999988776 99999999975321 223456789999999983 4567899999999999999999
Q ss_pred CCCCCCCCCCHHH--HHHHHH-cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 586 FALQPYYGLTHEE--VVKYIK-EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 586 ~~~~p~~~~~~~e--~~~~i~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|. .||......+ ....+. .+.....+..+++++.+++.+||+.||.+|||++++++.|.+
T Consensus 224 g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 224 GE-GPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp SS-CTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CC-CCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 54 5887654332 234433 344456677899999999999999999999999999998875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=351.20 Aligned_cols=253 Identities=22% Similarity=0.375 Sum_probs=206.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||+||+|+.. .+++.||||++.... .....+.+.+|++++++++||||+++++++...+..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNR-----DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccceEeeEEeecCCeEEEEEEeC-----CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeE
Confidence 57899999999999999999864 356889999886543 344566788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++++|.++++ ....+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 78 ~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~ 137 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDR--------------------YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITK 137 (311)
T ss_dssp EEEEECCSEEHHHHHHH--------------------TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEEeCCCchHHHHHh--------------------hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcC
Confidence 99999999999999876 2245899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||++....... .......+|..|+|||.+.+ ..++.++||||||+++|||++| ..||.+.+..+....
T Consensus 138 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~p~~~~~~~~~~~~ 214 (311)
T 4agu_A 138 HSVIKLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYL 214 (311)
T ss_dssp TSCEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHH
T ss_pred CCCEEEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 9999999999997653222 12234467889999999976 5789999999999999999995 568988877766554
Q ss_pred HHcC--------------------CccCC----------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--------------------NILQA----------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--------------------~~~~~----------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... ..... ...++.++.+|+.+||+.||.+|||++++++|.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 287 (311)
T 4agu_A 215 IRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY 287 (311)
T ss_dssp HHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence 4321 00001 1357788999999999999999999999999875
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=354.81 Aligned_cols=258 Identities=18% Similarity=0.283 Sum_probs=213.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||.++.... .+.+.+|+.+++++ +||||+++++++..++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNL-----YTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEET-----TTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred cCCeEEEEEeeccCCceEEEEEEC-----CCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 468999999999999999999853 4568999999865432 23578999999999 99999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+.+|+||||||+|||++
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~ 139 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLC-------------------DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIG 139 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred cEEEEEeC-CCCHHHHHHHc-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeec
Confidence 99999999 99999999732 24689999999999999999999999999999999999999
Q ss_pred CCCc-----EEEeccCcccccccccccc-----CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 523 DQMV-----VKIADFGLSRKMYLQDYYK-----GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 523 ~~~~-----vkI~DfGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
.++. +||+|||+++......... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.
T Consensus 140 ~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~-~Pf~ 218 (330)
T 2izr_A 140 RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGS-LPWQ 218 (330)
T ss_dssp CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-CTTT
T ss_pred cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCC-CCcc
Confidence 8887 9999999998654332211 124567899999999999999999999999999999999954 5887
Q ss_pred CCC---HHHHHHHHHcCCccCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 593 GLT---HEEVVKYIKEGNILQA----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 593 ~~~---~~e~~~~i~~~~~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+.+ ..+.+..+........ ....+ ++.+++..||+.+|.+||++++|.+.|.++.+++
T Consensus 219 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 219 GLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp TCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 743 3444555443322111 23355 8999999999999999999999999999887654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=347.26 Aligned_cols=255 Identities=24% Similarity=0.338 Sum_probs=212.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||.||+|+.. .++..||||.++........+.+.+|+.+++.++||||+++++++..++..+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEeecCCCcEEEEEEEC-----CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEE
Confidence 46899999999999999999864 3567899999976554445678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||+++++|.+++. ....+++..++.++.|++.||+|||+++++|+||||+|||++.+
T Consensus 82 lv~e~~~~~~L~~~l~--------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 141 (276)
T 2yex_A 82 LFLEYCSGGELFDRIE--------------------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (276)
T ss_dssp EEEECCTTEEGGGGSB--------------------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred EEEEecCCCcHHHHHh--------------------hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC
Confidence 9999999999998875 22458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHE-EVVKY 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~-e~~~~ 602 (653)
+.+||+|||++................++..|+|||.+.+..+ +.++||||||+++|||++|. .||.+.... .....
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~~~~~~~ 220 (276)
T 2yex_A 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSD 220 (276)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS-CCCSCSCTTSHHHHH
T ss_pred CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCchHHHHHHH
Confidence 9999999999976543332223345568899999999987765 78999999999999999955 587665432 23333
Q ss_pred HHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.... .......++..+.+++.+||+.||.+|||+++++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (276)
T 2yex_A 221 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 264 (276)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred hhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCcc
Confidence 33332 22333468899999999999999999999999998876
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.89 Aligned_cols=277 Identities=22% Similarity=0.295 Sum_probs=214.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc----cHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~----~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
.++|++.+.||+|+||.||+|+.. .++..||+|+++... .....+.+.+|++++++++||||+++++++..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIEN-----QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhheeecceeeecCCeEEEEEEEC-----CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 457999999999999999999864 456889999986532 22345679999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccc-------------------c-ccccCCCCCCHHHHHHHHHHHHH
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM-------------------E-SSIHRVPQLSTCDLITIALQIAS 499 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~-------------------~-~~~~~~~~l~~~~~~~i~~qia~ 499 (653)
.+..++||||+++|+|.++++............... . ........+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999996322111000000000 0 00001123467788999999999
Q ss_pred HHHHhhhCCceecCCCCCCEeEcCCC--cEEEeccCcccccccccc--ccCCCCCCCccccccchhhcc--CCCCCchhH
Q psy5539 500 GMVYLSDRKFVHRDLATRNCLINDQM--VVKIADFGLSRKMYLQDY--YKGDENDAIPVRWMPLESILY--NKYTVESDV 573 (653)
Q Consensus 500 gL~yLH~~~ivHrDLkp~NILl~~~~--~vkI~DfGla~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~--~~~t~ksDV 573 (653)
||+|||+++|+||||||+|||++.++ .+||+|||+++....... ........+|+.|+|||.+.+ ..++.++||
T Consensus 180 ~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 180 ALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 99999999999999999999998776 899999999986533221 112334568899999999975 678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 574 wSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
||||+++|||++|. .||.+.+..+....+..+...... ..+++++.+|+.+||+.+|.+|||+.+++++.|-
T Consensus 260 wslG~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~ 334 (345)
T 3hko_A 260 WSAGVLLHLLLMGA-VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334 (345)
T ss_dssp HHHHHHHHHHHHSS-CSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHH
T ss_pred HHHHHHHHHHHHCC-CCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhh
Confidence 99999999999965 599998888888777766543222 2378999999999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.69 Aligned_cols=248 Identities=19% Similarity=0.230 Sum_probs=200.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||+||+|++. .+++.||||++... ........+..|+..+.++ +||||+++++++..++.
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSK-----EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hheeeeheeccCCCeEEEEEEEC-----CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE
Confidence 57999999999999999999864 35689999998643 2233344455666555555 99999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~-------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~ 191 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAW-------------------GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG 191 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHH-------------------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred EEEEEecc-CCCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEC
Confidence 99999999 67999998632 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.+||+|||++....... ......+|+.|+|||.+.+ .++.++||||||+++|||++|..+|+.. +....
T Consensus 192 ~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~ 263 (311)
T 3p1a_A 192 PRGRCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQ 263 (311)
T ss_dssp GGGCEEECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHH
T ss_pred CCCCEEEccceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHH
Confidence 99999999999987653221 2234568999999998875 7999999999999999999987656542 22333
Q ss_pred HHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+.. ...+..+++++.+++.+||+.||++|||++++++++|
T Consensus 264 ~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 307 (311)
T 3p1a_A 264 LRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPV 307 (311)
T ss_dssp HTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcc
Confidence 333332 1234568899999999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.15 Aligned_cols=264 Identities=23% Similarity=0.400 Sum_probs=211.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||.||+|+.. .++..||||.++.. ........+.+|+.++++++||||+++++++...+
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 105 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACL-----LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN 105 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEET-----TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccceEEEEeecCCCCceEEEEEEc-----CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 357999999999999999999864 35688999998742 33455678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+.+++||||||+|||+
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~ 169 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFK----------------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 169 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred cEEEEEecCCCCCHHHHHHHhc----------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE
Confidence 9999999999999999997321 123568999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC--CHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL--THEEV 599 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~--~~~e~ 599 (653)
+.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|.. ||.+. ...++
T Consensus 170 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~-p~~~~~~~~~~~ 246 (310)
T 2wqm_A 170 TATGVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS-PFYGDKMNLYSL 246 (310)
T ss_dssp CTTSCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSC-TTC---CCHHHH
T ss_pred cCCCCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCC-CCcccchhHHHH
Confidence 999999999999997653222 12233457889999999999999999999999999999999665 66543 44566
Q ss_pred HHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 600 VKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 600 ~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
...+..+.....+ ..++.++.+++.+||+.||.+|||+++|++.|..++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 6777776654443 568999999999999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=346.56 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=221.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|.+.+.||+|+||.||+|+.. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 87 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 87 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cccceEEEEEEeecCCEEEEEEEEC-----CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence 3467999999999999999999864 356789999986542 344567789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil 147 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKR--------------------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 147 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CEEEEEEecCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEE
Confidence 999999999999999998862 235889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++| ..||.+....+..
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~ 224 (294)
T 2rku_A 148 LNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-KPPFETSCLKETY 224 (294)
T ss_dssp ECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHS-SCTTCCSSHHHHH
T ss_pred EcCCCCEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Confidence 9999999999999997653222 122345678899999999999999999999999999999995 5699888888887
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+. ...+...+..+.+++.+||+.||++|||+++++++.|-.
T Consensus 225 ~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~ 270 (294)
T 2rku_A 225 LRIKKNE-YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270 (294)
T ss_dssp HHHHTTC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred HHHhhcc-CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhee
Confidence 7777665 356678899999999999999999999999999988753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=358.38 Aligned_cols=256 Identities=23% Similarity=0.362 Sum_probs=204.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
....++|++.+.||+|+||+||+|+.. .+++.||||.+..... ..+.+.+|+.++++++||||+++++++...
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 88 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDK-----LTKELVAVKYIERGAA--IDENVQREIINHRSLRHPNIVRFKEVILTP 88 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEET-----TTCCEEEEEEEESSTT--SCHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEEC-----CCCcEEEEEEEecCcc--ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC
Confidence 345678999999999999999999864 3568999999975432 234678999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 89 ~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nil 148 (361)
T 3uc3_A 89 THLAIIMEYASGGELYERICN--------------------AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTL 148 (361)
T ss_dssp SEEEEEEECCCSCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEE
T ss_pred CEEEEEEEeCCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 999999999999999999862 235899999999999999999999999999999999999
Q ss_pred EcCCCc--EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCCC--
Q psy5539 521 INDQMV--VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVE-SDVWAFGVCLWEIFSFALQPYYGLT-- 595 (653)
Q Consensus 521 l~~~~~--vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~k-sDVwSlGvvl~ellt~~~~p~~~~~-- 595 (653)
++.++. +||+|||+++..... .......+|+.|+|||.+.+..++.+ +||||||+++|||++|. .||.+..
T Consensus 149 l~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~Pf~~~~~~ 224 (361)
T 3uc3_A 149 LDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEP 224 (361)
T ss_dssp ECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS-CSCC----C
T ss_pred EcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC-CCCCCCccH
Confidence 987765 999999999743221 12234568999999999988888755 89999999999999955 5887643
Q ss_pred --HHHHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 --HEEVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 --~~e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
....+..+...... +....+++++.+|+.+||+.+|.+|||++++++|.|-.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 279 (361)
T 3uc3_A 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFL 279 (361)
T ss_dssp CCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHH
T ss_pred HHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchh
Confidence 34455555554432 22235789999999999999999999999999998864
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.90 Aligned_cols=259 Identities=22% Similarity=0.324 Sum_probs=214.5
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-----CCc
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-----HPN 429 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-----Hpn 429 (653)
..+....+..++|.+.+.||+|+||+||+|+.. .+++.||||+++.. ......+.+|+.+++.++ |||
T Consensus 25 ~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 25 FSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-----DNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CCCCTTCEETTTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred eeeecceEecCEEEEEEEEcccCCeEEEEEEEC-----CCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 445556677889999999999999999999864 35688999999743 334556788999999996 999
Q ss_pred cceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 430 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
|+++++++...+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+++|
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~i 158 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN------------------NYNGFHIEDIKLYCIEILKALNYLRKMSL 158 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHT------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 999999999999999999999 89999999732 22358899999999999999999999999
Q ss_pred eecCCCCCCEeEcC-------------------------CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc
Q psy5539 510 VHRDLATRNCLIND-------------------------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY 564 (653)
Q Consensus 510 vHrDLkp~NILl~~-------------------------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 564 (653)
+||||||+|||+++ ++.+||+|||+++.... ......+|+.|+|||.+.+
T Consensus 159 vHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~ 233 (360)
T 3llt_A 159 THTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILN 233 (360)
T ss_dssp ECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTT
T ss_pred eeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcC
Confidence 99999999999975 78999999999975321 2234567899999999999
Q ss_pred CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccC-------------------------CCC------
Q psy5539 565 NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQ-------------------------APD------ 613 (653)
Q Consensus 565 ~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~-------------------------~~~------ 613 (653)
..++.++||||||+++|||++|. .||.+.+..+....+....... .+.
T Consensus 234 ~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 312 (360)
T 3llt_A 234 LGWDVSSDMWSFGCVLAELYTGS-LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312 (360)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSS-CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHH
T ss_pred CCCCCccchHHHHHHHHHHHHCC-CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchh
Confidence 99999999999999999999954 5898888777666554321100 000
Q ss_pred --------------CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 614 --------------NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 614 --------------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..++.+.+|+.+||+.||.+|||++++++|.|
T Consensus 313 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~ 358 (360)
T 3llt_A 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF 358 (360)
T ss_dssp HHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred hhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence 12367889999999999999999999998875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=346.75 Aligned_cols=263 Identities=22% Similarity=0.326 Sum_probs=202.3
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHH-HHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL-QTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
+++..++|++.+.||+|+||.||+|+.. .+++.||||+++....... .+.+.++...++.++||||+++++++.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHV-----PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEec-----CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 3566789999999999999999999863 3568999999986544333 334455556688899999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATR 517 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~ 517 (653)
.++..++||||++ |+|.+++.... .....+++..++.++.||+.||+|||++ +|+||||||+
T Consensus 77 ~~~~~~lv~e~~~-~~l~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~ 139 (290)
T 3fme_A 77 REGDVWICMELMD-TSLDKFYKQVI----------------DKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPS 139 (290)
T ss_dssp CSSSEEEEEECCS-EEHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGG
T ss_pred ccCCEEEEEehhc-cchHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHH
Confidence 9999999999997 59988886321 2345689999999999999999999998 9999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhh----ccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI----LYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|||++.++.+||+|||+++...... ......+++.|+|||.+ ....++.++||||||+++|||++|. .||..
T Consensus 140 Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~ 215 (290)
T 3fme_A 140 NVLINALGQVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR-FPYDS 215 (290)
T ss_dssp GCEECTTCCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS-CSSCC
T ss_pred HEEECCCCCEEEeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC-CCccc
Confidence 9999999999999999997653221 22334678899999996 5567899999999999999999966 47764
Q ss_pred -CCHH-HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 594 -LTHE-EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 594 -~~~~-e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.... .+...+........+..++.++.+++.+||+.+|++|||+.++++|+|--.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 216 WGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred cCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 3333 344444444433344578999999999999999999999999999987543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=357.37 Aligned_cols=260 Identities=23% Similarity=0.367 Sum_probs=218.0
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
.++..++|++.+.||+|+||.||+|+.. .++..||+|+++........+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 102 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 102 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEEC-----CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE
Confidence 3556678999999999999999999864 35688999999876666677889999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCC
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRN 518 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~N 518 (653)
++..++||||+++|+|.++++.. ..+++..+..++.|++.||+|||+. +|+||||||+|
T Consensus 103 ~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N 162 (360)
T 3eqc_A 103 DGEISICMEHMDGGSLDQVLKKA--------------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 162 (360)
T ss_dssp TTEEEEEECCCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred CCEEEEEEECCCCCCHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHH
Confidence 99999999999999999999732 3478999999999999999999996 99999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||++...... ......+|..|+|||.+.+..++.++||||||+++|||++|. .||...+..+
T Consensus 163 il~~~~~~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~ 237 (360)
T 3eqc_A 163 ILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR-YPIPPPDAKE 237 (360)
T ss_dssp EEECTTCCEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTS-CCSSCCCHHH
T ss_pred EEECCCCCEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCHHH
Confidence 99999999999999999755322 223456789999999999999999999999999999999965 5887665544
Q ss_pred H------------------------------------------HHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCC
Q psy5539 599 V------------------------------------------VKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 599 ~------------------------------------------~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RP 635 (653)
+ .+.+........+ ..++.++.+|+.+||+.||++||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 317 (360)
T 3eqc_A 238 LELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA 317 (360)
T ss_dssp HHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred HHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC
Confidence 3 2233333332222 34788999999999999999999
Q ss_pred CHHHHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWNIKR 649 (653)
Q Consensus 636 s~~eil~~L~~l~~ 649 (653)
|++++++|.|--..
T Consensus 318 t~~ell~hp~~~~~ 331 (360)
T 3eqc_A 318 DLKQLMVHAFIKRS 331 (360)
T ss_dssp CHHHHHTSHHHHHH
T ss_pred CHHHHhhChHhhcc
Confidence 99999999985543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=353.45 Aligned_cols=256 Identities=20% Similarity=0.316 Sum_probs=221.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|.+.+.||+|+||.||+++.. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++...
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 113 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDA-----DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN 113 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred cCCceEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 4567999999999999999999864 356789999986542 344567789999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++++|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+|||
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~--------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 173 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKR--------------------RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLF 173 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CeEEEEEecCCCCCHHHHHhc--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEE
Confidence 999999999999999999862 235889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++++.+||+|||+++...... .......++..|+|||.+.+..++.++||||||+++|||++| ..||......+..
T Consensus 174 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~ 250 (335)
T 2owb_A 174 LNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVG-KPPFETSCLKETY 250 (335)
T ss_dssp ECTTCCEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHS-SCTTCCSSHHHHH
T ss_pred EcCCCCEEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHC-cCCCCCCCHHHHH
Confidence 9999999999999997653222 122345678899999999999999999999999999999995 5689888888887
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+.. ..+..++..+.+|+.+||+.||++|||+++++++.|--
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~ 296 (335)
T 2owb_A 251 LRIKKNEY-SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296 (335)
T ss_dssp HHHHHTCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHH
T ss_pred HHHhcCCC-CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccc
Confidence 77777653 46678899999999999999999999999999988743
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=344.65 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=210.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .++..||||.++.. ........+.+|+..+..+ +||||+++++++...+.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~ 85 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKR-----LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH 85 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred chhhhhhhhcCCCceEEEEEEEc-----CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 57899999999999999999864 35689999998754 2233456788999999999 99999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++.... .....+++..++.++.||+.||+|||+++|+||||||+|||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~ 149 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENY----------------RIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFIS 149 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEEEecCCCcHHHHHHhhc----------------ccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEc
Confidence 999999999999999997321 1224689999999999999999999999999999999999998
Q ss_pred C-------------------CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHH
Q psy5539 523 D-------------------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWE 582 (653)
Q Consensus 523 ~-------------------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~e 582 (653)
. ...+||+|||++..... .....++..|+|||.+.+. .++.++||||||+++||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 150 RTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp --------------------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred CCCCCcccccccccccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 4 44899999999976532 2334588999999999876 56789999999999999
Q ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 583 IFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 583 llt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
|+++.. ++... +....+..+.....+..+++++.+++.+||+.||++|||+.+++++.|-.
T Consensus 224 l~~~~~-~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 224 AAGAEP-LPRNG---DQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HTTCCC-CCSSS---HHHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred HhcCCC-CCcch---hHHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 998554 33222 33556667777777888999999999999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=357.61 Aligned_cols=254 Identities=27% Similarity=0.415 Sum_probs=204.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .++..||||+++..........+.+|++++++++||||+++++++..++..+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSK-----LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEEC-----CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEE
Confidence 57999999999999999999864 3568899999976544333335668999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
+||||++ |+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+|||++.+
T Consensus 77 lv~e~~~-~~l~~~~~~~-------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~ 136 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDC-------------------GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINER 136 (324)
T ss_dssp EEEECCS-EEHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTT
T ss_pred EEecccc-cCHHHHHHhc-------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCC
Confidence 9999997 5999998632 2458899999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||+++...... .......+|..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+..+....+
T Consensus 137 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~i 213 (324)
T 3mtl_A 137 GELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFI 213 (324)
T ss_dssp CCEEECSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS-CSCCCSSHHHHHHHH
T ss_pred CCEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCC-CCCCCCCHHHHHHHH
Confidence 999999999997543221 12234467899999999886 56899999999999999999955 699988887776665
Q ss_pred HcCCcc-----------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEGNIL-----------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
...... .....+++++.+|+.+||+.||.+|||++++++|+|-
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f 285 (324)
T 3mtl_A 214 FRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFF 285 (324)
T ss_dssp HHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred HHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhh
Confidence 431000 0112467889999999999999999999999998874
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=347.10 Aligned_cols=253 Identities=29% Similarity=0.451 Sum_probs=198.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh--CCCCccceEEeEEec-
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE--FDHPNIVKLLGVCAV- 439 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~- 439 (653)
..++|++.+.||+|+||+||+|+.. ++.||||+++.... ..+.+|.+++.. ++||||+++++++..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~----~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSWQ-------GENVAVKIFSSRDE----KSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEET-------TEEEEEEEECGGGH----HHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEEC-------CEEEEEEEeccccc----hhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 3568999999999999999999863 47899999975432 344556666555 899999999998654
Q ss_pred ---CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh--------hCC
Q psy5539 440 ---GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS--------DRK 508 (653)
Q Consensus 440 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~ 508 (653)
....++||||+++|+|.++++ ...+++..++.++.||+.||+||| +++
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~---------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ 133 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQ---------------------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA 133 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHT---------------------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE
T ss_pred cCCCceeEEehhhccCCCHHHHHh---------------------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC
Confidence 356899999999999999995 135889999999999999999999 999
Q ss_pred ceecCCCCCCEeEcCCCcEEEeccCccccccccccc--cCCCCCCCccccccchhhccC------CCCCchhHHHHHHHH
Q psy5539 509 FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILYN------KYTVESDVWAFGVCL 580 (653)
Q Consensus 509 ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~------~~t~ksDVwSlGvvl 580 (653)
|+||||||+|||++.++.+||+|||+++........ .......+|+.|+|||.+.+. .++.++||||||+++
T Consensus 134 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il 213 (301)
T 3q4u_A 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL 213 (301)
T ss_dssp EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence 999999999999999999999999999765332221 122344789999999999877 455799999999999
Q ss_pred HHHHhCC---------CCCCCCC-----CHHHHHHHHHcC-CccCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 581 WEIFSFA---------LQPYYGL-----THEEVVKYIKEG-NILQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 581 ~ellt~~---------~~p~~~~-----~~~e~~~~i~~~-~~~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
|||++|. ..||.+. ....+...+... .....+ +..+.++.+|+.+||+.||++|||+.+|
T Consensus 214 ~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i 293 (301)
T 3q4u_A 214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293 (301)
T ss_dssp HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence 9999971 4566543 223333333222 222222 2245789999999999999999999999
Q ss_pred HHHHHHH
Q psy5539 641 YQTLWNI 647 (653)
Q Consensus 641 l~~L~~l 647 (653)
++.|..+
T Consensus 294 ~~~L~~i 300 (301)
T 3q4u_A 294 KKTLTKI 300 (301)
T ss_dssp HHHHHHH
T ss_pred HHHHhcc
Confidence 9999875
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-41 Score=349.44 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=205.3
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc----HHHHHHHHHHHHHHhhC---CCCccceEE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS----EYLQTDFEREACLLAEF---DHPNIVKLL 434 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~----~~~~~~f~~Ei~il~~l---~HpnIv~l~ 434 (653)
+..++|++.+.||+|+||+||+|++. .+++.||||+++.... ......+.+|+.+++++ +||||++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~ 80 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDP-----HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLM 80 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECT-----TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEee
Confidence 34568999999999999999999853 4568999999864321 11123456777777666 499999999
Q ss_pred eEEecCC-----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 435 GVCAVGK-----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 435 g~~~~~~-----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
+++.... ..++||||+. |+|.+++... ....+++..++.++.||+.||+|||+++|
T Consensus 81 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~i 141 (308)
T 3g33_A 81 DVCATSRTDREIKVTLVFEHVD-QDLRTYLDKA------------------PPPGLPAETIKDLMRQFLRGLDFLHANCI 141 (308)
T ss_dssp EEEEECCSSSEEEEEEEEECCC-CBHHHHHHTC------------------CTTCSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeeccCCCCceeEEEEehhhh-cCHHHHHhhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9997654 4799999997 5999999722 12348999999999999999999999999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
+||||||+|||++.++.+||+|||+++..... .......+|+.|+|||.+.+..++.++||||||+++|||++| .+
T Consensus 142 vH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~ 217 (308)
T 3g33_A 142 VHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP 217 (308)
T ss_dssp CCSCCCTTTEEECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTS-SC
T ss_pred ccCCCCHHHEEEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhC-CC
Confidence 99999999999999999999999999765322 122334678899999999999999999999999999999985 56
Q ss_pred CCCCCCHHHHHHHHHcCCcc--------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNIL--------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~--------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
||.+.+..+....+.+.... .....+++++.+|+.+||+.||++|||+.++++|
T Consensus 218 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 218 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 99888887776665431100 0113567899999999999999999999999999
Q ss_pred HHHH
Q psy5539 644 LWNI 647 (653)
Q Consensus 644 L~~l 647 (653)
.|--
T Consensus 298 ~~~~ 301 (308)
T 3g33_A 298 SYLH 301 (308)
T ss_dssp TTC-
T ss_pred cccc
Confidence 8743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=358.58 Aligned_cols=257 Identities=21% Similarity=0.338 Sum_probs=207.5
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCC--CCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFD--HPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~--HpnIv~l~g~~ 437 (653)
.+...+|.+.+.||+|+||.||+|... .+..||||+++.. ......+.+.+|+.++++++ ||||+++++++
T Consensus 52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~ 125 (390)
T 2zmd_A 52 SVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125 (390)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred cccCCceEEEEEEccCCCeEEEEEEcC------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEE
Confidence 444567999999999999999999852 2678999998643 34455678999999999996 59999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..+|||| +.+++|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+
T Consensus 126 ~~~~~~~lv~E-~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~ 184 (390)
T 2zmd_A 126 ITDQYIYMVME-CGNIDLNSWLKK--------------------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184 (390)
T ss_dssp ECSSEEEEEEE-CCSEEHHHHHHH--------------------CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGG
T ss_pred ecCCEEEEEEe-cCCCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHH
Confidence 99999999999 568899999972 235788899999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----------CCCCCchhHHHHHHHHHHHHhC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----------NKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~t~ksDVwSlGvvl~ellt~ 586 (653)
|||++ ++.+||+|||+++.+.............+|+.|+|||.+.+ ..++.++||||||+++|||++|
T Consensus 185 NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G 263 (390)
T 2zmd_A 185 NFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYG 263 (390)
T ss_dssp GEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHS
T ss_pred HEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHC
Confidence 99995 57999999999987643332222344578999999999875 4689999999999999999995
Q ss_pred CCCCCCCCC-HHHHHHHHHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 587 ALQPYYGLT-HEEVVKYIKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 587 ~~~p~~~~~-~~e~~~~i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
. .||.+.. ....+..+..+. ....+...+.++.+|+.+||+.||.+|||+.++++++|-
T Consensus 264 ~-~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 264 K-TPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp S-CTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred C-CcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 5 5776643 334455555443 345566678999999999999999999999999999874
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=346.96 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=190.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||.||+|+.. .+++.||||.++..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESI-----HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY 85 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred ccceeeeeecCCCceEEEEEEEc-----cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence 57899999999999999999863 35678999999654221 123578999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++.. ....+++..++.++.|++.||.|||+++|+||||||+|||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~ 146 (278)
T 3cok_A 86 VYLVLEMCHNGEMNRYLKN-------------------RVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146 (278)
T ss_dssp EEEEEECCTTEEHHHHHHT-------------------CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC
T ss_pred EEEEEecCCCCcHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 9999999999999999972 224689999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.+||+|||++....... .......+++.|+|||.+.+..++.++||||||+++|||++|. .||......+....
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~~~~~~ 223 (278)
T 3cok_A 147 RNMNIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR-PPFDTDTVKNTLNK 223 (278)
T ss_dssp TTCCEEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSS-CSSCCCSCC-----
T ss_pred CCCCEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCC-CCCCChhHHHHHHH
Confidence 99999999999997653221 1122345788999999999999999999999999999999954 58876665554443
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.... ...+..++.++.+++.+||+.||++|||+++++++.|-
T Consensus 224 ~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 266 (278)
T 3cok_A 224 VVLAD-YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266 (278)
T ss_dssp CCSSC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTT
T ss_pred Hhhcc-cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccc
Confidence 33322 24566789999999999999999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=360.81 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=199.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCC-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGK- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~- 441 (653)
++|++.+.||+|+||.||+|.+. .+++.||||++... ........+.+|+.++.++. ||||+++++++...+
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDR-----RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp TTEEEEEC-------CEEEEEET-----TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CceEEEEEeeeCCCeEEEEEEEC-----CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 57999999999999999999864 45688999998643 23444567889999999997 999999999997543
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..++||||++ |+|.++++. ..+++..+..++.||+.||+|||+.+|+||||||+|||
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIl 141 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRA---------------------NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNIL 141 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHH---------------------TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred CEEEEEecccC-cCHHHHHHc---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeE
Confidence 7899999997 599999862 35788999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccccc-------------------ccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDY-------------------YKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCL 580 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~-------------------~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl 580 (653)
++.++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++||||||+++
T Consensus 142 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il 221 (388)
T 3oz6_A 142 LNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221 (388)
T ss_dssp ECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred EcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHH
Confidence 99999999999999986532110 111223468899999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCcc----------------------------------------------CCCCC
Q psy5539 581 WEIFSFALQPYYGLTHEEVVKYIKEGNIL----------------------------------------------QAPDN 614 (653)
Q Consensus 581 ~ellt~~~~p~~~~~~~e~~~~i~~~~~~----------------------------------------------~~~~~ 614 (653)
|||++| .+||.+.+..+.+..+...... ..+..
T Consensus 222 ~ell~g-~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (388)
T 3oz6_A 222 GEILCG-KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKAD 300 (388)
T ss_dssp HHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCC
T ss_pred HHHHhC-CCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhccccccccc
Confidence 999995 5699888877666555321000 01126
Q ss_pred CcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 615 TPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 615 ~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+++++.+|+.+||..||.+|||++++++|+|
T Consensus 301 ~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~ 331 (388)
T 3oz6_A 301 CNEEALDLLDKLLQFNPNKRISANDALKHPF 331 (388)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTSTT
T ss_pred CCHHHHHHHHHhhccCcccCCCHHHHhCCHH
Confidence 7889999999999999999999999999876
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.56 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=213.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++|.+.+.||+|+||.||+|+.. .+++.||+|.++..... ...+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 79 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQK-----GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN 79 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhHHhhcccCceEEEEEEEc-----CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC
Confidence 46899999999999999999864 35678999998654211 124678999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~--------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni 139 (283)
T 3bhy_A 80 KTDVVLILELVSGGELFDFLAE--------------------KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI 139 (283)
T ss_dssp SSEEEEEEECCCSCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCeEEEEEeecCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence 9999999999999999999962 23578999999999999999999999999999999999
Q ss_pred eEcCCC----cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 520 LINDQM----VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 520 Ll~~~~----~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+++++ .+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||++|. .||.+.+
T Consensus 140 l~~~~~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~ 215 (283)
T 3bhy_A 140 MLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA-SPFLGET 215 (283)
T ss_dssp EESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS-CTTCCSS
T ss_pred EEecCCCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCC-CCCCCcc
Confidence 998877 89999999997653222 123345788999999999999999999999999999999954 5998888
Q ss_pred HHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+....+........ ....+..+.+++.+||+.||++|||+.+++++.|-
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 269 (283)
T 3bhy_A 216 KQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269 (283)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHH
T ss_pred hHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHH
Confidence 8888888776553221 24678999999999999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=356.75 Aligned_cols=267 Identities=26% Similarity=0.436 Sum_probs=211.3
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEe
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLG 435 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g 435 (653)
.+..++...++|.+.+.||+|+||.||+|+.. +++.||||+++..........+.+|+++++.++||||+++++
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLA------DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECCS------SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEec------CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 44566788899999999999999999999742 457899999986544433446899999999999999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC---Cceec
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR---KFVHR 512 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---~ivHr 512 (653)
++...+..++||||+++|+|.++++... .....+++..++.++.|++.||+|||++ +|+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~ 158 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERP----------------ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR 158 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCS----------------TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence 9999999999999999999999997322 1234589999999999999999999999 99999
Q ss_pred CCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
||||+|||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.
T Consensus 159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~ 236 (326)
T 3uim_A 159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQ-RAFD 236 (326)
T ss_dssp CCSGGGEEECTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCC-CSBC
T ss_pred CCchhhEEECCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCC-Cccc
Confidence 9999999999999999999999986532221 2223445899999999999999999999999999999999955 4774
Q ss_pred CC-----CHHHHHHHHHc----CCcc---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 593 GL-----THEEVVKYIKE----GNIL---------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 593 ~~-----~~~e~~~~i~~----~~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.. ......+.+.. .... ..+...+..+.+++.+||+.+|.+|||+++|+++|+.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 237 LARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 11 11111111111 1110 1111234789999999999999999999999999974
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=356.44 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=211.7
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|+.. .++..||||.++.... .+.+|++++.++ +||||+++++++..++..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~-----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHK-----ATNMEFAVKIIDKSKR-----DPTEEIEILLRYGQHPNIITLKDVYDDGKYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTTC-----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEcccC-----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEE
Confidence 46899999999999999999864 3568999999975432 245788888888 799999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++|+||||||+|||+.+
T Consensus 92 ~lv~E~~~gg~L~~~i~--------------------~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~ 151 (342)
T 2qr7_A 92 YVVTELMKGGELLDKIL--------------------RQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVD 151 (342)
T ss_dssp EEEECCCCSCBHHHHHH--------------------TCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESS
T ss_pred EEEEeCCCCCcHHHHHH--------------------HcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEec
Confidence 99999999999999986 2245899999999999999999999999999999999999843
Q ss_pred C----CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC---CCH
Q psy5539 524 Q----MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG---LTH 596 (653)
Q Consensus 524 ~----~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~---~~~ 596 (653)
+ +.+||+|||+++....... ......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+ .+.
T Consensus 152 ~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~Pf~~~~~~~~ 228 (342)
T 2qr7_A 152 ESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG-YTPFANGPDDTP 228 (342)
T ss_dssp SSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHS-SCSSCSSTTSCH
T ss_pred CCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcC-CCCCCCCCcCCH
Confidence 3 3599999999986533221 22345678999999999988899999999999999999995 457765 467
Q ss_pred HHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.++...+..+..... ...+++++.+|+++||+.||++|||+.++++|.|-.
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~ 282 (342)
T 2qr7_A 229 EEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV 282 (342)
T ss_dssp HHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred HHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence 788888888765432 246889999999999999999999999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=342.02 Aligned_cols=255 Identities=26% Similarity=0.372 Sum_probs=212.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+..++|.+.+.||+|+||.||+|+.. .+++.||||.++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 82 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQ-----LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST 82 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred ceeccEEEEeeecCCCCeEEEEEEEC-----CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 34568999999999999999999864 3567899999865421 1234578899999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+||
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 142 (276)
T 2h6d_A 83 PTDFFMVMEYVSGGELFDYICKH--------------------GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV 142 (276)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------------------CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence 99999999999999999999632 3478999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|++.++.+||+|||++....... ......+++.|+|||.+.+..+ +.++||||||+++|||++| ..||.+....+
T Consensus 143 l~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~ 218 (276)
T 2h6d_A 143 LLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG-TLPFDDEHVPT 218 (276)
T ss_dssp EECTTSCEEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHS-SCSSCCSSHHH
T ss_pred EECCCCCEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhC-CCCCCCCcHHH
Confidence 99999999999999997653222 1233467889999999988765 6899999999999999995 56898888888
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+.+.+..+. ...+..++..+.+++.+||+.||.+|||+++++++.|-
T Consensus 219 ~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~ 265 (276)
T 2h6d_A 219 LFKKIRGGV-FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF 265 (276)
T ss_dssp HHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred HHHHhhcCc-ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence 888887765 34567789999999999999999999999999999874
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=350.84 Aligned_cols=254 Identities=29% Similarity=0.452 Sum_probs=204.9
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc---ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~---~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV 446 (653)
.+.||+|+||.||+|+. .+..||||.+... ..+...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 36 ~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 108 (307)
T 2nru_A 36 GNKMGEGGFGVVYKGYV-------NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108 (307)
T ss_dssp CCEEEECSSEEEEEEES-------SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CCccccCCCeEEEEEEE-------CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEE
Confidence 37899999999999985 2468999998643 2234566799999999999999999999999999999999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
|||+++|+|.+++... .....+++..++.++.||+.||.|||+++|+||||||+|||+++++.
T Consensus 109 ~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCL-----------------DGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT 171 (307)
T ss_dssp EECCTTCBHHHHHHTG-----------------GGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC
T ss_pred EEecCCCcHHHHHHhc-----------------cCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc
Confidence 9999999999999722 12346899999999999999999999999999999999999999999
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE----EVVKY 602 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~----e~~~~ 602 (653)
+||+|||+++...............++..|+|||.+.+ .++.++||||||+++|||++| .+||.+.... .+...
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g-~~p~~~~~~~~~~~~~~~~ 249 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLDIKEE 249 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC-CCSBCTTBSSSBTTHHHHH
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC-CCCcccCcchHHHHHHHHH
Confidence 99999999976533222222334568899999998764 589999999999999999995 5577654332 22222
Q ss_pred HHcC----------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 603 IKEG----------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 603 i~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+... .....+...+..+.+++.+||+.+|.+|||+++|+++|..+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 250 IEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp HHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred hhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 2221 1122233355789999999999999999999999999998864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=376.11 Aligned_cols=257 Identities=23% Similarity=0.304 Sum_probs=218.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|++.+.||+|+||.||+|+.. .+++.||||+++.... ......+.+|+.+++.++|||||++++++.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 254 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVR-----ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE 254 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEEC-----CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence 355678999999999999999999864 3568999999965321 122356789999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 255 ~~~~l~lVmEy~~gg~L~~~l~~~------------------~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeN 316 (576)
T 2acx_A 255 TKDALCLVLTLMNGGDLKFHIYHM------------------GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPEN 316 (576)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHSS------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchhe
Confidence 999999999999999999999721 12348999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL---- 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~---- 594 (653)
|||+.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+.
T Consensus 317 ILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG-~~PF~~~~~~~ 392 (576)
T 2acx_A 317 ILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAG-QSPFQQRKKKI 392 (576)
T ss_dssp EEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHS-SCSSSCSSSCC
T ss_pred EEEeCCCCeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhC-CCCCcccccch
Confidence 9999999999999999986533221 2334789999999999999999999999999999999995 4588765
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
...++...+.... ...+..++.++.+|+++||+.||.+|| ++++|++|.|
T Consensus 393 ~~~~i~~~i~~~~-~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf 447 (576)
T 2acx_A 393 KREEVERLVKEVP-EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447 (576)
T ss_dssp CHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred hHHHHHHHhhccc-ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence 3456666666554 356678999999999999999999999 7899999876
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=343.37 Aligned_cols=257 Identities=23% Similarity=0.349 Sum_probs=214.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---HHHHHHHHHHHHHHhhCCCCccceEEeEEe--c
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---EYLQTDFEREACLLAEFDHPNIVKLLGVCA--V 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~ 439 (653)
++|++.+.||+|+||.||+|+.. .++..||+|.++.... ....+.+.+|+.++++++||||+++++++. .
T Consensus 5 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 5 GKYLMGDLLGEGSYGKVKEVLDS-----ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp CCBCCCCEEEECSSCEEEEEEBT-----TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred cceeEeeEEecCCCeEEEEEEEC-----CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 57888999999999999999863 4568899999975432 124567999999999999999999999984 4
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....++||||++++ |.+++... ....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NI 140 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSV------------------PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHS------------------TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CCeEEEEehhccCC-HHHHHHhC------------------cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 56889999999876 88877632 234589999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++.++.+||+|||++................++..|+|||.+.+.. ++.++||||||+++|||++|. .||.+.+..
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~ 219 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL-YPFEGDNIY 219 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSS-CSCCCSSHH
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCC-CCCCCchHH
Confidence 99999999999999997654322222223456889999999987654 378999999999999999954 699998888
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
++.+.+..+.. ..+..++..+.+++.+||+.||.+|||+++++++.|--
T Consensus 220 ~~~~~i~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 268 (305)
T 2wtk_C 220 KLFENIGKGSY-AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268 (305)
T ss_dssp HHHHHHHHCCC-CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHhcCCC-CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 88888887753 56678899999999999999999999999999998754
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-41 Score=384.96 Aligned_cols=256 Identities=24% Similarity=0.374 Sum_probs=220.9
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+..++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|..++..+ +||||+++++++
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~-----~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~ 411 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERK-----GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF 411 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEES-----SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC
T ss_pred cccccceEEEEEEccCCCEEEEEEEEC-----CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE
Confidence 456678999999999999999999964 356889999997532 122234677899999988 799999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+.++|||||+++|+|.++++.. ..+++..++.++.||+.||+|||+++|+||||||+
T Consensus 412 ~~~~~~~lV~E~~~gg~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~ 471 (674)
T 3pfq_A 412 QTMDRLYFVMEYVNGGDLMYHIQQV--------------------GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471 (674)
T ss_dssp BCSSEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCST
T ss_pred EeCCEEEEEEeCcCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChh
Confidence 9999999999999999999999732 35889999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||+.++.+||+|||+++...... .......||+.|||||.+.+..++.++||||||++||||++ |.+||.+.+..
T Consensus 472 NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyellt-G~~Pf~~~~~~ 548 (674)
T 3pfq_A 472 NVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA-GQAPFEGEDED 548 (674)
T ss_dssp TEEECSSSCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHH-SSCSSCCSSHH
T ss_pred hEEEcCCCcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHc-CCCCCCCCCHH
Confidence 9999999999999999998542222 22344578999999999999999999999999999999999 55699999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
++.+.|..+. ...|..++.++.+|+++||+.||++||++ ++|++|.|
T Consensus 549 ~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f 600 (674)
T 3pfq_A 549 ELFQSIMEHN-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600 (674)
T ss_dssp HHHHHHHSSC-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence 9999998876 45778899999999999999999999997 88988765
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=345.75 Aligned_cols=259 Identities=19% Similarity=0.236 Sum_probs=208.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||.++... .....+.+.+|+.++++++||||+++++++..++
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDT-----VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred eccEEEEEEEcCCCCeeEEEEEEc-----CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 368999999999999999999864 356899999997542 3445678999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|.++++.. ..+++..++.++.||+.||.|||+.+|+||||||+|||+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~ 167 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQ--------------------GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV 167 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHH--------------------CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred eEEEEEEecCCCCHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE
Confidence 999999999999999999732 358899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++| ..||.+.+...+..
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~ 245 (309)
T 2h34_A 168 SADDFAYLVDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG-SPPYQGDQLSVMGA 245 (309)
T ss_dssp CTTSCEEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS-SCSSCSCHHHHHHH
T ss_pred cCCCCEEEecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC-CCCCCCchHHHHHH
Confidence 999999999999997653322 1222345678899999999999999999999999999999994 56888877665555
Q ss_pred HHHcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHHH
Q psy5539 602 YIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRP-SFRTIYQTLWNIKR 649 (653)
Q Consensus 602 ~i~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~~ 649 (653)
.+..... ...+..++.++.+++.+||+.||++|| +++++++.|..+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~ 296 (309)
T 2h34_A 246 HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA 296 (309)
T ss_dssp HHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred HhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence 5554322 234567889999999999999999999 99999999876543
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=353.68 Aligned_cols=262 Identities=20% Similarity=0.334 Sum_probs=201.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe--
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA-- 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~-- 438 (653)
.+..++|++.+.||+|+||.||+|+.. ++.||||+++...... ...+.|+..+..++||||+++++.+.
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~--~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSLD-------ERPVAVKVFSFANRQN--FINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEET-------TEEEEEEEEEGGGHHH--HHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEEC-------CeEEEEEEeeccchhh--HHHHHHHHHHHhccCcchhhheeccccc
Confidence 456689999999999999999999863 4789999997543221 12234444455689999999998653
Q ss_pred ---cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC--------
Q psy5539 439 ---VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-------- 507 (653)
Q Consensus 439 ---~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-------- 507 (653)
.....++||||+++|+|.++++. ...++..++.++.||+.||.|||+.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~---------------------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL---------------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh---------------------cccchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 23367899999999999999962 2247889999999999999999999
Q ss_pred -CceecCCCCCCEeEcCCCcEEEeccCccccccccccc------cCCCCCCCccccccchhhcc-------CCCCCchhH
Q psy5539 508 -KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYY------KGDENDAIPVRWMPLESILY-------NKYTVESDV 573 (653)
Q Consensus 508 -~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~------~~~~~~~~t~~y~aPE~~~~-------~~~t~ksDV 573 (653)
+|+||||||+|||++.++.+||+|||+++.+...... .......+|+.|+|||.+.+ ..++.++||
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 9999999999999999999999999999866432211 11224468999999999986 456789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCC-----------------HHHHHHHHHc-CCccCCCCC------CcHHHHHHHHHhhcc
Q psy5539 574 WAFGVCLWEIFSFALQPYYGLT-----------------HEEVVKYIKE-GNILQAPDN------TPDALYDLMKLCWNM 629 (653)
Q Consensus 574 wSlGvvl~ellt~~~~p~~~~~-----------------~~e~~~~i~~-~~~~~~~~~------~~~~l~~li~~cl~~ 629 (653)
||||+++|||++|+.+++.+.. ..++...+.. ......++. .++++.+|+.+||+.
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 9999999999998776665432 1122222222 222233333 345799999999999
Q ss_pred CCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 630 KPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 630 dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
||++|||++++++.|..+...++
T Consensus 299 dP~~Rps~~e~l~~L~~ll~~~~ 321 (336)
T 3g2f_A 299 DAEARLTAQXAEERMAELMMIWE 321 (336)
T ss_dssp SGGGSCCHHHHHHHHHHHHHCCC
T ss_pred ChhhCcchHHHHHHHHHHHHHHH
Confidence 99999999999999999887654
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=353.18 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=201.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
...++|++.+.||+|+||+||+|+.. .+++.||||+++.... ....+.+.+|+.++++++||||+++++++..+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDT-----VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN 105 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET
T ss_pred cchhhEEEEEEEEecCCeEEEEEEEC-----CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC
Confidence 34468999999999999999999863 4578999999975432 33455688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||++ |+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 106 ~~~~lv~e~~~-~~L~~~~~~--------------------~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl 164 (329)
T 3gbz_A 106 HRLHLIFEYAE-NDLKKYMDK--------------------NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL 164 (329)
T ss_dssp TEEEEEEECCS-EEHHHHHHH--------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEecCC-CCHHHHHhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence 99999999998 599999862 235889999999999999999999999999999999999
Q ss_pred E-----cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 521 I-----NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 521 l-----~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
+ ++++.+||+|||+++...... .......+|..|+|||.+.+. .++.++||||||+++|||++| .+||.+.
T Consensus 165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~ 241 (329)
T 3gbz_A 165 LSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGD 241 (329)
T ss_dssp EEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS-SCSSCCS
T ss_pred EecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHC-CCCcCCC
Confidence 9 455669999999997653221 222344568899999999875 489999999999999999995 5688888
Q ss_pred CHHHHHHHHHcCCccCC-----------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQA-----------------------------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+....+........ +..+++++.+|+.+||+.||.+|||++++++|.|
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 321 (329)
T 3gbz_A 242 SEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321 (329)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcc
Confidence 77766655543110000 0116789999999999999999999999999887
Q ss_pred H
Q psy5539 646 N 646 (653)
Q Consensus 646 ~ 646 (653)
-
T Consensus 322 f 322 (329)
T 3gbz_A 322 F 322 (329)
T ss_dssp G
T ss_pred c
Confidence 3
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-41 Score=349.24 Aligned_cols=269 Identities=22% Similarity=0.342 Sum_probs=197.4
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
...+..++|++.+.||+|+||.||+|+.. .++..||||.+.........+++.+|+.++++++||||+++++++.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 83 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCA-----PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV 83 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC---------CEEEEECCC----------------CCCCCCCTTBCCEEEEEE
T ss_pred ccccchhhhhhhheeccccceEEEEEEEC-----CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe
Confidence 34667789999999999999999999853 3567899999976554455667899999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++....... ......+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~N 151 (303)
T 2vwi_A 84 VKDELWLVMKLLSGGSVLDIIKHIVAKG------------EHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGN 151 (303)
T ss_dssp SSSCEEEEEECCTTCBHHHHHHHHHHTT------------TTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred ecCCcEEEehhccCCchHHHHHHHhhcc------------ccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhh
Confidence 9999999999999999999997432110 1123568999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc---cCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY---KGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+++++.+||+|||++......... .......+++.|+|||.+.+ ..++.++||||||+++|||++|. .||.+.
T Consensus 152 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~ 230 (303)
T 2vwi_A 152 ILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA-APYHKY 230 (303)
T ss_dssp EEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS-CTTTTS
T ss_pred EEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC-CCCccC
Confidence 99999999999999998765332211 11233467889999999876 57899999999999999999954 588777
Q ss_pred CHHHHHHHHHcCCccC---------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQ---------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+............ ....++.++.+++.+||+.||.+|||+.+++++.|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 231 PPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp CGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred chhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 6655544444332211 22457889999999999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.42 Aligned_cols=251 Identities=27% Similarity=0.389 Sum_probs=209.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----- 439 (653)
++|++.+.||+|+||.||+|+.. .+++.||+|.++... +.+.+|++++++++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 80 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHR-----IDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDP 80 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEET-----TTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-
T ss_pred cccceeeeeccCCceEEEEEEEc-----CCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCc
Confidence 46899999999999999999864 356889999997543 246789999999999999999998754
Q ss_pred -----------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5539 440 -----------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK 508 (653)
Q Consensus 440 -----------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 508 (653)
....++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++
T Consensus 81 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 142 (284)
T 2a19_B 81 ETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR------------------RGEKLDKVLALELFEQITKGVDYIHSKK 142 (284)
T ss_dssp --------CCEEEEEEEEECCCCSCBHHHHHHHG------------------GGSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccCcceEEEEEeccCCCCHHHHHhhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 44589999999999999999732 1245889999999999999999999999
Q ss_pred ceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 509 FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 509 ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
|+|+||||+|||+++++.+||+|||++....... ......+++.|+|||.+.+..++.++||||||+++|||+++..
T Consensus 143 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 219 (284)
T 2a19_B 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219 (284)
T ss_dssp EECSCCSGGGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCS
T ss_pred eeeccCCHHHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999997653322 2234567899999999999999999999999999999999765
Q ss_pred CCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 589 QPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
|+. ...+....+..+. .+...+..+.+++.+||+.||.+|||+.+++++|+.+++..+
T Consensus 220 -~~~--~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 220 -TAF--ETSKFFTDLRDGI---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp -SHH--HHHHHHHHHHTTC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred -cch--hHHHHHHHhhccc---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 332 2234445555543 456788999999999999999999999999999999876644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.70 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=203.6
Q ss_pred CCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCc
Q psy5539 365 NDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~ 442 (653)
+.|.+. +.||+|+||.||+|+.. .+++.||||+++.... ...+.+.+|++++.++ +||||+++++++..++.
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~ 85 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINL-----ITSQEYAVKIIEKQPG-HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR 85 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECS-----SSCCEEEEEEEECCSS-CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred eeEEecCceecCCceEEEEEEEEc-----CCCcEEEEEEEeeCcc-hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 457774 67999999999999853 4568899999975432 2345788999999985 79999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~ 145 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKR--------------------RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCE 145 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEES
T ss_pred EEEEEEcCCCCcHHHHHhcc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEc
Confidence 99999999999999999732 3578999999999999999999999999999999999999
Q ss_pred CCCc---EEEeccCccccccccccc-----cCCCCCCCccccccchhhcc-----CCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 523 DQMV---VKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILY-----NKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 523 ~~~~---vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~-----~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
.++. +||+|||++......... .......+|..|+|||.+.. ..++.++||||||+++|||++|. .
T Consensus 146 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~-~ 224 (316)
T 2ac3_A 146 HPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-P 224 (316)
T ss_dssp CSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS-C
T ss_pred cCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC-C
Confidence 8776 999999998765322111 11123458899999999875 56899999999999999999955 5
Q ss_pred CCCCCC---------------HHHHHHHHHcCCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLT---------------HEEVVKYIKEGNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~---------------~~e~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||.+.. ...+.+.+..+... .+ ..++.++.+|+.+||+.||.+|||++++++|.|
T Consensus 225 pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 298 (316)
T 2ac3_A 225 PFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE-FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPW 298 (316)
T ss_dssp SCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC-CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTT
T ss_pred CCcccccccccccccccchhHHHHHHHHHhccCcc-cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChh
Confidence 886653 24466667666542 22 357899999999999999999999999999876
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=353.93 Aligned_cols=243 Identities=25% Similarity=0.381 Sum_probs=188.0
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.||+|+||.||+|+.. .+++.||||+++... ...+.+|+.+++.+. ||||+++++++..+...++||||
T Consensus 17 ~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~ 87 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHK-----KSNQAFAVKIISKRM----EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMEL 87 (325)
T ss_dssp CCSEEETTEEEEEEEET-----TTCCEEEEEEEEGGG----HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC
T ss_pred CccccCCCeEEEEEEEC-----CCCCEEEEEEEChhh----hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEc
Confidence 67999999999999864 356889999996542 346788999999997 99999999999999999999999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCC---c
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM---V 526 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~---~ 526 (653)
+++|+|.+++.. ...+++.++..++.||+.||+|||+++|+||||||+|||++.++ .
T Consensus 88 ~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 147 (325)
T 3kn6_A 88 LNGGELFERIKK--------------------KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLE 147 (325)
T ss_dssp CCSCBHHHHHHH--------------------CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CE
T ss_pred cCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCccc
Confidence 999999999972 24589999999999999999999999999999999999997665 8
Q ss_pred EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC-------HHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-------HEEV 599 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~-------~~e~ 599 (653)
+||+|||+++...... .......+|+.|+|||.+.+..++.++||||||+++|||++| ..||.+.+ ..++
T Consensus 148 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~ 224 (325)
T 3kn6_A 148 IKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG-QVPFQSHDRSLTCTSAVEI 224 (325)
T ss_dssp EEECCCTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHS-SCTTC-------CCCHHHH
T ss_pred EEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhC-CCCCCCCccccccccHHHH
Confidence 9999999997543222 122344568999999999999999999999999999999995 45886543 3567
Q ss_pred HHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...+..+...... ..+++++.+|+.+||+.||.+|||+++++++.|
T Consensus 225 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w 273 (325)
T 3kn6_A 225 MKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW 273 (325)
T ss_dssp HHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred HHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence 7777776543222 257899999999999999999999999998876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=345.61 Aligned_cols=251 Identities=24% Similarity=0.362 Sum_probs=214.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|.+.+.||+|+||.||+|+.. .+++.||+|.++.... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQR-----LTGKLFALKCIKKSPA-FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYY 82 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccceeeeeccCCCCceEEEEEEC-----CCCCEEEEEEEecccc-cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEE
Confidence 47899999999999999999864 3568899999975432 23456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE---
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI--- 521 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl--- 521 (653)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 83 lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~ 142 (304)
T 2jam_A 83 LVMQLVSGGELFDRILER--------------------GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP 142 (304)
T ss_dssp EEECCCCSCBHHHHHHHH--------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS
T ss_pred EEEEcCCCccHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC
Confidence 999999999999998622 357899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++..... ......+++.|+|||.+.+..++.++||||||+++|||++| ..||.+.+..++..
T Consensus 143 ~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~~~~~~~~ 217 (304)
T 2jam_A 143 EENSKIMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG-YPPFYEETESKLFE 217 (304)
T ss_dssp STTCCEEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHH
T ss_pred CCCCCEEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHC-CCCCCCCCHHHHHH
Confidence 78899999999998753211 11223468899999999999999999999999999999995 46898888888888
Q ss_pred HHHcCCcc---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+... .....++.++.+++.+||+.||++|||+++++++.|-
T Consensus 218 ~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~ 265 (304)
T 2jam_A 218 KIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265 (304)
T ss_dssp HHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred HHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence 88877542 2235688999999999999999999999999998874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=368.73 Aligned_cols=254 Identities=27% Similarity=0.446 Sum_probs=215.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH------------HHHHHHHHHHHHHhhCCCCccc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE------------YLQTDFEREACLLAEFDHPNIV 431 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~------------~~~~~f~~Ei~il~~l~HpnIv 431 (653)
.++|.+.+.||+|+||+||+|+.. .++..||||+++..... ...+.+.+|+.++++++||||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEK-----NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEEC-----CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCC
Confidence 467999999999999999999864 35678999998754321 2346789999999999999999
Q ss_pred eEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 432 KLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 432 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
++++++..+...++||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++|+|
T Consensus 110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 169 (504)
T 3q5i_A 110 KLFDVFEDKKYFYLVTEFYEGGELFEQIIN--------------------RHKFDECDAANIMKQILSGICYLHKHNIVH 169 (504)
T ss_dssp CEEEEEECSSEEEEEEECCTTCBHHHHHHH--------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred eEEEEEEcCCEEEEEEecCCCCcHHHHHHH--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 999999999999999999999999999862 235899999999999999999999999999
Q ss_pred cCCCCCCEeEcCCC---cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 512 RDLATRNCLINDQM---VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 512 rDLkp~NILl~~~~---~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
|||||+|||++.++ .+||+|||+++...... ......+|+.|+|||.+. +.++.++||||||+++|+|++| .
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g-~ 244 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCG-Y 244 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHS-S
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhC-C
Confidence 99999999998776 69999999997653221 223456899999999876 5799999999999999999995 5
Q ss_pred CCCCCCCHHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+||.+.+..+++..+..+..... ...+++++.+|+++||+.||.+|||++++++|+|--
T Consensus 245 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~ 306 (504)
T 3q5i_A 245 PPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIK 306 (504)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhh
Confidence 69999999999999988765322 156889999999999999999999999999998753
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.94 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=203.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||++... ......+.+.+|+++++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEEC-----CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCc
Confidence 467999999999999999999863 45688999998643 34445677899999999999999999999997653
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
..++||||+ +++|.++++. ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---------------------~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp 156 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---------------------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 156 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCH
Confidence 469999999 7899999862 3478999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||++.++.+||+|||+++.... ......+|..|+|||.+.+ ..++.++||||||+++|||++|. +||.+.+
T Consensus 157 ~NIll~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~ 230 (367)
T 1cm8_A 157 GNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK-TLFKGSD 230 (367)
T ss_dssp GGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSS-CSSCCSS
T ss_pred HHEEEcCCCCEEEEeeeccccccc-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCC-CCCCCCC
Confidence 999999999999999999986422 2234567899999999887 68999999999999999999954 6898887
Q ss_pred HHHHHHHHHcC------------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEG------------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.+..+... .........++.+.+|+.+||..||.+|||++++++|+|
T Consensus 231 ~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~ 310 (367)
T 1cm8_A 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 310 (367)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence 76655544320 111223456889999999999999999999999999876
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=368.90 Aligned_cols=250 Identities=23% Similarity=0.273 Sum_probs=200.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|++++.||+|+||+||+|+.. .+++.||||++... ......+.+.+|+.+++.++||||+++++++...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 135 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 135 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred cCCeEEEEEeecCCCeEEEEEEEC-----CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCc
Confidence 468999999999999999999864 45688999999754 2344566789999999999999999999999654
Q ss_pred ----CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 441 ----KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 441 ----~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...+|||||+++ +|.+.+. ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 136 ~~~~~~~~lv~E~~~~-~l~~~~~----------------------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp 192 (464)
T 3ttj_A 136 LEEFQDVYLVMELMDA-NLCQVIQ----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 192 (464)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHT----------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred cccCCeEEEEEeCCCC-CHHHHHh----------------------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 356999999976 5766664 2378999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||++.++.+||+|||+++..... .......+|..|+|||.+.+..++.++||||||+++|||++| .+||.+.+.
T Consensus 193 ~NIll~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g-~~pF~g~~~ 268 (464)
T 3ttj_A 193 SNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDY 268 (464)
T ss_dssp GGEEECTTSCEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS-SCSSCCSSH
T ss_pred HhEEEeCCCCEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhC-CCCCCCCCH
Confidence 9999999999999999999865322 122345678999999999999999999999999999999995 569998887
Q ss_pred HHHHHHHHcCCccC---------------------C---------CCC-----------CcHHHHHHHHHhhccCCCCCC
Q psy5539 597 EEVVKYIKEGNILQ---------------------A---------PDN-----------TPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 597 ~e~~~~i~~~~~~~---------------------~---------~~~-----------~~~~l~~li~~cl~~dP~~RP 635 (653)
.+.+..+....-.+ . +.. .++++.+|+.+||..||++||
T Consensus 269 ~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 348 (464)
T 3ttj_A 269 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 348 (464)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC
Confidence 66655543310000 0 000 146789999999999999999
Q ss_pred CHHHHHHHHH
Q psy5539 636 SFRTIYQTLW 645 (653)
Q Consensus 636 s~~eil~~L~ 645 (653)
|++|+++|+|
T Consensus 349 ta~e~L~Hp~ 358 (464)
T 3ttj_A 349 SVDDALQHPY 358 (464)
T ss_dssp CHHHHHTSTT
T ss_pred CHHHHhcChh
Confidence 9999999976
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=340.10 Aligned_cols=253 Identities=24% Similarity=0.349 Sum_probs=209.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV- 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~- 439 (653)
.....|.+.+.||+|+||.||+|... .++..||+|.++.. ......+.+.+|+.++++++||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 97 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEec-----CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccc
Confidence 33455889999999999999999864 35678999998754 244556789999999999999999999998864
Q ss_pred ---CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCC
Q psy5539 440 ---GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHRDL 514 (653)
Q Consensus 440 ---~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHrDL 514 (653)
+...++||||+++|+|.++++.. ..+++..++.++.||+.||.|||+++ |+||||
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~di 157 (290)
T 1t4h_A 98 VKGKKCIVLVTELMTSGTLKTYLKRF--------------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDL 157 (290)
T ss_dssp SSSCEEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCC
T ss_pred cCCCceEEEEEEecCCCCHHHHHHHc--------------------cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCC
Confidence 45689999999999999999732 35789999999999999999999999 999999
Q ss_pred CCCCEeEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 515 ATRNCLIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 515 kp~NILl~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
||+|||++ +++.+||+|||++...... ......+++.|+|||.+. +.++.++||||||+++|+|++|.. ||.+
T Consensus 158 kp~Nil~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~-pf~~ 231 (290)
T 1t4h_A 158 KCDNIFITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEY-PYSE 231 (290)
T ss_dssp CGGGEEESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSC-TTTT
T ss_pred CHHHEEEECCCCCEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCC-CCCC
Confidence 99999997 8899999999999654221 122345788999999876 569999999999999999999654 7766
Q ss_pred -CCHHHHHHHHHcCCc-cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 594 -LTHEEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 594 -~~~~e~~~~i~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
....++...+..+.. ...+...++++.+++.+||+.+|.+|||+++++++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~ 285 (290)
T 1t4h_A 232 CQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 285 (290)
T ss_dssp CSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred cCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence 455566666655433 2334567789999999999999999999999999876
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=370.13 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=219.2
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+..++|.+.+.||+|+||+||+|+.. .+++.||+|+++..... .....+.+|+.++++++||||+++++++.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~-----~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~ 255 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE 255 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 355678999999999999999999864 35689999999754221 22356889999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 256 ~~~~l~lVmE~~~gg~L~~~l~~~~----------------~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~N 319 (543)
T 3c4z_A 256 TKTDLCLVMTIMNGGDIRYHIYNVD----------------EDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPEN 319 (543)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTSS----------------TTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred eCCEEEEEEEeccCCCHHHHHHHhh----------------cccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHH
Confidence 9999999999999999999997321 123468999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC----
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL---- 594 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~---- 594 (653)
|||+.++.+||+|||+++.+.... .......+|+.|+|||.+.+..++.++||||||+++|||++|. +||.+.
T Consensus 320 ILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~-~PF~~~~~~~ 396 (543)
T 3c4z_A 320 VLLDDDGNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR-GPFRARGEKV 396 (543)
T ss_dssp EEECTTSCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS-CSSCCTTCCC
T ss_pred EEEeCCCCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCC-CCCCCCccch
Confidence 999999999999999998653222 1223347899999999999999999999999999999999954 588764
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCH-----HHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSF-----RTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~eil~~L~ 645 (653)
...++...+.... ...+..++.++.+|+++||+.||.+||++ ++|++|.|
T Consensus 397 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf 451 (543)
T 3c4z_A 397 ENKELKQRVLEQA-VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451 (543)
T ss_dssp CHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred hHHHHHHHHhhcc-cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence 4567777776654 35678899999999999999999999964 78888765
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=359.37 Aligned_cols=251 Identities=20% Similarity=0.320 Sum_probs=199.2
Q ss_pred CCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHh-hCCCCccceEEeEEec---
Q psy5539 365 NDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA-EFDHPNIVKLLGVCAV--- 439 (653)
Q Consensus 365 ~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~-~l~HpnIv~l~g~~~~--- 439 (653)
++|.+. +.||+|+||+||+|+.. .++..||||+++.. ..+.+|++++. ..+||||+++++++..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~-----~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~ 129 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 129 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred ccceeccceeeeccCeEEEEEEEC-----CCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeeccc
Confidence 356665 78999999999999864 45688999999642 24667888874 4589999999999865
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
....+|||||+++|+|.+++... ....+++..+..|+.||+.||.|||+++|+||||||+|
T Consensus 130 ~~~~~~lv~E~~~gg~L~~~l~~~------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 191 (400)
T 1nxk_A 130 GRKCLLIVMECLDGGELFSRIQDR------------------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 191 (400)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHCC---------------------CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CCcEEEEEEEeCCCCcHHHHHHHh------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcce
Confidence 56789999999999999999721 12358999999999999999999999999999999999
Q ss_pred EeEcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 519 CLIND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 519 ILl~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||++. ++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+..
T Consensus 192 ill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~ 267 (400)
T 1nxk_A 192 LLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY-PPFYSNH 267 (400)
T ss_dssp EEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSS-CSCCCCT
T ss_pred EEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCC-CCCCCCc
Confidence 99997 7899999999998653221 123456789999999999999999999999999999999955 5776654
Q ss_pred HH----HHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 596 HE----EVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 596 ~~----e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.. .+...+..+..... ...++.++.+||++||+.||++|||+.+|++|+|-..
T Consensus 268 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~ 327 (400)
T 1nxk_A 268 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 327 (400)
T ss_dssp TCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred cccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence 32 24455555544221 1468899999999999999999999999999988653
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=363.47 Aligned_cols=257 Identities=21% Similarity=0.345 Sum_probs=191.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec---
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--- 439 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--- 439 (653)
.++|++.+.||+|+||+||+|++. .+++.||||++... ......+.+.+|++++++++|||||++++++..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDK-----LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEEC-----C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEEC-----CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCc
Confidence 368999999999999999999864 35689999998653 233445678999999999999999999999843
Q ss_pred --CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 --GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
....++||||+. |+|.++++ ....+++..+..++.||+.||+|||+.+|+||||||+
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~--------------------~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~ 185 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFR--------------------TPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPA 185 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHH--------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGG
T ss_pred ccCceEEEEEeccc-cchhhhcc--------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChh
Confidence 357899999984 69999986 2345899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccc-------------------------cCCCCCCCccccccchhhc-cCCCCCch
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYY-------------------------KGDENDAIPVRWMPLESIL-YNKYTVES 571 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~-------------------------~~~~~~~~t~~y~aPE~~~-~~~~t~ks 571 (653)
||||+.++.+||+|||+++........ .......+|..|+|||.+. ...++.++
T Consensus 186 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~ 265 (458)
T 3rp9_A 186 NCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265 (458)
T ss_dssp GEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHH
T ss_pred hEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHh
Confidence 999999999999999999865322110 0122345688999999864 56799999
Q ss_pred hHHHHHHHHHHHHhC----------CCCCCCCCCH--------------------HHHHHHHHc--C-------------
Q psy5539 572 DVWAFGVCLWEIFSF----------ALQPYYGLTH--------------------EEVVKYIKE--G------------- 606 (653)
Q Consensus 572 DVwSlGvvl~ellt~----------~~~p~~~~~~--------------------~e~~~~i~~--~------------- 606 (653)
|||||||+||||++| +.++|.+.+. .+.+..+.+ |
T Consensus 266 DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~ 345 (458)
T 3rp9_A 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE 345 (458)
T ss_dssp HHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCH
T ss_pred HHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCH
Confidence 999999999999984 5566655431 111111110 0
Q ss_pred ---------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 607 ---------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 607 ---------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.........++++.+|+++||..||.+|||++|+++|.|-
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f 400 (458)
T 3rp9_A 346 DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFF 400 (458)
T ss_dssp HHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence 0011123468899999999999999999999999999863
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=367.73 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=212.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++++.||+|+||+||+|+.. .++..||||+++.... ......+.+|+.+++.++||||+++++++......
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDK-----VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEET-----TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cCeEEeeEEecCCCEEEEEEEEC-----CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 36999999999999999999864 3567899999875421 22245688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.
T Consensus 112 ~lv~e~~~~g~L~~~~~~~--------------------~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~ 171 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHR--------------------MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171 (494)
T ss_dssp EEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESC
T ss_pred EEEEecCCCCcHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeC
Confidence 9999999999999988622 35889999999999999999999999999999999999976
Q ss_pred ---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 ---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.+||+|||+++...... ......+|+.|+|||.+. ..++.++||||||+++|+|++| .+||.+.+..++.
T Consensus 172 ~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~ 246 (494)
T 3lij_A 172 KEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAG-YPPFGGQTDQEIL 246 (494)
T ss_dssp SSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred CCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Confidence 4569999999997653322 223456899999999876 5799999999999999999994 5699999999999
Q ss_pred HHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+...... ..+++++.+|+++||+.+|.+|||+.++++|+|-
T Consensus 247 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~ 295 (494)
T 3lij_A 247 RKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295 (494)
T ss_dssp HHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred HHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCccc
Confidence 999887654322 4688999999999999999999999999999874
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=350.85 Aligned_cols=255 Identities=24% Similarity=0.351 Sum_probs=204.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH----HHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE----YLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
.++|.+.+.||+|+||.||+|+.. .++..||||.++..... .....+.+|+.++++++||||+++++++..
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred hcccEEEeEEeecCCEEEEEEEEC-----CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 467899999999999999999863 35688999999753221 223468899999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++ +|.+++.. ....+++..+..++.|++.||+|||+++|+||||||+||
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 143 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKD-------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 143 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTT-------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCceEEEEEcCCC-CHHHHHHh-------------------cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence 9999999999986 89888862 224578889999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|++.++.+||+|||+++...... .......+|+.|+|||.+.+. .++.++||||||+++|||++ +.+||.+.+..+
T Consensus 144 l~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~-g~~~~~~~~~~~ 220 (346)
T 1ua2_A 144 LLDENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLD 220 (346)
T ss_dssp EECTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHH
T ss_pred EEcCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH-CCCCCCCCCHHH
Confidence 99999999999999997653222 222345678999999999765 58999999999999999999 567888888777
Q ss_pred HHHHHHcCCccC---------------------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQ---------------------------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 599 ~~~~i~~~~~~~---------------------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+....... .....+.++.+|+.+||+.||++|||+++++++.|-
T Consensus 221 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f 295 (346)
T 1ua2_A 221 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295 (346)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhh
Confidence 666554310000 013456899999999999999999999999998763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=342.22 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=210.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
...++|++.+.||+|+||.||+|+.. .++..||||.++.... .+.+.+|+.++++++||||+++++++...+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 97 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHK-----ETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNT 97 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEET-----TTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred cchhhhhhheeeccCCCeEEEEEEEC-----CCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence 34568999999999999999999864 3568899999975432 346889999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.. ....+++..++.++.||+.||.|||+.+++|+||||+|||+
T Consensus 98 ~~~lv~e~~~~~~L~~~~~~-------------------~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 98 DLWIVMEYCGAGSVSDIIRL-------------------RNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp EEEEEEECCTTEEHHHHHHH-------------------HTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEeecCCCCCHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 99999999999999999862 12458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||++....... .......++..|+|||.+.+..++.++||||||+++|||++|. .||.+....+...
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~~~~~ 235 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK-PPYADIHPMRAIF 235 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSS-CTTTTSCHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCC-CCCCCCChHHHHH
Confidence 999999999999997653221 2233456789999999999999999999999999999999954 5888877766666
Q ss_pred HHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+...... ..+..++..+.+++.+||+.||.+|||+.+++++.|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~ 282 (314)
T 3com_A 236 MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFV 282 (314)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred HHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHH
Confidence 55554322 2345578999999999999999999999999998764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=367.06 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=215.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||+||+|+.. .++..||||+++... .......+.+|++++++++||||+++++++......
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 96 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEET-----TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred cceEEeEEEeecCCEEEEEEEEC-----CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEE
Confidence 47899999999999999999864 356889999986431 112345788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN- 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~- 522 (653)
++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 97 ~lv~e~~~~~~L~~~~~~~--------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~ 156 (486)
T 3mwu_A 97 YIVGELYTGGELFDEIIKR--------------------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (486)
T ss_dssp EEEECCCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESS
T ss_pred EEEEEcCCCCcHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEec
Confidence 9999999999999988622 3588999999999999999999999999999999999995
Q ss_pred --CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
.++.+||+|||+++...... ......+|+.|+|||.+.+ .++.++||||||+++|+|++| .+||.+.+..++.
T Consensus 157 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~ 231 (486)
T 3mwu_A 157 KEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG-TPPFYGKNEYDIL 231 (486)
T ss_dssp SSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred CCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhC-CCCCCCCCHHHHH
Confidence 55689999999997653221 2234568999999999875 699999999999999999995 5699999999999
Q ss_pred HHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 601 ~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+..+..... ...+++++.+|+++||+.+|.+|||+.++++|+|--
T Consensus 232 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~ 281 (486)
T 3mwu_A 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQ 281 (486)
T ss_dssp HHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHH
T ss_pred HHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhc
Confidence 99988765322 235789999999999999999999999999998753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=350.08 Aligned_cols=255 Identities=24% Similarity=0.369 Sum_probs=207.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||++... ......+.+.+|+.++++++||||+++++++...+.
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNK-----DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEET-----TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhheeeeEEeecCCEEEEEEEEC-----CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 457999999999999999999864 35688999988644 334456678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++. ....+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 99 ~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~ 158 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLEL--------------------FPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158 (331)
T ss_dssp EEEEEECCSEEHHHHHHH--------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred EEEEEecCCcchHHHHHh--------------------hccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc
Confidence 999999999999988765 234589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
.++.+||+|||+++...... .......++..|+|||.+.+. .++.++||||||+++|||++|. +||.+.+..+...
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~~~~ 235 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE-PLFPGDSDIDQLY 235 (331)
T ss_dssp TTSCEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS-CSCCCSSHHHHHH
T ss_pred CCCcEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCC-CCCCCCCcHHHHH
Confidence 99999999999997653322 122345678899999999876 7899999999999999999965 6888877666554
Q ss_pred HHHcC--C------------------ccC----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEG--N------------------ILQ----------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~--~------------------~~~----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+... . ..+ ....+++++.+|+.+||+.||.+|||+++++++.|-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f 310 (331)
T 4aaa_A 236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310 (331)
T ss_dssp HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 43210 0 000 012568899999999999999999999999999874
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=352.86 Aligned_cols=262 Identities=16% Similarity=0.228 Sum_probs=202.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH----------HHHHHHHHHHHHhhCCCCcc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY----------LQTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~----------~~~~f~~Ei~il~~l~HpnI 430 (653)
.+..++|.+.+.||+|+||.||+|+... ....+..||||.+....... ....+.+|+.+++.++||||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTN--KPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGI 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESS--SCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecC--CCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCc
Confidence 3456789999999999999999999753 23366889999987543211 11246688899999999999
Q ss_pred ceEEeEEec----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh
Q psy5539 431 VKLLGVCAV----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD 506 (653)
Q Consensus 431 v~l~g~~~~----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~ 506 (653)
+++++++.. ....++||||+ +++|.+++.. ...+++.+++.++.||+.||+|||+
T Consensus 111 ~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 111 PLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--------------------NGTFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp CCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBG--------------------GGBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ceeecccccccCCCcEEEEEEecc-CCCHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 999999977 77899999999 9999999862 1258999999999999999999999
Q ss_pred CCceecCCCCCCEeEcCCC--cEEEeccCcccccccccccc-----CCCCCCCccccccchhhccCCCCCchhHHHHHHH
Q psy5539 507 RKFVHRDLATRNCLINDQM--VVKIADFGLSRKMYLQDYYK-----GDENDAIPVRWMPLESILYNKYTVESDVWAFGVC 579 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~--~vkI~DfGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvv 579 (653)
++|+||||||+|||++.++ .+||+|||+++.+....... ......+|..|+|||.+.+..++.++||||||++
T Consensus 170 ~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 249 (345)
T 2v62_A 170 NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249 (345)
T ss_dssp TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence 9999999999999999887 99999999998764332111 1134468899999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC--CHHHHHHHHHcCCccCCC---------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 580 LWEIFSFALQPYYGL--THEEVVKYIKEGNILQAP---------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 580 l~ellt~~~~p~~~~--~~~e~~~~i~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+|||++|. .||.+. +...+. ..........+ ..++.++.+++..||+.+|++||++++|++.|..+
T Consensus 250 l~ell~g~-~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 250 MLRWLCGK-LPWEQNLKDPVAVQ-TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp HHHHHHSS-CTTGGGTTCHHHHH-HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred HHHHHhCC-CCccccccccHHHH-HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 99999955 588542 222222 21111111111 27889999999999999999999999999998754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=350.25 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=215.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-------cHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-------SEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-------~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
++|.+.+.||+|+||.||+|++. .++..||||+++... .....+.+.+|+.+++++ +||||++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~-----~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHR-----ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhcccceEEecCCCEEEEEEEEC-----CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 57899999999999999999864 356889999986432 123356788999999999 79999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+......++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+|+||||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp 228 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE--------------------KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKP 228 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 9999999999999999999999962 23588999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC------CCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN------KYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
+|||+++++.+||+|||++..+.... ......+|+.|+|||.+.+. .++.++||||||+++|||++|. .|
T Consensus 229 ~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~-~p 304 (365)
T 2y7j_A 229 ENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS-PP 304 (365)
T ss_dssp GGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSS-CS
T ss_pred HHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCC-CC
Confidence 99999999999999999997654322 22345688999999998643 5889999999999999999954 58
Q ss_pred CCCCCHHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.+.+..+....+..+..... ....+..+.+++.+||+.||++|||+.+++++.|
T Consensus 305 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~ 362 (365)
T 2y7j_A 305 FWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPF 362 (365)
T ss_dssp SCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence 988888888888877654322 1467889999999999999999999999999876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=337.40 Aligned_cols=259 Identities=20% Similarity=0.318 Sum_probs=210.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE-ecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC-AVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~-~~~~~ 442 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||++..... ...+.+|+.+++.++|++++..+.++ ..++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~---~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEEESCSS---CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEc-----CCCcEEEEEEecCCcc---hhHHHHHHHHHHHhhcCCCCCccccccCCCCc
Confidence 468999999999999999999863 4568999999865432 23588999999999999877777665 56778
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE-
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI- 521 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl- 521 (653)
.++||||+ +++|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~ 139 (296)
T 3uzp_A 80 NVMVMELL-GPSLEDLFNFC-------------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred eEEEEEec-CCCHHHHHHhh-------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEe
Confidence 89999999 89999999622 2458999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 522 --NDQMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 522 --~~~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
++++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.
T Consensus 140 ~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~ 218 (296)
T 3uzp_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-LPWQGL 218 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-CTTSSC
T ss_pred cCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCC-CCCCCc
Confidence 58899999999999876433221 1224557889999999999999999999999999999999955 588763
Q ss_pred C---HHHHHHHHHcCC----ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 595 T---HEEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 595 ~---~~e~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
. ..+....+.... .......+++++.+++.+||+.+|.+|||+++|++.|..+..+.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 3 222333332221 11223678899999999999999999999999999999887664
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.79 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=209.9
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
..++|++.+.||+|+||.||+|+.. .++..||+|.+..... ...+.+.+|+.++++++||||+++++++...+.
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 90 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNK-----ETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK 90 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEET-----TTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred CccceeecceeccCCCeEEEEEEEc-----CCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence 3467999999999999999999874 3567899999875432 234578899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+++++|.+++... ...+++..++.++.||+.||.|||+.+++||||||+|||++
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~-------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~ 151 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLEL-------------------DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT 151 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHH-------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhh-------------------ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEC
Confidence 99999999999999998632 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
.++.+||+|||++....... .......++..|+|||.+. ...++.++||||||+++|||++|. .||...+..
T Consensus 152 ~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~-~p~~~~~~~ 228 (302)
T 2j7t_A 152 LEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE-PPHHELNPM 228 (302)
T ss_dssp TTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS-CTTTTSCHH
T ss_pred CCCCEEEEECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC-CCCccCCHH
Confidence 99999999999976432111 1223456789999999984 667899999999999999999954 588888887
Q ss_pred HHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+....+..+... ..+..++.++.+++.+||+.||.+|||+.+++++.|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 278 (302)
T 2j7t_A 229 RVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPF 278 (302)
T ss_dssp HHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred HHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChH
Confidence 777666655432 234568899999999999999999999999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=344.26 Aligned_cols=262 Identities=21% Similarity=0.364 Sum_probs=211.1
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEe
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLG 435 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g 435 (653)
+..+....++|++.+.||+|+||.||+|+.. .+++.||||++..... ..+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~ 88 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHV-----KTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYG 88 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEEC-----CCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeee
Confidence 4455667789999999999999999999864 3567899999865432 235688999999999 8999999999
Q ss_pred EEec------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 436 VCAV------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 436 ~~~~------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
++.. .+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+++|
T Consensus 89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 150 (326)
T 2x7f_A 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT------------------KGNTLKEEWIAYICREILRGLSHLHQHKV 150 (326)
T ss_dssp EEEECC--CCCCEEEEEEECCTTEEHHHHHHHS------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEeeccCccccceEEEEEEcCCCCcHHHHHHhc------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 9876 46789999999999999999732 12457899999999999999999999999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHH
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ell 584 (653)
+|+||||+|||+++++.+||+|||++....... .......++..|+|||.+. ...++.++||||||+++|||+
T Consensus 151 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~ 228 (326)
T 2x7f_A 151 IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMA 228 (326)
T ss_dssp CCCCCSGGGEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHH
T ss_pred cccCCcHHHEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHH
Confidence 999999999999999999999999997653221 1223346789999999987 567899999999999999999
Q ss_pred hCCCCCCCCCCHHHHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 585 SFALQPYYGLTHEEVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 585 t~~~~p~~~~~~~e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+|. .||.+....+....+...... ..+..++..+.+++.+||+.||.+||++++++++.|-
T Consensus 229 ~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~ 290 (326)
T 2x7f_A 229 EGA-PPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290 (326)
T ss_dssp HSS-CTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred hCC-CCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence 954 588888777666666554332 2345688999999999999999999999999998763
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=338.47 Aligned_cols=259 Identities=20% Similarity=0.310 Sum_probs=207.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE-ecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC-AVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~-~~~~~ 442 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||++.... ....+.+|+.+++.++|++++..++.+ ..++.
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~---~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~ 79 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKT---KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 79 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEC------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTE
T ss_pred CCceEEeeeecCCCCeEEEEEEEc-----CCCceEEEEeecccc---cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCc
Confidence 367999999999999999999863 356899999875432 223578999999999998888777666 56778
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE-
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI- 521 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl- 521 (653)
.++||||+ +|+|.+++... ...+++..++.++.||+.||+|||+++|+||||||+|||+
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~ 139 (296)
T 4hgt_A 80 NVMVMELL-GPSLEDLFNFC-------------------SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 139 (296)
T ss_dssp EEEEEECC-CCBHHHHHHHT-------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred eEEEEEcc-CCCHHHHHHHh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeee
Confidence 89999999 99999998622 2458999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 522 --NDQMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 522 --~~~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
++++.+||+|||+++........ .......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.
T Consensus 140 ~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~ 218 (296)
T 4hgt_A 140 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-LPWQGL 218 (296)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-CTTSSC
T ss_pred ccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCC-CCCccc
Confidence 78999999999999876433221 1233557899999999999999999999999999999999955 588764
Q ss_pred CHH---HHHHHHHcC----CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 595 THE---EVVKYIKEG----NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 595 ~~~---e~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+.. +....+... ........+++++.+++..||+.+|++|||+++|++.|..+.++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 219 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp CCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 321 222222221 111223567899999999999999999999999999999887764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=338.85 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=216.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--------cHHHHHHHHHHHHHHhhCC-CCccceEE
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--------SEYLQTDFEREACLLAEFD-HPNIVKLL 434 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--------~~~~~~~f~~Ei~il~~l~-HpnIv~l~ 434 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||.++... .....+.+.+|+++++++. ||||++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~ 90 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhccceeeeecCCCceEEEEEEEc-----CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 468999999999999999999864 356899999986432 1234567889999999996 99999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++..++..++||||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||
T Consensus 91 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 150 (298)
T 1phk_A 91 DTYETNTFFFLVFDLMKKGELFDYLTEK--------------------VTLSEKETRKIMRALLEVICALHKLNIVHRDL 150 (298)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred eeeccCCeEEEEEeccCCCcHHHHHhcc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 9999999999999999999999999732 35889999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc------cCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL------YNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~------~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
||+|||++.++.+||+|||++....... ......++..|+|||.+. ...++.++||||||+++|||++| .
T Consensus 151 ~p~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g-~ 226 (298)
T 1phk_A 151 KPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-S 226 (298)
T ss_dssp SGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS-S
T ss_pred CcceEEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC-C
Confidence 9999999999999999999997653222 223456788999999885 45689999999999999999995 4
Q ss_pred CCCCCCCHHHHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.||.+.+..+....+..+...... ..++..+.+++.+||+.||.+|||+.+++++.|
T Consensus 227 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (298)
T 1phk_A 227 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 286 (298)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChH
Confidence 688888888888888776543222 357899999999999999999999999998876
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=351.54 Aligned_cols=254 Identities=23% Similarity=0.277 Sum_probs=210.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
.++|++.+.||+|+||.||+|+.. .++..||||+++........+.+.+|++++++++||||+++++++...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDN-----LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEEC-----CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence 358999999999999999999863 456899999998666666667899999999999999999999998654
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++||||++ |+|.++++. ..+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 101 ~~~~~~iv~e~~~-~~L~~~l~~---------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 158 (364)
T 3qyz_A 101 QMKDVYIVQDLME-TDLYKLLKT---------------------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSN 158 (364)
T ss_dssp TCCCEEEEEECCS-EEHHHHHHH---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred ccceEEEEEcccC-cCHHHHHHh---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHh
Confidence 46899999997 599998862 348899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccccc-CCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYK-GDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
||++.++.+||+|||+++......... ......+|+.|+|||.+.+. .++.++||||||+++|||++|. +||.+.+.
T Consensus 159 Il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~ 237 (364)
T 3qyz_A 159 LLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHY 237 (364)
T ss_dssp EEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSS-CSSCCSSG
T ss_pred EEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCC-CCCCCCCh
Confidence 999999999999999998654332211 12345789999999987654 5899999999999999999954 68988776
Q ss_pred HHHHHHHHcC--Cc----------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEG--NI----------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~--~~----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+....+... .. .......+.++.+|+.+||+.||.+|||++++++|.|
T Consensus 238 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 316 (364)
T 3qyz_A 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 316 (364)
T ss_dssp GGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 6555444320 00 0012456889999999999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=354.41 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=205.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-------HHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-------EYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-------~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
++|++.+.||+|+||.||+|+.. .++..||||+++.... ....+.+.+|+.++++++||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDK-----EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEET-----TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEEC-----CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 57899999999999999999864 4578999999875421 11233577899999999999999999999
Q ss_pred ecCCceEEEEeecCCC-ChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 438 AVGKPMCLLFEYMGRG-DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~g-sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...+..++||||+.+| +|.++++ ....+++..++.|+.||+.||.|||+++|+||||||
T Consensus 99 ~~~~~~~lv~e~~~~g~~l~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 158 (335)
T 3dls_A 99 ENQGFFQLVMEKHGSGLDLFAFID--------------------RHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKD 158 (335)
T ss_dssp ECSSEEEEEEECCTTSCBHHHHHH--------------------TCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeCCEEEEEEEeCCCCccHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCH
Confidence 9999999999999777 9999986 234589999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||+++++.+||+|||+++...... ......+|+.|+|||.+.+..+ +.++||||||+++|||++|. .||....
T Consensus 159 ~NIll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~ 234 (335)
T 3dls_A 159 ENIVIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE-NPFCELE 234 (335)
T ss_dssp GGEEECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSS-CSCSSGG
T ss_pred HHEEEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCC-CchhhHH
Confidence 99999999999999999997653222 1223457899999999998877 78999999999999999965 4776532
Q ss_pred HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
. . .......+..++.++.+|+.+||+.||.+|||+++++++.|
T Consensus 235 ~------~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~ 277 (335)
T 3dls_A 235 E------T-VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277 (335)
T ss_dssp G------G-TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTT
T ss_pred H------H-HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 1 1 11223456678999999999999999999999999999876
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-40 Score=344.58 Aligned_cols=256 Identities=25% Similarity=0.415 Sum_probs=201.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh--CCCCccceEEeEEecC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE--FDHPNIVKLLGVCAVG- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~~- 440 (653)
.++|++.+.||+|+||.||+|+.. +..||||++..... ..+.+|.+++.. ++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~-------~~~vavK~~~~~~~----~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR-------GEKVAVKVFFTTEE----ASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEEEGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred ccceEEEeEeecCCCeEEEEEEEC-------CceEEEEEEecccc----chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 457999999999999999999863 47899999865432 233445555544 4999999999999876
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC--------Cc
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR--------KF 509 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~--------~i 509 (653)
...++||||+++|+|.++++. ..+++..++.++.|++.||.|||++ +|
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 163 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKS---------------------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAI 163 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCE
T ss_pred CCCCceEEEEeccCCCcHHHHhhc---------------------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCE
Confidence 678999999999999999962 2478999999999999999999998 99
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccCCCCCc------hhHHHHHHHHH
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNKYTVE------SDVWAFGVCLW 581 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~t~k------sDVwSlGvvl~ 581 (653)
+||||||+|||++.++.+||+|||+++......... ......+|+.|+|||.+.+...+.+ +||||||+++|
T Consensus 164 vH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 243 (337)
T 3mdy_A 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILW 243 (337)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHH
T ss_pred EecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHH
Confidence 999999999999999999999999997654332211 1224568999999999988877765 99999999999
Q ss_pred HHHhCC---------CCCCCCC-----CHHHHHHHHHcCCc-cCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 582 EIFSFA---------LQPYYGL-----THEEVVKYIKEGNI-LQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 582 ellt~~---------~~p~~~~-----~~~e~~~~i~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
||++|. ..||... ...++...+..... ...+ +.+++++.+|+.+||+.||.+|||+.+|+
T Consensus 244 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell 323 (337)
T 3mdy_A 244 EVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323 (337)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence 999973 3456442 22333333332222 1222 24567899999999999999999999999
Q ss_pred HHHHHHHHHh
Q psy5539 642 QTLWNIKRDL 651 (653)
Q Consensus 642 ~~L~~l~~~l 651 (653)
++|..+.++.
T Consensus 324 ~~L~~l~~~~ 333 (337)
T 3mdy_A 324 KTLAKMSESQ 333 (337)
T ss_dssp HHHHHHHHTT
T ss_pred HHHHHHHhhc
Confidence 9999998764
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=356.94 Aligned_cols=256 Identities=22% Similarity=0.349 Sum_probs=202.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|.+.+.||+|+||.||+|+.. .++..||||+++.. ......+.+.+|+.++++++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDK-----NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEEC-----CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCC
Confidence 468999999999999999999864 45789999999754 2334456789999999999999999999998765
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...++||||++ |+|.++++ ....+++..+..++.||+.||+|||+.+|+||||||+
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~--------------------~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~ 158 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFK--------------------TPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPA 158 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHH--------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred CcCCeEEEEEecCC-cCHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 57899999986 59999986 2345899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccc--------------------cCCCCCCCccccccchhh-ccCCCCCchhHHHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYY--------------------KGDENDAIPVRWMPLESI-LYNKYTVESDVWAF 576 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~--------------------~~~~~~~~t~~y~aPE~~-~~~~~t~ksDVwSl 576 (653)
||||+.++.+||+|||+++........ .......+|..|+|||.+ ....++.++|||||
T Consensus 159 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSl 238 (432)
T 3n9x_A 159 NCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238 (432)
T ss_dssp GEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchH
Confidence 999999999999999999876432211 112445678999999986 45679999999999
Q ss_pred HHHHHHHHh----------CCCCCCCCCCH-----------------------------------------HHHHHHHHc
Q psy5539 577 GVCLWEIFS----------FALQPYYGLTH-----------------------------------------EEVVKYIKE 605 (653)
Q Consensus 577 Gvvl~ellt----------~~~~p~~~~~~-----------------------------------------~e~~~~i~~ 605 (653)
||++|||++ ++.++|.+.+. .+....+..
T Consensus 239 G~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~ 318 (432)
T 3n9x_A 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKL 318 (432)
T ss_dssp HHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHT
T ss_pred HHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHh
Confidence 999999996 35556655431 111122221
Q ss_pred CCccC------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 606 GNILQ------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 606 ~~~~~------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..... .....++++.+|+++||..||.+|||++++++|+|
T Consensus 319 ~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 364 (432)
T 3n9x_A 319 FPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364 (432)
T ss_dssp SCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGG
T ss_pred CCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChh
Confidence 11100 01357899999999999999999999999999876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=354.88 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=213.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
+..++|++.+.||+|+||.||+|+... ...+++.||||+++... .....+.+.+|+++++++ +||||+++++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECS--STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcc--cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 345789999999999999999998742 23467899999987532 112234577899999999 699999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..++||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~ 188 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQR--------------------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 188 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHH--------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred eeCceEEEEeecCCCCCHHHHHHHc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 9999999999999999999999732 35789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCC-
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGL- 594 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~- 594 (653)
|||++.++.+||+|||+++....... .......+|+.|+|||.+.+. .++.++||||||+++|||++|. .||...
T Consensus 189 NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~-~pf~~~~ 266 (355)
T 1vzo_A 189 NILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-SPFTVDG 266 (355)
T ss_dssp GEEECTTSCEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS-CTTSCTT
T ss_pred HEEECCCCcEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCC-CCCccCC
Confidence 99999999999999999976532221 122334678999999999863 4789999999999999999955 577532
Q ss_pred ---CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHHH
Q psy5539 595 ---THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLWN 646 (653)
Q Consensus 595 ---~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~~ 646 (653)
...++...+.... ...+..++..+.+|+.+||+.||.+|| +++++++++|-
T Consensus 267 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 267 EKNSQAEISRRILKSE-PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp SCCCHHHHHHHHHHCC-CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred ccchHHHHHHHHhccC-CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 3455555555543 456678899999999999999999999 99999998864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=368.41 Aligned_cols=254 Identities=27% Similarity=0.377 Sum_probs=217.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||.||+|+.. .++..||||++.... .....+.+.+|+.++++++||||+++++++...+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDK-----ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred cCceEEeeEEecCCCEEEEEEEEC-----CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 357899999999999999999864 356889999985432 1223467899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+.+|+|.+++. ....+++..+..++.||+.||.|||+++|+||||||+|||+
T Consensus 100 ~~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 159 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEII--------------------SRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159 (484)
T ss_dssp EEEEEECCCCSCBHHHHHH--------------------TCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEEEEEecCCCCCHHHHHH--------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 9999999999999999986 22458999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 522 ---NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 522 ---~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
+.++.+||+|||+++...... ......+|+.|+|||.+.+ .++.++||||||+++|+|++| .+||.+.+..+
T Consensus 160 ~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~ 234 (484)
T 3nyv_A 160 ESKSKDANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSG-CPPFNGANEYD 234 (484)
T ss_dssp SSSSTTCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHH
T ss_pred ecCCCCCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHC-CCCCCCCCHHH
Confidence 567899999999997653222 1123457899999999875 799999999999999999994 56999999999
Q ss_pred HHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+...+..+..... ...+++++.+|+++||+.+|.+|||+.++++|+|--
T Consensus 235 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~ 286 (484)
T 3nyv_A 235 ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQ 286 (484)
T ss_dssp HHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred HHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence 9999988765322 245789999999999999999999999999998853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=351.85 Aligned_cols=251 Identities=22% Similarity=0.258 Sum_probs=200.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
.++|++.+.||+|+||.||+|+.. .++..||||+++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 98 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDA-----ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKS 98 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCS
T ss_pred hhheeEeeeeEecCCEEEEEEEEC-----CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccc
Confidence 368999999999999999999863 35688999998753 33445567899999999999999999999997654
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
..++||||+++ +|.+++. ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 99 ~~~~~~~~lv~e~~~~-~l~~~~~----------------------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp 155 (371)
T 2xrw_A 99 LEEFQDVYIVMELMDA-NLCQVIQ----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKP 155 (371)
T ss_dssp TTTCCEEEEEEECCSE-EHHHHHH----------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cccccceEEEEEcCCC-CHHHHHh----------------------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCH
Confidence 68999999974 7888875 2478899999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+|||++.++.+||+|||+++...... ......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.+.
T Consensus 156 ~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~~ 231 (371)
T 2xrw_A 156 SNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-VLFPGTDH 231 (371)
T ss_dssp GGEEECTTSCEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS-CSSCCSSH
T ss_pred HHEEEcCCCCEEEEEeeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCC-CCCCCCCH
Confidence 99999999999999999997653211 123456788999999999999999999999999999999955 58988887
Q ss_pred HHHHHHHHcCCccCC-----------------------------------CC------CCcHHHHHHHHHhhccCCCCCC
Q psy5539 597 EEVVKYIKEGNILQA-----------------------------------PD------NTPDALYDLMKLCWNMKPMNRP 635 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~-----------------------------------~~------~~~~~l~~li~~cl~~dP~~RP 635 (653)
.+....+......+. +. ..+.++.+|+.+||..||++||
T Consensus 232 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~ 311 (371)
T 2xrw_A 232 IDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311 (371)
T ss_dssp HHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC
Confidence 776666544211110 00 0146789999999999999999
Q ss_pred CHHHHHHHHHH
Q psy5539 636 SFRTIYQTLWN 646 (653)
Q Consensus 636 s~~eil~~L~~ 646 (653)
|++++++|.|-
T Consensus 312 t~~e~l~hp~~ 322 (371)
T 2xrw_A 312 SVDEALQHPYI 322 (371)
T ss_dssp CHHHHHHSHHH
T ss_pred CHHHHhCCcch
Confidence 99999999874
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=351.01 Aligned_cols=267 Identities=22% Similarity=0.341 Sum_probs=217.5
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
..+...++..++|++.+.||+|+||.||+|+..+ .||+|.++... .....+.+.+|+.++++++||||+++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--------EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--------SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC--------eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEE
Confidence 4566778899999999999999999999998742 38999987432 12223457889999999999999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecC
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRD 513 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrD 513 (653)
++++...+..++||||+++++|.++++. ....+++..++.++.||+.||+|||+++|+|||
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~d 155 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRD-------------------AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKD 155 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTS-------------------SCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Confidence 9999999999999999999999999861 224588999999999999999999999999999
Q ss_pred CCCCCEeEcCCCcEEEeccCcccccccccc---ccCCCCCCCccccccchhhcc---------CCCCCchhHHHHHHHHH
Q psy5539 514 LATRNCLINDQMVVKIADFGLSRKMYLQDY---YKGDENDAIPVRWMPLESILY---------NKYTVESDVWAFGVCLW 581 (653)
Q Consensus 514 Lkp~NILl~~~~~vkI~DfGla~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~---------~~~t~ksDVwSlGvvl~ 581 (653)
|||+|||++ ++.+||+|||+++....... ........++..|+|||.+.. ..++.++||||||+++|
T Consensus 156 lkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 234 (319)
T 2y4i_B 156 LKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234 (319)
T ss_dssp CCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHH
T ss_pred CChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHH
Confidence 999999998 67999999999875422111 112233457889999999874 45789999999999999
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 582 EIFSFALQPYYGLTHEEVVKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 582 ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
||++|. .||.+....++...+..+...... ..++.++.+++.+||+.+|.+|||++++++.|..+.++
T Consensus 235 el~~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 235 ELHARE-WPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHHHSS-CSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred HHHhCC-CCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 999955 599999988888888777654433 35788999999999999999999999999999877654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-40 Score=351.02 Aligned_cols=267 Identities=14% Similarity=0.168 Sum_probs=209.0
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC---CCccceEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD---HPNIVKLL 434 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~ 434 (653)
..+++..++|.+.+.||+|+||+||+|..........++.||||+++... ..++.+|++++.+++ |+||++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 44567788999999999999999999975433345667899999998653 235778888888887 99999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++...+..+|||||+++|+|.++++.... .....+++..++.|+.||+.||+|||+++|+||||
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDi 198 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKN---------------TPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDI 198 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHT---------------STTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhc---------------ccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCC
Confidence 999999999999999999999999974321 12356899999999999999999999999999999
Q ss_pred CCCCEeEcC-----------CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHH
Q psy5539 515 ATRNCLIND-----------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583 (653)
Q Consensus 515 kp~NILl~~-----------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~el 583 (653)
||+||||+. ++.+||+|||+++.+.............+|..|||||.+.+..++.++||||||+++|||
T Consensus 199 Kp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 278 (365)
T 3e7e_A 199 KPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCM 278 (365)
T ss_dssp SGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHH
T ss_pred CHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHH
Confidence 999999998 899999999999765322222233456789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHHHH
Q psy5539 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNR-PSFRTIYQTLWNIKR 649 (653)
Q Consensus 584 lt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~eil~~L~~l~~ 649 (653)
++|.. ||........ ...... .....++.+.+++..|++.+|.+| |+++++.+.|..+..
T Consensus 279 ltg~~-pf~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 279 LFGTY-MKVKNEGGEC----KPEGLF-RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp HHSSC-CCEEEETTEE----EECSCC-TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred HhCCC-ccccCCCCce----eechhc-cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 99665 5543221100 000011 111346788999999999999998 678888877776644
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.90 Aligned_cols=268 Identities=19% Similarity=0.321 Sum_probs=211.0
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
.+.+..++|++.+.||+|+||.||+|+.. .+++.||||++... .....+.+.+|+++++.++||||+++++++.
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGL-----HDGHFYALKRILCH-EQQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEET-----TTCCEEEEEEEEES-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEec-----CCCcEEEEEEEecC-CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34567788999999999999999999863 35689999998653 3345667999999999999999999999986
Q ss_pred ----cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 439 ----VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 439 ----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
.....++||||+++|+|.+++.... .....+++..++.++.||+.||+|||+++|+||||
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dl 160 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLK----------------DKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHH----------------TTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHH----------------hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 3457899999999999999997432 12356899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCcccccccccccc-------CCCCCCCccccccchhhccCC---CCCchhHHHHHHHHHHHH
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYK-------GDENDAIPVRWMPLESILYNK---YTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~---~t~ksDVwSlGvvl~ell 584 (653)
||+|||++.++.+||+|||++.......... ......+++.|+|||.+.+.. ++.++||||||+++|||+
T Consensus 161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 9999999999999999999987542111000 001123578899999987554 789999999999999999
Q ss_pred hCCCCCCCCCC--HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 585 SFALQPYYGLT--HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 585 t~~~~p~~~~~--~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+|. .||.... ...+...+......+.+..++.++.+++.+||+.||.+|||+++++++|..+..
T Consensus 241 ~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 241 FGE-GPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp HSS-CTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred hCC-CChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 965 4774311 112233334433344456789999999999999999999999999999987754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=354.12 Aligned_cols=254 Identities=21% Similarity=0.271 Sum_probs=204.3
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
+...++|.+.+.||+|+||.||+|+.. .++..||||++..... ...+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~~~~~~~-----~~~~E~~il~~l~hpnIv~l~~~~~~~ 72 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDI-----ESGKRFALKKVLQDPR-----YKNRELDIMKVLDHVNIIKLVDYFYTT 72 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEET-----TTCCEEEEEEEECCTT-----SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred ccccceEEEEEEEEeccCEEEEEEEEC-----CCCCEEEEEEEecCcc-----hHHHHHHHHHHcCCCCccchhheeeec
Confidence 456778999999999999999999864 4568999999865422 235799999999999999999998432
Q ss_pred --------------------------------------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCC
Q psy5539 441 --------------------------------------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482 (653)
Q Consensus 441 --------------------------------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~ 482 (653)
...++||||++ |+|.+.++... ...
T Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----------------~~~ 135 (383)
T 3eb0_A 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFI----------------RSG 135 (383)
T ss_dssp -------------------------------------CCEEEEEECCCS-EEHHHHHHHHH----------------HTT
T ss_pred CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHH----------------hcC
Confidence 34889999998 58888886321 234
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchh
Q psy5539 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLES 561 (653)
Q Consensus 483 ~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~ 561 (653)
..+++..+..++.||+.||+|||+++|+||||||+|||++ +++.+||+|||+++...... ......+|..|+|||.
T Consensus 136 ~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~ 212 (383)
T 3eb0_A 136 RSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPEL 212 (383)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHH
Confidence 5689999999999999999999999999999999999998 68999999999998653222 2234567889999999
Q ss_pred hccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--C-----------------c---------cCCC
Q psy5539 562 ILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG--N-----------------I---------LQAP 612 (653)
Q Consensus 562 ~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~--~-----------------~---------~~~~ 612 (653)
+.+. .++.++||||||+++|||++| .+||.+.+..+.+..+... . . ...+
T Consensus 213 ~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (383)
T 3eb0_A 213 MLGATEYTPSIDLWSIGCVFGELILG-KPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILP 291 (383)
T ss_dssp HTTCSSCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSC
T ss_pred hcCCCCCCcchhhhhHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCC
Confidence 8875 489999999999999999995 4699888777665554320 0 0 0124
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 613 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...++++.+|+.+||+.+|.+|||+.++++|.|
T Consensus 292 ~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (383)
T 3eb0_A 292 EGTPSLAIDLLEQILRYEPDLRINPYEAMAHPF 324 (383)
T ss_dssp TTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhcCHH
Confidence 457889999999999999999999999999876
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=348.42 Aligned_cols=256 Identities=24% Similarity=0.379 Sum_probs=206.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
++|++.+.||+|+||.||+|+.. .+++.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEET-----TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cceeEEEEEecCCCcEEEEEEEC-----CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 57999999999999999999864 3568899999864422 2233467899999999999999999999876
Q ss_pred ----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 440 ----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 440 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++..++||||+++ +|.+.+.. ....+++.+++.++.||+.||+|||+++|+|||||
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 151 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSN-------------------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHC-------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred cccCCceEEEEEeccCC-CHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 4468999999975 88887751 22458999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccc--cCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYY--KGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|+|||++.++.+||+|||+++........ .......+|+.|+|||.+.+ ..++.++||||||+++|||++| .+||.
T Consensus 152 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~ 230 (351)
T 3mi9_A 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQ 230 (351)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS-SCSCC
T ss_pred HHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhC-CCCCC
Confidence 99999999999999999999865422211 12234567899999999876 4589999999999999999995 56898
Q ss_pred CCCHHHHHHHHHcCCccCCCC---C----------------------------CcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 593 GLTHEEVVKYIKEGNILQAPD---N----------------------------TPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~~~~~~~---~----------------------------~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
+.+..+....+........+. . .++.+.+|+.+||+.||.+|||+++++
T Consensus 231 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 310 (351)
T 3mi9_A 231 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310 (351)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHh
Confidence 888877766654311100000 0 256799999999999999999999999
Q ss_pred HHHHH
Q psy5539 642 QTLWN 646 (653)
Q Consensus 642 ~~L~~ 646 (653)
+|.|-
T Consensus 311 ~hp~f 315 (351)
T 3mi9_A 311 NHDFF 315 (351)
T ss_dssp TSGGG
T ss_pred CCCCc
Confidence 98764
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=360.04 Aligned_cols=252 Identities=23% Similarity=0.348 Sum_probs=199.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-------cHHHHHHHHHHHHHHhhCCCCccceEEeE
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-------SEYLQTDFEREACLLAEFDHPNIVKLLGV 436 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-------~~~~~~~f~~Ei~il~~l~HpnIv~l~g~ 436 (653)
.++|.+.+.||+|+||.||+|... .+++.||||++.... .......+.+|+.++++++||||++++++
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~ 208 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF 208 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEE
T ss_pred hccEEEEeEEeeCCCeEEEEEEEC-----CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 468999999999999999999864 356889999986432 11223358899999999999999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
+.. +..++||||+++|+|.+++. ....+++..+..++.||+.||+|||+++|+||||||
T Consensus 209 ~~~-~~~~lv~e~~~~g~L~~~l~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp 267 (419)
T 3i6u_A 209 FDA-EDYYIVLELMEGGELFDKVV--------------------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKP 267 (419)
T ss_dssp EES-SEEEEEEECCTTCBGGGGTS--------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred Eec-CceEEEEEcCCCCcHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCh
Confidence 754 45799999999999998874 234689999999999999999999999999999999
Q ss_pred CCEeEcCC---CcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 517 RNCLINDQ---MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 517 ~NILl~~~---~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
+|||++.+ +.+||+|||+++...... ......+|+.|+|||.+.. ..++.++||||||+++|||++|. +|
T Consensus 268 ~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~-~p 343 (419)
T 3i6u_A 268 ENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-PP 343 (419)
T ss_dssp GGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS-CS
T ss_pred HhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC-CC
Confidence 99999754 459999999998653221 2234567899999999863 67889999999999999999954 57
Q ss_pred CCCCCH-HHHHHHHHcCCccCCC---CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 591 YYGLTH-EEVVKYIKEGNILQAP---DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 591 ~~~~~~-~e~~~~i~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|.+... ..+.+.+..+.....+ ..+++.+.+|+.+||+.||.+|||++++++|.|
T Consensus 344 f~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~ 402 (419)
T 3i6u_A 344 FSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 402 (419)
T ss_dssp SCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcc
Confidence 765433 3455666666543322 467899999999999999999999999999986
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=363.71 Aligned_cols=253 Identities=15% Similarity=0.109 Sum_probs=197.4
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc--ccHHHHHHHHHHH---HHHhhCCCCccceEE--
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREA---CLLAEFDHPNIVKLL-- 434 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~--~~~~~~~~f~~Ei---~il~~l~HpnIv~l~-- 434 (653)
...++|.+.+.||+|+||.||+|+.. .+++.||||+++.. ......+.+.+|+ +++++++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CCCceEEEcceeecCCCEEEEEEEEC-----CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 34568999999999999999999853 35689999998642 2233456789999 556666899999998
Q ss_pred -----eEEecCC-----------------ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHH
Q psy5539 435 -----GVCAVGK-----------------PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492 (653)
Q Consensus 435 -----g~~~~~~-----------------~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 492 (653)
+++...+ ..+|||||+ +|+|.++++..... ......+++..++.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~-------------~~~~~~l~~~~~~~ 210 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSH-------------SSTHKSLVHHARLQ 210 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHT-------------TTTTHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccc-------------ccccccccHHHHHH
Confidence 6665543 378999999 68999999743210 01123355688899
Q ss_pred HHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-------
Q psy5539 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN------- 565 (653)
Q Consensus 493 i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~------- 565 (653)
|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.... ......+ +.|+|||.+.+.
T Consensus 211 i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~ 284 (377)
T 3byv_A 211 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHR 284 (377)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHH
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccc
Confidence 999999999999999999999999999999999999999999985321 1123345 889999999988
Q ss_pred ----CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 566 ----KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 566 ----~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
.++.++||||||+++|||++| ..||.+....+....+ ......+++++.+|+.+||+.||++|||+.+++
T Consensus 285 ~~~~~~~~~~DvwSlG~il~elltg-~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l 358 (377)
T 3byv_A 285 DRRTLMTFSFDAWALGLVIYWIWCA-DLPITKDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAM 358 (377)
T ss_dssp CCEEECCHHHHHHHHHHHHHHHHHS-SCCC------CCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHH
T ss_pred cccccCChhhhHHHHHHHHHHHHHC-CCCCcccccccchhhh-----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHh
Confidence 899999999999999999994 5688765544333222 223467899999999999999999999999999
Q ss_pred HHHH
Q psy5539 642 QTLW 645 (653)
Q Consensus 642 ~~L~ 645 (653)
++.|
T Consensus 359 ~hp~ 362 (377)
T 3byv_A 359 ETPE 362 (377)
T ss_dssp TSHH
T ss_pred hChH
Confidence 8876
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-40 Score=346.02 Aligned_cols=255 Identities=26% Similarity=0.415 Sum_probs=207.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhh--CCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE--FDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~--l~HpnIv~l~g~~~~~~ 441 (653)
.++|.+.+.||+|+||.||+|+.. ++.||||.++... ...+.+|++++.. ++||||+++++++....
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET-------TEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc-------CccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 457899999999999999999863 4789999997543 2456788888887 79999999999998765
Q ss_pred ----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh--------hCCc
Q psy5539 442 ----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS--------DRKF 509 (653)
Q Consensus 442 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--------~~~i 509 (653)
..++||||+++|+|.++++. ..+++..++.++.|++.||.||| +.+|
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~---------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 168 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR---------------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 168 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred CccceeEEEEeecCCCcHHHHHhc---------------------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCe
Confidence 78999999999999999962 24789999999999999999999 8999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccCC------CCCchhHHHHHHHHH
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNK------YTVESDVWAFGVCLW 581 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~t~ksDVwSlGvvl~ 581 (653)
+||||||+|||+++++.+||+|||++.......... ......++..|+|||.+.+.. ++.++||||||+++|
T Consensus 169 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ 248 (342)
T 1b6c_B 169 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248 (342)
T ss_dssp ECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred eeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHH
Confidence 999999999999999999999999997654332111 234456889999999988763 347899999999999
Q ss_pred HHHhCC---------CCCCCCC-----CHHHHHHHHHcCCcc-CCCC-----CCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 582 EIFSFA---------LQPYYGL-----THEEVVKYIKEGNIL-QAPD-----NTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 582 ellt~~---------~~p~~~~-----~~~e~~~~i~~~~~~-~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
||++|. ..||... ..+++...+...... ..+. ..+..+.+|+.+||+.+|++|||+++|+
T Consensus 249 el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~ 328 (342)
T 1b6c_B 249 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328 (342)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHH
Confidence 999973 4577654 344555555443322 2222 2346899999999999999999999999
Q ss_pred HHHHHHHHH
Q psy5539 642 QTLWNIKRD 650 (653)
Q Consensus 642 ~~L~~l~~~ 650 (653)
++|..+.++
T Consensus 329 ~~L~~i~~~ 337 (342)
T 1b6c_B 329 KTLSQLSQQ 337 (342)
T ss_dssp HHHHHHHHT
T ss_pred HHHHHHHHH
Confidence 999998765
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.38 Aligned_cols=256 Identities=23% Similarity=0.350 Sum_probs=212.0
Q ss_pred CCCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCC-CCccceEEeEEecC
Q psy5539 364 RNDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFD-HPNIVKLLGVCAVG 440 (653)
Q Consensus 364 ~~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~ 440 (653)
.+.|.+. +.||+|+||.||+|+.. .+++.||||+++.... ......+.+|+.++..++ ||||+++++++...
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISK-----STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred hhEEeeccceeCCCCCeEEEEEEEC-----CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 3456666 88999999999999864 3568999999875422 223457889999999995 69999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.. .....+++..++.++.||+.||+|||+++|+||||||+|||
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~------------------~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl 163 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLP------------------ELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSS------------------CC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred CeEEEEEEecCCCcHHHHHHH------------------hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEE
Confidence 999999999999999998741 12356899999999999999999999999999999999999
Q ss_pred EcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 IND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++. ++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+.+..
T Consensus 164 ~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~ 239 (327)
T 3lm5_A 164 LSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHT-SPFVGEDNQ 239 (327)
T ss_dssp ESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS-CSSCCSSHH
T ss_pred EecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCch
Confidence 987 7899999999998653221 123356889999999999999999999999999999999955 599888888
Q ss_pred HHHHHHHcCCcc---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 598 e~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
+....+...... .....++..+.+|+.+||+.||.+|||+++++++.|-
T Consensus 240 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~ 291 (327)
T 3lm5_A 240 ETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWL 291 (327)
T ss_dssp HHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred HHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence 887777665432 2234688999999999999999999999999998763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=347.09 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=208.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
.++|.+.+.||+|+||.||+|+.. .++..||||.++..........+.+|+.++++++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHK-----PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred ccceEEeeEEcCCCCeEEEEEEEC-----CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 468999999999999999999864 356899999998666666677889999999999999999999987653
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
...++||||+. |+|.+++.. ..+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~---------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 142 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVIST---------------------QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSN 142 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHH---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ccceEEEEEeccC-ccHHHHHhh---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 67899999997 699998861 358899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCcccccccccccc--------CCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYK--------GDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~--------~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
||++.++.+||+|||+++......... ......+|..|+|||.+.. ..++.++||||||+++|||++| .+
T Consensus 143 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g-~~ 221 (353)
T 2b9h_A 143 LLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP 221 (353)
T ss_dssp EEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHS-SC
T ss_pred eEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhC-CC
Confidence 999999999999999998654221111 1123467899999998765 6789999999999999999995 56
Q ss_pred CCCCCCHHHHHHHHHc--CC---------------------cc--------CCCCCCcHHHHHHHHHhhccCCCCCCCHH
Q psy5539 590 PYYGLTHEEVVKYIKE--GN---------------------IL--------QAPDNTPDALYDLMKLCWNMKPMNRPSFR 638 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~--~~---------------------~~--------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 638 (653)
||.+.+..+....+.. +. .. .....+++++.+|+.+||+.||++|||++
T Consensus 222 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 301 (353)
T 2b9h_A 222 IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAK 301 (353)
T ss_dssp SCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHH
Confidence 8888776554443321 00 00 01135788999999999999999999999
Q ss_pred HHHHHHHH
Q psy5539 639 TIYQTLWN 646 (653)
Q Consensus 639 eil~~L~~ 646 (653)
++++|.|-
T Consensus 302 ell~hp~~ 309 (353)
T 2b9h_A 302 EALEHPYL 309 (353)
T ss_dssp HHHTSGGG
T ss_pred HHhcCccc
Confidence 99998763
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=357.24 Aligned_cols=262 Identities=21% Similarity=0.261 Sum_probs=212.2
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
...++|.+.+.||+|+||+||+|++. .+++.||||+++........+.+.+|++++++++||||+++++++...+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 80 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHK-----KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT 80 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEEC-----CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC
Confidence 34567999999999999999999874 3568999999986544444567889999999999999999999987654
Q ss_pred --ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 442 --PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 442 --~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++||||+++|+|.++++... ....+++..++.++.||+.||+|||+++|+||||||+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 81 TRHKVLIMEFCPCGSLYTVLEEPS-----------------NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp TCCEEEEECCCTTEEHHHHTTSGG-----------------GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CCeeEEEEecCCCCCHHHHHHhhh-----------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 7799999999999999986221 123489999999999999999999999999999999999
Q ss_pred eE----cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc--------CCCCCchhHHHHHHHHHHHHhCC
Q psy5539 520 LI----NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY--------NKYTVESDVWAFGVCLWEIFSFA 587 (653)
Q Consensus 520 Ll----~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--------~~~t~ksDVwSlGvvl~ellt~~ 587 (653)
|+ +.++.+||+|||+++...... ......+|..|+|||.+.+ ..++.++||||||+++|||++|.
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~ 220 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred EEeecCCCceeEEEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCC
Confidence 99 788899999999998654332 1234568899999999875 56788999999999999999955
Q ss_pred CCCCCC----CCHHHHHHHHHcCCccCC------------------------CCCCcHHHHHHHHHhhccCCCCCCCHHH
Q psy5539 588 LQPYYG----LTHEEVVKYIKEGNILQA------------------------PDNTPDALYDLMKLCWNMKPMNRPSFRT 639 (653)
Q Consensus 588 ~~p~~~----~~~~e~~~~i~~~~~~~~------------------------~~~~~~~l~~li~~cl~~dP~~RPs~~e 639 (653)
.||.. ....+++..+..+..... +...+..+.+++++||+.||++||++++
T Consensus 221 -~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e 299 (396)
T 4eut_A 221 -LPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299 (396)
T ss_dssp -CSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHH
T ss_pred -CCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHH
Confidence 47753 233455655555432211 1124467889999999999999999999
Q ss_pred HHHHHHHHHH
Q psy5539 640 IYQTLWNIKR 649 (653)
Q Consensus 640 il~~L~~l~~ 649 (653)
+++.+.++..
T Consensus 300 ~l~~l~~il~ 309 (396)
T 4eut_A 300 FFAETSDILH 309 (396)
T ss_dssp HHHHHHHHHT
T ss_pred HHHHHHHHhh
Confidence 9999988764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=348.44 Aligned_cols=263 Identities=13% Similarity=0.200 Sum_probs=208.7
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCC---CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccce-------
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLK---HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVK------- 432 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~---~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~------- 432 (653)
..++|.+.+.||+|+||.||+|+...... ...+..||||.++.. +.+.+|++++++++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 35789999999999999999999753111 013678999998754 35789999999999999998
Q ss_pred --------EEeEEec-CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHH
Q psy5539 433 --------LLGVCAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVY 503 (653)
Q Consensus 433 --------l~g~~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~y 503 (653)
+++++.. +...++||||+ +|+|.+++... ....+++.+++.++.||+.||+|
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~------------------~~~~l~~~~~~~i~~qi~~~L~~ 174 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS------------------PKHVLSERSVLQVACRLLDALEF 174 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS------------------GGGCCCHHHHHHHHHHHHHHHHH
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC------------------CcCCCCHHHHHHHHHHHHHHHHH
Confidence 5677765 77889999999 99999999732 12458999999999999999999
Q ss_pred hhhCCceecCCCCCCEeEcCCC--cEEEeccCcccccccccccc-----CCCCCCCccccccchhhccCCCCCchhHHHH
Q psy5539 504 LSDRKFVHRDLATRNCLINDQM--VVKIADFGLSRKMYLQDYYK-----GDENDAIPVRWMPLESILYNKYTVESDVWAF 576 (653)
Q Consensus 504 LH~~~ivHrDLkp~NILl~~~~--~vkI~DfGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSl 576 (653)
||+++|+||||||+|||++.++ .+||+|||+++......... ......+|+.|+|||.+.+..++.++|||||
T Consensus 175 LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 254 (352)
T 2jii_A 175 LHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSL 254 (352)
T ss_dssp HHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHH
Confidence 9999999999999999999998 99999999998664332211 1133468899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC--CHHHHHHHHHc--CCccCCC------CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 577 GVCLWEIFSFALQPYYGL--THEEVVKYIKE--GNILQAP------DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 577 Gvvl~ellt~~~~p~~~~--~~~e~~~~i~~--~~~~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
|+++|||++|. .||.+. ....+...... ....... ..++.++.+|+.+||+.||++|||+++|++.|..
T Consensus 255 G~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~ 333 (352)
T 2jii_A 255 GYCMLKWLYGF-LPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA 333 (352)
T ss_dssp HHHHHHHHHSC-CTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHHHHHHHhCC-CCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence 99999999955 588765 33333333221 1111111 2468999999999999999999999999999999
Q ss_pred HHHHh
Q psy5539 647 IKRDL 651 (653)
Q Consensus 647 l~~~l 651 (653)
+.++.
T Consensus 334 ~~~~~ 338 (352)
T 2jii_A 334 LLQDL 338 (352)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 88764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=355.56 Aligned_cols=253 Identities=20% Similarity=0.291 Sum_probs=209.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC------CCCccceEEe
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF------DHPNIVKLLG 435 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l------~HpnIv~l~g 435 (653)
....+|++.+.||+|+||.||+|+.. .++..||||+++.. ......+.+|+++++.+ +|+||+++++
T Consensus 94 ~~~~ry~~~~~LG~G~fg~V~~a~~~-----~~~~~vAvK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~ 166 (429)
T 3kvw_A 94 HVAYRYEVLKVIGKGSFGQVVKAYDH-----KVHQHVALKMVRNE--KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE 166 (429)
T ss_dssp EETTTEEEEEEEEESSSEEEEEEEET-----TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred cccCcEEEEEEcccCccEEEEEEEEC-----CCCcEEEEEEECCc--cchHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence 34567999999999999999999864 35689999999754 33455678888888887 5779999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++......++||||+. ++|.+++... ....+++..++.++.||+.||+|||+++|+|||||
T Consensus 167 ~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 227 (429)
T 3kvw_A 167 NFTFRNHICMTFELLS-MNLYELIKKN------------------KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLK 227 (429)
T ss_dssp EEEETTEEEEEECCCC-CBHHHHHHHT------------------TTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCS
T ss_pred ecccCCeEEEEEeccC-CCHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 9999999999999996 6999998732 22458999999999999999999999999999999
Q ss_pred CCCEeEcCCCc--EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q psy5539 516 TRNCLINDQMV--VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593 (653)
Q Consensus 516 p~NILl~~~~~--vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~ 593 (653)
|+||||+.++. +||+|||+++.... ......+|+.|+|||.+.+..++.++||||||+++|||++| .+||.+
T Consensus 228 p~NILl~~~~~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG-~~pf~~ 301 (429)
T 3kvw_A 228 PENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPG 301 (429)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHS-SCSSCC
T ss_pred HHHeEEccCCCcceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhC-CCCCCC
Confidence 99999999987 99999999975421 22345678999999999999999999999999999999995 569988
Q ss_pred CCHHHHHHHHHcCCcc----------------------------------------------------------CCCCCC
Q psy5539 594 LTHEEVVKYIKEGNIL----------------------------------------------------------QAPDNT 615 (653)
Q Consensus 594 ~~~~e~~~~i~~~~~~----------------------------------------------------------~~~~~~ 615 (653)
.+..+.+..+.+..-. ..+...
T Consensus 302 ~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 381 (429)
T 3kvw_A 302 EDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCD 381 (429)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCC
T ss_pred CCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccc
Confidence 8877665554321000 001123
Q ss_pred cHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 616 PDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 616 ~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
++++.+|+++||+.||++|||++|+++|+|-
T Consensus 382 ~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred hHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence 6789999999999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=336.92 Aligned_cols=258 Identities=23% Similarity=0.339 Sum_probs=207.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..+++.....||+|+||.||+|+.. .++..||||.++.... ...+.+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 92 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDL-----SNQVRIAIKEIPERDS-RYSQPLHEEIALHKHLKHKNIVQYLGSFSENG 92 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEET-----TTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred ccccCCCCcEEEeecCcEEEEEEEEC-----CCCeEEEEEEccCCch-HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCC
Confidence 33444455567999999999999864 3567899999876543 34567899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++|+|+||||+|||+
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 155 (295)
T 2clq_A 93 FIKIFMEQVPGGSLSALLRSKW-----------------GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI 155 (295)
T ss_dssp EEEEEEECCSEEEHHHHHHHTT-----------------CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred cEEEEEEeCCCCCHHHHHHhhc-----------------cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE
Confidence 9999999999999999997321 12346788899999999999999999999999999999999
Q ss_pred cC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC--CCCchhHHHHHHHHHHHHhCCCCCCCCCCH-H
Q psy5539 522 ND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTH-E 597 (653)
Q Consensus 522 ~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~--~t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~ 597 (653)
+. ++.+||+|||++....... .......++..|+|||.+.+.. ++.++||||||+++|||++|. .||..... .
T Consensus 156 ~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~~~~ 232 (295)
T 2clq_A 156 NTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK-PPFYELGEPQ 232 (295)
T ss_dssp ETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTS-CTTGGGSSHH
T ss_pred ECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCC-CCccCCCchh
Confidence 97 8999999999997653221 1223456789999999997654 889999999999999999955 57765432 2
Q ss_pred H-HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 E-VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e-~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
. .............+..++.++.+++.+||+.||++|||+.+++++.|
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~ 281 (295)
T 2clq_A 233 AAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281 (295)
T ss_dssp HHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 2 22222333445567788999999999999999999999999998875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=344.02 Aligned_cols=265 Identities=22% Similarity=0.316 Sum_probs=196.3
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~ 436 (653)
..+++...+|++.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|+.++.++. ||||++++++
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~ 94 (337)
T 3ll6_A 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDV-----GSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94 (337)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEEET-----TTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred ceeeccCceEEEEEEEccCCceEEEEEEEC-----CCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhcccc
Confidence 345667778999999999999999999864 356789999986543 344567899999999996 9999999999
Q ss_pred Ee--------cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC
Q psy5539 437 CA--------VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK 508 (653)
Q Consensus 437 ~~--------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ 508 (653)
+. .....++||||+. |+|.++++... ....+++..++.++.||+.||+|||+.+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~-----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 156 (337)
T 3ll6_A 95 ASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKME-----------------SRGPLSCDTVLKIFYQTCRAVQHMHRQK 156 (337)
T ss_dssp EEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHH-----------------TTCSCCHHHHHHHHHHHHHHHHHHHTSS
T ss_pred ccccccccccCCceEEEEEEecC-CCHHHHHHHhh-----------------ccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 84 3345899999996 79999987321 2345899999999999999999999999
Q ss_pred --ceecCCCCCCEeEcCCCcEEEeccCcccccccccccc----------CCCCCCCccccccchhh---ccCCCCCchhH
Q psy5539 509 --FVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK----------GDENDAIPVRWMPLESI---LYNKYTVESDV 573 (653)
Q Consensus 509 --ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~----------~~~~~~~t~~y~aPE~~---~~~~~t~ksDV 573 (653)
|+||||||+|||+++++.+||+|||+++......... ......+|+.|+|||.+ .+..++.++||
T Consensus 157 ~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv 236 (337)
T 3ll6_A 157 PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI 236 (337)
T ss_dssp SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHH
T ss_pred CCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH
Confidence 9999999999999999999999999998653322111 11134578899999998 56678999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 574 WAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 574 wSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
||||+++|||++|. .||.+....++.. .......+...+..+.+|+.+||+.+|.+|||+.+++++|+.+...
T Consensus 237 ~slG~il~el~~g~-~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~ 309 (337)
T 3ll6_A 237 WALGCILYLLCFRQ-HPFEDGAKLRIVN---GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA 309 (337)
T ss_dssp HHHHHHHHHHHHSS-CCC---------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCC-CCCcchhHHHhhc---CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999965 5776554433322 2222334556778899999999999999999999999999988764
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.26 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=204.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
.++|.+.+.||+|+||.||+|+.. .+++.||||+++.. ..+...+.+.+|+.+++.++||||+++++++...+.
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred cccEEEEeEEecCCCeEEEEEEEC-----CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 368999999999999999999864 46789999999754 344456788999999999999999999999987765
Q ss_pred e------EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 443 M------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 443 ~------~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
. ++||||+. ++|.+++. ..+++..+..++.||+.||+|||+++|+||||||
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 172 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG----------------------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKP 172 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT----------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cccceeEEEEEcccc-ccHHHHhh----------------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCH
Confidence 5 99999997 68887764 3488999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||+++++.+||+|||+++.... ......+|..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+
T Consensus 173 ~NIll~~~~~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~-~pf~~~~ 246 (371)
T 4exu_A 173 GNLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKD 246 (371)
T ss_dssp GGEEECTTCCEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS-CSCCCSS
T ss_pred HHeEECCCCCEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCC-CCCCCCC
Confidence 999999999999999999975422 2234567899999999987 68999999999999999999954 5898887
Q ss_pred HHHHHHHHHcCC------------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGN------------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+.... ........++++.+|+.+||+.||.+|||+++++++.|
T Consensus 247 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~ 326 (371)
T 4exu_A 247 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 326 (371)
T ss_dssp HHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred hHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcc
Confidence 766555543200 00112356889999999999999999999999999876
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=341.18 Aligned_cols=247 Identities=20% Similarity=0.316 Sum_probs=202.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEec--C
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAV--G 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~--~ 440 (653)
.++|++.+.||+|+||.||+|+.. .+++.||||+++... .+.+.+|+.++++++ ||||+++++++.. .
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~ 105 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVS 105 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT
T ss_pred CCceEEEEEecccCCeEEEEEEEC-----CCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC
Confidence 467999999999999999999864 356889999997543 346889999999997 9999999999987 6
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
...++||||+++++|.++++ .+++.++..++.||+.||+|||+++|+||||||+|||
T Consensus 106 ~~~~lv~e~~~~~~l~~~~~-----------------------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil 162 (330)
T 3nsz_A 106 RTPALVFEHVNNTDFKQLYQ-----------------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM 162 (330)
T ss_dssp CCEEEEEECCCCCCHHHHGG-----------------------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred CceEEEEeccCchhHHHHHH-----------------------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence 67899999999999999875 2788899999999999999999999999999999999
Q ss_pred EcCCC-cEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 521 INDQM-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 521 l~~~~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
++.++ .+||+|||+++...... ......++..|+|||.+.+ ..++.++||||||+++|||++|..+.+.+....+
T Consensus 163 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~ 239 (330)
T 3nsz_A 163 IDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD 239 (330)
T ss_dssp EETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH
T ss_pred EcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH
Confidence 99776 89999999997653222 2234567889999999887 6799999999999999999997764444444433
Q ss_pred HHHH-------------HHcCCcc-----------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 599 VVKY-------------IKEGNIL-----------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 599 ~~~~-------------i~~~~~~-----------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
.+.. +...... ..+..+++++.+|+.+||+.||.+|||++++++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 240 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 2222 2211110 011226899999999999999999999999999
Q ss_pred HHH
Q psy5539 643 TLW 645 (653)
Q Consensus 643 ~L~ 645 (653)
|.|
T Consensus 320 hp~ 322 (330)
T 3nsz_A 320 HPY 322 (330)
T ss_dssp SGG
T ss_pred Ccc
Confidence 876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=337.41 Aligned_cols=263 Identities=21% Similarity=0.333 Sum_probs=208.7
Q ss_pred cccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCC--CCccce
Q psy5539 356 KLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFD--HPNIVK 432 (653)
Q Consensus 356 ~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~--HpnIv~ 432 (653)
.+..+.+..++|.+.+.||+|+||.||+|+.. ++..||||.++.. ......+.+.+|+.++.+++ |+||++
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~ 92 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECT------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCC
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcC------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEE
Confidence 34455677788999999999999999999852 3678999998643 34445678999999999997 599999
Q ss_pred EEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 433 LLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 433 l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
+++++...+..++||| +.+++|.+++.. ...+++..++.++.||+.||.|||+++|+||
T Consensus 93 ~~~~~~~~~~~~lv~e-~~~~~L~~~l~~--------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 151 (313)
T 3cek_A 93 LYDYEITDQYIYMVME-CGNIDLNSWLKK--------------------KKSIDPWERKSYWKNMLEAVHTIHQHGIVHS 151 (313)
T ss_dssp EEEEEECSSEEEEEEC-CCSEEHHHHHHH--------------------CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEEeecCCEEEEEEe-cCCCcHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 9999999999999999 568899999972 2357899999999999999999999999999
Q ss_pred CCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-----------CCCCCchhHHHHHHHHH
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-----------NKYTVESDVWAFGVCLW 581 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-----------~~~t~ksDVwSlGvvl~ 581 (653)
||||+|||+++ +.+||+|||+++...............++..|+|||.+.+ ..++.++||||||+++|
T Consensus 152 dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~ 230 (313)
T 3cek_A 152 DLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILY 230 (313)
T ss_dssp CCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHH
T ss_pred CCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHH
Confidence 99999999975 8999999999986543332222334567899999999875 47889999999999999
Q ss_pred HHHhCCCCCCCCCC-HHHHHHHHHcC-CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 582 EIFSFALQPYYGLT-HEEVVKYIKEG-NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 582 ellt~~~~p~~~~~-~~e~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
||++|.. ||.... .......+... .....+...+.++.+++.+||+.||.+|||+.++++++|--
T Consensus 231 el~~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~ 297 (313)
T 3cek_A 231 YMTYGKT-PFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297 (313)
T ss_dssp HHHHSSC-TTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred HHHhCCC-chhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcccc
Confidence 9999654 776543 33333444333 33455667789999999999999999999999999998753
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.69 Aligned_cols=251 Identities=23% Similarity=0.386 Sum_probs=200.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----- 439 (653)
++|++.+.||+|+||.||+|+.. .+++.||||.++.. ....+.+.+|+.++++++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNA-----LDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred ccchhhheeccCCcEEEEEEEEc-----CCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 46899999999999999999864 35688999999653 3345678999999999999999999998754
Q ss_pred --------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCcee
Q psy5539 440 --------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVH 511 (653)
Q Consensus 440 --------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivH 511 (653)
....++||||+++|+|.++++.. ...+++..++.++.||+.||+|||+++|+|
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 139 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-------------------NLNQQRDEYWRLFRQILEALSYIHSQGIIH 139 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHS-------------------CGGGCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhcc-------------------ccccchHHHHHHHHHHHHHHHHHHhCCeec
Confidence 45789999999999999999731 234678899999999999999999999999
Q ss_pred cCCCCCCEeEcCCCcEEEeccCcccccccccc------------ccCCCCCCCccccccchhhccC-CCCCchhHHHHHH
Q psy5539 512 RDLATRNCLINDQMVVKIADFGLSRKMYLQDY------------YKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGV 578 (653)
Q Consensus 512 rDLkp~NILl~~~~~vkI~DfGla~~~~~~~~------------~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGv 578 (653)
|||||+|||++.++.+||+|||++........ ........++..|+|||.+.+. .++.++||||||+
T Consensus 140 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (303)
T 1zy4_A 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHH
T ss_pred ccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHH
Confidence 99999999999999999999999976532110 1112234578899999999865 7899999999999
Q ss_pred HHHHHHhCCCCCCC-CCCHHHHHHHHHcCCcc---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 579 CLWEIFSFALQPYY-GLTHEEVVKYIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 579 vl~ellt~~~~p~~-~~~~~e~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++|||++ |+. +.+..++...+...... ..+...+..+.+++++||+.||.+|||+.++++++|
T Consensus 220 il~~l~~----p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 286 (303)
T 1zy4_A 220 IFFEMIY----PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGW 286 (303)
T ss_dssp HHHHHHS----CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSC
T ss_pred HHHHHHh----ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCC
Confidence 9999997 443 33445566666654321 233456788999999999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.47 Aligned_cols=260 Identities=21% Similarity=0.344 Sum_probs=214.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHH----------------HHHHHHHHHHHHhh
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEY----------------LQTDFEREACLLAE 424 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~----------------~~~~f~~Ei~il~~ 424 (653)
....++|.+.+.||+|+||.||+|+. ++..||||.+....... ..+.+.+|+.++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 99 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK-------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE-------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc-------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHh
Confidence 44457899999999999999999985 45899999986432110 11678999999999
Q ss_pred CCCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5539 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504 (653)
Q Consensus 425 l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 504 (653)
++||||+++++++...+..++||||+++|+|.+++...... .......+++..++.++.||+.||.||
T Consensus 100 l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l------------~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 100 IKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL------------DKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp CCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESS------------CSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhh------------hhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999884311000 001246789999999999999999999
Q ss_pred hh-CCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCC-chhHHHHHHHHH
Q psy5539 505 SD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTV-ESDVWAFGVCLW 581 (653)
Q Consensus 505 H~-~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~-ksDVwSlGvvl~ 581 (653)
|+ ++|+||||||+|||++.++.+||+|||++...... ......++..|+|||.+.+. .++. ++||||||+++|
T Consensus 168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 99 99999999999999999999999999999765322 22345678999999999887 6666 999999999999
Q ss_pred HHHhCCCCCCCCCCH-HHHHHHHHcCCccCCC-------------------CCCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 582 EIFSFALQPYYGLTH-EEVVKYIKEGNILQAP-------------------DNTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 582 ellt~~~~p~~~~~~-~e~~~~i~~~~~~~~~-------------------~~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
||++|. .||.+... .++...+..+.. ..+ ..++.++.+|+.+||+.||.+|||+++++
T Consensus 244 ~l~~g~-~pf~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l 321 (348)
T 2pml_X 244 VMFYNV-VPFSLKISLVELFNNIRTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDAL 321 (348)
T ss_dssp HHHHSS-CSSCCSSCSHHHHHHHTSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred HHHhCC-CCCCCCCcHHHHHHHHhccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 999955 58877666 778887776653 233 56889999999999999999999999999
Q ss_pred HHHH
Q psy5539 642 QTLW 645 (653)
Q Consensus 642 ~~L~ 645 (653)
++.|
T Consensus 322 ~hp~ 325 (348)
T 2pml_X 322 KHEW 325 (348)
T ss_dssp TSGG
T ss_pred cCcc
Confidence 8764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=334.11 Aligned_cols=254 Identities=27% Similarity=0.394 Sum_probs=214.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++.+.||+|+||.||+|+.. .+++.||||+++.... ....+.+.+|++++++++||||+++++++...+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~-----~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDR-----ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEc-----CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 57899999999999999999864 3567899999864322 22345788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+||+++++|.+++... ..+++..++.++.||+.||.|||+++++|+||||+|||++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~~--------------------~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~ 156 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR--------------------KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESC
T ss_pred EEEEEccCCCCHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEec
Confidence 9999999999999988622 34789999999999999999999999999999999999975
Q ss_pred C---CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 Q---MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ~---~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+ +.+||+|||++....... ......++..|+|||.+.+ .++.++||||||+++|+|++| ..||.+.+..++.
T Consensus 157 ~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g-~~p~~~~~~~~~~ 231 (287)
T 2wei_A 157 KEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSG-TPPFYGKNEYDIL 231 (287)
T ss_dssp SSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred CCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhC-CCCCCCCCHHHHH
Confidence 4 479999999997643221 1123346888999998865 589999999999999999995 5699898888888
Q ss_pred HHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 601 ~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+..+..... ...++.++.+++++||+.+|++|||+.+++++.|-..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~ 282 (287)
T 2wei_A 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282 (287)
T ss_dssp HHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred HHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence 88887764322 2467899999999999999999999999999987544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=337.80 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=201.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe-----
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA----- 438 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~----- 438 (653)
.++|.+.+.||+|+||.||+|+.. .+++.||||++.... ....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDN-----DCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQ 83 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEET-----TTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCB
T ss_pred CCceeEEEEeccCCCeEEEEEEEC-----CCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccc
Confidence 468999999999999999999864 356899999987543 445667899999999999999999999873
Q ss_pred ---------cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 439 ---------VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 439 ---------~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
.....++||||++ |+|.++++ ...+++..++.++.||+.||+|||+++|
T Consensus 84 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~---------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i 141 (320)
T 2i6l_A 84 LTDDVGSLTELNSVYIVQEYME-TDLANVLE---------------------QGPLLEEHARLFMYQLLRGLKYIHSANV 141 (320)
T ss_dssp CCC----CCSCSEEEEEEECCS-EEHHHHHT---------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cccccccccccCceeEEeeccC-CCHHHHhh---------------------cCCccHHHHHHHHHHHHHHHHHHHhCCE
Confidence 3467899999998 69999985 1357899999999999999999999999
Q ss_pred eecCCCCCCEeEc-CCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhC
Q psy5539 510 VHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSF 586 (653)
Q Consensus 510 vHrDLkp~NILl~-~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~ 586 (653)
+||||||+|||++ +++.+||+|||+++........ .......++..|+|||.+.. ..++.++||||||+++|||++|
T Consensus 142 ~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 221 (320)
T 2i6l_A 142 LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221 (320)
T ss_dssp BCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHS
T ss_pred ecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhC
Confidence 9999999999997 5779999999999865322111 11123345788999998876 6789999999999999999995
Q ss_pred CCCCCCCCCHHHHHHHHHcCCc-----------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCH
Q psy5539 587 ALQPYYGLTHEEVVKYIKEGNI-----------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSF 637 (653)
Q Consensus 587 ~~~p~~~~~~~e~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 637 (653)
..||.+.+..+....+..... ......++.++.+|+++||+.||++|||+
T Consensus 222 -~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~ 300 (320)
T 2i6l_A 222 -KTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTA 300 (320)
T ss_dssp -SCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCH
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCH
Confidence 468988877666555443210 01124578999999999999999999999
Q ss_pred HHHHHHHHHH
Q psy5539 638 RTIYQTLWNI 647 (653)
Q Consensus 638 ~eil~~L~~l 647 (653)
++++++.|--
T Consensus 301 ~ell~hp~~~ 310 (320)
T 2i6l_A 301 EEALSHPYMS 310 (320)
T ss_dssp HHHHTSHHHH
T ss_pred HHHhCCcccc
Confidence 9999998753
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=339.22 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=207.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-HHHHHHHHHHHHHhhC---CCCccceEEeEEe-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-YLQTDFEREACLLAEF---DHPNIVKLLGVCA- 438 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~- 438 (653)
.++|++.+.||+|+||.||+|+.. ..+++.||||+++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~ 85 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDL----KNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV 85 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEET----TTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred hhceeeeeeecccccEEEEEEEec----CCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence 468999999999999999999863 135688999998643321 1122456777777666 8999999999987
Q ss_pred ----cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 439 ----VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 439 ----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
.....++||||++ |+|.+++.... ...+++..++.++.||+.||.|||+++|+||||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~------------------~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dl 146 (326)
T 1blx_A 86 SRTDRETKLTLVFEHVD-QDLTTYLDKVP------------------EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDL 146 (326)
T ss_dssp EECSSEEEEEEEEECCS-CBHHHHHHHSC------------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred cccCCCceEEEEEecCC-CCHHHHHHhcc------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 5567899999998 69999997321 234889999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||++.++.+||+|||+++...... ......++..|+|||.+.+..++.++||||||+++|||++| .+||.+.
T Consensus 147 kp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g-~~pf~~~ 222 (326)
T 1blx_A 147 KPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGS 222 (326)
T ss_dssp CGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSCCCS
T ss_pred CHHHeEEcCCCCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcC-CCCCCCC
Confidence 9999999999999999999997653222 22345678899999999999999999999999999999995 5689888
Q ss_pred CHHHHHHHHHcCC--------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGN--------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~--------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+....+.+.. .......++..+.+|+.+||+.||.+|||+.+++++.|
T Consensus 223 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 299 (326)
T 1blx_A 223 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299 (326)
T ss_dssp SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 8776665554310 01123467899999999999999999999999998875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.84 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=191.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG--- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~--- 440 (653)
++|++.+.||+|+||.||+|+.. .++..||||+++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 103 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 103 (367)
T ss_dssp TTEEEEEECC----CCEEEEEET-----TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred CceEEeeEEeecCCeEEEEEEEC-----CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcc
Confidence 68999999999999999999863 46789999999654 3344566788999999999999999999998654
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...++|+||+ +++|.++++ ...+++..+..++.||+.||+|||+.+|+||||||+
T Consensus 104 ~~~~~~~lv~e~~-~~~L~~~~~---------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~ 161 (367)
T 2fst_X 104 EEFNDVYLVTHLM-GADLNNIVK---------------------CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 161 (367)
T ss_dssp GGCCCCEEEEECC-CEECC--------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred ccCCeEEEEeccc-CCCHHHHHh---------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHh
Confidence 5679999999 689988875 135899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||++.++.+||+|||+++.... ......+|..|+|||.+.+ ..++.++||||||+++|||++| .+||.+.+.
T Consensus 162 NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~ 235 (367)
T 2fst_X 162 NLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDH 235 (367)
T ss_dssp GEEECTTCCEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHS-SCSCCCSSH
T ss_pred hEEECCCCCEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhC-CCCCCCCCH
Confidence 99999999999999999976422 1234567889999999887 6799999999999999999995 469988887
Q ss_pred HHHHHHHHcC--C--------------------ccC--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEG--N--------------------ILQ--------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~--~--------------------~~~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.+..+... . ... .....++.+.+|+.+||..||.+|||+.++++|.|
T Consensus 236 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~ 314 (367)
T 2fst_X 236 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 314 (367)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence 6655554321 0 000 01246788999999999999999999999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=338.59 Aligned_cols=254 Identities=21% Similarity=0.307 Sum_probs=208.4
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc------cceEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN------IVKLL 434 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn------Iv~l~ 434 (653)
+.-.++|++.+.||+|+||.||+|... ..++..||||+++.. ....+.+.+|+.+++.++|+| +++++
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~ 83 (339)
T 1z57_A 10 DVLSARYEIVDTLGEGAFGKVVECIDH----KAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQML 83 (339)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEET----TTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEE
T ss_pred CCccCceEEEEEEecCCCeEEEEEEec----CCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeee
Confidence 344578999999999999999999862 245689999999753 334567889999999997665 99999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++|+||||
T Consensus 84 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dl 144 (339)
T 1z57_A 84 EWFEHHGHICIVFELL-GLSTYDFIKEN------------------GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDL 144 (339)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHT------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred cccccCCcEEEEEcCC-CCCHHHHHHhc------------------CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 9999999999999999 88999999732 1235789999999999999999999999999999
Q ss_pred CCCCEeEcC-------------------CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHH
Q psy5539 515 ATRNCLIND-------------------QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWA 575 (653)
Q Consensus 515 kp~NILl~~-------------------~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwS 575 (653)
||+|||++. ++.+||+|||+++.... ......+|..|+|||.+.+..++.++||||
T Consensus 145 kp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 219 (339)
T 1z57_A 145 KPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWSQPCDVWS 219 (339)
T ss_dssp CGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHH
T ss_pred CHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCCcchhhHH
Confidence 999999987 67899999999975321 223456789999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--c-----------------------------------------cCCC
Q psy5539 576 FGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN--I-----------------------------------------LQAP 612 (653)
Q Consensus 576 lGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~--~-----------------------------------------~~~~ 612 (653)
||+++|||++| ..||.+.+..+....+.... . ...+
T Consensus 220 lG~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (339)
T 1z57_A 220 IGCILIEYYLG-FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQ 298 (339)
T ss_dssp HHHHHHHHHHS-SCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCC
T ss_pred HHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccc
Confidence 99999999995 55888877766554442210 0 0111
Q ss_pred CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 613 DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 613 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...++++.+|+.+||+.||.+|||+++++++.|
T Consensus 299 ~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~ 331 (339)
T 1z57_A 299 DVEHERLFDLIQKMLEYDPAKRITLREALKHPF 331 (339)
T ss_dssp SHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred hhhHHHHHHHHHHHhCcCcccccCHHHHhcCHH
Confidence 223577999999999999999999999999876
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.95 Aligned_cols=251 Identities=23% Similarity=0.321 Sum_probs=201.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-------HHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-------EYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-------~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
++|.+.+.||+|+||.||+|+.. .+++.||||.++.... ......+.+|++++++++||||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFER-----KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEc-----CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEE
Confidence 47899999999999999999864 3568999999865321 12234588999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..+. .++||||+++|+|.+++. ....+++..++.++.||+.||.|||+++|+||||||+
T Consensus 85 ~~~~-~~lv~e~~~~~~L~~~~~--------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 143 (322)
T 2ycf_A 85 DAED-YYIVLELMEGGELFDKVV--------------------GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPE 143 (322)
T ss_dssp ESSS-EEEEEECCTTEETHHHHS--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred cCCc-eEEEEecCCCCcHHHHHh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 7655 899999999999999885 2345889999999999999999999999999999999
Q ss_pred CEeEcCCCc---EEEeccCccccccccccccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 518 NCLINDQMV---VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 518 NILl~~~~~---vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
|||++.++. +||+|||+++....... .....++..|+|||.+. ...++.++||||||+++|||++|. .||
T Consensus 144 NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf 219 (322)
T 2ycf_A 144 NVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY-PPF 219 (322)
T ss_dssp GEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS-CSS
T ss_pred HEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC-CCC
Confidence 999987654 99999999976532211 11234688999999974 467899999999999999999955 577
Q ss_pred CCCCH-HHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 592 YGLTH-EEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 592 ~~~~~-~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+... ..+...+..+..... ...++.++.+|+.+||+.||++|||+.+++++.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~ 277 (322)
T 2ycf_A 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPW 277 (322)
T ss_dssp CSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred cccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcC
Confidence 65433 345555665544322 2467899999999999999999999999998765
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=341.31 Aligned_cols=247 Identities=23% Similarity=0.326 Sum_probs=203.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP- 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~- 442 (653)
++|.+.+.||+|+||.||+|+.. .++..||||.++.. ..+...+.+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 98 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDK-----RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSL 98 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSG
T ss_pred ceEEEeeeEecCCCeEEEEEEEC-----CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccc
Confidence 57999999999999999999864 45789999998754 344456778999999999999999999999987654
Q ss_pred -----eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 443 -----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 443 -----~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.++||||+. |+|.+++. ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 99 ~~~~~~~lv~e~~~-~~l~~~~~----------------------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~ 155 (353)
T 3coi_A 99 RNFYDFYLVMPFMQ-TDLQKIMG----------------------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155 (353)
T ss_dssp GGCCCCEEEEECCS-EEGGGTTT----------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGG
T ss_pred ccceeEEEEecccc-CCHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 499999997 58877653 24889999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||+++++.+||+|||+++.... ......+|..|+|||.+.+ ..++.++||||||+++|||++|. .||.+.+.
T Consensus 156 NIl~~~~~~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~-~pf~~~~~ 229 (353)
T 3coi_A 156 NLAVNEDCELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDY 229 (353)
T ss_dssp GEEECTTCCEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSS-CSSBSSCH
T ss_pred HEeECCCCcEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCC-CCCCCCCH
Confidence 99999999999999999975422 1233467889999999887 67899999999999999999954 68888776
Q ss_pred HHHHHHHHcC------------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEG------------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.+.+..+... .........+.++.+|+.+||+.||++|||++++++|.|
T Consensus 230 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~ 308 (353)
T 3coi_A 230 LDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPF 308 (353)
T ss_dssp HHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence 6655444320 111223467899999999999999999999999999876
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=340.52 Aligned_cols=266 Identities=21% Similarity=0.352 Sum_probs=193.4
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHH-HHhhCCCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC-LLAEFDHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~-il~~l~HpnIv~l~g~ 436 (653)
...++..++|++.+.||+|+||.||+|+.. .+++.||||.++.........++.+|+. +++.++||||++++++
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~ 89 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHK-----PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEET-----TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEc-----CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence 345677889999999999999999999864 3568999999987655555556666666 7788899999999999
Q ss_pred EecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCC
Q psy5539 437 CAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLA 515 (653)
Q Consensus 437 ~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLk 515 (653)
+...+..++||||+++ +|.+++.... ......+++..+..++.|++.||.|||+. +|+|||||
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk 153 (327)
T 3aln_A 90 LFREGDCWICMELMST-SFDKFYKYVY---------------SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153 (327)
T ss_dssp EECSSEEEEEECCCSE-EHHHHHHHHH---------------HTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred EEeCCceEEEEeecCC-ChHHHHHHHH---------------hhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence 9999999999999985 8888876211 01235689999999999999999999999 99999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhh----ccCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI----LYNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~----~~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
|+|||++.++.+||+|||+++...... ......++..|+|||.+ .+..++.++||||||+++|||++|. .||
T Consensus 154 p~NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf 229 (327)
T 3aln_A 154 PSNILLDRSGNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR-FPY 229 (327)
T ss_dssp GGGEEEETTTEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSC-CCS
T ss_pred HHHEEEcCCCCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCC-CCC
Confidence 999999999999999999997653221 12334678899999998 4567899999999999999999955 577
Q ss_pred CCCCH-HHHHHHHHcCCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 592 YGLTH-EEVVKYIKEGNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 592 ~~~~~-~e~~~~i~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.+... .+....+..+.....+ ..++.++.+|+.+||+.||.+|||+.+|++++|-..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~ 291 (327)
T 3aln_A 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291 (327)
T ss_dssp SCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence 66432 2222222222222222 357899999999999999999999999999987554
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=346.92 Aligned_cols=259 Identities=22% Similarity=0.298 Sum_probs=204.0
Q ss_pred ccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc----------cHHHHHHHHHHHHHHhhCC
Q psy5539 357 LEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA----------SEYLQTDFEREACLLAEFD 426 (653)
Q Consensus 357 l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~----------~~~~~~~f~~Ei~il~~l~ 426 (653)
+..+....++|.+.+.||+|+||.||+|... .+..||||++.... .....+.+.+|++++++++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 87 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDS------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECT------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECC------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC
Confidence 3445666789999999999999999999852 36889999986432 2234467999999999999
Q ss_pred CCccceEEeEEec-----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHH
Q psy5539 427 HPNIVKLLGVCAV-----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM 501 (653)
Q Consensus 427 HpnIv~l~g~~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL 501 (653)
||||+++++++.. ....++||||++ |+|.+++.. ....+++..+..++.||+.||
T Consensus 88 h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l 147 (362)
T 3pg1_A 88 HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-------------------QRIVISPQHIQYFMYHILLGL 147 (362)
T ss_dssp CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-------------------TTSCCCHHHHHHHHHHHHHHH
T ss_pred CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-------------------cccCCCHHHHHHHHHHHHHHH
Confidence 9999999999843 336799999998 689988861 234689999999999999999
Q ss_pred HHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHH
Q psy5539 502 VYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCL 580 (653)
Q Consensus 502 ~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl 580 (653)
.|||+++|+||||||+|||++.++.+||+|||+++..... .......++..|+|||.+.+ ..++.++||||||+++
T Consensus 148 ~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 224 (362)
T 3pg1_A 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVM 224 (362)
T ss_dssp HHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHH
T ss_pred HHHHHCcCEecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHH
Confidence 9999999999999999999999999999999999754222 12234567889999999887 6799999999999999
Q ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-----------------------Ccc--------CCCCCCcHHHHHHHHHhhcc
Q psy5539 581 WEIFSFALQPYYGLTHEEVVKYIKEG-----------------------NIL--------QAPDNTPDALYDLMKLCWNM 629 (653)
Q Consensus 581 ~ellt~~~~p~~~~~~~e~~~~i~~~-----------------------~~~--------~~~~~~~~~l~~li~~cl~~ 629 (653)
|||++|. .||.+.+..+....+... ... ..+...++.+.+|+.+||+.
T Consensus 225 ~~l~~g~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 303 (362)
T 3pg1_A 225 AEMFNRK-ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEF 303 (362)
T ss_dssp HHHHHSS-CSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCS
T ss_pred HHHHhCC-CCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcC
Confidence 9999954 588888776665554320 000 11235678899999999999
Q ss_pred CCCCCCCHHHHHHHHH
Q psy5539 630 KPMNRPSFRTIYQTLW 645 (653)
Q Consensus 630 dP~~RPs~~eil~~L~ 645 (653)
||.+|||+.++++|+|
T Consensus 304 dP~~Rpt~~ell~hp~ 319 (362)
T 3pg1_A 304 NPQRRISTEQALRHPY 319 (362)
T ss_dssp SGGGSCCHHHHHTSGG
T ss_pred ChhhCCCHHHHHcCch
Confidence 9999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=353.02 Aligned_cols=251 Identities=17% Similarity=0.157 Sum_probs=184.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhC--CCCccceEE------
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEF--DHPNIVKLL------ 434 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l--~HpnIv~l~------ 434 (653)
.+|.+.+.||+|+||.||+|++. .+++.||||+++... .....+.+.+|+.++..| +||||++++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p 136 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDV-----ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLP 136 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEEC-----CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEee
Confidence 45889999999999999999864 356899999998653 334455678885544444 699988754
Q ss_pred -eEEecC-----------------CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHH------
Q psy5539 435 -GVCAVG-----------------KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDL------ 490 (653)
Q Consensus 435 -g~~~~~-----------------~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~------ 490 (653)
+++... ...+|||||++ |+|.++++... ..+++..+
T Consensus 137 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-------------------~~~~~~~~~~~~vk 196 (371)
T 3q60_A 137 SDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-------------------FVYVFRGDEGILAL 196 (371)
T ss_dssp CEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-------------------HSCCCCHHHHHHHH
T ss_pred ehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-------------------cccchhhhhhhhhH
Confidence 444332 33799999999 89999997431 12344455
Q ss_pred HHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc--CCCC
Q psy5539 491 ITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY--NKYT 568 (653)
Q Consensus 491 ~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~t 568 (653)
+.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...... ....+++.|+|||.+.+ ..++
T Consensus 197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~ 271 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFT 271 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECC
T ss_pred HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcC
Confidence 7888999999999999999999999999999999999999999998653211 13345689999999987 6799
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH--HH---HHc---CCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHH
Q psy5539 569 VESDVWAFGVCLWEIFSFALQPYYGLTHEEVV--KY---IKE---GNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTI 640 (653)
Q Consensus 569 ~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~--~~---i~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei 640 (653)
.++||||||+++|||++| ..||.+....... .. ... ....+....+++++.+||.+||+.||++|||+.++
T Consensus 272 ~~~DiwSlG~il~elltg-~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 350 (371)
T 3q60_A 272 HALNAWQLGLSIYRVWCL-FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350 (371)
T ss_dssp HHHHHHHHHHHHHHHHHS-SCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHH
T ss_pred ccccHHHHHHHHHHHHhC-CCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 999999999999999995 4588766432110 00 000 11112224688999999999999999999999999
Q ss_pred HHHHHH
Q psy5539 641 YQTLWN 646 (653)
Q Consensus 641 l~~L~~ 646 (653)
++|.|-
T Consensus 351 l~hp~f 356 (371)
T 3q60_A 351 METPEF 356 (371)
T ss_dssp TTSHHH
T ss_pred hcCHHH
Confidence 998873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=346.66 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=201.1
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC--------CCccceE
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD--------HPNIVKL 433 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~--------HpnIv~l 433 (653)
+-.++|++.+.||+|+||+||+|+.. .+++.||||+++.. ....+.+.+|+.+++.++ |+||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~ 106 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDI-----QGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQL 106 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEec-----CCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence 33578999999999999999999863 45689999999753 334567899999999995 7889999
Q ss_pred EeEEe----cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-C
Q psy5539 434 LGVCA----VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-K 508 (653)
Q Consensus 434 ~g~~~----~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ 508 (653)
++++. .+...++||||+ +++|.+++... ....+++..++.++.||+.||+|||++ +
T Consensus 107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~------------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~g 167 (397)
T 1wak_A 107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKS------------------NYQGLPLPCVKKIIQQVLQGLDYLHTKCR 167 (397)
T ss_dssp EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHT------------------TTSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ecceeecCCCCceEEEEEecc-CccHHHHHHhc------------------ccCCCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 99987 566899999999 56777776521 224589999999999999999999998 9
Q ss_pred ceecCCCCCCEeEcCCC-------------------------------------------------cEEEeccCcccccc
Q psy5539 509 FVHRDLATRNCLINDQM-------------------------------------------------VVKIADFGLSRKMY 539 (653)
Q Consensus 509 ivHrDLkp~NILl~~~~-------------------------------------------------~vkI~DfGla~~~~ 539 (653)
|+||||||+|||++.++ .+||+|||+++...
T Consensus 168 ivHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~ 247 (397)
T 1wak_A 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVH 247 (397)
T ss_dssp EECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETT
T ss_pred EecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccc
Confidence 99999999999999775 89999999997653
Q ss_pred ccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC------HHHHHHHHHc--CC----
Q psy5539 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT------HEEVVKYIKE--GN---- 607 (653)
Q Consensus 540 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~------~~e~~~~i~~--~~---- 607 (653)
. ......+|..|+|||.+.+..++.++||||||+++|||++|. .||.+.+ ..+....+.. +.
T Consensus 248 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 321 (397)
T 1wak_A 248 K-----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGD-YLFEPHSGEEYTRDEDHIALIIELLGKVPRK 321 (397)
T ss_dssp B-----CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS-CSCCCCCCSSSCHHHHHHHHHHHHHCSCCHH
T ss_pred c-----cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCC-CCCCCCcccccCchHHHHHHHHHhcCCCChH
Confidence 2 223456799999999999999999999999999999999955 5776543 2222222211 10
Q ss_pred ------cc-----------------------------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 608 ------IL-----------------------------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 608 ------~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.. ..+...+..+.+|+.+||+.||++|||++++++|.|
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 394 (397)
T 1wak_A 322 LIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW 394 (397)
T ss_dssp HHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred HhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence 00 011223467889999999999999999999999876
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=331.27 Aligned_cols=259 Identities=20% Similarity=0.344 Sum_probs=195.0
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHH-HHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYL-QTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~-~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
......++|++.+.||+|+||.||+|+.. .+++.||||.++....... .+.+.++..+++.++||||+++++++
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~ 93 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFR-----KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTF 93 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEET-----TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEe-----cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEE
Confidence 33555678999999999999999999864 3567899999976544333 33455555678888999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLAT 516 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp 516 (653)
...+..++||||+ ++.+..++.. ....+++..++.++.||+.||.|||++ +|+||||||
T Consensus 94 ~~~~~~~lv~e~~-~~~~~~l~~~-------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp 153 (318)
T 2dyl_A 94 ITNTDVFIAMELM-GTCAEKLKKR-------------------MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKP 153 (318)
T ss_dssp ECSSEEEEEECCC-SEEHHHHHHH-------------------HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCG
T ss_pred ecCCcEEEEEecc-CCcHHHHHHH-------------------hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCH
Confidence 9999999999999 4455444431 124588999999999999999999995 999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPY 591 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~ 591 (653)
+|||++.++.+||+|||++....... ......+++.|+|||.+. ...++.++||||||+++|||++|. .||
T Consensus 154 ~Nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~-~pf 229 (318)
T 2dyl_A 154 SNILLDERGQIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ-FPY 229 (318)
T ss_dssp GGEEECTTSCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS-CTT
T ss_pred HHEEECCCCCEEEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC-CCC
Confidence 99999999999999999997653222 223346788999999984 557899999999999999999955 577
Q ss_pred CC-CCHHHHHHHHHcCCccCCC--CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 592 YG-LTHEEVVKYIKEGNILQAP--DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 592 ~~-~~~~e~~~~i~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.. ....+....+..+.....+ ..++.++.+++.+||+.||.+||++++|+++.|-
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~ 287 (318)
T 2dyl_A 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFI 287 (318)
T ss_dssp TTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHH
T ss_pred CCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHH
Confidence 66 4556666666665544333 3578999999999999999999999999998874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=352.16 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=209.3
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC-ccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP-NIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp-nIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||.||+|+.. .++..||||+++..... ..+.+|+++++.++|+ +|..+..++...+.
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNI-----QTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEET-----TTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEEC-----CCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 468999999999999999999864 35678999987654322 3578999999999875 55555566677888
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE-
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI- 521 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl- 521 (653)
.+|||||+ +++|.+++... ...+++..++.|+.||+.||+|||+++|+||||||+||||
T Consensus 78 ~~lvme~~-g~sL~~ll~~~-------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~ 137 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFC-------------------SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMG 137 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHT-------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred EEEEEECC-CCCHHHHHHhh-------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEe
Confidence 99999999 99999999732 2458999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeccCcccccccccc-----ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 522 --NDQMVVKIADFGLSRKMYLQDY-----YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 522 --~~~~~vkI~DfGla~~~~~~~~-----~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
++++.+||+|||+++....... +.......+|..|+|||.+.+..++.++||||||++||||++|. .||.+.
T Consensus 138 ~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~-~Pf~~~ 216 (483)
T 3sv0_A 138 LGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGS-LPWQGL 216 (483)
T ss_dssp CGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-CTTSSC
T ss_pred cCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCC-CCCccc
Confidence 6889999999999987643322 12223567899999999999999999999999999999999954 588764
Q ss_pred CH---HHHHHHHHcCC----ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 595 TH---EEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 595 ~~---~e~~~~i~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.. .+.+..+.... .......++.++.+|+..||+.+|.+||++++|++.|..+...
T Consensus 217 ~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 217 KAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp CCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 43 33333333322 2223357889999999999999999999999999999888654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=334.87 Aligned_cols=253 Identities=19% Similarity=0.308 Sum_probs=206.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc------cceEEe
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN------IVKLLG 435 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn------Iv~l~g 435 (653)
.-.++|++.+.||+|+||+||+|+... ..+..||||+++.. ....+.+.+|+.++++++|++ ++.+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~ 89 (355)
T 2eu9_A 16 WLQERYEIVGNLGEGTFGKVVECLDHA----RGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSD 89 (355)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEE
T ss_pred eecccEEEEEEeeccCCeEEEEEEecC----CCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeee
Confidence 345789999999999999999998642 23378999999753 334567889999999998766 899999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++...+..++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++|+|||||
T Consensus 90 ~~~~~~~~~lv~e~~-~~~l~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 90 WFNFHGHMCIAFELL-GKNTFEFLKEN------------------NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHT------------------TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred eeeeCCeEEEEEecc-CCChHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 999999999999999 66888877622 22458999999999999999999999999999999
Q ss_pred CCCEeE-------------------cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHH
Q psy5539 516 TRNCLI-------------------NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAF 576 (653)
Q Consensus 516 p~NILl-------------------~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSl 576 (653)
|+|||+ +.++.+||+|||+++.... ......+|..|+|||.+.+..++.++|||||
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 225 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-----HHTTIVATRHYRPPEVILELGWAQPCDVWSI 225 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHH
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-----cccCCcCCCcccCCeeeecCCCCCccchHHH
Confidence 999999 6788999999999975321 2234568899999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--Ccc-----------------------------------------CCCC
Q psy5539 577 GVCLWEIFSFALQPYYGLTHEEVVKYIKEG--NIL-----------------------------------------QAPD 613 (653)
Q Consensus 577 Gvvl~ellt~~~~p~~~~~~~e~~~~i~~~--~~~-----------------------------------------~~~~ 613 (653)
|+++|||++| ..||.+.+..+....+... ... ....
T Consensus 226 G~il~el~~g-~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (355)
T 2eu9_A 226 GCILFEYYRG-FTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDS 304 (355)
T ss_dssp HHHHHHHHHS-SCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCS
T ss_pred HHHHHHHHhC-CCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccc
Confidence 9999999995 5689887776655443321 000 0011
Q ss_pred CCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 614 NTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 614 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.++.+|+.+||+.||++|||+.++++|.|
T Consensus 305 ~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~ 336 (355)
T 2eu9_A 305 LEHVQLFDLMRRMLEFDPAQRITLAEALLHPF 336 (355)
T ss_dssp HHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGG
T ss_pred hhHHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 12457899999999999999999999998876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=349.74 Aligned_cols=251 Identities=22% Similarity=0.274 Sum_probs=199.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG---- 440 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~---- 440 (653)
.+|.+.+.||+|+||.||+|++. .++..||||++..... .+.+|++++++++|||||++++++...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~ 123 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK 123 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred ceEEeeeEEeeCCCEEEEEEEEC-----CCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence 36899999999999999999974 3568899999865421 245799999999999999999988532
Q ss_pred --CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 441 --KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 441 --~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+++||||+++ +|.+.+.... .....+++..+..++.||+.||+|||+++|+||||||+|
T Consensus 124 ~~~~~~lv~e~~~~-~l~~~~~~~~----------------~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 124 DEVYLNLVLDYVPE-TVYRVARHYS----------------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp TEEEEEEEEECCCE-EHHHHHHHHH----------------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred cceeEEeehhcccc-cHHHHHHHHh----------------hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 236799999986 6777665211 223568999999999999999999999999999999999
Q ss_pred EeEcCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 519 CLINDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 519 ILl~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||+.+ +.+||+|||+++...... ......+|..|+|||.+.+. .++.++|||||||++|||++| .+||.+.+.
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G-~~pf~~~~~ 262 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSG 262 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSSCCSSH
T ss_pred EEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhC-CCCCCCCCH
Confidence 999954 678999999998653222 22345678899999999765 799999999999999999995 568988876
Q ss_pred HHHHHHHHcC--------------Cc--cC------------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKEG--------------NI--LQ------------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~~--------------~~--~~------------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+.+..+... .. .. .+...+.++.+|+.+||..||.+|||+.++++|.|-
T Consensus 263 ~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f 340 (420)
T 1j1b_A 263 VDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 340 (420)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence 5544433220 00 00 123567899999999999999999999999998763
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=340.76 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=206.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CC-----ccceEE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HP-----NIVKLL 434 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-Hp-----nIv~l~ 434 (653)
+...++|++.+.||+|+||+||+|+.. .+++.||||+++.. ......+.+|+.+++.++ |+ +|++++
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~ 122 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDR-----VEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK 122 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEc-----CCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence 444678999999999999999999864 35689999999753 334567788999988885 44 499999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh--hCCceec
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS--DRKFVHR 512 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~ivHr 512 (653)
+++...+..++||||++ |+|.+++... ....+++..+..++.||+.||.||| +.+|+||
T Consensus 123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHr 183 (382)
T 2vx3_A 123 RHFMFRNHLCLVFEMLS-YNLYDLLRNT------------------NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHC 183 (382)
T ss_dssp EEEEETTEEEEEEECCC-CBHHHHHHHT------------------TTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECC
T ss_pred eeeccCCceEEEEecCC-CCHHHHHhhc------------------CcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcC
Confidence 99999999999999996 5999999732 1245899999999999999999999 4699999
Q ss_pred CCCCCCEeEc--CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 513 DLATRNCLIN--DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 513 DLkp~NILl~--~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||||+|||++ .++.+||+|||+++.... ......+|+.|+|||.+.+..++.++||||||+++|||++| .+|
T Consensus 184 Dlkp~NIll~~~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~p 257 (382)
T 2vx3_A 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPL 257 (382)
T ss_dssp CCSGGGEEESSTTSCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCS
T ss_pred CCCcccEEEecCCCCcEEEEeccCceeccc-----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhC-CCC
Confidence 9999999994 578899999999976522 22345678899999999999999999999999999999995 569
Q ss_pred CCCCCHHHHHHHHHcCCccC-----------------CCC------------------C---------------------
Q psy5539 591 YYGLTHEEVVKYIKEGNILQ-----------------APD------------------N--------------------- 614 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~~~~-----------------~~~------------------~--------------------- 614 (653)
|.+.+..+.+..+....... .++ .
T Consensus 258 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 337 (382)
T 2vx3_A 258 FSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAG 337 (382)
T ss_dssp SCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTT
T ss_pred CCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccc
Confidence 98888777666654310000 000 0
Q ss_pred -------CcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 615 -------TPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 615 -------~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+++.+|+.+||+.||++|||++++++|.|-
T Consensus 338 ~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f 376 (382)
T 2vx3_A 338 ESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376 (382)
T ss_dssp CTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGG
T ss_pred cccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCccc
Confidence 01378999999999999999999999998873
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=339.55 Aligned_cols=257 Identities=21% Similarity=0.231 Sum_probs=193.8
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
...++|++.+.||+|+||.||+|+.. .++..||||++..... ....+.+|++.++.++||||+++++++...+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vavK~~~~~~~--~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEK-----STGMSVAIKKVIQDPR--FRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHTTEEEC----------CEEEEET-----TTCCEEEEEEEECCTT--CCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhccceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEecCcc--ccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34568999999999999999999864 3567899998864322 2234567888899999999999999986533
Q ss_pred c-------eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh--hCCceec
Q psy5539 442 P-------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS--DRKFVHR 512 (653)
Q Consensus 442 ~-------~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH--~~~ivHr 512 (653)
. .++||||+++ +|.+.+... ......+++..+..++.|++.||.||| +++|+||
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~ 155 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNY----------------YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR 155 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHH----------------HTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred cccccceeEEEEeecccc-cHHHHHHHH----------------hhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence 3 7899999986 566555421 123456889999999999999999999 9999999
Q ss_pred CCCCCCEeEcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCC
Q psy5539 513 DLATRNCLIND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 513 DLkp~NILl~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||||+|||++. ++.+||+|||+++...... ......+|..|+|||.+.+.. ++.++||||||+++|||++| ..|
T Consensus 156 Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g-~~p 231 (360)
T 3e3p_A 156 DIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231 (360)
T ss_dssp CCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCS
T ss_pred cCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC-CCC
Confidence 99999999997 8999999999998653222 223456789999999987654 89999999999999999995 469
Q ss_pred CCCCCHHHHHHHHHcCC-------------------------------ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHH
Q psy5539 591 YYGLTHEEVVKYIKEGN-------------------------------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~-------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 639 (653)
|.+.+..+....+.... ....+...+.++.+|+.+||+.||.+|||+.+
T Consensus 232 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 311 (360)
T 3e3p_A 232 FRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311 (360)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHH
Confidence 98888776665554310 00112235688999999999999999999999
Q ss_pred HHHHHHH
Q psy5539 640 IYQTLWN 646 (653)
Q Consensus 640 il~~L~~ 646 (653)
+++|+|-
T Consensus 312 ~l~hp~f 318 (360)
T 3e3p_A 312 ALCHPYF 318 (360)
T ss_dssp HTTSGGG
T ss_pred HhcCccc
Confidence 9998763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.45 Aligned_cols=250 Identities=20% Similarity=0.261 Sum_probs=197.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK-- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~-- 441 (653)
..+|.+.+.||+|+||+||+|+... + ..||+|++..... ...+|+++++.++||||+++++++...+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~-----~-~~~aikk~~~~~~-----~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVE-----S-DEVAIKKVLQDKR-----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETT-----T-EEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECC-----C-CeEEEEEEecCcc-----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3578999999999999999998642 2 3488887754321 2347999999999999999999985433
Q ss_pred ----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 442 ----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 442 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++||||++++ |.+.+... ......+++..+..++.||+.||+|||+++|+||||||+
T Consensus 108 ~~~~~~~lv~e~~~~~-l~~~~~~~----------------~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~ 170 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPET-VYRASRHY----------------AKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQ 170 (394)
T ss_dssp SSCEEEEEEEECCSEE-HHHHHHHH----------------HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCceEEEEEeeccCcc-HHHHHHHH----------------HhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHH
Confidence 378999999874 44443311 112356899999999999999999999999999999999
Q ss_pred CEeEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 518 NCLIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 518 NILl~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|||++ +++.+||+|||+++...... ......+|..|+|||.+.+. .++.++||||||+++|||++| .+||.+.+
T Consensus 171 Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g-~~pf~~~~ 246 (394)
T 4e7w_A 171 NLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGES 246 (394)
T ss_dssp GEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred HEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhC-CCCCCCCC
Confidence 99999 79999999999998653222 22345678899999998765 589999999999999999995 56998887
Q ss_pred HHHHHHHHHcC-------------------Ccc---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEG-------------------NIL---------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~-------------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.+..+... ... ..+...++++.+|+.+||+.||.+|||+.++++|.|
T Consensus 247 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 324 (394)
T 4e7w_A 247 GIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324 (394)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence 76655444321 000 012347889999999999999999999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.05 Aligned_cols=255 Identities=20% Similarity=0.311 Sum_probs=201.5
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-----------CC
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-----------HP 428 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-----------Hp 428 (653)
..+..++|.+.+.||+|+||.||+|+.. .+++.||||+++.. ......+.+|+.++++++ |+
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 14 EPYKDARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGD--KVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CcccCCeEEEEEeeeecCCeEEEEEEec-----CCCcEEEEEEecCC--ccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 3455678999999999999999999863 45689999999753 234567889999999886 89
Q ss_pred ccceEEeEEecCC----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHh
Q psy5539 429 NIVKLLGVCAVGK----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYL 504 (653)
Q Consensus 429 nIv~l~g~~~~~~----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yL 504 (653)
||+++++++...+ ..++||||+ +++|.+++... ....+++..++.++.||+.||+||
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~------------------~~~~~~~~~~~~i~~qi~~aL~~l 147 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKY------------------EHRGIPLIYVKQISKQLLLGLDYM 147 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHT------------------TTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHh------------------hccCCcHHHHHHHHHHHHHHHHHH
Confidence 9999999987544 789999999 88999999732 123488999999999999999999
Q ss_pred hhC-CceecCCCCCCEeEc------CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHH
Q psy5539 505 SDR-KFVHRDLATRNCLIN------DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFG 577 (653)
Q Consensus 505 H~~-~ivHrDLkp~NILl~------~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlG 577 (653)
|++ +|+||||||+|||++ ..+.+||+|||+++.... ......+|+.|+|||.+.+..++.++||||||
T Consensus 148 H~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG 222 (373)
T 1q8y_A 148 HRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTA 222 (373)
T ss_dssp HHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHH
T ss_pred HhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHH
Confidence 998 999999999999994 445899999999976532 22345678999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCH------HHHHHHHHc--CC---------------------------------------ccC
Q psy5539 578 VCLWEIFSFALQPYYGLTH------EEVVKYIKE--GN---------------------------------------ILQ 610 (653)
Q Consensus 578 vvl~ellt~~~~p~~~~~~------~e~~~~i~~--~~---------------------------------------~~~ 610 (653)
+++|||++|. .||.+.+. .+.+..+.+ +. ...
T Consensus 223 ~il~el~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (373)
T 1q8y_A 223 CLIFELITGD-FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYK 301 (373)
T ss_dssp HHHHHHHHSS-CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTC
T ss_pred HHHHHHHhCC-CCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhccc
Confidence 9999999955 58875432 122222111 00 011
Q ss_pred CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 611 APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 611 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+...+.++.+|+.+||+.||.+|||++++++|.|-
T Consensus 302 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f 337 (373)
T 1q8y_A 302 FSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337 (373)
T ss_dssp CCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGG
T ss_pred CCcchHHHHHHHHHHHhccCccccCCHHHHhhChhh
Confidence 223446788999999999999999999999998763
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=345.34 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=186.1
Q ss_pred eeE-EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe--cCCce
Q psy5539 367 IIY-VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA--VGKPM 443 (653)
Q Consensus 367 ~~~-~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~--~~~~~ 443 (653)
|.+ .+.||+|+||+||+|+... ..++..||||+++..... ..+.+|+.++++++||||+++++++. .....
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~---~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKD---GKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp EECSSCCCC-----EEEEEEESS---SSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhcCcEeeecCCeEEEEEEEcc---CCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 444 3479999999999999642 235678999999754332 35789999999999999999999995 46789
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE--
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI-- 521 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl-- 521 (653)
++||||+. |+|.+++....... .......+++..++.|+.||+.||+|||+++|+||||||+||||
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~ 163 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASK-----------ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 163 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC------------------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECC
T ss_pred EEEEeCCC-CCHHHHHHHhcccc-----------ccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEec
Confidence 99999997 58998886332100 01122358999999999999999999999999999999999999
Q ss_pred --cCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 522 --NDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 522 --~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
++++.+||+|||+++........ .......+|+.|+|||.+.+. .++.++||||||+++|||++|. +||.+....
T Consensus 164 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~-~pf~~~~~~ 242 (405)
T 3rgf_A 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQED 242 (405)
T ss_dssp SSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSS-CTTCCCC--
T ss_pred CCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCC-CCCCCcccc
Confidence 77899999999999865432111 122345678999999999874 5899999999999999999954 588654431
Q ss_pred ---------HHHHHHHc--CCcc-----------------------------------CCCCCCcHHHHHHHHHhhccCC
Q psy5539 598 ---------EVVKYIKE--GNIL-----------------------------------QAPDNTPDALYDLMKLCWNMKP 631 (653)
Q Consensus 598 ---------e~~~~i~~--~~~~-----------------------------------~~~~~~~~~l~~li~~cl~~dP 631 (653)
+.+..+.. +... ......++.+.+|+.+||..||
T Consensus 243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP 322 (405)
T 3rgf_A 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322 (405)
T ss_dssp ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence 22222211 0000 0001125678999999999999
Q ss_pred CCCCCHHHHHHHHHH
Q psy5539 632 MNRPSFRTIYQTLWN 646 (653)
Q Consensus 632 ~~RPs~~eil~~L~~ 646 (653)
.+|||++++++|.|-
T Consensus 323 ~~R~ta~e~L~hp~f 337 (405)
T 3rgf_A 323 IKRITSEQAMQDPYF 337 (405)
T ss_dssp GGSCCHHHHHTSGGG
T ss_pred ccCCCHHHHhcChhh
Confidence 999999999999874
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=333.87 Aligned_cols=251 Identities=20% Similarity=0.325 Sum_probs=176.9
Q ss_pred CCCeeEEe-eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec---
Q psy5539 364 RNDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--- 439 (653)
Q Consensus 364 ~~~~~~~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--- 439 (653)
.++|.+.+ .||+|+||+||+|+.. .+++.||||++.... ... .+....++.++||||+++++++..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~-----~~~~~vavK~~~~~~--~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~ 96 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHR-----RTGQKCALKLLYDSP--KAR---QEVDHHWQASGGPHIVCILDVYENMHH 96 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEESSH--HHH---HHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cceeEecceeeeeCCCeEEEEEEEC-----CCCCEEEEEEecCcH--HHH---HHHHHHHHhcCCCChHHHHHHHhhccC
Confidence 35788855 6999999999999864 356889999997532 112 223344667799999999999875
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+...++||||+++|+|.+++... ....+++.+++.++.||+.||.|||+++|+||||||+|
T Consensus 97 ~~~~~~lv~e~~~gg~L~~~l~~~------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~N 158 (336)
T 3fhr_A 97 GKRCLLIIMECMEGGELFSRIQER------------------GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPEN 158 (336)
T ss_dssp TEEEEEEEEECCTTEEHHHHHHTC-------------------CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEEeccCCCCHHHHHHhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 45589999999999999999722 12468999999999999999999999999999999999
Q ss_pred EeEcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 519 CLIND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 519 ILl~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||++. ++.+||+|||+++..... ......+|+.|+|||.+.+..++.++||||||+++|||++|. .||.+..
T Consensus 159 Ill~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~-~pf~~~~ 233 (336)
T 3fhr_A 159 LLYTSKEKDAVLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGF-PPFYSNT 233 (336)
T ss_dssp EEESCSSTTCCEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSS-CCC----
T ss_pred EEEEecCCCceEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCC-CCCCCcc
Confidence 99976 456999999999764321 223446688999999998889999999999999999999955 5887655
Q ss_pred HHHH----HHHHHcCCc---cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 HEEV----VKYIKEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 ~~e~----~~~i~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
.... ...+..+.. ......++.++.+|+.+||+.||.+|||++++++++|--
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~ 292 (336)
T 3fhr_A 234 GQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWIN 292 (336)
T ss_dssp -----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHH
T ss_pred chhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccc
Confidence 4433 222222221 112246889999999999999999999999999998854
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=336.13 Aligned_cols=248 Identities=23% Similarity=0.331 Sum_probs=205.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhCC--CCccceE
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEFD--HPNIVKL 433 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l~--HpnIv~l 433 (653)
+...++|++.+.||+|+||.||+|+.. .+++.||||.++..... ...+.+.+|+.++++++ |+||+++
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEET-----TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 455678999999999999999999863 35689999998654221 11235678999999996 5999999
Q ss_pred EeEEecCCceEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceec
Q psy5539 434 LGVCAVGKPMCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHR 512 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHr 512 (653)
++++...+..++|+||+.+ ++|.+++.. ...+++..++.++.||+.||+|||+.+|+||
T Consensus 114 ~~~~~~~~~~~lv~e~~~~~~~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~ 173 (320)
T 3a99_A 114 LDWFERPDSFVLILERPEPVQDLFDFITE--------------------RGALQEELARSFFWQVLEAVRHCHNCGVLHR 173 (320)
T ss_dssp EEEEECSSEEEEEEECCSSEEEHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EEEEecCCcEEEEEEcCCCCccHHHHHhc--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeC
Confidence 9999999999999999976 899999973 2357899999999999999999999999999
Q ss_pred CCCCCCEeEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCC
Q psy5539 513 DLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQP 590 (653)
Q Consensus 513 DLkp~NILl~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p 590 (653)
||||+|||++ +++.+||+|||+++..... ......+|..|+|||.+.+..+ +.++||||||+++|||++|. .|
T Consensus 174 Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~-~p 248 (320)
T 3a99_A 174 DIKDENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-IP 248 (320)
T ss_dssp CCSGGGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS-CS
T ss_pred CCCHHHEEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC-CC
Confidence 9999999999 7899999999999765322 1234568899999999987776 68899999999999999955 57
Q ss_pred CCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 591 YYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 591 ~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
|... .+ +..+. ...+..+++++.+|+.+||+.||++|||+++|+++.|
T Consensus 249 f~~~--~~----~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~ 296 (320)
T 3a99_A 249 FEHD--EE----IIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 296 (320)
T ss_dssp CCSH--HH----HHHCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCh--hh----hhccc-ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence 7542 22 22232 3456778999999999999999999999999998875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=346.46 Aligned_cols=257 Identities=21% Similarity=0.266 Sum_probs=193.9
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
...+...+|...+.||+|+||+||.... .+++.||||++...... .+.+|+.+++.+ +|||||++++++
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~------~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~ 87 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGM------FDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTE 87 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEE------SSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEE------eCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEE
Confidence 3456667899999999999999654322 24578999998754322 356899999999 799999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
......++||||++ |+|.+++.... ..+....++.++.||+.||+|||+++|+||||||+
T Consensus 88 ~~~~~~~lv~E~~~-g~L~~~l~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 147 (432)
T 3p23_A 88 KDRQFQYIAIELCA-ATLQEYVEQKD-------------------FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147 (432)
T ss_dssp EETTEEEEEEECCS-EEHHHHHHSSS-------------------CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTT
T ss_pred ecCCEEEEEEECCC-CCHHHHHHhcC-------------------CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHH
Confidence 99999999999996 59999997221 22344456789999999999999999999999999
Q ss_pred CEeEcC-----CCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhc---cCCCCCchhHHHHHHHHHHHHhCCC
Q psy5539 518 NCLIND-----QMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 518 NILl~~-----~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~---~~~~t~ksDVwSlGvvl~ellt~~~ 588 (653)
|||++. ...+||+|||+++....... ........+|+.|+|||.+. ...++.++||||||+++|||++++.
T Consensus 148 NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~ 227 (432)
T 3p23_A 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227 (432)
T ss_dssp SEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSC
T ss_pred HEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCC
Confidence 999953 34688999999986543221 12233456899999999997 4678889999999999999999777
Q ss_pred CCCCCCCHHHHHHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.||...........+...... ......+..+.+|+.+||+.||.+|||+++|++|+|
T Consensus 228 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~ 286 (432)
T 3p23_A 228 HPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPF 286 (432)
T ss_dssp BTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTT
T ss_pred CCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCcc
Confidence 888765554433332222111 111224566899999999999999999999998764
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-38 Score=342.28 Aligned_cols=255 Identities=23% Similarity=0.291 Sum_probs=189.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~~~ 443 (653)
+.+...+.||+|+||+||.+.. .+++.||||++.... .+.+.+|+.++.++ +|||||++++++..++..
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~------~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 84 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGS------FQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFL 84 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEE------SSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEE
T ss_pred heeeccCeEeeCCCeEEEEEEE------ECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeE
Confidence 3456678899999999976532 346899999987543 23567899999876 899999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||++ |+|.+++....... ......++..++.++.||+.||+|||+++|+||||||+|||++.
T Consensus 85 ~lv~E~~~-gsL~~~l~~~~~~~-------------~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~ 150 (434)
T 2rio_A 85 YIALELCN-LNLQDLVESKNVSD-------------ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150 (434)
T ss_dssp EEEECCCS-EEHHHHHHTC-------------------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEC
T ss_pred EEEEecCC-CCHHHHHhccCCCc-------------hhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEec
Confidence 99999996 69999997432110 00111244456889999999999999999999999999999975
Q ss_pred C-------------CcEEEeccCcccccccccccc--CCCCCCCccccccchhhcc-------CCCCCchhHHHHHHHHH
Q psy5539 524 Q-------------MVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILY-------NKYTVESDVWAFGVCLW 581 (653)
Q Consensus 524 ~-------------~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~-------~~~t~ksDVwSlGvvl~ 581 (653)
+ +.+||+|||+++......... ......+|+.|+|||.+.+ ..++.++||||||+++|
T Consensus 151 ~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ 230 (434)
T 2rio_A 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY 230 (434)
T ss_dssp CHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHH
T ss_pred CcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHH
Confidence 4 489999999998764322111 1223468999999999976 67899999999999999
Q ss_pred HHHhCCCCCCCCCCHHHHHHHHHcCCc-cCCC-----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 582 EIFSFALQPYYGLTHEEVVKYIKEGNI-LQAP-----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 582 ellt~~~~p~~~~~~~e~~~~i~~~~~-~~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||+++|..||.+....+ . .+..+.. .... ..++.++.+|+.+||+.||.+|||+.+|++|+|
T Consensus 231 ellt~g~~Pf~~~~~~~-~-~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~ 298 (434)
T 2rio_A 231 YILSKGKHPFGDKYSRE-S-NIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298 (434)
T ss_dssp HHHTTSCCTTCSTTTHH-H-HHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred HHHhCCCCCCCCchhhH-H-HHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence 99997778987655443 2 2222221 1111 123578999999999999999999999998765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=331.21 Aligned_cols=248 Identities=24% Similarity=0.345 Sum_probs=197.1
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----HHHHHHHHHHHHHhhC----CCCccc
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----YLQTDFEREACLLAEF----DHPNIV 431 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----~~~~~f~~Ei~il~~l----~HpnIv 431 (653)
+.-.++|++.+.||+|+||.||+|+.. .++..||||+++..... .....+.+|+.++.++ +||||+
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRL-----TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECT-----TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEc-----cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 445678999999999999999999853 35688999999754321 1233466899999998 899999
Q ss_pred eEEeEEecCCceEEEEee-cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 432 KLLGVCAVGKPMCLLFEY-MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 432 ~l~g~~~~~~~~~LV~Ey-~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
++++++...+..++|+|| +.+++|.+++... ..+++..++.++.||+.||+|||+++|+
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 161 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEK--------------------GPLGEGPSRCFFGQVVAAIQHCHSRGVV 161 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHH--------------------CSCCHHHHHHHHHHHHHHHHHHHHHTEE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 999999999999999999 7899999999732 3488999999999999999999999999
Q ss_pred ecCCCCCCEeEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCC-CchhHHHHHHHHHHHHhCCC
Q psy5539 511 HRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYT-VESDVWAFGVCLWEIFSFAL 588 (653)
Q Consensus 511 HrDLkp~NILl~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t-~ksDVwSlGvvl~ellt~~~ 588 (653)
||||||+|||++ +++.+||+|||+++...... .....++..|+|||.+.+..+. .++||||||+++|||++|.
T Consensus 162 H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~- 236 (312)
T 2iwi_A 162 HRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD- 236 (312)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS-
T ss_pred ecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC-
Confidence 999999999999 88999999999998653322 2345678899999999877764 5899999999999999955
Q ss_pred CCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 589 QPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 589 ~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.||... .+ +... ....+..++.++.+++.+||+.+|++|||+++++++.|
T Consensus 237 ~pf~~~--~~----~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~ 286 (312)
T 2iwi_A 237 IPFERD--QE----ILEA-ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPW 286 (312)
T ss_dssp CSCCSH--HH----HHHT-CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTT
T ss_pred CCCCCh--HH----Hhhh-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 577542 22 2222 23466788999999999999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=315.18 Aligned_cols=230 Identities=13% Similarity=0.074 Sum_probs=188.9
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+..++|++.+.||+|+||.||+|++. .+++.||||+++.... ....+.+.+|+.++++++||||+++++++..
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 102 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDT-----ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT 102 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEET-----TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEec-----CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence 45578999999999999999999864 3568999999976532 4556789999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
++..++||||+++++|.++++. .....++.+|+.||+.||+|||+++|+||||||+||
T Consensus 103 ~~~~~lv~e~~~g~~L~~~l~~----------------------~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI 160 (286)
T 3uqc_A 103 RAGGLVVAEWIRGGSLQEVADT----------------------SPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV 160 (286)
T ss_dssp TTEEEEEEECCCEEEHHHHHTT----------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred CCcEEEEEEecCCCCHHHHHhc----------------------CCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence 9999999999999999999851 135567889999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.+||+++|. ++ .++.++||||||+++|||++|. .||.+.+..+.
T Consensus 161 ll~~~g~~kl~~~~~----------------------~~-------~~~~~~Di~slG~il~elltg~-~Pf~~~~~~~~ 210 (286)
T 3uqc_A 161 RVSIDGDVVLAYPAT----------------------MP-------DANPQDDIRGIGASLYALLVNR-WPLPEAGVRSG 210 (286)
T ss_dssp EEETTSCEEECSCCC----------------------CT-------TCCHHHHHHHHHHHHHHHHHSE-ECSCCCSBCCC
T ss_pred EEcCCCCEEEEeccc----------------------cC-------CCCchhHHHHHHHHHHHHHHCC-CCCCcCCcchh
Confidence 999999999985543 22 3688999999999999999955 58876554321
Q ss_pred HH---HHHcCCcc---CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 600 VK---YIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 600 ~~---~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+. ....+... .....+++++.+++.+||+.||++| |+.++++.|..+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 211 LAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp SEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred hHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 10 00011111 1235688999999999999999999 99999999988754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=315.36 Aligned_cols=230 Identities=22% Similarity=0.366 Sum_probs=182.5
Q ss_pred CCeeEE-eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHH-hhCCCCccceEEeEEec---
Q psy5539 365 NDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL-AEFDHPNIVKLLGVCAV--- 439 (653)
Q Consensus 365 ~~~~~~-~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il-~~l~HpnIv~l~g~~~~--- 439 (653)
++|.+. +.||+|+||.||+|+.. .++..||||+++.. ..+.+|+.++ +.++||||+++++++..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~ 85 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 85 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cchhhcCcccccCCCeEEEEEEEc-----CCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcC
Confidence 356666 78999999999999864 35689999999642 2466788887 66699999999999876
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+...++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++|+||||||+|
T Consensus 86 ~~~~~~lv~e~~~~~~L~~~l~~~------------------~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~N 147 (299)
T 3m2w_A 86 GRKCLLIVMECLDGGELFSRIQDR------------------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 147 (299)
T ss_dssp TEEEEEEEECCCCSCBHHHHHHHC------------------TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCceEEEEEeecCCCcHHHHHHhc------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 67789999999999999999732 12458999999999999999999999999999999999
Q ss_pred EeEcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 519 CLIND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 519 ILl~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||++. ++.+||+|||++.... +..++.++||||||+++|||++| ..||.+..
T Consensus 148 il~~~~~~~~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg-~~pf~~~~ 202 (299)
T 3m2w_A 148 LLYTSKRPNAILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCG-YPPFYSNH 202 (299)
T ss_dssp EEESSSSTTCCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHS-SCSCCC--
T ss_pred EEEecCCCCCcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHC-CCCCCCCc
Confidence 99998 7899999999986431 23567899999999999999995 45887665
Q ss_pred HHHHHHHHHcCC---ccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGN---ILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 596 ~~e~~~~i~~~~---~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
..+....+.... ....+ ..++.++.+++.+||+.||.+|||++++++|+|-..
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~ 262 (299)
T 3m2w_A 203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 262 (299)
T ss_dssp -----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred chhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence 443322111110 01112 457899999999999999999999999999988543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-36 Score=349.67 Aligned_cols=245 Identities=19% Similarity=0.217 Sum_probs=196.0
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||.||+|++.. .+++.||||++...........+.+|+.++++++||||+++++++...
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~----~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRN----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGG----GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcC----CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 4445789999999999999999998632 256889999997665566677899999999999999999999999876
Q ss_pred Cc-----eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 441 KP-----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 441 ~~-----~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
+. .+|||||+++++|.+++. ..+++.+++.|+.||+.||.|||+++|+|||||
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~----------------------~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlk 209 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKG----------------------QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLK 209 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC--------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHh----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeecccC
Confidence 55 699999999999988764 258999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||++++ .+||+|||+++.... .....+|+.|+|||.+.+.. +.++||||||+++|||++| .+|+.+..
T Consensus 210 p~NIll~~~-~~kl~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g-~~~~~~~~ 280 (681)
T 2pzi_A 210 PENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLD-LPTRNGRY 280 (681)
T ss_dssp GGGEEECSS-CEEECCCTTCEETTC------CSCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSC-CCEETTEE
T ss_pred hHHeEEeCC-cEEEEecccchhccc------CCccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhC-CCCCcccc
Confidence 999999986 899999999976532 13456889999999987754 8999999999999999985 55665421
Q ss_pred HHHHHHHHHcCCccCC--CCCCcHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQA--PDNTPDALYDLMKLCWNMKPMNRPS-FRTIYQTLWNIKR 649 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs-~~eil~~L~~l~~ 649 (653)
.. ..... ....++.+.+|+.+||+.||.+||+ ++++.+.+..+.+
T Consensus 281 ~~---------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 281 VD---------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp CS---------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred cc---------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 10 00000 0113478999999999999999995 5556666655543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=350.12 Aligned_cols=255 Identities=21% Similarity=0.258 Sum_probs=199.1
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----- 439 (653)
++|++.+.||+|+||.||+|... .++..||||+++........+.+.+|++++++++||||+++++++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~-----~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQ-----DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCT-----TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCC
T ss_pred CCeEEEEEEeeCCCeEEEEEEEC-----CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccccccc
Confidence 57889999999999999999753 45678999999876666677789999999999999999999998755
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
++..++||||+++|+|.+++.... ....+++..++.++.||+.||+|||+.+|+||||||+|
T Consensus 89 ~~~~~~LVmEy~~ggsL~~~L~~~~-----------------~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~N 151 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGGDLRKYLNQFE-----------------NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPEN 151 (676)
T ss_dssp TTSSCCCEEECCSSCBHHHHHHSSS-----------------CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTT
T ss_pred CCCeEEEEEEeCCCCCHHHHHHhcc-----------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHH
Confidence 677899999999999999997321 12358888999999999999999999999999999999
Q ss_pred EeEcCCCc---EEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 519 CLINDQMV---VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 519 ILl~~~~~---vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||++.++. +||+|||++....... ......+|..|+|||.+.+..++.++||||||+++|||++|.. ||.+..
T Consensus 152 ILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~-Pf~~~~ 227 (676)
T 3qa8_A 152 IVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR-PFLPNW 227 (676)
T ss_dssp EEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCS-SCCSSC
T ss_pred eEeecCCCceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCC-CCCccc
Confidence 99997664 9999999998653222 2234568899999999999999999999999999999999654 775543
Q ss_pred HHHH-HHHH-------------HcCC-----ccCC----CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEV-VKYI-------------KEGN-----ILQA----PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~-~~~i-------------~~~~-----~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...- ...+ ..+. ..+. ...+++.+.+++..||..||++|||+++++++.|
T Consensus 228 ~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~ 300 (676)
T 3qa8_A 228 QPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300 (676)
T ss_dssp HHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTT
T ss_pred chhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHH
Confidence 2211 0000 0000 0011 1235688999999999999999999998765544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.97 Aligned_cols=253 Identities=14% Similarity=0.088 Sum_probs=189.1
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH--HHHHHHHHHHHHHhhCCC-Cccce------
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE--YLQTDFEREACLLAEFDH-PNIVK------ 432 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~--~~~~~f~~Ei~il~~l~H-pnIv~------ 432 (653)
....+|...+.||+|+||.||+|++. .+++.||||+++..... ...+.+.+|+.+++.++| +|...
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~-----~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQ-----ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCceeEEEecccccCCCEEEEEEEec-----CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 34456888899999999999999964 35679999998743222 224678999999999987 22111
Q ss_pred ---EEeE------------Eec-----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHH
Q psy5539 433 ---LLGV------------CAV-----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT 492 (653)
Q Consensus 433 ---l~g~------------~~~-----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 492 (653)
.+.. ... ....+++|+++ +++|.++++.... .......+++..++.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~-------------~~~~~~~l~~~~~~~ 215 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS-------------HSSTHKSLVHHARLQ 215 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHH-------------HTTTSHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhc-------------ccccCCCCCHHHHHH
Confidence 1111 111 22456777765 6899999863210 011234578889999
Q ss_pred HHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhh----------
Q psy5539 493 IALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESI---------- 562 (653)
Q Consensus 493 i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~---------- 562 (653)
|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++..... .....+ +.|||||.+
T Consensus 216 i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~ 289 (413)
T 3dzo_A 216 LTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQH 289 (413)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGG
T ss_pred HHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccc
Confidence 9999999999999999999999999999999999999999998764322 223345 899999999
Q ss_pred ccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 563 LYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 563 ~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
....++.++||||||+++|||++|. .||.+.+..+....+ ......+++++.+||.+||+.||++||++.++++
T Consensus 290 ~~~~~~~~~DvwSlGvil~elltg~-~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 290 HPTLMTFAFDTWTLGLAIYWIWCAD-LPNTDDAALGGSEWI-----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp CCEEECHHHHHHHHHHHHHHHHHSS-CCCCTTGGGSCSGGG-----GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred cCcCCCchhhHHHHHHHHHHHHHCC-CCCCCcchhhhHHHH-----HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 5556889999999999999999954 588776654433322 2223467899999999999999999999999987
Q ss_pred HHH
Q psy5539 643 TLW 645 (653)
Q Consensus 643 ~L~ 645 (653)
+.|
T Consensus 364 ~~~ 366 (413)
T 3dzo_A 364 TPE 366 (413)
T ss_dssp SHH
T ss_pred CHH
Confidence 754
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=318.07 Aligned_cols=242 Identities=18% Similarity=0.205 Sum_probs=184.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-------cHHHHHHHHHHHHHHhhCC--------
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-------SEYLQTDFEREACLLAEFD-------- 426 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-------~~~~~~~f~~Ei~il~~l~-------- 426 (653)
+..++|++.+.||+|+||+||+|+. +++.||||+++... .....+.+.+|+.+++.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~-------~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~ 89 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA-------DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCN 89 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE-------TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSS
T ss_pred cccccchheeeecccCceEEEEEEe-------CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccc
Confidence 3446788899999999999999986 34899999997542 1222356889999998886
Q ss_pred -CCccceEEeEEe-----------------c-------------CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccc
Q psy5539 427 -HPNIVKLLGVCA-----------------V-------------GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSM 475 (653)
Q Consensus 427 -HpnIv~l~g~~~-----------------~-------------~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~ 475 (653)
|||||++.+++. . .+..+|||||+++|++.+.+.
T Consensus 90 ~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~--------------- 154 (336)
T 2vuw_A 90 RTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR--------------- 154 (336)
T ss_dssp BCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT---------------
T ss_pred cCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH---------------
Confidence 777777766542 2 678999999999998766653
Q ss_pred cccccCCCCCCHHHHHHHHHHHHHHHHHhh-hCCceecCCCCCCEeEcCCC--------------------cEEEeccCc
Q psy5539 476 ESSIHRVPQLSTCDLITIALQIASGMVYLS-DRKFVHRDLATRNCLINDQM--------------------VVKIADFGL 534 (653)
Q Consensus 476 ~~~~~~~~~l~~~~~~~i~~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~--------------------~vkI~DfGl 534 (653)
...+++..++.++.||+.||+||| +++|+||||||+||||+.++ .+||+|||+
T Consensus 155 ------~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~ 228 (336)
T 2vuw_A 155 ------TKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTL 228 (336)
T ss_dssp ------TTCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTT
T ss_pred ------hcCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccc
Confidence 134789999999999999999999 99999999999999999887 999999999
Q ss_pred cccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHH-HHHHHhCCCCCCCCCCH-HHHHHHHHcCC-ccCC
Q psy5539 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVC-LWEIFSFALQPYYGLTH-EEVVKYIKEGN-ILQA 611 (653)
Q Consensus 535 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvv-l~ellt~~~~p~~~~~~-~e~~~~i~~~~-~~~~ 611 (653)
|+.... ....+|..|||||.+.+.. +.++||||||.+ .+++++ +..||.+... ..+.+.+.... ....
T Consensus 229 a~~~~~-------~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 299 (336)
T 2vuw_A 229 SRLERD-------GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWG-EYHPYSNVLWLHYLTDKMLKQMTFKTK 299 (336)
T ss_dssp CBEEET-------TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTT-SCCTHHHHHHHHHHHHHHHHTCCCSSC
T ss_pred cEecCC-------CcEEEeecccChhhhcCCC-ccceehhhhhCCCCccccc-ccCCCcchhhhhHHHHhhhhhhccCcc
Confidence 986532 1236788999999998766 899999998777 555665 4456643211 22333333221 1111
Q ss_pred -----CCCCcHHHHHHHHHhhccCCCCCCCHHHHH-HHHH
Q psy5539 612 -----PDNTPDALYDLMKLCWNMKPMNRPSFRTIY-QTLW 645 (653)
Q Consensus 612 -----~~~~~~~l~~li~~cl~~dP~~RPs~~eil-~~L~ 645 (653)
+..+++++.+|+++||+.| |+++++ +|+|
T Consensus 300 ~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~ 334 (336)
T 2vuw_A 300 CNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334 (336)
T ss_dssp CCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred cchhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCC
Confidence 1236788999999999976 999999 8865
|
| >1i71_A APO(A), apolipoprotein(A); alipoprotein(A), kringle, protein-ligand interaction, lysine binding, hydrolase; 1.45A {Homo sapiens} SCOP: g.14.1.1 PDB: 1kiv_A 3kiv_A 4kiv_A 1krn_A 1pmk_A 2pk4_A 1pk4_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=220.54 Aligned_cols=82 Identities=45% Similarity=1.038 Sum_probs=78.6
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
+||.|+|.+|||++++|.+|++||+|+++.||.|.+.+..+|..++.|||||||||+. +|||||+++.++||||+||+|
T Consensus 1 ~C~~g~G~~YRG~~s~T~sG~~Cq~W~s~~ph~h~~~~~~~p~~gl~~NyCRNPdg~~-~PWCyt~d~~~~weyC~ip~C 79 (83)
T 1i71_A 1 DCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEI-RPWCYTMDPSVRWEYCNLTQC 79 (83)
T ss_dssp CEECTTSTTCCCCCCBBTTSCBBCCTTCCSSCCCCCSTTTCTTTTCCTTCCBCSSSCS-SCEEEBSSTTCCEEEBSCEEC
T ss_pred CCccCCCCccEeccccCCCCCccCCCCCCCccccccchhhCcccCcCcccccCCCCCC-CCceEeCCCCeeeEeCCCCcC
Confidence 5999999999999999999999999999999999999999999999999999999995 999999999999999999999
Q ss_pred CCC
Q psy5539 266 ADS 268 (653)
Q Consensus 266 ~~~ 268 (653)
.+.
T Consensus 80 ~~~ 82 (83)
T 1i71_A 80 PVM 82 (83)
T ss_dssp CCC
T ss_pred CCC
Confidence 863
|
| >2qj2_A Hepatocyte growth factor; HGF/SF, hormone/growth factor; 1.81A {Homo sapiens} SCOP: g.10.1.1 g.14.1.1 PDB: 1nk1_A 3mkp_A* 1gmn_A* 1gmo_A* 1bht_A* 1gp9_A* 2qj4_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-32 Score=253.84 Aligned_cols=141 Identities=31% Similarity=0.707 Sum_probs=109.9
Q ss_pred CCCcccchhhhhh--hccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccccccccccc
Q psy5539 111 SLPLCYEDCIAVR--YSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188 (653)
Q Consensus 111 ~~p~C~~~c~~~~--~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~~~~~~~C~ 188 (653)
+..-|+..|...+ ...| ++|.+.. ....|+.+|....+.....-....+....+.....+||
T Consensus 41 ~~e~Ca~~C~~~~~~~~~C-~af~y~~---------------~~~~C~~~p~~~~s~~~~~~~~~~~~~~~~~~~~~~Cy 104 (184)
T 2qj2_A 41 TADQCANRCTRNKGLPFTC-KAFVFDK---------------ARKQCLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCI 104 (184)
T ss_dssp CHHHHHHHHHTTTTCSSCC-CEEEEET---------------TTTEEEEESSCTTSTTEEEEECTTEEEEEEGGGSCCSB
T ss_pred CHHHHHHHHHhccCCccee-ecceEec---------------cCCeEEEcCCcCCCchhhhhcCcccccccccccccCCc
Confidence 4678999999876 4667 4554432 22349999976533322111111111122333467899
Q ss_pred cCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCCCC
Q psy5539 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267 (653)
Q Consensus 189 ~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C~~ 267 (653)
.|+|.+|||++++|.+|++||+|+++.||.|.+.|..+|..++.|||||||||++.+|||||+++.++||||+||.|++
T Consensus 105 ~G~G~~YRGt~s~T~SG~~Cq~W~s~~ph~h~~~p~~~p~~~l~hNYCRNPDgd~~~PWCYt~d~~~~wEyCdIp~C~~ 183 (184)
T 2qj2_A 105 IGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSE 183 (184)
T ss_dssp SSSCTTCCCCCCBBTTCCBBCCTTCCSSCCCCCCGGGGTTSCCCTTCCBCSSCCTTCSEEEBSSTTCCEEEBCCCBTTC
T ss_pred cCCCCCCccccccCCCCCCCCCCCCCCccccccccccccCcCCCCCcccCCCCCCCCCceEcCCCCcceeeCCCCcCCC
Confidence 9999999999999999999999999999999999999999999999999999997799999999999999999999975
|
| >5hpg_A Plasminogen; serine protease, kringle 5, fibrinolysis; 1.66A {Homo sapiens} SCOP: g.14.1.1 PDB: 2knf_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-31 Score=216.59 Aligned_cols=82 Identities=44% Similarity=0.980 Sum_probs=78.5
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCC-CCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE-RPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~-~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
|||.|+|.+|||++++|.+|++||+|+++.+|.|. +.+..+|..+++|||||||||+..+|||||+++.++||||+||.
T Consensus 1 dC~~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~p~~gl~~NyCRNPdgd~~~PWCyt~~~~~~weyC~ip~ 80 (84)
T 5hpg_A 1 DCMFGNGKGYRGKRVTTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQ 80 (84)
T ss_dssp CCBSTTCTTCCCCCCBCTTSCBBCCTTCCSSSCCSSSCTTTSTTSCCCTTCCBCTTCCTTCCEEEBSCTTCCEEECCCCB
T ss_pred CCcccCCCcCCcccccCCCCCcCccCcCcCcccccccCcccCcccCcccccccCCCCCCCCCEeEECCCCceeEeCCCCc
Confidence 69999999999999999999999999999999998 88889999999999999999997799999999999999999999
Q ss_pred CCC
Q psy5539 265 CAD 267 (653)
Q Consensus 265 C~~ 267 (653)
|++
T Consensus 81 C~~ 83 (84)
T 5hpg_A 81 CAA 83 (84)
T ss_dssp CCC
T ss_pred CCC
Confidence 975
|
| >1jfn_A APO(A) KIV-T6, apolipoprotein A, KIV-T6, apolipoprotein; kringle domain, protein-protein recognition, LP(A), lipid transport; NMR {Homo sapiens} SCOP: g.14.1.1 | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-30 Score=225.01 Aligned_cols=86 Identities=45% Similarity=0.989 Sum_probs=81.3
Q ss_pred cccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeeccc
Q psy5539 183 ITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEI 262 (653)
Q Consensus 183 ~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~i 262 (653)
...+||.|+|.+|||++++|.+|++||+|+++.+|.|.+.+..+|..+++|||||||||+. +|||||+++.++||||+|
T Consensus 21 ~~~~Cy~g~G~~YRG~~s~T~sG~~Cq~W~s~~ph~h~~~~~~~p~~gL~hNYCRNPDgd~-~PWCYt~d~~~~weyCdI 99 (119)
T 1jfn_A 21 GVQDCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEI-SPWCYTMDPNVRWEYCNL 99 (119)
T ss_dssp CCCCCBSTTTTTCCSCCCBBTTSCBBCCTTCCSSSCCSSCGGGCTTTCCCTTCCBCTTCCS-SCEEEBSSTTCCEEEBSC
T ss_pred CcCcCCCCCCCccccccccCCCCCcCCCCcCCCccccccChhhCcccCcCCccccCCCCCC-CCceEeCCCCeeeEecCC
Confidence 4568999999999999999999999999999999999999999999999999999999995 999999999999999999
Q ss_pred CCCCCCC
Q psy5539 263 PTCADSM 269 (653)
Q Consensus 263 p~C~~~~ 269 (653)
|.|.+..
T Consensus 100 p~C~~~~ 106 (119)
T 1jfn_A 100 TQCPVTE 106 (119)
T ss_dssp CBCCCCS
T ss_pred CcCCCCC
Confidence 9998654
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3e-29 Score=283.35 Aligned_cols=183 Identities=13% Similarity=0.017 Sum_probs=126.2
Q ss_pred eecccCCeeEEEEEeCCCCCCccceEEEEEEcccc---------ccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecCC
Q psy5539 372 DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---------ASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGK 441 (653)
Q Consensus 372 ~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~---------~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~~ 441 (653)
.++.|++|.+..++- ...+..+++|.+... ..+...++|.+|+++|+++ .|+||+++++++++++
T Consensus 241 ~~~~~~~~~h~~~rr-----~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~ 315 (569)
T 4azs_A 241 QPYAGAGLAHKRSRR-----YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ 315 (569)
T ss_dssp C-C--------CCEE-----EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred ccccCCccccccccc-----ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence 457777777766542 234677999998643 2234456799999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..||||||++||+|.++|+. .++++.. +|+.||+.||+|||++|||||||||+||||
T Consensus 316 ~~yLVMEyv~G~~L~d~i~~--------------------~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL 372 (569)
T 4azs_A 316 SGWLVMEKLPGRLLSDMLAA--------------------GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV 372 (569)
T ss_dssp EEEEEEECCCSEEHHHHHHT--------------------TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE
T ss_pred EEEEEEecCCCCcHHHHHHh--------------------CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE
Confidence 99999999999999999972 2345543 588999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHh
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt 585 (653)
+++|.+||+|||+|+...... .......||+.|||||++.+ ++..++|+||+|++++++.+
T Consensus 373 ~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 373 DARQHARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp CTTSCEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred CCCCCEEEeecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 999999999999998653221 11223457899999998865 56788999999998887654
|
| >1pml_A Tissue plasminogen activator kringle 2; hydrolase(serine protease); 2.38A {Homo sapiens} SCOP: g.14.1.1 PDB: 1pk2_A* 1tpk_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-29 Score=209.04 Aligned_cols=80 Identities=31% Similarity=0.796 Sum_probs=72.0
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCC--CCCCCC-CCCccCCCCCCCCCCeEEEe-CCCcceeecc
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPV--FPELNN-SENYCRNAGGEEPSPWCYTM-DPNVRWQRCE 261 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~--~~~~~~-~~nyCRNp~~~~~~pWC~~~-~~~~~~~~C~ 261 (653)
+||.|+|.+|||++++|.||++||+|+++.+|.|.+.+.. +|.+++ .|||||||||+. +|||||+ ++.++||||+
T Consensus 2 ~C~~g~G~~YRG~~s~T~sG~~Cq~W~s~~~~~~~~~~~~~~~~~~glg~~NyCRNPdg~~-~PWCyt~~~~~~~weyC~ 80 (86)
T 1pml_A 2 DCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDA-KPWCHVLKNRRLTWEYCD 80 (86)
T ss_dssp CSBCTTSTTCCCCCCBBTTSCBCCCTTCGGGTTCSSSTTSTTHHHHTCSSSCCCBCSSCCS-SCEEEEEETTEEEEEEBC
T ss_pred cCccCCCccceeccccCCCCCccCCCCCCCccccccCcccccccccccccCccccCCCCCC-CCceEecCCCCeeeEecC
Confidence 6999999999999999999999999999999999887654 344455 799999999997 9999997 7789999999
Q ss_pred cCCCC
Q psy5539 262 IPTCA 266 (653)
Q Consensus 262 ip~C~ 266 (653)
||.|+
T Consensus 81 ip~C~ 85 (86)
T 1pml_A 81 VPSCS 85 (86)
T ss_dssp CCBTT
T ss_pred CccCC
Confidence 99996
|
| >3sp8_A Hepatocyte growth factor alpha chain; kringle domain, Met tyrosine kinase, hormone; HET: MES; 1.86A {Homo sapiens} PDB: 3hn4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.5e-30 Score=252.57 Aligned_cols=141 Identities=31% Similarity=0.702 Sum_probs=117.4
Q ss_pred CCCcccchhhhhhh--ccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccccccccccc
Q psy5539 111 SLPLCYEDCIAVRY--SFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKTDEITYDCI 188 (653)
Q Consensus 111 ~~p~C~~~c~~~~~--~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~~~~~~~C~ 188 (653)
...-|+..|+..+. +.| ++|.+...+.+ |+.||....+.....=..+.+....+..+..+||
T Consensus 41 ~~~~ca~~c~~~~~~~f~c-raf~~~~~~~~---------------c~~~~~~~~s~~~~~~~~~~~~l~ekk~~~~~Cy 104 (264)
T 3sp8_A 41 TADQCANRCTRNKGLPFTC-KAFVFDKARKQ---------------CLWFPFNSMSSGVKKEFGHEFDLYENKDYIRNCI 104 (264)
T ss_dssp CHHHHHHHHHSTTCSSSCC-CEEEEETTTTE---------------EEEESCCTTSTTEEEEECTTEEEEEEHHHHCSSB
T ss_pred CHHHHHHHHhhccCCCccc-cceeeeccCCe---------------EEEccccCCCCceEeecCccEEeeecCCccccCc
Confidence 45679999999877 666 78877665554 9999988755443222222223344445678999
Q ss_pred cCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCCCC
Q psy5539 189 RGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCAD 267 (653)
Q Consensus 189 ~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C~~ 267 (653)
.|+|.+|||++++|.+|++||+|+++.||.|.+.|..+|..++.|||||||||+..+|||||+++.++||||+||.|.+
T Consensus 105 ~g~G~~YRGt~s~T~sG~~Cq~W~S~~ph~~~~~p~~~p~~~L~~NYCRNPDgd~~~PWCyt~~p~~rweyC~Ip~C~e 183 (264)
T 3sp8_A 105 IGKGRSYKGTVSITKSDIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQCSE 183 (264)
T ss_dssp STTCTTCCCCCCBCTTCCBBCCTTCCSSSCCSCCTTTSTTTTCCTTCCBCTTCCTTCSEEEBSSTTCCEEECCCCBHHH
T ss_pred cCCCCCceeccccCCCCCcCCCCcccCccccccCcccccccccccccccCCCCCcCCCccccccCCccccccccccccc
Confidence 9999999999999999999999999999999999999999999999999999998799999999999999999999974
|
| >3k65_A Prothrombin; coagulation, zymogen, hydrolase; 1.85A {Homo sapiens} PDB: 2hpq_P* 2hpp_P* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.8e-29 Score=218.85 Aligned_cols=88 Identities=27% Similarity=0.694 Sum_probs=76.5
Q ss_pred ccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccC
Q psy5539 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIP 263 (653)
Q Consensus 184 ~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip 263 (653)
..+||.|+|.+|||++++|.+|++||+|+++.+|.|.+.+..+|...+.||||||||++..+|||||+++.++||||+||
T Consensus 12 ~~~Cy~g~G~~YRG~~s~T~sG~~Cq~W~s~~~~~~~~~p~~~~~~~l~hNYCRNPDgd~~gPWCYt~d~~~~weyCdIp 91 (116)
T 3k65_A 12 LEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLN 91 (116)
T ss_dssp --CCBCGGGTTCCCCCCBCTTSCBCCCTTSHHHHHHHTTSCCCTTSCCCTTCCBCTTCCTTCCEEECSSSTTCEEECCCC
T ss_pred cCcCccCCCCCCccccccCCCCCccCcCcccCccccccCcccCcccccccccccCCCCCCCCCeeEeCCCCceeEeCCCC
Confidence 45799999999999999999999999999999888877788889888999999999999889999999999999999999
Q ss_pred CCCCCCcc
Q psy5539 264 TCADSMQD 271 (653)
Q Consensus 264 ~C~~~~~~ 271 (653)
.|.+....
T Consensus 92 ~C~~~~~~ 99 (116)
T 3k65_A 92 YCEEAVEE 99 (116)
T ss_dssp BC------
T ss_pred cCCCcccc
Confidence 99876543
|
| >1nl1_A Prothrombin; hydrolase; HET: CGU NAG; 1.90A {Bos taurus} SCOP: g.14.1.1 g.32.1.1 PDB: 2pf2_A* 2pf1_A* 1nl2_A* 2spt_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.5e-28 Score=220.77 Aligned_cols=83 Identities=37% Similarity=0.893 Sum_probs=79.9
Q ss_pred cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 185 ~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
.+||.|+|.+|||++++|.+|++||+|+++.||.|.+.+..+|..++.|||||||||+..+|||||+++.++||||+||.
T Consensus 64 g~C~~g~G~~YRG~~s~T~sG~~Cq~W~s~~ph~~~~~~~~~p~~~l~~NYCRNPd~~~~~PWCYt~d~~~~weyC~ip~ 143 (147)
T 1nl1_A 64 GNCAEGVGMNYRGNVSVTRSGIECQLWRSRYPHKPEINSTTHPGADLRENFCRNPDGSITGPWCYTTSPTLRREECSVPV 143 (147)
T ss_dssp TSSBCTTSTTCCCCCCBBTTSCBBCCTTCCSSSCCSSCTTTSTTSCCCTTCCBCTTCCTTCSEEEBSSTTCCEEEBCCCB
T ss_pred CcCCCCCCCccccccccCCCCCcCCCCcccCccccccCcccCccccCCCccCcCCCCCCCCCceEeCCCCcceeeCCCCC
Confidence 57999999999999999999999999999999999999999999889999999999997799999999999999999999
Q ss_pred CCC
Q psy5539 265 CAD 267 (653)
Q Consensus 265 C~~ 267 (653)
|++
T Consensus 144 C~~ 146 (147)
T 1nl1_A 144 CGQ 146 (147)
T ss_dssp TTC
T ss_pred CCC
Confidence 975
|
| >3sp8_A Hepatocyte growth factor alpha chain; kringle domain, Met tyrosine kinase, hormone; HET: MES; 1.86A {Homo sapiens} PDB: 3hn4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.1e-28 Score=240.54 Aligned_cols=114 Identities=39% Similarity=1.006 Sum_probs=102.1
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|+++++.+ ..|||+..-..++++|| .+|.|.
T Consensus 151 YCRNPDgd~-~~PWCyt~~p~~rweyC-----------------------~Ip~C~------------------------ 182 (264)
T 3sp8_A 151 YCRNPRGEE-GGPWCFTSNPEVRYEVC-----------------------DIPQCS------------------------ 182 (264)
T ss_dssp CCBCTTCCT-TCSEEEBSSTTCCEEEC-----------------------CCCBHH------------------------
T ss_pred cccCCCCCc-CCCccccccCCcccccc-----------------------cccccc------------------------
Confidence 577777643 36999998889999999 455561
Q ss_pred cccccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeec
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C 260 (653)
..+||.|+|.+|||++++|.+|++||+|+++.||.|.+.+..+|+.++.|||||||||+. +|||||+++.++||||
T Consensus 183 ---e~~C~~g~G~~YRG~vs~T~sG~~Cq~W~s~~ph~h~~~~~~~p~~gL~~NYCRNPDgd~-~PWCyt~dp~~~weyC 258 (264)
T 3sp8_A 183 ---EVECMTSNGESYRGLMDHTESGKICQRWDHQTPHRHKFLPERYPDKGFDDNYCRNPDGQP-RPWCYTLDPHTRWEYC 258 (264)
T ss_dssp ---HHCEESTTSTTCCSCCCBCTTCCBBCCTTCCSSSCCSCCTTTCTTSCCCTTCCBCCSCCS-SCEEEBSCTTCSEEEC
T ss_pred ---cccccccCcccccceeeECCCCCccCCCcccCccccccChhhCcccCcccccccCCCCCC-CCceEeCCCCceeEec
Confidence 136999999999999999999999999999999999999999999999999999999997 9999999999999999
Q ss_pred ccCCCC
Q psy5539 261 EIPTCA 266 (653)
Q Consensus 261 ~ip~C~ 266 (653)
+||.|.
T Consensus 259 dIp~C~ 264 (264)
T 3sp8_A 259 KIKTCK 264 (264)
T ss_dssp CCEECC
T ss_pred CCccCC
Confidence 999994
|
| >3e6p_L Prothrombin; meizothrombin, allostery, linkage, Na+ binding, AC phase, blood coagulation, cleavage on PAIR of basic residue disease mutation; HET: DFK NAG; 2.10A {Homo sapiens} PDB: 1a0h_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-28 Score=223.41 Aligned_cols=88 Identities=27% Similarity=0.694 Sum_probs=80.7
Q ss_pred ccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccC
Q psy5539 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIP 263 (653)
Q Consensus 184 ~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip 263 (653)
..+||.|+|.+|||++++|.+|++||+|+++.+|.|.+.+..+|...+.||||||||++..+|||||+++.++||||+||
T Consensus 5 ~~~Cy~g~G~~YRGt~s~T~sG~~Cq~W~s~~~h~~~~~p~~~p~~~l~hNYCRNPDgd~~gPWCYt~d~~~~weyCdIp 84 (158)
T 3e6p_L 5 LEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLN 84 (158)
T ss_dssp --CCBCGGGSSCCCCCCBCTTSCBCCCTTSHHHHHHHTTSCCCTTSCCCTTCCBCTTCCTTCCEEECSSSTTCEEECCCC
T ss_pred cccCccCCCCCCccccccCCCCCccCcCcccCccccccCcccCcccccccccccCCCCCCCCCeeEeCCCCceeeeCCCC
Confidence 35799999999999999999999999999999988888888999888999999999999889999999999999999999
Q ss_pred CCCCCCcc
Q psy5539 264 TCADSMQD 271 (653)
Q Consensus 264 ~C~~~~~~ 271 (653)
.|.+....
T Consensus 85 ~C~~~~~~ 92 (158)
T 3e6p_L 85 YCEEAVEE 92 (158)
T ss_dssp BCCCCCCC
T ss_pred CCCCcccc
Confidence 99986543
|
| >1ki0_A Angiostatin; kringle domains, hydrolase; HET: BCN; 1.75A {Homo sapiens} SCOP: g.14.1.1 g.14.1.1 g.14.1.1 PDB: 2doh_X* 2doi_X 1cea_A 1ceb_A* 1b2i_A* 1pkr_A 2l0s_A 2kj4_A 1i5k_A 1hpj_A 1hpk_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-26 Score=232.63 Aligned_cols=120 Identities=43% Similarity=0.989 Sum_probs=105.3
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|+++++. .+|||++....++++|| .+|.|...+..
T Consensus 134 yCRNPdg~--~~PWCyt~~~~~~we~C-----------------------~ip~C~~~~~~------------------- 169 (253)
T 1ki0_A 134 YCRNPDRE--LRPWCFTTDPNKRWELC-----------------------DIPRCTTPPPS------------------- 169 (253)
T ss_dssp CCBCSSSC--SSCEEEBSCTTCSEEEC-----------------------CCCBCCSCCCC-------------------
T ss_pred ccCCCCCC--CCceeeecCCCcceecc-----------------------cccccCCCCcc-------------------
Confidence 58777764 48999999888999999 67788654311
Q ss_pred cccccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeec
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C 260 (653)
...+.+|+.|+|..|||++++|.+|++||+|+++.+|.|.+.+..+|.+++.|||||||||++ +|||||+++.++||||
T Consensus 170 ~~~~~~C~~g~G~~YrG~~s~T~sG~~Cq~W~s~~ph~h~~t~~~~p~~gl~~NyCRNPdg~~-~PWCyt~~~~~~~eyC 248 (253)
T 1ki0_A 170 SGPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHERTPENFPCKNLDENYCRNPDGKR-APWCHTTNSQVRWEYC 248 (253)
T ss_dssp CCCCBSSBCTTSTTBCCCCCBCTTCCBBCCTTCCSSCCCSCCTTTCGGGCCCTTCCBCCSSCS-SCEEEBSSTTCSEEEC
T ss_pred ccceeccccccccccccceeeeccCCceeeccCCCccccccCHhhCcccCcccccCCCcCCCC-CCceEcCCCCcccccc
Confidence 012357999999999999999999999999999999999999999999999999999999995 9999999999999999
Q ss_pred ccCCC
Q psy5539 261 EIPTC 265 (653)
Q Consensus 261 ~ip~C 265 (653)
+||.|
T Consensus 249 ~i~~C 253 (253)
T 1ki0_A 249 KIPSC 253 (253)
T ss_dssp CCCBC
T ss_pred CCCcC
Confidence 99998
|
| >1ki0_A Angiostatin; kringle domains, hydrolase; HET: BCN; 1.75A {Homo sapiens} SCOP: g.14.1.1 g.14.1.1 g.14.1.1 PDB: 2doh_X* 2doi_X 1cea_A 1ceb_A* 1b2i_A* 1pkr_A 2l0s_A 2kj4_A 1i5k_A 1hpj_A 1hpk_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-26 Score=228.23 Aligned_cols=115 Identities=41% Similarity=0.999 Sum_probs=102.7
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|+++++.+ ..|||++....++++|| .+|.|.
T Consensus 52 yCRNPd~~~-~gpWCyt~dp~~r~e~C-----------------------~ip~C~------------------------ 83 (253)
T 1ki0_A 52 YCRNPDNDP-QGPWCYTTDPEKRYDYC-----------------------DILECE------------------------ 83 (253)
T ss_dssp CCBCTTCCT-TCCEEEBSCTTCSEEEC-----------------------CCCBCB------------------------
T ss_pred cccCCCCCC-CCCccEecCCCceeeec-----------------------ccCCcc------------------------
Confidence 477776654 23999999999999999 455562
Q ss_pred cccccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeec
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C 260 (653)
.+||.++|..|||++++|.||++||+|+++.||.|.+.+..+|..++.|||||||||+. +|||||+++..+||||
T Consensus 84 ----~~C~~~~G~~YrG~~s~T~sG~~Cq~W~s~~ph~~~~~~~~~p~~~l~~NyCRNPdg~~-~PWCyt~~~~~~we~C 158 (253)
T 1ki0_A 84 ----EECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDREL-RPWCFTTDPNKRWELC 158 (253)
T ss_dssp ----CSSBCTTSTTBCCCCCBCTTCCBBCCTTCCSSSCCSCCTTTSTTSCCCTTCCBCSSSCS-SCEEEBSCTTCSEEEC
T ss_pred ----ccceeCCCCccceeeccCCCCccCccccccCccccccChhhCCCcCcccCccCCCCCCC-CceeeecCCCcceecc
Confidence 15999999999999999999999999999999999999999999999999999999986 9999999999999999
Q ss_pred ccCCCCCC
Q psy5539 261 EIPTCADS 268 (653)
Q Consensus 261 ~ip~C~~~ 268 (653)
+||.|...
T Consensus 159 ~ip~C~~~ 166 (253)
T 1ki0_A 159 DIPRCTTP 166 (253)
T ss_dssp CCCBCCSC
T ss_pred cccccCCC
Confidence 99999864
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-25 Score=259.88 Aligned_cols=135 Identities=33% Similarity=0.839 Sum_probs=109.4
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|+++++.. .|||++....++|+|| .+|.|...|.......+.. ....
T Consensus 304 yCRNPdg~~--~pWCyt~d~~~~we~C-----------------------~ip~C~~~~~~~~~~~~t~-------P~~~ 351 (791)
T 4dur_A 304 YCRNPDGKR--APWCHTTNSQVRWEYC-----------------------KIPSCDSSPVSTEQLAPTA-------PPEL 351 (791)
T ss_dssp CCBCSSCCS--SCEEEESSSSCCEEEC-----------------------CCCBCC----------CCC-------CCCC
T ss_pred cccCCCCCC--CCcceecCCCcceecc-----------------------ccccccCCCcccccccccc-------cccc
Confidence 588777754 8999999999999999 7889988764321011100 0111
Q ss_pred cccccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeec
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C 260 (653)
...+.+||.|+|.+|||++++|.+|++||+|+++.||.|.+.+..+|..+++|||||||||+. +|||||+++.++||||
T Consensus 352 ~~~~~~C~~g~G~~YrG~~~~t~sG~~C~~W~s~~~~~~~~~~~~~p~~~l~~NyCRNPd~~~-~pWCyt~~~~~~~e~C 430 (791)
T 4dur_A 352 TPVVQDCYHGDGQSYRGTSSTTTTGKKCQSWSSMTPHRHQKTPENYPNAGLTMNYCRNPDADK-GPWCFTTDPSVRWEYC 430 (791)
T ss_dssp CCSSCCEESTTSSSCCCCCCBBTTSCBBCCTTCCSSSCCCCCTTTCTTTTCCTTCCBCTTCCS-SCEEEBSCTTBCEEEB
T ss_pred CccccccccCCCcccccccccCCCCCccCCcCCCCccccCCCcccCcccccccccCCCcCCCC-CCceEecCCcceeEee
Confidence 223568999999999999999999999999999999999999999999999999999999997 9999999999999999
Q ss_pred ccCCCCCC
Q psy5539 261 EIPTCADS 268 (653)
Q Consensus 261 ~ip~C~~~ 268 (653)
+||.|+..
T Consensus 431 ~i~~C~~~ 438 (791)
T 4dur_A 431 NLKKCSGT 438 (791)
T ss_dssp SCEECCC-
T ss_pred CCCcCCCc
Confidence 99999864
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-25 Score=251.83 Aligned_cols=180 Identities=18% Similarity=0.101 Sum_probs=137.7
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-------cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-------SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-------~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
..+.||+|+||.||+|+.. +..+++|...... .....+.+.+|++++++++||||+++..++...+
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-------~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 412 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-------DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD 412 (540)
T ss_dssp --------CCEEEEEEECS-------SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT
T ss_pred CCCEEeeCCCEEEEEEEEC-------CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC
Confidence 3567999999999999643 3668888753221 1122456899999999999999996666666777
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..+|||||+++|+|.++++. ++.++.|+++||+|||+++|+||||||+|||+
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~----------------------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl 464 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED----------------------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF 464 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT----------------------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE
T ss_pred ccEEEEECCCCCCHHHHHHH----------------------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE
Confidence 88999999999999999861 45899999999999999999999999999999
Q ss_pred cCCCcEEEeccCcccccccccccc-----CCCCCCCccccccchhhcc--CCCCCchhHHHHHHHHHHHHh
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYK-----GDENDAIPVRWMPLESILY--NKYTVESDVWAFGVCLWEIFS 585 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~t~ksDVwSlGvvl~ellt 585 (653)
++ .+||+|||+++......... ......+|+.|||||.+.. ..|+..+|+||..+-..+-+.
T Consensus 465 ~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 465 DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 99 99999999998764322111 1123457899999999986 568888999999887777665
|
| >2i9a_A Urokinase-type plasminogen activator; growth factor-like domain, kringle domain, hydrolase; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 2i9b_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.7e-26 Score=207.24 Aligned_cols=114 Identities=25% Similarity=0.485 Sum_probs=90.1
Q ss_pred CCCCCCCccc---CCCCcCCCCCCCCccccccc--cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCC--CCC
Q psy5539 155 CDTLPKYEVV---NGKPTCSHAQLTEMKTDEIT--YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPP--VFP 227 (653)
Q Consensus 155 C~~lp~~~~~---~~~~~C~~~~~~~~~~~~~~--~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~--~~~ 227 (653)
|.+....... .+-+.|.++..+.++.|++. .+||.|+|..|||++++|.+|++||+|+++.+|.|.+.+. .++
T Consensus 15 C~NGGtC~~~~~~s~~~~C~Cp~g~~G~~Cei~~~~~C~~g~G~~YrG~~s~T~sG~~Cq~W~s~~~~~~~~~~~~~~~~ 94 (145)
T 2i9a_A 15 CLNGGTCVSNKYFSNIHWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDAL 94 (145)
T ss_dssp CCTTCEEEECSSSTTCEEEECCTTEESTTSCEESSCCEECTTCTTCCSCCCBBTTSCBCCCTTSTTGGGSSSCTTSTTHH
T ss_pred CCCCCCcCCCccccCCccccCCCCCCCCceeccccccCCCCCccccccceecCCcCCcccCCccCCccccccCccccccc
Confidence 6665543211 12247999999999999874 4799999999999999999999999999999999887665 344
Q ss_pred CCCC-CCCccCCCCCCCCCCeEEEeC--CCcceeecccCCCCCCCc
Q psy5539 228 ELNN-SENYCRNAGGEEPSPWCYTMD--PNVRWQRCEIPTCADSMQ 270 (653)
Q Consensus 228 ~~~~-~~nyCRNp~~~~~~pWC~~~~--~~~~~~~C~ip~C~~~~~ 270 (653)
.+++ .|||||||||+. +|||||++ +.++|| |+||+|.+...
T Consensus 95 ~~glg~~NyCRNPdg~~-~PWCyt~~~~~~~~~e-C~ip~C~~~~~ 138 (145)
T 2i9a_A 95 QLGLGKHNYCRNPDNRR-RPWCYVQVGLKPLVQE-CMVHDCADGKK 138 (145)
T ss_dssp HHTCCSSCCCBCTTCBS-SCEEEEEETTEEEEEE-BSCEECC----
T ss_pred ccccccCCcCcCCCCCC-CCCeEecCCCCceeeE-cCCCcCCCCCC
Confidence 4445 899999999997 99999986 457899 99999986543
|
| >2fd6_A Urokinase-type plasminogen activator; UPAR, ATF, ATN-615 antibody, FAB, ternary complex, immune SY hydrolase; HET: PGE NAG FUC NDG PG4; 1.90A {Homo sapiens} SCOP: g.3.11.1 g.14.1.1 PDB: 3bt2_A* 3bt1_A* 3u73_A* 1urk_A* 3laq_A* 1kdu_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-25 Score=198.33 Aligned_cols=97 Identities=27% Similarity=0.567 Sum_probs=84.7
Q ss_pred CcCCCCCCCCccccccc--cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCC--CCCCCCC-CCCccCCCCCC
Q psy5539 168 PTCSHAQLTEMKTDEIT--YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPP--VFPELNN-SENYCRNAGGE 242 (653)
Q Consensus 168 ~~C~~~~~~~~~~~~~~--~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~--~~~~~~~-~~nyCRNp~~~ 242 (653)
..|.+++.+.+..+++. .+|+.++|..|||++++|.+|++||+|+++.+|.|.+.+. .++.+++ .|||||||||+
T Consensus 19 ~~C~Cp~g~~G~~Ce~~~~~~C~~g~G~~YrG~~~~t~sG~~Cq~W~s~~~~~~~~~~~~~~~~~~gl~~~NyCRNPdg~ 98 (122)
T 2fd6_A 19 HWCNCPKKFGGQHCEIDKSKTCYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNR 98 (122)
T ss_dssp EEEECCTTEESTTSCEESSCCSBCSSCTTCCSCCCBBTTSCBBCCTTSTTGGGSSSCTTSTTHHHHTCSSSCCCBCSSCC
T ss_pred CCccCCCCCCCccccccCcCCCcccccccceeeccccccCCcccCccCCCccccccCcccCcchhccCccCCccCCCCCC
Confidence 38999999999999873 4799999999999999999999999999999999887665 3444445 79999999999
Q ss_pred CCCCeEEEeC--CCcceeecccCCCC
Q psy5539 243 EPSPWCYTMD--PNVRWQRCEIPTCA 266 (653)
Q Consensus 243 ~~~pWC~~~~--~~~~~~~C~ip~C~ 266 (653)
. +|||||++ +.++|| |+||+|+
T Consensus 99 ~-~PWCyt~~~~~~~~~e-C~ip~C~ 122 (122)
T 2fd6_A 99 R-RPWCYVQVGLKPLVQE-CMVHDCA 122 (122)
T ss_dssp S-SCEEEEEETTEEEEEE-BSCCBCC
T ss_pred C-CCCeEecCCCCceeeE-cCCCCCc
Confidence 7 99999984 568999 9999995
|
| >2k4r_A Neurotrypsin; kringle domain, disulfide-rich protein fold, serine endopeptidase, hydrolase, extracellular proteolysis; NMR {Rattus norvegicus} PDB: 2k51_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.9e-25 Score=177.97 Aligned_cols=70 Identities=30% Similarity=0.731 Sum_probs=58.0
Q ss_pred ccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCC-CCccCCCCCCCCCCeEEEeCC--CcceeecccCC
Q psy5539 194 FYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNS-ENYCRNAGGEEPSPWCYTMDP--NVRWQRCEIPT 264 (653)
Q Consensus 194 ~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~-~nyCRNp~~~~~~pWC~~~~~--~~~~~~C~ip~ 264 (653)
-|||++++|.||++||+|+++.+|.|.++...+.++.+. |||||||||++ +|||||+++ .++||||+||+
T Consensus 4 ~yrG~~s~T~sG~~Cq~W~s~~~~~~~~p~~gl~~~~~~~~NyCRNPdg~~-~PWCyt~~~~~~~~weyCdip~ 76 (77)
T 2k4r_A 4 AGEPWGNATNLGVPCLHWDEVPPFLERSPPASWAELRGQPHNFCRSPDGAG-RPWCFYRNAQGKVDWGYCDCGQ 76 (77)
T ss_dssp TTCCCSSBSTTSSBBCCGGGSCSSCSSCCSSCGGGTCCTTSCCCEEEETTT-EEEEEEECTTSCEEEEECSSSC
T ss_pred cccCccccCCCCCcCCCCCCCCCcccccccccccccccccCccccCCCCCC-CCcceecCCCCceeeecCCCcC
Confidence 599999999999999999999998876544333221112 99999999995 999999988 68999999996
|
| >4dur_A Plasminogen, serine protease; fibrinolysis, hydrolase; HET: NAG GAL SIA; 2.45A {Homo sapiens} PDB: 4a5t_S* 4duu_A 2feb_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.7e-24 Score=245.28 Aligned_cols=123 Identities=41% Similarity=0.962 Sum_probs=108.2
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|++++..+ .|||+..-..++|+|| .+|.|+..|...
T Consensus 214 yCRNPd~~~--~PWCyt~~~~~~we~C-----------------------~ip~C~~~~~~~------------------ 250 (791)
T 4dur_A 214 YCRNPDREL--RPWCFTTDPNKRWELC-----------------------DIPRCTTPPPSS------------------ 250 (791)
T ss_dssp CCBCSSCCS--SCEEEBSSTTCCEEEC-----------------------CCCBCSSCCCCC------------------
T ss_pred cccCCCCCC--CCCeEeCCCCCceEec-----------------------cccccCCCCCCC------------------
Confidence 587777766 7999999888899999 688896543211
Q ss_pred cccccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeec
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRC 260 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C 260 (653)
..+.+||.|+|.+|||++++|.+|++||+|+++.||.|.+.+..+|..+++|||||||||+. +|||||+++.++||||
T Consensus 251 -~~~~~C~~g~G~~YrG~~s~T~sG~~Cq~W~s~~ph~h~~~~~~~p~~~l~~NyCRNPdg~~-~pWCyt~d~~~~we~C 328 (791)
T 4dur_A 251 -GPTYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHNRTPENFPCKNLDENYCRNPDGKR-APWCHTTNSQVRWEYC 328 (791)
T ss_dssp -SCCBSSBCTTSTTBCCCCCBCTTSCBEECTTCCSSCCCSCCTTTSTTTTCCTTCCBCSSCCS-SCEEEESSSSCCEEEC
T ss_pred -ccccceecCCCcccccccccCCCCCccCCCcCCCccccCcCcccCCccCcccccccCCCCCC-CCcceecCCCcceecc
Confidence 12458999999999999999999999999999999999999999999999999999999987 9999999999999999
Q ss_pred ccCCCCCC
Q psy5539 261 EIPTCADS 268 (653)
Q Consensus 261 ~ip~C~~~ 268 (653)
+||.|...
T Consensus 329 ~ip~C~~~ 336 (791)
T 4dur_A 329 KIPSCDSS 336 (791)
T ss_dssp CCCBCC--
T ss_pred ccccccCC
Confidence 99999653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=210.34 Aligned_cols=146 Identities=21% Similarity=0.166 Sum_probs=116.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH-----------------HHHHHHHHHHHHHhhCCC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE-----------------YLQTDFEREACLLAEFDH 427 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~-----------------~~~~~f~~Ei~il~~l~H 427 (653)
..|.+.+.||+|+||.||+|+. .++..||||.++..... .....+.+|+.++++++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE------TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred eEEEecCEeccCCCceEEEEEe------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 3456779999999999999986 24689999999643211 23567899999999999
Q ss_pred CccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC
Q psy5539 428 PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR 507 (653)
Q Consensus 428 pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~ 507 (653)
| +++.+++.. +..++||||+++|+|.+ +. ......++.||+.||.|||+.
T Consensus 163 -~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~--------------------------~~~~~~i~~qi~~~l~~lH~~ 212 (282)
T 1zar_A 163 -G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR--------------------------VENPDEVLDMILEEVAKFYHR 212 (282)
T ss_dssp -T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC--------------------------CSCHHHHHHHHHHHHHHHHHT
T ss_pred -C-CCcCeEEec-cceEEEEEecCCCcHHH-cc--------------------------hhhHHHHHHHHHHHHHHHHHC
Confidence 4 666665443 56799999999999987 42 012347999999999999999
Q ss_pred CceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhc
Q psy5539 508 KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL 563 (653)
Q Consensus 508 ~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 563 (653)
+|+||||||+|||++ ++.+||+|||+++.. ..++|||.+.
T Consensus 213 giiHrDlkp~NILl~-~~~vkl~DFG~a~~~---------------~~~~a~e~l~ 252 (282)
T 1zar_A 213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV---------------GEEGWREILE 252 (282)
T ss_dssp TEECSCCSTTSEEEE-TTEEEECCCTTCEET---------------TSTTHHHHHH
T ss_pred CCEeCCCCHHHEEEE-CCcEEEEECCCCeEC---------------CCCCHHHHHH
Confidence 999999999999999 999999999999632 2368899774
|
| >3nxp_A Prethrombin-1; allostery, blood coagulation, hydro kringle, serine protease, zymogen; HET: NAG; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=5.9e-23 Score=223.69 Aligned_cols=86 Identities=28% Similarity=0.693 Sum_probs=80.5
Q ss_pred ccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccC
Q psy5539 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIP 263 (653)
Q Consensus 184 ~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip 263 (653)
..+||.|+|.+|||++++|.+|++||+|+++.+|.|.+.+..+|..+++|||||||||+..+|||||+++.++||||+||
T Consensus 12 ~~~C~~~~g~~YrG~~~~t~~g~~C~~W~~~~~~~~~~~~~~~~~~~l~~nyCRNPd~~~~~pWCy~~~~~~~~~~C~i~ 91 (424)
T 3nxp_A 12 LEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLN 91 (424)
T ss_dssp --CCBCGGGTTCCSCCCBCTTSCBBCCTTSHHHHSSSCSSCCCTTSCCCTTCCBCTTCCTTCCEEEBSSSTTCEEECCCC
T ss_pred cccCCCCCCCCCCcccccCCCCCcCCCCcccCCccccCCcccCcccCcccccccCCCCCCCCceEEeCCCCcceEeCCCC
Confidence 45899999999999999999999999999999999999899999999999999999999889999999999999999999
Q ss_pred CCCCCC
Q psy5539 264 TCADSM 269 (653)
Q Consensus 264 ~C~~~~ 269 (653)
.|++..
T Consensus 92 ~C~~~~ 97 (424)
T 3nxp_A 92 YCEEAV 97 (424)
T ss_dssp BCCCCC
T ss_pred cCcccc
Confidence 998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=5.9e-19 Score=179.34 Aligned_cols=137 Identities=23% Similarity=0.230 Sum_probs=105.5
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceE--EEEEEcccccc-----------------------HHHHHHHHHHHHH
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTL--VAVKMLKDEAS-----------------------EYLQTDFEREACL 421 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~--VAVK~l~~~~~-----------------------~~~~~~f~~Ei~i 421 (653)
+.+.+.||+|+||.||+|+.. .++.. ||||+++.... ......+.+|+.+
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~-----~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGV-----FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEE-----ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEc-----CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 567889999999999999862 24567 99998754311 1123468899999
Q ss_pred HhhCCCCcc--ceEEeEEecCCceEEEEeecCC-C----ChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHH
Q psy5539 422 LAEFDHPNI--VKLLGVCAVGKPMCLLFEYMGR-G----DLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIA 494 (653)
Q Consensus 422 l~~l~HpnI--v~l~g~~~~~~~~~LV~Ey~~~-g----sL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 494 (653)
+.+++|+++ ..+++. ...+|||||+.+ | +|.++.. ..++..+..++
T Consensus 124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~-----------------------~~~~~~~~~i~ 176 (258)
T 1zth_A 124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR-----------------------ELKELDVEGIF 176 (258)
T ss_dssp HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG-----------------------GGGGSCHHHHH
T ss_pred HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh-----------------------ccChHHHHHHH
Confidence 999988764 344443 467899999942 4 5655432 01244567899
Q ss_pred HHHHHHHHHhh-hCCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 495 LQIASGMVYLS-DRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 495 ~qia~gL~yLH-~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
.|++.||.||| +.+|+||||||+|||+++ .++|+|||+|..
T Consensus 177 ~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 177 NDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 99999999999 999999999999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=3.7e-16 Score=166.12 Aligned_cols=137 Identities=9% Similarity=0.073 Sum_probs=97.1
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----------------H----HHHHHHHHHHHHHhhC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----------------E----YLQTDFEREACLLAEF 425 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----------------~----~~~~~f~~Ei~il~~l 425 (653)
|.+.+.||+|+||.||+|... +++.||||+++.... . ..+....+|...|.++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~------~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE------KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT------TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC------CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 788999999999999999852 468899998753210 0 0111234566666666
Q ss_pred CCCccceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhh
Q psy5539 426 DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLS 505 (653)
Q Consensus 426 ~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH 505 (653)
.+.++....-+.. ...+|||||+++++|.++.. ......++.||+.+|.+||
T Consensus 171 ~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~--------------------------~~~~~~l~~qll~~l~~lH 222 (397)
T 4gyi_A 171 YEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSS--------------------------VPDPASLYADLIALILRLA 222 (397)
T ss_dssp HHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCC--------------------------CSCHHHHHHHHHHHHHHHH
T ss_pred HhcCCCCCeeeec--cCceEEEEecCCccHhhhcc--------------------------cHHHHHHHHHHHHHHHHHH
Confidence 5443321111111 23479999999987754321 1134568899999999999
Q ss_pred hCCceecCCCCCCEeEcCCC----------cEEEeccCcccc
Q psy5539 506 DRKFVHRDLATRNCLINDQM----------VVKIADFGLSRK 537 (653)
Q Consensus 506 ~~~ivHrDLkp~NILl~~~~----------~vkI~DfGla~~ 537 (653)
+.|||||||||.||||++++ .+.|+||+-+..
T Consensus 223 ~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 223 KHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp HTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 99999999999999998877 489999998743
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.6e-11 Score=124.21 Aligned_cols=138 Identities=18% Similarity=0.117 Sum_probs=108.1
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 444 (653)
.|.+...+|.|+.+.||++... +..+++|+....... ....+.+|+++++.+. +..+.+++++....+..+
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~-------~~~~vlK~~~~~~~~-~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGE-------NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECS-------SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred cceeEeeccCCCCCeEEEEECC-------CCcEEEEeCCcccCC-CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 5778888899999999998742 367999998753211 1235889999999884 677889999998888899
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh------------------
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD------------------ 506 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~------------------ 506 (653)
+||||++|.+|.+.+. +......++.+++++|..||+
T Consensus 87 lv~e~i~G~~l~~~~~-------------------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------------------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp EEEECCSSEEHHHHCC-------------------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred EEEEecCCeehhhccC-------------------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 9999999998876531 111234678888999999997
Q ss_pred -----------------------------------------CCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 507 -----------------------------------------RKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 507 -----------------------------------------~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
..++|+|++|.|||++++..+.|+||+.+.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 348899999999999887677899999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.8e-10 Score=115.54 Aligned_cols=133 Identities=18% Similarity=0.117 Sum_probs=91.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc--cceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN--IVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~~~~~~~~ 443 (653)
++.+....+.|..+.||++... ++..+++|...... ...+.+|+.+++.+.+.+ +.+++++...++..
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~------~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~ 90 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD 90 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT------TSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred CCceEecccCCCCceEEEEecC------CCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence 3444443346667999998642 34569999876541 235788999999886545 45688888887889
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC----------------
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR---------------- 507 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~---------------- 507 (653)
++||||++|.+|. .. ..+ ...++.+++..|..||+.
T Consensus 91 ~~v~e~i~G~~l~--~~-----------------------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~ 142 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS-----------------------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIE 142 (264)
T ss_dssp EEEEECCSSEETT--TS-----------------------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHH
T ss_pred EEEEEecCCcccC--cC-----------------------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH
Confidence 9999999998774 11 000 113344444444444432
Q ss_pred ------------------------------------------CceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 508 ------------------------------------------KFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 508 ------------------------------------------~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
.++|+|++|.|||+++++.+.|+|||.+.
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 143 RARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 38999999999999988777899999975
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.7e-10 Score=120.79 Aligned_cols=140 Identities=16% Similarity=0.223 Sum_probs=103.6
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcc--ccccHHHHHHHHHHHHHHhhCC--CCccceEEeEEecC---C
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASEYLQTDFEREACLLAEFD--HPNIVKLLGVCAVG---K 441 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~--~~~~~~~~~~f~~Ei~il~~l~--HpnIv~l~g~~~~~---~ 441 (653)
.++.|+.|.++.||+.+.. +..+++|+.. ..........+.+|+.+++.+. +..+.++++++... +
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEEC-------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 4677899999999998753 2468888876 4322222346889999999997 45678889888766 4
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh---------------
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD--------------- 506 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~--------------- 506 (653)
..++||||+++..+.+. ....++..++..++.+++..|..||+
T Consensus 115 ~~~~vme~v~G~~l~~~----------------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~ 172 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQ----------------------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPG 172 (359)
T ss_dssp SCEEEEECCCCBCCCCT----------------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCS
T ss_pred CeEEEEEecCCeecCCC----------------------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCC
Confidence 58999999998766431 11236778888899999999999996
Q ss_pred -------------------------------------------CCceecCCCCCCEeEcCCC--cEEEeccCcccc
Q psy5539 507 -------------------------------------------RKFVHRDLATRNCLINDQM--VVKIADFGLSRK 537 (653)
Q Consensus 507 -------------------------------------------~~ivHrDLkp~NILl~~~~--~vkI~DfGla~~ 537 (653)
..++|+|+++.|||+++++ .+.|+||+.+..
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 173 NYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 3589999999999999765 369999999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.80 E-value=8.4e-09 Score=106.61 Aligned_cols=132 Identities=17% Similarity=0.139 Sum_probs=90.4
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCc--cceEEeEEecCC---ceE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPN--IVKLLGVCAVGK---PMC 444 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-Hpn--Iv~l~g~~~~~~---~~~ 444 (653)
+.++.|....||+.. ..+++|+.+.. .....+.+|.++++.+. +.. +.+++......+ ..+
T Consensus 26 ~~~~~G~~n~v~~v~----------~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~ 92 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----------RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSF 92 (304)
T ss_dssp CEEEECSSEEEEEST----------TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSC
T ss_pred EecCCCCcceEEEEC----------CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcce
Confidence 448999999999852 24888886543 33457889999998884 332 345555543333 348
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh------------------
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD------------------ 506 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~------------------ 506 (653)
+|||+++|.+|.+... ..++..++..++.+++..|..||+
T Consensus 93 ~vm~~i~G~~l~~~~~----------------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~ 150 (304)
T 3sg8_A 93 AGFTKIKGVPLTPLLL----------------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKI 150 (304)
T ss_dssp EEEECCCCEECCHHHH----------------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHH
T ss_pred EEEcccCCeECCcccc----------------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHH
Confidence 8999999988865321 123444555555555555555553
Q ss_pred ----------------------------------------CCceecCCCCCCEeEcC--CCcEEEeccCcccc
Q psy5539 507 ----------------------------------------RKFVHRDLATRNCLIND--QMVVKIADFGLSRK 537 (653)
Q Consensus 507 ----------------------------------------~~ivHrDLkp~NILl~~--~~~vkI~DfGla~~ 537 (653)
..++|+|++|.|||+++ +..+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 151 NEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 24799999999999998 56789999999864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=2.8e-06 Score=85.63 Aligned_cols=78 Identities=13% Similarity=0.055 Sum_probs=55.4
Q ss_pred ecccCCe-eEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceEEEEeec
Q psy5539 373 LGQGAFG-RVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMCLLFEYM 450 (653)
Q Consensus 373 LG~G~fG-~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 450 (653)
+..|..| .||+.... ..+..+++|+-... ...++.+|...|+.+. +--+.++++++...+..++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~-----~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGK-----PNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECC-----TTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ccCCCcCCeEEEEEec-----CCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEee
Confidence 3445444 68987642 23456888886543 2346788999988884 334667888988888999999999
Q ss_pred CCCChHHHH
Q psy5539 451 GRGDLNDFL 459 (653)
Q Consensus 451 ~~gsL~~~L 459 (653)
++.++.+..
T Consensus 103 ~G~~~~~~~ 111 (272)
T 4gkh_A 103 PGKTAFQVL 111 (272)
T ss_dssp CSEEHHHHH
T ss_pred CCccccccc
Confidence 998876654
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=4.4e-06 Score=86.29 Aligned_cols=75 Identities=15% Similarity=0.097 Sum_probs=54.1
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC---ccceEEeEEe-cCCceEE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP---NIVKLLGVCA-VGKPMCL 445 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp---nIv~l~g~~~-~~~~~~L 445 (653)
++.++.|....||+. + ..+++|..+. ......+.+|.++|+.+.+. .+.+.+.+.. ..+..++
T Consensus 24 v~~l~~G~~n~v~~v---g-------~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---N-------GDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE---T-------TTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred eeecCCCcceeEEEE---C-------CEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence 455788999999986 1 3477887532 23455789999999999753 3556666664 4456789
Q ss_pred EEeecCCCChHH
Q psy5539 446 LFEYMGRGDLND 457 (653)
Q Consensus 446 V~Ey~~~gsL~~ 457 (653)
||||++|.+|.+
T Consensus 91 v~e~i~G~~l~~ 102 (306)
T 3tdw_A 91 GYRKVQGQILGE 102 (306)
T ss_dssp EEECCCSEECHH
T ss_pred EEeccCCeECch
Confidence 999999988865
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=5.3e-06 Score=87.30 Aligned_cols=91 Identities=7% Similarity=0.039 Sum_probs=57.3
Q ss_pred eeEEeee-cccCCeeEEEEEeCCCCCCc-cceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCC---CccceEEeEEec
Q psy5539 367 IIYVRDL-GQGAFGRVFQAKAPGLLKHE-EFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDH---PNIVKLLGVCAV 439 (653)
Q Consensus 367 ~~~~~~L-G~G~fG~Vy~a~~~~~~~~~-~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~H---pnIv~l~g~~~~ 439 (653)
+...+.| +.|....+|+.......+.. ++..+++|....... ......+.+|+.+++.+.. ..+.+++++...
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3455678 88999999998642000000 146788888764320 0001346788888888742 356678887765
Q ss_pred C---CceEEEEeecCCCChHH
Q psy5539 440 G---KPMCLLFEYMGRGDLND 457 (653)
Q Consensus 440 ~---~~~~LV~Ey~~~gsL~~ 457 (653)
. +..++||||++|..+.+
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp STTTSSCEEEEECCCCBCCCB
T ss_pred CCccCCceEEEEecCCCChhh
Confidence 4 35689999999876643
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=2.4e-05 Score=83.70 Aligned_cols=78 Identities=14% Similarity=0.141 Sum_probs=49.0
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc---H---HHHHHHHHHHHHHhhCCC--Ccc-ceEEeEEec
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS---E---YLQTDFEREACLLAEFDH--PNI-VKLLGVCAV 439 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~---~---~~~~~f~~Ei~il~~l~H--pnI-v~l~g~~~~ 439 (653)
..+.||.|..+.||+++... .+..++||....... + .....+..|.++++.+.. +.. .+++.+ .
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~-----~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d 106 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQE-----HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D 106 (397)
T ss_dssp EEEECCSSSSEEEEEEEC---------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred EEEECCCCceEEEEEEEECC-----CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence 35679999999999997421 246799997653211 0 012346778888887742 443 455544 3
Q ss_pred CCceEEEEeecCCC
Q psy5539 440 GKPMCLLFEYMGRG 453 (653)
Q Consensus 440 ~~~~~LV~Ey~~~g 453 (653)
.+..++||||+++.
T Consensus 107 ~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 107 TEMAVTVMEDLSHL 120 (397)
T ss_dssp TTTTEEEECCCTTS
T ss_pred CCccEEEEEeCCCc
Confidence 45568999999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.73 E-value=0.00029 Score=73.04 Aligned_cols=30 Identities=20% Similarity=0.365 Sum_probs=27.3
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 578999999999999888899999999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.0006 Score=73.35 Aligned_cols=79 Identities=11% Similarity=0.141 Sum_probs=47.0
Q ss_pred hhCCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC---CCCCchhHHHHHHHHH
Q psy5539 505 SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN---KYTVESDVWAFGVCLW 581 (653)
Q Consensus 505 H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~---~~t~ksDVwSlGvvl~ 581 (653)
+...++|+|+++.|||+++++ ++|+||+.+......-.. ...-......|.+|+..... .-....++.+....+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 456799999999999999876 999999988643110000 00000001235555544311 1122355668888888
Q ss_pred HHHh
Q psy5539 582 EIFS 585 (653)
Q Consensus 582 ellt 585 (653)
+.++
T Consensus 308 ~~y~ 311 (420)
T 2pyw_A 308 NLFN 311 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8875
|
| >1ijy_A Frizzled homolog 8; WNT receptor, frizzled protein structure, cysteine-rich, signaling protein; 1.35A {Mus musculus} SCOP: a.141.1.1 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00012 Score=65.22 Aligned_cols=88 Identities=16% Similarity=0.402 Sum_probs=61.4
Q ss_pred CCCCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH--HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCC
Q psy5539 30 QPQGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA--LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNG 107 (653)
Q Consensus 30 ~~~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~--~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~ 107 (653)
+..+.|++-.-..|.. |..+ .++|+.... ...|+....+ .|..| +...|++.+..+||..++|.|.+...
T Consensus 5 ~~~~~C~pI~~~~C~~-l~Yn-~T~~PN~l~---h~~q~ea~~~l~~f~~L---~~~~C~~~l~~FlCs~~~P~C~~~~~ 76 (130)
T 1ijy_A 5 AKELACQEITVPLCKG-IGYE-YTYMPNQFN---HDTQDEAGLEVHQFWPL---VEIQCSPDLKFFLCSMYTPICLEDYK 76 (130)
T ss_dssp --CCCCEECCCGGGTT-SSCC-EECSSCTTC---CCSHHHHHHHHGGGHHH---HHHTSCTTHHHHHHHHHSCBCCSSCC
T ss_pred CCCCeeeeCChhHhCC-CCCC-eeECCCcCC---CcCHHHHHHHHHHHHHH---hccCcCHHHHHHHHHhhCCcccCCCC
Confidence 3678999999999998 6653 556654322 1223322222 46666 34699999999999999999976443
Q ss_pred CCCCCCcccchhhhhhhccch
Q psy5539 108 IPMSLPLCYEDCIAVRYSFCY 128 (653)
Q Consensus 108 ~~~~~p~C~~~c~~~~~~~c~ 128 (653)
.+.+-||..|+.++ .-|.
T Consensus 77 --~~~~PCRslCe~v~-~~C~ 94 (130)
T 1ijy_A 77 --KPLPPCRSVCERAK-AGCA 94 (130)
T ss_dssp --SCCCBCHHHHHHHH-HHHH
T ss_pred --cccCccHHHHHHHh-cchH
Confidence 44667999999998 6673
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00066 Score=68.97 Aligned_cols=81 Identities=20% Similarity=0.228 Sum_probs=56.5
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC---CccceEEeEEecC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH---PNIVKLLGVCAVG 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H---pnIv~l~g~~~~~ 440 (653)
...+.-++.+|.|..+.||+.+. .+++.|++|+....... ....|.+|++.|+.|.- --+.+.+++
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l------~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~---- 82 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVEL------ADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGW---- 82 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEE------TTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEE----
T ss_pred CCCeEEEEecCCCCCeEEEEEEE------CCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEec----
Confidence 34566788899999999999986 34678999987643221 12357889998888842 234455554
Q ss_pred CceEEEEeecCCCCh
Q psy5539 441 KPMCLLFEYMGRGDL 455 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL 455 (653)
+.-++||||++.+..
T Consensus 83 ~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 DDRTLAMEWVDERPP 97 (288)
T ss_dssp ETTEEEEECCCCCCC
T ss_pred cCceEEEEeecccCC
Confidence 235789999987654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0037 Score=64.36 Aligned_cols=78 Identities=21% Similarity=0.210 Sum_probs=59.9
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC---CCccceEEeEEecCCce
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD---HPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~---HpnIv~l~g~~~~~~~~ 443 (653)
+.-.+.|+.|....+|+.... +..+++|+..... ...+.+|.+.|+.|. ...+.+++++....+..
T Consensus 38 i~~~~~l~gG~~n~~y~v~~~-------~~~~vlK~~~~~~----~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 38 IKHKEKLYSGEMNEIWLINDE-------VQTVFVKINERSY----RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp CCEEEEECCSSSSEEEEEESS-------SCEEEEEEEEGGG----HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeeeEEeCCccceeeeEEEEC-------CCeEEEEeCCccc----HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 344677899999999998742 3568888875432 346788988888874 35688889888877889
Q ss_pred EEEEeecCCCCh
Q psy5539 444 CLLFEYMGRGDL 455 (653)
Q Consensus 444 ~LV~Ey~~~gsL 455 (653)
++||||+++..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.15 E-value=0.004 Score=60.03 Aligned_cols=127 Identities=12% Similarity=0.090 Sum_probs=84.6
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHhhh-CCceecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccch
Q psy5539 482 VPQLSTCDLITIALQIASGMVYLSD-RKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLE 560 (653)
Q Consensus 482 ~~~l~~~~~~~i~~qia~gL~yLH~-~~ivHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE 560 (653)
..++++.+++.++.|.+.+|.-+-. +.-..+=+-|..|++..+|.|.+.+ +.+. .....+.|||
T Consensus 43 ~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~~~~~~~~pe 107 (229)
T 2yle_A 43 NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------AGEPPPVAGK 107 (229)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------------------C
T ss_pred CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------ccccCCCChh
Confidence 4689999999999999999888722 1111233456889999999888763 1110 1112356777
Q ss_pred hhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhcc-----------
Q psy5539 561 SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNM----------- 629 (653)
Q Consensus 561 ~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~----------- 629 (653)
... ...+.+.-|||||+++|.-+-+++++- .+..+++.|.+||..|.+.
T Consensus 108 ~~~-~~~te~~~IysLG~tLY~ALDygL~e~-------------------eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~ 167 (229)
T 2yle_A 108 LGY-SQCMETEVIESLGIIIYKALDYGLKEN-------------------EERELSPPLEQLIDHMANTVEADGSNDEGY 167 (229)
T ss_dssp CSS-SSSCHHHHHHHHHHHHHHHHTTTCCTT-------------------EEECCCHHHHHHHHHHTTCCC---------
T ss_pred hcc-ccchHHHHHHHHHHHHHHHhhcCCCcc-------------------cchhhCHHHHHHHHHHHhcccccccccccc
Confidence 652 455788999999999999998776332 2335677788888887655
Q ss_pred --------------CCCCCCCHHHHHHH
Q psy5539 630 --------------KPMNRPSFRTIYQT 643 (653)
Q Consensus 630 --------------dP~~RPs~~eil~~ 643 (653)
.+..|+++++|++.
T Consensus 168 ~~~~eg~~d~~~~~~~~~~~sl~~Vi~~ 195 (229)
T 2yle_A 168 EAAEEGLGDEDEKRKISAIRSYRDVMKL 195 (229)
T ss_dssp -----------CCSCCCCCCSHHHHHHH
T ss_pred cccccccccccccccccCcCCHHHHHHH
Confidence 34678999999865
|
| >1ijx_A Secreted frizzled-related sequence protein 3; WNT receptor, frizzled protein structure, cysteine-rich, SIG protein; 1.90A {Mus musculus} SCOP: a.141.1.1 | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00033 Score=62.09 Aligned_cols=106 Identities=21% Similarity=0.391 Sum_probs=70.1
Q ss_pred CCccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHH--HHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCC
Q psy5539 32 QGYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIV--MALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIP 109 (653)
Q Consensus 32 ~g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~--~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~ 109 (653)
+|.|++-+-..|.. |..+ ..+++.-.. ...|+... ...|..| +...|++.+..+||..++|.|...+. .
T Consensus 2 ~~~C~pi~~~~C~~-l~Yn-~T~~PN~lg---h~~q~ea~~~~~~f~~L---v~~~C~~~l~~FlCs~~~P~C~~~~~-~ 72 (127)
T 1ijx_A 2 SAACEPVRIPLCKS-LPWE-MTKMPNHLH---HSTQANAILAMEQFEGL---LGTHCSPDLLFFLCAMYAPICTIDFQ-H 72 (127)
T ss_dssp -CCCEECCCGGGGG-SSCC-EECSSCTTC---CSSHHHHHHHHHTTHHH---HTTTCCTTHHHHHHHHHSCBCBSSCS-S
T ss_pred CCccccCChhHhCC-CCCC-eeECCCcCC---CcCHHHHHHHHHHHHHH---HccCcCHHHHhhhhhccCCcccCCCC-C
Confidence 57899999999998 5543 555544321 12233222 2345566 66899999999999999999976533 2
Q ss_pred CCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCC---CCCCCCCC
Q psy5539 110 MSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELP---NCDTLPKY 161 (653)
Q Consensus 110 ~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp---~C~~lp~~ 161 (653)
.+.+=||..|+.++ .-|... +.. ..+..| +|+.+|..
T Consensus 73 ~~i~PCRslCe~vr-~~C~~~---~~~-----------~g~~WP~~l~C~~fP~~ 112 (127)
T 1ijx_A 73 EPIKPCKSVCERAR-QGCEPI---LIK-----------YRHSWPESLACDELPVY 112 (127)
T ss_dssp SCCCBCHHHHHHHH-HHHHHH---HHH-----------TTCCCCGGGCGGGCCCT
T ss_pred cccCccHHHHHHHH-HHHHHH---HHH-----------hCCCCCCcCccccCCCC
Confidence 44666999999999 667322 211 123454 79999864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0015 Score=66.68 Aligned_cols=72 Identities=17% Similarity=0.177 Sum_probs=43.8
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc-ceEEeEEecCCceEEEEe
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI-VKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E 448 (653)
++.|+.|....+|+. ..+++|+....... ..+..+|+.+++.+....+ .+++++ ..+.-++|+|
T Consensus 23 i~~l~gG~tN~~~~~-----------~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e 87 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----------GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR 87 (301)
T ss_dssp CEEEESCSSEEEEEE-----------TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred eeEcCCcccccccee-----------eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence 567888999999987 13788877643211 1123567777776643233 355554 3334578999
Q ss_pred ec-CCCChH
Q psy5539 449 YM-GRGDLN 456 (653)
Q Consensus 449 y~-~~gsL~ 456 (653)
|+ ++.+|.
T Consensus 88 ~i~~g~~l~ 96 (301)
T 3dxq_A 88 YIAGAQTMS 96 (301)
T ss_dssp CCTTCEECC
T ss_pred ecCCCccCC
Confidence 99 665553
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.81 E-value=0.003 Score=64.92 Aligned_cols=153 Identities=12% Similarity=0.120 Sum_probs=78.5
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc--cceEEeE------E
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN--IVKLLGV------C 437 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn--Iv~l~g~------~ 437 (653)
...-++.|+.|....+|+....+ ..+++|....... ...+..|+.++..|.... +.+++.. .
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-------g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-------DPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-------CCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred cceEeeccCCCcccceEEEEeCC-------ccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 33456678889999999987532 2478888765211 124556777776663212 2333321 1
Q ss_pred ecCCceEEEEeecCCCChHH-----------H---HhhcCCCCCcCCCcccccccccCCCCCCHHHHHH-----------
Q psy5539 438 AVGKPMCLLFEYMGRGDLND-----------F---LRICSPNNYINGTYSSMESSIHRVPQLSTCDLIT----------- 492 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~-----------~---L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~----------- 492 (653)
...+..++|+||++|..+.. . ++.... .+...... ......|...+.
T Consensus 93 ~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~-~~~~~~~~-------~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASE-GFEIKRPN-------ALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTT-TCCCCCBC-------TTSHHHHHHHHHHHGGGGGGTST
T ss_pred EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhc-cCCCcccC-------ccChHHHHHHHHHHHHHHHhhhh
Confidence 22355789999999865421 1 121111 00000000 000000111000
Q ss_pred -HHHHHHHHHHHhhh-------CCceecCCCCCCEeEcCCCcEEEeccCccc
Q psy5539 493 -IALQIASGMVYLSD-------RKFVHRDLATRNCLINDQMVVKIADFGLSR 536 (653)
Q Consensus 493 -i~~qia~gL~yLH~-------~~ivHrDLkp~NILl~~~~~vkI~DfGla~ 536 (653)
+...+...++.+++ .+++|+|+.+.|||++++..+.|+||+.+.
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 00113334444442 368999999999999988777899999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0043 Score=64.21 Aligned_cols=31 Identities=32% Similarity=0.415 Sum_probs=27.1
Q ss_pred CCceecCCCCCCEeEcCC----CcEEEeccCcccc
Q psy5539 507 RKFVHRDLATRNCLINDQ----MVVKIADFGLSRK 537 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~----~~vkI~DfGla~~ 537 (653)
..++|+|+.+.|||++++ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 468999999999999874 7899999998864
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0058 Score=65.89 Aligned_cols=79 Identities=15% Similarity=0.262 Sum_probs=49.3
Q ss_pred EeeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc-ceEEeEEecCCceEEE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI-VKLLGVCAVGKPMCLL 446 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV 446 (653)
++.|+.|....||++..++... ...+..+++|+...... ...+.+|..+++.|...++ .++++.+.. .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 4568888889999998643110 11245788998854222 1234578888887753334 567776542 389
Q ss_pred EeecCCCCh
Q psy5539 447 FEYMGRGDL 455 (653)
Q Consensus 447 ~Ey~~~gsL 455 (653)
+||+++.+|
T Consensus 151 ~e~l~G~~l 159 (429)
T 1nw1_A 151 EEYIPSRPL 159 (429)
T ss_dssp ECCCCEEEC
T ss_pred EEEeCCccc
Confidence 999986444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.0084 Score=63.48 Aligned_cols=149 Identities=18% Similarity=0.141 Sum_probs=79.4
Q ss_pred eeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc-cceEEeEEecCCceEEEE
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN-IVKLLGVCAVGKPMCLLF 447 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV~ 447 (653)
+.|..|-...+|+....+... ..++..+++|+...... ....+.+|.++++.|.-.+ ..++++.+.. .+||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~--~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQ--GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---C--CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccc--hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 446668888899987642111 12346788888643221 1234568888888774322 3566766543 3999
Q ss_pred eecCCCChHH--------------HHhhcCCCCCcCCCcccccccccCCCCC--CHHHHHHHHHHHH-------------
Q psy5539 448 EYMGRGDLND--------------FLRICSPNNYINGTYSSMESSIHRVPQL--STCDLITIALQIA------------- 498 (653)
Q Consensus 448 Ey~~~gsL~~--------------~L~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~qia------------- 498 (653)
||++|.+|.. .|...+..... -.... -+.++.++..++.
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~------------~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~ 197 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMP------------FTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLL 197 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCS------------SCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCC------------CCCCcccHHHHHHHHHHHHHhccCcccchhhhh
Confidence 9999865531 11111110000 00111 1233333333221
Q ss_pred ------HHHHHh----hh----CCceecCCCCCCEeEcCC----CcEEEeccCcccc
Q psy5539 499 ------SGMVYL----SD----RKFVHRDLATRNCLINDQ----MVVKIADFGLSRK 537 (653)
Q Consensus 499 ------~gL~yL----H~----~~ivHrDLkp~NILl~~~----~~vkI~DfGla~~ 537 (653)
..+..| .. ..++|+|+.+.|||++++ +.+.|+||..+..
T Consensus 198 ~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 198 EMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 122333 22 257899999999999876 7899999998853
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.27 E-value=0.013 Score=60.33 Aligned_cols=156 Identities=12% Similarity=0.114 Sum_probs=79.2
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCC--ccceEEeE-----EecCCce
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHP--NIVKLLGV-----CAVGKPM 443 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hp--nIv~l~g~-----~~~~~~~ 443 (653)
..|+ |....||+.... ++..+++|..+.... ....+..|..++..+... .+.+++.. ...++..
T Consensus 32 ~~l~-g~~n~~y~v~~~------~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~ 102 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE------DRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY 102 (328)
T ss_dssp EEEC-CSSSEEEEECCT------TCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred Eeec-CcccceEEEEcC------CCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence 3456 888899987532 335689999864321 123456677777776421 23444443 1124456
Q ss_pred EEEEeecCCCChH-----------HH---HhhcCCC-CCcC-CCccc--c----cccccCCCCCCH---HHHHHHHHHHH
Q psy5539 444 CLLFEYMGRGDLN-----------DF---LRICSPN-NYIN-GTYSS--M----ESSIHRVPQLST---CDLITIALQIA 498 (653)
Q Consensus 444 ~LV~Ey~~~gsL~-----------~~---L~~~~~~-~~~~-~~~~~--~----~~~~~~~~~l~~---~~~~~i~~qia 498 (653)
++||||++|..+. .. ++..... .... ..... . .........++. ......+..++
T Consensus 103 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 182 (328)
T 1zyl_A 103 FAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELI 182 (328)
T ss_dssp EEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHH
T ss_pred EEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHH
Confidence 7899999875432 11 1111110 0000 00000 0 000000011111 11122333333
Q ss_pred HHHHHh----hhCCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 499 SGMVYL----SDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 499 ~gL~yL----H~~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
..+.-+ ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 183 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 183 AAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp HHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 333332 234578999999999999 4 899999988753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.16 E-value=0.01 Score=62.38 Aligned_cols=80 Identities=15% Similarity=0.100 Sum_probs=44.1
Q ss_pred EeeecccCCeeEEEEEeCCCC---CCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc-cceEEeEEecCCceEE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLL---KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN-IVKLLGVCAVGKPMCL 445 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~---~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~L 445 (653)
++.|+.|....+|+....+.. ....+..+++|+....... . .+...|.++++.+...+ +.++++.. .-++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~-~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-L-YNTISEFEVYKTMSKYKIAPQLLNTF----NGGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-T-SCHHHHHHHHHHHHHTTSSCCEEEEE----TTEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-e-ecHHHHHHHHHHHHhcCCCCceEEec----CCcE
Confidence 456788888999998753200 0001256888887643221 1 12357777777774333 34666554 1378
Q ss_pred EEeecCCCCh
Q psy5539 446 LFEYMGRGDL 455 (653)
Q Consensus 446 V~Ey~~~gsL 455 (653)
||||+++..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987544
|
| >3e6p_L Prothrombin; meizothrombin, allostery, linkage, Na+ binding, AC phase, blood coagulation, cleavage on PAIR of basic residue disease mutation; HET: DFK NAG; 2.10A {Homo sapiens} PDB: 1a0h_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.0087 Score=54.54 Aligned_cols=56 Identities=16% Similarity=0.370 Sum_probs=43.9
Q ss_pred CCCCCCCCCCCCCcccchhhhhhhccchhHHHHHHhhhccccccccCCCcCCCCCCCCCCCcccCCCCcCCCCCCCCccc
Q psy5539 101 QCVTSNGIPMSLPLCYEDCIAVRYSFCYNDWAYIEENKARGIRFKSRGHFELPNCDTLPKYEVVNGKPTCSHAQLTEMKT 180 (653)
Q Consensus 101 ~c~~~~~~~~~~p~C~~~c~~~~~~~c~~e~~~~~~~~~~~~~~~~~~~~~lp~C~~lp~~~~~~~~~~C~~~~~~~~~~ 180 (653)
.|++++..+ ..|||+.....++|+|| .+|.|...
T Consensus 56 YCRNPDgd~-~gPWCYt~d~~~~weyC-----------------------dIp~C~~~---------------------- 89 (158)
T 3e6p_L 56 FCRNPDGDE-EGVWCYVAGKPGDFGYC-----------------------DLNYCEEA---------------------- 89 (158)
T ss_dssp CCBCTTCCT-TCCEEECSSSTTCEEEC-----------------------CCCBCCCC----------------------
T ss_pred cccCCCCCC-CCCeeEeCCCCceeeeC-----------------------CCCCCCCc----------------------
Confidence 588777643 36999999889999999 57777321
Q ss_pred cccccccccCCccccceeeeccCCCCcc
Q psy5539 181 DEITYDCIRGRGRFYQGTVNTTVGGLAC 208 (653)
Q Consensus 181 ~~~~~~C~~~~g~~yrg~~~~t~sg~~C 208 (653)
+...+|..|||+++.|.+|+++
T Consensus 90 ------~~~~~g~~y~g~~~~~~~Grt~ 111 (158)
T 3e6p_L 90 ------VEEETGDGLDEDSDRAIEGRTA 111 (158)
T ss_dssp ------CCCCTTCCCCCCSCSSCCCCCT
T ss_pred ------cccccCcccccccccccCCccc
Confidence 2224799999999999999977
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.49 E-value=0.05 Score=58.97 Aligned_cols=75 Identities=16% Similarity=0.172 Sum_probs=47.1
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc-ceEEeEEecCCceEEEEe
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI-VKLLGVCAVGKPMCLLFE 448 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI-v~l~g~~~~~~~~~LV~E 448 (653)
++.|+.|-...+|++...+ .+..+++|+....... . -+..+|..+++.|...++ .++++.+. + .+|+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~-----~~~~~vLRi~g~~~~~-~-idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e 181 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS-----KQAKYLIRLYGPKTDE-I-INREREKKISCILYNKNIAKKIYVFFT-N---GRIEE 181 (458)
T ss_dssp EEEECC--CEEEEEEEETT-----TTEEEEEEEECC-CCS-C-SCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEE
T ss_pred EEEcCCCeEeEEEEEEECC-----CCceEEEEECCCChhh-h-cCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEE
Confidence 4568888889999998632 2356888887543211 1 112578888888865555 46777663 2 36999
Q ss_pred ecCCCCh
Q psy5539 449 YMGRGDL 455 (653)
Q Consensus 449 y~~~gsL 455 (653)
|+++.+|
T Consensus 182 ~I~G~~l 188 (458)
T 2qg7_A 182 FMDGYAL 188 (458)
T ss_dssp CCCSEEC
T ss_pred eeCCccC
Confidence 9987554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=94.33 E-value=0.11 Score=53.70 Aligned_cols=31 Identities=19% Similarity=0.316 Sum_probs=27.5
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
..++|+|+.+.|||+++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888999999988754
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=93.19 E-value=0.13 Score=55.02 Aligned_cols=80 Identities=10% Similarity=0.091 Sum_probs=47.2
Q ss_pred EeeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCc-cceEEeEEecCCceEEE
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN-IVKLLGVCAVGKPMCLL 446 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~Hpn-Iv~l~g~~~~~~~~~LV 446 (653)
++.|..|--..+|+....+... ...+..+++|+....... .-+..+|..+++.+.-.+ ..++++.+. -++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~--~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK--FYDSKVELDVFRYLSNINIAPNIIADFP----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C--CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch--hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEE
Confidence 4556778888999988642100 011467888886543211 112357777777774323 345665432 3789
Q ss_pred EeecCCCCh
Q psy5539 447 FEYMGRGDL 455 (653)
Q Consensus 447 ~Ey~~~gsL 455 (653)
+||++|..|
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999998664
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.31 E-value=0.39 Score=50.86 Aligned_cols=29 Identities=28% Similarity=0.464 Sum_probs=25.0
Q ss_pred ceecCCCCCCEeE------cCCCcEEEeccCcccc
Q psy5539 509 FVHRDLATRNCLI------NDQMVVKIADFGLSRK 537 (653)
Q Consensus 509 ivHrDLkp~NILl------~~~~~vkI~DfGla~~ 537 (653)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.49 E-value=0.29 Score=34.18 Aligned_cols=7 Identities=14% Similarity=0.135 Sum_probs=2.8
Q ss_pred eEehhHH
Q psy5539 294 IVLAVIF 300 (653)
Q Consensus 294 i~~~~i~ 300 (653)
|+..+++
T Consensus 13 IA~gVVg 19 (44)
T 2ks1_B 13 IATGMVG 19 (44)
T ss_dssp STHHHHH
T ss_pred EEeehhH
Confidence 3334443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.69 E-value=3.3 Score=39.72 Aligned_cols=50 Identities=12% Similarity=0.090 Sum_probs=42.1
Q ss_pred CCCHHHHHHHHHHHHHHHH-HhhhCCceecCCCCCCEeEcCCCcEEEeccCcc
Q psy5539 484 QLSTCDLITIALQIASGMV-YLSDRKFVHRDLATRNCLINDQMVVKIADFGLS 535 (653)
Q Consensus 484 ~l~~~~~~~i~~qia~gL~-yLH~~~ivHrDLkp~NILl~~~~~vkI~DfGla 535 (653)
.++..++++++.+|+.... ++++ -+|-=|.|+|++++.++.++|.-.|+-
T Consensus 81 ~~~~~eKlrll~nl~~L~~~~~~~--r~tf~l~P~NL~f~~~~~p~i~hRGi~ 131 (219)
T 4ano_A 81 KTTLLSRIRAAIHLVSKVKHHSAR--RLIFIVCPENLMFNRALEPFFLHVGVK 131 (219)
T ss_dssp TSCHHHHHHHHHHHHHHHSSCCSS--SEECCCCGGGEEECTTCCEEESCCEET
T ss_pred hcCHHHHHHHHHHHHHHHHHhhhC--ceeEEEeCceEEEeCCCcEEEEEcCCc
Confidence 4788899999999988766 5554 477789999999999999999988875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 653 | ||||
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-90 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-73 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-70 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-69 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-68 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-68 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-67 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-67 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-66 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-64 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-64 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-62 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-57 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-52 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-51 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-50 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-50 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-45 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-44 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-36 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-34 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-32 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-32 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-32 | |
| d1a0ha1 | 109 | g.14.1.1 (A:164-270) Meizothrombin {Cow (Bos tauru | 4e-31 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-31 | |
| d2hpqp_ | 79 | g.14.1.1 (P:) Meizothrombin {Human (Homo sapiens) | 3e-30 | |
| d1ki0a1 | 83 | g.14.1.1 (A:81-163) Plasminogen {Human (Homo sapie | 4e-30 | |
| d2qj2a2 | 83 | g.14.1.1 (A:127-209) NK1 fragment of hepatocyte gr | 5e-30 | |
| d1nl1a1 | 82 | g.14.1.1 (A:66-147) Prothrombin {Cow (Bos taurus) | 2e-29 | |
| d1ki0a3 | 83 | g.14.1.1 (A:251-333) Plasminogen {Human (Homo sapi | 2e-29 | |
| d1i71a_ | 83 | g.14.1.1 (A:) Apolipoprotein A {Human (Homo sapien | 9e-29 | |
| d5hpga_ | 84 | g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [T | 1e-28 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-28 | |
| d1ki0a2 | 87 | g.14.1.1 (A:164-250) Plasminogen {Human (Homo sapi | 2e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-27 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-26 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-25 | |
| d2i9aa2 | 83 | g.14.1.1 (A:50-132) Urokinase-type plasminogen act | 3e-25 | |
| d1pmla_ | 86 | g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [T | 1e-24 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-17 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-15 |
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 280 bits (717), Expect = 3e-90
Identities = 193/299 (64%), Positives = 238/299 (79%), Gaps = 4/299 (1%)
Query: 353 LNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ 412
LNPKL LE+PRN+I YVRD+G+GAFGRVFQA+APGLL +E FT+VAVKMLK+EAS +Q
Sbjct: 1 LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60
Query: 413 TDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY 472
DF+REA L+AEFD+PNIVKLLGVCAVGKPMCLLFEYM GDLN+FLR SP+ + ++
Sbjct: 61 ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120
Query: 473 SSMESSIHRV----PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528
S + + P LS + + IA Q+A+GM YLS+RKFVHRDLATRNCL+ + MVVK
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 180
Query: 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588
IADFGLSR +Y DYYK D NDAIP+RWMP ESI YN+YT ESDVWA+GV LWEIFS+ L
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 589 QPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
QPYYG+ HEEV+ Y+++GNIL P+N P LY+LM+LCW+ P +RPSF +I++ L +
Sbjct: 241 QPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (606), Expect = 1e-73
Identities = 110/309 (35%), Positives = 157/309 (50%), Gaps = 5/309 (1%)
Query: 341 PCNASYHQTDARLNPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAV 400
+ Y D R + EFPR ++ + + LG GAFG+V A A G+ K VAV
Sbjct: 13 SSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV 72
Query: 401 KMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFL 459
KMLK++A + E ++ + H NIV LLG C + P+ L+FEY GDL ++L
Sbjct: 73 KMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYL 132
Query: 460 RICS---PNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516
R + I + L+ DL+ A Q+A GM +L + VHRDLA
Sbjct: 133 RSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192
Query: 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAF 576
RN L+ VVKI DFGL+R + Y N +PV+WM ES+ YT++SDVW++
Sbjct: 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 252
Query: 577 GVCLWEIFSFALQPYYGLTHEEVV-KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635
G+ LWEIFS + PY G+ + K I+ G + P + +Y +M+ CW RP
Sbjct: 253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP 312
Query: 636 SFRTIYQTL 644
SF + L
Sbjct: 313 SFPNLTSFL 321
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 5e-70
Identities = 119/287 (41%), Positives = 176/287 (61%), Gaps = 10/287 (3%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
++ E R I R+LGQG+FG V++ A G++K E T VA+K + + AS + +F
Sbjct: 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
EA ++ EF+ ++V+LLGV + G+P ++ E M RGDL +LR P +
Sbjct: 73 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP----------AMA 122
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
+ + S +I +A +IA GM YL+ KFVHRDLA RNC++ + VKI DFG++R
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+Y DYY+ +PVRWM ES+ +T SDVW+FGV LWEI + A QPY GL++E
Sbjct: 183 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 242
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+V++++ EG +L PDN PD L++LM++CW P RPSF I ++
Sbjct: 243 QVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-69
Identities = 121/296 (40%), Positives = 179/296 (60%), Gaps = 7/296 (2%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEE--FTLVAVKMLKDEASEYLQ 412
P+ + E PR+ ++ + LG+GAFG+V A+A GL K + T VAVKMLK +A+E
Sbjct: 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDL 62
Query: 413 TDFEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGT 471
+D E ++ H NI+ LLG C P+ ++ EY +G+L ++L+ P G
Sbjct: 63 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPP----GL 118
Query: 472 YSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIAD 531
S S + QLS+ DL++ A Q+A GM YL+ +K +HRDLA RN L+ + V+KIAD
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
FGL+R ++ DYYK N +PV+WM E++ YT +SDVW+FGV LWEIF+ PY
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 592 YGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
G+ EE+ K +KEG+ + P N + LY +M+ CW+ P RP+F+ + + L I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 3e-68
Identities = 92/290 (31%), Positives = 149/290 (51%), Gaps = 34/290 (11%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
++ ++ +G+G FG V G VAVK +K++A+ F EA
Sbjct: 3 ALNMKELKLLQTIGKGEFGDVMLGDYRG-------NKVAVKCIKNDAT---AQAFLAEAS 52
Query: 421 LLAEFDHPNIVKLLGVCAVGK-PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
++ + H N+V+LLGV K + ++ EYM +G L D+LR
Sbjct: 53 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS------------------ 94
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
L L+ +L + M YL FVHRDLA RN L+++ V K++DFGL++
Sbjct: 95 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--- 151
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ + +PV+W E++ K++ +SDVW+FG+ LWEI+SF PY + ++V
Sbjct: 152 --EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649
V +++G + APD P A+Y++MK CW++ RPSF + + L +IK
Sbjct: 210 VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 8e-68
Identities = 114/292 (39%), Positives = 165/292 (56%), Gaps = 4/292 (1%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P + EFPRN + + + LG GAFG+V +A A GL+K + VAVKMLK A +
Sbjct: 13 PYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA 72
Query: 415 FEREACLLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
E +L+ +H NIV LLG C +G P ++ EY GDL +FLR + + T
Sbjct: 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFG 533
++ L DL++ + Q+A GM +L+ + +HRDLA RN L+ + KI DFG
Sbjct: 133 AIMEDDELA--LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 534 LSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYG 593
L+R + Y N +PV+WM ESI YT ESDVW++G+ LWE+FS PY G
Sbjct: 191 LARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250
Query: 594 LTHEEVV-KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ + K IKEG + +P++ P +YD+MK CW+ P+ RP+F+ I Q +
Sbjct: 251 MPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 4e-67
Identities = 80/300 (26%), Positives = 125/300 (41%), Gaps = 38/300 (12%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREA 419
E P I + +G G+FG V++ K G VAVKML + F+ E
Sbjct: 4 EIPDGQITVGQRIGSGSFGTVYKGKWHGD--------VAVKMLNVTAPTPQQLQAFKNEV 55
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L + H NI+ +G + ++ ++ L L I
Sbjct: 56 GVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET--------------- 99
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ LI IA Q A GM YL + +HRDL + N +++ + VKI DFGL+
Sbjct: 100 ----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 540 LQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
E + + WM E I N Y+ +SDV+AFG+ L+E+ + L PY + +
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL-PYSNINN 214
Query: 597 EEVVKYIKEGNIL-----QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
+ + ++ L + N P A+ LM C K RP F I ++ + R L
Sbjct: 215 RDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 5e-67
Identities = 91/289 (31%), Positives = 150/289 (51%), Gaps = 25/289 (8%)
Query: 358 EQLEFPRNDIIYV-RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFE 416
++L R++++ +LG G FG V Q ++ VA+K+LK + +
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGV---YRMRKKQIDVAIKVLKQGTEKADTEEMM 57
Query: 417 REACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSME 476
REA ++ + D+P IV+L+GVC + + L+ E G G L+ FL
Sbjct: 58 REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLV---------------- 100
Query: 477 SSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSR 536
+ ++ ++ + Q++ GM YL ++ FVHRDLA RN L+ ++ KI+DFGLS+
Sbjct: 101 ---GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSK 157
Query: 537 KMYLQD-YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595
+ D YY P++W E I + K++ SDVW++GV +WE S+ +PY +
Sbjct: 158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217
Query: 596 HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
EV+ +I++G ++ P P LY LM CW K +RP F T+ Q +
Sbjct: 218 GPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 3e-66
Identities = 99/287 (34%), Positives = 151/287 (52%), Gaps = 28/287 (9%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
++ E PR + V LG G FG V+ + T VAVK LK + F
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGY------YNGHTKVAVKSLKQGSMS--PDAFLA 57
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
EA L+ + H +V+L V +P+ ++ EYM G L DFL+ S
Sbjct: 58 EANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGI------------ 104
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
+L+ L+ +A QIA GM ++ +R ++HRDL N L++D + KIADFGL+R
Sbjct: 105 ------KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ + Y E P++W E+I Y +T++SDVW+FG+ L EI + PY G+T+
Sbjct: 159 IE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
EV++ ++ G + PDN P+ LY LM+LCW +P +RP+F + L
Sbjct: 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (551), Expect = 1e-65
Identities = 112/294 (38%), Positives = 159/294 (54%), Gaps = 11/294 (3%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
NDI + +G+G FG+V +A+ + K A+K +K+ AS+ DF E
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKAR---IKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 421 LLAEF-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L + HPNI+ LLG C + L EY G+L DFLR + + T + +
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR----KSRVLETDPAFAIAN 118
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
LS+ L+ A +A GM YLS ++F+HRDLA RN L+ + V KIADFGLSR
Sbjct: 119 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ- 177
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ Y +PVRWM +ES+ Y+ YT SDVW++GV LWEI S PY G+T E+
Sbjct: 178 --EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 235
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ + +G L+ P N D +YDLM+ CW KP RPSF I +L + + +
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (543), Expect = 1e-64
Identities = 99/293 (33%), Positives = 151/293 (51%), Gaps = 24/293 (8%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E + + + +G G FG V L + VA+K LK +E + DF EA
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLK--LPGKREIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +FDHPN++ L GV P+ ++ E+M G L+ FLR
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR-------------------Q 120
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM-- 538
Q + L+ + IA+GM YL+D +VHRDLA RN L+N +V K++DFGLSR +
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 539 -YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
Y IP+RW E+I Y K+T SDVW++G+ +WE+ S+ +PY+ +T++
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+V+ I++ L P + P AL+ LM CW +RP F I TL + R+
Sbjct: 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 7e-64
Identities = 101/290 (34%), Positives = 145/290 (50%), Gaps = 23/290 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E R I R +G+G FG V Q VA+K K+ S+ ++ F +EA
Sbjct: 3 EIQRERIELGRCIGEGQFGDVHQGIYMS--PENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+ +FDHP+IVKL+GV P+ ++ E G+L F
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSF-------------------LQV 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
R L LI A Q+++ + YL ++FVHRD+A RN L++ VK+ DFGLSR M
Sbjct: 101 RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
YYK + +P++WM ESI + ++T SDVW FGVC+WEI ++P+ G+ + +V+
Sbjct: 161 STYYKASKG-KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
I+ G L P N P LY LM CW P RP F + L I +
Sbjct: 220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 8e-64
Identities = 93/284 (32%), Positives = 149/284 (52%), Gaps = 28/284 (9%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
D+ ++++LG G FG V K VA+KM+K+ + + +F EA ++
Sbjct: 3 PKDLTFLKELGTGQFGVVKYGK------WRGQYDVAIKMIKEGSMS--EDEFIEEAKVMM 54
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
H +V+L GVC +P+ ++ EYM G L ++LR
Sbjct: 55 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-------------------EMRH 95
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+ T L+ + + M YL ++F+HRDLA RNCL+NDQ VVK++DFGLSR + +Y
Sbjct: 96 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
PVRW P E ++Y+K++ +SD+WAFGV +WEI+S PY T+ E ++I
Sbjct: 156 TS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
+G L P + +Y +M CW+ K RP+F+ + + ++
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 9e-64
Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 21/284 (7%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
++ LG GAFG V++ + VA+K L++ S + EA ++A D+P+
Sbjct: 14 IKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+ +LLG+C + + L+ + M G L D+ + +
Sbjct: 73 VCRLLGIC-LTSTVQLITQLMPFGCLLDY-------------------VREHKDNIGSQY 112
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
L+ +QIA GM YL DR+ VHRDLA RN L+ VKI DFGL++ + ++ E
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 550 DAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNIL 609
+P++WM LESIL+ YT +SDVW++GV +WE+ +F +PY G+ E+ +++G L
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232
Query: 610 QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
P +Y +M CW + +RP FR + + RD +
Sbjct: 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 207 bits (528), Expect = 1e-62
Identities = 107/296 (36%), Positives = 166/296 (56%), Gaps = 26/296 (8%)
Query: 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
P ++ E R DI LG G +G V++ + VAVK LK++ E +
Sbjct: 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTME--VEE 59
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSS 474
F +EA ++ E HPN+V+LLGVC P ++ E+M G+L D+LR C+
Sbjct: 60 FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR---------- 109
Query: 475 MESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGL 534
++S L+ +A QI+S M YL + F+HRDLA RNCL+ + +VK+ADFGL
Sbjct: 110 --------QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 161
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
SR M D Y P++W ES+ YNK++++SDVWAFGV LWEI ++ + PY G+
Sbjct: 162 SRLMT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220
Query: 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650
+V + +++ ++ P+ P+ +Y+LM+ CW P +RPSF I+Q + ++
Sbjct: 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 96/285 (33%), Positives = 147/285 (51%), Gaps = 26/285 (9%)
Query: 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPN 429
++LG G FG V + + VAVK+LK+EA L+ + EA ++ + D+P
Sbjct: 13 KELGSGNFGTVKKGY---YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 69
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
IV+++G+C + L+ E G LN + + + + +
Sbjct: 70 IVRMIGICEA-ESWMLVMEMAELGPLNKY--------------------LQQNRHVKDKN 108
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY-LQDYYKGDE 548
+I + Q++ GM YL + FVHRDLA RN L+ Q KI+DFGLS+ + ++YYK
Sbjct: 109 IIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
+ PV+W E I Y K++ +SDVW+FGV +WE FS+ +PY G+ EV +++G
Sbjct: 169 HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228
Query: 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+ P P +YDLM LCW NRP F + L N D+ N
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 2e-62
Identities = 101/324 (31%), Positives = 158/324 (48%), Gaps = 35/324 (10%)
Query: 333 VNIDLSKLPCNASYHQTDARLNPKLEQLEFPRNDII--YVRDLGQGAFGRVFQAKAPGLL 390
V+IDLS L + L ++ + + +I + +G+G FG V+
Sbjct: 2 VHIDLSAL---------NPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLD-- 50
Query: 391 KHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK-PMCLLFEY 449
+ AVK L + F E ++ +F HPN++ LLG+C + ++ Y
Sbjct: 51 NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110
Query: 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509
M GDL +F + + DLI LQ+A GM +L+ +KF
Sbjct: 111 MKHGDLRNF-------------------IRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAI--PVRWMPLESILYNKY 567
VHRDLA RNC+++++ VK+ADFGL+R MY +++ PV+WM LES+ K+
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 568 TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCW 627
T +SDVW+FGV LWE+ + PY + ++ Y+ +G L P+ PD LY++M CW
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCW 271
Query: 628 NMKPMNRPSFRTIYQTLWNIKRDL 651
+ K RPSF + + I
Sbjct: 272 HPKAEMRPSFSELVSRISAIFSTF 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-61
Identities = 90/284 (31%), Positives = 146/284 (51%), Gaps = 28/284 (9%)
Query: 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLA 423
+++ +V+++G G FG V VA+K +++ A + DF EA ++
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGY------WLNKDKVAIKTIREGAMS--EEDFIEEAEVMM 55
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
+ HP +V+L GVC P+CL+FE+M G L+D+LR +
Sbjct: 56 KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLR-------------------TQRG 96
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+ L+ + L + GM YL + +HRDLA RNCL+ + V+K++DFG++R + D
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQ 155
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
Y PV+W E +++Y+ +SDVW+FGV +WE+FS PY ++ EVV+ I
Sbjct: 156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
G L P +Y +M CW +P +RP+F + + L I
Sbjct: 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 5e-61
Identities = 110/290 (37%), Positives = 160/290 (55%), Gaps = 7/290 (2%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
EFPR+ + + LG+GAFG+V +A A G+ K VAVKMLK+ A+ E
Sbjct: 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 68
Query: 421 LLAEFDH-PNIVKLLGVCAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESS 478
+L H N+V LLG C G P+ ++ E+ G+L+ +LR
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 479 IHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
L+ LI + Q+A GM +L+ RK +HRDLA RN L++++ VVKI DFGL+R +
Sbjct: 129 DF----LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 184
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT-HE 597
Y Y + +P++WM E+I YT++SDVW+FGV LWEIFS PY G+ E
Sbjct: 185 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
E + +KEG ++APD T +Y M CW+ +P RP+F + + L N+
Sbjct: 245 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 5e-61
Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 28/287 (9%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
+ E PR + LGQG FG V+ T VA+K LK F +
Sbjct: 10 DAWEIPRESLRLEVKLGQGCFGEVWMGT------WNGTTRVAIKTLKPGTMS--PEAFLQ 61
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
EA ++ + H +V+L V + P+ ++ EYM +G L DFL+ +
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLP------- 113
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRK 537
L+ +A QIASGM Y+ +VHRDL N L+ + +V K+ADFGL+R
Sbjct: 114 -----------QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 162
Query: 538 MYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ +Y + P++W E+ LY ++T++SDVW+FG+ L E+ + PY G+ +
Sbjct: 163 IEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
EV+ ++ G + P P++L+DLM CW +P RP+F + L
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 100/294 (34%), Positives = 155/294 (52%), Gaps = 21/294 (7%)
Query: 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREAC 420
E + + + +G G FG V++ ++ VA+K LK +E + DF EA
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
++ +F H NI++L GV + KPM ++ EYM G L+ FLR
Sbjct: 62 IMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-------------------E 102
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ + S L+ + IA+GM YL++ +VHRDLA RN L+N +V K++DFGLSR +
Sbjct: 103 KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162
Query: 541 -QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
+ IP+RW E+I Y K+T SDVW+FG+ +WE+ ++ +PY+ L++ EV
Sbjct: 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222
Query: 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+K I +G L P + P A+Y LM CW + RP F I L + R ++
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-57
Identities = 91/286 (31%), Positives = 137/286 (47%), Gaps = 26/286 (9%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREAC 420
D+ + LG G+FG V + + + VAVK LK + + DF RE
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 421 LLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+ DH N+++L GV + PM ++ E G L D
Sbjct: 64 AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDR-------------------LRK 103
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
L A+Q+A GM YL ++F+HRDLA RN L+ + +VKI DFGL R +
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 541 -QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599
D+Y E+ +P W ES+ ++ SD W FGV LWE+F++ +P+ GL ++
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223
Query: 600 VKYI-KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
+ I KEG L P++ P +Y++M CW KP +RP+F + L
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 4e-56
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 35/290 (12%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P + + +LG GAFG+V++A+ E L A K++ ++ E L+ D+ E +L
Sbjct: 10 PEDFWEIIGELGDGAFGKVYKAQ-----NKETSVLAAAKVIDTKSEEELE-DYMVEIDIL 63
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
A DHPNIVKLL + +L E+ G ++ +
Sbjct: 64 ASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-------------------ELE 104
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
L+ + + Q + YL D K +HRDL N L +K+ADFG+S K
Sbjct: 105 RPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164
Query: 543 YYKGDENDAIPVRWMPLESILYN-----KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597
+ WM E ++ Y ++DVW+ G+ L E+ P++ L
Sbjct: 165 QRRDSF--IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP-PHHELNPM 221
Query: 598 EVVKYIKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
V+ I + L P D +K C R + + Q +
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-55
Identities = 59/284 (20%), Positives = 110/284 (38%), Gaps = 32/284 (11%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
+ +G G++GR + + + + ++ K L +E + E LL E HP
Sbjct: 9 LYTIGTGSYGRCQKIR-----RKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 429 NIVKLLGVC--AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLS 486
NIV+ + ++ EY GDL + + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER----------------QYLD 107
Query: 487 TCDLITIALQIASGMVYLSDR-----KFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
++ + Q+ + R +HRDL N ++ + VK+ DFGL+R +
Sbjct: 108 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD 167
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
+ +M E + Y +SD+W+ G L+E+ + P+ + +E+
Sbjct: 168 TSFAKAFVG--TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP-PFTAFSQKELAG 224
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
I+EG + P D L +++ N+K +RPS I +
Sbjct: 225 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (470), Expect = 5e-54
Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 41/300 (13%)
Query: 355 PKLEQLEFPRN-DIIY--VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--DEASE 409
P + +L F + + ++ +R++G G+FG V+ A+ +VA+K + + S
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR-----DVRNSEVVAIKKMSYSGKQSN 56
Query: 410 YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN 469
D +E L + HPN ++ G L+ EY + P
Sbjct: 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP----- 111
Query: 470 GTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529
L ++ + G+ YL +HRD+ N L+++ +VK+
Sbjct: 112 ---------------LQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKL 156
Query: 530 ADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL---YNKYTVESDVWAFGVCLWEIFSF 586
DFG + M + + G WM E IL +Y + DVW+ G+ E+
Sbjct: 157 GDFGSASIMAPANSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE- 209
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQA-PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
P + + + +I + + + + + C P +RP+ + + +
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 8e-52
Identities = 55/285 (19%), Positives = 99/285 (34%), Gaps = 32/285 (11%)
Query: 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLL 422
P+ +GQGA G V+ A VA++ + + + E ++
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAM-----DVATGQEVAIRQMNLQQQPKKE-LIINEILVM 71
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
E +PNIV L VG + ++ EY+ G L D +
Sbjct: 72 RENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM------------------ 113
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + + + +L + +HRD+ + N L+ VK+ DFG ++ +
Sbjct: 114 ---DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ WM E + Y + D+W+ G+ E+ PY +
Sbjct: 171 SKRSTM--VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP-PYLNENPLRALYL 227
Query: 603 IKEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
I LQ P+ D + C +M R S + + Q +
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 2e-51
Identities = 63/283 (22%), Positives = 107/283 (37%), Gaps = 33/283 (11%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLL 422
D R LG+G FG V+ A+ + + ++A+K+L ++ RE +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAR-----EKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ HPNI++L G + L+ EY G + L+ S
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK------------------ 102
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
T ++A+ + Y ++ +HRD+ N L+ +KIADFG S
Sbjct: 103 --FDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ ++P E I + + D+W+ GV +E P+ T++E K
Sbjct: 161 RT----TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFL-VGKPPFEANTYQETYKR 215
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
I PD + DL+ P RP R + + W
Sbjct: 216 ISRVE-FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 2e-50
Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 28/285 (9%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
V+ LG+GA+G V A VAVK++ + + + ++E C+ +H N
Sbjct: 10 VQTLGEGAYGEVQLAV-----NRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
+VK G G L EY G+L D I + D
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDR--------------------IEPDIGMPEPD 104
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
Q+ +G+VYL HRD+ N L++++ +KI+DFGL+ + +
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 550 DAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYG-LTHEEVVKYIKEGN 607
+ ++ E + ++ DVW+ G+ L + + L + +E + ++
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 224
Query: 608 ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652
L A L+ P R + I + W + L+
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW-YNKPLK 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 175 bits (445), Expect = 6e-50
Identities = 56/289 (19%), Positives = 103/289 (35%), Gaps = 35/289 (12%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +LG GAFG V + + + K + T + E ++ + HP
Sbjct: 34 LEELGSGAFGVVHRCV-----EKATGRVFVAKFINTPYPLDKYT-VKNEISIMNQLHHPK 87
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
++ L M L+ E++ G+L D + ++S +
Sbjct: 88 LINLHDAFEDKYEMVLILEFLSGGELFDRIA-------------------AEDYKMSEAE 128
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQMVVKIADFGLSRKMYLQDYYKGD 547
+I Q G+ ++ + VH D+ N + VKI DFGL+ K+ + K
Sbjct: 129 VINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK-- 186
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
+ E + +D+WA GV + + S P+ G E ++ +K +
Sbjct: 187 -VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS-PFAGEDDLETLQNVKRCD 244
Query: 608 I---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
A + D +K +P R + + W +K D N
Sbjct: 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW-LKGDHSN 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (442), Expect = 7e-50
Identities = 46/289 (15%), Positives = 110/289 (38%), Gaps = 36/289 (12%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
DLG+G FG V + + K +K + ++ Q ++E +L H N
Sbjct: 10 AEDLGRGEFGIVHRCV-----ETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRN 62
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
I+ L + + ++FE++ D+ + + +L+ +
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERIN-------------------TSAFELNERE 103
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLI--NDQMVVKIADFGLSRKMYLQDYYKGD 547
+++ Q+ + +L H D+ N + +KI +FG +R++ D ++
Sbjct: 104 IVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR-- 161
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
+ E ++ + +D+W+ G ++ + S + P+ T++++++ I
Sbjct: 162 -LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIENIMNAE 219
Query: 608 IL---QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653
+A D + + +R + Q W +K+ +E
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW-LKQKIER 267
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 2e-49
Identities = 55/280 (19%), Positives = 106/280 (37%), Gaps = 32/280 (11%)
Query: 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREA 419
+E +D + +LG G G VF+ ++A K++ E ++ RE
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVS-----HKPSGLVMARKLIHLEIKPAIRNQIIREL 55
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+L E + P IV G + + E+M G L+ +
Sbjct: 56 QVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQV--------------------L 95
Query: 480 HRVPQLSTCDLITIALQIASGMVYL-SDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM 538
+ ++ L +++ + G+ YL K +HRD+ N L+N + +K+ DFG+S ++
Sbjct: 96 KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 539 YLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
+ +M E + Y+V+SD+W+ G+ L E+ P +E
Sbjct: 156 IDSMAN----SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY-PIPPPDAKE 210
Query: 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
+ + + TP + + +RP
Sbjct: 211 LEL-MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMA 249
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 172 bits (437), Expect = 7e-49
Identities = 50/297 (16%), Positives = 106/297 (35%), Gaps = 38/297 (12%)
Query: 358 EQLEFPRNDIIY----VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQT 413
+ +E + ++ +LG GAFG V + + A K + +T
Sbjct: 15 QPVEIKHDHVLDHYDIHEELGTGAFGVVHRVT-----ERATGNNFAAKFVMTPHESDKET 69
Query: 414 DFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYS 473
+E ++ HP +V L M +++E+M G+L + +
Sbjct: 70 -VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA------------- 115
Query: 474 SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM--VVKIAD 531
++S + + Q+ G+ ++ + +VH DL N + + +K+ D
Sbjct: 116 ------DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 532 FGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPY 591
FGL+ + D + + + E +D+W+ GV + + S P+
Sbjct: 170 FGLTAHL---DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS-PF 225
Query: 592 YGLTHEEVVKYIKEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
G +E ++ +K + A + D ++ P R + + W
Sbjct: 226 GGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-47
Identities = 51/282 (18%), Positives = 101/282 (35%), Gaps = 29/282 (10%)
Query: 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLLA 423
D + + LG+G+F V A+ + A+K+L+ E RE +++
Sbjct: 9 DFKFGKILGEGSFSTVVLAR-----ELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 424 EFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
DHP VKL + + Y G+L + I ++
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY--------------------IRKIG 103
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
+I S + YL + +HRDL N L+N+ M ++I DFG ++ + +
Sbjct: 104 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163
Query: 544 YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
+ +++ E + SD+WA G ++++ + P+ + + I
Sbjct: 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP-PFRAGNEYLIFQKI 222
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ P+ DL++ + R +
Sbjct: 223 IKLE-YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 4e-46
Identities = 65/294 (22%), Positives = 107/294 (36%), Gaps = 35/294 (11%)
Query: 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFER 417
+Q E R+ + LG GAF V A+ LVA+K + +A E + E
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAE-----DKRTQKLVAIKCIAKKALEGKEGSMEN 56
Query: 418 EACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMES 477
E +L + HPNIV L + G + L+ + + G+L D
Sbjct: 57 EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDR------------------- 97
Query: 478 SIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI---NDQMVVKIADFGL 534
I + D + Q+ + YL D VHRDL N L ++ + I+DFGL
Sbjct: 98 -IVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGL 156
Query: 535 SRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594
S+ ++ E + Y+ D W+ GV + + P+Y
Sbjct: 157 SKMEDPGSVLS---TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP-PFYDE 212
Query: 595 THEEVVKYIKEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
++ + I + D+ D+ D ++ P R + Q W
Sbjct: 213 NDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 32/277 (11%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACL 421
D I + LG+G+FG+VF A+ + A+K LK + + ++ + L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAE-----FKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 56
Query: 422 LAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
++HP + + + + + EY+ GDL I
Sbjct: 57 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH--------------------IQS 96
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQ 541
+ A +I G+ +L + V+RDL N L++ +KIADFG+ ++ L
Sbjct: 97 CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156
Query: 542 DYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601
D ++ E +L KY D W+FGV L+E+ P++G EE+
Sbjct: 157 DAKTNTF--CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS-PFHGQDEEELFH 213
Query: 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
I+ N P DL+ + +P R R
Sbjct: 214 SIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVR 249
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-45
Identities = 59/290 (20%), Positives = 105/290 (36%), Gaps = 43/290 (14%)
Query: 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEF 425
+ + ++G+G+F V++ E VA L+D ++ + F+ EA +L
Sbjct: 11 LKFDIEIGRGSFKTVYKGL-----DTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 426 DHPNIVKLLGVCAV----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHR 481
HPNIV+ K + L+ E M G L + + R
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY--------------------LKR 105
Query: 482 VPQLSTCDLITIALQIASGMVYLSDRK--FVHRDLATRNCLINDQ-MVVKIADFGLSRKM 538
+ L + QI G+ +L R +HRDL N I VKI D GL+
Sbjct: 106 FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-- 163
Query: 539 YLQDYYKGDENDAI--PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596
+ A+ +M E + KY DV+AFG+C+ E+ +
Sbjct: 164 ----LKRASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNA 218
Query: 597 EEVVKYIKEGNI-LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
++ + + G + ++++ C R S + + +
Sbjct: 219 AQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 6e-45
Identities = 60/318 (18%), Positives = 104/318 (32%), Gaps = 54/318 (16%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAE 424
I+ +G+G FG V++ K G VAVK+ E E
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRG-------EEVAVKIFSSREER--SWFREAEIYQTVM 53
Query: 425 FDHPNIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
H NI+ + + L+ +Y G L D+L ++
Sbjct: 54 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------------RYTVTVE 100
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKM-- 538
+ +L+ +A + HRDL ++N L+ IAD GL+ +
Sbjct: 101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 160
Query: 539 YLQDYYKGDENDAIPVRWMPLESIL------YNKYTVESDVWAFGVCLWEIFSFAL---- 588
+ R+M E + + + +D++A G+ WEI
Sbjct: 161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 220
Query: 589 -----QPYYGL-----THEEVVKYIKEGNI------LQAPDNTPDALYDLMKLCWNMKPM 632
PYY L + EE+ K + E + + +M+ CW
Sbjct: 221 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGA 280
Query: 633 NRPSFRTIYQTLWNIKRD 650
R + I +TL + +
Sbjct: 281 ARLTALRIKKTLSQLSQQ 298
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 5e-44
Identities = 58/288 (20%), Positives = 107/288 (37%), Gaps = 41/288 (14%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK--------DEASEYLQTDFEREACLLAE 424
LG+G V + AVK++ E + L+ +E +L +
Sbjct: 11 LGRGVSSVVRRCI-----HKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 425 F-DHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
HPNI++L L+F+ M +G+L D+ +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDY--------------------LTEKV 105
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
LS + I + + L VHRDL N L++D M +K+ DFG S ++ +
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 165
Query: 544 YK---GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ G + P + + Y E D+W+ GV ++ + + P++ ++
Sbjct: 166 LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA-GSPPFWHRKQMLML 224
Query: 601 KYIKEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ I GN D+ D + DL+ ++P R + +
Sbjct: 225 RMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-42
Identities = 66/288 (22%), Positives = 111/288 (38%), Gaps = 41/288 (14%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-----DEASEYLQTDFEREACLLAE 424
+LG G F V + + + A K +K + D ERE +L E
Sbjct: 15 GEELGSGQFAVVKKCR-----EKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 425 FDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQ 484
HPN++ L V + L+ E + G+L DF +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDF--------------------LAEKES 109
Query: 485 LSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV----VKIADFGLSRKMYL 540
L+ + QI +G+ YL + H DL N ++ D+ V +KI DFGL+ K+
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
+ +K N ++ E + Y +E+D+W+ GV + + S P+ G T +E +
Sbjct: 170 GNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS-GASPFLGDTKQETL 225
Query: 601 KYIKEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
+ N + NT D ++ P R + + Q W
Sbjct: 226 ANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 150 bits (380), Expect = 1e-41
Identities = 52/277 (18%), Positives = 91/277 (32%), Gaps = 36/277 (12%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDH 427
LG G V A+ VAVK+L+ + F REA A +H
Sbjct: 12 GEILGFGGMSEVHLAR-----DLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 428 PNIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
P IV + G ++ EY+ L D + P
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------------- 107
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDY 543
++ I + + + +HRD+ N +I+ VK+ DFG++R +
Sbjct: 108 -MTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166
Query: 544 YKGDENDAI-PVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
I +++ E + SDV++ G L+E+ + P+ G + V
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP-PFTGDSPVSVAYQ 225
Query: 603 IKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ + + L ++ P NR
Sbjct: 226 HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 149 bits (376), Expect = 9e-41
Identities = 54/276 (19%), Positives = 101/276 (36%), Gaps = 34/276 (12%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQ--TDFEREACLL 422
D +R LG G+FGRV + A+K+LK E L+ E +L
Sbjct: 4 QDFQILRTLGTGSFGRVHLIR-----SRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLML 58
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
+ HP I+++ G + + ++ +Y+ G+L LR
Sbjct: 59 SIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF----------------- 101
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
A ++ + YL + ++RDL N L++ +KI DFG ++ +
Sbjct: 102 ---PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
Y ++ E + Y D W+FG+ ++E+ + P+Y + +
Sbjct: 159 YTL-----CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT-PFYDSNTMKTYEK 212
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR 638
I + + P + + DL+ R
Sbjct: 213 ILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNL 247
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (373), Expect = 1e-40
Identities = 48/293 (16%), Positives = 100/293 (34%), Gaps = 43/293 (14%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
R +G G+FG ++ VA+K+ + E+ +
Sbjct: 12 GRKIGSGSFGDIYLGT-----DIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGV 63
Query: 430 IVKLLGVCAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
+ + C G ++ E +G + F + S
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLF--------------------NFCSRKFSLK 103
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ---MVVKIADFGLSRKM-----YL 540
++ +A Q+ S + Y+ + F+HRD+ N L+ +V I DFGL++K +
Sbjct: 104 TVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ 163
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
Y+ ++N R+ + + L + + D+ + G L +L +
Sbjct: 164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
Query: 601 KYIKEGN------ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647
KY + I P + C +++ ++P + + Q N+
Sbjct: 224 KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 31/274 (11%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--ASEYLQTDFEREACLL 422
ND Y++ LG+G FG+V + + A+K+L+ E ++ E+ +L
Sbjct: 5 NDFDYLKLLGKGTFGKVILVR-----EKATGRYYAMKILRKEVIIAKDEVAHTVTESRVL 59
Query: 423 AEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
HP + L +C + EY G+L + R
Sbjct: 60 QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH--------------------LSRE 99
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ +I S + YL R V+RD+ N +++ +KI DFGL ++
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ ++ E + N Y D W GV ++E+ L P+Y HE + +
Sbjct: 160 ATM--KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL-PFYNQDHERLFEL 216
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
I I + P L+ P R
Sbjct: 217 ILMEEI-RFPRTLSPEAKSLLAGLLKKDPKQRLG 249
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 144 bits (363), Expect = 2e-38
Identities = 52/280 (18%), Positives = 102/280 (36%), Gaps = 38/280 (13%)
Query: 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-----DEASEYLQTDFEREA 419
ND R +G+G FG V+ + K + A+K L + E L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGK-----MYAMKCLDKKRIKMKQGETLALNERIML 58
Query: 420 CLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
L++ D P IV + + + + M GDL+ +
Sbjct: 59 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYH--------------------L 98
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ S D+ A +I G+ ++ +R V+RDL N L+++ V+I+D GL+
Sbjct: 99 SQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158
Query: 540 LQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598
+ + +M E + Y +D ++ G L+++ P+ ++
Sbjct: 159 KKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR-GHSPFRQHKTKD 213
Query: 599 VVKYIK--EGNILQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ + ++ PD+ L L++ R
Sbjct: 214 KHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLG 253
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 4e-38
Identities = 53/306 (17%), Positives = 102/306 (33%), Gaps = 53/306 (17%)
Query: 360 LEFPRNDI-----IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTD 414
L+ +N I + + LG G G+V Q A+KML+D
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIF-----NKRTQEKFALKMLQDCP------K 50
Query: 415 FEREACLLA-EFDHPNIVKLLGVC----AVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN 469
RE L P+IV+++ V A K + ++ E + G+L ++
Sbjct: 51 ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-------- 102
Query: 470 GTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQM---V 526
+ + I I + YL HRD+ N L + +
Sbjct: 103 ----------RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAI 152
Query: 527 VKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSF 586
+K+ DFG +++ + ++ E + KY D+W+ GV ++ +
Sbjct: 153 LKLTDFGFAKETTSHNSLTTPCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 209
Query: 587 ALQPYYGLTHEEVVKYIKEGNILQAPD-------NTPDALYDLMKLCWNMKPMNRPSFRT 639
P+Y + +K + + + + L++ +P R +
Sbjct: 210 YP-PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268
Query: 640 IYQTLW 645
W
Sbjct: 269 FMNHPW 274
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 2e-36
Identities = 52/282 (18%), Positives = 94/282 (33%), Gaps = 45/282 (15%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-----DEASEYLQTDFEREACLLAEFD- 426
LG G FG V+ + + VA+K ++ D T E LL +
Sbjct: 12 LGSGGFGSVYSGI-----RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 427 -HPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
+++LL L+ E I L
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF-------------------ITERGAL 107
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYY 544
+ Q+ + + + +HRD+ N LI+ ++ +K+ DFG + Y
Sbjct: 108 QEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT 167
Query: 545 KGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
+ P E I Y++Y + VW+ G+ L+++ + P+ I
Sbjct: 168 DF----DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI-PFEHDEE------I 216
Query: 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645
G + L++ C ++P +RP+F I W
Sbjct: 217 IRGQVFF-RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 135 bits (341), Expect = 3e-36
Identities = 44/299 (14%), Positives = 90/299 (30%), Gaps = 45/299 (15%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-P 428
R +G+G+FG +F+ VA+K + E
Sbjct: 10 GRRIGEGSFGVIFEGT-----NLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCT 61
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
I + G L+ + +G + + S
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--------------------CGRKFSVK 101
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV-----VKIADFGLSRKMY---- 539
+ A Q+ + + + ++ V+RD+ N LI + + DFG+ +
Sbjct: 102 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT 161
Query: 540 -LQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS--FALQPYYGLTH 596
Y+ +N + R+M + + L + + D+ A G Q T+
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 597 EEVVKYIKEGN----ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
++ + I E + + P+ Y M N+ P + + + L
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 3e-34
Identities = 63/304 (20%), Positives = 101/304 (33%), Gaps = 58/304 (19%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK----DEASEYLQTDFEREACLLAEFDHP 428
LG+G F V++A+ +VA+K +K EA + + RE LL E HP
Sbjct: 6 LGEGQFATVYKAR-----DKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NI+ LL + L+F++M L+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVII--------------------KDNSLVLTPS 100
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ L G+ YL +HRDL N L+++ V+K+ADFGL++
Sbjct: 101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTH 159
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
P Y V D+WA G L E+ + G + + + I E
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL-LRVPFLPGDSDLDQLTRIFETLG 218
Query: 609 LQAPDNTPDA---------------------------LYDLMKLCWNMKPMNRPSFRTIY 641
+ PD L DL++ + P R +
Sbjct: 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278
Query: 642 QTLW 645
+ +
Sbjct: 279 KMKY 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 4e-34
Identities = 62/330 (18%), Positives = 114/330 (34%), Gaps = 73/330 (22%)
Query: 360 LEFPRNDII----YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVK-MLKDEASEYLQTD 414
+E P D + + +GQG FG VF+A+ + VA+K +L + E
Sbjct: 1 VECPFCDEVSKYEKLAKIGQGTFGEVFKAR-----HRKTGQKVALKKVLMENEKEGFPIT 55
Query: 415 FEREACLLAEFDHPNIVKLLGVCAVGKP--------MCLLFEYMGRGDLNDFLRICSPNN 466
RE +L H N+V L+ +C + L+F++
Sbjct: 56 ALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL-------- 107
Query: 467 YINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526
+ + + + ++ + + +G+ Y+ K +HRD+ N LI V
Sbjct: 108 ------------SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 155
Query: 527 VKIADFGLSRKMYL--QDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEI 583
+K+ADFGL+R L N + + + P E +L + Y D+W G + E+
Sbjct: 156 LKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215
Query: 584 FSFALQPYYGLTHEEVVKYIKEGNILQAPDNTPD-------------------------- 617
++ + G T + + I + P+ P+
Sbjct: 216 WTRSP-IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKA 274
Query: 618 -----ALYDLMKLCWNMKPMNRPSFRTIYQ 642
DL+ + P R
Sbjct: 275 YVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 129 bits (324), Expect = 5e-34
Identities = 60/306 (19%), Positives = 119/306 (38%), Gaps = 59/306 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHP 428
+ +G+G +G V++A+ + A+K ++ ++ E + + RE +L E H
Sbjct: 7 LEKIGEGTYGVVYKAQ------NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHS 60
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIVKL V K + L+FE++ + L +
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLL--------------------DVCEGGLESV 100
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ LQ+ +G+ Y DR+ +HRDL +N LIN + +KIADFGL+R +
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY--T 158
Query: 549 NDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGN 607
++ + + + + ++ KY+ D+W+ G E+ + + G++ + + I
Sbjct: 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN-GTPLFPGVSEADQLMRIFRIL 217
Query: 608 ILQAPDNTPD----------------------------ALYDLMKLCWNMKPMNRPSFRT 639
N P+ + DL+ + P R + +
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQ 277
Query: 640 IYQTLW 645
+ +
Sbjct: 278 ALEHAY 283
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 6e-34
Identities = 48/276 (17%), Positives = 98/276 (35%), Gaps = 33/276 (11%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE---ASEYLQTDFEREACLLAEFD 426
++ LG GA+G+VF + + H+ L A+K+LK E +L
Sbjct: 29 LKVLGTGAYGKVFLVRK--ISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 427 H-PNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQL 485
P +V L + L+ +Y+ G+L + + +
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTH--------------------LSQRERF 126
Query: 486 STCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYK 545
+ ++ +I + +L ++RD+ N L++ V + DFGLS++ + +
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186
Query: 546 GDENDAIPVRWMPLESILYNK--YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603
+ +M + + + D W+ GV ++E+ + A P+ + I
Sbjct: 187 AYDFCGTI-EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS-PFTVDGEKNSQAEI 244
Query: 604 KEGNI---LQAPDNTPDALYDLMKLCWNMKPMNRPS 636
+ P DL++ P R
Sbjct: 245 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLG 280
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (325), Expect = 1e-33
Identities = 60/287 (20%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 357 LEQLEFPRNDII------YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE--AS 408
L++ E P + ++ LG G+FGRV K E A+K+L +
Sbjct: 27 LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK-----HKESGNHYAMKILDKQKVVK 81
Query: 409 EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYI 468
E +L + P +VKL + ++ EY+ G++ L
Sbjct: 82 LKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--------- 132
Query: 469 NGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVK 528
R+ + S A QI YL ++RDL N LI+ Q ++
Sbjct: 133 -----------RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQ 181
Query: 529 IADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFAL 588
+ DFG ++++ + + + E IL Y D WA GV ++E+ +
Sbjct: 182 VTDFGFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
Query: 589 QPYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP 635
P++ ++ + I G + + P + L DL++ + R
Sbjct: 237 -PFFADQPIQIYEKIVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-33
Identities = 67/321 (20%), Positives = 125/321 (38%), Gaps = 64/321 (19%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACL---LAEF 425
V ++G+GA+G+VF+A+ VA+K ++ E + RE + L F
Sbjct: 12 VAEIGEGAYGKVFKAR----DLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67
Query: 426 DHPNIVKLLGVCAVGKP-----MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIH 480
+HPN+V+L VC V + + L+FE++ + ++ P
Sbjct: 68 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--------------- 112
Query: 481 RVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYL 540
+ T + + Q+ G+ +L + VHRDL +N L+ +K+ADFGL+R
Sbjct: 113 ----VPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF 168
Query: 541 QDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600
Q + + + + E +L + Y D+W+ G E+F + G + + +
Sbjct: 169 QMALT---SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQL 224
Query: 601 KYIKEG--------------------------NILQAPDNTPDALYDLMKLCWNMKPMNR 634
I + I + + + DL+ C P R
Sbjct: 225 GKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 284
Query: 635 PSFRTIYQTLW--NIKRDLEN 653
S + + +++R EN
Sbjct: 285 ISAYSALSHPYFQDLERCKEN 305
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-32
Identities = 51/311 (16%), Positives = 90/311 (28%), Gaps = 65/311 (20%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +G G+FG V+QAK + LVA+K + + + RE ++ + DH N
Sbjct: 25 TKVIGNGSFGVVYQAK-----LCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCN 74
Query: 430 IVKLLGVCAVGKP------MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVP 483
IV+L + L+ +Y+
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ----------------- 117
Query: 484 QLSTCDLITIALQIASGMVYLSDRKFVHRDL-ATRNCLINDQMVVKIADFGLSRKMYLQD 542
L + Q+ + Y+ HRD+ L D V+K+ DFG ++++ +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
P YT DVW+ G L E+ + G + + +
Sbjct: 178 PNVSYICS--RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP-IFPGDSGVDQLVE 234
Query: 603 IKEGNILQAPD----------------------------NTPDALYDLMKLCWNMKPMNR 634
I + + TP L P R
Sbjct: 235 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 294
Query: 635 PSFRTIYQTLW 645
+ +
Sbjct: 295 LTPLEACAHSF 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (313), Expect = 2e-32
Identities = 64/306 (20%), Positives = 115/306 (37%), Gaps = 57/306 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHP 428
+ +G+G +G VF+AK E +VA+K ++ D+ E + + RE CLL E H
Sbjct: 7 LEKIGEGTYGTVFKAK-----NRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIV+L V K + L+FE+ + F +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDP--------------------E 101
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ + Q+ G+ + R +HRDL +N LIN +K+A+FGL+R + E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 549 NDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG- 606
+ + + P + + K Y+ D+W+ G E+ + + G ++ +K I
Sbjct: 162 --VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 607 ---------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639
+++ DL++ P+ R S
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 640 IYQTLW 645
Q +
Sbjct: 280 ALQHPY 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-32
Identities = 63/306 (20%), Positives = 118/306 (38%), Gaps = 57/306 (18%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLK-DEASEYLQTDFEREACLLAEFDHP 428
V +G+G +G V++A+ +VA+K ++ D +E + + RE LL E +HP
Sbjct: 7 VEKIGEGTYGVVYKAR-----NKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
NIVKLL V + L+FE++ + DL F+ + +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDA------------------SALTGIPLP 102
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ + Q+ G+ + + +HRDL +N LIN + +K+ADFGL+R + E
Sbjct: 103 LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 162
Query: 549 NDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG- 606
+ + + E +L KY + D+W+ G E+ + + G + + + I
Sbjct: 163 --VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL 219
Query: 607 ---------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRT 639
+ + + L+ + P R S +
Sbjct: 220 GTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKA 279
Query: 640 IYQTLW 645
+
Sbjct: 280 ALAHPF 285
|
| >d1a0ha1 g.14.1.1 (A:164-270) Meizothrombin {Cow (Bos taurus) [TaxId: 9913]} Length = 109 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Meizothrombin species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (287), Expect = 4e-31
Identities = 26/87 (29%), Positives = 43/87 (49%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
C+ RGR Y+G + T G C W +++ A + P + +EN+CRN G+E
Sbjct: 6 TCVPDRGREYRGRLAVTTHGSRCLAWSSEQAKALSKDQDFNPAVPLAENFCRNPDGDEEG 65
Query: 246 PWCYTMDPNVRWQRCEIPTCADSMQDD 272
WCY D ++ C++ C + + D
Sbjct: 66 AWCYVADQPGDFEYCDLNYCEEPVDGD 92
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 5e-31
Identities = 57/308 (18%), Positives = 98/308 (31%), Gaps = 55/308 (17%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
+ +G+GA+G V A + VA+K + + RE +L F H N
Sbjct: 13 LSYIGEGAYGMVCSAY-----DNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHEN 67
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
I+ + + + Y+ + + + + LS
Sbjct: 68 IIGINDIIRAPTIEQMKDVYL-----------------VTHLMGADLYKLLKTQHLSNDH 110
Query: 490 LITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDEN 549
+ QI G+ Y+ +HRDL N L+N +KI DFGL+R + G
Sbjct: 111 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170
Query: 550 DAIPVRW-MPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEG- 606
+ + RW E +L + YT D+W+ G L E+ S + G + + + +I
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP-IFPGKHYLDQLNHILGIL 229
Query: 607 -----------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSF 637
+ N DL+ P R
Sbjct: 230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEV 289
Query: 638 RTIYQTLW 645
+
Sbjct: 290 EQALAHPY 297
|
| >d2hpqp_ g.14.1.1 (P:) Meizothrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 79 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Meizothrombin species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 3e-30
Identities = 24/79 (30%), Positives = 36/79 (45%)
Query: 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSP 246
C+ RG+ YQG + T GL C W + + A + + EN+CRN G+E
Sbjct: 1 CVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGV 60
Query: 247 WCYTMDPNVRWQRCEIPTC 265
WCY + C++ C
Sbjct: 61 WCYVAGKPGDFGYCDLNYC 79
|
| >d1ki0a1 g.14.1.1 (A:81-163) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-30
Identities = 32/80 (40%), Positives = 43/80 (53%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
+C G G+ Y+GT++ T G+ CQ+W + PH P P ENYCRN +
Sbjct: 3 ECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQG 62
Query: 246 PWCYTMDPNVRWQRCEIPTC 265
PWCYT DP R+ C+I C
Sbjct: 63 PWCYTTDPEKRYDYCDILEC 82
|
| >d2qj2a2 g.14.1.1 (A:127-209) NK1 fragment of hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: NK1 fragment of hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 5e-30
Identities = 38/82 (46%), Positives = 53/82 (64%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
+CI G+GR Y+GTV+ T G+ CQ W + PH H P + + ENYCRN GEE
Sbjct: 1 NCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGG 60
Query: 246 PWCYTMDPNVRWQRCEIPTCAD 267
PWC+T +P VR++ C+IP C++
Sbjct: 61 PWCFTSNPEVRYEVCDIPQCSE 82
|
| >d1nl1a1 g.14.1.1 (A:66-147) Prothrombin {Cow (Bos taurus) [TaxId: 9913]} Length = 82 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Prothrombin species: Cow (Bos taurus) [TaxId: 9913]
Score = 109 bits (273), Expect = 2e-29
Identities = 31/81 (38%), Positives = 41/81 (50%)
Query: 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSP 246
C G G Y+G V+ T G+ CQ W ++ PH E P + EN+CRN G P
Sbjct: 1 CAEGVGMNYRGNVSVTRSGIECQLWRSRYPHKPEINSTTHPGADLRENFCRNPDGSITGP 60
Query: 247 WCYTMDPNVRWQRCEIPTCAD 267
WCYT P +R + C +P C
Sbjct: 61 WCYTTSPTLRREECSVPVCGQ 81
|
| >d1ki0a3 g.14.1.1 (A:251-333) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-29
Identities = 42/82 (51%), Positives = 53/82 (64%), Gaps = 1/82 (1%)
Query: 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEE 243
TY C++G G Y+G V TV G CQ W A+ PH HER P FP N ENYCRN G+
Sbjct: 3 TYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHERTPENFPCKNLDENYCRNPDGKR 62
Query: 244 PSPWCYTMDPNVRWQRCEIPTC 265
+PWC+T + VRW+ C+IP+C
Sbjct: 63 -APWCHTTNSQVRWEYCKIPSC 83
|
| >d1i71a_ g.14.1.1 (A:) Apolipoprotein A {Human (Homo sapiens), IV-7 variant [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Apolipoprotein A species: Human (Homo sapiens), IV-7 variant [TaxId: 9606]
Score = 107 bits (268), Expect = 9e-29
Identities = 37/80 (46%), Positives = 48/80 (60%), Gaps = 1/80 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
DC G G+ Y+G+ +TTV G CQ W + PH H+R +P + NYCRN E
Sbjct: 1 DCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDA-EIR 59
Query: 246 PWCYTMDPNVRWQRCEIPTC 265
PWCYTMDP+VRW+ C + C
Sbjct: 60 PWCYTMDPSVRWEYCNLTQC 79
|
| >d5hpga_ g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} Length = 84 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (267), Expect = 1e-28
Identities = 36/83 (43%), Positives = 46/83 (55%), Gaps = 1/83 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE-RPPPVFPELNNSENYCRNAGGEEP 244
DC+ G G+ Y+G TTV G CQ W A+EPH H P P +NYCRN G+
Sbjct: 1 DCMFGNGKGYRGKRVTTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVG 60
Query: 245 SPWCYTMDPNVRWQRCEIPTCAD 267
PWCYT +P + C++P CA
Sbjct: 61 GPWCYTTNPRKLYDYCDVPQCAA 83
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 3e-28
Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 40/290 (13%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
++ +G GA+G V A VA+K L + SE RE LL H
Sbjct: 23 LQPVGSGAYGAVCSAV-----DGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 429 NIVKLLGVCAVGKPM------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
N++ LL V + + L+ +MG + + +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMG----------------------TDLGKLMKH 115
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+L + + Q+ G+ Y+ +HRDL N +N+ +KI DFGL+R+ +
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
P + + +YT D+W+ G + E+ + + G H + +K
Sbjct: 176 T----GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT-LFKGSDHLDQLKE 230
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKP-MNRPSFRTIYQTLWNIKRDL 651
I + + D K P + + F +I + +L
Sbjct: 231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d1ki0a2 g.14.1.1 (A:164-250) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} Length = 87 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 2e-27
Identities = 38/82 (46%), Positives = 49/82 (59%), Gaps = 1/82 (1%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPS 245
+C+ G Y G ++ T+ GL CQ WD++ PHAH P FP N +NYCRN E
Sbjct: 2 ECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDR-ELR 60
Query: 246 PWCYTMDPNVRWQRCEIPTCAD 267
PWC+T DPN RW+ C+IP C
Sbjct: 61 PWCFTTDPNKRWELCDIPRCTT 82
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 111 bits (277), Expect = 2e-27
Identities = 61/361 (16%), Positives = 118/361 (32%), Gaps = 81/361 (22%)
Query: 326 APAPSQDVNIDLSKLPCNASYHQTDARLNPKLEQLEFP-RNDIIYVRDLGQGAFGRVFQA 384
P PS+ +++ + + H+ + + +E+ ++D VR LG+G + VF+A
Sbjct: 1 GPVPSR------ARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEA 54
Query: 385 KAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC--AVGK 441
V VK+LK + +RE +L PNI+ L + V +
Sbjct: 55 I-----NITNNEKVVVKILKPVKKK----KIKREIKILENLRGGPNIITLADIVKDPVSR 105
Query: 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGM 501
L+FE++ D + L+ D+ +I +
Sbjct: 106 TPALVFEHVNNTDFKQLYQ-----------------------TLTDYDIRFYMYEILKAL 142
Query: 502 VYLSDRKFVHRDLATRNCLI-NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLE 560
Y +HRD+ N +I ++ +++ D+GL+ + Y A P
Sbjct: 143 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN--VRVASRYFKGPEL 200
Query: 561 SILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK-------------YIKEGN 607
+ Y Y D+W+ G L + ++G + + + YI + N
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 608 ILQAPD-----------------------NTPDALYDLMKLCWNMKPMNRPSFRTIYQTL 644
I P D + +R + R +
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320
Query: 645 W 645
+
Sbjct: 321 Y 321
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 3e-26
Identities = 55/284 (19%), Positives = 100/284 (35%), Gaps = 28/284 (9%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
+ +G GA+G V A + VAVK L + S RE LL H
Sbjct: 23 LSPVGSGAYGSVCAAF-----DTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 429 NIVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTC 488
N++ LL V + + + + + ++I + +L+
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVY----------------LVTHLMGADLNNIVKCQKLTDD 121
Query: 489 DLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDE 548
+ + QI G+ Y+ +HRDL N +N+ +KI DFGL+R +
Sbjct: 122 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT----DDEMTG 177
Query: 549 NDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608
A P + + Y D+W+ G + E+ + G H + +K I
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFPGTDHIDQLKLILRLVG 236
Query: 609 LQAPDNTPDALYD-LMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651
+ + ++ M + +F ++ + DL
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDL 280
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-25
Identities = 51/279 (18%), Positives = 89/279 (31%), Gaps = 39/279 (13%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKML-KDEASEYLQTDFEREACLLAEFDHP 428
++ +G GA G V A VA+K L + ++ RE L+ +H
Sbjct: 22 LKPIGSGAQGIVCAAY-----DAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 429 NIVKLLGVCAVGKPM------CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRV 482
NI+ LL V K + L+ E M
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHE----------------- 119
Query: 483 PQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMYLQD 542
+ + Q+ G+ +L +HRDL N ++ +KI DFGL+R
Sbjct: 120 ------RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
Query: 543 YYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602
+ + E IL Y D+W+ G + E+ + + G + +
Sbjct: 174 MMT---PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI-LFPGRDYIDQWNK 229
Query: 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIY 641
+ E P+ + N +F ++
Sbjct: 230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLF 268
|
| >d2i9aa2 g.14.1.1 (A:50-132) Urokinase-type plasminogen activator {Human (Homo sapiens) [TaxId: 9606]} Length = 83 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Urokinase-type plasminogen activator species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.1 bits (241), Expect = 3e-25
Identities = 23/84 (27%), Positives = 28/84 (33%), Gaps = 5/84 (5%)
Query: 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPP---PVFPELNNSENYCRNAGGEE 243
C G G FY+G +T G C W++ NYCRN
Sbjct: 1 CYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRR 60
Query: 244 PSPWCYTM-DPNVRWQRCEIPTCA 266
PWCY Q C + CA
Sbjct: 61 -RPWCYVQVGLKPLVQECMVHDCA 83
|
| >d1pmla_ g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} Length = 86 | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.9 bits (238), Expect = 1e-24
Identities = 24/85 (28%), Positives = 39/85 (45%), Gaps = 5/85 (5%)
Query: 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPP---PVFPELNNSENYCRNAGGE 242
DC G G Y+GT + T G +C W++ NYCRN G
Sbjct: 2 DCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDG- 60
Query: 243 EPSPWCYTM-DPNVRWQRCEIPTCA 266
+ PWC+ + + + W+ C++P+C+
Sbjct: 61 DAKPWCHVLKNRRLTWEYCDVPSCS 85
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 83.2 bits (204), Expect = 1e-17
Identities = 36/218 (16%), Positives = 73/218 (33%), Gaps = 13/218 (5%)
Query: 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPN 429
VR LG G F V+ AK T VA+K+++ + E E LL + +
Sbjct: 18 VRKLGWGHFSTVWLAK-----DMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDAD 70
Query: 430 IVKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCD 489
K + A L + + + + G + +
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF----EVLGENLLALIKKYEHRGIPLIY 126
Query: 490 LITIALQIASGMVYLS-DRKFVHRDLATRNCLIN-DQMVVKIADFGLSRKMYLQDYYKGD 547
+ I+ Q+ G+ Y+ +H D+ N L+ + ++ Y +
Sbjct: 127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 186
Query: 548 ENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFS 585
N + E +L + +D+W+ ++E+ +
Sbjct: 187 TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 224
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 73.3 bits (179), Expect = 1e-15
Identities = 36/218 (16%), Positives = 64/218 (29%), Gaps = 58/218 (26%)
Query: 373 LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE---------YLQTDFEREACLLA 423
+G+G VF E+F VK K + Y F A A
Sbjct: 8 MGEGKESAVFNCY------SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 424 EFDHPNIVKLLGVCAVGK----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSI 479
+ + KL G+ +L E + +L
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP---------------- 105
Query: 480 HRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKIADFGLSRKMY 539
+ I + R VH DL+ N L++++ + I DF S ++
Sbjct: 106 -----------DEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII-DFPQSVEV- 152
Query: 540 LQDYYKGDENDAIPVRWMPLESIL--YNK-YTVESDVW 574
E + + +I+ +++ Y E D+
Sbjct: 153 -------GEEGWREILERDVRNIITYFSRTYRTEKDIN 183
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 653 | |||
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1nl1a1 | 82 | Prothrombin {Cow (Bos taurus) [TaxId: 9913]} | 99.96 | |
| d2qj2a2 | 83 | NK1 fragment of hepatocyte growth factor {Human (H | 99.96 | |
| d1ki0a1 | 83 | Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1ki0a2 | 87 | Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1ki0a3 | 83 | Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1i71a_ | 83 | Apolipoprotein A {Human (Homo sapiens), IV-7 varia | 99.95 | |
| d5hpga_ | 84 | Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d2hpqp_ | 79 | Meizothrombin {Human (Homo sapiens) [TaxId: 9606]} | 99.95 | |
| d1a0ha1 | 109 | Meizothrombin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d1pmla_ | 86 | Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | 99.94 | |
| d2i9aa2 | 83 | Urokinase-type plasminogen activator {Human (Homo | 99.93 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.77 | |
| d1ijya_ | 122 | Frizzled 8 (FZ8) {Mouse (Mus musculus) [TaxId: 100 | 97.68 | |
| d1ijxa_ | 125 | Secreted Frizzled-related protein 3 (SFRP-3;fzb) { | 97.46 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.92 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 93.49 |
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.9e-56 Score=459.38 Aligned_cols=295 Identities=65% Similarity=1.126 Sum_probs=254.8
Q ss_pred CccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceE
Q psy5539 354 NPKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKL 433 (653)
Q Consensus 354 ~~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l 433 (653)
+|++..+|+++++|++.+.||+|+||+||+|++.+.....+++.||||+++........++|.+|++++++++||||+++
T Consensus 2 ~p~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~ 81 (301)
T d1lufa_ 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 81 (301)
T ss_dssp CHHHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CcchhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccc
Confidence 67888999999999999999999999999999987667778899999999877777777889999999999999999999
Q ss_pred EeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCc----ccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCc
Q psy5539 434 LGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTY----SSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKF 509 (653)
Q Consensus 434 ~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~i 509 (653)
++++...+..++||||+++|+|.++|+............ ............+++..++.|+.||+.||+|||+++|
T Consensus 82 ~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i 161 (301)
T d1lufa_ 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161 (301)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCe
Confidence 999999999999999999999999998655432211000 0000112234568999999999999999999999999
Q ss_pred eecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 510 VHRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 510 vHrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
|||||||+|||||.++.+||+|||+|+.+...+.........+++.|||||.+.+..+|.++|||||||++|||++++.+
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 99999999999999999999999999877655555555566788999999999999999999999999999999999899
Q ss_pred CCCCCCHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
||.+.+..++...+.++..+..++.+++++.+|+.+||+.+|++||||.+|++.|++|+
T Consensus 242 p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 99999999999999999988889999999999999999999999999999999998875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-54 Score=447.91 Aligned_cols=269 Identities=36% Similarity=0.654 Sum_probs=227.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
++..++|++.+.||+|+||+||+|++.. .......||||.+.........++|.+|+++|++++|||||+++|++..+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKL--PGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeC--CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4556789999999999999999999753 22344679999998777777778899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.+++.. ....+++.+++.++.|||+||+|||+++|+||||||+|||
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~-------------------~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NIL 160 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQ-------------------NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL 160 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHT-------------------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CEEEEEEEecCCCcceeeecc-------------------ccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEE
Confidence 999999999999999999872 2346899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccc---cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYY---KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++++.+||+|||+|+.+...... .......+|+.|||||.+.++.++.++|||||||++|||+|+|.+||.+.+..
T Consensus 161 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 161 VNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp ECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999876433221 12223457899999999999999999999999999999999888899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++...+..+..++.+..+++++.+||.+||+.||++|||+++|++.|.++.++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 241 DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence 99999999888888889999999999999999999999999999999987654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=438.39 Aligned_cols=261 Identities=34% Similarity=0.715 Sum_probs=223.6
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
+..++|++.+.||+|+||+||+|++. ++..||||+++..... .++|.+|++++++++|||||+++|++..++
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~ 73 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL------NKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQA 73 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET------TTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC------CCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCC
Confidence 34578999999999999999999874 3467999999865432 457999999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.. ....+++..++.|+.|||.||+|||+++|+||||||+|||+
T Consensus 74 ~~~lv~E~~~~g~L~~~l~~-------------------~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill 134 (263)
T d1sm2a_ 74 PICLVFEFMEHGCLSDYLRT-------------------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134 (263)
T ss_dssp SCEEEEECCTTCBHHHHHHT-------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE
T ss_pred ceEEEEEecCCCcHHHHhhc-------------------cccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee
Confidence 99999999999999999862 23468899999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++....... .......+|+.|||||.+.+..++.++||||||+++|||+|++.+|+...+..++.+
T Consensus 135 ~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~ 213 (263)
T d1sm2a_ 135 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213 (263)
T ss_dssp CGGGCEEECSCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH
T ss_pred cCCCCeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 9999999999999987643332 233445688999999999999999999999999999999999999999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+..+.....|..+++++.+|+.+||+.||++|||+++|+++|.++.+.
T Consensus 214 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 214 DISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 9999988888889999999999999999999999999999999998763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-54 Score=441.50 Aligned_cols=269 Identities=34% Similarity=0.636 Sum_probs=234.9
Q ss_pred cccCCCCeeEEee-ecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 360 LEFPRNDIIYVRD-LGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 360 ~e~~~~~~~~~~~-LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
+-+.++++.+.+. ||+|+||+||+|.+.. ..++..||||+++........++|.+|+++|++++|||||+++|++.
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRM---RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ 79 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEec---CCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec
Confidence 3456678888884 9999999999998743 23456899999987776767788999999999999999999999986
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
. +..+|||||+++|+|.+++.. ....+++.+++.++.||+.||+|||+++|+||||||+|
T Consensus 80 ~-~~~~lvmE~~~~g~L~~~l~~-------------------~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 139 (285)
T d1u59a_ 80 A-EALMLVMEMAGGGPLHKFLVG-------------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 139 (285)
T ss_dssp S-SSEEEEEECCTTEEHHHHHTT-------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred c-CeEEEEEEeCCCCcHHHHhhc-------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhh
Confidence 5 568999999999999999851 23468999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++++.+||+|||+|+.+...+.. .......+|+.|||||.+.++.++.++|||||||++|||+|.|.+||.+.+..
T Consensus 140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred eeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999877544322 23334567899999999999999999999999999999999788899999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
++...+..+..++.|+.+++++++||.+||+.+|++|||+.+|++.|.....++
T Consensus 220 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~ 273 (285)
T d1u59a_ 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273 (285)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 999999999988899999999999999999999999999999999888665543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.7e-54 Score=444.16 Aligned_cols=268 Identities=40% Similarity=0.786 Sum_probs=237.8
Q ss_pred ccccccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEE
Q psy5539 355 PKLEQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL 434 (653)
Q Consensus 355 ~~l~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~ 434 (653)
|.+.++|+..++|++.+.||+|+||+||+|++. .++..||||+++..... .++|.+|+++|++++|||||+++
T Consensus 7 p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~ 79 (287)
T d1opja_ 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWK-----KYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLL 79 (287)
T ss_dssp TTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEG-----GGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCcccEecHHHeEEeeEEeeCCCeEEEEEEEC-----CCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCC
Confidence 455677899999999999999999999999864 35689999999765433 45799999999999999999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
|++..++..++||||+++|+|.+++... ....+++..++.|+.||+.||+|||+++|+||||
T Consensus 80 ~~~~~~~~~~iv~E~~~~g~l~~~l~~~------------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDl 141 (287)
T d1opja_ 80 GVCTREPPFYIITEFMTYGNLLDYLREC------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDL 141 (287)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHS------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ccEeeCCeeEEEeecccCcchHHHhhhc------------------cccchHHHHHHHHHHHHHHHHHHHHHCCcccCcc
Confidence 9999999999999999999999999732 2346899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+||||++++.+||+|||+|+...... ........+++.|||||.+.++.++.++||||||+++|||++++.+|+.+.
T Consensus 142 Kp~NILl~~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~ 220 (287)
T d1opja_ 142 AARNCLVGENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 220 (287)
T ss_dssp SGGGEEECGGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccCeEEECCCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcc
Confidence 9999999999999999999998654322 222234457889999999999999999999999999999999999889899
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
+..++.+.+..+..++.++.+++++.+|+.+||+.||++|||+++|++.|..+.
T Consensus 221 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 221 DLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred hHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 999999999888888888999999999999999999999999999999887764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=436.99 Aligned_cols=270 Identities=37% Similarity=0.664 Sum_probs=231.8
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
|+..++|...+.||+|+||+||+|++.+. .......||||+++....+....+|.+|++++++++|||||+++|++...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~-~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTS-SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCC-CCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 66778899999999999999999987542 12334689999998776666777899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+.+|+|.+++.. ....+++.++++++.||+.||+|||+++|+||||||+|||
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NIL 142 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLRE-------------------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNIL 142 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHH-------------------TTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred CceEEEEEecccCcchhhhhc-------------------ccccccHHHHHHHHHHHHHhhhhccccccccCccccceEE
Confidence 999999999999999998862 2356899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+.++.+||+|||+++.+..... ........+|+.|||||.+.++.++.++||||||+++|||++++.+|+.+.+..++
T Consensus 143 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~ 222 (283)
T d1mqba_ 143 VNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 222 (283)
T ss_dssp ECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH
Confidence 99999999999999987643322 12233456789999999999999999999999999999999999989999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+.+.++..++.+..++.++.+|+.+||+.+|++|||+++|++.|..+.+.
T Consensus 223 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp HHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 999999988888899999999999999999999999999999999887653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-53 Score=437.58 Aligned_cols=265 Identities=37% Similarity=0.697 Sum_probs=234.0
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
+.+|++.++|++.+.||+|+||+||+|++. ++..||||+++..... .+.|.+|++++++++|||||+++|++
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~ 77 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN------GHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVV 77 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEET------TTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEEC------CCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeee
Confidence 456788899999999999999999999874 3468999999764332 45799999999999999999999987
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.. +..++||||+++|+|.+++... ....+++..+++|+.||++||+|||+++|+||||||+
T Consensus 78 ~~-~~~~iv~Ey~~~g~L~~~~~~~------------------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~ 138 (272)
T d1qpca_ 78 TQ-EPIYIITEYMENGSLVDFLKTP------------------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138 (272)
T ss_dssp CS-SSCEEEEECCTTCBHHHHTTSH------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhc------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchh
Confidence 54 5679999999999999987521 1235899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||++++.+||+|||+|+.+.... ........+|+.|||||.+.++.++.++||||||+++|||+|++.+|+...+..
T Consensus 139 NIll~~~~~~Kl~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~ 217 (272)
T d1qpca_ 139 NILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217 (272)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred heeeecccceeeccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998764333 233345678899999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++...+..+..+..|+.+++++.+|+.+||+.||++|||+++|++.|.++..+
T Consensus 218 ~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 218 EVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 99999999988888899999999999999999999999999999999887654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=433.77 Aligned_cols=266 Identities=29% Similarity=0.477 Sum_probs=219.2
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
.+|++.++|.+.+.||+|+||+||+|+.. ..||||+++.. ......+.|.+|++++++++|||||+++|++
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 46788899999999999999999999853 24999999743 2344567899999999999999999999987
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
.. +..+|||||+++|+|.++|+. ....+++..++.|+.||++||+|||+++||||||||+
T Consensus 74 ~~-~~~~lv~Ey~~~g~L~~~l~~-------------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~ 133 (276)
T d1uwha_ 74 TA-PQLAIVTQWCEGSSLYHHLHI-------------------IETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133 (276)
T ss_dssp CS-SSCEEEEECCCEEEHHHHHHT-------------------SCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ec-cEEEEEEecCCCCCHHHHHhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHH
Confidence 54 568999999999999999962 2345899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||||++++.+||+|||+|+...............+|+.|||||.+.+ +.++.++|||||||++|||+||. .||.+.
T Consensus 134 NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~-~Pf~~~ 212 (276)
T d1uwha_ 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ-LPYSNI 212 (276)
T ss_dssp GEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSS-CTTTTC
T ss_pred HEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCC-CCCCCC
Confidence 99999999999999999987644333333345678999999999864 35899999999999999999955 689876
Q ss_pred CHH-HHHHHHHcCCc----cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhhC
Q psy5539 595 THE-EVVKYIKEGNI----LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLEN 653 (653)
Q Consensus 595 ~~~-e~~~~i~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~~ 653 (653)
+.. .+...+..+.. ...+..+++++.+||.+||+.||++|||+++|+++|+.+.+.+++
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~Pk 276 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCC
T ss_pred ChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcCCC
Confidence 654 45555555433 234567899999999999999999999999999999999988764
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=444.39 Aligned_cols=287 Identities=37% Similarity=0.651 Sum_probs=232.3
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.+|+++++|++.+.||+|+||+||+|++.+.........||||.+...........+.+|+.++.++ +|||||++++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~ 110 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence 4678899999999999999999999998765555666789999998766655667899999999998 899999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcC-CCcc--cccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYIN-GTYS--SMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~-~~~~--~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
...+..+|||||+++|+|.++|+......... ..+. ...........+++..++.|+.||++||+|||+++||||||
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 111 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 99999999999999999999998543211000 0000 00011123456899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||++.++.+||+|||+|+...............+|+.|||||.+.++.++.++|||||||++|||+|+|.+||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654443333344567899999999999999999999999999999999778899886
Q ss_pred CH-HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 TH-EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~-~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+. +.+.+.+..+..++.|..+++++.+||.+||+.||++|||+++|+++|.
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 55 4555666777777788899999999999999999999999999999985
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-53 Score=431.33 Aligned_cols=268 Identities=37% Similarity=0.704 Sum_probs=228.2
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+|+++++|++.+.||+|+||.||+|++.. ....+..||||.++........+.|.+|+.++++++|||||+++|++.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~--~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMS--PENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECC--C--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEec--CCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 57888999999999999999999998753 234567899999987777777788999999999999999999999985
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..++||||+++|+|.+++.. ....+++..++.++.||++||+|||+++|+||||||+||
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~-------------------~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NI 139 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQV-------------------RKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNV 139 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHH-------------------TTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred cCeEEEEEEeccCCcHHhhhhc-------------------cCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhhe
Confidence 4678999999999999998862 234689999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
|+++++.+||+|||+|+....... .......+|+.|||||.+.+..++.++|||||||++|||+++|.+||.+.+..++
T Consensus 140 ll~~~~~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 140 LVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp EEEETTEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred eecCCCcEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999987543322 2334456789999999999999999999999999999999988899999999999
Q ss_pred HHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 600 VKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 600 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
...+..+...+.+..+++++.+||.+||+.||++|||+++|+++|..+.++
T Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 999999988888999999999999999999999999999999999988765
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-53 Score=431.36 Aligned_cols=256 Identities=37% Similarity=0.708 Sum_probs=221.3
Q ss_pred eeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceEEEEee
Q psy5539 371 RDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 371 ~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+.||+|+||+||+|.+.. ...++.||||+++... .....++|.+|+++|++++|||||+++|++.. +..+|||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~---~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~ 88 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQM---KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEM 88 (277)
T ss_dssp EEEEECSSEEEEEEEEEC---SSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred CCcccCCCeEEEEEEEcc---CCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEc
Confidence 469999999999998642 3456889999997543 33456789999999999999999999999865 467899999
Q ss_pred cCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCcEEE
Q psy5539 450 MGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMVVKI 529 (653)
Q Consensus 450 ~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~vkI 529 (653)
+++|+|.++++. ...+++..++.|+.||+.||+|||+++|+||||||+||||+.++.+||
T Consensus 89 ~~~g~L~~~l~~--------------------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl 148 (277)
T d1xbba_ 89 AELGPLNKYLQQ--------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148 (277)
T ss_dssp CTTEEHHHHHHH--------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred CCCCcHHHHHhh--------------------ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccc
Confidence 999999999972 245899999999999999999999999999999999999999999999
Q ss_pred eccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCc
Q psy5539 530 ADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIKEGNI 608 (653)
Q Consensus 530 ~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~~~~~ 608 (653)
+|||+++....... ........+|++|||||.+.+..++.++||||||+++|||+|.|.+||.+.+..++...+..+..
T Consensus 149 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228 (277)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999987643322 22334557899999999999999999999999999999999988889999999999999999988
Q ss_pred cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 609 LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 609 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
++.|..+++++++||.+||+.||++|||+++|++.|.....+
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 889999999999999999999999999999998888766443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=433.15 Aligned_cols=289 Identities=38% Similarity=0.671 Sum_probs=233.1
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGV 436 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~ 436 (653)
.+++++.++|++.+.||+|+||+||+|++.+.....+++.||||+++........+.+.+|+.++.++ +|+|||.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 45678889999999999999999999998776666778999999998776666677788888888877 68999999999
Q ss_pred Eec-CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 437 CAV-GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 437 ~~~-~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
+.. +...++||||+++|+|.++|+.......... ..........+++.+++.++.||++||+|||+++|+|||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~----~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlK 161 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK----VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 161 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC---------------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccc----cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCC
Confidence 865 4568999999999999999985432111000 00011123568999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+||||++++.+||+|||+|+...............||+.|||||.+.++.++.++|||||||++|||++++.+||.+..
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544443344456789999999999999999999999999999999998888998765
Q ss_pred -HHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 596 -HEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 596 -~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
.+++...+..+..+..++.+++++.+||.+||+.||++|||+++|+++|..+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 4567777888888888899999999999999999999999999999999988653
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=425.20 Aligned_cols=255 Identities=36% Similarity=0.727 Sum_probs=228.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||+||+|+.+ ++..||||+++..... .++|.+|+.++++++|||||+++|++...+..
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~ 74 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR------GQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 74 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET------TTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC------CCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCce
Confidence 468889999999999999999973 3578999999765432 45799999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+++|+|.+++.. ....+++..+++++.||++||+|||+++|+||||||+|||+++
T Consensus 75 ~iv~Ey~~~g~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 75 FIITEYMANGCLLNYLRE-------------------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp EEEEECCTTEEHHHHHHS-------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred EEEEEccCCCcHHHhhhc-------------------cccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcC
Confidence 999999999999999862 2345789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+++....... .......+|+.|||||.+.+..++.++||||||+++|||+|++..||.+.+..++...+
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i 214 (258)
T d1k2pa_ 136 QGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214 (258)
T ss_dssp TCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred CCcEEECcchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999999986644332 23345678999999999999999999999999999999999888899999999999999
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.++..+..|..+++++.+||++||+.||++|||+++|+++|.+
T Consensus 215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 9998888899999999999999999999999999999999854
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=433.66 Aligned_cols=279 Identities=43% Similarity=0.798 Sum_probs=247.3
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEe
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCA 438 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~ 438 (653)
++|++.++|.+.+.||+|+||+||+|.+.+..+..+++.||||+++..........|.+|+.++++++|||||+++|++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 46888999999999999999999999986654555678999999987666666778999999999999999999999999
Q ss_pred cCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 439 VGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 439 ~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
..+..++||||+++|+|.+++...... .........+++..+++++.|+|+||.|||+++|+||||||+|
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~----------~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~N 163 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPA----------MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARN 163 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHH----------HHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGG
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccc----------cccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCc
Confidence 999999999999999999999743210 0111233467999999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|||++++.+||+|||+|+.+.............+|+.|||||.+.++.++.++||||||+++|||+|++.+||.+.+..+
T Consensus 164 iLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~ 243 (308)
T d1p4oa_ 164 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243 (308)
T ss_dssp EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred eeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999999877655544444556789999999999999999999999999999999999889999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+...+.++..++.+..++..+.+||.+||+.+|++|||+++|+++|...
T Consensus 244 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred HHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 9999999998888999999999999999999999999999999988654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=421.84 Aligned_cols=254 Identities=24% Similarity=0.391 Sum_probs=224.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|++++++++|||||++++++.+++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREK-----QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEEC-----CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 468999999999999999999964 356899999986432 1223567899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~--------------------~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQK--------------------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred EEEEEEeecCCCcHHHHHhh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 99999999999999999973 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+|+..... ......||+.|||||.+.+..++.++|||||||++|||++|. .||.+.+..++..
T Consensus 140 ~~~~~~kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~-~Pf~~~~~~~~~~ 214 (263)
T d2j4za1 140 GSAGELKIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-PPFEANTYQETYK 214 (263)
T ss_dssp CTTSCEEECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS-CTTCCSSHHHHHH
T ss_pred cCCCCEeecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCC-CCCCCCCHHHHHH
Confidence 99999999999999765322 123356899999999999999999999999999999999955 5999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIK 648 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~ 648 (653)
.+..+.. ..|+.+++++.+|+.+||+.||++|||++|+++|+|--.
T Consensus 215 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 215 RISRVEF-TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHTTCC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHcCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 9888764 567889999999999999999999999999999998543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=432.10 Aligned_cols=266 Identities=34% Similarity=0.620 Sum_probs=227.0
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++++.||+|+||+||+|++... .......||||+++........++|.+|++++++++|||||+++|++..+ ..
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPE-GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC-----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCC-CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence 35799999999999999999987532 11223579999998765555677899999999999999999999999864 56
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++++||+.+|+|.+++.. ....+++..+++++.|||.||+|||+++|+||||||+||||+.
T Consensus 86 ~~v~e~~~~~~l~~~~~~-------------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~ 146 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVRE-------------------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKT 146 (317)
T ss_dssp EEEEECCTTCBHHHHHHH-------------------TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEE
T ss_pred eEEEEeccCCcccccccc-------------------cccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCC
Confidence 788999999999998862 2356899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+|+...............+|+.|||||.+.++.++.++||||||+++|||+|++.+||.+.+..++...+
T Consensus 147 ~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i 226 (317)
T d1xkka_ 147 PQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226 (317)
T ss_dssp TTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH
T ss_pred CCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 99999999999987755444334445568999999999999999999999999999999999889999999999999999
Q ss_pred HcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 604 KEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 604 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
..+..++.|+.+++++.+|+.+||+.||++|||+++|+++|..+.++
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 99988888899999999999999999999999999999999887654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=426.50 Aligned_cols=257 Identities=23% Similarity=0.397 Sum_probs=215.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEec--CC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV--GK 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~--~~ 441 (653)
++|++++.||+|+||+||+|+.. .+++.||||.++... .+...+.+.+|++++++++|||||++++++.+ .+
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 78 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRK-----SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNT 78 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----
T ss_pred hhCEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCC
Confidence 57999999999999999999864 456889999987543 44556779999999999999999999999864 45
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC-----ceecCCCC
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK-----FVHRDLAT 516 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----ivHrDLkp 516 (653)
.++|||||+++|+|.+++.... .....+++..++.++.||+.||+|||+++ |+||||||
T Consensus 79 ~~~ivmEy~~~g~L~~~i~~~~----------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp 142 (269)
T d2java1 79 TLYIVMEYCEGGDLASVITKGT----------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKP 142 (269)
T ss_dssp CEEEEEECCTTEEHHHHHHHHH----------------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCG
T ss_pred EEEEEEecCCCCcHHHHHHhcc----------------ccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCch
Confidence 6899999999999999997322 12356899999999999999999999875 99999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
+||||++++.+||+|||+|+...... .......+|+.|||||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 143 ~NIll~~~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg-~~Pf~~~~~ 219 (269)
T d2java1 143 ANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL-MPPFTAFSQ 219 (269)
T ss_dssp GGEEECTTSCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS-SCSCCCSSH
T ss_pred hhcCcCCCCcEEEeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhC-CCCCCCCCH
Confidence 99999999999999999998764322 122345789999999999999999999999999999999995 569999999
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
.++...+..+.....+..+++++.+|+++||+.||++|||++||++|+|
T Consensus 220 ~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~ 268 (269)
T d2java1 220 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 268 (269)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence 9999999999888888899999999999999999999999999999875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=424.49 Aligned_cols=288 Identities=41% Similarity=0.737 Sum_probs=241.9
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCC--ccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKH--EEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLL 434 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~--~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~ 434 (653)
.+++++.++|++.+.||+|+||.||+|+..+..+. ..+..||||+++.........++.+|+..+.++ +|||||+++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~ 85 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLL 85 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecc
Confidence 44678899999999999999999999987553322 345789999998877777778899999999888 899999999
Q ss_pred eEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCC
Q psy5539 435 GVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDL 514 (653)
Q Consensus 435 g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDL 514 (653)
+++..++..++||||+++|+|.++|+......... ...........+++.+++.++.||+.||+|||+++||||||
T Consensus 86 ~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~----~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 86 GACTQDGPLYVIVEYASKGNLREYLQARRPPGLEY----SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp EEECSSSSCEEEECCCTTCBHHHHHHTTSCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cccccCCeEEEEEEccCCCcHHHHHHhhcCCcccc----ccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 99999999999999999999999998554322100 00111123467899999999999999999999999999999
Q ss_pred CCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 515 ATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 515 kp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
||+|||++.++.+||+|||+++...............+++.|||||.+.++.++.++||||||+++|||++++.+||.+.
T Consensus 162 Kp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~ 241 (299)
T d1fgka_ 162 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 241 (299)
T ss_dssp SGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred cccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCC
Confidence 99999999999999999999987755544444555678899999999999999999999999999999999889999999
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+.+++.+.+.++..+..|..+++++.+|+.+||+.||++|||+.+|++.|.++..
T Consensus 242 ~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999998888899999999999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=423.55 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=212.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++........+.+.+|++++++++|||||++++++..++..+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNR-----VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 57999999999999999999864 3568999999976554445567999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|||||+++|+|.++|+ ....+++.++..++.||++||+|||+++|+||||||+|||++++
T Consensus 80 ivmEy~~gg~L~~~l~--------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIE--------------------PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139 (271)
T ss_dssp EEEECCTTEEGGGGSB--------------------TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred EEEeccCCCcHHHHHh--------------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC
Confidence 9999999999999885 23468999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCCCH-HHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGLTH-EEVVKY 602 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~~~-~e~~~~ 602 (653)
+.+||+|||+|+.....+.........||+.|||||.+.+..+ +.++|||||||++|||++|. +||.+... ......
T Consensus 140 ~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~-~pf~~~~~~~~~~~~ 218 (271)
T d1nvra_ 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSD 218 (271)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSS-CSCSSSSTTSHHHHH
T ss_pred CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCC-CCCCCCChHHHHHHH
Confidence 9999999999987654444444456679999999999988876 57899999999999999955 57765443 233333
Q ss_pred HHcCC-ccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGN-ILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.... .......+++++.+|+.+||+.||++|||++|+++|.|
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence 33332 23333568899999999999999999999999999877
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-51 Score=423.98 Aligned_cols=292 Identities=39% Similarity=0.679 Sum_probs=247.3
Q ss_pred ccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEE
Q psy5539 359 QLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVC 437 (653)
Q Consensus 359 ~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~ 437 (653)
.++++.++|++.+.||+|+||.||+|++.+..+..+++.||||+++..........|.+|+.+++++ +|||||+++|++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 5688899999999999999999999998766666788999999998776666677899999999999 699999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..++..+|||||+++|+|.++|+........... ...........+++..+++++.||+.||+|||+++++||||||+
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT--SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhcccccccccc--ccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999866543221110 01111234467999999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH-
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH- 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~- 596 (653)
|||++.++.+||+|||+++...............+|+.|||||.+.++.++.++||||||+++|||+|++.+|+.+.+.
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998765444444445567899999999999999999999999999999999988888877665
Q ss_pred HHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHhh
Q psy5539 597 EEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDLE 652 (653)
Q Consensus 597 ~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l~ 652 (653)
+.+.+.+..+..+..+..+++++.+||.+||+.||++|||+++|++.|+++..+-.
T Consensus 255 ~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~~~ 310 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST 310 (311)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhccCC
Confidence 44556677777777888899999999999999999999999999999998776644
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=423.25 Aligned_cols=264 Identities=35% Similarity=0.640 Sum_probs=225.8
Q ss_pred cccccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 358 EQLEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 358 ~~~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
..++++.++|++.+.||+|+||+||+|++.+ ...||||+++..... .+.|.+|+.++++++|||||+++|++
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~------~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~ 81 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNG------TTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVV 81 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETT------TEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cceEcCHHHEEEeeEEeeCCCeEEEEEEECC------CCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEE
Confidence 4567888899999999999999999998742 357999999765432 45799999999999999999999998
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
. .+..++||||+++|+|.+++... ....+++.+++.|+.||+.||+|||+++|+||||||+
T Consensus 82 ~-~~~~~lv~Ey~~~g~l~~~~~~~------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~ 142 (285)
T d1fmka3 82 S-EEPIYIVTEYMSKGSLLDFLKGE------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA 142 (285)
T ss_dssp C-SSSCEEEECCCTTCBHHHHHSHH------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred e-cCCeEEEEEecCCCchhhhhhhc------------------ccccchHHHHHHHHHHHHHHHHHHhhhheecccccce
Confidence 5 45689999999999999998622 2245899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
||||++++.+||+|||+++...... ........+|+.|+|||.+..+.++.++||||||+++|||++++.+|+.+....
T Consensus 143 NIll~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~ 221 (285)
T d1fmka3 143 NILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221 (285)
T ss_dssp GEEECGGGCEEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEECCCCcEEEcccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence 9999999999999999998654332 233344678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 598 EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 598 e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
+++..+..+...+.+..+++++.+|+.+||+.||++|||+++|++.|.....
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp HHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 9999999888788889999999999999999999999999999988876543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=418.90 Aligned_cols=258 Identities=35% Similarity=0.669 Sum_probs=222.9
Q ss_pred cccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 360 LEFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 360 ~e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+++..++|++.+.||+|+||.||+|++. ++.||||+++.+. ..++|.+|++++++++|||||+++|++..
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~-------~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~ 71 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR-------GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVE 71 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-------TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC-------CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 5677889999999999999999999974 3679999997643 34578999999999999999999999865
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
.+.++|||||+++|+|.++|.... ...+++..+++|+.||+.||+|||+.+|+||||||+|
T Consensus 72 ~~~~~~lv~ey~~~g~L~~~l~~~~------------------~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 72 EKGGLYIVTEYMAKGSLVDYLRSRG------------------RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp C--CCEEEECCCTTEEHHHHHHHHH------------------HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cCCcEEEEEeccCCCCHHHHHHhcC------------------CCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence 466899999999999999996321 1247899999999999999999999999999999999
Q ss_pred EeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 519 CLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 519 ILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||++.++.+||+|||+++.... ......+|..|||||.+.++.+|.++||||||+++|||+|++.+|+.+.+..+
T Consensus 134 il~~~~~~~kl~dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~ 208 (262)
T d1byga_ 134 VLVSEDNVAKVSDFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 208 (262)
T ss_dssp EEECTTSCEEECCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG
T ss_pred heecCCCCEeecccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999986532 22334568899999999999999999999999999999998889999999999
Q ss_pred HHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 599 VVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 599 ~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+...+..+..++.+..+++++++|+++||+.||.+|||+.+|+++|..+++.
T Consensus 209 ~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 209 VVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp HHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 9999999888889999999999999999999999999999999999998753
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-51 Score=419.38 Aligned_cols=252 Identities=21% Similarity=0.381 Sum_probs=217.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|++.+.||+|+||+||+|+.. .+++.||||+++..... ..+.+.+|++++++++|||||++++++..++..
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~-----~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 92 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDV-----ATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBT-----TTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred ccccEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEE
Confidence 357899999999999999999863 45689999998754322 245789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+|||||+++|+|.+++.. ..+++.++..++.||+.||+|||++||+||||||+|||++.
T Consensus 93 ~ivmEy~~gg~L~~~~~~---------------------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 151 (293)
T d1yhwa1 93 WVVMEYLAGGSLTDVVTE---------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM 151 (293)
T ss_dssp EEEEECCTTCBHHHHHHH---------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred EEEEEecCCCcHHHHhhc---------------------cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECC
Confidence 999999999999998751 34899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
++.+||+|||+|+.+.... .......||+.|||||.+.+..++.++|||||||++|||++| .+||.+.+..+....+
T Consensus 152 ~~~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG-~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 152 DGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG-EPPYLNENPLRALYLI 228 (293)
T ss_dssp TCCEEECCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHS-SCTTTTSCHHHHHHHH
T ss_pred CCcEeeccchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhC-CCCCCCCCHHHHHHHH
Confidence 9999999999998764332 223455789999999999999999999999999999999995 5699888877766665
Q ss_pred HcCCc--cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNI--LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..... ...+..+++++.+|+.+||+.||++|||++|+++|.|
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~ 272 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGG
T ss_pred HhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 44332 3445678999999999999999999999999999876
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-51 Score=421.85 Aligned_cols=253 Identities=27% Similarity=0.404 Sum_probs=217.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
+.|++++.||+|+||+||+|+.. .++..||||+++..... ..+.+.+|+++|++++|||||++++++...+..+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 85 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNK-----ETSVLAAAKVIDTKSEE-ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 85 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECSSSG-GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEEC-----CCCeEEEEEEECcCCHH-HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence 46899999999999999999864 35688999998754332 3457899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|||||+++|+|.+++.. ....+++.++..++.||+.||+|||+++|+||||||+|||++.+
T Consensus 86 lvmEy~~~g~L~~~~~~-------------------~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLE-------------------LERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp EEEECCTTEEHHHHHHH-------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEEecCCCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 99999999999999862 22458999999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhc-----cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESIL-----YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
+.+||+|||+|+...... .......||+.|||||.+. ...++.++|||||||++|||++| .+||.+.+..++
T Consensus 147 ~~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg-~~Pf~~~~~~~~ 223 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEI-EPPHHELNPMRV 223 (288)
T ss_dssp SCEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHS-SCTTTTSCGGGH
T ss_pred CCEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhC-CCCCCCCCHHHH
Confidence 999999999997653222 1223457899999999984 45689999999999999999995 469999888888
Q ss_pred HHHHHcCCcc--CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 600 VKYIKEGNIL--QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 600 ~~~i~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+..+... ..+..+++++.+||.+||+.||++|||++|+++|.|
T Consensus 224 ~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 224 LLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp HHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred HHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 8888776543 345678999999999999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-50 Score=417.42 Aligned_cols=263 Identities=36% Similarity=0.699 Sum_probs=223.8
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEec-CCceEEE
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV-GKPMCLL 446 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~-~~~~~LV 446 (653)
.+.+.||+|+||+||+|++.. .......||||+++........++|.+|+++|++++|||||+++|++.. +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~--~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLD--NDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEEC--CCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 346789999999999999753 2223457999999876667677889999999999999999999999865 5688999
Q ss_pred EeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCCCc
Q psy5539 447 FEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQMV 526 (653)
Q Consensus 447 ~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~~~ 526 (653)
|||+++|+|.++++. ....+++..+++++.|++.||.|||+.+|+||||||+||||++++.
T Consensus 108 ~E~~~~g~l~~~~~~-------------------~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~ 168 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRN-------------------ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT 168 (311)
T ss_dssp EECCTTCBHHHHHHC-------------------TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC
T ss_pred EEEeecCchhhhhcc-------------------ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC
Confidence 999999999999872 2345778899999999999999999999999999999999999999
Q ss_pred EEEeccCcccccccccccc--CCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Q psy5539 527 VKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYIK 604 (653)
Q Consensus 527 vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i~ 604 (653)
+||+|||+++......... ......+|..|+|||.+..+.++.++||||||+++|||++++.+|+...+..++...+.
T Consensus 169 ~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~ 248 (311)
T d1r0pa_ 169 VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 248 (311)
T ss_dssp EEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHH
T ss_pred EEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 9999999998765433222 22345678999999999999999999999999999999999998888888888888899
Q ss_pred cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 605 EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 605 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
.+..+..|+.+++++.+||.+||+.||++|||+.||+++|..+.+..
T Consensus 249 ~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 249 QGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred cCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence 99888888999999999999999999999999999999999987653
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-51 Score=418.85 Aligned_cols=254 Identities=20% Similarity=0.300 Sum_probs=218.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .+...+.+.+|++++++++|||||++++++.+++.
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 82 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLAREL-----ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK 82 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE
T ss_pred CCCEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE
Confidence 57999999999999999999864 356889999986432 12234578999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.+|||||+++|+|.+++.. .+.+++..+..++.|++.||+|||+++|+||||||+|||++
T Consensus 83 ~~ivmEy~~gg~L~~~~~~--------------------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~ 142 (288)
T d1uu3a_ 83 LYFGLSYAKNGELLKYIRK--------------------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 142 (288)
T ss_dssp EEEEECCCTTEEHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEEEccCCCCHHHhhhc--------------------cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccC
Confidence 9999999999999999873 24589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+|+.+.............||+.|||||.+.+..++.++|||||||++|||++| ..||.+.+..++...
T Consensus 143 ~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g-~~Pf~~~~~~~~~~~ 221 (288)
T d1uu3a_ 143 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG-LPPFRAGNEYLIFQK 221 (288)
T ss_dssp TTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHH
T ss_pred CCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhC-CCCCCCcCHHHHHHH
Confidence 9999999999999876433333333445789999999999999999999999999999999995 569999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+.. ..|+.+++++.+|+++||+.||++|||++|++++.+
T Consensus 222 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 222 IIKLEY-DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp HHTTCC-CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred HHcCCC-CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 888764 567889999999999999999999999998765544
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=413.71 Aligned_cols=264 Identities=34% Similarity=0.614 Sum_probs=216.1
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
+..++|++.+.||+|+||.||+|+... .......||||+++... .+...++|.+|+.++++++|||||+++|++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~--~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~ 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDA--PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEEC--TTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEEC--CCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 345689999999999999999998743 23345689999987542 33455689999999999999999999999965
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
+..++||||+++|+|.+++... ...+++..++.++.|||.||.|||+++|+||||||+||
T Consensus 83 -~~~~lv~e~~~~~~l~~~~~~~-------------------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NI 142 (273)
T d1u46a_ 83 -PPMKMVTELAPLGSLLDRLRKH-------------------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNL 142 (273)
T ss_dssp -SSCEEEEECCTTCBHHHHHHHH-------------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred -cchheeeeeecCcchhhhhhcc-------------------cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHh
Confidence 5678999999999999988622 24589999999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
||+.++.+||+|||+++....... ........+|..|+|||.+.+..++.++||||||+++|||+|+|.+||.+.+..+
T Consensus 143 ll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~ 222 (273)
T d1u46a_ 143 LLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ 222 (273)
T ss_dssp EEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred ccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH
Confidence 999999999999999987643322 2223344578899999999999999999999999999999997788999999999
Q ss_pred HHHHHHcC-CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 599 VVKYIKEG-NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 599 ~~~~i~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
+...+... ..++.++.++.++.+|+.+||+.||++|||+++|++.|.+.
T Consensus 223 ~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 223 ILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp HHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 88887554 45667788999999999999999999999999999888765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=419.89 Aligned_cols=279 Identities=39% Similarity=0.662 Sum_probs=231.0
Q ss_pred cCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEecC
Q psy5539 362 FPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAVG 440 (653)
Q Consensus 362 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~~ 440 (653)
+..++|++.+.||+|+||+||+|++.+ ......||||+++........++|.+|+++|+++ +|||||+++|++..+
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 445789999999999999999998742 1223468899987655555667899999999999 799999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+..++||||+++|+|.++|+........ ............+++..+++++.|||.||.|||+++|+||||||+|||
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETD----PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHC----HHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccc----hhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 9999999999999999999733210000 000001123467999999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.++.+||+|||+++..... .......+|..|+|||.+.++.++.++||||||+++|||++|+.+||.+.+..++.
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~ 236 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236 (309)
T ss_dssp ECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred EcCCCceEEcccccccccccc---ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999754322 22234567899999999999999999999999999999999988899999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRD 650 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~ 650 (653)
+.+.++..+..+..+++++.+||.+||+.||++|||+++|+++|..+.++
T Consensus 237 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 99999888888889999999999999999999999999999999988765
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=421.95 Aligned_cols=258 Identities=23% Similarity=0.376 Sum_probs=214.7
Q ss_pred ccCCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 361 EFPRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 361 e~~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
|+..++|++++.||+|+||+||+|+.. .++..||+|+++........+.+.+|+.+|++++|||||++++++...
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 76 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHK-----PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 76 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEET-----TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 566789999999999999999999864 467899999997665555667899999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhC-CceecCCCCCCE
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDR-KFVHRDLATRNC 519 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~ivHrDLkp~NI 519 (653)
+..+|||||+++|+|.++++.. ..+++..+..++.||+.||.|||++ +|+||||||+||
T Consensus 77 ~~~~iVmEy~~gg~L~~~l~~~--------------------~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NI 136 (322)
T d1s9ja_ 77 GEISICMEHMDGGSLDQVLKKA--------------------GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 136 (322)
T ss_dssp SEEEEEEECCTTEEHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCcHHHHHhhc--------------------CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHe
Confidence 9999999999999999999732 3589999999999999999999975 999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEV 599 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~ 599 (653)
||++++.+||+|||+|+..... ......||+.|||||++.+..|+.++|||||||++|||++|. .||.+.+..+.
T Consensus 137 Ll~~~~~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~-~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 137 LVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR-YPIPPPDAKEL 211 (322)
T ss_dssp EECTTCCEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSS-CCSSCCCTTHH
T ss_pred eECCCCCEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCC-CCCCCCCHHHH
Confidence 9999999999999999865322 223457899999999999999999999999999999999954 58865543221
Q ss_pred ------------------------------------------HHHHHcCCccCCC-CCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 600 ------------------------------------------VKYIKEGNILQAP-DNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 600 ------------------------------------------~~~i~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
...+........+ ...+.++.+|+.+||..||.+|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t 291 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC
Confidence 1111111111122 235789999999999999999999
Q ss_pred HHHHHHHHHHHH
Q psy5539 637 FRTIYQTLWNIK 648 (653)
Q Consensus 637 ~~eil~~L~~l~ 648 (653)
++|+++|+|--.
T Consensus 292 a~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 292 LKQLMVHAFIKR 303 (322)
T ss_dssp HHHHHTSHHHHH
T ss_pred HHHHhhCHhhCc
Confidence 999999988544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8e-50 Score=415.57 Aligned_cols=249 Identities=21% Similarity=0.374 Sum_probs=215.9
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.|+.++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++++|||||++++++..++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDV-----RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred hcEeeEEEecCCCeEEEEEEEC-----CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEE
Confidence 4899999999999999999864 457899999986543 334456799999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+|||||+.+|+|..++. ....+++.+++.++.||+.||.|||+++|+||||||+||||++
T Consensus 91 ~iv~E~~~~g~l~~~~~--------------------~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~ 150 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEV--------------------HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSE 150 (309)
T ss_dssp EEEEECCSEEHHHHHHH--------------------HTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEET
T ss_pred EEEEEecCCCchHHHHH--------------------hCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECC
Confidence 99999999999977664 2346899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhcc---CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY---NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++.+||+|||+|+... ......||+.|||||.+.+ +.|+.++|||||||++|||++|. .||.+.+..+.+
T Consensus 151 ~~~~Kl~DFG~a~~~~------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~-~Pf~~~~~~~~~ 223 (309)
T d1u5ra_ 151 PGLVKLGDFGSASIMA------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK-PPLFNMNAMSAL 223 (309)
T ss_dssp TTEEEECCCTTCBSSS------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSS-CTTTTSCHHHHH
T ss_pred CCCEEEeecccccccC------CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCC-CCCCCCCHHHHH
Confidence 9999999999997642 2234578999999999864 46899999999999999999955 599888888887
Q ss_pred HHHHcCCccCC-CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 601 KYIKEGNILQA-PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 601 ~~i~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
..+..+..... +..+++++.+|+.+||+.||.+|||++++++|.|-
T Consensus 224 ~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp HHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred HHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence 77777655433 45689999999999999999999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-50 Score=417.46 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=205.4
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.+.|++.+.||+|+||+||+|+.. .+++.||||++.........+.+.+|+.+|++++|||||++++++..++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 82 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDK-----RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHL 82 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEET-----TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEeeccCeEEEEEEEC-----CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 456999999999999999999864 356889999997655444556789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN- 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~- 522 (653)
+|||||+++|+|.++|. ....+++.++..++.||+.||+|||+++|+||||||+|||+.
T Consensus 83 ~lvmE~~~gg~L~~~l~--------------------~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~ 142 (307)
T d1a06a_ 83 YLIMQLVSGGELFDRIV--------------------EKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYS 142 (307)
T ss_dssp EEEECCCCSCBHHHHHH--------------------TCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESS
T ss_pred EEEEeccCCCcHHHhhh--------------------cccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecc
Confidence 99999999999999996 234689999999999999999999999999999999999994
Q ss_pred --CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
+++.+||+|||+|+...... ......||+.|||||.+.+..++.++|||||||++|||++| .+||.+.+..++.
T Consensus 143 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g-~~Pf~~~~~~~~~ 218 (307)
T d1a06a_ 143 LDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG-YPPFYDENDAKLF 218 (307)
T ss_dssp SSTTCCEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHH
T ss_pred cCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhC-CCCCCCCCHHHHH
Confidence 57899999999998653222 22345689999999999999999999999999999999994 5699999999999
Q ss_pred HHHHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 601 KYIKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+..+.... .+..+++++.+|+.+||+.||++|||++|+++|+|
T Consensus 219 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp HHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred HHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 9888876532 23568999999999999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-49 Score=402.74 Aligned_cols=248 Identities=24% Similarity=0.360 Sum_probs=207.6
Q ss_pred eeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec----CC
Q psy5539 367 IIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV----GK 441 (653)
Q Consensus 367 ~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~----~~ 441 (653)
+++.+.||+|+||+||+|++. .++..||+|.++.. ......+.|.+|+++|++++|||||++++++.. +.
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~-----~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDT-----ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred EEeeeEEecCcCcEEEEEEEC-----CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCC
Confidence 467778999999999999864 35678999998754 344556789999999999999999999999864 45
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCC--ceecCCCCCCE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRK--FVHRDLATRNC 519 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~--ivHrDLkp~NI 519 (653)
.++|||||+++|+|.++++.. ..+++..+..++.||++||+|||+++ |+||||||+||
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~--------------------~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NI 145 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRF--------------------KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNI 145 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGE
T ss_pred EEEEEEeCCCCCcHHHHHhcc--------------------ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhc
Confidence 689999999999999999732 35889999999999999999999998 99999999999
Q ss_pred eEc-CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCC-CHH
Q psy5539 520 LIN-DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGL-THE 597 (653)
Q Consensus 520 Ll~-~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~-~~~ 597 (653)
||+ +++.+||+|||+|+..... ......||+.|||||.+.+ .++.++|||||||++|||++|. .||.+. +..
T Consensus 146 Ll~~~~~~~Kl~DFGla~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~-~Pf~~~~~~~ 219 (270)
T d1t4ha_ 146 FITGPTGSVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSE-YPYSECQNAA 219 (270)
T ss_dssp EESSTTSCEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSS-CTTTTCSSHH
T ss_pred eeeCCCCCEEEeecCcceeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCC-CCCCCcccHH
Confidence 996 5899999999999754221 1234568999999998764 6999999999999999999965 588664 456
Q ss_pred HHHHHHHcCCcc-CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKEGNIL-QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
++.+.+..+... ..+...++++.+|+.+||+.||++|||++|+++|.|
T Consensus 220 ~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~ 268 (270)
T d1t4ha_ 220 QIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF 268 (270)
T ss_dssp HHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence 667777665432 344567899999999999999999999999999876
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-49 Score=413.17 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=224.0
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG 440 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~ 440 (653)
..++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++++|||||++++++.+.
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~-----~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 77 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREK-----ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred chHhcEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc
Confidence 4468999999999999999999864 467899999997542 122345688999999999999999999999999
Q ss_pred CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 441 KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 441 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
+.+++||||+++|+|.++++. ...+++..+..++.||+.||+|||+++|+||||||+|||
T Consensus 78 ~~~~iv~ey~~gg~L~~~~~~--------------------~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIL 137 (337)
T d1o6la_ 78 DRLCFVMEYANGGELFFHLSR--------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM 137 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHH--------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred cccccceeccCCCchhhhhhc--------------------ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeE
Confidence 999999999999999999873 245889999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVV 600 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~ 600 (653)
++++|.+||+|||+|+...... .......||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+..++.
T Consensus 138 l~~~g~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G-~~pf~~~~~~~~~ 214 (337)
T d1o6la_ 138 LDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCG-RLPFYNQDHERLF 214 (337)
T ss_dssp ECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHS-SCSSCCSSHHHHH
T ss_pred ecCCCCEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHC-CCCCCCcCHHHHH
Confidence 9999999999999998653322 223345789999999999999999999999999999999994 5799999999999
Q ss_pred HHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 601 KYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 601 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
+.+..+. ...|..+++++.+||++||+.||.+||+ +++|++|.|
T Consensus 215 ~~i~~~~-~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 215 ELILMEE-IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp HHHHHCC-CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred HHHhcCC-CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcc
Confidence 9998876 4678889999999999999999999994 899999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-49 Score=406.04 Aligned_cols=252 Identities=26% Similarity=0.378 Sum_probs=219.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----HHHHHHHHHHHHHHhhCCCCccceEEeEEec
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----EYLQTDFEREACLLAEFDHPNIVKLLGVCAV 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~ 439 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++.... ....+.+.+|+.+|++++|||||++++++.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREK-----STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEET-----TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCEEEeEEEecCCCeEEEEEEEC-----CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 56999999999999999999964 3568999999864321 1235679999999999999999999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
.+..+|||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~--------------------~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni 144 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEK--------------------ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI 144 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCEEEEEEEcCCCccccchhccc--------------------cccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence 99999999999999999999732 3589999999999999999999999999999999999
Q ss_pred eEcCCC----cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 520 LINDQM----VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 520 Ll~~~~----~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|++.++ .+||+|||+|+...... ......+|+.|||||.+.+..++.++|||||||++|||++| ..||.+.+
T Consensus 145 ll~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g-~~Pf~~~~ 220 (293)
T d1jksa_ 145 MLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-ASPFLGDT 220 (293)
T ss_dssp EESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred EEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcC-CCCCCCCC
Confidence 998776 59999999998653322 22345678999999999999999999999999999999995 56999999
Q ss_pred HHHHHHHHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..++...+..+..... +..++.++.+||++||+.||++|||++++++|.|
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 273 (293)
T d1jksa_ 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273 (293)
T ss_dssp HHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred HHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 9999998888764322 3578999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.9e-49 Score=414.91 Aligned_cols=252 Identities=19% Similarity=0.323 Sum_probs=219.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++.+.||+|+||+||+|+.. .++..||||++.... ....+.+.+|+.+|++++|||||++++++..++..+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~-----~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTER-----ATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEcccc-hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 47999999999999999999864 467899999997643 334567999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc--
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-- 522 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~-- 522 (653)
|||||+++|+|.+++. .....+++..+..|+.||+.||+|||+++|+||||||+|||++
T Consensus 100 ivmE~~~gg~L~~~l~-------------------~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~ 160 (350)
T d1koaa2 100 MIYEFMSGGELFEKVA-------------------DEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK 160 (350)
T ss_dssp EEECCCCSCBHHHHHT-------------------CTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEEEcCCCCCHHHHHH-------------------hhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccC
Confidence 9999999999999985 1234689999999999999999999999999999999999995
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.+||+|||+|+.+.... ......+|+.|||||++.+..++.++|||||||++|||++ |..||.+.+..+++..
T Consensus 161 ~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~-G~~Pf~~~~~~~~~~~ 236 (350)
T d1koaa2 161 RSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS-GLSPFGGENDDETLRN 236 (350)
T ss_dssp TSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHH-SSCSSCCSSHHHHHHH
T ss_pred CCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHh-CCCCCCCCCHHHHHHH
Confidence 46899999999998653322 1233567999999999999999999999999999999999 4569999999999999
Q ss_pred HHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+..... ...+++++.+|+.+||+.||++|||++|+++|.|
T Consensus 237 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 237 VKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp HHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 888764322 2458899999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-48 Score=407.00 Aligned_cols=250 Identities=21% Similarity=0.362 Sum_probs=221.2
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc--HHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS--EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~--~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++++.||+|+||+||+|+.. .+++.||||+++.... ....+.+.+|+.++++++|||||++++++...+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~-----~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 77 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSR-----HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ 77 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence 368999999999999999999864 4568999999975421 223457899999999999999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|..++.. ...+++..+..++.||+.||+|||+++|+||||||+||||
T Consensus 78 ~~~ivmE~~~gg~l~~~~~~--------------------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl 137 (316)
T d1fota_ 78 QIFMIMDYIEGGELFSLLRK--------------------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 137 (316)
T ss_dssp EEEEEECCCCSCBHHHHHHH--------------------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred eeeeEeeecCCccccccccc--------------------cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE
Confidence 99999999999999998862 3457888999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+.++.+||+|||+|+..... .....||+.|||||.+.+..++.++|||||||++|||++| ..||.+.+..++..
T Consensus 138 ~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG-~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 138 DKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG-YTPFYDSNTMKTYE 211 (316)
T ss_dssp CTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS-SCTTCCSSHHHHHH
T ss_pred cCCCCEEEecCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC-CCCCCCcCHHHHHH
Confidence 99999999999999875322 2345789999999999999999999999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
.+..+.. ..|..+++++.+++.+||..||.+|+ |+++|++|+|
T Consensus 212 ~i~~~~~-~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 212 KILNAEL-RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp HHHHCCC-CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HHHcCCC-CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcc
Confidence 9988764 56778999999999999999999996 9999999876
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-48 Score=412.84 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=219.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
++|++++.||+|+||+||+|+.. .++..||||+++.... ...+.+.+|+++|++++|||||++++++..++..+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEK-----ATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred cceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECCcch-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 46999999999999999999864 4568999999876433 33567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc--
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN-- 522 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~-- 522 (653)
|||||+++|+|.+++. .....+++.+++.|+.||+.||+|||++||+||||||+||||+
T Consensus 103 ivmE~~~gg~L~~~~~-------------------~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~ 163 (352)
T d1koba_ 103 LILEFLSGGELFDRIA-------------------AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 163 (352)
T ss_dssp EEEECCCCCBHHHHTT-------------------CTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESST
T ss_pred EEEEcCCCChHHHHHH-------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccccccccc
Confidence 9999999999998875 1234689999999999999999999999999999999999998
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
+++.+||+|||+|+....... .....+|+.|||||.+.+..++.++|||||||++|||++| ..||.+.+..+++..
T Consensus 164 ~~~~vkL~DFGla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG-~~Pf~~~~~~~~~~~ 239 (352)
T d1koba_ 164 KASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG-LSPFAGEDDLETLQN 239 (352)
T ss_dssp TCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS-CCSSCCSSHHHHHHH
T ss_pred CCCeEEEeecccceecCCCCc---eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHH
Confidence 678999999999987643221 2234678899999999999999999999999999999995 569999999999999
Q ss_pred HHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+..+.... ....+++++.+||.+||+.||.+|||++|+++|.|
T Consensus 240 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 240 VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred HHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 88876432 23568999999999999999999999999999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-47 Score=391.50 Aligned_cols=252 Identities=23% Similarity=0.324 Sum_probs=218.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--------cHHHHHHHHHHHHHHhhCC-CCccceEEe
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--------SEYLQTDFEREACLLAEFD-HPNIVKLLG 435 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--------~~~~~~~f~~Ei~il~~l~-HpnIv~l~g 435 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .+...+.+.+|+.++++++ |||||++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~-----~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 77 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHK-----PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 77 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred ccCEEceEEecCcCeEEEEEEEC-----CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEe
Confidence 58999999999999999999863 467899999986432 1334557889999999997 999999999
Q ss_pred EEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 436 VCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 436 ~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
++.+++..+|||||+++|||.++|+. ...+++.++..++.||+.||+|||+++|+|||||
T Consensus 78 ~~~~~~~~~ivmE~~~~g~L~~~l~~--------------------~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlk 137 (277)
T d1phka_ 78 TYETNTFFFLVFDLMKKGELFDYLTE--------------------KVTLSEKETRKIMRALLEVICALHKLNIVHRDLK 137 (277)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH--------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred ecccCcceEEEEEcCCCchHHHHHHh--------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccc
Confidence 99999999999999999999999972 2458999999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc------CCCCCchhHHHHHHHHHHHHhCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY------NKYTVESDVWAFGVCLWEIFSFALQ 589 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~------~~~t~ksDVwSlGvvl~ellt~~~~ 589 (653)
|+|||+++++.+||+|||+++.+.... ......+|..|+|||.+.+ ..++.++||||+|+++|||++| ..
T Consensus 138 p~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g-~~ 213 (277)
T d1phka_ 138 PENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-SP 213 (277)
T ss_dssp GGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS-SC
T ss_pred cceEEEcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccC-CC
Confidence 999999999999999999998653321 2344678999999999864 3568899999999999999994 56
Q ss_pred CCCCCCHHHHHHHHHcCCccC---CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 590 PYYGLTHEEVVKYIKEGNILQ---APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 590 p~~~~~~~e~~~~i~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
||.+.+..+..+.+..+.... ....+++++++|+.+||+.+|++|||++||++|.|
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence 999999999888888776432 22368999999999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-47 Score=405.94 Aligned_cols=249 Identities=24% Similarity=0.347 Sum_probs=220.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCc
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKP 442 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~ 442 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|+.++|||||++++++.....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~-----~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHK-----ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEEC-----CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 57999999999999999999864 456899999986432 11234568899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~--------------------~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~ 175 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRI--------------------GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHH--------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred cccccccccccchhhhHhhc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccC
Confidence 99999999999999998632 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 523 DQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 523 ~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
.++.+||+|||+|+.+... .....||+.|||||++.+..++.++|||||||++|||++| .+||.+.+..++...
T Consensus 176 ~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG-~~Pf~~~~~~~~~~~ 249 (350)
T d1rdqe_ 176 QQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG-YPPFFADQPIQIYEK 249 (350)
T ss_dssp TTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHH
T ss_pred CCCCEEeeeceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhC-CCCCCCcCHHHHHHH
Confidence 9999999999999875322 2345789999999999999999999999999999999995 569999999999999
Q ss_pred HHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 603 IKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 603 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
+..+.. ..+..+++++.+|+++||+.||.+|+ |+++|++|.|
T Consensus 250 i~~~~~-~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 250 IVSGKV-RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp HHHCCC-CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred HhcCCC-CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcc
Confidence 988764 56778999999999999999999994 9999999876
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-48 Score=402.75 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=218.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHh-hCCCCccceEEeEEecCC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLA-EFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~-~l~HpnIv~l~g~~~~~~ 441 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.++. .++|||||++++++..++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~-----~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFK-----KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEEC-----CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 57999999999999999999864 467899999997432 1122345666766655 689999999999999999
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..+|||||+++|+|.++++.. ..+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~--------------------~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~ 136 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSC--------------------HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 136 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHH--------------------SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred ceeEEEeecCCCcHHHHhhcc--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee
Confidence 999999999999999999732 357889999999999999999999999999999999999
Q ss_pred cCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 522 NDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 522 ~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
++++.+||+|||+++...... .......||+.|||||.+.+..++.++|||||||++|||++| ..||.+.+..++..
T Consensus 137 ~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG-~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 137 DKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG-QSPFHGQDEEELFH 213 (320)
T ss_dssp CTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHH
T ss_pred cCCCceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC-CCCCCCCCHHHHHH
Confidence 999999999999998653322 223445789999999999999999999999999999999995 56999999999999
Q ss_pred HHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHH-HHHHHHH
Q psy5539 602 YIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFR-TIYQTLW 645 (653)
Q Consensus 602 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L~ 645 (653)
.+..+.. ..|..+++++.+|+++||+.||++|||+. ++++|+|
T Consensus 214 ~i~~~~~-~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpf 257 (320)
T d1xjda_ 214 SIRMDNP-FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPL 257 (320)
T ss_dssp HHHHCCC-CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred HHHcCCC-CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCch
Confidence 9988764 56778999999999999999999999995 7887764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-47 Score=389.17 Aligned_cols=259 Identities=19% Similarity=0.263 Sum_probs=212.7
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc--cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA--SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~--~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~ 441 (653)
.++|++.+.||+|+||+||+|+.. .+++.||||+++... .....+.|.+|++++++++|||||++++++...+
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDL-----RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc
Confidence 367999999999999999999864 457899999997542 3445668999999999999999999999987543
Q ss_pred ----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 442 ----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 442 ----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
..+|||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+++|+||||||+
T Consensus 81 ~~~~~~~lvmE~~~g~~L~~~~~~--------------------~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~ 140 (277)
T d1o6ya_ 81 PAGPLPYIVMEYVDGVTLRDIVHT--------------------EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPA 140 (277)
T ss_dssp SSSEEEEEEEECCCEEEHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred CCCceEEEEEECCCCCEehhhhcc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCc
Confidence 37999999999999998862 245899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCcccccccccc-ccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDY-YKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||++.++..+|+|||.+........ ........||+.|||||.+.+..++.++|||||||++|||++| .+||.+.+.
T Consensus 141 NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG-~~Pf~~~~~ 219 (277)
T d1o6ya_ 141 NIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG-EPPFTGDSP 219 (277)
T ss_dssp GEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS-SCSCCCSSH
T ss_pred ccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhC-CCCCCCcCH
Confidence 99999999999999999875532221 1223345689999999999999999999999999999999995 569999888
Q ss_pred HHHHHHHHcCCcc---CCCCCCcHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNIL---QAPDNTPDALYDLMKLCWNMKPMNRP-SFRTIYQTLWNIK 648 (653)
Q Consensus 597 ~e~~~~i~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~l~ 648 (653)
.++...+...... ...+.+++++.+++++||+.||.+|| |++++++.|.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 220 VSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp HHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 8877666554432 23457899999999999999999999 8999998888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-47 Score=397.16 Aligned_cols=253 Identities=17% Similarity=0.295 Sum_probs=218.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
.++|.+.+.||+|+||+||+|+.. .++..||||.++..... ...+.+|+++|+.++|||||++++++.+++..
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~-----~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 76 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVET-----SSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEEL 76 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEE
T ss_pred ccceEEEEEEecCCCeEEEEEEEC-----CCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 357999999999999999999864 35689999999765432 44688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
+|||||+++|+|.++++. ....+++.++..++.||+.||+|||+++|+||||||+|||++.
T Consensus 77 ~lvmE~~~gg~L~~~i~~-------------------~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINT-------------------SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EEEECCCCCCBHHHHHTS-------------------SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEEecCCCCcHHHHHHh-------------------cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 999999999999999961 2246899999999999999999999999999999999999985
Q ss_pred C--CcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Q psy5539 524 Q--MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVK 601 (653)
Q Consensus 524 ~--~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~ 601 (653)
+ ..+||+|||+++....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+++.
T Consensus 138 ~~~~~ikl~DFG~~~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~-G~~Pf~~~~~~~~~~ 213 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS-GINPFLAETNQQIIE 213 (321)
T ss_dssp SSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHH-SSCTTCCSSHHHHHH
T ss_pred CCceEEEEcccchhhccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHh-CCCCCCCCCHHHHHH
Confidence 4 5899999999986533221 122456889999999999999999999999999999999 556999999999999
Q ss_pred HHHcCCccCC---CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 602 YIKEGNILQA---PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 602 ~i~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
.+..+..... ...+++++.+|+++||..||++|||++|+++|.|-
T Consensus 214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence 9988764322 13688999999999999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1e-46 Score=400.88 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=207.8
Q ss_pred CCCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----HHHHHHHHHHHHHHhhCCCCccceEEeEE
Q psy5539 363 PRNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----EYLQTDFEREACLLAEFDHPNIVKLLGVC 437 (653)
Q Consensus 363 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----~~~~~~f~~Ei~il~~l~HpnIv~l~g~~ 437 (653)
+.++|++.+.||+|+||+||+|+.. .+++.||||++..... ........+|+.+++.++|||||++++++
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~-----~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~ 76 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKA-----DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 76 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEEC-----CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE
Confidence 3578999999999999999999864 4568999999864321 11122234457788888999999999999
Q ss_pred ecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 438 AVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...+..+|||||+++|+|.++|... ..+++..+..++.||+.||+|||+++|+||||||+
T Consensus 77 ~~~~~~~ivmE~~~gg~L~~~l~~~--------------------~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~ 136 (364)
T d1omwa3 77 HTPDKLSFILDLMNGGDLHYHLSQH--------------------GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPA 136 (364)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHHH--------------------CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EECCEEEEEEEecCCCcHHHHHHhc--------------------ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccc
Confidence 9999999999999999999999732 45788999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||+++++.+||+|||+|+..... ......||+.|||||.+.. ..++.++|||||||++|||++| ..||.+.+.
T Consensus 137 NILl~~~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG-~~Pf~~~~~ 211 (364)
T d1omwa3 137 NILLDEHGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG-HSPFRQHKT 211 (364)
T ss_dssp GEEECSSSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHS-SCSSCSSCS
T ss_pred eeEEcCCCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhC-CCCCCCCCH
Confidence 999999999999999999865322 2234578999999999975 4689999999999999999995 568876544
Q ss_pred HHHHHHHH--cCCccCCCCCCcHHHHHHHHHhhccCCCCCCC-----HHHHHHHHH
Q psy5539 597 EEVVKYIK--EGNILQAPDNTPDALYDLMKLCWNMKPMNRPS-----FRTIYQTLW 645 (653)
Q Consensus 597 ~e~~~~i~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 645 (653)
.+...... .......++.+++++.+||.+||+.||++||| +++|++|.|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 212 KDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp SCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred HHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence 33222222 22234556789999999999999999999999 799999876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-46 Score=388.21 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=202.7
Q ss_pred EEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccH----HHHHHHHHHHHHHhhCCCCccceEEeEEecCCceE
Q psy5539 369 YVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASE----YLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 369 ~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~----~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~~ 444 (653)
.++.||+|+||+||+|++. .+++.||||+++..... ...+.+.+|+.++++++|||||++++++..++..+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDK-----NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECS-----SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred cceEeccCcCeEEEEEEEC-----CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence 4578999999999999863 45789999999654322 22346889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcCC
Q psy5539 445 LLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLINDQ 524 (653)
Q Consensus 445 LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~~ 524 (653)
|||||+.++++..++. ....+++..+..++.||+.||+|||+++|+||||||+|||++++
T Consensus 77 ivmE~~~~~~~~~~~~--------------------~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~ 136 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKD--------------------NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN 136 (299)
T ss_dssp EEEECCSEEHHHHHTT--------------------CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred ehhhhhcchHHhhhhh--------------------cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCC
Confidence 9999999877665543 23468889999999999999999999999999999999999999
Q ss_pred CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Q psy5539 525 MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKYI 603 (653)
Q Consensus 525 ~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~i 603 (653)
+.+||+|||+|+...... .......+|+.|||||.+... .++.++|||||||++|||++| .+||.+.+..+.+..+
T Consensus 137 ~~~KL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g-~~pf~~~~~~~~l~~i 213 (299)
T d1ua2a_ 137 GVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLDQLTRI 213 (299)
T ss_dssp CCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHS-SCSSCCSSHHHHHHHH
T ss_pred CccccccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhC-cCCCCCCCHHHHHHHH
Confidence 999999999997653322 222345688999999998755 579999999999999999995 5799998888877766
Q ss_pred HcCCcc-------------------C--------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 604 KEGNIL-------------------Q--------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 604 ~~~~~~-------------------~--------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
...... . .....++++.+|+.+||+.||++|||++|+++|.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~ 282 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 282 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred HHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence 431000 0 01245789999999999999999999999999876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=381.40 Aligned_cols=254 Identities=24% Similarity=0.395 Sum_probs=206.9
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++.... +...+.+.+|++++++++|||||++++++..++..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNK-----LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred CCCEeccEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccce
Confidence 58999999999999999999864 4568899999975432 23356789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++||||+.+ ++.+++.. .....+++..+..++.||+.||+|||+++||||||||+|||++.
T Consensus 77 ~iv~e~~~~-~~~~~~~~------------------~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~ 137 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDA------------------SALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137 (298)
T ss_dssp EEEEECCSE-EHHHHHHH------------------TTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred eEEEeecCC-chhhhhhh------------------hcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence 999999975 55555541 23356899999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||+|+...... .......+|+.|+|||.+.... ++.++|||||||++|||++| ..||.+.+..+.+..
T Consensus 138 ~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G-~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 138 EGAIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR-RALFPGDSEIDQLFR 214 (298)
T ss_dssp TSCEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHH
T ss_pred cCcceeccCCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhC-CCCCCCCCHHHHHHH
Confidence 9999999999998653322 2334557899999999887765 58999999999999999995 569988887776655
Q ss_pred HHcC--Ccc---------------C-----------CCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--NIL---------------Q-----------APDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--~~~---------------~-----------~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... ... . .....+.++.+|+++||..||++|||++|+++|.|
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 4321 000 0 01245688999999999999999999999999866
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-46 Score=391.01 Aligned_cols=249 Identities=21% Similarity=0.347 Sum_probs=201.2
Q ss_pred CCeeEEe-eecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhC-CCCccceEEeEEec---
Q psy5539 365 NDIIYVR-DLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEF-DHPNIVKLLGVCAV--- 439 (653)
Q Consensus 365 ~~~~~~~-~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l-~HpnIv~l~g~~~~--- 439 (653)
++|.++. .||+|+||+||+|+.. .+++.||||+++.. ..+.+|++++.++ +|||||++++++..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNK-----RTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEET-----TTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred cCEEEeeEEeeeccCeEEEEEEEC-----CCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeeccc
Confidence 5788875 5999999999999864 35688999999642 2467899887654 89999999999864
Q ss_pred -CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCC
Q psy5539 440 -GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRN 518 (653)
Q Consensus 440 -~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~N 518 (653)
+...+|||||+++|||.++|+.. ....+++.++..|+.||+.||+|||+++|+||||||+|
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~N 141 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDR------------------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPEN 141 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSC------------------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCCEEEEEEECCCCCcHHHHHHhc------------------CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccc
Confidence 46789999999999999999721 22468999999999999999999999999999999999
Q ss_pred EeEcC---CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 519 CLIND---QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 519 ILl~~---~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
||+++ ++.+||+|||+|+...... ......||+.|||||.+.+..|+.++|||||||++|||++| .+||.+.+
T Consensus 142 Ill~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg-~~Pf~~~~ 217 (335)
T d2ozaa1 142 LLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-YPPFYSNH 217 (335)
T ss_dssp EEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTS-SCSCEETT
T ss_pred cccccccccccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhC-CCCCCCCC
Confidence 99985 5679999999998654332 23456789999999999999999999999999999999995 56887766
Q ss_pred HHHHHHHHHc----CCccCCC----CCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHH
Q psy5539 596 HEEVVKYIKE----GNILQAP----DNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNI 647 (653)
Q Consensus 596 ~~e~~~~i~~----~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l 647 (653)
..+....+.. +.. ..+ ..+++++.+|+++||+.||++|||+.++++|.|-.
T Consensus 218 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~ 276 (335)
T d2ozaa1 218 GLAISPGMKTRIRMGQY-EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276 (335)
T ss_dssp CC--------CCCSCSS-SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHH
T ss_pred HHHHHHHHHHHHhcCCC-CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhh
Confidence 5444433322 221 222 24788999999999999999999999999998754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-45 Score=382.23 Aligned_cols=255 Identities=24% Similarity=0.331 Sum_probs=200.0
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
.+|.+.+.||+|+||.||+|++. +..||||+++..... ...++.|+..+..++|||||++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-------g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~ 73 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-------GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTW 73 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-------TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-------CEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcc
Confidence 46788999999999999999863 478999999754322 223445666677889999999999997543
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh--------CCceec
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD--------RKFVHR 512 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~--------~~ivHr 512 (653)
.++|||||+++|+|.++|+. ..+++..+++++.|+|.||+|||+ ++|+||
T Consensus 74 ~~~~lv~Ey~~~g~L~~~l~~---------------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 74 TQLWLVSDYHEHGSLFDYLNR---------------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp EEEEEEEECCTTCBHHHHHHH---------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred eEEEEEEecccCCCHHHHHhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 57999999999999999972 247899999999999999999996 599999
Q ss_pred CCCCCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccCC------CCCchhHHHHHHHHHHHH
Q psy5539 513 DLATRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYNK------YTVESDVWAFGVCLWEIF 584 (653)
Q Consensus 513 DLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~------~t~ksDVwSlGvvl~ell 584 (653)
||||+||||++++.+||+|||+++......... ......+|+.|||||.+.+.. ++.++||||||++||||+
T Consensus 133 DlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 999999999999999999999998765433221 233567899999999987653 577999999999999999
Q ss_pred hCCCCCCC----------C-----CCHHHHHHHHHcCCc-cCCCCC-----CcHHHHHHHHHhhccCCCCCCCHHHHHHH
Q psy5539 585 SFALQPYY----------G-----LTHEEVVKYIKEGNI-LQAPDN-----TPDALYDLMKLCWNMKPMNRPSFRTIYQT 643 (653)
Q Consensus 585 t~~~~p~~----------~-----~~~~e~~~~i~~~~~-~~~~~~-----~~~~l~~li~~cl~~dP~~RPs~~eil~~ 643 (653)
||.. |+. . ...+++.+.+..+.. +..+.. .+..+.+|+.+||+.||++|||+.||+++
T Consensus 213 tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 213 RRCS-IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HTBC-BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hCCC-CCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 9653 321 1 233445554444333 222222 23568999999999999999999999999
Q ss_pred HHHHHHH
Q psy5539 644 LWNIKRD 650 (653)
Q Consensus 644 L~~l~~~ 650 (653)
|..+.++
T Consensus 292 L~~i~~~ 298 (303)
T d1vjya_ 292 LSQLSQQ 298 (303)
T ss_dssp HHHHHHH
T ss_pred HHHHHHh
Confidence 9988765
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=381.19 Aligned_cols=254 Identities=25% Similarity=0.417 Sum_probs=206.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-HHHHHHHHHHHHHHhhC---CCCccceEEeEEec-
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-EYLQTDFEREACLLAEF---DHPNIVKLLGVCAV- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-~~~~~~f~~Ei~il~~l---~HpnIv~l~g~~~~- 439 (653)
++|++++.||+|+||+||+|++.. ..++.||||+++.... +.....+.+|+.+++.| +||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLK----NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT----TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CCEEEEEEEecccCeEEEEEEEEC----CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 589999999999999999998632 2357899999865422 11223456777776665 89999999999853
Q ss_pred ----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 440 ----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 440 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
....+++|||++++++..... .....+++..+..++.||+.||+|||+++|+|||||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiK 143 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLDK-------------------VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 143 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHHH-------------------SCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred ccccCceEEEEEEeccCCchhhhhh-------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCC
Confidence 347899999999877665443 233568899999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
|+|||+++++.+||+|||+++...... ......||+.|||||.+.+..++.++|||||||++|||++| .+||.+.+
T Consensus 144 p~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g-~~pf~~~~ 219 (305)
T d1blxa_ 144 PQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSS 219 (305)
T ss_dssp GGGEEECTTCCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS-SCSCCCSS
T ss_pred ccEEEEcCCCCeeecchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHC-CCCCCCCC
Confidence 999999999999999999987643222 23456789999999999999999999999999999999995 57999988
Q ss_pred HHHHHHHHHcC--------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEG--------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~--------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+.+..+... .....+...++.+.+|+++||+.||++|||++|+++|+|
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 220 DVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp HHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 88777665431 001123457889999999999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.9e-45 Score=375.00 Aligned_cols=252 Identities=23% Similarity=0.352 Sum_probs=206.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++++.||+|+||+||+|+++ +++.||||+++... .+...+.+.+|+.+|++++|||||++++++...+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 75 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRL 75 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCE
T ss_pred CCceeccEEecCCCcEEEEEEeC------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCce
Confidence 58999999999999999999863 45789999996542 233356789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++++||+.++.+..+.+ ....+++..+..++.||+.||+|||+++|+||||||+|||++.
T Consensus 76 ~i~~e~~~~~~~~~~~~--------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~ 135 (286)
T d1ob3a_ 76 VLVFEHLDQDLKKLLDV--------------------CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (286)
T ss_dssp EEEEECCSEEHHHHHHT--------------------STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred eEEEEeehhhhHHHHHh--------------------hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcC
Confidence 99999998876666553 3356999999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||++....... .......+++.|+|||.+... .++.++||||||+++|||++| ..||.+.+..+....
T Consensus 136 ~~~~kl~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G-~~pf~~~~~~~~~~~ 212 (286)
T d1ob3a_ 136 EGELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEADQLMR 212 (286)
T ss_dssp TSCEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS-SCSCCCSSHHHHHHH
T ss_pred CCCEEecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHC-CCCCCCCCHHHHHHH
Confidence 9999999999998653322 122344578899999998765 568999999999999999995 569998887776655
Q ss_pred HHcC--Cc--------------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG--NI--------------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~--~~--------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... .. .......++++.+|+++||+.||++|||++|+++|+|
T Consensus 213 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~ 283 (286)
T d1ob3a_ 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283 (286)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence 4320 00 0113456789999999999999999999999998876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-45 Score=376.94 Aligned_cols=244 Identities=22% Similarity=0.318 Sum_probs=202.8
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----HHHHHHHHHHHHHHhhCC--CCccceEEeEE
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----EYLQTDFEREACLLAEFD--HPNIVKLLGVC 437 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----~~~~~~f~~Ei~il~~l~--HpnIv~l~g~~ 437 (653)
++|++.+.||+|+||+||+|+.. .+++.||||+++.... ......+.+|+.++++++ |||||++++++
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRV-----SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CeEEEeEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 57999999999999999999864 3568999999864321 111234678999999997 89999999999
Q ss_pred ecCCceEEEEeecCC-CChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 438 AVGKPMCLLFEYMGR-GDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 438 ~~~~~~~LV~Ey~~~-gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
...+..++||||+.+ +++.++++. ...+++.++..++.||+.||+|||+++|+||||||
T Consensus 79 ~~~~~~~lv~e~~~~~~~l~~~~~~--------------------~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp 138 (273)
T d1xwsa_ 79 ERPDSFVLILERPEPVQDLFDFITE--------------------RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKD 138 (273)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH--------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred eeCCeEEEEEEeccCcchHHHHHhc--------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcc
Confidence 999999999999976 688888762 24589999999999999999999999999999999
Q ss_pred CCEeEcC-CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCC
Q psy5539 517 RNCLIND-QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKY-TVESDVWAFGVCLWEIFSFALQPYYGL 594 (653)
Q Consensus 517 ~NILl~~-~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-t~ksDVwSlGvvl~ellt~~~~p~~~~ 594 (653)
+|||++. ++.+||+|||+|+..... ......||+.|||||.+.+..+ +.++|||||||++|||++|. .||.+.
T Consensus 139 ~NIll~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~-~Pf~~~ 213 (273)
T d1xwsa_ 139 ENILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD-IPFEHD 213 (273)
T ss_dssp GGEEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS-CSCCSH
T ss_pred cceEEecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCC-CCCCCc
Confidence 9999985 579999999999764222 2234578999999999988776 57789999999999999965 588652
Q ss_pred CHHHHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 595 THEEVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 595 ~~~e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
. .+..+. ...+..+++++.+|+++||+.||++|||++|+++|+|
T Consensus 214 --~----~i~~~~-~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 214 --E----EIIRGQ-VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp --H----HHHHCC-CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred --h----HHhhcc-cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence 2 233343 3466789999999999999999999999999999876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-44 Score=367.40 Aligned_cols=254 Identities=25% Similarity=0.384 Sum_probs=213.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~~~ 443 (653)
++|++++.||+|+||+||+|++. .+++.||||+++... .+.....+.+|+.+++.++||||+++++++......
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNR-----ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCEeeeEEecCcCeEEEEEEEC-----CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccce
Confidence 57999999999999999999964 456889999986442 334567899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEcC
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIND 523 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~~ 523 (653)
++|+|++.+++|..+++ ....+++..+..++.|++.||+|||+++|+||||||+|||++.
T Consensus 77 ~iv~~~~~~~~l~~~~~--------------------~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~ 136 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDS--------------------CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINR 136 (292)
T ss_dssp EEEEECCSEEHHHHHHH--------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECT
T ss_pred eEEeeeccccccccccc--------------------cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccccc
Confidence 99999999999888775 2346789999999999999999999999999999999999999
Q ss_pred CCcEEEeccCccccccccccccCCCCCCCccccccchhhccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Q psy5539 524 QMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNK-YTVESDVWAFGVCLWEIFSFALQPYYGLTHEEVVKY 602 (653)
Q Consensus 524 ~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e~~~~ 602 (653)
++.+||+|||.++...... .......++..|+|||.+.... ++.++|||||||++|||++|+.+++.+.+..+.+..
T Consensus 137 ~~~~kl~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 137 NGELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp TCCEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred CCceeeeecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 9999999999998654322 2233445678899999988765 699999999999999999988877888777776666
Q ss_pred HHcC----------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 603 IKEG----------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 603 i~~~----------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+... .........++.+.+|+++||+.||.+|||++|+++|.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 215 IFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp HHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred HHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 5321 001122345788999999999999999999999999876
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=373.20 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=201.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC-
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK- 441 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~- 441 (653)
.++|++++.||+|+||+||+|++. .+++.||||+++.. ..+...+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDG-----RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEET-----TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcc
Confidence 468999999999999999999864 45789999999754 34455678899999999999999999999997654
Q ss_pred -----ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCC
Q psy5539 442 -----PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLAT 516 (653)
Q Consensus 442 -----~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp 516 (653)
.++|||||+ +++|..+++ ...+++..+..++.||+.||+|||+++|+||||||
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~---------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp 149 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMK---------------------HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKP 149 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHH---------------------HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ccccceEEEEEecc-cccHHHHHH---------------------hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCc
Confidence 579999999 557777664 13589999999999999999999999999999999
Q ss_pred CCEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 517 RNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 517 ~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
+|||++.++.+||+|||+|+.... ......+|+.|+|||.+.+. .++.++|||||||++|||++| .+||.+.+
T Consensus 150 ~NIL~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g-~~pf~~~~ 223 (346)
T d1cm8a_ 150 GNLAVNEDCELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTLFKGSD 223 (346)
T ss_dssp GGEEECTTCCEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS-SCSSCCSS
T ss_pred chhhcccccccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC-cCCCCCCC
Confidence 999999999999999999986532 23456788999999998865 568999999999999999995 56998877
Q ss_pred HHHHHHHHHcC------------------------------CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 596 HEEVVKYIKEG------------------------------NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 596 ~~e~~~~i~~~------------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
..+....+... .........++++.+|+.+||..||++|||++|+++|+|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~ 303 (346)
T d1cm8a_ 224 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY 303 (346)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred hHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence 66554333220 011223457889999999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=373.44 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=203.5
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecCC---
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVGK--- 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~~--- 441 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++........+.+.+|+++|++++||||+++++++....
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~ 82 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDN-----VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 82 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEET-----TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTT
T ss_pred CCeEEEEEEeeccCeEEEEEEEC-----CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccc
Confidence 36999999999999999999863 4568899999986655666778999999999999999999999986543
Q ss_pred -ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEe
Q psy5539 442 -PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCL 520 (653)
Q Consensus 442 -~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NIL 520 (653)
..++++||+.+|+|.+++.. ..+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 83 ~~~~~l~~~~~~g~L~~~l~~---------------------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL 141 (345)
T d1pmea_ 83 MKDVYLVTHLMGADLYKLLKT---------------------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 141 (345)
T ss_dssp CCCEEEEEECCCEEHHHHHHH---------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cceEEEEEeecCCchhhhhhc---------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence 33555667789999999961 24899999999999999999999999999999999999
Q ss_pred EcCCCcEEEeccCccccccccccc-cCCCCCCCccccccchhhc-cCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Q psy5539 521 INDQMVVKIADFGLSRKMYLQDYY-KGDENDAIPVRWMPLESIL-YNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHEE 598 (653)
Q Consensus 521 l~~~~~vkI~DfGla~~~~~~~~~-~~~~~~~~t~~y~aPE~~~-~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~e 598 (653)
|++++.+||+|||+++........ .......+|+.|+|||.+. ...++.++||||+|+++|||++| ..||.+.+..+
T Consensus 142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g-~~pf~~~~~~~ 220 (345)
T d1pmea_ 142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RPIFPGKHYLD 220 (345)
T ss_dssp ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHS-SCSCCCSSHHH
T ss_pred ECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhC-CCCCCCCCHHH
Confidence 999999999999999865433222 2234456889999999985 45678999999999999999996 56898777655
Q ss_pred HHHHHHcC-------------------------Cc-----cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 599 VVKYIKEG-------------------------NI-----LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 599 ~~~~i~~~-------------------------~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
........ .. .......+.++.+|+.+||+.||.+|||++++++|.|
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 44333210 00 0012356788999999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=370.22 Aligned_cols=255 Identities=23% Similarity=0.353 Sum_probs=202.3
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
++|++++.||+|+||+||+|++. .+++.||||+++.. ..+...+++.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHR-----KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-----TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccc
Confidence 58999999999999999999864 46789999998643 223344568899999999999999999999854
Q ss_pred ----CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCC
Q psy5539 440 ----GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLA 515 (653)
Q Consensus 440 ----~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLk 515 (653)
....++||||+.++++..+.. ....++...+..++.||+.||.|||+++|+|||||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~--------------------~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlK 144 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSN--------------------VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 144 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTC--------------------TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred ccccCceEEEEEeccCCCccchhhh--------------------cccccccHHHHHHHHHHHHHHHHhccCCEEecCcC
Confidence 346899999998876654432 23568889999999999999999999999999999
Q ss_pred CCCEeEcCCCcEEEeccCcccccccccccc--CCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 516 TRNCLINDQMVVKIADFGLSRKMYLQDYYK--GDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 516 p~NILl~~~~~vkI~DfGla~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
|+|||+++++.+||+|||+++......... ......+|+.|+|||.+.+. .++.++|||||||++|||++| .+||.
T Consensus 145 p~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g-~~pf~ 223 (318)
T d3blha1 145 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQ 223 (318)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS-SCSCC
T ss_pred chheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhC-CCCCC
Confidence 999999999999999999997654332221 22334689999999998765 689999999999999999995 57999
Q ss_pred CCCHHHHHHHHHcCCccCCCC-------------------------------CCcHHHHHHHHHhhccCCCCCCCHHHHH
Q psy5539 593 GLTHEEVVKYIKEGNILQAPD-------------------------------NTPDALYDLMKLCWNMKPMNRPSFRTIY 641 (653)
Q Consensus 593 ~~~~~e~~~~i~~~~~~~~~~-------------------------------~~~~~l~~li~~cl~~dP~~RPs~~eil 641 (653)
+.+..+....+........+. ..++++.+||.+||+.||++|||++|++
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHH
Confidence 888877666654311100000 1246778999999999999999999999
Q ss_pred HHHH
Q psy5539 642 QTLW 645 (653)
Q Consensus 642 ~~L~ 645 (653)
+|.|
T Consensus 304 ~Hpf 307 (318)
T d3blha1 304 NHDF 307 (318)
T ss_dssp HSGG
T ss_pred cChh
Confidence 9987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-44 Score=374.16 Aligned_cols=257 Identities=20% Similarity=0.304 Sum_probs=210.6
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc---cHHHHHHHHHHHHHHhhCCC-CccceEEeEEec
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA---SEYLQTDFEREACLLAEFDH-PNIVKLLGVCAV 439 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~---~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~ 439 (653)
.++|++++.||+|+||+||+|+... ...+++.||||.++... .....+.+.+|++++++++| |||+++++++..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~--~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKIS--GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECS--STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECc--cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3679999999999999999998632 34567899999986432 12234568899999999977 899999999999
Q ss_pred CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 440 GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 440 ~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
....+++|||+.+|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~~--------------------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Ni 160 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQR--------------------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENI 160 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHHH--------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CCceeeeeecccccHHHHHHHhc--------------------ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccce
Confidence 99999999999999999999732 3467888999999999999999999999999999999
Q ss_pred eEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC--CCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 520 LINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN--KYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 520 Ll~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++.++.+||+|||+++.+...... ......+++.|+|||.+.+. .++.++|||||||+||||++|. .||.+.+..
T Consensus 161 ll~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~-~PF~~~~~~ 238 (322)
T d1vzoa_ 161 LLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-SPFTVDGEK 238 (322)
T ss_dssp EECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSS-CTTSCTTSC
T ss_pred eecCCCCEEEeeccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCC-CCCCCCCHH
Confidence 9999999999999999866433322 22345678899999999765 4688999999999999999955 588765433
Q ss_pred ----HHHHHHHcCCccCCCCCCcHHHHHHHHHhhccCCCCCC-----CHHHHHHHHH
Q psy5539 598 ----EVVKYIKEGNILQAPDNTPDALYDLMKLCWNMKPMNRP-----SFRTIYQTLW 645 (653)
Q Consensus 598 ----e~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 645 (653)
.+....... ....+..+++++.+|+.+||+.||.+|| |++|+++|+|
T Consensus 239 ~~~~~i~~~~~~~-~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 239 NSQAEISRRILKS-EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp CCHHHHHHHHHHC-CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred HHHHHHHHhcccC-CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence 333333333 3456678999999999999999999999 5899999876
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-42 Score=358.97 Aligned_cols=256 Identities=19% Similarity=0.270 Sum_probs=200.4
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEE-eEEecCCce
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLL-GVCAVGKPM 443 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~-g~~~~~~~~ 443 (653)
++|++.+.||+|+||+||+|++. .+++.||||+++.... ..++.+|+++++.++|+|++..+ ++...++..
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~ 78 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDI-----AAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYN 78 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEET-----TTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEEC-----CCCCEEEEEEEchhcc---CHHHHHHHHHHHHccCCCcccEEEEEEecCCEE
Confidence 46999999999999999999864 3568999999875432 23578999999999887766554 555778889
Q ss_pred EEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc-
Q psy5539 444 CLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN- 522 (653)
Q Consensus 444 ~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~- 522 (653)
++||||+ +|+|.+.+.. ....+++..++.++.|++.||+|||+++|+||||||+|||++
T Consensus 79 ~ivme~~-~~~l~~~~~~-------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~ 138 (299)
T d1ckia_ 79 VMVMELL-GPSLEDLFNF-------------------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 138 (299)
T ss_dssp EEEEECC-CCBHHHHHHH-------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred EEEEEEc-CCchhhhhhh-------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccc
Confidence 9999998 4577776652 235689999999999999999999999999999999999975
Q ss_pred --CCCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCC
Q psy5539 523 --DQMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLT 595 (653)
Q Consensus 523 --~~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~ 595 (653)
.+..+||+|||+|+........ .......||+.|||||.+.+..++.++||||||+++|||++|. .||.+..
T Consensus 139 ~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~-~P~~~~~ 217 (299)
T d1ckia_ 139 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS-LPWQGLK 217 (299)
T ss_dssp GGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSS-CTTCCCC
T ss_pred cCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCC-Ccccccc
Confidence 4567999999999876433221 1233457899999999999999999999999999999999965 5887665
Q ss_pred HHHHHHHH---H----cCCccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q psy5539 596 HEEVVKYI---K----EGNILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKR 649 (653)
Q Consensus 596 ~~e~~~~i---~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~ 649 (653)
..+....+ . ..........+|+++.++|..||+.+|++||++++|.+.|+.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 218 AATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 44332221 1 111222346789999999999999999999999999888776643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-43 Score=370.75 Aligned_cols=249 Identities=22% Similarity=0.273 Sum_probs=199.0
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccceEEeEEecC-----
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG----- 440 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~----- 440 (653)
+|..++.||+|+||+||+|++. .+++.||||+++.... .+.+|+++|++++|||||++++++...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~ 90 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLC-----DSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 90 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEET-----TTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred CcEeeeEEeeCcCeEEEEEEEC-----CCCCEEEEEEECccch-----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence 6788999999999999999964 3568999999975432 235799999999999999999998532
Q ss_pred -CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCE
Q psy5539 441 -KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNC 519 (653)
Q Consensus 441 -~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NI 519 (653)
..++|||||++++. .+.+... ......+++.++..++.||+.||+|||++||+||||||+||
T Consensus 91 ~~~~~lv~Ey~~~~~-~~~l~~~----------------~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NI 153 (350)
T d1q5ka_ 91 EVYLNLVLDYVPETV-YRVARHY----------------SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNL 153 (350)
T ss_dssp CCEEEEEEECCSEEH-HHHHHHH----------------HHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred ceEEEEEEeccCCcc-HHHHHhh----------------hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceE
Confidence 34789999998754 4443311 12345689999999999999999999999999999999999
Q ss_pred eEcCCC-cEEEeccCccccccccccccCCCCCCCccccccchhhcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 520 LINDQM-VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILY-NKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 520 Ll~~~~-~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|++.++ .+||+|||+++...... ......++..|+|||.+.+ ..++.++|||||||++|||++| .+||.+.+..
T Consensus 154 Ll~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g-~~pf~~~~~~ 229 (350)
T d1q5ka_ 154 LLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGV 229 (350)
T ss_dssp EECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT-SCSSCCSSHH
T ss_pred EEecCCCceeEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhC-CCCCCCCCHH
Confidence 999765 89999999998653332 2234567889999998875 4689999999999999999995 5799888776
Q ss_pred HHHHHHHc--C-----------------Ccc---------CCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 598 EVVKYIKE--G-----------------NIL---------QAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 598 e~~~~i~~--~-----------------~~~---------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+.+..+.. + ... ......++++.+|+.+||..||++|||++|+++|.|
T Consensus 230 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~ 305 (350)
T d1q5ka_ 230 DQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 305 (350)
T ss_dssp HHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence 65555432 0 000 012346789999999999999999999999999876
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.2e-42 Score=362.69 Aligned_cols=245 Identities=21% Similarity=0.336 Sum_probs=197.2
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEec--CC
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAV--GK 441 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~--~~ 441 (653)
++|++++.||+|+||+||+|+.. .+++.||||+++... .+++.+|+++|+.++ ||||+++++++.. ..
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~-----~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~ 105 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINI-----TNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSR 105 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred cCeEEEEEEecCcCeEEEEEEEC-----CCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence 57999999999999999999864 467899999997643 346789999999995 9999999999874 45
Q ss_pred ceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeE
Q psy5539 442 PMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLI 521 (653)
Q Consensus 442 ~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl 521 (653)
..++||||+++|+|..+. ..+++.++..++.||+.||+|||+++|+||||||+|||+
T Consensus 106 ~~~~v~e~~~~~~L~~~~-----------------------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY-----------------------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp SEEEEEECCCSCBGGGTT-----------------------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ceeEEEeecCCCcHHHHh-----------------------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 689999999999987643 348899999999999999999999999999999999999
Q ss_pred cCC-CcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCC-CCCHHH
Q psy5539 522 NDQ-MVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYY-GLTHEE 598 (653)
Q Consensus 522 ~~~-~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~-~~~~~e 598 (653)
+.+ +.+||+|||+|+...... ......+|..|+|||.+.+. .++.++||||+|+++|||++|.. ||. +.+..+
T Consensus 163 ~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~-pf~~~~~~~~ 238 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE-PFFHGHDNYD 238 (328)
T ss_dssp ETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS-SSSCCSSHHH
T ss_pred cCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCC-CCCCCchhHH
Confidence 865 569999999998653322 23445678999999998876 47999999999999999999765 554 333332
Q ss_pred HHHHHH-------------cCCc-----------------------cCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHH
Q psy5539 599 VVKYIK-------------EGNI-----------------------LQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQ 642 (653)
Q Consensus 599 ~~~~i~-------------~~~~-----------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~ 642 (653)
....+. .... ......+++++.+||++||..||++|||++|+++
T Consensus 239 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 239 QLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 222111 0000 0011236788999999999999999999999999
Q ss_pred HHH
Q psy5539 643 TLW 645 (653)
Q Consensus 643 ~L~ 645 (653)
|+|
T Consensus 319 Hp~ 321 (328)
T d3bqca1 319 HPY 321 (328)
T ss_dssp SGG
T ss_pred Ccc
Confidence 876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=5.6e-42 Score=353.91 Aligned_cols=259 Identities=18% Similarity=0.246 Sum_probs=210.1
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC-CccceEEeEEecCCc
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH-PNIVKLLGVCAVGKP 442 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H-pnIv~l~g~~~~~~~ 442 (653)
.++|++.+.||+|+||+||+|++. .+++.||||+++.... ...+.+|++.++.++| +|++.+++++..+..
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~-----~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 75 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNL-----LNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 75 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEET-----TTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred CCceEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEEccccC---cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence 468999999999999999999964 3568999999865432 2346788999999976 899999999999999
Q ss_pred eEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCCCEeEc
Q psy5539 443 MCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATRNCLIN 522 (653)
Q Consensus 443 ~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~NILl~ 522 (653)
.++||||+ +|+|.++++. ....++..++..++.|++.||+|||+++|+||||||+|||++
T Consensus 76 ~~~vme~~-~~~l~~~~~~-------------------~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~ 135 (293)
T d1csna_ 76 NVLVIDLL-GPSLEDLLDL-------------------CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIG 135 (293)
T ss_dssp EEEEEECC-CCBHHHHHHH-------------------TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred cEEEEEec-CCCHHHHHHh-------------------hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeec
Confidence 99999998 6899998863 224588999999999999999999999999999999999997
Q ss_pred C-----CCcEEEeccCccccccccccc-----cCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCC
Q psy5539 523 D-----QMVVKIADFGLSRKMYLQDYY-----KGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYY 592 (653)
Q Consensus 523 ~-----~~~vkI~DfGla~~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~ 592 (653)
. ++.+||+|||+|+........ .......||+.|||||.+.+..++.++||||||+++|||++|. .||.
T Consensus 136 ~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~-~Pf~ 214 (293)
T d1csna_ 136 RPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS-LPWQ 214 (293)
T ss_dssp CSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSS-CTTS
T ss_pred CcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCC-CcCC
Confidence 4 578999999999875432211 1223456899999999999999999999999999999999955 5886
Q ss_pred CCC---HHHHHHHHHcC----CccCCCCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHHHHHHh
Q psy5539 593 GLT---HEEVVKYIKEG----NILQAPDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWNIKRDL 651 (653)
Q Consensus 593 ~~~---~~e~~~~i~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~l~~~l 651 (653)
+.. ..+....+... ........+|+++.+++..|+..+|++||+++.+.+.+.++.++.
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 543 33333333322 122234578899999999999999999999999999888876553
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=364.40 Aligned_cols=251 Identities=23% Similarity=0.269 Sum_probs=203.8
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc-cHHHHHHHHHHHHHHhhCCCCccceEEeEEecC--
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA-SEYLQTDFEREACLLAEFDHPNIVKLLGVCAVG-- 440 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~-~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~~-- 440 (653)
.++|++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+++|++++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~ 91 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDT-----KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEET-----TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred CCCeEEEEEEecCCCeEEEEEEEC-----CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccc
Confidence 367999999999999999999863 467899999997542 334456789999999999999999999998643
Q ss_pred ---CceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 441 ---KPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 441 ---~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
...++|+||+.+|+|.++++ ...+++.++..++.||+.||+|||+++|+||||||+
T Consensus 92 ~~~~~~~~i~~~~~gg~L~~~~~---------------------~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~ 150 (348)
T d2gfsa1 92 LEEFNDVYLVTHLMGADLNNIVK---------------------CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPS 150 (348)
T ss_dssp TTTCCCCEEEEECCSEEHHHHHT---------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cccCceEEEEEeecCCchhhhcc---------------------cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCc
Confidence 34567778889999999985 135899999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccC-CCCCchhHHHHHHHHHHHHhCCCCCCCCCCH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYN-KYTVESDVWAFGVCLWEIFSFALQPYYGLTH 596 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~ 596 (653)
|||++.++.+|++|||++.... .......++..|+|||.+.+. .++.++||||||+++|+|++| .+||.+.+.
T Consensus 151 NILi~~~~~~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g-~~pF~~~~~ 224 (348)
T d2gfsa1 151 NLAVNEDCELKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTLFPGTDH 224 (348)
T ss_dssp GEEECTTCCEEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHS-SCSCCCSSH
T ss_pred cccccccccccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhC-CCCCCCCCH
Confidence 9999999999999999997542 222445688899999987765 468999999999999999995 569988887
Q ss_pred HHHHHHHHcCCcc----------------------CC--------CCCCcHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q psy5539 597 EEVVKYIKEGNIL----------------------QA--------PDNTPDALYDLMKLCWNMKPMNRPSFRTIYQTLWN 646 (653)
Q Consensus 597 ~e~~~~i~~~~~~----------------------~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 646 (653)
......+...... .. ....++++.+||++||..||++|||++|+++|.|-
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f 304 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred HHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence 7666555331100 00 13467889999999999999999999999998763
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-42 Score=363.65 Aligned_cols=250 Identities=23% Similarity=0.265 Sum_probs=194.6
Q ss_pred CCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccc-ccHHHHHHHHHHHHHHhhCCCCccceEEeEEec----
Q psy5539 365 NDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDE-ASEYLQTDFEREACLLAEFDHPNIVKLLGVCAV---- 439 (653)
Q Consensus 365 ~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~-~~~~~~~~f~~Ei~il~~l~HpnIv~l~g~~~~---- 439 (653)
++|++++.||+|+||+||+|++. .++..||||+++.. ......+.+.+|+.++++++|||||++++++..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~-----~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDA-----VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEET-----TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEEC-----CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccc
Confidence 57999999999999999999864 46789999999754 334455678999999999999999999999864
Q ss_pred --CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCceecCCCCC
Q psy5539 440 --GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFVHRDLATR 517 (653)
Q Consensus 440 --~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~ivHrDLkp~ 517 (653)
....++||||+.++ |.+.+. ..+++..+..++.||+.||+|||++||+||||||+
T Consensus 92 ~~~~~~~iv~Ey~~~~-l~~~~~----------------------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~ 148 (355)
T d2b1pa1 92 EEFQDVYLVMELMDAN-LCQVIQ----------------------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPS 148 (355)
T ss_dssp TTCCEEEEEEECCSEE-HHHHHT----------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred ccCceeEEEEeccchH-HHHhhh----------------------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcc
Confidence 36789999999765 444443 34789999999999999999999999999999999
Q ss_pred CEeEcCCCcEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHHHhCCCCCCCCCCHH
Q psy5539 518 NCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEIFSFALQPYYGLTHE 597 (653)
Q Consensus 518 NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~ellt~~~~p~~~~~~~ 597 (653)
|||++.++.+|++|||+++..... .......+|..|+|||.+.+..++.++||||+||+++||++| .+||.+.+..
T Consensus 149 Nil~~~~~~~kl~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g-~~pF~~~~~~ 224 (355)
T d2b1pa1 149 NIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KILFPGRDYI 224 (355)
T ss_dssp GEEECTTCCEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS-SCSSCCSSHH
T ss_pred ccccccccceeeechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhC-CCCCCCCCHH
Confidence 999999999999999998754322 223445678899999999999999999999999999999996 5699887766
Q ss_pred HHHHHHHc----------------------CCccCC-------------C------CCCcHHHHHHHHHhhccCCCCCCC
Q psy5539 598 EVVKYIKE----------------------GNILQA-------------P------DNTPDALYDLMKLCWNMKPMNRPS 636 (653)
Q Consensus 598 e~~~~i~~----------------------~~~~~~-------------~------~~~~~~l~~li~~cl~~dP~~RPs 636 (653)
.....+.. ...... + ...++++.+|+++||..||++|||
T Consensus 225 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t 304 (355)
T d2b1pa1 225 DQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC
Confidence 55444321 100000 0 013467899999999999999999
Q ss_pred HHHHHHHHHH
Q psy5539 637 FRTIYQTLWN 646 (653)
Q Consensus 637 ~~eil~~L~~ 646 (653)
++|+++|+|-
T Consensus 305 a~elL~Hpw~ 314 (355)
T d2b1pa1 305 VDDALQHPYI 314 (355)
T ss_dssp HHHHHTSTTT
T ss_pred HHHHhcCccc
Confidence 9999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-36 Score=319.26 Aligned_cols=252 Identities=19% Similarity=0.260 Sum_probs=188.9
Q ss_pred CCCeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-----------CCccce
Q psy5539 364 RNDIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-----------HPNIVK 432 (653)
Q Consensus 364 ~~~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-----------HpnIv~ 432 (653)
.++|++++.||+|+||+||+|+.. .+++.||||+++... ...+.+.+|+.+++.++ |+||++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~-----~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~ 84 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDM-----VNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 84 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEET-----TTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred CCcEEEEEEEeeCCCeEEEEEEEC-----CCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEE
Confidence 346999999999999999999863 467899999998543 23456788999988875 578999
Q ss_pred EEeEEec--CCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhh-CCc
Q psy5539 433 LLGVCAV--GKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSD-RKF 509 (653)
Q Consensus 433 l~g~~~~--~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~i 509 (653)
+++++.. .....+++++...+........ ......+++..+..++.||+.||+|||+ .||
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~i~~i~~qil~al~~lh~~~~I 147 (362)
T d1q8ya_ 85 LLDHFNHKGPNGVHVVMVFEVLGENLLALIK-----------------KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 147 (362)
T ss_dssp CCEEEEEEETTEEEEEEEECCCCEEHHHHHH-----------------HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred EEEEeeeccccceeeeeeecccccccccccc-----------------cccccCCcHHHHHHHHHHHHHHHHHHhhhcCc
Confidence 9988764 3456677777655544333321 1234568899999999999999999998 899
Q ss_pred eecCCCCCCEeEcCCC------cEEEeccCccccccccccccCCCCCCCccccccchhhccCCCCCchhHHHHHHHHHHH
Q psy5539 510 VHRDLATRNCLINDQM------VVKIADFGLSRKMYLQDYYKGDENDAIPVRWMPLESILYNKYTVESDVWAFGVCLWEI 583 (653)
Q Consensus 510 vHrDLkp~NILl~~~~------~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~t~ksDVwSlGvvl~el 583 (653)
+||||||+||||+.++ .++++|||.+.... .......+|+.|+|||.+....++.++||||+|++++||
T Consensus 148 vHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 222 (362)
T d1q8ya_ 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFEL 222 (362)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHH
T ss_pred ccccCChhHeeeeccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHH
Confidence 9999999999998665 49999999997542 223456789999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCHH------HH-HHHHH-----------cCC----------c-------------------cCCCCCCc
Q psy5539 584 FSFALQPYYGLTHE------EV-VKYIK-----------EGN----------I-------------------LQAPDNTP 616 (653)
Q Consensus 584 lt~~~~p~~~~~~~------e~-~~~i~-----------~~~----------~-------------------~~~~~~~~ 616 (653)
++|. .||...... +. ...+. .+. . .......+
T Consensus 223 ~~g~-~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (362)
T d1q8ya_ 223 ITGD-FLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 301 (362)
T ss_dssp HHSS-CCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHH
T ss_pred HHCC-CCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccC
Confidence 9955 477643221 11 11100 000 0 00111235
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q psy5539 617 DALYDLMKLCWNMKPMNRPSFRTIYQTLW 645 (653)
Q Consensus 617 ~~l~~li~~cl~~dP~~RPs~~eil~~L~ 645 (653)
+++.+|+.+|+..||.+|||++|+++|.|
T Consensus 302 ~~~~dll~~mL~~dP~~Rpta~e~L~Hp~ 330 (362)
T d1q8ya_ 302 KEISDFLSPMLQLDPRKRADAGGLVNHPW 330 (362)
T ss_dssp HHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 67899999999999999999999999876
|
| >d1nl1a1 g.14.1.1 (A:66-147) Prothrombin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Prothrombin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=8.3e-30 Score=208.18 Aligned_cols=81 Identities=38% Similarity=0.922 Sum_probs=78.5
Q ss_pred cccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCCC
Q psy5539 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTCA 266 (653)
Q Consensus 187 C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C~ 266 (653)
||.|+|.+|||++++|.+|++||.|+++.+|.+.+.+..+|...+.||||||||++..+|||||+++.++||||+||.|+
T Consensus 1 Cy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~~NyCRNP~~~~~~PWCyv~~~~~~~eyC~ip~C~ 80 (82)
T d1nl1a1 1 CAEGVGMNYRGNVSVTRSGIECQLWRSRYPHKPEINSTTHPGADLRENFCRNPDGSITGPWCYTTSPTLRREECSVPVCG 80 (82)
T ss_dssp SBCTTSTTCCCCCCBBTTSCBBCCTTCCSSSCCSSCTTTSTTSCCCTTCCBCTTCCTTCSEEEBSSTTCCEEEBCCCBTT
T ss_pred CccCCCCCCccCCeECCCCCcccCCccCCCcccceecccccCcCcccccccCCCCCCCCCCeEeCCCCCceeeCCCCcCC
Confidence 89999999999999999999999999999999999999999999999999999999889999999999999999999998
Q ss_pred C
Q psy5539 267 D 267 (653)
Q Consensus 267 ~ 267 (653)
+
T Consensus 81 ~ 81 (82)
T d1nl1a1 81 Q 81 (82)
T ss_dssp C
T ss_pred C
Confidence 6
|
| >d2qj2a2 g.14.1.1 (A:127-209) NK1 fragment of hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: NK1 fragment of hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=6.9e-30 Score=209.37 Aligned_cols=82 Identities=46% Similarity=1.067 Sum_probs=79.0
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
|||.|+|.+|||++++|.+|++||+|+++.++.|.+.+..++...+.||||||||++..+|||||.++..+||||+||+|
T Consensus 1 dCy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~hNyCRNP~~~~~~PWCy~~~~~~~~eyC~ip~C 80 (83)
T d2qj2a2 1 NCIIGKGRSYKGTVSITKSGIKCQPWSSMIPHEHSFLPSSYRGKDLQENYCRNPRGEEGGPWCFTSNPEVRYEVCDIPQC 80 (83)
T ss_dssp CSBSSSCTTCCCCCCBBTTCCBBCCTTCCSSCCCCCCGGGGTTSCCCTTCCBCSSCCTTCSEEEBSSTTCCEEEBCCCBT
T ss_pred CCccCCCCCceecceECCCCCcccCCccCCCccccEeeccCcccccccccccCCCCCCCCcceEeCCCCcceEecCCCcC
Confidence 79999999999999999999999999999999999999999999999999999999988999999999999999999999
Q ss_pred CC
Q psy5539 266 AD 267 (653)
Q Consensus 266 ~~ 267 (653)
++
T Consensus 81 ~~ 82 (83)
T d2qj2a2 81 SE 82 (83)
T ss_dssp TC
T ss_pred CC
Confidence 86
|
| >d1ki0a1 g.14.1.1 (A:81-163) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-29 Score=207.28 Aligned_cols=82 Identities=39% Similarity=0.960 Sum_probs=78.5
Q ss_pred cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 185 ~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
+|||.|+|..|||++++|.||++||+|+++.++.+.+.+..+|...++||||||||++..+|||||+++..+||||+||.
T Consensus 2 ~dCy~g~G~~YrG~~s~T~sG~~C~~W~~~~~~~~~~~~~~~~~~~l~hNyCRNP~~~~~~PWCy~~~~~~~~e~C~ip~ 81 (83)
T d1ki0a1 2 SECKTGNGKNYRGTMSKTKNGITCQKWSSTSPHRPRFSPATHPSEGLEENYCRNPDNDPQGPWCYTTDPEKRYDYCDILE 81 (83)
T ss_dssp CSSBCTTCTTCCCCCCBCTTSCBBCCTTCCSSSCCSCCTTTCTTSCCCTTCCBCTTCCTTCCEEEBSCTTCSEEECCCCB
T ss_pred CCCcCCCCCCCeecceeCCCCCccCCCccCCCcccceecccCcccCcccccccCCCCCCCCCceEecCCCcceEcCCCCc
Confidence 47999999999999999999999999999999999999999999999999999999998799999999999999999999
Q ss_pred CC
Q psy5539 265 CA 266 (653)
Q Consensus 265 C~ 266 (653)
|.
T Consensus 82 C~ 83 (83)
T d1ki0a1 82 CE 83 (83)
T ss_dssp CB
T ss_pred CC
Confidence 94
|
| >d1ki0a2 g.14.1.1 (A:164-250) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2e-29 Score=207.93 Aligned_cols=82 Identities=46% Similarity=1.085 Sum_probs=78.5
Q ss_pred cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 185 ~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
++||.|+|..|||++++|.+|++||.|+++.+|.|.+.+..++...+.||||||||++. +|||||+++..+||||+||.
T Consensus 1 eeCy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~hNyCRNP~~~~-~PWCy~~~~~~~weyC~ip~ 79 (87)
T d1ki0a2 1 EECMHCSGENYDGKISKTMSGLECQAWDSQSPHAHGYIPSKFPNKNLKKNYCRNPDREL-RPWCFTTDPNKRWELCDIPR 79 (87)
T ss_dssp CSSBCTTSTTBCCCCCBCTTCCBBCCTTCCSSSCCSCCTTTSTTSCCCTTCCBCSSSCS-SCEEEBSCTTCSEEECCCCB
T ss_pred CcCCccCCCCCcccceecCCCCccccCcccCCcccccccccccccCCCcccccCCCCCc-ccceEeccCCcceEeCCCCc
Confidence 37999999999999999999999999999999999999999999999999999999986 99999999999999999999
Q ss_pred CCC
Q psy5539 265 CAD 267 (653)
Q Consensus 265 C~~ 267 (653)
|+.
T Consensus 80 C~~ 82 (87)
T d1ki0a2 80 CTT 82 (87)
T ss_dssp CCS
T ss_pred CCC
Confidence 985
|
| >d1ki0a3 g.14.1.1 (A:251-333) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.7e-29 Score=206.61 Aligned_cols=81 Identities=52% Similarity=1.183 Sum_probs=77.8
Q ss_pred ccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccC
Q psy5539 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIP 263 (653)
Q Consensus 184 ~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip 263 (653)
+.+||.|+|.+|||++++|.+|++||+|+++.++.|.+.+..++...+.||||||||++. +|||||.++.++||||+||
T Consensus 3 ~~dCy~g~G~~YrG~~~~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~hNyCRNP~~~~-~PWCy~~~~~~~weyC~Ip 81 (83)
T d1ki0a3 3 TYQCLKGTGENYRGNVAVTVSGHTCQHWSAQTPHTHERTPENFPCKNLDENYCRNPDGKR-APWCHTTNSQVRWEYCKIP 81 (83)
T ss_dssp CBSSBCTTSTTBCCCCCBCTTCCBBCCTTCCSSCCCSCCTTTCGGGCCCTTCCBCCSSCS-SCEEEBSSTTCSEEECCCC
T ss_pred cccCCcCCCCCCccccEecCCCCccCCCcCCCCcccccccccCcccccccccccCCCCCC-CcceEeCCCCcceEeCCCC
Confidence 568999999999999999999999999999999999999999999999999999999996 9999999999999999999
Q ss_pred CC
Q psy5539 264 TC 265 (653)
Q Consensus 264 ~C 265 (653)
+|
T Consensus 82 ~C 83 (83)
T d1ki0a3 82 SC 83 (83)
T ss_dssp BC
T ss_pred cC
Confidence 98
|
| >d1i71a_ g.14.1.1 (A:) Apolipoprotein A {Human (Homo sapiens), IV-7 variant [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Apolipoprotein A species: Human (Homo sapiens), IV-7 variant [TaxId: 9606]
Probab=99.95 E-value=3.5e-29 Score=204.94 Aligned_cols=81 Identities=46% Similarity=1.056 Sum_probs=77.7
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
+||.|+|.+|||++++|.+|++||.|+++.++.+.+.+..++...+.||||||||++. +|||||+++..+||||+||+|
T Consensus 1 dCy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~hNyCRNP~~~~-~PWCyv~~~~~~~eyC~I~~C 79 (83)
T d1i71a_ 1 DCYHGDGQSYRGSFSTTVTGRTCQSWSSMTPHWHQRTTEYYPNGGLTRNYCRNPDAEI-RPWCYTMDPSVRWEYCNLTQC 79 (83)
T ss_dssp CEECTTSTTCCCCCCBBTTSCBBCCTTCCSSCCCCCSTTTCTTTTCCTTCCBCSSSCS-SCEEEBSSTTCCEEEBSCEEC
T ss_pred CCcccCCCCCccccEeCCCCCcccCCccCCCcccccccccccCCCcccccccCCCCCC-CceEEecCCCcceEeCCCCcC
Confidence 6999999999999999999999999999999999999999999999999999999986 999999999999999999999
Q ss_pred CC
Q psy5539 266 AD 267 (653)
Q Consensus 266 ~~ 267 (653)
+-
T Consensus 80 ~~ 81 (83)
T d1i71a_ 80 PV 81 (83)
T ss_dssp CC
T ss_pred CC
Confidence 74
|
| >d5hpga_ g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.9e-29 Score=204.26 Aligned_cols=82 Identities=44% Similarity=0.980 Sum_probs=76.1
Q ss_pred ccccCCccccceeeeccCCCCcccccCCCCCCCCC-CCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCC
Q psy5539 186 DCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHE-RPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPT 264 (653)
Q Consensus 186 ~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~-~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~ 264 (653)
|||.|+|..|||++++|.+|++||+|+++.+|.|. +.+..++...+.||||||||++..+|||||.++...||||+||.
T Consensus 1 dCy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~~l~~NyCRNP~~~~~~PWCy~~~~~~~~eyC~ip~ 80 (84)
T d5hpga_ 1 DCMFGNGKGYRGKRVTTVTGTPCQDWAAQEPHRHSIFTPETNPRAGLEKNYCRNPDGDVGGPWCYTTNPRKLYDYCDVPQ 80 (84)
T ss_dssp CCBSTTCTTCCCCCCBCTTSCBBCCTTCCSSSCCSSSCTTTSTTSCCCTTCCBCTTCCTTCCEEEBSCTTCCEEECCCCB
T ss_pred CCcccCCCCCccccEecCCCCccCCccccCCccccccccccCcccCCccccccCCCCCcCCCCeEeCCCCcceeeCCCCc
Confidence 69999999999999999999999999999998886 46678888889999999999998899999999999999999999
Q ss_pred CCC
Q psy5539 265 CAD 267 (653)
Q Consensus 265 C~~ 267 (653)
|+.
T Consensus 81 C~~ 83 (84)
T d5hpga_ 81 CAA 83 (84)
T ss_dssp CCC
T ss_pred CCC
Confidence 974
|
| >d2hpqp_ g.14.1.1 (P:) Meizothrombin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Meizothrombin species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=1.2e-29 Score=205.39 Aligned_cols=79 Identities=30% Similarity=0.744 Sum_probs=76.0
Q ss_pred cccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccCCC
Q psy5539 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIPTC 265 (653)
Q Consensus 187 C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip~C 265 (653)
||.|+|.+|||++++|.+|++||+|+++.++.+.+.+..++..++.||||||||++..+|||||.++..+||||+||.|
T Consensus 1 Cy~g~G~~YrG~~s~T~sG~~C~~W~~~~~~~~~~~~~~~~~~~l~~NyCRNP~~~~~~PWCyt~~~~~~~eyC~Ip~C 79 (79)
T d2hpqp_ 1 CVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYC 79 (79)
T ss_dssp CBCGGGTTCCCCCCBBTTSCBCCCTTCSSHHHHGGGSCCCTTSCCCTTCCBCSSCCSSCCBCBCSSSTTCBCCBCCCBC
T ss_pred CcCCCCCCCccCceECCCCCccCCCCCCCCcccccccccCcccccccccccCCCCCCCCcceEeCCCCcceEeCCCCcC
Confidence 8999999999999999999999999999999988889999999999999999999988999999999999999999998
|
| >d1a0ha1 g.14.1.1 (A:164-270) Meizothrombin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Meizothrombin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.2e-28 Score=211.84 Aligned_cols=87 Identities=29% Similarity=0.736 Sum_probs=81.4
Q ss_pred ccccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCCCCCCCCccCCCCCCCCCCeEEEeCCCcceeecccC
Q psy5539 184 TYDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPELNNSENYCRNAGGEEPSPWCYTMDPNVRWQRCEIP 263 (653)
Q Consensus 184 ~~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~~~~~~nyCRNp~~~~~~pWC~~~~~~~~~~~C~ip 263 (653)
..+||.|+|..|||++++|.+|++||.|+++.+|.|.+.+..+|...+.||||||||++..+|||||.++..+||||+||
T Consensus 4 ~e~Cy~~~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~l~hNyCRNPdg~~~~PWCYv~~~~~~~eyC~ip 83 (109)
T d1a0ha1 4 LETCVPDRGREYRGRLAVTTHGSRCLAWSSEQAKALSKDQDFNPAVPLAENFCRNPDGDEEGAWCYVADQPGDFEYCDLN 83 (109)
T ss_dssp SCCCBCGGGTTCCCCCCCCTTSCCCCCSSSTTHHHHSTTSCCCCSSCCCTTSCBCTTCCTTCCEEECSSSTTCEEECCCC
T ss_pred CccCCCCCCCCCccccccCCCCCccccccccCCcccccccccCcccCcccccccCCCCCCCCceeEecCCCCCeEeCCCC
Confidence 45899999999999999999999999999999999999999999999999999999999889999999999999999999
Q ss_pred CCCCCCc
Q psy5539 264 TCADSMQ 270 (653)
Q Consensus 264 ~C~~~~~ 270 (653)
.|.+...
T Consensus 84 ~C~~~~~ 90 (109)
T d1a0ha1 84 YCEEPVD 90 (109)
T ss_dssp BSSCCCC
T ss_pred cCCCCCC
Confidence 9987543
|
| >d1pmla_ g.14.1.1 (A:) Plasminogen {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Plasminogen species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.4e-27 Score=196.98 Aligned_cols=82 Identities=29% Similarity=0.731 Sum_probs=72.2
Q ss_pred cccccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCCC---CCCCCCccCCCCCCCCCCeEEEe-CCCcceeec
Q psy5539 185 YDCIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFPE---LNNSENYCRNAGGEEPSPWCYTM-DPNVRWQRC 260 (653)
Q Consensus 185 ~~C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~~---~~~~~nyCRNp~~~~~~pWC~~~-~~~~~~~~C 260 (653)
+|||.|+|.+|||++++|.+|++||.|+++.++.|.+.+..++. ..+.|||||||||+. +|||||. ++.++||||
T Consensus 1 ~dCy~g~G~~YrG~~~~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~~~~~~hNyCRNP~g~~-~PWCy~~~~~~~~we~C 79 (86)
T d1pmla_ 1 SDCYFGNGSAYRGTHSLTESGASCLPWNSMILIGKVYTAQNPSAQALGLGKHNYCRNPDGDA-KPWCHVLKNRRLTWEYC 79 (86)
T ss_dssp CCSBCTTSTTCCCCCCBBTTSCBCCCTTCGGGTTCSSSTTSTTHHHHTCSSSCCCBCSSCCS-SCEEEEEETTEEEEEEB
T ss_pred CcCccCCCCCcccceeECCCCCccCCCcCCCccccccccccCcccccCccccccccCCCCCc-cceEEEeCCCCceeEeC
Confidence 47999999999999999999999999999999988887666553 346899999999986 8999996 667899999
Q ss_pred ccCCCCC
Q psy5539 261 EIPTCAD 267 (653)
Q Consensus 261 ~ip~C~~ 267 (653)
+||.|+.
T Consensus 80 ~ip~C~s 86 (86)
T d1pmla_ 80 DVPSCST 86 (86)
T ss_dssp CCCBTTC
T ss_pred CCccCCC
Confidence 9999973
|
| >d2i9aa2 g.14.1.1 (A:50-132) Urokinase-type plasminogen activator {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Kringle-like superfamily: Kringle-like family: Kringle modules domain: Urokinase-type plasminogen activator species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=4.4e-27 Score=192.86 Aligned_cols=79 Identities=29% Similarity=0.639 Sum_probs=69.9
Q ss_pred cccCCccccceeeeccCCCCcccccCCCCCCCCCCCCCCCC---CCCCCCCccCCCCCCCCCCeEEEe-CCCcceeeccc
Q psy5539 187 CIRGRGRFYQGTVNTTVGGLACQRWDAKEPHAHERPPPVFP---ELNNSENYCRNAGGEEPSPWCYTM-DPNVRWQRCEI 262 (653)
Q Consensus 187 C~~~~g~~yrg~~~~t~sg~~C~~W~~~~~~~~~~~~~~~~---~~~~~~nyCRNp~~~~~~pWC~~~-~~~~~~~~C~i 262 (653)
||.|+|..|||++++|.+|++||+|+++.++.+.+.+..++ ...+.||||||||++. +|||||. ++.++||||+|
T Consensus 1 Cy~g~G~~YrG~~s~T~sG~~C~~W~s~~~~~~~~~~~~~~~~~~~~~~hNyCRNP~~~~-~PWCy~~~~~~~~~e~C~i 79 (83)
T d2i9aa2 1 CYEGNGHFYRGKASTDTMGRPCLPWNSATVLQQTYHAHRSDALQLGLGKHNYCRNPDNRR-RPWCYVQVGLKPLVQECMV 79 (83)
T ss_dssp EECTTCTTCCSCCCBBTTSCBCCCTTSTTGGGSSSCTTSTTHHHHTCCSSCCCBCTTCBS-SCEEEEEETTEEEEEEBSC
T ss_pred CcCCCCCcccccceecCCCCcCCCCCCCCCcccccCcccCCcccccccCcccccCCCCCc-CceeEEecCCCeeeEecCC
Confidence 89999999999999999999999999999998877666554 3457899999999986 9999995 45578999999
Q ss_pred CCCC
Q psy5539 263 PTCA 266 (653)
Q Consensus 263 p~C~ 266 (653)
|.|+
T Consensus 80 p~Cs 83 (83)
T d2i9aa2 80 HDCA 83 (83)
T ss_dssp EECC
T ss_pred CcCc
Confidence 9996
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=9.7e-23 Score=195.37 Aligned_cols=165 Identities=18% Similarity=0.182 Sum_probs=119.0
Q ss_pred eEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEcccccc-----------------HHHHHHHHHHHHHHhhCCCCcc
Q psy5539 368 IYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEAS-----------------EYLQTDFEREACLLAEFDHPNI 430 (653)
Q Consensus 368 ~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~-----------------~~~~~~f~~Ei~il~~l~HpnI 430 (653)
.+.+.||+|+||+||+|++. +++.||||+++.... ......+.+|...+.++.|.++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v 76 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAV 76 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSS
T ss_pred hhCCEeeeCcceEEEEEECC------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCc
Confidence 46788999999999999862 467899998753211 1223456678999999999999
Q ss_pred ceEEeEEecCCceEEEEeecCCCChHHHHhhcCCCCCcCCCcccccccccCCCCCCHHHHHHHHHHHHHHHHHhhhCCce
Q psy5539 431 VKLLGVCAVGKPMCLLFEYMGRGDLNDFLRICSPNNYINGTYSSMESSIHRVPQLSTCDLITIALQIASGMVYLSDRKFV 510 (653)
Q Consensus 431 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~iv 510 (653)
+..+++. ..+++|||++++.+.+ ++......++.|++.+|.|||+++|+
T Consensus 77 ~~~~~~~----~~~lvme~~~~~~~~~---------------------------l~~~~~~~i~~ql~~~l~~lH~~gii 125 (191)
T d1zara2 77 PKVYAWE----GNAVLMELIDAKELYR---------------------------VRVENPDEVLDMILEEVAKFYHRGIV 125 (191)
T ss_dssp CCEEEEE----TTEEEEECCCCEEGGG---------------------------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred ceEEEec----CCEEEEEeeccccccc---------------------------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence 9988663 2479999998754422 23344568999999999999999999
Q ss_pred ecCCCCCCEeEcCCCcEEEeccCccccccccccccCCCCCCCcccccc--ch---hhccCCCCCchhHHHHHHHH
Q psy5539 511 HRDLATRNCLINDQMVVKIADFGLSRKMYLQDYYKGDENDAIPVRWMP--LE---SILYNKYTVESDVWAFGVCL 580 (653)
Q Consensus 511 HrDLkp~NILl~~~~~vkI~DfGla~~~~~~~~~~~~~~~~~t~~y~a--PE---~~~~~~~t~ksDVwSlGvvl 580 (653)
||||||+|||+++++ ++|+|||+|........ ..|.. .+ .....+|+.++|+||..--+
T Consensus 126 HrDiKP~NILv~~~~-~~liDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 126 HGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CSCCSTTSEEEETTE-EEECCCTTCEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EccCChhheeeeCCC-EEEEECCCcccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999999999765 88999999965421110 01111 00 11245788999999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.27 E-value=1.6e-06 Score=84.53 Aligned_cols=85 Identities=16% Similarity=0.063 Sum_probs=57.7
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCC-CCccceEEeEEecCCceE
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFD-HPNIVKLLGVCAVGKPMC 444 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~-HpnIv~l~g~~~~~~~~~ 444 (653)
.++.++..+.++.+.||+... ++..+++|+....... ....+.+|...+..+. +--+.+++.+...++..+
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~-------~~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVG-------ENENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEEC-------SSCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred ceEEEEcCCCCCCCcEEEEEe-------CCCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 456666655566679998863 2345778877543221 1224677888877764 333567788888888899
Q ss_pred EEEeecCCCChHHH
Q psy5539 445 LLFEYMGRGDLNDF 458 (653)
Q Consensus 445 LV~Ey~~~gsL~~~ 458 (653)
+|||++++.++.+.
T Consensus 87 lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 87 LLMSEADGVLCSEE 100 (263)
T ss_dssp EEEECCSSEEHHHH
T ss_pred EEEEeccccccccc
Confidence 99999999877543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.77 E-value=4.3e-05 Score=73.56 Aligned_cols=74 Identities=22% Similarity=0.137 Sum_probs=50.3
Q ss_pred ecccC-CeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCC--CccceEEeEEecCCceEEEEee
Q psy5539 373 LGQGA-FGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDH--PNIVKLLGVCAVGKPMCLLFEY 449 (653)
Q Consensus 373 LG~G~-fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~H--pnIv~l~g~~~~~~~~~LV~Ey 449 (653)
+..|. -+.||+.... .+..+++|....... ..+.+|+..++.+.. -.+.+++++...++..++||||
T Consensus 18 ~~~G~s~~~v~r~~~~------~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~ 87 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ------GRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 87 (255)
T ss_dssp CSCTTSSCEEEEEECT------TSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred cCCcccCCeEEEEEeC------CCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence 44444 3679998753 234588888765432 246677777776643 3356778888888889999999
Q ss_pred cCCCChH
Q psy5539 450 MGRGDLN 456 (653)
Q Consensus 450 ~~~gsL~ 456 (653)
+++.++.
T Consensus 88 i~G~~~~ 94 (255)
T d1nd4a_ 88 VPGQDLL 94 (255)
T ss_dssp CSSEETT
T ss_pred eeccccc
Confidence 9876553
|
| >d1ijya_ a.141.1.1 (A:) Frizzled 8 (FZ8) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Frizzled cysteine-rich domain superfamily: Frizzled cysteine-rich domain family: Frizzled cysteine-rich domain domain: Frizzled 8 (FZ8) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.68 E-value=1.3e-05 Score=68.65 Aligned_cols=86 Identities=17% Similarity=0.422 Sum_probs=58.5
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHH--HHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMA--LWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPM 110 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~--~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~ 110 (653)
.-|++-+-..|+. |..+ .++|..... ...++| .... .|..+ +...|++.+..+||.-+||.|.+.+..+
T Consensus 2 ~~C~pi~~~~C~~-l~Yn-~T~~PN~~~--h~~~~e-~~~~~~~~~~l---~~~~C~~~l~~flCs~~~P~C~~~~~~~- 72 (122)
T d1ijya_ 2 LACQEITVPLCKG-IGYE-YTYMPNQFN--HDTQDE-AGLEVHQFWPL---VEIQCSPDLKFFLCSMYTPICLEDYKKP- 72 (122)
T ss_dssp CCCEECCCGGGTT-SSCC-EECSSCTTC--CCSHHH-HHHHHGGGHHH---HHHTSCTTHHHHHHHHHSCBCCSSCCSC-
T ss_pred CeeeecChhhhCC-CCCC-ceECcCccc--CcCHHH-HHHHHHHHhhh---hccccCHhHHHHHhhhccCcccCCCCCc-
Confidence 4688989999987 6654 455554432 112222 2222 24445 4458999999999999999997655433
Q ss_pred CCCcccchhhhhhhccchh
Q psy5539 111 SLPLCYEDCIAVRYSFCYN 129 (653)
Q Consensus 111 ~~p~C~~~c~~~~~~~c~~ 129 (653)
.+-||..|+.++.. |..
T Consensus 73 -~~PCrs~Ceev~~~-C~~ 89 (122)
T d1ijya_ 73 -LPPCRSVCERAKAG-CAP 89 (122)
T ss_dssp -CCBCHHHHHHHHHH-HHH
T ss_pred -cCccHHHHHHHHhh-hHH
Confidence 67799999999955 843
|
| >d1ijxa_ a.141.1.1 (A:) Secreted Frizzled-related protein 3 (SFRP-3;fzb) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: Frizzled cysteine-rich domain superfamily: Frizzled cysteine-rich domain family: Frizzled cysteine-rich domain domain: Secreted Frizzled-related protein 3 (SFRP-3;fzb) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.46 E-value=3.4e-05 Score=66.29 Aligned_cols=88 Identities=18% Similarity=0.370 Sum_probs=59.1
Q ss_pred CccccCccchhhhhhcCCCeEEEcCCCcCCcccHHHHHHHHHHHHHHHhhccccHHHHHHhhhhhcCCCCCCCCCCCCCC
Q psy5539 33 GYCSQYNGKICKNYLNRTGRVWFNSSLESAGGDLNEQIVMALWKEMIAILANPCKQAAEKLLCTYAFPQCVTSNGIPMSL 112 (653)
Q Consensus 33 g~c~~y~g~~c~~~l~~~~~v~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~C~~~a~~~lC~~~f~~c~~~~~~~~~~ 112 (653)
|.|++-+-..|+. |..+ .++|..... ...++.+.+.+ ..+...+...|++....++|.-+||.|...+. ..+.
T Consensus 1 ~~C~pi~~~~C~~-l~Yn-~T~~PN~~g---h~~~~e~~~~~-~~~~~l~~~~C~p~~~~flCs~~~P~C~~~~~-~~~~ 73 (125)
T d1ijxa_ 1 AACEPVRIPLCKS-LPWE-MTKMPNHLH---HSTQANAILAM-EQFEGLLGTHCSPDLLFFLCAMYAPICTIDFQ-HEPI 73 (125)
T ss_dssp CCCEECCCGGGGG-SSCC-EECSSCTTC---CSSHHHHHHHH-HTTHHHHTTTCCTTHHHHHHHHHSCBCBSSCS-SSCC
T ss_pred CcCccCCcchhcC-CCCC-ceECcCcCC---CcCHHHHHHHH-HHHHHHhhcccCHHHHHHHHHhhCCCccCCCC-CccC
Confidence 5799999999988 6654 566654432 12233333333 33323355689999999999999999976443 2345
Q ss_pred Ccccchhhhhhhccch
Q psy5539 113 PLCYEDCIAVRYSFCY 128 (653)
Q Consensus 113 p~C~~~c~~~~~~~c~ 128 (653)
+-||..|+.++.. |.
T Consensus 74 ~PCrs~Ce~v~~~-C~ 88 (125)
T d1ijxa_ 74 KPCKSVCERARQG-CE 88 (125)
T ss_dssp CBCHHHHHHHHHH-HH
T ss_pred CcCHHHHHHHHhh-hH
Confidence 5599999999844 74
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.31 E-value=0.00027 Score=72.86 Aligned_cols=78 Identities=14% Similarity=0.108 Sum_probs=46.8
Q ss_pred EeeecccCCeeEEEEEeCCCCCCccceEEEEEEccccc------cHHHHHHHHHHHHHHhhCC-C--CccceEEeEEecC
Q psy5539 370 VRDLGQGAFGRVFQAKAPGLLKHEEFTLVAVKMLKDEA------SEYLQTDFEREACLLAEFD-H--PNIVKLLGVCAVG 440 (653)
Q Consensus 370 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~------~~~~~~~f~~Ei~il~~l~-H--pnIv~l~g~~~~~ 440 (653)
.+.||.|....||+++.. ..++.++||.-.... ......+...|.+.|+.+. + ..+.+++.+ +.
T Consensus 31 ~~eig~G~~N~vfrV~~~-----~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~ 103 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQ-----EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DT 103 (392)
T ss_dssp EEECCSSSSEEEEEEEC---------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ET
T ss_pred EEEeCCCceEeEEEEEeC-----CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cC
Confidence 556899999999999753 234678888643211 0001123456777776652 2 345566654 44
Q ss_pred CceEEEEeecCCCC
Q psy5539 441 KPMCLLFEYMGRGD 454 (653)
Q Consensus 441 ~~~~LV~Ey~~~gs 454 (653)
+..++|||++++..
T Consensus 104 ~~~~lvmE~L~~~~ 117 (392)
T d2pula1 104 EMAVTVMEDLSHLK 117 (392)
T ss_dssp TTTEEEECCCTTSE
T ss_pred CCCEEEEeccCCcc
Confidence 56689999997654
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.07 E-value=0.013 Score=59.65 Aligned_cols=82 Identities=16% Similarity=0.258 Sum_probs=51.2
Q ss_pred CeeEEeeecccCCeeEEEEEeCCCCC--CccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCccc-eEEeEEecCCc
Q psy5539 366 DIIYVRDLGQGAFGRVFQAKAPGLLK--HEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNIV-KLLGVCAVGKP 442 (653)
Q Consensus 366 ~~~~~~~LG~G~fG~Vy~a~~~~~~~--~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnIv-~l~g~~~~~~~ 442 (653)
+++ ++.|+.|--=.+|+++.+.... ......|.+++....... .+..+|..+++.+.-.++. ++++++..
T Consensus 44 ~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~--- 116 (395)
T d1nw1a_ 44 HLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE---SHLVAESVIFTLLSERHLGPKLYGIFSG--- 116 (395)
T ss_dssp GEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT---
T ss_pred ceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC---
Confidence 444 4568888889999998753211 123345777766532221 2456788888887533444 77777643
Q ss_pred eEEEEeecCCCCh
Q psy5539 443 MCLLFEYMGRGDL 455 (653)
Q Consensus 443 ~~LV~Ey~~~gsL 455 (653)
.+|+||+++..|
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 689999987544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.92 E-value=0.0089 Score=59.28 Aligned_cols=69 Identities=14% Similarity=0.145 Sum_probs=42.3
Q ss_pred CeeEEEEEeCCCCCCccceEEEEEEccccccHHHHHHHHHHHHHHhhCCCCcc--ceEEe-----EEecCCceEEEEeec
Q psy5539 378 FGRVFQAKAPGLLKHEEFTLVAVKMLKDEASEYLQTDFEREACLLAEFDHPNI--VKLLG-----VCAVGKPMCLLFEYM 450 (653)
Q Consensus 378 fG~Vy~a~~~~~~~~~~~~~VAVK~l~~~~~~~~~~~f~~Ei~il~~l~HpnI--v~l~g-----~~~~~~~~~LV~Ey~ 450 (653)
--.||+++. .++..+++|+.+.+... .+++..|...+..|....+ +..+. ....++..+.+++++
T Consensus 35 EN~vy~v~~------~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~ 106 (325)
T d1zyla1 35 ENRVYQFQD------EDRRRFVVKFYRPERWT--ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 106 (325)
T ss_dssp SSEEEEECC------TTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred cceeEEEEc------CCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence 358999875 35677999998765321 2456778888777742222 11111 123456678899998
Q ss_pred CCCC
Q psy5539 451 GRGD 454 (653)
Q Consensus 451 ~~gs 454 (653)
+|..
T Consensus 107 ~G~~ 110 (325)
T d1zyla1 107 GGRQ 110 (325)
T ss_dssp CCEE
T ss_pred CCcC
Confidence 7643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=93.49 E-value=0.4 Score=46.17 Aligned_cols=31 Identities=19% Similarity=0.291 Sum_probs=27.8
Q ss_pred CCceecCCCCCCEeEcCCCcEEEeccCcccc
Q psy5539 507 RKFVHRDLATRNCLINDQMVVKIADFGLSRK 537 (653)
Q Consensus 507 ~~ivHrDLkp~NILl~~~~~vkI~DfGla~~ 537 (653)
.++||+|+.++||+++++...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 3799999999999999998889999999853
|